archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00011241,1.537,1.2608,1,1
1,GO BLEB ASSEMBLY,7.5427e-07,1.4154,1.3489,1,1
1,GO MEMBRANE RAFT ASSEMBLY,4.4712e-06,1.2358,1.5163,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00021167,1.2056,0.95503,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,9.8628e-07,1.1754,1.0451,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.547e-05,1.1571,1.0689,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.3441e-06,1.1242,0.91694,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.2308e-06,1.1203,0.98856,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.2308e-06,1.1023,0.88733,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.4268e-07,1.0912,0.96573,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.7343e-05,1.0659,1.0305,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.0571e-06,1.0451,0.84663,1,1
1,GO NEUTROPHIL HOMEOSTASIS,6.8936e-07,1.0348,0.95632,1,1
1,GO HYALURONAN CATABOLIC PROCESS,8.8325e-08,1.0272,1.0677,1,1
1,GO RESPONSE TO INTERFERON BETA,5.2837e-06,1.0058,0.95522,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,6.8936e-07,1.005,0.97272,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,6.6003e-08,0.99651,0.93643,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,9.0179e-06,0.97374,0.88506,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.0833e-05,0.96933,0.86163,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,5.9841e-06,0.92892,0.81475,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.0184e-05,0.92141,0.85013,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,2.2524e-05,0.9193,0.83878,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.9532e-05,0.91599,0.76443,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.8251e-06,0.90962,0.8913,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,6.8936e-07,0.90337,0.8783,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,8.2505e-07,0.89939,0.9415,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.0311e-06,0.89792,0.86043,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0833e-05,0.89618,0.8202,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.4039e-05,0.88685,0.90152,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00017796,0.88164,0.67859,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.1964e-05,0.87587,1.0178,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.0311e-06,0.8661,0.79589,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,8.2505e-07,0.86521,0.73738,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.725e-07,0.86182,0.85373,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,5.6999e-08,0.85508,0.86054,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,4.3218e-05,0.84298,0.69293,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.906e-06,0.84221,0.79432,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,1.4963e-07,0.83936,0.88264,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,8.628e-07,0.83891,0.79643,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.7955e-07,0.83422,0.76919,1,1
1,GO CD40 SIGNALING PATHWAY,2.6322e-07,0.82693,0.75279,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,6.5896e-07,0.82175,0.75757,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,8.628e-07,0.81759,0.9393,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0001547,0.81247,0.80749,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,0.80802,0.65228,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.7118e-05,0.80747,0.79519,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,3.7791e-06,0.80446,0.61049,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,4.4712e-06,0.80137,0.63953,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.2366e-07,0.79893,0.77862,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.4609e-05,0.78483,0.71869,1,1
1,GO BONE TRABECULA FORMATION,0.0013872,0.77688,0.68728,1,1
1,GO CYSTEINE METABOLIC PROCESS,9.0179e-06,0.77326,0.70772,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,9.7801e-06,0.77167,0.65368,1,1
1,GO HEMIDESMOSOME ASSEMBLY,8.7323e-05,0.7686,0.96727,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.9263e-05,0.76795,0.76236,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,9.0551e-05,0.76685,0.59459,1,1
1,GO MEMBRANE RAFT ORGANIZATION,3.4728e-06,0.76502,0.90504,1,1
1,GO ENDODERM FORMATION,1.9873e-07,0.76452,0.7813,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,5.0226e-05,0.75597,0.61585,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.3916e-06,0.75467,0.60584,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.4039e-05,0.75269,0.81062,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,3.6228e-06,0.74902,0.79816,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,3.3287e-06,0.74535,0.69776,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.0198e-07,0.74381,0.73628,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00032948,0.74124,0.68579,1,1
1,GO EPIBOLY,8.2505e-07,0.73565,0.74625,1,1
1,GO FIBRINOLYSIS,4.5813e-07,0.73217,0.84192,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.5774e-06,0.73207,0.72211,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,1.071e-07,0.72741,0.70426,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,6.5896e-07,0.72416,0.70257,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.4728e-06,0.71898,0.62269,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.4205e-05,0.71653,0.54698,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,9.3916e-06,0.71488,0.59952,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.1237e-07,0.7087,0.76602,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.3763e-07,0.70559,0.65939,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.9263e-05,0.7019,0.62981,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.1267e-06,0.69998,0.66072,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.2879e-07,0.69817,0.63569,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,3.0689e-05,0.69677,0.5846,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00026903,0.69422,0.59941,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.0833e-05,0.69285,0.65659,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.7578e-07,0.69195,0.65986,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,5.4977e-07,0.6903,0.68842,1,1
1,GO VASCULOGENESIS,2.8891e-07,0.68204,0.60772,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.9926e-07,0.67903,0.82883,1,1
1,GO ZYMOGEN INHIBITION,9.8628e-07,0.67684,0.76927,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,4.2876e-06,0.67397,0.58869,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.2876e-06,0.66972,0.61669,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,5.2533e-07,0.66879,0.67063,1,1
1,GO MUCUS SECRETION,0.0010206,0.66378,0.54299,1,1
1,GO LATERAL MESODERM DEVELOPMENT,0.00013433,0.6614,0.51919,1,1
1,GO GAP JUNCTION ASSEMBLY,1.906e-06,0.65852,0.64444,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.906e-06,0.65837,0.64209,1,1
1,GO T CELL EXTRAVASATION,7.9801e-06,0.65778,0.67023,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00079435,0.65408,0.59279,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.4609e-05,0.65247,0.63607,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00021167,0.65225,0.43711,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.3418e-05,0.64875,0.58355,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00019079,0.64754,0.61095,1,1
1,GO APOPTOTIC CELL CLEARANCE,1.9873e-07,0.64512,0.6998,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,2.2658e-06,0.64417,0.57289,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.4772e-07,0.64148,0.62079,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,5.2837e-06,0.64011,0.58999,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.6015e-06,0.64007,0.63919,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00047456,0.63816,0.57281,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,4.6597e-05,0.63785,0.69186,1,1
1,GO CYTOLYSIS,6.5896e-07,0.63631,0.52563,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016595,0.6359,0.61335,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,8.3127e-06,0.6355,0.55588,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00011241,0.63336,0.52638,1,1
1,GO PLASMINOGEN ACTIVATION,0.00012074,0.632,0.59402,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.2658e-06,0.63149,0.72703,1,1
1,GO PIGMENT GRANULE MATURATION,5.8301e-05,0.63062,0.45628,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00016595,0.63061,0.60135,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.7413e-06,0.62864,0.5387,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,5.0683e-06,0.6273,0.62028,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,5.9841e-06,0.62689,0.54878,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,4.5813e-07,0.6261,0.58698,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00021909,0.62305,0.4791,1,1
1,GO AMYLOID BETA CLEARANCE,8.8325e-08,0.61524,0.54771,1,1
1,GO ENDODERM DEVELOPMENT,5.2533e-07,0.61414,0.62754,1,1
1,GO VAGINA DEVELOPMENT,1.8251e-06,0.61256,0.63281,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,3.3132e-05,0.61217,0.5207,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.0604e-05,0.61142,0.69842,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0011199,0.60891,0.68414,1,1
1,GO SNRNA PROCESSING,0.0014299,0.60744,0.61019,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,3.9418e-06,0.60598,0.65011,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.1493e-05,0.60518,0.44499,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.0571e-06,0.60394,0.54883,1,1
1,GO DNA DEAMINATION,0.00017796,0.60388,0.54412,1,1
1,GO HIPPO SIGNALING,4.0073e-05,0.60314,0.52158,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,4.1617e-05,0.60059,0.45143,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.6015e-06,0.60033,0.58713,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.6623e-06,0.60007,0.60259,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00038934,0.59872,0.59526,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.071e-07,0.59871,0.52846,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0017641,0.59711,0.44239,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,7.3528e-06,0.59621,0.4713,1,1
1,GO LIVER REGENERATION,7.2756e-08,0.59611,0.58887,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,3.4728e-06,0.59505,0.62581,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0015653,0.59432,0.41219,1,1
1,GO HEME METABOLIC PROCESS,8.628e-07,0.59409,0.5417,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0017123,0.59369,0.71293,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,0.00010092,0.59323,0.52915,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,1.1493e-05,0.59277,0.52879,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.2111e-07,0.59276,0.57948,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,9.3916e-06,0.59215,0.56794,1,1
1,GO CELLULAR RESPONSE TO IRON ION,2.1663e-05,0.59125,0.52586,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2454e-05,0.59078,0.51763,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,1.104e-05,0.58993,0.54238,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7791e-06,0.58951,0.60575,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,2.0033e-05,0.5891,0.54928,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.5331e-06,0.58654,0.63837,1,1
1,GO VASCULAR TRANSPORT,0.00040247,0.58499,0.60959,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,3.4728e-06,0.58346,0.51086,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0001165,0.58306,0.53845,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.547e-05,0.58261,0.48879,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00044439,0.58163,0.50904,1,1
1,GO NOTOCHORD DEVELOPMENT,4.4712e-06,0.58159,0.62701,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.011904,0.58136,0.47177,1,1
1,GO MACROPHAGE PROLIFERATION,2.9532e-05,0.57999,0.57871,1,1
1,GO GERMINAL CENTER FORMATION,7.8282e-05,0.5783,0.49181,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,8.628e-07,0.57664,0.56484,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.57606,0.61619,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.00028792,0.57588,0.6732,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,7.6603e-06,0.5743,0.4517,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.3441e-06,0.57329,0.58982,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,2.9301e-06,0.57042,0.78019,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.7145e-05,0.56884,0.44019,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00011241,0.5673,0.55614,1,1
1,GO SALIVARY GLAND DEVELOPMENT,9.3916e-06,0.56562,0.57411,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.4994e-06,0.56519,0.48699,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,7.6603e-06,0.56348,0.58536,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0001165,0.56287,0.48441,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,2.6322e-07,0.5619,0.60744,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0073363,0.55977,0.4192,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.8077e-06,0.55959,0.50285,1,1
1,GO REGULATION OF PINOCYTOSIS,8.1192e-05,0.55809,0.59329,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.047551,0.55357,0.3317,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.906e-06,0.55258,0.48156,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00036427,0.5513,0.44875,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00010845,0.5513,0.55142,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.6015e-06,0.55084,0.57227,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00019079,0.5507,0.44553,1,1
1,GO TYPE 2 IMMUNE RESPONSE,1.6455e-05,0.5506,0.52926,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,1.4674e-06,0.5505,0.53454,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00037661,0.54938,0.66246,1,1
1,GO OLIGOPEPTIDE TRANSPORT,4.6597e-05,0.54807,0.58807,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.3287e-06,0.54645,0.50099,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0027346,0.54596,0.47813,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.8521e-05,0.54574,0.57904,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00017796,0.54443,0.47833,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.00084609,0.54281,0.39211,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0014738,0.54243,0.41268,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,6.2367e-06,0.53952,0.49564,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4878e-05,0.53714,0.47846,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4609e-05,0.53683,0.50142,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.8891e-07,0.53474,0.5653,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,6.5149e-05,0.53468,0.59405,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,8.3127e-06,0.53405,0.60437,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.9532e-05,0.53243,0.53651,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.1192e-05,0.53094,0.50812,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00026903,0.53002,0.4861,1,1
1,GO BLOOD VESSEL REMODELING,1.4039e-05,0.52826,0.45572,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.8301e-05,0.5282,0.56509,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.0311e-06,0.52641,0.5637,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,2.4692e-06,0.52558,0.45121,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00074557,0.52543,0.41595,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.5122e-07,0.52369,0.48616,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.0779e-06,0.52137,0.49501,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00013917,0.52118,0.45354,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.6307e-05,0.52103,0.45467,1,1
1,GO RESPONSE TO X RAY,1.7474e-06,0.51835,0.48479,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00022676,0.51653,0.52593,1,1
1,GO RESPONSE TO ANGIOTENSIN,4.5813e-07,0.51612,0.49285,1,1
1,GO CELLULAR RESPONSE TO DSRNA,7.889e-07,0.51519,0.54181,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00044439,0.51399,0.4838,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,2.0784e-06,0.51344,0.44181,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.1904e-06,0.51198,0.61663,1,1
1,GO CERAMIDE CATABOLIC PROCESS,3.0689e-05,0.51182,0.41253,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,8.6584e-06,0.51169,0.42884,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00055855,0.51114,0.39945,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00026903,0.51094,0.41409,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.030383,0.51089,0.27329,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,4.1617e-05,0.51052,0.48797,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00011241,0.50936,0.49799,1,1
1,GO REGULATION OF MYOBLAST FUSION,0.0001547,0.50823,0.52942,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00055855,0.50777,0.54666,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,4.1802e-07,0.50775,0.53009,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,2.1831e-07,0.50662,0.58609,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00044439,0.50574,0.46614,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,7.2754e-05,0.5042,0.52851,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.010773,0.50407,0.30699,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.5813e-07,0.50241,0.4823,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,5.4977e-07,0.50231,0.48178,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.8084e-07,0.50054,0.48803,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.2505e-07,0.49918,0.49475,1,1
1,GO PEPTIDE CROSS LINKING,0.00010462,0.49844,0.4696,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.6452e-07,0.49828,0.50718,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.8958e-07,0.49818,0.49215,1,1
1,GO NCRNA 3 END PROCESSING,0.011326,0.49751,0.39701,1,1
1,GO SNRNA METABOLIC PROCESS,0.00050664,0.49715,0.49267,1,1
1,GO LYMPHANGIOGENESIS,4.8612e-06,0.49659,0.46652,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.6902e-06,0.49539,0.42828,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0010528,0.49536,0.42819,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,4.2876e-06,0.49519,0.53925,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.0033e-05,0.49238,0.43112,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,2.8077e-06,0.49232,0.55277,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.0184e-05,0.492,0.43273,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,9.389e-05,0.49198,0.43036,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00063551,0.49094,0.4742,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.8891e-07,0.49069,0.48807,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00057693,0.49024,0.43283,1,1
1,GO ENTRY INTO HOST,1.2308e-06,0.4882,0.54455,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,7.9801e-06,0.48819,0.40833,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00023468,0.48593,0.46465,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0013457,0.48586,0.37887,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,6.5896e-07,0.48568,0.46434,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,5.753e-07,0.48462,0.48376,1,1
1,GO BIOLOGICAL PHASE,0.0016129,0.48375,0.47289,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0001165,0.48285,0.39629,1,1
1,GO PROTEIN OXIDATION,0.0021062,0.48177,0.44301,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,7.5427e-07,0.48147,0.49939,1,1
1,GO TOLERANCE INDUCTION,0.00054072,0.4814,0.44512,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.9841e-06,0.48118,0.49495,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,2.7343e-05,0.48075,0.43882,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.00029782,0.48075,0.46732,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0041716,0.47847,0.34278,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0028141,0.47736,0.39927,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,7.547e-05,0.47731,0.48538,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00042998,0.47719,0.58203,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.1237e-07,0.4766,0.42098,1,1
1,GO LEUKOCYTE AGGREGATION,0.0017123,0.47612,0.50773,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0028141,0.47559,0.36338,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,2.1702e-06,0.47554,0.37848,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.6902e-06,0.47487,0.4906,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9263e-05,0.47429,0.42041,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00024286,0.47378,0.44706,1,1
1,GO HYALURONAN METABOLIC PROCESS,3.6414e-07,0.47297,0.50332,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.2876e-06,0.47292,0.65896,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.1663e-05,0.47181,0.45684,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.3916e-06,0.47118,0.39525,1,1
1,GO REGULATION OF TRANSPOSITION,0.00067758,0.47114,0.4247,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,1.104e-05,0.47006,0.44936,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.001662,0.46949,0.4101,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.508e-06,0.4693,0.50794,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,5.2139e-05,0.46878,0.38492,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.7145e-05,0.46805,0.43633,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,7.2754e-05,0.46771,0.45471,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0030654,0.46719,0.41668,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,3.9418e-06,0.46564,0.6276,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.5201e-05,0.46553,0.47111,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00072223,0.46486,0.42236,1,1
1,GO RESPONSE TO HYPEROXIA,0.00017186,0.4646,0.45097,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.7413e-06,0.46434,0.44191,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,1.7806e-05,0.46419,0.46842,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.7343e-05,0.46346,0.49951,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00098941,0.46336,0.4039,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,5.508e-06,0.46301,0.65301,1,1
1,GO PROTEIN ACTIVATION CASCADE,2.9301e-06,0.46284,0.48885,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.00013433,0.46245,0.41804,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.011612,0.46232,0.34341,1,1
1,GO VIRAL RNA GENOME REPLICATION,2.4692e-06,0.46228,0.40926,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.4609e-05,0.46103,0.58362,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.9926e-07,0.46054,0.51588,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,1.8521e-05,0.46005,0.47417,1,1
1,GO REGULATION OF MRNA BINDING,5.8301e-05,0.45842,0.3778,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,2.7343e-05,0.45818,0.47404,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00012512,0.45815,0.40308,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.3132e-05,0.45784,0.49634,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,2.2658e-06,0.45774,0.48419,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.1493e-05,0.45741,0.42755,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.8612e-06,0.45695,0.41531,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,7.0571e-06,0.45694,0.44243,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,9.3916e-06,0.45662,0.40273,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,1.906e-06,0.45594,0.4245,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.8077e-06,0.4558,0.44992,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.0576e-06,0.45481,0.38617,1,1
1,GO PROTEASOME ASSEMBLY,3.3132e-05,0.45437,0.34344,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,4.4712e-06,0.45315,0.50815,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00026903,0.453,0.4399,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.0779e-06,0.4525,0.47427,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2308e-06,0.45234,0.47015,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,9.389e-05,0.45187,0.34083,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.8131e-07,0.4502,0.4325,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00026003,0.45014,0.41233,1,1
1,GO ZYMOGEN ACTIVATION,6.2786e-05,0.4498,0.46659,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.9904e-06,0.44963,0.37917,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.2837e-06,0.44934,0.51209,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.7791e-06,0.44908,0.43108,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,4.3763e-07,0.44889,0.44875,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0073363,0.44839,0.35817,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00014418,0.44817,0.37272,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.6455e-05,0.44693,0.39643,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,1.8521e-05,0.44634,0.33629,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,9.0179e-06,0.44429,0.34274,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0001547,0.4436,0.39892,1,1
1,GO ANIMAL ORGAN REGENERATION,2.8891e-07,0.44352,0.49892,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.023741,0.44343,0.38215,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.001986,0.44264,0.34268,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0779e-06,0.44195,0.47215,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0010859,0.44193,0.32697,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,3.6414e-07,0.44172,0.39394,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00022676,0.44142,0.36744,1,1
1,GO PINOCYTOSIS,2.0833e-05,0.44128,0.55129,1,1
1,GO VIRAL TRANSLATION,1.0184e-05,0.44097,0.43034,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.8418e-05,0.44096,0.43973,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00019079,0.43955,0.53118,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.0833e-05,0.43912,0.40917,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.5896e-07,0.43851,0.39324,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.7806e-05,0.43848,0.39092,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00011241,0.43709,0.44855,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,7.889e-07,0.43604,0.47937,1,1
1,GO CYTOKINE METABOLIC PROCESS,5.7413e-06,0.43528,0.38378,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.0311e-06,0.43504,0.59842,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.43425,0.42242,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.7343e-05,0.434,0.45995,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0056288,0.43397,0.30406,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.8418e-05,0.4337,0.41835,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00010092,0.43306,0.39178,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.6729e-06,0.43302,0.39028,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.4205e-05,0.43301,0.44875,1,1
1,GO T CELL MEDIATED IMMUNITY,2.3418e-05,0.43294,0.43132,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016129,0.43223,0.31898,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0039469,0.43152,0.3404,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00011241,0.43024,0.37407,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,9.7346e-05,0.42954,0.3678,1,1
1,GO REGULATION OF STEROL TRANSPORT,5.4977e-07,0.42921,0.38506,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0010859,0.4288,0.38788,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.7474e-06,0.42879,0.41779,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,0.00057693,0.42801,0.44989,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.1888e-05,0.42797,0.31308,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,9.7346e-05,0.42792,0.36368,1,1
1,GO RIBOSOME ASSEMBLY,0.00014935,0.42689,0.38359,1,1
1,GO VIRAL GENOME REPLICATION,9.0551e-05,0.42635,0.38899,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.7955e-07,0.42457,0.53885,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,4.0073e-05,0.42431,0.5105,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.6902e-06,0.42352,0.4317,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017641,0.42316,0.36181,1,1
1,GO RESPONSE TO INTERLEUKIN 12,8.2505e-07,0.42189,0.42007,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.4121e-05,0.42162,0.37435,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,7.0571e-06,0.42144,0.40671,1,1
1,GO IMMATURE T CELL PROLIFERATION,2.6307e-05,0.42026,0.49836,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5813e-07,0.41976,0.37619,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.6623e-06,0.41936,0.45435,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0018173,0.41897,0.34452,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00081984,0.41897,0.41049,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,9.3916e-06,0.4188,0.38159,1,1
1,GO DETECTION OF BIOTIC STIMULUS,2.9532e-05,0.41854,0.43909,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00017796,0.41852,0.35019,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,6.0504e-05,0.41844,0.38278,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0006154,0.41814,0.3531,1,1
1,GO ARGININE METABOLIC PROCESS,0.00010462,0.4181,0.41107,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00074557,0.41809,0.42156,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00063551,0.41768,0.5798,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,9.0179e-06,0.41632,0.42222,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.024288,0.41519,0.26605,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.9926e-07,0.41452,0.41836,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.8379e-05,0.41433,0.45873,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0011199,0.41409,0.46453,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00081984,0.41356,0.41999,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.02268,0.41255,0.42416,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.5759e-05,0.41234,0.37726,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.0264e-07,0.41168,0.36706,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,9.0221e-07,0.41158,0.35183,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.02166,0.41127,0.47968,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.41106,0.33093,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,4.1617e-05,0.41104,0.37512,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.7806e-05,0.41091,0.55035,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.8077e-06,0.41089,0.55163,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,7.6603e-06,0.41081,0.45724,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00040247,0.41069,0.35544,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0015653,0.41068,0.31208,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.104e-05,0.41012,0.39364,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00042998,0.41007,0.58424,1,1
1,GO BONE GROWTH,1.7806e-05,0.40957,0.49196,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,2.9301e-06,0.40911,0.47525,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00081984,0.40881,0.33209,1,1
1,GO PLATELET AGGREGATION,9.7801e-06,0.40867,0.35177,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00022676,0.40834,0.34613,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00016023,0.40829,0.42981,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.6623e-06,0.40786,0.36784,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.4121e-05,0.40756,0.40881,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,3.1888e-05,0.40731,0.41164,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.9904e-06,0.40661,0.45923,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00028792,0.4064,0.45695,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.7801e-06,0.40615,0.40005,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.2837e-06,0.40585,0.37506,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0056288,0.40564,0.29879,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.6455e-05,0.40522,0.47059,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00059588,0.4051,0.34899,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,3.3132e-05,0.40466,0.35495,1,1
1,GO I KAPPAB PHOSPHORYLATION,0.00069957,0.40407,0.25504,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.7791e-06,0.40407,0.4811,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,4.2876e-06,0.40378,0.46616,1,1
1,GO EMBRYO IMPLANTATION,1.8251e-06,0.40352,0.49936,1,1
1,GO RESPONSE TO SALT STRESS,3.6228e-06,0.40292,0.36979,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,7.2754e-05,0.40291,0.3783,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,6.2985e-07,0.40182,0.39726,1,1
1,GO TRANSLATIONAL INITIATION,0.00012512,0.40113,0.34676,1,1
1,GO COPPER ION HOMEOSTASIS,7.013e-05,0.40065,0.43269,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0039469,0.40052,0.40235,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.5331e-06,0.40003,0.35478,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,8.4205e-05,0.39932,0.38771,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00353,0.39848,0.28745,1,1
1,GO RECEPTOR CATABOLIC PROCESS,5.0683e-06,0.39806,0.41105,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,2.6307e-05,0.3978,0.43566,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00054072,0.39738,0.56699,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,5.8301e-05,0.39652,0.36412,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.2308e-06,0.39626,0.42411,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012512,0.39596,0.32744,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0050528,0.39577,0.44972,1,1
1,GO ENAMEL MINERALIZATION,0.0060989,0.3951,0.35062,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.4609e-05,0.39508,0.47439,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.001662,0.39493,0.31427,1,1
1,GO MATURATION OF SSU RRNA,0.00018427,0.39468,0.35995,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00063551,0.39437,0.35727,1,1
1,GO PHAGOCYTOSIS RECOGNITION,9.0551e-05,0.39416,0.53215,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.001662,0.39414,0.30097,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.004408,0.39382,0.34936,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7806e-05,0.39375,0.36255,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.001872,0.39327,0.39788,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00025131,0.39326,0.38694,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,1.2862e-06,0.3928,0.36984,1,1
1,GO PLATELET DEGRANULATION,6.2367e-06,0.39201,0.44332,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.1493e-05,0.39129,0.34242,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6015e-06,0.39081,0.39597,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,8.6584e-06,0.38981,0.33762,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00092958,0.3896,0.43877,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0016129,0.38956,0.44264,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.4772e-07,0.38928,0.36477,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,8.1192e-05,0.38855,0.34552,1,1
1,GO NIK NF KAPPAB SIGNALING,2.8077e-06,0.38828,0.37791,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,7.3528e-06,0.38815,0.34372,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00027832,0.38806,0.33187,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.8521e-05,0.38784,0.37162,1,1
1,GO INTERLEUKIN 1 PRODUCTION,2.6307e-05,0.38763,0.42949,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,2.6307e-05,0.38715,0.40294,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.4609e-05,0.38665,0.37361,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.007729,0.38663,0.26781,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,2.2658e-06,0.38657,0.36238,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0042883,0.38622,0.2631,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.5896e-07,0.38616,0.36261,1,1
1,GO RESPONSE TO ESTROGEN,1.8251e-06,0.38605,0.38527,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.7118e-05,0.38565,0.34917,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.001191,0.38558,0.39717,1,1
1,GO INTERACTION WITH SYMBIONT,1.4609e-05,0.38551,0.3132,1,1
1,GO MUSCLE FILAMENT SLIDING,8.3127e-06,0.38506,0.38801,1,1
1,GO REGULATION OF GASTRULATION,3.8131e-07,0.38483,0.3985,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0019282,0.38462,0.3193,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0031536,0.38451,0.46419,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,0.38394,0.35213,1,1
1,GO ERAD PATHWAY,4.3763e-07,0.3822,0.3356,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00050664,0.3818,0.35294,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.01282,0.38142,0.44127,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0016129,0.3813,0.34476,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.3132e-05,0.38085,0.37999,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00065623,0.38048,0.33666,1,1
1,GO MATURATION OF 5 8S RRNA,0.00054072,0.38036,0.29417,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0022332,0.38035,0.39456,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,5.4121e-05,0.38004,0.3727,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0037331,0.37968,0.29113,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00032948,0.37959,0.40143,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,3.7145e-05,0.37932,0.35011,1,1
1,GO MRNA TRANSCRIPTION,1.7806e-05,0.37828,0.37027,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,4.8612e-06,0.37824,0.32762,1,1
1,GO TRACHEA MORPHOGENESIS,0.001228,0.37823,0.28537,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,1.2454e-05,0.37795,0.32154,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.2658e-06,0.37791,0.45673,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,9.7801e-06,0.37751,0.41373,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.5308e-05,0.37681,0.39881,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.004408,0.37671,0.39976,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.4334e-07,0.37668,0.41834,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,0.00017186,0.37616,0.39524,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00023468,0.37615,0.3754,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00098941,0.37609,0.31495,1,1
1,GO VIRAL LIFE CYCLE,4.1112e-06,0.37592,0.37706,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00052342,0.37505,0.28395,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,6.7596e-05,0.37455,0.40034,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,8.6584e-06,0.37454,0.30846,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,4.1112e-06,0.37434,0.3106,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,2.9532e-05,0.37424,0.32414,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0062634,0.37378,0.29908,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00063551,0.37329,0.28967,1,1
1,GO B CELL MEDIATED IMMUNITY,3.6228e-06,0.37314,0.34566,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.2139e-05,0.37214,0.32511,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0022992,0.3718,0.31992,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.2366e-07,0.37145,0.36907,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.7145e-05,0.37105,0.57021,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.038561,0.37062,0.21752,1,1
1,GO INTERLEUKIN 17 PRODUCTION,5.2837e-06,0.37025,0.45293,1,1
1,GO PROTEIN DEGLYCOSYLATION,6.2786e-05,0.36992,0.36676,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.4039e-05,0.36944,0.40058,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,4.3218e-05,0.36943,0.34803,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00037661,0.36934,0.42686,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,3.3287e-06,0.36899,0.44836,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0022332,0.36879,0.2984,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010859,0.36839,0.3766,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0031536,0.36793,0.27519,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.7145e-05,0.3679,0.31367,1,1
1,GO FOREGUT MORPHOGENESIS,2.1663e-05,0.36774,0.42836,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00026903,0.36747,0.32269,1,1
1,GO MEMBRANE INVAGINATION,2.7578e-07,0.36711,0.3797,1,1
1,GO VIRAL GENE EXPRESSION,5.6174e-05,0.36689,0.35832,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.36683,0.4031,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00031859,0.36675,0.29582,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00012964,0.36654,0.36218,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0012662,0.36646,0.31732,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00049035,0.36612,0.34316,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.3916e-06,0.36579,0.41093,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.00023468,0.36535,0.38754,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,6.0504e-05,0.36524,0.34463,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00047456,0.36523,0.35379,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,7.547e-05,0.36486,0.36554,1,1
1,GO REGULATION OF COAGULATION,2.2524e-05,0.3648,0.41692,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.014138,0.36446,0.24899,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,0.00011241,0.36424,0.42569,1,1
1,GO INTERFERON BETA PRODUCTION,0.00098941,0.36403,0.25876,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,2.0033e-05,0.36381,0.41762,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,2.4346e-05,0.3636,0.31759,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,7.8282e-05,0.3634,0.46777,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.6623e-06,0.36329,0.47993,1,1
1,GO EOSINOPHIL MIGRATION,0.0020453,0.36287,0.39334,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.038561,0.36277,0.36805,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00057693,0.36221,0.29613,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00063551,0.36215,0.39509,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,6.5149e-05,0.36169,0.35785,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.4421e-05,0.36163,0.32911,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.00030804,0.36159,0.33424,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00040247,0.36122,0.45759,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0025083,0.36107,0.39992,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00010462,0.36098,0.35786,1,1
1,GO MEMBRANE DISASSEMBLY,0.00081984,0.36097,0.28046,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011326,0.36038,0.22668,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0050528,0.36023,0.28442,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013433,0.36021,0.3424,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00098941,0.36016,0.33777,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00045924,0.35941,0.28838,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00035231,0.3591,0.33544,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,6.0504e-05,0.35868,0.31711,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.35858,0.35493,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,0.0028141,0.35804,0.30273,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00038934,0.35803,0.39665,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00024286,0.35799,0.26362,1,1
1,GO COMPLEMENT ACTIVATION,1.9904e-06,0.35716,0.33147,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,4.6597e-05,0.35696,0.29767,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,6.4994e-06,0.35555,0.36526,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0059384,0.35551,0.38726,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,3.7791e-06,0.35539,0.37605,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,8.4205e-05,0.35492,0.38537,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0029794,0.3548,0.43176,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8418e-05,0.35458,0.29481,1,1
1,GO CELL REDOX HOMEOSTASIS,7.0571e-06,0.35446,0.31273,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.7806e-05,0.35382,0.38829,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.4878e-05,0.35382,0.36658,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0081404,0.35323,0.27821,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.0504e-05,0.35295,0.32595,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,5.9841e-06,0.35225,0.31952,1,1
1,GO INTERACTION WITH HOST,3.4728e-06,0.35211,0.38531,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0014299,0.35206,0.3438,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.2837e-06,0.35194,0.40041,1,1
1,GO PEPTIDE CATABOLIC PROCESS,2.2658e-06,0.3514,0.33042,1,1
1,GO PIGMENT ACCUMULATION,0.00017186,0.35138,0.30007,1,1
1,GO RESPONSE TO MANGANESE ION,5.6174e-05,0.35094,0.31756,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00040247,0.35092,0.32178,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,8.3127e-06,0.35072,0.35452,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.1964e-05,0.35064,0.3842,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.001662,0.35002,0.3871,1,1
1,GO STEROL IMPORT,0.00014935,0.34946,0.48474,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00040247,0.3493,0.35453,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.4121e-05,0.34914,0.42489,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00016023,0.34882,0.31859,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.8521e-05,0.34857,0.45195,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2139e-05,0.34844,0.37431,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,7.8282e-05,0.34756,0.27125,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.033894,0.34753,0.24139,1,1
1,GO DEFENSE RESPONSE TO VIRUS,0.00018427,0.34722,0.3618,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.00049035,0.34701,0.26388,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0017641,0.34645,0.37603,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00030804,0.34625,0.32705,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00092958,0.346,0.32294,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.027188,0.34586,0.26881,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00041602,0.34569,0.3965,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0001165,0.34546,0.3106,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014138,0.34523,0.26141,1,1
1,GO FIBROBLAST PROLIFERATION,7.2754e-05,0.34473,0.31209,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.029719,0.34465,0.38839,1,1
1,GO T CELL APOPTOTIC PROCESS,1.349e-05,0.34464,0.32233,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.104e-05,0.34461,0.36997,1,1
1,GO NCRNA PROCESSING,8.4205e-05,0.34461,0.28622,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0034322,0.34434,0.25027,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00079435,0.34412,0.31669,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,5.6174e-05,0.34369,0.36476,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,6.5149e-05,0.34364,0.31605,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.7118e-05,0.34358,0.3233,1,1
1,GO INTERLEUKIN 8 PRODUCTION,4.8379e-05,0.34287,0.34114,1,1
1,GO L GLUTAMATE IMPORT,0.00069957,0.34248,0.34083,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0015189,0.3422,0.26861,1,1
1,GO NUCLEOSIDE SALVAGE,0.0075304,0.34187,0.39781,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0013872,0.34158,0.35852,1,1
1,GO GASTRULATION,5.753e-07,0.34155,0.35375,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.00069957,0.34141,0.25457,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.001662,0.34048,0.60189,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.2862e-06,0.34036,0.42252,1,1
1,GO TYPE I INTERFERON PRODUCTION,0.00012964,0.34016,0.29242,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00069957,0.33985,0.28992,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0071468,0.33959,0.27577,1,1
1,GO STEROID ESTERIFICATION,0.015574,0.3394,0.26258,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0014299,0.33884,0.44823,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00024286,0.3383,0.34272,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0012662,0.33799,0.29857,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.6597e-05,0.33793,0.30707,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00079435,0.33769,0.27747,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.001872,0.33762,0.34175,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.8583e-05,0.33751,0.2902,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,1.4609e-05,0.33744,0.28317,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00047456,0.3374,0.29433,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0031536,0.33719,0.29311,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0013054,0.33709,0.29155,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00042998,0.33702,0.37908,1,1
1,GO REGULATION OF LIPASE ACTIVITY,2.0033e-05,0.33699,0.27071,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,2.6307e-05,0.33693,0.31502,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.8418e-05,0.33688,0.36014,1,1
1,GO FIBROBLAST MIGRATION,6.2786e-05,0.33648,0.36292,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00026903,0.33586,0.42069,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.8077e-06,0.33562,0.37146,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00090094,0.33556,0.32385,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.3287e-06,0.33541,0.30406,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.1831e-07,0.33511,0.3177,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.2754e-05,0.33476,0.28537,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,2.9301e-06,0.33466,0.4082,1,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.027803,0.33462,0.21742,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.00021167,0.33426,0.38879,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.0576e-06,0.3341,0.41314,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.0033e-05,0.33349,0.40429,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.046579,0.33342,0.29811,1,1
1,GO DECIDUALIZATION,0.0042883,0.33303,0.39013,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00019753,0.33299,0.34253,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.02068,0.33282,0.33429,1,1
1,GO CELL SUBSTRATE ADHESION,8.3127e-06,0.33236,0.36747,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,9.7801e-06,0.33194,0.38149,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00065623,0.33181,0.3048,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00052342,0.3317,0.37624,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00029782,0.33169,0.31674,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00057693,0.33142,0.24826,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.6307e-05,0.33137,0.44931,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0085714,0.33093,0.24478,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.8583e-05,0.33059,0.28725,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00019753,0.33016,0.31645,1,1
1,GO SPROUTING ANGIOGENESIS,5.6174e-05,0.3294,0.32542,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,3.5759e-05,0.32917,0.29849,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.2658e-06,0.3284,0.3232,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.016339,0.32801,0.42791,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0031536,0.32797,0.30753,1,1
1,GO MESODERM MORPHOGENESIS,4.4712e-06,0.32796,0.33244,1,1
1,GO PIGMENT METABOLIC PROCESS,5.2837e-06,0.32794,0.31617,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0022992,0.32768,0.27284,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.32752,0.30053,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.7806e-05,0.32725,0.37807,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.0226e-05,0.3271,0.37941,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00012074,0.32695,0.25945,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0021062,0.32691,0.34883,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.349e-05,0.32683,0.35903,1,1
1,GO GLIAL CELL ACTIVATION,8.7323e-05,0.32655,0.33759,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,3.6228e-06,0.32641,0.36147,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00032948,0.32625,0.25598,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00079435,0.32567,0.2931,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00028792,0.32549,0.36101,1,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.035393,0.32506,0.18889,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00038934,0.32476,0.27149,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.036164,0.32433,0.2982,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00017186,0.32402,0.28187,1,1
1,GO XENOBIOTIC TRANSPORT,0.00012964,0.32348,0.34371,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00024286,0.32296,0.34319,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,1.1964e-05,0.3221,0.35049,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.025994,0.32175,0.1945,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0087944,0.32174,0.3836,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.001986,0.32125,0.27967,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0001547,0.32093,0.38266,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.2862e-06,0.32031,0.31402,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.104e-05,0.32021,0.3217,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00032948,0.32,0.40818,1,1
1,GO STEROL TRANSPORT,1.5816e-05,0.3199,0.27835,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.1617e-05,0.31989,0.27908,1,1
1,GO REGENERATION,2.4692e-06,0.31985,0.29033,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,9.7801e-06,0.31928,0.25774,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0040578,0.31924,0.19311,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.7118e-05,0.31917,0.37203,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.6174e-05,0.31903,0.35121,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.0011199,0.31864,0.31829,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00019753,0.31827,0.28433,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,9.3916e-06,0.31788,0.29115,1,1
1,GO PROTEIN TARGETING TO VACUOLE,1.4609e-05,0.31767,0.28005,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00022676,0.3167,0.26454,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0041716,0.31665,0.37183,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010859,0.31639,0.2379,1,1
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.011612,0.31575,0.28647,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,0.3152,0.26446,1,1
1,GO LIPOPROTEIN LOCALIZATION,1.5201e-05,0.31491,0.42758,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.5816e-05,0.31482,0.3313,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,1.6455e-05,0.31461,0.34434,1,1
1,GO ASTROCYTE ACTIVATION,0.0040578,0.3141,0.2812,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00069957,0.31353,0.32601,1,1
1,GO FOCAL ADHESION ASSEMBLY,4.3218e-05,0.3134,0.3458,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00042998,0.31336,0.28864,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.9263e-05,0.31318,0.31931,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.8521e-05,0.31282,0.2931,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9532e-05,0.31274,0.31394,1,1
1,GO MULTI ORGANISM LOCALIZATION,9.2696e-08,0.31267,0.39481,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.035393,0.31188,0.22418,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0057817,0.31176,0.24307,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.1493e-05,0.31173,0.29015,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,7.8282e-05,0.31172,0.29648,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.508e-06,0.31138,0.32949,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,1.5816e-05,0.31079,0.30918,1,1
1,GO VESICLE CARGO LOADING,0.00012074,0.31075,0.28228,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0028957,0.31042,0.28734,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0038387,0.31041,0.2579,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,7.6603e-06,0.30986,0.38895,1,1
1,GO MUSCLE CELL PROLIFERATION,8.3127e-06,0.30978,0.30248,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,6.2786e-05,0.30967,0.28478,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00026003,0.30939,0.29388,1,1
1,GO RESPONSE TO PROGESTERONE,0.0028957,0.30884,0.28714,1,1
1,GO RRNA METABOLIC PROCESS,0.00059588,0.30865,0.2759,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,4.4878e-05,0.30839,0.32298,1,1
1,GO TRNA 5 LEADER REMOVAL,7.547e-05,0.30833,0.32904,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.020205,0.30809,0.25944,1,1
1,GO VASCULATURE DEVELOPMENT,2.1663e-05,0.30803,0.27843,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,2.6307e-05,0.30763,0.2608,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.5816e-05,0.30761,0.31313,1,1
1,GO SYNCYTIUM FORMATION,0.00014935,0.30751,0.30735,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,3.4421e-05,0.30748,0.24653,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00014935,0.30748,0.25314,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.906e-06,0.30743,0.27574,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.7806e-05,0.30724,0.27564,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00029782,0.30683,0.26034,1,1
1,GO RNA 5 END PROCESSING,0.0006154,0.30678,0.27477,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017137,0.30664,0.45029,1,1
1,GO CHOLESTEROL EFFLUX,2.9301e-06,0.30658,0.32701,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00055855,0.30656,0.36215,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,2.0833e-05,0.30651,0.34083,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,4.8379e-05,0.30647,0.33515,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,3.7791e-06,0.30577,0.46217,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,3.8583e-05,0.30552,0.28185,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0025817,0.30549,0.25958,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,9.7346e-05,0.30525,0.25152,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,1.8521e-05,0.30497,0.34962,1,1
1,GO NCRNA METABOLIC PROCESS,0.00020448,0.30479,0.25039,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.02166,0.30457,0.291,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00047456,0.3043,0.20931,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00017186,0.30383,0.29238,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0006154,0.3038,0.28275,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,0.0007696,0.30362,0.27073,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00040247,0.30354,0.27221,1,1
1,GO REPLICATIVE SENESCENCE,0.0056288,0.3035,0.35725,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0053338,0.30343,0.34291,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.8583e-05,0.30314,0.26005,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,7.6603e-06,0.30281,0.3271,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0019282,0.3027,0.30538,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.013798,0.30232,0.32532,1,1
1,GO TRANSLATIONAL TERMINATION,0.00020448,0.30227,0.26005,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.1267e-06,0.30227,0.39455,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.4692e-06,0.30181,0.34719,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00026003,0.30164,0.27295,1,1
1,GO SELECTIVE AUTOPHAGY,5.753e-07,0.30121,0.31157,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,4.4878e-05,0.30117,0.29564,1,1
1,GO IRON ION HOMEOSTASIS,3.9418e-06,0.30112,0.2716,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.8379e-05,0.30087,0.3547,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,0.30077,0.32689,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00023468,0.3006,0.27651,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.5816e-05,0.30054,0.30942,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00065623,0.30023,0.30066,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00040247,0.30018,0.32099,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0022332,0.30016,0.28472,1,1
1,GO T CELL CYTOKINE PRODUCTION,1.1964e-05,0.29996,0.40171,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.033166,0.29984,0.18303,1,1
1,GO SPERM EGG RECOGNITION,7.0571e-06,0.29954,0.26285,1,1
1,GO ETHANOL OXIDATION,0.025994,0.2994,0.34528,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.024846,0.29933,0.17885,1,1
1,GO COAGULATION,9.3916e-06,0.29928,0.29345,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,7.0571e-06,0.29871,0.33008,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00031859,0.2987,0.32752,1,1
1,GO FOAM CELL DIFFERENTIATION,0.00021909,0.29858,0.32187,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00037661,0.29845,0.3388,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.9801e-06,0.29839,0.31096,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00044439,0.29837,0.24867,1,1
1,GO ENDOTHELIAL CELL MIGRATION,3.8583e-05,0.29833,0.32035,1,1
1,GO HISTONE PHOSPHORYLATION,7.013e-05,0.29794,0.26461,1,1
1,GO GENITALIA MORPHOGENESIS,0.0051916,0.29794,0.26145,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.6902e-06,0.29785,0.37812,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,9.0179e-06,0.29783,0.28229,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0022332,0.29761,0.28685,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.5308e-05,0.29729,0.30696,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.014841,0.29695,0.33142,1,1
1,GO RIBOSOME BIOGENESIS,0.00022676,0.29663,0.30191,1,1
1,GO RESPONSE TO INTERLEUKIN 1,6.2367e-06,0.29659,0.32397,1,1
1,GO RRNA MODIFICATION,0.0064317,0.29658,0.20815,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0059384,0.2965,0.28176,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,4.3218e-05,0.29604,0.33321,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0025083,0.29562,0.2379,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.9301e-06,0.2948,0.27844,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,1.349e-05,0.2947,0.2881,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,8.4205e-05,0.29465,0.46101,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,2.7343e-05,0.29455,0.31929,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.00044439,0.2945,0.41243,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,2.1702e-06,0.29382,0.32347,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,9.7346e-05,0.29352,0.30949,1,1
1,GO RNA CATABOLIC PROCESS,1.0604e-05,0.29348,0.25048,1,1
1,GO GLAND MORPHOGENESIS,0.00025131,0.29338,0.34541,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.001872,0.29263,0.22975,1,1
1,GO NUCLEOTIDE SALVAGE,0.0085714,0.29261,0.35796,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.7806e-05,0.29254,0.33553,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,7.0571e-06,0.29254,0.29431,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2139e-05,0.29231,0.25315,1,1
1,GO CYTOKINETIC PROCESS,0.00059588,0.29205,0.24649,1,1
1,GO ACUTE PHASE RESPONSE,0.0081404,0.29174,0.26684,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,8.4205e-05,0.29144,0.28589,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0022332,0.29141,0.23291,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0037331,0.2912,0.38334,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0049174,0.29098,0.32068,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.0025083,0.29091,0.26861,1,1
1,GO HYPOTONIC RESPONSE,0.001872,0.29084,0.27435,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00021167,0.29074,0.33648,1,1
1,GO NATURAL KILLER CELL ACTIVATION,3.0689e-05,0.29073,0.29608,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.015203,0.29056,0.27687,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00095906,0.29044,0.34307,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,9.0179e-06,0.2904,0.2884,1,1
1,GO MYOBLAST DIFFERENTIATION,2.8418e-05,0.29037,0.29657,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.2786e-05,0.29035,0.25548,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.5201e-05,0.29034,0.28593,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.0833e-05,0.29014,0.25417,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,0.29011,0.30343,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.2454e-05,0.28985,0.24381,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00014418,0.28974,0.29344,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,6.5149e-05,0.28965,0.42812,1,1
1,GO REGULATION OF CELL AGING,7.9801e-06,0.28901,0.29885,1,1
1,GO TRNA 5 END PROCESSING,0.00019753,0.28894,0.29483,1,1
1,GO FATTY ACID BETA OXIDATION,0.0001547,0.28883,0.26101,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0011199,0.28817,0.28423,1,1
1,GO AMYLOID FIBRIL FORMATION,0.041093,0.28798,0.23184,1,1
1,GO PLASMA MEMBRANE TUBULATION,8.3127e-06,0.28789,0.32541,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00037661,0.28779,0.28148,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.9263e-05,0.28753,0.28626,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,5.8301e-05,0.2875,0.30316,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00081984,0.28737,0.29265,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0049174,0.28678,0.1505,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0001165,0.28677,0.2568,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0037331,0.28653,0.26852,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00022676,0.28627,0.27082,1,1
1,GO TISSUE REGENERATION,0.00028792,0.286,0.27952,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0075304,0.28584,0.43039,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0001547,0.28566,0.28832,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.001228,0.2856,0.20845,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.28493,0.20442,1,1
1,GO REGULATION OF RNA BINDING,9.7346e-05,0.28465,0.27196,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.0010206,0.28428,0.36524,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,0.00012512,0.2842,0.23611,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,6.2367e-06,0.28364,0.22215,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.0073e-05,0.28352,0.26008,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0024367,0.28352,0.25791,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00010845,0.28284,0.27477,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,4.6623e-06,0.28283,0.30362,1,1
1,GO MACROPHAGE MIGRATION,7.2754e-05,0.2827,0.31274,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.7791e-06,0.28258,0.23106,1,1
1,GO RESPONSE TO REDOX STATE,0.014138,0.28225,0.22447,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,3.7145e-05,0.28186,0.2801,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0053338,0.28167,0.30166,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.28105,0.26236,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00038934,0.2808,0.21745,1,1
1,GO RESPONSE TO VIRUS,0.00011241,0.28059,0.31142,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.035393,0.28043,0.22074,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0037331,0.28031,0.32364,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00014418,0.2802,0.30751,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00079435,0.28011,0.28781,1,1
1,GO CELL CELL RECOGNITION,2.3654e-06,0.27998,0.27849,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00074557,0.27998,0.2521,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0039469,0.27995,0.27049,1,1
1,GO CARTILAGE DEVELOPMENT,0.00010462,0.27982,0.26426,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00074557,0.27969,0.24075,1,1
1,GO CERAMIDE TRANSPORT,0.00072223,0.27968,0.28907,1,1
1,GO MACROPHAGE DIFFERENTIATION,0.00042998,0.27938,0.31408,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0022332,0.27913,0.22429,1,1
1,GO TISSUE REMODELING,0.00027832,0.27882,0.26003,1,1
1,GO RIG I SIGNALING PATHWAY,0.00022676,0.2788,0.32239,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0059384,0.27878,0.20371,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.8251e-06,0.27864,0.27152,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0019282,0.27833,0.23393,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,7.6603e-06,0.27832,0.25706,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.015203,0.27828,0.25675,1,1
1,GO NECROTIC CELL DEATH,0.00032948,0.27799,0.36252,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0040578,0.27774,0.23828,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,8.4205e-05,0.27769,0.2571,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0017123,0.27753,0.27471,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00027832,0.27752,0.33925,1,1
1,GO RESPONSE TO THYROID HORMONE,0.00010092,0.27749,0.33802,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00016595,0.27727,0.27958,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0013872,0.2772,0.282,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.3528e-06,0.27713,0.27992,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00035231,0.27707,0.31298,1,1
1,GO MUSCLE CELL MIGRATION,0.030383,0.27703,0.20333,1,1
1,GO FATTY ACID HOMEOSTASIS,0.02068,0.27702,0.19798,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0010528,0.2769,0.22858,1,1
1,GO PROTEIN FOLDING,4.6623e-06,0.27687,0.25493,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,6.7596e-05,0.27685,0.27706,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0029794,0.27677,0.23845,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.1904e-06,0.27661,0.43311,1,1
1,GO ASYMMETRIC CELL DIVISION,0.0006154,0.27633,0.2671,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,2.2524e-05,0.27631,0.25036,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,8.1192e-05,0.27628,0.25984,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,7.013e-05,0.27611,0.31835,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0011549,0.27596,0.26297,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00072223,0.27573,0.2931,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0017641,0.27462,0.24484,1,1
1,GO T CELL MIGRATION,0.00013433,0.27459,0.28752,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00040247,0.27412,0.28372,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.0179e-06,0.27378,0.23665,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00024286,0.27365,0.25213,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00353,0.27355,0.26567,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0050528,0.27267,0.27392,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.00057693,0.27264,0.29138,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.1964e-05,0.27254,0.24116,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022332,0.27247,0.30455,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.27242,0.24876,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.27235,0.33254,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00065623,0.27225,0.27178,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0031536,0.27215,0.24825,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00023468,0.27167,0.29317,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,4.4878e-05,0.27138,0.24915,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0010859,0.27069,0.27304,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0025083,0.27045,0.20339,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.00027832,0.27043,0.28966,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.1493e-05,0.27039,0.24042,1,1
1,GO AUTOPHAGOSOME MATURATION,2.0033e-05,0.27008,0.27774,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,3.1888e-05,0.26991,0.24044,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,3.3287e-06,0.26972,0.35679,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0017123,0.26948,0.22757,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00010845,0.2694,0.26344,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,8.7323e-05,0.2693,0.31086,1,1
1,GO NEURAL CREST CELL MIGRATION,0.024846,0.26889,0.213,1,1
1,GO WOUND HEALING,1.7118e-05,0.26848,0.31277,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5201e-05,0.26843,0.30732,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0097392,0.26835,0.25864,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00040247,0.26828,0.25305,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00040247,0.26823,0.22811,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0046564,0.26799,0.21459,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.0689e-05,0.26769,0.21093,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00059588,0.26756,0.22398,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.007729,0.26744,0.20208,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0012662,0.26717,0.31953,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,9.0551e-05,0.26705,0.2558,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.6623e-06,0.26683,0.33035,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.001191,0.26681,0.22061,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0059384,0.26669,0.30031,1,1
1,GO RESPONSE TO WOUNDING,2.5308e-05,0.26666,0.26625,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0012662,0.26639,0.25762,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0042883,0.26596,0.26721,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.033894,0.26595,0.17465,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00059588,0.2659,0.32457,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00010092,0.2657,0.36794,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0012662,0.26553,0.2286,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0011199,0.26549,0.24274,1,1
1,GO KERATINOCYTE MIGRATION,0.0010859,0.26548,0.30483,1,1
1,GO ERK1 AND ERK2 CASCADE,1.6455e-05,0.26541,0.24267,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0017123,0.26522,0.34044,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00047456,0.26516,0.23725,1,1
1,GO SEQUESTERING OF METAL ION,0.0022992,0.265,0.26248,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0028957,0.26489,0.26142,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00092958,0.26471,0.27358,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.104e-05,0.26463,0.27783,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00035231,0.26455,0.21453,1,1
1,GO TRABECULA FORMATION,0.0051916,0.26432,0.38548,1,1
1,GO TRANSPOSITION,0.033166,0.26424,0.2001,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0013872,0.26397,0.22525,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.001986,0.26389,0.22297,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00087311,0.26365,0.25668,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00047456,0.2636,0.23742,1,1
1,GO OSTEOBLAST DIFFERENTIATION,4.3218e-05,0.26351,0.27413,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.050569,0.26345,0.26964,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00019753,0.2633,0.29087,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.01282,0.26327,0.24,1,1
1,GO RESPONSE TO DSRNA,4.4712e-06,0.26311,0.35276,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00038934,0.26306,0.35165,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00018427,0.26292,0.20817,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00040247,0.2628,0.23588,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00030804,0.26219,0.24028,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.2139e-05,0.2621,0.3582,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.1702e-06,0.26207,0.26085,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0081404,0.26201,0.33709,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00084609,0.26192,0.27023,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0010859,0.26192,0.20667,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.021165,0.26173,0.2186,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00059588,0.26168,0.25116,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00098941,0.2616,0.2968,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.4044e-06,0.26143,0.32046,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.3418e-05,0.26141,0.30087,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00092958,0.2614,0.30752,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,5.4121e-05,0.261,0.21045,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.0033e-05,0.26079,0.25306,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.042857,0.26057,0.16455,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.9418e-06,0.26056,0.30914,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,5.8301e-05,0.26053,0.29154,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,3.3287e-06,0.26052,0.21318,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00026903,0.26035,0.29849,1,1
1,GO REGULATION OF GENE SILENCING,4.8612e-06,0.25966,0.23508,1,1
1,GO RNA DESTABILIZATION,2.9532e-05,0.25959,0.2442,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00084609,0.25947,0.2843,1,1
1,GO TRANSLATIONAL ELONGATION,0.00023468,0.25944,0.22865,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00026903,0.2593,0.27559,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0013457,0.25898,0.21123,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,7.8282e-05,0.25867,0.27227,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.0604e-05,0.25854,0.26951,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,4.3218e-05,0.25835,0.24482,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00049035,0.25819,0.23027,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00059588,0.25753,0.28494,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00069957,0.25728,0.24972,1,1
1,GO CELL MATRIX ADHESION,6.2786e-05,0.25728,0.30955,1,1
1,GO COPPER ION TRANSPORT,0.00012964,0.25727,0.26811,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00063551,0.25712,0.24306,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00012964,0.25682,0.28251,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.0011199,0.25661,0.23054,1,1
1,GO PEROXISOMAL TRANSPORT,0.0010859,0.25657,0.20495,1,1
1,GO DE NOVO PROTEIN FOLDING,0.00040247,0.25653,0.20866,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00020448,0.25642,0.25059,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0083534,0.25635,0.33533,1,1
1,GO PROTEIN DENEDDYLATION,0.00037661,0.25587,0.21676,1,1
1,GO PEPTIDE METABOLIC PROCESS,3.7791e-06,0.25568,0.22655,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0006154,0.25555,0.22148,1,1
1,GO REGULATION OF VASOCONSTRICTION,8.1192e-05,0.25539,0.26592,1,1
1,GO P38MAPK CASCADE,5.0226e-05,0.25495,0.32666,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.014841,0.25492,0.22429,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.001986,0.25489,0.23494,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.024846,0.25432,0.2084,1,1
1,GO PROTEIN KINASE B SIGNALING,2.7343e-05,0.25431,0.21321,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.8583e-05,0.25405,0.24707,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0006154,0.25399,0.29968,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0022332,0.25386,0.21283,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001662,0.25378,0.30928,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,5.508e-06,0.25366,0.23089,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,7.547e-05,0.25329,0.23484,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.0051916,0.25309,0.15727,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,9.7346e-05,0.25285,0.24654,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013872,0.25269,0.28184,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0012662,0.25267,0.2615,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,4.3218e-05,0.25241,0.29873,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.4346e-05,0.25239,0.36995,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.001228,0.2522,0.21407,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0017123,0.25203,0.25859,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,3.7145e-05,0.25203,0.28064,1,1
1,GO REGULATION OF HEART GROWTH,0.00012512,0.25195,0.253,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,5.4121e-05,0.25174,0.27464,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.547e-05,0.25155,0.27506,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,2.9532e-05,0.25146,0.20936,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,7.547e-05,0.25138,0.31439,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0015653,0.25053,0.22678,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00031859,0.25006,0.26585,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0069616,0.24987,0.1668,1,1
1,GO FIBROBLAST ACTIVATION,0.0017123,0.24974,0.31119,1,1
1,GO INNATE IMMUNE RESPONSE,7.8282e-05,0.24955,0.24117,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0024367,0.24951,0.25624,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,9.0179e-06,0.24942,0.20866,1,1
1,GO LYMPHOCYTE MIGRATION,0.00044439,0.24937,0.20977,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0066042,0.24934,0.18346,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,0.24926,0.27419,1,1
1,GO SYMBIOTIC PROCESS,2.1702e-06,0.24921,0.25465,1,1
1,GO REGULATION OF ORGAN GROWTH,1.7474e-06,0.24884,0.2961,1,1
1,GO DETECTION OF OTHER ORGANISM,0.014138,0.24871,0.25884,1,1
1,GO LIPID IMPORT INTO CELL,0.010506,0.24871,0.21907,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.1192e-05,0.24866,0.18607,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.1112e-06,0.24865,0.27965,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0001165,0.24857,0.22413,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.9904e-06,0.2484,0.24239,1,1
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00013917,0.24825,0.29861,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.24795,0.24763,1,1
1,GO TOXIN TRANSPORT,0.00353,0.24783,0.16488,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.2454e-05,0.24769,0.22989,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.6603e-06,0.2467,0.33632,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0075304,0.24667,0.24946,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.033166,0.24652,0.307,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00029782,0.24651,0.29361,1,1
1,GO UV PROTECTION,0.035393,0.24647,0.21394,1,1
1,GO RESPONSE TO CYTOKINE,3.4421e-05,0.24614,0.27416,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,3.7145e-05,0.24599,0.25647,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00095906,0.24564,0.18294,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0022332,0.24528,0.22393,1,1
1,GO PHAGOCYTOSIS,3.7791e-06,0.2452,0.30331,1,1
1,GO LUNG MORPHOGENESIS,0.0087944,0.24487,0.18886,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,7.0571e-06,0.24477,0.2447,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,4.3218e-05,0.24469,0.25139,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.029068,0.24469,0.12373,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00059588,0.2446,0.18566,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037747,0.24452,0.15409,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.0033e-05,0.24432,0.23734,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00074557,0.244,0.22176,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00063551,0.24394,0.21521,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0010859,0.24364,0.25578,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.013e-05,0.24311,0.20688,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0025083,0.24281,0.36934,1,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.033894,0.24259,0.35673,1,1
1,GO REGULATION OF MITOPHAGY,0.015203,0.24256,0.19602,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0060989,0.24249,0.24991,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.0057817,0.24247,0.31467,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0030654,0.2422,0.216,1,1
1,GO LIPID STORAGE,0.00032948,0.24203,0.24591,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.0038387,0.24167,0.18055,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.9532e-05,0.24101,0.27936,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026903,0.2409,0.20714,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0050528,0.24076,0.20615,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00038934,0.24076,0.23237,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00042998,0.2407,0.2695,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,4.6597e-05,0.24051,0.19471,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00021167,0.24023,0.22143,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00031859,0.24011,0.32537,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.8583e-05,0.24009,0.25335,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0006154,0.24005,0.20228,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,9.7801e-06,0.24005,0.2344,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.0311e-06,0.23991,0.25795,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.0049174,0.23945,0.20956,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,9.0551e-05,0.23943,0.21103,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0015189,0.23939,0.17646,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00019079,0.23932,0.20562,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0087944,0.23915,0.28976,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0010528,0.23891,0.24992,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.013465,0.23889,0.251,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.9532e-05,0.23874,0.36917,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0097392,0.23864,0.20217,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.23845,0.29123,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.02068,0.23809,0.23026,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0010528,0.23799,0.25792,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0087944,0.23785,0.27543,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,0.00010092,0.23777,0.27645,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.2376,0.22836,1,1
1,GO GONADOTROPIN SECRETION,0.033894,0.23735,0.21726,1,1
1,GO PLATELET ACTIVATION,0.00084609,0.23675,0.21716,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00052342,0.23659,0.30264,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.001872,0.23651,0.26648,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00021167,0.23563,0.22252,1,1
1,GO MACROPHAGE CHEMOTAXIS,0.00010462,0.2356,0.31174,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.0033e-05,0.23525,0.28973,1,1
1,GO DNA LIGATION,0.0011199,0.23519,0.24137,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.4346e-05,0.23499,0.27588,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.001662,0.23439,0.1937,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0056288,0.2343,0.18511,1,1
1,GO PROTEIN TARGETING,2.8418e-05,0.2342,0.20124,1,1
1,GO TRNA PROCESSING,0.00098941,0.23411,0.1781,1,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.033166,0.23352,0.15885,1,1
1,GO MESODERM DEVELOPMENT,0.00037661,0.23329,0.17728,1,1
1,GO SULFUR COMPOUND TRANSPORT,4.4712e-06,0.23329,0.26602,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00028792,0.23319,0.28166,1,1
1,GO RESPONSE TO PH,0.00041602,0.23317,0.26305,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,1.7474e-06,0.23313,0.26392,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0036303,0.23311,0.17998,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,4.1112e-06,0.2331,0.26075,1,1
1,GO MEMBRANE BIOGENESIS,0.035393,0.23287,0.1775,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00052342,0.23282,0.21221,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.2754e-05,0.23272,0.23448,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031748,0.23255,0.18525,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00030804,0.23253,0.30301,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0034322,0.23194,0.18264,1,1
1,GO CRISTAE FORMATION,0.012203,0.23155,0.20042,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019282,0.23144,0.21763,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.017969,0.23124,0.16584,1,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0025083,0.2312,0.18091,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.026586,0.23105,0.16121,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,4.4878e-05,0.23071,0.28204,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00084609,0.2307,0.33682,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,1.5816e-05,0.23069,0.22498,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.023205,0.23068,0.1924,1,1
1,GO MITOPHAGY,5.8301e-05,0.2301,0.25019,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.029719,0.22985,0.3475,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0019282,0.22952,0.2642,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.027803,0.2295,0.17556,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,8.1192e-05,0.22948,0.22999,1,1
1,GO RRNA METHYLATION,0.014486,0.22941,0.17624,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,3.3287e-06,0.22929,0.23198,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00079435,0.22915,0.17578,1,1
1,GO PODOSOME ASSEMBLY,0.0011199,0.22897,0.30391,1,1
1,GO PEROXISOME ORGANIZATION,0.00065623,0.22882,0.19624,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.017137,0.22833,0.34774,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.5759e-05,0.22807,0.23393,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00020448,0.22771,0.19873,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00074557,0.2277,0.24524,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0029794,0.22763,0.23455,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00014935,0.22762,0.24166,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0085714,0.22756,0.2165,1,1
1,GO MYOBLAST FUSION,0.00092958,0.22732,0.29882,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0001547,0.22729,0.32015,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0066042,0.22693,0.17165,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00072223,0.22633,0.20584,1,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.023741,0.22623,0.1912,1,1
1,GO SUPEROXIDE ANION GENERATION,0.0028957,0.22601,0.25458,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,8.4205e-05,0.22582,0.21601,1,1
1,GO RNA 3 END PROCESSING,0.0029794,0.22577,0.17401,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00353,0.22558,0.17691,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.3218e-05,0.22528,0.21702,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.22483,0.22143,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0007696,0.22451,0.29784,1,1
1,GO BONE MORPHOGENESIS,0.00067758,0.22448,0.23455,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00021167,0.2244,0.21491,1,1
1,GO VIRION ASSEMBLY,0.0031536,0.22433,0.15878,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.8521e-05,0.22396,0.33896,1,1
1,GO RESPONSE TO RETINOIC ACID,0.00026003,0.22393,0.2271,1,1
1,GO T CELL CHEMOTAXIS,0.00010092,0.22383,0.24521,1,1
1,GO RESPONSE TO BACTERIUM,3.5759e-05,0.22374,0.25043,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00014418,0.22367,0.24554,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.0014299,0.22224,0.23157,1,1
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.010506,0.22222,0.17829,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,5.6174e-05,0.22182,0.20397,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.017969,0.22171,0.15606,1,1
1,GO OSTEOCLAST DIFFERENTIATION,0.00050664,0.22122,0.18974,1,1
1,GO TISSUE MIGRATION,0.00012964,0.22101,0.27629,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00074557,0.22086,0.2022,1,1
1,GO INTEGRIN ACTIVATION,0.0087944,0.22079,0.19335,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.8521e-05,0.22065,0.27193,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0007696,0.22058,0.18725,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0011549,0.22031,0.37458,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0057817,0.22008,0.19272,1,1
1,GO IMMUNE EFFECTOR PROCESS,2.7343e-05,0.21949,0.25781,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00034072,0.21924,0.21958,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.349e-05,0.21904,0.23556,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0071468,0.21884,0.15974,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.001228,0.21844,0.18741,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.014841,0.21837,0.26201,1,1
1,GO REGULATION OF VASCULOGENESIS,0.025994,0.2178,0.27389,1,1
1,GO DNA DEALKYLATION,0.010506,0.21762,0.18777,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00079435,0.21761,0.32068,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,9.0551e-05,0.2176,0.18842,1,1
1,GO TRNA METABOLIC PROCESS,0.0022332,0.21758,0.16383,1,1
1,GO METANEPHROS DEVELOPMENT,0.0071468,0.21727,0.16327,1,1
1,GO URETER DEVELOPMENT,0.019283,0.21691,0.2134,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.0689e-05,0.2169,0.24889,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0056288,0.21662,0.26556,1,1
1,GO RNA MODIFICATION,0.00019753,0.21654,0.1872,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0056288,0.21653,0.1954,1,1
1,GO REGULATION OF URINE VOLUME,0.00026003,0.21647,0.24333,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,7.547e-05,0.21637,0.2547,1,1
1,GO REGULATION OF WOUND HEALING,0.00065623,0.2163,0.27508,1,1
1,GO CHEMOKINE PRODUCTION,0.007729,0.21626,0.21076,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00067758,0.21617,0.17887,1,1
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.030383,0.21604,0.17602,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.216,0.18635,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0097392,0.21594,0.14677,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.009256,0.21593,0.21181,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6597e-05,0.21583,0.21554,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.010773,0.2155,0.18745,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0014299,0.21518,0.18012,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0025817,0.21477,0.20658,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.001191,0.21465,0.2486,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.6597e-05,0.21463,0.18851,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00052342,0.21436,0.21518,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0026572,0.21412,0.21996,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.21411,0.26717,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00038934,0.21398,0.1916,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00044439,0.21394,0.24524,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.011612,0.21359,0.19559,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.00057693,0.21325,0.23537,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,7.5427e-07,0.21325,0.2127,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0021062,0.21323,0.18102,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.7145e-05,0.21259,0.26038,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.7323e-05,0.21252,0.23964,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00041602,0.21162,0.27415,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00057693,0.21094,0.21144,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0006154,0.2109,0.21137,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,4.3218e-05,0.21076,0.19207,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0042883,0.21057,0.20764,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001872,0.21035,0.23326,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0025083,0.21008,0.2039,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.1663e-05,0.21005,0.23867,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00025131,0.21005,0.20279,1,1
1,GO HEAD MORPHOGENESIS,0.0016129,0.21003,0.23744,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0028957,0.2098,0.19104,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0066042,0.20969,0.15718,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00024286,0.20959,0.19367,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00063551,0.20948,0.19846,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,6.7596e-05,0.20944,0.19811,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.015203,0.20934,0.20268,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0030654,0.20929,0.17862,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028141,0.20909,0.2525,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.029068,0.20847,0.22748,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.014841,0.20819,0.15681,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0099891,0.20806,0.1628,1,1
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0081404,0.20762,0.22912,1,1
1,GO REGULATION OF CELLULAR RESPIRATION,0.04854,0.20735,0.13198,1,1
1,GO RESPONSE TO KETONE,0.0037331,0.2073,0.15105,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0056288,0.20728,0.25872,1,1
1,GO REGULATION OF LIPID STORAGE,0.00090094,0.20727,0.23765,1,1
1,GO BLASTOCYST GROWTH,0.001662,0.20725,0.23881,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00034072,0.20696,0.18331,1,1
1,GO CYTOKINE PRODUCTION,6.7596e-05,0.20687,0.24059,1,1
1,GO PLATELET MORPHOGENESIS,0.0027346,0.2068,0.18649,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.050569,0.20646,0.13341,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,7.547e-05,0.20632,0.19292,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00063551,0.20625,0.22606,1,1
1,GO TOOTH MINERALIZATION,0.044685,0.2058,0.20521,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0015653,0.2057,0.19745,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,4.8379e-05,0.20569,0.22161,1,1
1,GO COENZYME A METABOLIC PROCESS,0.0056288,0.20558,0.18203,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00072223,0.20538,0.18739,1,1
1,GO RETINOL METABOLIC PROCESS,0.0025083,0.20526,0.26604,1,1
1,GO CELLULAR RESPONSE TO ATP,6.2786e-05,0.2048,0.22956,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.1904e-06,0.20451,0.19158,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00045924,0.20436,0.16143,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,5.4121e-05,0.20401,0.26813,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.015203,0.20391,0.14333,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.0047853,0.20338,0.26387,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0053338,0.20333,0.21691,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.00027832,0.20285,0.19223,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.0039469,0.20285,0.23706,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,1.0184e-05,0.2026,0.18584,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00016595,0.20259,0.22825,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0050528,0.20253,0.1806,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0056288,0.20239,0.26155,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0046564,0.2023,0.21458,1,1
1,GO REGULATION OF PROTEOLYSIS,4.4878e-05,0.20227,0.18819,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0064317,0.20192,0.25524,1,1
1,GO RESPONSE TO VITAMIN A,0.029068,0.2018,0.20832,1,1
1,GO MYELOID CELL HOMEOSTASIS,5.8301e-05,0.2016,0.19613,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00041602,0.20144,0.23486,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,1.7118e-05,0.20137,0.20491,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00353,0.20123,0.22492,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,7.5427e-07,0.20121,0.16593,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0015189,0.20117,0.18085,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0029794,0.20055,0.15339,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00038934,0.20037,0.21244,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00054072,0.20027,0.21725,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.9904e-06,0.20027,0.18311,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.0033369,0.20026,0.22317,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,5.6174e-05,0.20019,0.23506,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00044439,0.19975,0.21679,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00072223,0.19966,0.19195,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00010845,0.19958,0.26307,1,1
1,GO PROTEIN REFOLDING,0.033166,0.19938,0.16315,1,1
1,GO NUCLEAR EXPORT,2.5308e-05,0.19868,0.17592,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.049546,0.19839,0.1668,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.011326,0.19838,0.18058,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,4.4878e-05,0.19829,0.22937,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00084609,0.19824,0.25885,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.00050664,0.19783,0.17903,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.011904,0.19754,0.14355,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.013465,0.19748,0.18192,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0027346,0.19748,0.20325,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.001191,0.19739,0.17131,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0060989,0.19738,0.22686,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00026903,0.19711,0.22214,1,1
1,GO CELL AGING,6.5149e-05,0.19708,0.19676,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.031059,0.19694,0.099016,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.043763,0.1968,0.22342,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0066042,0.19663,0.30776,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00017186,0.19663,0.24126,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.9532e-05,0.19651,0.20253,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.041093,0.19618,0.19627,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001191,0.19604,0.21682,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.011612,0.19602,0.27393,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00029782,0.196,0.24369,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.004408,0.19587,0.19322,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.01282,0.19586,0.13807,1,1
1,GO VESICLE TARGETING,0.00019753,0.19585,0.21512,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.050569,0.19568,0.13477,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,0.19561,0.17211,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00040247,0.1955,0.18762,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0013054,0.1954,0.20548,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.024288,0.19506,0.16905,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00036427,0.19487,0.2301,1,1
1,GO GRANULOCYTE MIGRATION,0.00034072,0.19483,0.2609,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00090094,0.1948,0.22922,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.02166,0.19479,0.26578,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.050569,0.19444,0.17051,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.004408,0.1944,0.22723,1,1
1,GO OXALATE TRANSPORT,0.0024367,0.19428,0.17281,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0015653,0.19376,0.20578,1,1
1,GO REGULATION OF HEMOPOIESIS,0.00017796,0.19367,0.17188,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0029794,0.19352,0.17088,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00054072,0.19346,0.1934,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.033166,0.19313,0.13798,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0037331,0.19292,0.17585,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.015203,0.19275,0.1257,1,1
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00095906,0.19266,0.17756,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.0784e-06,0.19244,0.18052,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.025414,0.19226,0.12251,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028957,0.19214,0.20358,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0046564,0.19172,0.2187,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0083534,0.19166,0.32409,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00012074,0.19156,0.19386,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.017969,0.19106,0.13369,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0015653,0.19097,0.15238,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00021167,0.19085,0.18422,1,1
1,GO BODY FLUID SECRETION,0.00030804,0.1905,0.20494,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.02068,0.1905,0.14566,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0013872,0.19043,0.20103,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0054795,0.19035,0.23448,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.2524e-05,0.19027,0.19624,1,1
1,GO SECRETION BY TISSUE,0.025994,0.18996,0.16438,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.18985,0.1755,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0017641,0.18973,0.19389,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00036427,0.18966,0.14411,1,1
1,GO INFLAMMATORY RESPONSE,0.00013433,0.18964,0.23165,1,1
1,GO BONE REMODELING,0.001228,0.18964,0.1998,1,1
1,GO MITOTIC CYTOKINESIS,0.015203,0.18938,0.14429,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0022992,0.18912,0.2938,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00041602,0.1887,0.23182,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00042998,0.18864,0.15948,1,1
1,GO BODY MORPHOGENESIS,0.0069616,0.18856,0.16146,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011612,0.18844,0.17893,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.18839,0.14197,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00020448,0.1883,0.19676,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0047853,0.18812,0.22023,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,5.2139e-05,0.1879,0.1827,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,4.5813e-07,0.18718,0.1775,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.017969,0.18713,0.16553,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.3132e-05,0.18678,0.21959,1,1
1,GO CARNITINE SHUTTLE,0.053746,0.18677,0.15195,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,6.4994e-06,0.18634,0.22356,1,1
1,GO PROTEIN DEMANNOSYLATION,0.0083534,0.18607,0.23504,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0013872,0.18605,0.14893,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0010859,0.18591,0.18684,1,1
1,GO DEFENSE RESPONSE,0.0001547,0.1859,0.20176,1,1
1,GO DRUG METABOLIC PROCESS,0.0032441,0.18571,0.15716,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00020448,0.18567,0.18437,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,5.0226e-05,0.18534,0.19726,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.018398,0.1848,0.14923,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0071468,0.18468,0.27192,1,1
1,GO CELLULAR RESPONSE TO PH,0.02268,0.18423,0.13389,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00016595,0.18421,0.17208,1,1
1,GO FACE DEVELOPMENT,0.00054072,0.18399,0.22677,1,1
1,GO TUBE MORPHOGENESIS,0.00042998,0.18388,0.18362,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.009256,0.18374,0.13591,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.00013433,0.18355,0.19307,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.5813e-07,0.18352,0.17865,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0090226,0.18339,0.21099,1,1
1,GO STEROL HOMEOSTASIS,0.02268,0.18324,0.12976,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00032948,0.18319,0.15661,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.004408,0.18319,0.18307,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00010845,0.18318,0.15641,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.027188,0.18316,0.14589,1,1
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.034637,0.18268,0.12608,1,1
1,GO PEPTIDYL ARGININE METHYLATION,0.010773,0.18262,0.14353,1,1
1,GO MESENCHYME DEVELOPMENT,0.0022992,0.18252,0.18625,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00092958,0.18244,0.27006,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.9841e-06,0.18241,0.20403,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0013872,0.18194,0.16516,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00012964,0.18187,0.17916,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00059588,0.18182,0.23001,1,1
1,GO FLUID TRANSPORT,0.00087311,0.18171,0.18846,1,1
1,GO OVULATION,0.033894,0.18151,0.2627,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0018173,0.18071,0.14682,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,0.00069957,0.18018,0.23089,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,2.6902e-06,0.18013,0.18546,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0041716,0.18,0.1462,1,1
1,GO STRESS FIBER ASSEMBLY,0.0024367,0.17983,0.19675,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025083,0.17982,0.20421,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0029794,0.17969,0.14267,1,1
1,GO T CELL PROLIFERATION,0.0018173,0.17934,0.17807,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00011241,0.1793,0.19226,1,1
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.033166,0.17914,0.19029,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00084609,0.17888,0.16935,1,1
1,GO PROTEIN KINASE A SIGNALING,0.0001547,0.17858,0.21538,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.0018173,0.17844,0.35723,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.011612,0.1778,0.13423,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024286,0.17718,0.23667,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00016023,0.1768,0.2551,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.8521e-05,0.17676,0.19562,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014935,0.17673,0.20373,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00092958,0.17672,0.16669,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0059384,0.17666,0.17945,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0045306,0.17649,0.15313,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00054072,0.1761,0.23454,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.004408,0.17602,0.13656,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.041967,0.17592,0.20342,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00012512,0.17575,0.18015,1,1
1,GO CELL ACTIVATION,5.8301e-05,0.17569,0.21438,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00026003,0.17564,0.14802,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00014935,0.17562,0.18547,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00095906,0.17561,0.19831,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0028957,0.1756,0.13733,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00040247,0.17514,0.18312,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.027803,0.17493,0.20602,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,7.9801e-06,0.17487,0.16646,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0056288,0.17479,0.1412,1,1
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.015953,0.17475,0.14728,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.036948,0.17454,0.14395,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0029794,0.17445,0.16573,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0013054,0.17419,0.17739,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0047853,0.17402,0.14301,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.052669,0.17397,0.15423,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0079323,0.17384,0.14892,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.02268,0.17357,0.12989,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00063551,0.17353,0.15789,1,1
1,GO HISTONE H2B UBIQUITINATION,0.047551,0.17351,0.11235,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,4.3218e-05,0.17328,0.16006,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0045306,0.17324,0.14326,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00019753,0.17295,0.19293,1,1
1,GO AGING,0.0001165,0.17285,0.17198,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.0027346,0.17279,0.13282,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.0311e-06,0.17273,0.16812,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0038387,0.17268,0.19195,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00031859,0.17247,0.17471,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00063551,0.17242,0.16713,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0015653,0.17233,0.17409,1,1
1,GO RESPONSE TO CHEMOKINE,0.010506,0.17226,0.1937,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.004408,0.17219,0.15038,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0053338,0.17213,0.14796,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.012203,0.17202,0.12345,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,6.0504e-05,0.17194,0.18266,1,1
1,GO LYSOSOMAL TRANSPORT,0.00016023,0.17172,0.17593,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.0066042,0.1716,0.22069,1,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.033166,0.17153,0.11873,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00041602,0.1715,0.23614,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.035393,0.17149,0.17172,1,1
1,GO GOLGI VESICLE TRANSPORT,1.7118e-05,0.17119,0.16327,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00049035,0.17119,0.16844,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00090094,0.17104,0.14414,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,0.00026903,0.17057,0.18771,1,1
1,GO VACUOLAR TRANSPORT,0.00050664,0.17011,0.14489,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0036303,0.17001,0.15965,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00055855,0.16996,0.18211,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,0.00025131,0.16984,0.15981,1,1
1,GO REGULATION OF IMMUNE RESPONSE,9.389e-05,0.16961,0.19226,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.9263e-05,0.16941,0.17695,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0031536,0.16934,0.16578,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,0.00041602,0.16914,0.18842,1,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.041967,0.1691,0.16031,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.004408,0.16855,0.16765,1,1
1,GO NEURAL TUBE PATTERNING,0.029068,0.16812,0.14849,1,1
1,GO AEROBIC RESPIRATION,0.025994,0.1676,0.10393,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,5.0683e-06,0.16748,0.15451,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.011612,0.16736,0.25925,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.014841,0.16732,0.17006,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00059588,0.16683,0.16525,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0069616,0.16679,0.13913,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.036948,0.16664,0.16179,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.053746,0.1665,0.20365,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00031859,0.16619,0.21434,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.017137,0.16616,0.17919,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.026586,0.16599,0.18423,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.019739,0.16589,0.14262,1,1
1,GO OSSIFICATION,0.0013872,0.16572,0.18465,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0047853,0.16556,0.12184,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.889e-07,0.16539,0.18005,1,1
1,GO SPINDLE LOCALIZATION,0.00034072,0.16534,0.16821,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.0040578,0.16529,0.13787,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0019282,0.16525,0.16262,1,1
1,GO RNA CAPPING,0.00028792,0.16511,0.16155,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0053338,0.16487,0.17361,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.004408,0.16483,0.14411,1,1
1,GO FATTY ACID METABOLIC PROCESS,0.0013457,0.16474,0.13468,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0017641,0.16429,0.12938,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0019282,0.16417,0.1501,1,1
1,GO REGULATION OF RESPONSE TO STRESS,8.4205e-05,0.16413,0.14832,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.014138,0.16405,0.13503,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0015653,0.1638,0.14961,1,1
1,GO VACUOLE ORGANIZATION,8.1192e-05,0.16375,0.15449,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,7.547e-05,0.16367,0.15474,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,5.7413e-06,0.16349,0.24456,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00067758,0.16347,0.20729,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.017549,0.16333,0.17875,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00019753,0.16327,0.18155,1,1
1,GO RNA DECAPPING,0.00079435,0.16313,0.16857,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.0028141,0.16311,0.17001,1,1
1,GO REGULATION OF ERAD PATHWAY,5.508e-06,0.16299,0.19997,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.00019079,0.16282,0.17744,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,7.2111e-07,0.16273,0.16007,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00017186,0.16272,0.23239,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0033369,0.16251,0.17216,1,1
1,GO SULFATE TRANSPORT,3.1888e-05,0.16227,0.18152,1,1
1,GO ORGANELLE INHERITANCE,0.0027346,0.16215,0.16437,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.001191,0.16207,0.14492,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0017123,0.16205,0.21821,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.0006154,0.16192,0.19177,1,1
1,GO MYELOID CELL DIFFERENTIATION,0.00016023,0.16177,0.15119,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0036303,0.16174,0.11042,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.026586,0.16173,0.1307,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,2.4346e-05,0.16168,0.1835,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.0017123,0.16122,0.20934,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00034072,0.16094,0.1535,1,1
1,GO GLOMERULUS DEVELOPMENT,0.00095906,0.16071,0.30176,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00353,0.1607,0.12855,1,1
1,GO TRANSLESION SYNTHESIS,0.023741,0.16065,0.11507,1,1
1,GO MUSCLE ADAPTATION,0.015953,0.1606,0.11035,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.010506,0.16022,0.13772,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0050528,0.16009,0.22129,1,1
1,GO T CELL ACTIVATION,0.00074557,0.15913,0.17288,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00026903,0.159,0.1453,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021689,0.1587,0.28981,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0067808,0.15855,0.17187,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0010206,0.15852,0.17217,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,7.889e-07,0.15824,0.17142,1,1
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00098941,0.15804,0.1463,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00023468,0.15773,0.27416,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0016129,0.15767,0.19632,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.00059588,0.15752,0.11977,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.00021167,0.15735,0.13349,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.014841,0.1573,0.13989,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0056288,0.15718,0.15719,1,1
1,GO LIPID CATABOLIC PROCESS,0.0017123,0.15687,0.12025,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00025131,0.15682,0.15007,1,1
1,GO ERBB SIGNALING PATHWAY,0.00095906,0.1568,0.20645,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0010206,0.15661,0.20956,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0017641,0.15647,0.18786,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00044439,0.15647,0.1907,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00041602,0.15622,0.16288,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.014486,0.15558,0.11678,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.012508,0.15539,0.16851,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.015574,0.15529,0.16438,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00020448,0.15474,0.1697,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0023671,0.15449,0.20261,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.05161,0.15441,0.15714,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.024846,0.15429,0.1288,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.031748,0.15415,0.20239,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0064317,0.15401,0.15353,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.029719,0.15399,0.13957,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.013798,0.15383,0.18928,1,1
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0021062,0.1537,0.15512,1,1
1,GO PROTEIN IMPORT,0.00017796,0.15338,0.14214,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.033894,0.1531,0.11471,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,9.4334e-07,0.15283,0.16324,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.6597e-05,0.15261,0.16028,1,1
1,GO TELOMERE ORGANIZATION,0.0030654,0.15251,0.10648,1,1
1,GO MAINTENANCE OF LOCATION,5.8301e-05,0.15245,0.16646,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0064317,0.15232,0.15718,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.017969,0.15217,0.18717,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0021062,0.15197,0.14681,1,1
1,GO PROTEIN STABILIZATION,0.00012512,0.15163,0.14007,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.040234,0.15162,0.10915,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.00040247,0.15087,0.17696,1,1
1,GO HEART GROWTH,0.0071468,0.15054,0.15243,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00036427,0.15054,0.13107,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.0081404,0.15051,0.12033,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0073363,0.15048,0.15646,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,3.3287e-06,0.15033,0.14399,1,1
1,GO MACROPHAGE ACTIVATION,0.016339,0.14995,0.15586,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.013139,0.14992,0.12982,1,1
1,GO CELL KILLING,0.013798,0.14984,0.1285,1,1
1,GO GOLGI VESICLE BUDDING,0.0010528,0.14979,0.17832,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0015189,0.14968,0.12168,1,1
1,GO PROTEIN CATABOLIC PROCESS,2.4692e-06,0.14928,0.14378,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.00090094,0.14923,0.13881,1,1
1,GO REGULATION OF B CELL ACTIVATION,0.02268,0.14921,0.10072,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00010092,0.1492,0.12053,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.001872,0.14899,0.12804,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00013917,0.14841,0.13167,1,1
1,GO NEUTROPHIL MIGRATION,0.0036303,0.1484,0.22611,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00024286,0.14825,0.12998,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00031859,0.14819,0.12762,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0081404,0.1481,0.15544,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.0017123,0.14809,0.18845,1,1
1,GO RESPONSE TO LIPID,0.0010528,0.148,0.15452,1,1
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0099891,0.14694,0.11183,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.04854,0.1468,0.096196,1,1
1,GO REGULATION OF CATABOLIC PROCESS,1.8251e-06,0.14674,0.1534,1,1
1,GO PROTEOLYSIS,3.3132e-05,0.14668,0.13285,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.0019282,0.14623,0.20615,1,1
1,GO RESPONSE TO LEPTIN,0.040234,0.14618,0.16901,1,1
1,GO LEUKOCYTE MIGRATION,0.004408,0.14574,0.17027,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.0090226,0.14538,0.11596,1,1
1,GO MITOTIC RECOMBINATION,0.021165,0.14529,0.14765,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0059384,0.14525,0.10739,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00092958,0.14507,0.13924,1,1
1,GO CELLULAR RESPONSE TO UV,0.0022332,0.14497,0.1358,1,1
1,GO NUCLEAR TRANSPORT,9.389e-05,0.14458,0.12429,1,1
1,GO RNA LOCALIZATION,0.00072223,0.14429,0.16848,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0037331,0.14414,0.14374,1,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.009256,0.14388,0.20218,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00010092,0.14377,0.13671,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0038387,0.14376,0.23148,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0032441,0.14364,0.13886,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0010206,0.14352,0.20597,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.001191,0.14326,0.13364,1,1
1,GO RESPONSE TO UV,0.001228,0.14281,0.13018,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00029782,0.14275,0.15571,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00029782,0.1427,0.15963,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.012508,0.14261,0.13551,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0010206,0.14239,0.14346,1,1
1,GO COPII COATED VESICLE BUDDING,0.0027346,0.14234,0.17351,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00016023,0.14229,0.14699,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.029068,0.14156,0.083702,1,1
1,GO HISTONE DEACETYLATION,0.0032441,0.14151,0.11148,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.0017641,0.14151,0.10732,1,1
1,GO RNA PROCESSING,0.00081984,0.14111,0.14663,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0040578,0.14109,0.11285,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00042998,0.14103,0.15178,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.00081984,0.14087,0.16713,1,1
1,GO GOLGI ORGANIZATION,0.00079435,0.14082,0.12747,1,1
1,GO PROTEIN MATURATION,0.00035231,0.14056,0.13927,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.012508,0.14055,0.098786,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.034637,0.14052,0.13358,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,9.0221e-07,0.14045,0.16487,1,1
1,GO TRABECULA MORPHOGENESIS,0.0087944,0.14038,0.2327,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00021909,0.14025,0.18092,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0010859,0.14011,0.12621,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00041602,0.13999,0.13417,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,8.1192e-05,0.13975,0.16103,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.0047853,0.13958,0.12705,1,1
1,GO DNA BIOSYNTHETIC PROCESS,5.0683e-06,0.13951,0.14674,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0015653,0.13918,0.13088,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0024367,0.13907,0.15564,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00054072,0.13896,0.16604,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.4712e-06,0.13892,0.16024,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0021062,0.13853,0.16544,1,1
1,GO ORGAN GROWTH,0.00081984,0.13827,0.17608,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.01282,0.13823,0.11367,1,1
1,GO REGULATION OF MAPK CASCADE,0.00037661,0.13812,0.15013,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00074557,0.13775,0.1546,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.0057817,0.13752,0.14792,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00019079,0.13733,0.1878,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0050528,0.13659,0.13214,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.045624,0.13656,0.19835,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0024367,0.13656,0.18657,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0060989,0.13651,0.11176,1,1
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.009256,0.13643,0.12188,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.040234,0.13629,0.10284,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.037747,0.13625,0.10553,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.030383,0.13559,0.13415,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.0024367,0.13554,0.14722,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00021167,0.1353,0.15152,1,1
1,GO POSTREPLICATION REPAIR,0.019283,0.13502,0.093146,1,1
1,GO RECEPTOR RECYCLING,0.011047,0.13488,0.1176,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.019283,0.13471,0.20065,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00081984,0.13462,0.14953,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0021689,0.13435,0.14069,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0054795,0.13398,0.15623,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00055855,0.13374,0.15661,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0006154,0.13345,0.13871,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.011326,0.13339,0.10542,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0038387,0.13337,0.17088,1,1
1,GO REGULATION OF TUBE SIZE,0.0028957,0.13331,0.15857,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0062634,0.1333,0.10197,1,1
1,GO REGULATION OF CHEMOTAXIS,0.0087944,0.13307,0.12612,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.009256,0.13301,0.16506,1,1
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.034637,0.13289,0.13456,1,1
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0031536,0.13271,0.1861,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0037331,0.13234,0.12712,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.012203,0.13223,0.096783,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.0036303,0.13195,0.15698,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.004408,0.1317,0.15371,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0099891,0.13161,0.11896,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00098941,0.13161,0.11007,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0046564,0.13123,0.083306,1,1
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.0056288,0.13122,0.095844,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.0045306,0.1312,0.21379,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.033166,0.13109,0.1099,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,0.018398,0.13042,0.17991,1,1
1,GO GENITALIA DEVELOPMENT,0.024288,0.13028,0.10052,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.04854,0.13023,0.12712,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00074557,0.13009,0.14656,1,1
1,GO STEM CELL DIFFERENTIATION,0.00074557,0.13003,0.14406,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,9.7346e-05,0.12978,0.15804,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00021909,0.12951,0.16883,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.023205,0.1295,0.1359,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.0054795,0.12937,0.15265,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00034072,0.12898,0.14932,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00036427,0.12896,0.11852,1,1
1,GO LIPID HOMEOSTASIS,0.0075304,0.12884,0.11767,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00020448,0.12869,0.15823,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00016595,0.12868,0.12138,1,1
1,GO REGULATION OF CELL ADHESION,0.0071468,0.12826,0.14991,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.013798,0.12798,0.14332,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0039469,0.12772,0.11019,1,1
1,GO SPHINGOID METABOLIC PROCESS,0.038561,0.12687,0.091166,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0099891,0.12658,0.16782,1,1
1,GO EXOCYTOSIS,0.0011549,0.12645,0.1365,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00079435,0.12642,0.11659,1,1
1,GO MRNA METABOLIC PROCESS,0.00063551,0.12576,0.13509,1,1
1,GO RESPONSE TO HORMONE,0.0013872,0.12561,0.11326,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.013465,0.12488,0.11042,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0059384,0.12466,0.13618,1,1
1,GO MRNA CLEAVAGE,0.0038387,0.12463,0.11476,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0014738,0.1243,0.12751,1,1
1,GO RESPONSE TO DRUG,0.027188,0.12422,0.0933,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00069957,0.1236,0.1215,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.9801e-06,0.12358,0.12318,1,1
1,GO TUBE DEVELOPMENT,0.0022992,0.12345,0.1417,1,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.016734,0.12307,0.10088,1,1
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0045306,0.12232,0.095736,1,1
1,GO AMINE METABOLIC PROCESS,0.015574,0.12209,0.09778,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00065623,0.12208,0.12198,1,1
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.036164,0.12201,0.094771,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00013433,0.12199,0.13636,1,1
1,GO MODIFIED AMINO ACID TRANSPORT,0.0049174,0.12174,0.22391,1,1
1,GO APOPTOTIC PROCESS,0.00049035,0.12164,0.1131,1,1
1,GO RUFFLE ORGANIZATION,0.033166,0.12151,0.11262,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.033894,0.12121,0.10027,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.015574,0.12119,0.23406,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.010245,0.12118,0.082715,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0011199,0.12107,0.095532,1,1
1,GO CELLULAR SENESCENCE,0.0049174,0.12096,0.11824,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0024367,0.12088,0.099654,1,1
1,GO B CELL ACTIVATION,0.0041716,0.12078,0.11358,1,1
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0021062,0.12063,0.10171,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.00095906,0.12045,0.091814,1,1
1,GO BONE RESORPTION,0.016734,0.12039,0.13276,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.019283,0.12031,0.095259,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.024288,0.11968,0.071051,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0036303,0.11961,0.098563,1,1
1,GO GENE SILENCING,0.00047456,0.11959,0.1052,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.052669,0.11952,0.10832,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.0036303,0.11934,0.088891,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.021165,0.11915,0.086832,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0011199,0.11912,0.13759,1,1
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0066042,0.1189,0.084199,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0039469,0.11889,0.10019,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.018836,0.11866,0.12005,1,1
1,GO REGULATION OF CELL DEATH,0.0007696,0.11828,0.11533,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00057693,0.11806,0.12714,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0041716,0.11793,0.11511,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00098941,0.11784,0.12546,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.04854,0.11724,0.12419,1,1
1,GO RESPONSE TO PEPTIDE,0.00095906,0.11713,0.10566,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00353,0.11704,0.15824,1,1
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.041967,0.11677,0.2058,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0012662,0.11674,0.12603,1,1
1,GO ORGANELLE DISASSEMBLY,6.7596e-05,0.11624,0.13366,1,1
1,GO CELL DIVISION,0.033166,0.11603,0.064421,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0090226,0.11602,0.10396,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.001872,0.1157,0.098597,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.001872,0.11558,0.10881,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0023671,0.11557,0.12127,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0029794,0.11529,0.11674,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0013457,0.11487,0.1161,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.009256,0.11482,0.12054,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0017123,0.11406,0.10015,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.041093,0.114,0.082113,1,1
1,GO NUCLEUS ORGANIZATION,0.0022332,0.11397,0.11021,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00014418,0.11372,0.12071,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.015203,0.11346,0.08548,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.6174e-05,0.1134,0.12098,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0031536,0.11331,0.11122,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,9.7346e-05,0.11317,0.13437,1,1
1,GO TISSUE MORPHOGENESIS,0.0034322,0.11287,0.13088,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.004408,0.11266,0.12768,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.018398,0.11212,0.092914,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.009256,0.1119,0.084189,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00084609,0.11173,0.16788,1,1
1,GO RNA SURVEILLANCE,0.0025817,0.11171,0.18862,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00087311,0.11126,0.13647,1,1
1,GO MEMBRANE ORGANIZATION,0.0019282,0.11121,0.10019,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.046579,0.1108,0.085237,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.0021689,0.11067,0.091016,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,9.3916e-06,0.11022,0.12181,1,1
1,GO REGULATION OF PROTEIN STABILITY,0.001228,0.10983,0.099934,1,1
1,GO ALCOHOL METABOLIC PROCESS,0.017969,0.10979,0.09155,1,1
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.049546,0.10976,0.1203,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.030383,0.10963,0.1429,1,1
1,GO LIPID LOCALIZATION,0.019739,0.10962,0.08383,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.010773,0.10955,0.073269,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.038561,0.10947,0.10366,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.033894,0.1092,0.1072,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.0010859,0.10897,0.12139,1,1
1,GO MRNA TRANSPORT,0.0023671,0.10885,0.14504,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00045924,0.10882,0.20137,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.015203,0.10828,0.081241,1,1
1,GO REGULATION OF AUTOPHAGY,0.00020448,0.10801,0.12626,1,1
1,GO REGULATION OF BINDING,0.004408,0.10774,0.11089,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.053746,0.10765,0.14814,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0023671,0.10743,0.11347,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.031059,0.10726,0.060164,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.037747,0.10726,0.12695,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00098941,0.10715,0.10501,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0041716,0.10665,0.097192,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.0018173,0.10649,0.10604,1,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.10637,0.079326,1,1
1,GO ENDOSOME ORGANIZATION,0.0067808,0.10635,0.11225,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.0032441,0.10498,0.15251,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.052669,0.10386,0.12376,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012512,0.10295,0.14151,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0023671,0.10227,0.11742,1,1
1,GO MACROAUTOPHAGY,3.3132e-05,0.10204,0.13102,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0026572,0.10156,0.10504,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.022165,0.10081,0.098573,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.031059,0.10072,0.064933,1,1
1,GO CELLULAR LIPID METABOLIC PROCESS,0.018836,0.10034,0.070884,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.016734,0.099295,0.08854,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.052669,0.099202,0.085092,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.0020453,0.099168,0.1049,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0075304,0.099043,0.1249,1,1
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.013465,0.098844,0.10236,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.02068,0.098714,0.090272,1,1
1,GO MITOTIC CELL CYCLE,0.017137,0.097865,0.073566,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.010506,0.097647,0.067536,1,1
1,GO REGULATION OF CELL CELL ADHESION,0.022165,0.096985,0.1069,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0020453,0.096464,0.089919,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0062634,0.096153,0.19151,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.05161,0.095704,0.11133,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.024846,0.095113,0.072107,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0018173,0.094944,0.092787,1,1
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.0090226,0.094927,0.079496,1,1
1,GO REGULATION OF PROTEIN TARGETING,0.033894,0.094425,0.076724,1,1
1,GO IRON ION TRANSPORT,0.0059384,0.094137,0.092237,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.052669,0.094119,0.12079,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01282,0.094044,0.11085,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0012662,0.093582,0.073772,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.01282,0.093459,0.09369,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.009256,0.092602,0.085195,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.0050528,0.092486,0.12975,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011904,0.092341,0.077757,1,1
1,GO FEMALE GAMETE GENERATION,0.010506,0.092027,0.081161,1,1
1,GO ORGANELLE FISSION,0.041967,0.09179,0.064505,1,1
1,GO CELL CYCLE PROCESS,0.016734,0.091379,0.061397,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0050528,0.091064,0.10055,1,1
1,GO CARBOHYDRATE METABOLIC PROCESS,0.0013054,0.090818,0.090659,1,1
1,GO ENDOCYTOSIS,0.00052342,0.090729,0.13266,1,1
1,GO LIPID METABOLIC PROCESS,0.009256,0.090616,0.074221,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.019283,0.0906,0.08505,1,1
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.017137,0.090032,0.084838,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.025994,0.089848,0.086138,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0011199,0.089732,0.10857,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.052669,0.089708,0.12396,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0039469,0.089576,0.094815,1,1
1,GO MACROMOLECULE DEACYLATION,0.019283,0.089207,0.073475,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036303,0.089055,0.098192,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.010773,0.088977,0.085759,1,1
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.03245,0.088046,0.05433,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0033369,0.087693,0.092003,1,1
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.012508,0.087675,0.13449,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0062634,0.08754,0.062304,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0062634,0.087472,0.11474,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0045306,0.087284,0.087382,1,1
1,GO VESICLE ORGANIZATION,0.02166,0.087253,0.078672,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0051916,0.086983,0.11228,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0001165,0.086551,0.095347,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00090094,0.086383,0.07513,1,1
1,GO REGULATION OF CELL CYCLE,0.021165,0.086329,0.051161,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0036303,0.085498,0.090485,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.033894,0.085489,0.088794,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.015203,0.085441,0.081388,1,1
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.02268,0.085261,0.055854,1,1
1,GO HEART DEVELOPMENT,0.0057817,0.084846,0.11847,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.019739,0.084262,0.09466,1,1
1,GO CELL CELL SIGNALING BY WNT,0.049546,0.083516,0.079892,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0021062,0.083293,0.077974,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0079323,0.082353,0.074466,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.031059,0.082329,0.098216,1,1
1,GO PROTEIN TETRAMERIZATION,0.0032441,0.081875,0.10924,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.052669,0.081689,0.067064,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.081321,0.081777,1,1
1,GO POLYOL METABOLIC PROCESS,0.015953,0.081257,0.072481,1,1
1,GO CHROMOSOME CONDENSATION,0.012508,0.080985,0.10983,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.047551,0.080774,0.074369,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0027346,0.080359,0.073048,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.049546,0.079753,0.083091,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.011047,0.079508,0.066618,1,1
1,GO AMMONIUM TRANSPORT,0.038561,0.079287,0.16962,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.02843,0.07644,0.075022,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00065623,0.075665,0.074404,1,1
1,GO DNA METABOLIC PROCESS,0.004408,0.07527,0.065823,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.02843,0.075054,0.074653,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00090094,0.07495,0.073843,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.049546,0.071957,0.067535,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0051916,0.071891,0.084881,1,1
1,GO CELL CYCLE,0.02166,0.071665,0.048243,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.052669,0.06974,0.055211,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.047551,0.068365,0.07433,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.004408,0.066826,0.12945,1,1
1,GO SNRNA TRANSCRIPTION,0.0054795,0.066311,0.081546,1,1
1,GO REGULATION OF DNA REPLICATION,0.0087944,0.065776,0.079769,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011326,0.064378,0.081993,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.038561,0.064163,0.069412,1,1
1,GO INTRACELLULAR TRANSPORT,0.0015653,0.063527,0.06897,1,1
1,GO RESPONSE TO NITROGEN COMPOUND,0.05161,0.062695,0.054534,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0027346,0.060104,0.11703,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.023741,0.055721,0.07687,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0032441,0.054613,0.064768,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0090226,0.054601,0.073468,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.014841,0.051543,0.11681,1,1
1,GO SECRETION,0.036164,0.04739,0.064008,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.014138,0.51381,0.37508,1,0
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.0689e-05,0.47298,0.46362,1,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00090094,0.46854,0.37228,1,0
1,GO MATURATION OF LSU RRNA,0.00012512,0.46526,0.43215,1,0
1,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00018427,0.4524,0.39437,1,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,9.389e-05,0.44332,0.41742,1,0
1,GO RETINAL METABOLIC PROCESS,0.0062634,0.44287,0.3278,1,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.0049174,0.4317,0.42077,1,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0017641,0.43133,0.31494,1,0
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00020448,0.42292,0.41788,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0028957,0.40512,0.41674,1,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,1.7806e-05,0.40265,0.47147,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.038561,0.39009,0.43007,1,0
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.011612,0.37971,0.31224,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0017123,0.37538,0.36463,1,0
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0012662,0.35931,0.44728,1,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.0001547,0.35531,0.33966,1,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.5816e-05,0.35343,0.33267,1,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00032948,0.35111,0.38547,1,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0013457,0.35078,0.26783,1,0
1,GO HAIR FOLLICLE MATURATION,0.013139,0.34834,0.24196,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0014299,0.34361,0.32341,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0010206,0.34033,0.35128,1,0
1,GO PENTOSE METABOLIC PROCESS,0.0012662,0.33969,0.24122,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,9.0551e-05,0.33819,0.41442,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.00014935,0.33415,0.36226,1,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.046579,0.3275,0.24827,1,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0075304,0.32422,0.24519,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00087311,0.31534,0.32619,1,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.034637,0.31141,0.24022,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0025083,0.30794,0.24473,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.02268,0.29646,0.18977,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00098941,0.29628,0.27291,1,0
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.010245,0.29376,0.27879,1,0
1,GO MYOBLAST PROLIFERATION,0.025414,0.2849,0.17548,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00059588,0.28472,0.29144,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0023671,0.28403,0.34208,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0064317,0.28375,0.24739,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0056288,0.27928,0.30061,1,0
1,GO GLYCINE METABOLIC PROCESS,0.020205,0.27465,0.22228,1,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00041602,0.26831,0.24864,1,0
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0028141,0.26827,0.39803,1,0
1,GO EOSINOPHIL CHEMOTAXIS,0.020205,0.26561,0.36374,1,0
1,GO GTP METABOLIC PROCESS,0.0011199,0.25925,0.28396,1,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0081404,0.25787,0.21788,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0073363,0.25772,0.2204,1,0
1,GO MONONUCLEAR CELL MIGRATION,0.00067758,0.25605,0.27957,1,0
1,GO CELLULAR RESPONSE TO ETHANOL,0.0050528,0.2558,0.26621,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0028957,0.25344,0.25908,1,0
1,GO SERTOLI CELL DEVELOPMENT,0.035393,0.25307,0.20498,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0062634,0.25169,0.30384,1,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00047456,0.25046,0.2385,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00022676,0.24863,0.33167,1,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0087944,0.24674,0.22858,1,0
1,GO NADP METABOLIC PROCESS,0.014841,0.24624,0.19099,1,0
1,GO RESPONSE TO PROTOZOAN,0.0025817,0.24492,0.25704,1,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0016129,0.242,0.18816,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0083534,0.24155,0.32104,1,0
1,GO RESPONSE TO CORTICOSTEROID,0.00032948,0.2415,0.23871,1,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.017137,0.24021,0.23084,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,4.6597e-05,0.24007,0.29004,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.001872,0.23997,0.27262,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.052669,0.23892,0.25197,1,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.007729,0.236,0.22298,1,0
1,GO LIPID OXIDATION,0.0015189,0.23544,0.19584,1,0
1,GO AMINE CATABOLIC PROCESS,0.00063551,0.23447,0.26221,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0028141,0.23423,0.23819,1,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0032441,0.23404,0.28693,1,0
1,GO MITOCHONDRIAL TRANSLATION,0.00065623,0.23347,0.21636,1,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.013465,0.23201,0.17373,1,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.014841,0.23112,0.25277,1,0
1,GO CELL JUNCTION DISASSEMBLY,0.0087944,0.23111,0.20217,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0085714,0.23088,0.22731,1,0
1,GO TRNA METHYLATION,0.0010206,0.23037,0.19904,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.012203,0.23012,0.34967,1,0
1,GO HISTONE H4 DEACETYLATION,0.0090226,0.22953,0.20996,1,0
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0097392,0.22804,0.36295,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0049174,0.22739,0.28803,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.013465,0.22533,0.19823,1,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.023741,0.22489,0.18009,1,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0011549,0.22232,0.2016,1,0
1,GO NUCLEAR PORE ORGANIZATION,0.001228,0.22224,0.23928,1,0
1,GO RRNA TRANSCRIPTION,0.0030654,0.22162,0.17716,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013054,0.22103,0.23507,1,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.00353,0.22049,0.20997,1,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0054795,0.22049,0.15573,1,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0060989,0.22025,0.18127,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.007729,0.2196,0.2008,1,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.00042998,0.21848,0.19938,1,0
1,GO ETHER METABOLIC PROCESS,0.018836,0.21754,0.18034,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0016129,0.21614,0.24424,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0017123,0.21315,0.22164,1,0
1,GO TRNA MODIFICATION,0.0013872,0.21222,0.18275,1,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0014299,0.2106,0.24165,1,0
1,GO REGULATION OF VIRAL TRANSCRIPTION,7.013e-05,0.20964,0.22466,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.026586,0.20931,0.15378,1,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00057693,0.20909,0.2462,1,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.00353,0.20744,0.17179,1,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.011047,0.20144,0.26269,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00052342,0.20139,0.21775,1,0
1,GO ETHANOL METABOLIC PROCESS,0.010773,0.19997,0.21652,1,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.029719,0.19893,0.14399,1,0
1,GO CAMP METABOLIC PROCESS,0.02268,0.19701,0.22716,1,0
1,GO TRACHEA DEVELOPMENT,0.018836,0.19555,0.20642,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.047551,0.19424,0.13177,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.050569,0.19337,0.18086,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00353,0.1919,0.19615,1,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00011241,0.18966,0.19656,1,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0049174,0.18748,0.18559,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.019283,0.18723,0.13865,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0060989,0.18689,0.18466,1,0
1,GO RESPONSE TO TUMOR CELL,0.034637,0.18641,0.15849,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0032441,0.1862,0.19007,1,0
1,GO AMINO ACID ACTIVATION,0.015574,0.18597,0.17915,1,0
1,GO RNA METHYLATION,0.00092958,0.18327,0.17456,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0011549,0.18257,0.19277,1,0
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0079323,0.18139,0.18011,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.024288,0.18025,0.16284,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0022332,0.17979,0.15832,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00010462,0.1795,0.18965,1,0
1,GO REGULATION OF CELL KILLING,0.0097392,0.17899,0.17175,1,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.03939,0.17852,0.10462,1,0
1,GO REGULATION OF AMYLOID BETA FORMATION,0.053746,0.17794,0.15043,1,0
1,GO ANION HOMEOSTASIS,0.0067808,0.17785,0.17167,1,0
1,GO NCRNA EXPORT FROM NUCLEUS,0.0029794,0.17648,0.18655,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.011326,0.17354,0.20987,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.047551,0.17286,0.19519,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.17276,0.21929,1,0
1,GO SERTOLI CELL DIFFERENTIATION,0.012203,0.17124,0.19538,1,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.027803,0.17077,0.19466,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0071468,0.17023,0.20451,1,0
1,GO POSITIVE CHEMOTAXIS,0.011904,0.17006,0.20483,1,0
1,GO RESPONSE TO MINERALOCORTICOID,0.0087944,0.1699,0.23229,1,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.022165,0.16941,0.18341,1,0
1,GO REGULATION OF BIOMINERALIZATION,0.0059384,0.16796,0.22134,1,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.042857,0.16763,0.15171,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.1648,0.16968,1,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0056288,0.16433,0.21496,1,0
1,GO RESPONSE TO GONADOTROPIN,0.0067808,0.16422,0.26316,1,0
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0014299,0.16351,0.14179,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.014138,0.16176,0.20915,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0030654,0.16135,0.1808,1,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0060989,0.16095,0.30948,1,0
1,GO RESPONSE TO ISCHEMIA,0.001191,0.16011,0.18138,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.010245,0.16002,0.1526,1,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.052669,0.15949,0.10296,1,0
1,GO DETOXIFICATION,0.015203,0.15753,0.13283,1,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.0097392,0.15696,0.15233,1,0
1,GO RESPONSE TO GAMMA RADIATION,0.00020448,0.15624,0.18716,1,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.041967,0.15615,0.26399,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.046579,0.15454,0.19197,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.020205,0.15377,0.14434,1,0
1,GO POSITIVE REGULATION OF COAGULATION,0.0083534,0.15371,0.28133,1,0
1,GO REGULATION OF BONE MINERALIZATION,0.012203,0.15364,0.21697,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.024846,0.15346,0.19777,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0021062,0.15319,0.20901,1,0
1,GO PLACENTA DEVELOPMENT,0.0054795,0.15292,0.16837,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00027832,0.15289,0.18016,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.02843,0.15166,0.14401,1,0
1,GO VACUOLAR ACIDIFICATION,0.0024367,0.14956,0.17,1,0
1,GO AMYLOID BETA FORMATION,0.05161,0.14939,0.14359,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0097392,0.14874,0.15546,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.014841,0.1479,0.13304,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.024846,0.14664,0.11223,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.021165,0.14616,0.20813,1,0
1,GO IMPORT INTO NUCLEUS,0.0006154,0.14596,0.10718,1,0
1,GO INTESTINAL LIPID ABSORPTION,0.053746,0.14524,0.185,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0047853,0.14471,0.13412,1,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00081984,0.14389,0.15324,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.0022992,0.14338,0.12807,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.027803,0.14327,0.12527,1,0
1,GO ELECTRON TRANSPORT CHAIN,0.004408,0.14311,0.11693,1,0
1,GO CELLULAR RESPONSE TO HEAT,0.0021689,0.14308,0.13969,1,0
1,GO TRNA TRANSPORT,0.016734,0.14284,0.13769,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.023205,0.1422,0.17899,1,0
1,GO RESPONSE TO UV C,0.018398,0.14159,0.16791,1,0
1,GO RESPONSE TO STEROL,0.045624,0.14152,0.15511,1,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015203,0.14074,0.19463,1,0
1,GO PROTEIN NEDDYLATION,0.0079323,0.14027,0.16006,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0064317,0.14013,0.18109,1,0
1,GO PORE COMPLEX ASSEMBLY,0.02268,0.13964,0.1408,1,0
1,GO LEUKOCYTE HOMEOSTASIS,0.0045306,0.13858,0.15431,1,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.050569,0.13794,0.12028,1,0
1,GO PROTEIN PROCESSING,0.00065623,0.13703,0.17764,1,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0027346,0.13679,0.21182,1,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.014841,0.13628,0.20903,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.036948,0.13586,0.14741,1,0
1,GO CELLULAR RESPIRATION,0.0079323,0.13492,0.11775,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.042857,0.1334,0.090761,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0046564,0.1311,0.15485,1,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.015574,0.13079,0.13943,1,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.015203,0.1306,0.14498,1,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.014486,0.13045,0.1403,1,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.046579,0.13034,0.1532,1,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.033166,0.13024,0.11645,1,0
1,GO RECEPTOR METABOLIC PROCESS,0.00063551,0.12983,0.14221,1,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001872,0.12972,0.16018,1,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.042857,0.12968,0.21711,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.011904,0.12914,0.12305,1,0
1,GO OXIDATION REDUCTION PROCESS,0.001986,0.12885,0.11257,1,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0032441,0.12766,0.11237,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.041093,0.12739,0.19779,1,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.049546,0.12702,0.1834,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.015203,0.12687,0.11635,1,0
1,GO TERPENOID METABOLIC PROCESS,0.052669,0.12653,0.14032,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.021165,0.12632,0.11872,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.042857,0.12629,0.21919,1,0
1,GO CELLULAR EXTRAVASATION,0.0019282,0.1259,0.18302,1,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.045624,0.12563,0.088238,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0056288,0.12472,0.12821,1,0
1,GO BLASTOCYST FORMATION,0.0069616,0.12461,0.14698,1,0
1,GO REGULATION OF OSSIFICATION,0.0053338,0.12455,0.17635,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.026586,0.12423,0.12257,1,0
1,GO LEUKOCYTE DIFFERENTIATION,0.0027346,0.12257,0.13204,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0051916,0.12099,0.10284,1,0
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.019283,0.11973,0.096853,1,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.033894,0.11912,0.083656,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.015953,0.11832,0.12716,1,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.043763,0.11798,0.13912,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.053746,0.11746,0.094867,1,0
1,GO RESPONSE TO NUTRIENT,0.041093,0.11721,0.12098,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.014841,0.11572,0.1154,1,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.11342,0.11666,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.041967,0.11328,0.07489,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0010859,0.11276,0.1519,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.022165,0.11229,0.15175,1,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.050569,0.11187,0.065912,1,0
1,GO OXIDATIVE PHOSPHORYLATION,0.030383,0.11085,0.11257,1,0
1,GO RESPONSE TO ANTIBIOTIC,0.019283,0.10883,0.12535,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.035393,0.10662,0.12219,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.0090226,0.1066,0.099623,1,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.050569,0.10638,0.15144,1,0
1,GO CELL CHEMOTAXIS,0.015953,0.10515,0.15754,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.03939,0.10365,0.10656,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE,0.024288,0.10342,0.090589,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.045624,0.10277,0.10458,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.049546,0.10225,0.16041,1,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.043763,0.10153,0.10739,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.013465,0.10021,0.13225,1,0
1,GO RNA POLYADENYLATION,0.0099891,0.099815,0.12449,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.038561,0.098958,0.097689,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0032441,0.098007,0.29961,1,0
1,GO HORMONE METABOLIC PROCESS,0.0071468,0.097909,0.1354,1,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.041967,0.097753,0.11532,1,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.052669,0.097713,0.16227,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,0.010773,0.097659,0.10043,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0064317,0.09764,0.19658,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.05161,0.096974,0.12482,1,0
1,GO LIPID MODIFICATION,0.015574,0.096851,0.088338,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.01282,0.096648,0.12794,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0083534,0.094028,0.16484,1,0
1,GO T CELL DIFFERENTIATION,0.029068,0.093564,0.088791,1,0
1,GO REGULATION OF ATP METABOLIC PROCESS,0.03939,0.09195,0.084328,1,0
1,GO RESPONSE TO ACID CHEMICAL,0.029068,0.091766,0.12058,1,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.0060989,0.091314,0.1095,1,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0090226,0.089186,0.12063,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.011904,0.088142,0.066116,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.033166,0.087044,0.12974,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.034637,0.086486,0.078391,1,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.014486,0.084745,0.13555,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.025994,0.084052,0.078974,1,0
1,GO ATP METABOLIC PROCESS,0.019739,0.083907,0.080388,1,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.023205,0.083748,0.10155,1,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.045624,0.082012,0.082398,1,0
1,GO MULTI ORGANISM PROCESS,0.0051916,0.081029,0.063897,1,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.018398,0.079559,0.10988,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.023741,0.079459,0.071401,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.033894,0.07915,0.054772,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.0081404,0.078995,0.099493,1,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.016734,0.077648,0.11198,1,0
1,GO NCRNA TRANSCRIPTION,0.043763,0.076101,0.068752,1,0
1,GO CELL CYCLE ARREST,0.041093,0.074587,0.061981,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.025994,0.074512,0.059689,1,0
1,GO KERATINOCYTE PROLIFERATION,0.043763,0.074333,0.21034,1,0
1,GO VITAMIN METABOLIC PROCESS,0.016339,0.073716,0.12707,1,0
1,GO MIRNA METABOLIC PROCESS,0.031059,0.0724,0.10841,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.011904,0.070786,0.11101,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.049546,0.0681,0.069051,1,0
1,GO SKELETAL SYSTEM DEVELOPMENT,0.016339,0.067127,0.13129,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0025083,0.06686,0.089346,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.029719,0.065266,0.087271,1,0
1,GO RNA EXPORT FROM NUCLEUS,0.040234,0.063539,0.089051,1,0
1,GO ODONTOGENESIS,0.04854,0.06304,0.15603,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0030654,0.054857,0.083361,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.052669,0.052954,0.097486,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.026586,0.051121,0.15261,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.031748,0.046887,0.071983,1,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.010506,0.043367,0.10868,1,0
1,GO BIOLOGICAL ADHESION,0.049546,0.043035,0.08995,1,0
1,GO HEART MORPHOGENESIS,0.041967,0.040037,0.1117,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.036948,0.03874,0.070059,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.036164,0.031189,0.067121,1,0
1,GO REGULATION OF CILIUM MOVEMENT,0.026586,-0.046098,-0.11253,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0064317,-0.052434,-0.10821,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.05161,-0.059381,-0.077648,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.046579,-0.061912,-0.10564,1,0
1,GO RHYTHMIC PROCESS,0.052669,-0.06252,-0.057281,1,0
1,GO PROTEIN ACETYLATION,0.0030654,-0.067968,-0.096638,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.0013054,-0.06813,-0.10579,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.012203,-0.068315,-0.095007,1,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0079323,-0.073011,-0.12707,1,0
1,GO NUCLEOSOME ORGANIZATION,0.036948,-0.074116,-0.086992,1,0
1,GO CHROMATIN ORGANIZATION,0.0090226,-0.076688,-0.068015,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.050569,-0.077175,-0.05845,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.03939,-0.079161,-0.18558,1,0
1,GO OOCYTE DIFFERENTIATION,0.041967,-0.079564,-0.083828,1,0
1,GO NUCLEOSOME ASSEMBLY,0.02268,-0.081042,-0.11532,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.013798,-0.08204,-0.087411,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.029719,-0.083315,-0.081107,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0083534,-0.083589,-0.084601,1,0
1,GO RECEPTOR CLUSTERING,0.041093,-0.085227,-0.16627,1,0
1,GO METAL ION TRANSPORT,0.0087944,-0.086656,-0.090644,1,0
1,GO CIRCADIAN RHYTHM,0.0012662,-0.087676,-0.1096,1,0
1,GO PROTEIN ACYLATION,0.00016023,-0.087762,-0.11188,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.012508,-0.088432,-0.07535,1,0
1,GO NEURON DEATH,0.047551,-0.089457,-0.054216,1,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0075304,-0.092363,-0.094792,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.0087944,-0.092481,-0.099567,1,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.0028957,-0.093755,-0.11221,1,0
1,GO T CELL HOMEOSTASIS,0.011326,-0.094037,-0.13307,1,0
1,GO PEPTIDE SECRETION,0.0090226,-0.096216,-0.094862,1,0
1,GO BRAIN MORPHOGENESIS,0.035393,-0.096651,-0.13987,1,0
1,GO MATING,0.049546,-0.097115,-0.084378,1,0
1,GO MAST CELL ACTIVATION,0.041093,-0.097174,-0.14514,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0081404,-0.09836,-0.20182,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.0081404,-0.099892,-0.09866,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.017137,-0.099969,-0.1013,1,0
1,GO FEAR RESPONSE,0.0023671,-0.1021,-0.17458,1,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.015203,-0.10244,-0.093187,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.047551,-0.10287,-0.092891,1,0
1,GO MULTICELLULAR ORGANISM AGING,0.0083534,-0.1037,-0.16086,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.044685,-0.10379,-0.11529,1,0
1,GO PH REDUCTION,0.0083534,-0.10444,-0.11344,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.0062634,-0.10468,-0.1232,1,0
1,GO REGULATION OF CELL CYCLE ARREST,0.030383,-0.10516,-0.067973,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0039469,-0.10646,-0.14037,1,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.019739,-0.10647,-0.089905,1,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.042857,-0.10799,-0.16184,1,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.017549,-0.10822,-0.17397,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0056288,-0.10919,-0.10049,1,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.020205,-0.10926,-0.08771,1,0
1,GO EAR MORPHOGENESIS,0.015574,-0.11007,-0.13728,1,0
1,GO ADULT FEEDING BEHAVIOR,0.036164,-0.11069,-0.14279,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0042883,-0.11132,-0.12306,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.029068,-0.11148,-0.13078,1,0
1,GO ION TRANSPORT,0.010773,-0.11224,-0.085235,1,0
1,GO SOMITOGENESIS,0.013465,-0.11326,-0.12162,1,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.0049174,-0.11372,-0.1243,1,0
1,GO REGULATION OF APPETITE,0.040234,-0.11396,-0.105,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.014138,-0.11402,-0.19416,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.011904,-0.11443,-0.094232,1,0
1,GO CELL PROJECTION ORGANIZATION,0.0010206,-0.11446,-0.11692,1,0
1,GO G0 TO G1 TRANSITION,0.017549,-0.11521,-0.11013,1,0
1,GO RESPONSE TO FUNGUS,0.031059,-0.11539,-0.13823,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.029068,-0.11564,-0.11484,1,0
1,GO REGULATION OF HORMONE LEVELS,0.015953,-0.11647,-0.10211,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.010773,-0.11696,-0.15434,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.033894,-0.11791,-0.087001,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0017641,-0.1188,-0.11467,1,0
1,GO CHROMATIN SILENCING,0.015574,-0.11955,-0.089026,1,0
1,GO DETECTION OF STIMULUS,0.00092958,-0.11999,-0.097967,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.010245,-0.12019,-0.12093,1,0
1,GO SECRETORY GRANULE ORGANIZATION,0.042857,-0.12068,-0.10899,1,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.027188,-0.12146,-0.14997,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.0051916,-0.1219,-0.1013,1,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.02068,-0.1223,-0.070087,1,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.03245,-0.12304,-0.0853,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0064317,-0.12339,-0.11441,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00059588,-0.12588,-0.14231,1,0
1,GO REGULATION OF CELL DEVELOPMENT,0.001872,-0.12597,-0.13313,1,0
1,GO REGULATION OF ACTIN NUCLEATION,0.0014299,-0.12626,-0.20226,1,0
1,GO NEURON APOPTOTIC PROCESS,0.00037661,-0.12694,-0.1257,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0053338,-0.12726,-0.10909,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0081404,-0.12886,-0.13876,1,0
1,GO CHLORIDE TRANSPORT,0.036164,-0.13153,-0.088039,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.041093,-0.13156,-0.14691,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0059384,-0.1321,-0.15698,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02268,-0.13214,-0.13756,1,0
1,GO CELL CELL SIGNALING,0.00035231,-0.13282,-0.11991,1,0
1,GO MAST CELL MEDIATED IMMUNITY,0.023205,-0.1335,-0.14529,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.001872,-0.13386,-0.12202,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.0014738,-0.13555,-0.12115,1,0
1,GO CELL FATE COMMITMENT,0.0028957,-0.13578,-0.15411,1,0
1,GO POLYOL CATABOLIC PROCESS,0.010506,-0.13598,-0.14188,1,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.05161,-0.13645,-0.16722,1,0
1,GO KETONE BODY METABOLIC PROCESS,0.023741,-0.13779,-0.26173,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00034072,-0.13787,-0.16975,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0085714,-0.13807,-0.18566,1,0
1,GO WATER HOMEOSTASIS,0.013798,-0.13962,-0.1338,1,0
1,GO CATION TRANSPORT,0.0007696,-0.13988,-0.12063,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00055855,-0.1401,-0.13149,1,0
1,GO OXIDATIVE DEMETHYLATION,0.0036303,-0.14045,-0.14666,1,0
1,GO CELL JUNCTION ORGANIZATION,0.0064317,-0.1408,-0.11386,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.011612,-0.14154,-0.15621,1,0
1,GO STRIATUM DEVELOPMENT,0.029719,-0.14179,-0.20411,1,0
1,GO HINDBRAIN MORPHOGENESIS,0.0015653,-0.14181,-0.17254,1,0
1,GO NOTCH SIGNALING PATHWAY,0.050569,-0.14254,-0.094574,1,0
1,GO CELL MATURATION,0.00050664,-0.14294,-0.13537,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.052669,-0.14315,-0.10524,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.033894,-0.14351,-0.15812,1,0
1,GO REGULATION OF SYSTEM PROCESS,0.0014738,-0.14496,-0.12264,1,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0090226,-0.14522,-0.13085,1,0
1,GO REGULATION OF SECRETION,0.00016595,-0.14554,-0.13913,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0054795,-0.14558,-0.1615,1,0
1,GO CHROMATIN REMODELING,0.0034322,-0.14678,-0.12216,1,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.015574,-0.14726,-0.15965,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00032948,-0.14738,-0.15188,1,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.016339,-0.14754,-0.16935,1,0
1,GO SENSORY PERCEPTION,0.00029782,-0.14818,-0.12714,1,0
1,GO DEVELOPMENTAL CELL GROWTH,0.0007696,-0.1487,-0.16648,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.0033369,-0.15002,-0.13407,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.004408,-0.151,-0.17437,1,0
1,GO COCHLEA DEVELOPMENT,0.0060989,-0.15149,-0.23324,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.001191,-0.15161,-0.1226,1,0
1,GO SODIUM ION TRANSPORT,0.0020453,-0.15174,-0.1443,1,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.045624,-0.15203,-0.14926,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0013872,-0.15287,-0.14755,1,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.031059,-0.15291,-0.13541,1,0
1,GO PEPTIDYL LYSINE METHYLATION,0.0028141,-0.15346,-0.14414,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.010773,-0.15411,-0.11425,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0014738,-0.15416,-0.15725,1,0
1,GO PROTEIN DEMETHYLATION,0.010506,-0.15475,-0.176,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0085714,-0.15855,-0.13747,1,0
1,GO INNER EAR MORPHOGENESIS,0.001986,-0.15896,-0.19645,1,0
1,GO DETECTION OF LIGHT STIMULUS,0.00050664,-0.16027,-0.055504,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.040234,-0.16042,-0.2141,1,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.02068,-0.1607,-0.16151,1,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.011612,-0.16086,-0.19721,1,0
1,GO HEAD DEVELOPMENT,0.00031859,-0.16095,-0.16316,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0018173,-0.16132,-0.1534,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.021165,-0.16136,-0.20082,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.0062634,-0.16226,-0.21108,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.0033369,-0.16238,-0.14606,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.001986,-0.16282,-0.1586,1,0
1,GO REGULATION OF ION TRANSPORT,0.00026903,-0.16317,-0.15091,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.001191,-0.16318,-0.16304,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.036164,-0.16328,-0.11402,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0010528,-0.16339,-0.18851,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0038387,-0.16424,-0.14233,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0081404,-0.1654,-0.15393,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00055855,-0.16572,-0.17411,1,0
1,GO RESPONSE TO FOOD,0.00059588,-0.16619,-0.16717,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00019079,-0.16679,-0.18066,1,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.0042883,-0.16701,-0.15921,1,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.018398,-0.16702,-0.15356,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0015653,-0.16766,-0.12671,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.0025817,-0.16848,-0.20804,1,0
1,GO REGULATION OF BLOOD CIRCULATION,0.0034322,-0.16908,-0.13656,1,0
1,GO STRIATED MUSCLE CONTRACTION,0.031748,-0.16926,-0.11445,1,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.029068,-0.16968,-0.10232,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0054795,-0.17006,-0.1699,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.036164,-0.17042,-0.10626,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.015203,-0.17069,-0.19393,1,0
1,GO HEART PROCESS,0.0030654,-0.1712,-0.14189,1,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.036164,-0.17196,-0.094833,1,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0094949,-0.17212,-0.16656,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0025817,-0.17217,-0.14001,1,0
1,GO RESPONSE TO ALKALOID,1.7806e-05,-0.17279,-0.20072,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.023741,-0.17362,-0.12059,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.034637,-0.17368,-0.17025,1,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0011549,-0.1737,-0.1983,1,0
1,GO LIPID DROPLET ORGANIZATION,0.00353,-0.17397,-0.18178,1,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.030383,-0.17462,-0.10817,1,0
1,GO NEUROGENESIS,0.00014418,-0.17462,-0.17359,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00026003,-0.17538,-0.16595,1,0
1,GO ACROSOME REACTION,0.036164,-0.17609,-0.13103,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.026586,-0.17654,-0.26016,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0034322,-0.17666,-0.14572,1,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.03939,-0.17753,-0.098799,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.041093,-0.17791,-0.16991,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.0010859,-0.1782,-0.20598,1,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.0013054,-0.17832,-0.19121,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00030804,-0.17862,-0.18578,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.031059,-0.17905,-0.11445,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.015574,-0.17993,-0.14419,1,0
1,GO EATING BEHAVIOR,0.0024367,-0.18045,-0.16148,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.042857,-0.18133,-0.15455,1,0
1,GO RESPONSE TO AMPHETAMINE,0.0033369,-0.18397,-0.24066,1,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.052669,-0.18479,-0.1819,1,0
1,GO NEUROMUSCULAR PROCESS,0.00065623,-0.18582,-0.18673,1,0
1,GO SLEEP,0.0016129,-0.18585,-0.17356,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,6.2786e-05,-0.18602,-0.17041,1,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.012203,-0.1861,-0.195,1,0
1,GO EAR DEVELOPMENT,0.00074557,-0.1862,-0.20282,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00050664,-0.18629,-0.15512,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.001986,-0.18644,-0.27706,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.027188,-0.18691,-0.19402,1,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.031059,-0.18705,-0.13872,1,0
1,GO NERVOUS SYSTEM PROCESS,1.4039e-05,-0.18872,-0.17886,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.010506,-0.18921,-0.18502,1,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0059384,-0.18927,-0.14931,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.011047,-0.18979,-0.16581,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.011904,-0.19138,-0.13187,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.03939,-0.19233,-0.15418,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.024288,-0.1924,-0.1938,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0031536,-0.19251,-0.1961,1,0
1,GO DEVELOPMENTAL INDUCTION,0.014841,-0.1944,-0.16226,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0025083,-0.19459,-0.18873,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.010506,-0.19487,-0.18366,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.5816e-05,-0.19511,-0.1898,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00017796,-0.19517,-0.19741,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00019079,-0.19543,-0.22916,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00010462,-0.19556,-0.2062,1,0
1,GO DIGESTION,0.0079323,-0.19629,-0.14271,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.03245,-0.19654,-0.18367,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.018398,-0.19747,-0.22328,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,8.7323e-05,-0.19768,-0.18226,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.025414,-0.198,-0.18347,1,0
1,GO ORGANIC CATION TRANSPORT,0.0011199,-0.19806,-0.21103,1,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.0062634,-0.19848,-0.14892,1,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00087311,-0.19872,-0.3513,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0037331,-0.19973,-0.21002,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0056288,-0.20084,-0.20632,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0071468,-0.2013,-0.17275,1,0
1,GO LIPID TRANSLOCATION,0.016734,-0.20292,-0.16733,1,0
1,GO REGULATION OF GLIOGENESIS,0.0016129,-0.20335,-0.1566,1,0
1,GO HISTONE H4 ACETYLATION,4.6597e-05,-0.20336,-0.18651,1,0
1,GO DEVELOPMENTAL MATURATION,6.0504e-05,-0.20359,-0.19086,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,6.0504e-05,-0.20392,-0.20951,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0040578,-0.20461,-0.19553,1,0
1,GO V D J RECOMBINATION,0.02166,-0.2048,-0.18708,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,4.1617e-05,-0.20545,-0.22575,1,0
1,GO KERATINIZATION,0.049546,-0.20685,-0.14789,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,2.3418e-05,-0.20687,-0.23403,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00079435,-0.20786,-0.20586,1,0
1,GO POSTSYNAPSE ORGANIZATION,0.00017796,-0.20824,-0.25092,1,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0019282,-0.2088,-0.25441,1,0
1,GO PHAGOSOME ACIDIFICATION,0.0010859,-0.21008,-0.2029,1,0
1,GO AMINO ACID TRANSPORT,0.0059384,-0.21014,-0.14499,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.00067758,-0.21082,-0.1957,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.016734,-0.2112,-0.20399,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.031059,-0.2121,-0.20096,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0001547,-0.21384,-0.23484,1,0
1,GO ACID SECRETION,0.0006154,-0.21393,-0.19838,1,0
1,GO MEMORY,0.00017186,-0.21395,-0.19913,1,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.023205,-0.21496,-0.21997,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00025131,-0.21531,-0.19548,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.014138,-0.21544,-0.18976,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,9.7801e-06,-0.21569,-0.24744,1,0
1,GO SODIUM ION HOMEOSTASIS,0.00063551,-0.21594,-0.25733,1,0
1,GO HAIR CELL DIFFERENTIATION,0.00059588,-0.21671,-0.29376,1,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0014738,-0.21713,-0.26235,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00028792,-0.21853,-0.18894,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0071468,-0.2194,-0.14547,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.0015189,-0.2198,-0.19043,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,4.3218e-05,-0.22057,-0.24012,1,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0018173,-0.22167,-0.19271,1,0
1,GO REGULATION OF HORMONE SECRETION,1.5816e-05,-0.22532,-0.22798,1,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00038934,-0.22551,-0.29414,1,0
1,GO RESPONSE TO PAIN,0.0028957,-0.22578,-0.22595,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.011326,-0.22584,-0.28415,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.01282,-0.22677,-0.15531,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,7.013e-05,-0.22735,-0.28508,1,0
1,GO TUBULIN DEACETYLATION,0.014138,-0.2279,-0.25547,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00035231,-0.22816,-0.23598,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.00074557,-0.22835,-0.23523,1,0
1,GO REGULATION OF CELL MATURATION,1.2962e-05,-0.22855,-0.27927,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00030804,-0.22918,-0.30504,1,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.001872,-0.2294,-0.21615,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.019283,-0.23,-0.18656,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,9.0551e-05,-0.23014,-0.23142,1,0
1,GO SECONDARY PALATE DEVELOPMENT,0.0025083,-0.23134,-0.2196,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0030654,-0.23162,-0.22687,1,0
1,GO HISTONE H3 K4 METHYLATION,0.00036427,-0.2318,-0.23939,1,0
1,GO FOREBRAIN DEVELOPMENT,4.8379e-05,-0.23226,-0.211,1,0
1,GO HORMONE TRANSPORT,1.1964e-05,-0.23286,-0.23515,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,5.508e-06,-0.23357,-0.21357,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0030654,-0.23466,-0.26941,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00055855,-0.23577,-0.24234,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0099891,-0.23616,-0.27064,1,0
1,GO REGULATION OF CHROMATIN BINDING,3.4421e-05,-0.23634,-0.27294,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0056288,-0.2364,-0.17838,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0015189,-0.23652,-0.22937,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.5308e-05,-0.23659,-0.27877,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.3287e-06,-0.23676,-0.2309,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0069616,-0.23684,-0.2408,1,0
1,GO HISTONE H4 K16 ACETYLATION,1.2454e-05,-0.23684,-0.30705,1,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.036164,-0.23719,-0.13926,1,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.031748,-0.2376,-0.15153,1,0
1,GO BEHAVIOR,4.1112e-06,-0.23774,-0.22442,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00040247,-0.23993,-0.21466,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.019283,-0.23995,-0.16662,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,1.7806e-05,-0.24041,-0.24433,1,0
1,GO REGULATION OF HEART RATE,0.0051916,-0.24199,-0.19018,1,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.00041602,-0.24213,-0.18248,1,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.04854,-0.24281,-0.11873,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.046579,-0.24295,-0.16986,1,0
1,GO BILE ACID METABOLIC PROCESS,0.0053338,-0.24305,-0.15273,1,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.025994,-0.24418,-0.2621,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.010506,-0.24464,-0.26628,1,0
1,GO MEMBRANE FISSION,0.00054072,-0.24506,-0.30192,1,0
1,GO RESPONSE TO CATECHOLAMINE,2.5308e-05,-0.2454,-0.22685,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0025817,-0.2475,-0.18795,1,0
1,GO REGULATION OF ICOSANOID SECRETION,0.0022332,-0.24873,-0.2008,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.0025817,-0.24962,-0.18405,1,0
1,GO CARDIAC CONDUCTION,0.00023468,-0.25079,-0.24623,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00019079,-0.25098,-0.18372,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0026572,-0.25234,-0.29517,1,0
1,GO REGULATION OF INSULIN SECRETION,6.5149e-05,-0.25273,-0.24956,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.00079435,-0.25314,-0.26104,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,8.1192e-05,-0.25368,-0.2253,1,0
1,GO COGNITION,3.0689e-05,-0.25402,-0.21082,1,0
1,GO FEEDING BEHAVIOR,2.8077e-06,-0.25467,-0.25428,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.02166,-0.25497,-0.1686,1,0
1,GO RESPONSE TO DOPAMINE,2.1702e-06,-0.25522,-0.24986,1,0
1,GO CRANIAL NERVE DEVELOPMENT,0.00019753,-0.25697,-0.28359,1,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.029719,-0.25712,-0.26674,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0026572,-0.25786,-0.26121,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00045924,-0.25787,-0.25557,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.03939,-0.25845,-0.17094,1,0
1,GO SEX DETERMINATION,0.00021167,-0.25923,-0.28551,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0028957,-0.25975,-0.19457,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0028141,-0.25991,-0.27126,1,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.00037661,-0.26053,-0.25945,1,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.00072223,-0.26433,-0.20635,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,2.8077e-06,-0.26457,-0.23804,1,0
1,GO LIPOXYGENASE PATHWAY,0.019283,-0.26614,-0.2791,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.0075304,-0.26678,-0.20241,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0053338,-0.26819,-0.23974,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,8.1192e-05,-0.26841,-0.21364,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0006154,-0.2692,-0.26925,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,7.0571e-06,-0.26995,-0.26871,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.013139,-0.2715,-0.23281,1,0
1,GO PEPTIDE HORMONE SECRETION,5.508e-06,-0.27336,-0.28026,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,9.7346e-05,-0.2739,-0.25427,1,0
1,GO PANCREAS DEVELOPMENT,0.0013457,-0.27529,-0.20216,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0097392,-0.27616,-0.25671,1,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,1.8521e-05,-0.27772,-0.38211,1,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0099891,-0.2789,-0.25013,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0010528,-0.27998,-0.35109,1,0
1,GO SIGNAL RELEASE,8.2505e-07,-0.28052,-0.25831,1,0
1,GO THYMUS DEVELOPMENT,0.0033369,-0.28117,-0.18947,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0024367,-0.28232,-0.26905,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0079323,-0.28303,-0.2197,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,5.2139e-05,-0.28329,-0.23128,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00081984,-0.28445,-0.25871,1,0
1,GO SENSORY PERCEPTION OF PAIN,1.1267e-06,-0.2845,-0.27404,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,1.5201e-05,-0.28584,-0.2137,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0033369,-0.2861,-0.33789,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,6.4994e-06,-0.28664,-0.29611,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.00054072,-0.28774,-0.24824,1,0
1,GO INSULIN SECRETION,2.3418e-05,-0.28775,-0.26997,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0045306,-0.28809,-0.25537,1,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.02166,-0.28842,-0.28464,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.017969,-0.28851,-0.22646,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00014418,-0.29036,-0.30427,1,0
1,GO NEURON PROJECTION ARBORIZATION,0.0025083,-0.29145,-0.25521,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0036303,-0.29157,-0.29707,1,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0018173,-0.29427,-0.24934,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0015189,-0.29438,-0.36085,1,0
1,GO ASSOCIATIVE LEARNING,8.1192e-05,-0.29605,-0.24636,1,0
1,GO PROTEIN PALMITOYLATION,2.5308e-05,-0.29612,-0.27213,1,0
1,GO HINDBRAIN DEVELOPMENT,4.1112e-06,-0.29671,-0.28966,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0028957,-0.29809,-0.23424,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00031859,-0.3005,-0.29698,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,1.6455e-05,-0.30185,-0.27266,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,6.5896e-07,-0.30221,-0.3047,1,0
1,GO POTASSIUM ION HOMEOSTASIS,0.00063551,-0.30379,-0.2518,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.034637,-0.30411,-0.29018,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,2.1663e-05,-0.30427,-0.27913,1,0
1,GO RESPONSE TO HYDROXYUREA,0.00017186,-0.30461,-0.29994,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0001547,-0.30591,-0.30815,1,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.023205,-0.30642,-0.23794,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.013798,-0.30711,-0.19866,1,0
1,GO SKELETAL MUSCLE ADAPTATION,0.0037331,-0.30721,-0.23407,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.018398,-0.30827,-0.23667,1,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.00032948,-0.30827,-0.24806,1,0
1,GO ENERGY HOMEOSTASIS,0.0021062,-0.30937,-0.25711,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.018398,-0.31009,-0.22191,1,0
1,GO GENETIC IMPRINTING,0.00016595,-0.31081,-0.23587,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00030804,-0.31099,-0.53108,1,0
1,GO SYNAPSE ORGANIZATION,1.2454e-05,-0.31157,-0.30009,1,0
1,GO RESPONSE TO MAGNESIUM ION,0.004408,-0.31211,-0.28249,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.00020448,-0.31232,-0.24306,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,1.0604e-05,-0.31241,-0.31373,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,3.0576e-06,-0.31344,-0.29748,1,0
1,GO ADRENAL GLAND DEVELOPMENT,0.00067758,-0.314,-0.32794,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,1.349e-05,-0.31434,-0.32154,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.04854,-0.31489,-0.15203,1,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0057817,-0.31786,-0.3055,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,6.5149e-05,-0.31822,-0.30637,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00090094,-0.31859,-0.35962,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.013798,-0.32028,-0.33793,1,0
1,GO SECRETORY GRANULE LOCALIZATION,0.00013433,-0.3209,-0.58548,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,2.7343e-05,-0.32225,-0.30328,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0016129,-0.32265,-0.21354,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.0029794,-0.32272,-0.31575,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.2786e-05,-0.32272,-0.30682,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0056288,-0.32338,-0.25219,1,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.025414,-0.32355,-0.40541,1,0
1,GO ACTION POTENTIAL,7.547e-05,-0.32453,-0.29762,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0011199,-0.32501,-0.28768,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00081984,-0.32543,-0.23824,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0034322,-0.32672,-0.26284,1,0
1,GO HISTONE H4 K5 ACETYLATION,2.7343e-05,-0.32763,-0.31273,1,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.017549,-0.32839,-0.27245,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,5.508e-06,-0.32961,-0.31619,1,0
1,GO NERVE DEVELOPMENT,2.7343e-05,-0.33006,-0.30779,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,2.5774e-06,-0.33061,-0.29443,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.049546,-0.33303,-0.18577,1,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.014486,-0.33404,-0.23291,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0012662,-0.33468,-0.35135,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,1.4609e-05,-0.33482,-0.29764,1,0
1,GO MEMBRANE DEPOLARIZATION,0.00016023,-0.33694,-0.27659,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00030804,-0.3375,-0.30128,1,0
1,GO CELL MIGRATION IN HINDBRAIN,3.7145e-05,-0.33921,-0.4443,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0040578,-0.33985,-0.36011,1,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.010506,-0.34055,-0.23995,1,0
1,GO PRESYNAPSE ORGANIZATION,0.00072223,-0.34171,-0.27924,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.4044e-06,-0.34233,-0.31842,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.009256,-0.3437,-0.27692,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,3.3287e-06,-0.34377,-0.35558,1,0
1,GO LEARNING,1.0184e-05,-0.34827,-0.3029,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.040234,-0.34925,-0.3057,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0020453,-0.35115,-0.2779,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.5816e-05,-0.35184,-0.32542,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0013054,-0.35248,-0.32321,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00010092,-0.35324,-0.31367,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0011199,-0.35486,-0.27635,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,3.3132e-05,-0.35543,-0.39018,1,0
1,GO REGULATION OF EXOCYTOSIS,5.0683e-06,-0.35666,-0.29304,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.0021062,-0.35687,-0.41288,1,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0097392,-0.35882,-0.28702,1,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.020205,-0.35889,-0.24746,1,0
1,GO LOCOMOTORY BEHAVIOR,1.4268e-07,-0.36024,-0.39256,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,1.1493e-05,-0.36038,-0.35236,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00030804,-0.36214,-0.27636,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,1.0184e-05,-0.3625,-0.41867,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.4728e-06,-0.36368,-0.33872,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00014935,-0.36487,-0.30577,1,0
1,GO SYNAPTIC SIGNALING,1.0311e-06,-0.3675,-0.31935,1,0
1,GO POTASSIUM ION TRANSPORT,9.4334e-07,-0.36758,-0.32786,1,0
1,GO DENDRITIC TRANSPORT,0.0015189,-0.36963,-0.35125,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,2.3654e-06,-0.37388,-0.34265,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.001228,-0.37421,-0.27379,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0028957,-0.37478,-0.29716,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00030804,-0.3763,-0.3427,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00027832,-0.37914,-0.34261,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,7.547e-05,-0.37921,-0.39685,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.024288,-0.37976,-0.51932,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.8379e-05,-0.38064,-0.32796,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0097392,-0.38066,-0.41867,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,2.3654e-06,-0.38304,-0.34898,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.037747,-0.38313,-0.18183,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00017796,-0.38397,-0.43499,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.5816e-05,-0.3841,-0.46052,1,0
1,GO OTIC VESICLE MORPHOGENESIS,0.010245,-0.38421,-0.40632,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0026572,-0.38468,-0.33282,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0081404,-0.38595,-0.46718,1,0
1,GO GROOMING BEHAVIOR,3.4421e-05,-0.38644,-0.39565,1,0
1,GO RESPONSE TO INSECTICIDE,0.00010845,-0.38749,-0.38985,1,0
1,GO LIPID DROPLET FORMATION,0.0033369,-0.38829,-0.36974,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,3.3132e-05,-0.395,-0.4058,1,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.014841,-0.39588,-0.25207,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00041602,-0.39824,-0.34182,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0015189,-0.4,-0.42764,1,0
1,GO PSEUDOPODIUM ORGANIZATION,0.053746,-0.40124,-0.23467,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,2.1663e-05,-0.40178,-0.37197,1,0
1,GO RESPONSE TO COCAINE,1.0207e-07,-0.40183,-0.4533,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,1.1776e-06,-0.40284,-0.43969,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0028957,-0.4048,-0.31895,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,7.2111e-07,-0.40504,-0.48327,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00030804,-0.40677,-0.35227,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,7.6603e-06,-0.4069,-0.42008,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0037331,-0.40918,-0.29053,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00038934,-0.41082,-0.34829,1,0
1,GO MRNA SPLICE SITE SELECTION,6.0198e-07,-0.41236,-0.41272,1,0
1,GO N GLYCAN PROCESSING,6.7596e-05,-0.4126,-0.38211,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00050664,-0.41407,-0.39728,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,2.6902e-06,-0.41447,-0.43301,1,0
1,GO RESPONSE TO ACETYLCHOLINE,8.1192e-05,-0.41467,-0.3782,1,0
1,GO RESPONSE TO NICOTINE,0.00016595,-0.41615,-0.30291,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.014486,-0.41897,-0.38141,1,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.042857,-0.42028,-0.24959,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.0083534,-0.42284,-0.26244,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,8.4205e-05,-0.42312,-0.38597,1,0
1,GO MALE SEX DETERMINATION,0.00063551,-0.42581,-0.37674,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,1.0207e-07,-0.4272,-0.44706,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0018173,-0.42796,-0.34291,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,1.4039e-05,-0.43092,-0.42603,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,4.6623e-06,-0.43093,-0.3703,1,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.00090094,-0.43326,-0.39453,1,0
1,GO RESPONSE TO L GLUTAMATE,0.0010206,-0.43447,-0.45471,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00026903,-0.43491,-0.42533,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.00081984,-0.43768,-0.34335,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.016339,-0.4391,-0.29651,1,0
1,GO EXOCYTIC PROCESS,7.889e-07,-0.43991,-0.39978,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012074,-0.44006,-0.41545,1,0
1,GO CATECHOLAMINE UPTAKE,0.00069957,-0.44176,-0.34044,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,7.8282e-05,-0.44442,-0.33074,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,9.4334e-07,-0.44613,-0.4594,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,9.389e-05,-0.44637,-0.40354,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.4044e-06,-0.44752,-0.40056,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,4.1617e-05,-0.45042,-0.51225,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,6.5896e-07,-0.45289,-0.42395,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.4609e-05,-0.45385,-0.44612,1,0
1,GO LIMB BUD FORMATION,0.025994,-0.46115,-0.34927,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00011241,-0.46242,-0.55636,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,9.389e-05,-0.46274,-0.38055,1,0
1,GO SUCKLING BEHAVIOR,0.00011241,-0.46444,-0.43785,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00047456,-0.46466,-0.38037,1,0
1,GO FOREBRAIN REGIONALIZATION,0.00022676,-0.46517,-0.39595,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00026903,-0.4684,-0.44584,1,0
1,GO NEURON MATURATION,1.2862e-06,-0.4691,-0.46464,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00023468,-0.47054,-0.36145,1,0
1,GO OTIC VESICLE DEVELOPMENT,0.00054072,-0.47828,-0.41794,1,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0071468,-0.47917,-0.47768,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0021062,-0.47981,-0.31658,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00013433,-0.48121,-0.46405,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00026903,-0.48329,-0.41216,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.016339,-0.48405,-0.33481,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,4.1112e-06,-0.48487,-0.42531,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.1112e-06,-0.48539,-0.43026,1,0
1,GO MAST CELL MIGRATION,0.0036303,-0.48999,-0.39773,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.00059588,-0.4916,-0.46053,1,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.00017796,-0.4966,-0.5005,1,0
1,GO ENDOCARDIUM DEVELOPMENT,0.00084609,-0.49748,-0.3867,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00045924,-0.50684,-0.47162,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.017549,-0.50915,-0.34256,1,0
1,GO CGMP METABOLIC PROCESS,1.7118e-05,-0.51359,-0.50075,1,0
1,GO SYNAPTIC VESICLE MATURATION,3.7145e-05,-0.51414,-0.67872,1,0
1,GO EPITHELIAL CELL MATURATION,2.9301e-06,-0.51935,-0.53642,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0014738,-0.51969,-0.40233,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0054795,-0.5202,-0.36982,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.8131e-07,-0.52415,-0.52019,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,6.0198e-07,-0.52809,-0.48421,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,2.5308e-05,-0.54165,-0.46832,1,0
1,GO GROWTH HORMONE SECRETION,1.5331e-06,-0.54266,-0.51499,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.00017186,-0.54493,-0.49692,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,2.6307e-05,-0.54539,-0.46773,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,3.1904e-06,-0.54756,-0.56711,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,1.349e-05,-0.55268,-0.56185,1,0
1,GO REGULATION OF NEURON MATURATION,3.9418e-06,-0.56085,-0.58553,1,0
1,GO REFLEX,4.3218e-05,-0.56442,-0.52995,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,8.4205e-05,-0.56974,-0.49581,1,0
1,GO DOPAMINE METABOLIC PROCESS,1.5691e-07,-0.57283,-0.58717,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00050664,-0.57347,-0.37427,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,9.0551e-05,-0.57483,-0.46301,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,5.4977e-07,-0.57509,-0.54104,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0011199,-0.5778,-0.51953,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.4044e-06,-0.58789,-0.58243,1,0
1,GO RESPONSE TO HISTAMINE,4.1617e-05,-0.5879,-0.59664,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,2.8891e-07,-0.5896,-0.51014,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.00059588,-0.58992,-0.56654,1,0
1,GO DETECTION OF CALCIUM ION,9.0179e-06,-0.58999,-0.56428,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,5.2533e-07,-0.59134,-0.60063,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,3.4772e-07,-0.59338,-0.62562,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,3.4728e-06,-0.59485,-0.51631,1,0
1,GO LUNG CELL DIFFERENTIATION,0.0015653,-0.59552,-0.46439,1,0
1,GO SIALYLATION,1.104e-05,-0.59554,-0.51875,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,3.8131e-07,-0.59617,-0.53711,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0022332,-0.59841,-0.41257,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,6.6003e-08,-0.59904,-0.65052,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,8.6584e-06,-0.60295,-0.57217,1,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00040247,-0.60377,-0.56146,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00012964,-0.60404,-0.56127,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00034072,-0.60694,-0.59955,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00016595,-0.60794,-0.49699,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.8958e-07,-0.60951,-0.56871,1,0
1,GO STARTLE RESPONSE,2.9301e-06,-0.61158,-0.52408,1,0
1,GO REGULATION OF GLUTAMATE SECRETION,5.508e-06,-0.61251,-0.52382,1,0
1,GO SPINAL CORD PATTERNING,5.9841e-06,-0.61927,-0.58423,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,3.3202e-07,-0.62089,-0.55189,1,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0021062,-0.62505,-0.45102,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,2.5122e-07,-0.63093,-0.62574,1,0
1,GO REGULATION OF SYNAPSE MATURATION,2.8418e-05,-0.63237,-0.61774,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,9.3916e-06,-0.63427,-0.59474,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,4.8612e-06,-0.63903,-0.71848,1,0
1,GO NEURONAL ACTION POTENTIAL,2.5122e-07,-0.63973,-0.66983,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.0683e-06,-0.64095,-0.49592,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.00013433,-0.6433,-0.51117,1,0
1,GO DENTATE GYRUS DEVELOPMENT,9.389e-05,-0.64548,-0.59019,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,5.6174e-05,-0.65474,-0.66939,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.65841,-0.56214,1,0
1,GO RESPONSE TO LITHIUM ION,4.1617e-05,-0.67459,-0.56926,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,2.5122e-07,-0.68263,-0.59545,1,0
1,GO NEURON FATE COMMITMENT,5.4977e-07,-0.68474,-0.7207,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.9873e-07,-0.70577,-0.67441,1,0
1,GO THALAMUS DEVELOPMENT,2.5774e-06,-0.72111,-0.63717,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,0.00011241,-0.72123,-0.68743,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,3.4772e-07,-0.72341,-0.67944,1,0
1,GO MONOAMINE TRANSPORT,5.2533e-07,-0.73409,-0.62398,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.7413e-06,-0.73789,-0.56382,1,0
1,GO SYNAPTIC VESICLE DOCKING,2.2524e-05,-0.74256,-0.66137,1,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0062634,-0.74485,-0.46278,1,0
1,GO SYNAPSE MATURATION,6.2367e-06,-0.74947,-0.77073,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.9263e-05,-0.74999,-0.78216,1,0
1,GO AMINE TRANSPORT,3.9926e-07,-0.76692,-0.59139,1,0
1,GO INNERVATION,5.508e-06,-0.76895,-0.6185,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.6015e-06,-0.77378,-0.76486,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.906e-06,-0.77848,-0.77434,1,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0040578,-0.77924,-0.52955,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,8.6584e-06,-0.78722,-0.6295,1,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.0689e-05,-0.79211,-0.71365,1,0
1,GO SEROTONIN METABOLIC PROCESS,1.4674e-06,-0.80773,-0.7009,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,1.5691e-07,-0.82029,-0.81706,1,0
1,GO NEURON CELL CELL ADHESION,5.0194e-07,-0.82878,-0.97178,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,1.2962e-05,-0.83173,-0.78933,1,0
1,GO PROTEIN LOCALIZATION TO AXON,4.1112e-06,-0.83901,-0.92114,1,0
1,GO DOPAMINE TRANSPORT,4.3763e-07,-0.84347,-0.746,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,3.17e-07,-0.85528,-0.87544,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,4.1617e-05,-0.8649,-0.7681,1,0
1,GO SYNAPTIC VESICLE PRIMING,3.9418e-06,-0.88096,-0.73267,1,0
1,GO DENDRITE EXTENSION,5.6999e-08,-0.88462,-0.80999,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,4.2876e-06,-0.88749,-0.78449,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,1.3605e-07,-0.88979,-0.81193,1,0
1,GO REGULATION OF DENDRITE EXTENSION,3.3202e-07,-0.89271,-0.81993,1,0
1,GO RETINA LAYER FORMATION,5.508e-06,-0.89975,-0.705,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,1.1493e-05,-0.90131,-0.85718,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,5.2837e-06,-0.90692,-0.74119,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,8.6584e-06,-0.90845,-0.77596,1,0
1,GO CATECHOLAMINE SECRETION,8.2505e-07,-0.92713,-0.74508,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,7.547e-05,-0.96013,-0.83195,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,4.7955e-07,-0.97149,-0.86456,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.7806e-05,-0.99483,-0.84924,1,0
1,GO REGULATION OF DOPAMINE SECRETION,3.9926e-07,-1.0539,-0.93866,1,0
1,GO GANGLION DEVELOPMENT,3.3202e-07,-1.0795,-0.91242,1,0
1,GO GABAERGIC NEURON DIFFERENTIATION,1.6729e-06,-1.0796,-0.98538,1,0
1,GO NOSE DEVELOPMENT,1.0311e-06,-1.1182,-0.92219,1,0
1,GO MECHANOSENSORY BEHAVIOR,1.8521e-05,-1.1257,-0.91593,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,5.0683e-06,-1.2957,-1.1331,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,5.7413e-06,-1.5731,-1.3968,1,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,4.7955e-07,-1.5971,-1.4187,1,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.079444,0.42765,0.19236,0,1
1,GO PHOSPHOLIPID EFFLUX,0.073629,0.41422,0.27961,0,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.060602,0.40223,0.2666,0,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.068167,0.35447,0.22182,0,1
1,GO RESPONSE TO MUSCLE STRETCH,0.2839,0.3445,0.1536,0,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.15264,0.31136,0.21602,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.061812,0.30894,0.28035,0,1
1,GO L SERINE METABOLIC PROCESS,0.11434,0.30828,0.13747,0,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.18508,0.28058,0.17178,0,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.20937,0.2746,0.18112,0,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.25729,0.2693,0.090799,0,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.097379,0.25411,0.17824,0,1
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.061812,0.24772,0.20231,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.15264,0.24225,0.091704,0,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.055956,0.23543,0.13581,0,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.079444,0.23509,0.34977,0,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.23245,0.23363,0.094306,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.24643,0.23138,0.16325,0,1
1,GO MITRAL VALVE DEVELOPMENT,0.28785,0.23057,0.18377,0,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.072231,0.23007,0.17577,0,1
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.17099,0.22888,0.15487,0,1
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.18219,0.22417,0.11572,0,1
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.060602,0.22203,0.11263,0,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.13355,0.22125,0.15502,0,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.055956,0.2175,0.13972,0,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.079444,0.21521,0.18201,0,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.084046,0.21291,0.094365,0,1
1,GO RESPONSE TO INTERLEUKIN 6,0.064293,0.21095,0.12957,0,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.10096,0.21066,0.13476,0,1
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.16559,0.20722,0.10557,0,1
1,GO ACTIN FILAMENT NETWORK FORMATION,0.53167,0.20354,0.031269,0,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.18219,0.19785,0.08262,0,1
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.12908,0.1961,0.14063,0,1
1,GO PROTEIN AUTOPROCESSING,0.070855,0.1944,0.14688,0,1
1,GO TONGUE DEVELOPMENT,0.11039,0.19356,0.15826,0,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.54903,0.19221,0.030752,0,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.055956,0.19129,0.14714,0,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.11039,0.1911,0.14839,0,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.23245,0.19001,0.088534,0,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.16559,0.18549,0.13206,0,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.13583,0.18445,0.11053,0,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.055956,0.1818,0.1434,0,1
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.13814,0.1814,0.20353,0,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.15015,0.17706,0.25375,0,1
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.3746,0.17648,0.072109,0,1
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.085627,0.17581,0.13517,0,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.065563,0.17515,0.1455,0,1
1,GO VITAMIN D METABOLIC PROCESS,0.11039,0.17298,0.19033,0,1
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.44402,0.17193,0.16302,0,1
1,GO ATP TRANSPORT,0.065563,0.17122,0.08114,0,1
1,GO NUCLEUS LOCALIZATION,0.082489,0.17038,0.10907,0,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.10654,0.16919,0.14003,0,1
1,GO REGULATION OF GONAD DEVELOPMENT,0.59059,0.1679,0.0064821,0,1
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.070855,0.16687,0.11539,0,1
1,GO FOLIC ACID METABOLIC PROCESS,0.12473,0.16684,0.12091,0,1
1,GO INOSITOL METABOLIC PROCESS,0.14769,0.16565,0.078089,0,1
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.080955,0.16541,0.12088,0,1
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.54321,0.16538,0.058368,0,1
1,GO HINDLIMB MORPHOGENESIS,0.15264,0.16497,0.13591,0,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.19095,0.16246,0.12877,0,1
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.31653,0.16028,0.086691,0,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.10845,0.15901,0.14811,0,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.18219,0.15895,0.089805,0,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.26471,0.15864,0.070643,0,1
1,GO ER NUCLEUS SIGNALING PATHWAY,0.080955,0.15559,0.1087,0,1
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.12473,0.15445,0.097794,0,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.12473,0.15274,0.11133,0,1
1,GO AMP METABOLIC PROCESS,0.10845,0.15248,0.21789,0,1
1,GO ACETYL COA METABOLIC PROCESS,0.17653,0.15113,0.05298,0,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.2,0.15109,0.10839,0,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.21256,0.15106,0.078444,0,1
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.22568,0.1495,0.13605,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.35153,0.14931,0.13246,0,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.16294,0.14862,0.11416,0,1
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.087232,0.14766,0.094943,0,1
1,GO NEURAL TUBE FORMATION,0.066855,0.14497,0.10438,0,1
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.073629,0.14491,0.12602,0,1
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.29586,0.14344,0.094755,0,1
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.16559,0.14332,0.13024,0,1
1,GO REGULATION OF INTEGRIN ACTIVATION,0.27999,0.14328,0.07492,0,1
1,GO REGULATION OF MYELINATION,0.060602,0.14237,0.10946,0,1
1,GO AMELOGENESIS,0.17653,0.14176,0.13207,0,1
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.092194,0.14149,0.074279,0,1
1,GO REGULATION OF MRNA POLYADENYLATION,0.16559,0.13928,0.079884,0,1
1,GO DNA DEMETHYLATION,0.25729,0.13882,0.092423,0,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0695,0.13766,0.13464,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.48131,0.13748,0.033673,0,1
1,GO HISTONE ARGININE METHYLATION,0.068167,0.13575,0.090267,0,1
1,GO NCRNA CATABOLIC PROCESS,0.16294,0.13542,0.11403,0,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.10845,0.13229,0.098804,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.22568,0.13169,0.078934,0,1
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.10654,0.12984,0.080639,0,1
1,GO LYMPHOCYTE COSTIMULATION,0.087232,0.12944,0.083376,0,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.079444,0.1288,0.1088,0,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.065563,0.12816,0.11208,0,1
1,GO MUSCLE HYPERTROPHY,0.26847,0.12741,0.067988,0,1
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.27611,0.12563,0.042785,0,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.23937,0.12541,0.14478,0,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.077957,0.12518,0.10841,0,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.19393,0.12487,0.13492,0,1
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.50337,0.12435,0.032278,0,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.079444,0.12402,0.19242,0,1
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.31232,0.12395,0.063934,0,1
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.188,0.12381,0.18618,0,1
1,GO BICARBONATE TRANSPORT,0.19393,0.12366,0.09775,0,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.2,0.12345,0.077223,0,1
1,GO PIRNA METABOLIC PROCESS,0.16294,0.12242,0.18083,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.12237,0.056081,0,1
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.11235,0.12192,0.15859,0,1
1,GO REGULATION OF DNA BINDING,0.32938,0.12024,0.031469,0,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.066855,0.11954,0.17751,0,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.40843,0.11901,0.065299,0,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.16294,0.1182,0.1163,0,1
1,GO MIDBODY ABSCISSION,0.20621,0.11794,0.077417,0,1
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.1313,0.11659,0.11315,0,1
1,GO RESPIRATORY SYSTEM PROCESS,0.29586,0.11579,0.061797,0,1
1,GO RESPONSE TO PROSTAGLANDIN E,0.11235,0.11409,0.089505,0,1
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.14769,0.11385,0.06281,0,1
1,GO PYRUVATE METABOLIC PROCESS,0.19695,0.11358,0.055906,0,1
1,GO LAMELLIPODIUM ASSEMBLY,0.1028,0.11318,0.097976,0,1
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.072231,0.11284,0.080881,0,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.1028,0.1123,0.077747,0,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.82348,0.11207,-0.091749,0,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.22568,0.1117,0.083107,0,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.16294,0.1117,0.063844,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.30815,0.11163,0.052011,0,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.082489,0.10891,0.1609,0,1
1,GO VASODILATION,0.87833,0.10875,-0.029167,0,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.16294,0.1077,0.071777,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.35607,0.10706,0.02845,0,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.11841,0.10697,0.080299,0,1
1,GO ADHERENS JUNCTION ASSEMBLY,0.50337,0.10668,0.047887,0,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.27611,0.10653,0.063481,0,1
1,GO REGULATION OF HISTONE DEACETYLATION,0.11434,0.10638,0.096894,0,1
1,GO SPINDLE ORGANIZATION,0.063042,0.10392,0.074242,0,1
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.57857,0.10279,0.0061978,0,1
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.38888,0.10208,0.082353,0,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.082489,0.10147,0.19982,0,1
1,GO FAT CELL DIFFERENTIATION,0.072231,0.10133,0.072077,0,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.23589,0.10123,0.12168,0,1
1,GO MACROMOLECULE DEPALMITOYLATION,0.16294,0.10095,0.089225,0,1
1,GO REGULATION OF DNA REPAIR,0.10654,0.099424,0.05153,0,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.40843,0.098951,0.03544,0,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.061812,0.098875,0.10249,0,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.13583,0.098528,0.099728,0,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.11235,0.09848,0.11496,0,1
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.073629,0.098443,0.074737,0,1
1,GO REGULATION OF PROTEIN SUMOYLATION,0.30815,0.097492,0.077012,0,1
1,GO CYTOKINESIS,0.075049,0.096771,0.073018,0,1
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.10465,0.096206,0.079772,0,1
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.093897,0.095769,0.053561,0,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.10654,0.094172,0.091401,0,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.188,0.093582,0.039082,0,1
1,GO VIRAL BUDDING,0.055956,0.092451,0.089788,0,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.25363,0.091926,0.075745,0,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.065563,0.090947,0.06476,0,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.068167,0.08894,0.085073,0,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.070855,0.088742,0.076408,0,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.054842,0.088145,0.13002,0,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.12049,0.087658,0.077686,0,1
1,GO REPLACEMENT OSSIFICATION,0.12908,0.087243,0.16139,0,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.10845,0.087243,0.12852,0,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.22568,0.086746,0.035836,0,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.079444,0.085605,0.098102,0,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.23245,0.082826,0.056502,0,1
1,GO LEUKOCYTE CHEMOTAXIS,0.099158,0.082507,0.12073,0,1
1,GO METAPHASE PLATE CONGRESSION,0.2,0.080379,0.063396,0,1
1,GO RESPONSE TO INSULIN,0.15517,0.076314,0.030037,0,1
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.076492,0.0758,0.066578,0,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.10465,0.074587,0.10051,0,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.072231,0.074367,0.10508,0,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.17653,0.073479,0.061258,0,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.188,0.07217,0.085023,0,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.076492,0.07176,0.068469,0,1
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.3746,0.071716,0.053336,0,1
1,GO HEXOSE CATABOLIC PROCESS,0.2839,0.071325,0.041609,0,1
1,GO CENTRIOLE ASSEMBLY,0.30402,0.071252,0.046187,0,1
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.14048,0.07059,0.059983,0,1
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.62732,0.069384,0.016289,0,1
1,GO STEM CELL PROLIFERATION,0.97557,0.069337,-0.031345,0,1
1,GO NEUTROPHIL CHEMOTAXIS,0.10845,0.068602,0.1691,0,1
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.29184,0.068503,0.041508,0,1
1,GO SPINDLE ASSEMBLY,0.097379,0.067873,0.046795,0,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.087232,0.067642,0.074867,0,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.099158,0.065762,0.062034,0,1
1,GO RESPONSE TO RADIATION,0.05824,0.064521,0.050433,0,1
1,GO HOMEOSTATIC PROCESS,0.12473,0.062829,0.028966,0,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0695,0.062647,0.089724,0,1
1,GO CHROMOSOME SEPARATION,0.054842,0.062233,0.098427,0,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.057089,0.061272,0.10827,0,1
1,GO CALCINEURIN MEDIATED SIGNALING,0.35607,0.060444,0.029641,0,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.079444,0.057616,0.06884,0,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.24643,0.057541,0.041682,0,1
1,GO PROTEIN MONOUBIQUITINATION,0.29992,0.057527,0.037787,0,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.16294,0.055695,0.035008,0,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.075049,0.055534,0.080324,0,1
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.19695,0.055,0.054741,0,1
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.22905,0.054678,0.028022,0,1
1,GO T CELL LINEAGE COMMITMENT,0.26098,0.052976,0.068055,0,1
1,GO NEGATIVE REGULATION OF GROWTH,0.12473,0.051856,0.05642,0,1
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.1313,0.051834,0.061579,0,1
1,GO DNA CATABOLIC PROCESS,0.17099,0.050874,0.027909,0,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.16294,0.050787,0.02674,0,1
1,GO REGULATION OF CELL SHAPE,0.090515,0.050017,0.10213,0,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.13814,0.049955,0.031492,0,1
1,GO DNA REPAIR,0.079444,0.049007,0.044163,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.54903,0.047304,0.02936,0,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.060602,0.047153,0.08024,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.25001,0.045849,0.027423,0,1
1,GO CELL CYCLE CHECKPOINT,0.16559,0.043875,0.029439,0,1
1,GO CHROMOSOME SEGREGATION,0.26098,0.043665,0.039183,0,1
1,GO DNA RECOMBINATION,0.1313,0.041885,0.049694,0,1
1,GO DNA INTEGRITY CHECKPOINT,0.27611,0.040682,0.031307,0,1
1,GO CERAMIDE METABOLIC PROCESS,0.17934,0.040467,0.020826,0,1
1,GO ORGANELLE ASSEMBLY,0.063042,0.039794,0.044152,0,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.36991,0.038082,0.080959,0,1
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.25001,0.036958,0.025815,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE,0.63354,0.028793,0.002547,0,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.42347,0.026009,0.02721,0,1
1,GO SKIN MORPHOGENESIS,4.1617e-05,0.50895,0.70181,0,0
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.00036427,0.47379,0.49039,0,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0013054,0.36729,0.45634,0,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0001165,0.35638,0.38927,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.021165,0.35445,0.35448,0,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00047456,0.34091,0.43601,0,0
1,GO NADPH REGENERATION,0.00013917,0.33842,0.34121,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.060602,0.33581,0.25458,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00024286,0.31185,0.40798,0,0
1,GO HEPARIN METABOLIC PROCESS,0.0028141,0.29926,0.38995,0,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.009256,0.29657,0.25754,0,0
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00023468,0.29,0.2791,0,0
1,GO PROTEIN HYDROXYLATION,0.0062634,0.2873,0.36063,0,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0017641,0.28595,0.27531,0,0
1,GO PROSTATIC BUD FORMATION,0.0071468,0.28454,0.39466,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.097379,0.27353,0.20381,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.077957,0.27275,0.17164,0,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.012508,0.26606,0.2532,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00047456,0.26352,0.4075,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0057817,0.26309,0.32674,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.033166,0.25147,0.48299,0,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.025414,0.25068,0.28347,0,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.16294,0.24512,0.20263,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.60272,0.24453,0.092016,0,0
1,GO OXYGEN TRANSPORT,0.55487,0.23956,0.10032,0,0
1,GO ACTIN FILAMENT SEVERING,0.20621,0.23799,0.11971,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.063042,0.23247,0.13935,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.077957,0.22974,0.16227,0,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.095625,0.22955,0.17946,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.43883,0.21983,0.11758,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.034637,0.21877,0.30633,0,0
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.025414,0.21811,0.17751,0,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0695,0.21642,0.14191,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.0051916,0.2164,0.37149,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.093897,0.21476,0.16171,0,0
1,GO REGULATION OF HEART MORPHOGENESIS,0.027803,0.20823,0.23139,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.19095,0.20562,0.20808,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,0.20254,0.17264,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.095625,0.20154,0.21827,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.043763,0.20151,0.17615,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.14526,0.19991,0.11639,0,0
1,GO FOREBRAIN MORPHOGENESIS,0.15264,0.19702,0.13491,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.12049,0.19631,0.1193,0,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.092194,0.19458,0.15813,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.10845,0.19439,0.15918,0,0
1,GO INTERLEUKIN 5 PRODUCTION,0.059411,0.19106,0.20307,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.33373,0.18944,0.094232,0,0
1,GO GAS TRANSPORT,0.15773,0.18942,0.18834,0,0
1,GO HEMOGLOBIN METABOLIC PROCESS,0.065563,0.18885,0.14405,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.15015,0.18834,0.33731,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.015574,0.18789,0.20187,0,0
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0039469,0.18589,0.21415,0,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0069616,0.1858,0.24856,0,0
1,GO REGULATION OF RECEPTOR BINDING,0.044685,0.18577,0.26225,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.05161,0.18388,0.14181,0,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0087944,0.18297,0.36444,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.3746,0.18294,0.109,0,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.12908,0.1812,0.12533,0,0
1,GO RENAL FILTRATION,0.088862,0.18115,0.23312,0,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.020205,0.18114,0.14962,0,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.37932,0.18053,0.088586,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.066855,0.17896,0.2535,0,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.60272,0.17827,0.039462,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.4598,0.17727,0.0809,0,0
1,GO HEPATOCYTE DIFFERENTIATION,0.29992,0.17548,0.14129,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.16032,0.17461,0.10197,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.10654,0.17272,0.088649,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.1313,0.17129,0.16219,0,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.43883,0.17115,0.063934,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.27227,0.17093,0.13248,0,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.070855,0.16894,0.17492,0,0
1,GO EMBRYONIC EYE MORPHOGENESIS,0.077957,0.16865,0.15575,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.016734,0.1675,0.21204,0,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.22905,0.16522,0.097377,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.94073,0.16482,-0.019596,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.38888,0.16444,0.09162,0,0
1,GO MIDGUT DEVELOPMENT,0.10465,0.16436,0.19942,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.10845,0.16402,0.22762,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.05161,0.16328,0.21767,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.31232,0.16245,0.083888,0,0
1,GO LAMELLIPODIUM MORPHOGENESIS,0.52594,0.16161,0.087153,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.56075,0.1614,0.068467,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.17934,0.1609,0.20304,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.25001,0.16076,0.15662,0,0
1,GO BONE DEVELOPMENT,0.00047456,0.16064,0.18843,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.063042,0.15917,0.13268,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.54321,0.15896,0.082877,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.21905,0.15862,0.07857,0,0
1,GO NEUROBLAST DIVISION,0.25001,0.15779,0.16257,0,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.12908,0.15739,0.3137,0,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.02843,0.15712,0.17911,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.23589,0.15701,0.23096,0,0
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.27999,0.15663,0.093452,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.077957,0.15501,0.19211,0,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.1313,0.15463,0.15315,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.26471,0.15438,0.19732,0,0
1,GO RRNA 3 END PROCESSING,0.011326,0.15438,0.16464,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.35607,0.15404,0.08085,0,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.050569,0.15363,0.20207,0,0
1,GO REGULATION OF ANOIKIS,0.10845,0.15337,0.16006,0,0
1,GO ANIMAL ORGAN FORMATION,0.0695,0.15173,0.14211,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.188,0.15129,0.086671,0,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.0695,0.14828,0.12596,0,0
1,GO LIPID DIGESTION,0.16032,0.14786,0.12269,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.11636,0.14717,0.091889,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.17099,0.14699,0.073951,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.013798,0.14695,0.23566,0,0
1,GO AMINO ACID IMPORT,0.19095,0.1466,0.14546,0,0
1,GO HEART VALVE DEVELOPMENT,0.0033369,0.14631,0.24859,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.16828,0.1452,0.076321,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.085627,0.14491,0.1868,0,0
1,GO REGULATION OF GTP BINDING,0.14048,0.14481,0.15628,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.20937,0.14451,0.081763,0,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.061812,0.14355,0.17811,0,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.15773,0.14349,0.11378,0,0
1,GO INCLUSION BODY ASSEMBLY,0.61497,0.14277,0.0073637,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.76948,0.14273,-0.00072397,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.68418,0.14146,0.055941,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.063042,0.14115,0.10789,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.16032,0.14059,0.07187,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.26471,0.14034,0.10196,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.21579,0.14025,0.071216,0,0
1,GO PROTEIN ADP RIBOSYLATION,0.16032,0.14008,0.1014,0,0
1,GO MYELIN MAINTENANCE,0.21905,0.13982,0.11083,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.088862,0.13972,0.1352,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.12908,0.1391,0.14465,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.46512,0.137,0.079411,0,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.077957,0.13644,0.32231,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.05824,0.13503,0.10356,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.16828,0.13479,0.10391,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.061812,0.13467,0.12044,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.087232,0.13463,0.1731,0,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.040234,0.1342,0.20488,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.26471,0.13397,0.083326,0,0
1,GO AXIS ELONGATION,0.077957,0.13301,0.13744,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.30402,0.13289,0.079803,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.33812,0.13255,0.079696,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.35607,0.13238,0.088009,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.063042,0.13238,0.13792,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.62113,0.1323,0.0331,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.1313,0.13213,0.2106,0,0
1,GO MANGANESE ION TRANSPORT,0.090515,0.132,0.12914,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.29992,0.13195,0.038239,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.042857,0.13114,0.14857,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.079444,0.13073,0.069673,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.093897,0.13027,0.13016,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.23245,0.1297,0.076474,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.14285,0.1297,0.25114,0,0
1,GO REGULATION OF PLATELET ACTIVATION,0.21256,0.12876,0.093273,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.22568,0.12852,0.11317,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.15015,0.12798,0.12929,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.33373,0.12728,0.034626,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.12259,0.12696,0.26068,0,0
1,GO REGULATION OF SENSORY PERCEPTION,0.12473,0.12648,0.085475,0,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.31653,0.12639,0.075929,0,0
1,GO RESPONSE TO HEAT,0.00040247,0.12605,0.15304,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.10465,0.12564,0.20055,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.095625,0.12534,0.13124,0,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.188,0.12451,0.10785,0,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.25363,0.12436,0.10345,0,0
1,GO MYOBLAST MIGRATION,0.28785,0.12401,0.13238,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.12908,0.12374,0.13289,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.1313,0.12339,0.121,0,0
1,GO PROTEIN KINASE C SIGNALING,0.11636,0.12293,0.085302,0,0
1,GO THIOESTER METABOLIC PROCESS,0.057089,0.1229,0.086336,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.065563,0.12289,0.23868,0,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.064293,0.1223,0.13875,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.085627,0.12193,0.090725,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.14769,0.12158,0.12378,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.68418,0.12101,0.027699,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.23937,0.12093,0.11269,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.31653,0.12067,0.073338,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.53742,0.11964,0.035321,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29992,0.11872,0.16539,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.031748,0.11871,0.10847,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.19393,0.11864,0.11208,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.86455,0.11827,0.068474,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.079444,0.11814,0.080853,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.12259,0.11808,0.12617,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.10845,0.11794,0.15673,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.27227,0.11782,0.093455,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.44924,0.1173,0.037758,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.22235,0.11702,0.15478,0,0
1,GO LYSINE METABOLIC PROCESS,0.19695,0.11698,0.11968,0,0
1,GO GOLGI LOCALIZATION,0.48131,0.11647,0.033503,0,0
1,GO RESPONSE TO ACIDIC PH,0.093897,0.11618,0.12945,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.56075,0.11603,0.12026,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.084046,0.11556,0.081034,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.047551,0.11537,0.12759,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.12689,0.11529,0.12868,0,0
1,GO DISTAL TUBULE DEVELOPMENT,0.30815,0.11471,0.17429,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.23937,0.1142,0.056891,0,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.04854,0.11413,0.12805,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.087232,0.11396,0.15431,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.14526,0.11396,0.079384,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.26847,0.11376,0.047047,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.12049,0.11324,0.086027,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.32506,0.11261,0.25964,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.079444,0.11223,0.21482,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.30815,0.11191,0.15894,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.43367,0.11182,0.13852,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.20621,0.11148,0.19037,0,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.11434,0.11112,0.061951,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.092194,0.11109,0.096257,0,0
1,GO REGULATION OF TISSUE REMODELING,0.065563,0.11089,0.098009,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.34256,0.11084,0.11602,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.064293,0.11069,0.075127,0,0
1,GO OVULATION CYCLE,0.024846,0.11029,0.13649,0,0
1,GO NEURAL CREST CELL DIFFERENTIATION,0.13583,0.11007,0.13726,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.65234,0.10974,0.072059,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.60883,0.10949,0.063227,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.055956,0.10947,0.10371,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.55487,0.10919,0.03737,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.43367,0.10911,0.084814,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.37932,0.10865,0.15328,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.31653,0.10854,0.068352,0,0
1,GO KINETOCHORE ASSEMBLY,0.32077,0.1075,0.089147,0,0
1,GO VITAMIN TRANSPORT,0.10845,0.10722,0.11207,0,0
1,GO MESENCHYME MORPHOGENESIS,0.042857,0.10713,0.22646,0,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.22235,0.10705,0.072782,0,0
1,GO EXTRACELLULAR TRANSPORT,0.24643,0.10686,0.090953,0,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.1028,0.10653,0.077411,0,0
1,GO RESPONSE TO ATP,0.0049174,0.10628,0.12389,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.86455,0.10606,-0.10207,0,0
1,GO OVULATION CYCLE PROCESS,0.19695,0.10602,0.081857,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.25363,0.10591,0.04846,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.39371,0.1057,0.071163,0,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.072231,0.10544,0.084126,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.32506,0.10539,0.087845,0,0
1,GO NEGATIVE T CELL SELECTION,0.084046,0.10499,0.14839,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.65234,0.10409,0.11155,0,0
1,GO REGULATION OF ATPASE ACTIVITY,0.026586,0.10408,0.10074,0,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.10465,0.10378,0.12541,0,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.27611,0.10288,0.056879,0,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.25001,0.10259,0.057207,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.14048,0.10245,0.1061,0,0
1,GO PERICARDIUM DEVELOPMENT,0.033166,0.10224,0.1954,0,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.082489,0.10153,0.27005,0,0
1,GO LACTATION,0.033166,0.10132,0.14073,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.11039,0.10117,0.15097,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.20309,0.10115,0.041958,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.24288,0.10069,0.063152,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.19393,0.10057,0.11285,0,0
1,GO MEIOTIC SPINDLE ORGANIZATION,0.088862,0.10051,0.10023,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.33812,0.1004,0.11036,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.059411,0.10014,0.15523,0,0
1,GO GLIAL CELL MIGRATION,0.12049,0.09957,0.12826,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.021165,0.09938,0.21723,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.25001,0.098765,0.052307,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.18508,0.09799,0.097184,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.090515,0.097647,0.17087,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.007729,0.097529,0.17094,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.14285,0.097103,0.12077,0,0
1,GO STEROL METABOLIC PROCESS,0.13583,0.097022,0.054633,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.070855,0.096499,0.14385,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.50896,0.096437,0.062986,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.34702,0.095885,0.049262,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.43883,0.095781,0.05609,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.19695,0.09568,0.14594,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.070855,0.095178,0.11618,0,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.18508,0.095138,0.055495,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.8303,0.094931,0.064956,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.087232,0.094865,0.098757,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.1028,0.094705,0.072006,0,0
1,GO RESPONSE TO VITAMIN,0.11636,0.093502,0.11615,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.32506,0.093484,0.050138,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.24643,0.093299,0.074724,0,0
1,GO ERYTHROCYTE MATURATION,0.085627,0.093218,0.13291,0,0
1,GO REGULATION OF T CELL MIGRATION,0.19695,0.092845,0.094724,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.15773,0.092789,0.034127,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.61497,0.092606,0.010971,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.097379,0.092186,0.090381,0,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.14048,0.09215,0.052793,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.05824,0.091843,0.076885,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.12689,0.091513,0.092445,0,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.25729,0.09109,0.086686,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.12259,0.091034,0.056112,0,0
1,GO ALANINE TRANSPORT,0.59059,0.090932,0.047673,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.038561,0.090919,0.13672,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.60272,0.090574,0.079988,0,0
1,GO GLIAL CELL DEVELOPMENT,0.34256,0.090275,0.033547,0,0
1,GO LAMELLIPODIUM ORGANIZATION,0.063042,0.09014,0.12011,0,0
1,GO IMP METABOLIC PROCESS,0.18508,0.089957,0.19421,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.71006,0.088947,0.023485,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.36064,0.088726,0.065905,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.066855,0.088713,0.15313,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.56666,0.088084,0.042349,0,0
1,GO DIOL METABOLIC PROCESS,0.32506,0.088059,0.044342,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.16032,0.087887,0.094476,0,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.10654,0.087804,0.095602,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.56075,0.087562,0.047134,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.2,0.087491,0.084783,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.23937,0.0864,0.021985,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.24643,0.086393,0.14993,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.50896,0.086282,0.062856,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.65866,0.086149,0.027639,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.082489,0.08614,0.10517,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.22905,0.085922,0.10513,0,0
1,GO CELLULAR PIGMENTATION,0.15773,0.085719,0.045731,0,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.24288,0.085343,0.10253,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.064293,0.085319,0.24199,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.41341,0.085043,0.031635,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.19095,0.084933,0.12843,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.027803,0.084929,0.16125,0,0
1,GO CHROMOSOME LOCALIZATION,0.21256,0.084605,0.075275,0,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.13583,0.084058,0.070514,0,0
1,GO L AMINO ACID TRANSPORT,0.44924,0.084034,0.077328,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.082489,0.083955,0.12652,0,0
1,GO RECEPTOR INTERNALIZATION,0.050569,0.083887,0.085122,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.15264,0.083799,0.12473,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.13814,0.083694,0.093472,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.024288,0.083651,0.079901,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.20937,0.083126,0.055095,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.13814,0.083004,0.14693,0,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.16294,0.082716,0.056356,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32938,0.082643,0.032691,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.21579,0.082441,0.065259,0,0
1,GO RESPONSE TO CADMIUM ION,0.62732,0.082228,0.055506,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.44924,0.082228,0.034215,0,0
1,GO RESPONSE TO IRON ION,0.17374,0.08222,0.067146,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.18219,0.082075,0.14792,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.26471,0.08165,0.079373,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.057089,0.08151,0.088758,0,0
1,GO REGULATION OF SPINDLE ORGANIZATION,0.04854,0.081368,0.089792,0,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0695,0.081139,0.066926,0,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.14048,0.081131,0.11868,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.10845,0.080977,0.11159,0,0
1,GO STEROID METABOLIC PROCESS,0.1028,0.080366,0.062414,0,0
1,GO FATTY ACID TRANSPORT,0.085627,0.080255,0.063295,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.31653,0.079901,0.062735,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.33812,0.079801,0.059483,0,0
1,GO TONGUE MORPHOGENESIS,0.27999,0.079797,0.14838,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.05161,0.07979,0.094005,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.12908,0.079256,0.1438,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.14048,0.079231,0.085935,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.27999,0.079112,0.082747,0,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.027188,0.07911,0.06214,0,0
1,GO MICROVILLUS ASSEMBLY,0.85768,0.078632,0.0019761,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.50896,0.078468,0.19351,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.20309,0.078466,0.069175,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.26847,0.07803,0.044171,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.55487,0.077932,0.070106,0,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.12259,0.07755,0.041916,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.55487,0.077536,0.041454,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.91293,0.077465,-0.026736,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.17653,0.077431,0.061817,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.40843,0.077346,0.031296,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36526,0.077045,0.063672,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.061812,0.076946,0.11948,0,0
1,GO AORTA DEVELOPMENT,0.17934,0.07674,0.18353,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.55487,0.076562,0.026035,0,0
1,GO B CELL APOPTOTIC PROCESS,0.69707,0.076486,0.0051204,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.12049,0.076399,0.14273,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.62113,0.076365,0.10189,0,0
1,GO RNA INTERFERENCE,0.62113,0.076106,0.034759,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.20937,0.075809,0.13604,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.24643,0.075745,0.05934,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.78962,0.075619,0.031212,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.58456,0.07555,0.040815,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.095625,0.075186,0.074886,0,0
1,GO BASE EXCISION REPAIR,0.15517,0.075158,0.086171,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.14285,0.075131,0.10729,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.063042,0.074679,0.069652,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.35607,0.074417,0.10311,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.074391,0.064325,0,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0062634,0.074384,0.070916,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.23245,0.074333,0.051506,0,0
1,GO NUCLEOTIDE TRANSPORT,0.31653,0.074217,0.027847,0,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.063042,0.074194,0.085917,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.46512,0.074184,0.03092,0,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.16294,0.074101,0.08238,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.44924,0.0741,0.072984,0,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.10465,0.074033,0.1129,0,0
1,GO TRNA CATABOLIC PROCESS,0.41842,0.073786,0.094132,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.24288,0.073711,0.042626,0,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.71006,0.073515,0.0089606,0,0
1,GO MITOCHONDRION ORGANIZATION,0.0021062,0.073405,0.080775,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.30402,0.073171,0.039597,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.32077,0.07276,0.11759,0,0
1,GO RNA STABILIZATION,0.16032,0.072717,0.072005,0,0
1,GO KETONE CATABOLIC PROCESS,0.61497,0.072333,0.051931,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.33373,0.072214,0.11015,0,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.12908,0.07213,0.11107,0,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.91987,0.071516,-0.0058567,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.16559,0.071422,0.065225,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.98255,0.071333,-0.06878,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.42855,0.071277,0.15114,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.71658,0.071167,0.060713,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.16828,0.071149,0.10579,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.022165,0.071122,0.13938,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.27999,0.071092,0.15313,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.53167,0.070978,0.075317,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.095625,0.070703,0.14634,0,0
1,GO FERTILIZATION,0.13583,0.070662,0.049269,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.8303,0.070555,0.06688,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.32938,0.070513,0.092788,0,0
1,GO MRNA 3 END PROCESSING,0.12049,0.070501,0.063362,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.061812,0.070464,0.070357,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.21256,0.070447,0.13714,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.47588,0.070378,0.026343,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.2,0.07032,0.095553,0,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.12049,0.070136,0.11444,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.71006,0.069739,0.066401,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.50337,0.069735,0.033568,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.26471,0.069678,0.09622,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.61497,0.06956,0.095055,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.14285,0.069457,0.10106,0,0
1,GO REGULATION OF CENTROSOME CYCLE,0.20937,0.069149,0.050866,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.15517,0.0691,0.079871,0,0
1,GO LIVER MORPHOGENESIS,0.25729,0.068979,0.10696,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.11636,0.068915,0.15636,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.13355,0.068668,0.095693,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.22568,0.068473,0.064645,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.80312,0.068318,0.11032,0,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.066855,0.068286,0.10722,0,0
1,GO STEM CELL DIVISION,0.17934,0.068002,0.10705,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.29184,0.067924,0.061342,0,0
1,GO CHOLESTEROL STORAGE,0.17653,0.067769,0.15961,0,0
1,GO RESPONSE TO AMYLOID BETA,0.2,0.067672,0.14942,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.53742,0.067591,0.046303,0,0
1,GO CELLULAR RESPONSE TO DRUG,0.10465,0.067579,0.087393,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.36064,0.067345,0.061284,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.19393,0.067292,0.039121,0,0
1,GO MAMMARY GLAND DEVELOPMENT,0.11235,0.067228,0.097319,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.092194,0.067221,0.13934,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.50337,0.06705,0.062115,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.33373,0.066986,0.10068,0,0
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.49227,0.066944,0.0097325,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.090515,0.066769,0.075646,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.60272,0.066711,0.02991,0,0
1,GO MYOTUBE DIFFERENTIATION,0.15773,0.066491,0.095633,0,0
1,GO NEURON PROJECTION REGENERATION,0.47049,0.066317,0.040324,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.30815,0.06614,0.12281,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.12689,0.066134,0.060537,0,0
1,GO PLASMA MEMBRANE FUSION,0.27999,0.065842,0.10283,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.75615,0.065827,0.034885,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.46512,0.065718,0.016525,0,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14285,0.065694,0.060138,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.29992,0.065481,0.040812,0,0
1,GO OOCYTE MATURATION,0.42855,0.065429,0.032505,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.54903,0.065299,0.010244,0,0
1,GO RESPONSE TO ESTRADIOL,0.087232,0.065103,0.091672,0,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.11841,0.064836,0.054758,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.49227,0.064772,0.070959,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.72969,0.064752,0.0054394,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.24643,0.064411,0.049249,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.38888,0.064383,0.05099,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.63978,0.064293,0.02598,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.26098,0.064231,0.060278,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.088862,0.063428,0.0614,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.066855,0.063351,0.044495,0,0
1,GO ENSHEATHMENT OF NEURONS,0.28785,0.063347,0.037317,0,0
1,GO TISSUE HOMEOSTASIS,0.12473,0.062816,0.051686,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13814,0.062551,0.051139,0,0
1,GO KINETOCHORE ORGANIZATION,0.5726,0.062385,0.035934,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17934,0.062181,0.069618,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.20309,0.062121,0.093218,0,0
1,GO GOLGI RIBBON FORMATION,0.65234,0.062114,0.037936,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.68418,0.061868,0.053248,0,0
1,GO ARTERY DEVELOPMENT,0.02068,0.061505,0.2173,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.54903,0.061312,0.018493,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.50896,0.061298,0.051389,0,0
1,GO EPITHELIUM DEVELOPMENT,0.17934,0.060936,0.047967,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0097392,0.060909,0.12475,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.12908,0.060884,0.082691,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.10096,0.0607,0.050495,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.57857,0.060692,0.030436,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.35153,0.060584,0.091749,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.16294,0.060474,0.19003,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.11841,0.060463,0.14668,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.65866,0.06035,0.010757,0,0
1,GO RESPONSE TO CAMP,0.12689,0.059979,0.11756,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.25363,0.059764,0.13222,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.67137,0.059643,0.050826,0,0
1,GO PANCREATIC JUICE SECRETION,0.57857,0.05948,0.065817,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.52594,0.059449,0.026775,0,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.46512,0.059334,0.01338,0,0
1,GO ION HOMEOSTASIS,0.17934,0.059062,0.037533,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.40843,0.058957,0.034407,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.043763,0.058932,0.045445,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.39858,0.058786,0.036646,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.7495,0.058707,0.0025744,0,0
1,GO REGULATION OF EXCRETION,0.91987,0.05854,0.0070861,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.63978,0.05851,-0.0053909,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.084046,0.058204,0.061145,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.80989,0.057978,-0.021497,0,0
1,GO DNA GEOMETRIC CHANGE,0.26471,0.057954,0.058184,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.74288,0.057914,0.031406,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.53167,0.057816,-0.13911,0,0
1,GO RESPIRATORY BURST,0.72313,0.057569,0.0011998,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.30815,0.057302,0.021355,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.15517,0.057223,0.068088,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.90599,0.056063,-0.021834,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.13355,0.055547,0.065566,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.24643,0.055352,0.038653,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.69061,0.05526,0.019914,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.32938,0.055073,0.17989,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.63978,0.054994,0.04363,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.27999,0.054943,0.1001,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.7495,0.054901,0.031075,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.15773,0.054766,0.081468,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.22568,0.054578,0.040639,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.44402,0.054485,0.033154,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.20621,0.054434,0.12439,0,0
1,GO MUSCLE SYSTEM PROCESS,0.25729,0.054403,0.04636,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.21579,0.054331,0.053808,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.90599,0.054213,0.023918,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.11636,0.054191,0.086215,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.67776,0.054103,0.057803,0,0
1,GO LOCOMOTOR RHYTHM,0.65234,0.054025,0.046342,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.32938,0.053877,0.098268,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.36526,0.052544,0.060023,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.41842,0.052543,0.035842,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.84397,0.052478,-0.0070997,0,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.072231,0.052343,0.088751,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.088862,0.052266,0.069732,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.11841,0.052215,0.0631,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.27611,0.052113,0.074099,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.50337,0.05192,0.037235,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.12689,0.051703,0.063831,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.63354,0.051594,0.019537,0,0
1,GO HISTONE H3 DEACETYLATION,0.32938,0.051391,0.063919,0,0
1,GO POSITIVE REGULATION OF CELL DIVISION,0.47049,0.051367,0.067295,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.2839,0.051331,0.10316,0,0
1,GO REGULATION OF CELL DIVISION,0.33812,0.051171,0.038267,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.11434,0.051148,0.082514,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.23937,0.051116,0.052392,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.29184,0.051051,0.092501,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.23245,0.05094,0.070655,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.097379,0.050728,0.061428,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.47588,0.050559,0.057458,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.62732,0.050414,0.060023,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.11235,0.0504,0.055645,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.059411,0.050216,0.065512,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.36991,0.050143,0.091291,0,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.4545,0.050112,0.036711,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.16828,0.050024,0.044365,0,0
1,GO PROTEIN DESTABILIZATION,0.4545,0.04981,0.023951,0,0
1,GO DNA REPLICATION INITIATION,0.72313,0.049697,-0.0069126,0,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.67137,0.049643,0.091249,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.74288,0.049473,0.030579,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.20937,0.049442,0.080159,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.21905,0.049376,0.040427,0,0
1,GO PEPTIDYL THREONINE MODIFICATION,0.24288,0.049332,0.047811,0,0
1,GO CELL MOTILITY,0.073629,0.049224,0.076765,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.22235,0.048978,0.077764,0,0
1,GO ANOIKIS,0.5726,0.048974,0.0503,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.24643,0.048877,0.040528,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.67137,0.048794,0.038577,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.91293,0.048757,-0.025475,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.060602,0.048658,0.10695,0,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.11039,0.048559,0.098757,0,0
1,GO MALE SEX DIFFERENTIATION,0.65234,0.048441,0.017508,0,0
1,GO TRANSCYTOSIS,0.36991,0.048409,0.078743,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.99651,0.048383,-0.00013636,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.41842,0.048339,0.047825,0,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.27999,0.04814,0.079436,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.2839,0.048077,0.053565,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.088862,0.047968,0.039568,0,0
1,GO EPITHELIAL TUBE FORMATION,0.50337,0.047891,0.035929,0,0
1,GO RUFFLE ASSEMBLY,0.40349,0.047816,0.044435,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.20309,0.047639,0.039249,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.088862,0.047637,0.083442,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.30402,0.047564,0.077729,0,0
1,GO DOUBLE STRAND BREAK REPAIR,0.088862,0.047564,0.049239,0,0
1,GO REGULATION OF CYTOKINESIS,0.47049,0.047283,0.018723,0,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.32077,0.047151,0.048676,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.33812,0.047077,0.046375,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.88523,0.047057,0.00096878,0,0
1,GO RESPONSE TO COPPER ION,0.77618,0.04697,0.02506,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.16294,0.04664,0.088805,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.057089,0.046604,0.058523,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.16559,0.046237,0.050783,0,0
1,GO MRNA EXPORT FROM NUCLEUS,0.090515,0.046232,0.060956,0,0
1,GO PRO B CELL DIFFERENTIATION,0.78962,0.045908,-0.035044,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.48131,0.045858,0.060892,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.47049,0.045846,0.045905,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.34702,0.045615,0.060321,0,0
1,GO NEGATIVE CHEMOTAXIS,0.188,0.045497,0.14192,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.11841,0.045444,0.05312,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.84397,0.045369,-0.028468,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.96163,0.045201,-0.0030665,0,0
1,GO TRANSFERRIN TRANSPORT,0.79636,0.045175,-0.0010626,0,0
1,GO MITOCHONDRIAL FISSION,0.29586,0.044935,0.048215,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.69707,0.044651,0.013332,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.5726,0.044629,0.031367,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.54903,0.044512,0.048178,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.79636,0.0444,0.039958,0,0
1,GO CELLULAR HOMEOSTASIS,0.10096,0.04418,0.044569,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.21256,0.044159,0.022807,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.18508,0.044062,0.051579,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.25363,0.043989,0.069372,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.17099,0.043982,0.10274,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.52594,0.043754,0.045968,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.11636,0.043738,0.13464,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.12689,0.043689,0.14184,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.31232,0.04366,0.06129,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.29184,0.043531,0.060339,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.1313,0.043496,0.042931,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.77618,0.043435,0.037402,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.16828,0.043285,0.060478,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.47588,0.043121,0.022603,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.21905,0.043,0.050397,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.42347,0.04277,0.0531,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.26098,0.042622,0.050277,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.55487,0.042468,0.020539,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.90599,0.042384,-0.00028044,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.51459,0.042183,0.02047,0,0
1,GO REGULATION OF CELL SIZE,0.65234,0.042108,0.0071955,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.22568,0.042066,0.034127,0,0
1,GO RESPONSE TO ALCOHOL,0.53742,0.042002,0.019609,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.1313,0.041995,0.21998,0,0
1,GO POSITIVE REGULATION OF CELL SIZE,0.63354,0.041856,0.095407,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.89907,0.041772,-0.0086772,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.32506,0.041551,0.025852,0,0
1,GO NEGATIVE REGULATION OF BINDING,0.16032,0.04134,0.065497,0,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.14285,0.041264,0.11218,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.92682,0.041101,0.0065719,0,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.093897,0.040901,0.07284,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.41341,0.040883,0.032442,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.77618,0.040871,0.011621,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.14769,0.040681,0.088557,0,0
1,GO PROTEIN TRIMERIZATION,0.59664,0.040629,0.052557,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.53167,0.040472,0.047087,0,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.093897,0.040393,0.038944,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.4598,0.040373,0.022809,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.16828,0.040313,0.064111,0,0
1,GO REGULATION OF GTPASE ACTIVITY,0.25363,0.040283,0.03492,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.15517,0.040215,0.047269,0,0
1,GO MALE GENITALIA DEVELOPMENT,1,0.040092,-0.022296,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.85082,0.040087,0.027962,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.44402,0.040079,0.0047505,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.65866,0.040058,0.018836,0,0
1,GO ENDOCRINE PROCESS,0.066855,0.039995,0.10289,0,0
1,GO ACTIN FILAMENT BASED PROCESS,0.2,0.039949,0.053625,0,0
1,GO MICROTUBULE NUCLEATION,0.38408,0.039848,0.051961,0,0
1,GO POSITIVE REGULATION OF SIGNALING,0.066855,0.039844,0.054149,0,0
1,GO TUBE FORMATION,0.22568,0.039844,0.058583,0,0
1,GO MRNA METHYLATION,0.63354,0.039841,0.027471,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.61497,0.039831,0.057287,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.24288,0.039747,0.075452,0,0
1,GO B CELL PROLIFERATION,0.90599,0.039737,-0.014099,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.72313,0.039736,-0.0088432,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.43367,0.039603,0.071628,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.80989,0.039554,0.013733,0,0
1,GO DENDRITIC CELL MIGRATION,0.9686,0.039529,0.010452,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.36064,0.0392,0.071859,0,0
1,GO REPRODUCTION,0.14048,0.039184,0.032425,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.16294,0.039071,0.045067,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.20309,0.038978,0.053381,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.66501,0.038977,-0.031101,0,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.18219,0.038318,0.12908,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.65234,0.038298,0.03108,0,0
1,GO METAL ION HOMEOSTASIS,0.23245,0.038153,0.036573,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.63978,0.038113,0.042426,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.4598,0.037627,0.028243,0,0
1,GO MEMBRANE FUSION,0.44402,0.037534,0.020579,0,0
1,GO SKIN DEVELOPMENT,0.52025,0.037221,0.059136,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.46512,0.036966,0.028764,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.52594,0.036842,0.032691,0,0
1,GO ERYTHROCYTE DEVELOPMENT,0.22905,0.036614,0.08235,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.98255,0.036457,0.029875,0,0
1,GO CENTROSOME DUPLICATION,0.78962,0.036272,0.004328,0,0
1,GO SULFATION,0.59059,0.036169,0.052362,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.96163,0.036169,-0.0258,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.78962,0.035562,0.031172,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.23245,0.035552,0.04285,0,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.26098,0.035533,0.038325,0,0
1,GO BIOMINERALIZATION,0.14048,0.035428,0.12156,0,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,0.035321,0.046739,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.23937,0.03527,0.034216,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.44924,0.035223,0.10251,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.54903,0.035127,0.022774,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.37932,0.035091,0.059514,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.32077,0.03497,0.02398,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.62732,0.034685,-0.00049648,0,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.50337,0.034595,0.030248,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.29586,0.03421,0.022318,0,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.12049,0.03392,0.084867,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.76948,0.033795,-0.00071626,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.35607,0.033668,0.10238,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.51459,0.033559,0.066544,0,0
1,GO SPECIFICATION OF SYMMETRY,0.26471,0.033546,0.039967,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.64605,0.033414,0.02696,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.33373,0.033387,0.04946,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.9686,0.033207,0.013955,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.2839,0.033006,0.048915,0,0
1,GO JNK CASCADE,0.15773,0.032793,0.038421,0,0
1,GO NEPHRON DEVELOPMENT,0.17934,0.032651,0.096677,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.52025,0.032148,0.06264,0,0
1,GO MITOCHONDRIAL FUSION,0.33373,0.031797,0.041076,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.54321,0.03173,0.11713,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.57857,0.031617,0.022117,0,0
1,GO GLUCOSE IMPORT,0.71658,0.031488,0.005797,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.69707,0.031395,-0.069411,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.070855,0.031338,0.092141,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.24643,0.0312,0.1189,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.53167,0.031014,0.044346,0,0
1,GO PHOSPHATE ION TRANSPORT,0.80312,0.030929,0.012072,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.4598,0.030895,0.020184,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.68418,0.030814,0.013046,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.95466,0.030713,-0.0049192,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.92682,0.030653,0.0033961,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.87144,0.030331,-0.027075,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.53742,0.030157,0.0031553,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.62732,0.030023,0.025107,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.80312,0.029976,0.028291,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.188,0.029968,0.092584,0,0
1,GO PROSTAGLANDIN SECRETION,0.26471,0.029937,0.087974,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.80312,0.029717,0.00038657,0,0
1,GO APPENDAGE DEVELOPMENT,0.64605,0.029515,0.027199,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.88523,0.029486,-0.0081766,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.48678,0.029442,0.050947,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.62113,0.029399,0.032045,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.79636,0.029383,0.0080157,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.42347,0.029363,0.02422,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.22905,0.029231,0.085373,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.2,0.029192,0.10233,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.16294,0.029191,0.15497,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.40349,0.029166,0.027602,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.87833,0.029123,-0.0039705,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.62113,0.029074,0.0065472,0,0
1,GO NUCLEAR MIGRATION,0.93377,0.029066,0.0193,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.56666,0.029055,0.028493,0,0
1,GO LACTATE METABOLIC PROCESS,0.71006,0.029039,0.021059,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.85768,0.028968,0.009252,0,0
1,GO DNA MODIFICATION,0.29184,0.028473,0.042023,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.15264,0.028455,0.059269,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.27999,0.028427,0.084526,0,0
1,GO SECONDARY METABOLIC PROCESS,0.37932,0.028233,0.088464,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.39858,0.028218,0.062465,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.75615,0.028199,0.015488,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.2839,0.028118,0.038014,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.5726,0.028081,0.040894,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.96163,0.027909,-0.007202,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.17653,0.02784,0.039674,0,0
1,GO MRNA MODIFICATION,0.60883,0.027591,0.048024,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.21579,0.027561,0.10468,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.092194,0.027504,0.062475,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.65866,0.027445,0.025561,0,0
1,GO GLYCOSYLATION,0.66501,0.027161,-0.017612,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.67776,0.026986,0.0021563,0,0
1,GO MUSCLE ATROPHY,0.81668,0.026889,0.010289,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.79636,0.026854,-0.010616,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.56075,0.026671,0.021153,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.24643,0.026669,0.075157,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.91293,0.026561,0.028732,0,0
1,GO PROTEIN POLYMERIZATION,0.69707,0.026431,0.010821,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.41341,0.026336,0.049556,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.51459,0.026251,0.050825,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.95466,0.026228,0.00051608,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.54903,0.026094,0.070201,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.5726,0.025977,0.022893,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.65866,0.025665,0.031113,0,0
1,GO MISMATCH REPAIR,0.59664,0.02548,0.022011,0,0
1,GO OSTEOBLAST PROLIFERATION,0.36064,0.025463,0.12033,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.41842,0.025365,0.033898,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.71006,0.025247,0.017043,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.69707,0.02516,0.029632,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.47049,0.024882,0.064223,0,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.20621,0.024806,0.071579,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.44402,0.02478,0.095833,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.18508,0.024521,0.031654,0,0
1,GO CARBOHYDRATE TRANSPORT,0.44402,0.024384,0.013623,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.89215,0.024289,0.012713,0,0
1,GO EMBRYO DEVELOPMENT,0.21256,0.024158,0.041676,0,0
1,GO RESPONSE TO ACTIVITY,0.75615,0.024097,-0.0009328,0,0
1,GO QUINONE METABOLIC PROCESS,0.37932,0.024087,0.12475,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.97557,0.024042,-0.011561,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.41842,0.024001,0.052189,0,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.4545,0.023919,0.087825,0,0
1,GO RRNA CATABOLIC PROCESS,0.92682,0.023731,-0.024331,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.32077,0.023686,0.087784,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.46512,0.023612,0.049071,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.80312,0.023568,0.054916,0,0
1,GO NADH METABOLIC PROCESS,0.43367,0.02353,0.061303,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.29586,0.02337,0.029056,0,0
1,GO SINGLE FERTILIZATION,0.71658,0.023287,0.011654,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.48131,0.023176,0.054136,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.94769,0.023166,-0.0057817,0,0
1,GO B CELL DIFFERENTIATION,0.21256,0.022996,0.056474,0,0
1,GO COCHLEA MORPHOGENESIS,0.73628,0.022887,-0.0077795,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.48678,0.022786,0.02025,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.97557,0.022703,-0.0089605,0,0
1,GO RNA SPLICING,0.63978,0.022592,0.0080401,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.31232,0.022578,0.020867,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.33812,0.022432,0.012723,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.2839,0.022266,0.16389,0,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.98953,0.022174,0.009897,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.42855,0.022096,0.018538,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.64605,0.021988,0.036277,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.94769,0.021965,-0.0070756,0,0
1,GO DRUG CATABOLIC PROCESS,0.53167,0.02181,0.023337,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.76281,0.021805,-0.048653,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.88523,0.021674,-0.023005,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.62732,0.021378,0.01093,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.26098,0.021075,0.051794,0,0
1,GO MICROTUBULE ANCHORING,0.79636,0.020879,0.019314,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.87833,0.02076,0.0080166,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.21579,0.020438,0.068427,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.96163,0.020045,-0.0025561,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.67137,0.020039,0.014515,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.85768,0.01985,0.023608,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.69707,0.019845,0.012791,0,0
1,GO FUCOSE METABOLIC PROCESS,0.8303,0.019839,-0.0091742,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.71006,0.019178,0.020978,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,1,0.01895,0.002283,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.75615,0.018942,0.0025485,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.70355,0.01894,0.0093497,0,0
1,GO CYTOKINE SECRETION,0.77618,0.018768,0.021293,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.90599,0.018667,-0.00060193,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.69061,0.018625,0.0089437,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.56075,0.018377,0.070444,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.65866,0.01826,0.015314,0,0
1,GO ADULT HEART DEVELOPMENT,1,0.01822,-0.030107,0,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.39371,0.018188,0.031697,0,0
1,GO MUSCLE CONTRACTION,0.35153,0.018108,0.042246,0,0
1,GO HEART TRABECULA FORMATION,0.4978,0.017976,0.15709,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.82348,0.017843,0.0042177,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.26098,0.01762,0.10238,0,0
1,GO SISTER CHROMATID SEGREGATION,0.86455,0.017576,0.0031783,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.71006,0.017512,-0.0042411,0,0
1,GO GLAND DEVELOPMENT,0.42347,0.017313,0.035329,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.32506,0.017298,0.034547,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.9686,0.017255,-0.017783,0,0
1,GO ENDOSOMAL TRANSPORT,0.38408,0.017127,0.026196,0,0
1,GO REGULATION OF HAIR CYCLE,0.68418,0.016897,0.070304,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.91987,0.016864,-0.025242,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.92682,0.016669,-0.018206,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.76948,0.016368,0.006801,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.33373,0.016366,0.094388,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.21579,0.016291,0.13833,0,0
1,GO MRNA PROCESSING,0.7495,0.016035,0.0080762,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.41341,0.01603,0.021238,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.73628,0.015984,0.018218,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.50337,0.015852,0.045846,0,0
1,GO HISTONE EXCHANGE,0.92682,0.015696,0.021026,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.68418,0.015654,0.022526,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.81668,0.015617,0.031433,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.32938,0.015389,0.093438,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.38408,0.015227,0.039034,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.94769,0.015178,0.037365,0,0
1,GO PROTEIN SUMOYLATION,0.35607,0.014863,0.038163,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.82348,0.014857,0.0099092,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.62113,0.014734,-0.041802,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.83713,0.014732,0.017984,0,0
1,GO PHOTOPERIODISM,0.93377,0.014614,-0.014044,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.89215,0.014375,-0.0048002,0,0
1,GO SEXUAL REPRODUCTION,0.67776,0.014131,0.0073058,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.40349,0.014047,0.060356,0,0
1,GO METHIONINE METABOLIC PROCESS,0.91987,0.014042,-0.041051,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.64605,0.013635,0.028677,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.44924,0.01359,0.025111,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.88523,0.013572,-0.0055904,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.41842,0.013531,0.051677,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.95466,0.013296,-0.02341,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,1,0.013025,0.014215,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.17653,0.012996,0.042656,0,0
1,GO CELL PROJECTION ASSEMBLY,0.71658,0.012912,0.011372,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.5726,0.012867,0.022698,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.7495,0.01249,0.016509,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.67137,0.012336,0.00012518,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.63354,0.01203,-0.054257,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.44924,0.01199,0.028991,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.22235,0.011988,0.038442,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0119,0.022813,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.94073,0.011855,-0.009708,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.91987,0.011831,0.022795,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.78962,0.011725,-0.041422,0,0
1,GO APPENDAGE MORPHOGENESIS,0.92682,0.011655,-0.0095892,0,0
1,GO DNA CONFORMATION CHANGE,0.92682,0.011452,0.0037278,0,0
1,GO BLASTODERM SEGMENTATION,0.35607,0.011208,0.15433,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.7495,0.011175,0.021803,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.66501,0.011156,0.016649,0,0
1,GO DIVALENT METAL ION EXPORT,0.72313,0.011072,0.024108,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.98255,0.010802,0.0015916,0,0
1,GO CHEMICAL HOMEOSTASIS,0.78289,0.010753,0.0015527,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.91293,0.010629,-0.0073568,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.63978,0.010615,0.068215,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.20309,0.010349,0.15004,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.98255,0.010101,-0.01387,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.93377,0.010018,0.0090231,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.83713,0.009984,-0.042315,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.95466,0.00965,0.013734,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.60272,0.009575,0.012416,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.53167,0.0094272,-0.033408,0,0
1,GO CYTOSKELETON ORGANIZATION,0.4978,0.009311,0.024263,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.49227,0.0089747,0.049409,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.91987,0.0089561,0.01163,0,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.62732,0.0086611,0.022237,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.18508,0.0086104,0.053825,0,0
1,GO ARTERY MORPHOGENESIS,0.66501,0.0085965,0.12949,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,1,0.0085898,-0.0044389,0,0
1,GO NAD METABOLIC PROCESS,0.34256,0.0085115,0.086127,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.8303,0.0083418,0.011199,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.43367,0.0083347,-0.061534,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.80989,0.0082025,-0.0099773,0,0
1,GO ACTIVATED T CELL PROLIFERATION,0.57857,0.0081431,0.03065,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.94073,0.0080999,-0.0017781,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.63354,0.0080108,-0.026566,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.87144,0.0079761,0.002748,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.78289,0.0079322,0.013834,0,0
1,GO DNA REPLICATION,0.53742,0.0078542,0.0062754,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.29992,0.0078275,0.039134,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.80312,0.0074836,0.018588,0,0
1,GO HISTONE H3 ACETYLATION,0.85768,0.007064,0.0034204,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.68418,0.0068882,0.0080354,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,0.0068856,0.034519,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.58456,0.0067313,-0.019335,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.64605,0.0067251,0.023971,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.8303,0.0067018,0.0018566,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.4978,0.0066564,0.033451,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.66501,0.0066156,0.0060862,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.85768,0.0063538,0.035517,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.76281,0.0063455,0.057276,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.92682,0.006109,-0.0034292,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.87144,0.0056284,0.00085354,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.50896,0.0055483,0.050217,0,0
1,GO ZINC ION TRANSPORT,0.46512,0.0053888,0.044436,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.91987,0.0052955,-0.01884,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.50896,0.0052667,0.018458,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.80989,0.0049806,-0.035395,0,0
1,GO REGULATION OF GROWTH,0.33373,0.0047398,0.028186,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.65234,0.0046735,-0.018924,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.68418,0.0044527,0.034292,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.81668,0.0044289,0.014171,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.47588,0.0043921,0.097121,0,0
1,GO MAINTENANCE OF CELL NUMBER,0.58456,0.004237,0.036167,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.65866,0.00371,0.048458,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.88523,0.003638,0.0021152,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.72313,0.0033873,0.018999,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.8303,0.0032863,-0.020467,0,0
1,GO LYMPH NODE DEVELOPMENT,0.70355,0.0032849,0.087394,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.8303,0.0032766,0.015832,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.96163,0.0031032,0.0047769,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.62732,0.0030262,0.062565,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.72313,0.0028631,0.023348,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.90599,0.0027542,-0.011241,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,1,0.0025162,0.014011,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.67137,0.00228,-0.060115,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.72969,0.0020122,0.018914,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.55487,0.0019989,-0.083369,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.8303,0.0019248,-0.034456,0,0
1,GO ACTIN FILAMENT ORGANIZATION,0.47049,0.0018925,0.042326,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.89215,0.0018439,0.0011564,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.55487,0.0017137,0.027779,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1,0.0014288,0.022616,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.40349,0.0013746,0.071681,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,1,0.0013543,0.073888,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.87833,0.0012256,-0.056269,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.85768,0.0011268,0.0012732,0,0
1,GO MYELIN ASSEMBLY,0.72313,0.0008571,0.040872,0,0
1,GO CELL CELL ADHESION,0.48678,0.00075557,0.023761,0,0
1,GO NEPHRON TUBULE FORMATION,0.67137,0.00055891,0.049085,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.3746,0.00051687,0.042356,0,0
1,GO CENTROSOME SEPARATION,0.54321,0.00036474,0.053359,0,0
1,GO GROWTH,0.36064,-0.00016626,0.029127,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.90599,-0.00021799,-0.0058781,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.89907,-0.00023215,-0.0020739,0,0
1,GO EPIDERMIS DEVELOPMENT,0.96163,-0.00029416,0.016506,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.75615,-0.0003035,-0.033027,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.73628,-0.00031436,0.045983,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.71006,-0.00032005,-0.022769,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.67137,-0.00035819,0.041271,0,0
1,GO TAXIS,0.67137,-0.00061046,0.010416,0,0
1,GO RENAL SODIUM EXCRETION,0.65866,-0.00067146,-0.03437,0,0
1,GO PENILE ERECTION,0.91293,-0.00074146,-0.025759,0,0
1,GO REGULATION OF FERTILIZATION,0.74288,-0.00080319,0.0093199,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.60272,-0.00081044,0.051053,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.91987,-0.0010596,-0.022025,0,0
1,GO PRE MIRNA PROCESSING,0.78289,-0.0011086,0.01755,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.93377,-0.001125,0.046201,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.56075,-0.0012078,-0.018911,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.87833,-0.0013098,0.0010891,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.35607,-0.0015287,0.060418,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.60883,-0.0016425,0.066601,0,0
1,GO VIRAL LATENCY,0.98255,-0.0020848,-0.0028111,0,0
1,GO ADAPTIVE THERMOGENESIS,0.93377,-0.0021392,-0.00574,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,-0.0023256,0.072293,0,0
1,GO RESPONSE TO UV B,0.73628,-0.0023844,0.05814,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.59059,-0.0024347,-0.030608,0,0
1,GO HISTONE DEUBIQUITINATION,0.59664,-0.0027848,0.029194,0,0
1,GO RESPONSE TO STARVATION,0.84397,-0.0028254,0.0022218,0,0
1,GO RESPONSE TO BMP,0.39371,-0.0029235,0.054766,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.80312,-0.0029405,0.056498,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.96163,-0.0029491,0.0039517,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.87144,-0.0030064,-0.025886,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.60883,-0.003387,0.033092,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.98953,-0.0034284,-0.0096446,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.72313,-0.0034598,-0.027278,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.86455,-0.0035244,0.00063186,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.85768,-0.0035252,0.0060179,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.43883,-0.0035747,-0.08755,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.84397,-0.0040489,0.013079,0,0
1,GO RETINA HOMEOSTASIS,0.83713,-0.0040532,0.018812,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.96163,-0.0040781,-0.0048882,0,0
1,GO ENDOCYTIC RECYCLING,0.98953,-0.004168,-0.0065994,0,0
1,GO RESPONSE TO WATER,0.93377,-0.004231,0.029448,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.62113,-0.0044206,-0.031489,0,0
1,GO MIDBRAIN DEVELOPMENT,0.62732,-0.0046353,0.020638,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.82348,-0.0046696,-0.043141,0,0
1,GO ORGAN INDUCTION,0.71658,-0.0048771,0.044222,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.9686,-0.0049403,0.0072519,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.94769,-0.0049642,-0.0059642,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.80312,-0.005098,0.021915,0,0
1,GO RECOMBINATIONAL REPAIR,0.85082,-0.0054466,-0.0023439,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.57857,-0.0055463,-0.02692,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.43883,-0.0056576,-0.031293,0,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.42347,-0.0058853,0.03602,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.95466,-0.0059212,0.083498,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.89215,-0.0060474,0.0041913,0,0
1,GO RESPONSE TO COLD,0.52025,-0.0061696,-0.071392,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.98255,-0.0064268,-0.0060927,0,0
1,GO GAMETE GENERATION,0.8303,-0.0064943,0.0063158,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.66501,-0.0065039,-0.016292,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.5726,-0.0065337,-0.043391,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98255,-0.0065943,-0.046594,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.97557,-0.0068255,0.012299,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.79636,-0.0071016,-0.035374,0,0
1,GO RESPONSE TO GLUCAGON,0.88523,-0.0073071,-0.01173,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.85082,-0.0074621,-0.0066157,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.74288,-0.0077819,-0.02942,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.66501,-0.0077865,0.030839,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.89907,-0.0078124,-0.0059955,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.59059,-0.0078185,0.063139,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.98953,-0.0078851,-0.0007146,0,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.90599,-0.0081334,0.017158,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.30402,-0.00823,-0.041968,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.83713,-0.0082839,-0.01128,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.91987,-0.0083239,-0.0013288,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.71006,-0.0085413,-0.00037165,0,0
1,GO PRENYLATION,0.98255,-0.0085747,0.032267,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.73628,-0.0086346,-0.056878,0,0
1,GO CELL RECOGNITION,0.53742,-0.0086487,-0.030391,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.37932,-0.0087254,-0.1192,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.71658,-0.0088543,-0.031614,0,0
1,GO RESPONSE TO LEAD ION,0.60272,-0.0088741,0.049249,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.89907,-0.0088847,-0.0090249,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.59059,-0.0088944,-0.043545,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.85768,-0.0089133,0.061239,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.87144,-0.0091939,-0.012244,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.31653,-0.0093122,0.14972,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.66501,-0.00932,-0.021251,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.50337,-0.0094236,-0.068853,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.88523,-0.0094576,-0.013702,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.82348,-0.0094784,-0.018048,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.48131,-0.0099767,0.048613,0,0
1,GO REGULATION OF CELLULAR PH,0.83713,-0.0099831,-0.014517,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.54321,-0.010368,0.03842,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.85082,-0.010522,-0.0015101,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.89907,-0.010637,-0.0066217,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.89907,-0.010708,0.020688,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.80989,-0.010858,0.007042,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.47588,-0.010869,-0.10461,0,0
1,GO PROSTATE GLAND GROWTH,0.85768,-0.010952,0.057194,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.87833,-0.011327,-0.00031415,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.87144,-0.011351,0.028376,0,0
1,GO METHYLATION,0.67776,-0.011373,-0.0089762,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.99651,-0.011482,-0.0037029,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.86455,-0.011534,-0.019872,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.60883,-0.011572,0.10918,0,0
1,GO RESPONSE TO FATTY ACID,0.88523,-0.011587,0.032783,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.91987,-0.011666,-0.0097484,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.67776,-0.01181,-0.026114,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.96163,-0.012084,0.027996,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.44924,-0.01214,-0.022515,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.51459,-0.012194,-0.034025,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.14048,-0.012303,-0.083172,0,0
1,GO DNA REPLICATION CHECKPOINT,0.80989,-0.012489,-0.036428,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.27999,-0.012497,-0.13033,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.38888,-0.012553,-0.067822,0,0
1,GO HISTAMINE TRANSPORT,0.83713,-0.012581,-0.056156,0,0
1,GO RESPONSE TO AXON INJURY,0.71658,-0.012632,-0.028215,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.4978,-0.012711,-0.02791,0,0
1,GO ACTIN NUCLEATION,0.67137,-0.012729,-0.044057,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.76281,-0.012809,0.011401,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.4978,-0.012918,-0.027267,0,0
1,GO BONE CELL DEVELOPMENT,0.94769,-0.013057,-0.0042082,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.78962,-0.013122,-0.016422,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.61497,-0.013136,0.048455,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.61497,-0.013238,-0.022013,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.91987,-0.013287,0.0075592,0,0
1,GO THYROID GLAND DEVELOPMENT,0.74288,-0.013331,-0.026163,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.71658,-0.013529,-0.023665,0,0
1,GO INORGANIC ANION TRANSPORT,0.89215,-0.013969,-0.0018821,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.78289,-0.01406,-0.006061,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.7495,-0.014218,-0.032008,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.4598,-0.014259,-0.061828,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.76948,-0.014288,0.024798,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.74288,-0.014297,0.058981,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.57857,-0.014298,0.059692,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.35607,-0.014354,-0.13056,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.36991,-0.014565,-0.16748,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.82348,-0.014569,-0.025396,0,0
1,GO CYTOSOLIC TRANSPORT,0.66501,-0.014764,0.023519,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.84397,-0.014805,-0.0092016,0,0
1,GO REGULATION OF RNA SPLICING,0.24288,-0.014811,-0.060814,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.85082,-0.014816,0.0061555,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.81668,-0.014996,-0.0032645,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.88523,-0.015148,-0.0090053,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.47049,-0.015204,-0.02529,0,0
1,GO LIPID PHOSPHORYLATION,0.36526,-0.015309,-0.039908,0,0
1,GO ORGANIC ANION TRANSPORT,0.72969,-0.015604,-0.010879,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.53167,-0.015642,-0.058532,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.61497,-0.015725,-0.012342,0,0
1,GO GMP METABOLIC PROCESS,0.79636,-0.015894,-0.036225,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.87144,-0.015995,-0.001107,0,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.25363,-0.016013,0.1708,0,0
1,GO WATER TRANSPORT,0.81668,-0.01603,-0.0087243,0,0
1,GO SNORNA 3 END PROCESSING,0.80312,-0.016105,-0.011183,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.66501,-0.016193,0.078695,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.99651,-0.016414,0.03046,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.7495,-0.016473,-0.0062126,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.85082,-0.016889,-0.010122,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.87144,-0.016959,-0.0012596,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.63354,-0.017129,-0.026816,0,0
1,GO TOR SIGNALING,0.71658,-0.017162,0.0013925,0,0
1,GO ANION TRANSPORT,0.65866,-0.017597,-0.010504,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.29586,-0.017773,0.090833,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.94073,-0.017978,0.046569,0,0
1,GO MICROVILLUS ORGANIZATION,0.11039,-0.01807,-0.16043,0,0
1,GO EXPLORATION BEHAVIOR,0.30402,-0.018083,-0.11915,0,0
1,GO RENAL ABSORPTION,0.86455,-0.018212,0.035125,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.78289,-0.018305,-0.032527,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.55487,-0.018488,-0.087381,0,0
1,GO DEPHOSPHORYLATION,0.43883,-0.018712,-0.027944,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.70355,-0.018785,-0.012397,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.36064,-0.018818,-0.040173,0,0
1,GO PLASMA MEMBRANE REPAIR,0.69061,-0.018946,-0.050313,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.35607,-0.018979,0.088974,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.50896,-0.018984,0.060912,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.50337,-0.018986,-0.020154,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.93377,-0.019292,0.025897,0,0
1,GO SEX DIFFERENTIATION,0.78962,-0.019303,-0.018036,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.53742,-0.019355,-0.074102,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.13583,-0.019376,-0.092794,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.8303,-0.019382,-0.046306,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.59664,-0.019487,0.033665,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.32077,-0.019599,-0.068139,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.33812,-0.019616,0.085005,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.18219,-0.019903,-0.12096,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.52594,-0.01992,-0.035345,0,0
1,GO MYELOID CELL DEVELOPMENT,0.86455,-0.020031,0.012881,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.8303,-0.02017,-0.0022517,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.9686,-0.020273,0.0066882,0,0
1,GO O GLYCAN PROCESSING,0.27999,-0.0203,-0.10594,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.95466,-0.020312,0.01761,0,0
1,GO TELOMERE CAPPING,0.82348,-0.020676,0.013994,0,0
1,GO CALCIUM ION IMPORT,0.088862,-0.020732,-0.087162,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.76281,-0.021165,-0.031639,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.72313,-0.021174,-0.016236,0,0
1,GO CGMP MEDIATED SIGNALING,0.79636,-0.021307,-0.020671,0,0
1,GO STEROID CATABOLIC PROCESS,0.5726,-0.021345,0.040191,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.64605,-0.021397,-0.0020159,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.077957,-0.021549,-0.067503,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.9686,-0.022162,0.073239,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.73628,-0.02223,0.019684,0,0
1,GO ORGANELLE FUSION,0.95466,-0.022544,-0.0011129,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.36991,-0.022562,-0.093826,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.92682,-0.022634,0.080671,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.35153,-0.022664,-0.11363,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.90599,-0.022777,-0.0069527,0,0
1,GO ER OVERLOAD RESPONSE,0.60272,-0.023044,0.052433,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.44924,-0.023069,-0.043213,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.72969,-0.023284,-0.01546,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.33373,-0.023311,-0.042464,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.59664,-0.023359,0.06007,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.36991,-0.023557,-0.040472,0,0
1,GO HISTONE H3 K27 METHYLATION,0.9686,-0.023692,-0.0076952,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.26847,-0.023704,-0.077103,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.59664,-0.023837,0.050958,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.27999,-0.024096,-0.065902,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.42855,-0.0241,0.076681,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.46512,-0.024342,-0.04602,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.71006,-0.024992,-0.013295,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.89907,-0.025043,0.0020026,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.82348,-0.025231,0.013367,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.7495,-0.025347,-0.0043788,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.99651,-0.025438,-0.0075495,0,0
1,GO PIGMENTATION,0.49227,-0.025498,-0.023626,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.3746,-0.025529,-0.074716,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.53167,-0.025545,0.064409,0,0
1,GO RESPONSE TO ZINC ION,0.86455,-0.025548,-0.018575,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.86455,-0.025755,0.045136,0,0
1,GO ARACHIDONIC ACID SECRETION,0.26471,-0.026078,-0.11695,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.55487,-0.026097,-0.048747,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.93377,-0.026113,-0.025294,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.9686,-0.026114,0.0039628,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.94073,-0.026223,0.028531,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.44924,-0.026303,-0.049957,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.40843,-0.026349,-0.041132,0,0
1,GO CHROMOSOME ORGANIZATION,0.57857,-0.027009,-0.010654,0,0
1,GO MALE GAMETE GENERATION,0.76948,-0.027407,-0.0028045,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.57857,-0.027418,-0.045621,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.31232,-0.027449,-0.076904,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.75615,-0.027853,0.059643,0,0
1,GO DEVELOPMENTAL GROWTH,0.59664,-0.02788,-0.017139,0,0
1,GO MANNOSYLATION,0.7495,-0.027968,0.033025,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.13583,-0.028141,-0.053843,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.79636,-0.02828,0.009669,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.67776,-0.028333,-0.010762,0,0
1,GO BONE MINERALIZATION,0.56666,-0.028439,0.087346,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.54321,-0.0285,-0.017329,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.59059,-0.028794,-0.011117,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.58456,-0.028846,-0.0010429,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.43883,-0.028854,-0.067664,0,0
1,GO PROTEIN NITROSYLATION,0.73628,-0.02903,-0.039379,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.89215,-0.029495,-0.004426,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.32938,-0.029639,-0.18104,0,0
1,GO RESPONSE TO CALCIUM ION,0.60272,-0.029673,-0.030339,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.95466,-0.029707,0.073653,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.4978,-0.02981,-0.029536,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.8303,-0.03001,-0.0023486,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.50896,-0.030069,-0.049094,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.59664,-0.030146,-0.010959,0,0
1,GO HISTAMINE SECRETION,0.8303,-0.030177,-0.043164,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.38408,-0.030509,-0.040236,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.42855,-0.03059,-0.054742,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.88523,-0.030635,0.02889,0,0
1,GO THYMIC T CELL SELECTION,0.43367,-0.030702,-0.014714,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.7495,-0.031508,0.012801,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.21905,-0.031704,-0.055744,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.43367,-0.031799,-0.073021,0,0
1,GO GLIOGENESIS,0.48678,-0.031936,-0.031093,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.7495,-0.031948,0.014655,0,0
1,GO SNORNA METABOLIC PROCESS,0.87144,-0.032256,0.0028673,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.67137,-0.032654,0.0054022,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.33812,-0.032693,-0.15393,0,0
1,GO REGULATION OF PH,0.8303,-0.03273,-0.010867,0,0
1,GO STRESS GRANULE ASSEMBLY,0.26098,-0.032896,-0.060217,0,0
1,GO ORGANELLE LOCALIZATION,0.060602,-0.033062,-0.041464,0,0
1,GO DNA METHYLATION,0.51459,-0.033316,-0.034838,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.46512,-0.033559,-0.042962,0,0
1,GO MICROTUBULE BASED PROCESS,0.17374,-0.033714,-0.044484,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.33373,-0.033976,-0.090604,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.23245,-0.034082,-0.04305,0,0
1,GO OOGENESIS,0.23589,-0.034085,-0.041914,0,0
1,GO BLASTOCYST DEVELOPMENT,0.35607,-0.034196,-0.032225,0,0
1,GO MEIOTIC CELL CYCLE,0.74288,-0.034252,0.0098251,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.43883,-0.034277,-0.070867,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.67776,-0.034433,-0.14083,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.20937,-0.034541,-0.061709,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.69707,-0.034813,-0.0155,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.56666,-0.034859,-0.068143,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.29992,-0.035,-0.069575,0,0
1,GO MOLTING CYCLE,0.82348,-0.035489,0.044915,0,0
1,GO RESPONSE TO METAL ION,0.61497,-0.035558,-0.020318,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.90599,-0.035647,0.017185,0,0
1,GO BONE MATURATION,0.88523,-0.035674,-0.018662,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.78289,-0.035779,0.0090824,0,0
1,GO HISTONE UBIQUITINATION,0.69707,-0.035804,-0.012288,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.71006,-0.036059,-0.042217,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.093897,-0.036151,-0.060353,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.85768,-0.036333,0.00095989,0,0
1,GO ECTODERM DEVELOPMENT,0.72313,-0.036342,-0.013218,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.9686,-0.03643,0.0078716,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.98255,-0.03644,0.008462,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.94073,-0.03666,-0.0025575,0,0
1,GO CELL GROWTH,0.68418,-0.036691,-0.0047824,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.24288,-0.036815,-0.090821,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.65866,-0.037016,-0.015526,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.29184,-0.037401,-0.032695,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.84397,-0.037509,0.022994,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.89215,-0.037535,-0.019024,0,0
1,GO P BODY ASSEMBLY,0.44402,-0.03772,-0.029891,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.53742,-0.037859,-0.020221,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.188,-0.038242,-0.034028,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.75615,-0.038445,0.0023876,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.72969,-0.038644,-0.034444,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.39371,-0.038727,-0.058331,0,0
1,GO REGULATION OF MRNA PROCESSING,0.26098,-0.039238,-0.054416,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.67137,-0.039276,-0.019631,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.90599,-0.039457,0.023972,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.29992,-0.039592,-0.061638,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.039735,0.017719,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.37932,-0.039826,-0.066257,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.18219,-0.039882,-0.075835,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.27611,-0.039914,-0.087008,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.4545,-0.040137,-0.043345,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.54903,-0.04015,-0.021208,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.3746,-0.040159,-0.042512,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.13814,-0.040306,-0.051433,0,0
1,GO RESPONSE TO POTASSIUM ION,0.2,-0.040722,-0.18378,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.86455,-0.041259,0.052909,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.59059,-0.042022,-0.045021,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.81668,-0.042048,-0.014962,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.98255,-0.042104,0.025931,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.20621,-0.042151,-0.058201,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.78289,-0.042182,0.038211,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.054842,-0.042256,-0.070237,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.91293,-0.042271,-0.002693,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.87144,-0.042494,0.022946,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.54321,-0.04261,-0.017215,0,0
1,GO REGULATION OF AXON GUIDANCE,0.76281,-0.042876,-0.03062,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.51459,-0.042936,-0.0097805,0,0
1,GO REGULATION OF OOGENESIS,0.38408,-0.043009,-0.02873,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.86455,-0.043184,0.016114,0,0
1,GO NODAL SIGNALING PATHWAY,0.73628,-0.043425,-0.02286,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.054842,-0.043489,-0.099141,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.87833,-0.043721,-0.00045691,0,0
1,GO RESPONSE TO SALT,0.82348,-0.043846,-0.053744,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.17374,-0.043973,-0.15513,0,0
1,GO REGULATION OF BONE REMODELING,0.98255,-0.043973,0.00058933,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.12689,-0.04398,-0.14396,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.55487,-0.044052,-0.039849,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.29184,-0.044178,-0.038897,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.92682,-0.044343,-0.004644,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.12473,-0.045065,-0.091779,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.89215,-0.045256,0.0022197,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.98255,-0.045399,0.063602,0,0
1,GO MALE MEIOSIS I,0.56075,-0.045446,-0.064277,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.21579,-0.045488,-0.16336,0,0
1,GO AUTOPHAGIC CELL DEATH,0.80312,-0.045573,0.054053,0,0
1,GO FUCOSYLATION,0.32077,-0.045647,-0.066568,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.31232,-0.046041,-0.056144,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.061812,-0.046196,-0.052067,0,0
1,GO REGULATION OF ANION TRANSPORT,0.064293,-0.046227,-0.097404,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.52025,-0.046362,-0.027815,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.68418,-0.046363,0.13439,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.53167,-0.046434,-0.035348,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.25363,-0.046467,-0.10992,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.78962,-0.046683,-0.0096703,0,0
1,GO SPERM CAPACITATION,0.62732,-0.046736,-0.030759,0,0
1,GO DIET INDUCED THERMOGENESIS,0.21256,-0.047087,-0.11031,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.84397,-0.047103,-0.021318,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.43883,-0.047119,-0.035017,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.62113,-0.047129,0.0041388,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.80989,-0.047212,0.0094585,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.20309,-0.04773,-0.058018,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.28785,-0.047966,-0.1216,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.78962,-0.048229,0.013972,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.048572,0.025481,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.65234,-0.04867,0.0033605,0,0
1,GO LYSOSOME LOCALIZATION,0.1313,-0.049037,-0.059635,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.18219,-0.049848,-0.061594,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.89907,-0.049945,0.006947,0,0
1,GO REGULATION OF ODONTOGENESIS,0.62113,-0.050038,-0.022057,0,0
1,GO ORGANIC ACID TRANSPORT,0.27611,-0.050206,-0.032296,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.0695,-0.050393,-0.080101,0,0
1,GO SEGMENTATION,0.26847,-0.050397,-0.058358,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.36526,-0.050688,-0.10496,0,0
1,GO NEPHRON MORPHOGENESIS,0.4598,-0.050716,-0.019424,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.12908,-0.050834,-0.15436,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.15264,-0.050914,-0.049837,0,0
1,GO SPERM MOTILITY,0.090515,-0.051172,-0.064679,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.43883,-0.051242,-0.11315,0,0
1,GO DRINKING BEHAVIOR,0.21256,-0.051287,-0.11804,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.43883,-0.05164,-0.059484,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.21905,-0.051753,-0.076402,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.78289,-0.052349,0.07195,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.92682,-0.052398,-0.016732,0,0
1,GO MICROTUBULE SEVERING,0.19393,-0.052549,-0.088044,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.67776,-0.052692,-0.00061923,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.32938,-0.052912,-0.051518,0,0
1,GO NEUROBLAST PROLIFERATION,0.188,-0.053249,-0.11909,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.44402,-0.05437,-0.074923,0,0
1,GO EXIT FROM MITOSIS,0.23937,-0.054406,-0.044142,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.60272,-0.054503,-0.011813,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.11434,-0.054912,-0.051373,0,0
1,GO PROTEIN MANNOSYLATION,0.86455,-0.054923,-0.0013646,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.53742,-0.054984,-0.026465,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.21256,-0.05517,-0.067838,0,0
1,GO CELL CYCLE DNA REPLICATION,0.20937,-0.055736,-0.083378,0,0
1,GO RESPONSE TO MONOSACCHARIDE,0.60883,-0.055878,-0.0042486,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.75615,-0.056099,0.060383,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0695,-0.056246,-0.078493,0,0
1,GO LONG TERM MEMORY,0.4545,-0.056364,-0.054922,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.46512,-0.056419,-0.10387,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.24643,-0.056516,-0.038014,0,0
1,GO AXON EXTENSION,0.30402,-0.056545,-0.065636,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.4598,-0.05658,-0.078232,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.38408,-0.057293,-0.059849,0,0
1,GO CILIUM MOVEMENT,0.17099,-0.058044,-0.054382,0,0
1,GO REGULATION OF ACROSOME REACTION,0.78289,-0.05807,-0.026859,0,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.16294,-0.058176,-0.081497,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.48678,-0.058272,-0.080932,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.12908,-0.058366,-0.1185,0,0
1,GO MEMBRANE DOCKING,0.11841,-0.058383,-0.048157,0,0
1,GO B CELL HOMEOSTASIS,0.19695,-0.058544,-0.085159,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.21256,-0.058692,-0.059366,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.60272,-0.05871,-0.026459,0,0
1,GO REGULATION OF TRANSPORT,0.085627,-0.058922,-0.048119,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.35607,-0.058981,-0.075841,0,0
1,GO TRANSMEMBRANE TRANSPORT,0.1028,-0.059289,-0.0491,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.15773,-0.059317,-0.083455,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.54321,-0.059322,-0.026506,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.014138,-0.059344,-0.12604,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.80312,-0.059373,0.010782,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.17099,-0.059451,-0.076364,0,0
1,GO RESPONSE TO INACTIVITY,0.58456,-0.059873,-0.052658,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.97557,-0.060142,0.012804,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.51459,-0.060146,-0.047942,0,0
1,GO GLIAL CELL PROLIFERATION,0.73628,-0.060183,-0.0037145,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.36526,-0.060303,-0.015205,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.10096,-0.060735,-0.11482,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.24643,-0.060786,-0.067205,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.48678,-0.06119,-0.0077441,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.7495,-0.061478,0.051786,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.14769,-0.061809,-0.10007,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.044685,-0.061812,-0.053858,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.65234,-0.061889,-0.043667,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.34702,-0.061928,-0.049365,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.50896,-0.061996,-0.020329,0,0
1,GO DNA PACKAGING,0.10845,-0.062111,-0.056336,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.21579,-0.062347,-0.076314,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.68418,-0.062455,-0.0294,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.072231,-0.062457,-0.05812,0,0
1,GO HEART VALVE FORMATION,0.77618,-0.062533,-0.010266,0,0
1,GO HISTONE H2A ACETYLATION,0.3746,-0.062817,-0.049698,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.88523,-0.063023,-0.013128,0,0
1,GO T CELL SELECTION,0.19095,-0.063024,-0.041364,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.50896,-0.063364,-0.042734,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.62732,-0.063458,0.003717,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.076492,-0.063666,-0.064671,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.30815,-0.063731,-0.030495,0,0
1,GO GERM CELL DEVELOPMENT,0.073629,-0.063786,-0.053686,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.21905,-0.063895,-0.081746,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.3746,-0.064049,-0.044627,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.27611,-0.064058,-0.1068,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.25729,-0.064315,-0.036857,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.079444,-0.064481,-0.098843,0,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.070855,-0.065133,-0.10464,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.065312,-0.049484,0,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.14526,-0.06542,-0.27563,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.2,-0.065431,-0.080119,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.29992,-0.0657,-0.089519,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.080955,-0.06573,-0.18178,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.23245,-0.065735,-0.074365,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.52594,-0.065788,-0.033144,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.9686,-0.065934,-0.0072689,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.11434,-0.066049,-0.095845,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.31653,-0.06641,-0.092643,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.19095,-0.066925,-0.03865,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.30402,-0.066974,-0.051927,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.084046,-0.067302,-0.23319,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.49227,-0.067534,-0.036899,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.25001,-0.06778,-0.046991,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.15773,-0.067823,-0.040287,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.92682,-0.06795,0.0049486,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.63978,-0.067966,-0.00036374,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.56666,-0.068124,0.0035755,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.2839,-0.068178,-0.049359,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.082489,-0.068238,-0.080639,0,0
1,GO REPLICATION FORK PROCESSING,0.33812,-0.068325,-0.020461,0,0
1,GO ZINC ION HOMEOSTASIS,0.61497,-0.068331,-0.055178,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.78289,-0.06841,0.036582,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.69707,-0.068531,-0.017145,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.44402,-0.068858,-0.067477,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.90599,-0.068879,0.002835,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.86455,-0.06895,0.0090039,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.38408,-0.069288,-0.041822,0,0
1,GO RESPONSE TO ETHANOL,0.064293,-0.069333,-0.082563,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.60883,-0.069417,-0.036984,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.62732,-0.06942,-0.032405,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.087232,-0.06971,-0.066739,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.81668,-0.06978,-0.0042387,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.80312,-0.069819,0.018758,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.18508,-0.06983,-0.055574,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.055956,-0.070478,-0.11969,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.15773,-0.071041,-0.070907,0,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31232,-0.071351,-0.037566,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.36526,-0.071582,-0.039972,0,0
1,GO PHAGOSOME MATURATION,0.51459,-0.071674,-0.03556,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.23937,-0.071979,-0.15434,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.85768,-0.072077,0.031795,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.75615,-0.072491,0.027837,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.33812,-0.072584,-0.023982,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.60883,-0.072668,-0.0022632,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.15264,-0.073114,-0.039072,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.070855,-0.073352,-0.1144,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.65866,-0.073401,-0.0041338,0,0
1,GO HISTONE MONOUBIQUITINATION,0.32938,-0.073463,-0.041081,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.20937,-0.073572,-0.042977,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.36526,-0.074143,-0.077225,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.53742,-0.074208,-0.019773,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.63978,-0.074325,-0.037044,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.17653,-0.07445,-0.096987,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.025414,-0.074517,-0.084028,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.16032,-0.074751,-0.071715,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.69707,-0.074826,0.011323,0,0
1,GO CILIUM ORGANIZATION,0.21579,-0.074994,-0.032939,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.68418,-0.07591,-0.049415,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.22568,-0.075925,-0.055476,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.36064,-0.076217,-0.053699,0,0
1,GO POLYOL TRANSPORT,0.33812,-0.076851,-0.048908,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.35607,-0.076877,-0.03884,0,0
1,GO PARTURITION,0.59664,-0.076936,-0.068591,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.48131,-0.077085,-0.026611,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.033166,-0.077396,-0.16728,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.026586,-0.077839,-0.10703,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.10096,-0.077968,-0.087556,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.99651,-0.078124,0.027367,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.082489,-0.078303,-0.089104,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.11434,-0.078871,-0.10285,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.59664,-0.079157,-0.020845,0,0
1,GO REGULATION OF TOR SIGNALING,0.16828,-0.079197,-0.03766,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.27611,-0.079319,-0.11411,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.94769,-0.079533,-0.0053052,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.10654,-0.079828,-0.080615,0,0
1,GO HISTONE H3 K36 METHYLATION,0.10845,-0.080364,-0.11685,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.073629,-0.080368,-0.1068,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.43883,-0.080649,-0.056995,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.22568,-0.080718,-0.10295,0,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.25001,-0.08072,-0.029819,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.080955,-0.080871,-0.057582,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.40349,-0.081189,-0.074732,0,0
1,GO CELL MORPHOGENESIS,0.016339,-0.081443,-0.095572,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.17934,-0.082078,-0.070115,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.63978,-0.082091,-0.032326,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.62732,-0.082379,-0.042601,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.71006,-0.082398,-0.0017612,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.16032,-0.08245,-0.036056,0,0
1,GO REGULATION OF BEHAVIOR,0.024846,-0.08251,-0.13243,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.17653,-0.0826,-0.094343,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.31232,-0.082799,-0.058256,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.21905,-0.08296,-0.054096,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.15264,-0.083094,-0.045957,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.56075,-0.08354,0.00010221,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.16032,-0.083775,-0.075446,0,0
1,GO CELL JUNCTION ASSEMBLY,0.14048,-0.083981,-0.060255,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.15264,-0.083988,-0.079791,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.17653,-0.084012,-0.074563,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.91293,-0.084349,0.0095449,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.055956,-0.084438,-0.10606,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.22235,-0.085488,-0.049975,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.054842,-0.085573,-0.075144,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.082489,-0.08625,-0.070467,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.33373,-0.086391,-0.11938,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.092194,-0.086441,-0.070868,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.041967,-0.086559,-0.068562,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.4545,-0.086561,-0.055343,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.22568,-0.08665,-0.14015,0,0
1,GO REGULATION OF DNA METHYLATION,0.1028,-0.086741,-0.10818,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.23937,-0.086787,-0.057447,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.34702,-0.08701,-0.078516,0,0
1,GO MAGNESIUM ION TRANSPORT,0.19393,-0.087865,-0.079751,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.71006,-0.087919,-0.0092698,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.05824,-0.088025,-0.13247,0,0
1,GO TORC1 SIGNALING,0.19095,-0.088256,-0.049892,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.43883,-0.088448,-0.053794,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.25729,-0.089566,-0.099723,0,0
1,GO POSITIVE T CELL SELECTION,0.19393,-0.089576,-0.014392,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.29992,-0.08986,-0.04032,0,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.070855,-0.089891,-0.062727,0,0
1,GO VESICLE LOCALIZATION,0.023741,-0.090324,-0.066287,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.17374,-0.091076,-0.072709,0,0
1,GO SPLEEN DEVELOPMENT,0.44402,-0.091086,-0.02429,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.15015,-0.091414,-0.069389,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.4978,-0.091627,-0.096002,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.09163,-0.11002,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.068167,-0.091637,-0.14318,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.19393,-0.09171,-0.079674,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.13814,-0.091841,-0.067914,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.46512,-0.092128,-0.059741,0,0
1,GO DEMETHYLATION,0.11434,-0.092298,-0.046852,0,0
1,GO EYE MORPHOGENESIS,0.31232,-0.092318,-0.051104,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.20937,-0.092502,-0.20826,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.90599,-0.092564,0.0060277,0,0
1,GO HORMONE CATABOLIC PROCESS,0.84397,-0.0929,0.035229,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.13355,-0.092996,-0.085275,0,0
1,GO RENAL SYSTEM PROCESS,0.27999,-0.093631,-0.043372,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.51459,-0.09437,-0.016205,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.52025,-0.095541,-0.031746,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.5726,-0.095809,-0.016672,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.1313,-0.095932,-0.11632,0,0
1,GO REGULATION OF NEURON MIGRATION,0.10096,-0.096182,-0.1445,0,0
1,GO EXCRETION,0.5726,-0.096233,-0.017917,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.068167,-0.096466,-0.090882,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.059411,-0.096957,-0.086371,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.059411,-0.097014,-0.085662,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.36526,-0.097366,-0.05346,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.29992,-0.097418,-0.041395,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.18508,-0.097453,-0.050069,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.046579,-0.097473,-0.062468,0,0
1,GO ANIMAL ORGAN MATURATION,0.85768,-0.097505,-0.0065184,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0695,-0.097832,-0.071059,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.12049,-0.097873,-0.12898,0,0
1,GO ESTROUS CYCLE,0.86455,-0.098024,-0.0073176,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.61497,-0.098339,-0.061532,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.041093,-0.098725,0.021693,0,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.088862,-0.099251,-0.11307,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.39858,-0.099369,-0.047589,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.11841,-0.099802,-0.095298,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.34256,-0.099856,-0.062691,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.35607,-0.10008,-0.052654,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.05161,-0.10023,-0.10399,0,0
1,GO MITOTIC DNA REPLICATION,0.12689,-0.10061,-0.1182,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.23937,-0.10089,-0.038802,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.12473,-0.10102,-0.10134,0,0
1,GO RHYTHMIC BEHAVIOR,0.076492,-0.10134,-0.1149,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.20621,-0.102,-0.04495,0,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.15773,-0.10251,-0.047798,0,0
1,GO INTRACILIARY TRANSPORT,0.16294,-0.10303,-0.093778,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.58456,-0.10348,-0.059314,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.2,-0.10367,-0.098925,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.52025,-0.10425,-0.0084117,0,0
1,GO HEART INDUCTION,1,-0.10538,0.020369,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.62113,-0.10556,0.0028095,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.29992,-0.10567,-0.034287,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.26847,-0.10589,-0.038395,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.33373,-0.10599,-0.059675,0,0
1,GO DOSAGE COMPENSATION,0.064293,-0.10619,-0.092871,0,0
1,GO MYOFIBRIL ASSEMBLY,0.56075,-0.10655,0.014394,0,0
1,GO ACTIN CROSSLINK FORMATION,0.26098,-0.10658,-0.14445,0,0
1,GO UTERUS DEVELOPMENT,0.082489,-0.1068,-0.17303,0,0
1,GO CHROMATIN DISASSEMBLY,0.23937,-0.10699,-0.10436,0,0
1,GO MESONEPHROS DEVELOPMENT,0.40349,-0.10716,-0.022735,0,0
1,GO HISTONE H2A UBIQUITINATION,0.18219,-0.10736,-0.056195,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.40843,-0.10736,0.0028616,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.15015,-0.10765,-0.084671,0,0
1,GO MEMBRANE REPOLARIZATION,0.12259,-0.10846,-0.10943,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.095625,-0.10871,-0.083443,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.12259,-0.10894,-0.16906,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.47049,-0.10913,-0.044391,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.023741,-0.10952,-0.14095,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.13355,-0.10952,-0.072604,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.19393,-0.10975,-0.069175,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.019739,-0.10977,-0.13499,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.080955,-0.10988,-0.087199,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.17374,-0.11009,-0.072424,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.070855,-0.11025,-0.070965,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.35607,-0.11027,-0.076913,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.12908,-0.11036,-0.10324,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.079444,-0.11053,-0.078186,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.18219,-0.11121,-0.133,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.10096,-0.11152,-0.090896,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.74288,-0.1119,-0.011941,0,0
1,GO MATING BEHAVIOR,0.087232,-0.11207,-0.1102,0,0
1,GO AXIS SPECIFICATION,0.02843,-0.11212,-0.14766,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.12049,-0.11215,-0.13226,0,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.05824,-0.11225,-0.12729,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.36064,-0.11324,-0.053685,0,0
1,GO REGIONALIZATION,0.092194,-0.11325,-0.10419,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.34256,-0.11332,-0.064638,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.14285,-0.11336,-0.090862,0,0
1,GO GLUTAMATE METABOLIC PROCESS,0.37932,-0.1135,-0.051257,0,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.029068,-0.11363,-0.11282,0,0
1,GO SOMITE DEVELOPMENT,0.0015653,-0.11386,-0.1569,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.093897,-0.114,-0.18109,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.23937,-0.11435,-0.086702,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.11636,-0.11439,-0.095909,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.12473,-0.11453,-0.087092,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.73628,-0.11458,-0.019102,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.2,-0.11467,-0.12236,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.44924,-0.11516,-0.030143,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.26471,-0.11564,-0.0863,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0024367,-0.11593,-0.13914,0,0
1,GO SPERMATID DIFFERENTIATION,0.10845,-0.11684,-0.06398,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.64605,-0.117,-0.063929,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.79636,-0.1175,-0.016689,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.26098,-0.11756,-0.053855,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.16294,-0.11767,-0.08206,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.066855,-0.11784,-0.14398,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.38888,-0.11804,-0.095076,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.50896,-0.11844,-0.044532,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.090515,-0.11877,-0.11282,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.1313,-0.11958,-0.1233,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.35153,-0.11968,-0.059169,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.19695,-0.11979,-0.11144,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.073629,-0.12018,-0.10256,0,0
1,GO DNA STRAND ELONGATION,0.082489,-0.12041,-0.13512,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.16828,-0.12046,-0.084651,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.32506,-0.12072,-0.087368,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.15773,-0.1209,-0.060754,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.10845,-0.12097,-0.10501,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.099158,-0.12103,-0.1418,0,0
1,GO RESPONSE TO CAFFEINE,0.60883,-0.12231,-0.030994,0,0
1,GO VESICLE DOCKING,0.0081404,-0.12257,-0.13917,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.38408,-0.12319,-0.091369,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.10845,-0.12335,-0.097795,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.092194,-0.12425,0.031822,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.32506,-0.12467,-0.059781,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.13355,-0.12476,-0.052053,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.05161,-0.12521,-0.15136,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0056288,-0.12607,-0.1187,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.055956,-0.12616,-0.26321,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.1028,-0.12625,-0.083339,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.32077,-0.12842,-0.067659,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0075304,-0.1288,-0.10009,0,0
1,GO IMPORT INTO CELL,0.11235,-0.12911,-0.077315,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.20937,-0.12913,-0.065517,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.11434,-0.12978,-0.079711,0,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.054842,-0.12992,-0.16789,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.25001,-0.13015,-0.064598,0,0
1,GO DENDRITE SELF AVOIDANCE,0.56666,-0.13042,-0.018959,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.023205,-0.13069,-0.12811,0,0
1,GO FEVER GENERATION,0.20309,-0.13098,-0.018914,0,0
1,GO LIPID EXPORT FROM CELL,0.32938,-0.13106,-0.059969,0,0
1,GO PHOTOTRANSDUCTION,0.0033369,-0.13223,-0.02162,0,0
1,GO SISTER CHROMATID COHESION,0.02843,-0.13245,-0.12053,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.2839,-0.13278,-0.12083,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.12473,-0.13278,-0.2842,0,0
1,GO RESPONSE TO ETHER,0.10096,-0.13289,-0.15042,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.15015,-0.1331,-0.13983,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.98953,-0.13377,0.038058,0,0
1,GO COLLATERAL SPROUTING,0.16032,-0.13639,-0.083477,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.022165,-0.13658,-0.17425,0,0
1,GO BRONCHUS DEVELOPMENT,0.82348,-0.13662,-0.033744,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.023205,-0.13666,-0.18673,0,0
1,GO RESPONSE TO AMINE,0.072231,-0.13686,-0.12502,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.58456,-0.13727,-0.031459,0,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.11841,-0.13827,-0.16823,0,0
1,GO AXO DENDRITIC TRANSPORT,0.0085714,-0.13835,-0.17736,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00079435,-0.13856,-0.16718,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.3746,-0.13964,-0.24636,0,0
1,GO RESPONSE TO VITAMIN D,0.50337,-0.13974,-0.047757,0,0
1,GO KIDNEY MORPHOGENESIS,0.13355,-0.14008,-0.074299,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.10654,-0.14035,-0.1251,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12049,-0.14043,-0.16081,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.33812,-0.14054,-0.07522,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.059411,-0.14056,-0.11806,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.27999,-0.14086,-0.069588,0,0
1,GO MICROTUBULE POLYMERIZATION,0.0071468,-0.14158,-0.14646,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.12049,-0.14237,-0.094704,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.22235,-0.14365,-0.037032,0,0
1,GO METANEPHROS MORPHOGENESIS,0.18508,-0.14432,-0.11588,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.0028141,-0.14516,-0.14402,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.12049,-0.14533,-0.17623,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.11039,-0.14668,-0.15186,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.27611,-0.14683,-0.084113,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.36526,-0.14684,-0.075133,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.084046,-0.14809,-0.09557,0,0
1,GO CONVERGENT EXTENSION,0.17653,-0.14817,-0.13574,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.065563,-0.14839,-0.21464,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.30815,-0.14851,-0.12411,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.16032,-0.14852,-0.074271,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.1028,-0.14868,-0.13997,0,0
1,GO SARCOMERE ORGANIZATION,0.50896,-0.14893,-0.0017895,0,0
1,GO RENAL WATER HOMEOSTASIS,0.019739,-0.14899,-0.11467,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0041716,-0.14911,-0.14513,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.16032,-0.14956,-0.069976,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.038561,-0.15004,-0.13335,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.0017641,-0.15061,-0.15486,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.05824,-0.15073,-0.12632,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0069616,-0.15193,-0.12686,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.047551,-0.15212,-0.18053,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.085627,-0.15251,-0.12455,0,0
1,GO STEROID HORMONE SECRETION,0.13355,-0.15313,-0.12532,0,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.15517,-0.15397,-0.2339,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.068167,-0.15406,-0.10507,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.26847,-0.15526,-0.086148,0,0
1,GO AXONEME ASSEMBLY,0.090515,-0.15541,-0.13011,0,0
1,GO COPULATION,0.31653,-0.15589,-0.080627,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0017123,-0.15599,-0.18415,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.14769,-0.15695,-0.10728,0,0
1,GO DETECTION OF VISIBLE LIGHT,0.001872,-0.15811,-0.043664,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.34702,-0.15815,-0.091802,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.15517,-0.15851,-0.085942,0,0
1,GO AORTA MORPHOGENESIS,0.27227,-0.15855,0.014636,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.099158,-0.15891,-0.077006,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.065563,-0.15911,-0.18624,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.009256,-0.1595,-0.13502,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.0025817,-0.16034,-0.14881,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.0090226,-0.16068,-0.16592,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.099158,-0.16118,-0.10789,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.13355,-0.16204,-0.15116,0,0
1,GO HISTONE METHYLATION,0.00069957,-0.16257,-0.14367,0,0
1,GO AXONAL TRANSPORT,0.0037331,-0.1633,-0.20772,0,0
1,GO PROTEIN METHYLATION,0.0013054,-0.16377,-0.14016,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.17653,-0.16429,-0.092386,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.064293,-0.16473,-0.1193,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.03245,-0.16494,-0.14168,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.15773,-0.16522,-0.17032,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.28785,-0.16553,-0.062541,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.35153,-0.16678,-0.051952,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.13814,-0.16838,-0.14083,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.044685,-0.16889,-0.21767,0,0
1,GO GASTRIC ACID SECRETION,0.2,-0.16948,-0.085248,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.24643,-0.16954,-0.10966,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00010092,-0.16969,-0.18677,0,0
1,GO INTESTINAL ABSORPTION,0.064293,-0.16999,-0.13472,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0057817,-0.17032,-0.13234,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.090515,-0.1712,-0.085848,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0099891,-0.17137,-0.19278,0,0
1,GO CYTOPLASM ORGANIZATION,0.41842,-0.17158,-0.0634,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.017969,-0.1716,-0.16093,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00031859,-0.17196,-0.19341,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.16032,-0.17288,-0.12682,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.23245,-0.1746,-0.13822,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0695,-0.17538,-0.19176,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.004408,-0.1757,-0.12221,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.13355,-0.17615,-0.13775,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.0010859,-0.17624,-0.16386,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.11841,-0.17634,-0.13109,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.030383,-0.1764,-0.14326,0,0
1,GO REGULATION OF AXONOGENESIS,0.00035231,-0.17669,-0.21806,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.14285,-0.17672,-0.087735,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.084046,-0.17702,-0.14263,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.082489,-0.17828,-0.11871,0,0
1,GO TOXIN METABOLIC PROCESS,0.077957,-0.17859,-0.20544,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.1028,-0.17891,-0.13902,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00024286,-0.17913,-0.19711,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.11235,-0.17954,-0.13753,0,0
1,GO GDP METABOLIC PROCESS,0.026586,-0.18017,-0.25154,0,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.05824,-0.18053,-0.19954,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.43883,-0.1811,-0.051114,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.036948,-0.18116,-0.12458,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.21256,-0.1813,-0.084054,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.00010092,-0.1816,-0.2027,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.26847,-0.18216,0.0086968,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.80989,-0.18257,0.0027063,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.030383,-0.18287,-0.19782,0,0
1,GO NEURON PROJECTION GUIDANCE,0.0021689,-0.1842,-0.206,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.027188,-0.18425,-0.14941,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.018836,-0.18474,-0.15665,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.016734,-0.18474,-0.1783,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.18508,-0.18485,-0.17758,0,0
1,GO SPERM AXONEME ASSEMBLY,0.10096,-0.18489,-0.12817,0,0
1,GO NEURAL CREST FORMATION,0.11841,-0.18491,-0.14474,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.065563,-0.18524,-0.17738,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.13583,-0.18535,-0.16215,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.075049,-0.18562,-0.13861,0,0
1,GO CELL AGGREGATION,0.1313,-0.18579,-0.10893,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.011904,-0.18612,-0.14699,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.093897,-0.18642,-0.19788,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.27227,-0.187,-0.09469,0,0
1,GO TELENCEPHALON DEVELOPMENT,0.00029782,-0.18794,-0.18803,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.001191,-0.18874,-0.22814,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.14285,-0.18933,-0.12426,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.10465,-0.18976,-0.16755,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.18219,-0.19057,-0.15207,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.035393,-0.19092,-0.098392,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.23245,-0.19095,-0.17019,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.2,-0.19104,-0.11706,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.31653,-0.19187,-0.13083,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0029794,-0.19214,-0.12459,0,0
1,GO RESPONSE TO EPINEPHRINE,0.14526,-0.19225,-0.16011,0,0
1,GO RESPONSE TO FORSKOLIN,0.097379,-0.19247,-0.17013,0,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.057089,-0.19294,-0.13503,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.00034072,-0.19402,-0.16164,0,0
1,GO RELAXATION OF MUSCLE,0.17099,-0.19509,-0.13306,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.0064317,-0.19538,-0.19354,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.059411,-0.19563,-0.13459,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.020205,-0.19663,-0.25101,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0011549,-0.19681,-0.38661,0,0
1,GO HISTONE H3 K9 METHYLATION,0.00014418,-0.19701,-0.20558,0,0
1,GO FORELIMB MORPHOGENESIS,0.092194,-0.1972,-0.12335,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.01282,-0.19798,-0.2207,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.31232,-0.19966,-0.12597,0,0
1,GO AXON DEVELOPMENT,0.00026903,-0.2016,-0.22256,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.061812,-0.2034,-0.19061,0,0
1,GO VASCULAR WOUND HEALING,0.15517,-0.20394,-0.17069,0,0
1,GO PALLIUM DEVELOPMENT,0.00022676,-0.20428,-0.21308,0,0
1,GO GLYCINE TRANSPORT,0.16828,-0.20633,-0.12834,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,7.013e-05,-0.20634,-0.23577,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.0038387,-0.20759,-0.22719,0,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00041602,-0.20791,-0.25504,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.013465,-0.20835,-0.24275,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.14769,-0.21029,-0.12004,0,0
1,GO NEURON REMODELING,0.31232,-0.21029,-0.079985,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.188,-0.21107,-0.10069,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.52594,-0.21158,-0.047282,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.59664,-0.21318,-0.11597,0,0
1,GO CORNIFICATION,0.097379,-0.21421,-0.14521,0,0
1,GO CELL PART MORPHOGENESIS,8.1192e-05,-0.21523,-0.22482,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0040578,-0.21553,-0.20193,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.00067758,-0.21575,-0.21213,0,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.036164,-0.21904,-0.14639,0,0
1,GO NEURON PROJECTION EXTENSION,0.00072223,-0.21912,-0.20674,0,0
1,GO CARDIAC CHAMBER FORMATION,0.14526,-0.22097,-0.31509,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.15264,-0.22149,-0.098816,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.090515,-0.22203,-0.12355,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0094949,-0.22211,-0.22363,0,0
1,GO NEURON DEVELOPMENT,3.3132e-05,-0.22235,-0.21035,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.088862,-0.22245,-0.11798,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00084609,-0.22261,-0.23312,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.0011549,-0.22278,-0.19635,0,0
1,GO MITOCHONDRION LOCALIZATION,0.0069616,-0.22395,-0.22624,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,0.0047853,-0.22496,-0.16308,0,0
1,GO NEURON DIFFERENTIATION,1.2962e-05,-0.22496,-0.21649,0,0
1,GO CELL JUNCTION MAINTENANCE,0.018398,-0.22571,-0.22744,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00022676,-0.22921,-0.28011,0,0
1,GO RESPONSE TO LIGHT INTENSITY,0.0099891,-0.22968,-0.21706,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.00030804,-0.2308,-0.24543,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.082489,-0.23124,-0.18239,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.71006,-0.23176,0.043034,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.12049,-0.2356,-0.15749,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0087944,-0.23586,-0.21875,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00059588,-0.23742,-0.20941,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.00055855,-0.2382,-0.26804,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0001165,-0.23934,-0.19472,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.1313,-0.23975,-0.20163,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.00012512,-0.24141,-0.31211,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00032948,-0.24334,-0.25341,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0011199,-0.24438,-0.17488,0,0
1,GO SPINAL CORD DEVELOPMENT,8.1192e-05,-0.24452,-0.2833,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.017969,-0.24699,-0.21328,0,0
1,GO PROTEIN DEPOLYMERIZATION,4.6597e-05,-0.24704,-0.23775,0,0
1,GO HIPPOCAMPUS DEVELOPMENT,1.4039e-05,-0.24818,-0.30423,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.017969,-0.24854,-0.15983,0,0
1,GO FOREBRAIN CELL MIGRATION,0.0056288,-0.25199,-0.21869,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.097379,-0.25261,-0.14495,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,2.0033e-05,-0.25359,-0.27942,0,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00021167,-0.254,-0.24512,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.019283,-0.25406,-0.2185,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00084609,-0.25442,-0.22889,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.011904,-0.25481,-0.22573,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,6.5149e-05,-0.25483,-0.33314,0,0
1,GO VISUAL BEHAVIOR,6.0504e-05,-0.25617,-0.21283,0,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00021909,-0.25661,-0.28698,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0054795,-0.25798,-0.3225,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.087232,-0.25849,-0.14694,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,2.8077e-06,-0.26123,-0.32742,0,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.017137,-0.26266,-0.18373,0,0
1,GO NOREPINEPHRINE SECRETION,0.0071468,-0.26329,-0.19264,0,0
1,GO INSEMINATION,0.11841,-0.26515,-0.14318,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,7.8282e-05,-0.26571,-0.32836,0,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00049035,-0.26928,-0.27841,0,0
1,GO HEART FORMATION,0.026586,-0.27122,-0.19174,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00014935,-0.273,-0.20413,0,0
1,GO CELL FATE DETERMINATION,0.017137,-0.27301,-0.2163,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0079323,-0.27336,-0.21889,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,0.0006154,-0.27403,-0.21785,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00050664,-0.27424,-0.22235,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0047853,-0.27505,-0.21388,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,2.1663e-05,-0.27789,-0.29376,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,1.6015e-06,-0.27984,-0.27381,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00049035,-0.27986,-0.2361,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.05161,-0.28037,-0.42805,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.15773,-0.28221,-0.15823,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.066855,-0.28276,-0.35176,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00025131,-0.28278,-0.28,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,5.9841e-06,-0.28381,-0.29483,0,0
1,GO SYNAPTIC VESICLE RECYCLING,7.6603e-06,-0.28603,-0.33155,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.047551,-0.28697,-0.24644,0,0
1,GO ACROSOME ASSEMBLY,0.00023468,-0.28782,-0.25559,0,0
1,GO FILOPODIUM ASSEMBLY,4.8379e-05,-0.28913,-0.28654,0,0
1,GO CARTILAGE MORPHOGENESIS,0.075049,-0.29022,-0.21695,0,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.01282,-0.29144,-0.25832,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00022676,-0.29967,-0.37065,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00020448,-0.30253,-0.31503,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0085714,-0.30524,-0.27341,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.50896,-0.30838,-0.080244,0,0
1,GO SHORT TERM MEMORY,0.012203,-0.30861,-0.25157,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.095625,-0.31116,-0.15143,0,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,8.6584e-06,-0.3134,-0.29729,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.2454e-05,-0.31433,-0.32412,0,0
1,GO HEAT GENERATION,0.035393,-0.3147,-0.1954,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.4728e-06,-0.3212,-0.3255,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.016734,-0.32414,-0.38421,0,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,2.2524e-05,-0.32417,-0.38113,0,0
1,GO CELL FATE SPECIFICATION,2.9532e-05,-0.32505,-0.37441,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.00072223,-0.32525,-0.33926,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.041093,-0.32608,-0.24403,0,0
1,GO DENDRITE DEVELOPMENT,4.4712e-06,-0.32669,-0.30358,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.070855,-0.32961,-0.19811,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.00067758,-0.33331,-0.27945,0,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,2.0784e-06,-0.33419,-0.37926,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.01282,-0.33473,-0.28259,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.011326,-0.33586,-0.24133,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.00018427,-0.33657,-0.32185,0,0
1,GO NEUROTRANSMITTER REUPTAKE,0.00042998,-0.33721,-0.31097,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,6.7728e-06,-0.33722,-0.37052,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,7.0571e-06,-0.33931,-0.40228,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,2.1702e-06,-0.34314,-0.32243,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00014935,-0.34423,-0.35581,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00016595,-0.35125,-0.33105,0,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00045924,-0.35135,-0.36411,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,3.0689e-05,-0.3528,-0.36745,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0025083,-0.35315,-0.26998,0,0
1,GO NEURAL RETINA DEVELOPMENT,2.6307e-05,-0.35603,-0.40465,0,0
1,GO METENCEPHALON DEVELOPMENT,1.3441e-06,-0.35615,-0.36905,0,0
1,GO RESPONSE TO LEUCINE,0.033894,-0.35627,-0.29122,0,0
1,GO DENDRITE MORPHOGENESIS,4.4712e-06,-0.36036,-0.33615,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.12049,-0.36109,-0.18593,0,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00074557,-0.36178,-0.27243,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00017796,-0.3629,-0.32482,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0081404,-0.36478,-0.26422,0,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.1964e-05,-0.36675,-0.42895,0,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,4.6597e-05,-0.36788,-0.33887,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.0011549,-0.36813,-0.28228,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,2.2658e-06,-0.36838,-0.34435,0,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00017186,-0.36879,-0.30164,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,7.3528e-06,-0.36949,-0.36225,0,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00084609,-0.37116,-0.32688,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.4044e-06,-0.37306,-0.36678,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00065623,-0.37339,-0.31387,0,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,5.508e-06,-0.37655,-0.41616,0,0
1,GO WALKING BEHAVIOR,0.00016023,-0.37669,-0.33142,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,9.3916e-06,-0.38337,-0.3442,0,0
1,GO FAT CELL PROLIFERATION,0.00016023,-0.38476,-0.37626,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,4.0073e-05,-0.38554,-0.40049,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,7.547e-05,-0.38644,-0.35779,0,0
1,GO REGULATION OF VESICLE FUSION,0.0053338,-0.38645,-0.33673,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.001191,-0.38679,-0.40301,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00014418,-0.38869,-0.43032,0,0
1,GO NEUROTRANSMITTER UPTAKE,0.00074557,-0.39143,-0.28394,0,0
1,GO PARENTAL BEHAVIOR,0.0006154,-0.39326,-0.3727,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.024288,-0.39639,-0.33527,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00098941,-0.39912,-0.33624,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0067808,-0.40102,-0.30278,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0001547,-0.40141,-0.53887,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.076492,-0.40264,-0.22963,0,0
1,GO HEART FIELD SPECIFICATION,0.044685,-0.40383,-0.2358,0,0
1,GO NEURON MIGRATION,1.1493e-05,-0.40478,-0.38822,0,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.00030804,-0.41069,-0.54173,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,1.5331e-06,-0.41481,-0.4292,0,0
1,GO PITUITARY GLAND DEVELOPMENT,1.1964e-05,-0.41687,-0.45213,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,6.5896e-07,-0.41814,-0.42319,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00026903,-0.42031,-0.42238,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,3.4728e-06,-0.4208,-0.42265,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.42238,-0.35803,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.00012512,-0.42705,-0.36254,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.6623e-06,-0.42952,-0.4166,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.349e-05,-0.43047,-0.49397,0,0
1,GO SEROTONIN TRANSPORT,1.6015e-06,-0.43436,-0.54684,0,0
1,GO ADULT BEHAVIOR,8.8325e-08,-0.43465,-0.48269,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00012074,-0.43795,-0.37726,0,0
1,GO SUBPALLIUM DEVELOPMENT,0.00026003,-0.44163,-0.3866,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.017969,-0.44331,-0.27798,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,2.9532e-05,-0.44488,-0.39294,0,0
1,GO SYNAPSE ASSEMBLY,3.9926e-07,-0.44959,-0.45876,0,0
1,GO DIENCEPHALON DEVELOPMENT,1.906e-06,-0.45163,-0.41172,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,2.0784e-06,-0.45302,-0.47582,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.018398,-0.45647,-0.44249,0,0
1,GO SEGMENT SPECIFICATION,1.5201e-05,-0.45782,-0.51998,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,1.6455e-05,-0.46072,-0.43757,0,0
1,GO REGULATION OF CELL PROJECTION SIZE,3.5759e-05,-0.46147,-0.45261,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.00087311,-0.46429,-0.45672,0,0
1,GO NEURON RECOGNITION,3.3132e-05,-0.46521,-0.439,0,0
1,GO SOMATIC STEM CELL DIVISION,0.02843,-0.46841,-0.29697,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,2.5308e-05,-0.46947,-0.47032,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00010092,-0.47106,-0.36968,0,0
1,GO GLUTAMATE SECRETION,2.6307e-05,-0.47254,-0.40581,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.3441e-06,-0.47778,-0.53314,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,3.5759e-05,-0.47791,-0.43578,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,1.1493e-05,-0.47881,-0.45473,0,0
1,GO CEREBELLAR CORTEX FORMATION,9.8628e-07,-0.48788,-0.50882,0,0
1,GO AXONAL FASCICULATION,8.1192e-05,-0.49154,-0.52032,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.00044439,-0.49258,-0.41184,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.3218e-05,-0.50665,-0.56044,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.6455e-05,-0.51129,-0.59537,0,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,7.889e-07,-0.51299,-0.47108,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.0026572,-0.52001,-0.45363,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.2862e-06,-0.52845,-0.47204,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,2.0833e-05,-0.53281,-0.48337,0,0
1,GO DENSE CORE GRANULE TRANSPORT,4.2876e-06,-0.53817,-0.91075,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,3.0689e-05,-0.54227,-0.4679,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,7.5427e-07,-0.54554,-0.50531,0,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,6.4994e-06,-0.55845,-0.55527,0,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,3.9926e-07,-0.5719,-0.53377,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,3.3287e-06,-0.57226,-0.6711,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,5.508e-06,-0.57289,-0.58593,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,1.0311e-06,-0.57696,-0.52707,0,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,1.5816e-05,-0.58344,-0.59794,0,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.8891e-07,-0.58526,-0.61705,0,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00027832,-0.58553,-0.52139,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,1.4609e-05,-0.58637,-0.57716,0,0
1,GO NEUROTRANSMITTER TRANSPORT,1.2308e-06,-0.60784,-0.51319,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.2524e-05,-0.62132,-0.50048,0,0
1,GO CARDIOBLAST PROLIFERATION,0.0041716,-0.62291,-0.47761,0,0
1,GO REGULATION OF HEAT GENERATION,0.0029794,-0.62961,-0.39766,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.0031536,-0.63039,-0.41795,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.2308e-06,-0.63091,-0.6118,0,0
1,GO NEUROTRANSMITTER SECRETION,1.1776e-06,-0.65295,-0.56552,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,2.5774e-06,-0.66092,-0.65946,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,3.5759e-05,-0.69226,-0.65216,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1904e-06,-0.69841,-0.58479,0,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,4.1802e-07,-0.7019,-0.65859,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,3.5759e-05,-0.70256,-0.62778,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.3441e-06,-0.7295,-0.66599,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,3.6414e-07,-0.73801,-0.67874,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,6.5149e-05,-0.74826,-0.63845,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.6729e-06,-0.75045,-0.65951,0,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.0683e-06,-0.79042,-0.6974,0,0
1,GO SEROTONIN SECRETION,6.6003e-08,-0.79114,-0.71843,0,0
1,GO PREPULSE INHIBITION,5.9841e-06,-0.81764,-0.73881,0,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7145e-05,-0.82605,-0.61919,0,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.9904e-06,-0.8381,-0.74228,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,8.3127e-06,-0.84231,-0.78966,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,1.9873e-07,-0.86819,-0.80718,0,0
1,GO VOCALIZATION BEHAVIOR,2.3654e-06,-0.86899,-0.83727,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,2.9532e-05,-0.8758,-0.77607,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,2.1831e-07,-0.89506,-0.84149,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,1.2454e-05,-0.91301,-0.6782,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,7.2111e-07,-0.92161,-0.92127,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.9904e-06,-0.95863,-0.88545,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,1.4674e-06,-0.96241,-0.9021,0,0
1,GO NEURON FATE SPECIFICATION,2.7578e-07,-1.0126,-0.99553,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.4674e-06,-1.2163,-1.0997,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,2.3975e-07,1.2188,0.98077,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0038387,1.138,0.85188,1,1
2,GO ETHANOL OXIDATION,6.8936e-07,1.0574,0.91957,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00025131,0.96721,0.71972,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00353,0.96422,0.68716,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0028957,0.8366,0.52159,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.6414e-07,0.82551,0.76751,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00049035,0.82084,0.6559,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7791e-06,0.80051,0.61412,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00024286,0.79234,0.65233,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4963e-07,0.77703,0.7163,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00012074,0.75668,0.61402,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0001547,0.7414,0.61311,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00067758,0.73434,0.48717,1,1
2,GO RESPONSE TO INTERLEUKIN 18,8.4205e-05,0.71907,0.69033,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,9.7801e-06,0.70935,0.70201,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00353,0.70604,0.44328,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00021909,0.69788,0.51912,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.2876e-06,0.68144,0.51662,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.8131e-07,0.68021,0.52836,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3202e-07,0.67989,0.64115,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,2.0833e-05,0.67581,0.59002,1,1
2,GO BIOLOGICAL PHASE,5.8301e-05,0.67252,0.64455,1,1
2,GO MUCUS SECRETION,0.00041602,0.66447,0.62258,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00014418,0.66081,0.48671,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00012512,0.65356,0.55602,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0032441,0.64671,0.46843,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,0.0025083,0.63952,0.43062,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00079435,0.63924,0.56895,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0067808,0.63783,0.41816,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,8.1192e-05,0.62672,0.54969,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026903,0.62238,0.47929,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,7.9801e-06,0.61743,0.54446,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00079435,0.6163,0.43915,1,1
2,GO MYOBLAST MIGRATION,0.012203,0.61214,0.48969,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.9904e-06,0.61141,0.58141,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0006154,0.60615,0.39289,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.8077e-06,0.59842,0.53565,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.013e-05,0.59822,0.57271,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0050528,0.59403,0.40774,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.4421e-05,0.59241,0.56255,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.001662,0.5892,0.41026,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0037331,0.58809,0.38473,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0014738,0.58398,0.48389,1,1
2,GO PROSTATE GLAND GROWTH,2.6902e-06,0.58277,0.66094,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.2454e-05,0.57692,0.50387,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036303,0.57617,0.5243,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.5746,0.41042,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8612e-06,0.5727,0.41492,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.3127e-06,0.57002,0.51339,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00054072,0.56861,0.49296,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.0226e-05,0.56849,0.50487,1,1
2,GO HAIR FOLLICLE MATURATION,5.0226e-05,0.56535,0.46299,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.8379e-05,0.56446,0.5591,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,7.547e-05,0.56443,0.52748,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,6.0504e-05,0.5639,0.50941,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00029782,0.55977,0.55728,1,1
2,GO ETHER METABOLIC PROCESS,2.2658e-06,0.55969,0.52151,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00041602,0.55842,0.38525,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00057693,0.54504,0.45648,1,1
2,GO LYSINE METABOLIC PROCESS,0.00027832,0.54427,0.50937,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.5331e-06,0.53953,0.52941,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.00035231,0.53863,0.44538,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2533e-07,0.5381,0.50383,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1493e-05,0.53748,0.58244,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00035231,0.53501,0.54111,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014299,0.53424,0.37862,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0085714,0.53404,0.37151,1,1
2,GO RETINAL METABOLIC PROCESS,0.011612,0.52399,0.33519,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.5201e-05,0.52013,0.45297,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.1192e-05,0.50824,0.40378,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00040247,0.50678,0.4586,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0023671,0.50474,0.3476,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00045924,0.50334,0.43411,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.0184e-05,0.50221,0.42961,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012964,0.50121,0.46953,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.8418e-05,0.50099,0.40463,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.00013433,0.49905,0.45815,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0034322,0.49763,0.40906,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014299,0.49496,0.35548,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0073363,0.49416,0.4227,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00037661,0.49345,0.43814,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.48643,0.35473,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00034072,0.48059,0.47727,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,0.47901,0.43059,1,1
2,GO ACTIN FILAMENT SEVERING,0.03939,0.47803,0.31778,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00011241,0.47764,0.43602,1,1
2,GO OXYGEN TRANSPORT,0.0097392,0.47714,0.44234,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,6.7728e-06,0.47699,0.47013,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.2139e-05,0.4752,0.43857,1,1
2,GO ETHANOL METABOLIC PROCESS,3.9418e-06,0.47423,0.53454,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0094949,0.47382,0.31455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7806e-05,0.47187,0.42891,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.043763,0.47024,0.31162,1,1
2,GO RESPONSE TO INTERFERON BETA,0.014841,0.46842,0.33406,1,1
2,GO MUSCLE ATROPHY,0.0056288,0.46832,0.35363,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.46758,0.36777,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8077e-06,0.46665,0.46345,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.017969,0.46374,0.33599,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.052669,0.46175,0.2215,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0039469,0.46115,0.3362,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010092,0.45356,0.32321,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0683e-06,0.45162,0.44542,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0025083,0.45013,0.35679,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.2139e-05,0.44985,0.38143,1,1
2,GO NEPHRON TUBULE FORMATION,0.0051916,0.44818,0.29165,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.8521e-05,0.44531,0.36481,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39268,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.44402,0.44861,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4434,0.31054,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00079435,0.44175,0.41148,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00065623,0.43886,0.40518,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0012662,0.43534,0.28381,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00065623,0.43487,0.32608,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0037331,0.43454,0.36136,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.021165,0.4339,0.38552,1,1
2,GO DENDRITIC CELL MIGRATION,0.00023468,0.43328,0.35887,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013054,0.43308,0.34556,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0014738,0.43185,0.41882,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.43045,0.34009,1,1
2,GO HEME METABOLIC PROCESS,0.0001165,0.43026,0.36397,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0042883,0.42078,0.35767,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0099891,0.41912,0.31179,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00081984,0.41675,0.40011,1,1
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0019282,0.41489,0.4172,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.7323e-05,0.41199,0.35263,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.6603e-06,0.41126,0.34496,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00095906,0.40983,0.34481,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00067758,0.40915,0.3631,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.013798,0.40864,0.36164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0013872,0.40716,0.36921,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.036948,0.40538,0.21569,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00059588,0.40313,0.31314,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00024286,0.40309,0.35282,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0021689,0.40206,0.36819,1,1
2,GO PIGMENT GRANULE MATURATION,0.0064317,0.40113,0.28935,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.39563,0.37481,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0007696,0.39535,0.36431,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00084609,0.39496,0.37627,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.012508,0.39302,0.25517,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.4609e-05,0.39275,0.36363,1,1
2,GO NEURAL CREST FORMATION,0.001986,0.39274,0.31258,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00010462,0.39259,0.33245,1,1
2,GO TOLERANCE INDUCTION,0.0081404,0.39066,0.29059,1,1
2,GO PORE COMPLEX ASSEMBLY,1.5331e-06,0.39017,0.3861,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.39002,0.30019,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0036303,0.38886,0.24956,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0056288,0.38851,0.34701,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0057817,0.3878,0.26355,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0021062,0.38673,0.39568,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00024286,0.38641,0.33182,1,1
2,GO CYSTEINE METABOLIC PROCESS,0.00052342,0.38428,0.45613,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0071468,0.3838,0.34373,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.6228e-06,0.38376,0.3767,1,1
2,GO GAS TRANSPORT,0.0027346,0.38344,0.3948,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00047456,0.38307,0.29409,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00034072,0.38284,0.29717,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0085714,0.38202,0.30739,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.010506,0.38191,0.27894,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00013917,0.37995,0.34824,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.2139e-05,0.3795,0.44891,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0060989,0.37871,0.24295,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0059384,0.37771,0.34512,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022992,0.3771,0.31748,1,1
2,GO LIMB BUD FORMATION,0.004408,0.37637,0.45708,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.3522,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.9801e-06,0.37499,0.34095,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00081984,0.37398,0.26276,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00020448,0.3725,0.44521,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00019753,0.37234,0.31057,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.6015e-06,0.37228,0.38208,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00059588,0.37187,0.25297,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.001986,0.37038,0.27804,1,1
2,GO VESICLE CARGO LOADING,7.6603e-06,0.36955,0.32422,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00079435,0.36948,0.30425,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00017186,0.36863,0.3066,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.011612,0.36735,0.27613,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.36734,0.34248,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00095906,0.36619,0.34868,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.36571,0.30276,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00050664,0.36557,0.26279,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.042857,0.36536,0.1533,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.015574,0.36517,0.32126,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0015189,0.36464,0.39153,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025083,0.3632,0.3316,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0099891,0.36188,0.30721,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0007696,0.36136,0.28495,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.00013433,0.36053,0.30139,1,1
2,GO PENTOSE METABOLIC PROCESS,9.389e-05,0.36036,0.36299,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,2.5308e-05,0.35899,0.36324,1,1
2,GO ERYTHROCYTE MATURATION,0.0032441,0.35683,0.33047,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.3557,0.30435,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,5.4121e-05,0.35549,0.35851,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011199,0.35417,0.25943,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.044685,0.35396,0.22261,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.0040578,0.35337,0.21368,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,4.4878e-05,0.35275,0.36296,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.015203,0.35094,0.22572,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00079435,0.35091,0.3868,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0013872,0.35069,0.28011,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0006154,0.35048,0.29794,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00037661,0.34998,0.27938,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7791e-06,0.3499,0.32381,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5149e-05,0.34977,0.29849,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.8379e-05,0.34956,0.49294,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0011199,0.34881,0.38049,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.020205,0.34859,0.23365,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00029782,0.34843,0.37059,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0001165,0.34839,0.33558,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,8.7323e-05,0.34835,0.24901,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0015653,0.34824,0.25943,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00017796,0.34744,0.30255,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.016734,0.34708,0.26331,1,1
2,GO T CELL MEDIATED IMMUNITY,0.00047456,0.34696,0.27333,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0010859,0.34597,0.28162,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.017969,0.34567,0.21733,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.020205,0.34249,0.23351,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0028957,0.34167,0.22797,1,1
2,GO PRE MIRNA PROCESSING,0.0024367,0.34144,0.21951,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.015953,0.34087,0.33089,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0001165,0.33992,0.29113,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.33906,0.28396,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0099891,0.33904,0.22043,1,1
2,GO REGULATION OF DNA METHYLATION,0.00049035,0.3388,0.242,1,1
2,GO NEUROBLAST DIVISION,0.00072223,0.33846,0.37127,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.017969,0.33702,0.30073,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057693,0.33599,0.28252,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0024367,0.33597,0.23208,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.038561,0.3359,0.18055,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0019282,0.33542,0.26919,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00017186,0.3353,0.50849,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.021165,0.33524,0.21581,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027803,0.3351,0.19838,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.33447,0.3165,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0033369,0.3344,0.33026,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0083534,0.33389,0.21814,1,1
2,GO RNA DECAPPING,1.1493e-05,0.33388,0.25129,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00035231,0.3336,0.25115,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,1.6455e-05,0.33295,0.37286,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00353,0.33197,0.20721,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.001662,0.33102,0.3149,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00074557,0.33092,0.25496,1,1
2,GO TONGUE MORPHOGENESIS,0.019283,0.33071,0.29047,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001228,0.33066,0.33854,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,2.5308e-05,0.33032,0.35008,1,1
2,GO RETINOL METABOLIC PROCESS,8.1192e-05,0.33001,0.34236,1,1
2,GO FIBROBLAST ACTIVATION,0.00032948,0.32998,0.33966,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.32972,0.32863,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.001662,0.32941,0.2276,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00031859,0.32938,0.3004,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0087944,0.32827,0.20394,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00084609,0.32825,0.27999,1,1
2,GO MICROVILLUS ASSEMBLY,0.010506,0.32748,0.307,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0062634,0.3265,0.22607,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0067808,0.32616,0.21725,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017969,0.32523,0.24907,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00063551,0.32312,0.24574,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0057817,0.32299,0.26181,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,9.7801e-06,0.32178,0.32829,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0011199,0.32154,0.29743,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0010528,0.32145,0.2392,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0036303,0.32106,0.27455,1,1
2,GO FOREGUT MORPHOGENESIS,0.001228,0.32032,0.36484,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0066042,0.3199,0.31447,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00013917,0.31908,0.42465,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00022676,0.31757,0.28225,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.4692e-06,0.31751,0.26071,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.3218e-05,0.31731,0.30741,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0059384,0.31716,0.23558,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024288,0.31666,0.21477,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0012662,0.31647,0.25098,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,6.2985e-07,0.31647,0.29308,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0053338,0.31633,0.24956,1,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.014486,0.31618,0.27754,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0013054,0.31594,0.27754,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.31574,0.2736,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00013917,0.31551,0.29973,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31543,0.26202,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00021909,0.31514,0.27835,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012203,0.31502,0.22058,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.6902e-06,0.31497,0.33393,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0075304,0.31489,0.24774,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0081404,0.31474,0.29061,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00050664,0.3143,0.2573,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.02268,0.31397,0.26268,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.011326,0.31389,0.23893,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00017186,0.3137,0.29961,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00027832,0.31301,0.28947,1,1
2,GO CARNITINE SHUTTLE,4.4878e-05,0.31298,0.32458,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0069616,0.31284,0.29225,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022992,0.31212,0.25508,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.31211,0.22347,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.001228,0.31164,0.26226,1,1
2,GO GERMINAL CENTER FORMATION,0.047551,0.31157,0.1849,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,3.6228e-06,0.3115,0.30406,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0604e-05,0.31107,0.26557,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0040578,0.31092,0.30449,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00087311,0.31004,0.25051,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00050664,0.30986,0.21472,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.6455e-05,0.3096,0.24778,1,1
2,GO AMP METABOLIC PROCESS,0.0083534,0.30824,0.24605,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015953,0.30823,0.22793,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013872,0.30794,0.20978,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0025817,0.30789,0.24625,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017186,0.3076,0.27318,1,1
2,GO OVULATION,7.547e-05,0.30732,0.34627,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00055855,0.30703,0.26567,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0097392,0.30686,0.26815,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0028957,0.30673,0.22582,1,1
2,GO DNA LIGATION,0.0013872,0.30662,0.22916,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0087944,0.30646,0.24362,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00059588,0.30575,0.26266,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.4121e-05,0.3057,0.27806,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.8301e-05,0.30565,0.2589,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.30557,0.27088,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014138,0.305,0.3023,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.019283,0.30472,0.30503,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0010528,0.30438,0.22548,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0016129,0.30433,0.37661,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0087944,0.30363,0.18653,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0010859,0.30308,0.29313,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0010528,0.30198,0.25207,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00016595,0.29938,0.32981,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00072223,0.29931,0.23673,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0020453,0.2993,0.2478,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0020453,0.2992,0.25235,1,1
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.035393,0.29898,0.22937,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,2.3418e-05,0.29884,0.2868,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00010092,0.29871,0.25627,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0030654,0.29827,0.2272,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0064317,0.29801,0.21124,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00040247,0.29755,0.24907,1,1
2,GO RESPONSE TO TUMOR CELL,0.001228,0.29688,0.2561,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00012512,0.29589,0.29569,1,1
2,GO URETER DEVELOPMENT,0.017137,0.29587,0.27349,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.29584,0.32224,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.29582,0.18248,1,1
2,GO NUCLEAR PORE ORGANIZATION,5.9841e-06,0.29577,0.36087,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0010859,0.29556,0.20829,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.29527,0.28158,1,1
2,GO ENTRY INTO HOST,0.0021689,0.29495,0.21752,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00010092,0.29466,0.24138,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0012662,0.29446,0.24354,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,7.2111e-07,0.29425,0.2659,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0046564,0.2937,0.26234,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00022676,0.29315,0.29834,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0010206,0.29304,0.23921,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0038387,0.29291,0.19189,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0097392,0.29273,0.26839,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00032948,0.29162,0.30054,1,1
2,GO MATURATION OF LSU RRNA,0.0025083,0.29137,0.3167,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,7.013e-05,0.29107,0.24873,1,1
2,GO HISTONE H4 DEACETYLATION,4.4878e-05,0.29103,0.3279,1,1
2,GO ZYMOGEN INHIBITION,0.010245,0.29042,0.24546,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0032441,0.29041,0.22435,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001547,0.29001,0.29361,1,1
2,GO PODOSOME ASSEMBLY,0.0022332,0.28995,0.25805,1,1
2,GO REGULATION OF GTP BINDING,0.050569,0.28956,0.18015,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0034322,0.28871,0.23378,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0038387,0.28853,0.27612,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0010859,0.28853,0.22523,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00022676,0.28845,0.29004,1,1
2,GO MRNA MODIFICATION,0.001191,0.28832,0.21786,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00017796,0.28826,0.26875,1,1
2,GO GASTRIC ACID SECRETION,0.0024367,0.28823,0.22976,1,1
2,GO RIG I SIGNALING PATHWAY,9.389e-05,0.2881,0.25117,1,1
2,GO VIRAL TRANSLATION,0.00029782,0.2879,0.3207,1,1
2,GO EPIBOLY,0.053746,0.28775,0.16702,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.023741,0.28738,0.34516,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00027832,0.28729,0.27398,1,1
2,GO PEPTIDE CROSS LINKING,0.0021689,0.28685,0.26412,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.020205,0.28525,0.3749,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0060989,0.28503,0.23448,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018427,0.28472,0.21719,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00032948,0.28463,0.2552,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.001872,0.28431,0.27043,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.1888e-05,0.28428,0.28014,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00012074,0.28381,0.26318,1,1
2,GO BLASTODERM SEGMENTATION,0.027803,0.28377,0.28331,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0054795,0.28375,0.24407,1,1
2,GO DETOXIFICATION,0.00023468,0.28367,0.25648,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0001547,0.28128,0.25224,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00065623,0.28103,0.19887,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0037331,0.28095,0.2198,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00016023,0.28011,0.24105,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00050664,0.27965,0.2655,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00023468,0.27964,0.36523,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.001228,0.27896,0.4369,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.27855,0.2719,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0037331,0.2768,0.36624,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.27659,0.25955,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0017641,0.27646,0.20075,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.0033e-05,0.27471,0.25233,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,4.3218e-05,0.27462,0.37623,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0013457,0.27447,0.17784,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0059384,0.27414,0.33267,1,1
2,GO REGULATION OF CELL KILLING,0.0036303,0.27402,0.19491,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.001872,0.27392,0.26244,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00029782,0.27323,0.27101,1,1
2,GO HIPPO SIGNALING,0.0017123,0.27315,0.33362,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.029719,0.27292,0.33387,1,1
2,GO CHROMATIN DISASSEMBLY,0.0033369,0.27261,0.19177,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00052342,0.2726,0.39055,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0038387,0.27242,0.24319,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015189,0.27208,0.20134,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27153,0.26824,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0036303,0.27045,0.252,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.04854,0.2695,0.16692,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013457,0.26947,0.21333,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0032441,0.26892,0.23371,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0081404,0.26871,0.20036,1,1
2,GO MIRNA METABOLIC PROCESS,2.7343e-05,0.26846,0.21557,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,7.013e-05,0.2683,0.23074,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,8.1192e-05,0.26805,0.24199,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0017641,0.26734,0.28463,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26711,0.27004,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00047456,0.26689,0.19917,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.018398,0.26687,0.20717,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031859,0.26667,0.23997,1,1
2,GO VIRAL GENE EXPRESSION,0.0013872,0.26609,0.24196,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00049035,0.2655,0.24123,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.009256,0.26545,0.19744,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0087944,0.2652,0.21549,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.046579,0.26516,0.14257,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0017123,0.26478,0.19242,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001191,0.26443,0.29381,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0064317,0.26433,0.24907,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0019282,0.26382,0.2562,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26309,0.20352,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.026586,0.263,0.21919,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0020453,0.26282,0.18821,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.26253,0.26756,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017549,0.26251,0.14963,1,1
2,GO RESPONSE TO CADMIUM ION,0.04854,0.26217,0.18851,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.004408,0.26155,0.19522,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.001986,0.26104,0.19359,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0040578,0.26074,0.30895,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00092958,0.26067,0.25007,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.26031,0.22615,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0013054,0.26006,0.18805,1,1
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.019739,0.26004,0.24362,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.017969,0.25969,0.15241,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00017186,0.25959,0.22385,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00035231,0.25894,0.24524,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.25804,0.21197,1,1
2,GO T CELL CHEMOTAXIS,0.00018427,0.25766,0.2468,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0016129,0.25764,0.2328,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0024367,0.25744,0.20189,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.007729,0.2573,0.15246,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.25722,0.18507,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0011549,0.25712,0.20929,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00069957,0.2569,0.2449,1,1
2,GO MATURATION OF SSU RRNA,0.00084609,0.25673,0.29059,1,1
2,GO AMINE CATABOLIC PROCESS,0.0036303,0.25667,0.29734,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.04854,0.25663,0.21703,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.00081984,0.25639,0.41676,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00019079,0.25586,0.23492,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.021165,0.25578,0.2371,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0047853,0.25545,0.30462,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00069957,0.255,0.2861,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0014738,0.25496,0.20245,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0046564,0.25488,0.20254,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0028957,0.25469,0.27699,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.010773,0.25458,0.16782,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7118e-05,0.2542,0.27672,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0021689,0.2539,0.28436,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0034322,0.25361,0.27097,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0015653,0.25339,0.25632,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.011047,0.2531,0.31198,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0040578,0.25298,0.25278,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0013457,0.25295,0.22878,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.8379e-05,0.25284,0.22507,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0041716,0.25283,0.28006,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0013054,0.25253,0.19678,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0062634,0.25197,0.248,1,1
2,GO HISTONE H3 K9 ACETYLATION,7.2754e-05,0.25194,0.23856,1,1
2,GO NUCLEAR MIGRATION,0.015203,0.25191,0.17003,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0047853,0.25176,0.16018,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.00014418,0.25118,0.24104,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0024367,0.25058,0.24338,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.0007696,0.25012,0.29923,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.001986,0.25005,0.2615,1,1
2,GO TRNA METHYLATION,0.00032948,0.25004,0.22206,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0010206,0.24986,0.17177,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.044685,0.24969,0.14031,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00026003,0.24904,0.27761,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00063551,0.24882,0.23474,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.03245,0.24865,0.26531,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0049174,0.2486,0.2264,1,1
2,GO L SERINE METABOLIC PROCESS,0.010245,0.24727,0.27613,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00065623,0.24712,0.21993,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.050569,0.247,0.2102,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00038934,0.24674,0.24009,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00029782,0.24587,0.23021,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0034322,0.2458,0.24629,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0027346,0.24537,0.16134,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.011612,0.24511,0.23128,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0006154,0.24507,0.18006,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,3.7145e-05,0.24489,0.30063,1,1
2,GO AMINO ACID ACTIVATION,0.00012512,0.2448,0.28844,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.038561,0.24479,0.19904,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.2446,0.23915,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,4.1617e-05,0.24431,0.21518,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.05161,0.24393,0.10771,1,1
2,GO PIGMENT ACCUMULATION,0.0018173,0.24311,0.23967,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.014138,0.24257,0.14992,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0020453,0.2422,0.17979,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.046579,0.24218,0.16041,1,1
2,GO ALDITOL METABOLIC PROCESS,0.00042998,0.24196,0.29156,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0033369,0.24189,0.25778,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001986,0.24169,0.24642,1,1
2,GO SECRETION BY TISSUE,0.00084609,0.24153,0.26552,1,1
2,GO RESPONSE TO X RAY,0.00021167,0.24149,0.32623,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.02166,0.24111,0.23275,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00084609,0.24081,0.28566,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0010859,0.24071,0.20213,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00079435,0.24069,0.18663,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0013054,0.24067,0.22835,1,1
2,GO RESPONSE TO PROTOZOAN,0.029719,0.24025,0.1423,1,1
2,GO RESPIRATORY BURST,0.0071468,0.24015,0.208,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.2401,0.23034,1,1
2,GO RESPONSE TO SALT STRESS,0.015203,0.23956,0.21946,1,1
2,GO LIPID OXIDATION,0.0021062,0.23939,0.17205,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00041602,0.23939,0.21465,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0037331,0.23853,0.16552,1,1
2,GO RNA DESTABILIZATION,0.0024367,0.2384,0.17203,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.024846,0.2383,0.23175,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.025994,0.23823,0.18665,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00065623,0.23789,0.20556,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0025817,0.23788,0.2218,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.4205e-05,0.2378,0.21736,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0031536,0.23774,0.16335,1,1
2,GO PROTEASOME ASSEMBLY,0.0045306,0.23755,0.17653,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00092958,0.23742,0.22919,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00072223,0.23741,0.19308,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0033369,0.23721,0.1863,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.547e-05,0.23686,0.22712,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0037331,0.23681,0.25739,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0013457,0.23666,0.23242,1,1
2,GO PIGMENT METABOLIC PROCESS,0.00079435,0.23664,0.21849,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.23639,0.23097,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00069957,0.23604,0.23027,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.010245,0.23464,0.22901,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0069616,0.23437,0.19769,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0042883,0.23412,0.21176,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0069616,0.23371,0.21872,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014841,0.23354,0.15149,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0057817,0.23337,0.23912,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0033369,0.23332,0.25122,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0056288,0.23319,0.23287,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.010773,0.23317,0.23857,1,1
2,GO PLATELET MORPHOGENESIS,0.00035231,0.23317,0.22927,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0045306,0.23289,0.16763,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0016129,0.23281,0.16276,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014738,0.23278,0.1853,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.017969,0.232,0.23813,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00087311,0.23158,0.14143,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00069957,0.23138,0.18493,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0021062,0.23137,0.2324,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001986,0.23108,0.20533,1,1
2,GO BLASTOCYST FORMATION,0.00018427,0.23087,0.21374,1,1
2,GO RESPONSE TO MANGANESE ION,0.0032441,0.23076,0.21233,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0027346,0.23076,0.21381,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0006154,0.23059,0.22253,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.23008,0.16171,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,4.4878e-05,0.22963,0.18907,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0022332,0.22962,0.29499,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0021062,0.22959,0.2365,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012074,0.22931,0.24113,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0073363,0.22907,0.20161,1,1
2,GO GOLGI LOCALIZATION,0.013798,0.22894,0.17862,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0030654,0.22886,0.28273,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0029794,0.22867,0.16082,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00014418,0.22856,0.19017,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0010528,0.22811,0.15312,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.029068,0.22789,0.2342,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.7728e-06,0.2271,0.20914,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00028792,0.22699,0.22064,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00054072,0.22693,0.18568,1,1
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.05161,0.22623,0.21643,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00047456,0.22602,0.17607,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0051916,0.22589,0.25335,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.22506,0.15516,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0051916,0.22504,0.19169,1,1
2,GO LIVER REGENERATION,0.009256,0.22487,0.17921,1,1
2,GO MATURATION OF 5 8S RRNA,0.0013872,0.22463,0.26926,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0028141,0.22434,0.18227,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0059384,0.22408,0.14845,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0025817,0.22397,0.23425,1,1
2,GO FATTY ACID BETA OXIDATION,0.0097392,0.22386,0.13625,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0022992,0.22377,0.25427,1,1
2,GO ARGININE METABOLIC PROCESS,0.042857,0.22346,0.19524,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.22342,0.23147,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0024367,0.22328,0.16015,1,1
2,GO TRANSLATIONAL TERMINATION,0.001662,0.22313,0.21854,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00353,0.22311,0.19444,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.047551,0.22297,0.12548,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.001986,0.22295,0.22217,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001228,0.22269,0.1664,1,1
2,GO NUCLEUS LOCALIZATION,0.0022992,0.22255,0.17072,1,1
2,GO INTESTINAL ABSORPTION,0.0087944,0.22167,0.19457,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1888e-05,0.22099,0.21191,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021062,0.22023,0.22781,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,6.7596e-05,0.22022,0.21071,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.026586,0.21991,0.22807,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0073363,0.21941,0.17182,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0014299,0.21924,0.20608,1,1
2,GO RIBOSOME BIOGENESIS,0.00027832,0.21919,0.25342,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.21916,0.1558,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00034072,0.21914,0.23942,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001165,0.21882,0.18182,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.001986,0.21868,0.18629,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.2786e-05,0.21847,0.19701,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.21796,0.18325,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.00057693,0.2177,0.19629,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.010245,0.21766,0.12813,1,1
2,GO STEM CELL DIVISION,0.0024367,0.21697,0.2289,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.017137,0.21665,0.1399,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.21655,0.15534,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0013457,0.21629,0.18669,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.21627,0.18511,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.02843,0.21616,0.17568,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00042998,0.21578,0.23293,1,1
2,GO IRON ION HOMEOSTASIS,0.00353,0.21575,0.16266,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.042857,0.21563,0.1387,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00047456,0.21534,0.22068,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0054795,0.21529,0.23026,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.00028792,0.21523,0.20008,1,1
2,GO REGULATION OF GENE SILENCING,5.0683e-06,0.21484,0.20369,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0045306,0.21476,0.17825,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0020453,0.2146,0.23118,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0024367,0.21452,0.16188,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017969,0.21442,0.17791,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.0013457,0.21402,0.19559,1,1
2,GO AMYLOID BETA CLEARANCE,0.0053338,0.21354,0.19606,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0013054,0.21353,0.17504,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0014299,0.21348,0.16489,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00035231,0.2133,0.22123,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.015953,0.21288,0.16625,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0087944,0.2128,0.19349,1,1
2,GO B CELL HOMEOSTASIS,0.05161,0.21235,0.1073,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.010245,0.21234,0.19501,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017641,0.21185,0.19463,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00038934,0.21182,0.21758,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0062634,0.21164,0.15797,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.14712,1,1
2,GO INTERACTION WITH HOST,0.0015653,0.21138,0.17433,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00059588,0.21126,0.22841,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00011241,0.21104,0.18282,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0028957,0.21095,0.16386,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00017186,0.21095,0.22245,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0031536,0.21046,0.1433,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00035231,0.21028,0.20847,1,1
2,GO RRNA TRANSCRIPTION,0.00045924,0.21026,0.2361,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0025817,0.2102,0.1538,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.035393,0.21012,0.17625,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00059588,0.21,0.20423,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.001986,0.20965,0.18519,1,1
2,GO LEUKOCYTE PROLIFERATION,0.00081984,0.20964,0.16127,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,5.0226e-05,0.2095,0.19498,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00024286,0.20924,0.16592,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00012074,0.20924,0.19773,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.011047,0.20914,0.15851,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00353,0.20899,0.1704,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.010506,0.20862,0.17098,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.010773,0.20837,0.21633,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0059384,0.20828,0.15751,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031059,0.20813,0.13046,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0034322,0.20778,0.16856,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0064317,0.20764,0.17278,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.20759,0.20384,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0025817,0.20756,0.17138,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0079323,0.20737,0.13116,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00013433,0.20735,0.26378,1,1
2,GO RNA POLYADENYLATION,0.00090094,0.20729,0.15255,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0017123,0.20708,0.19953,1,1
2,GO CYTOPLASM ORGANIZATION,0.014138,0.20701,0.22853,1,1
2,GO RNA STABILIZATION,0.0010859,0.20696,0.15655,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.017549,0.20675,0.17263,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.047551,0.20663,0.1471,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.045624,0.20643,0.17967,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0040578,0.20642,0.15938,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00041602,0.20632,0.23578,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043763,0.20628,0.15932,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0050528,0.20625,0.15868,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0010206,0.20549,0.16386,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.20513,0.18979,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00011241,0.20513,0.18637,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00098941,0.20481,0.21861,1,1
2,GO RRNA MODIFICATION,0.0064317,0.20453,0.20358,1,1
2,GO NCRNA PROCESSING,0.00041602,0.20423,0.2166,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0013872,0.20411,0.18274,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,9.7801e-06,0.20398,0.25326,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.1765,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.00079435,0.2034,0.26889,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0030654,0.20338,0.21657,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0099891,0.20327,0.15712,1,1
2,GO COPPER ION TRANSPORT,0.009256,0.2032,0.1839,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.050569,0.2029,0.10848,1,1
2,GO HISTONE DEUBIQUITINATION,7.547e-05,0.2029,0.18267,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00353,0.20256,0.21796,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0021062,0.20239,0.17034,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00021167,0.20213,0.2128,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0010859,0.20199,0.18167,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0006154,0.2018,0.18869,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0099891,0.20159,0.14887,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0038387,0.20083,0.15725,1,1
2,GO RESPONSE TO ESTROGEN,0.0087944,0.20081,0.17641,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.031748,0.20068,0.16199,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0051916,0.20066,0.225,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0028957,0.20054,0.14857,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0023671,0.20051,0.12722,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.015203,0.20034,0.11934,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.02166,0.20016,0.1438,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0038387,0.2001,0.20733,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025994,0.20005,0.18769,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.0551e-05,0.20004,0.17681,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.025414,0.19993,0.16782,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029782,0.19988,0.18905,1,1
2,GO INTERACTION WITH SYMBIONT,0.00013917,0.19985,0.21832,1,1
2,GO TRACHEA DEVELOPMENT,0.036164,0.19939,0.18053,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.19936,0.23072,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010506,0.19913,0.15499,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0015189,0.19911,0.25399,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.0551e-05,0.19886,0.19566,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.030383,0.19871,0.14288,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00013917,0.19847,0.1919,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0085714,0.19833,0.20911,1,1
2,GO B CELL MEDIATED IMMUNITY,0.0059384,0.19809,0.14249,1,1
2,GO RNA METHYLATION,0.00092958,0.19798,0.16294,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0030654,0.1979,0.13998,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0094949,0.19781,0.19501,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017186,0.1976,0.2146,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.19753,0.16624,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014299,0.19602,0.1642,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0049174,0.196,0.18078,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.0075304,0.19591,0.12552,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0047853,0.1957,0.14912,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.049546,0.19565,0.13607,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0085714,0.19557,0.23464,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0031536,0.19524,0.19626,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.016339,0.19508,0.18222,1,1
2,GO RRNA METABOLIC PROCESS,0.00055855,0.1949,0.22801,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,5.2139e-05,0.19463,0.21572,1,1
2,GO AEROBIC RESPIRATION,0.00067758,0.19461,0.20015,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.041967,0.19459,0.11585,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0011549,0.19456,0.20914,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011047,0.19441,0.16738,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.019283,0.19425,0.13959,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.19389,0.16848,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.017137,0.19358,0.19846,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.016734,0.19333,0.15527,1,1
2,GO GENITALIA MORPHOGENESIS,0.033894,0.19304,0.18236,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.00081984,0.19263,0.15868,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,0.1925,0.15136,1,1
2,GO CHYLOMICRON ASSEMBLY,0.010245,0.19239,0.13701,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.0054795,0.19231,0.21851,1,1
2,GO AXIS ELONGATION,0.0057817,0.19211,0.29493,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0019282,0.19199,0.16639,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.030383,0.19172,0.21302,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00021909,0.19153,0.23874,1,1
2,GO NEGATIVE T CELL SELECTION,0.0097392,0.19146,0.10581,1,1
2,GO TRNA TRANSPORT,1.2962e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0022992,0.19126,0.18958,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.19105,0.1935,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0015653,0.191,0.15022,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0013872,0.19076,0.15061,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02166,0.19062,0.1709,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.018836,0.19027,0.12598,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.19023,0.1697,1,1
2,GO TRNA METABOLIC PROCESS,0.00024286,0.19017,0.18626,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0064317,0.19007,0.16536,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.036948,0.18975,0.13877,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.004408,0.18971,0.13579,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0071468,0.18946,0.13467,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0087944,0.1893,0.17194,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.013798,0.18928,0.1723,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0046564,0.18915,0.16219,1,1
2,GO T CELL PROLIFERATION,0.0013054,0.1891,0.16658,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00026903,0.18909,0.24946,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.8251e-06,0.18902,0.20438,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00057693,0.18899,0.15748,1,1
2,GO THYMUS DEVELOPMENT,0.0037331,0.18875,0.16836,1,1
2,GO NCRNA METABOLIC PROCESS,0.00055855,0.18855,0.19249,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0051916,0.18804,0.21643,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0022332,0.18785,0.18755,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.041093,0.18769,0.11979,1,1
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.052669,0.18756,0.18764,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.001662,0.18718,0.18496,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.104e-05,0.18701,0.20664,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.001662,0.18686,0.20618,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0025817,0.18598,0.19064,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.016734,0.18597,0.12578,1,1
2,GO RNA INTERFERENCE,0.0079323,0.18581,0.17857,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0012662,0.18571,0.18463,1,1
2,GO PIGMENT GRANULE ORGANIZATION,8.7323e-05,0.18527,0.22708,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.18433,0.11737,1,1
2,GO ENAMEL MINERALIZATION,0.05161,0.18393,0.28276,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0069616,0.18345,0.13427,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.052669,0.18337,0.15964,1,1
2,GO PINOCYTOSIS,0.014841,0.18316,0.12439,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0006154,0.18295,0.19425,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0022332,0.18237,0.14422,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00012964,0.18213,0.16658,1,1
2,GO TERPENOID METABOLIC PROCESS,0.014138,0.18173,0.16093,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.035393,0.18155,0.17467,1,1
2,GO NECROTIC CELL DEATH,0.020205,0.18127,0.16414,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0045306,0.18087,0.15133,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0022332,0.18054,0.22706,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.0069616,0.18054,0.22126,1,1
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.046579,0.18021,0.16375,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0015653,0.18012,0.16492,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.03245,0.18005,0.25633,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,7.547e-05,0.17989,0.2359,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.011047,0.17951,0.15129,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.023741,0.17946,0.15152,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016734,0.17875,0.21327,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001228,0.17842,0.16056,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.17838,0.13751,1,1
2,GO FATTY ACID TRANSPORT,0.00047456,0.17825,0.15179,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.052669,0.17825,0.12082,1,1
2,GO RNA MODIFICATION,0.00044439,0.17762,0.15747,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.17744,0.16598,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.023205,0.17733,0.16175,1,1
2,GO SYMBIOTIC PROCESS,0.00024286,0.17731,0.1543,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.041093,0.17726,0.15127,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00095906,0.17713,0.16939,1,1
2,GO LIPID MODIFICATION,0.0021689,0.17696,0.12455,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034322,0.17693,0.1522,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.024288,0.17676,0.2034,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0053338,0.17656,0.13126,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00017796,0.17655,0.1617,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0604e-05,0.17621,0.15951,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00044439,0.17616,0.15531,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00081984,0.17614,0.17901,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0039469,0.17582,0.12905,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00026003,0.17577,0.17065,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023468,0.17535,0.20304,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0028957,0.17527,0.15919,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.020205,0.17464,0.13701,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0057817,0.17464,0.21213,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.019739,0.17461,0.12015,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0090226,0.17438,0.13526,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0094949,0.17437,0.15959,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.047551,0.1743,0.13988,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.17424,0.14521,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17327,0.20141,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021689,0.17303,0.13629,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.014486,0.17283,0.1539,1,1
2,GO ANIMAL ORGAN REGENERATION,0.027188,0.17246,0.12398,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0037331,0.17227,0.19047,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.026586,0.17219,0.12706,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0059384,0.17209,0.13113,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.017549,0.17208,0.16465,1,1
2,GO RESPONSE TO CORTICOSTEROID,0.052669,0.17206,0.11945,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00050664,0.17196,0.17433,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.025414,0.17191,0.10941,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0015653,0.1718,0.17091,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049546,0.17176,0.11927,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.001662,0.17143,0.14687,1,1
2,GO MYOBLAST DIFFERENTIATION,0.009256,0.17078,0.18835,1,1
2,GO HISTONE H2B UBIQUITINATION,0.007729,0.17077,0.14854,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.015574,0.17074,0.15454,1,1
2,GO TRNA PROCESSING,0.00049035,0.17067,0.17675,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.052669,0.17062,0.11496,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00054072,0.17004,0.17289,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0006154,0.16995,0.19681,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00042998,0.1698,0.17626,1,1
2,GO STEROL METABOLIC PROCESS,0.011612,0.16977,0.11677,1,1
2,GO METANEPHROS DEVELOPMENT,0.043763,0.16974,0.14965,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0025083,0.16922,0.21776,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.023205,0.16919,0.17737,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.01282,0.16889,0.11203,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0046564,0.16874,0.16218,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00038934,0.1686,0.16018,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0027346,0.16813,0.18006,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.025414,0.16808,0.2129,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00074557,0.16787,0.13555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.03939,0.16748,0.16595,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.041967,0.16729,0.11507,1,1
2,GO B CELL PROLIFERATION,0.0047853,0.16701,0.14361,1,1
2,GO MRNA METHYLATION,0.043763,0.16696,0.13958,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.001228,0.16684,0.19329,1,1
2,GO VIRAL LIFE CYCLE,0.0036303,0.16567,0.15337,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0053338,0.16558,0.16805,1,1
2,GO KERATINOCYTE PROLIFERATION,0.049546,0.16557,0.26095,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0001165,0.16544,0.16381,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.018836,0.16524,0.13202,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0022332,0.16519,0.13686,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0085714,0.16502,0.17276,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.16474,0.13628,1,1
2,GO LIPID HOMEOSTASIS,0.0066042,0.16454,0.13305,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.03939,0.16403,0.11607,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.030383,0.16397,0.099348,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014486,0.16376,0.14946,1,1
2,GO REGULATION OF PHAGOCYTOSIS,0.012203,0.1637,0.1256,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0024367,0.1636,0.14178,1,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014738,0.16358,0.14047,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.16351,0.16534,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0010528,0.16319,0.1454,1,1
2,GO PHOTOPERIODISM,0.037747,0.163,0.10871,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.011904,0.16298,0.11383,1,1
2,GO CYTOKINE PRODUCTION,0.0064317,0.16274,0.1265,1,1
2,GO RNA CATABOLIC PROCESS,0.00065623,0.16236,0.15626,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0036303,0.16221,0.11467,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00092958,0.16212,0.13204,1,1
2,GO MRNA TRANSCRIPTION,0.0054795,0.1621,0.15992,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0011199,0.16207,0.18441,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.023205,0.16192,0.14178,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035393,0.16185,0.15526,1,1
2,GO CYTOKINE METABOLIC PROCESS,0.0047853,0.16174,0.13514,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.16152,0.1328,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.017969,0.1614,0.10898,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0029794,0.16138,0.13888,1,1
2,GO POSITIVE CHEMOTAXIS,0.02068,0.16138,0.13575,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014138,0.16136,0.10153,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.010506,0.16111,0.10097,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.023741,0.16092,0.10399,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.05161,0.16072,0.13974,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0051916,0.16065,0.11368,1,1
2,GO CD40 SIGNALING PATHWAY,0.023205,0.1606,0.1248,1,1
2,GO RESPONSE TO BACTERIUM,0.013798,0.16045,0.1005,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.018398,0.16042,0.12306,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.013139,0.16041,0.17544,1,1
2,GO INNATE IMMUNE RESPONSE,0.0066042,0.16021,0.13071,1,1
2,GO ERBB SIGNALING PATHWAY,0.0025083,0.16019,0.13469,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.023205,0.16015,0.15877,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.0028141,0.15981,0.12407,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00050664,0.15975,0.16706,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0039469,0.15965,0.13605,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001662,0.15962,0.17465,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.014841,0.1596,0.14453,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0029794,0.15939,0.13956,1,1
2,GO T CELL DIFFERENTIATION,0.0038387,0.15926,0.13341,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.035393,0.15896,0.12123,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.014138,0.1585,0.12078,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.15845,0.25468,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.022165,0.15811,0.16841,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0020453,0.15803,0.2254,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.010773,0.1578,0.10157,1,1
2,GO PROTEIN KINASE B SIGNALING,0.024846,0.15722,0.099977,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0099891,0.15693,0.16133,1,1
2,GO REGULATION OF CELL ACTIVATION,0.0036303,0.15647,0.1229,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0032441,0.15641,0.15467,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.037747,0.15628,0.13703,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0071468,0.15591,0.12945,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00026003,0.15589,0.16989,1,1
2,GO P BODY ASSEMBLY,0.0021062,0.15574,0.13824,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00092958,0.15548,0.15424,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0099891,0.15546,0.11883,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.02843,0.1554,0.11709,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00016023,0.15532,0.16415,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0010206,0.15521,0.19759,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0037331,0.1552,0.11424,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0020453,0.1547,0.12485,1,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0087944,0.15451,0.1445,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038387,0.15392,0.11986,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0007696,0.15353,0.18701,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.0075304,0.15341,0.1267,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00016023,0.15322,0.17951,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012662,0.15321,0.26055,1,1
2,GO VESICLE TARGETING,0.0027346,0.15303,0.13314,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0064317,0.15296,0.14558,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00055855,0.15295,0.14861,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019753,0.15285,0.13176,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.038561,0.15277,0.2914,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.038561,0.15271,0.13388,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.014138,0.1527,0.15803,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00054072,0.15264,0.1465,1,1
2,GO PHAGOCYTOSIS,0.0053338,0.15245,0.14532,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0023671,0.15244,0.16936,1,1
2,GO DIGESTION,0.010245,0.15226,0.12736,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.01282,0.15211,0.13598,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.013139,0.15199,0.095955,1,1
2,GO RESPONSE TO CYTOKINE,0.010245,0.15167,0.11094,1,1
2,GO PLATELET ACTIVATION,0.050569,0.15154,0.089358,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,8.1192e-05,0.15147,0.14497,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.2454e-05,0.15134,0.17892,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0099891,0.15133,0.228,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0059384,0.15083,0.17458,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.15068,0.1261,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0019282,0.15066,0.16843,1,1
2,GO T CELL ACTIVATION,0.0071468,0.15054,0.12592,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026903,0.15027,0.16241,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0029794,0.15024,0.15125,1,1
2,GO INTERFERON BETA PRODUCTION,0.027803,0.15021,0.14766,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029782,0.15017,0.14509,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.023741,0.14998,0.10987,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0011549,0.14967,0.1426,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028957,0.14932,0.15495,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.029719,0.14929,0.20822,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0094949,0.14907,0.11794,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0025083,0.1487,0.13906,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.024846,0.14852,0.15197,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.016734,0.14825,0.22555,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.014138,0.14815,0.12236,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0069616,0.14791,0.18175,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00055855,0.14791,0.14492,1,1
2,GO B CELL DIFFERENTIATION,0.0083534,0.14779,0.11728,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.015203,0.14779,0.12728,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00065623,0.14779,0.13653,1,1
2,GO GOLGI VESICLE BUDDING,0.001191,0.1476,0.12614,1,1
2,GO PROTEIN IMPORT,0.0019282,0.14747,0.13069,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.019283,0.14734,0.19193,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0099891,0.14711,0.16459,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.009256,0.14702,0.13791,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.030383,0.147,0.13639,1,1
2,GO REGULATION OF T CELL ACTIVATION,0.0067808,0.14699,0.12821,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,0.00353,0.1469,0.14386,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.0073e-05,0.14657,0.1437,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.041967,0.14637,0.30564,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0071468,0.14637,0.11556,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.023205,0.14637,0.15217,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0064317,0.14602,0.12032,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.0022992,0.14556,0.12527,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0014299,0.14556,0.13322,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013872,0.14542,0.16642,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.041967,0.14542,0.10338,1,1
2,GO IMPORT INTO NUCLEUS,0.02166,0.14532,0.11211,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.013465,0.1451,0.10265,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0039469,0.1451,0.16692,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.029068,0.14507,0.1199,1,1
2,GO CELL KILLING,0.010245,0.14501,0.12763,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14451,0.14198,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.011904,0.14415,0.10279,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0097392,0.14404,0.10802,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0027346,0.14395,0.22552,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.038561,0.14392,0.11589,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.010506,0.14334,0.10937,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.013139,0.14308,0.11518,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.023741,0.14298,0.20433,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.004408,0.1428,0.16105,1,1
2,GO GOLGI RIBBON FORMATION,0.018398,0.14271,0.13842,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.050569,0.14237,0.11908,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.14237,0.09459,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00065623,0.14228,0.12581,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.034637,0.14212,0.12967,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0017641,0.14183,0.12411,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.016339,0.14159,0.09467,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0079323,0.1415,0.17319,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.0066042,0.14144,0.12496,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14128,0.12944,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.012508,0.14123,0.11833,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.001228,0.14088,0.18212,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.021165,0.14081,0.13514,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.02843,0.14062,0.16459,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00034072,0.14024,0.1391,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0062634,0.14016,0.12479,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.010245,0.14011,0.14857,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.011047,0.14009,0.1295,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0021062,0.14006,0.1955,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00045924,0.14001,0.18454,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0017641,0.13993,0.1523,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.015574,0.13976,0.11239,1,1
2,GO POLYOL METABOLIC PROCESS,0.00022676,0.13931,0.16091,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.014138,0.13922,0.1544,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0060989,0.13914,0.11523,1,1
2,GO TISSUE HOMEOSTASIS,0.010506,0.13892,0.095562,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.8282e-05,0.13869,0.13004,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0024367,0.13867,0.13598,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.8301e-05,0.13846,0.13368,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.027188,0.1384,0.18867,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0075304,0.13836,0.10637,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0090226,0.13832,0.11569,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02268,0.13821,0.12472,1,1
2,GO MALE SEX DIFFERENTIATION,0.050569,0.13817,0.12307,1,1
2,GO RESPONSE TO IRON ION,0.050569,0.13805,0.14981,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.1888e-05,0.13781,0.14227,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0017123,0.13778,0.12931,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.020205,0.13768,0.1028,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,7.8282e-05,0.1376,0.15382,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0034322,0.13759,0.1665,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00028792,0.13758,0.17884,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.018398,0.13753,0.087825,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.013465,0.13733,0.1162,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0027346,0.13732,0.13605,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010859,0.13715,0.12497,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.016734,0.1369,0.14322,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.13686,0.14357,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0036303,0.13685,0.11346,1,1
2,GO RESPONSE TO ACTIVITY,0.02843,0.13685,0.096477,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.023205,0.13679,0.11631,1,1
2,GO REGULATION OF HEMOPOIESIS,0.007729,0.13664,0.11952,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0059384,0.13645,0.15131,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00025131,0.13617,0.13029,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020205,0.13609,0.13976,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.015953,0.13589,0.10866,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00049035,0.13545,0.15649,1,1
2,GO BASE EXCISION REPAIR,0.0038387,0.13528,0.12574,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.13523,0.16091,1,1
2,GO ERK1 AND ERK2 CASCADE,0.019739,0.13512,0.11902,1,1
2,GO FEVER GENERATION,0.050569,0.13509,0.1561,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.001986,0.13488,0.16073,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.13487,0.12132,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.027188,0.13476,0.15834,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.019283,0.13353,0.10579,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.010245,0.13342,0.11188,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00029782,0.13335,0.15018,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.013798,0.13291,0.12961,1,1
2,GO TELOMERE ORGANIZATION,0.00038934,0.13287,0.13776,1,1
2,GO LIPID METABOLIC PROCESS,0.0011199,0.13283,0.11064,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0025817,0.13282,0.11717,1,1
2,GO LYMPHOCYTE ACTIVATION,0.010773,0.13245,0.10337,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.050569,0.13238,0.13667,1,1
2,GO DNA GEOMETRIC CHANGE,0.00014418,0.13213,0.15335,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00049035,0.13205,0.12337,1,1
2,GO CELL ACTIVATION,0.013465,0.13196,0.098859,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.034637,0.13135,0.13753,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.04854,0.13121,0.097599,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.041967,0.13121,0.16611,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2754e-05,0.13118,0.13638,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0010859,0.13044,0.11862,1,1
2,GO CELL CELL RECOGNITION,0.016734,0.13043,0.10222,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00052342,0.13042,0.15987,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0054795,0.12974,0.12503,1,1
2,GO DEFENSE RESPONSE,0.021165,0.12953,0.082723,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0090226,0.12856,0.12848,1,1
2,GO MRNA CLEAVAGE,2.2524e-05,0.12849,0.1658,1,1
2,GO BODY FLUID SECRETION,0.00090094,0.12831,0.15203,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.011612,0.12821,0.09855,1,1
2,GO MRNA 3 END PROCESSING,0.00045924,0.12808,0.14323,1,1
2,GO HISTONE PHOSPHORYLATION,0.0090226,0.12784,0.10778,1,1
2,GO OXIDATIVE DEMETHYLATION,0.020205,0.12765,0.092979,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,0.12758,0.1446,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0090226,0.12752,0.13045,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0015189,0.12696,0.098636,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0022332,0.12681,0.13721,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.042857,0.1268,0.083463,1,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.046579,0.12674,0.081802,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.12617,0.12099,1,1
2,GO STEROL IMPORT,0.01282,0.12604,0.17471,1,1
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.019283,0.12555,0.088981,1,1
2,GO LIPID CATABOLIC PROCESS,0.011904,0.1254,0.099419,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,9.7346e-05,0.12488,0.11788,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.019739,0.12444,0.084239,1,1
2,GO HISTONE H3 DEACETYLATION,0.019283,0.12442,0.11692,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0015189,0.12418,0.16255,1,1
2,GO RNA PROCESSING,0.00016595,0.12406,0.15172,1,1
2,GO GENE SILENCING,1.4609e-05,0.12385,0.13436,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.041967,0.12359,0.091026,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015574,0.1223,0.1206,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0026572,0.12217,0.14542,1,1
2,GO MRNA METABOLIC PROCESS,0.00017796,0.12179,0.13519,1,1
2,GO PROTEIN SUMOYLATION,0.00012074,0.12162,0.12794,1,1
2,GO STRESS GRANULE ASSEMBLY,0.012203,0.12125,0.11656,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.038561,0.1209,0.10299,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.016339,0.1207,0.11852,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0069616,0.1204,0.10391,1,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.024288,0.12038,0.18032,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.12029,0.1183,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0053338,0.12013,0.14305,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033894,0.1196,0.069089,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.029068,0.11945,0.11822,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0099891,0.11889,0.15156,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.027803,0.11866,0.083935,1,1
2,GO REGULATION OF MYELINATION,0.038561,0.11862,0.10344,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.033166,0.11851,0.10815,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,0.11847,0.10615,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.014486,0.11797,0.090136,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.02068,0.11795,0.1316,1,1
2,GO PROTEIN NEDDYLATION,0.029719,0.1179,0.10556,1,1
2,GO RESPONSE TO STEROID HORMONE,0.047551,0.11788,0.095905,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00022676,0.11771,0.13518,1,1
2,GO FOCAL ADHESION ASSEMBLY,0.044685,0.11749,0.15245,1,1
2,GO ACTIN NUCLEATION,0.018836,0.11733,0.11748,1,1
2,GO REGULATION OF ORGAN GROWTH,0.044685,0.11715,0.1211,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0094949,0.11703,0.1006,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0037331,0.11662,0.091428,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.11653,0.15272,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0033369,0.11639,0.10396,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0032441,0.11633,0.097154,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0033369,0.1161,0.10579,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.00035231,0.11606,0.10502,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.037747,0.11605,0.10562,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.017137,0.11562,0.16704,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00042998,0.11559,0.13664,1,1
2,GO PEROXISOMAL TRANSPORT,0.0062634,0.11531,0.13382,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0022992,0.11526,0.12147,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.047551,0.11417,0.086022,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0083534,0.11383,0.10364,1,1
2,GO EAR MORPHOGENESIS,0.017969,0.11382,0.13164,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.033894,0.11371,0.11804,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.033166,0.11368,0.091151,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0046564,0.11353,0.16041,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.02268,0.11326,0.098049,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.041967,0.11319,0.066742,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017969,0.11311,0.078825,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015203,0.11295,0.095117,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.11292,0.15119,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.0099891,0.11272,0.098411,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00047456,0.11254,0.13846,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.033166,0.11249,0.11698,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.013139,0.11244,0.092192,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.015203,0.11232,0.11,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,0.11221,0.11821,1,1
2,GO NUCLEAR TRANSPORT,0.0018173,0.11205,0.11881,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.027803,0.11186,0.085733,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.033894,0.11167,0.081114,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0018173,0.11141,0.12801,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.02843,0.11116,0.10349,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.031748,0.11092,0.13206,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.013798,0.1109,0.1266,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.0001165,0.11068,0.16892,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0026572,0.11053,0.13885,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.010506,0.11016,0.10935,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0067808,0.11001,0.12022,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.05161,0.10988,0.07732,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.035393,0.10958,0.078272,1,1
2,GO HUMORAL IMMUNE RESPONSE,0.021165,0.10956,0.070156,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00020448,0.10956,0.14177,1,1
2,GO PEROXISOME ORGANIZATION,0.0079323,0.10944,0.11875,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0024367,0.1094,0.11329,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00084609,0.10883,0.11147,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.025414,0.10792,0.091682,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0087944,0.10781,0.10084,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0029794,0.10774,0.082699,1,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.016339,0.10697,0.087305,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.013139,0.1067,0.087767,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.042857,0.10645,0.11624,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.035393,0.10585,0.09222,1,1
2,GO VIRAL RELEASE FROM HOST CELL,0.017969,0.10491,0.12078,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.031748,0.10467,0.10111,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.036164,0.10462,0.10478,1,1
2,GO MRNA TRANSPORT,0.00098941,0.10385,0.13743,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00024286,0.1037,0.11292,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.023741,0.1036,0.13061,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.017137,0.10317,0.081932,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.004408,0.10246,0.096349,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.011326,0.10223,0.12461,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,6.2786e-05,0.10215,0.13018,1,1
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.012508,0.10205,0.18478,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0014738,0.10198,0.11941,1,1
2,GO MRNA PROCESSING,0.00098941,0.10175,0.10927,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.10162,0.13468,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.036164,0.10158,0.11777,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.02068,0.1014,0.0759,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.02843,0.10107,0.10756,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.016734,0.099552,0.073165,1,1
2,GO RNA 3 END PROCESSING,0.0057817,0.099327,0.11797,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00057693,0.099124,0.098164,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.023741,0.098839,0.081716,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036164,0.098715,0.07261,1,1
2,GO RNA LOCALIZATION,0.00018427,0.098195,0.15138,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.018398,0.097919,0.08746,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.097503,0.12772,1,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.045624,0.097182,0.075032,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.00037661,0.097151,0.15034,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.018398,0.096798,0.066552,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.017969,0.096777,0.11998,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.014138,0.096221,0.11691,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0045306,0.096121,0.075563,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.03245,0.09567,0.095013,1,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0099891,0.09543,0.095039,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.019283,0.094969,0.095211,1,1
2,GO DNA METHYLATION,0.009256,0.09471,0.090647,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.007729,0.094352,0.098635,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.03245,0.094176,0.085156,1,1
2,GO STEM CELL DIFFERENTIATION,0.010506,0.094058,0.12132,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.03939,0.093606,0.13947,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00026903,0.093346,0.10056,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0059384,0.093334,0.12289,1,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.013139,0.092965,0.11187,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0037331,0.092719,0.099204,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.011904,0.091509,0.11392,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.05161,0.091497,0.07557,1,1
2,GO DNA CONFORMATION CHANGE,0.0094949,0.090581,0.083715,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.033166,0.09009,0.05905,1,1
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.029068,0.089912,0.078888,1,1
2,GO CELL AGING,0.029719,0.089427,0.077403,1,1
2,GO RESPONSE TO UV,0.0054795,0.089115,0.12713,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0017123,0.089078,0.099938,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.029068,0.088773,0.086824,1,1
2,GO RNA SPLICING,0.0020453,0.088566,0.107,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0001165,0.088133,0.11976,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00074557,0.0881,0.11853,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.013465,0.087811,0.079473,1,1
2,GO GLUCOSE METABOLIC PROCESS,0.025414,0.087595,0.056385,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.021165,0.087472,0.072275,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.0064317,0.08741,0.077006,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.001986,0.087387,0.081898,1,1
2,GO B CELL ACTIVATION,0.0071468,0.087369,0.096825,1,1
2,GO CHROMATIN REMODELING,0.0028141,0.08717,0.097614,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.024288,0.086722,0.099406,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.037747,0.086203,0.081786,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.013465,0.084988,0.07816,1,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0051916,0.084422,0.074039,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.043763,0.083876,0.064938,1,1
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.050569,0.083464,0.052446,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011904,0.083078,0.08958,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001872,0.082814,0.090291,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031059,0.080511,0.077587,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.014841,0.080462,0.056878,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.080457,0.097065,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.015203,0.080293,0.083498,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.018398,0.080161,0.17197,1,1
2,GO HISTONE H3 ACETYLATION,0.0027346,0.079136,0.091673,1,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.033166,0.078754,0.15685,1,1
2,GO CELLULAR RESPONSE TO UV,0.0069616,0.078364,0.11375,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.036948,0.077488,0.050192,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0094949,0.077022,0.090903,1,1
2,GO EPITHELIAL TUBE FORMATION,0.052669,0.076783,0.11943,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.024288,0.07674,0.09339,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.073512,0.070546,1,1
2,GO MACROAUTOPHAGY,0.017137,0.0718,0.058488,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0064317,0.071385,0.10616,1,1
2,GO REGULATION OF GLUCONEOGENESIS,0.05161,0.071089,0.068492,1,1
2,GO RESPONSE TO RADIATION,0.026586,0.070833,0.063464,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.015203,0.068177,0.080644,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0051916,0.068134,0.076837,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.067604,0.060824,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.023741,0.065549,0.083447,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.02268,0.063877,0.05164,1,1
2,GO DNA METABOLIC PROCESS,0.004408,0.0637,0.06765,1,1
2,GO DNA MODIFICATION,0.015203,0.06315,0.059423,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.017137,0.062306,0.080172,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.042857,0.060125,0.1171,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.044685,0.059932,0.075487,1,1
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.01282,0.059742,0.066338,1,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.052669,0.059572,0.058881,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.025414,0.059455,0.10878,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02268,0.058892,0.11355,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0056288,0.058792,0.05732,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.042857,0.057639,0.060944,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.017137,0.053453,0.051302,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.04854,0.051571,0.065494,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.014486,0.048574,0.065694,1,1
2,GO CHROMOSOME ORGANIZATION,0.033894,0.03304,0.055595,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.03245,0.41769,0.28844,1,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.01282,0.38181,0.34354,1,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.018836,0.35986,0.33488,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00042998,0.34749,0.40917,1,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0073363,0.3201,0.28901,1,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.050569,0.31374,0.16713,1,0
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0090226,0.30346,0.27204,1,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.033894,0.29084,0.31826,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,0.044685,0.28763,0.17223,1,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.037747,0.28284,0.2367,1,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.02268,0.28104,0.37924,1,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.02166,0.27533,0.19504,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.027803,0.27488,0.28056,1,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0083534,0.26208,0.22252,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0067808,0.25369,0.22767,1,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.016734,0.24912,0.22943,1,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0049174,0.24796,0.25013,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0037331,0.24227,0.3657,1,0
2,GO NADP METABOLIC PROCESS,0.0040578,0.24197,0.21318,1,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00049035,0.24142,0.25504,1,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.019739,0.23977,0.25071,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.014841,0.23949,0.29946,1,0
2,GO BONE GROWTH,0.029068,0.23881,0.1969,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0036303,0.23737,0.20855,1,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00032948,0.23636,0.18846,1,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.033894,0.23465,0.19223,1,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0083534,0.23382,0.19717,1,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.023205,0.23139,0.1733,1,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00084609,0.23136,0.20754,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.023741,0.2311,0.23819,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.050569,0.22646,0.16166,1,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.036164,0.22639,0.15966,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.031059,0.22358,0.213,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.022165,0.22068,0.17369,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001986,0.21951,0.22876,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.016339,0.21488,0.18081,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031059,0.21126,0.19432,1,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.036948,0.21016,0.12121,1,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0073363,0.20983,0.34947,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0013457,0.2097,0.23096,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.029068,0.20715,0.23126,1,0
2,GO ASYMMETRIC CELL DIVISION,0.017549,0.20512,0.17735,1,0
2,GO CORNIFICATION,0.0054795,0.20373,0.26068,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.031748,0.20364,0.16144,1,0
2,GO CYTOPLASMIC TRANSLATION,0.027803,0.20244,0.1905,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0024367,0.20161,0.18814,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.0075304,0.20095,0.25875,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.031748,0.20084,0.13299,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.03939,0.19964,0.14,1,0
2,GO RIBOSOME ASSEMBLY,0.0046564,0.199,0.23715,1,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.02268,0.19854,0.17481,1,0
2,GO MICROVILLUS ORGANIZATION,0.018398,0.19815,0.28573,1,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0019282,0.19743,0.15948,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.015574,0.19701,0.14489,1,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.0021062,0.19675,0.16849,1,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0064317,0.19616,0.20011,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.024288,0.19573,0.21444,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0029794,0.19218,0.16155,1,0
2,GO SERTOLI CELL DEVELOPMENT,0.024846,0.19142,0.24298,1,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0020453,0.19051,0.18013,1,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.023741,0.18962,0.18593,1,0
2,GO TOXIN TRANSPORT,0.0057817,0.1885,0.1456,1,0
2,GO EPOXYGENASE P450 PATHWAY,0.05161,0.18786,0.17388,1,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.045624,0.18763,0.15208,1,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0030654,0.18731,0.17513,1,0
2,GO TRANSLATIONAL INITIATION,0.030383,0.18694,0.17979,1,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0071468,0.18672,0.17147,1,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.025994,0.1818,0.11009,1,0
2,GO CELL AGGREGATION,0.018398,0.1811,0.17618,1,0
2,GO RNA 5 END PROCESSING,0.00353,0.18042,0.19983,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0090226,0.17921,0.19403,1,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.17721,0.16503,1,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0013872,0.17632,0.31742,1,0
2,GO STEROL HOMEOSTASIS,0.011047,0.17565,0.15574,1,0
2,GO TRANSLATIONAL ELONGATION,0.0083534,0.17542,0.1696,1,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0042883,0.17306,0.17563,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0014738,0.17259,0.17271,1,0
2,GO TRNA MODIFICATION,0.0010528,0.17206,0.17241,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.029719,0.17203,0.12588,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.03939,0.17135,0.20164,1,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.040234,0.17131,0.1715,1,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.046579,0.17014,0.12077,1,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0094949,0.16996,0.16746,1,0
2,GO MACROPHAGE CHEMOTAXIS,0.014841,0.16833,0.16284,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.01282,0.16756,0.17904,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,0.011904,0.1666,0.17072,1,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.050569,0.16568,0.15236,1,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.053746,0.16377,0.10305,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.021165,0.1624,0.14384,1,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.044685,0.16235,0.15542,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.05161,0.16181,0.16158,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.0083534,0.16154,0.13889,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.0028141,0.16123,0.16319,1,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0064317,0.16078,0.11643,1,0
2,GO DEFENSE RESPONSE TO VIRUS,0.053746,0.15992,0.12457,1,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.011326,0.15945,0.14807,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.040234,0.15938,0.10529,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.046579,0.15901,0.17462,1,0
2,GO CHEMOKINE PRODUCTION,0.0060989,0.15687,0.19117,1,0
2,GO POLYAMINE METABOLIC PROCESS,0.018836,0.15685,0.13907,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.027188,0.15363,0.12555,1,0
2,GO REGULATION OF HAIR CYCLE,0.015203,0.15329,0.21629,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.047551,0.15299,0.15692,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.037747,0.15073,0.2,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00095906,0.14965,0.18134,1,0
2,GO COCHLEA MORPHOGENESIS,0.023741,0.14914,0.15472,1,0
2,GO TRNA 5 LEADER REMOVAL,0.0037331,0.14896,0.18576,1,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0017641,0.14824,0.14279,1,0
2,GO ANION HOMEOSTASIS,0.049546,0.14786,0.13483,1,0
2,GO REGULATION OF ACTION POTENTIAL,0.035393,0.14703,0.12533,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.031059,0.14634,0.1214,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.023741,0.14512,0.11237,1,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0062634,0.14475,0.14604,1,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.016734,0.1447,0.19623,1,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.041967,0.14461,0.16146,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0053338,0.1438,0.17457,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0073363,0.1434,0.12064,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.0060989,0.14273,0.16905,1,0
2,GO SIGNAL PEPTIDE PROCESSING,0.024846,0.14192,0.18904,1,0
2,GO STRESS FIBER ASSEMBLY,0.04854,0.1413,0.1257,1,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.013465,0.14105,0.18162,1,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.033166,0.14087,0.19502,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.050569,0.14071,0.10297,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0031536,0.14025,0.183,1,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.009256,0.13947,0.11403,1,0
2,GO TRNA 5 END PROCESSING,0.011326,0.13873,0.15724,1,0
2,GO MACROPHAGE MIGRATION,0.025994,0.1348,0.13815,1,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0001547,0.13381,0.17833,1,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0060989,0.13199,0.16888,1,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.050569,0.13139,0.13625,1,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.017137,0.13073,0.1163,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.015203,0.13047,0.25445,1,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036303,0.12951,0.12591,1,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.0053338,0.12924,0.12441,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.047551,0.12911,0.13171,1,0
2,GO REGULATION OF CELL ADHESION,0.035393,0.12796,0.10496,1,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.018398,0.12784,0.17315,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.037747,0.1276,0.11031,1,0
2,GO RESPONSE TO KETONE,0.050569,0.12686,0.092858,1,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.012508,0.12586,0.16701,1,0
2,GO MYELOID CELL HOMEOSTASIS,0.0075304,0.12576,0.1236,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.026586,0.12342,0.11507,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.018836,0.12338,0.18031,1,0
2,GO SPROUTING ANGIOGENESIS,0.014138,0.12281,0.14236,1,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.047551,0.12157,0.097572,1,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.029068,0.12124,0.11861,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.050569,0.12115,0.1093,1,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.014486,0.1204,0.15337,1,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.033894,0.12019,0.15197,1,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.013465,0.1201,0.10696,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0017123,0.11902,0.14885,1,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.004408,0.11894,0.17245,1,0
2,GO OXIDATIVE PHOSPHORYLATION,0.041967,0.11893,0.11637,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0026572,0.11731,0.11132,1,0
2,GO KERATINOCYTE DIFFERENTIATION,0.011047,0.11693,0.21399,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.025994,0.11658,0.10127,1,0
2,GO RESPONSE TO ALCOHOL,0.030383,0.11596,0.089355,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.02268,0.11509,0.16863,1,0
2,GO EPIDERMIS DEVELOPMENT,0.021165,0.11342,0.16004,1,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0049174,0.11225,0.094239,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.03939,0.11133,0.11888,1,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.011047,0.11097,0.083466,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.012508,0.11064,0.11214,1,0
2,GO CELLULAR RESPIRATION,0.0090226,0.11016,0.14416,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.052669,0.11011,0.095652,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.001986,0.10989,0.11985,1,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.020205,0.10936,0.088882,1,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0045306,0.10927,0.12488,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.031059,0.10864,0.088391,1,0
2,GO RESPONSE TO SALT,0.025414,0.10581,0.16652,1,0
2,GO CELLULAR RESPONSE TO DRUG,0.012203,0.10453,0.11572,1,0
2,GO KERATINIZATION,0.043763,0.10427,0.17057,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.046579,0.1041,0.10784,1,0
2,GO SENSORY PERCEPTION OF TASTE,0.0079323,0.10355,0.24638,1,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0039469,0.10171,0.10602,1,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,0.10103,0.090429,1,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.018398,0.10015,0.12694,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.041967,0.10013,0.12686,1,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.049546,0.099204,0.075117,1,0
2,GO CELLULAR RESPONSE TO LIPID,0.017549,0.098976,0.096403,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.033894,0.097259,0.11515,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.007729,0.09698,0.14849,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.025414,0.096758,0.084518,1,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.04854,0.096747,0.14137,1,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,0.092147,0.084753,1,0
2,GO SNRNA PROCESSING,0.015953,0.091876,0.089899,1,0
2,GO SKIN DEVELOPMENT,0.037747,0.091574,0.15729,1,0
2,GO REGULATION OF CELL SHAPE,0.040234,0.091423,0.1247,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.016734,0.090882,0.17315,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.031748,0.090444,0.1863,1,0
2,GO RNA CAPPING,0.011326,0.089316,0.09395,1,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.018836,0.088762,0.10341,1,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0081404,0.088757,0.10054,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.045624,0.088661,0.13228,1,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0020453,0.087903,0.080348,1,0
2,GO CELLULAR RESPONSE TO HEAT,0.027803,0.087546,0.10435,1,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.007729,0.087517,0.074423,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.017549,0.08723,0.086512,1,0
2,GO PLACENTA DEVELOPMENT,0.047551,0.08683,0.11298,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.023741,0.086541,0.12529,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.022165,0.085765,0.10052,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0062634,0.085721,0.14359,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.011047,0.085512,0.11567,1,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0027346,0.085276,0.13248,1,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.04854,0.084751,0.10662,1,0
2,GO STEROID METABOLIC PROCESS,0.0094949,0.08392,0.10543,1,0
2,GO ENDOCRINE PROCESS,0.036948,0.083704,0.099355,1,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.052669,0.08195,0.073113,1,0
2,GO RRNA METHYLATION,0.031059,0.081485,0.15902,1,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.05161,0.081166,0.12635,1,0
2,GO ERAD PATHWAY,0.012508,0.081021,0.10279,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.033894,0.080907,0.14041,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.040234,0.080415,0.094849,1,0
2,GO NCRNA TRANSCRIPTION,0.01282,0.080268,0.092715,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.044685,0.080223,0.064321,1,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.019739,0.080129,0.14325,1,0
2,GO SELECTIVE AUTOPHAGY,0.017137,0.079739,0.094735,1,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.012508,0.078993,0.14714,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.016734,0.077577,0.087139,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.024288,0.077301,0.066165,1,0
2,GO TISSUE MIGRATION,0.034637,0.07691,0.12267,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.047551,0.076601,0.11128,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.04854,0.075743,0.09271,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.031748,0.075335,0.085187,1,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.047551,0.075331,0.056464,1,0
2,GO SNRNA METABOLIC PROCESS,0.0053338,0.07527,0.09641,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.020205,0.075099,0.085013,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.034637,0.074611,0.10856,1,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.015953,0.074118,0.083679,1,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.018836,0.073754,0.10395,1,0
2,GO ALCOHOL CATABOLIC PROCESS,0.026586,0.073346,0.13253,1,0
2,GO HISTONE DEACETYLATION,0.0099891,0.073149,0.086896,1,0
2,GO MITOCHONDRIAL TRANSPORT,0.011047,0.072808,0.090779,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.042857,0.071806,0.089381,1,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.029068,0.071761,0.097148,1,0
2,GO REGULATION OF PROTEIN STABILITY,0.017969,0.06935,0.068076,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.043763,0.068468,0.10681,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.04854,0.066692,0.060075,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.037747,0.063522,0.070517,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0085714,0.063147,0.064397,1,0
2,GO CELLULAR RESPONSE TO RADIATION,0.052669,0.062614,0.086433,1,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.043763,0.062204,0.059861,1,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.034637,0.061746,0.08234,1,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.035393,0.061512,0.08402,1,0
2,GO CHROMOSOME CONDENSATION,0.047551,0.061065,0.077465,1,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.042857,0.060539,0.090977,1,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.044685,0.059404,0.068066,1,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.021165,0.058186,0.084135,1,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.025414,0.054148,0.046814,1,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.013465,0.046629,0.059808,1,0
2,GO METHYLATION,0.0064317,0.04502,0.071068,1,0
2,GO SNRNA TRANSCRIPTION,0.014841,0.038684,0.074131,1,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.041093,0.032896,0.044536,1,0
2,GO POSITIVE REGULATION OF GROWTH,0.052669,-0.039828,-0.060784,1,0
2,GO NEURON DEATH,0.042857,-0.048111,-0.063209,1,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.014486,-0.050377,-0.07353,1,0
2,GO CIRCADIAN RHYTHM,0.019283,-0.052637,-0.064605,1,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.049546,-0.061049,-0.088915,1,0
2,GO PEPTIDE SECRETION,0.033166,-0.062393,-0.088797,1,0
2,GO FEAR RESPONSE,0.042857,-0.062561,-0.12621,1,0
2,GO SPERM MOTILITY,0.0071468,-0.063174,-0.12621,1,0
2,GO CELL GROWTH,0.045624,-0.065897,-0.072663,1,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.015203,-0.0666,-0.10497,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.037747,-0.067655,-0.11884,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,-0.070236,-0.067997,1,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.001662,-0.073666,-0.13373,1,0
2,GO GERM CELL DEVELOPMENT,0.0049174,-0.077626,-0.09572,1,0
2,GO HINDBRAIN MORPHOGENESIS,0.019283,-0.078538,-0.12392,1,0
2,GO METAL ION TRANSPORT,0.015953,-0.080093,-0.088956,1,0
2,GO SENSORY PERCEPTION OF SMELL,0.044685,-0.080246,-0.075703,1,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.031748,-0.084532,-0.081316,1,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.013465,-0.085073,-0.077396,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.0071468,-0.085082,-0.10242,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.03939,-0.085362,-0.08028,1,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0032441,-0.085741,-0.12898,1,0
2,GO HEART PROCESS,0.046579,-0.086201,-0.089287,1,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.02166,-0.088061,-0.085515,1,0
2,GO REGULATION OF SECRETION,0.02068,-0.088713,-0.0923,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.014486,-0.090757,-0.11501,1,0
2,GO CATION TRANSPORT,0.015203,-0.092023,-0.089465,1,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0069616,-0.093862,-0.11782,1,0
2,GO CILIUM MOVEMENT,0.0041716,-0.094022,-0.12914,1,0
2,GO CELL PROJECTION ORGANIZATION,0.0075304,-0.095528,-0.1012,1,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0099891,-0.096128,-0.10281,1,0
2,GO ENERGY HOMEOSTASIS,0.041967,-0.096654,-0.15343,1,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.030383,-0.097112,-0.078806,1,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.037747,-0.098227,-0.13525,1,0
2,GO REGULATION OF SYSTEM PROCESS,0.0040578,-0.098446,-0.11473,1,0
2,GO REGULATION OF CELL DEVELOPMENT,0.0067808,-0.099974,-0.10964,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.046579,-0.099978,-0.10098,1,0
2,GO REGULATION OF BLOOD CIRCULATION,0.02268,-0.10223,-0.10572,1,0
2,GO TORC1 SIGNALING,0.02068,-0.1023,-0.083363,1,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.02843,-0.10265,-0.16494,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.0023671,-0.104,-0.14276,1,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.027188,-0.10437,-0.086604,1,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.026586,-0.10452,-0.10419,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.03245,-0.10569,-0.1523,1,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.011326,-0.10759,-0.12913,1,0
2,GO CHLORIDE TRANSPORT,0.031748,-0.1081,-0.098541,1,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0075304,-0.10842,-0.10558,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0094949,-0.11008,-0.11269,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.025994,-0.1107,-0.1761,1,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.050569,-0.11076,-0.12312,1,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.016734,-0.11176,-0.11239,1,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.041967,-0.11254,-0.12601,1,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.0090226,-0.11309,-0.1,1,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0029794,-0.11341,-0.15675,1,0
2,GO IMPORT INTO CELL,0.042857,-0.11405,-0.10311,1,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.036948,-0.11428,-0.093852,1,0
2,GO CELL CELL SIGNALING,0.0018173,-0.11591,-0.10968,1,0
2,GO RESPONSE TO ALKALOID,0.0028957,-0.11633,-0.15109,1,0
2,GO FEEDING BEHAVIOR,0.033894,-0.11713,-0.098931,1,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.013465,-0.11736,-0.10042,1,0
2,GO CELL MATURATION,0.0067808,-0.11822,-0.11562,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.027188,-0.11822,-0.095743,1,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.027188,-0.11827,-0.14011,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0040578,-0.11977,-0.13897,1,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.024288,-0.12008,-0.17897,1,0
2,GO CILIUM ORGANIZATION,0.0017123,-0.12008,-0.11921,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.024288,-0.12062,-0.13558,1,0
2,GO CRANIAL NERVE DEVELOPMENT,0.020205,-0.12068,-0.15033,1,0
2,GO NEUROGENESIS,0.0014738,-0.12269,-0.12542,1,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0028141,-0.12363,-0.14604,1,0
2,GO NEUROBLAST PROLIFERATION,0.03245,-0.12431,-0.14259,1,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.022165,-0.12446,-0.11748,1,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.036948,-0.12448,-0.12108,1,0
2,GO REGULATION OF ION TRANSPORT,0.0087944,-0.12549,-0.10957,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.04854,-0.12554,-0.14773,1,0
2,GO PHAGOSOME MATURATION,0.02068,-0.12601,-0.13216,1,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0025817,-0.12765,-0.12346,1,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.009256,-0.12785,-0.12117,1,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.047551,-0.12838,-0.095889,1,0
2,GO REGULATION OF HORMONE SECRETION,0.0028141,-0.12856,-0.13032,1,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.053746,-0.12872,-0.15065,1,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0011549,-0.12904,-0.14394,1,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0057817,-0.13102,-0.14918,1,0
2,GO PIRNA METABOLIC PROCESS,0.044685,-0.13253,-0.18969,1,0
2,GO DEVELOPMENTAL CELL GROWTH,0.00057693,-0.13303,-0.16903,1,0
2,GO NERVOUS SYSTEM PROCESS,0.0057817,-0.1338,-0.10528,1,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0016129,-0.13543,-0.16682,1,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.00050664,-0.13561,-0.16453,1,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00081984,-0.13677,-0.17393,1,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.016734,-0.13783,-0.31307,1,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0083534,-0.13822,-0.15085,1,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0019282,-0.13902,-0.12211,1,0
2,GO REGULATION OF APPETITE,0.034637,-0.14129,-0.10958,1,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.02843,-0.14133,-0.096811,1,0
2,GO COCHLEA DEVELOPMENT,0.024288,-0.14188,-0.13103,1,0
2,GO HEAD DEVELOPMENT,0.0028957,-0.1424,-0.11874,1,0
2,GO SODIUM ION TRANSPORT,0.0032441,-0.14244,-0.13786,1,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0097392,-0.14281,-0.25729,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.033894,-0.14309,-0.15081,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0032441,-0.14309,-0.14919,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001872,-0.1432,-0.1353,1,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.044685,-0.14359,-0.14032,1,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0050528,-0.14442,-0.1548,1,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.00063551,-0.14502,-0.13949,1,0
2,GO HORMONE TRANSPORT,0.0033369,-0.14561,-0.1338,1,0
2,GO DEVELOPMENTAL INDUCTION,0.04854,-0.14564,-0.16164,1,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.019739,-0.14668,-0.1028,1,0
2,GO RESPONSE TO AXON INJURY,0.034637,-0.1472,-0.12804,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.011612,-0.14724,-0.14223,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.035393,-0.1493,-0.14091,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00010462,-0.15014,-0.1726,1,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.030383,-0.15016,-0.13885,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00065623,-0.15063,-0.17227,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0060989,-0.15074,-0.14546,1,0
2,GO REPRODUCTIVE BEHAVIOR,0.0023671,-0.1508,-0.20795,1,0
2,GO CELLULAR RESPONSE TO PH,0.031748,-0.15159,-0.12339,1,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.0038387,-0.15385,-0.15896,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0030654,-0.15462,-0.15878,1,0
2,GO REGULATION OF DNA BINDING,0.017137,-0.15475,-0.11958,1,0
2,GO RESPONSE TO CALCIUM ION,0.0053338,-0.15485,-0.148,1,0
2,GO COLLATERAL SPROUTING,0.027188,-0.15496,-0.18408,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0083534,-0.15529,-0.097714,1,0
2,GO POSTSYNAPSE ORGANIZATION,0.0038387,-0.15542,-0.17316,1,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.0062634,-0.15569,-0.096481,1,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.023205,-0.15738,-0.13104,1,0
2,GO REGULATION OF INSULIN SECRETION,0.0066042,-0.15835,-0.13039,1,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.025994,-0.1585,-0.12969,1,0
2,GO SENSORY PERCEPTION OF PAIN,0.00353,-0.15857,-0.16196,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0026572,-0.15857,-0.16968,1,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.034637,-0.16016,-0.13244,1,0
2,GO NEURON PROJECTION REGENERATION,0.04854,-0.16035,-0.12272,1,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.012203,-0.16064,-0.20274,1,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.027803,-0.16067,-0.12286,1,0
2,GO CARDIAC CONDUCTION,0.01282,-0.16117,-0.15155,1,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0017123,-0.16124,-0.1522,1,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.0015189,-0.16153,-0.19814,1,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.036164,-0.16169,-0.18281,1,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.041093,-0.16269,-0.12979,1,0
2,GO SUCKLING BEHAVIOR,0.014841,-0.16275,-0.23342,1,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.016734,-0.16358,-0.1648,1,0
2,GO RESPONSE TO POTASSIUM ION,0.041967,-0.16481,-0.17361,1,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.017969,-0.16588,-0.22832,1,0
2,GO HINDBRAIN DEVELOPMENT,0.00012964,-0.16636,-0.19848,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0023671,-0.16698,-0.17207,1,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0053338,-0.168,-0.14838,1,0
2,GO LONG TERM MEMORY,0.015574,-0.17206,-0.15929,1,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0064317,-0.17263,-0.20861,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.04854,-0.17581,-0.176,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.02068,-0.17582,-0.20035,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0075304,-0.17893,-0.26668,1,0
2,GO ANDROGEN METABOLIC PROCESS,0.040234,-0.17912,-0.071323,1,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.049546,-0.17935,-0.24481,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0006154,-0.17982,-0.16591,1,0
2,GO INSULIN SECRETION,0.0066042,-0.17994,-0.14029,1,0
2,GO DENDRITE SELF AVOIDANCE,0.021165,-0.18006,-0.21701,1,0
2,GO NEUROMUSCULAR PROCESS,0.0075304,-0.1808,-0.14975,1,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0027346,-0.18109,-0.15826,1,0
2,GO CAMP METABOLIC PROCESS,0.038561,-0.1818,-0.17325,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.010506,-0.18225,-0.18591,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.047551,-0.18306,-0.18781,1,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0033369,-0.18623,-0.14935,1,0
2,GO PROTEIN KINASE C SIGNALING,0.0064317,-0.18628,-0.21498,1,0
2,GO AMINO ACID TRANSPORT,0.00098941,-0.1863,-0.19181,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0007696,-0.18694,-0.19989,1,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00020448,-0.18717,-0.1579,1,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.02843,-0.18747,-0.22547,1,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.010506,-0.19095,-0.22819,1,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0090226,-0.1915,-0.15378,1,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00074557,-0.19168,-0.15348,1,0
2,GO DEVELOPMENTAL MATURATION,8.1192e-05,-0.19179,-0.18135,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0011199,-0.19204,-0.17957,1,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00037661,-0.19293,-0.1986,1,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00045924,-0.19383,-0.18392,1,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.041967,-0.19387,-0.14763,1,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.023205,-0.19584,-0.28975,1,0
2,GO BEHAVIOR,5.0226e-05,-0.19727,-0.18304,1,0
2,GO SKELETAL MUSCLE CONTRACTION,0.018836,-0.1975,-0.14701,1,0
2,GO COGNITION,0.00013917,-0.19805,-0.19697,1,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0016129,-0.19819,-0.19221,1,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00087311,-0.19823,-0.26404,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0010206,-0.19835,-0.18128,1,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0014738,-0.19929,-0.22693,1,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.0045306,-0.20074,-0.16755,1,0
2,GO STRIATUM DEVELOPMENT,0.0069616,-0.20081,-0.23813,1,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0001547,-0.20083,-0.21197,1,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.033894,-0.20092,-0.21033,1,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0059384,-0.20111,-0.1339,1,0
2,GO MEMORY,5.8301e-05,-0.20125,-0.2259,1,0
2,GO PEPTIDE HORMONE SECRETION,0.00045924,-0.20159,-0.17852,1,0
2,GO REGULATION OF FERTILIZATION,0.0015653,-0.2019,-0.1974,1,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.0021062,-0.20234,-0.25539,1,0
2,GO RESPONSE TO FUNGUS,0.0037331,-0.20389,-0.14599,1,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0039469,-0.20411,-0.23054,1,0
2,GO SIGNAL RELEASE,0.00012074,-0.20499,-0.16978,1,0
2,GO SYNAPSE ORGANIZATION,0.001191,-0.20513,-0.19479,1,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.0029794,-0.20549,-0.28145,1,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0024367,-0.20554,-0.21439,1,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,7.547e-05,-0.20693,-0.22894,1,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0064317,-0.2075,-0.20056,1,0
2,GO REGULATION OF CILIUM MOVEMENT,2.6307e-05,-0.2099,-0.20293,1,0
2,GO FOREBRAIN DEVELOPMENT,0.00024286,-0.20996,-0.16718,1,0
2,GO DENDRITIC TRANSPORT,0.025414,-0.21053,-0.20565,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.00079435,-0.21056,-0.22187,1,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.018836,-0.21069,-0.22139,1,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.024288,-0.2111,-0.18921,1,0
2,GO CALCIUM ION IMPORT,0.00021909,-0.21137,-0.20977,1,0
2,GO RESPONSE TO PH,0.023205,-0.21215,-0.14171,1,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.031059,-0.21246,-0.14597,1,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.00016023,-0.21445,-0.21678,1,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0015653,-0.21561,-0.2136,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.045624,-0.21626,-0.23385,1,0
2,GO DIVALENT METAL ION EXPORT,0.017137,-0.21757,-0.20318,1,0
2,GO SECONDARY PALATE DEVELOPMENT,0.0090226,-0.2176,-0.22318,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.010245,-0.2195,-0.17283,1,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,3.1888e-05,-0.22034,-0.22296,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.011326,-0.22129,-0.18969,1,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.001191,-0.22222,-0.19739,1,0
2,GO FACIAL NERVE MORPHOGENESIS,0.03939,-0.22369,-0.29967,1,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00037661,-0.22444,-0.22699,1,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0046564,-0.22523,-0.29187,1,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.033166,-0.22603,-0.20853,1,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.03939,-0.22788,-0.24771,1,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.049546,-0.22808,-0.20625,1,0
2,GO MYELIN MAINTENANCE,0.029068,-0.22874,-0.20169,1,0
2,GO REGULATION OF EXOCYTOSIS,0.0071468,-0.2305,-0.18465,1,0
2,GO CGMP METABOLIC PROCESS,0.045624,-0.23291,-0.20903,1,0
2,GO EPITHELIAL CELL MATURATION,0.0085714,-0.2347,-0.26325,1,0
2,GO INSEMINATION,0.052669,-0.23544,-0.19735,1,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.012203,-0.23558,-0.26128,1,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.001662,-0.23585,-0.22547,1,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.00023468,-0.23711,-0.21995,1,0
2,GO ASSOCIATIVE LEARNING,0.0014738,-0.23927,-0.20993,1,0
2,GO VITAMIN CATABOLIC PROCESS,0.025994,-0.24011,-0.23319,1,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.019283,-0.24333,-0.20231,1,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00023468,-0.2434,-0.2281,1,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,6.2786e-05,-0.2467,-0.22982,1,0
2,GO RESPONSE TO MUSCLE STRETCH,0.011326,-0.24853,-0.27218,1,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,-0.24873,-0.22131,1,0
2,GO REGULATION OF MEMBRANE POTENTIAL,5.6174e-05,-0.24929,-0.23828,1,0
2,GO ACROSOME REACTION,0.00034072,-0.25085,-0.22925,1,0
2,GO LEARNING,0.00065623,-0.25137,-0.23618,1,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0040578,-0.25177,-0.18548,1,0
2,GO SECRETORY GRANULE ORGANIZATION,0.00024286,-0.25222,-0.24678,1,0
2,GO SIALYLATION,0.02843,-0.25261,-0.2102,1,0
2,GO RESPONSE TO AMYLOID BETA,0.0049174,-0.25483,-0.17216,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.001662,-0.25748,-0.3272,1,0
2,GO RESPONSE TO COCAINE,0.00069957,-0.25761,-0.23012,1,0
2,GO THALAMUS DEVELOPMENT,0.012203,-0.25771,-0.23578,1,0
2,GO MICROTUBULE BUNDLE FORMATION,1.2454e-05,-0.26023,-0.27713,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.0057817,-0.26182,-0.27576,1,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,3.3132e-05,-0.26191,-0.28373,1,0
2,GO MEMBRANE FISSION,0.0028957,-0.26481,-0.25935,1,0
2,GO RESPONSE TO CATECHOLAMINE,1.7806e-05,-0.26511,-0.25978,1,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.009256,-0.26573,-0.3094,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,9.389e-05,-0.2658,-0.28206,1,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,5.2139e-05,-0.26617,-0.24721,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.031748,-0.26628,-0.22889,1,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0094949,-0.2669,-0.30182,1,0
2,GO CELL MIGRATION IN HINDBRAIN,0.0032441,-0.26722,-0.31052,1,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0011199,-0.2678,-0.24778,1,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.0784e-06,-0.26834,-0.26998,1,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0024367,-0.26922,-0.23852,1,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.044685,-0.27008,-0.20895,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0099891,-0.27012,-0.21728,1,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.011047,-0.27069,-0.34342,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.0062634,-0.27163,-0.19677,1,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.02068,-0.27243,-0.30108,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0062634,-0.27246,-0.28057,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.009256,-0.27352,-0.30867,1,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.03245,-0.27422,-0.25295,1,0
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.011612,-0.27433,-0.29277,1,0
2,GO NERVE DEVELOPMENT,2.8418e-05,-0.27625,-0.28724,1,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.001986,-0.27644,-0.33458,1,0
2,GO MEMBRANE DEPOLARIZATION,7.547e-05,-0.27841,-0.30182,1,0
2,GO PROTEIN PALMITOYLATION,0.00074557,-0.27874,-0.22261,1,0
2,GO POTASSIUM ION TRANSPORT,9.0551e-05,-0.27874,-0.22649,1,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00028792,-0.27923,-0.32231,1,0
2,GO REGULATION OF ACROSOME REACTION,0.0039469,-0.28107,-0.27225,1,0
2,GO RETINA LAYER FORMATION,0.0038387,-0.28213,-0.2967,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0056288,-0.28343,-0.23293,1,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,1.6455e-05,-0.28349,-0.32418,1,0
2,GO ALANINE TRANSPORT,0.014486,-0.28426,-0.19128,1,0
2,GO MEMBRANE BIOGENESIS,0.0067808,-0.28516,-0.21802,1,0
2,GO SKELETAL MUSCLE ADAPTATION,0.027188,-0.2861,-0.20521,1,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,2.8418e-05,-0.28626,-0.32466,1,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0036303,-0.28726,-0.22272,1,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0013457,-0.28732,-0.23763,1,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,6.2786e-05,-0.28806,-0.29603,1,0
2,GO HORMONE CATABOLIC PROCESS,0.026586,-0.29056,-0.18762,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.019283,-0.29231,-0.2116,1,0
2,GO SYNAPTIC SIGNALING,1.349e-05,-0.29393,-0.27318,1,0
2,GO RESPONSE TO DOPAMINE,2.0784e-06,-0.29538,-0.28501,1,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.011047,-0.29623,-0.26894,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00026003,-0.29653,-0.25121,1,0
2,GO OPTIC NERVE DEVELOPMENT,0.00353,-0.29833,-0.31267,1,0
2,GO RESPONSE TO ACETYLCHOLINE,0.0071468,-0.29835,-0.26746,1,0
2,GO NOTCH RECEPTOR PROCESSING,0.0085714,-0.30207,-0.28486,1,0
2,GO NEURON PROJECTION ARBORIZATION,8.4205e-05,-0.30274,-0.34189,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,1.9263e-05,-0.30462,-0.28124,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0016129,-0.3054,-0.3088,1,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.018836,-0.30616,-0.23974,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.004408,-0.30724,-0.21713,1,0
2,GO NEURON MATURATION,0.0013872,-0.30768,-0.23605,1,0
2,GO SECRETORY GRANULE LOCALIZATION,0.0057817,-0.30858,-0.3296,1,0
2,GO LOCOMOTORY BEHAVIOR,7.9801e-06,-0.30916,-0.27576,1,0
2,GO TOXIN METABOLIC PROCESS,0.041093,-0.3095,-0.2175,1,0
2,GO NOREPINEPHRINE TRANSPORT,0.001191,-0.3096,-0.25154,1,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0012662,-0.31016,-0.24519,1,0
2,GO PRESYNAPSE ORGANIZATION,0.00022676,-0.31055,-0.29473,1,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0041716,-0.31092,-0.29813,1,0
2,GO TUBULIN DEACETYLATION,0.0056288,-0.31111,-0.23405,1,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.023205,-0.31189,-0.23159,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,3.1888e-05,-0.31288,-0.33587,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,8.1192e-05,-0.31378,-0.29285,1,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.013139,-0.31491,-0.25885,1,0
2,GO GROOMING BEHAVIOR,0.0011199,-0.31825,-0.29764,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0028141,-0.31932,-0.273,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,6.5149e-05,-0.32139,-0.28044,1,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.019739,-0.32165,-0.22635,1,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.00010462,-0.32373,-0.30426,1,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.0033369,-0.32549,-0.25505,1,0
2,GO EXOCYTIC PROCESS,6.5149e-05,-0.32779,-0.27868,1,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.00032948,-0.32902,-0.27937,1,0
2,GO REFLEX,0.0062634,-0.33049,-0.33856,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00087311,-0.33136,-0.36021,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00034072,-0.33215,-0.35432,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00014418,-0.33256,-0.33006,1,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.9418e-06,-0.3328,-0.33353,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0064317,-0.33964,-0.32578,1,0
2,GO DORSAL AORTA DEVELOPMENT,2.0033e-05,-0.35222,-0.38177,1,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,6.0504e-05,-0.3543,-0.40923,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.349e-05,-0.35759,-0.39984,1,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00057693,-0.35917,-0.27599,1,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00019753,-0.36027,-0.33874,1,0
2,GO RESPONSE TO DIETARY EXCESS,0.00041602,-0.36072,-0.38641,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.4728e-06,-0.36368,-0.39828,1,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00055855,-0.37017,-0.37113,1,0
2,GO TRANSMISSION OF NERVE IMPULSE,1.4039e-05,-0.37042,-0.36846,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00021909,-0.3711,-0.3776,1,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,6.4994e-06,-0.37119,-0.45625,1,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,2.9532e-05,-0.37203,-0.3619,1,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,8.7323e-05,-0.37254,-0.43785,1,0
2,GO CATECHOLAMINE UPTAKE,0.0017641,-0.3765,-0.29749,1,0
2,GO EXPLORATION BEHAVIOR,1.1493e-05,-0.37666,-0.44339,1,0
2,GO AXONEME ASSEMBLY,3.7145e-05,-0.38059,-0.34033,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,9.389e-05,-0.38303,-0.35509,1,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.5759e-05,-0.38486,-0.34848,1,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0015653,-0.38614,-0.46382,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0030654,-0.39009,-0.35103,1,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0045306,-0.39075,-0.34257,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0029794,-0.39131,-0.33692,1,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.1663e-05,-0.39358,-0.34316,1,0
2,GO NEURONAL ACTION POTENTIAL,0.00012964,-0.39375,-0.38255,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00016595,-0.39718,-0.35308,1,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00012512,-0.39729,-0.28993,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.906e-06,-0.39738,-0.40355,1,0
2,GO ADRENAL GLAND DEVELOPMENT,4.4878e-05,-0.39755,-0.41232,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.8583e-05,-0.41092,-0.35373,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00014935,-0.41146,-0.42288,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,3.4421e-05,-0.41294,-0.37964,1,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075304,-0.41315,-0.32271,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,9.389e-05,-0.41611,-0.32533,1,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.41759,-0.40071,1,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00021167,-0.41761,-0.47672,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.9263e-05,-0.41802,-0.38864,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,1.104e-05,-0.41953,-0.42704,1,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00032948,-0.42147,-0.34325,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00029782,-0.42396,-0.32309,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,8.3127e-06,-0.42864,-0.47246,1,0
2,GO STARTLE RESPONSE,9.7346e-05,-0.43451,-0.41573,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.0021062,-0.43651,-0.33772,1,0
2,GO CATECHOLAMINE METABOLIC PROCESS,3.6228e-06,-0.44661,-0.44857,1,0
2,GO NEURON FATE COMMITMENT,9.389e-05,-0.45099,-0.40042,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.4609e-05,-0.45131,-0.40182,1,0
2,GO SPINAL CORD PATTERNING,0.00014418,-0.45579,-0.43606,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00072223,-0.45579,-0.44077,1,0
2,GO GLIAL CELL FATE COMMITMENT,0.0069616,-0.45634,-0.38429,1,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.024846,-0.46498,-0.296,1,0
2,GO RESPONSE TO HISTAMINE,0.00042998,-0.46764,-0.52218,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00059588,-0.4731,-0.62579,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.4609e-05,-0.47385,-0.48456,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0057817,-0.4742,-0.38282,1,0
2,GO DETECTION OF CALCIUM ION,2.1663e-05,-0.47921,-0.4581,1,0
2,GO RESPONSE TO LITHIUM ION,0.0013872,-0.48226,-0.3472,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.1776e-06,-0.48566,-0.43682,1,0
2,GO TELENCEPHALON REGIONALIZATION,0.00090094,-0.48665,-0.43538,1,0
2,GO DOPAMINE METABOLIC PROCESS,4.8612e-06,-0.493,-0.45643,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0020453,-0.49519,-0.44063,1,0
2,GO PROTEIN LOCALIZATION TO AXON,0.0042883,-0.49988,-0.51522,1,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,1.1493e-05,-0.50426,-0.45948,1,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0056288,-0.50641,-0.4666,1,0
2,GO FOREBRAIN REGIONALIZATION,1.8521e-05,-0.50683,-0.44827,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.3441e-06,-0.50969,-0.55469,1,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,9.0179e-06,-0.51127,-0.4967,1,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.00040247,-0.51533,-0.43402,1,0
2,GO SEROTONIN METABOLIC PROCESS,0.00012964,-0.51618,-0.48398,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00047456,-0.5209,-0.55834,1,0
2,GO POSTSYNAPSE ASSEMBLY,4.0073e-05,-0.53093,-0.54051,1,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02268,-0.53215,-0.42098,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,4.6623e-06,-0.53818,-0.44798,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.00032948,-0.53915,-0.44638,1,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.00019079,-0.54665,-0.54081,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS,3.7791e-06,-0.54756,-0.51119,1,0
2,GO PLASMA MEMBRANE REPAIR,5.6174e-05,-0.5512,-0.59354,1,0
2,GO AMINE TRANSPORT,1.0604e-05,-0.55393,-0.47415,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00045924,-0.55607,-0.41556,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,1.2454e-05,-0.55775,-0.47568,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,7.9801e-06,-0.56854,-0.56987,1,0
2,GO REGULATION OF GLUTAMATE SECRETION,1.4039e-05,-0.5753,-0.49886,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,6.2786e-05,-0.57945,-0.49844,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00019753,-0.59447,-0.57583,1,0
2,GO SYNAPTIC MEMBRANE ADHESION,4.6623e-06,-0.59578,-0.60314,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.4609e-05,-0.59663,-0.62733,1,0
2,GO DENDRITE EXTENSION,2.6902e-06,-0.61273,-0.54732,1,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,1.349e-05,-0.61804,-0.51355,1,0
2,GO MONOAMINE TRANSPORT,1.1964e-05,-0.61853,-0.48974,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.2454e-05,-0.62242,-0.60131,1,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.2862e-06,-0.63003,-0.58564,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,2.8418e-05,-0.63175,-0.57593,1,0
2,GO REGULATION OF DENDRITE EXTENSION,1.4044e-06,-0.63491,-0.67112,1,0
2,GO GROWTH HORMONE SECRETION,3.17e-07,-0.64066,-0.60111,1,0
2,GO RESPONSE TO INSECTICIDE,1.3441e-06,-0.64942,-0.58409,1,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.001986,-0.65138,-0.49689,1,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,5.9841e-06,-0.67669,-0.59296,1,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,6.5896e-07,-0.67931,-0.65628,1,0
2,GO NOSE DEVELOPMENT,0.00037661,-0.68387,-0.53349,1,0
2,GO SYNAPTIC VESICLE DOCKING,0.00081984,-0.68503,-0.54517,1,0
2,GO SYNAPTIC VESICLE PRIMING,6.7596e-05,-0.68553,-0.56218,1,0
2,GO SYNAPSE MATURATION,2.9532e-05,-0.68558,-0.63869,1,0
2,GO NEURON CELL CELL ADHESION,7.6603e-06,-0.69428,-0.74771,1,0
2,GO INNERVATION,1.2862e-06,-0.69684,-0.70258,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,6.7728e-06,-0.70171,-0.64283,1,0
2,GO SYNAPTIC VESICLE MATURATION,8.3127e-06,-0.70729,-0.76326,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,1.7806e-05,-0.70774,-0.61998,1,0
2,GO MECHANOSENSORY BEHAVIOR,0.00065623,-0.71598,-0.62206,1,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00026903,-0.72004,-0.49951,1,0
2,GO DOPAMINE TRANSPORT,3.5759e-05,-0.72243,-0.57568,1,0
2,GO GANGLION DEVELOPMENT,2.5774e-06,-0.72491,-0.75393,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,4.7955e-07,-0.73288,-0.7439,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,6.7596e-05,-0.76375,-0.65106,1,0
2,GO CATECHOLAMINE SECRETION,5.4121e-05,-0.77421,-0.58309,1,0
2,GO REGULATION OF DOPAMINE SECRETION,0.00021909,-0.81849,-0.65869,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00038934,-0.82534,-0.63904,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,4.3763e-07,-0.89906,-0.86905,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,7.8282e-05,-0.92275,-0.71216,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,6.8936e-07,-0.94969,-0.82317,1,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.7118e-05,-0.9647,-0.8053,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.4346e-05,-0.98847,-0.92485,1,0
2,GO GABAERGIC NEURON DIFFERENTIATION,5.9841e-06,-1.0785,-0.85681,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00353,-1.1089,-0.88928,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,8.2505e-07,-1.3246,-1.3117,1,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,5.0683e-06,-1.4504,-1.1919,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.063042,0.54113,0.22231,0,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.080955,0.38487,0.22266,0,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.082489,0.37762,0.26315,0,1
2,GO BLEB ASSEMBLY,0.093897,0.35148,0.21631,0,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.29184,0.33582,0.14403,0,1
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.2839,0.3324,0.09428,0,1
2,GO RESPONSE TO HYDROPEROXIDE,0.065563,0.32846,0.2261,0,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.057089,0.32157,0.14601,0,1
2,GO REGULATION OF GLOMERULAR FILTRATION,0.099158,0.31969,0.23045,0,1
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.56666,0.31933,0.038372,0,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.088862,0.2992,0.19098,0,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.22235,0.2954,0.1369,0,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.087232,0.29077,0.33096,0,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.077957,0.27839,0.26011,0,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.093897,0.2779,0.20106,0,1
2,GO LIPID DROPLET FORMATION,0.24643,0.27697,0.1663,0,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13814,0.27522,0.11734,0,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.15015,0.27108,0.12299,0,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.054842,0.27104,0.13684,0,1
2,GO LATERAL MESODERM DEVELOPMENT,0.58456,0.26822,0.079068,0,1
2,GO MUSCLE CELL FATE COMMITMENT,0.095625,0.26686,0.2174,0,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.19095,0.26562,0.11913,0,1
2,GO REPLICATIVE SENESCENCE,0.16294,0.26561,0.1168,0,1
2,GO NUCLEOTIDE SALVAGE,0.27227,0.25074,0.12218,0,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.073629,0.24623,0.18956,0,1
2,GO ZYMOGEN ACTIVATION,0.088862,0.246,0.19494,0,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.064293,0.24328,0.25429,0,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.092194,0.24267,0.13945,0,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.092194,0.2398,0.19845,0,1
2,GO ENDODERMAL CELL DIFFERENTIATION,0.38408,0.23773,0.10749,0,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.32077,0.23439,0.087182,0,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.16828,0.2329,0.082452,0,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.22905,0.23287,0.17104,0,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.068167,0.22679,0.19783,0,1
2,GO REGULATION OF GASTRULATION,0.085627,0.22362,0.11002,0,1
2,GO LENS FIBER CELL DEVELOPMENT,0.11636,0.22162,0.15686,0,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.057089,0.21735,0.17258,0,1
2,GO MAGNESIUM ION HOMEOSTASIS,0.064293,0.21305,0.24165,0,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.055956,0.21293,0.157,0,1
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.20621,0.2098,0.14021,0,1
2,GO TROPHOBLAST CELL MIGRATION,0.068167,0.20951,0.1586,0,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.054842,0.20936,0.16877,0,1
2,GO REGULATION OF NEURON MATURATION,0.12259,0.20895,0.17081,0,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.25363,0.20678,0.074198,0,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.055956,0.20611,0.19914,0,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.061812,0.20547,0.1102,0,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.080955,0.20477,0.14161,0,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.073629,0.2029,0.16161,0,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.29184,0.20147,0.08261,0,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.17099,0.19838,0.077583,0,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0695,0.19812,0.13539,0,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.20937,0.19587,0.11256,0,1
2,GO RESPONSE TO LIGHT INTENSITY,0.20621,0.19564,0.11576,0,1
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.27999,0.19559,0.17439,0,1
2,GO SEQUESTERING OF METAL ION,0.063042,0.1939,0.17141,0,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.19393,0.19236,0.041747,0,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.11434,0.19048,0.095229,0,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.60883,0.19032,0.082736,0,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.088862,0.18848,0.1969,0,1
2,GO GRANULOCYTE MIGRATION,0.057089,0.18658,0.089707,0,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.066855,0.18597,0.12651,0,1
2,GO PIGMENT CELL DIFFERENTIATION,0.080955,0.18587,0.089522,0,1
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.16559,0.18416,0.10967,0,1
2,GO HISTAMINE TRANSPORT,0.16032,0.1811,0.11397,0,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22235,0.18056,0.087653,0,1
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.084046,0.18006,0.10998,0,1
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.079444,0.17995,0.14984,0,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.31232,0.17875,0.052113,0,1
2,GO VIRAL GENOME REPLICATION,0.065563,0.17838,0.13495,0,1
2,GO EMBRYO IMPLANTATION,0.068167,0.17722,0.12447,0,1
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.05824,0.17372,0.095999,0,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.26847,0.17367,0.080919,0,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.059411,0.17272,0.11077,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.060602,0.1715,0.16258,0,1
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.15264,0.17048,0.13938,0,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.070855,0.16931,0.14962,0,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.11434,0.16861,0.098807,0,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.37932,0.16802,0.058955,0,1
2,GO PROTEIN AUTOPROCESSING,0.15015,0.16767,0.11861,0,1
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.1313,0.16705,0.12838,0,1
2,GO FOREBRAIN MORPHOGENESIS,0.17374,0.16695,0.11023,0,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.068167,0.16637,0.09031,0,1
2,GO CERAMIDE TRANSPORT,0.17374,0.16584,0.13205,0,1
2,GO NEGATIVE REGULATION OF CELL AGING,0.23245,0.16551,0.11312,0,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.068167,0.16503,0.077257,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.2,0.16435,0.069143,0,1
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.055956,0.16396,0.17549,0,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.059411,0.16298,0.10188,0,1
2,GO DEVELOPMENTAL PIGMENTATION,0.11235,0.16095,0.072407,0,1
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.22235,0.1605,0.14003,0,1
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.54903,0.15754,0.01227,0,1
2,GO DIOL BIOSYNTHETIC PROCESS,0.188,0.15724,0.065485,0,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.065563,0.15653,0.15437,0,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.063042,0.15644,0.1737,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.11235,0.15541,0.12413,0,1
2,GO GOLGI TO VACUOLE TRANSPORT,0.27611,0.15487,0.073976,0,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.10845,0.15396,0.089352,0,1
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.58456,0.15238,0.010018,0,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.33373,0.15205,0.1027,0,1
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.53167,0.15089,0.039508,0,1
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.14769,0.15085,0.11782,0,1
2,GO RESPONSE TO VIRUS,0.059411,0.15,0.099898,0,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.068167,0.14909,0.15697,0,1
2,GO HISTAMINE SECRETION,0.092194,0.14889,0.15752,0,1
2,GO INTRACELLULAR MRNA LOCALIZATION,0.27999,0.14869,0.12168,0,1
2,GO REGULATION OF URINE VOLUME,0.057089,0.14863,0.14911,0,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.079444,0.14797,0.08087,0,1
2,GO COBALAMIN METABOLIC PROCESS,0.11636,0.14752,0.086772,0,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.12908,0.1472,0.13816,0,1
2,GO MULTI ORGANISM CELLULAR PROCESS,0.19095,0.14704,0.093555,0,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.099158,0.14695,0.075805,0,1
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.061812,0.14632,0.18406,0,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.22568,0.14624,0.10786,0,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.080955,0.14554,0.1267,0,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.11434,0.14549,0.08678,0,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.057089,0.14532,0.14845,0,1
2,GO CELLULAR RESPONSE TO DSRNA,0.093897,0.14396,0.089456,0,1
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.10845,0.14315,0.095776,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.064293,0.1431,0.1027,0,1
2,GO RESPONSE TO COPPER ION,0.25363,0.14301,0.13107,0,1
2,GO INNER EAR MORPHOGENESIS,0.055956,0.1429,0.11297,0,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.14769,0.14187,0.068057,0,1
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.085627,0.14173,0.11721,0,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.070855,0.14156,0.093252,0,1
2,GO SOMATIC STEM CELL DIVISION,0.33373,0.14148,0.1415,0,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.065563,0.1414,0.1243,0,1
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.10654,0.14132,0.095675,0,1
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.22905,0.14099,0.10207,0,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.25001,0.14053,0.050568,0,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.13583,0.14016,0.089871,0,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.05824,0.13917,0.10256,0,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.092194,0.13818,0.10126,0,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.060602,0.13814,0.093329,0,1
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.10654,0.1376,0.098199,0,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.20309,0.13741,0.078497,0,1
2,GO REGULATION OF STEROL TRANSPORT,0.11841,0.1366,0.10535,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0695,0.13642,0.10682,0,1
2,GO LEUKOCYTE HOMEOSTASIS,0.1313,0.13639,0.063869,0,1
2,GO RETINAL CONE CELL DIFFERENTIATION,0.31653,0.1363,0.12241,0,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.063042,0.1361,0.11484,0,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.1028,0.13577,0.11402,0,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.057089,0.13573,0.10493,0,1
2,GO DIOL METABOLIC PROCESS,0.17934,0.13564,0.089759,0,1
2,GO HISTONE MONOUBIQUITINATION,0.15264,0.13517,0.079626,0,1
2,GO LYMPHOCYTE COSTIMULATION,0.10845,0.13515,0.076141,0,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.079444,0.13486,0.09668,0,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.055956,0.13462,0.096665,0,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.084046,0.13404,0.10988,0,1
2,GO MUSCLE CELL MIGRATION,0.070855,0.13384,0.13158,0,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.24288,0.13346,0.086675,0,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.13355,0.13276,0.065381,0,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.26098,0.13206,0.12818,0,1
2,GO GASTRULATION,0.24288,0.1316,0.091063,0,1
2,GO FIBROBLAST PROLIFERATION,0.21256,0.13067,0.090643,0,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.090515,0.13029,0.098373,0,1
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.62732,0.13006,0.0037658,0,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.063042,0.12901,0.11476,0,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.15015,0.12816,0.088549,0,1
2,GO INFLAMMATORY RESPONSE,0.085627,0.12814,0.061529,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.085627,0.12767,0.10489,0,1
2,GO RRNA 3 END PROCESSING,0.088862,0.12745,0.11038,0,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.13583,0.12666,0.11127,0,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.12473,0.12631,0.082532,0,1
2,GO NEGATIVE REGULATION OF CELL SIZE,0.079444,0.12625,0.10138,0,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.16828,0.12622,0.053136,0,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.13583,0.12586,0.1188,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.22568,0.12586,0.078873,0,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.064293,0.12579,0.11107,0,1
2,GO REGULATION OF PROTEOLYSIS,0.0695,0.12535,0.07339,0,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.063042,0.12517,0.10421,0,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.12049,0.12507,0.069283,0,1
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.17099,0.12488,0.061163,0,1
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.2839,0.12441,0.10232,0,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.095625,0.12422,0.087534,0,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.17934,0.1229,0.065533,0,1
2,GO RESPONSE TO VITAMIN A,0.092194,0.12268,0.15362,0,1
2,GO RUFFLE ORGANIZATION,0.092194,0.12238,0.072639,0,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.61497,0.12177,0.031894,0,1
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.39858,0.12175,0.063185,0,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.18219,0.12165,0.078352,0,1
2,GO CARNITINE METABOLIC PROCESS,0.29992,0.11888,0.049815,0,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.21579,0.11808,0.056079,0,1
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.079444,0.11779,0.10406,0,1
2,GO NEPHRON DEVELOPMENT,0.088862,0.1177,0.11667,0,1
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.26847,0.11758,0.04733,0,1
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.30815,0.11751,0.067843,0,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.26471,0.11709,0.052568,0,1
2,GO UV PROTECTION,0.13355,0.11661,0.11273,0,1
2,GO TONGUE DEVELOPMENT,0.19095,0.11632,0.11962,0,1
2,GO HISTONE UBIQUITINATION,0.088862,0.11564,0.066123,0,1
2,GO EXIT FROM MITOSIS,0.088862,0.11516,0.064135,0,1
2,GO PLATELET AGGREGATION,0.092194,0.1149,0.11076,0,1
2,GO REGULATION OF CELL MATURATION,0.088862,0.11449,0.12117,0,1
2,GO WOUND HEALING,0.12259,0.1142,0.081568,0,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.30815,0.11409,0.047113,0,1
2,GO LIPID LOCALIZATION,0.05824,0.11397,0.069322,0,1
2,GO BILE ACID METABOLIC PROCESS,0.057089,0.11361,0.15449,0,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.32506,0.11341,0.043418,0,1
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.22568,0.11314,0.10885,0,1
2,GO PROTEIN PROCESSING,0.32938,0.11263,0.048001,0,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.47588,0.11205,0.030682,0,1
2,GO REGULATION OF ACTIN NUCLEATION,0.12689,0.11137,0.13614,0,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.054842,0.11128,0.087777,0,1
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.42347,0.11091,0.082201,0,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.075049,0.11039,0.088663,0,1
2,GO SPHINGOID METABOLIC PROCESS,0.12689,0.10921,0.11144,0,1
2,GO SPLEEN DEVELOPMENT,0.079444,0.10899,0.11865,0,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.060602,0.10815,0.12756,0,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.11636,0.10775,0.076252,0,1
2,GO BODY MORPHOGENESIS,0.94073,0.10764,-0.017362,0,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0695,0.10759,0.099446,0,1
2,GO LYMPH VESSEL DEVELOPMENT,0.23937,0.10715,0.15126,0,1
2,GO RESPONSE TO INACTIVITY,0.30815,0.10681,0.068087,0,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.088862,0.10676,0.10972,0,1
2,GO PEPTIDYL ARGININE METHYLATION,0.1313,0.10648,0.095011,0,1
2,GO RESPONSE TO LIPID,0.0695,0.1062,0.072828,0,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.059411,0.10605,0.094489,0,1
2,GO REGULATION OF BODY FLUID LEVELS,0.10654,0.10573,0.061124,0,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.088862,0.10546,0.076086,0,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.21256,0.1053,0.033189,0,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.14769,0.10305,0.055041,0,1
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.20937,0.10286,0.061079,0,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.22905,0.10279,0.086979,0,1
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.41842,0.10154,0.044147,0,1
2,GO RESPONSE TO DSRNA,0.082489,0.10092,0.076593,0,1
2,GO ALPHA BETA T CELL PROLIFERATION,0.11841,0.10057,0.080837,0,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.15264,0.099755,0.09644,0,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.10845,0.099611,0.15451,0,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.066855,0.099294,0.056174,0,1
2,GO PROTEIN MONOUBIQUITINATION,0.077957,0.098914,0.06319,0,1
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.71006,0.096537,0.024914,0,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.087232,0.096435,0.062645,0,1
2,GO METHIONINE METABOLIC PROCESS,0.58456,0.095339,0.0018157,0,1
2,GO REGULATION OF DNA REPAIR,0.079444,0.095058,0.057662,0,1
2,GO PROTEOLYSIS,0.064293,0.09465,0.054824,0,1
2,GO DRUG CATABOLIC PROCESS,0.33373,0.094332,0.050661,0,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.060602,0.094182,0.08205,0,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.082489,0.09414,0.063575,0,1
2,GO DNA REPLICATION INITIATION,0.23589,0.092476,0.071566,0,1
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.1313,0.091865,0.058301,0,1
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.22235,0.091694,0.080191,0,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.12689,0.091074,0.047437,0,1
2,GO PROTEIN NITROSYLATION,0.43367,0.091042,0.079073,0,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.14526,0.090379,0.049426,0,1
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.23937,0.090124,0.069741,0,1
2,GO PROTEIN MATURATION,0.13814,0.089251,0.054372,0,1
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.12049,0.088419,0.087538,0,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.084046,0.088338,0.08885,0,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.075049,0.088034,0.0786,0,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.11636,0.087563,0.069361,0,1
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.12049,0.0869,0.042364,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.22905,0.086725,0.068068,0,1
2,GO NEURAL TUBE DEVELOPMENT,0.29184,0.086613,0.092549,0,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.38408,0.086494,0.034244,0,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.29586,0.085383,0.032481,0,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.12689,0.084897,0.06924,0,1
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.21905,0.084164,0.054765,0,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.12473,0.083965,0.12297,0,1
2,GO ACTIVATION OF MAPKK ACTIVITY,0.48131,0.083842,0.035298,0,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.11841,0.083459,0.09335,0,1
2,GO PIGMENTATION,0.24288,0.083208,0.048605,0,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.05824,0.082925,0.065111,0,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.16294,0.082884,0.067025,0,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.32938,0.082092,0.04531,0,1
2,GO HISTONE H2A UBIQUITINATION,0.4598,0.081142,0.040003,0,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11841,0.081074,0.063127,0,1
2,GO REGULATION OF CELL DEATH,0.066855,0.080025,0.064078,0,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.099158,0.079117,0.09513,0,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.079444,0.078719,0.064374,0,1
2,GO MAST CELL MEDIATED IMMUNITY,0.28785,0.078598,0.08807,0,1
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.12689,0.078591,0.068206,0,1
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.13583,0.078207,0.030329,0,1
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.12473,0.07689,0.040457,0,1
2,GO SEQUESTERING OF CALCIUM ION,0.31232,0.076715,0.050178,0,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.095625,0.07619,0.049325,0,1
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.39858,0.075778,0.10638,0,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.080955,0.075706,0.11539,0,1
2,GO CELLULAR PIGMENTATION,0.085627,0.075329,0.091981,0,1
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.11841,0.075183,0.055451,0,1
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.26471,0.07503,0.024294,0,1
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.29586,0.073398,0.052743,0,1
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.33812,0.073247,0.051448,0,1
2,GO RESPONSE TO INSULIN,0.070855,0.072547,0.042346,0,1
2,GO PROTEIN N LINKED GLYCOSYLATION,0.21579,0.071987,0.04243,0,1
2,GO PHOSPHOLIPID TRANSPORT,0.39371,0.071167,0.02047,0,1
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.29992,0.07025,0.073023,0,1
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.4545,0.070059,0.01594,0,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.5726,0.070004,0.026147,0,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.62113,0.06794,0.014666,0,1
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.14285,0.067801,0.059931,0,1
2,GO LIPID PHOSPHORYLATION,0.10096,0.066729,0.055988,0,1
2,GO POLYOL CATABOLIC PROCESS,0.20621,0.065999,0.04707,0,1
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.17099,0.064642,0.095309,0,1
2,GO REGULATION OF SPINDLE ASSEMBLY,0.11636,0.064357,0.1064,0,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.55487,0.063907,0.040183,0,1
2,GO NEURAL TUBE FORMATION,0.11039,0.063658,0.11713,0,1
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.20621,0.063312,0.089835,0,1
2,GO AUTOPHAGOSOME ORGANIZATION,0.15015,0.061766,0.057686,0,1
2,GO SPINDLE ASSEMBLY,0.21256,0.059852,0.03875,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.12689,0.059295,0.050526,0,1
2,GO RESPONSE TO PEPTIDE HORMONE,0.080955,0.059078,0.046692,0,1
2,GO TELOMERE CAPPING,0.11039,0.058457,0.057419,0,1
2,GO CENTRIOLE ASSEMBLY,0.36991,0.05839,0.050098,0,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.072231,0.057372,0.042179,0,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.087232,0.05687,0.044303,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.13355,0.056524,0.037642,0,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.11235,0.056502,0.084675,0,1
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.073629,0.054566,0.046402,0,1
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.22905,0.052412,0.05365,0,1
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.85768,0.051175,-0.0061845,0,1
2,GO MACROMOLECULE DEACYLATION,0.12473,0.051139,0.044017,0,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.63978,0.050179,-0.001188,0,1
2,GO REGULATION OF RNA SPLICING,0.11434,0.049129,0.064477,0,1
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.84397,0.048118,0.0097135,0,1
2,GO REGULATION OF MITOTIC CELL CYCLE,0.14526,0.048039,0.050601,0,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.073629,0.047949,0.063547,0,1
2,GO MITOCHONDRION MORPHOGENESIS,0.0695,0.046419,0.099192,0,1
2,GO REGULATION OF ATPASE ACTIVITY,0.13355,0.046244,0.054773,0,1
2,GO MITOTIC CELL CYCLE,0.11235,0.045536,0.05095,0,1
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.22568,0.044901,0.030597,0,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.19095,0.043626,0.042786,0,1
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.1313,0.04351,0.035579,0,1
2,GO REGULATION OF AUTOPHAGY,0.12049,0.043328,0.038046,0,1
2,GO INTRACELLULAR TRANSPORT,0.11039,0.036052,0.036249,0,1
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.15264,0.035014,0.059982,0,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.18508,0.034566,0.076017,0,1
2,GO COVALENT CHROMATIN MODIFICATION,0.13355,0.033243,0.039948,0,1
2,GO BLASTOCYST DEVELOPMENT,0.20309,0.032582,0.039575,0,1
2,GO PEPTIDYL LYSINE MODIFICATION,0.077957,0.028043,0.041344,0,1
2,GO CELL CYCLE PROCESS,0.088862,0.027517,0.046,0,1
2,GO VACUOLE ORGANIZATION,0.64605,0.026761,0.0044229,0,1
2,GO REGULATION OF CELL CYCLE,0.35607,0.024321,0.030757,0,1
2,GO CELL CYCLE,0.15264,0.022449,0.035142,0,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.16294,0.39154,0.28594,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0014738,0.30768,0.32743,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.0069616,0.30486,0.24256,0,0
2,GO NADPH REGENERATION,0.0017641,0.28635,0.26696,0,0
2,GO IMP METABOLIC PROCESS,0.060602,0.28529,0.25349,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.13583,0.28361,0.17335,0,0
2,GO RESPONSE TO TYPE I INTERFERON,0.082489,0.27709,0.15385,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.44402,0.27411,0.019861,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.057089,0.26803,0.14163,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.12689,0.26768,0.17934,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.063042,0.26146,0.21245,0,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.029719,0.25735,0.17793,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.93377,0.25142,-0.059376,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.017549,0.24908,0.15923,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.32938,0.24062,0.099074,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.26471,0.23828,0.060823,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.13355,0.23608,0.15843,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.4978,0.23175,0.033712,0,0
2,GO HEART VALVE FORMATION,0.18219,0.22788,0.16582,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.13583,0.22586,0.14651,0,0
2,GO GAP JUNCTION ASSEMBLY,0.31232,0.2231,0.085722,0,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.25729,0.21603,0.12694,0,0
2,GO LIPID IMPORT INTO CELL,0.061812,0.2143,0.14245,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.11841,0.21248,0.19384,0,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.10465,0.21225,0.13291,0,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0695,0.21084,0.10684,0,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0695,0.20974,0.13068,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10096,0.20819,0.13771,0,0
2,GO DETECTION OF OTHER ORGANISM,0.12908,0.20762,0.083082,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.10465,0.20713,0.18127,0,0
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.12049,0.20656,0.15656,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.037747,0.2052,0.14902,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.073629,0.20446,0.19594,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.18219,0.20133,0.14194,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.41842,0.20094,0.067461,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.077957,0.19846,0.17008,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.12689,0.19668,0.11638,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.19095,0.19591,0.096522,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.12049,0.19584,0.11147,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.10845,0.19376,0.14501,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.070855,0.19227,0.17953,0,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.054842,0.19195,0.23784,0,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.23245,0.19122,0.070318,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.087232,0.19109,0.11793,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.39371,0.19101,0.049554,0,0
2,GO CYTIDINE TO URIDINE EDITING,0.099158,0.18903,0.26021,0,0
2,GO VASCULOGENESIS,0.055956,0.18889,0.14778,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.1313,0.18883,0.28085,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.077957,0.1882,0.22282,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.50896,0.18519,0.083008,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.072231,0.18518,0.19348,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.29184,0.18435,0.078925,0,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.084046,0.18345,0.12892,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.064293,0.18338,0.12435,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.63978,0.18262,0.0021483,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.12473,0.18182,0.11063,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.20937,0.17896,0.11266,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.073629,0.17874,0.13278,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.059411,0.17867,0.14436,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.072231,0.17611,0.13289,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.073629,0.17551,0.11475,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.10465,0.17281,0.22753,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.087232,0.17181,0.11405,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.8303,0.17173,-0.021904,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.10845,0.17084,0.16805,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.088862,0.17039,0.15067,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.21579,0.17028,0.45232,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.055956,0.17002,0.3346,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.11636,0.1694,0.15093,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.16032,0.16865,0.19145,0,0
2,GO ENDODERM DEVELOPMENT,0.26847,0.16863,0.10656,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.13583,0.16853,0.10269,0,0
2,GO PRO B CELL DIFFERENTIATION,0.13814,0.16811,0.17448,0,0
2,GO LIPOXYGENASE PATHWAY,0.16559,0.16772,0.15902,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.53167,0.16765,0.038435,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.44402,0.16763,0.035114,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.19695,0.16755,0.05786,0,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.32938,0.16689,0.043929,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20621,0.16687,0.1257,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.092194,0.16684,0.13711,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.025414,0.16674,0.14619,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.13814,0.16669,0.10982,0,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.11235,0.16663,0.09743,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.060602,0.16635,0.14814,0,0
2,GO PENILE ERECTION,0.22568,0.16534,0.065227,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.014138,0.16502,0.47093,0,0
2,GO SKIN MORPHOGENESIS,0.42347,0.16451,0.072708,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.37932,0.16397,0.084627,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.61497,0.16366,0.018161,0,0
2,GO BRONCHUS DEVELOPMENT,0.23245,0.16304,0.12625,0,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.073629,0.16297,0.091833,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.066855,0.16285,0.099333,0,0
2,GO CYTOLYSIS,0.17099,0.16233,0.12004,0,0
2,GO HYPOTONIC RESPONSE,0.11039,0.162,0.1295,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.12689,0.16184,0.15446,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.21905,0.16119,0.14073,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0050528,0.16108,0.23242,0,0
2,GO NAD METABOLIC PROCESS,0.11235,0.16039,0.12541,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.31232,0.16014,0.08255,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.48131,0.15964,0.012996,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.15264,0.15934,0.10203,0,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.11434,0.15829,0.13917,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.29992,0.15824,0.081431,0,0
2,GO COPPER ION HOMEOSTASIS,0.14526,0.15823,0.058481,0,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.12473,0.15818,0.063564,0,0
2,GO MALE SEX DETERMINATION,0.088862,0.15768,0.14581,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.092194,0.1561,0.11948,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.31232,0.15558,0.20794,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.26471,0.15469,0.071473,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.099158,0.1544,0.14888,0,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.018836,0.15387,0.12064,0,0
2,GO REGULATION OF PLATELET ACTIVATION,0.16559,0.15364,0.10391,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.21905,0.15361,0.068908,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.079444,0.15288,0.14247,0,0
2,GO TRACHEA MORPHOGENESIS,0.16828,0.15286,0.084797,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.11636,0.15262,0.11212,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.084046,0.15148,0.12569,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.093897,0.15144,0.12422,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.50896,0.15115,0.040151,0,0
2,GO VIRAL LATENCY,0.30815,0.15043,0.075981,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.4598,0.14994,0.047045,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19695,0.1499,0.13802,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.27611,0.14969,0.089586,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.1028,0.14911,0.12537,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.26098,0.14801,0.072995,0,0
2,GO RESPONSE TO THYROID HORMONE,0.064293,0.14797,0.16201,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.56075,0.14566,0.033947,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.40349,0.14509,0.055244,0,0
2,GO GMP METABOLIC PROCESS,0.029068,0.14505,0.14564,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.26847,0.14406,0.053756,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.12259,0.14405,0.095081,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.3746,0.14401,0.058861,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.077957,0.1439,0.13831,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.0695,0.14388,0.12377,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.30402,0.14372,0.078414,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.060602,0.14229,0.1496,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.13814,0.14202,0.14797,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.079444,0.14194,0.12858,0,0
2,GO MACROPHAGE PROLIFERATION,0.32077,0.14173,0.087752,0,0
2,GO GONADOTROPIN SECRETION,0.33373,0.1416,0.07184,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.21256,0.14155,0.17677,0,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.072231,0.14087,0.10585,0,0
2,GO REGULATION OF ANOIKIS,0.15773,0.14065,0.1159,0,0
2,GO V D J RECOMBINATION,0.10654,0.13993,0.14102,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.090515,0.13993,0.090351,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.080955,0.13988,0.14825,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.10096,0.13961,0.092271,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.25001,0.1396,0.075345,0,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.72969,0.13933,-0.008866,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.34702,0.13923,0.077272,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.099158,0.13848,0.10269,0,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.064293,0.13815,0.089921,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.11841,0.13786,0.1347,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.36991,0.13785,0.10663,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.17653,0.13774,0.13468,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.27227,0.13761,0.036422,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.13814,0.13738,0.12182,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.070855,0.13729,0.32097,0,0
2,GO RESPONSE TO UV C,0.075049,0.13699,0.1781,0,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.079444,0.13675,0.1534,0,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.14769,0.13653,0.031313,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.28785,0.13615,0.070826,0,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.092194,0.13604,0.16583,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.28785,0.13587,0.14681,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.11235,0.13587,0.10433,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12908,0.1355,0.061498,0,0
2,GO PLASMA MEMBRANE FUSION,0.27999,0.13487,0.063169,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.61497,0.13482,0.0336,0,0
2,GO PANCREATIC JUICE SECRETION,0.19095,0.13455,0.11508,0,0
2,GO RESPONSE TO TESTOSTERONE,0.16559,0.13454,0.095674,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.25001,0.13426,0.085579,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.23589,0.13391,0.11047,0,0
2,GO RESPONSE TO UV B,0.43883,0.13376,0.09136,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.53742,0.13374,0.075356,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.11434,0.13364,0.080248,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.1028,0.13318,0.12515,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.059411,0.13209,0.09131,0,0
2,GO MYOBLAST FUSION,0.24288,0.13208,0.052877,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.40843,0.13206,0.039793,0,0
2,GO ACTIN CROSSLINK FORMATION,0.27999,0.13198,0.049633,0,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.010245,0.13166,0.14685,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.060602,0.13151,0.08933,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.53742,0.13123,0.083537,0,0
2,GO COAGULATION,0.12049,0.13102,0.067262,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.12049,0.13099,0.12141,0,0
2,GO GDP METABOLIC PROCESS,0.33812,0.13079,0.078605,0,0
2,GO PROTEIN HYDROXYLATION,0.18508,0.13071,0.074944,0,0
2,GO REGULATION OF COAGULATION,0.54903,0.1304,0.040398,0,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.14526,0.13037,0.063631,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.11434,0.13015,0.10944,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.085627,0.12976,0.18558,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.11841,0.12957,0.1228,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.38888,0.12944,0.067557,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.21579,0.12935,0.052737,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.12259,0.12925,0.14068,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.1313,0.12919,0.079426,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.36064,0.12918,0.05576,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.25363,0.12877,0.15628,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.1028,0.12868,0.080478,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.29586,0.12856,0.075636,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.16828,0.12843,0.08257,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.23245,0.12822,0.08049,0,0
2,GO LEUKOCYTE AGGREGATION,0.27227,0.12819,0.11164,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.055956,0.12774,0.11468,0,0
2,GO FILOPODIUM ASSEMBLY,0.51459,0.12761,0.023456,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.4545,0.12746,0.023906,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.33373,0.12736,0.05348,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.10654,0.1268,0.1099,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.066855,0.12677,0.11821,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.20621,0.12664,0.21301,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.188,0.12639,0.090517,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.090515,0.12583,0.13983,0,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.12473,0.12577,0.11613,0,0
2,GO POSITIVE REGULATION OF CELL SIZE,0.16828,0.12538,0.13284,0,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.060602,0.12528,0.3753,0,0
2,GO TELOMERIC LOOP DISASSEMBLY,0.057089,0.12506,0.12334,0,0
2,GO MYELIN ASSEMBLY,0.38408,0.12493,0.079493,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.64605,0.12462,0.021644,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.54321,0.12457,0.052761,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.084046,0.1245,0.15396,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.11841,0.12402,0.11408,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.21256,0.12287,0.1068,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.40843,0.12287,0.041964,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.48131,0.12276,0.087928,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.066855,0.12262,0.091816,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.42855,0.12241,0.14488,0,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.12689,0.1224,0.082685,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.25001,0.12218,0.084396,0,0
2,GO LYMPHANGIOGENESIS,0.14526,0.12207,0.10848,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.15773,0.12124,0.16123,0,0
2,GO MAST CELL ACTIVATION,0.14285,0.12117,0.10219,0,0
2,GO CHOLESTEROL STORAGE,0.10654,0.12112,0.1439,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.2,0.12095,0.1175,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.044685,0.12059,0.087742,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.21579,0.12041,0.040357,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.057089,0.12041,0.12085,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.22568,0.1204,0.097014,0,0
2,GO RESPONSE TO FATTY ACID,0.079444,0.12023,0.10232,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.33812,0.11995,0.033225,0,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.073629,0.1199,0.099555,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.14769,0.11968,0.06432,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.30402,0.11961,0.15989,0,0
2,GO RENAL ABSORPTION,0.20621,0.11918,0.15836,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.60272,0.11917,0.028142,0,0
2,GO KERATINOCYTE MIGRATION,0.080955,0.11906,0.11853,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.097379,0.11906,0.12386,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.4545,0.11878,0.21283,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.23937,0.11867,0.17945,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.072231,0.11849,0.10903,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.14048,0.11846,0.096823,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.55487,0.11824,0.0074321,0,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.22905,0.11799,0.12028,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.4598,0.11721,0.019327,0,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.14526,0.1168,0.15146,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.12473,0.11669,0.31063,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.25363,0.11655,0.1283,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.30402,0.11647,0.081891,0,0
2,GO PLASMINOGEN ACTIVATION,0.16828,0.11645,0.12835,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.060602,0.1164,0.08925,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.188,0.11623,0.11115,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.099158,0.1162,0.30427,0,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.093897,0.11597,0.16274,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.21579,0.11505,0.095892,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.13583,0.11501,0.063598,0,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.073629,0.1149,0.073663,0,0
2,GO NEPHRON MORPHOGENESIS,0.16294,0.11469,0.07751,0,0
2,GO REGULATION OF WOUND HEALING,0.25001,0.11457,0.074979,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.9686,0.11446,-0.0006603,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.62113,0.11428,-0.0079114,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.20621,0.11406,0.073129,0,0
2,GO ENDODERM FORMATION,0.44924,0.11395,0.07845,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.17374,0.11324,0.069741,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.12689,0.11318,0.13556,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.025994,0.11296,0.17457,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.22905,0.11272,0.052374,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11434,0.11249,0.084839,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.40843,0.11248,0.097408,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.27227,0.11221,0.088019,0,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.19695,0.11214,0.057077,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.15264,0.11211,0.099759,0,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.057089,0.11197,0.08541,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.053746,0.11196,0.11981,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.059411,0.11195,0.15856,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.26847,0.11175,0.089364,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.17653,0.11127,0.1901,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.076492,0.11116,0.10593,0,0
2,GO ZINC ION HOMEOSTASIS,0.13814,0.11109,0.20186,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.077957,0.11106,0.11157,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.43367,0.11053,0.026849,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.54321,0.11039,0.055093,0,0
2,GO RESPONSE TO LEPTIN,0.2839,0.11018,0.063978,0,0
2,GO RESPONSE TO HYPEROXIA,0.61497,0.11014,0.017471,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.054842,0.10998,0.084576,0,0
2,GO CELL CHEMOTAXIS,0.066855,0.10986,0.087616,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.61497,0.10984,0.016772,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.38408,0.10959,0.077868,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.23245,0.1094,0.062074,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52594,0.10933,0.029219,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.40349,0.10928,0.079367,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.29586,0.10926,0.13615,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.25363,0.10909,0.062985,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.25001,0.10878,0.099767,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.67776,0.10842,0.033637,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.89907,0.10817,-0.027581,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.21579,0.10801,0.099652,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.43367,0.1079,0.04157,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.30402,0.10781,0.1409,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.059411,0.10776,0.12099,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.75615,0.10733,0.017307,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.14526,0.10711,0.082571,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.40843,0.10707,0.1772,0,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.76281,0.10697,0.020478,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.11235,0.10677,0.082631,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.15773,0.10673,0.08894,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.13355,0.10663,0.089021,0,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.18508,0.10652,0.038049,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.52594,0.10649,0.029711,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.26098,0.10637,0.14889,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.099158,0.10627,0.10818,0,0
2,GO NEURAL CREST CELL MIGRATION,0.32506,0.10617,0.0677,0,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.059411,0.1055,0.1336,0,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.075049,0.10544,0.17634,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.22235,0.10485,0.083723,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.15264,0.10456,0.18017,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.054842,0.10455,0.10282,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.092194,0.10451,0.096344,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.18508,0.10447,0.1401,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.38408,0.10443,0.089899,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.47049,0.10405,0.025789,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.34702,0.10402,0.090579,0,0
2,GO HAIR CELL DIFFERENTIATION,0.22568,0.10399,0.075128,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.087232,0.1039,0.12863,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.061812,0.10352,0.06748,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.41341,0.10341,0.029649,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.14769,0.10338,0.17649,0,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.18219,0.10315,0.090404,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.11235,0.10298,0.17594,0,0
2,GO MUSCLE FILAMENT SLIDING,0.38408,0.10294,0.057297,0,0
2,GO CELLULAR DEFENSE RESPONSE,0.21579,0.10288,0.023808,0,0
2,GO CYTOKINETIC PROCESS,0.11636,0.10261,0.10373,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.67137,0.1026,0.027999,0,0
2,GO RESPONSE TO RETINOIC ACID,0.17099,0.10255,0.1089,0,0
2,GO ACUTE PHASE RESPONSE,0.10654,0.10216,0.082293,0,0
2,GO T CELL MIGRATION,0.37932,0.10216,0.052318,0,0
2,GO LEUKOCYTE CHEMOTAXIS,0.054842,0.10188,0.079892,0,0
2,GO FIBRINOLYSIS,0.93377,0.10186,-0.018493,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.23937,0.10173,0.13546,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.26471,0.1017,0.086367,0,0
2,GO MEMBRANE INVAGINATION,0.12259,0.10167,0.076923,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.27999,0.10138,0.082795,0,0
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.20937,0.10088,0.10962,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.22568,0.10084,0.042231,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.59664,0.10081,0.052241,0,0
2,GO REGENERATION,0.11434,0.1002,0.081626,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.4545,0.10003,-0.070845,0,0
2,GO INTERLEUKIN 12 PRODUCTION,0.099158,0.099976,0.099231,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.23589,0.09988,0.076684,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.13583,0.099757,0.070787,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.34256,0.099506,0.078523,0,0
2,GO RESPONSE TO NUTRIENT,0.42347,0.099491,0.040713,0,0
2,GO LIVER MORPHOGENESIS,0.20937,0.099285,0.069364,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.10465,0.099192,0.14364,0,0
2,GO MUSCLE ADAPTATION,0.53167,0.09915,0.036455,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.56666,0.099032,0.030653,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.087232,0.098624,0.15229,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.072231,0.098218,0.070119,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0046564,0.098112,0.12286,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.23245,0.097973,0.092468,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.37932,0.097927,0.063185,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.32506,0.097921,0.10248,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.42855,0.097736,0.0099991,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.94073,0.097726,-0.026272,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.29992,0.097471,0.041019,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.1028,0.097279,0.11535,0,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.063042,0.097247,0.075757,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.26471,0.097242,0.090795,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.15517,0.096737,0.071417,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.065563,0.096697,0.16723,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.12473,0.096681,0.084971,0,0
2,GO BONE MORPHOGENESIS,0.068167,0.09644,0.12503,0,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.072231,0.096436,0.084495,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.34256,0.096344,0.096742,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.51459,0.096297,0.072128,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.096202,0.15998,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,0.096189,0.063134,0,0
2,GO LIPID STORAGE,0.11039,0.096141,0.07665,0,0
2,GO TISSUE REGENERATION,0.063042,0.095834,0.11722,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.22568,0.095769,0.10472,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.13583,0.095613,0.10298,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.56075,0.095587,0.015111,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.24288,0.095559,0.056253,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.15015,0.095451,0.086097,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.05161,0.094905,0.10417,0,0
2,GO MANGANESE ION TRANSPORT,0.30815,0.094835,0.063081,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.39371,0.094815,0.097405,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.063042,0.094804,0.063511,0,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.13814,0.094647,0.10892,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.61497,0.094526,0.032514,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.68418,0.094423,0.019796,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.20621,0.094244,0.10102,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.090515,0.094207,0.066378,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.11434,0.094117,0.11679,0,0
2,GO COENZYME A METABOLIC PROCESS,0.13583,0.094107,0.087217,0,0
2,GO RENAL FILTRATION,0.63354,0.094037,0.00096906,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.1313,0.094024,0.096368,0,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.42855,0.093847,0.090528,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.16294,0.093667,0.073057,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.97557,0.093433,-0.054127,0,0
2,GO RESPONSE TO DRUG,0.11636,0.093337,0.064976,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.5726,0.093292,0.012496,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.31653,0.093155,0.062193,0,0
2,GO OSTEOBLAST PROLIFERATION,0.188,0.093068,0.10656,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.061812,0.092713,0.099242,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.20937,0.092703,0.11412,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.16294,0.092678,0.11635,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.21905,0.092669,0.094173,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.21256,0.09258,0.092422,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.1028,0.092521,0.15063,0,0
2,GO MESONEPHROS DEVELOPMENT,0.29586,0.092384,0.075402,0,0
2,GO MUSCLE CELL PROLIFERATION,0.17653,0.092315,0.080449,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59059,0.092213,0.08617,0,0
2,GO RESPONSE TO HEAT,0.023205,0.092209,0.096968,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.18508,0.092175,0.084447,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.20937,0.092023,0.057879,0,0
2,GO NEUTROPHIL MIGRATION,0.17099,0.091633,0.032042,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.15517,0.091431,0.12159,0,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.24643,0.091392,0.096258,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.32938,0.091315,0.066117,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.05824,0.091289,0.27887,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.14048,0.091261,0.11753,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.39371,0.091067,0.087993,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.42347,0.090986,0.045114,0,0
2,GO MOLTING CYCLE,0.11636,0.090904,0.12444,0,0
2,GO RESPONSE TO PROGESTERONE,0.25729,0.090795,0.10099,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.47049,0.090757,0.051336,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.41842,0.090617,0.070806,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.26847,0.090611,0.08548,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.22568,0.090496,0.046941,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.072231,0.090359,0.10641,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.072231,0.090322,0.11147,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20309,0.090209,0.06768,0,0
2,GO GLOMERULUS DEVELOPMENT,0.11235,0.090139,0.1677,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.25001,0.090106,0.21318,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.13583,0.089697,0.09415,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.1313,0.089421,0.12692,0,0
2,GO ASTROCYTE DEVELOPMENT,0.41842,0.089405,0.056937,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.063042,0.089166,0.06544,0,0
2,GO ORGANELLE INHERITANCE,0.057089,0.089061,0.063955,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.036948,0.088925,0.086146,0,0
2,GO PEPTIDYL ARGININE N METHYLATION,0.19695,0.08886,0.11773,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.37932,0.088799,0.072739,0,0
2,GO MACROPHAGE ACTIVATION,0.075049,0.088741,0.058071,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.31232,0.088665,0.091196,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.35607,0.088611,0.064784,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.9686,0.088383,-0.024385,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.16828,0.088368,0.055699,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.98255,0.088299,-0.014168,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.25729,0.087746,0.04585,0,0
2,GO CELL CELL ADHESION,0.20937,0.08758,0.048905,0,0
2,GO AORTA MORPHOGENESIS,0.64605,0.087484,0.03621,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.27227,0.087448,0.10435,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.59059,0.08732,-0.01058,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.024288,0.087296,0.15212,0,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.080955,0.087273,0.1248,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.064293,0.087165,0.065531,0,0
2,GO PERICARDIUM DEVELOPMENT,0.18508,0.087023,0.12926,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.14048,0.08695,0.091156,0,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.17099,0.086829,0.052305,0,0
2,GO RESPONSE TO ETHANOL,0.16828,0.086561,0.066735,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.23937,0.086227,0.046253,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.81668,0.086178,0.0042539,0,0
2,GO ANOIKIS,0.26847,0.0861,0.072002,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.37932,0.086034,0.060725,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.64605,0.085809,0.036181,0,0
2,GO SYNCYTIUM FORMATION,0.21579,0.085778,0.057868,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.13814,0.085723,0.11213,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.43883,0.085063,0.058101,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.95466,0.084825,-0.0078341,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.18508,0.084715,0.078109,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.44402,0.084673,0.040067,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.35153,0.084302,0.046332,0,0
2,GO REGULATION OF LIPID STORAGE,0.16828,0.084122,0.058116,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.21256,0.084095,0.069034,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.16559,0.084042,0.16198,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.20621,0.084034,0.1635,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.2,0.084018,0.082088,0,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.15264,0.083882,0.096195,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.082489,0.083856,0.081404,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,0.083764,0.052465,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.30402,0.083734,0.031997,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.52594,0.083659,0.031965,0,0
2,GO POSTREPLICATION REPAIR,0.14526,0.083645,0.044703,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0695,0.083536,0.12491,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.89215,0.083423,0.01096,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.17653,0.083265,0.087848,0,0
2,GO MYOBLAST PROLIFERATION,0.43883,0.083189,0.042293,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.80989,0.082922,-0.050793,0,0
2,GO CRISTAE FORMATION,0.063042,0.082908,0.13426,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0695,0.082895,0.13943,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.27999,0.082817,0.063307,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.12473,0.082697,0.089399,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.44924,0.082646,0.070745,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.12049,0.08263,0.059723,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.18508,0.082554,0.074205,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.11039,0.082511,0.093174,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.5726,0.081927,0.047205,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.27611,0.081828,0.098635,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.39858,0.081808,0.086525,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.31232,0.081742,0.043632,0,0
2,GO MYOTUBE DIFFERENTIATION,0.36526,0.08157,0.037138,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.26847,0.081418,0.11727,0,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0695,0.081236,0.065082,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.072231,0.081171,0.12902,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.50337,0.08066,0.044958,0,0
2,GO TRANSLESION SYNTHESIS,0.23245,0.080556,0.03765,0,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.11235,0.080543,0.065889,0,0
2,GO GENITALIA DEVELOPMENT,0.12049,0.080401,0.070371,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.90599,0.080215,-0.011087,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.18508,0.080097,0.052439,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.32077,0.07987,0.044413,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.72969,0.079749,0.067673,0,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.054842,0.079717,0.066517,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.060602,0.07959,0.070055,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.095625,0.079399,0.1268,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.082489,0.079372,0.14946,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.12689,0.079212,0.065304,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.87144,0.079179,-0.002172,0,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.25363,0.079126,0.071764,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.31653,0.07899,0.048058,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.29184,0.078989,0.059958,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.60883,0.078934,0.060271,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.099158,0.078786,0.11244,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.19095,0.078723,0.12738,0,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.054842,0.078703,0.072775,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.20621,0.078274,0.094806,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.10096,0.077965,0.086054,0,0
2,GO STEROID ESTERIFICATION,0.16032,0.077939,0.087396,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.05824,0.077561,0.070672,0,0
2,GO VASCULATURE DEVELOPMENT,0.21579,0.07744,0.072908,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.44924,0.077381,0.023105,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.33373,0.077273,0.038413,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.99651,0.077114,-0.049793,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.58456,0.076884,0.057007,0,0
2,GO RESPONSE TO HORMONE,0.16294,0.076735,0.044275,0,0
2,GO RENAL SYSTEM PROCESS,0.25001,0.076609,0.048952,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.24288,0.076378,0.034462,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.32938,0.076357,0.041056,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.23589,0.076336,0.092755,0,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.097379,0.076232,0.080975,0,0
2,GO RESPONSE TO ESTRADIOL,0.33812,0.076073,0.039108,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.11235,0.076035,0.043356,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.10096,0.075956,0.085506,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.20309,0.075847,0.075634,0,0
2,GO XENOBIOTIC TRANSPORT,0.53167,0.075706,0.072644,0,0
2,GO TISSUE REMODELING,0.78962,0.075662,0.0031628,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.17934,0.075632,0.061281,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.41341,0.075529,0.0081552,0,0
2,GO LEUKOCYTE MIGRATION,0.13355,0.075468,0.058185,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.4545,0.075327,0.041534,0,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.53167,0.075269,-0.11028,0,0
2,GO HISTONE ARGININE METHYLATION,0.22905,0.075256,0.063656,0,0
2,GO ORGAN GROWTH,0.097379,0.075231,0.11457,0,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.072231,0.075185,0.061397,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.99651,0.074887,-0.031894,0,0
2,GO KIDNEY MORPHOGENESIS,0.14769,0.074182,0.074984,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.074162,0.089584,0,0
2,GO TRNA CATABOLIC PROCESS,0.50337,0.073786,0.077552,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,0.073768,0.063863,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.037747,0.073641,0.090477,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.21905,0.073635,0.052971,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.11636,0.073265,0.057768,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.48131,0.073198,0.083978,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.23937,0.073142,0.047939,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.88523,0.073125,-0.044063,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.19095,0.073008,0.056941,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.055956,0.072966,0.12744,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.29184,0.07291,0.036466,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.12259,0.072879,0.064063,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.53742,0.072807,0.0020666,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.37932,0.072784,0.034731,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.14285,0.072782,0.096903,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.29992,0.072697,0.038802,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.21256,0.072562,0.041164,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.36991,0.072556,0.10527,0,0
2,GO DNA STRAND ELONGATION,0.30815,0.072537,0.046847,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.46512,0.072331,0.058579,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.18219,0.07219,0.051368,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.03245,0.072105,0.1759,0,0
2,GO ENDOSOME ORGANIZATION,0.14285,0.072082,0.067592,0,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.11235,0.072074,0.058623,0,0
2,GO RUFFLE ASSEMBLY,0.19695,0.072029,0.057157,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.10465,0.071932,0.11124,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.35153,0.07191,0.043249,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.18508,0.071851,0.09253,0,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.30815,0.071737,0.12124,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.78962,0.071665,0.0070213,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.12259,0.071568,0.095413,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.092194,0.071566,0.073684,0,0
2,GO REGULATION OF CELL AGING,0.33373,0.071439,0.039404,0,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.079444,0.071435,0.063845,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15517,0.071369,0.10321,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.27611,0.071197,0.044131,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.22905,0.071195,0.061893,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.29184,0.071089,0.07567,0,0
2,GO AUTOPHAGOSOME MATURATION,0.188,0.070855,0.059502,0,0
2,GO GLIAL CELL ACTIVATION,0.22235,0.070847,0.054778,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.48678,0.070742,0.056992,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.67137,0.070719,0.017186,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.36526,0.070674,0.072818,0,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.25363,0.070657,0.061644,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.27999,0.070647,0.053058,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.32938,0.070572,0.045885,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.87144,0.07057,0.0030165,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.061812,0.070512,0.13806,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.17934,0.070509,0.049555,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.24288,0.0705,0.087909,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.17374,0.070333,0.08018,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.30815,0.070287,0.037393,0,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.20937,0.069902,0.11581,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.34702,0.069837,0.026482,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.12908,0.069697,0.088339,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.080955,0.069672,0.13257,0,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.063042,0.069657,0.20039,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.38888,0.069472,0.055228,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.87144,0.069295,-0.00035789,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.95466,0.06929,-0.030714,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.27227,0.069046,0.060352,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.12689,0.068975,0.084159,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.055956,0.068934,0.062965,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.2,0.068798,0.18985,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.98953,0.068728,-0.025439,0,0
2,GO MESODERM DEVELOPMENT,0.23937,0.068722,0.069906,0,0
2,GO BICARBONATE TRANSPORT,0.32077,0.068715,0.066466,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.27611,0.06863,0.066392,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.27999,0.068606,0.10096,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52594,0.06857,0.017132,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.69061,0.068507,0.041163,0,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.15773,0.068483,0.063138,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.10654,0.068472,0.073738,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.44924,0.068389,0.074364,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.7495,0.068361,0.04339,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.26098,0.068196,0.029662,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.47588,0.068109,0.015972,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.26847,0.067985,0.063865,0,0
2,GO REGULATION OF ERAD PATHWAY,0.055956,0.067916,0.075182,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.072231,0.067854,0.094771,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.42855,0.067826,0.053204,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.057089,0.067719,0.083894,0,0
2,GO AMMONIUM TRANSPORT,0.47049,0.067664,0.050254,0,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.19695,0.06755,0.032662,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.26098,0.067498,0.072428,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.070855,0.06747,0.078884,0,0
2,GO TRANSCYTOSIS,0.17653,0.067317,0.071398,0,0
2,GO SUPEROXIDE ANION GENERATION,0.25001,0.067255,0.09332,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.16559,0.067186,0.22309,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.98953,0.067092,-0.016826,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.4598,0.067088,0.043355,0,0
2,GO NADH METABOLIC PROCESS,0.34702,0.067056,0.068801,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.7495,0.067043,0.058175,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.14285,0.066977,0.097502,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.53742,0.066972,0.02261,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.42347,0.066892,0.044659,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.73628,0.066832,-0.0098556,0,0
2,GO RNA SURVEILLANCE,0.12473,0.066628,0.097117,0,0
2,GO RESPONSE TO WOUNDING,0.29184,0.066617,0.052858,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.69707,0.066378,-0.010361,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.11039,0.066311,0.04756,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.046579,0.066185,0.065842,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.19695,0.066124,0.059684,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.32938,0.066063,0.058131,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.33373,0.065958,0.051236,0,0
2,GO EXOCYTOSIS,0.22905,0.065642,0.033676,0,0
2,GO CELLULAR EXTRAVASATION,0.14769,0.065606,0.062092,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.53167,0.065404,0.030318,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.10845,0.065279,0.10475,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.11039,0.065114,0.12516,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.25363,0.065055,0.027797,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.78289,0.065043,-0.015947,0,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.079444,0.065017,0.069519,0,0
2,GO HORMONE METABOLIC PROCESS,0.1313,0.064958,0.084313,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.89215,0.064939,-0.035654,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.76948,0.064931,-0.018214,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.19095,0.064915,0.14503,0,0
2,GO NCRNA CATABOLIC PROCESS,0.066855,0.06463,0.10967,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.42347,0.064588,0.058606,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.070855,0.064521,0.077683,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.16294,0.064399,0.041157,0,0
2,GO ER OVERLOAD RESPONSE,0.51459,0.06436,0.058558,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.13583,0.063934,0.065174,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.53167,0.063833,0.049612,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.188,0.063792,0.052637,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.48131,0.063774,0.017469,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.18508,0.063767,0.085786,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.23245,0.063755,0.059672,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.4978,0.063578,-0.099994,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.43883,0.063562,0.02257,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.25363,0.063539,0.10307,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.12049,0.063486,0.15647,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.88523,0.063472,-0.014339,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.65234,0.063441,0.010904,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.59664,0.063388,0.027366,0,0
2,GO GLYCOSYLATION,0.35607,0.063382,0.0022593,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.095625,0.063363,0.095752,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.76948,0.063301,0.057677,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15264,0.063284,0.042523,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.38888,0.06321,0.013181,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.05824,0.063191,0.11528,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.16032,0.063126,0.069114,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.32938,0.063053,0.056422,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.47049,0.062748,0.078003,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.18219,0.062608,0.099802,0,0
2,GO VIRION ASSEMBLY,0.30402,0.062566,0.03971,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.1028,0.062462,0.053973,0,0
2,GO CELL MATRIX ADHESION,0.30815,0.062385,0.068191,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.23937,0.062231,0.079162,0,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18219,0.062219,0.065854,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.17374,0.06218,0.10736,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.17653,0.062154,0.037275,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.12689,0.062107,0.11944,0,0
2,GO EOSINOPHIL MIGRATION,0.53167,0.062024,0.030003,0,0
2,GO APOPTOTIC PROCESS,0.11235,0.062024,0.045331,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.33373,0.061993,0.09053,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.25001,0.061992,0.059602,0,0
2,GO HOMEOSTATIC PROCESS,0.14285,0.06184,0.026156,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.63978,0.061722,0.030241,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.1313,0.061657,0.083221,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.1313,0.061642,0.060189,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.59664,0.061632,0.0073668,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.12259,0.061523,0.19262,0,0
2,GO MAINTENANCE OF LOCATION,0.20309,0.06152,0.041113,0,0
2,GO MUSCLE HYPERTROPHY,0.52025,0.061505,0.048203,0,0
2,GO DE NOVO PROTEIN FOLDING,0.70355,0.061453,0.014449,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.26098,0.061358,0.051267,0,0
2,GO PROTEIN DESTABILIZATION,0.13583,0.061293,0.066914,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.095625,0.061175,0.11034,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.17374,0.061073,0.11841,0,0
2,GO PROTEIN STABILIZATION,0.15517,0.06103,0.052538,0,0
2,GO RESPONSE TO CHEMOKINE,0.14526,0.060975,0.049648,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.011326,0.06093,0.084026,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.18508,0.060872,0.10956,0,0
2,GO FEMALE GAMETE GENERATION,0.10465,0.060855,0.045256,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.27611,0.060831,0.077906,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.14769,0.060777,0.12163,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.70355,0.060566,-0.00091479,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.13355,0.060353,0.075027,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.22235,0.060332,0.04458,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.67776,0.060304,0.0094515,0,0
2,GO CHOLESTEROL EFFLUX,0.18219,0.06026,0.074667,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.13814,0.060158,0.085756,0,0
2,GO PROTEIN KINASE A SIGNALING,0.13814,0.059906,0.058759,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.11841,0.0599,0.084224,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.055956,0.059895,0.080027,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.60272,0.059866,0.014885,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.75615,0.059804,0.03003,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.17374,0.059721,0.032726,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.15015,0.059703,0.060585,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.47049,0.059545,0.024318,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.39858,0.059469,0.035602,0,0
2,GO LIPID DIGESTION,0.81668,0.059464,0.02361,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.25729,0.05942,0.14124,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.1028,0.059347,0.041993,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.097379,0.059264,0.050593,0,0
2,GO BIOLOGICAL ADHESION,0.26471,0.059241,0.043815,0,0
2,GO SPERM EGG RECOGNITION,0.1313,0.059211,0.062231,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.17099,0.059151,0.055058,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.14769,0.059121,0.047274,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.51459,0.05905,0.053807,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.72969,0.058997,0.029669,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.54903,0.05892,0.066151,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.10654,0.058886,0.22075,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.38888,0.058769,0.023079,0,0
2,GO PROTEIN POLYMERIZATION,0.22568,0.05864,0.030805,0,0
2,GO THYROID GLAND DEVELOPMENT,0.64605,0.058613,0.01634,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.67137,0.058537,0.011682,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.23937,0.058502,0.0282,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.53742,0.058315,0.12352,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.12259,0.058285,0.090305,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.79636,0.058264,-0.012582,0,0
2,GO NODAL SIGNALING PATHWAY,0.27999,0.058251,0.052669,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.51459,0.05823,0.033042,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.36064,0.058189,0.04263,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.35153,0.058115,0.056884,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.13583,0.057925,0.13194,0,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.12689,0.057862,0.050336,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.60272,0.057685,0.040924,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.44402,0.057612,0.052166,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.91293,0.05738,-0.0030978,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.16559,0.057364,0.078912,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.66501,0.057312,-0.018015,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.14285,0.057261,0.092605,0,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.27999,0.057258,0.020029,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.16032,0.057201,0.039392,0,0
2,GO CELLULAR SENESCENCE,0.44924,0.057061,0.032098,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.94769,0.056992,0.011154,0,0
2,GO BLASTOCYST GROWTH,0.12049,0.056992,0.070176,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.063042,0.056932,0.082073,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.57857,0.05693,0.071173,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.26471,0.056924,0.045021,0,0
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.4545,0.056898,0.092314,0,0
2,GO DNA REPAIR,0.010506,0.056856,0.066843,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.22905,0.056353,0.1366,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.16559,0.056087,0.13162,0,0
2,GO RETINA HOMEOSTASIS,0.22905,0.055983,0.073195,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.35607,0.055956,0.12611,0,0
2,GO VITAMIN METABOLIC PROCESS,0.12259,0.055938,0.078718,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.42347,0.05584,0.048543,0,0
2,GO FOAM CELL DIFFERENTIATION,0.32506,0.055815,0.064432,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.18508,0.055791,0.14098,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.8303,0.055743,0.071818,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.36526,0.05567,0.060907,0,0
2,GO BONE REMODELING,0.67776,0.055495,0.0018481,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.27999,0.055451,0.034104,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.33812,0.055397,0.10871,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.36064,0.055328,0.073663,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.3746,0.055305,0.10122,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.40843,0.055285,0.024037,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.67137,0.055266,0.011387,0,0
2,GO CELL SUBSTRATE ADHESION,0.26098,0.055121,0.074961,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.5726,0.054957,0.0029024,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.35153,0.054829,0.046507,0,0
2,GO STEROL TRANSPORT,0.36064,0.054801,0.057541,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.076492,0.054714,0.073762,0,0
2,GO MEMBRANE DISASSEMBLY,0.56075,0.054697,0.026081,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.40349,0.054672,0.069374,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.093897,0.054671,0.11261,0,0
2,GO AGING,0.24643,0.054642,0.041461,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.62113,0.054495,0.080096,0,0
2,GO RESPONSE TO VITAMIN,0.40349,0.054491,0.052149,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.44402,0.054363,0.045512,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.42855,0.054257,0.031819,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.29586,0.054233,0.051363,0,0
2,GO LACTATION,0.061812,0.054089,0.10072,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.23937,0.054042,0.081445,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.22905,0.053994,0.03087,0,0
2,GO SEX DIFFERENTIATION,0.49227,0.053991,0.026913,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.16559,0.053981,0.065246,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.29586,0.05398,0.15941,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.27611,0.053965,0.040676,0,0
2,GO ARTERY MORPHOGENESIS,0.23589,0.053948,0.08456,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.080955,0.053932,0.089151,0,0
2,GO RESPONSE TO ISCHEMIA,0.16828,0.053809,0.06112,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.72969,0.053687,-0.015973,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.16828,0.053519,0.088209,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.27999,0.053497,0.045256,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.99651,0.053398,-0.00069992,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.77618,0.053311,0.039,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.25729,0.053275,0.052918,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.14048,0.053218,0.047171,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.12049,0.053161,0.033873,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.36991,0.05315,0.013936,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.28785,0.052902,0.037388,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.31232,0.052645,0.068914,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.69707,0.052616,0.017502,0,0
2,GO BONE DEVELOPMENT,0.42347,0.052598,0.052045,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.097379,0.052565,0.04853,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.9686,0.052474,-0.022629,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.5726,0.052461,-0.0025141,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.14526,0.052445,0.039609,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.15773,0.052414,0.13329,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.17653,0.052285,0.070454,0,0
2,GO CYTOKINE SECRETION,0.2839,0.052253,0.045762,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26098,0.05217,0.080184,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.60883,0.052093,0.033458,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.83713,0.052062,0.00071116,0,0
2,GO CHROMOSOME SEPARATION,0.064293,0.052028,0.066195,0,0
2,GO NCRNA 3 END PROCESSING,0.27999,0.051993,0.049113,0,0
2,GO TUBE FORMATION,0.052669,0.051947,0.11581,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.43367,0.051915,0.027256,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.92682,0.051803,-0.0077261,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.84397,0.051702,-0.0041795,0,0
2,GO SEGMENTATION,0.20309,0.05169,0.056251,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.76281,0.051655,0.013767,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.21579,0.051421,0.034838,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.35607,0.051345,0.051473,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.65866,0.051232,0.01177,0,0
2,GO REGULATION OF PROTEIN BINDING,0.33812,0.051084,0.037003,0,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.22235,0.050999,0.06295,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.32938,0.050946,0.055806,0,0
2,GO REGULATION OF HEAT GENERATION,0.69707,0.050858,0.018577,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.25363,0.050834,0.21206,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.96163,0.050764,-0.037167,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.39371,0.050672,0.051543,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.39371,0.050646,0.041394,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.84397,0.050566,-0.035629,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.15264,0.050409,0.080732,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.48678,0.049972,0.034318,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.34256,0.049815,0.083913,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.38408,0.049664,0.033353,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.25363,0.049598,0.053925,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.61497,0.049588,0.1048,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.29586,0.049531,0.039461,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.85082,0.0494,0.0089154,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.18508,0.049323,0.055498,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.57857,0.04929,0.03603,0,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.19695,0.049276,0.11657,0,0
2,GO COMPLEMENT ACTIVATION,0.25363,0.049225,0.055402,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.48678,0.048945,0.050184,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.86455,0.048812,-0.020336,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.70355,0.04875,-0.003524,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.63354,0.04863,0.011377,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.26098,0.048504,0.085795,0,0
2,GO REPLACEMENT OSSIFICATION,0.32506,0.048461,0.12281,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.072231,0.048251,0.097913,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.088862,0.048177,0.049392,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.25729,0.048158,0.11566,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.20309,0.048074,0.045711,0,0
2,GO DNA DEAMINATION,0.3746,0.048018,0.075219,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.12049,0.047907,0.057357,0,0
2,GO SISTER CHROMATID COHESION,0.37932,0.047877,0.064265,0,0
2,GO CARTILAGE MORPHOGENESIS,0.85768,0.047535,0.0067048,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.78962,0.04753,-0.0015796,0,0
2,GO RENAL SODIUM EXCRETION,0.48131,0.047487,0.072455,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.27611,0.047483,0.11032,0,0
2,GO G0 TO G1 TRANSITION,0.47588,0.047383,0.045866,0,0
2,GO RECOMBINATIONAL REPAIR,0.32506,0.047318,0.060457,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.37932,0.047132,0.049471,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.85768,0.047027,0.0034197,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.32938,0.046968,0.057114,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.063042,0.046927,0.057468,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.42855,0.046872,0.12127,0,0
2,GO RECEPTOR INTERNALIZATION,0.29992,0.046865,0.048028,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.11636,0.046819,0.063289,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.29184,0.046771,0.029323,0,0
2,GO AUTOPHAGIC CELL DEATH,0.82348,0.046658,0.0027666,0,0
2,GO MITOTIC CYTOKINESIS,0.30815,0.046613,0.067228,0,0
2,GO EPITHELIUM DEVELOPMENT,0.42347,0.046485,0.050241,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.21579,0.046463,0.049333,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.11235,0.046332,0.053318,0,0
2,GO RESPONSE TO AMINE,0.72969,0.046229,0.010764,0,0
2,GO LUNG MORPHOGENESIS,0.1313,0.046194,0.19256,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.72969,0.046183,0.031357,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.33812,0.046154,0.052627,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.043763,0.045971,0.15646,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.89907,0.045845,-0.016325,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.7495,0.045814,0.010805,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.65234,0.045804,0.034302,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.16828,0.045799,0.03886,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.60272,0.045751,0.0099525,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.24643,0.045723,0.033676,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.82348,0.045637,0.020347,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.11636,0.045625,0.0581,0,0
2,GO PROTEIN TARGETING,0.15517,0.045481,0.064985,0,0
2,GO PROSTATIC BUD FORMATION,0.72969,0.04529,0.032502,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.029068,0.045261,0.11508,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.56075,0.045257,0.018639,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.060602,0.045243,0.070766,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.29184,0.045223,0.072978,0,0
2,GO GLIAL CELL DEVELOPMENT,0.76281,0.04497,0.0047427,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.87833,0.044883,0.011785,0,0
2,GO INTERLEUKIN 6 PRODUCTION,0.25001,0.044826,0.055048,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47588,0.044822,-0.087458,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.47049,0.044746,0.022234,0,0
2,GO DECIDUALIZATION,0.83713,0.044745,-0.010069,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.69707,0.044698,0.0093733,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.24643,0.044696,0.071539,0,0
2,GO QUINONE METABOLIC PROCESS,0.44924,0.044673,0.06904,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.89215,0.044629,-0.0095757,0,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.14048,0.044477,0.043083,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.83713,0.044178,-0.00079444,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.25729,0.044033,0.053022,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.27611,0.043973,0.053388,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.58456,0.043855,0.027109,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.36526,0.043854,0.021532,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.20937,0.043799,0.048456,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.56666,0.043746,0.066707,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.39371,0.04347,0.030976,0,0
2,GO MYOFIBRIL ASSEMBLY,0.27611,0.043396,0.044495,0,0
2,GO MICROTUBULE NUCLEATION,0.79636,0.043375,-0.029253,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.60883,0.043335,0.054661,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.17099,0.043279,0.061053,0,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1,0.043253,-0.05713,0,0
2,GO LIPID EXPORT FROM CELL,0.2839,0.043223,0.050833,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.31232,0.043194,0.025754,0,0
2,GO HINDLIMB MORPHOGENESIS,0.17934,0.043168,0.098308,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.20309,0.043095,0.064295,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.4978,0.043091,0.014743,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.092194,0.042995,0.058439,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.17653,0.042892,0.12975,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.4598,0.042892,0.06622,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.28785,0.042805,0.019618,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.92682,0.042794,0.0022004,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.48678,0.042786,0.025058,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.50337,0.042741,0.022365,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.44924,0.04269,0.02059,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.53167,0.042618,0.029094,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.15264,0.042403,0.11119,0,0
2,GO PRENYLATION,0.33373,0.042256,0.076529,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.59664,0.042106,0.028992,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.32077,0.041973,0.037874,0,0
2,GO DNA RECOMBINATION,0.073629,0.041972,0.063612,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.7495,0.041947,0.0011604,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.21905,0.041944,0.085095,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.55487,0.041857,0.02113,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.34702,0.04181,0.032928,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.72313,0.041801,0.014719,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.40843,0.04157,0.020369,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.40843,0.041394,0.033425,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.39371,0.041308,0.059175,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.67137,0.041209,0.020544,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.18508,0.041175,0.095371,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.11636,0.041174,0.21743,0,0
2,GO FACE DEVELOPMENT,0.72313,0.040916,0.039901,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.38408,0.040885,0.073523,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.1313,0.040883,0.0633,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.65234,0.040842,0.014004,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.85768,0.040832,-0.0087024,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.63978,0.040784,0.026218,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.67776,0.040758,-0.0047225,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.72969,0.040714,0.043791,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.40843,0.040672,0.025004,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.86455,0.040574,-0.023526,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.52594,0.040529,0.04381,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.85768,0.04052,0.021853,0,0
2,GO RESPONSE TO ZINC ION,0.32938,0.04037,0.10388,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.11434,0.040316,0.070428,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.10845,0.04019,0.081764,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.80989,0.040132,0.03321,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.54903,0.039991,0.045055,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.31653,0.039908,0.044427,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.73628,0.039736,-0.005372,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72969,0.039659,0.021379,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.30402,0.039517,0.051608,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.23589,0.039502,0.038332,0,0
2,GO CELLULAR RESPONSE TO ATP,0.52025,0.0395,-0.055219,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.54903,0.039445,0.038314,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.58456,0.039428,0.01829,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.61497,0.039356,0.018642,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.21579,0.039281,0.032189,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.30815,0.039262,0.033494,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.25363,0.039238,0.037812,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.80989,0.039216,0.028084,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.29992,0.039193,0.026193,0,0
2,GO ATP METABOLIC PROCESS,0.060602,0.039159,0.071659,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.16294,0.039028,0.031862,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.090515,0.038997,0.068984,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.35607,0.03892,0.11798,0,0
2,GO SARCOMERE ORGANIZATION,0.59059,0.038797,0.034242,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.93377,0.03867,-0.01905,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.8303,0.038662,0.0060126,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.37932,0.038637,0.029254,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.21256,0.038631,0.073191,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.98953,0.038607,-0.013592,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.7495,0.038597,-0.016891,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.16294,0.038524,0.052742,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.48131,0.038449,0.044117,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.36064,0.038378,0.055452,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.74288,0.038324,0.062177,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.24643,0.03826,0.031995,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.4598,0.038212,0.053896,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.44402,0.038091,0.025581,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.68418,0.038058,0.056383,0,0
2,GO VAGINA DEVELOPMENT,0.78962,0.037925,-0.047127,0,0
2,GO REGULATION OF MRNA PROCESSING,0.24288,0.037671,0.045098,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.7495,0.037623,-0.02575,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.4598,0.037597,0.052169,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.46512,0.037582,0.039643,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.93377,0.037574,-0.010417,0,0
2,GO RECEPTOR RECYCLING,0.70355,0.037371,0.013687,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.87144,0.037353,0.026408,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.60272,0.037353,0.028599,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.38408,0.037328,0.10176,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.42855,0.037287,0.023202,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.71006,0.037185,0.054928,0,0
2,GO SECRETION,0.5726,0.037036,0.0020986,0,0
2,GO REGULATION OF MAPK CASCADE,0.25001,0.036943,0.039906,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.70355,0.036921,0.013616,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.71006,0.03677,0.013583,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.29184,0.036694,0.065826,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.80989,0.036635,0.061339,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.56075,0.036622,0.0085201,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.97557,0.036604,-0.042554,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.59664,0.036566,0.028603,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.32938,0.036552,0.056788,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.5726,0.036531,0.013194,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.69707,0.036392,0.056279,0,0
2,GO AXONAL FASCICULATION,0.82348,0.036389,0.0024468,0,0
2,GO PROTEIN TRIMERIZATION,0.35607,0.036297,0.069392,0,0
2,GO O GLYCAN PROCESSING,0.46512,0.03606,0.0082653,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.69061,0.035962,0.015121,0,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.25729,0.03594,0.12133,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.46512,0.035904,0.025741,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.10465,0.035804,0.11171,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.53742,0.035662,0.015703,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.075049,0.035549,0.056404,0,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.61497,0.035503,0.025501,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.91987,0.035488,0.0059609,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.35607,0.035477,0.020796,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.63978,0.035456,0.027149,0,0
2,GO FLUID TRANSPORT,0.73628,0.035326,0.010579,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.42347,0.035276,0.11124,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.53742,0.035207,0.015664,0,0
2,GO P38MAPK CASCADE,0.71006,0.035144,0.006867,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.4545,0.035083,0.038645,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.46512,0.035031,0.019268,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.9686,0.034904,-0.02223,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.97557,0.03487,-0.003393,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.46512,0.034825,0.028811,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.29586,0.034589,0.044475,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.046579,0.034587,0.061009,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.72969,0.034552,0.0085737,0,0
2,GO BONE MINERALIZATION,0.76281,0.034529,-0.027994,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.37932,0.034336,0.046111,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.14526,0.034313,0.054407,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.21905,0.034257,0.039903,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.068167,0.03413,0.046116,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.32077,0.033934,0.037139,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.14048,0.033852,0.10169,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.041967,0.033803,0.069917,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.44402,0.033725,0.041712,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.94073,0.033663,0.0021918,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.83713,0.033583,-0.031972,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.29184,0.033551,0.04952,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.43883,0.033417,0.039235,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.40349,0.033339,0.020056,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.76948,0.03327,0.0068478,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.90599,0.033141,-0.021652,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.1028,0.033129,0.038402,0,0
2,GO EMBRYO DEVELOPMENT,0.48131,0.032976,0.037728,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.98953,0.032932,0.002905,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.55487,0.03287,0.014214,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.69061,0.032807,0.006582,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.57857,0.032781,-0.05103,0,0
2,GO REGULATION OF RNA BINDING,0.53742,0.032718,0.041695,0,0
2,GO HEAD MORPHOGENESIS,0.99651,0.032695,-0.0077516,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,1,0.032516,-0.015681,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.63978,0.032462,0.10884,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.25363,0.032462,0.030518,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.75615,0.032445,-0.0043502,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.65234,0.03244,0.0039803,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.36991,0.032262,0.052637,0,0
2,GO ATP TRANSPORT,0.91293,0.032258,-0.007011,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.2,0.032057,0.039871,0,0
2,GO APPENDAGE DEVELOPMENT,0.18508,0.03204,0.086136,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.42347,0.032008,0.065739,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.47588,0.031521,0.024743,0,0
2,GO PLATELET DEGRANULATION,0.78962,0.031469,-0.0028543,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.52025,0.031418,0.027699,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.48678,0.031389,0.051235,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.31653,0.03131,0.032266,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.27999,0.031305,0.048618,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.19695,0.031297,0.039334,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.73628,0.031236,0.036241,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.48131,0.031182,0.030152,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.53167,0.031,0.0099123,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.14285,0.030974,0.23046,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.90599,0.03097,0.0046589,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.74288,0.030965,-0.012795,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.61497,0.030908,0.0071251,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.82348,0.030891,-0.0083575,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.62732,0.030771,0.013266,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.90599,0.030763,0.0064894,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.7495,0.030692,0.033281,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.59664,0.030609,0.016718,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.31232,0.030586,0.070966,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.76948,0.03054,0.0027782,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.78289,0.030472,0.02464,0,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.32506,0.030433,0.047082,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.4545,0.03036,0.056778,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.42347,0.030289,0.03224,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.31653,0.030101,0.073736,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.83713,0.029998,0.018595,0,0
2,GO RESPONSE TO STEROL,0.29586,0.029937,0.078741,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.91987,0.029902,-0.01766,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.65866,0.029873,0.03232,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.79636,0.029833,0.010621,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.71658,0.029788,0.037452,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.14285,0.029697,0.039902,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.2839,0.029653,0.040152,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.065563,0.029589,0.046567,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.36526,0.029547,0.043763,0,0
2,GO TUBE MORPHOGENESIS,0.36526,0.02949,0.059156,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.25001,0.029489,0.064294,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.56075,0.029395,0.045257,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.21905,0.029375,0.037604,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.80989,0.029323,-0.034324,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.26847,0.029292,0.065104,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.4978,0.029202,0.020868,0,0
2,GO MITOCHONDRION ORGANIZATION,0.063042,0.0292,0.055407,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.20621,0.028946,0.088579,0,0
2,GO LYMPHOCYTE MIGRATION,0.72313,0.028894,0.018142,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.59664,0.028797,0.016951,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.70355,0.028782,0.0064481,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.54903,0.028766,0.021342,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.33373,0.028672,0.050185,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.56666,0.028641,0.0071574,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.22235,0.028598,0.046478,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.29992,0.02859,0.091538,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.47049,0.028517,0.020525,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.42347,0.028448,0.027729,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.188,0.028386,0.10489,0,0
2,GO REGULATION OF T CELL MIGRATION,0.44402,0.028174,0.036356,0,0
2,GO JNK CASCADE,0.29992,0.028047,0.036871,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.35153,0.028027,0.05416,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.42855,0.028019,0.03263,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.14526,0.028001,0.064574,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.43367,0.027942,0.070998,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.21256,0.027936,0.076261,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.47588,0.027911,0.033602,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.36526,0.027829,0.037581,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.58456,0.027781,0.015785,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.43883,0.027726,0.077576,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.42347,0.027708,0.053747,0,0
2,GO HISTONE H2A ACETYLATION,0.75615,0.027704,0.0088158,0,0
2,GO RESPONSE TO PEPTIDE,0.38408,0.027684,0.022862,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.77618,0.027672,0.015587,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.19393,0.027589,0.04921,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.61497,0.027361,0.010952,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.58456,0.027307,0.0058109,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.54321,0.027137,-0.044071,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.69061,0.027113,0.022769,0,0
2,GO ENDOCYTOSIS,0.4545,0.027025,0.016522,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.36991,0.026877,0.041981,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.97557,0.026853,0.0075853,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.42347,0.026648,0.0098656,0,0
2,GO CHROMATIN SILENCING,0.31232,0.026638,0.06477,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.78962,0.026614,0.0031865,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.72969,0.026485,0.0078607,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.49227,0.026358,0.030857,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.85768,0.026332,-0.0065069,0,0
2,GO RESPONSE TO VITAMIN D,0.90599,0.026294,-0.037903,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.75615,0.026243,-0.021933,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.80312,0.026175,0.0025297,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.60883,0.025945,0.050321,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.66501,0.025811,0.021853,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.25363,0.025784,0.032654,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.52025,0.025618,0.0015567,0,0
2,GO FERTILIZATION,0.7495,0.025285,0.00047148,0,0
2,GO ORGANELLE DISASSEMBLY,0.46512,0.025228,0.017058,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.29586,0.025151,0.076327,0,0
2,GO SINGLE FERTILIZATION,0.69061,0.025042,-0.024283,0,0
2,GO TRABECULA FORMATION,0.48131,0.025003,0.050973,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.49227,0.024976,0.056146,0,0
2,GO NEURON REMODELING,0.89907,0.024973,-0.030406,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.47588,0.024924,0.014087,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.4978,0.024857,-0.061763,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.42855,0.024784,0.025493,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.33373,0.024767,0.02688,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.88523,0.024756,0.014385,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.78962,0.02452,0.034119,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.51459,0.024496,0.026824,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.93377,0.024331,0.010955,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.67776,0.024296,0.0129,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.65866,0.024258,0.038721,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.53742,0.024154,0.042654,0,0
2,GO MIDGUT DEVELOPMENT,0.80989,0.024043,0.071845,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.54903,0.024034,0.015968,0,0
2,GO METANEPHROS MORPHOGENESIS,0.78289,0.024021,0.0078214,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.39858,0.024006,0.023334,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.63978,0.023907,0.0080017,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.69061,0.023824,0.033469,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.98953,0.023721,0.0029453,0,0
2,GO CHROMATIN ORGANIZATION,0.23589,0.023718,0.03341,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.98953,0.023712,-0.0083586,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.89907,0.023672,-0.0031214,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.82348,0.023668,-0.0022776,0,0
2,GO REGULATION OF DNA REPLICATION,0.65234,0.023625,0.03358,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.8303,0.023547,-0.016275,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.80989,0.023451,0.028645,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.87833,0.02345,-0.014675,0,0
2,GO RESPONSE TO ATP,0.9686,0.023282,-0.015126,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.33373,0.022965,0.055703,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.71006,0.022929,0.0014662,0,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.21256,0.02283,0.056155,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.77618,0.022795,0.0054464,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.23937,0.02277,0.031305,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.87144,0.02271,0.0025128,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.50337,0.022646,0.04877,0,0
2,GO NUCLEOSOME ORGANIZATION,0.80312,0.022427,0.024905,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.41341,0.022287,0.025259,0,0
2,GO VACUOLAR ACIDIFICATION,0.94769,0.022273,-0.015556,0,0
2,GO REGULATION OF HEART GROWTH,0.62113,0.022233,0.024104,0,0
2,GO SISTER CHROMATID SEGREGATION,0.19393,0.0222,0.063441,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.43883,0.022176,0.041355,0,0
2,GO MATING BEHAVIOR,0.99651,0.022062,-0.009965,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.7495,0.02204,0.012448,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.69061,0.021801,0.013839,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.7495,0.021682,-0.0027375,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.15264,0.021488,0.037039,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.94073,0.021359,-0.013155,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.36064,0.021256,0.035434,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.85082,0.021009,-0.0070816,0,0
2,GO UTERUS DEVELOPMENT,0.64605,0.020986,-0.059039,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.48678,0.020916,0.046324,0,0
2,GO SEX DETERMINATION,0.72313,0.020867,-0.0014263,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.8303,0.020862,0.010301,0,0
2,GO GOLGI ORGANIZATION,0.43883,0.02072,0.027036,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.94769,0.020712,-0.03594,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.67776,0.020673,0.0090346,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.91987,0.02064,-0.014575,0,0
2,GO MITOCHONDRIAL FUSION,0.59059,0.020533,0.017529,0,0
2,GO DRINKING BEHAVIOR,0.85082,0.020339,-0.0051647,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.77618,0.020329,0.030799,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.57857,0.020293,0.0042949,0,0
2,GO DNA PACKAGING,0.73628,0.020284,0.018157,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.91987,0.020225,-0.025808,0,0
2,GO FAT CELL DIFFERENTIATION,0.8303,0.020208,0.015048,0,0
2,GO CYTOSOLIC TRANSPORT,0.64605,0.020185,0.013705,0,0
2,GO SPECIFICATION OF SYMMETRY,0.4978,0.020146,0.025093,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.80989,0.020108,-0.0063958,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.63354,0.020032,0.035783,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.53742,0.020018,0.026049,0,0
2,GO PHOSPHOLIPID EFFLUX,0.5726,0.019895,0.058125,0,0
2,GO LIPID DROPLET ORGANIZATION,0.50896,0.01982,0.05302,0,0
2,GO NEGATIVE CHEMOTAXIS,0.75615,0.019443,-0.059141,0,0
2,GO TUBE DEVELOPMENT,0.71006,0.019328,0.035888,0,0
2,GO BLOOD VESSEL REMODELING,0.48678,0.019247,0.01552,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.60883,0.019238,-0.044648,0,0
2,GO CGMP MEDIATED SIGNALING,0.88523,0.019229,-0.026413,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.48678,0.018993,0.046698,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.73628,0.018971,0.070063,0,0
2,GO PROTEIN TETRAMERIZATION,0.67776,0.018952,0.012088,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.36526,0.018916,-0.059513,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.59059,0.018874,0.039145,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.60272,0.018789,0.010702,0,0
2,GO REGULATION OF MRNA BINDING,0.36526,0.018765,0.067555,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.66501,0.018742,0.075501,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.63354,0.018599,0.013832,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.60883,0.018535,0.0055299,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.8303,0.018479,0.012257,0,0
2,GO REGULATION OF METAL ION TRANSPORT,1,0.018415,-0.0056358,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.8303,0.018393,-0.0083662,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.50896,0.018105,0.036055,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.79636,0.018054,0.018746,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.40349,0.01798,0.033161,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.99651,0.017869,-0.00038742,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.15015,0.017842,0.10863,0,0
2,GO OOCYTE DIFFERENTIATION,0.7495,0.017722,0.0099445,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.74288,0.017697,0.018622,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.48131,0.017621,0.013141,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.60272,0.017522,0.013426,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.90599,0.017475,-0.025743,0,0
2,GO LIPID TRANSLOCATION,0.85768,0.017406,-0.026045,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.50896,0.017366,0.030647,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.98953,0.017365,-0.011546,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.86455,0.017239,-0.017393,0,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.14526,0.017052,0.083043,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.65866,0.016672,-0.034107,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.98255,0.016616,0.0031485,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42855,0.016576,0.037121,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.20937,0.016546,0.027842,0,0
2,GO PROTEIN REFOLDING,0.89907,0.016486,0.0016649,0,0
2,GO L GLUTAMATE IMPORT,0.87833,0.016469,-0.01442,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.78289,0.016337,0.0038758,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.41341,0.016285,-0.087819,0,0
2,GO RESPONSE TO ETHER,0.25729,0.016208,0.072016,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.89907,0.016105,0.074946,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.65234,0.016101,0.083137,0,0
2,GO MUSCLE SYSTEM PROCESS,0.97557,0.016034,-0.0089498,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.56075,0.015993,0.07165,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.36064,0.015979,0.072749,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.29586,0.015937,0.25288,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.89907,0.015922,-0.020164,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.9686,0.015533,-0.027975,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.93377,0.015515,0.0033865,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.27999,0.015412,0.14544,0,0
2,GO APPENDAGE MORPHOGENESIS,0.59059,0.015397,0.060253,0,0
2,GO REPLICATION FORK PROCESSING,0.52594,0.015266,0.054076,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.32077,0.01517,0.087686,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.14526,0.0151,0.056854,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.69707,0.015062,0.049906,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.64605,0.014858,0.013312,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.44402,0.014455,0.053455,0,0
2,GO NEURAL TUBE PATTERNING,0.60883,0.014338,-0.016108,0,0
2,GO EATING BEHAVIOR,0.53167,0.01433,0.024148,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27999,0.014258,0.051218,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.9686,0.014153,-0.0083412,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.91987,0.014062,0.047162,0,0
2,GO DNA REPLICATION CHECKPOINT,0.31653,0.013991,0.086732,0,0
2,GO BRAIN MORPHOGENESIS,0.78962,0.013964,-0.035771,0,0
2,GO MEMBRANE ORGANIZATION,0.95466,0.013837,-0.0053667,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.38888,0.013815,0.036363,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.48678,0.013812,0.010328,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.75615,0.013802,0.055013,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.73628,0.01373,0.022867,0,0
2,GO CELL MOTILITY,0.74288,0.013634,0.011931,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.72969,0.013625,0.0045963,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.65234,0.013461,-0.04808,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.67776,0.013443,0.0065223,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.86455,0.013359,0.0072627,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.46512,0.013255,0.041123,0,0
2,GO RESPONSE TO LEAD ION,0.67137,0.013088,0.039547,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.63354,0.012902,0.016399,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.94073,0.0129,-0.0099678,0,0
2,GO ARTERY DEVELOPMENT,0.69061,0.012857,0.050188,0,0
2,GO PHOTOTRANSDUCTION,0.59059,0.012838,0.11626,0,0
2,GO SPINDLE ORGANIZATION,0.78289,0.012775,0.012031,0,0
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.80312,0.012655,0.069119,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.85082,0.012635,-0.025164,0,0
2,GO PROTEIN ACYLATION,0.60272,0.012622,-0.0069486,0,0
2,GO MYELOID CELL DEVELOPMENT,0.50896,0.012618,0.040322,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.47049,0.012544,0.098085,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.78962,0.012481,0.0093054,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.96163,0.012399,0.026879,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.61497,0.012312,0.029205,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.56075,0.012283,0.027255,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.41341,0.012271,0.046036,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.67137,0.012162,0.019518,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.68418,0.012041,0.0070634,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.5726,0.012039,0.040014,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.91987,0.012015,-0.013353,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.72969,0.011852,0.015393,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.78289,0.011822,-0.022931,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.72969,0.01182,0.057109,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.57857,0.011807,0.023794,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.50337,0.011793,0.043602,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.61497,0.01175,0.027737,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.80312,0.01175,0.009354,0,0
2,GO T CELL HOMEOSTASIS,0.53167,0.011627,-0.058445,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.57857,0.011501,0.020879,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.94073,0.01144,-0.0038807,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.4978,0.011111,0.021609,0,0
2,GO ORGANELLE ASSEMBLY,0.80312,0.011049,-0.0078397,0,0
2,GO CHEMICAL HOMEOSTASIS,0.86455,0.011002,-0.004875,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.75615,0.01098,0.024542,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.97557,0.010968,0.037476,0,0
2,GO SULFATE TRANSPORT,0.55487,0.010757,0.050956,0,0
2,GO MUSCLE CONTRACTION,0.74288,0.010675,-0.022861,0,0
2,GO RESPONSE TO L GLUTAMATE,0.67776,0.01036,0.045009,0,0
2,GO MISMATCH REPAIR,0.7495,0.010326,0.015596,0,0
2,GO REGULATION OF TOR SIGNALING,0.61497,0.010233,-0.021166,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.71658,0.010171,0.021268,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.32506,0.010076,0.13771,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.89215,0.010036,-0.0097549,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.44924,0.010004,0.056128,0,0
2,GO MESODERM MORPHOGENESIS,0.41341,0.0098992,0.063608,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.52594,0.0098922,0.064383,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.87833,0.0098736,-0.016701,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.70355,0.0098523,-0.025832,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.74288,0.0098396,0.009699,0,0
2,GO CELL CYCLE CHECKPOINT,0.22235,0.0098329,0.055913,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.66501,0.0096986,0.050184,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.40349,0.009694,0.077622,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.82348,0.0096727,-0.012382,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.39858,0.0096105,0.028944,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.77618,0.0095893,0.035763,0,0
2,GO CELL DIVISION,0.36526,0.0095324,0.045682,0,0
2,GO GLAND DEVELOPMENT,0.92682,0.0095112,0.018506,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.85768,0.0094649,0.0017085,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33812,0.0094588,0.058016,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.91987,0.009406,-0.010454,0,0
2,GO CHROMOSOME SEGREGATION,0.39371,0.0092842,0.038284,0,0
2,GO HEAT GENERATION,0.68418,0.0092815,0.022541,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.69707,0.00926,0.07722,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.73628,0.0092581,-0.053737,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.72313,0.0091907,-0.019616,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.89215,0.0091848,-0.006986,0,0
2,GO MAGNESIUM ION TRANSPORT,0.63978,0.00906,-0.067355,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.59059,0.0089028,0.053729,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.91293,0.0088526,0.0067403,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.75615,0.0088429,-0.0090987,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.4978,0.00876,0.040308,0,0
2,GO REGULATION OF TISSUE REMODELING,0.80989,0.0086779,0.0023625,0,0
2,GO MITOCHONDRIAL FISSION,0.36991,0.008547,-0.059483,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.79636,0.0084836,-0.013987,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.88523,0.0084633,0.0050016,0,0
2,GO ENDOSOMAL TRANSPORT,0.59059,0.0082531,0.02519,0,0
2,GO PROTEIN OXIDATION,0.69707,0.0082262,0.051567,0,0
2,GO WATER TRANSPORT,0.95466,0.0077279,-0.028291,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.77618,0.0077134,0.023652,0,0
2,GO INOSITOL METABOLIC PROCESS,0.80989,0.0077052,-0.022306,0,0
2,GO CELL CYCLE DNA REPLICATION,0.5726,0.0075946,0.034854,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.53742,0.0075504,0.039163,0,0
2,GO NUCLEUS ORGANIZATION,0.5726,0.0074728,0.011678,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.4598,0.0074041,0.034769,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.74288,0.0073751,0.021727,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.75615,0.0072565,0.010879,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.71658,0.0071937,-0.030661,0,0
2,GO REGULATION OF AXON GUIDANCE,0.76948,0.0071827,-0.053506,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.79636,0.0071708,0.015467,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.52594,0.0071061,0.0050166,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.90599,0.0069861,-0.004411,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.85082,0.0069724,0.0062615,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.68418,0.0069102,-0.031353,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.84397,0.0067318,-0.0030574,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.92682,0.0067243,0.0044902,0,0
2,GO CYTOSKELETON ORGANIZATION,0.63978,0.0066741,0.014277,0,0
2,GO PROTEIN ACETYLATION,0.52594,0.006589,0.024734,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.76948,0.0064927,0.034092,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.89215,0.0064517,-0.015807,0,0
2,GO OVULATION CYCLE PROCESS,0.80989,0.0063019,-0.021438,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.56075,0.0061494,0.024294,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.66501,0.006082,0.031611,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.89907,0.006076,-0.032917,0,0
2,GO BONE RESORPTION,0.85768,0.0060643,-0.010131,0,0
2,GO SODIUM ION HOMEOSTASIS,0.94769,0.0057869,-0.015416,0,0
2,GO KETONE CATABOLIC PROCESS,0.84397,0.005628,0.022782,0,0
2,GO PH REDUCTION,0.93377,0.005601,-0.0081931,0,0
2,GO PROTEIN DENEDDYLATION,0.78962,0.0055024,0.0072892,0,0
2,GO WALKING BEHAVIOR,0.4598,0.0054161,-0.054516,0,0
2,GO DEPHOSPHORYLATION,0.87833,0.0053724,-0.0066831,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.71006,0.0053297,-0.030461,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.91987,0.0051927,0.010535,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.82348,0.0051331,-0.0021245,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.77618,0.0051145,0.0090304,0,0
2,GO HISTONE EXCHANGE,0.83713,0.0049908,0.012825,0,0
2,GO REGULATION OF CELLULAR PH,0.90599,0.0049615,-0.017841,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.95466,0.0049114,-0.0043188,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.76281,0.0049073,0.034467,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.84397,0.0048482,-0.028904,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.5726,0.004383,0.017424,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.94073,0.0043415,0.0062301,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.8303,0.0042569,-0.024802,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.61497,0.0042378,-0.08825,0,0
2,GO IRON ION TRANSPORT,0.78962,0.0041465,0.0021447,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.91293,0.0041299,0.0027496,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.33373,0.00398,0.10037,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.52594,0.0037629,0.028498,0,0
2,GO CELLULAR HOMEOSTASIS,0.74288,0.0037499,0.0051812,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.87833,0.0037383,-0.024991,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.84397,0.0037307,0.052826,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.78289,0.0031905,-0.013152,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.58456,0.003086,0.053702,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.97557,0.0029426,-0.0051277,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.56075,0.0027484,0.036652,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.63978,0.0024382,-0.031982,0,0
2,GO REPRODUCTION,0.72313,0.0021527,-0.013962,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.94073,0.0019425,-0.0018992,0,0
2,GO SENSORY PERCEPTION,0.65234,0.0018956,-0.016888,0,0
2,GO MATING,0.36526,0.0018918,-0.054081,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.82348,0.0018274,0.0095585,0,0
2,GO VIRAL BUDDING,0.97557,0.0016543,0.016957,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.30815,0.0016021,0.062639,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.99651,0.001597,0.0014926,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.87833,0.0015336,0.0040787,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.56075,0.0014938,-0.038684,0,0
2,GO VESICLE ORGANIZATION,0.68418,0.0013084,0.0062369,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.98953,0.0011613,0.0043153,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.82348,0.00116,-0.0097459,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.89215,0.0011231,0.042199,0,0
2,GO EAR DEVELOPMENT,0.77618,0.0010406,0.013661,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.99651,0.00086165,-0.0038053,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.74288,0.00077932,-0.027932,0,0
2,GO GLIAL CELL PROLIFERATION,0.52594,0.00075536,0.036686,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1,0.00058687,0.001803,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.93377,0.00056386,0.10696,0,0
2,GO REGULATION OF PH,0.76281,0.00039771,-0.030528,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.90599,0.00036424,0.021547,0,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.52025,0.00033945,0.066979,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.67776,0.0003183,0.045074,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.75615,0.00026735,0.03115,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.82348,0.00025621,-0.0098244,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.49227,0.00018928,0.040537,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.79636,0.00014742,0.017455,0,0
2,GO TAXIS,0.72313,6.2914e-05,-0.024804,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.95466,1.8455e-05,0.0122,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.87833,-0.00012537,0.0068972,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.70355,-0.00016878,-0.037091,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.37932,-0.00029308,0.052587,0,0
2,GO CARTILAGE DEVELOPMENT,0.9686,-0.00029828,0.0093014,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.98953,-0.00039405,0.021472,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.76281,-0.00056072,0.0034267,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.72313,-0.00059637,-0.050412,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.43367,-0.00059704,-0.040982,0,0
2,GO REGULATION OF CHEMOTAXIS,0.88523,-0.00068344,-0.0020245,0,0
2,GO IMMUNOGLOBULIN SECRETION,0.8303,-0.00077609,-0.052762,0,0
2,GO POSITIVE REGULATION OF BINDING,0.91987,-0.00089924,0.0026498,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.72313,-0.00097177,-0.018705,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.56666,-0.0010306,-0.057381,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.87833,-0.0010726,0.0030977,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.8303,-0.0010925,0.00047146,0,0
2,GO FORELIMB MORPHOGENESIS,0.87833,-0.0011968,-0.031024,0,0
2,GO GLAND MORPHOGENESIS,0.36991,-0.0012119,0.11897,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.89907,-0.0013098,-0.0018572,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.38888,-0.0013866,0.022974,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.69707,-0.0014435,0.064384,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.94073,-0.0014555,-0.014599,0,0
2,GO ION HOMEOSTASIS,0.94769,-0.0014913,-0.0059473,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.97557,-0.0015183,-0.0027313,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.88523,-0.001591,0.0283,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.87833,-0.0016381,0.0038563,0,0
2,GO TOR SIGNALING,0.51459,-0.0016716,-0.021523,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.76281,-0.0016826,-0.013681,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.57857,-0.0017304,0.037301,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.98255,-0.0020826,0.0044694,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.91293,-0.0021085,-0.023585,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.79636,-0.0021736,0.036788,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.54321,-0.0021904,0.033113,0,0
2,GO AMINE METABOLIC PROCESS,0.67137,-0.0022021,0.020501,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.65866,-0.0022196,0.022488,0,0
2,GO CELL CELL SIGNALING BY WNT,0.91293,-0.0022395,0.018842,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.98255,-0.0024613,-0.0048535,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.67137,-0.0024702,0.080555,0,0
2,GO ADAPTIVE THERMOGENESIS,0.54903,-0.0024934,-0.03146,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.25729,-0.0025068,0.04698,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.32506,-0.0026135,-0.035664,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.69707,-0.0027167,0.016843,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.72313,-0.0027333,0.018203,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.96163,-0.0027628,0.007237,0,0
2,GO RRNA CATABOLIC PROCESS,0.94073,-0.0027738,-0.021793,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.59664,-0.0028348,-0.02644,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.94073,-0.0028998,-0.0017574,0,0
2,GO AMYLOID BETA FORMATION,0.51459,-0.0029539,0.035364,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.97557,-0.002971,-0.00084455,0,0
2,GO BIOMINERALIZATION,0.80989,-0.0029999,-0.014685,0,0
2,GO WATER HOMEOSTASIS,0.73628,-0.0031569,-0.029147,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.80312,-0.0032039,0.02597,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.67137,-0.0032594,-0.028665,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.60272,-0.0033201,0.048687,0,0
2,GO ENSHEATHMENT OF NEURONS,0.73628,-0.0033464,-0.026519,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.33812,-0.0033693,-0.058144,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.53167,-0.0035456,0.052798,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.92682,-0.0037123,0.00080376,0,0
2,GO RESPONSE TO GLUCAGON,0.59664,-0.0037547,-0.027582,0,0
2,GO VASODILATION,0.75615,-0.0038696,-0.062143,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.65866,-0.0039272,-0.041717,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.85768,-0.0039392,-0.014985,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.71006,-0.0039408,0.040754,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.79636,-0.0039936,0.013037,0,0
2,GO MANNOSYLATION,0.88523,-0.0042661,0.0064654,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.8303,-0.0043896,0.0090485,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.96163,-0.0044958,-0.048995,0,0
2,GO CELL CYCLE ARREST,0.44924,-0.0046931,0.029086,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.72313,-0.0048028,-0.033319,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.71658,-0.0048601,0.01158,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.52025,-0.0048895,-0.058711,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.46512,-0.0051292,0.088929,0,0
2,GO OXALATE TRANSPORT,0.76281,-0.0052229,-0.018883,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.83713,-0.0052623,-0.016513,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.89907,-0.0054368,0.0028789,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.85082,-0.0054609,0.016751,0,0
2,GO GROWTH,0.5726,-0.0055105,-0.016685,0,0
2,GO SPINDLE LOCALIZATION,0.98255,-0.0055741,-0.0070161,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.91293,-0.0058966,0.015035,0,0
2,GO SECONDARY METABOLIC PROCESS,0.74288,-0.0059259,-2.0443e-05,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.76948,-0.0059273,-0.0076739,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.71658,-0.0060155,0.046057,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.33812,-0.0060251,-0.068516,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.88523,-0.0060664,-0.0074116,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.59059,-0.0061222,0.034564,0,0
2,GO OVULATION CYCLE,0.85082,-0.0061384,-0.02061,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.58456,-0.0065534,-0.07631,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.44402,-0.0065608,-0.026814,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.38408,-0.0065622,0.087586,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.84397,-0.0065923,0.016348,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.87833,-0.0067291,-0.010366,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.88523,-0.0068799,0.010563,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.89907,-0.006896,0.0053878,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.58456,-0.0070655,0.040279,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.89907,-0.0070769,0.0079739,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.98953,-0.0071707,-0.0013146,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.81668,-0.0071842,-0.012407,0,0
2,GO LACTATE METABOLIC PROCESS,0.63354,-0.0072825,0.037983,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.63978,-0.0073265,-0.036832,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.5726,-0.007482,-0.029554,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.27999,-0.0076264,-0.11404,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.92682,-0.0076962,-0.01278,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.87144,-0.0077009,-0.011609,0,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.53167,-0.0078082,0.051855,0,0
2,GO NOTCH SIGNALING PATHWAY,0.38408,-0.0078258,-0.046534,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76948,-0.0078298,0.010051,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.96163,-0.0078352,-0.00023404,0,0
2,GO BONE TRABECULA FORMATION,0.57857,-0.0080774,0.09708,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.98255,-0.0081972,0.028712,0,0
2,GO MEMBRANE FUSION,0.42855,-0.0085795,-0.041218,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.78289,-0.0086888,-0.005884,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.91987,-0.008701,0.0071416,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.71658,-0.0088635,-0.026352,0,0
2,GO AXIS SPECIFICATION,0.98953,-0.009185,1.2987e-05,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.77618,-0.0093159,-0.017755,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.43367,-0.0093751,-0.11005,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.98255,-0.0093771,0.009943,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.84397,-0.0094787,0.0093582,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.42855,-0.0095387,-0.054569,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.69707,-0.0095574,-0.035775,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.42855,-0.0098818,0.054415,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.96163,-0.0099162,-0.0044856,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.79636,-0.010054,-0.019376,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.89907,-0.010102,-0.03043,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.89907,-0.010147,-0.0043319,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.59664,-0.010295,-0.021603,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.84397,-0.010349,0.0039356,0,0
2,GO VACUOLAR TRANSPORT,0.88523,-0.010383,0.0044945,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.81668,-0.010426,0.036238,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.91293,-0.010513,-0.017921,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.58456,-0.01057,-0.024469,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.97557,-0.010601,0.0074659,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.70355,-0.010632,-0.040248,0,0
2,GO DNA REPLICATION,0.7495,-0.010667,0.040908,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.91293,-0.010719,-0.0032229,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.27611,-0.010776,-0.048037,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.70355,-0.010863,0.017354,0,0
2,GO SOMITOGENESIS,0.98953,-0.010913,0.0086586,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.69061,-0.010932,-0.030905,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.36064,-0.010969,-0.034786,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.80312,-0.011023,-0.015826,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.56666,-0.011113,-0.027263,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.87144,-0.011281,-0.0051471,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.60883,-0.011285,-0.031787,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.88523,-0.011296,0.0051333,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.59059,-0.011298,-0.033658,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.89907,-0.011358,-0.0093428,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.8303,-0.011383,-0.022394,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.91987,-0.011455,0.015282,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.011487,-0.024704,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.94769,-0.011568,-0.006151,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.65234,-0.011633,0.026623,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.73628,-0.011654,-0.014688,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.47049,-0.011714,-0.036674,0,0
2,GO DNA DEALKYLATION,0.64605,-0.011793,0.032167,0,0
2,GO EXCRETION,0.82348,-0.011851,0.008984,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.96163,-0.011859,0.00021095,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.84397,-0.01189,0.008715,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.54903,-0.011947,-0.050972,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.96163,-0.012099,0.010214,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.76948,-0.012111,-0.017649,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.96163,-0.012247,0.020975,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.77618,-0.012366,0.021347,0,0
2,GO REGULATION OF BONE REMODELING,0.82348,-0.012425,-0.042416,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.78962,-0.012555,-0.023784,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.72313,-0.012921,-0.016024,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.76948,-0.012923,-0.02426,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.65234,-0.013032,-0.025508,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.59059,-0.013042,-0.049284,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.87833,-0.013235,0.028008,0,0
2,GO MIDBODY ABSCISSION,0.9686,-0.013379,0.036093,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.89215,-0.01347,0.014831,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.95466,-0.013559,0.0061666,0,0
2,GO CELL JUNCTION ASSEMBLY,0.70355,-0.013663,-0.016974,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.39371,-0.013666,-0.03591,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.58456,-0.013689,-0.026542,0,0
2,GO METAL ION HOMEOSTASIS,0.86455,-0.013714,-0.0040677,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.9686,-0.013829,0.028536,0,0
2,GO RESPONSE TO LEUCINE,0.63978,-0.013848,-0.057766,0,0
2,GO REGULATION OF ODONTOGENESIS,0.94769,-0.013859,-0.021025,0,0
2,GO ORGANELLE FISSION,0.80989,-0.013953,0.00059308,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.98255,-0.014185,0.002911,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.78962,-0.014215,0.011186,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.59059,-0.014293,-0.069135,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.98953,-0.014308,0.091397,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.44402,-0.014545,0.16305,0,0
2,GO OOGENESIS,0.63978,-0.01462,-0.036198,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.98953,-0.014844,0.00022346,0,0
2,GO METAPHASE PLATE CONGRESSION,0.7495,-0.0149,0.029571,0,0
2,GO CENTROSOME DUPLICATION,0.52025,-0.015034,-0.0093029,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.78962,-0.015331,-0.030094,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.87833,-0.015427,-0.043867,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.86455,-0.015443,0.015143,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.67776,-0.015606,0.0016209,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.82348,-0.015717,-0.0019405,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.36064,-0.015822,-0.028301,0,0
2,GO RESPONSE TO STARVATION,0.76948,-0.015825,-0.021181,0,0
2,GO FUCOSE METABOLIC PROCESS,0.4978,-0.015903,0.046013,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.86455,-0.015928,-0.0080455,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.51459,-0.015996,-0.03295,0,0
2,GO VESICLE LOCALIZATION,0.83713,-0.016024,-0.018983,0,0
2,GO MULTI ORGANISM PROCESS,0.43367,-0.016092,-0.027922,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.20309,-0.016125,-0.055509,0,0
2,GO AMELOGENESIS,0.17099,-0.016261,0.16302,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.67137,-0.016512,9.9475e-05,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.5726,-0.016694,-0.015029,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.68418,-0.017019,-0.010342,0,0
2,GO INTEGRIN ACTIVATION,0.87833,-0.017089,-0.0030735,0,0
2,GO ORGANELLE FUSION,0.62732,-0.017171,-0.026173,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.63354,-0.017183,0.03977,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.98953,-0.017205,-0.019084,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.85768,-0.017257,-0.0096711,0,0
2,GO T CELL SELECTION,0.87144,-0.017361,0.0047008,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.98953,-0.017592,0.020635,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.26847,-0.017631,-0.047189,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.4545,-0.017693,-0.12573,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.89215,-0.017717,0.0047196,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.72313,-0.017801,-0.051456,0,0
2,GO LYSOSOME LOCALIZATION,0.97557,-0.018245,-0.0037694,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.75615,-0.018273,-0.014383,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.36526,-0.018484,-0.047006,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.64605,-0.018594,0.024563,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.76281,-0.01881,-0.098425,0,0
2,GO HEART GROWTH,1,-0.01894,0.01549,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.76281,-0.019128,-0.018297,0,0
2,GO MICROTUBULE ANCHORING,0.47588,-0.019147,-0.035487,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,1,-0.019162,0.032099,0,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1,-0.019299,-0.00031802,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.65866,-0.019308,0.056119,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.71658,-0.01932,-0.012586,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.5726,-0.01936,-0.042953,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.17653,-0.019374,-0.084506,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.85082,-0.019467,-0.023315,0,0
2,GO TISSUE MORPHOGENESIS,0.71658,-0.019739,0.03387,0,0
2,GO OSSIFICATION,0.66501,-0.019761,-0.015105,0,0
2,GO SHORT TERM MEMORY,0.77618,-0.019992,0.020355,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.77618,-0.020032,-0.0093307,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.42347,-0.020034,-0.0493,0,0
2,GO REGULATION OF TRANSPORT,0.21579,-0.020034,-0.044335,0,0
2,GO RESPONSE TO FOOD,0.18219,-0.020137,-0.065747,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.60272,-0.020255,0.032877,0,0
2,GO HEART DEVELOPMENT,0.96163,-0.020326,0.011576,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.74288,-0.020533,-0.025706,0,0
2,GO REGULATION OF CELL DIVISION,0.81668,-0.020543,0.0028317,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.88523,-0.020632,0.0080921,0,0
2,GO SOMITE DEVELOPMENT,0.24643,-0.021163,-0.03564,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.63354,-0.021189,-0.044895,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.16294,-0.021193,-0.060615,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.39858,-0.021416,-0.070684,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.69707,-0.021563,0.038531,0,0
2,GO HISTONE H3 K36 METHYLATION,0.76281,-0.021667,0.041624,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.50337,-0.021679,0.069387,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,-0.021683,-0.0040034,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.85082,-0.021896,0.030312,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.95466,-0.022045,-0.014615,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.89907,-0.0221,0.012742,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.80312,-0.022194,-0.014232,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.26098,-0.022207,-0.071443,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.56666,-0.022296,0.00097749,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.4545,-0.022392,-0.025868,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.49227,-0.022409,-0.049302,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.71658,-0.022526,-0.061517,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.40843,-0.022631,-0.031686,0,0
2,GO KINETOCHORE ASSEMBLY,0.63354,-0.022648,-0.024484,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.9686,-0.022757,0.012039,0,0
2,GO REGULATION OF BINDING,0.62113,-0.022959,-0.014841,0,0
2,GO DETECTION OF STIMULUS,0.55487,-0.0231,-0.016357,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.80312,-0.023271,-0.016593,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.34702,-0.023286,-0.046481,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.42855,-0.023339,-0.046163,0,0
2,GO MITOPHAGY,0.86455,-0.023514,-0.0090201,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.94073,-0.02364,-0.014966,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.37932,-0.0239,-0.0738,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.66501,-0.023993,-0.085396,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.81668,-0.024007,0.006539,0,0
2,GO GAMETE GENERATION,0.28785,-0.024278,-0.037436,0,0
2,GO SEXUAL REPRODUCTION,0.26847,-0.024443,-0.03858,0,0
2,GO PROTEIN FOLDING,0.94073,-0.024472,0.0025148,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.93377,-0.024573,-0.020054,0,0
2,GO GLIAL CELL MIGRATION,0.76948,-0.024752,-0.025941,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.91987,-0.025332,0.013851,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.52594,-0.025364,-0.025083,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.8303,-0.02539,-0.0075711,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.84397,-0.025424,0.016235,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.97557,-0.025741,-0.016785,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.92682,-0.02576,0.01655,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.41842,-0.025802,-0.020666,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.46512,-0.026013,-0.026384,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.59664,-0.026051,-0.048228,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.72969,-0.026141,-0.013437,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.87833,-0.02615,0.0052452,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.74288,-0.026299,-0.0089633,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.33812,-0.026483,-0.037923,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.39371,-0.026505,-0.056251,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.71658,-0.026529,-0.0034536,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.36526,-0.026618,0.049572,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.62113,-0.026708,0.056237,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.9686,-0.026846,0.0022645,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.38888,-0.026921,-0.033704,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.91987,-0.026986,-0.0020084,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.95466,-0.026993,0.0027768,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.36526,-0.027009,-0.15265,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.91987,-0.027315,0.01477,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.72969,-0.027356,-0.013964,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.58456,-0.027524,-0.00014057,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.95466,-0.027679,0.010391,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.31232,-0.027695,-0.045453,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.42855,-0.027783,-0.02595,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.76948,-0.027953,-0.02756,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.53167,-0.028121,-0.089281,0,0
2,GO ORGANIC ANION TRANSPORT,0.87144,-0.028141,-0.0037958,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.85082,-0.028252,0.017435,0,0
2,GO HISTONE H3 K9 METHYLATION,0.85082,-0.028265,0.0062881,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.58456,-0.028513,-0.020902,0,0
2,GO SNORNA METABOLIC PROCESS,0.86455,-0.02859,-0.015164,0,0
2,GO GLUCOSE IMPORT,0.13814,-0.02869,-0.070984,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.32938,-0.0287,0.099575,0,0
2,GO MIDBRAIN DEVELOPMENT,0.92682,-0.028785,0.046084,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.36991,-0.028859,-0.038214,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.41341,-0.028914,-0.050075,0,0
2,GO REGULATION OF CELL SIZE,0.14048,-0.02905,-0.07173,0,0
2,GO HEART TRABECULA FORMATION,0.56075,-0.029148,-0.070081,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.24643,-0.029197,0.043572,0,0
2,GO OOCYTE MATURATION,0.54321,-0.029201,-0.049253,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.26098,-0.029376,-0.053581,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.58456,-0.029458,-0.020593,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.50896,-0.029691,-0.07775,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.4978,-0.029884,0.13171,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.38408,-0.029942,-0.026644,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.63978,-0.029948,-0.010646,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.53742,-0.030015,-0.0065412,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.65234,-0.030076,-0.024977,0,0
2,GO MALE GAMETE GENERATION,0.26847,-0.030132,-0.039988,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.22905,-0.030148,-0.14243,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.64605,-0.03028,-0.011078,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.62113,-0.030451,-0.024901,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.15773,-0.030462,-0.064731,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.74288,-0.030539,-0.0412,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.87833,-0.030543,-0.0088713,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.61497,-0.030586,-0.013107,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.95466,-0.030716,0.032102,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.23245,-0.030805,-0.027262,0,0
2,GO INORGANIC ANION TRANSPORT,0.35153,-0.030947,-0.031482,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.2839,-0.031143,-0.063615,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.95466,-0.031616,-0.01396,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.46512,-0.031751,-0.047314,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.69707,-0.032064,-0.027486,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.7495,-0.032305,-0.045568,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.52594,-0.032955,-0.10194,0,0
2,GO ANION TRANSPORT,0.66501,-0.033115,-0.01571,0,0
2,GO RENAL WATER HOMEOSTASIS,0.4978,-0.03376,-0.038089,0,0
2,GO ACID SECRETION,0.63978,-0.033773,-0.014139,0,0
2,GO AORTA DEVELOPMENT,0.62732,-0.033787,-0.0197,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.27999,-0.033875,-0.052183,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.26098,-0.033978,-0.040893,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.61497,-0.03421,-0.028086,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.2839,-0.034363,-0.069568,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.10845,-0.034452,-0.076053,0,0
2,GO ENDOCYTIC RECYCLING,0.53742,-0.034465,-0.025211,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.87144,-0.034617,-0.0012699,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.76281,-0.034838,0.058907,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.80989,-0.035077,0.0064644,0,0
2,GO VASCULAR WOUND HEALING,0.68418,-0.03512,-0.047522,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.35607,-0.035191,-0.068666,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.85768,-0.035198,-0.12188,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.86455,-0.035362,-0.011997,0,0
2,GO REGULATION OF GROWTH,0.29184,-0.035374,-0.034842,0,0
2,GO FUCOSYLATION,1,-0.035418,-0.0056255,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.9686,-0.035452,0.034349,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.23937,-0.035528,-0.055804,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.81668,-0.035558,-0.00021331,0,0
2,GO RESPONSE TO PAIN,0.51459,-0.035642,-0.072615,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.69061,-0.035756,0.032522,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.36064,-0.035853,-0.077823,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.38408,-0.035927,-0.11027,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.90599,-0.035976,0.013261,0,0
2,GO CYTOKINESIS,0.60883,-0.036034,-0.010199,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.41842,-0.03607,-0.041351,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.5726,-0.036082,-0.022996,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.46512,-0.036477,-0.026513,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.27227,-0.036518,-0.059104,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.79636,-0.036618,0.093057,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.33373,-0.036764,-0.08679,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.54321,-0.036963,-0.047315,0,0
2,GO CELL JUNCTION ORGANIZATION,0.17934,-0.037074,-0.062279,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.30402,-0.037264,-0.062774,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.46512,-0.037369,-0.091547,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.98953,-0.037387,0.01358,0,0
2,GO CELL PROJECTION ASSEMBLY,0.33373,-0.037516,-0.022587,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.62113,-0.037564,-0.014106,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.78289,-0.037755,0.032919,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.61497,-0.037975,-0.032724,0,0
2,GO REGULATION OF PINOCYTOSIS,0.63354,-0.038108,0.044776,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.3746,-0.038253,-0.046474,0,0
2,GO PROTEIN METHYLATION,0.27611,-0.038343,-0.0080718,0,0
2,GO DEVELOPMENTAL GROWTH,0.30402,-0.038458,-0.033293,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.59664,-0.038478,-0.053823,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.13583,-0.038544,-0.04613,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.8303,-0.038612,0.0083334,0,0
2,GO REGULATION OF CYTOKINESIS,0.53742,-0.038623,-0.020439,0,0
2,GO PHOSPHATE ION TRANSPORT,0.31232,-0.03872,-0.047115,0,0
2,GO POSITIVE T CELL SELECTION,0.7495,-0.038726,-9.7204e-06,0,0
2,GO VASCULAR TRANSPORT,0.92682,-0.038771,-0.010297,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.31653,-0.038901,-0.063993,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.73628,-0.039334,-0.011981,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.47049,-0.039905,-0.042693,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.087232,-0.040181,-0.060754,0,0
2,GO REGULATION OF EXCRETION,0.72313,-0.040283,0.06041,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.9686,-0.040353,0.014672,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.22568,-0.040423,-0.084093,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.93377,-0.040449,-0.0032401,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.71658,-0.040471,-0.013124,0,0
2,GO HISTONE METHYLATION,0.48131,-0.040562,-0.0028625,0,0
2,GO MEIOTIC CELL CYCLE,0.095625,-0.040567,-0.041578,0,0
2,GO ZINC ION TRANSPORT,0.76281,-0.04059,0.019141,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.40843,-0.040909,-0.064698,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.11235,-0.041019,-0.053328,0,0
2,GO DNA CATABOLIC PROCESS,0.39858,-0.041351,-0.035638,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.47588,-0.041353,-0.040267,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.59059,-0.041376,-0.052631,0,0
2,GO CHROMOSOME LOCALIZATION,0.38408,-0.041405,-0.015596,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.44924,-0.041419,-0.044605,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.66501,-0.041442,-0.064975,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.94769,-0.041505,-0.0027582,0,0
2,GO REGULATION OF TUBE SIZE,0.13355,-0.041671,-0.07919,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.8303,-0.041691,-0.0098863,0,0
2,GO PROSTAGLANDIN SECRETION,0.91293,-0.041734,0.0039218,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.93377,-0.042096,-0.037719,0,0
2,GO CENTROSOME SEPARATION,0.54903,-0.042115,-0.016338,0,0
2,GO RESPONSE TO INTERLEUKIN 6,0.23245,-0.042278,-0.078595,0,0
2,GO REGULATION OF OSSIFICATION,0.94073,-0.042528,0.024121,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.72969,-0.042759,-0.032082,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.43367,-0.042777,-0.065802,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.52594,-0.042794,0.034217,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.48678,-0.042899,-0.041009,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.18508,-0.042901,-0.03755,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.23245,-0.043006,-0.074609,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.85768,-0.043017,0.02078,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.44924,-0.043113,-0.039185,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.21905,-0.043124,-0.038631,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.21579,-0.043126,-0.066544,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.91293,-0.043553,0.061676,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.44402,-0.04377,-0.062866,0,0
2,GO ASTROCYTE ACTIVATION,0.63978,-0.043899,-0.030368,0,0
2,GO VITAMIN TRANSPORT,0.64605,-0.043911,-0.008399,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.9686,-0.043957,0.037473,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.89215,-0.044064,0.031097,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.079444,-0.044238,-0.048435,0,0
2,GO T CELL EXTRAVASATION,0.64605,-0.044242,-0.075127,0,0
2,GO NUCLEOTIDE TRANSPORT,0.21256,-0.044327,-0.076097,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.43883,-0.044329,-0.011793,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40843,-0.044442,-0.066447,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.36526,-0.044455,-0.019908,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.22568,-0.044473,-0.043817,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.31232,-0.044665,-0.10835,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.51459,-0.044861,-0.073885,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.21579,-0.044977,-0.036125,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.69707,-0.045278,0.064034,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.4545,-0.045397,-0.020003,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.48131,-0.045435,-0.095853,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.33373,-0.045543,-0.043934,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.72969,-0.0456,-0.051668,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.25729,-0.045638,-0.049157,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.42855,-0.045924,-0.055066,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.22235,-0.045987,-0.065267,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.80989,-0.046029,0.035084,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.78289,-0.046144,0.015188,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.85768,-0.046435,-0.019542,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.35607,-0.046786,-0.038609,0,0
2,GO SULFATION,0.5726,-0.046986,0.018196,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.25363,-0.047016,-0.043905,0,0
2,GO TRABECULA MORPHOGENESIS,0.95466,-0.047126,0.022908,0,0
2,GO DRUG METABOLIC PROCESS,0.78962,-0.047336,0.015121,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.59664,-0.047347,-0.029478,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20621,-0.047515,-0.060449,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.31232,-0.047807,-0.14525,0,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.31653,-0.04812,-0.093822,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.74288,-0.048221,-0.031974,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.55487,-0.048293,-0.06501,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.38408,-0.048366,-0.019921,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.46512,-0.048599,-0.032635,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.23937,-0.048606,-0.046691,0,0
2,GO ORGANIC ACID TRANSPORT,0.4598,-0.04865,-0.017585,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.065563,-0.048836,-0.096684,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.72969,-0.048882,-0.020977,0,0
2,GO REGULATION OF VASCULOGENESIS,0.37932,-0.048933,-0.097995,0,0
2,GO ONE CARBON COMPOUND TRANSPORT,0.72313,-0.049393,0.046123,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.41341,-0.049428,-0.055265,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.98953,-0.049444,0.064661,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.72969,-0.049484,-0.0012847,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.47588,-0.04952,-0.049253,0,0
2,GO HISTONE H4 ACETYLATION,0.39371,-0.049613,-0.020019,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.26847,-0.049927,-0.069337,0,0
2,GO ORGANELLE LOCALIZATION,0.22568,-0.050186,-0.029873,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.51459,-0.050322,-0.043136,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.11434,-0.050329,-0.070378,0,0
2,GO EYE MORPHOGENESIS,0.71658,-0.050436,-0.010371,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.60272,-0.050598,-0.043531,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.17099,-0.050746,-0.046507,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.39371,-0.050782,-0.088637,0,0
2,GO RHYTHMIC PROCESS,0.26471,-0.050802,-0.032595,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.15015,-0.050831,-0.1095,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.2,-0.051029,-0.14215,0,0
2,GO MICROTUBULE BASED PROCESS,0.022165,-0.051252,-0.064916,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.11434,-0.051253,-0.15515,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.99651,-0.051278,-0.0074236,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.22568,-0.051408,-0.03978,0,0
2,GO BONE CELL DEVELOPMENT,0.60883,-0.051431,-0.017881,0,0
2,GO NEURON APOPTOTIC PROCESS,0.090515,-0.051539,-0.054554,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.65234,-0.051598,-0.02741,0,0
2,GO HEART MORPHOGENESIS,0.82348,-0.051725,0.0082847,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.86455,-0.052147,-0.012337,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.71006,-0.052262,-0.029372,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.72313,-0.052279,-0.032658,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.25363,-0.052366,-0.068526,0,0
2,GO GENETIC IMPRINTING,0.47588,-0.052394,-0.042353,0,0
2,GO MESENCHYME DEVELOPMENT,0.68418,-0.052527,0.0084847,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.26098,-0.052602,-0.07102,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.063042,-0.052647,-0.18424,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.67776,-0.052956,-0.000308,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.84397,-0.05297,0.017507,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.19393,-0.05302,-0.067996,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.95466,-0.053109,0.064628,0,0
2,GO REGULATION OF MITOPHAGY,0.21256,-0.053177,-0.060991,0,0
2,GO RESPONSE TO REDOX STATE,0.98953,-0.053199,-0.017689,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.85768,-0.053201,0.067541,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.82348,-0.053277,-0.010364,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.56666,-0.053301,-0.052062,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.087232,-0.053536,-0.081352,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.22905,-0.054231,-0.084796,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.47049,-0.054518,-0.013404,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.53742,-0.05466,-0.016985,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.49227,-0.054766,-0.045024,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.12473,-0.054853,-0.14175,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.30815,-0.054965,-0.13053,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.32506,-0.05523,-0.077225,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.33373,-0.055265,-0.087901,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.82348,-0.055324,0.026021,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.18508,-0.05535,-0.031325,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.010773,-0.055575,-0.078245,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.49227,-0.055629,-0.028897,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.85082,-0.055773,0.04983,0,0
2,GO RHYTHMIC BEHAVIOR,0.28785,-0.055791,-0.058893,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.40349,-0.055891,-0.048092,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.095625,-0.05593,-0.050506,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.20937,-0.056098,-0.084387,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.41341,-0.056256,-0.004091,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.32938,-0.056319,-0.064915,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.87833,-0.056386,-0.04041,0,0
2,GO THYMIC T CELL SELECTION,0.35153,-0.056415,-0.034688,0,0
2,GO REGULATION OF BEHAVIOR,0.34256,-0.056445,-0.048972,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.44924,-0.056445,-0.059471,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.98953,-0.056627,-0.0020032,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.54903,-0.056738,-0.014405,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.72969,-0.056738,-0.026157,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.77618,-0.056997,0.039936,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.33373,-0.057029,-0.064355,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.68418,-0.057132,-0.024346,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.99651,-0.057243,0.0056578,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.093897,-0.057306,-0.063062,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.26847,-0.057378,-0.025327,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.087232,-0.057401,-0.085223,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.11235,-0.057844,-0.058791,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.19095,-0.058063,-0.11712,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.31232,-0.058116,-0.083821,0,0
2,GO CARBOHYDRATE TRANSPORT,0.13583,-0.058121,-0.070379,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.89215,-0.058394,0.0092809,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.57857,-0.058668,0.00423,0,0
2,GO RESPONSE TO METAL ION,0.26847,-0.058676,-0.049653,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.20937,-0.058759,-0.067843,0,0
2,GO CELL FATE COMMITMENT,0.15773,-0.058795,-0.05904,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.090515,-0.058893,-0.10655,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.81668,-0.05919,-0.00083678,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.32938,-0.059263,-0.073786,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.18508,-0.059266,-0.097543,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.59059,-0.059657,-0.041606,0,0
2,GO RESPONSE TO AMPHETAMINE,0.51459,-0.059932,-0.034617,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.99651,-0.060124,0.0029968,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.15517,-0.060165,-0.075885,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.69707,-0.060185,0.033631,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.32506,-0.06033,-0.068785,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4978,-0.060357,-0.024197,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.50896,-0.060604,-0.033191,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.56075,-0.060615,-0.044859,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.25001,-0.060697,-0.055959,0,0
2,GO GLIOGENESIS,0.20937,-0.060827,-0.058978,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.13583,-0.060883,-0.097349,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.11235,-0.060924,-0.11574,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.23245,-0.061064,-0.047249,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.073629,-0.06125,-0.013978,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.89215,-0.061412,0.055096,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.12908,-0.061435,-0.10799,0,0
2,GO SEGMENT SPECIFICATION,0.36526,-0.061625,-0.091425,0,0
2,GO LYSOSOMAL TRANSPORT,0.7495,-0.061674,-0.014669,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.29184,-0.061806,-0.036513,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.76281,-0.061857,-0.045413,0,0
2,GO REGULATION OF HORMONE LEVELS,0.188,-0.061874,-0.060799,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.064293,-0.061962,-0.079133,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.89215,-0.062097,0.014146,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.37932,-0.062197,-0.025281,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.50896,-0.062227,-0.040126,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.16559,-0.062234,-0.059356,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.53167,-0.062237,-0.032079,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.4598,-0.062635,-0.023972,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.73628,-0.062895,0.064902,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.69707,-0.062914,-0.012719,0,0
2,GO HISTONE H3 K27 METHYLATION,0.34256,-0.0632,-0.038491,0,0
2,GO SLEEP,0.69061,-0.063328,0.005272,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.13355,-0.063335,-0.067574,0,0
2,GO MEMBRANE REPOLARIZATION,0.1313,-0.063438,-0.10407,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.031748,-0.063511,-0.059013,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.60272,-0.063727,-0.019814,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.36991,-0.063827,-0.069585,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.60272,-0.063839,-0.05088,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,1,-0.063886,0.016312,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.29586,-0.063894,-0.040709,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.16294,-0.063912,-0.10677,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.75615,-0.063948,-0.02357,0,0
2,GO DEMETHYLATION,0.43367,-0.064005,-0.01497,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23589,-0.064231,-0.060601,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.2839,-0.064239,-0.10486,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.88523,-0.064419,-0.036031,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.81668,-0.064456,-0.016517,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.11434,-0.064583,-0.11656,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.2839,-0.064641,-0.045622,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.075049,-0.065407,-0.064969,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.62732,-0.065427,-0.0078982,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.1028,-0.065429,-0.055874,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.21579,-0.065554,-0.070829,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.29586,-0.066348,-0.040096,0,0
2,GO ION TRANSPORT,0.099158,-0.066432,-0.057574,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.015953,-0.066456,-0.10693,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.50337,-0.066576,-0.023972,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.13814,-0.066579,-0.094896,0,0
2,GO SNORNA 3 END PROCESSING,0.48131,-0.0667,-0.061327,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.19095,-0.066803,-0.051865,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.58456,-0.066982,-0.029499,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.40349,-0.067076,-0.042411,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.11636,-0.067122,-0.059899,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.21579,-0.067209,-0.10196,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.25363,-0.067372,-0.086467,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.27227,-0.067376,-0.063143,0,0
2,GO RESPONSE TO COLD,0.05824,-0.067722,-0.17604,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.97557,-0.068004,0.0038735,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.70355,-0.068197,0.0039817,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.33373,-0.068277,-0.032062,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.0695,-0.06839,-0.10995,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.79636,-0.068403,0.0023372,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.29992,-0.068459,-0.03458,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.80989,-0.069164,-0.012833,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.24288,-0.069299,-0.046934,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.33812,-0.069373,-0.033491,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.7495,-0.069818,0.07963,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.55487,-0.070029,-0.039567,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.15015,-0.070104,-0.1102,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.13355,-0.070246,-0.098535,0,0
2,GO STEROID HORMONE SECRETION,0.98953,-0.070397,-0.023594,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.19095,-0.070428,-0.071238,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.20621,-0.070565,-0.079939,0,0
2,GO HEART VALVE DEVELOPMENT,0.58456,-0.070739,-0.029514,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.1313,-0.070935,-0.073739,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.79636,-0.071229,0.02707,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.17099,-0.07136,-0.097154,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.32938,-0.071396,-0.055229,0,0
2,GO DIET INDUCED THERMOGENESIS,0.12908,-0.071429,-0.13198,0,0
2,GO RECEPTOR CLUSTERING,0.21579,-0.071505,-0.10225,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.50896,-0.071639,-0.010929,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.99651,-0.071646,0.042389,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.011612,-0.071705,-0.13161,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.39371,-0.071749,-0.038725,0,0
2,GO ODONTOGENESIS,0.97557,-0.071949,0.022468,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.24643,-0.072084,-0.11824,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.19695,-0.072111,-0.070293,0,0
2,GO PANCREAS DEVELOPMENT,0.47049,-0.072176,-0.0357,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.12689,-0.072244,-0.073364,0,0
2,GO CELL JUNCTION MAINTENANCE,0.40843,-0.072356,-0.042054,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.44924,-0.072378,-0.012235,0,0
2,GO RESPONSE TO FORSKOLIN,0.35153,-0.072381,-0.13813,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.80989,-0.072472,0.041786,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.12908,-0.072766,-0.11958,0,0
2,GO REGULATION OF ANION TRANSPORT,0.11434,-0.072769,-0.088328,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.035393,-0.072864,-0.11203,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.39858,-0.07289,-0.019567,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.0067808,-0.073036,-0.11756,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.26471,-0.073121,-0.09997,0,0
2,GO PROTEIN DEMETHYLATION,0.76281,-0.073123,-0.0082881,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.9686,-0.073175,0.0022449,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.57857,-0.073347,-0.005607,0,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.44402,-0.073465,-0.057385,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.56075,-0.073562,-0.010615,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.4545,-0.073666,-0.05009,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.98255,-0.073864,0.054342,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.72969,-0.073952,0.0042436,0,0
2,GO T CELL LINEAGE COMMITMENT,0.76948,-0.074005,0.015368,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.87144,-0.074126,0.0068299,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.49227,-0.074484,-0.016629,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.12049,-0.074542,-0.069182,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.40349,-0.07458,-0.04181,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.54321,-0.07459,-0.024109,0,0
2,GO ECTODERM DEVELOPMENT,0.12259,-0.074657,-0.051655,0,0
2,GO PROTEIN MANNOSYLATION,0.28785,-0.074832,-0.066359,0,0
2,GO RESPONSE TO HYDROXYUREA,0.91293,-0.075051,0.026236,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.31232,-0.075392,-0.055371,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.27227,-0.075503,-0.054488,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.87833,-0.075606,-0.0086654,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.36064,-0.075694,-0.11124,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.080955,-0.076127,-0.087841,0,0
2,GO CELL RECOGNITION,0.068167,-0.076332,-0.079491,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.21256,-0.076383,-0.05364,0,0
2,GO STEM CELL PROLIFERATION,0.71006,-0.076459,-0.010431,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.36991,-0.076593,-0.043299,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.67137,-0.077137,-0.0087186,0,0
2,GO BONE MATURATION,0.23245,-0.077311,-0.080771,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.27611,-0.077435,-0.058174,0,0
2,GO NUCLEOSOME ASSEMBLY,0.15264,-0.077522,-0.043279,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.56666,-0.077686,-0.0051062,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.89907,-0.077937,0.022457,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.29184,-0.078094,-0.1796,0,0
2,GO HISTONE H3 K4 METHYLATION,0.78962,-0.078417,0.019897,0,0
2,GO RESPONSE TO BMP,0.25363,-0.078794,-0.033804,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.30402,-0.079454,-0.040451,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.05824,-0.079628,-0.098131,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.82348,-0.079878,0.028623,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.15773,-0.080014,-0.059344,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.23245,-0.080084,-0.10693,0,0
2,GO MICROTUBULE POLYMERIZATION,0.12049,-0.080307,-0.10055,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.52025,-0.080309,-0.055825,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.52594,-0.08032,-0.03684,0,0
2,GO CELLULAR ANION HOMEOSTASIS,0.50337,-0.08037,-0.021891,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.14285,-0.080522,-0.09474,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.097379,-0.080884,-0.11402,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4598,-0.08095,-0.04505,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.50896,-0.081153,-0.040243,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.16294,-0.081179,-0.061797,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.58456,-0.081193,-0.03291,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.10465,-0.081427,-0.081287,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.5726,-0.081803,-0.050244,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.28785,-0.082087,-0.066249,0,0
2,GO AXON EXTENSION,0.01282,-0.08211,-0.15953,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.17934,-0.082134,-0.057602,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.15773,-0.082405,0.05873,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.35607,-0.082541,-0.06777,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.088862,-0.082657,-0.1399,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.10845,-0.082762,-0.052332,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.25363,-0.083035,-0.061169,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.8303,-0.083239,-0.012646,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.12689,-0.083294,-0.10674,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.4598,-0.083486,-0.052829,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.48678,-0.083504,-0.025853,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.50896,-0.08362,-0.059529,0,0
2,GO TRANSFERRIN TRANSPORT,0.063042,-0.083863,-0.11041,0,0
2,GO AMINO ACID IMPORT,0.63354,-0.083922,0.018102,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.10465,-0.084116,-0.079904,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.4545,-0.084333,-0.068777,0,0
2,GO DOSAGE COMPENSATION,0.31232,-0.084426,0.0052337,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.71658,-0.084473,-0.029654,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.054842,-0.085285,-0.078652,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.56666,-0.085701,-0.0020953,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.16294,-0.085779,-0.049638,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.099158,-0.085879,-0.094679,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.30815,-0.086002,-0.046272,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.097379,-0.086113,-0.090619,0,0
2,GO HEPARIN METABOLIC PROCESS,0.76281,-0.086115,0.0031747,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.24288,-0.08625,-0.12657,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.78962,-0.08632,-0.04243,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.31653,-0.086833,-0.039914,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.81668,-0.087032,0.036815,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.036948,-0.08713,-0.10318,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.15264,-0.08734,-0.057935,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.4598,-0.087612,-0.041122,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.63978,-0.087694,-0.043043,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.090515,-0.088046,-0.13276,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.75615,-0.088121,0.017645,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.50896,-0.088139,-0.027352,0,0
2,GO AXO DENDRITIC TRANSPORT,0.016734,-0.08822,-0.10836,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.068167,-0.088323,-0.10719,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.099158,-0.08841,-0.072969,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.29992,-0.088442,-0.080892,0,0
2,GO DNA DEMETHYLATION,0.10845,-0.088479,-0.074689,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.19095,-0.088728,-0.078426,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.0011549,-0.088785,-0.10941,0,0
2,GO RESPONSE TO CAMP,0.095625,-0.089059,-0.087935,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.60272,-0.089122,-0.074893,0,0
2,GO NEURON PROJECTION GUIDANCE,0.015203,-0.089162,-0.15271,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.61497,-0.089206,-0.01618,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.36526,-0.089357,-0.053387,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.41341,-0.089375,-0.11296,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.4598,-0.089807,-0.090348,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0060989,-0.08995,-0.10948,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.21256,-0.090005,-0.041903,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.15517,-0.090186,-0.15367,0,0
2,GO AXON DEVELOPMENT,0.0071468,-0.090403,-0.15315,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.20309,-0.090673,-0.13826,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.51459,-0.090806,-0.045232,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.045624,-0.090954,-0.18368,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.18508,-0.09121,-0.11886,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.17934,-0.091221,-0.079817,0,0
2,GO MITOCHONDRION LOCALIZATION,0.02843,-0.091259,-0.12136,0,0
2,GO REGULATION OF GLIOGENESIS,0.18508,-0.091735,-0.072454,0,0
2,GO REGIONALIZATION,0.087232,-0.091947,-0.07666,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.25363,-0.09205,-0.065236,0,0
2,GO NUCLEOSIDE SALVAGE,0.78962,-0.09228,-0.019331,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.33373,-0.092517,-0.053062,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.02268,-0.09254,-0.10872,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.43883,-0.092559,-0.10846,0,0
2,GO ANIMAL ORGAN MATURATION,0.23245,-0.092597,-0.054761,0,0
2,GO POLYOL TRANSPORT,0.4598,-0.092676,-0.021326,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.30815,-0.09275,-0.040577,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.25001,-0.092841,-0.066566,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.76281,-0.092926,-0.016774,0,0
2,GO REGULATION OF HEART RATE,0.17934,-0.093261,-0.073595,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.48678,-0.093276,-0.065741,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.72313,-0.093469,0.0021383,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.15517,-0.093766,-0.12039,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.21905,-0.093794,-0.083748,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.22235,-0.093991,-0.060278,0,0
2,GO N GLYCAN PROCESSING,0.066855,-0.094133,-0.19033,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.40843,-0.094189,-0.028715,0,0
2,GO L AMINO ACID TRANSPORT,0.11636,-0.094203,-0.050848,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.084046,-0.094471,-0.10586,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.30402,-0.094654,-0.15534,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.060602,-0.094911,-0.10163,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.075049,-0.095183,-0.10684,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.51459,-0.095377,-0.035019,0,0
2,GO STEROID CATABOLIC PROCESS,0.14769,-0.095932,-0.096242,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.12049,-0.09646,-0.11419,0,0
2,GO MITOTIC RECOMBINATION,0.49227,-0.096936,-0.021279,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.10465,-0.09724,-0.125,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.31653,-0.097338,-0.18139,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.023205,-0.097567,-0.10192,0,0
2,GO RESPONSE TO NICOTINE,0.30815,-0.097801,-0.073712,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.36064,-0.09829,-0.023491,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.20621,-0.098657,-0.067353,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.5726,-0.098933,0.153,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.012203,-0.099207,-0.1286,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.18219,-0.099341,-0.088766,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.30402,-0.09937,-0.049236,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.12473,-0.099545,-0.10934,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.11636,-0.099561,-0.070567,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.73628,-0.099578,-0.064133,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.16559,-0.099636,-0.098829,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.20937,-0.099731,-0.11087,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.030383,-0.099758,-0.10895,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.48131,-0.10012,-0.10864,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.41842,-0.10023,-0.12573,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.14526,-0.10024,-0.081395,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.029068,-0.10046,-0.091212,0,0
2,GO CELL MORPHOGENESIS,0.065563,-0.10053,-0.082466,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.088862,-0.10074,-0.06938,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.41842,-0.10086,-0.065862,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.48131,-0.10099,-0.012107,0,0
2,GO SPERMATID DIFFERENTIATION,0.009256,-0.10126,-0.096652,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.0025817,-0.10147,-0.1004,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.67137,-0.10154,-0.066936,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.001986,-0.10171,-0.10579,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,1,-0.10188,0.05218,0,0
2,GO ADULT FEEDING BEHAVIOR,0.11434,-0.10199,-0.096285,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.53742,-0.10212,-0.01945,0,0
2,GO RESPONSE TO EPINEPHRINE,0.69061,-0.10213,-0.021762,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.32077,-0.10245,-0.10431,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.42855,-0.10284,-0.036568,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.13583,-0.10289,-0.066505,0,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.53167,-0.10293,-0.055704,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.30402,-0.10309,-0.039559,0,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.41842,-0.10322,-0.093205,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.23245,-0.10323,-0.1142,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.16032,-0.1034,-0.067653,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.12473,-0.10349,-0.081884,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.14048,-0.10367,-0.086065,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.27227,-0.104,-0.068824,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.72313,-0.10421,-0.026541,0,0
2,GO ORGANIC CATION TRANSPORT,0.42347,-0.1046,-0.047827,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.031748,-0.10465,-0.09525,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.23937,-0.10473,-0.11168,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.024846,-0.10513,-0.099811,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.11841,-0.10537,-0.079774,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.072231,-0.10537,-0.17324,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.087232,-0.10545,-0.094851,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.37932,-0.10547,-0.10631,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.76281,-0.10568,0.038714,0,0
2,GO TOOTH MINERALIZATION,0.90599,-0.10569,0.067913,0,0
2,GO CONVERGENT EXTENSION,0.87833,-0.10573,0.02668,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.20621,-0.10595,-0.044676,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.47049,-0.10597,-0.033148,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.10465,-0.10619,-0.086287,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0020453,-0.10625,-0.16321,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.066855,-0.1063,-0.11892,0,0
2,GO RELAXATION OF MUSCLE,0.28785,-0.10667,-0.084047,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.059411,-0.10712,-0.11061,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.22235,-0.1076,-0.086417,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.4545,-0.10785,-0.061927,0,0
2,GO ORGAN INDUCTION,0.12049,-0.10798,-0.12241,0,0
2,GO CELL FATE SPECIFICATION,0.22235,-0.10805,-0.083766,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.10837,-0.064474,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.1028,-0.10871,-0.19712,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.034637,-0.10884,-0.15788,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.17099,-0.10893,-0.086647,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.54321,-0.10941,0.051535,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.16828,-0.11005,-0.12855,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.29586,-0.11013,-0.036117,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.10654,-0.11043,-0.12801,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.1028,-0.11048,-0.10618,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.019739,-0.1105,-0.12531,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.51459,-0.11075,-0.042363,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0017123,-0.1108,-0.1633,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.018398,-0.11087,-0.17341,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.024288,-0.11144,-0.088272,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.41341,-0.11203,-0.035811,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.4978,-0.11204,-0.016094,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.71006,-0.11216,-0.062843,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.20309,-0.1124,-0.082332,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.11288,-0.034736,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.18508,-0.11304,-0.076532,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.5726,-0.11313,-0.0065659,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.05824,-0.11321,-0.15226,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.31653,-0.11336,-0.081342,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.038561,-0.11345,-0.10901,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.011612,-0.11465,-0.17034,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.19695,-0.11481,-0.087168,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.75615,-0.11493,-0.024123,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.42347,-0.11517,-0.033985,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.17374,-0.11519,-0.065427,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.36991,-0.11536,-0.082397,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.15773,-0.11539,-0.064974,0,0
2,GO ACTION POTENTIAL,0.060602,-0.1155,-0.10784,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.25363,-0.11617,-0.056325,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.32506,-0.11617,-0.071486,0,0
2,GO SPERM CAPACITATION,0.054842,-0.11638,-0.12947,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.061812,-0.11674,-0.077513,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.085627,-0.11692,-0.12063,0,0
2,GO REGULATION OF AXONOGENESIS,0.0013054,-0.11737,-0.19695,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.11636,-0.11739,-0.14344,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.44402,-0.11777,-0.047844,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0018173,-0.1183,-0.22776,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.12473,-0.11864,-0.077517,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.13814,-0.1191,-0.20047,0,0
2,GO KINETOCHORE ORGANIZATION,0.24288,-0.1196,-0.062911,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.25001,-0.11962,-0.037633,0,0
2,GO ANIMAL ORGAN FORMATION,0.24643,-0.11995,-0.046849,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.063042,-0.11999,-0.13983,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.017549,-0.12014,-0.0085071,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.15517,-0.12043,-0.093358,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.62732,-0.12086,-0.028047,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.18508,-0.12135,-0.09244,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.23245,-0.12154,-0.053399,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.24643,-0.12155,-0.032938,0,0
2,GO MEMBRANE DOCKING,0.001228,-0.12196,-0.10505,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.095625,-0.12338,-0.18995,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.015953,-0.12381,-0.13768,0,0
2,GO FIBROBLAST MIGRATION,0.41842,-0.12387,-0.01757,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.67137,-0.12403,-0.035,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.43367,-0.12442,-0.073922,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.2839,-0.12475,-0.11974,0,0
2,GO MITOTIC DNA REPLICATION,0.049546,-0.12486,-0.10157,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.1313,-0.12502,-0.11919,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.010773,-0.12562,-0.12681,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.21905,-0.12567,-0.080485,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.14526,-0.126,-0.13703,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.23937,-0.12607,-0.082686,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.0036303,-0.12617,-0.13951,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.188,-0.12642,-0.083421,0,0
2,GO VISUAL BEHAVIOR,0.25001,-0.12713,-0.076983,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.046579,-0.12716,-0.12553,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.05824,-0.12734,-0.090576,0,0
2,GO CELL PART MORPHOGENESIS,0.0007696,-0.12743,-0.16279,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.095625,-0.12863,-0.10272,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.0695,-0.12889,-0.087897,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.15264,-0.12904,-0.073056,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.42855,-0.12924,-0.071783,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.16032,-0.12938,-0.11749,0,0
2,GO EXTRACELLULAR TRANSPORT,0.095625,-0.12951,-0.12535,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.090515,-0.13017,-0.075954,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.2,-0.13111,-0.17212,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.37932,-0.13185,-0.081329,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.29184,-0.13263,-0.044778,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.18508,-0.13273,-0.063127,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.35153,-0.13443,-0.083634,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.50896,-0.13464,-0.066784,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.073629,-0.13477,-0.10075,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.32077,-0.13509,-0.060756,0,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.055956,-0.13532,-0.10442,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.060602,-0.13562,-0.23041,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17934,-0.13566,-0.082839,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.095625,-0.13572,-0.10661,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.4978,-0.13583,-0.013967,0,0
2,GO MESENCHYME MORPHOGENESIS,0.27227,-0.13621,-0.04142,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.72969,-0.13645,-0.023551,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.71658,-0.13659,0.019399,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.19095,-0.13748,-0.058047,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.31653,-0.13793,-0.05097,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.12259,-0.13824,-0.11649,0,0
2,GO AXONAL TRANSPORT,0.0085714,-0.13841,-0.13215,0,0
2,GO PHAGOSOME ACIDIFICATION,0.068167,-0.13845,-0.11882,0,0
2,GO DENDRITE MORPHOGENESIS,0.0016129,-0.13885,-0.17899,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.11039,-0.13891,-0.060742,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.15015,-0.13897,-0.11496,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.088862,-0.13902,-0.13056,0,0
2,GO MRNA SPLICE SITE SELECTION,0.14769,-0.13913,-0.1072,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.092194,-0.1393,-0.076793,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.055956,-0.1394,-0.14777,0,0
2,GO LOCOMOTOR RHYTHM,0.22568,-0.13949,-0.085562,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.10654,-0.13965,-0.19386,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.5726,-0.13966,0.012214,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.077957,-0.14051,-0.10708,0,0
2,GO NEURON DEVELOPMENT,0.00052342,-0.14058,-0.15873,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.017549,-0.14079,-0.1273,0,0
2,GO REGULATION OF TRANSPOSITION,0.94073,-0.14101,-0.035037,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.17374,-0.14137,-0.11384,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.27999,-0.14221,-0.046313,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00098941,-0.14278,-0.11432,0,0
2,GO NEURON DIFFERENTIATION,0.00047456,-0.14352,-0.15109,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4545,-0.14418,-0.048201,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.076492,-0.14445,-0.14835,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0051916,-0.14452,-0.15605,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.013798,-0.14468,-0.17854,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.32938,-0.14541,-0.045377,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.085627,-0.14547,-0.15961,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.11841,-0.14568,-0.14823,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.32506,-0.14591,-0.10264,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.48678,-0.14609,-0.0063551,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.1313,-0.14613,-0.16932,0,0
2,GO PARTURITION,0.12259,-0.14688,-0.1508,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.59059,-0.14714,-0.068868,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.001228,-0.14715,-0.224,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.20621,-0.14732,-0.11173,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.079444,-0.14748,-0.12168,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.061812,-0.14797,-0.13079,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.30815,-0.14801,-0.041878,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.077957,-0.14865,-0.16494,0,0
2,GO ADULT HEART DEVELOPMENT,0.11039,-0.14922,-0.12612,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.93377,-0.15029,0.035227,0,0
2,GO TRANSPOSITION,0.19095,-0.15048,-0.12826,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.059411,-0.15056,-0.16974,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.0062634,-0.15076,-0.18356,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.11841,-0.15218,-0.09414,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.29184,-0.15229,-0.053789,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.079444,-0.15233,-0.11913,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00044439,-0.15257,-0.20677,0,0
2,GO LYMPH NODE DEVELOPMENT,0.0027346,-0.15363,-0.2055,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.11636,-0.15404,-0.1528,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.10096,-0.15576,-0.17193,0,0
2,GO ESTROUS CYCLE,0.24643,-0.15718,-0.099037,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.23245,-0.15787,-0.11544,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.013798,-0.15888,-0.15902,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.0016129,-0.15933,-0.16154,0,0
2,GO AMYLOID FIBRIL FORMATION,0.082489,-0.16004,-0.15912,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.14285,-0.16033,-0.098759,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.18508,-0.16231,-0.067551,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.060602,-0.16271,-0.1142,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.17374,-0.16292,-0.11459,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.52025,-0.1631,-0.035196,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.11235,-0.1635,-0.17497,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.21256,-0.16382,-0.094304,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.10465,-0.16414,-0.096025,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.66501,-0.16478,-0.02275,0,0
2,GO RESPONSE TO WATER,0.62113,-0.16512,-0.032047,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.10096,-0.16536,-0.18354,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.51459,-0.16756,-0.0099698,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.011047,-0.16814,-0.17292,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13814,-0.16831,-0.12968,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.0049174,-0.16946,-0.25552,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.25001,-0.17009,-0.091077,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.15264,-0.17013,-0.16543,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.14048,-0.17063,-0.12202,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0045306,-0.17069,-0.18542,0,0
2,GO RESPONSE TO ACIDIC PH,0.23937,-0.17072,-0.068509,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.16559,-0.17136,-0.23761,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.05824,-0.17249,-0.2604,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.27999,-0.17354,-0.098364,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.29184,-0.17428,-0.037531,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.057089,-0.17434,-0.12944,0,0
2,GO ACROSOME ASSEMBLY,0.0051916,-0.17449,-0.20243,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.092194,-0.17759,-0.24386,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.077957,-0.17792,-0.1111,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0695,-0.17866,-0.18624,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.13355,-0.17884,-0.13873,0,0
2,GO PALLIUM DEVELOPMENT,0.0012662,-0.17991,-0.14982,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.099158,-0.18005,-0.1472,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.13355,-0.18018,-0.18614,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20309,-0.18088,-0.10667,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.11636,-0.18103,-0.11612,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.16828,-0.18178,-0.082065,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.055956,-0.18189,-0.13368,0,0
2,GO DENDRITE DEVELOPMENT,0.00074557,-0.18222,-0.17873,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.13355,-0.18245,-0.12033,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.188,-0.18247,-0.20972,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21256,-0.18364,-0.10485,0,0
2,GO REGULATION OF NEURON MIGRATION,0.014841,-0.18404,-0.19345,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.0099891,-0.18411,-0.16927,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.24288,-0.18434,-0.16383,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.39858,-0.18474,-0.021356,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0695,-0.18493,-0.25813,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.087232,-0.18582,-0.13971,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.0025083,-0.18613,-0.1903,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.031059,-0.18633,-0.13876,0,0
2,GO SEROTONIN TRANSPORT,0.052669,-0.18672,-0.15653,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.36064,-0.18745,-0.10274,0,0
2,GO GLYCINE TRANSPORT,0.17934,-0.18777,-0.1055,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1313,-0.18835,-0.10397,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.16828,-0.18843,-0.12204,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.17374,-0.18869,-0.065057,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.035393,-0.18877,-0.13545,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.25001,-0.18891,-0.1918,0,0
2,GO RESPONSE TO CAFFEINE,0.42347,-0.19098,-0.040653,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.03245,-0.19231,-0.17406,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.001191,-0.19298,-0.2005,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0010859,-0.19314,-0.20653,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.066855,-0.19373,-0.1132,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.10845,-0.19469,-0.27994,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0094949,-0.19529,-0.18911,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0022992,-0.19601,-0.26976,0,0
2,GO FAT CELL PROLIFERATION,0.027188,-0.197,-0.18016,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0695,-0.19736,-0.13162,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00050664,-0.19737,-0.20649,0,0
2,GO SPINAL CORD DEVELOPMENT,0.001191,-0.1981,-0.18808,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.0046564,-0.19978,-0.14732,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.21256,-0.19981,-0.081556,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.16032,-0.20007,-0.12623,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.0099891,-0.20082,-0.1651,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.37932,-0.20125,-0.097044,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.11636,-0.20132,-0.1543,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.20621,-0.20216,-0.090998,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.23937,-0.20318,-0.19951,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0022992,-0.20403,-0.15169,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.043763,-0.20414,-0.23725,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.0018173,-0.2043,-0.15583,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.14769,-0.20464,-0.19872,0,0
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.15517,-0.20486,-0.16489,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.00019079,-0.20582,-0.27432,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0046564,-0.20588,-0.29512,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.39371,-0.2063,-0.075492,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.029068,-0.20975,-0.26026,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.05161,-0.21006,-0.18794,0,0
2,GO REGULATION OF OOGENESIS,0.00081984,-0.21013,-0.1946,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.00023468,-0.21206,-0.1721,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.023741,-0.21261,-0.21123,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0001547,-0.21312,-0.25368,0,0
2,GO METENCEPHALON DEVELOPMENT,0.00012074,-0.21327,-0.22203,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.19393,-0.21455,-0.15355,0,0
2,GO NEURON PROJECTION EXTENSION,9.7346e-05,-0.21487,-0.22502,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.26471,-0.21725,-0.091142,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.0033369,-0.21902,-0.22971,0,0
2,GO COPULATION,0.065563,-0.2195,-0.12403,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.095625,-0.21992,-0.17932,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.15015,-0.22231,-0.20103,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.10654,-0.22275,-0.1224,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.085627,-0.22589,-0.11232,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00012074,-0.23028,-0.22111,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.045624,-0.23087,-0.17644,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.036948,-0.23482,-0.15327,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.076492,-0.23486,-0.167,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00092958,-0.23537,-0.23076,0,0
2,GO MALE MEIOSIS I,0.00047456,-0.23568,-0.30661,0,0
2,GO VESICLE DOCKING,0.00032948,-0.23716,-0.22693,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.23937,-0.23722,-0.099567,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0025817,-0.23733,-0.32751,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0006154,-0.23832,-0.16553,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.40349,-0.24025,-0.074586,0,0
2,GO MICROTUBULE SEVERING,0.023205,-0.24075,-0.18688,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0097392,-0.24089,-0.18148,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.097379,-0.2423,-0.16936,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.2,-0.24277,-0.085125,0,0
2,GO SEROTONIN SECRETION,0.054842,-0.24417,-0.19844,0,0
2,GO CELL FATE DETERMINATION,0.016339,-0.24432,-0.17805,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0007696,-0.24627,-0.27139,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.011047,-0.24633,-0.32227,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00072223,-0.24779,-0.25411,0,0
2,GO SYNAPSE ASSEMBLY,0.00028792,-0.24913,-0.23467,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00087311,-0.25066,-0.19984,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.00010092,-0.25131,-0.29239,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.0050528,-0.25304,-0.33587,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.30402,-0.25338,-0.11827,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.023741,-0.25381,-0.23691,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.021165,-0.25403,-0.19439,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.088862,-0.2547,-0.19483,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.1028,-0.2548,-0.13637,0,0
2,GO FOREBRAIN CELL MIGRATION,0.00042998,-0.25831,-0.22002,0,0
2,GO CARDIAC CHAMBER FORMATION,0.16294,-0.25868,-0.2115,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00031859,-0.2593,-0.23481,0,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,2.4346e-05,-0.26317,-0.26987,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.037747,-0.26323,-0.16705,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.00055855,-0.26744,-0.26926,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.56666,-0.26881,0.011367,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.004408,-0.26914,-0.23244,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0039469,-0.27158,-0.26802,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.00022676,-0.27186,-0.31015,0,0
2,GO INTRACILIARY TRANSPORT,0.0013054,-0.27466,-0.23595,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.049546,-0.27534,-0.18113,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.099158,-0.27536,-0.094569,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.14526,-0.27672,-0.16164,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0010859,-0.28015,-0.23914,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.0026572,-0.28163,-0.31205,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0030654,-0.28232,-0.2738,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0013054,-0.28309,-0.30464,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.10465,-0.28726,-0.11925,0,0
2,GO NEURON RECOGNITION,0.00025131,-0.29167,-0.32172,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0066042,-0.29207,-0.23654,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00092958,-0.29337,-0.25233,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.00047456,-0.29791,-0.22352,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,4.8379e-05,-0.29943,-0.28855,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.14048,-0.30236,-0.18742,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.085627,-0.3027,-0.18191,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.17934,-0.30401,-0.32927,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.14285,-0.30645,-0.18095,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.0040578,-0.30719,-0.22644,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00016595,-0.30761,-0.33353,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.00014935,-0.30829,-0.303,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.023205,-0.3085,-0.24635,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.011047,-0.31029,-0.40552,0,0
2,GO DIENCEPHALON DEVELOPMENT,5.8301e-05,-0.31156,-0.29536,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.32506,-0.31157,-0.12432,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.7413e-06,-0.31537,-0.29574,0,0
2,GO PROTEIN POLYGLUTAMYLATION,9.0551e-05,-0.31768,-0.27997,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.031748,-0.31881,-0.22796,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,5.2837e-06,-0.32164,-0.34556,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12689,-0.32264,-0.27234,0,0
2,GO MAST CELL MIGRATION,0.25363,-0.32279,-0.11083,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,9.7801e-06,-0.32295,-0.31446,0,0
2,GO NEURON MIGRATION,8.1192e-05,-0.32354,-0.2878,0,0
2,GO NOREPINEPHRINE SECRETION,0.00055855,-0.32373,-0.3068,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00020448,-0.32505,-0.32347,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.001191,-0.32514,-0.32941,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0079323,-0.32674,-0.33154,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016595,-0.32774,-0.3059,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.001228,-0.32889,-0.25414,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.088862,-0.33395,-0.17094,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00353,-0.334,-0.34468,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0059384,-0.33413,-0.21619,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,2.0833e-05,-0.34114,-0.31289,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00011241,-0.34176,-0.32099,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,2.0033e-05,-0.34653,-0.31578,0,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0011199,-0.34695,-0.2692,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.073629,-0.34723,-0.18373,0,0
2,GO ADULT BEHAVIOR,5.7413e-06,-0.34936,-0.30585,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,6.2786e-05,-0.34987,-0.3304,0,0
2,GO SYNAPTIC VESICLE RECYCLING,9.7801e-06,-0.35485,-0.3546,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00079435,-0.35599,-0.32389,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00069957,-0.35672,-0.33649,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,6.2367e-06,-0.36445,-0.31262,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,1.1493e-05,-0.3655,-0.38361,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.0022992,-0.37045,-0.25323,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0073363,-0.37229,-0.26976,0,0
2,GO LUNG CELL DIFFERENTIATION,0.40843,-0.37364,-0.12833,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00052342,-0.37804,-0.40865,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00031859,-0.37851,-0.29406,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,4.4878e-05,-0.37901,-0.35527,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.00018427,-0.38009,-0.35303,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00028792,-0.38038,-0.32131,0,0
2,GO REGULATION OF VESICLE FUSION,0.018398,-0.38038,-0.26224,0,0
2,GO HEART INDUCTION,0.0047853,-0.3811,-0.51035,0,0
2,GO CEREBELLAR CORTEX FORMATION,1.0184e-05,-0.38599,-0.3695,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00044439,-0.38707,-0.29461,0,0
2,GO SPERM AXONEME ASSEMBLY,0.0019282,-0.38751,-0.29654,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.066855,-0.39573,-0.23367,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,-0.39646,-0.37475,0,0
2,GO HEART FORMATION,0.00019753,-0.39792,-0.37544,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,2.7343e-05,-0.40049,-0.35982,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00032948,-0.40117,-0.39776,0,0
2,GO INCLUSION BODY ASSEMBLY,0.00037661,-0.40517,-0.35682,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.0001165,-0.4078,-0.41052,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00030804,-0.41188,-0.48725,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0032441,-0.41686,-0.37001,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0069616,-0.41804,-0.33531,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00016595,-0.42106,-0.37432,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0041716,-0.42401,-0.41182,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0001547,-0.43245,-0.46212,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,9.7346e-05,-0.4335,-0.3702,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.00036427,-0.43471,-0.52049,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.3218e-05,-0.4381,-0.36893,0,0
2,GO NEUROTRANSMITTER SECRETION,0.0001165,-0.43911,-0.39431,0,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0007696,-0.43936,-0.49714,0,0
2,GO PITUITARY GLAND DEVELOPMENT,2.8418e-05,-0.44241,-0.40207,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.19393,-0.44887,-0.18028,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.00031859,-0.44954,-0.51172,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00019753,-0.45114,-0.39929,0,0
2,GO CARDIOBLAST PROLIFERATION,0.0041716,-0.45976,-0.48552,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,2.0833e-05,-0.46481,-0.42169,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.5759e-05,-0.46495,-0.48686,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,5.2837e-06,-0.47011,-0.50826,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0019282,-0.47184,-0.3142,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,3.1904e-06,-0.47613,-0.44787,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,2.0033e-05,-0.47806,-0.59416,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0020453,-0.47903,-0.36518,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00027832,-0.48431,-0.38024,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0027346,-0.50924,-0.43193,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00012964,-0.51217,-0.46023,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0006154,-0.51565,-0.46508,0,0
2,GO PARENTAL BEHAVIOR,2.2658e-06,-0.5173,-0.52335,0,0
2,GO DENSE CORE GRANULE TRANSPORT,2.8418e-05,-0.51826,-0.60454,0,0
2,GO GLUTAMATE SECRETION,7.9801e-06,-0.52196,-0.45489,0,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.001191,-0.52376,-0.48236,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00022676,-0.54078,-0.50822,0,0
2,GO NEURON FATE SPECIFICATION,0.00084609,-0.55274,-0.43307,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00036427,-0.55378,-0.45042,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.7806e-05,-0.55845,-0.49749,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,1.8251e-06,-0.56376,-0.53302,0,0
2,GO SUBPALLIUM DEVELOPMENT,5.508e-06,-0.56698,-0.51447,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,4.4712e-06,-0.57623,-0.63792,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.1964e-05,-0.57795,-0.48891,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,8.1192e-05,-0.58511,-0.56837,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.4039e-05,-0.58792,-0.49606,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,7.013e-05,-0.58816,-0.43887,0,0
2,GO PREPULSE INHIBITION,0.0017641,-0.59001,-0.48413,0,0
2,GO HEART FIELD SPECIFICATION,8.4205e-05,-0.60151,-0.54288,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0010528,-0.61174,-0.5662,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,3.0576e-06,-0.62233,-0.57237,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,6.2786e-05,-0.64945,-0.57445,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,7.889e-07,-0.65177,-0.63147,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00019753,-0.68225,-0.59851,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,2.4692e-06,-0.71759,-0.69427,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0007696,-0.73672,-0.60238,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,2.9301e-06,-0.76196,-0.67725,0,0
2,GO VOCALIZATION BEHAVIOR,1.5816e-05,-0.77548,-0.68249,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,2.0784e-06,-0.80624,-0.81764,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0021062,-0.82314,-0.61269,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,2.8418e-05,-1.2441,-0.96112,0,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0073363,0.30895,0.2251,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
3,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
3,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
3,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO MATING,0.033166,0.12237,0.091484,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
3,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00081984,0.49751,0.48283,1,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.00038934,0.44341,0.47686,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.020205,0.4197,0.32519,1,0
3,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.0049174,0.37793,0.30971,1,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.0081404,0.35604,0.31425,1,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.013798,0.32666,0.44768,1,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.053746,0.31706,0.17246,1,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0047853,0.3128,0.27844,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.01282,0.30544,0.21362,1,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,0
3,GO PHAGOCYTOSIS RECOGNITION,0.052669,0.29655,0.16095,1,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.031748,0.29573,0.37958,1,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.29312,0.23126,1,0
3,GO BONE TRABECULA FORMATION,0.016339,0.29217,0.28867,1,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0010859,0.28339,0.25764,1,0
3,GO ARGININE METABOLIC PROCESS,0.0079323,0.27497,0.29089,1,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0010859,0.27257,0.30115,1,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.018398,0.27165,0.20893,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.013465,0.26825,0.30375,1,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.03245,0.26305,0.1703,1,0
3,GO GTP METABOLIC PROCESS,0.0021689,0.26286,0.23585,1,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038387,0.25753,0.34078,1,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00035231,0.24686,0.23419,1,0
3,GO REGULATION OF DOPAMINE SECRETION,0.025414,0.24193,0.30834,1,0
3,GO COLLAGEN METABOLIC PROCESS,0.020205,0.24009,0.14035,1,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0026572,0.23251,0.2819,1,0
3,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.22828,0.26749,1,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0016129,0.22746,0.18799,1,0
3,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,1,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,1,0
3,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,1,0
3,GO POSTSYNAPSE ORGANIZATION,7.8282e-05,0.22101,0.24513,1,0
3,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,1,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.0037331,0.21351,0.17163,1,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.033894,0.21116,0.18694,1,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019283,0.20829,0.13889,1,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.00087311,0.20663,0.2178,1,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,1,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0062634,0.20156,0.21024,1,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0079323,0.20082,0.20231,1,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,0
3,GO CGMP MEDIATED SIGNALING,0.022165,0.19695,0.13884,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.014486,0.19694,0.17506,1,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.014138,0.19562,0.16247,1,0
3,GO DENDRITE SELF AVOIDANCE,0.041967,0.19194,0.1856,1,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,1,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,1,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013798,0.18278,0.18877,1,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0045306,0.18258,0.17858,1,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,1,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.013798,0.18198,0.12879,1,0
3,GO PRESYNAPSE ORGANIZATION,0.007729,0.18186,0.20793,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.049546,0.18136,0.15569,1,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.045624,0.18131,0.1476,1,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.011904,0.18024,0.16927,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.045624,0.17967,0.12845,1,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,1,0
3,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17726,0.17885,1,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,0.17692,0.23384,1,0
3,GO LONG TERM MEMORY,0.0041716,0.17645,0.19976,1,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.1762,0.13534,1,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,0
3,GO POSITIVE REGULATION OF HEART RATE,0.040234,0.16813,0.18861,1,0
3,GO DENDRITIC TRANSPORT,0.010506,0.16695,0.24093,1,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,1,0
3,GO FATTY ACID HOMEOSTASIS,0.044685,0.16644,0.20355,1,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.010506,0.16562,0.19049,1,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,1,0
3,GO RESPONSE TO ACETYLCHOLINE,0.04854,0.16384,0.18446,1,0
3,GO RESPONSE TO AMINE,0.0094949,0.16148,0.17707,1,0
3,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,1,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041967,0.16069,0.13783,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.042857,0.15679,0.097057,1,0
3,GO COPPER ION HOMEOSTASIS,0.024846,0.15663,0.14424,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.02068,0.15485,0.11071,1,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.015203,0.15295,0.097831,1,0
3,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,1,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.042857,0.15178,0.12137,1,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,1,0
3,GO MEMBRANE REPOLARIZATION,0.014138,0.14965,0.13738,1,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0069616,0.14894,0.15764,1,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.043763,0.14864,0.13656,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0087944,0.14827,0.14805,1,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.14759,0.15602,1,0
3,GO COLLATERAL SPROUTING,0.02843,0.14592,0.15473,1,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.047551,0.14515,0.10055,1,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0026572,0.14459,0.15038,1,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,0
3,GO DEVELOPMENTAL CELL GROWTH,0.00074557,0.14342,0.149,1,0
3,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.04854,0.13973,0.12553,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0094949,0.13631,0.16419,1,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.009256,0.13573,0.11999,1,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043763,0.13544,0.12947,1,0
3,GO LIVER REGENERATION,0.040234,0.13541,0.077176,1,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,1,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0038387,0.13277,0.1505,1,0
3,GO NEUROMUSCULAR PROCESS,0.0060989,0.13239,0.14602,1,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.0087944,0.13195,0.11512,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.02166,0.12912,0.12848,1,0
3,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,1,0
3,GO SYNAPTIC SIGNALING,0.001986,0.12747,0.172,1,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0025083,0.12726,0.12677,1,0
3,GO MEMORY,0.0067808,0.12525,0.13818,1,0
3,GO MRNA SPLICE SITE SELECTION,0.042857,0.123,0.13568,1,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.041093,0.12291,0.091021,1,0
3,GO GLUTAMINE METABOLIC PROCESS,0.0031536,0.12242,0.15681,1,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11981,0.10207,1,0
3,GO PEPTIDE METABOLIC PROCESS,0.024846,0.11942,0.091635,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.015574,0.11796,0.081204,1,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026586,0.11785,0.1383,1,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,1,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.11532,0.078129,1,0
3,GO RNA 5 END PROCESSING,0.035393,0.11506,0.12281,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.022165,0.11502,0.13665,1,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.010506,0.11484,0.11228,1,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.043763,0.1138,0.13072,1,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.03245,0.11289,0.1031,1,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,0
3,GO GLIAL CELL MIGRATION,0.052669,0.11218,0.13199,1,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.0037331,0.11212,0.17851,1,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.018836,0.11181,0.17577,1,0
3,GO COGNITION,0.0031536,0.11159,0.15657,1,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11156,0.096039,1,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.045624,0.11137,0.11873,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11107,0.10628,1,0
3,GO TRNA METABOLIC PROCESS,0.0034322,0.10892,0.14407,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047551,0.1078,0.085432,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,0.10605,0.11104,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.015953,0.10552,0.11118,1,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.016734,0.1037,0.11503,1,0
3,GO RESPONSE TO AMYLOID BETA,0.0094949,0.10326,0.1324,1,0
3,GO POTASSIUM ION TRANSPORT,0.035393,0.10273,0.1169,1,0
3,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,1,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0023671,0.10243,0.09872,1,0
3,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.011047,0.10155,0.11642,1,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,0.10018,0.11791,1,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.024846,0.099707,0.083464,1,0
3,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,1,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.031059,0.098422,0.099572,1,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0060989,0.098297,0.099857,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015953,0.09826,0.081023,1,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.029068,0.097005,0.08091,1,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.038561,0.096255,0.11449,1,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.020205,0.095754,0.083423,1,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0079323,0.09519,0.12173,1,0
3,GO RNA MODIFICATION,0.0075304,0.09438,0.12402,1,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.021165,0.093074,0.086229,1,0
3,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.089731,0.099952,1,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02843,0.089345,0.091656,1,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,1,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.036164,0.089277,0.11426,1,0
3,GO RESPONSE TO CALCIUM ION,0.050569,0.088902,0.089481,1,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,1,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.010245,0.088589,0.06583,1,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.033166,0.088546,0.11543,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,1,0
3,GO ORGANIC CATION TRANSPORT,0.02268,0.085963,0.1203,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,1,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.041093,0.080665,0.085237,1,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.026586,0.073598,0.10531,1,0
3,GO CELL CYCLE DNA REPLICATION,0.044685,0.07298,0.079722,1,0
3,GO LOCOMOTORY BEHAVIOR,0.036164,0.072435,0.13478,1,0
3,GO NUCLEAR EXPORT,0.024846,0.070434,0.06326,1,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.047551,0.068477,0.092842,1,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.024846,0.067091,0.096255,1,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.03245,0.066848,0.090725,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.016734,0.063443,0.10185,1,0
3,GO RNA EXPORT FROM NUCLEUS,0.041967,0.063385,0.083155,1,0
3,GO BEHAVIOR,0.013139,0.062013,0.11244,1,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,0.061913,0.066182,1,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.060199,0.081212,1,0
3,GO REGULATION OF CELL SIZE,0.027803,0.06009,0.078054,1,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.044685,0.060003,0.063979,1,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.045624,0.057252,0.082736,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031059,0.056379,0.062983,1,0
3,GO NUCLEAR TRANSPORT,0.023741,0.052646,0.053247,1,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.035393,0.052448,0.055266,1,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.041093,0.036656,0.074008,1,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.031748,0.035939,0.067457,1,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.050569,0.032713,0.064769,1,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.019739,-0.024923,-0.086715,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.049546,-0.031431,-0.054434,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.036167,-0.13545,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.047551,-0.037358,-0.049977,1,0
3,GO VESICLE ORGANIZATION,0.053746,-0.037366,-0.070643,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.049546,-0.03837,-0.055105,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.049546,-0.04202,-0.041943,1,0
3,GO TISSUE MORPHOGENESIS,0.047551,-0.042047,-0.080539,1,0
3,GO HETEROCHROMATIN ORGANIZATION,0.04854,-0.044763,-0.052471,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.027803,-0.046405,-0.057805,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.025414,-0.046584,-0.13269,1,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.030383,-0.047395,-0.0479,1,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.025994,-0.047781,-0.15593,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,-0.048096,-0.056265,1,0
3,GO NON RECOMBINATIONAL REPAIR,0.029719,-0.049058,-0.070112,1,0
3,GO EPITHELIAL CELL PROLIFERATION,0.053746,-0.050618,-0.10607,1,0
3,GO ACTIN FILAMENT BASED PROCESS,0.036948,-0.05139,-0.072544,1,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.047551,-0.052509,-0.059863,1,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.052873,-0.041961,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037747,-0.053669,-0.068959,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.014138,-0.053852,-0.15297,1,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.037747,-0.055403,-0.066143,1,0
3,GO CYTOSKELETON ORGANIZATION,0.04854,-0.055548,-0.051262,1,0
3,GO POSITIVE REGULATION OF SIGNALING,0.033166,-0.055813,-0.065149,1,0
3,GO MALE GAMETE GENERATION,0.0045306,-0.056225,-0.08556,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,-0.056332,-0.085675,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.03245,-0.056358,-0.056157,1,0
3,GO MACROAUTOPHAGY,0.0054795,-0.057538,-0.080368,1,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019283,-0.057979,-0.084699,1,0
3,GO ACTIN FILAMENT ORGANIZATION,0.017549,-0.058128,-0.094691,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.038561,-0.058545,-0.10222,1,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.019739,-0.058587,-0.081149,1,0
3,GO SEXUAL REPRODUCTION,0.0025817,-0.059443,-0.071044,1,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024288,-0.059497,-0.077715,1,0
3,GO ORGANELLE FISSION,0.019283,-0.060777,-0.053453,1,0
3,GO HISTONE UBIQUITINATION,0.041093,-0.061309,-0.066636,1,0
3,GO PROTEIN AUTOUBIQUITINATION,0.027188,-0.061491,-0.065572,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.013139,-0.061745,-0.099152,1,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.05161,-0.061757,-0.075136,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.03939,-0.061936,-0.17826,1,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.045624,-0.0624,-0.12938,1,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.053746,-0.062759,-0.071512,1,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.012203,-0.062843,-0.080199,1,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.019739,-0.062998,-0.085776,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.0013872,-0.063414,-0.13611,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.06359,-0.11612,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.023741,-0.063699,-0.12651,1,0
3,GO VACUOLE ORGANIZATION,0.049546,-0.063873,-0.080909,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0067808,-0.064341,-0.1042,1,0
3,GO CELL MOTILITY,0.036948,-0.064481,-0.079393,1,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.053746,-0.064966,-0.079914,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.024288,-0.065264,-0.08581,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.042857,-0.065369,-0.13007,1,0
3,GO TUBE MORPHOGENESIS,0.041093,-0.06564,-0.099175,1,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033894,-0.065921,-0.067849,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.011047,-0.066015,-0.10214,1,0
3,GO MULTICELLULAR ORGANISM AGING,0.017549,-0.066565,-0.12547,1,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.05161,-0.067007,-0.10693,1,0
3,GO SECRETION,0.012508,-0.067035,-0.08332,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.03245,-0.067433,-0.079096,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,-0.06747,-0.092176,1,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.024846,-0.067811,-0.070702,1,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.030383,-0.067849,-0.11162,1,0
3,GO TUBE DEVELOPMENT,0.033894,-0.069626,-0.094207,1,0
3,GO MUSCLE ADAPTATION,0.05161,-0.070042,-0.090495,1,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0079323,-0.070156,-0.080998,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.04854,-0.07016,-0.070453,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.070793,-0.12646,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.02166,-0.071389,-0.099685,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.025994,-0.071424,-0.085065,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.014138,-0.071536,-0.11367,1,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0038387,-0.072065,-0.074907,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.03245,-0.072305,-0.11245,1,0
3,GO LYMPHOCYTE ACTIVATION,0.0075304,-0.072443,-0.11104,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0085714,-0.072665,-0.087308,1,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.013139,-0.074079,-0.11156,1,0
3,GO MULTI ORGANISM PROCESS,0.009256,-0.074202,-0.06881,1,0
3,GO PEPTIDE SECRETION,0.025414,-0.074792,-0.08505,1,0
3,GO NEGATIVE T CELL SELECTION,0.0027346,-0.075183,-0.16075,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.0064317,-0.075297,-0.092052,1,0
3,GO SPERM MOTILITY,0.012203,-0.075329,-0.091459,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.038561,-0.076032,-0.079738,1,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017969,-0.07604,-0.099561,1,0
3,GO EAR DEVELOPMENT,0.035393,-0.0763,-0.099769,1,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031059,-0.07751,-0.091504,1,0
3,GO DEPHOSPHORYLATION,0.021165,-0.077657,-0.058171,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.0097392,-0.07785,-0.076389,1,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011326,-0.077982,-0.078376,1,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.041967,-0.078097,-0.11692,1,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.041967,-0.078222,-0.095114,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.031748,-0.078364,-0.079138,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.03245,-0.078499,-0.10286,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039469,-0.078562,-0.08408,1,0
3,GO EXOCYTOSIS,0.011047,-0.078638,-0.10281,1,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.018836,-0.078865,-0.058864,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.045624,-0.079261,-0.13395,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.017549,-0.079405,-0.10827,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0015653,-0.079454,-0.10403,1,0
3,GO DETECTION OF STIMULUS,0.0010859,-0.079666,-0.097326,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.0049174,-0.079687,-0.077954,1,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.049546,-0.08022,-0.12088,1,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.027188,-0.080418,-0.06057,1,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015574,-0.080753,-0.10773,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.037747,-0.080788,-0.11695,1,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.019739,-0.080956,-0.12703,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.042857,-0.081063,-0.10309,1,0
3,GO GAMETE GENERATION,0.0010206,-0.081244,-0.088169,1,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0021062,-0.081483,-0.10326,1,0
3,GO REGULATION OF HEMOPOIESIS,0.010773,-0.081738,-0.105,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.044685,-0.081822,-0.10828,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0064317,-0.08192,-0.10728,1,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.045624,-0.081921,-0.088216,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,-0.081932,-0.096147,1,0
3,GO ENDOSOMAL TRANSPORT,0.00028792,-0.082157,-0.10138,1,0
3,GO REGULATION OF IMMUNE RESPONSE,0.010773,-0.082422,-0.11106,1,0
3,GO VACUOLAR TRANSPORT,0.0094949,-0.082562,-0.1011,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.049546,-0.082713,-0.09224,1,0
3,GO FATTY ACID METABOLIC PROCESS,0.031059,-0.082955,-0.10209,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038561,-0.083001,-0.11834,1,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,-0.083325,-0.12337,1,0
3,GO FAT CELL DIFFERENTIATION,0.0067808,-0.083727,-0.12377,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014486,-0.084075,-0.1136,1,0
3,GO MAST CELL MEDIATED IMMUNITY,0.019739,-0.084268,-0.18989,1,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.027803,-0.08431,-0.14589,1,0
3,GO GLUCOSE METABOLIC PROCESS,0.044685,-0.084349,-0.067101,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.084664,-0.10493,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035393,-0.084752,-0.069618,1,0
3,GO EXIT FROM MITOSIS,0.022165,-0.084988,-0.10847,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.010773,-0.085104,-0.11029,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.013139,-0.085154,-0.12442,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0056288,-0.08531,-0.10888,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011904,-0.08548,-0.080851,1,0
3,GO RESPONSE TO ANTIBIOTIC,0.037747,-0.085625,-0.11302,1,0
3,GO CILIUM MOVEMENT,0.0020453,-0.085741,-0.127,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.04854,-0.085844,-0.10889,1,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.011047,-0.085863,-0.17353,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.050569,-0.086101,-0.12924,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0094949,-0.086271,-0.12897,1,0
3,GO REGULATION OF PROTEOLYSIS,0.0057817,-0.086679,-0.112,1,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.014486,-0.086788,-0.13458,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.041967,-0.08685,-0.069253,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.009256,-0.087266,-0.095113,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013798,-0.087488,-0.13861,1,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.036948,-0.08754,-0.090013,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00081984,-0.087676,-0.10881,1,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033166,-0.087948,-0.13159,1,0
3,GO EMBRYONIC MORPHOGENESIS,0.012203,-0.088139,-0.10272,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.047551,-0.088301,-0.081081,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.014841,-0.088522,-0.1165,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,-0.088558,-0.11587,1,0
3,GO CELLULAR SENESCENCE,0.017549,-0.088653,-0.11054,1,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.053746,-0.089326,-0.087658,1,0
3,GO PROTEOLYSIS,0.00044439,-0.089362,-0.10478,1,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.04854,-0.089702,-0.075698,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.011904,-0.089745,-0.13561,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.043763,-0.089812,-0.09272,1,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02268,-0.089912,-0.090142,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,-0.090064,-0.10809,1,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.030383,-0.090119,-0.20065,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0064317,-0.090415,-0.098557,1,0
3,GO REGULATION OF CELLULAR PH,0.0049174,-0.090578,-0.097889,1,0
3,GO CELL CELL ADHESION,0.004408,-0.09071,-0.12249,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0069616,-0.09084,-0.1134,1,0
3,GO CELLULAR PIGMENTATION,0.0036303,-0.09092,-0.13554,1,0
3,GO REGULATION OF NUCLEAR DIVISION,0.0050528,-0.091131,-0.08089,1,0
3,GO CELL MATRIX ADHESION,0.038561,-0.091166,-0.1199,1,0
3,GO GERM CELL DEVELOPMENT,0.0056288,-0.091316,-0.088962,1,0
3,GO REGULATION OF PH,0.0062634,-0.091444,-0.094954,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02268,-0.091575,-0.10198,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.010245,-0.091642,-0.12579,1,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.030383,-0.091662,-0.14272,1,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.015953,-0.091744,-0.12223,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.016339,-0.092052,-0.097263,1,0
3,GO MALE SEX DIFFERENTIATION,0.0069616,-0.092178,-0.10836,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012508,-0.092218,-0.10432,1,0
3,GO RESPONSE TO GAMMA RADIATION,0.036948,-0.092257,-0.093986,1,0
3,GO GLAND DEVELOPMENT,0.013139,-0.092267,-0.099714,1,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0099891,-0.092299,-0.10271,1,0
3,GO ERBB SIGNALING PATHWAY,0.02843,-0.092544,-0.11082,1,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.042857,-0.092571,-0.14696,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.012203,-0.092747,-0.12479,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.092966,-0.091004,1,0
3,GO PROTEIN MATURATION,0.015574,-0.092989,-0.10116,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.017137,-0.093242,-0.1859,1,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.019739,-0.093259,-0.14598,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.018836,-0.093434,-0.18171,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0024367,-0.093456,-0.1471,1,0
3,GO LIPID LOCALIZATION,0.0079323,-0.09371,-0.11778,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.017969,-0.093974,-0.093809,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0042883,-0.09409,-0.12622,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013798,-0.094359,-0.11699,1,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.04854,-0.094558,-0.099281,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010245,-0.094843,-0.12706,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,-0.094888,-0.15669,1,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02268,-0.095105,-0.13525,1,0
3,GO RESPONSE TO ALCOHOL,0.044685,-0.095276,-0.077525,1,0
3,GO GOLGI VESICLE BUDDING,0.0081404,-0.095367,-0.11661,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0097392,-0.095573,-0.10692,1,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0013872,-0.095585,-0.121,1,0
3,GO POSTREPLICATION REPAIR,0.011904,-0.096376,-0.08894,1,0
3,GO COPII COATED VESICLE BUDDING,0.0053338,-0.096385,-0.11379,1,0
3,GO RESPONSE TO BMP,0.042857,-0.096422,-0.11419,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.052669,-0.096441,-0.12145,1,0
3,GO REGULATION OF BODY FLUID LEVELS,0.0010859,-0.096588,-0.1364,1,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.038561,-0.09677,-0.13006,1,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.03939,-0.096774,-0.14335,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.041967,-0.097474,-0.17357,1,0
3,GO GENITALIA DEVELOPMENT,0.031748,-0.097801,-0.11878,1,0
3,GO GOLGI ORGANIZATION,0.0025083,-0.097875,-0.11643,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015574,-0.098282,-0.13644,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027803,-0.098302,-0.10269,1,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.098544,-0.10396,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.001986,-0.098769,-0.11462,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.017549,-0.098956,-0.093767,1,0
3,GO ORGANELLE DISASSEMBLY,0.0087944,-0.099028,-0.092583,1,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023205,-0.099219,-0.1092,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0069616,-0.099376,-0.12092,1,0
3,GO COAGULATION,0.0051916,-0.099857,-0.13878,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.009256,-0.099859,-0.13181,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00044439,-0.099918,-0.12903,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.022165,-0.099988,-0.15007,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.010773,-0.099989,-0.13459,1,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0023671,-0.1002,-0.15959,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.10043,-0.1099,1,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.022165,-0.1009,-0.15697,1,0
3,GO ERAD PATHWAY,0.010506,-0.10131,-0.11486,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,-0.10153,-0.12119,1,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00050664,-0.1016,-0.097924,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.03939,-0.10185,-0.078305,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00054072,-0.10187,-0.1406,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0060989,-0.10191,-0.14091,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.10192,-0.14426,1,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0054795,-0.10192,-0.097993,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.014486,-0.10213,-0.14414,1,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.034637,-0.10216,-0.10785,1,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.047551,-0.10217,-0.13505,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.045624,-0.10218,-0.10611,1,0
3,GO REGULATION OF CELL ADHESION,0.0026572,-0.10247,-0.1538,1,0
3,GO REGULATION OF CELL ACTIVATION,0.0022992,-0.10248,-0.13089,1,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023671,-0.10265,-0.10487,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.015574,-0.10293,-0.1546,1,0
3,GO ENDOCYTIC RECYCLING,0.0020453,-0.10297,-0.1284,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0053338,-0.10314,-0.1281,1,0
3,GO EAR MORPHOGENESIS,0.012203,-0.1035,-0.12465,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,-0.10358,-0.137,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,-0.10358,-0.14937,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0025083,-0.10375,-0.13773,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00092958,-0.10393,-0.11064,1,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.026586,-0.10435,-0.085846,1,0
3,GO PH REDUCTION,0.0021689,-0.10437,-0.14997,1,0
3,GO CELL ACTIVATION,0.0027346,-0.10443,-0.13744,1,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.033166,-0.10445,-0.079391,1,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.041093,-0.10467,-0.12192,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.015574,-0.10467,-0.13052,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.03245,-0.10489,-0.13769,1,0
3,GO ADAPTIVE THERMOGENESIS,0.02268,-0.10497,-0.09286,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.043763,-0.10516,-0.10536,1,0
3,GO HISTONE MONOUBIQUITINATION,0.00026903,-0.10577,-0.13101,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02166,-0.10578,-0.18634,1,0
3,GO DIGESTIVE SYSTEM PROCESS,0.033894,-0.10582,-0.12398,1,0
3,GO T CELL DIFFERENTIATION,0.0046564,-0.10597,-0.12217,1,0
3,GO PROTEIN POLYUBIQUITINATION,7.547e-05,-0.10635,-0.12601,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.10682,-0.21834,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.038561,-0.10693,-0.11031,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011326,-0.10731,-0.18883,1,0
3,GO RESPONSE TO OSMOTIC STRESS,0.023205,-0.10739,-0.11405,1,0
3,GO SEX DETERMINATION,0.033894,-0.10741,-0.13898,1,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0069616,-0.10748,-0.13913,1,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,-0.10761,-0.18224,1,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.012508,-0.10772,-0.16527,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.033894,-0.10795,-0.1079,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.00049035,-0.10805,-0.13497,1,0
3,GO PROTEIN KINASE B SIGNALING,0.0042883,-0.10819,-0.13353,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0049174,-0.10864,-0.10882,1,0
3,GO LIPID DIGESTION,0.012508,-0.10865,-0.28191,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.030383,-0.10907,-0.14524,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.026586,-0.10914,-0.17042,1,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.025414,-0.1093,-0.17811,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0037331,-0.10936,-0.13087,1,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.042857,-0.10946,-0.09126,1,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.053746,-0.10949,-0.15808,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,8.7323e-05,-0.10953,-0.14344,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016734,-0.1097,-0.10881,1,0
3,GO REPRODUCTION,0.0007696,-0.10999,-0.092536,1,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.016734,-0.11011,-0.10868,1,0
3,GO REGULATION OF PEPTIDE SECRETION,0.0083534,-0.11015,-0.099042,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.031748,-0.11072,-0.18395,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.00087311,-0.11132,-0.14441,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.1115,-0.082264,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.0023671,-0.11176,-0.13851,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.020205,-0.11203,-0.13579,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00042998,-0.11209,-0.15393,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.041093,-0.1121,-0.089285,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0071468,-0.11215,-0.088894,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00087311,-0.11217,-0.14572,1,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.0023671,-0.11228,-0.11441,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00090094,-0.11244,-0.15274,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.010506,-0.11274,-0.16972,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014486,-0.11296,-0.11908,1,0
3,GO INNATE IMMUNE RESPONSE,0.00092958,-0.11297,-0.16868,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.001662,-0.11298,-0.15534,1,0
3,GO CARBOHYDRATE TRANSPORT,0.0067808,-0.11335,-0.10615,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00052342,-0.11337,-0.19464,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.014138,-0.11384,-0.10532,1,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.031748,-0.11388,-0.22195,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.044685,-0.11432,-0.19369,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037331,-0.11433,-0.10729,1,0
3,GO MYELOID CELL DIFFERENTIATION,0.00025131,-0.11435,-0.12563,1,0
3,GO MITOTIC CYTOKINESIS,0.0030654,-0.11455,-0.12727,1,0
3,GO PLATELET MORPHOGENESIS,0.0051916,-0.11539,-0.20988,1,0
3,GO RESPONSE TO UV C,0.030383,-0.11551,-0.1629,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.049546,-0.11558,-0.19466,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.00087311,-0.11577,-0.14916,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0019282,-0.11619,-0.11366,1,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.042857,-0.11675,-0.12906,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.017969,-0.11697,-0.13148,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0064317,-0.11699,-0.1915,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.02268,-0.11734,-0.11495,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,-0.11734,-0.21546,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02166,-0.11741,-0.21897,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0021689,-0.11744,-0.21493,1,0
3,GO MYOBLAST DIFFERENTIATION,0.00353,-0.1177,-0.18566,1,0
3,GO DENDRITIC CELL MIGRATION,0.03939,-0.11815,-0.17082,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0042883,-0.11821,-0.15809,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.020205,-0.11829,-0.15136,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0030654,-0.1183,-0.175,1,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0071468,-0.11846,-0.13149,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00079435,-0.11849,-0.1507,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0046564,-0.11865,-0.10903,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00037661,-0.11881,-0.14684,1,0
3,GO LYMPHOCYTE COSTIMULATION,0.016734,-0.1192,-0.12062,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,-0.11925,-0.16242,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014138,-0.11938,-0.17878,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.030383,-0.1196,-0.11207,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00057693,-0.1198,-0.17694,1,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0062634,-0.12015,-0.103,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00065623,-0.12034,-0.1434,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.049546,-0.12065,-0.13147,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.036948,-0.12079,-0.19372,1,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.016339,-0.12098,-0.13489,1,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.036948,-0.12122,-0.16682,1,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.038561,-0.12132,-0.16502,1,0
3,GO DIGESTION,0.0037331,-0.12135,-0.15953,1,0
3,GO NOTCH SIGNALING PATHWAY,0.0041716,-0.12161,-0.12592,1,0
3,GO T CELL ACTIVATION,0.00084609,-0.1218,-0.15324,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010245,-0.12181,-0.091078,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.027188,-0.12199,-0.11447,1,0
3,GO RESPONSE TO WOUNDING,0.0097392,-0.12206,-0.13851,1,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,-0.12209,-0.13789,1,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.052669,-0.12216,-0.15298,1,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.036164,-0.12218,-0.12394,1,0
3,GO SPINDLE LOCALIZATION,0.001228,-0.12219,-0.14155,1,0
3,GO RESPONSE TO BACTERIUM,0.011612,-0.12235,-0.12854,1,0
3,GO PROTEIN DESTABILIZATION,0.0045306,-0.1224,-0.12012,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.036164,-0.12245,-0.17099,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0073363,-0.1225,-0.12381,1,0
3,GO TISSUE MIGRATION,0.052669,-0.12264,-0.10693,1,0
3,GO CYTOKINE PRODUCTION,0.00021167,-0.12282,-0.17499,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.0045306,-0.1229,-0.11055,1,0
3,GO TISSUE HOMEOSTASIS,5.508e-06,-0.12321,-0.18363,1,0
3,GO EPITHELIUM DEVELOPMENT,4.6597e-05,-0.12322,-0.15616,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014418,-0.12327,-0.15893,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0045306,-0.12336,-0.10713,1,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.012508,-0.12338,-0.14282,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00041602,-0.12341,-0.1536,1,0
3,GO BONE CELL DEVELOPMENT,0.021165,-0.12346,-0.13918,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00010845,-0.12354,-0.12675,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.015203,-0.12356,-0.19931,1,0
3,GO REGULATION OF DEFENSE RESPONSE,0.00049035,-0.12387,-0.14928,1,0
3,GO VIRAL LATENCY,0.024288,-0.12407,-0.12119,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.038561,-0.12409,-0.20943,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00013433,-0.12422,-0.14223,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.0026572,-0.12426,-0.16489,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.0028141,-0.12432,-0.19311,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0085714,-0.1248,-0.21404,1,0
3,GO TRANSLESION SYNTHESIS,0.004408,-0.12481,-0.11409,1,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.031748,-0.12484,-0.12044,1,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.04854,-0.12484,-0.15094,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.1252,-0.19543,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.0064317,-0.12528,-0.19474,1,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.04854,-0.12536,-0.11375,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.042857,-0.12547,-0.24358,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0014738,-0.12559,-0.16921,1,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.00017186,-0.12589,-0.15114,1,0
3,GO VESICLE TARGETING,0.0010859,-0.12596,-0.15258,1,0
3,GO DEFENSE RESPONSE,0.00067758,-0.12607,-0.14936,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.05161,-0.12688,-0.10507,1,0
3,GO RESPIRATORY BURST,0.0030654,-0.12709,-0.24633,1,0
3,GO DNA DEALKYLATION,0.021165,-0.12709,-0.13663,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.0073363,-0.12709,-0.13064,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0050528,-0.12729,-0.17163,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.00024286,-0.12733,-0.1873,1,0
3,GO REGULATION OF PINOCYTOSIS,0.0049174,-0.12742,-0.21435,1,0
3,GO VIRAL LIFE CYCLE,0.0006154,-0.12754,-0.18525,1,0
3,GO INFLAMMATORY RESPONSE,0.0010528,-0.12767,-0.14813,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.029719,-0.1277,-0.13862,1,0
3,GO RESPONSE TO IRON ION,0.017969,-0.12784,-0.15696,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0014738,-0.12842,-0.14968,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013465,-0.12854,-0.12884,1,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.0046564,-0.12856,-0.12382,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,-0.1286,-0.17838,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023468,-0.12895,-0.16558,1,0
3,GO CILIUM ORGANIZATION,0.00052342,-0.12901,-0.13345,1,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.042857,-0.12913,-0.2315,1,0
3,GO WOUND HEALING,0.0054795,-0.1293,-0.15726,1,0
3,GO FIBROBLAST MIGRATION,0.007729,-0.12942,-0.17907,1,0
3,GO REGULATION OF CELL SHAPE,0.007729,-0.12957,-0.13399,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.014138,-0.12982,-0.14473,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00084609,-0.12995,-0.18643,1,0
3,GO RESPONSE TO INTERLEUKIN 6,0.0012662,-0.13027,-0.18833,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00042998,-0.13033,-0.17338,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024288,-0.13054,-0.14495,1,0
3,GO PHAGOSOME ACIDIFICATION,0.011047,-0.13061,-0.16997,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.004408,-0.13062,-0.18148,1,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019739,-0.13104,-0.13652,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.042857,-0.13113,-0.13624,1,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.05161,-0.13174,-0.18714,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00050664,-0.132,-0.16849,1,0
3,GO REGULATION OF CHEMOTAXIS,0.0025817,-0.13201,-0.13346,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0083534,-0.13223,-0.22541,1,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.042857,-0.13227,-0.10183,1,0
3,GO NEURAL TUBE DEVELOPMENT,0.00079435,-0.13232,-0.14758,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.013465,-0.13233,-0.11869,1,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00067758,-0.13237,-0.17463,1,0
3,GO HISTONE H2A UBIQUITINATION,0.0036303,-0.13238,-0.12349,1,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10656,1,0
3,GO PEPTIDE CROSS LINKING,0.031059,-0.1329,-0.19153,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031536,-0.1334,-0.14323,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0083534,-0.13365,-0.18128,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.004408,-0.13383,-0.18717,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.13394,-0.14216,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,-0.13405,-0.18566,1,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00037661,-0.1343,-0.18074,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0071468,-0.13466,-0.25989,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00045924,-0.13472,-0.18616,1,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,-0.1348,-0.14885,1,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03245,-0.13487,-0.15042,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0073363,-0.13507,-0.13492,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0034322,-0.1352,-0.20747,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0010206,-0.13529,-0.18728,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00012512,-0.13531,-0.11985,1,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028957,-0.13533,-0.18301,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017549,-0.1354,-0.11915,1,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.00044439,-0.13553,-0.14304,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.035393,-0.13556,-0.122,1,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.018398,-0.13599,-0.16919,1,0
3,GO B CELL ACTIVATION,1.349e-05,-0.13627,-0.16989,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00034072,-0.13627,-0.17261,1,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.025994,-0.13635,-0.1584,1,0
3,GO PIGMENT GRANULE LOCALIZATION,0.01282,-0.13658,-0.1564,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0057817,-0.13663,-0.16375,1,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.044685,-0.13707,-0.10245,1,0
3,GO RESPONSE TO CYTOKINE,0.0015653,-0.13722,-0.15304,1,0
3,GO LEUKOCYTE PROLIFERATION,5.2139e-05,-0.13752,-0.18262,1,0
3,GO CYTOKINE SECRETION,0.00036427,-0.13774,-0.16718,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00059588,-0.13782,-0.13632,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.017969,-0.13784,-0.13105,1,0
3,GO ATP BIOSYNTHETIC PROCESS,0.017137,-0.13838,-0.12921,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015653,-0.13838,-0.16625,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0036303,-0.13851,-0.13108,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.13857,-0.19007,1,0
3,GO B CELL PROLIFERATION,0.0047853,-0.13915,-0.14366,1,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.025414,-0.13941,-0.14385,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.0013457,-0.13943,-0.17667,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0011199,-0.13949,-0.21885,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.13965,-0.1945,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.019283,-0.14022,-0.1494,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.0085714,-0.14029,-0.15571,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,-0.14034,-0.14479,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011549,-0.14036,-0.19254,1,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.019739,-0.14046,-0.16668,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,-0.14116,-0.15776,1,0
3,GO T CELL PROLIFERATION,0.00047456,-0.14122,-0.17393,1,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0028141,-0.14125,-0.16001,1,0
3,GO GRANULOCYTE MIGRATION,0.0039469,-0.14139,-0.1513,1,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.030383,-0.14149,-0.14655,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.016734,-0.14167,-0.18334,1,0
3,GO RESPONSE TO ETHER,0.024288,-0.14185,-0.11441,1,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0057817,-0.14203,-0.15264,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00035231,-0.14214,-0.22517,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012512,-0.14214,-0.20648,1,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.013465,-0.14252,-0.17536,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029782,-0.14289,-0.16849,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.0025083,-0.14291,-0.18684,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,-0.14298,-0.17715,1,0
3,GO V D J RECOMBINATION,0.011904,-0.14309,-0.19634,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0047853,-0.14328,-0.23072,1,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0024367,-0.14331,-0.18293,1,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.035393,-0.14355,-0.18871,1,0
3,GO BLOOD VESSEL REMODELING,0.0053338,-0.14366,-0.2213,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,-0.14393,-0.18759,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14432,-0.21244,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.14442,-0.18871,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.014486,-0.14453,-0.12149,1,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.042857,-0.14456,-0.15514,1,0
3,GO INTERLEUKIN 4 PRODUCTION,0.0014299,-0.14457,-0.20697,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0037331,-0.14465,-0.17389,1,0
3,GO EPITHELIAL TUBE FORMATION,0.00022676,-0.14479,-0.15709,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14492,-0.17924,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00022676,-0.14503,-0.1583,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.014841,-0.14516,-0.13223,1,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.035393,-0.14517,-0.18809,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.017137,-0.14525,-0.11333,1,0
3,GO CHEMOKINE PRODUCTION,0.00035231,-0.14531,-0.21654,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0018173,-0.14548,-0.14576,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0014738,-0.14601,-0.16132,1,0
3,GO MAST CELL ACTIVATION,0.0090226,-0.14638,-0.18771,1,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.017549,-0.14655,-0.14279,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0010528,-0.14678,-0.18093,1,0
3,GO SENSORY PERCEPTION OF TASTE,0.00087311,-0.14694,-0.17863,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,-0.14704,-0.21074,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00019079,-0.14753,-0.18056,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00027832,-0.14789,-0.19066,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001872,-0.14792,-0.17967,1,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.033166,-0.14877,-0.19191,1,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.05161,-0.1488,-0.1726,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.9904e-06,-0.14883,-0.18084,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0015653,-0.14894,-0.18765,1,0
3,GO ENDOTHELIUM DEVELOPMENT,0.0013872,-0.14899,-0.16446,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.011904,-0.14926,-0.19602,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.015574,-0.1494,-0.12683,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.009256,-0.14942,-0.17523,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00353,-0.14945,-0.15172,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.00057693,-0.14947,-0.2105,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14956,-0.1439,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.6174e-05,-0.14956,-0.17964,1,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00059588,-0.14964,-0.12514,1,0
3,GO MICROTUBULE BUNDLE FORMATION,0.00087311,-0.14969,-0.16357,1,0
3,GO RENAL TUBULE DEVELOPMENT,0.001191,-0.14991,-0.17985,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.14994,-0.20246,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,-0.14999,-0.11888,1,0
3,GO NUCLEOTIDE TRANSPORT,0.033166,-0.15011,-0.098094,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00032948,-0.15014,-0.18851,1,0
3,GO SECRETION BY TISSUE,0.013465,-0.15017,-0.16291,1,0
3,GO SECONDARY METABOLIC PROCESS,0.0029794,-0.15038,-0.21197,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.02166,-0.15049,-0.19718,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.00028792,-0.15059,-0.17344,1,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0038387,-0.15116,-0.14668,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00027832,-0.15117,-0.17891,1,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.0075304,-0.1512,-0.1891,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.0015653,-0.15155,-0.14694,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0032441,-0.15164,-0.14705,1,0
3,GO LEUKOCYTE MIGRATION,0.00052342,-0.15167,-0.16869,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.0007696,-0.15171,-0.20216,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013433,-0.15188,-0.18461,1,0
3,GO CELL PROJECTION ASSEMBLY,5.4121e-05,-0.15189,-0.12875,1,0
3,GO PINOCYTOSIS,0.017549,-0.15217,-0.18144,1,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00037661,-0.15284,-0.21262,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019079,-0.15285,-0.22724,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.007729,-0.15288,-0.25354,1,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.031748,-0.15312,-0.2892,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.045624,-0.15342,-0.1403,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.03939,-0.15348,-0.13741,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0039469,-0.15351,-0.21867,1,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00012074,-0.15356,-0.20431,1,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,-0.15376,-0.16147,1,0
3,GO REGULATION OF CELL CELL ADHESION,0.00019753,-0.15387,-0.18583,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00036427,-0.15402,-0.19018,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.15411,-0.20674,1,0
3,GO INTESTINAL LIPID ABSORPTION,0.0057817,-0.15426,-0.30133,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0066042,-0.15435,-0.18217,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.004408,-0.15444,-0.14176,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,5.0226e-05,-0.15451,-0.18967,1,0
3,GO IMMUNE EFFECTOR PROCESS,0.00027832,-0.15462,-0.18866,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010528,-0.15478,-0.19313,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032441,-0.15482,-0.23943,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.01282,-0.15482,-0.17457,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00027832,-0.15485,-0.20869,1,0
3,GO ACTIN NUCLEATION,9.3916e-06,-0.15517,-0.17974,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,-0.15535,-0.19323,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.00084609,-0.15538,-0.14248,1,0
3,GO EYE MORPHOGENESIS,0.0007696,-0.15573,-0.15378,1,0
3,GO GENETIC IMPRINTING,0.001662,-0.1559,-0.18531,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.012508,-0.15608,-0.25662,1,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.020205,-0.15641,-0.32179,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.001191,-0.15661,-0.24229,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0056288,-0.15663,-0.43877,1,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,-0.15667,-0.12284,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00021909,-0.15674,-0.17691,1,0
3,GO RESPONSE TO REDOX STATE,0.042857,-0.15686,-0.15179,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00074557,-0.15704,-0.18448,1,0
3,GO INTERACTION WITH HOST,0.00019079,-0.15709,-0.20914,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.019739,-0.1571,-0.15153,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00079435,-0.15766,-0.18699,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,-0.15773,-0.2157,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014486,-0.15774,-0.12947,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00057693,-0.15783,-0.1292,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,-0.15786,-0.21085,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00067758,-0.15788,-0.18079,1,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.035393,-0.15803,-0.10595,1,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0026572,-0.15807,-0.2037,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0087944,-0.15853,-0.16251,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0038387,-0.15858,-0.15479,1,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.041967,-0.15888,-0.19555,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00034072,-0.1591,-0.19399,1,0
3,GO FOAM CELL DIFFERENTIATION,0.019283,-0.15919,-0.17345,1,0
3,GO RESPONSE TO DSRNA,0.0051916,-0.1593,-0.15298,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,-0.15932,-0.20877,1,0
3,GO HISTAMINE TRANSPORT,0.02843,-0.15977,-0.22185,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0060989,-0.15995,-0.27992,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010092,-0.16008,-0.19963,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00017796,-0.16016,-0.18245,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.8379e-05,-0.16017,-0.21337,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.020205,-0.16021,-0.17337,1,0
3,GO MALE GENITALIA DEVELOPMENT,0.036164,-0.16024,-0.16504,1,0
3,GO CELL KILLING,0.00074557,-0.16039,-0.18127,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,-0.16045,-0.19554,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5816e-05,-0.16078,-0.24415,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.017549,-0.16089,-0.24785,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0025083,-0.16094,-0.13679,1,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.033894,-0.16114,-0.19282,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00026903,-0.16179,-0.2271,1,0
3,GO ENDOTHELIAL CELL MIGRATION,0.017137,-0.16179,-0.13681,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0036303,-0.16222,-0.20852,1,0
3,GO RESPONSE TO VIRUS,7.2754e-05,-0.16236,-0.22056,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,8.7323e-05,-0.16304,-0.15477,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.023205,-0.16307,-0.22829,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0037331,-0.16314,-0.18802,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024286,-0.16323,-0.17159,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0039469,-0.16341,-0.16958,1,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.017549,-0.16375,-0.15881,1,0
3,GO BONE RESORPTION,0.001662,-0.16393,-0.2021,1,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0050528,-0.16395,-0.16202,1,0
3,GO EPITHELIAL CELL DEVELOPMENT,4.0073e-05,-0.16412,-0.20926,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.16446,-0.21357,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.16459,-0.23974,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014138,-0.16466,-0.14851,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,8.6584e-06,-0.16481,-0.16849,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.019739,-0.16498,-0.16212,1,0
3,GO PROTEIN PROCESSING,0.00031859,-0.16503,-0.17643,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016339,-0.16508,-0.20976,1,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.030383,-0.16509,-0.17813,1,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,-0.16521,-0.21723,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00035231,-0.16611,-0.20067,1,0
3,GO PROTEIN DEMANNOSYLATION,0.016734,-0.16667,-0.1826,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,-0.16682,-0.20585,1,0
3,GO REGULATION OF ICOSANOID SECRETION,0.043763,-0.16685,-0.13495,1,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0053338,-0.16686,-0.18038,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,5.4121e-05,-0.16691,-0.21403,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,4.4712e-06,-0.1672,-0.18873,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0090226,-0.16723,-0.18053,1,0
3,GO ALPHA BETA T CELL ACTIVATION,1.5816e-05,-0.16759,-0.22358,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072223,-0.16822,-0.19688,1,0
3,GO RESPONSE TO ISCHEMIA,0.001986,-0.16838,-0.16397,1,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042883,-0.1685,-0.20823,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.16857,-0.18176,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.0037331,-0.16864,-0.19095,1,0
3,GO RESPONSE TO PROGESTERONE,0.0049174,-0.1687,-0.22083,1,0
3,GO MESONEPHROS DEVELOPMENT,0.012508,-0.16888,-0.15112,1,0
3,GO REGULATION OF CHROMATIN BINDING,0.00095906,-0.16935,-0.21586,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.0014299,-0.16935,-0.16125,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,-0.16944,-0.1757,1,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0033369,-0.16957,-0.33203,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.038561,-0.17029,-0.16591,1,0
3,GO ZYMOGEN ACTIVATION,0.0051916,-0.17036,-0.27421,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.049546,-0.17037,-0.23522,1,0
3,GO RIG I SIGNALING PATHWAY,0.0025083,-0.17043,-0.18276,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0010859,-0.17043,-0.23775,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,1.0184e-05,-0.17048,-0.1646,1,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,-0.17053,-0.3756,1,0
3,GO ENTRY INTO HOST,0.00050664,-0.17066,-0.26205,1,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00035231,-0.17079,-0.15974,1,0
3,GO ACUTE PHASE RESPONSE,0.0031536,-0.17081,-0.1885,1,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.013465,-0.17095,-0.14719,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0022332,-0.17123,-0.19664,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0028141,-0.17125,-0.20777,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1617e-05,-0.17141,-0.24649,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.0024367,-0.17178,-0.21932,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0015653,-0.17192,-0.16732,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00037661,-0.17193,-0.21364,1,0
3,GO DIOL METABOLIC PROCESS,0.019739,-0.17195,-0.17019,1,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.004408,-0.17196,-0.17018,1,0
3,GO CENTROSOME DUPLICATION,9.389e-05,-0.17204,-0.17864,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.00055855,-0.17215,-0.159,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0025817,-0.17218,-0.21653,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00063551,-0.17254,-0.21976,1,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.033894,-0.17272,-0.17615,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0029794,-0.17299,-0.21201,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.17333,-0.18159,1,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0028957,-0.17377,-0.17369,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.012508,-0.17408,-0.20794,1,0
3,GO ERYTHROCYTE DEVELOPMENT,0.0032441,-0.17411,-0.13457,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0051916,-0.1742,-0.17726,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0014738,-0.17422,-0.17904,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.019283,-0.17445,-0.2578,1,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0075304,-0.17471,-0.2284,1,0
3,GO CYTOLYSIS,0.0054795,-0.17473,-0.22888,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013872,-0.17476,-0.1755,1,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.0037331,-0.17487,-0.14148,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0045306,-0.17502,-0.19628,1,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0022992,-0.17542,-0.16577,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.7596e-05,-0.17559,-0.19025,1,0
3,GO MYOTUBE CELL DEVELOPMENT,0.016339,-0.17563,-0.15797,1,0
3,GO ENDOCRINE HORMONE SECRETION,0.0056288,-0.17573,-0.15316,1,0
3,GO O GLYCAN PROCESSING,0.0031536,-0.17579,-0.2369,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.00079435,-0.17596,-0.1982,1,0
3,GO RETINA HOMEOSTASIS,0.00032948,-0.17619,-0.14676,1,0
3,GO DNA DEMETHYLATION,0.00029782,-0.17626,-0.19988,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001228,-0.17636,-0.17727,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2139e-05,-0.17658,-0.2252,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015574,-0.17694,-0.22061,1,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0047853,-0.17737,-0.19456,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001165,-0.17743,-0.194,1,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.00052342,-0.17744,-0.15958,1,0
3,GO EPOXYGENASE P450 PATHWAY,0.03939,-0.17744,-0.19399,1,0
3,GO PLATELET ACTIVATION,4.1617e-05,-0.17749,-0.21602,1,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018836,-0.17791,-0.15795,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.013465,-0.17804,-0.23875,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.17827,-0.19891,1,0
3,GO B CELL DIFFERENTIATION,4.1112e-06,-0.17886,-0.20911,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,-0.1789,-0.24823,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.17895,-0.21136,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00036427,-0.17899,-0.16736,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.17912,-0.19717,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017186,-0.17933,-0.24299,1,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036164,-0.17974,-0.1366,1,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,-0.17976,-0.23816,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,-0.1798,-0.18452,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0034322,-0.17994,-0.15644,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011549,-0.18011,-0.26679,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0018173,-0.18039,-0.20622,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031536,-0.18041,-0.17537,1,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0056288,-0.1806,-0.16351,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0067808,-0.18146,-0.20684,1,0
3,GO PHOSPHOLIPID TRANSPORT,9.7346e-05,-0.18173,-0.18523,1,0
3,GO NEPHRON DEVELOPMENT,0.00034072,-0.18181,-0.18869,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00052342,-0.18189,-0.2359,1,0
3,GO CELLULAR RESPONSE TO VIRUS,3.5759e-05,-0.18208,-0.22268,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0081404,-0.18208,-0.18681,1,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00081984,-0.18246,-0.19194,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00036427,-0.18249,-0.21438,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.18284,-0.21292,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00019753,-0.18286,-0.20857,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00017796,-0.18323,-0.26212,1,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0053338,-0.1835,-0.18746,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00049035,-0.18353,-0.2607,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,-0.18402,-0.23911,1,0
3,GO MYELOID CELL HOMEOSTASIS,1.7806e-05,-0.18416,-0.19416,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00090094,-0.18552,-0.17905,1,0
3,GO DEFENSE RESPONSE TO VIRUS,3.6228e-06,-0.18591,-0.29096,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0011549,-0.18602,-0.16315,1,0
3,GO ENDOSOME ORGANIZATION,5.7413e-06,-0.18602,-0.1872,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0027346,-0.18632,-0.20252,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.7118e-05,-0.18636,-0.21519,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00032948,-0.18658,-0.16686,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.18666,-0.16861,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,-0.18693,-0.22136,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0028957,-0.18694,-0.3128,1,0
3,GO REGULATION OF TISSUE REMODELING,0.00353,-0.18727,-0.18813,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.2786e-05,-0.18748,-0.24241,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00010845,-0.18759,-0.23729,1,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.010245,-0.18772,-0.19643,1,0
3,GO PRO B CELL DIFFERENTIATION,0.03939,-0.18773,-0.17599,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0039469,-0.18868,-0.22033,1,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.029068,-0.18875,-0.28838,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,3.6228e-06,-0.18876,-0.24018,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0087944,-0.18891,-0.22537,1,0
3,GO IMMUNOGLOBULIN SECRETION,5.8301e-05,-0.18902,-0.32871,1,0
3,GO KERATINOCYTE PROLIFERATION,0.023741,-0.18905,-0.1901,1,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.020205,-0.18916,-0.18951,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0053338,-0.18936,-0.20841,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,-0.18937,-0.20372,1,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,4.6597e-05,-0.18985,-0.20809,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,2.3418e-05,-0.19054,-0.23827,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.042857,-0.19116,-0.1446,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.1617e-05,-0.19125,-0.20666,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.0079323,-0.19127,-0.24139,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042998,-0.19132,-0.18364,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045924,-0.19145,-0.25472,1,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,-0.19155,-0.18675,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.0039469,-0.19155,-0.20908,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.009256,-0.1917,-0.21063,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0014738,-0.19173,-0.19582,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0007696,-0.19186,-0.24411,1,0
3,GO CELL MIGRATION IN HINDBRAIN,0.041093,-0.19215,-0.19747,1,0
3,GO HISTONE H4 DEACETYLATION,0.0083534,-0.19221,-0.18168,1,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,-0.19228,-0.17259,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.025994,-0.19261,-0.19316,1,0
3,GO MACROPHAGE MIGRATION,0.016734,-0.19285,-0.15018,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,-0.19285,-0.19495,1,0
3,GO REGULATION OF GASTRULATION,0.0036303,-0.19303,-0.19391,1,0
3,GO TYPE I INTERFERON PRODUCTION,0.00012512,-0.19307,-0.22172,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,-0.19317,-0.20567,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,-0.19418,-0.24207,1,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.0030654,-0.19429,-0.21205,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0053338,-0.1944,-0.18269,1,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.030383,-0.19452,-0.19046,1,0
3,GO RESPONSE TO INTERLEUKIN 2,0.0024367,-0.19464,-0.21173,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.00034072,-0.19467,-0.17473,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.0022992,-0.19468,-0.25638,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00020448,-0.19474,-0.22513,1,0
3,GO LIPID DROPLET ORGANIZATION,0.00057693,-0.19506,-0.24384,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0083534,-0.19517,-0.14355,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00052342,-0.19534,-0.26544,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0041716,-0.19545,-0.23709,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.013798,-0.19553,-0.16904,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0028141,-0.19558,-0.17657,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,-0.19644,-0.24342,1,0
3,GO B CELL MEDIATED IMMUNITY,4.1617e-05,-0.19658,-0.25168,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013465,-0.19668,-0.20185,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.0027346,-0.19669,-0.18498,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0053338,-0.19672,-0.37465,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0001165,-0.19674,-0.23763,1,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0090226,-0.19698,-0.16844,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025817,-0.19709,-0.1548,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,-0.1971,-0.17857,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.00031859,-0.19742,-0.19113,1,0
3,GO MICROVILLUS ASSEMBLY,0.053746,-0.19753,-0.20991,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,1.5201e-05,-0.19811,-0.24424,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024367,-0.19818,-0.25076,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,-0.19822,-0.26604,1,0
3,GO SARCOMERE ORGANIZATION,0.0040578,-0.19847,-0.18119,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.021165,-0.19857,-0.19446,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0031536,-0.19869,-0.15963,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0034322,-0.19925,-0.25923,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.050569,-0.19937,-0.14583,1,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00035231,-0.1996,-0.20529,1,0
3,GO VIRAL GENOME REPLICATION,0.00019079,-0.19966,-0.25058,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.017549,-0.19969,-0.24726,1,0
3,GO CELL CHEMOTAXIS,0.00014935,-0.19992,-0.19702,1,0
3,GO MICROVILLUS ORGANIZATION,0.0040578,-0.20036,-0.24987,1,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0047853,-0.20082,-0.23713,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0038387,-0.20094,-0.21145,1,0
3,GO VASCULAR WOUND HEALING,0.047551,-0.20094,-0.1695,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,4.0073e-05,-0.20127,-0.26159,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010092,-0.20136,-0.21635,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.20164,-0.24896,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0027346,-0.20192,-0.23749,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,3.1888e-05,-0.20196,-0.18645,1,0
3,GO ETHANOL METABOLIC PROCESS,0.018836,-0.20221,-0.22088,1,0
3,GO ENDOCRINE PROCESS,0.0021689,-0.20277,-0.19742,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.0015189,-0.2029,-0.20107,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,-0.20301,-0.21454,1,0
3,GO VIRION ASSEMBLY,4.8612e-06,-0.20303,-0.20821,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.019739,-0.20305,-0.31241,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.018836,-0.2032,-0.29272,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0032441,-0.20377,-0.19792,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1702e-06,-0.20405,-0.22395,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00090094,-0.20412,-0.23801,1,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.035393,-0.20415,-0.19456,1,0
3,GO RESPONSE TO COPPER ION,0.0094949,-0.20454,-0.28372,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.015574,-0.20459,-0.15958,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.00027832,-0.20468,-0.24762,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,8.3127e-06,-0.20517,-0.19981,1,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00090094,-0.20534,-0.19398,1,0
3,GO BONE REMODELING,0.0067808,-0.20576,-0.18857,1,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.043763,-0.20577,-0.115,1,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.036948,-0.2058,-0.3584,1,0
3,GO CELLULAR DEFENSE RESPONSE,3.0576e-06,-0.20588,-0.28847,1,0
3,GO REGULATION OF RESPIRATORY BURST,0.0011549,-0.20635,-0.22913,1,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.389e-05,-0.2064,-0.21255,1,0
3,GO CYTOKINETIC PROCESS,1.1493e-05,-0.20698,-0.2535,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.001872,-0.20732,-0.23,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,4.3218e-05,-0.20756,-0.21244,1,0
3,GO LIPID STORAGE,0.0019282,-0.20795,-0.18547,1,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0016129,-0.20814,-0.22175,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0006154,-0.20853,-0.23021,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.00031859,-0.2086,-0.20416,1,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033166,-0.20879,-0.1891,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,-0.2088,-0.23571,1,0
3,GO REPLICATIVE SENESCENCE,0.037747,-0.2091,-0.18202,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00072223,-0.20911,-0.22309,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,-0.20922,-0.2255,1,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0034322,-0.20965,-0.15386,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,-0.20979,-0.26298,1,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.0024367,-0.21051,-0.25494,1,0
3,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,-0.21059,-0.23706,1,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010462,-0.21082,-0.26754,1,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.026586,-0.21085,-0.2233,1,0
3,GO MONOCYTE CHEMOTAXIS,0.00098941,-0.21086,-0.24741,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.21109,-0.17954,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.21165,-0.21018,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017969,-0.21172,-0.29752,1,0
3,GO B CELL APOPTOTIC PROCESS,0.00049035,-0.21179,-0.25333,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00081984,-0.21195,-0.26482,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,-0.21209,-0.27498,1,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0013054,-0.2125,-0.18284,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.024846,-0.21262,-0.19456,1,0
3,GO POSITIVE T CELL SELECTION,0.0020453,-0.21266,-0.17666,1,0
3,GO HORMONE CATABOLIC PROCESS,0.0040578,-0.21298,-0.268,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00016595,-0.21323,-0.23457,1,0
3,GO ACTIVATED T CELL PROLIFERATION,0.00090094,-0.21349,-0.20102,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0039469,-0.2135,-0.28308,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,-0.21379,-0.2708,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.8301e-05,-0.21386,-0.22757,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,-0.21438,-0.24567,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.0015189,-0.21458,-0.24055,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0027346,-0.21505,-0.19654,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0022332,-0.21511,-0.20742,1,0
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0073363,-0.21563,-0.22312,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00023468,-0.21583,-0.2611,1,0
3,GO ERBB2 SIGNALING PATHWAY,2.0833e-05,-0.21644,-0.26576,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.547e-05,-0.21684,-0.28659,1,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0028141,-0.21714,-0.20972,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,-0.21721,-0.20417,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.036948,-0.21748,-0.15889,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.00026903,-0.21769,-0.26574,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.21769,-0.26093,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.018836,-0.21834,-0.1872,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0067808,-0.2186,-0.188,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.023741,-0.21892,-0.25559,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040234,-0.21923,-0.20719,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024286,-0.21992,-0.23488,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018836,-0.22005,-0.2922,1,0
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0085714,-0.22029,-0.24136,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.013139,-0.22034,-0.24011,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0020453,-0.22041,-0.21338,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00014935,-0.22042,-0.22091,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00074557,-0.22052,-0.23118,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,6.7596e-05,-0.22062,-0.24206,1,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.0014738,-0.22117,-0.26106,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0042883,-0.22129,-0.15994,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0050528,-0.22173,-0.1835,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,-0.22194,-0.24205,1,0
3,GO INTERLEUKIN 12 PRODUCTION,3.4728e-06,-0.22211,-0.29373,1,0
3,GO REGULATION OF CELL KILLING,4.8379e-05,-0.22214,-0.25679,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00063551,-0.22233,-0.19661,1,0
3,GO MALE SEX DETERMINATION,0.0038387,-0.22247,-0.24751,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,5.8301e-05,-0.22287,-0.2445,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.011326,-0.22309,-0.29545,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.046579,-0.2238,-0.16822,1,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.017137,-0.22444,-0.21637,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.508e-06,-0.22459,-0.26358,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.016734,-0.22463,-0.21877,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012203,-0.2247,-0.24322,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0038387,-0.2247,-0.22273,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00021167,-0.22558,-0.22814,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00084609,-0.22566,-0.24754,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.015203,-0.22589,-0.30842,1,0
3,GO AUTOPHAGOSOME MATURATION,8.3127e-06,-0.22632,-0.24604,1,0
3,GO AMYLOID BETA CLEARANCE,0.00098941,-0.22633,-0.22719,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,3.5759e-05,-0.22635,-0.21966,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.8583e-05,-0.22652,-0.25966,1,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00011241,-0.22664,-0.19871,1,0
3,GO PANCREAS DEVELOPMENT,0.00079435,-0.22667,-0.21684,1,0
3,GO ICOSANOID METABOLIC PROCESS,4.8612e-06,-0.22668,-0.29497,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011326,-0.2269,-0.28724,1,0
3,GO HAIR CELL DIFFERENTIATION,0.00067758,-0.22705,-0.30225,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00018427,-0.22775,-0.31642,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.034637,-0.22817,-0.22697,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.015574,-0.22819,-0.32833,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,1.349e-05,-0.22914,-0.21975,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025083,-0.22917,-0.21106,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00019079,-0.22951,-0.28921,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013433,-0.22958,-0.24524,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00018427,-0.22973,-0.26764,1,0
3,GO INTERFERON BETA PRODUCTION,7.8282e-05,-0.22975,-0.2223,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.0011199,-0.23004,-0.21837,1,0
3,GO SPERM CAPACITATION,0.00035231,-0.23005,-0.20641,1,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0014299,-0.23007,-0.22609,1,0
3,GO TISSUE REMODELING,0.00045924,-0.23097,-0.22321,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,-0.23157,-0.25202,1,0
3,GO ESTROUS CYCLE,0.0071468,-0.23163,-0.24358,1,0
3,GO T CELL MEDIATED IMMUNITY,0.00022676,-0.23181,-0.28114,1,0
3,GO LIVER MORPHOGENESIS,0.0060989,-0.23202,-0.26133,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001872,-0.23253,-0.22796,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,6.5149e-05,-0.23294,-0.30385,1,0
3,GO PLACENTA DEVELOPMENT,5.2837e-06,-0.23308,-0.24538,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.011612,-0.23334,-0.22078,1,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.05161,-0.23341,-0.20904,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.4346e-05,-0.23393,-0.25058,1,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.02268,-0.23406,-0.20338,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0013457,-0.23426,-0.22204,1,0
3,GO REGULATION OF COAGULATION,0.00042998,-0.23454,-0.28661,1,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0018173,-0.23487,-0.22772,1,0
3,GO GLOMERULUS DEVELOPMENT,0.00040247,-0.23508,-0.27223,1,0
3,GO PIGMENT ACCUMULATION,0.00069957,-0.23533,-0.24213,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00011241,-0.23554,-0.26285,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.00016595,-0.2363,-0.24885,1,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.0032441,-0.23642,-0.22832,1,0
3,GO SKELETAL MUSCLE ADAPTATION,0.04854,-0.23652,-0.1312,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.011326,-0.23688,-0.29969,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00084609,-0.23692,-0.31663,1,0
3,GO RESPONSE TO LEPTIN,0.014841,-0.23696,-0.21683,1,0
3,GO BILE ACID METABOLIC PROCESS,0.0001547,-0.23739,-0.24479,1,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0040578,-0.23753,-0.29836,1,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099891,-0.23757,-0.19277,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,1.0311e-06,-0.23775,-0.24534,1,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.029068,-0.23779,-0.17505,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,-0.23804,-0.24279,1,0
3,GO REGULATION OF BONE REMODELING,0.0059384,-0.23806,-0.20804,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.013798,-0.23846,-0.24683,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0011549,-0.2385,-0.23034,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0016129,-0.23864,-0.21939,1,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0024367,-0.2387,-0.29907,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.23954,-0.27036,1,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0014738,-0.24015,-0.29273,1,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.001191,-0.24059,-0.28135,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,9.3916e-06,-0.24069,-0.31282,1,0
3,GO RUFFLE ORGANIZATION,5.753e-07,-0.2416,-0.25942,1,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0066042,-0.24254,-0.23492,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00023468,-0.24255,-0.22243,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.007729,-0.24275,-0.27836,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,5.2139e-05,-0.24295,-0.32085,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.4421e-05,-0.24328,-0.26399,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00044439,-0.24388,-0.23842,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,3.4728e-06,-0.24465,-0.27055,1,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047853,-0.24528,-0.28865,1,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00049035,-0.24546,-0.21638,1,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.017549,-0.24561,-0.25071,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.027188,-0.24568,-0.13963,1,0
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0053338,-0.24622,-0.29305,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0031536,-0.24657,-0.19922,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00069957,-0.2476,-0.32612,1,0
3,GO RUFFLE ASSEMBLY,7.889e-07,-0.24772,-0.25036,1,0
3,GO MAGNESIUM ION TRANSPORT,5.7413e-06,-0.24806,-0.30052,1,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00011241,-0.24842,-0.29403,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00032948,-0.24865,-0.22503,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0013457,-0.24887,-0.22264,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.00092958,-0.24896,-0.26571,1,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00084609,-0.24956,-0.22203,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.016734,-0.24956,-0.38989,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00018427,-0.24982,-0.23766,1,0
3,GO INTERLEUKIN 6 PRODUCTION,1.0311e-06,-0.24986,-0.25164,1,0
3,GO SKIN DEVELOPMENT,3.1888e-05,-0.25008,-0.24267,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.014486,-0.25132,-0.20024,1,0
3,GO INTERLEUKIN 8 PRODUCTION,3.4421e-05,-0.25161,-0.26375,1,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0067808,-0.25167,-0.24715,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,-0.25182,-0.21858,1,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.040234,-0.25236,-0.22468,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,5.7413e-06,-0.25266,-0.30234,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00016023,-0.25312,-0.30547,1,0
3,GO EOSINOPHIL MIGRATION,0.0039469,-0.25314,-0.33673,1,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.040234,-0.25318,-0.31809,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031748,-0.2535,-0.21394,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,8.2505e-07,-0.25363,-0.32642,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.8379e-05,-0.25406,-0.28955,1,0
3,GO EPIDERMIS DEVELOPMENT,2.2524e-05,-0.2541,-0.2431,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00041602,-0.25555,-0.29162,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0038387,-0.25562,-0.29218,1,0
3,GO SPINAL CORD PATTERNING,0.0087944,-0.25563,-0.24283,1,0
3,GO BIOLOGICAL PHASE,0.033166,-0.2559,-0.32727,1,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00036427,-0.25617,-0.26599,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0045306,-0.25629,-0.38517,1,0
3,GO EMBRYONIC HEMOPOIESIS,0.001228,-0.2566,-0.21903,1,0
3,GO GERMINAL CENTER FORMATION,0.017969,-0.25681,-0.28634,1,0
3,GO TRANSCYTOSIS,6.7596e-05,-0.25794,-0.24346,1,0
3,GO VIRAL RELEASE FROM HOST CELL,4.5813e-07,-0.25822,-0.27857,1,0
3,GO T CELL SELECTION,0.0025817,-0.25841,-0.17252,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,5.0226e-05,-0.25842,-0.31036,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0016129,-0.25925,-0.26186,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.5331e-06,-0.25932,-0.29812,1,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016734,-0.26101,-0.26029,1,0
3,GO NECROTIC CELL DEATH,0.00069957,-0.26175,-0.24807,1,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0007696,-0.2618,-0.30188,1,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013917,-0.26277,-0.25581,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,7.013e-05,-0.26277,-0.25226,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,4.4712e-06,-0.26339,-0.28481,1,0
3,GO ER OVERLOAD RESPONSE,0.033166,-0.26405,-0.20384,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042998,-0.26408,-0.32444,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00012074,-0.26412,-0.24638,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.012203,-0.26518,-0.2249,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.26547,-0.32186,1,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.015574,-0.26558,-0.25503,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,-0.26567,-0.28976,1,0
3,GO WATER HOMEOSTASIS,0.0010859,-0.2666,-0.24307,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0030654,-0.26752,-0.26249,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0099891,-0.26796,-0.43197,1,0
3,GO REGULATION OF WOUND HEALING,6.5149e-05,-0.26837,-0.28992,1,0
3,GO INTERLEUKIN 10 PRODUCTION,1.1964e-05,-0.26843,-0.2883,1,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.029719,-0.26862,-0.19443,1,0
3,GO ENDOCARDIUM DEVELOPMENT,0.018398,-0.2693,-0.2307,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.0006154,-0.26939,-0.31114,1,0
3,GO INTERLEUKIN 13 PRODUCTION,0.0059384,-0.26991,-0.26897,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.27,-0.25704,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0046564,-0.27219,-0.35907,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0018173,-0.27289,-0.32491,1,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.036164,-0.2733,-0.22995,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0576e-06,-0.27331,-0.32003,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.00036427,-0.27386,-0.27448,1,0
3,GO SIGNAL PEPTIDE PROCESSING,6.2786e-05,-0.27455,-0.35918,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,1.8251e-06,-0.2747,-0.28631,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.2533e-07,-0.27599,-0.30411,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.27599,-0.27453,1,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.043763,-0.2761,-0.25581,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.1112e-06,-0.27697,-0.2946,1,0
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.019739,-0.27818,-0.22433,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.9532e-05,-0.27823,-0.2547,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,6.2367e-06,-0.27843,-0.31747,1,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.02068,-0.2801,-0.36336,1,0
3,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,-0.28027,-0.3648,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0010528,-0.28029,-0.33755,1,0
3,GO INTERLEUKIN 5 PRODUCTION,0.011047,-0.28092,-0.21074,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00072223,-0.28173,-0.30843,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.7145e-05,-0.2822,-0.29097,1,0
3,GO ACTIN FILAMENT SEVERING,0.0047853,-0.2824,-0.31525,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4674e-06,-0.28415,-0.31777,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.7596e-05,-0.28487,-0.29067,1,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.00014418,-0.2852,-0.26135,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00019079,-0.28537,-0.35242,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,2.7343e-05,-0.28633,-0.34976,1,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.041967,-0.28645,-0.22356,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,-0.28692,-0.30594,1,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0081404,-0.28721,-0.20979,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026903,-0.28802,-0.26272,1,0
3,GO INTERLEUKIN 1 PRODUCTION,2.2658e-06,-0.2884,-0.34316,1,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0024367,-0.28859,-0.21119,1,0
3,GO PLATELET AGGREGATION,2.6307e-05,-0.28918,-0.28722,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.1702e-06,-0.28972,-0.2868,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019079,-0.28997,-0.36913,1,0
3,GO POSITIVE REGULATION OF CELL SIZE,0.00012512,-0.29019,-0.33138,1,0
3,GO MUSCLE CELL MIGRATION,5.0226e-05,-0.29145,-0.2889,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00013433,-0.29179,-0.3439,1,0
3,GO INTESTINAL ABSORPTION,0.00014935,-0.29193,-0.32136,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.0013872,-0.29235,-0.36432,1,0
3,GO HETEROTYPIC CELL CELL ADHESION,3.0576e-06,-0.29252,-0.34378,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.00010462,-0.29321,-0.32558,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,4.1617e-05,-0.29375,-0.31832,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.018836,-0.29395,-0.20767,1,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.027803,-0.29423,-0.30208,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00067758,-0.29434,-0.31884,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,7.0571e-06,-0.29463,-0.30316,1,0
3,GO SPLEEN DEVELOPMENT,1.4044e-06,-0.29584,-0.28265,1,0
3,GO OSTEOBLAST PROLIFERATION,0.00010462,-0.29629,-0.3177,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.0179e-06,-0.29686,-0.29205,1,0
3,GO DECIDUALIZATION,0.0038387,-0.29723,-0.29606,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9904e-06,-0.29804,-0.33319,1,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.32016,1,0
3,GO ANOIKIS,1.104e-05,-0.29847,-0.32652,1,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.020205,-0.29852,-0.27063,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00054072,-0.29897,-0.33388,1,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.019283,-0.29926,-0.345,1,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,-0.29949,-0.23421,1,0
3,GO T HELPER CELL LINEAGE COMMITMENT,4.8379e-05,-0.30004,-0.27867,1,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0075304,-0.30162,-0.26013,1,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0028957,-0.3024,-0.25799,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.0184e-05,-0.30264,-0.28678,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0054795,-0.30381,-0.29111,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,1.7806e-05,-0.30409,-0.34839,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0059384,-0.30429,-0.41633,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042998,-0.30511,-0.32144,1,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.02843,-0.30537,-0.18731,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9926e-07,-0.3054,-0.31235,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.017137,-0.30542,-0.47191,1,0
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,-0.30585,-0.29082,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0079323,-0.30608,-0.25945,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.7145e-05,-0.30622,-0.36877,1,0
3,GO AXONEME ASSEMBLY,3.1888e-05,-0.30878,-0.31671,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.3132e-05,-0.30958,-0.33903,1,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0087944,-0.31152,-0.43355,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.0504e-05,-0.31164,-0.4274,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2367e-06,-0.31241,-0.29558,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.00010092,-0.31387,-0.41922,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,-0.316,-0.30444,1,0
3,GO T CELL LINEAGE COMMITMENT,3.7145e-05,-0.31675,-0.28651,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010528,-0.31782,-0.3985,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.014138,-0.31831,-0.24614,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,-0.3189,-0.30745,1,0
3,GO NATURAL KILLER CELL PROLIFERATION,0.00022676,-0.31933,-0.35296,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012512,-0.31948,-0.27264,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,9.7346e-05,-0.32053,-0.26301,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,2.5774e-06,-0.32067,-0.35368,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,-0.32067,-0.4067,1,0
3,GO ETHER METABOLIC PROCESS,0.00024286,-0.32158,-0.3238,1,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0081404,-0.32171,-0.29305,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010092,-0.32231,-0.41032,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.00022676,-0.32293,-0.31857,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.32306,-0.3267,1,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0053338,-0.32368,-0.23044,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00087311,-0.32478,-0.33323,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.4346e-05,-0.32514,-0.37414,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.17e-07,-0.32574,-0.36739,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.906e-06,-0.32644,-0.35873,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,9.0551e-05,-0.32649,-0.49659,1,0
3,GO LIPOXYGENASE PATHWAY,0.0015653,-0.32839,-0.35137,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,-0.32858,-0.25416,1,0
3,GO LEFT RIGHT PATTERN FORMATION,0.00012964,-0.32909,-0.30426,1,0
3,GO KERATINOCYTE DEVELOPMENT,0.025414,-0.33042,-0.28399,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.031059,-0.33255,-0.23364,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,3.5759e-05,-0.33346,-0.36409,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.3916e-06,-0.33422,-0.36738,1,0
3,GO PROGESTERONE METABOLIC PROCESS,0.00044439,-0.3345,-0.46742,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.3528e-06,-0.33772,-0.40042,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,-0.33785,-0.39231,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.8301e-05,-0.33818,-0.3144,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.4044e-06,-0.33845,-0.33214,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0010206,-0.33953,-0.36921,1,0
3,GO SUPEROXIDE ANION GENERATION,0.00017186,-0.34021,-0.32774,1,0
3,GO TRANSPOSITION,1.7118e-05,-0.34022,-0.41665,1,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0019282,-0.34024,-0.27362,1,0
3,GO ZYMOGEN INHIBITION,0.00018427,-0.34126,-0.40275,1,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00054072,-0.3422,-0.34746,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.0024367,-0.34261,-0.46016,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3218e-05,-0.34314,-0.35544,1,0
3,GO PROSTANOID METABOLIC PROCESS,2.3418e-05,-0.34391,-0.43093,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.017969,-0.34458,-0.29141,1,0
3,GO DETECTION OF OTHER ORGANISM,4.3218e-05,-0.34508,-0.39188,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,-0.34512,-0.34359,1,0
3,GO REFLEX,0.00087311,-0.34684,-0.36676,1,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0069616,-0.34711,-0.41594,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.7596e-05,-0.34729,-0.42145,1,0
3,GO LIPID TRANSLOCATION,1.8251e-06,-0.34769,-0.32187,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.1192e-05,-0.34789,-0.33195,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,9.7801e-06,-0.34994,-0.32441,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0031536,-0.3503,-0.31511,1,0
3,GO HISTAMINE SECRETION,0.004408,-0.35224,-0.34449,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,5.2533e-07,-0.35314,-0.34367,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,5.1671e-08,-0.35462,-0.38135,1,0
3,GO KERATINOCYTE DIFFERENTIATION,1.104e-05,-0.35542,-0.33714,1,0
3,GO GONADOTROPIN SECRETION,0.00055855,-0.35713,-0.35836,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0021062,-0.35735,-0.34442,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.8891e-07,-0.35749,-0.37725,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.35752,-0.4848,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,-0.35926,-0.38583,1,0
3,GO PROTEIN ADP RIBOSYLATION,1.1493e-05,-0.35936,-0.31088,1,0
3,GO POSITIVE REGULATION OF COAGULATION,2.8077e-06,-0.35968,-0.36426,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.0039469,-0.35989,-0.27633,1,0
3,GO VIRAL BUDDING,4.1802e-07,-0.36018,-0.30959,1,0
3,GO REGULATION OF ANOIKIS,3.5759e-05,-0.36079,-0.41494,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0014299,-0.36235,-0.41913,1,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021062,-0.36436,-0.37608,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00016595,-0.36442,-0.39438,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0079323,-0.36585,-0.46838,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,5.4977e-07,-0.36655,-0.37184,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.00072223,-0.36744,-0.33667,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0073e-05,-0.36865,-0.39858,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0021062,-0.36881,-0.41526,1,0
3,GO RESPONSE TO INTERFERON BETA,0.0015189,-0.36925,-0.47942,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.2837e-06,-0.36938,-0.38245,1,0
3,GO ADRENAL GLAND DEVELOPMENT,0.00045924,-0.36996,-0.30908,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00016595,-0.3702,-0.37092,1,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0099891,-0.37217,-0.32764,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.3528e-06,-0.37291,-0.4365,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00027832,-0.37409,-0.36678,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.6455e-05,-0.37503,-0.39173,1,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.0010528,-0.37541,-0.29342,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,2.9532e-05,-0.37623,-0.38386,1,0
3,GO GAP JUNCTION ASSEMBLY,3.8583e-05,-0.37954,-0.47572,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.37995,-0.37162,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9263e-05,-0.3813,-0.36927,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,3.3132e-05,-0.38141,-0.47901,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0014738,-0.38151,-0.48088,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.5201e-05,-0.3827,-0.38461,1,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0017641,-0.38506,-0.33924,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00017186,-0.38724,-0.38847,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2879e-07,-0.38762,-0.46097,1,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0059384,-0.3883,-0.31908,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,-0.38891,-0.42751,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,6.0504e-05,-0.38909,-0.49545,1,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00092958,-0.39007,-0.34123,1,0
3,GO INTERFERON ALPHA PRODUCTION,9.4334e-07,-0.39028,-0.38184,1,0
3,GO TOXIN METABOLIC PROCESS,0.010506,-0.39189,-0.28136,1,0
3,GO DNA DEAMINATION,0.001191,-0.39408,-0.37956,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.5816e-05,-0.3966,-0.39359,1,0
3,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,-0.3972,-0.51811,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0194e-07,-0.40082,-0.44143,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.0689e-05,-0.40384,-0.38688,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,2.5774e-06,-0.40399,-0.41128,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3287e-06,-0.40454,-0.44126,1,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.038561,-0.40676,-0.32394,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.00040247,-0.4106,-0.35141,1,0
3,GO GLIAL CELL FATE COMMITMENT,0.0079323,-0.41107,-0.33351,1,0
3,GO VASCULAR TRANSPORT,0.00032948,-0.41351,-0.43145,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,-0.41442,-0.5307,1,0
3,GO REGULATION OF PLATELET AGGREGATION,7.8282e-05,-0.41461,-0.4927,1,0
3,GO REGULATION OF TRANSPOSITION,7.9801e-06,-0.4174,-0.47822,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.1888e-05,-0.41765,-0.35528,1,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,2.2879e-07,-0.41917,-0.37594,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0025817,-0.41948,-0.3296,1,0
3,GO TOLERANCE INDUCTION,0.00035231,-0.41976,-0.4532,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.4994e-06,-0.42159,-0.52534,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,6.2786e-05,-0.42252,-0.46546,1,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0085714,-0.42279,-0.3354,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.6015e-06,-0.4252,-0.49017,1,0
3,GO KERATINIZATION,2.7343e-05,-0.42753,-0.36981,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,5.2533e-07,-0.42842,-0.47284,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,3.7145e-05,-0.4294,-0.39364,1,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,-0.43125,-0.3942,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.1192e-05,-0.4321,-0.41443,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.2366e-07,-0.43419,-0.49423,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.00017796,-0.43898,-0.42635,1,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0019282,-0.43953,-0.34183,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00074557,-0.44239,-0.4068,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,2.6902e-06,-0.44317,-0.50979,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4268e-07,-0.44578,-0.45789,1,0
3,GO RESPONSE TO INTERLEUKIN 18,0.00017796,-0.44644,-0.5171,1,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,6.7728e-06,-0.44842,-0.39402,1,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012662,-0.45043,-0.52504,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7801e-06,-0.45496,-0.55607,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00042998,-0.45839,-0.45926,1,0
3,GO CORNIFICATION,3.5759e-05,-0.45883,-0.41776,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.0226e-05,-0.45926,-0.63387,1,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.2754e-05,-0.46042,-0.40321,1,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.7413e-06,-0.46129,-0.46877,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,1.2962e-05,-0.46211,-0.39934,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00017186,-0.46555,-0.43602,1,0
3,GO RESPONSE TO WATER,6.7596e-05,-0.46905,-0.42596,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0013872,-0.4696,-0.39297,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,-0.47305,-0.4793,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.508e-06,-0.47602,-0.47528,1,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.00036427,-0.48016,-0.39339,1,0
3,GO RETINA LAYER FORMATION,0.00010845,-0.48066,-0.42623,1,0
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.1964e-05,-0.48384,-0.45744,1,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.038561,-0.49499,-0.24544,1,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.9418e-06,-0.49691,-0.52259,1,0
3,GO RESPONSE TO LITHIUM ION,3.7145e-05,-0.49709,-0.47986,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,-0.50367,-0.36502,1,0
3,GO RESPONSE TO FORSKOLIN,4.2876e-06,-0.50527,-0.46257,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,9.3916e-06,-0.50832,-0.45937,1,0
3,GO SEROTONIN METABOLIC PROCESS,0.011326,-0.50881,-0.31563,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.4692e-06,-0.51142,-0.47635,1,0
3,GO NOTCH RECEPTOR PROCESSING,8.6584e-06,-0.52724,-0.48523,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00050664,-0.52989,-0.49198,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6597e-05,-0.5309,-0.47422,1,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,5.6174e-05,-0.53712,-0.45348,1,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0045306,-0.53873,-0.35833,1,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.00024286,-0.54336,-0.47666,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.2837e-06,-0.55036,-0.52776,1,0
3,GO EPITHELIAL CELL MORPHOGENESIS,4.1112e-06,-0.5572,-0.53601,1,0
3,GO APICAL JUNCTION ASSEMBLY,4.9191e-08,-0.56098,-0.52845,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00016595,-0.56502,-0.52614,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.00032948,-0.57307,-0.47633,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.57605,-0.58621,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,2.8077e-06,-0.57759,-0.60574,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3418e-05,-0.57882,-0.57934,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049035,-0.5793,-0.43966,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,-0.58673,-0.52029,1,0
3,GO PSEUDOPODIUM ORGANIZATION,0.00020448,-0.5905,-0.44339,1,0
3,GO GAMMA DELTA T CELL ACTIVATION,1.4044e-06,-0.59862,-0.56138,1,0
3,GO MUCUS SECRETION,0.00084609,-0.60014,-0.52376,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.1702e-06,-0.61866,-0.60316,1,0
3,GO CYTIDINE TO URIDINE EDITING,0.0001165,-0.61921,-0.65655,1,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0025817,-0.63422,-0.53362,1,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,6.4994e-06,-0.63775,-0.59594,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.3218e-05,-0.64222,-0.63275,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.2754e-05,-0.64706,-0.7541,1,0
3,GO LUNG CELL DIFFERENTIATION,0.00012074,-0.65646,-0.51701,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,9.4334e-07,-0.67958,-0.63089,1,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,7.6603e-06,-0.72682,-0.57253,1,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.6322e-07,-0.74931,-0.65572,1,0
3,GO EPITHELIAL CELL CELL ADHESION,1.5691e-07,-0.7504,-0.79986,1,0
3,GO LIPID DROPLET FORMATION,7.3528e-06,-0.767,-0.68572,1,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.1904e-06,-0.77652,-0.71411,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,6.0504e-05,-0.8094,-0.88752,1,0
3,GO NOSE DEVELOPMENT,0.0001547,-0.96706,-0.65925,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,5.0194e-07,-0.96787,-0.81736,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,7.8282e-05,-0.99536,-1.0952,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,1.8084e-07,-0.99605,-1.0676,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,3.0264e-07,-1.0047,-0.89157,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.2308e-06,-1.1075,-0.9977,1,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.14048,0.3332,0.13527,0,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.079444,0.32819,0.20651,0,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.060602,0.30348,0.18271,0,1
3,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,0,1
3,GO TOOTH MINERALIZATION,0.075049,0.29597,0.14282,0,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.10465,0.27498,0.12566,0,1
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.077957,0.2721,0.20978,0,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,0,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.23858,0.17847,0,1
3,GO THALAMUS DEVELOPMENT,0.42347,0.211,0.095315,0,1
3,GO NEUROBLAST DIVISION,0.10465,0.20113,0.16202,0,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.14285,0.19643,0.11303,0,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.10654,0.19335,0.18023,0,1
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.30402,0.18828,0.071766,0,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.2839,0.18712,0.13208,0,1
3,GO COCHLEA MORPHOGENESIS,0.070855,0.185,0.11256,0,1
3,GO RESPONSE TO VITAMIN A,0.15015,0.18388,0.10886,0,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.12908,0.18381,0.11776,0,1
3,GO DETECTION OF TEMPERATURE STIMULUS,0.15264,0.18144,0.16619,0,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.065563,0.17947,0.11335,0,1
3,GO BASIC AMINO ACID TRANSPORT,0.13583,0.17471,0.16587,0,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.1745,0.11047,0,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20937,0.16977,0.091043,0,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.099158,0.1652,0.11653,0,1
3,GO ODONTOGENESIS,0.13814,0.16051,0.075846,0,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.061812,0.15431,0.10314,0,1
3,GO NUCLEUS LOCALIZATION,0.082489,0.15271,0.095375,0,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072231,0.14838,0.1029,0,1
3,GO BONE MORPHOGENESIS,0.10654,0.1475,0.072442,0,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.11235,0.13913,0.10017,0,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.10096,0.13825,0.077172,0,1
3,GO MESODERMAL CELL FATE COMMITMENT,0.28785,0.13813,0.055579,0,1
3,GO T CELL HOMEOSTASIS,0.12689,0.13464,0.053061,0,1
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.075049,0.12975,0.11657,0,1
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20937,0.12905,0.064557,0,1
3,GO AORTIC VALVE DEVELOPMENT,0.18508,0.12903,0.083409,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.13583,0.12709,0.104,0,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12908,0.1266,0.11207,0,1
3,GO REGULATION OF ODONTOGENESIS,0.40843,0.12506,0.031587,0,1
3,GO SMOOTH MUSCLE CONTRACTION,0.11636,0.12434,0.063471,0,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.11039,0.12311,0.08545,0,1
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.093897,0.12094,0.068757,0,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.19695,0.12009,0.063184,0,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.070855,0.11661,0.15768,0,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.25001,0.11002,0.084059,0,1
3,GO SLEEP,0.29184,0.10954,0.05629,0,1
3,GO HEART VALVE DEVELOPMENT,0.27227,0.10804,0.063939,0,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.064293,0.10773,0.10406,0,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.21905,0.1076,0.065025,0,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.26847,0.10608,0.07133,0,1
3,GO SECRETORY GRANULE ORGANIZATION,0.22568,0.10553,0.055856,0,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.075049,0.10372,0.095769,0,1
3,GO SPINDLE MIDZONE ASSEMBLY,0.60272,0.1027,0.03177,0,1
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.060602,0.10188,0.083724,0,1
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17099,0.10112,0.059583,0,1
3,GO RESPONSE TO LEAD ION,0.2,0.099167,0.066486,0,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.10654,0.096015,0.079689,0,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.068167,0.09548,0.080124,0,1
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.070855,0.095187,0.082986,0,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.2,0.093725,0.074412,0,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.070855,0.093583,0.11512,0,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.072231,0.09215,0.069895,0,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.12908,0.091841,0.068493,0,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.073629,0.090744,0.0655,0,1
3,GO RRNA 3 END PROCESSING,0.1313,0.090271,0.099363,0,1
3,GO RNA STABILIZATION,0.13583,0.088143,0.071223,0,1
3,GO CELLULAR RESPONSE TO UV,0.090515,0.086893,0.060283,0,1
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.30815,0.085366,0.044127,0,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.075049,0.084777,0.056319,0,1
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.14526,0.084508,0.05929,0,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.38408,0.084446,0.047501,0,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.29184,0.083715,0.0484,0,1
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25363,0.081677,0.04365,0,1
3,GO REGULATION OF DNA METHYLATION,0.55487,0.078676,0.022381,0,1
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.3746,0.078174,0.024524,0,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.082489,0.076793,0.056017,0,1
3,GO MAINTENANCE OF CELL POLARITY,0.23937,0.076611,0.073465,0,1
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.55487,0.076436,0.026264,0,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.17653,0.075733,0.040967,0,1
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.77618,0.074206,-0.012709,0,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068167,0.073734,0.06478,0,1
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.12049,0.071179,0.052823,0,1
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.37932,0.069578,0.054866,0,1
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.059411,0.068576,0.062462,0,1
3,GO MITOCHONDRIAL FISSION,0.17934,0.066962,0.067096,0,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.092194,0.066661,0.065468,0,1
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.060602,0.065935,0.06487,0,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.063042,0.064006,0.038941,0,1
3,GO MISMATCH REPAIR,0.26098,0.061634,0.040266,0,1
3,GO RNA CAPPING,0.087232,0.061067,0.064207,0,1
3,GO PRENYLATION,0.43883,0.060469,0.026651,0,1
3,GO HISTONE DEUBIQUITINATION,0.22905,0.058474,0.029267,0,1
3,GO MRNA EXPORT FROM NUCLEUS,0.059411,0.057863,0.069993,0,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56666,0.056407,0.022729,0,1
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.079444,0.055331,0.075593,0,1
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.050937,0.02684,0,1
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.11434,0.050566,0.041946,0,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.33373,0.048465,0.043883,0,1
3,GO MRNA TRANSPORT,0.095625,0.047191,0.05429,0,1
3,GO CHROMATIN SILENCING,0.46512,0.044804,0.026672,0,1
3,GO DNA REPAIR,0.077957,0.037393,0.035463,0,1
3,GO REGULATION OF HISTONE METHYLATION,0.15773,0.036244,0.048961,0,1
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.0333,0.029814,0,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,0.58202,0.62154,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00059588,0.56333,0.5821,0,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.0551e-05,0.37466,0.4369,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00028792,0.37316,0.34224,0,0
3,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00090094,0.36122,0.49279,0,0
3,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,0,0
3,GO SHORT TERM MEMORY,0.0022332,0.35017,0.32134,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,2.1663e-05,0.32993,0.32988,0,0
3,GO REGULATION OF NEURON MIGRATION,0.00036427,0.32467,0.28077,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0067808,0.32231,0.3593,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.027188,0.31677,0.24137,0,0
3,GO PREPULSE INHIBITION,0.011047,0.31329,0.33627,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,0.30979,0.37234,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00017186,0.30909,0.303,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0010528,0.30801,0.47087,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.087232,0.30609,0.1616,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.21256,0.29727,0.11575,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,0,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0075304,0.28483,0.24571,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.015953,0.28339,0.195,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0027346,0.28208,0.29485,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,0,0
3,GO VOCALIZATION BEHAVIOR,0.030383,0.27735,0.35457,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.029068,0.27701,0.172,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0064317,0.27528,0.21508,0,0
3,GO GLUTAMATE SECRETION,0.00029782,0.27482,0.30144,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016023,0.27422,0.2883,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.012203,0.2705,0.32617,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.0551e-05,0.2694,0.31875,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0031536,0.26779,0.27331,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019739,0.2609,0.27203,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.2,0.25982,0.18244,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,0,0
3,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.11235,0.2487,0.20634,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0015653,0.2416,0.24139,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,2.0033e-05,0.2415,0.25324,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0059384,0.24118,0.17636,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.0012662,0.23757,0.23734,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0056288,0.23754,0.21434,0,0
3,GO RESPONSE TO HYPEROXIA,0.21905,0.23675,0.093777,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.033166,0.2364,0.23571,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.034637,0.2307,0.16896,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.7596e-05,0.22515,0.29582,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.097379,0.22447,0.14673,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1888e-05,0.22368,0.30447,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0087944,0.2208,0.20689,0,0
3,GO ENAMEL MINERALIZATION,0.19393,0.22049,0.12673,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.05824,0.21712,0.14067,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0027346,0.2165,0.26938,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.095625,0.21504,0.16926,0,0
3,GO NEURON RECOGNITION,0.014841,0.21085,0.20202,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.097379,0.21014,0.1369,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00021909,0.20953,0.26645,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.05824,0.2088,0.19463,0,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031059,0.20867,0.18668,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.00016023,0.20566,0.23771,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.1028,0.20502,0.1412,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00044439,0.20471,0.21521,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0056288,0.20426,0.24748,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.036948,0.20256,0.14063,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.0695,0.20112,0.27288,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.29586,0.20077,0.089066,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.3746,0.20026,0.1234,0,0
3,GO SEROTONIN TRANSPORT,0.092194,0.19987,0.13843,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.066855,0.19852,0.15497,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.12689,0.19843,0.1108,0,0
3,GO AMP METABOLIC PROCESS,0.14769,0.19832,0.097326,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0022332,0.1974,0.26312,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.064293,0.197,0.15482,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.015203,0.19653,0.20902,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.15773,0.19313,0.1908,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.26471,0.19306,0.087065,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00024286,0.19188,0.24956,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.00012074,0.19017,0.20882,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.01282,0.18917,0.28102,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.31232,0.18914,0.10494,0,0
3,GO AXONAL FASCICULATION,0.066855,0.18785,0.20241,0,0
3,GO RESPONSE TO MANGANESE ION,0.095625,0.18754,0.10711,0,0
3,GO NEURAL CREST CELL MIGRATION,0.064293,0.18719,0.12956,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18219,0.18645,0.15957,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0013054,0.18509,0.20822,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25001,0.18443,0.067083,0,0
3,GO FOREBRAIN CELL MIGRATION,0.00049035,0.18415,0.23235,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.11434,0.18411,0.11316,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.013139,0.18303,0.13074,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0695,0.18298,0.16604,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.045624,0.18289,0.16825,0,0
3,GO NEURON PROJECTION GUIDANCE,0.0056288,0.18235,0.16389,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.030383,0.18146,0.16576,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.18508,0.18137,0.13887,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0099891,0.18129,0.18737,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12473,0.18122,0.10465,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.19095,0.1812,0.11729,0,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.055956,0.17964,0.1357,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.012203,0.17899,0.17322,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.00084609,0.17881,0.23235,0,0
3,GO NEURON PROJECTION EXTENSION,0.00065623,0.1778,0.17702,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.1313,0.17674,0.16827,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00069957,0.17671,0.2571,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0081404,0.17668,0.20275,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.00014935,0.17661,0.21319,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.1313,0.17567,0.12315,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.092194,0.17496,0.12255,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.41341,0.17478,0.035279,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21256,0.17362,0.047425,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.20309,0.17338,0.15988,0,0
3,GO RELAXATION OF MUSCLE,0.082489,0.17281,0.12867,0,0
3,GO PROSTATE GLAND GROWTH,0.17099,0.17216,0.068806,0,0
3,GO LEUKOCYTE AGGREGATION,0.077957,0.17168,0.13519,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.51459,0.17098,0.078423,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.077957,0.17053,0.092339,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.027803,0.17038,0.1883,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.22905,0.17035,0.096224,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011549,0.17007,0.27365,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,0,0
3,GO NEUROTRANSMITTER SECRETION,0.0013054,0.16961,0.24314,0,0
3,GO NADH METABOLIC PROCESS,0.0020453,0.16892,0.23118,0,0
3,GO HEME METABOLIC PROCESS,0.13814,0.16832,0.099533,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0073363,0.1681,0.19008,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.059411,0.16806,0.13846,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.092194,0.16715,0.09528,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0075304,0.16634,0.16894,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10654,0.163,0.088909,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.13583,0.16295,0.09286,0,0
3,GO DENDRITE MORPHOGENESIS,0.0014738,0.16149,0.18245,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.082489,0.16141,0.11853,0,0
3,GO RECEPTOR CLUSTERING,0.065563,0.16141,0.10745,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.16023,0.13459,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.18508,0.16014,0.11315,0,0
3,GO RESPONSE TO PROTOZOAN,0.55487,0.15933,0.020455,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.11235,0.1591,0.15054,0,0
3,GO HEPARIN METABOLIC PROCESS,0.045624,0.15858,0.22973,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00081984,0.15747,0.20098,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015203,0.15686,0.17096,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.1313,0.15494,0.20744,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.15474,0.11877,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.20937,0.15455,0.1298,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.30815,0.15376,0.0535,0,0
3,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13814,0.15332,0.096099,0,0
3,GO VASCULOGENESIS,0.32077,0.15279,0.034338,0,0
3,GO RESPONSE TO CAFFEINE,0.10096,0.15263,0.1189,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.029068,0.15185,0.30318,0,0
3,GO NERVE DEVELOPMENT,0.11841,0.15175,0.09633,0,0
3,GO DENDRITE DEVELOPMENT,0.00087311,0.15132,0.17742,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.010506,0.14997,0.14022,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,0.14983,0.13446,0,0
3,GO XENOBIOTIC TRANSPORT,0.23937,0.14962,0.036327,0,0
3,GO AXON EXTENSION,0.0028957,0.14933,0.15833,0,0
3,GO SYNAPSE ASSEMBLY,0.012203,0.1488,0.16867,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12908,0.14773,0.09882,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.054842,0.14706,0.17956,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.68418,0.14644,0.042439,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.26098,0.14593,0.088138,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.34702,0.14582,0.067119,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.12259,0.14555,0.1142,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.2839,0.14515,0.061047,0,0
3,GO FIBRINOLYSIS,0.27227,0.14489,-0.014555,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.084046,0.14438,0.14979,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16294,0.14334,0.094518,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.20621,0.14262,0.15547,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.47588,0.14236,-0.15827,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.68418,0.14226,-0.019158,0,0
3,GO REGULATION OF AXON GUIDANCE,0.059411,0.14205,0.091043,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18219,0.14187,0.077712,0,0
3,GO LIPID IMPORT INTO CELL,0.27999,0.14127,0.061506,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.24643,0.14089,0.051468,0,0
3,GO REGULATION OF AXONOGENESIS,0.012203,0.13962,0.14762,0,0
3,GO CELL AGGREGATION,0.073629,0.13892,0.10884,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0011549,0.13884,0.15637,0,0
3,GO ALANINE TRANSPORT,0.14048,0.13877,0.13747,0,0
3,GO RESPONSE TO UV B,0.89215,0.13872,-0.044541,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.26471,0.13871,0.055067,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.097379,0.13833,0.14589,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.060602,0.13743,0.11847,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.47049,0.13733,-0.044057,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.033894,0.13709,0.18228,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0033369,0.13635,0.21006,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13583,0.13599,0.14502,0,0
3,GO PARENTAL BEHAVIOR,0.27611,0.13494,0.093322,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0090226,0.13417,0.19615,0,0
3,GO STARTLE RESPONSE,0.22235,0.13404,0.12204,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.092194,0.1338,0.0909,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.18219,0.13362,0.096613,0,0
3,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.15773,0.13179,0.072583,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.0030654,0.13151,0.15901,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.064293,0.1315,0.14118,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.11841,0.13124,0.05568,0,0
3,GO PROTEIN OXIDATION,0.12049,0.13088,0.072808,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.17374,0.13022,0.10472,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.034637,0.13006,0.14386,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.20621,0.12996,0.08712,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.085627,0.12959,0.12237,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.054842,0.12954,0.15753,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.49227,0.12951,0.027337,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.27999,0.1293,0.10607,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54903,0.12856,0.062475,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.52594,0.12846,0.04104,0,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0695,0.1279,0.11656,0,0
3,GO CATECHOLAMINE UPTAKE,0.16828,0.12781,0.13783,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0010528,0.12762,0.16732,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27611,0.12734,0.10221,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.8303,0.1273,0.00708,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.077957,0.12711,0.08124,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.064293,0.12701,0.11209,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077957,0.127,0.090624,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.23589,0.12658,0.067219,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.29184,0.12632,0.084081,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.20937,0.1263,0.14382,0,0
3,GO ENDODERM DEVELOPMENT,0.2839,0.12617,0.025249,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.099158,0.12532,0.16393,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.13355,0.12514,0.23131,0,0
3,GO METENCEPHALON DEVELOPMENT,0.0054795,0.12488,0.16011,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.097379,0.12458,0.11837,0,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.057089,0.12452,0.17914,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.070855,0.12428,0.11219,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.53167,0.12415,0.026669,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.10096,0.12406,0.11849,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.59059,0.12406,0.0070754,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.10654,0.12351,0.24502,0,0
3,GO REGULATION OF HEART RATE,0.10465,0.12348,0.095051,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.39858,0.12348,0.09055,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.11235,0.12275,0.11146,0,0
3,GO NEURAL CREST FORMATION,0.36991,0.12272,0.07721,0,0
3,GO CAMP METABOLIC PROCESS,0.31232,0.12264,0.054026,0,0
3,GO NEUROBLAST PROLIFERATION,0.14048,0.12256,0.087126,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17099,0.12222,0.077015,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.34702,0.12148,0.1034,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.20937,0.12099,0.079371,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.070855,0.12077,0.10228,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.14769,0.12009,0.1245,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.014841,0.11988,0.19226,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.0060989,0.11975,0.1029,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.14769,0.11937,0.073455,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.099158,0.11908,0.091544,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.12689,0.11897,0.11581,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.16294,0.11889,0.09017,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.20937,0.11875,0.13745,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.188,0.11867,0.089562,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.36526,0.1182,0.17894,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.10096,0.11796,0.079862,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080955,0.1175,0.098141,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.23245,0.11711,0.078572,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.11235,0.11693,0.064552,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.014138,0.1168,0.11783,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.14285,0.11668,0.19877,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.066855,0.11658,0.080127,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.44402,0.11647,0.034577,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.91987,0.11642,0.029245,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.14526,0.11641,0.08259,0,0
3,GO AXON DEVELOPMENT,0.0050528,0.11594,0.15111,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.059411,0.11573,0.1537,0,0
3,GO CELL PART MORPHOGENESIS,0.0024367,0.11485,0.1479,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.21256,0.11469,0.12975,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.066855,0.11431,0.13884,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,0.11422,0.1157,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.017137,0.11306,0.15792,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26098,0.11301,0.14473,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,0.11274,0.14697,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.35607,0.11239,0.068419,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.17653,0.11182,0.05138,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.20621,0.11179,0.051553,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.25729,0.1117,0.072017,0,0
3,GO URETER DEVELOPMENT,0.41842,0.11161,0.072538,0,0
3,GO SEQUESTERING OF METAL ION,0.11841,0.11155,0.077539,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.30402,0.11099,0.064195,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.34256,0.11099,0.048058,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.061812,0.11097,0.13005,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.16828,0.11045,0.16887,0,0
3,GO NEURON MIGRATION,0.042857,0.11025,0.14875,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.2,0.11014,0.02765,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26471,0.10971,0.089985,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.088862,0.10951,0.10544,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.015203,0.10934,0.19385,0,0
3,GO MYELIN MAINTENANCE,0.46512,0.10871,0.05417,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10845,0.10842,0.17539,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.10831,0.12606,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.066855,0.10823,0.083208,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.30402,0.10773,0.091316,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.004408,0.10765,0.16898,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.10761,0.13606,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.24288,0.10736,0.086646,0,0
3,GO ANION HOMEOSTASIS,0.17934,0.10723,0.076362,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.19393,0.10666,0.1672,0,0
3,GO DOPAMINE TRANSPORT,0.33812,0.10662,0.15678,0,0
3,GO ASYMMETRIC CELL DIVISION,0.39371,0.10648,0.0629,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.14526,0.10629,0.11146,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.39858,0.10609,0.041172,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.15264,0.10543,0.064202,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.20621,0.10501,0.038164,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.11434,0.105,0.12598,0,0
3,GO TOXIN TRANSPORT,0.10096,0.10474,0.067394,0,0
3,GO GROWTH HORMONE SECRETION,0.16294,0.10466,0.10545,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.27227,0.10464,0.079484,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12908,0.10451,0.12432,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.076492,0.1043,0.078154,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.36064,0.10427,0.032545,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.59059,0.10414,0.032692,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.34702,0.10387,0.057386,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,0.10371,0.094687,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.016734,0.10328,0.12458,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.19095,0.10319,0.058589,0,0
3,GO TRNA 5 END PROCESSING,0.12473,0.10284,0.079239,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.084046,0.10254,0.11759,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.097379,0.10248,0.094569,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.05824,0.10243,0.090781,0,0
3,GO WALKING BEHAVIOR,0.004408,0.10242,0.20944,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.26098,0.10238,0.15396,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38408,0.10184,0.054856,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.44924,0.1016,0.14169,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.32506,0.10158,0.057278,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.082489,0.10141,0.067514,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.049546,0.10137,0.11162,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.19393,0.10101,-0.010585,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.22235,0.10099,0.074943,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14048,0.1007,0.081393,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,0.10064,0.1404,0,0
3,GO AXO DENDRITIC TRANSPORT,0.043763,0.10041,0.10129,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.65866,0.10026,0.046327,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.57857,0.10015,-0.021418,0,0
3,GO PROSTAGLANDIN SECRETION,0.17099,0.10012,0.085141,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.5726,0.099913,0.02916,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.29992,0.099778,0.059685,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.63978,0.099585,0.039394,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.41341,0.099415,0.015277,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.17653,0.099388,0.090573,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.22235,0.099251,0.049878,0,0
3,GO ACROSOME ASSEMBLY,0.15773,0.098843,0.14126,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14285,0.098716,0.046371,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.70355,0.098621,0.01751,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.4545,0.097984,0.073768,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.25363,0.097836,0.044028,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.16032,0.097756,0.10818,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.097516,0.041001,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.065563,0.097368,0.064835,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23245,0.097273,0.072781,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.18219,0.09686,0.12136,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,0.09671,0.085387,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.99651,0.096493,-0.042264,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.72969,0.096301,-0.0135,0,0
3,GO RENAL SODIUM EXCRETION,0.095625,0.096118,0.077543,0,0
3,GO BICARBONATE TRANSPORT,0.16828,0.095931,0.057661,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.36526,0.095619,0.024502,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.18508,0.095579,0.15747,0,0
3,GO ENDODERM FORMATION,0.25363,0.095455,0.025382,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.05824,0.095351,0.080819,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.060602,0.095126,0.071842,0,0
3,GO PIGMENT METABOLIC PROCESS,0.13355,0.094987,0.079327,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.18219,0.094937,0.063127,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.29586,0.094911,0.033694,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011326,0.094873,0.17996,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.4978,0.094615,0.011696,0,0
3,GO CELL RECOGNITION,0.057089,0.094592,0.072826,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.14048,0.094365,0.078247,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.54903,0.09376,0.037638,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.32938,0.093651,0.17063,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.27227,0.0934,0.11352,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.44402,0.093148,0.037235,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.010773,0.092962,0.11854,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0024367,0.092894,0.131,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.44402,0.092883,0.11071,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.054842,0.092556,0.08351,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.092194,0.09236,0.080909,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.11636,0.092058,0.10672,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.095625,0.091975,0.14316,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0695,0.091905,0.040213,0,0
3,GO MEMBRANE DEPOLARIZATION,0.14769,0.091862,0.10733,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27999,0.091737,0.027537,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.63354,0.09169,0.023899,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,0.091628,-0.035297,0,0
3,GO AMELOGENESIS,0.72313,0.091497,0.017454,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.29992,0.091025,0.062368,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.079444,0.090943,0.089883,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.12908,0.090858,0.07639,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.19393,0.090771,0.067024,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.42855,0.090715,0.051687,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.36526,0.090547,0.066859,0,0
3,GO NUCLEOTIDE SALVAGE,0.16032,0.090474,0.12384,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.14769,0.090338,0.086928,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.15264,0.089392,0.1084,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.079444,0.089231,0.081202,0,0
3,GO AMINO ACID ACTIVATION,0.17099,0.089177,0.096164,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.17653,0.089087,0.13757,0,0
3,GO RESPONSE TO HEAT,0.017969,0.088863,0.079789,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,0.088542,0.06317,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.064293,0.088449,0.097257,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.43367,0.088351,0.053667,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15773,0.088278,0.063281,0,0
3,GO CATECHOLAMINE SECRETION,0.070855,0.088274,0.21533,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.94769,0.088241,-0.017123,0,0
3,GO RECEPTOR INTERNALIZATION,0.049546,0.088196,0.094469,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.060602,0.088074,0.064686,0,0
3,GO GROOMING BEHAVIOR,0.20621,0.088031,0.11623,0,0
3,GO COPPER ION TRANSPORT,0.19695,0.087859,0.074573,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.47588,0.087791,0.047237,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.39371,0.087635,0.037074,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25363,0.087382,0.067867,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.72969,0.087255,0.00042408,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.32938,0.087207,0.028107,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.39858,0.086961,0.037733,0,0
3,GO PALLIUM DEVELOPMENT,0.011612,0.086703,0.12236,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.047551,0.086679,0.097788,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.11039,0.086276,0.085481,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.36526,0.085893,0.021861,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.13814,0.08582,0.079721,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.17099,0.085525,0.043005,0,0
3,GO REGULATION OF ION TRANSPORT,0.14285,0.085163,0.060629,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0099891,0.085126,0.18506,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.28785,0.085014,0.067548,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.74288,0.084953,-0.011379,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.5726,0.084937,0.0074552,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.084792,0.1637,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.10845,0.084391,0.088945,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.38408,0.084332,0.03121,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.34256,0.084212,0.065424,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.088862,0.084073,0.16487,0,0
3,GO BLASTOCYST FORMATION,0.10465,0.083901,0.07186,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.093897,0.083683,0.095142,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.67776,0.083643,-0.0021424,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.3746,0.083425,0.053785,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.016734,0.083355,0.11394,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.083289,0.099556,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.31232,0.082899,0.010792,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.11434,0.082719,0.083548,0,0
3,GO PLASMINOGEN ACTIVATION,0.46512,0.082181,-0.039713,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.75615,0.082149,-0.074696,0,0
3,GO LACTATION,0.036948,0.081867,0.11724,0,0
3,GO PODOSOME ASSEMBLY,0.67137,0.081675,-0.064838,0,0
3,GO ZINC ION TRANSPORT,0.23937,0.081671,0.059316,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.28785,0.081668,0.10687,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.25001,0.081626,0.029616,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.74288,0.08162,0.0065297,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.23937,0.081615,0.073582,0,0
3,GO TONGUE MORPHOGENESIS,0.4598,0.081393,0.12758,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17934,0.081261,0.082883,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.064293,0.081174,0.14722,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.60272,0.080998,0.035328,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.059411,0.080954,0.067854,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.42347,0.080935,0.03634,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.22235,0.080834,0.17572,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32077,0.080806,0.049153,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.32077,0.080729,0.029259,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.50896,0.080652,0.027984,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.31232,0.08065,0.072418,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.095625,0.080499,0.080015,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.55487,0.080271,0.037342,0,0
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.2,0.080203,0.10426,0,0
3,GO GLIAL CELL ACTIVATION,0.69707,0.080002,0.010975,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.14526,0.079913,0.088509,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.52594,0.079881,0.033788,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.23245,0.079584,0.11512,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.36991,0.079189,0.044649,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18508,0.078595,0.066106,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12049,0.078554,0.08366,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.31653,0.078538,0.044265,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5726,0.07847,0.015,0,0
3,GO CELL GROWTH,0.075049,0.078358,0.049189,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0695,0.078322,0.089378,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.11039,0.078308,0.051503,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.30402,0.078271,0.048713,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.078262,0.069084,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.078197,0.048157,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.084046,0.078058,0.085615,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.21905,0.07805,0.047038,0,0
3,GO NUCLEAR MIGRATION,0.093897,0.077994,0.098162,0,0
3,GO TRABECULA FORMATION,0.22568,0.077658,0.066652,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.043763,0.077645,0.10789,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25729,0.077515,0.06121,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.29184,0.077403,0.034278,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.87833,0.077391,-0.031794,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.4598,0.077289,0.012326,0,0
3,GO ADULT BEHAVIOR,0.055956,0.077249,0.14414,0,0
3,GO DRUG CATABOLIC PROCESS,0.085627,0.077231,0.084308,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.070855,0.077169,0.095196,0,0
3,GO AXONAL TRANSPORT,0.070855,0.077143,0.10062,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.26098,0.077094,0.10614,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.56075,0.077027,0.080368,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.4545,0.076803,0.039002,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.19095,0.076794,0.038257,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.47049,0.076733,0.087098,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.46512,0.076668,0.05701,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,0.076578,0.019408,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.52594,0.076353,0.023953,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.67776,0.076184,0.045548,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.88523,0.076182,-0.051929,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.31653,0.075882,0.091314,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.32938,0.075861,0.085015,0,0
3,GO REGULATION OF EXCRETION,0.12259,0.075844,0.11051,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.3746,0.075674,0.0491,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.35607,0.075559,0.08742,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.37932,0.075513,0.046886,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.082489,0.07523,0.11739,0,0
3,GO CATION TRANSPORT,0.05824,0.075116,0.060237,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.30815,0.07504,0.048406,0,0
3,GO IRON ION HOMEOSTASIS,0.20309,0.074902,0.055373,0,0
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.14769,0.074629,0.10781,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76281,0.074518,0.0086407,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.66501,0.074091,-0.012677,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.085627,0.074082,0.062271,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11636,0.07407,0.079286,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.1313,0.073811,0.11994,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.21905,0.073492,0.093333,0,0
3,GO THIOESTER METABOLIC PROCESS,0.25729,0.073276,0.052488,0,0
3,GO PROTEIN KINASE A SIGNALING,0.2839,0.07278,0.047207,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.94073,0.072656,-0.016114,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.33812,0.072441,0.057914,0,0
3,GO HISTONE H3 K36 METHYLATION,0.51459,0.07244,0.031562,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23245,0.072351,0.14897,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.48131,0.072182,0.03863,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.085627,0.07167,0.091229,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.27999,0.071191,0.043413,0,0
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.60272,0.070872,0.029586,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.17099,0.07079,0.06219,0,0
3,GO RESPONSE TO COCAINE,0.47049,0.070694,0.053782,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.32506,0.070677,0.023749,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.054842,0.070652,0.070367,0,0
3,GO CELL JUNCTION ORGANIZATION,0.188,0.07046,0.04718,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.17934,0.070351,0.051365,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34702,0.070264,0.030359,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4545,0.070237,0.023566,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.14526,0.070001,0.11623,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.075049,0.069941,0.066948,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.090515,0.069754,0.13252,0,0
3,GO TRABECULA MORPHOGENESIS,0.68418,0.069601,0.00042882,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32506,0.069519,0.047766,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.065563,0.069382,0.070423,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.78962,0.069356,-0.046214,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12908,0.069332,0.057547,0,0
3,GO RESPONSE TO ACIDIC PH,0.61497,0.069269,-0.0041426,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.33812,0.068977,0.040546,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.068946,0.054595,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.05824,0.068821,0.071223,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.22905,0.068786,0.12685,0,0
3,GO REGULATION OF DNA BINDING,0.32506,0.068703,0.035944,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.092194,0.068576,0.10112,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.40349,0.068368,0.034789,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.054842,0.06832,0.13079,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.40349,0.067964,0.057793,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.32506,0.067907,0.051331,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.39371,0.067675,0.031582,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.16559,0.067378,0.083294,0,0
3,GO ACTION POTENTIAL,0.31653,0.066927,0.062919,0,0
3,GO NEURON DEVELOPMENT,0.015574,0.066648,0.10551,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.11039,0.066519,0.060207,0,0
3,GO RECOMBINATIONAL REPAIR,0.084046,0.066379,0.049275,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.4545,0.066267,0.05857,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.22235,0.066172,0.060251,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63354,0.066041,-0.0040107,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.14048,0.065507,0.039674,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.85768,0.065444,-0.0028137,0,0
3,GO HIPPO SIGNALING,0.68418,0.065365,-0.024942,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.024288,0.065336,0.096793,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.4598,0.065182,0.035594,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.17653,0.065071,0.077566,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.3746,0.064971,0.040328,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.41842,0.064863,0.016317,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.073629,0.064843,0.15596,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.064814,0.067937,0,0
3,GO HISTONE H3 K27 METHYLATION,0.40349,0.064767,0.041694,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.30402,0.064586,0.12124,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.12689,0.064443,0.07886,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.21905,0.064149,0.10092,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.11434,0.063924,0.11139,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.42855,0.063734,0.056971,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.93377,0.063732,-0.0072338,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.72969,0.063652,0.0051246,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.082489,0.063571,0.083382,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.05824,0.063493,0.061114,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.39371,0.063293,0.046665,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.54903,0.063118,0.086518,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.32938,0.062669,0.024869,0,0
3,GO RESPONSE TO SALT,0.92682,0.062643,0.00048644,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.22235,0.06263,0.0745,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.28785,0.062444,0.041102,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.58456,0.062265,0.054427,0,0
3,GO NEURON MATURATION,0.073629,0.062192,0.1618,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.50337,0.062074,0.015222,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.90599,0.062055,-0.0055476,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.31232,0.062028,0.069046,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.52025,0.062015,0.00011165,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.3746,0.06199,0.028828,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.15264,0.061525,0.032862,0,0
3,GO SNRNA PROCESSING,0.15773,0.061408,-0.0063667,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.63978,0.061342,0.018724,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.44924,0.061284,0.069574,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.58456,0.061271,0.021532,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.76281,0.061217,0.038906,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13355,0.061175,0.11112,0,0
3,GO NEURON DIFFERENTIATION,0.033166,0.061143,0.09311,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.40349,0.061015,0.054946,0,0
3,GO HEART PROCESS,0.12259,0.06089,0.068836,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.2,0.060871,0.062917,0,0
3,GO CERAMIDE TRANSPORT,0.11434,0.060835,0.045107,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.32938,0.060655,0.088409,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10654,0.060355,0.045853,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.060279,-0.055547,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.5726,0.060194,0.011848,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.041093,0.060038,0.10921,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.12049,0.060029,0.062462,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.36526,0.059805,0.094879,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.12908,0.059782,0.047589,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.26098,0.059782,0.039865,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.49227,0.059684,0.069472,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.87144,0.059626,-0.016596,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.12689,0.059588,0.062803,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38888,0.059495,0.059975,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,0.059474,0.0074326,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1028,0.059414,0.067347,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.71006,0.059403,-0.061317,0,0
3,GO REGULATION OF EXOCYTOSIS,0.12908,0.059169,0.083328,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.69061,0.059045,0.016918,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.23245,0.058912,0.051956,0,0
3,GO PROTEIN FOLDING,0.19695,0.058895,0.037073,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21905,0.05883,0.18293,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,0.058732,0.057713,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.36991,0.058589,0.04793,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.48678,0.058587,0.043292,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.42855,0.058445,0.01996,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.40349,0.058248,0.034762,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.17934,0.057919,0.052955,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.188,0.057766,0.070135,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.67137,0.057761,-0.0024584,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.088862,0.057756,0.05304,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32938,0.057662,0.027942,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.03109,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12908,0.057514,0.096921,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.83713,0.057268,-0.011995,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.25001,0.057197,0.081448,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.12689,0.056973,0.054069,0,0
3,GO FEEDING BEHAVIOR,0.088862,0.056843,0.084705,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.92682,0.056737,-0.0044084,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.44924,0.056697,0.032179,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.72969,0.05629,-0.0008014,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.11636,0.05621,0.064125,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.14526,0.056149,0.057714,0,0
3,GO CHROMOSOME CONDENSATION,0.10465,0.056019,0.064779,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85768,0.056012,-0.042994,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.47049,0.055942,0.047177,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.16032,0.055811,0.040261,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48678,0.055774,-0.077812,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.05573,0.0054114,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.23589,0.055727,0.111,0,0
3,GO NEPHRON TUBULE FORMATION,0.79636,0.055653,0.036197,0,0
3,GO NOREPINEPHRINE SECRETION,0.37932,0.055307,0.052206,0,0
3,GO REGULATION OF HEART GROWTH,0.23589,0.055286,0.066202,0,0
3,GO DNA GEOMETRIC CHANGE,0.054842,0.055228,0.060255,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.25729,0.055025,0.049114,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.065563,0.055002,0.04809,0,0
3,GO ANIMAL ORGAN REGENERATION,0.4978,0.054878,-0.0026538,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,0.054837,-0.034905,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.71006,0.054812,0.0049911,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.68418,0.0548,0.015893,0,0
3,GO G0 TO G1 TRANSITION,0.43367,0.05475,0.036869,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.24643,0.054744,0.073746,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.40349,0.054687,0.035538,0,0
3,GO TRACHEA DEVELOPMENT,0.4598,0.054649,0.060868,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34702,0.054639,0.074693,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29992,0.054492,0.03947,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.56666,0.054206,0.020814,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.58456,0.05399,0.016902,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.26471,0.053979,0.072737,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.71658,0.053975,0.017606,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.71658,0.053807,-0.021909,0,0
3,GO PROTEASOME ASSEMBLY,0.2,0.053773,0.053468,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.76948,0.053703,0.016269,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.11841,0.053664,0.080307,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.14526,0.053577,0.068468,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.42347,0.053419,0.04701,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.14526,0.053381,0.070599,0,0
3,GO PROTEIN NEDDYLATION,0.12049,0.053309,0.067427,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.26098,0.053132,0.13369,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.14048,0.05306,0.053304,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.33373,0.052918,0.067288,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.1313,0.052863,0.075474,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.29184,0.052824,0.043541,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.41842,0.05282,0.050627,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.84397,0.052755,-0.028331,0,0
3,GO NEURON CELL CELL ADHESION,0.61497,0.052642,0.10326,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.36064,0.052559,0.035699,0,0
3,GO MYELIN ASSEMBLY,0.49227,0.052436,0.042426,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.83713,0.05231,-0.055094,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.63354,0.052278,0.024987,0,0
3,GO NUCLEOSOME ORGANIZATION,0.14526,0.052174,0.050352,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.72969,0.052144,0.013265,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.32506,0.052067,0.043894,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.47588,0.051724,0.0425,0,0
3,GO MUSCLE CONTRACTION,0.13814,0.051623,0.053266,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.63978,0.05139,0.023118,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.14769,0.05134,0.11065,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.2839,0.051251,0.057719,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.59664,0.051103,-0.044502,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.71658,0.051083,0.0022241,0,0
3,GO MONOAMINE TRANSPORT,0.55487,0.051073,0.10533,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.16294,0.051029,0.064254,0,0
3,GO RESPONSE TO POTASSIUM ION,0.59059,0.050913,0.052922,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.96163,0.050771,-0.026791,0,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.24288,0.050528,0.091945,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.38408,0.050521,0.079565,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.5726,0.050321,0.033531,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.15015,0.050316,0.06293,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.33812,0.050176,0.083192,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.94769,0.050105,-0.0076313,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.53167,0.050087,0.016322,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.40349,0.049989,0.026336,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.25363,0.049893,0.036914,0,0
3,GO RHYTHMIC BEHAVIOR,0.47049,0.049745,0.042894,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.11434,0.049733,0.11575,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.69061,0.049532,0.0085766,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98953,0.049408,-0.006554,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.15015,0.049344,0.041168,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70355,0.049297,-0.011863,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.11841,0.049215,0.040787,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.98255,0.049192,-0.017618,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.16294,0.049185,0.099555,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.83713,0.049162,-0.0024512,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.91987,0.049093,-0.019411,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.42347,0.049075,0.01986,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.72313,0.048968,0.017815,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.86455,0.048931,0.016773,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,0,0
3,GO CHROMATIN DISASSEMBLY,0.22235,0.048408,0.125,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.42347,0.048374,0.038189,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.33812,0.048365,0.058467,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.43883,0.048133,0.06176,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.087232,0.048035,0.062806,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.17099,0.048005,0.046503,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,0.047761,0.0094245,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.38888,0.04765,0.031904,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.42855,0.047545,0.038869,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.58456,0.04754,0.013204,0,0
3,GO REGULATION OF ORGAN GROWTH,0.35607,0.04754,0.035379,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.25729,0.047341,0.061132,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.23937,0.047273,0.047214,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62732,0.047146,0.030781,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.62113,0.047105,0.047123,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,0.04698,0.0037934,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86455,0.046963,-0.036538,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.22905,0.046955,0.076249,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.62113,0.046823,0.028654,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.9686,0.046602,-0.055373,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43883,0.046447,0.052152,0,0
3,GO ACROSOME REACTION,0.54321,0.046437,0.028279,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.65234,0.046422,-0.0089847,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.41842,0.046411,0.052284,0,0
3,GO NEUROGENESIS,0.075049,0.046395,0.071918,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.55487,0.046293,0.032767,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.15773,0.046282,0.068317,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60883,0.046193,0.036286,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.35153,0.046032,0.060186,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.082489,0.045935,0.10175,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.60883,0.04592,0.03141,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.045851,0.068885,0,0
3,GO MICROTUBULE POLYMERIZATION,0.044685,0.045838,0.11001,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.63978,0.045735,0.048536,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.10465,0.045604,0.064125,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.71006,0.045453,-0.0036157,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.33812,0.045402,0.066379,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.21905,0.045383,0.045223,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.95466,0.045349,-0.026062,0,0
3,GO MYOBLAST FUSION,0.89215,0.045198,-0.025843,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.69707,0.045174,0.0098476,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.31232,0.044919,0.059493,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.093897,0.044885,0.10197,0,0
3,GO RESPONSE TO DOPAMINE,0.61497,0.044837,0.033992,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.71006,0.044783,0.016251,0,0
3,GO ORGAN GROWTH,0.54903,0.044716,0.018631,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.86455,0.044645,-0.072866,0,0
3,GO RRNA CATABOLIC PROCESS,0.62732,0.044437,0.04833,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78962,0.044324,0.0072863,0,0
3,GO HEART TRABECULA FORMATION,0.95466,0.044239,-0.0041626,0,0
3,GO HISTONE METHYLATION,0.1028,0.044139,0.047003,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.81668,0.044039,-0.020328,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16828,0.043899,0.12862,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.061812,0.043714,0.131,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32077,0.043609,0.049395,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.95466,0.043547,-0.012278,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,0.04348,0.037169,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.38888,0.043411,0.05894,0,0
3,GO MICROTUBULE NUCLEATION,0.67137,0.043043,0.030211,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10654,0.042921,0.09844,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.22905,0.042914,0.041127,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.48678,0.042716,0.033185,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.042581,0.023569,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.50896,0.042552,-0.11406,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.20621,0.042531,0.072654,0,0
3,GO PROTEIN HYDROXYLATION,0.78289,0.042499,0.014227,0,0
3,GO PROTEIN PALMITOYLATION,0.30815,0.042405,0.061275,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.21256,0.04236,0.096539,0,0
3,GO BONE DEVELOPMENT,0.3746,0.042278,0.014209,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.89907,0.042198,-0.021191,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.14285,0.041947,0.040574,0,0
3,GO TRNA 5 LEADER REMOVAL,0.63354,0.041775,0.01211,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.092194,0.041691,0.050936,0,0
3,GO PROTEIN STABILIZATION,0.52025,0.041628,0.017604,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.69707,0.041617,0.042231,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1,0.041609,-0.013308,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.60272,0.04137,-0.015169,0,0
3,GO LYMPHANGIOGENESIS,0.26098,0.041195,0.057051,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.41341,0.041186,0.027773,0,0
3,GO NADP METABOLIC PROCESS,0.70355,0.041152,-0.016033,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.05824,0.041143,0.037228,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.37932,0.040798,0.031763,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.10654,0.040787,0.053955,0,0
3,GO CARTILAGE MORPHOGENESIS,0.35153,0.04077,0.14204,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.4598,0.040627,0.046269,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.75615,0.040613,-0.040405,0,0
3,GO SNRNA METABOLIC PROCESS,0.25001,0.040524,-0.0053469,0,0
3,GO PROTEIN IMPORT,0.58456,0.040337,0.0071906,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.64605,0.039969,-0.042298,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,0.039865,-0.0085776,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.86455,0.039813,-0.0023915,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.78962,0.039672,-0.0087641,0,0
3,GO RESPONSE TO UV,0.12259,0.039584,0.042676,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.99651,0.039419,-0.019693,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80989,0.03933,0.024745,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.84397,0.039168,-0.0045513,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.91293,0.039067,-0.013666,0,0
3,GO CELL MORPHOGENESIS,0.14526,0.038997,0.058199,0,0
3,GO REGULATION OF URINE VOLUME,0.65234,0.038963,0.011216,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.95466,0.038951,-0.010853,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29184,0.038797,0.040875,0,0
3,GO POLYOL METABOLIC PROCESS,0.24288,0.038771,0.036067,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.96163,0.03877,-0.010743,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42855,0.038761,0.046427,0,0
3,GO OXIDATIVE DEMETHYLATION,0.15517,0.038625,0.072435,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.20621,0.038547,0.030599,0,0
3,GO ION TRANSPORT,0.23937,0.038322,0.031685,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.25729,0.038216,0.080229,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.76948,0.038215,0.0055821,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.78962,0.03819,-0.0078515,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.33373,0.038161,0.031432,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.76948,0.038053,0.035254,0,0
3,GO MITOCHONDRION ORGANIZATION,0.17653,0.038028,0.029368,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.72969,0.038013,-0.01894,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.30402,0.037981,0.042514,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.9686,0.037969,-0.025374,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.41842,0.03795,0.046741,0,0
3,GO CELL CELL SIGNALING,0.13355,0.037895,0.047582,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.17099,0.037849,0.099701,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.50896,0.037847,0.02657,0,0
3,GO REGULATION OF GENE SILENCING,0.28785,0.037828,0.031926,0,0
3,GO PROTEIN KINASE C SIGNALING,0.98953,0.037794,-0.0076044,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.090515,0.037701,0.056622,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.073629,0.037433,0.12602,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.68418,0.037332,0.015243,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.67137,0.037196,0.016443,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49227,0.037067,0.057624,0,0
3,GO DEVELOPMENTAL GROWTH,0.14285,0.037026,0.047565,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.38888,0.037015,0.016176,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.78289,0.036885,0.008726,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.71658,0.036778,-0.0092596,0,0
3,GO BLASTOCYST GROWTH,0.47049,0.036748,0.016377,0,0
3,GO COENZYME A METABOLIC PROCESS,0.80312,0.03672,0.013962,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56075,0.036493,0.040761,0,0
3,GO RESPONSE TO RETINOIC ACID,0.76948,0.036452,-0.016635,0,0
3,GO RESPONSE TO LEUCINE,0.4978,0.03628,0.078433,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,0.036273,0.026461,0,0
3,GO GMP METABOLIC PROCESS,0.80989,0.03627,0.042603,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.8303,0.036212,0.032197,0,0
3,GO REGULATION OF DNA REPAIR,0.7495,0.036026,0.0030106,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.67776,0.036019,0.00746,0,0
3,GO REGULATION OF ACROSOME REACTION,0.39371,0.035938,0.070154,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.13814,0.035896,0.10478,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.4598,0.035834,0.062649,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.89907,0.035827,-0.026239,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.21905,0.035753,0.10856,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.69707,0.035704,-0.011069,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.67137,0.035667,-0.061516,0,0
3,GO CHLORIDE TRANSPORT,0.49227,0.035636,0.025545,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.29184,0.035526,0.036014,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.020826,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.34702,0.035361,0.020919,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.47049,0.035198,0.041503,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,0.035074,-0.014027,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.63354,0.035062,0.0040174,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.17099,0.034998,0.078447,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010887,0,0
3,GO RESPONSE TO ESTROGEN,0.48678,0.034711,0.0087973,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.98953,0.034662,-0.030051,0,0
3,GO AMYLOID BETA FORMATION,0.84397,0.034629,0.0047639,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.16828,0.034385,0.030482,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.11434,0.034342,0.062309,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.71006,0.034128,0.023519,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.36991,0.034056,0.024522,0,0
3,GO AORTA MORPHOGENESIS,0.89215,0.034007,-0.028269,0,0
3,GO GROWTH,0.51459,0.033947,0.014628,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.63978,0.033925,0.0085486,0,0
3,GO REGULATION OF FERTILIZATION,0.39371,0.033886,0.034041,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.50337,0.033874,-0.070401,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.89907,0.033782,0.011946,0,0
3,GO TORC1 SIGNALING,0.088862,0.033763,0.062223,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,0.033624,0.05577,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,0.03326,0.034975,0,0
3,GO CHOLESTEROL EFFLUX,0.70355,0.033257,-0.045448,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.12473,0.033246,0.058581,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.43367,0.033047,0.036882,0,0
3,GO CELLULAR HOMEOSTASIS,0.23589,0.033012,0.031681,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.74288,0.032724,-0.042776,0,0
3,GO CARTILAGE DEVELOPMENT,0.73628,0.032683,-0.0058453,0,0
3,GO PORE COMPLEX ASSEMBLY,0.80989,0.032664,-0.034393,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.85768,0.032642,-0.01039,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.56075,0.032546,0.027683,0,0
3,GO DNA CONFORMATION CHANGE,0.16032,0.032404,0.03942,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.70355,0.032357,-0.046804,0,0
3,GO RNA INTERFERENCE,0.20621,0.03234,0.069483,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.47588,0.032237,0.011778,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.4978,0.032095,0.0372,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.55487,0.03197,0.044068,0,0
3,GO PROTEIN ACETYLATION,0.26847,0.031965,0.017669,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.52594,0.031952,0.059015,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.3746,0.031909,0.033044,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.031803,0.021365,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.71658,0.031783,0.0052435,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.24643,0.031667,0.018889,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.85082,0.031627,9.4196e-05,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.75615,0.031621,-0.0013877,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.097379,0.031562,0.062583,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.53167,0.031557,0.022321,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.2,0.031533,0.02891,0,0
3,GO NADPH REGENERATION,0.97557,0.03146,-0.014396,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68418,0.031428,0.018659,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.86455,0.031386,0.010408,0,0
3,GO FOREBRAIN DEVELOPMENT,0.15773,0.031358,0.064155,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.25001,0.031311,0.038895,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44402,0.031263,0.018939,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.67137,0.031137,0.014411,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.26847,0.030901,0.038266,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.42855,0.030871,0.025901,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.92682,0.030773,0.0029153,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.80989,0.030645,-0.0048553,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.78962,0.030489,0.0047626,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.51459,0.030433,0.023195,0,0
3,GO MUSCLE SYSTEM PROCESS,0.23937,0.030397,0.038068,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.78962,0.030362,0.0039012,0,0
3,GO ION HOMEOSTASIS,0.53742,0.030339,0.017595,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.20937,0.030078,0.067402,0,0
3,GO OVULATION CYCLE PROCESS,0.40349,0.030026,0.040106,0,0
3,GO DNA PACKAGING,0.33373,0.029913,0.028574,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.81668,0.029894,-0.012265,0,0
3,GO ENERGY HOMEOSTASIS,0.55487,0.029863,0.050136,0,0
3,GO QUINONE METABOLIC PROCESS,0.32938,0.029856,-0.15592,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.50896,0.029631,0.028245,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.58456,0.029594,0.057225,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.94769,0.029519,0.0078431,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96163,0.029503,-0.013801,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.14769,0.02944,0.043423,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.9686,0.029394,-0.0081614,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.44924,0.029312,0.026918,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.91987,0.029294,-0.067343,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.71006,0.029261,-0.043304,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.82348,0.029227,0.024267,0,0
3,GO RESPONSE TO GONADOTROPIN,0.92682,0.029167,-0.018143,0,0
3,GO MIRNA METABOLIC PROCESS,0.95466,0.029152,-0.00043178,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.66501,0.029119,0.0058449,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.94073,0.029071,-0.037658,0,0
3,GO DEVELOPMENTAL MATURATION,0.22905,0.028994,0.059102,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.96163,0.028993,0.013514,0,0
3,GO HISTONE EXCHANGE,0.31653,0.028887,0.039289,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.62113,0.028843,-0.063157,0,0
3,GO LYMPH NODE DEVELOPMENT,0.87144,0.028811,-0.013562,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.94769,0.028809,-0.0032546,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.67137,0.028734,0.051423,0,0
3,GO CONVERGENT EXTENSION,0.56666,0.028632,0.041216,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.4978,0.028512,0.02142,0,0
3,GO CHYLOMICRON ASSEMBLY,0.78962,0.028507,-0.019807,0,0
3,GO DNA REPLICATION,0.17653,0.028502,0.033985,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29184,0.028124,0.017059,0,0
3,GO MIDBRAIN DEVELOPMENT,0.76281,0.028068,-0.035876,0,0
3,GO OXIDATION REDUCTION PROCESS,0.68418,0.028046,0.0095475,0,0
3,GO INORGANIC ANION TRANSPORT,0.42347,0.027832,0.015758,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.42855,0.027774,0.047455,0,0
3,GO METAL ION HOMEOSTASIS,0.84397,0.02774,0.0037628,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.23245,0.027726,0.10127,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.94073,0.027714,0.004058,0,0
3,GO CELL CYCLE ARREST,0.33373,0.027653,0.025913,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.42347,0.027639,0.031295,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.61497,0.027606,0.0067171,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.89907,0.027545,-0.023932,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.56075,0.027486,0.042877,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.52594,0.027418,0.038913,0,0
3,GO IRON ION TRANSPORT,0.77618,0.027225,-0.0098631,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.47049,0.027036,0.011729,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.46512,0.027007,0.03849,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36526,0.026823,0.032309,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.5726,0.026772,0.026549,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.22568,0.026735,-0.14412,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.42347,0.026586,0.049709,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25363,0.026583,0.047106,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42347,0.026536,0.024151,0,0
3,GO PROTEIN ACYLATION,0.13583,0.026497,0.027667,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.80989,0.026417,0.0048714,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.88523,0.026403,-0.0021909,0,0
3,GO MRNA CLEAVAGE,0.22235,0.026381,0.051584,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.72969,0.026187,0.014482,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.72313,0.026019,-0.0023432,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.56075,0.026014,0.010009,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.12689,0.025895,0.046954,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55487,0.025797,0.023933,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.55487,0.025671,0.027042,0,0
3,GO SEGMENTATION,0.48678,0.025492,0.021605,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87833,0.025299,-0.040874,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.92682,0.025244,-0.012407,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.41842,0.025238,0.03403,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.87144,0.025062,-0.039824,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58456,0.024944,-0.06273,0,0
3,GO NERVOUS SYSTEM PROCESS,0.34702,0.024861,0.038292,0,0
3,GO REGULATION OF GLIOGENESIS,0.78289,0.024815,0.012054,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.38408,0.024716,0.01842,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.54321,0.02446,0.042752,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.82348,0.024273,0.004358,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.9686,0.02426,-0.035691,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.70355,0.02423,-0.006168,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.81668,0.024143,-0.031975,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.68418,0.024101,-0.09294,0,0
3,GO FILOPODIUM ASSEMBLY,0.46512,0.023969,0.037676,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.88523,0.023937,-0.016667,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.63978,0.02391,0.020487,0,0
3,GO CHROMOSOME SEPARATION,0.42855,0.02386,0.025272,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.98255,0.023852,-0.025406,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.39371,0.023753,0.024745,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72969,0.023648,0.032474,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.34256,0.023635,0.060195,0,0
3,GO HISTONE H3 K4 METHYLATION,0.95466,0.023547,0.0012104,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.65234,0.023542,0.012827,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.83713,0.023357,-0.018905,0,0
3,GO REGULATION OF GROWTH,0.90599,0.023354,-0.00044268,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.96163,0.023258,-0.033939,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.13814,0.023166,0.084946,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.96163,0.02307,-0.010031,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86455,0.023017,-0.017188,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.13583,0.022928,0.060352,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.70355,0.022912,0.010331,0,0
3,GO INTERACTION WITH SYMBIONT,0.4545,0.022889,0.0019219,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.72313,0.022857,-0.06373,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.62732,0.022769,0.022613,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.98953,0.022752,-0.017444,0,0
3,GO WATER TRANSPORT,0.91293,0.022676,-0.0035743,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.61497,0.022614,-0.038741,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.16828,0.022592,0.024635,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.64605,0.022425,0.03981,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.61497,0.022396,0.049255,0,0
3,GO REGULATION OF RNA SPLICING,0.2,0.021959,0.036933,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.61497,0.021905,0.09446,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.95466,0.021783,-0.0027989,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.37932,0.02162,0.035968,0,0
3,GO DNA METABOLIC PROCESS,0.39858,0.021597,0.015568,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.60272,0.021583,0.044211,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.72313,0.021456,0.004522,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.60272,0.021411,-0.075543,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79636,0.021405,-0.0081328,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.71006,0.021397,-0.059285,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.73628,0.021363,-0.015008,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.26471,0.021339,0.07162,0,0
3,GO PROTEIN METHYLATION,0.59059,0.021317,0.020162,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.39371,0.021265,0.10921,0,0
3,GO REGULATION OF BEHAVIOR,0.67137,0.021183,0.017133,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.98953,0.021103,0.002342,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.13814,0.020855,0.082401,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.53167,0.020774,0.023525,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.70355,0.020711,0.020402,0,0
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.36064,0.020512,0.024503,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.70355,0.020481,0.0053225,0,0
3,GO DNA RECOMBINATION,0.50896,0.020447,0.011395,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.17653,0.020436,0.12032,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.32938,0.02037,-0.10796,0,0
3,GO SNRNA TRANSCRIPTION,0.23937,0.020297,0.025213,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.85082,0.02027,0.0037798,0,0
3,GO FOREGUT MORPHOGENESIS,0.8303,0.02027,-0.019063,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.72313,0.020237,-0.00023766,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.39371,0.020216,0.097113,0,0
3,GO CHROMATIN REMODELING,0.23589,0.020082,0.036679,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.36991,0.020018,0.057893,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57857,0.019838,0.017424,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.94769,0.019723,-0.004214,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.56666,0.01962,-0.096087,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.68418,0.019617,0.028103,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.66501,0.019419,0.0024772,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.27999,0.019343,0.048686,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.42347,0.019231,0.069953,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.31653,0.01916,0.034708,0,0
3,GO NEURAL TUBE PATTERNING,0.98953,0.019061,-0.0099716,0,0
3,GO REGULATION OF MYELINATION,0.51459,0.019049,0.051814,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.78962,0.018996,-0.01939,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.53167,0.018966,-0.057617,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.91293,0.018898,0.0007021,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.30402,0.018874,0.14205,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.95466,0.018871,-0.019809,0,0
3,GO BRAIN MORPHOGENESIS,0.67776,0.018857,0.044687,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.67776,0.018855,0.01276,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48678,0.018828,0.059431,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.50896,0.018781,0.026803,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.92682,0.0187,0.014684,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.67776,0.018616,-0.066419,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.42855,0.018591,0.029812,0,0
3,GO DENDRITE EXTENSION,0.34702,0.018508,0.14333,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.43883,0.018494,0.025655,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.42347,0.018441,0.05027,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.4598,0.018052,0.021581,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.94073,0.018001,0.039363,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.87833,0.017889,-0.011816,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24643,0.017792,0.042424,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.47588,0.017532,0.01762,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.86455,0.017507,-0.0079791,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.27611,0.017285,0.039654,0,0
3,GO PROSTATIC BUD FORMATION,0.83713,0.017271,-0.094231,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.63354,0.017071,-0.059135,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.80312,0.017066,-0.0033325,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.85768,0.017032,-0.022861,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46512,0.016925,0.02599,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.56075,0.016895,0.015071,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.84397,0.016853,0.0044396,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.26847,0.016798,0.038712,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.27611,0.016703,0.053101,0,0
3,GO REGULATION OF OOGENESIS,0.44924,0.01662,-0.056119,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.90599,0.01645,0.007407,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.71006,0.016362,0.020384,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.53167,0.016183,0.025218,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.63354,0.016057,0.035845,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.48131,0.0159,0.044241,0,0
3,GO ORGANELLE FUSION,0.80989,0.015796,-0.0066239,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.89215,0.015664,-0.032996,0,0
3,GO NODAL SIGNALING PATHWAY,0.9686,0.015654,-0.016513,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.015603,0.049487,0,0
3,GO VESICLE DOCKING,0.48678,0.015435,0.035588,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.85082,0.015429,-0.010858,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.35607,0.015387,0.027589,0,0
3,GO ENSHEATHMENT OF NEURONS,0.75615,0.015249,0.0062892,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.38888,0.015212,0.045411,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.015163,0.026909,0,0
3,GO SOMATIC STEM CELL DIVISION,0.87144,0.015116,0.024833,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.95466,0.015107,-0.01713,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69707,0.015035,-0.00017288,0,0
3,GO RESPONSE TO CAMP,0.29184,0.014955,0.047401,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.64605,0.014931,0.018597,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.78289,0.014886,-0.048514,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.99651,0.014794,-0.053607,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.014788,0.015365,0,0
3,GO COMPLEMENT ACTIVATION,0.8303,0.014705,-0.056068,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.4598,0.014615,0.040127,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.94073,0.014529,-0.013746,0,0
3,GO LYSOSOME LOCALIZATION,0.43883,0.014507,-0.054235,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.54903,0.014507,0.016201,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.93377,0.014461,-0.018421,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.92682,0.014395,-0.020453,0,0
3,GO HISTONE DEACETYLATION,0.86455,0.014311,-0.0095593,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.81668,0.014272,-0.058788,0,0
3,GO SYNCYTIUM FORMATION,0.91293,0.014208,-0.00773,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.78962,0.014174,0.0070492,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.98953,0.014172,-0.014974,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.63354,0.014161,0.030027,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.36064,0.014122,0.06788,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.91987,0.01403,-0.0022613,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.73628,0.014016,-0.00043295,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.78962,0.013994,-0.0028564,0,0
3,GO MEMBRANE BIOGENESIS,0.91293,0.013919,-0.016019,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.56075,0.013905,0.031828,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.97557,0.013786,-0.000796,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98953,0.013741,9.2521e-05,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.99651,0.013716,0.0016867,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.23937,0.013563,0.0867,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.63354,0.013491,0.030871,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.48131,0.013438,0.010475,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.49227,0.013319,-0.052704,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.41341,0.013302,0.020149,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.65234,0.012963,0.019026,0,0
3,GO TERPENOID METABOLIC PROCESS,0.53167,0.012959,-0.048455,0,0
3,GO CELL CELL SIGNALING BY WNT,0.67776,0.012924,0.0040329,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1,0.012924,-0.010853,0,0
3,GO SOMITOGENESIS,0.75615,0.012884,-0.013891,0,0
3,GO NCRNA CATABOLIC PROCESS,0.92682,0.012874,-0.00061769,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.50337,0.012845,-0.03428,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.8303,0.012791,-0.0018795,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.68418,0.012757,0.015022,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.93377,0.012426,-0.011165,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.5726,0.012155,-0.022016,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.22905,0.01208,0.023931,0,0
3,GO HINDBRAIN DEVELOPMENT,0.34702,0.012054,0.056454,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.97557,0.011896,-0.010103,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.85768,0.011887,0.0023157,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.82348,0.01186,0.010332,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.79636,0.011832,-0.0006604,0,0
3,GO VASODILATION,0.30402,0.011816,0.058037,0,0
3,GO MITOCHONDRIAL TRNA PROCESSING,0.29184,0.011812,0.1047,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.68418,0.011693,0.037641,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.72313,0.011683,0.0096705,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62732,0.011669,-0.044504,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.52025,0.011663,-0.060471,0,0
3,GO MANNOSYLATION,0.72313,0.01166,-0.041711,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.57857,0.011623,0.0083721,0,0
3,GO MESENCHYME DEVELOPMENT,0.92682,0.011533,-0.017653,0,0
3,GO HEAD DEVELOPMENT,0.38888,0.011522,0.035896,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.85768,0.011515,-0.0063422,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.97557,0.011501,-0.0084849,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.70355,0.011466,0.010564,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.76948,0.011348,0.00081077,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.40843,0.011263,-0.051516,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.95466,0.011262,-0.0044998,0,0
3,GO RESPONSE TO ATP,0.54321,0.011184,0.023555,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.90599,0.011106,-0.077073,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.57857,0.011054,-0.021601,0,0
3,GO VISUAL BEHAVIOR,0.48678,0.011038,0.036199,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.76948,0.011037,-0.010956,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9686,0.010961,-0.042987,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.92682,0.010889,-0.0036678,0,0
3,GO DNA LIGATION,0.97557,0.010881,-0.0011536,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.71006,0.010711,0.0058404,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.9686,0.0107,-0.01829,0,0
3,GO SOMITE DEVELOPMENT,0.72969,0.010665,0.01032,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.57857,0.010611,0.05109,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.69707,0.010605,0.01992,0,0
3,GO CELL FATE COMMITMENT,0.77618,0.01056,-0.019383,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.56666,0.010495,0.017299,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.98953,0.010484,-0.0071665,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.5726,0.010333,0.045606,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.19095,0.010159,0.10225,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87833,0.010127,-0.010742,0,0
3,GO MITOTIC DNA REPLICATION,0.90599,0.010126,-0.013772,0,0
3,GO THYMUS DEVELOPMENT,0.93377,0.010049,-0.0022784,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.78289,0.010027,0.0062207,0,0
3,GO RHYTHMIC PROCESS,0.90599,0.0097994,0.002983,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.0097513,0.011355,0,0
3,GO STEM CELL DIFFERENTIATION,0.76281,0.0096906,-0.018138,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,0.0096897,-0.0073922,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.65866,0.0095956,0.0069814,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.81668,0.0094596,0.0014535,0,0
3,GO GLIAL CELL PROLIFERATION,0.72969,0.0093701,-0.038691,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.59059,0.0093476,0.01958,0,0
3,GO RESPONSE TO DRUG,0.57857,0.0091927,0.020593,0,0
3,GO INTRACELLULAR TRANSPORT,0.9686,0.0091498,-0.0026833,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.89907,0.0091333,-0.010242,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.91987,0.0091104,0.0022079,0,0
3,GO HEAD MORPHOGENESIS,0.73628,0.0090675,-0.054164,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.82348,0.0090306,0.012044,0,0
3,GO INSEMINATION,0.56666,0.0090097,-0.071983,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.83713,0.0088583,-0.029768,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.60272,0.0086388,-0.036803,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.78289,0.0085554,-0.042887,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.86455,0.0083696,-0.047653,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,0.0083209,-0.041158,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63978,0.0083131,-0.031907,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.73628,0.0082851,0.011449,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.52594,0.0082561,0.044908,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.9686,0.0081832,-0.010798,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.87144,0.0081344,-0.0070383,0,0
3,GO FIBROBLAST ACTIVATION,0.80312,0.0081279,-0.041497,0,0
3,GO NUCLEOSOME ASSEMBLY,0.55487,0.0080678,0.024743,0,0
3,GO RESPONSE TO FATTY ACID,0.63354,0.007977,0.014849,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.32077,0.0079634,-0.06499,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.5726,0.0078482,0.013017,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.39858,0.0078203,-0.050042,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.96163,0.0078085,-0.0010393,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.5726,0.0077551,0.11384,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.62732,0.0077524,0.039512,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.61497,0.0077184,-0.037848,0,0
3,GO POSITIVE REGULATION OF BINDING,0.89215,0.0076239,0.005204,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.76948,0.0075946,-0.023653,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.59059,0.007441,-0.043833,0,0
3,GO ENDOCYTOSIS,0.73628,0.0073062,0.0071156,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.41341,0.0072445,0.032636,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.78289,0.0070853,0.00025501,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.91987,0.0070363,-0.024636,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.43883,0.0069035,0.021505,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.96163,0.0068807,-0.025694,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.91987,0.0068506,-0.020342,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.72969,0.0068365,0.021299,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.90599,0.0067852,-0.0039021,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.73628,0.0067294,-0.0023183,0,0
3,GO DNA STRAND ELONGATION,0.79636,0.0066817,0.033476,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.40349,0.006628,0.032395,0,0
3,GO SPINAL CORD DEVELOPMENT,0.56666,0.0065917,0.036106,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,0.0064893,-0.02342,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.41842,0.0064745,-0.050097,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.39858,0.0064415,-0.082113,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.71006,0.0064107,-0.062065,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.81668,0.0064007,-0.0014967,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3746,0.0063876,0.036079,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.9686,0.0062893,-0.012317,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.69707,0.0062535,-0.03318,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.9686,0.0061402,0.0075368,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.85768,0.0060765,-0.0030939,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.71658,0.0059511,-0.039991,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50337,0.0059337,-0.048614,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.96163,0.0058761,-0.011583,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.74288,0.005827,0.038529,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.74288,0.005808,-0.056682,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.98953,0.0056344,0.0085193,0,0
3,GO VESICLE CARGO LOADING,0.96163,0.0055976,-0.034602,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.47049,0.0055959,-0.076542,0,0
3,GO STEROL TRANSPORT,0.5726,0.0055668,-0.042278,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.84397,0.0055293,0.0032237,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.98953,0.0053946,0.0052026,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0053581,-0.0010191,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.79636,0.005149,-0.026913,0,0
3,GO MIDGUT DEVELOPMENT,0.96163,0.0051445,-0.015151,0,0
3,GO CHONDROCYTE PROLIFERATION,0.91987,0.0051153,0.0016201,0,0
3,GO CELLULAR RESPONSE TO ATP,0.3746,0.0050817,0.047175,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.41842,0.0050806,0.031823,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.72969,0.0050624,-0.043073,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94073,0.0050359,-0.0048989,0,0
3,GO HEART GROWTH,0.2839,0.0050315,0.056927,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.30815,0.0050261,0.037477,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.63354,0.0049954,0.013793,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.61497,0.0049698,0.037935,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.97557,0.0049425,-0.0017851,0,0
3,GO CHROMATIN ORGANIZATION,0.98255,0.004924,-0.0017387,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.85082,0.0049136,-0.061184,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48131,0.0048492,0.023663,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.52025,0.0048344,0.01364,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.66501,0.0047222,-0.063692,0,0
3,GO MACROMOLECULE DEACYLATION,0.65866,0.0047171,0.015379,0,0
3,GO CELL CYCLE PROCESS,0.89215,0.0046228,-0.003076,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.74288,0.0046221,-0.027191,0,0
3,GO RECEPTOR RECYCLING,0.91293,0.004562,-0.012386,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.38408,0.0044266,0.080401,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.31653,0.0043766,0.044046,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.69061,0.0042673,-0.0027631,0,0
3,GO REGULATION OF BINDING,0.62732,0.0042594,-0.01871,0,0
3,GO HYPEROSMOTIC RESPONSE,0.78289,0.0042529,-0.031204,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.90599,0.004252,0.011128,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.33812,0.0041312,-0.028558,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.62732,0.0041212,-0.016858,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.90599,0.0039969,-0.011779,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.52594,0.0038315,0.034647,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.85082,0.0037939,-0.0089701,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.7495,0.0037598,0.0014151,0,0
3,GO DRUG METABOLIC PROCESS,0.7495,0.0037539,-0.0068088,0,0
3,GO METHIONINE METABOLIC PROCESS,0.91293,0.0036902,-0.018883,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.73628,0.0036781,-0.043312,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63978,0.0034803,-0.040616,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.63354,0.0034268,0.01767,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.72313,0.0033832,0.014453,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.97557,0.0033497,-0.0034348,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.33812,0.0033183,0.048085,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.77618,0.0032772,-0.0396,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.53167,0.0032278,0.045445,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.91293,0.0032274,-0.017486,0,0
3,GO MAST CELL MIGRATION,0.79636,0.0030541,-0.057608,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.9686,0.0030387,-0.0057029,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.72969,0.0030025,0.01727,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.75615,0.0029931,0.03214,0,0
3,GO MITOTIC CELL CYCLE,0.87144,0.0029303,-0.009113,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.96163,0.0028974,0.028137,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.93377,0.0028891,-0.0074689,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.89215,0.0028527,-0.012984,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.59059,0.0027225,-0.033148,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.68418,0.0026018,0.0055043,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75615,0.0024251,0.011794,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56666,0.0021858,0.027748,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66501,0.0021491,-0.012893,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.96163,0.0020983,-0.00019962,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.42855,0.0020975,0.092799,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.65234,0.0019754,0.060867,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.49227,0.0019008,-0.065546,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.76948,0.0018088,-0.0023158,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,0.0017719,0.0062413,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.69061,0.001762,0.016804,0,0
3,GO CELL PROJECTION ORGANIZATION,0.66501,0.0017527,0.018766,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.71658,0.0017109,0.023363,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.75615,0.0015939,-0.042717,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.9686,0.0014908,-0.0014358,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.9686,0.0014733,-0.0091945,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85082,0.0014074,-0.034616,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.52025,0.0012349,0.026247,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.89907,0.0012121,-0.012278,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.31232,0.0011984,-0.059052,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.59059,0.0011784,-0.036901,0,0
3,GO IMPORT INTO NUCLEUS,0.93377,0.0011547,-0.0035695,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.78289,0.0011132,-0.048874,0,0
3,GO LIPID PHOSPHORYLATION,0.50337,0.0010831,0.041144,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.53167,0.0010643,-0.039973,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.65866,0.0010595,0.033711,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.44402,0.00094454,0.029056,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.78962,0.00092425,-0.029875,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.72969,0.00085306,-0.076354,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.87144,0.00066066,0.0056869,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.97557,0.00061569,-0.001468,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.80312,0.00058415,0.013009,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.83713,0.00054748,-0.013983,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.85768,0.00049936,-0.030225,0,0
3,GO RESPONSE TO NICOTINE,0.69061,0.00045567,0.027831,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.54321,0.00034335,-0.014881,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.41341,0.00014907,0.021634,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,0.00013118,0.00040004,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.75615,0.00011039,0.014211,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.83713,5.2757e-05,-0.039116,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.5726,-4.8057e-05,-0.016782,0,0
3,GO MAINTENANCE OF LOCATION,0.78289,-6.148e-05,0.0098354,0,0
3,GO PROTEIN AUTOPROCESSING,0.98953,-0.00016379,-0.022545,0,0
3,GO PIRNA METABOLIC PROCESS,0.48131,-0.0002303,-0.10914,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.52025,-0.00023226,-0.028183,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.77618,-0.00036335,0.0048093,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.63354,-0.000428,-0.044165,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.96163,-0.00048452,0.0017186,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.80312,-0.00049308,-0.05234,0,0
3,GO MUSCLE HYPERTROPHY,0.72969,-0.00058105,-0.028925,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.41842,-0.0007005,-0.034803,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1,-0.00076563,-0.031239,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.76948,-0.00085104,-0.029858,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,-0.00086836,0.019572,0,0
3,GO FEVER GENERATION,0.53742,-0.0010039,0.030955,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.69061,-0.001153,-0.019731,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.80989,-0.0011931,-0.0028538,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0012676,-0.044833,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.0012742,0.0056948,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.96163,-0.0012755,-0.0061296,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.52594,-0.0013027,0.025534,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.78962,-0.001415,-0.014481,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.89215,-0.0014205,0.011426,0,0
3,GO BODY FLUID SECRETION,0.81668,-0.0014761,0.0029811,0,0
3,GO RESPONSE TO GLUCAGON,0.91987,-0.0015068,-0.014708,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.60883,-0.0015098,-0.030795,0,0
3,GO OVULATION CYCLE,0.4978,-0.0015213,0.032306,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.97557,-0.0016361,0.0037829,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.63354,-0.0016612,-0.02543,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.85768,-0.0016885,-0.0014084,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.94769,-0.0017264,-0.012812,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.67137,-0.0017465,-0.066126,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.59664,-0.0019113,-0.030114,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39858,-0.0019951,0.039776,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.85768,-0.0020953,-0.059625,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.78962,-0.0021106,-0.043574,0,0
3,GO REGULATION OF CYTOKINESIS,0.43883,-0.002141,-0.032988,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.78289,-0.0021447,0.0050345,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.97557,-0.0021541,-0.011407,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.7495,-0.0021752,-0.039342,0,0
3,GO NUCLEOSIDE SALVAGE,0.36991,-0.0022156,0.039444,0,0
3,GO EXOCYTIC PROCESS,0.56666,-0.002245,0.062948,0,0
3,GO PIGMENT GRANULE MATURATION,0.85768,-0.0023048,-0.054706,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.97557,-0.0023323,-0.0083782,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.84397,-0.0023651,-0.025005,0,0
3,GO TAXIS,0.7495,-0.0024014,-0.010814,0,0
3,GO NEURON DEATH,0.92682,-0.0025196,-0.0017035,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.95466,-0.0026231,-0.013383,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.83713,-0.0030017,0.0066233,0,0
3,GO DOSAGE COMPENSATION,0.8303,-0.0030349,-0.013877,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.58456,-0.0030703,-0.15633,0,0
3,GO CHROMOSOME ORGANIZATION,0.87833,-0.0030851,0.0056816,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.37932,-0.0032129,-0.048803,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.40349,-0.003424,0.021385,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.93377,-0.0035655,-0.017228,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.60883,-0.0037699,0.020089,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.80989,-0.0038033,0.010839,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.68418,-0.0038524,-0.013559,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.53742,-0.0038826,0.035653,0,0
3,GO CHEMICAL HOMEOSTASIS,0.95466,-0.003967,-0.0080533,0,0
3,GO HEART MORPHOGENESIS,0.99651,-0.0041449,-0.018148,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.54903,-0.0041466,-0.019115,0,0
3,GO ORGANIC ACID TRANSPORT,0.55487,-0.0042215,0.017458,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.94073,-0.004325,-0.0048182,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.97557,-0.0043475,-0.013154,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.94769,-0.0043516,-0.016717,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.80312,-0.0043878,-0.024818,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.67776,-0.0045072,0.0046049,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.52025,-0.0047153,-0.030987,0,0
3,GO RESPONSE TO PH,0.76948,-0.004738,-0.027486,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.69707,-0.0047639,-0.021699,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.71658,-0.0048014,-0.013175,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.80312,-0.0048961,-0.015413,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.75615,-0.0049049,-0.025801,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.97557,-0.005009,0.0067403,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.72313,-0.005061,-0.052126,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.55487,-0.0050735,0.08997,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.90599,-0.0050959,-0.0070516,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.0051145,-0.021377,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87144,-0.0051889,0.013658,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.72313,-0.0052208,-0.050558,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.82348,-0.0052434,-0.0048747,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.65866,-0.0052449,-0.048825,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.66501,-0.005382,-0.043445,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.20621,-0.0057439,-0.059669,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.87144,-0.0061845,-0.014707,0,0
3,GO LIPID CATABOLIC PROCESS,0.47588,-0.0062484,-0.037588,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65234,-0.0063962,-0.022471,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.56666,-0.0064213,-0.021922,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.3746,-0.0064736,0.045386,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91293,-0.0065886,-0.010019,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95466,-0.0066102,-0.030804,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,-0.0067242,0.0015205,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.48131,-0.0067761,0.044148,0,0
3,GO HEAT GENERATION,0.62113,-0.0067979,-0.041792,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.76281,-0.0068298,-0.040138,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.49227,-0.0068596,-0.061985,0,0
3,GO BLASTODERM SEGMENTATION,0.4978,-0.0069007,0.08959,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.44402,-0.0069391,-0.061373,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,-0.006964,-0.10786,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.58456,-0.0069784,-0.030028,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.76948,-0.0071088,-0.0088894,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.86455,-0.0071364,0.018294,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.87833,-0.007325,-0.045401,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7495,-0.0073674,-0.011251,0,0
3,GO HINDLIMB MORPHOGENESIS,0.66501,-0.0074091,0.010561,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.86455,-0.0074578,-0.016199,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.84397,-0.0076558,-0.01464,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.76281,-0.0076769,-0.0092746,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.92682,-0.0077309,-0.018139,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.80989,-0.008001,-0.01596,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,-0.0080193,-0.0045908,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.70355,-0.0080197,-0.011913,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.65234,-0.0080541,-0.025212,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.89215,-0.0080773,0.020725,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.83713,-0.0081249,-0.022048,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,-0.0081736,-0.041355,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.61497,-0.008546,0.029044,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80989,-0.0085715,-0.015401,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.54321,-0.0086583,-0.029287,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.82348,-0.0088617,-0.082832,0,0
3,GO ERK1 AND ERK2 CASCADE,0.51459,-0.0089105,-0.046951,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.85768,-0.0089968,-0.012245,0,0
3,GO TRACHEA MORPHOGENESIS,0.89907,-0.0091072,-0.018687,0,0
3,GO DRINKING BEHAVIOR,0.7495,-0.0093318,-0.0030326,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.97557,-0.0093498,0.0090277,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.69707,-0.009508,-0.004935,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.87144,-0.00953,-0.011361,0,0
3,GO RESPONSE TO X RAY,0.60272,-0.0096007,-0.065705,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0096237,-0.068419,0,0
3,GO FIBROBLAST PROLIFERATION,0.54903,-0.0097005,0.024163,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.59664,-0.00975,-0.0624,0,0
3,GO PERICARDIUM DEVELOPMENT,0.94073,-0.0097832,-0.011658,0,0
3,GO RESPONSE TO ETHANOL,0.99651,-0.0098929,-0.00047781,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.60883,-0.010035,-0.049841,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.65866,-0.01009,-0.037508,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,-0.010112,-0.030351,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.53167,-0.010163,-0.041355,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.69707,-0.010221,-0.027857,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.49227,-0.010278,0.037499,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.8303,-0.010279,-0.010079,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.73628,-0.010351,-0.018502,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.81668,-0.010369,0.0030049,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.65234,-0.010619,-0.0232,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97557,-0.010684,-0.013915,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.60272,-0.010713,-0.10836,0,0
3,GO HEART DEVELOPMENT,0.48678,-0.010727,-0.037599,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,-0.010749,-0.084745,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.99651,-0.010795,-0.023231,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.31653,-0.010802,-0.029142,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.80989,-0.010999,-0.0041155,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95466,-0.011084,0.01409,0,0
3,GO GENE SILENCING,0.40843,-0.011122,-0.021814,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.44924,-0.011182,-0.034949,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.67776,-0.011203,-0.1668,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.68418,-0.011264,-0.036411,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.64605,-0.011307,0.058723,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.19095,-0.011431,-0.080238,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.4545,-0.011468,-0.032258,0,0
3,GO RESPONSE TO AXON INJURY,0.91293,-0.011778,-0.0012456,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.62113,-0.011837,-0.034786,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.44402,-0.011893,0.12852,0,0
3,GO VESICLE LOCALIZATION,0.26847,-0.012029,-0.033037,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.47049,-0.012085,-0.032097,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.69061,-0.012213,-0.018482,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.40843,-0.012282,-0.041562,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.44924,-0.012391,-0.031789,0,0
3,GO MESODERM DEVELOPMENT,0.44924,-0.012459,-0.050142,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.56075,-0.012515,-0.022809,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.62732,-0.012588,0.025694,0,0
3,GO PROTEIN SUMOYLATION,0.77618,-0.012736,-0.0075734,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.50337,-0.012781,-0.022183,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.87833,-0.012867,-0.0079675,0,0
3,GO BIOMINERALIZATION,0.89215,-0.012871,-0.020201,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34256,-0.012913,-0.031051,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.55487,-0.012973,0.085402,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.17934,-0.013086,-0.058279,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.21579,-0.013223,-0.045768,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.33812,-0.01325,-0.059833,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.93377,-0.013264,0.0035065,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.57857,-0.013331,-0.027579,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.65866,-0.013388,-0.013358,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.76948,-0.013403,0.024341,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.20309,-0.013471,-0.05008,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.56666,-0.013499,-0.066469,0,0
3,GO POLYOL CATABOLIC PROCESS,0.78962,-0.013535,-0.024826,0,0
3,GO GASTRULATION,0.65866,-0.013544,-0.044904,0,0
3,GO MICROTUBULE ANCHORING,0.63978,-0.013549,-0.024947,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.56666,-0.013641,-0.035936,0,0
3,GO PHOTOPERIODISM,0.88523,-0.013648,-0.015083,0,0
3,GO BLASTOCYST DEVELOPMENT,0.60272,-0.013652,-0.018421,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.98255,-0.013772,-0.0020253,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.36064,-0.013815,-0.055739,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.7495,-0.013861,-0.027981,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.96163,-0.013871,-5.346e-05,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.93377,-0.013925,0.012308,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.65866,-0.013971,0.046057,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.8303,-0.013999,0.0024329,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.36526,-0.014096,-0.039662,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.72969,-0.014098,-0.032344,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.59664,-0.014158,-0.038722,0,0
3,GO MITOPHAGY,0.33812,-0.014368,-0.059769,0,0
3,GO VITAMIN TRANSPORT,0.78289,-0.01444,0.035671,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.96163,-0.014539,-0.053293,0,0
3,GO HISTONE PHOSPHORYLATION,0.5726,-0.014694,-0.040065,0,0
3,GO HISTONE H3 K9 METHYLATION,0.59664,-0.01473,-0.027067,0,0
3,GO CELL DIVISION,0.48131,-0.014868,-0.022416,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.80312,-0.015031,-0.031949,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60272,-0.015053,-0.043052,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.60272,-0.015136,-0.0088106,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.89215,-0.015318,-0.0092663,0,0
3,GO REGULATION OF T CELL MIGRATION,0.42347,-0.015403,-0.054232,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,-0.015546,-0.019983,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.87144,-0.015547,-0.015575,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.81668,-0.015593,-0.0057824,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.15517,-0.015865,-0.045594,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.98255,-0.015901,-0.023011,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39371,-0.015977,-0.05669,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4545,-0.016055,-0.03357,0,0
3,GO SPINDLE ORGANIZATION,0.39858,-0.016137,-0.028088,0,0
3,GO GLIOGENESIS,0.74288,-0.016142,-0.017504,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.59664,-0.016208,-0.068997,0,0
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.61497,-0.016301,0.028317,0,0
3,GO RESPONSE TO STEROL,0.77618,-0.016342,-0.017548,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.56666,-0.016354,-0.024477,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.39371,-0.016433,-0.052615,0,0
3,GO ORGAN INDUCTION,0.4978,-0.016484,-0.074804,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15264,-0.016519,-0.058883,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.24288,-0.016529,-0.032371,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.50337,-0.016546,-0.015016,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.50896,-0.016593,-0.053644,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20937,-0.016604,-0.065645,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.44924,-0.016703,-0.027995,0,0
3,GO SISTER CHROMATID COHESION,0.92682,-0.016719,0.0106,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,-0.016808,-0.052488,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.72313,-0.016871,-0.073009,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.46512,-0.016947,-0.030799,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.80312,-0.01708,-0.062657,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.4545,-0.017094,-0.030825,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.83713,-0.017231,-0.034079,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.33373,-0.017298,-0.048122,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72969,-0.017307,-0.013092,0,0
3,GO AUTOPHAGIC CELL DEATH,0.52594,-0.017344,-0.05563,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.70355,-0.017345,-0.030833,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,-0.017359,-0.012146,0,0
3,GO REGULATION OF TRANSPORT,0.61497,-0.017377,-0.014246,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.53742,-0.017379,-0.029342,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.5726,-0.01739,-0.0339,0,0
3,GO GLAND MORPHOGENESIS,0.46512,-0.017413,-0.092293,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27611,-0.017446,-0.045449,0,0
3,GO CALCIUM ION IMPORT,0.65866,-0.017459,0.027533,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.89907,-0.01748,0.01167,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.53167,-0.017485,-0.019121,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.77618,-0.017605,-0.041129,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.86455,-0.017617,-0.029001,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.74288,-0.017803,0.024424,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.58456,-0.017903,-0.012086,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.72313,-0.017932,-0.0043403,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.47049,-0.017987,-0.049102,0,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.36991,-0.01823,-0.09678,0,0
3,GO SISTER CHROMATID SEGREGATION,0.60272,-0.018329,-0.011517,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.91293,-0.01838,-0.080202,0,0
3,GO ANION TRANSPORT,0.7495,-0.018423,-0.010151,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.94769,-0.018629,0.018076,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.88523,-0.018726,-0.024389,0,0
3,GO RESPONSE TO ZINC ION,0.62113,-0.018737,-0.069647,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.58456,-0.018831,0.020753,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.53742,-0.018839,-0.060528,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.71006,-0.018859,-0.010004,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.34702,-0.018873,-0.071356,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.32506,-0.018886,-0.078006,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.53167,-0.01915,-0.046456,0,0
3,GO REGULATION OF CELL CYCLE,0.30815,-0.019229,-0.020215,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.41341,-0.019283,-0.022807,0,0
3,GO ORGANELLE INHERITANCE,0.49227,-0.019439,-0.037226,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.48131,-0.019447,-0.032394,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.49227,-0.019517,-0.042666,0,0
3,GO VASCULATURE DEVELOPMENT,0.25363,-0.019522,-0.066452,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48678,-0.019665,-0.050587,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.58456,-0.019705,0.028858,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.23589,-0.019711,-0.054555,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.39858,-0.019807,-0.060449,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.56666,-0.019892,-0.028081,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2,-0.019967,-0.071375,0,0
3,GO REGULATION OF AUTOPHAGY,0.4978,-0.019997,-0.022612,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.68418,-0.020077,-0.014108,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.50896,-0.020125,0.067618,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.67776,-0.020305,-0.012599,0,0
3,GO REGULATION OF PHOSPHORYLATION,0.20937,-0.020325,-0.042632,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.15264,-0.020357,-0.080097,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.23245,-0.020431,-0.059592,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.77618,-0.02049,-0.033878,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65234,-0.020664,-0.02965,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.24643,-0.020679,-0.10669,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65866,-0.021099,-0.030584,0,0
3,GO MEMBRANE FUSION,0.27999,-0.021176,-0.048341,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89907,-0.021317,0.071593,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25363,-0.02133,-0.028237,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.27227,-0.021344,-0.033256,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.89907,-0.021446,-0.0045247,0,0
3,GO MUSCLE FILAMENT SLIDING,0.91987,-0.021468,-0.016047,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.81668,-0.021567,-0.016558,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.4598,-0.021573,-0.051162,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67776,-0.021645,-0.032571,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.51459,-0.021663,-0.03962,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.4545,-0.021732,-0.015393,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.53167,-0.021734,-0.026713,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.67776,-0.021846,-0.0047164,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.70355,-0.021862,-0.021587,0,0
3,GO REGULATION OF VASCULOGENESIS,0.33373,-0.021997,-0.093101,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.50337,-0.022015,-0.027923,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.78289,-0.022044,-0.03604,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.67137,-0.022119,-0.031084,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.72313,-0.02213,-0.051099,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.59664,-0.022203,-0.017086,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21905,-0.022287,-0.090021,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.47588,-0.022386,-0.021315,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.80312,-0.022407,-0.038593,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.93377,-0.022455,-0.013078,0,0
3,GO FERTILIZATION,0.26098,-0.022487,-0.028927,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.188,-0.022569,-0.04408,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29586,-0.022607,-0.034894,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.18219,-0.02268,-0.13403,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.50337,-0.022701,-0.035619,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.89907,-0.022744,-0.020357,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.92682,-0.022747,-0.0033542,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.77618,-0.02277,-0.02659,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.61497,-0.02287,-0.023392,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.32938,-0.022926,-0.066363,0,0
3,GO BODY MORPHOGENESIS,0.31653,-0.022946,-0.081159,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.72313,-0.023015,-0.049528,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.59664,-0.023039,-0.081571,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.21579,-0.023048,-0.1047,0,0
3,GO P BODY ASSEMBLY,0.61497,-0.023064,-0.018746,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.95466,-0.023077,0.00022288,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.36991,-0.023133,-0.057583,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.32506,-0.023137,-0.056151,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.78962,-0.023186,-0.082528,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.29586,-0.023214,-0.038719,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.36064,-0.02324,-0.063778,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.40349,-0.023243,-0.049346,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17374,-0.023355,-0.046619,0,0
3,GO FATTY ACID TRANSPORT,0.72969,-0.023384,-0.024542,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.49227,-0.023425,-0.050692,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.49227,-0.023635,-0.021057,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38408,-0.023652,-0.068116,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049024,0,0
3,GO AMINE CATABOLIC PROCESS,0.44924,-0.024209,-0.093456,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.30402,-0.024269,-0.1025,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.27611,-0.024315,-0.054826,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.32938,-0.024508,-0.030476,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.52025,-0.024594,-0.023625,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35607,-0.024607,-0.033533,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.80989,-0.024674,-0.0090311,0,0
3,GO REGULATION OF DNA REPLICATION,0.92682,-0.02468,-0.0045385,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.65866,-0.024829,-0.01931,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.36064,-0.024879,-0.07039,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.41341,-0.024891,-0.055045,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.67137,-0.024914,-0.030866,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.30815,-0.024951,-0.031347,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.98255,-0.024992,0.01505,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35153,-0.025158,-0.071753,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.38888,-0.025203,-0.024403,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.41842,-0.025215,-0.021795,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.43367,-0.025222,-0.056351,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.78962,-0.025276,-0.01593,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.2839,-0.025285,-0.029132,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.44924,-0.025338,-0.030402,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.60272,-0.025653,-0.045093,0,0
3,GO AMINE TRANSPORT,0.99651,-0.025839,0.064469,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.98953,-0.025852,0.045742,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.53742,-0.025889,-0.011043,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99651,-0.025897,0.0025506,0,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.5726,-0.02593,-0.053479,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.11841,-0.025953,-0.040729,0,0
3,GO CELL CYCLE,0.25001,-0.025977,-0.022523,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.27227,-0.026075,-0.049069,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.24288,-0.026102,-0.018355,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.72313,-0.02615,0.0020184,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.87144,-0.026156,-0.015939,0,0
3,GO MEMBRANE DOCKING,0.20309,-0.026247,-0.029645,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.20621,-0.026289,-0.071253,0,0
3,GO RESPONSE TO RADIATION,0.65866,-0.02629,-0.0067871,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.24643,-0.026311,-0.028875,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.40349,-0.026345,-0.042672,0,0
3,GO MACROPHAGE ACTIVATION,0.84397,-0.026365,-0.024553,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.56075,-0.026375,-0.047339,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,1,-0.026387,-0.012159,0,0
3,GO T CELL MIGRATION,0.43367,-0.026446,-0.06959,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.9686,-0.026471,0.027409,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.25363,-0.026567,-0.076366,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.36064,-0.026647,-0.055413,0,0
3,GO BLEB ASSEMBLY,0.33373,-0.026684,-0.25347,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15773,-0.026729,-0.097364,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.43367,-0.026904,-0.028678,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.50337,-0.026967,-0.044751,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.36064,-0.027007,-0.033968,0,0
3,GO AXIS SPECIFICATION,0.69707,-0.027023,-0.00131,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46512,-0.027051,-0.040504,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.62732,-0.027099,-0.023682,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.87144,-0.027157,-0.0027098,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.85082,-0.02721,-0.0089129,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.17934,-0.027252,-0.048935,0,0
3,GO HOMEOSTATIC PROCESS,0.26847,-0.02729,-0.030685,0,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.027331,-0.13456,0,0
3,GO MUSCLE ATROPHY,0.51459,-0.027353,-0.093716,0,0
3,GO FACE DEVELOPMENT,0.2,-0.027398,-0.098459,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.81668,-0.02754,-0.022786,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.34256,-0.027581,-0.03578,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33373,-0.027635,-0.03034,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.67776,-0.027651,-0.017569,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.78289,-0.027837,-0.022079,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.56075,-0.027854,-0.10173,0,0
3,GO RESPONSE TO INSULIN,0.23937,-0.027872,-0.040946,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.95466,-0.027884,0.0057815,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.7495,-0.027931,-0.0022154,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.96163,-0.028046,-0.020998,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34256,-0.028056,-0.028641,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.61497,-0.028077,-0.044532,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.68418,-0.028218,-0.021905,0,0
3,GO RESPONSE TO STARVATION,0.69707,-0.028266,-0.019755,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32077,-0.028559,-0.044567,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.32938,-0.028631,-0.061288,0,0
3,GO CHROMOSOME SEGREGATION,0.4598,-0.028657,-0.022158,0,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12473,-0.028662,-0.054169,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.83713,-0.028844,-0.0091235,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.67776,-0.028846,0.028935,0,0
3,GO ORGANIC ANION TRANSPORT,0.52594,-0.028995,-0.022643,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.87144,-0.029194,-0.039638,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.69707,-0.0292,-0.0099276,0,0
3,GO CELL SUBSTRATE ADHESION,0.56666,-0.029225,-0.050192,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.88523,-0.029295,-0.023462,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.5726,-0.029314,-0.027981,0,0
3,GO OSSIFICATION,0.33373,-0.029494,-0.057957,0,0
3,GO REGULATION OF CELL DIVISION,0.25729,-0.029523,-0.04194,0,0
3,GO MUSCLE CELL PROLIFERATION,0.61497,-0.029577,-0.039756,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.43883,-0.029639,-0.064164,0,0
3,GO LEUKOCYTE HOMEOSTASIS,0.28785,-0.02964,-0.067543,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20937,-0.029771,-0.10267,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.27227,-0.029816,-0.030102,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.25729,-0.029835,-0.058054,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.25729,-0.029843,-0.056505,0,0
3,GO NIK NF KAPPAB SIGNALING,0.27227,-0.029898,-0.085049,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.059411,-0.02991,-0.065,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.070855,-0.030125,-0.036356,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.25001,-0.030207,-0.042938,0,0
3,GO MOLTING CYCLE,0.63354,-0.030221,-0.044955,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31653,-0.03029,-0.057567,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.62113,-0.030407,-0.03705,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21256,-0.030434,-0.071756,0,0
3,GO CELL JUNCTION ASSEMBLY,0.31232,-0.030441,-0.050339,0,0
3,GO STEM CELL DIVISION,0.94769,-0.03047,-0.0068845,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.4978,-0.030495,-0.053634,0,0
3,GO ACID SECRETION,0.90599,-0.030511,-0.0013233,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.77618,-0.030557,-0.010788,0,0
3,GO CELLULAR EXTRAVASATION,0.56075,-0.030612,-0.031455,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.50896,-0.030648,-0.056695,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.91987,-0.030648,-0.02002,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.40349,-0.030654,-0.052955,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.30402,-0.030756,-0.068411,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.080955,-0.030783,-0.083591,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.76948,-0.030822,-0.021881,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69707,-0.030851,-0.027205,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14526,-0.03092,-0.079507,0,0
3,GO REGULATION OF CELL AGING,0.32506,-0.030984,-0.064828,0,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.14526,-0.031013,-0.041615,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.20621,-0.031033,-0.058887,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22568,-0.031154,-0.053133,0,0
3,GO AGING,0.1028,-0.031162,-0.074528,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.54321,-0.031173,-0.040351,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.23589,-0.031365,-0.062076,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69707,-0.031397,-0.026546,0,0
3,GO HAIR FOLLICLE MATURATION,0.27611,-0.031505,-0.10466,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.095625,-0.031539,-0.052693,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.47588,-0.031565,-0.039208,0,0
3,GO SKIN MORPHOGENESIS,0.39371,-0.031647,-0.14764,0,0
3,GO SULFATE TRANSPORT,0.073629,-0.031684,-0.062673,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.69061,-0.03171,-0.032563,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.38888,-0.031726,-0.06098,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.068167,-0.031776,-0.037793,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.4545,-0.031787,-0.045034,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0695,-0.031794,-0.043171,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.44402,-0.031798,-0.036458,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65234,-0.031911,-0.028526,0,0
3,GO DNA CATABOLIC PROCESS,0.15773,-0.032259,-0.067355,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.23245,-0.032418,-0.05419,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.78962,-0.032572,-0.052148,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.03268,-0.16772,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.51459,-0.032754,-0.026166,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.22235,-0.032766,-0.090831,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24643,-0.032795,-0.071503,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.90599,-0.032901,-0.019411,0,0
3,GO SODIUM ION HOMEOSTASIS,0.27999,-0.032947,-0.046438,0,0
3,GO REGULATION OF PROTEIN BINDING,0.36064,-0.03295,-0.037602,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.89907,-0.033011,0.01014,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.22568,-0.033062,-0.068204,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.61497,-0.033134,-0.010585,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.23245,-0.033202,-0.07845,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.11039,-0.033212,-0.03158,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.60272,-0.033233,-0.022539,0,0
3,GO HISTONE H2B UBIQUITINATION,0.19095,-0.033276,-0.077911,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.36064,-0.033339,-0.15957,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.15517,-0.033368,-0.037576,0,0
3,GO DNA METHYLATION,0.59664,-0.033528,-0.014798,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.60883,-0.033558,-0.077682,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.85768,-0.03357,0.0008337,0,0
3,GO LYSOSOMAL TRANSPORT,0.32506,-0.033694,-0.053499,0,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.46512,-0.033767,-0.044268,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.32938,-0.033798,-0.055461,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.5726,-0.033834,-0.029344,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.22905,-0.033836,-0.080209,0,0
3,GO RESPONSE TO METAL ION,0.29184,-0.033855,-0.042174,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,-0.033886,-0.03698,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.89907,-0.033909,0.016014,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.69707,-0.033941,-0.029167,0,0
3,GO DETOXIFICATION,0.53167,-0.033965,-0.044965,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.48678,-0.033968,-0.067663,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,-0.034059,-0.10266,0,0
3,GO FLUID TRANSPORT,0.25363,-0.034061,-0.074638,0,0
3,GO SIGNAL RELEASE,0.65866,-0.034071,-0.0010474,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.20309,-0.034174,-0.10134,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.57857,-0.034258,-0.055949,0,0
3,GO MICROTUBULE BASED PROCESS,0.38408,-0.034271,-0.014227,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.12259,-0.034518,-0.043649,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.81668,-0.034534,0.0091153,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.62113,-0.03477,-0.047274,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.38408,-0.034804,-0.028389,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.034977,-0.0036248,0,0
3,GO CYTOSOLIC TRANSPORT,0.36526,-0.03502,-0.030797,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.51459,-0.035137,-0.030078,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.2,-0.035363,-0.031391,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.79636,-0.03559,-0.02196,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.39371,-0.035609,-0.026577,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.67776,-0.035659,-0.014561,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.43367,-0.035699,-0.042587,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.21256,-0.035736,-0.040174,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.093897,-0.035767,-0.054094,0,0
3,GO RESPONSE TO PEPTIDE,0.25729,-0.035808,-0.036664,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.22235,-0.035875,-0.065438,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.89215,-0.035892,0.015056,0,0
3,GO CIRCADIAN RHYTHM,0.24643,-0.035946,-0.029111,0,0
3,GO RESPONSE TO HYDROXYUREA,0.27999,-0.035971,-0.074191,0,0
3,GO REGULATION OF HEAT GENERATION,0.54903,-0.036122,-0.056632,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.58456,-0.036219,-0.018153,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.31653,-0.036249,-0.052113,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.55487,-0.03626,-0.098518,0,0
3,GO CELL REDOX HOMEOSTASIS,0.92682,-0.036266,-0.024957,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.54321,-0.03635,-0.019318,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.38408,-0.036384,-0.055867,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.95466,-0.03645,-0.0058813,0,0
3,GO NEURON APOPTOTIC PROCESS,0.63978,-0.036481,-0.0072482,0,0
3,GO RESPONSE TO THYROID HORMONE,0.82348,-0.036511,-0.029967,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.38408,-0.036559,-0.050379,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.72313,-0.036686,0.025592,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.13583,-0.036791,-0.10331,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.38408,-0.036805,-0.071526,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26471,-0.036864,-0.060497,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.36991,-0.036872,-0.066441,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.80989,-0.036963,-0.013388,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.14769,-0.037064,-0.045112,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.27999,-0.037255,-0.097812,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.93377,-0.03729,-0.0008696,0,0
3,GO NEPHRON MORPHOGENESIS,0.20309,-0.037413,-0.073062,0,0
3,GO LIPID MODIFICATION,0.061812,-0.037429,-0.071872,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.28785,-0.037451,-0.044029,0,0
3,GO GLIAL CELL DEVELOPMENT,0.40349,-0.037506,-0.044883,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.73628,-0.037519,-0.033958,0,0
3,GO LOCOMOTOR RHYTHM,0.94073,-0.037552,0.010264,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.51459,-0.037629,-0.069764,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.12049,-0.037645,-0.032588,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.29992,-0.03767,-0.062206,0,0
3,GO RENAL SYSTEM PROCESS,0.084046,-0.037818,-0.092098,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.84397,-0.038001,-0.039616,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.2,-0.038061,-0.10665,0,0
3,GO DE NOVO PROTEIN FOLDING,0.31653,-0.038069,-0.038373,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.59664,-0.038191,-0.018397,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.53167,-0.038201,-0.051807,0,0
3,GO RESPONSE TO ACTIVITY,0.23937,-0.03821,-0.067827,0,0
3,GO CYTOKINESIS,0.046579,-0.038365,-0.070188,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54903,-0.038384,-0.041155,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.20309,-0.03839,-0.059884,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.51459,-0.038394,-0.014103,0,0
3,GO N GLYCAN PROCESSING,0.39858,-0.038396,-0.10408,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.11841,-0.038424,-0.059097,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.49227,-0.038452,-0.11563,0,0
3,GO APPENDAGE DEVELOPMENT,0.12689,-0.038465,-0.09591,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.3746,-0.038467,-0.10747,0,0
3,GO CARNITINE SHUTTLE,0.91293,-0.038579,0.013771,0,0
3,GO ORGANELLE LOCALIZATION,0.05824,-0.038687,-0.039002,0,0
3,GO TRANSFERRIN TRANSPORT,0.2839,-0.038787,-0.062721,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.084046,-0.038791,-0.06953,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.073629,-0.038847,-0.04078,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.48678,-0.038902,-0.067253,0,0
3,GO DIET INDUCED THERMOGENESIS,0.73628,-0.038937,0.06081,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29586,-0.039185,-0.04237,0,0
3,GO DNA MODIFICATION,0.17653,-0.039344,-0.043046,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.057089,-0.039424,-0.10535,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12473,-0.039426,-0.062679,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.099158,-0.03947,-0.056999,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.84397,-0.039504,0.013789,0,0
3,GO REGENERATION,0.44924,-0.039542,-0.050252,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.061812,-0.039547,-0.085658,0,0
3,GO PEROXISOMAL TRANSPORT,0.33812,-0.039597,-0.047467,0,0
3,GO REGULATION OF INSULIN SECRETION,0.91987,-0.039604,-0.00057665,0,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.22905,-0.039639,-0.047706,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59664,-0.039711,-0.031453,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.86455,-0.03972,-0.00070276,0,0
3,GO NEURON PROJECTION REGENERATION,0.89215,-0.039762,0.010796,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.84397,-0.039803,-0.0012998,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.71658,-0.039815,-0.06205,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.11039,-0.0399,-0.060889,0,0
3,GO AXIS ELONGATION,0.43883,-0.039958,-0.092542,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.27611,-0.039994,-0.057518,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.80312,-0.039999,-0.020449,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.26847,-0.04001,-0.029269,0,0
3,GO LIPID OXIDATION,0.39371,-0.040258,-0.057369,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.51459,-0.040537,-0.031294,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.20309,-0.040573,-0.078009,0,0
3,GO METANEPHROS DEVELOPMENT,0.18219,-0.040599,-0.08717,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,-0.040689,-0.083843,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.9686,-0.040872,-0.0072722,0,0
3,GO VAGINA DEVELOPMENT,0.66501,-0.040942,-0.065526,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.30402,-0.040996,-0.030411,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.74288,-0.041092,-0.053444,0,0
3,GO ANIMAL ORGAN FORMATION,0.64605,-0.041307,-0.04753,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.62113,-0.041312,-0.014243,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.070855,-0.041433,-0.062038,0,0
3,GO CHOLESTEROL STORAGE,0.55487,-0.041642,-0.043475,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.43367,-0.041695,-0.070172,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.31232,-0.041744,-0.037809,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.11841,-0.041768,-0.1354,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.41341,-0.041783,-0.041813,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.5726,-0.041792,-0.0294,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13355,-0.041859,-0.046722,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.47588,-0.04197,-0.025186,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.65234,-0.041986,-0.10079,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.98953,-0.042116,0.020262,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.12049,-0.042272,-0.079071,0,0
3,GO PEROXISOME ORGANIZATION,0.22905,-0.04234,-0.053457,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,-0.042351,-0.032161,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.042466,-0.059192,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.71658,-0.042635,0.017626,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.19695,-0.042642,-0.054506,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.96163,-0.042652,-0.013778,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.21256,-0.042748,-0.068053,0,0
3,GO OOGENESIS,0.093897,-0.042759,-0.089788,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.53167,-0.042766,-0.062195,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.53742,-0.042845,-0.027221,0,0
3,GO CD40 SIGNALING PATHWAY,0.34702,-0.042873,-0.12019,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1313,-0.04288,-0.061497,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.061812,-0.042892,-0.10529,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.61497,-0.04295,-0.0063505,0,0
3,GO REGULATION OF APPETITE,0.31232,-0.042951,-0.063649,0,0
3,GO ZINC ION HOMEOSTASIS,0.52594,-0.042958,-0.094631,0,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.004408,-0.042958,-0.071349,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.72969,-0.043058,-0.013679,0,0
3,GO ASTROCYTE ACTIVATION,0.30402,-0.043064,-0.078155,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.38408,-0.043199,-0.024521,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29184,-0.043241,-0.051012,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.19095,-0.043286,-0.058209,0,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.064293,-0.04336,-0.054893,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.53167,-0.043416,-0.034598,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.1028,-0.043477,-0.074725,0,0
3,GO MEMBRANE ORGANIZATION,0.33812,-0.043611,-0.030583,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.082489,-0.043676,-0.056599,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.79636,-0.043696,-0.0084209,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.78289,-0.043801,-0.027243,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.36991,-0.043886,-0.054294,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16294,-0.044033,-0.045415,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.46512,-0.044044,-0.047773,0,0
3,GO REGULATION OF MITOPHAGY,0.25729,-0.044058,-0.068177,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.55487,-0.044097,-0.048412,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.56666,-0.04418,-0.033172,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.21256,-0.044222,-0.038824,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.14526,-0.044224,-0.094239,0,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.44924,-0.044239,-0.077296,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05824,-0.044253,-0.04826,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,-0.044285,-0.058075,0,0
3,GO PROTEIN POLYMERIZATION,0.42855,-0.044392,-0.022277,0,0
3,GO TOR SIGNALING,0.15517,-0.044434,-0.034649,0,0
3,GO RESPONSE TO HORMONE,0.29184,-0.044482,-0.03894,0,0
3,GO REGULATION OF SECRETION,0.17099,-0.044584,-0.046648,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.31232,-0.044735,-0.068603,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.52025,-0.044783,-0.023919,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29586,-0.044801,-0.12579,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.78962,-0.044913,0.036864,0,0
3,GO SPINDLE ASSEMBLY,0.05824,-0.044964,-0.053659,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.41842,-0.04497,-0.073289,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.088862,-0.044973,-0.10864,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.85082,-0.045019,-0.013569,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.21905,-0.045074,-0.044078,0,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.054842,-0.045134,-0.14388,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.8303,-0.045257,-0.051683,0,0
3,GO ORGANELLE ASSEMBLY,0.0066042,-0.045259,-0.058024,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.42347,-0.045265,-0.037511,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.72969,-0.04527,-0.037436,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17099,-0.045311,-0.073217,0,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.1313,-0.045372,-0.06962,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.14769,-0.045383,-0.037579,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83713,-0.045384,-0.031136,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.94769,-0.045392,-0.018674,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.44402,-0.045482,-0.055209,0,0
3,GO RESPONSE TO KETONE,0.17099,-0.045567,-0.077068,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.69061,-0.045643,-0.045265,0,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.079444,-0.045653,-0.065112,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0695,-0.045681,-0.090317,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.045849,-0.066294,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.22568,-0.045864,-0.093317,0,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.055956,-0.046016,-0.073182,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.62113,-0.046024,0.076036,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.48678,-0.046026,-0.060973,0,0
3,GO ASTROCYTE DEVELOPMENT,0.43883,-0.046047,-0.057739,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.73628,-0.046056,-0.023494,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,-0.04608,-0.052696,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.23937,-0.046175,-0.13623,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18219,-0.046193,-0.029822,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.24643,-0.046277,-0.050009,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12259,-0.0464,-0.055246,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.60272,-0.046604,-0.025664,0,0
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.27999,-0.046728,-0.2537,0,0
3,GO BONE MINERALIZATION,0.59664,-0.046734,-0.031952,0,0
3,GO RESPONSE TO NUTRIENT,0.32938,-0.046753,-0.060608,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.29586,-0.046767,-0.05418,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.44402,-0.046786,-0.032654,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.24643,-0.046825,-0.039587,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.046875,-0.044578,0,0
3,GO RESPONSE TO PAIN,0.65866,-0.047002,-0.062546,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.077957,-0.047005,-0.087691,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.13814,-0.047021,-0.037595,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13583,-0.047041,-0.062751,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.25363,-0.047043,-0.053979,0,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.085627,-0.047119,-0.056345,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.7495,-0.047182,0.022279,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.047234,-0.072339,0,0
3,GO LIPID HOMEOSTASIS,0.18508,-0.047324,-0.072075,0,0
3,GO METAPHASE PLATE CONGRESSION,0.014138,-0.047354,-0.09609,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.54903,-0.047375,-0.017306,0,0
3,GO JNK CASCADE,0.17653,-0.047471,-0.046982,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.9686,-0.047642,0.0054404,0,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,-0.047734,-0.074036,0,0
3,GO NUCLEUS ORGANIZATION,0.066855,-0.047765,-0.048761,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.43367,-0.047786,-0.033608,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.59664,-0.047815,-0.013753,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.077957,-0.048062,-0.084675,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.25729,-0.048159,-0.055455,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.98255,-0.048185,0.0053542,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.29992,-0.048244,-0.041564,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.8303,-0.048266,-0.017858,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.15015,-0.048332,-0.12801,0,0
3,GO GLUCOSE IMPORT,0.25363,-0.048497,-0.047554,0,0
3,GO PENILE ERECTION,0.74288,-0.048522,-0.028242,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.12049,-0.048531,-0.082053,0,0
3,GO VACUOLAR ACIDIFICATION,0.16294,-0.048637,-0.11439,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.18219,-0.048821,-0.045107,0,0
3,GO MANGANESE ION TRANSPORT,0.72313,-0.048862,-0.010146,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.21905,-0.048885,-0.066053,0,0
3,GO HISTONE H3 ACETYLATION,0.13583,-0.048885,-0.042872,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.092194,-0.049001,-0.069983,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.3746,-0.049032,-0.15971,0,0
3,GO RESPONSE TO TUMOR CELL,0.26098,-0.049036,-0.1034,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.64605,-0.049193,-0.053361,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.11039,-0.049196,-0.049893,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.82348,-0.049413,-0.061782,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.26847,-0.049473,-0.043069,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.060602,-0.049595,-0.054655,0,0
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.22905,-0.049611,-0.14107,0,0
3,GO INTEGRIN ACTIVATION,0.35153,-0.049632,-0.079514,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.83713,-0.049665,0.00089528,0,0
3,GO MEMBRANE INVAGINATION,0.20937,-0.049668,-0.072821,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15517,-0.049676,-0.13311,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.10096,-0.049693,-0.16087,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.43883,-0.04979,-0.039119,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22568,-0.049796,-0.044982,0,0
3,GO SINGLE FERTILIZATION,0.090515,-0.049836,-0.05013,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.1313,-0.04992,-0.059113,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.049942,-0.013333,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.075049,-0.049967,-0.085534,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.44402,-0.049996,-0.022489,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.7495,-0.050075,-0.022681,0,0
3,GO BIOLOGICAL ADHESION,0.13355,-0.050117,-0.073472,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23589,-0.050222,-0.094412,0,0
3,GO LYMPHOCYTE MIGRATION,0.24288,-0.050246,-0.078135,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21905,-0.050306,-0.091423,0,0
3,GO ARACHIDONIC ACID SECRETION,0.26847,-0.050416,-0.084436,0,0
3,GO REGIONALIZATION,0.29992,-0.050447,-0.039031,0,0
3,GO KINETOCHORE ORGANIZATION,0.41341,-0.050601,-0.055677,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.20937,-0.050746,-0.1183,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.70355,-0.050754,-0.029724,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.004387,0,0
3,GO RESPONSE TO ALKALOID,0.33373,-0.050782,-0.045193,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.17653,-0.050807,-0.069296,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.26471,-0.05083,-0.039678,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.12689,-0.050997,-0.040191,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.99651,-0.051017,-0.015055,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11434,-0.051027,-0.046379,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.91987,-0.051057,-0.0029276,0,0
3,GO STRESS FIBER ASSEMBLY,0.40349,-0.051068,-0.051594,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.32077,-0.051105,-0.056605,0,0
3,GO REGULATION OF TUBE SIZE,0.19393,-0.051248,-0.067098,0,0
3,GO CELL CYCLE CHECKPOINT,0.082489,-0.05134,-0.045361,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.19393,-0.051372,-0.079947,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.28785,-0.051375,-0.076763,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.50337,-0.051386,-0.034784,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.14526,-0.051479,-0.072734,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48678,-0.05157,-0.073262,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25729,-0.051725,-0.090823,0,0
3,GO PIGMENTATION,0.12908,-0.051755,-0.068555,0,0
3,GO OVULATION,0.44402,-0.051842,-0.081234,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.20309,-0.05186,-0.10054,0,0
3,GO RESPONSE TO CHEMOKINE,0.54903,-0.051865,-0.045098,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.093897,-0.051995,-0.11452,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.24643,-0.052098,-0.041733,0,0
3,GO REGULATION OF CELL DEATH,0.079444,-0.052102,-0.059277,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.15517,-0.052159,-0.046643,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.33373,-0.052205,-0.060209,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.35153,-0.052596,-0.088513,0,0
3,GO RESPONSE TO VITAMIN,0.55487,-0.052661,-0.045344,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.54321,-0.052702,-0.047104,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.3746,-0.052811,-0.037548,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.71006,-0.052823,-0.083316,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.17374,-0.052919,-0.042604,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.75615,-0.053214,-0.024949,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.13583,-0.053266,-0.066299,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.38888,-0.0533,-0.023923,0,0
3,GO PHAGOCYTOSIS,0.2839,-0.053521,-0.068683,0,0
3,GO NEGATIVE REGULATION OF SECRETION,0.12473,-0.053615,-0.055788,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.46512,-0.053724,-0.024273,0,0
3,GO ATP TRANSPORT,0.89907,-0.053776,0.0065594,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.52594,-0.053879,-0.040107,0,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.10096,-0.053887,-0.04293,0,0
3,GO EMBRYO DEVELOPMENT,0.1028,-0.053924,-0.053059,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.22235,-0.053968,-0.061382,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.27227,-0.054029,-0.073494,0,0
3,GO THYMIC T CELL SELECTION,0.20309,-0.054055,-0.050215,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.27999,-0.054061,-0.15296,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.5726,-0.05411,-0.066397,0,0
3,GO SYMBIOTIC PROCESS,0.087232,-0.054117,-0.079782,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.20309,-0.054237,-0.035746,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.093897,-0.054293,-0.060521,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.63354,-0.054364,-0.021443,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43367,-0.054601,-0.011595,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11039,-0.054657,-0.054942,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077944,0,0
3,GO MESENCHYME MORPHOGENESIS,0.092194,-0.054741,-0.13341,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.48131,-0.054777,-0.025516,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.43367,-0.054815,-0.060493,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.32938,-0.054824,-0.034578,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.2,-0.05483,-0.098465,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,-0.055013,-0.013454,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.2,-0.055256,-0.055429,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.076492,-0.055397,-0.065251,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.39858,-0.055449,-0.042461,0,0
3,GO PRE MIRNA PROCESSING,0.51459,-0.055494,-0.034901,0,0
3,GO SELECTIVE AUTOPHAGY,0.19695,-0.055543,-0.07192,0,0
3,GO APOPTOTIC PROCESS,0.1028,-0.055601,-0.054798,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.41842,-0.055681,-0.052568,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.25001,-0.055796,-0.043774,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.14769,-0.055822,-0.076351,0,0
3,GO DEMETHYLATION,0.088862,-0.055835,-0.051845,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.47588,-0.05587,-0.023843,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.2839,-0.056102,-0.05852,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.10654,-0.056109,-0.057024,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13355,-0.056217,-0.044563,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.53742,-0.056224,0.12115,0,0
3,GO CELL CELL RECOGNITION,0.11841,-0.056289,-0.073026,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.93377,-0.056476,-0.015392,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.34702,-0.05653,-0.031693,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.43367,-0.056572,-0.024253,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14048,-0.056629,-0.12413,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74288,-0.056701,-0.022079,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.38408,-0.056713,-0.047228,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.22235,-0.056787,-0.051562,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.60272,-0.057025,-0.0053905,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16032,-0.05722,-0.075605,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.12259,-0.057266,-0.061562,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.32506,-0.057299,-0.06991,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.065563,-0.05744,-0.13976,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.43367,-0.057444,-0.057828,0,0
3,GO RESPONSE TO TESTOSTERONE,0.4598,-0.057452,-0.053363,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.33812,-0.057477,-0.081057,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.11039,-0.057543,-0.13967,0,0
3,GO PROTEIN MANNOSYLATION,0.69707,-0.057564,-0.020375,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.16828,-0.05759,-0.040918,0,0
3,GO HISTONE H4 ACETYLATION,0.087232,-0.057684,-0.047474,0,0
3,GO SENSORY PERCEPTION,0.11841,-0.057936,-0.04304,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.32077,-0.058163,-0.063558,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.12908,-0.058167,-0.06074,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.30402,-0.058198,-0.055448,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.38408,-0.058241,-0.092118,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.042857,-0.058243,-0.13615,0,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.077957,-0.058284,-0.05069,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.49227,-0.058314,-0.050802,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.18219,-0.058361,-0.082675,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.91987,-0.058464,0.0099453,0,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.15517,-0.058631,-0.077146,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.31653,-0.05865,-0.095502,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.059411,-0.058702,-0.086829,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.11434,-0.058703,-0.11516,0,0
3,GO GLYCOSYLATION,0.15517,-0.058708,-0.07068,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32077,-0.058723,-0.035755,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.16828,-0.058764,-0.069985,0,0
3,GO FATTY ACID BETA OXIDATION,0.32077,-0.058862,-0.064597,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.085627,-0.059026,-0.091971,0,0
3,GO CAMP BIOSYNTHETIC PROCESS,0.36064,-0.059118,-0.096058,0,0
3,GO NEURONAL ACTION POTENTIAL,0.25001,-0.059138,-0.076407,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.76948,-0.059148,-0.0038809,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.19095,-0.05917,-0.1236,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.35607,-0.059229,-0.048949,0,0
3,GO TONGUE DEVELOPMENT,0.41341,-0.059263,-0.085089,0,0
3,GO GOLGI RIBBON FORMATION,0.38888,-0.059418,-0.062741,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.059444,-0.068701,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.24643,-0.059615,-0.15713,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12049,-0.059713,-0.082747,0,0
3,GO RESPONSE TO FUNGUS,0.30815,-0.059877,-0.047315,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.18219,-0.05992,-0.097341,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.095625,-0.059945,-0.069165,0,0
3,GO T CELL CHEMOTAXIS,0.12049,-0.059949,-0.082357,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.98953,-0.059995,0.029895,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.23937,-0.060031,-0.081232,0,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.059411,-0.060173,-0.10032,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.26098,-0.06027,-0.040523,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.12473,-0.060364,-0.082909,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.13583,-0.06039,-0.067139,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.20309,-0.0604,-0.10067,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.12259,-0.060446,-0.085593,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.36991,-0.060454,-0.041694,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.92682,-0.060632,0.0018042,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.12908,-0.060711,-0.11151,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.14048,-0.060887,-0.052195,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.17653,-0.060934,-0.11468,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.44402,-0.061,-0.041059,0,0
3,GO APPENDAGE MORPHOGENESIS,0.15773,-0.061007,-0.10467,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.53742,-0.061014,-0.037754,0,0
3,GO SEX DIFFERENTIATION,0.11636,-0.061016,-0.050249,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,-0.061072,-0.057507,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.36991,-0.061221,-0.056979,0,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.082489,-0.061364,-0.077825,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.2,-0.061378,-0.1525,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.25729,-0.061488,-0.067297,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.63978,-0.061547,-0.025898,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.15517,-0.061581,-0.11519,0,0
3,GO REGULATION OF TOR SIGNALING,0.15015,-0.061624,-0.047396,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11841,-0.0617,-0.068346,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.25001,-0.061778,-0.080982,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.24288,-0.061829,-0.1638,0,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.059411,-0.061852,-0.081493,0,0
3,GO RENAL FILTRATION,0.55487,-0.061867,-0.041388,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.33812,-0.06193,-0.0471,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.51459,-0.062005,-0.030543,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.16294,-0.062178,-0.10012,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.22235,-0.062194,-0.090051,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.16559,-0.062198,-0.044743,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.80312,-0.062241,-0.021675,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.44402,-0.062587,-0.02347,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.33373,-0.062824,-0.10819,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.19695,-0.062861,-0.070382,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.32077,-0.063034,-0.033723,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.35153,-0.063039,-0.069863,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.15015,-0.063307,-0.057595,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.1028,-0.063568,-0.11919,0,0
3,GO OOCYTE MATURATION,0.66501,-0.063675,-0.020409,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.065563,-0.063757,-0.063544,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.13583,-0.0638,-0.086583,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.25001,-0.063803,-0.094649,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.85768,-0.063809,0.0040887,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36064,-0.063845,-0.049305,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.23589,-0.063872,-0.10514,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.70355,-0.064012,-0.031214,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.14048,-0.06404,-0.070882,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13583,-0.064134,-0.12509,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.27611,-0.064153,-0.061548,0,0
3,GO REGULATION OF CELL MATURATION,0.087232,-0.064441,-0.072833,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.55487,-0.064485,0.094908,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.066855,-0.06483,-0.10504,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.18219,-0.064888,-0.10029,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.43367,-0.065007,-0.031353,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.18219,-0.065068,-0.11325,0,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.060602,-0.065325,-0.070494,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.16294,-0.065333,-0.050958,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.065418,-0.049418,0,0
3,GO PRIMARY MIRNA PROCESSING,0.48131,-0.065474,-0.048068,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.52594,-0.065615,-0.050706,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,-0.065623,-0.042442,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.14048,-0.065695,-0.089292,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.76948,-0.065715,0.0055686,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18219,-0.065767,-0.079642,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.11434,-0.065784,-0.15275,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.068167,-0.065843,-0.055671,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.088862,-0.066178,-0.098585,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.059411,-0.066245,-0.086528,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.12259,-0.066303,-0.10011,0,0
3,GO REGULATION OF ANION TRANSPORT,0.092194,-0.066316,-0.072435,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.24643,-0.066361,-0.08214,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.22568,-0.06646,-0.10443,0,0
3,GO EPIBOLY,0.29184,-0.066593,-0.129,0,0
3,GO EATING BEHAVIOR,0.21905,-0.066676,-0.069817,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.69061,-0.06671,0.0053828,0,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.061812,-0.066742,-0.086157,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.05824,-0.066789,-0.083841,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.65866,-0.066992,-0.020116,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.12049,-0.06706,-0.076101,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59664,-0.067076,-0.059338,0,0
3,GO VITAMIN METABOLIC PROCESS,0.98255,-0.067183,0.0024998,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.74288,-0.067271,-0.035863,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.78289,-0.067299,-0.0081928,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.082489,-0.067305,-0.089652,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.4598,-0.067345,-0.088499,0,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.095625,-0.067411,-0.069622,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.095625,-0.067649,-0.063693,0,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.10845,-0.067715,-0.05579,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.4545,-0.06773,-0.059121,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.064293,-0.067756,-0.080653,0,0
3,GO HISTONE H2A ACETYLATION,0.22235,-0.067757,-0.061376,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.16559,-0.067791,-0.08264,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.81668,-0.067959,0.006514,0,0
3,GO REGULATION OF MAPK CASCADE,0.21256,-0.068029,-0.055321,0,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.097379,-0.068033,-0.14833,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.4598,-0.068115,-0.19913,0,0
3,GO STEROID HORMONE SECRETION,0.25001,-0.068121,-0.099478,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.39858,-0.068122,-0.048999,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.25363,-0.068167,-0.091611,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27611,-0.068202,-0.070329,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94769,-0.06822,0.063735,0,0
3,GO STEROID CATABOLIC PROCESS,0.4545,-0.068223,-0.067968,0,0
3,GO LIPID METABOLIC PROCESS,0.082489,-0.06838,-0.061218,0,0
3,GO BONE MATURATION,0.39371,-0.068413,-0.070685,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.10465,-0.068465,-0.090477,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.17653,-0.068646,-0.067613,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.38888,-0.068737,-0.15186,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.24643,-0.068763,-0.17683,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11636,-0.068841,-0.13751,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11039,-0.068864,-0.084924,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.15773,-0.068878,-0.087709,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.49227,-0.069196,-0.09461,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.25729,-0.069239,-0.044835,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44924,-0.069307,-0.059768,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.32938,-0.069376,-0.083875,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.14048,-0.069387,-0.10439,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.10845,-0.069552,-0.097558,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063042,-0.069572,-0.07148,0,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.055956,-0.069583,-0.079324,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14285,-0.06961,-0.12077,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.52025,-0.069614,-0.072431,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.65866,-0.069665,-0.029161,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.42347,-0.069711,-0.12189,0,0
3,GO STEM CELL PROLIFERATION,0.085627,-0.069873,-0.088511,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.49227,-0.069902,-0.047194,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.14048,-0.069984,-0.069522,0,0
3,GO RESPONSE TO EPINEPHRINE,1,-0.070059,0.0084342,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.36526,-0.070127,-0.11902,0,0
3,GO L PHENYLALANINE METABOLIC PROCESS,0.34256,-0.070147,-0.16427,0,0
3,GO RESPONSE TO SALT STRESS,0.17099,-0.070179,-0.097227,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.55487,-0.07019,-0.051358,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.32077,-0.070281,-0.075533,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.070396,-0.15765,0,0
3,GO OOCYTE DIFFERENTIATION,0.088862,-0.070457,-0.11075,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23589,-0.070469,-0.048612,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.077957,-0.070546,-0.10172,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.076492,-0.070944,-0.075557,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.52025,-0.071008,-0.14249,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.18508,-0.071112,-0.073072,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12473,-0.071121,-0.13684,0,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.088862,-0.07116,-0.081142,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.26471,-0.071183,-0.050459,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.41842,-0.07124,-0.038872,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.34702,-0.071327,-0.081445,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.66501,-0.071361,-0.014335,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19393,-0.071443,-0.10888,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.12908,-0.071506,-0.057411,0,0
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.16032,-0.071682,-0.19393,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.20309,-0.071726,-0.19148,0,0
3,GO RESPONSE TO STEROID HORMONE,0.090515,-0.071862,-0.082773,0,0
3,GO REGULATION OF ERAD PATHWAY,0.11039,-0.072218,-0.056497,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.088862,-0.072555,-0.076916,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.079444,-0.072652,-0.096508,0,0
3,GO CELL MATURATION,0.095625,-0.072739,-0.059033,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.26098,-0.072774,-0.040754,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.22905,-0.072841,-0.10171,0,0
3,GO FEMALE GAMETE GENERATION,0.05824,-0.072977,-0.071017,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.073112,-0.063294,0,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.11636,-0.073163,-0.12615,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.38888,-0.073195,-0.069182,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.42855,-0.073636,-0.063622,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.31232,-0.073693,-0.086789,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.19695,-0.073724,-0.14012,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.084046,-0.073751,-0.072273,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.059411,-0.073851,-0.076544,0,0
3,GO REGULATION OF HORMONE SECRETION,0.17653,-0.074032,-0.05161,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.13583,-0.074207,-0.10346,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.19695,-0.074241,-0.085051,0,0
3,GO SPERM EGG RECOGNITION,0.14526,-0.07425,-0.060326,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.015203,-0.074726,-0.069842,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25729,-0.074747,-0.10372,0,0
3,GO FUCOSE METABOLIC PROCESS,0.33812,-0.074971,-0.086857,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.082489,-0.075002,-0.073294,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27999,-0.075064,-0.074805,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.29586,-0.075212,-0.11366,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.075306,-0.11015,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.16559,-0.075576,-0.098151,0,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.077957,-0.075608,-0.077803,0,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.42347,-0.075615,-0.030029,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.095625,-0.075639,-0.089565,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.076492,-0.075751,-0.2086,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.10096,-0.075787,-0.081429,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.34256,-0.075824,-0.063825,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.66501,-0.075893,-0.013919,0,0
3,GO HISTONE H3 DEACETYLATION,0.16294,-0.076023,-0.060796,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.068167,-0.07605,-0.079694,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.27227,-0.076241,-0.12255,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.188,-0.076252,-0.099063,0,0
3,GO OXALATE TRANSPORT,0.18508,-0.076339,-0.070137,0,0
3,GO STEROL METABOLIC PROCESS,0.36991,-0.076559,-0.044179,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.28785,-0.076608,-0.048475,0,0
3,GO GOLGI VESICLE TRANSPORT,0.064293,-0.076635,-0.067156,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.12259,-0.076699,-0.13211,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.14285,-0.076791,-0.075534,0,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.023205,-0.076905,-0.071375,0,0
3,GO PEPTIDE HORMONE SECRETION,0.53167,-0.077103,-0.0186,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.25363,-0.077124,-0.059487,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,-0.077268,-0.064251,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.077274,-0.06012,0,0
3,GO KIDNEY MORPHOGENESIS,0.054842,-0.077294,-0.10155,0,0
3,GO RESPONSE TO LIPID,0.13355,-0.077308,-0.066226,0,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070855,-0.077435,-0.099518,0,0
3,GO RESPONSE TO VITAMIN D,0.80989,-0.077594,0.039877,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.53167,-0.077645,-0.031668,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40349,-0.077647,-0.11588,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.19095,-0.077662,-0.098862,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.084046,-0.077666,-0.067344,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.16294,-0.077716,-0.099133,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.21905,-0.077791,-0.1154,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63354,-0.07786,0.021852,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.16559,-0.077919,-0.073781,0,0
3,GO NEUTROPHIL MIGRATION,0.082489,-0.078095,-0.096768,0,0
3,GO CELL AGING,0.061812,-0.078269,-0.080006,0,0
3,GO ARTERY MORPHOGENESIS,0.11039,-0.078324,-0.10161,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.1313,-0.078506,-0.057484,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.093897,-0.078605,-0.17566,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21579,-0.078614,-0.08538,0,0
3,GO REGULATION OF HORMONE LEVELS,0.095625,-0.078628,-0.068587,0,0
3,GO DEVELOPMENTAL INDUCTION,0.17099,-0.078658,-0.1118,0,0
3,GO REGULATION OF OSSIFICATION,0.12049,-0.078785,-0.0924,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.10845,-0.07879,-0.13168,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15517,-0.078833,-0.093369,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077957,-0.078852,-0.08791,0,0
3,GO FOREBRAIN MORPHOGENESIS,0.82348,-0.078887,-0.0056324,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.17653,-0.078912,-0.081512,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.087232,-0.079113,-0.065285,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.13814,-0.079144,-0.091213,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.072231,-0.079169,-0.082162,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.39858,-0.079174,-0.063072,0,0
3,GO INCLUSION BODY ASSEMBLY,0.89907,-0.079179,0.033338,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.082489,-0.079539,-0.095341,0,0
3,GO CHROMOSOME LOCALIZATION,0.0025817,-0.079572,-0.11324,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.62732,-0.079689,-0.12377,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.17653,-0.079723,-0.071325,0,0
3,GO STEROID ESTERIFICATION,0.11434,-0.079851,-0.19435,0,0
3,GO EMBRYO IMPLANTATION,0.24643,-0.079902,-0.10811,0,0
3,GO CENTRIOLE ASSEMBLY,0.13814,-0.079905,-0.068935,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10096,-0.079933,-0.089764,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.15517,-0.079957,-0.097999,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.66501,-0.079977,-0.12878,0,0
3,GO PHOSPHOLIPID EFFLUX,0.21905,-0.080125,-0.1366,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.088862,-0.080256,-0.13641,0,0
3,GO HORMONE TRANSPORT,0.19695,-0.080339,-0.05185,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32938,-0.080418,-0.079,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.21256,-0.08045,-0.092696,0,0
3,GO KERATINOCYTE MIGRATION,0.61497,-0.08049,-0.039674,0,0
3,GO AMINE METABOLIC PROCESS,0.12049,-0.080577,-0.079885,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.60883,-0.080587,-0.0053089,0,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,-0.08078,-0.068347,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14285,-0.08084,-0.24794,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.17934,-0.080883,-0.082861,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.38888,-0.081216,-0.039415,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.89907,-0.08135,0.012913,0,0
3,GO TUBE FORMATION,0.023205,-0.081475,-0.096162,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.79636,-0.081497,-0.014733,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.36064,-0.081499,-0.088131,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.46512,-0.081511,-0.043248,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.21905,-0.081737,-0.10744,0,0
3,GO MALE MEIOSIS I,0.14526,-0.081746,-0.16335,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.0018173,-0.081769,-0.08676,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.27999,-0.081823,-0.079765,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36991,-0.081949,-0.11858,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.11039,-0.081967,-0.073009,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.17934,-0.082008,-0.068604,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.98953,-0.082031,0.0090464,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.057089,-0.082351,-0.1822,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.12908,-0.082473,-0.10733,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.11636,-0.082782,-0.07921,0,0
3,GO REGULATION OF LIPID STORAGE,0.087232,-0.082949,-0.091851,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.14526,-0.082951,-0.092192,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21579,-0.082956,-0.10327,0,0
3,GO ERYTHROCYTE MATURATION,0.12049,-0.08344,-0.088107,0,0
3,GO PROTEIN DEGLYCOSYLATION,0.11039,-0.08417,-0.14361,0,0
3,GO REGULATION OF HAIR CYCLE,0.20937,-0.084269,-0.10289,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.20937,-0.084536,-0.056248,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.39858,-0.084864,-0.049769,0,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.12473,-0.0849,-0.10945,0,0
3,GO GASTRIC ACID SECRETION,0.60883,-0.08499,-0.037888,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.20309,-0.085085,-0.06729,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.55487,-0.085163,-0.041185,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.10654,-0.085236,-0.081822,0,0
3,GO B CELL HOMEOSTASIS,0.32506,-0.085482,-0.0654,0,0
3,GO P38MAPK CASCADE,0.095625,-0.085628,-0.11232,0,0
3,GO INNER EAR MORPHOGENESIS,0.055956,-0.085652,-0.10908,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.18508,-0.085753,-0.10198,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.076492,-0.086105,-0.076304,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.36064,-0.086299,-0.092187,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.29586,-0.086473,-0.083811,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.082489,-0.086596,-0.067863,0,0
3,GO TEMPERATURE HOMEOSTASIS,0.087232,-0.086657,-0.064314,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25363,-0.086693,-0.11179,0,0
3,GO INOSITOL METABOLIC PROCESS,0.060602,-0.086994,-0.11438,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.13814,-0.087059,-0.083389,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.059411,-0.0872,-0.13205,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.67776,-0.087223,-0.074606,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.092194,-0.087339,-0.18318,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.13814,-0.087407,-0.19943,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.057089,-0.087547,-0.16547,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.68418,-0.087736,-0.044953,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.080955,-0.087739,-0.094854,0,0
3,GO ACTIN CROSSLINK FORMATION,0.87144,-0.087869,0.077755,0,0
3,GO STEROL HOMEOSTASIS,0.20621,-0.088167,-0.089323,0,0
3,GO TISSUE REGENERATION,0.1028,-0.088299,-0.11001,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.13814,-0.088552,-0.066869,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.13583,-0.088655,-0.096032,0,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10096,-0.088765,-0.076278,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.095625,-0.088786,-0.10801,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13355,-0.088807,-0.1344,0,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.072231,-0.089101,-0.11879,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16559,-0.089316,-0.093759,0,0
3,GO POSITIVE CHEMOTAXIS,0.068167,-0.089478,-0.12492,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.15015,-0.089579,-0.11969,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.28785,-0.089763,-0.11846,0,0
3,GO RNA DESTABILIZATION,0.087232,-0.090047,-0.076442,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.91987,-0.090175,-0.0011283,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.87144,-0.090279,-0.050626,0,0
3,GO FUCOSYLATION,0.42347,-0.090311,-0.05878,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.12473,-0.090507,-0.078158,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,-0.090544,-0.089967,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.26098,-0.09056,-0.093363,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.084046,-0.09068,-0.10219,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21256,-0.090789,-0.040896,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.89907,-0.090943,-0.0083277,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.087232,-0.091064,-0.091989,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.0087944,-0.091301,-0.11058,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.054842,-0.091353,-0.054921,0,0
3,GO INSULIN SECRETION,0.41842,-0.091501,-0.034162,0,0
3,GO MEIOTIC CELL CYCLE,0.00037661,-0.091734,-0.09741,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.072231,-0.091962,-0.18076,0,0
3,GO MACROPHAGE PROLIFERATION,0.43883,-0.091977,-0.11518,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.073629,-0.092056,-0.086216,0,0
3,GO LUNG MORPHOGENESIS,0.072231,-0.092227,-0.14341,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.015203,-0.092248,-0.10601,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.21256,-0.092277,-0.063994,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.095625,-0.092371,-0.060268,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.12908,-0.092676,-0.074987,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.063042,-0.0929,-0.13949,0,0
3,GO RNA DECAPPING,0.063042,-0.093165,-0.084048,0,0
3,GO RESPONSE TO FOOD,0.064293,-0.093167,-0.092211,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.12689,-0.093304,-0.11504,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.38408,-0.093305,-0.080008,0,0
3,GO PHAGOSOME MATURATION,0.14526,-0.093437,-0.085654,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.14285,-0.093568,-0.094321,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.10096,-0.093605,-0.091261,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.48678,-0.093985,-0.065317,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.12049,-0.094103,-0.18566,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.09437,-0.026685,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.080955,-0.094409,-0.083872,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.21905,-0.094589,-0.086714,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.094642,-0.11428,0,0
3,GO KINETOCHORE ASSEMBLY,0.57857,-0.094721,-0.053244,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.15264,-0.095036,-0.13654,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.090515,-0.095162,-0.13351,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.44402,-0.095188,-0.03795,0,0
3,GO STEROID METABOLIC PROCESS,0.079444,-0.095191,-0.083801,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.099158,-0.095222,-0.11135,0,0
3,GO PROTEIN REFOLDING,0.29586,-0.09544,-0.053965,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.99651,-0.095512,-0.06923,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.18508,-0.095779,-0.12623,0,0
3,GO MITOCHONDRIAL FUSION,0.031748,-0.0959,-0.098395,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30402,-0.096014,-0.34622,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16294,-0.096559,-0.099548,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.44402,-0.09674,-0.097956,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.23937,-0.097144,-0.072208,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.20309,-0.097336,-0.073089,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.070855,-0.097522,-0.078017,0,0
3,GO CYTOPLASM ORGANIZATION,0.084046,-0.097634,-0.12684,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.0032441,-0.097681,-0.12134,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.64605,-0.097792,-0.053434,0,0
3,GO RENAL WATER HOMEOSTASIS,0.13355,-0.097948,-0.091902,0,0
3,GO ECTODERM DEVELOPMENT,0.015574,-0.09795,-0.11081,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.15264,-0.09813,-0.10051,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.81668,-0.098187,0.018086,0,0
3,GO SPROUTING ANGIOGENESIS,0.073629,-0.098418,-0.10615,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.054842,-0.098654,-0.13863,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.19695,-0.098759,-0.10064,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.5726,-0.098813,-0.040628,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.12473,-0.098825,-0.1131,0,0
3,GO MESODERM MORPHOGENESIS,0.077957,-0.098903,-0.11643,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.060602,-0.099032,-0.18398,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.080955,-0.099088,-0.11472,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.47588,-0.09924,-0.057015,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.23937,-0.099259,-0.062738,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.26098,-0.099356,-0.063304,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.25363,-0.099511,-0.10718,0,0
3,GO T CELL APOPTOTIC PROCESS,0.084046,-0.099884,-0.11709,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.12259,-0.099893,-0.08762,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.62732,-0.10003,-0.082911,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.085627,-0.10012,-0.096106,0,0
3,GO HEART INDUCTION,0.36064,-0.10018,-0.082211,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.4978,-0.10032,-0.068885,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.33812,-0.10033,-0.061251,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.072231,-0.10036,-0.1479,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.32938,-0.10056,-0.14047,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.097379,-0.10059,-0.072517,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.64605,-0.10088,-0.066347,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.20309,-0.10109,-0.14733,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.092194,-0.10111,-0.078679,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.60883,-0.10114,-0.049575,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.34256,-0.10131,-0.11721,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.46512,-0.10141,-0.083864,0,0
3,GO NOTOCHORD DEVELOPMENT,0.39371,-0.10143,-0.12899,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.11434,-0.10143,-0.12999,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.11636,-0.1018,-0.11731,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.15773,-0.10298,-0.10393,0,0
3,GO GOLGI LOCALIZATION,0.095625,-0.10299,-0.088866,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.35607,-0.10336,-0.057254,0,0
3,GO RESPONSE TO COLD,0.090515,-0.10342,-0.13864,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20621,-0.10359,-0.083018,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.34256,-0.10408,-0.054531,0,0
3,GO SULFATION,0.11235,-0.10413,-0.13199,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16828,-0.10432,-0.20675,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.23937,-0.10438,-0.14381,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.023741,-0.10443,-0.11891,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.10845,-0.10455,-0.077879,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.85768,-0.10474,-0.010847,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,-0.10487,-0.049168,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.05824,-0.10505,-0.15867,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.0060989,-0.10518,-0.13486,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.47049,-0.10567,-0.069096,0,0
3,GO PANCREATIC JUICE SECRETION,0.24288,-0.10591,-0.073648,0,0
3,GO RESPONSE TO ESTRADIOL,0.093897,-0.10593,-0.083027,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.55487,-0.10596,-0.081441,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.40843,-0.10605,-0.070457,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.22235,-0.10614,-0.084726,0,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.12049,-0.1064,-0.078279,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.1313,-0.1066,-0.088014,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.7495,-0.10672,-0.023395,0,0
3,GO SPERMATID DIFFERENTIATION,0.0087944,-0.1071,-0.10775,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.092194,-0.10818,-0.10951,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.25363,-0.10856,-0.05197,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.38408,-0.10867,-0.090366,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.27227,-0.10892,-0.076187,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.097379,-0.10894,-0.1109,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.24643,-0.1092,-0.076207,0,0
3,GO MRNA TRANSCRIPTION,0.25363,-0.10935,-0.072209,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.41341,-0.10941,-0.042975,0,0
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.63978,-0.10983,-0.14513,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.082489,-0.11013,-0.081344,0,0
3,GO FAT CELL PROLIFERATION,0.26098,-0.11081,-0.081584,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.16828,-0.11097,-0.14394,0,0
3,GO REPLACEMENT OSSIFICATION,0.035393,-0.11165,-0.16091,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00095906,-0.11176,-0.15167,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.072231,-0.11222,-0.16981,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.75615,-0.11251,-0.048589,0,0
3,GO KETONE CATABOLIC PROCESS,0.070855,-0.11282,-0.1894,0,0
3,GO RESPONSE TO INSECTICIDE,0.80989,-0.11311,-0.013078,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.079444,-0.11333,-0.084827,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.12049,-0.1136,-0.28901,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.068167,-0.11386,-0.18963,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.47588,-0.11402,-0.045653,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.21579,-0.1141,-0.11565,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.099158,-0.11447,-0.17675,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.91293,-0.11454,0.022408,0,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.12259,-0.11456,-0.16197,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.0085714,-0.1146,-0.11829,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.060602,-0.11507,-0.16772,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.14285,-0.11514,-0.10287,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.072231,-0.11557,-0.12803,0,0
3,GO MYOTUBE DIFFERENTIATION,0.10096,-0.11618,-0.088465,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.11621,-0.17828,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23937,-0.11666,-0.12927,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.088862,-0.11691,-0.12826,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.25001,-0.11722,-0.16384,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.2,-0.11725,-0.11246,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.092194,-0.11832,-0.1604,0,0
3,GO NEURON FATE COMMITMENT,0.41341,-0.11835,-0.040205,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15015,-0.11851,-0.15717,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.095625,-0.11896,-0.12616,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.17934,-0.11901,-0.068565,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090515,-0.11902,-0.13531,0,0
3,GO HORMONE METABOLIC PROCESS,0.11434,-0.1193,-0.098397,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.72313,-0.11935,-0.041044,0,0
3,GO STEROL IMPORT,0.34702,-0.11938,-0.055777,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.085627,-0.11962,-0.18799,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.25729,-0.11971,-0.079686,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.054842,-0.11977,-0.10854,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.27611,-0.12024,-0.076403,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.087232,-0.12111,-0.15455,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.11434,-0.12172,-0.08329,0,0
3,GO HEART FORMATION,0.25001,-0.12187,-0.08206,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.41842,-0.12194,-0.056898,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.085627,-0.12254,-0.10509,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.33373,-0.12264,-0.19267,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.36064,-0.12265,-0.09638,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.16828,-0.12326,-0.14239,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.25001,-0.12327,-0.12467,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.082489,-0.12343,-0.094469,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.15015,-0.12357,-0.10189,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.63354,-0.12361,-0.079345,0,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.22568,-0.12369,-0.10727,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.35153,-0.12382,-0.085274,0,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.084046,-0.12411,-0.18517,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,-0.12419,-0.11158,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0036303,-0.12448,-0.13972,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.13583,-0.12451,-0.12157,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.21579,-0.12457,-0.073951,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12908,-0.125,-0.10917,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10096,-0.12573,-0.1186,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18219,-0.126,-0.11398,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.036948,-0.12609,-0.18719,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.05161,-0.12619,-0.18499,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.054842,-0.12653,-0.11945,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.56666,-0.12668,-0.065246,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.054842,-0.12674,-0.11463,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.46512,-0.12681,-0.073083,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.15264,-0.12731,-0.085475,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.076492,-0.1274,-0.17121,0,0
3,GO RESPONSE TO CADMIUM ION,0.11039,-0.12778,-0.12653,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.075049,-0.12815,-0.11737,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.060602,-0.12853,-0.15283,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.29992,-0.12898,-0.14992,0,0
3,GO REGULATION OF GTP BINDING,0.40843,-0.12916,-0.069615,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.090515,-0.12965,-0.19235,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.12689,-0.12983,-0.19409,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.076492,-0.1303,-0.10402,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.095625,-0.13039,-0.10267,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.017549,-0.13045,-0.11113,0,0
3,GO AMMONIUM TRANSPORT,0.10845,-0.13054,-0.19741,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.072231,-0.1308,-0.1429,0,0
3,GO LIPID EXPORT FROM CELL,0.076492,-0.1312,-0.11281,0,0
3,GO SPECIFICATION OF SYMMETRY,0.001986,-0.13171,-0.11453,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.057089,-0.13195,-0.10423,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.077957,-0.13235,-0.13666,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0032441,-0.13243,-0.12134,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12908,-0.13297,-0.23336,0,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.12689,-0.13369,-0.12255,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13355,-0.13395,-0.18851,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.099158,-0.13406,-0.087686,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.32938,-0.13435,-0.081308,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.0010206,-0.13467,-0.13057,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010245,-0.13504,-0.138,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.066855,-0.1352,-0.15909,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.072231,-0.13536,-0.10553,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00040247,-0.13585,-0.15198,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.1313,-0.13603,-0.097823,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29992,-0.13626,-0.13545,0,0
3,GO REGULATION OF NEURON MATURATION,0.4598,-0.13662,-0.043819,0,0
3,GO RETINOL METABOLIC PROCESS,0.057089,-0.13684,-0.17424,0,0
3,GO PLASMA MEMBRANE FUSION,0.13814,-0.13697,-0.13578,0,0
3,GO FORELIMB MORPHOGENESIS,0.15264,-0.137,-0.11631,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19695,-0.13708,-0.070767,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.2839,-0.13874,-0.069496,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.00026003,-0.13967,-0.1549,0,0
3,GO UTERUS DEVELOPMENT,0.27999,-0.14048,-0.068691,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.12473,-0.14058,-0.11492,0,0
3,GO MEMBRANE FISSION,0.055956,-0.14069,-0.11701,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.0028957,-0.14073,-0.1457,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24288,-0.14184,-0.10259,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.37932,-0.1419,-0.095205,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.05824,-0.14226,-0.10691,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.052669,-0.14262,-0.11501,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.097379,-0.14286,-0.1077,0,0
3,GO PHOTOTRANSDUCTION,0.0073363,-0.14296,-0.14348,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.21905,-0.14358,-0.11073,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16294,-0.14358,-0.17508,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0028957,-0.1439,-0.19045,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.082489,-0.14419,-0.11358,0,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.00013917,-0.14424,-0.15291,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.24288,-0.14552,-0.19843,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.15264,-0.14566,-0.16436,0,0
3,GO ANIMAL ORGAN MATURATION,0.13355,-0.14576,-0.10707,0,0
3,GO CARNITINE METABOLIC PROCESS,0.38888,-0.14588,-0.064017,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26847,-0.14619,-0.090231,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.53742,-0.14649,-0.16679,0,0
3,GO MYELOID CELL DEVELOPMENT,0.00041602,-0.14679,-0.14912,0,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.10845,-0.14707,-0.17964,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.35607,-0.1471,-0.082958,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.066855,-0.14727,-0.1549,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.19393,-0.14817,-0.10305,0,0
3,GO PLATELET DEGRANULATION,0.20621,-0.1483,-0.1132,0,0
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.21256,-0.14852,-0.17387,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.48131,-0.14951,-0.075744,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.32506,-0.14965,-0.11279,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.093897,-0.14977,-0.11086,0,0
3,GO COPULATION,0.068167,-0.1504,-0.11843,0,0
3,GO REGULATION OF MYOBLAST FUSION,0.12049,-0.15075,-0.17769,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.20309,-0.15141,-0.14563,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.15142,-0.14635,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21579,-0.15203,-0.12687,0,0
3,GO DETECTION OF CALCIUM ION,0.2,-0.15249,-0.13043,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.22568,-0.15254,-0.10321,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023205,-0.15258,-0.1816,0,0
3,GO MICROTUBULE SEVERING,0.024846,-0.15297,-0.14641,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.20309,-0.15304,-0.15205,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12689,-0.15324,-0.15939,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0028957,-0.15332,-0.18154,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.070855,-0.15402,-0.13608,0,0
3,GO MYOFIBRIL ASSEMBLY,0.0013054,-0.15403,-0.1654,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.15015,-0.15425,-0.13189,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0049174,-0.1545,-0.18074,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.17099,-0.1547,-0.067165,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.29586,-0.15483,-0.054061,0,0
3,GO AMYLOID FIBRIL FORMATION,0.33373,-0.15512,-0.11336,0,0
3,GO SEROTONIN SECRETION,0.14526,-0.15553,-0.095884,0,0
3,GO GANGLION DEVELOPMENT,0.1313,-0.15648,-0.18093,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.20309,-0.15652,-0.16605,0,0
3,GO EPITHELIAL CELL MATURATION,0.070855,-0.1566,-0.13123,0,0
3,GO T CELL EXTRAVASATION,0.13583,-0.15669,-0.23466,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.073629,-0.15673,-0.15122,0,0
3,GO TELOMERE CAPPING,0.0041716,-0.15682,-0.11467,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.23589,-0.15705,-0.067929,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.007729,-0.1573,-0.18045,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0037331,-0.15743,-0.14227,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.18508,-0.15763,-0.13072,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0017641,-0.15846,-0.16745,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.12259,-0.15903,-0.20717,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.25363,-0.15953,-0.13287,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.054842,-0.1597,-0.22913,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.070855,-0.16018,-0.14161,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.25001,-0.16144,-0.11423,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.16191,-0.19482,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.42347,-0.1623,-0.10631,0,0
3,GO CELL FATE DETERMINATION,0.0094949,-0.16255,-0.18638,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.21256,-0.16348,-0.1121,0,0
3,GO LACTATE METABOLIC PROCESS,0.077957,-0.16484,-0.14518,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.74288,-0.16555,-0.03071,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.011904,-0.16609,-0.13149,0,0
3,GO LYSINE METABOLIC PROCESS,0.082489,-0.16717,-0.21034,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.20621,-0.16786,-0.12081,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.080955,-0.16839,-0.11155,0,0
3,GO TRNA CATABOLIC PROCESS,0.24643,-0.16872,-0.13514,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10465,-0.16995,-0.22625,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.024846,-0.17045,-0.16178,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.18219,-0.17115,-0.077585,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.53167,-0.17269,-0.038424,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.036164,-0.17361,-0.19823,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.23245,-0.17407,-0.10281,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.044685,-0.17453,-0.14119,0,0
3,GO METANEPHROS MORPHOGENESIS,0.25001,-0.17581,-0.075415,0,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0025083,-0.17613,-0.17621,0,0
3,GO SPERM AXONEME ASSEMBLY,0.018398,-0.17897,-0.14658,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.11039,-0.17905,-0.12555,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.14769,-0.17951,-0.12749,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.21256,-0.17955,-0.1377,0,0
3,GO BRONCHUS DEVELOPMENT,0.20309,-0.18006,-0.13595,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.013139,-0.18018,-0.17527,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.27999,-0.18063,-0.10727,0,0
3,GO CELL FATE SPECIFICATION,0.013798,-0.18077,-0.14292,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.12689,-0.18205,-0.097632,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.10654,-0.18215,-0.1864,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.080955,-0.18238,-0.2116,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0029794,-0.18274,-0.23216,0,0
3,GO RESPONSE TO INACTIVITY,0.02166,-0.18324,-0.15967,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.0025083,-0.18534,-0.14784,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.12689,-0.18625,-0.15532,0,0
3,GO INTRACILIARY TRANSPORT,0.0025083,-0.18655,-0.20942,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.16032,-0.1866,-0.18686,0,0
3,GO GENITALIA MORPHOGENESIS,0.1028,-0.18737,-0.14642,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00017796,-0.18756,-0.15865,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0069616,-0.18822,-0.15997,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.072231,-0.18966,-0.20207,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.22235,-0.18976,-0.20246,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.080955,-0.18988,-0.14246,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.32938,-0.18998,-0.11467,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.11235,-0.19042,-0.13911,0,0
3,GO RENAL ABSORPTION,0.082489,-0.19141,-0.23081,0,0
3,GO ETHANOL OXIDATION,0.15773,-0.19142,-0.23688,0,0
3,GO REGULATION OF CHLORIDE TRANSPORT,0.05824,-0.19226,-0.1733,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0040578,-0.19241,-0.17525,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.019283,-0.19244,-0.19172,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.10465,-0.19284,-0.15601,0,0
3,GO SEGMENT SPECIFICATION,0.016734,-0.1934,-0.22752,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17934,-0.19379,-0.14419,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.0062634,-0.19384,-0.15592,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.19414,-0.17633,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00072223,-0.19512,-0.22377,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.18508,-0.19669,-0.13112,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,2.8418e-05,-0.19715,-0.20872,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17934,-0.19725,-0.1207,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12473,-0.1974,-0.18682,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.073629,-0.19844,-0.1825,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.075049,-0.20108,-0.12896,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.10654,-0.20179,-0.12994,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.11636,-0.20224,-0.095155,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.1313,-0.20253,-0.1455,0,0
3,GO PARTURITION,0.082489,-0.2036,-0.1589,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0016129,-0.20414,-0.21579,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.070855,-0.20441,-0.18912,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.17374,-0.20468,-0.1526,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.017549,-0.20492,-0.26988,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.049546,-0.20493,-0.15013,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.11039,-0.20747,-0.10216,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.25729,-0.20766,-0.15062,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00014935,-0.2089,-0.20287,0,0
3,GO CENTROSOME SEPARATION,0.0067808,-0.20902,-0.19563,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.12259,-0.20926,-0.10614,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.13583,-0.20935,-0.15585,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00030804,-0.21007,-0.19438,0,0
3,GO REGULATION OF CENTROSOME CYCLE,7.6603e-06,-0.21304,-0.1946,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.40349,-0.21308,-0.034826,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12473,-0.2133,-0.15283,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16828,-0.21457,-0.11528,0,0
3,GO NEURAL TUBE FORMATION,5.508e-06,-0.21605,-0.21581,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.05161,-0.21646,-0.16836,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.0049174,-0.21697,-0.17376,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.076492,-0.21747,-0.23213,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.059411,-0.21796,-0.28744,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.044685,-0.21924,-0.23152,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.22055,-0.073047,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0032441,-0.22215,-0.3142,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0083534,-0.22244,-0.24134,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,9.0179e-06,-0.22561,-0.22652,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10845,-0.22751,-0.16087,0,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011047,-0.22869,-0.19893,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.060602,-0.22914,-0.31862,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.063042,-0.22994,-0.19183,0,0
3,GO CELL JUNCTION MAINTENANCE,0.0011549,-0.23176,-0.2268,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.079444,-0.23252,-0.16641,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.12689,-0.23289,-0.19345,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.21905,-0.23403,-0.11081,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.084046,-0.23463,-0.20178,0,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0020453,-0.23597,-0.2163,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.076492,-0.23651,-0.24512,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.17934,-0.23766,-0.081558,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.23937,-0.23921,-0.13675,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.15264,-0.23973,-0.14753,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.03245,-0.23999,-0.22587,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.8521e-05,-0.24306,-0.24897,0,0
3,GO REGULATION OF RECEPTOR BINDING,0.0051916,-0.24406,-0.24122,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,-0.2446,-0.21774,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00081984,-0.24588,-0.26629,0,0
3,GO RETINAL METABOLIC PROCESS,0.077957,-0.25064,-0.21635,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.03245,-0.25371,-0.31817,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,7.3528e-06,-0.25391,-0.26491,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0015189,-0.25565,-0.26237,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0001165,-0.25592,-0.26039,0,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.054842,-0.25594,-0.24168,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.001986,-0.25694,-0.27516,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.19393,-0.25813,-0.1016,0,0
3,GO MYOBLAST MIGRATION,0.082489,-0.2586,-0.2141,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.00087311,-0.26765,-0.27725,0,0
3,GO HEART FIELD SPECIFICATION,0.060602,-0.26833,-0.17541,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.061812,-0.26905,-0.21526,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017123,-0.26948,-0.25984,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.079444,-0.2717,-0.24901,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.00050664,-0.2724,-0.26348,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00055855,-0.27266,-0.22664,0,0
3,GO GDP METABOLIC PROCESS,0.0099891,-0.27545,-0.23466,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.068167,-0.27576,-0.22095,0,0
3,GO EXTRACELLULAR TRANSPORT,1.104e-05,-0.28703,-0.35817,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.070855,-0.29173,-0.17678,0,0
3,GO CARDIOBLAST PROLIFERATION,0.43883,-0.2964,-0.11467,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00052342,-0.31439,-0.28122,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.011612,-0.3153,-0.23936,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.057089,-0.31534,-0.16377,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.0019282,-0.31535,-0.23545,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081984,-0.31857,-0.24577,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.00013433,-0.32177,-0.30842,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.095625,-0.32207,-0.1348,0,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.097379,-0.32331,-0.24581,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00010462,-0.35389,-0.41795,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,7.0571e-06,-0.35948,-0.3418,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.00059588,-0.36813,-0.30731,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0025083,-0.36907,-0.34298,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.035393,-0.37892,-0.28382,0,0
3,GO RESPONSE TO MUSCLE INACTIVITY,2.9532e-05,-0.38095,-0.37791,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.00028792,-0.38116,-0.38153,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.12689,-0.38618,-0.17745,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00013917,-0.43491,-0.44366,0,0
3,GO NEURON FATE SPECIFICATION,0.0081404,-0.43561,-0.28917,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.04854,-0.43791,-0.27687,0,0
3,GO LEYDIG CELL DIFFERENTIATION,0.001986,-0.44113,-0.40441,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00016595,-0.44235,-0.4661,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.41235,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00065623,-0.46852,-0.37734,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.48127,-0.48072,0,0
3,GO MIDBODY ABSCISSION,1.5691e-07,-0.48641,-0.48507,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.0027346,-0.52433,-0.42865,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00020448,-0.53073,-0.48748,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,5.7413e-06,-0.53986,-0.59671,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,2.2524e-05,-0.55124,-0.4387,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00021909,-0.56212,-0.45463,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,8.3127e-06,-0.66246,-0.65678,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8891e-07,-0.92382,-0.82664,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0016129,1.595,1.0811,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0021062,1.2785,0.85328,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.001228,1.0061,0.81706,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.9263e-05,0.88673,0.8715,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.004408,0.86861,0.63815,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,8.7323e-05,0.84853,0.60522,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,3.4421e-05,0.81589,0.71168,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,4.4712e-06,0.77658,0.79908,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.7955e-07,0.77592,0.73098,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0041716,0.74103,0.47349,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.9263e-05,0.73465,0.62227,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00038934,0.72145,0.61132,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0028141,0.70946,0.45208,1,1
4,GO HISTAMINE SECRETION,5.4977e-07,0.70834,0.72677,1,1
4,GO TOLERANCE INDUCTION,0.0010206,0.68962,0.56278,1,1
4,GO LIPID DROPLET FORMATION,1.1267e-06,0.68501,0.70527,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,2.2524e-05,0.67693,0.63673,1,1
4,GO HISTAMINE TRANSPORT,6.0198e-07,0.66579,0.70146,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.00012512,0.66483,0.80898,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,5.9841e-06,0.65554,0.7291,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0049174,0.65551,0.41467,1,1
4,GO GERMINAL CENTER FORMATION,0.00024286,0.65307,0.50395,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0056288,0.6351,0.67446,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00034072,0.63072,0.62093,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0026572,0.6241,0.38487,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0053338,0.62052,0.52918,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00084609,0.61928,0.50499,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,3.0576e-06,0.59804,0.59917,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,7.3528e-06,0.59551,0.58745,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.59431,0.53559,1,1
4,GO RESPONSE TO TYPE I INTERFERON,0.00011241,0.58387,0.54614,1,1
4,GO INTESTINAL LIPID ABSORPTION,7.9801e-06,0.58025,0.66428,1,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.02843,0.57642,0.33379,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.0311e-06,0.56988,0.57077,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0010859,0.56844,0.47941,1,1
4,GO SIGNAL PEPTIDE PROCESSING,1.1267e-06,0.56665,0.50696,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,2.0833e-05,0.56344,0.53303,1,1
4,GO RENAL ABSORPTION,0.00011241,0.55776,0.52565,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00030804,0.55518,0.51269,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,7.0571e-06,0.5551,0.59071,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00081984,0.55424,0.50367,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,3.8583e-05,0.55335,0.50894,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,7.013e-05,0.55179,0.53045,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00084609,0.54937,0.43188,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.00016595,0.54565,0.57965,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.2454e-05,0.54504,0.52495,1,1
4,GO MUCUS SECRETION,0.0011549,0.54137,0.5277,1,1
4,GO RESPONSE TO EPINEPHRINE,0.011047,0.5336,0.32107,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,8.7323e-05,0.53059,0.58643,1,1
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.05161,0.52689,0.52972,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.3418e-05,0.52584,0.41793,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00028792,0.52573,0.46029,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.0033369,0.52551,0.37729,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,6.7596e-05,0.52234,0.52061,1,1
4,GO TOXIN METABOLIC PROCESS,9.3916e-06,0.51812,0.5009,1,1
4,GO LIPID DIGESTION,4.1617e-05,0.51795,0.57927,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00021909,0.51477,0.38194,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00029782,0.51326,0.44331,1,1
4,GO DETECTION OF OTHER ORGANISM,8.1192e-05,0.51251,0.50699,1,1
4,GO RESPONSE TO COLD,3.1904e-06,0.51096,0.4402,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0034322,0.5105,0.32012,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00013917,0.50952,0.42326,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0032441,0.50922,0.38982,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,6.7596e-05,0.50824,0.60333,1,1
4,GO CELLULAR DEFENSE RESPONSE,3.1904e-06,0.50509,0.44051,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.0264e-07,0.50437,0.55941,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,1.9263e-05,0.50383,0.52268,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,7.547e-05,0.50359,0.39041,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00040247,0.50336,0.38173,1,1
4,GO O GLYCAN PROCESSING,1.2962e-05,0.50276,0.43835,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00045924,0.50153,0.42802,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,1.7474e-06,0.49854,0.50119,1,1
4,GO ACTIN FILAMENT SEVERING,0.00052342,0.49705,0.44647,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.0013054,0.49693,0.391,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,3.4728e-06,0.49509,0.46133,1,1
4,GO RETINAL METABOLIC PROCESS,0.0022332,0.49188,0.48957,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,2.4346e-05,0.49087,0.47358,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,0.00026903,0.49059,0.47741,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.012203,0.48947,0.51317,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00029782,0.48942,0.3606,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.010245,0.4872,0.41634,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00012964,0.48679,0.57939,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.00041602,0.48615,0.40555,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.7806e-05,0.48435,0.44853,1,1
4,GO REGULATION OF BONE REMODELING,9.7801e-06,0.4827,0.43633,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00065623,0.48231,0.45014,1,1
4,GO BONE RESORPTION,6.7728e-06,0.47907,0.42225,1,1
4,GO INTESTINAL ABSORPTION,6.2985e-07,0.47706,0.59207,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,4.8379e-05,0.47648,0.42332,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00016023,0.4758,0.4013,1,1
4,GO RESPONSE TO PAIN,8.3127e-06,0.47426,0.44272,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.7955e-07,0.4733,0.46667,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.1617e-05,0.47324,0.42757,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00035231,0.47281,0.45029,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,7.3528e-06,0.47261,0.50256,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0020453,0.4723,0.48549,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0022332,0.47208,0.47211,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,4.3218e-05,0.47138,0.45162,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.7596e-05,0.46663,0.414,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,1.2962e-05,0.46623,0.50132,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00028792,0.46621,0.38121,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.9801e-06,0.46614,0.40505,1,1
4,GO PLASMINOGEN ACTIVATION,0.0020453,0.46443,0.44521,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.0087944,0.46358,0.36719,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0038387,0.46153,0.49925,1,1
4,GO ZYMOGEN ACTIVATION,0.00026903,0.46097,0.42066,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.00019753,0.46087,0.54289,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,4.5813e-07,0.45984,0.52123,1,1
4,GO KETONE CATABOLIC PROCESS,0.0015653,0.45459,0.38891,1,1
4,GO REGULATION OF NEURON MATURATION,1.9263e-05,0.45346,0.41919,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.00074557,0.45181,0.42126,1,1
4,GO RESPONSE TO DIETARY EXCESS,5.6174e-05,0.44928,0.45126,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00031859,0.44767,0.52321,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8084e-07,0.44507,0.51292,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00074557,0.44317,0.3744,1,1
4,GO QUINONE METABOLIC PROCESS,0.00020448,0.44188,0.56058,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0022992,0.43887,0.41796,1,1
4,GO PROTEIN DEGLYCOSYLATION,3.3132e-05,0.43817,0.41816,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0025083,0.43666,0.34753,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00032948,0.4358,0.54565,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00037661,0.4355,0.37659,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0018173,0.43421,0.32738,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,7.6603e-06,0.43392,0.44409,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0054795,0.43366,0.3997,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.011612,0.43156,0.32006,1,1
4,GO STEROID ESTERIFICATION,0.00029782,0.43018,0.50489,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00098941,0.42937,0.34002,1,1
4,GO SUPEROXIDE ANION GENERATION,0.00054072,0.42911,0.39557,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00013917,0.4289,0.38252,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.00025131,0.42826,0.42708,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0013054,0.42803,0.40386,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,7.8282e-05,0.42778,0.29852,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00041602,0.42654,0.37016,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00040247,0.42572,0.43097,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.001662,0.42545,0.33267,1,1
4,GO ACUTE PHASE RESPONSE,0.00011241,0.42389,0.35077,1,1
4,GO SEROTONIN METABOLIC PROCESS,8.1192e-05,0.41934,0.4831,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,5.0194e-07,0.41833,0.42757,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00036427,0.41786,0.54878,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0006154,0.41668,0.333,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0001547,0.41558,0.32405,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0081404,0.41526,0.37354,1,1
4,GO REGULATION OF PLATELET ACTIVATION,0.00011241,0.41524,0.3649,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0039469,0.4143,0.36511,1,1
4,GO REFLEX,0.00059588,0.41425,0.41102,1,1
4,GO REGULATION OF TISSUE REMODELING,2.0833e-05,0.41411,0.37457,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00052342,0.414,0.37541,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00087311,0.41308,0.31154,1,1
4,GO PROTEIN DEMANNOSYLATION,1.2454e-05,0.41187,0.43585,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00012074,0.41051,0.29568,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,9.0179e-06,0.40888,0.48676,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00079435,0.40557,0.37389,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00021167,0.40535,0.33052,1,1
4,GO EOSINOPHIL MIGRATION,0.0027346,0.40498,0.31192,1,1
4,GO RESPONSE TO REDOX STATE,2.4346e-05,0.40495,0.36714,1,1
4,GO VASODILATION,7.547e-05,0.40384,0.49646,1,1
4,GO B CELL APOPTOTIC PROCESS,2.8418e-05,0.40337,0.39571,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0029794,0.4003,0.37916,1,1
4,GO KETONE BODY METABOLIC PROCESS,0.0023671,0.39939,0.33693,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00022676,0.39914,0.55091,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.0179e-06,0.39908,0.38421,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00081984,0.3976,0.32998,1,1
4,GO MUSCLE ATROPHY,0.0050528,0.39736,0.2785,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0066042,0.3966,0.34264,1,1
4,GO PHAGOSOME ACIDIFICATION,1.8084e-07,0.3964,0.41805,1,1
4,GO REGULATION OF ANOIKIS,0.00055855,0.39621,0.38073,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0027346,0.39588,0.34768,1,1
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.049546,0.39544,0.31013,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0028141,0.39465,0.35936,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0034322,0.39441,0.41735,1,1
4,GO INSEMINATION,7.547e-05,0.39426,0.37805,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.5759e-05,0.39393,0.30537,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00027832,0.39369,0.30518,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.8301e-05,0.39158,0.38092,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00013433,0.39121,0.30904,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,2.9532e-05,0.39087,0.36534,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.0226e-05,0.3906,0.47672,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0017641,0.38943,0.37851,1,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.034637,0.38868,0.28556,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0016129,0.38747,0.5359,1,1
4,GO POSITIVE REGULATION OF CELL SIZE,2.0033e-05,0.38725,0.40212,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0059384,0.38654,0.28928,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.018836,0.38547,0.24086,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00044439,0.38505,0.37786,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0025083,0.38474,0.37657,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.0024367,0.3814,0.3232,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,4.0073e-05,0.38111,0.37753,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0037331,0.38069,0.32236,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00017186,0.38059,0.40923,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.3805,0.44097,1,1
4,GO N GLYCAN PROCESSING,0.00050664,0.38045,0.32136,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00040247,0.3804,0.35657,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00067758,0.37956,0.33417,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.007729,0.37885,0.4228,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00025131,0.37828,0.40212,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0022992,0.37737,0.30442,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.013139,0.37585,0.43854,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0006154,0.3757,0.30502,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,3.5759e-05,0.37551,0.34993,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.010245,0.37543,0.31731,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00067758,0.37326,0.41009,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00063551,0.37321,0.43614,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0001165,0.37295,0.34964,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,4.1617e-05,0.37294,0.34817,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0013872,0.37159,0.23163,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00028792,0.37151,0.35105,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00079435,0.37136,0.27749,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,8.1192e-05,0.37094,0.43648,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0051916,0.37005,0.29284,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.0011549,0.37,0.2934,1,1
4,GO RESPONSE TO LITHIUM ION,5.6174e-05,0.36859,0.44612,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00057693,0.36847,0.35405,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0090226,0.368,0.326,1,1
4,GO UBIQUINONE METABOLIC PROCESS,1.4039e-05,0.36694,0.33318,1,1
4,GO FOAM CELL DIFFERENTIATION,0.00021909,0.36689,0.29773,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0017123,0.36613,0.39951,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00054072,0.3661,0.37392,1,1
4,GO REGULATION OF COAGULATION,0.0012662,0.36578,0.28527,1,1
4,GO METHIONINE METABOLIC PROCESS,2.1663e-05,0.36572,0.32968,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0028141,0.36452,0.29935,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00081984,0.36447,0.33336,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0025817,0.36391,0.27295,1,1
4,GO REGULATION OF ICOSANOID SECRETION,9.3916e-06,0.36362,0.39011,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00026903,0.36356,0.39258,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00010462,0.36328,0.30941,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.00013433,0.36254,0.40141,1,1
4,GO RESPONSE TO COPPER ION,0.00079435,0.36221,0.4326,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.00016023,0.36186,0.33777,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00022676,0.36108,0.33069,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0022332,0.36107,0.30742,1,1
4,GO BONE REMODELING,0.00012964,0.36081,0.33058,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.004408,0.36077,0.35519,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.1617e-05,0.3604,0.32271,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.0025817,0.35993,0.45011,1,1
4,GO LIVER MORPHOGENESIS,0.0034322,0.35984,0.2949,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.00019753,0.35971,0.32092,1,1
4,GO RESPONSE TO INTERLEUKIN 2,2.2524e-05,0.35966,0.31123,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0039469,0.35902,0.29082,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0050528,0.35873,0.3919,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00016023,0.35851,0.33716,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.001228,0.35821,0.30315,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0028957,0.3582,0.36495,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00021167,0.35782,0.29137,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00052342,0.35758,0.2769,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0036303,0.35739,0.28699,1,1
4,GO INTEGRIN ACTIVATION,4.6623e-06,0.35733,0.37397,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0015653,0.35664,0.31956,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0042883,0.35575,0.29032,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.011904,0.35421,0.37455,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0057817,0.35295,0.21203,1,1
4,GO RESPONSE TO MINERALOCORTICOID,7.2754e-05,0.35291,0.30935,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,9.0551e-05,0.35259,0.28638,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00050664,0.35235,0.23804,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0010528,0.35215,0.29379,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0039469,0.35209,0.24091,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.0073363,0.35197,0.23866,1,1
4,GO RESPONSE TO THYROID HORMONE,0.0032441,0.35069,0.25742,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.0571e-06,0.35063,0.35641,1,1
4,GO VACUOLAR ACIDIFICATION,3.9926e-07,0.3506,0.41348,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,9.389e-05,0.3503,0.34583,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00032948,0.35023,0.26231,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.0022332,0.35001,0.22364,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00087311,0.34992,0.35634,1,1
4,GO OSTEOBLAST PROLIFERATION,0.00013917,0.34986,0.33068,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0014299,0.34975,0.26242,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.00013433,0.34972,0.28442,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.029719,0.34962,0.38255,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0039469,0.34924,0.35375,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.34921,0.30713,1,1
4,GO TISSUE REMODELING,7.8282e-05,0.34794,0.29049,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00041602,0.34678,0.23432,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.9904e-06,0.34628,0.3498,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0013054,0.34606,0.21377,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0011199,0.34592,0.24995,1,1
4,GO LYTIC VACUOLE ORGANIZATION,5.4977e-07,0.3459,0.35486,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0015653,0.3458,0.33571,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00023468,0.34549,0.41378,1,1
4,GO LIPID DROPLET ORGANIZATION,1.4039e-05,0.3443,0.31936,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0013054,0.34293,0.34049,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0022992,0.34252,0.31687,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0028141,0.34181,0.28569,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0028957,0.34171,0.29431,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.011612,0.34158,0.40121,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0071468,0.34143,0.35945,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.00010462,0.34105,0.28362,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0013054,0.34086,0.25846,1,1
4,GO STEROID HORMONE SECRETION,0.0025083,0.34067,0.30643,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00024286,0.34043,0.28808,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,3.1888e-05,0.34024,0.29281,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.0015653,0.33933,0.27199,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00052342,0.33916,0.34166,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.010773,0.33911,0.34197,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00059588,0.33903,0.31157,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.0833e-05,0.33872,0.34701,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00027832,0.33837,0.2709,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,5.2139e-05,0.33825,0.33639,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00030804,0.33752,0.22249,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,8.1192e-05,0.33703,0.42311,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0059384,0.33698,0.31224,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.011612,0.3369,0.24603,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0032441,0.33547,0.21152,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0013457,0.3352,0.26747,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0051916,0.33464,0.37769,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.007729,0.33439,0.3472,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.4421e-05,0.33401,0.32759,1,1
4,GO DIET INDUCED THERMOGENESIS,0.0042883,0.33281,0.24264,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.0028957,0.33281,0.3556,1,1
4,GO ANOIKIS,0.00013433,0.33217,0.29934,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.024288,0.33182,0.20022,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.0027346,0.33042,0.35634,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00055855,0.33028,0.37711,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.104e-05,0.33017,0.31564,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.00098941,0.33008,0.27321,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0045306,0.32937,0.35396,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0010859,0.32843,0.27609,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00069957,0.32748,0.2624,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.8379e-05,0.32745,0.25147,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.00013917,0.32517,0.26297,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0028141,0.32487,0.2846,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0017123,0.32461,0.23771,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.7323e-05,0.3242,0.34152,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,9.7346e-05,0.32403,0.33223,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00021909,0.32374,0.27691,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.013139,0.32364,0.2182,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,8.7323e-05,0.32338,0.29358,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.014841,0.32314,0.27474,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00018427,0.32247,0.3615,1,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.0066042,0.32233,0.22346,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0049174,0.32197,0.30813,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00031859,0.3216,0.32529,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0013872,0.32144,0.25445,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00041602,0.31989,0.31704,1,1
4,GO RESPONSE TO ACIDIC PH,0.0046564,0.31984,0.29136,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00047456,0.31981,0.24396,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,3.8583e-05,0.31964,0.30786,1,1
4,GO PLATELET DEGRANULATION,0.0021689,0.31951,0.22965,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00022676,0.31937,0.21772,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00016023,0.31936,0.31621,1,1
4,GO STEROID METABOLIC PROCESS,4.1617e-05,0.31933,0.27811,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0034322,0.31891,0.27195,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00027832,0.31834,0.35487,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00022676,0.31784,0.24115,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00017796,0.3176,0.31414,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0087944,0.31738,0.25928,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00074557,0.31711,0.43656,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0069616,0.31679,0.2761,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,6.7596e-05,0.31671,0.26187,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0027346,0.31629,0.20241,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.31628,0.27377,1,1
4,GO DIGESTION,2.7343e-05,0.31611,0.31485,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00016595,0.31609,0.34448,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00023468,0.31463,0.30643,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0011549,0.31441,0.25893,1,1
4,GO ENDOCRINE PROCESS,2.5308e-05,0.31421,0.29166,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0071468,0.3141,0.18785,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00031859,0.31368,0.33412,1,1
4,GO RESPONSE TO ISCHEMIA,0.00025131,0.31362,0.24819,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.001228,0.31321,0.21952,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0011549,0.31296,0.3183,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.0067808,0.31288,0.21927,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0022992,0.31253,0.30549,1,1
4,GO MATURE B CELL DIFFERENTIATION,0.00025131,0.31243,0.36736,1,1
4,GO LIPID TRANSLOCATION,0.0001547,0.31241,0.27296,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.8301e-05,0.31231,0.25863,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00084609,0.31214,0.32233,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00010092,0.31186,0.34048,1,1
4,GO PH REDUCTION,1.4674e-06,0.3106,0.28909,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.00065623,0.3101,0.23514,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,7.6603e-06,0.31003,0.35506,1,1
4,GO VITAMIN TRANSPORT,0.027188,0.30963,0.19779,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00026003,0.30929,0.41266,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0604e-05,0.30887,0.31794,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00079435,0.30863,0.27066,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00023468,0.30862,0.25635,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.019283,0.30841,0.17994,1,1
4,GO REGULATION OF B CELL PROLIFERATION,3.0689e-05,0.30833,0.30201,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.024288,0.30821,0.19918,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.004408,0.30802,0.32943,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.00010462,0.30793,0.3333,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0007696,0.30776,0.28701,1,1
4,GO PROTEIN AUTOPROCESSING,0.00045924,0.30774,0.3341,1,1
4,GO REGULATION OF B CELL ACTIVATION,9.0551e-05,0.30747,0.23871,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00011241,0.30665,0.23329,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0059384,0.30664,0.31583,1,1
4,GO NADP METABOLIC PROCESS,0.0049174,0.30661,0.2653,1,1
4,GO DIGESTIVE SYSTEM PROCESS,2.6307e-05,0.30615,0.28104,1,1
4,GO ICOSANOID METABOLIC PROCESS,7.8282e-05,0.30553,0.3253,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.014841,0.30548,0.22724,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,4.4878e-05,0.30517,0.299,1,1
4,GO PHAGOSOME MATURATION,5.0683e-06,0.30491,0.32552,1,1
4,GO MAGNESIUM ION TRANSPORT,8.1192e-05,0.30477,0.30069,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.8521e-05,0.30398,0.30173,1,1
4,GO LIPID LOCALIZATION,3.0689e-05,0.30354,0.26213,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0094949,0.30217,0.2755,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.00057693,0.30145,0.26539,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.4044e-06,0.30129,0.33221,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00029782,0.3011,0.31162,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,2.7343e-05,0.30093,0.31898,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,0.0053338,0.30079,0.27983,1,1
4,GO IMMUNE EFFECTOR PROCESS,0.00021167,0.30072,0.21808,1,1
4,GO RESPONSE TO PROTOZOAN,0.0022992,0.30048,0.20259,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.4878e-05,0.30046,0.32573,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0066042,0.30039,0.2353,1,1
4,GO CELL KILLING,4.3218e-05,0.29987,0.24761,1,1
4,GO ETHANOL METABOLIC PROCESS,0.0064317,0.29986,0.24883,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,9.389e-05,0.29962,0.24112,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,2.5308e-05,0.2996,0.30351,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0040578,0.29938,0.2709,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.0033369,0.29919,0.30881,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.00020448,0.29898,0.34112,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00074557,0.2984,0.26641,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00055855,0.29821,0.24874,1,1
4,GO RESPIRATORY BURST,0.00016023,0.29796,0.28415,1,1
4,GO MAST CELL ACTIVATION,8.7323e-05,0.29759,0.27691,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0069616,0.29745,0.24606,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00012074,0.29735,0.26422,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0028957,0.29704,0.25557,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0075304,0.29703,0.22399,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0019282,0.29681,0.37656,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.2754e-05,0.29679,0.24452,1,1
4,GO LYMPHOCYTE MIGRATION,0.001228,0.29638,0.19151,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.0184e-05,0.29586,0.26682,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,6.2367e-06,0.2957,0.25904,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00031859,0.29547,0.30001,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.00026003,0.29511,0.32856,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0017123,0.2948,0.25018,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.0010528,0.29478,0.27456,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.013139,0.29423,0.23898,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00026903,0.29357,0.26319,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.29311,0.23011,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,9.389e-05,0.293,0.26679,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.030383,0.29296,0.21189,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00012074,0.2927,0.22744,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0010206,0.29244,0.29609,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.0013457,0.29243,0.28085,1,1
4,GO INNATE IMMUNE RESPONSE,0.0001547,0.29238,0.22227,1,1
4,GO VIRAL GENOME REPLICATION,0.0028141,0.29216,0.18185,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00029782,0.29154,0.30628,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0094949,0.29118,0.28743,1,1
4,GO HORMONE METABOLIC PROCESS,0.00087311,0.29104,0.26804,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,2.6902e-06,0.29102,0.25226,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.010245,0.29061,0.28544,1,1
4,GO FUCOSYLATION,0.025994,0.29047,0.20927,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00012074,0.29029,0.31574,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0057817,0.29013,0.31288,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0021689,0.28967,0.26753,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.001662,0.28963,0.24584,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00018427,0.28946,0.3194,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00026003,0.28903,0.30125,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00067758,0.28875,0.19712,1,1
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.027188,0.28873,0.23263,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0018173,0.28846,0.23715,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00063551,0.28833,0.2204,1,1
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.015953,0.28706,0.17888,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0028957,0.2869,0.24765,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,8.7323e-05,0.2869,0.26977,1,1
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.03939,0.28687,0.21513,1,1
4,GO T CELL MIGRATION,0.0073363,0.28671,0.18459,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.3218e-05,0.28616,0.30773,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0030654,0.28611,0.22509,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.053746,0.28593,0.19981,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,3.7791e-06,0.28585,0.29216,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,5.6174e-05,0.28581,0.33354,1,1
4,GO PHOSPHOLIPID TRANSPORT,4.6597e-05,0.28562,0.23401,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,0.00072223,0.28558,0.24719,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00054072,0.28556,0.26403,1,1
4,GO TRANSFERRIN TRANSPORT,1.8251e-06,0.28526,0.34201,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,9.389e-05,0.28481,0.21748,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0015653,0.28468,0.19799,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0015653,0.28462,0.27205,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.027803,0.28459,0.17562,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0041716,0.2844,0.19447,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00014418,0.28432,0.29704,1,1
4,GO DEFENSE RESPONSE,0.00013433,0.28421,0.20869,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.00014418,0.28416,0.2352,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.011047,0.28385,0.20931,1,1
4,GO POLYOL TRANSPORT,0.001986,0.28374,0.31014,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.001662,0.28303,0.28357,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.015203,0.28293,0.22309,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.021165,0.2826,0.1951,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00038934,0.28254,0.35091,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,3.4421e-05,0.2821,0.25613,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00010092,0.28204,0.29344,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00072223,0.2817,0.22878,1,1
4,GO REGULATION OF CELL KILLING,0.00035231,0.28088,0.27697,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.007729,0.28078,0.24389,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0022332,0.28072,0.2795,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.0018173,0.28033,0.2293,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00022676,0.28032,0.27095,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.00092958,0.28011,0.21892,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0013872,0.27973,0.25592,1,1
4,GO NUCLEOTIDE SALVAGE,0.015953,0.27959,0.24396,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.2139e-05,0.27947,0.25012,1,1
4,GO DOPAMINE TRANSPORT,0.00084609,0.27926,0.34873,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00052342,0.27887,0.25208,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,1.7118e-05,0.27852,0.25077,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.0028957,0.27833,0.22072,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0010859,0.27827,0.29887,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0097392,0.27813,0.20336,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.7343e-05,0.27789,0.2719,1,1
4,GO CELLULAR RESPONSE TO STARVATION,7.6603e-06,0.2776,0.25237,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00017186,0.27745,0.20202,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.043763,0.27741,0.19016,1,1
4,GO REGULATION OF FERTILIZATION,0.0046564,0.27741,0.27883,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.011047,0.27734,0.22922,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00027832,0.2773,0.29079,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.001662,0.27728,0.2623,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0007696,0.27723,0.27123,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,0.0006154,0.27711,0.30374,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00038934,0.27689,0.26082,1,1
4,GO CATECHOLAMINE UPTAKE,0.0047853,0.27661,0.26865,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00012512,0.27651,0.23111,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.00045924,0.27642,0.21997,1,1
4,GO STEROL METABOLIC PROCESS,0.00047456,0.27641,0.23023,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,2.6307e-05,0.2763,0.23759,1,1
4,GO RESPONSE TO GROWTH HORMONE,4.1617e-05,0.2762,0.34265,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00049035,0.27598,0.28413,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00035231,0.27592,0.23157,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,5.4121e-05,0.27587,0.31258,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00084609,0.27527,0.1961,1,1
4,GO AMINE METABOLIC PROCESS,2.2658e-06,0.27516,0.28574,1,1
4,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,0.27475,0.31106,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.0050528,0.27454,0.38021,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0017123,0.27445,0.1912,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00036427,0.27402,0.24962,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0016129,0.27394,0.19362,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.0001547,0.27359,0.20838,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.015574,0.27322,0.27614,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0030654,0.27309,0.26651,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.00013917,0.27291,0.23118,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.010506,0.27288,0.2817,1,1
4,GO REGULATION OF WOUND HEALING,0.0010206,0.27212,0.2491,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00012512,0.27153,0.25612,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0085714,0.27145,0.21997,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,2.3418e-05,0.27122,0.30709,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.014138,0.27108,0.22079,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00095906,0.2706,0.2356,1,1
4,GO STEROL HOMEOSTASIS,0.0010206,0.27055,0.29223,1,1
4,GO RESPONSE TO BACTERIUM,0.00047456,0.27036,0.19233,1,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.0073363,0.27025,0.31019,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00019753,0.27017,0.24342,1,1
4,GO OXALATE TRANSPORT,0.0007696,0.26994,0.2247,1,1
4,GO GLYCOSYLATION,0.0001547,0.26985,0.25143,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.00049035,0.26963,0.2285,1,1
4,GO CHEMOKINE PRODUCTION,0.0031536,0.2693,0.18698,1,1
4,GO CORNIFICATION,0.00016595,0.26926,0.28866,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00041602,0.26912,0.22562,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0079323,0.26898,0.19251,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.02268,0.26884,0.2171,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0051916,0.26826,0.20997,1,1
4,GO RETINOL METABOLIC PROCESS,0.0025817,0.26806,0.34027,1,1
4,GO RESPONSE TO PROGESTERONE,0.0029794,0.26796,0.21446,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00098941,0.2677,0.18706,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,3.5759e-05,0.26765,0.25325,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,8.7323e-05,0.26762,0.2202,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00041602,0.26728,0.29735,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00353,0.26716,0.23297,1,1
4,GO NEUTROPHIL MIGRATION,9.0551e-05,0.26713,0.2118,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0014738,0.26655,0.2444,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.8583e-05,0.26625,0.25098,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.3218e-05,0.26598,0.23072,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00065623,0.26589,0.19641,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00016023,0.26582,0.20729,1,1
4,GO PARTURITION,0.024846,0.26554,0.19824,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.00069957,0.26544,0.21192,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00045924,0.26475,0.20693,1,1
4,GO PROTEIN PROCESSING,2.8418e-05,0.26463,0.26721,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00081984,0.2646,0.20248,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0006154,0.26458,0.24807,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,3.1904e-06,0.26386,0.25955,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0010528,0.26347,0.27029,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.00040247,0.26345,0.27085,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.016734,0.26302,0.20198,1,1
4,GO ALANINE TRANSPORT,0.0081404,0.26223,0.30307,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,4.6597e-05,0.26211,0.30428,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00018427,0.26196,0.24827,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,0.00021909,0.26194,0.22643,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0010528,0.26159,0.19013,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00016595,0.26145,0.23099,1,1
4,GO CARNITINE METABOLIC PROCESS,0.053746,0.26116,0.17979,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00045924,0.26106,0.20809,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0013457,0.26097,0.3118,1,1
4,GO KERATINIZATION,0.00016595,0.26076,0.25312,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.001191,0.26047,0.19919,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.001191,0.26047,0.23076,1,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.015953,0.26035,0.20382,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00016023,0.26031,0.21088,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00026903,0.25968,0.24072,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0047853,0.25948,0.20299,1,1
4,GO RESPONSE TO PH,0.0053338,0.25929,0.18537,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.001872,0.25901,0.26317,1,1
4,GO FATTY ACID CATABOLIC PROCESS,2.3418e-05,0.25898,0.27499,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0029794,0.25894,0.20244,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,5.4121e-05,0.25851,0.23795,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00042998,0.25803,0.25909,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,4.0073e-05,0.25795,0.22811,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0067808,0.25795,0.25664,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0023671,0.25794,0.16741,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,0.00028792,0.25788,0.18422,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0028957,0.25773,0.20469,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.001662,0.25765,0.18699,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.013798,0.25761,0.23924,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.011612,0.2573,0.24174,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0053338,0.25713,0.2115,1,1
4,GO TRANSCYTOSIS,0.00010845,0.25705,0.28141,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.013465,0.25681,0.14611,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00059588,0.25654,0.35614,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.00090094,0.25631,0.21072,1,1
4,GO B CELL PROLIFERATION,2.9532e-05,0.2563,0.25004,1,1
4,GO WATER HOMEOSTASIS,0.00079435,0.25618,0.24077,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0013457,0.25587,0.20785,1,1
4,GO RESPONSE TO CADMIUM ION,0.0025083,0.25583,0.25747,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.0075304,0.25572,0.27329,1,1
4,GO LIPID STORAGE,0.00069957,0.25546,0.23549,1,1
4,GO INFLAMMATORY RESPONSE,0.00025131,0.25514,0.20001,1,1
4,GO ADRENAL GLAND DEVELOPMENT,0.001986,0.25507,0.30531,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.017549,0.25502,0.20017,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.00021167,0.25492,0.20947,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00027832,0.25415,0.21149,1,1
4,GO REGULATION OF ANION TRANSPORT,0.00022676,0.2538,0.24724,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,2.9532e-05,0.25342,0.37274,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0012662,0.25329,0.38885,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02166,0.25302,0.16227,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0041716,0.25294,0.24309,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00017796,0.25211,0.21791,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0036303,0.25182,0.32254,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.0027346,0.25172,0.48053,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00084609,0.25169,0.26142,1,1
4,GO GOLGI VESICLE BUDDING,0.00026003,0.25163,0.21767,1,1
4,GO RESPONSE TO GONADOTROPIN,0.0032441,0.25162,0.23008,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0020453,0.25122,0.22517,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,8.7323e-05,0.25115,0.29993,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00067758,0.25103,0.21849,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,3.4421e-05,0.2499,0.21183,1,1
4,GO BILE ACID METABOLIC PROCESS,1.1964e-05,0.2499,0.36384,1,1
4,GO RESPONSE TO CYTOKINE,0.00041602,0.24975,0.18535,1,1
4,GO REGULATION OF CELLULAR PH,2.1702e-06,0.24968,0.23634,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00074557,0.2495,0.19852,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00037661,0.24941,0.25372,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02268,0.24882,0.14218,1,1
4,GO NUCLEOTIDE TRANSPORT,9.7801e-06,0.24847,0.25004,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.053746,0.24835,0.22895,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.00081984,0.24823,0.21151,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00072223,0.24817,0.16958,1,1
4,GO MUSCLE HYPERTROPHY,0.0012662,0.24771,0.1832,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.001662,0.24766,0.24673,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.001662,0.24753,0.23111,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.011904,0.24749,0.16308,1,1
4,GO CELL REDOX HOMEOSTASIS,0.00057693,0.24746,0.27065,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00353,0.24736,0.17833,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00026903,0.24729,0.28674,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.014486,0.24729,0.20539,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,2.0033e-05,0.24717,0.24994,1,1
4,GO SPLEEN DEVELOPMENT,0.00092958,0.24694,0.21036,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.5149e-05,0.2468,0.223,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00081984,0.24636,0.20233,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.0090226,0.24629,0.20909,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0010206,0.24612,0.24495,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0028957,0.24599,0.21829,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.0020453,0.24579,0.18928,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.00044439,0.2457,0.29716,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.014138,0.24554,0.20152,1,1
4,GO ZINC ION HOMEOSTASIS,0.0053338,0.24552,0.30155,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0025817,0.24548,0.19284,1,1
4,GO CHYLOMICRON ASSEMBLY,0.023205,0.24524,0.25732,1,1
4,GO COAGULATION,0.0040578,0.24514,0.15032,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00055855,0.24503,0.31514,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0045306,0.24462,0.24599,1,1
4,GO SECRETION BY TISSUE,0.0025083,0.24267,0.19931,1,1
4,GO MITOCHONDRIAL TRNA PROCESSING,0.0099891,0.24253,0.21379,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.001872,0.2425,0.17157,1,1
4,GO GRANULOCYTE MIGRATION,0.00030804,0.24218,0.19869,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.014841,0.24201,0.19135,1,1
4,GO INOSITOL METABOLIC PROCESS,7.013e-05,0.24192,0.30562,1,1
4,GO RESPONSE TO VIRUS,0.00090094,0.24177,0.19584,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0026572,0.24138,0.3229,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.0016129,0.24132,0.18116,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.004408,0.24101,0.32286,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0011549,0.24068,0.20872,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00067758,0.24066,0.22827,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.00059588,0.24044,0.24393,1,1
4,GO AMINO ACID ACTIVATION,0.0087944,0.24029,0.19191,1,1
4,GO CYTOKINE PRODUCTION,0.00047456,0.24024,0.1901,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0067808,0.24021,0.17852,1,1
4,GO AMELOGENESIS,0.017137,0.24017,0.2072,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.011904,0.24005,0.18158,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00049035,0.23999,0.24096,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.007729,0.23994,0.23774,1,1
4,GO LEUKOCYTE MIGRATION,0.00052342,0.23987,0.19182,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.8418e-05,0.23956,0.24701,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00079435,0.23943,0.19177,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.3218e-05,0.23909,0.28202,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0045306,0.2388,0.19395,1,1
4,GO REGULATION OF PH,3.3287e-06,0.23879,0.23247,1,1
4,GO CELL CHEMOTAXIS,0.00022676,0.23876,0.19305,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0007696,0.23875,0.27035,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00041602,0.23875,0.25042,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00019753,0.23807,0.27107,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00021167,0.23803,0.23356,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.012203,0.23797,0.26024,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0062634,0.23794,0.19349,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.0039469,0.23783,0.33152,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.0551e-05,0.2378,0.23017,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00010845,0.23737,0.19231,1,1
4,GO B CELL ACTIVATION,0.0001547,0.23724,0.18739,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0027346,0.23703,0.25983,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0025817,0.2367,0.21592,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0075304,0.23666,0.21115,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014486,0.23626,0.22646,1,1
4,GO PIGMENTATION,0.00037661,0.23614,0.16762,1,1
4,GO RESPONSE TO STARVATION,9.3916e-06,0.23612,0.24104,1,1
4,GO LIPID EXPORT FROM CELL,0.0067808,0.23604,0.26883,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00072223,0.23604,0.23179,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0010859,0.23595,0.21955,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.0014299,0.23584,0.22203,1,1
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0041716,0.23565,0.33539,1,1
4,GO INTERLEUKIN 12 PRODUCTION,2.5308e-05,0.23558,0.27325,1,1
4,GO RENAL SYSTEM PROCESS,0.001662,0.23557,0.18909,1,1
4,GO ER OVERLOAD RESPONSE,0.0050528,0.23538,0.24868,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00045924,0.23537,0.22598,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.0017123,0.23509,0.15832,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,1.7806e-05,0.23464,0.2607,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,7.547e-05,0.2346,0.22465,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0010206,0.23441,0.22973,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00079435,0.23392,0.20973,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.017137,0.23364,0.15586,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00023468,0.23356,0.31971,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00037661,0.23342,0.2302,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00045924,0.23333,0.20144,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00065623,0.23319,0.17611,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0022992,0.23308,0.185,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0021689,0.23272,0.18474,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.4878e-05,0.23236,0.23365,1,1
4,GO ENERGY HOMEOSTASIS,0.0042883,0.23234,0.20942,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0014299,0.23224,0.2601,1,1
4,GO RESPONSE TO FATTY ACID,0.0031536,0.23217,0.20012,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.00017796,0.23205,0.24099,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0071468,0.23204,0.15781,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.041093,0.23181,0.15351,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.001191,0.23167,0.17902,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00079435,0.23114,0.20797,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00014935,0.23114,0.21426,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00074557,0.23071,0.16844,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00092958,0.23058,0.19924,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00016023,0.23035,0.21326,1,1
4,GO COPII COATED VESICLE BUDDING,0.00047456,0.23024,0.2073,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.4421e-05,0.2302,0.21426,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0024367,0.22985,0.2358,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0031536,0.22982,0.17892,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.001986,0.22979,0.22082,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.0017641,0.22978,0.15356,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.0014299,0.2293,0.37706,1,1
4,GO B CELL HOMEOSTASIS,0.0010859,0.22922,0.23961,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0022332,0.22907,0.21412,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.010506,0.22906,0.15647,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,6.5149e-05,0.22906,0.24193,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.016734,0.22866,0.24846,1,1
4,GO PEPTIDE SECRETION,0.00010845,0.22862,0.18969,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.4346e-05,0.22834,0.30203,1,1
4,GO RESPONSE TO CAFFEINE,0.0033369,0.22816,0.23139,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0085714,0.22812,0.24569,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.00038934,0.22795,0.22436,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.00032948,0.22791,0.21374,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.022165,0.22788,0.20304,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00072223,0.22781,0.17869,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0040578,0.22774,0.27942,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0026572,0.22772,0.25908,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0066042,0.22763,0.17479,1,1
4,GO RESPONSE TO METAL ION,6.2786e-05,0.22759,0.20544,1,1
4,GO MEMBRANE FUSION,0.0014738,0.22715,0.17574,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0010859,0.22714,0.19129,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0034322,0.22706,0.20867,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00038934,0.22676,0.20862,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00038934,0.22664,0.24287,1,1
4,GO REGULATION OF T CELL MIGRATION,0.011047,0.22642,0.17571,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.00019079,0.22607,0.18849,1,1
4,GO STEROL TRANSPORT,0.00021909,0.22606,0.25024,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.00010092,0.22584,0.2001,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.018398,0.22567,0.24775,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.0011549,0.22557,0.22434,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00010845,0.22496,0.25385,1,1
4,GO RESPONSE TO KETONE,0.0022992,0.22491,0.16417,1,1
4,GO GLUCOSE METABOLIC PROCESS,2.8418e-05,0.22467,0.23722,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00041602,0.22466,0.24377,1,1
4,GO FLUID TRANSPORT,0.00040247,0.22446,0.21188,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00095906,0.2243,0.23148,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00024286,0.22425,0.27376,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0010528,0.22407,0.17573,1,1
4,GO SENSORY PERCEPTION OF SMELL,5.2837e-06,0.22403,0.21557,1,1
4,GO INSULIN SECRETION,0.0006154,0.2234,0.17869,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.013465,0.22332,0.23636,1,1
4,GO CYTOPLASM ORGANIZATION,0.0094949,0.22302,0.23652,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00016023,0.22224,0.27843,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00353,0.22217,0.23485,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0094949,0.22214,0.29388,1,1
4,GO VESICLE TARGETING,0.0045306,0.2221,0.19234,1,1
4,GO PROTEIN MATURATION,6.0504e-05,0.22207,0.21483,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.0013054,0.22199,0.1637,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.0039469,0.22198,0.29783,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00032948,0.22198,0.20356,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.00041602,0.22177,0.2219,1,1
4,GO POSITIVE CHEMOTAXIS,0.0071468,0.22176,0.15169,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.018836,0.22162,0.14473,1,1
4,GO RESPONSE TO NUTRIENT,0.024846,0.22084,0.13716,1,1
4,GO PIRNA METABOLIC PROCESS,0.0034322,0.22081,0.27367,1,1
4,GO LOCOMOTOR RHYTHM,0.02843,0.22063,0.16205,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.009256,0.2206,0.15195,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.038561,0.22053,0.3059,1,1
4,GO INTERLEUKIN 6 PRODUCTION,0.00028792,0.22038,0.20603,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.012508,0.22017,0.26367,1,1
4,GO REGULATION OF GLUCONEOGENESIS,3.3132e-05,0.21997,0.26577,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0099891,0.21992,0.17105,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0025817,0.21983,0.22775,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0015189,0.21919,0.19361,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.014138,0.21906,0.15283,1,1
4,GO RESPONSE TO ALCOHOL,0.0014738,0.21895,0.1486,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00014418,0.21881,0.21363,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.0025083,0.21868,0.21896,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0032441,0.21836,0.14937,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0039469,0.21795,0.20123,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.025994,0.21767,0.15194,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,2.0833e-05,0.21719,0.22847,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.4346e-05,0.21696,0.19885,1,1
4,GO MONOCYTE CHEMOTAXIS,0.024288,0.21681,0.14552,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0001547,0.2168,0.1977,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0030654,0.21637,0.177,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.0013872,0.21613,0.17763,1,1
4,GO RESPONSE TO CALCIUM ION,0.001662,0.2153,0.18327,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0021062,0.21527,0.18296,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.050569,0.21524,0.1488,1,1
4,GO STEROID CATABOLIC PROCESS,0.018398,0.21516,0.25193,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0017123,0.21504,0.16804,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.0024367,0.21459,0.19448,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00028792,0.21421,0.25639,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00040247,0.21378,0.17172,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0011199,0.21374,0.17427,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0030654,0.21369,0.20502,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.00032948,0.21327,0.1901,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.00022676,0.21312,0.21133,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0022992,0.21312,0.2907,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0038387,0.21278,0.30019,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.037747,0.21274,0.15035,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.02843,0.21234,0.13685,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0027346,0.21223,0.26158,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.041967,0.21219,0.19196,1,1
4,GO CARBOHYDRATE TRANSPORT,2.1663e-05,0.21193,0.23913,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00072223,0.21192,0.19142,1,1
4,GO RESPONSE TO CHEMOKINE,5.4121e-05,0.2119,0.20808,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.0083534,0.2118,0.1864,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0027346,0.21173,0.17626,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0081404,0.21168,0.28187,1,1
4,GO REGULATION OF HORMONE LEVELS,0.00021909,0.21148,0.2085,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0060989,0.21123,0.1771,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,5.0226e-05,0.21123,0.2045,1,1
4,GO GROOMING BEHAVIOR,0.043763,0.21118,0.17115,1,1
4,GO ORGANIC ANION TRANSPORT,0.00021167,0.21079,0.19507,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.017969,0.21073,0.28477,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025817,0.21064,0.16523,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0079323,0.21063,0.23423,1,1
4,GO REGULATION OF HORMONE SECRETION,0.00029782,0.21048,0.17868,1,1
4,GO BONE CELL DEVELOPMENT,0.031748,0.21044,0.15487,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00037661,0.21041,0.18962,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00059588,0.21012,0.20825,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2962e-05,0.21008,0.20086,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,4.4878e-05,0.20998,0.21745,1,1
4,GO SODIUM ION HOMEOSTASIS,0.0094949,0.20987,0.15676,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00019079,0.20977,0.24758,1,1
4,GO T CELL LINEAGE COMMITMENT,5.0226e-05,0.20969,0.21873,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0066042,0.20964,0.17879,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0026572,0.20958,0.23325,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0094949,0.20952,0.15841,1,1
4,GO LIPID OXIDATION,0.00087311,0.20944,0.19594,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.013798,0.20917,0.21226,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.029719,0.209,0.13126,1,1
4,GO TISSUE HOMEOSTASIS,0.00020448,0.20899,0.19356,1,1
4,GO ADAPTIVE THERMOGENESIS,1.2962e-05,0.20858,0.20853,1,1
4,GO REGULATION OF PEPTIDE SECRETION,3.5759e-05,0.20813,0.19281,1,1
4,GO VACUOLE ORGANIZATION,8.6584e-06,0.20791,0.22589,1,1
4,GO DIOL METABOLIC PROCESS,0.0028957,0.20781,0.268,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.00042998,0.20763,0.20573,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.001986,0.2076,0.17315,1,1
4,GO WOUND HEALING,0.0097392,0.20755,0.13282,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.00353,0.2075,0.1831,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00037661,0.20747,0.22374,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,2.2524e-05,0.20745,0.23258,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.00049035,0.20742,0.21185,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00027832,0.20739,0.19998,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0038387,0.20731,0.17504,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00013433,0.2071,0.21207,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00069957,0.20684,0.15524,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00026003,0.20677,0.27158,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0067808,0.20673,0.14454,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00054072,0.20641,0.18353,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0022332,0.20589,0.18477,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0047853,0.20579,0.15893,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,0.00023468,0.20559,0.19148,1,1
4,GO REGULATION OF TUBE SIZE,0.0011549,0.20554,0.19609,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,3.3132e-05,0.20535,0.25691,1,1
4,GO NECROTIC CELL DEATH,0.00052342,0.20525,0.25568,1,1
4,GO T CELL HOMEOSTASIS,0.0081404,0.20516,0.14397,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00092958,0.20504,0.15039,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0053338,0.205,0.19393,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.013798,0.205,0.14276,1,1
4,GO LEUKOCYTE PROLIFERATION,0.00090094,0.20451,0.17689,1,1
4,GO PLATELET MORPHOGENESIS,0.0045306,0.20448,0.20021,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,8.7323e-05,0.20427,0.19564,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.0011199,0.20407,0.18468,1,1
4,GO EXOCYTOSIS,0.00040247,0.20403,0.17819,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0037331,0.20375,0.17618,1,1
4,GO REGULATION OF LIPID STORAGE,0.0017123,0.20338,0.18859,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.011047,0.20336,0.13983,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00047456,0.20335,0.16849,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.017137,0.20324,0.17564,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0036303,0.20301,0.16124,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,0.00016595,0.20278,0.21577,1,1
4,GO XENOBIOTIC TRANSPORT,0.0015189,0.20258,0.30323,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00016595,0.20252,0.2295,1,1
4,GO PLASMA MEMBRANE FUSION,0.031059,0.20173,0.18856,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.00034072,0.20165,0.1609,1,1
4,GO RESPONSE TO STEROL,0.0073363,0.20111,0.20083,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0011199,0.2011,0.18533,1,1
4,GO HORMONE TRANSPORT,0.00027832,0.20107,0.18676,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0006154,0.20102,0.21289,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0062634,0.20101,0.24506,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0057817,0.20068,0.12764,1,1
4,GO LIPID HOMEOSTASIS,0.0024367,0.20065,0.20847,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.05161,0.20049,0.13015,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.013139,0.20047,0.1643,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.004408,0.20045,0.2162,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.0031536,0.20029,0.15812,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.0050528,0.20009,0.20274,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.0012662,0.19955,0.15737,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0075304,0.19923,0.16629,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,6.7596e-05,0.19901,0.16314,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.018398,0.19877,0.12169,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.015574,0.19848,0.22181,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0021062,0.19813,0.15758,1,1
4,GO T CELL DIFFERENTIATION,0.00055855,0.19787,0.14586,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0017123,0.19785,0.15333,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.004408,0.19775,0.2024,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.010773,0.19752,0.14951,1,1
4,GO CELL ACTIVATION,0.00069957,0.19749,0.16341,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.8301e-05,0.197,0.17846,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0041716,0.19698,0.18199,1,1
4,GO FATTY ACID TRANSPORT,0.00017796,0.19647,0.2171,1,1
4,GO ENDOCYTIC RECYCLING,0.0050528,0.19645,0.13333,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0099891,0.19617,0.16393,1,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.014486,0.1959,0.19989,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.004408,0.19587,0.29264,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.0021062,0.19561,0.14825,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.0037331,0.19553,0.16901,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.011612,0.19547,0.16621,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.02068,0.19543,0.15046,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.024846,0.1953,0.15097,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00036427,0.1952,0.20036,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0010528,0.19503,0.15773,1,1
4,GO BICARBONATE TRANSPORT,0.014138,0.195,0.15798,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.029068,0.19483,0.15962,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0046564,0.19466,0.20868,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.019739,0.19448,0.15479,1,1
4,GO PLATELET ACTIVATION,0.0025817,0.19427,0.15621,1,1
4,GO MUSCLE ADAPTATION,0.0041716,0.1942,0.15346,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0025817,0.19414,0.38803,1,1
4,GO LIPID METABOLIC PROCESS,0.00052342,0.19374,0.17421,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0020453,0.19367,0.19864,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00074557,0.19362,0.15775,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00041602,0.19344,0.31372,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.044685,0.19341,0.14182,1,1
4,GO CARNITINE SHUTTLE,0.0064317,0.19337,0.20901,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0017123,0.1929,0.17518,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0040578,0.19284,0.14983,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0036303,0.19265,0.15793,1,1
4,GO MANNOSYLATION,0.00010845,0.19248,0.23192,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00031859,0.19246,0.13781,1,1
4,GO B CELL DIFFERENTIATION,0.00010845,0.19222,0.19459,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00022676,0.19206,0.20093,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.00087311,0.19201,0.16165,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.020205,0.19192,0.11477,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00030804,0.19148,0.18377,1,1
4,GO COPPER ION TRANSPORT,0.025994,0.19116,0.17314,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,3.0689e-05,0.19115,0.24516,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00098941,0.1907,0.15521,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0029794,0.19021,0.21231,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.001228,0.18998,0.15393,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0029794,0.18998,0.17009,1,1
4,GO REGULATION OF HEART RATE,0.015953,0.18981,0.15731,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.00041602,0.18974,0.1715,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0087944,0.1897,0.20357,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0019282,0.18967,0.1341,1,1
4,GO GOLGI RIBBON FORMATION,0.0027346,0.18949,0.18899,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0017123,0.18943,0.30416,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0016129,0.1894,0.14009,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.019283,0.18937,0.17288,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.00063551,0.18933,0.20662,1,1
4,GO RESPONSE TO DSRNA,0.0007696,0.18921,0.1646,1,1
4,GO PEPTIDE HORMONE SECRETION,0.00042998,0.18902,0.17569,1,1
4,GO REGULATION OF APPETITE,0.015574,0.18891,0.12117,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.031748,0.18885,0.14214,1,1
4,GO PROTEIN KINASE B SIGNALING,0.013798,0.18885,0.11886,1,1
4,GO SECRETION,0.00069957,0.1888,0.15625,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.00037661,0.18835,0.17746,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0049174,0.18826,0.1133,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0059384,0.18816,0.17562,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0023671,0.18811,0.1393,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0049174,0.18789,0.12777,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00028792,0.18757,0.17307,1,1
4,GO MANGANESE ION TRANSPORT,0.00067758,0.18694,0.22277,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0021062,0.18686,0.14028,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00012512,0.1868,0.2338,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0081404,0.18676,0.14923,1,1
4,GO COPULATION,0.015953,0.18665,0.17526,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.025414,0.18646,0.18181,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0026572,0.18632,0.14451,1,1
4,GO ANION TRANSPORT,0.00028792,0.18622,0.17573,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.035393,0.1861,0.22119,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0075304,0.18595,0.12466,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.00012964,0.18589,0.20554,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0059384,0.18587,0.20703,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.014486,0.1858,0.25052,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0010528,0.18541,0.18868,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,7.8282e-05,0.18537,0.21402,1,1
4,GO RESPONSE TO IRON ION,0.03939,0.18519,0.15753,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0038387,0.18475,0.14084,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.021165,0.18464,0.23428,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.0001165,0.18452,0.16062,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00087311,0.18445,0.18102,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0046564,0.18424,0.13018,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.030383,0.18408,0.134,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0054795,0.184,0.21004,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0053338,0.18382,0.14319,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0012662,0.18372,0.16095,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.027188,0.18341,0.1529,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00067758,0.18307,0.16295,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.007729,0.18305,0.27538,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.02166,0.18302,0.19212,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.047551,0.183,0.17792,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.033166,0.18294,0.17523,1,1
4,GO RESPONSE TO ETHER,0.0022992,0.18285,0.18454,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00022676,0.1828,0.16908,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0027346,0.18252,0.20026,1,1
4,GO OXIDATION REDUCTION PROCESS,0.00045924,0.18239,0.19152,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0024367,0.18233,0.15992,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00090094,0.18208,0.21707,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,8.6584e-06,0.18201,0.22909,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00059588,0.1817,0.15981,1,1
4,GO TEMPERATURE HOMEOSTASIS,8.4205e-05,0.18151,0.1784,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.2524e-05,0.18148,0.19671,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00016023,0.18139,0.22489,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0045306,0.18135,0.11833,1,1
4,GO RESPONSE TO WOUNDING,0.024288,0.18134,0.10984,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0032441,0.18111,0.1536,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00017186,0.18069,0.1772,1,1
4,GO RESPONSE TO LIPID,0.0073363,0.18018,0.12293,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0019282,0.18,0.18953,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.011612,0.17997,0.14204,1,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.042857,0.17994,0.1566,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0038387,0.17991,0.15959,1,1
4,GO EATING BEHAVIOR,0.0021062,0.17985,0.17067,1,1
4,GO IRON ION TRANSPORT,0.00014935,0.17984,0.2298,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0057817,0.17976,0.12743,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001872,0.17949,0.22231,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00010462,0.17943,0.17041,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00028792,0.17925,0.17055,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.014138,0.17907,0.14114,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0017641,0.17877,0.12574,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0023671,0.1785,0.19758,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.017137,0.17844,0.25372,1,1
4,GO INORGANIC ANION TRANSPORT,0.00092958,0.1784,0.14201,1,1
4,GO CHEMICAL HOMEOSTASIS,0.00023468,0.17812,0.15675,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.004408,0.17806,0.16216,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.013798,0.17776,0.21733,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.024846,0.17769,0.13476,1,1
4,GO RESPONSE TO INSULIN,0.00081984,0.17768,0.15663,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0029794,0.17746,0.15182,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.018836,0.17741,0.27669,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.00014935,0.17691,0.18341,1,1
4,GO T CELL ACTIVATION,0.0017123,0.1769,0.14667,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00034072,0.17685,0.21303,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00098941,0.17684,0.16069,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0028957,0.17674,0.16496,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0075304,0.17665,0.15192,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.018836,0.17645,0.21004,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.001872,0.17637,0.15033,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0016129,0.17635,0.17096,1,1
4,GO CELLULAR PIGMENTATION,0.0010859,0.17593,0.1741,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0042883,0.1757,0.14594,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.030383,0.17568,0.11857,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00054072,0.1756,0.13331,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0021062,0.17551,0.16439,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.00049035,0.17538,0.17888,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.019283,0.17533,0.13938,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0014738,0.17501,0.12894,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0012662,0.17468,0.14524,1,1
4,GO LYMPHOCYTE ACTIVATION,0.0036303,0.17441,0.12449,1,1
4,GO CHLORIDE TRANSPORT,0.0012662,0.17441,0.14403,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00057693,0.17424,0.16731,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0014738,0.17423,0.11478,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0056288,0.17372,0.12311,1,1
4,GO METAL ION HOMEOSTASIS,0.00035231,0.17349,0.13924,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.016734,0.17348,0.13455,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.0015653,0.17346,0.12193,1,1
4,GO ACTIN NUCLEATION,0.00022676,0.17312,0.18032,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.011904,0.1726,0.1268,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00090094,0.17256,0.13921,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.0013872,0.17248,0.17769,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.041967,0.17218,0.1353,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010528,0.17216,0.16293,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0090226,0.17214,0.12609,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.014486,0.17205,0.23783,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0051916,0.17188,0.12682,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0087944,0.17184,0.16055,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.001986,0.17159,0.19703,1,1
4,GO AGING,0.0014299,0.17152,0.13455,1,1
4,GO ORGANELLE FUSION,0.0025817,0.17146,0.16009,1,1
4,GO VESICLE ORGANIZATION,0.0031536,0.17145,0.15405,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.049546,0.17129,0.1396,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0034322,0.17109,0.16096,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.010245,0.17101,0.13868,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.014138,0.1706,0.1471,1,1
4,GO PANCREAS DEVELOPMENT,0.042857,0.17031,0.13549,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0054795,0.17022,0.19474,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0015653,0.17015,0.15561,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.013798,0.16973,0.11841,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0053338,0.16955,0.12482,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0073363,0.16952,0.13714,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0066042,0.16952,0.13982,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0051916,0.16952,0.18469,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0097392,0.16942,0.12775,1,1
4,GO RESPONSE TO FUNGUS,0.00063551,0.16914,0.15966,1,1
4,GO CHOLESTEROL STORAGE,0.03245,0.16884,0.16508,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.004408,0.16842,0.11876,1,1
4,GO PROTEOLYSIS,0.00030804,0.1684,0.13651,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,3.0689e-05,0.1684,0.23441,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0051916,0.16769,0.13711,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0081404,0.16753,0.13304,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.02166,0.16751,0.1222,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.022165,0.16725,0.12456,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,4.4878e-05,0.167,0.18134,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00031859,0.16665,0.15748,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.0001547,0.16649,0.15849,1,1
4,GO PEROXISOME ORGANIZATION,0.00069957,0.16595,0.19799,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0050528,0.16571,0.12899,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00024286,0.1657,0.20405,1,1
4,GO CYTOKINE SECRETION,0.0006154,0.16552,0.19209,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0020453,0.16489,0.17654,1,1
4,GO ERK1 AND ERK2 CASCADE,0.046579,0.16487,0.10394,1,1
4,GO REGULATION OF SECRETION,0.0013872,0.16487,0.13895,1,1
4,GO FATTY ACID BETA OXIDATION,0.0021689,0.16475,0.21026,1,1
4,GO ORGANIC ACID TRANSPORT,0.00067758,0.16425,0.19392,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.02843,0.16417,0.1336,1,1
4,GO GLUCOSE IMPORT,0.0042883,0.16372,0.15853,1,1
4,GO MACROPHAGE ACTIVATION,0.0028957,0.16371,0.14928,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.031059,0.16333,0.21637,1,1
4,GO RESPONSE TO TUMOR CELL,0.03245,0.16333,0.22183,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0015653,0.16322,0.1381,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0021689,0.16314,0.14356,1,1
4,GO MONOAMINE TRANSPORT,0.018398,0.163,0.2258,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.0030654,0.16256,0.11543,1,1
4,GO ION HOMEOSTASIS,0.00044439,0.1624,0.1432,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.046579,0.16238,0.1008,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0020453,0.16199,0.13582,1,1
4,GO LIPID CATABOLIC PROCESS,7.8282e-05,0.16197,0.21809,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.004408,0.16174,0.12155,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.010506,0.16158,0.15158,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.0019282,0.16105,0.13896,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0050528,0.16087,0.12632,1,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0090226,0.16084,0.15104,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0022332,0.16075,0.1393,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.019739,0.16031,0.1779,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.037747,0.16026,0.14022,1,1
4,GO PROTEIN DESTABILIZATION,0.0014299,0.15978,0.14863,1,1
4,GO RENAL SODIUM EXCRETION,0.023205,0.15976,0.16111,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.011612,0.15953,0.2102,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.010506,0.15939,0.15944,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0036303,0.15933,0.14548,1,1
4,GO REGULATION OF CELL MATURATION,0.0041716,0.15932,0.17053,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0007696,0.15887,0.18558,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.004408,0.15855,0.13289,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0025083,0.15841,0.12373,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00072223,0.15833,0.17043,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.022165,0.15798,0.11253,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.013465,0.15796,0.15038,1,1
4,GO PEROXISOMAL TRANSPORT,0.00079435,0.1578,0.20749,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.036164,0.15744,0.14788,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0087944,0.15731,0.14714,1,1
4,GO DETECTION OF STIMULUS,8.4205e-05,0.15724,0.13002,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0022332,0.15707,0.12027,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.0024367,0.15704,0.12859,1,1
4,GO MUSCLE CELL MIGRATION,0.05161,0.15687,0.13874,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00074557,0.15681,0.20123,1,1
4,GO ION TRANSPORT,0.0011549,0.15653,0.13849,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.025414,0.15637,0.10801,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.0071468,0.15629,0.14803,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.010245,0.15628,0.12688,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0038387,0.15578,0.15019,1,1
4,GO DRUG METABOLIC PROCESS,0.00063551,0.15573,0.28706,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0040578,0.15571,0.1681,1,1
4,GO RESPONSE TO DRUG,0.0094949,0.15559,0.12911,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0046564,0.15553,0.14611,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.00054072,0.15544,0.13283,1,1
4,GO DEFENSE RESPONSE TO FUNGUS,0.0038387,0.1552,0.13015,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.004408,0.15504,0.17135,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.023741,0.15503,0.1037,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0071468,0.15457,0.18061,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0022992,0.15457,0.18675,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0067808,0.15439,0.11455,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0059384,0.1543,0.16796,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.033166,0.15422,0.12452,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00020448,0.15383,0.15629,1,1
4,GO HOMEOSTATIC PROCESS,0.00028792,0.1538,0.12848,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0036303,0.1537,0.14827,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0028141,0.15368,0.18393,1,1
4,GO REGULATION OF HEMOPOIESIS,0.001662,0.15367,0.12237,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0022332,0.15356,0.15309,1,1
4,GO REGULATION OF MITOPHAGY,0.033894,0.15345,0.12034,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0012662,0.15328,0.13467,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.022165,0.15326,0.12745,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0017641,0.15309,0.21308,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.011326,0.15246,0.22569,1,1
4,GO SECRETORY GRANULE ORGANIZATION,0.030383,0.15242,0.13464,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0021062,0.15226,0.13423,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.001986,0.15167,0.13973,1,1
4,GO CALCIUM ION IMPORT,0.034637,0.15116,0.081625,1,1
4,GO GOLGI ORGANIZATION,0.00013433,0.15093,0.17678,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0021689,0.15075,0.16718,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0099891,0.15033,0.12333,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0014738,0.15028,0.19599,1,1
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0094949,0.15001,0.13513,1,1
4,GO ENDOSOME ORGANIZATION,0.0014299,0.14987,0.16393,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.00024286,0.14986,0.13307,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.047551,0.14963,0.094516,1,1
4,GO AMINO ACID IMPORT,0.052669,0.14954,0.15667,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.014138,0.14945,0.13139,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0013872,0.14924,0.1419,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.033166,0.14921,0.17326,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.023741,0.14919,0.1103,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.0021062,0.14918,0.1831,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00072223,0.14891,0.14108,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0030654,0.14864,0.11738,1,1
4,GO RESPONSE TO ALKALOID,0.027188,0.14861,0.1066,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0099891,0.14832,0.12,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0054795,0.14817,0.14885,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0045306,0.14815,0.22262,1,1
4,GO REGULATION OF CELL ADHESION,0.010245,0.14791,0.12754,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0057817,0.14721,0.12671,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0015653,0.14673,0.17821,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0033369,0.14622,0.14676,1,1
4,GO RESPONSE TO HORMONE,0.0056288,0.14619,0.1261,1,1
4,GO REGULATION OF ION TRANSPORT,0.02068,0.14615,0.096612,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.014138,0.14598,0.12667,1,1
4,GO OOCYTE DIFFERENTIATION,0.0073363,0.14594,0.12295,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.046579,0.14591,0.077232,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0047853,0.14588,0.18855,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011612,0.14578,0.2101,1,1
4,GO PROSTAGLANDIN SECRETION,0.011326,0.14553,0.22229,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0097392,0.14545,0.14636,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.015203,0.14504,0.15872,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.027803,0.14482,0.13994,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00052342,0.14445,0.15411,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.03939,0.14443,0.095823,1,1
4,GO AMINE TRANSPORT,0.021165,0.14384,0.20282,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0083534,0.14378,0.10592,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0079323,0.1437,0.20253,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,2.1663e-05,0.14353,0.18619,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0025083,0.14353,0.12248,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.010506,0.14346,0.14575,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.035393,0.14343,0.15478,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.035393,0.1434,0.13271,1,1
4,GO METAL ION TRANSPORT,0.0079323,0.1428,0.10564,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.010506,0.14271,0.11114,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0031536,0.14188,0.1163,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0073363,0.1417,0.14905,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0041716,0.1417,0.15449,1,1
4,GO MYOTUBE DIFFERENTIATION,0.0056288,0.14153,0.13736,1,1
4,GO CELL CELL ADHESION,0.025994,0.14152,0.10675,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0060989,0.14145,0.15022,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.047551,0.14095,0.098299,1,1
4,GO T CELL SELECTION,0.00040247,0.14084,0.14498,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.02843,0.14068,0.13094,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0079323,0.14066,0.11531,1,1
4,GO T CELL PROLIFERATION,0.00353,0.14065,0.15408,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.03245,0.14061,0.1489,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.0017123,0.14042,0.12269,1,1
4,GO RETINA HOMEOSTASIS,0.033166,0.14015,0.070132,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0094949,0.13999,0.10401,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0036303,0.13993,0.17429,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00037661,0.13962,0.13887,1,1
4,GO RESPONSE TO ETHANOL,0.02166,0.13943,0.10623,1,1
4,GO CELL MATURATION,0.0029794,0.13936,0.11862,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.0090226,0.13929,0.14494,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.04854,0.13928,0.11573,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0031536,0.13919,0.12097,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.03939,0.13918,0.1993,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.034637,0.13913,0.09679,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.022165,0.13911,0.089462,1,1
4,GO EPITHELIUM DEVELOPMENT,0.0049174,0.13897,0.10469,1,1
4,GO VITAMIN METABOLIC PROCESS,0.013139,0.1389,0.18117,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0057817,0.13844,0.10697,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.001662,0.13844,0.16647,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.031748,0.13838,0.18722,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0047853,0.13818,0.18329,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00353,0.13817,0.17069,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0025083,0.13803,0.17074,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.018398,0.13802,0.10379,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.046579,0.13757,0.085564,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0064317,0.13742,0.23951,1,1
4,GO LYSOSOME LOCALIZATION,0.0051916,0.13734,0.13872,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.029068,0.13731,0.19606,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.0010206,0.13669,0.13515,1,1
4,GO REGULATION OF PROTEIN BINDING,0.021165,0.13663,0.10579,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0039469,0.13646,0.13555,1,1
4,GO PROTEIN MANNOSYLATION,0.015203,0.13642,0.15749,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.022165,0.13623,0.18303,1,1
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00052342,0.1362,0.16113,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.041967,0.13613,0.10801,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.014138,0.13609,0.10936,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.001191,0.13592,0.16393,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.029068,0.13589,0.13634,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0049174,0.13563,0.10733,1,1
4,GO CATION TRANSPORT,0.0042883,0.13521,0.11534,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0036303,0.13509,0.11597,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0010859,0.13503,0.11075,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0066042,0.13489,0.10645,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.02268,0.13472,0.10893,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0037331,0.1347,0.12116,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0083534,0.13455,0.1276,1,1
4,GO PROTEIN AUTOUBIQUITINATION,9.0551e-05,0.13427,0.13172,1,1
4,GO WATER TRANSPORT,0.045624,0.13358,0.088047,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0046564,0.13308,0.18828,1,1
4,GO NCRNA CATABOLIC PROCESS,0.02166,0.13308,0.11901,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.045624,0.13304,0.12961,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.050569,0.13271,0.10264,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.0045306,0.13271,0.10346,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.014841,0.13263,0.092704,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0013872,0.1323,0.16685,1,1
4,GO ORGANELLE DISASSEMBLY,0.0017641,0.13216,0.15359,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0073363,0.13187,0.19967,1,1
4,GO EXCRETION,0.020205,0.13179,0.12397,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0019282,0.13176,0.13008,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010859,0.13153,0.16051,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0067808,0.13149,0.13668,1,1
4,GO LIPID MODIFICATION,0.0030654,0.13139,0.14706,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.0066042,0.13116,0.12252,1,1
4,GO FEEDING BEHAVIOR,0.025994,0.13077,0.11935,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0032441,0.13074,0.1527,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0013457,0.13043,0.12381,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.029719,0.12942,0.16349,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.018836,0.12927,0.10456,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.009256,0.12914,0.1151,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0013457,0.12908,0.16156,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00079435,0.12907,0.1908,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.035393,0.12845,0.10099,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0053338,0.12835,0.11978,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0028141,0.12821,0.13955,1,1
4,GO RESPONSE TO ACTIVITY,0.011047,0.12816,0.17768,1,1
4,GO RESPONSE TO PEPTIDE,0.0087944,0.12796,0.10245,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.019283,0.12789,0.10897,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0045306,0.12728,0.11195,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0042883,0.12728,0.15045,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.0066042,0.12666,0.16814,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0021062,0.1265,0.12409,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.020205,0.12589,0.099783,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.011047,0.12546,0.11442,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.013798,0.12544,0.097266,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.053746,0.12521,0.077179,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.015574,0.12442,0.091448,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.010245,0.1244,0.12295,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0075304,0.12427,0.14766,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0085714,0.12421,0.11012,1,1
4,GO REGULATION OF CHEMOTAXIS,0.031059,0.12418,0.087359,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0060989,0.12387,0.15842,1,1
4,GO SIGNAL RELEASE,0.0051916,0.12365,0.1183,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00023468,0.12317,0.18084,1,1
4,GO SODIUM ION TRANSPORT,0.019739,0.12274,0.11762,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.012203,0.12263,0.13477,1,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.042857,0.12253,0.12075,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.029068,0.12247,0.091116,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0075304,0.12242,0.12654,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.025994,0.12195,0.097517,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.012203,0.12174,0.11391,1,1
4,GO TISSUE MIGRATION,0.038561,0.12168,0.11105,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.001872,0.12166,0.11488,1,1
4,GO RESPONSE TO SALT,0.04854,0.12162,0.10418,1,1
4,GO REGULATION OF TOR SIGNALING,0.00016023,0.12162,0.12297,1,1
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0083534,0.12135,0.13051,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.02166,0.12105,0.12361,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00024286,0.12063,0.209,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.015203,0.12046,0.096999,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.015574,0.12043,0.1116,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0081404,0.12006,0.11286,1,1
4,GO REGULATION OF CELL DEATH,0.011326,0.11905,0.089582,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0097392,0.11863,0.15488,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0022332,0.11851,0.1205,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.017137,0.11831,0.11073,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0056288,0.11815,0.14667,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00035231,0.11767,0.145,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0028141,0.11759,0.13269,1,1
4,GO GLAND DEVELOPMENT,0.0073363,0.11753,0.099768,1,1
4,GO ACID SECRETION,0.026586,0.11727,0.13644,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.0085714,0.11724,0.079847,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.013798,0.11692,0.10756,1,1
4,GO ORGANIC CATION TRANSPORT,0.014138,0.11682,0.16507,1,1
4,GO FAT CELL DIFFERENTIATION,0.012203,0.11682,0.11679,1,1
4,GO TOR SIGNALING,5.0226e-05,0.11657,0.10942,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.012203,0.11653,0.13513,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.01282,0.11552,0.11974,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0039469,0.11548,0.14531,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0081404,0.11536,0.13808,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.011326,0.11529,0.089672,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.0081404,0.11468,0.15172,1,1
4,GO VIRAL BUDDING,0.0039469,0.11466,0.14479,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0050528,0.11463,0.092525,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00084609,0.11459,0.11491,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.017969,0.11442,0.11598,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0056288,0.11396,0.14831,1,1
4,GO CATECHOLAMINE SECRETION,0.041967,0.11319,0.23026,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.050569,0.11268,0.11182,1,1
4,GO CELLULAR HOMEOSTASIS,0.0022332,0.11259,0.11704,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.020205,0.11245,0.079325,1,1
4,GO APOPTOTIC PROCESS,0.007729,0.11227,0.093199,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0067808,0.11215,0.10042,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0087944,0.1121,0.096927,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0087944,0.11157,0.14641,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.025994,0.11114,0.082216,1,1
4,GO MULTICELLULAR ORGANISM AGING,0.0046564,0.11083,0.12448,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0097392,0.11066,0.082445,1,1
4,GO REGULATION OF MAPK CASCADE,0.029719,0.1101,0.097867,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.016339,0.10963,0.11508,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.025414,0.1095,0.16478,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.011904,0.1094,0.12678,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.037747,0.10924,0.095895,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.015953,0.10897,0.11068,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0087944,0.10896,0.16001,1,1
4,GO CYTOSOLIC TRANSPORT,0.0011199,0.10866,0.11796,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.025994,0.10852,0.082465,1,1
4,GO REGULATION OF TRANSPORT,0.013139,0.10851,0.083908,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.017549,0.10803,0.10013,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.052669,0.1076,0.12641,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.015953,0.10741,0.11865,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.0041716,0.10666,0.19625,1,1
4,GO SOMITOGENESIS,0.011612,0.10662,0.10824,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0019282,0.10642,0.11835,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.022165,0.10612,0.12073,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.015203,0.10586,0.12885,1,1
4,GO BODY FLUID SECRETION,0.042857,0.10578,0.084114,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.033166,0.10518,0.12265,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.014486,0.10481,0.087373,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.031748,0.10471,0.096442,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0053338,0.10445,0.10948,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0045306,0.10438,0.10486,1,1
4,GO BIOMINERALIZATION,0.029068,0.10376,0.10807,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.011612,0.10349,0.085473,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.036164,0.10283,0.11437,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0053338,0.10224,0.097361,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.041967,0.10216,0.12316,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0090226,0.10181,0.094217,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.033894,0.10158,0.064627,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.042857,0.10009,0.1239,1,1
4,GO CIRCADIAN RHYTHM,0.011326,0.099818,0.086953,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.013465,0.098743,0.091038,1,1
4,GO SENSORY PERCEPTION,0.0071468,0.098146,0.080199,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.014841,0.098044,0.088794,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.03939,0.097285,0.075656,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.010506,0.096729,0.14359,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.027803,0.096359,0.09122,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.018836,0.095571,0.082763,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.019283,0.095282,0.082678,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.014841,0.095022,0.08576,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.027803,0.09446,0.076484,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0099891,0.094436,0.11334,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0097392,0.09434,0.12971,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.010245,0.094026,0.10664,1,1
4,GO MEMBRANE ORGANIZATION,0.026586,0.093429,0.084777,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.050569,0.092329,0.070225,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0094949,0.091356,0.12081,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.027803,0.091296,0.088025,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.050569,0.090993,0.091672,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.017969,0.090371,0.079633,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.031059,0.089747,0.076616,1,1
4,GO REGULATION OF AUTOPHAGY,0.0017123,0.089513,0.11434,1,1
4,GO POLYOL CATABOLIC PROCESS,0.013139,0.087931,0.13474,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0032441,0.087897,0.11781,1,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.029719,0.087496,0.072014,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.021165,0.087258,0.098165,1,1
4,GO BLASTOCYST DEVELOPMENT,0.011904,0.085403,0.085945,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.030383,0.084292,0.073914,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.036164,0.081358,0.098822,1,1
4,GO RUFFLE ORGANIZATION,0.038561,0.080076,0.12498,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.036948,0.079875,0.07782,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.014486,0.079585,0.092333,1,1
4,GO RESPONSE TO GAMMA RADIATION,0.050569,0.079242,0.085309,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.035393,0.079241,0.10493,1,1
4,GO JNK CASCADE,0.053746,0.078653,0.080888,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.041967,0.07659,0.14539,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.024288,0.072115,0.096386,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.052669,0.071907,0.064819,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.041093,0.071664,0.052813,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.024288,0.069543,0.072765,1,1
4,GO DNA CATABOLIC PROCESS,0.0073363,0.067745,0.10496,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.009256,0.067519,0.10746,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.022165,0.066628,0.075155,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0079323,0.062937,0.058477,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.047551,0.060799,0.047111,1,1
4,GO TORC1 SIGNALING,0.010506,0.056692,0.091293,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.02166,0.054742,0.11309,1,1
4,GO INTRACELLULAR TRANSPORT,0.017549,0.053311,0.064805,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00059588,0.68964,0.52094,1,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.037747,0.61192,0.45279,1,0
4,GO RESPONSE TO INTERFERON BETA,0.0028141,0.59599,0.4129,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00024286,0.5861,0.45233,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00025131,0.53253,0.47082,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0046564,0.52372,0.3644,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0013457,0.52335,0.41994,1,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00095906,0.48518,0.37949,1,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.00072223,0.47516,0.42989,1,0
4,GO T CELL EXTRAVASATION,0.0090226,0.46336,0.45067,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.016339,0.45618,0.35892,1,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0011199,0.43959,0.35611,1,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.0014299,0.41013,0.44491,1,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0027346,0.40538,0.31494,1,0
4,GO REGULATION OF PLATELET AGGREGATION,0.0017123,0.40047,0.33384,1,0
4,GO GAP JUNCTION ASSEMBLY,0.0059384,0.39086,0.3066,1,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0037331,0.38139,0.30014,1,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0022992,0.38078,0.28959,1,0
4,GO RESPONSE TO INTERFERON ALPHA,0.016734,0.37464,0.25376,1,0
4,GO REGULATION OF MYOBLAST FUSION,0.00063551,0.36889,0.32636,1,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0067808,0.36576,0.22901,1,0
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.013139,0.36513,0.31044,1,0
4,GO VASCULAR TRANSPORT,0.0017641,0.36365,0.35252,1,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00084609,0.36019,0.39261,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0011199,0.36017,0.32251,1,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0025083,0.35665,0.30522,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0013872,0.35397,0.25101,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0057817,0.35183,0.29642,1,0
4,GO ETHANOL OXIDATION,0.007729,0.35129,0.44787,1,0
4,GO ETHER METABOLIC PROCESS,0.0040578,0.34896,0.22057,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0006154,0.34882,0.32444,1,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0040578,0.34516,0.21359,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.011326,0.33647,0.26587,1,0
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.022165,0.3357,0.29643,1,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0011549,0.33491,0.24428,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00031859,0.32997,0.27944,1,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0018173,0.3294,0.2058,1,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0032441,0.32905,0.26646,1,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.023741,0.32894,0.25019,1,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.32478,0.29985,1,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0016129,0.32238,0.2716,1,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0012662,0.32038,0.1981,1,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00020448,0.32005,0.31223,1,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.0073363,0.31912,0.24086,1,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.050569,0.31818,0.19901,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.015203,0.3154,0.18885,1,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0046564,0.31533,0.27682,1,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.022165,0.31404,0.25463,1,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0015653,0.31343,0.27011,1,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.031059,0.3128,0.28234,1,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.012203,0.30622,0.26175,1,0
4,GO BLOOD VESSEL REMODELING,0.00092958,0.30548,0.27674,1,0
4,GO LUNG CELL DIFFERENTIATION,0.0094949,0.30201,0.34944,1,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0090226,0.30161,0.18799,1,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0018173,0.2987,0.25537,1,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.022165,0.29753,0.3057,1,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.033894,0.29683,0.28133,1,0
4,GO NEGATIVE REGULATION OF COAGULATION,0.0090226,0.29547,0.297,1,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.016339,0.29519,0.27913,1,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0067808,0.29501,0.27878,1,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0050528,0.29435,0.20627,1,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0028957,0.29401,0.23433,1,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0025083,0.29372,0.32903,1,0
4,GO ENTRY INTO HOST,0.00353,0.29371,0.21113,1,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00042998,0.2927,0.19743,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0053338,0.29205,0.24126,1,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.0041716,0.28994,0.19481,1,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.0013872,0.28939,0.21771,1,0
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0097392,0.28756,0.29518,1,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0021689,0.28728,0.18897,1,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0047853,0.2858,0.21968,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0026572,0.28553,0.2233,1,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0018173,0.28428,0.31951,1,0
4,GO CERAMIDE CATABOLIC PROCESS,0.010245,0.28272,0.33895,1,0
4,GO MAST CELL MEDIATED IMMUNITY,0.00041602,0.28068,0.25769,1,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.010506,0.27626,0.28091,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0029794,0.27498,0.21082,1,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0037331,0.27381,0.24918,1,0
4,GO DETECTION OF BIOTIC STIMULUS,0.0062634,0.27219,0.25639,1,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0081404,0.27153,0.27274,1,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.009256,0.27129,0.2315,1,0
4,GO MEMBRANE RAFT ORGANIZATION,0.038561,0.2706,0.1673,1,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.025414,0.268,0.34914,1,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.00353,0.26758,0.20993,1,0
4,GO CYTOKINE METABOLIC PROCESS,0.001228,0.26685,0.17897,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0041716,0.2668,0.23369,1,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.033166,0.26475,0.1793,1,0
4,GO RESPONSE TO MAGNESIUM ION,0.0014738,0.2642,0.36487,1,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.027803,0.26229,0.20857,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0007696,0.26215,0.20929,1,0
4,GO ZYMOGEN INHIBITION,0.0033369,0.26144,0.23462,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.011047,0.25911,0.17118,1,0
4,GO RESPONSE TO MUSCLE STRETCH,0.00353,0.25873,0.3166,1,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.036948,0.25865,0.2488,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.034637,0.25808,0.14014,1,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0022332,0.25586,0.18201,1,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.0060989,0.25552,0.40144,1,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0038387,0.25508,0.25908,1,0
4,GO HYALURONAN CATABOLIC PROCESS,0.04854,0.25416,0.11132,1,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.037747,0.25324,0.26088,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.027803,0.25292,0.19149,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0010206,0.25277,0.19437,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0034322,0.25261,0.27673,1,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.010506,0.25255,0.34667,1,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.033894,0.25182,0.26261,1,0
4,GO MOVEMENT IN HOST ENVIRONMENT,0.0028141,0.25103,0.19689,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.024288,0.24974,0.15964,1,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0039469,0.24842,0.24657,1,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.02268,0.24722,0.16132,1,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.017137,0.24714,0.31201,1,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.014841,0.24484,0.15163,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.03245,0.24203,0.17015,1,0
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0053338,0.24161,0.27596,1,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.016339,0.24153,0.20372,1,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.015953,0.24134,0.18703,1,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0045306,0.24016,0.38124,1,0
4,GO CELLULAR RESPONSE TO DSRNA,0.0047853,0.24009,0.18587,1,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.001986,0.24002,0.2954,1,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.04854,0.23863,0.24476,1,0
4,GO HYALURONAN METABOLIC PROCESS,0.0014738,0.23783,0.16952,1,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0046564,0.23744,0.25505,1,0
4,GO MICROVILLUS ORGANIZATION,0.0062634,0.23678,0.25858,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0046564,0.23583,0.1871,1,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0039469,0.23583,0.17481,1,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.045624,0.2342,0.18822,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.015953,0.23411,0.20516,1,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.049546,0.23332,0.1814,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0038387,0.23205,0.17678,1,0
4,GO PROTEIN REFOLDING,0.001986,0.2319,0.23654,1,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.052669,0.23187,0.13878,1,0
4,GO RESPONSE TO ANGIOTENSIN,0.013139,0.23164,0.21914,1,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.022165,0.22994,0.14735,1,0
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.011612,0.22985,0.1584,1,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00041602,0.22744,0.2712,1,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00021167,0.22656,0.28677,1,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0039469,0.22583,0.26054,1,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.009256,0.22566,0.15751,1,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0075304,0.22497,0.20805,1,0
4,GO REGULATION OF VASCULOGENESIS,0.044685,0.22417,0.17466,1,0
4,GO RESPONSE TO INTERLEUKIN 1,0.00072223,0.22357,0.1669,1,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.038561,0.2234,0.12098,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00040247,0.22324,0.20453,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0045306,0.22108,0.18332,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0033369,0.22042,0.26081,1,0
4,GO CD40 SIGNALING PATHWAY,0.0039469,0.22024,0.17491,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.02268,0.21935,0.23586,1,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.013139,0.21878,0.26626,1,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00028792,0.21856,0.26378,1,0
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.012508,0.21764,0.29973,1,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010528,0.21732,0.2127,1,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.0081404,0.21717,0.12644,1,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.014841,0.21688,0.17561,1,0
4,GO MYOBLAST FUSION,0.011612,0.21617,0.17827,1,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.025414,0.2157,0.24233,1,0
4,GO AMYLOID BETA CLEARANCE,0.0060989,0.21441,0.17921,1,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.011612,0.2137,0.22989,1,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.010506,0.21242,0.1943,1,0
4,GO AUTOPHAGOSOME MATURATION,0.00063551,0.21119,0.22003,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.007729,0.21094,0.15593,1,0
4,GO TRANSPOSITION,0.03939,0.21087,0.17302,1,0
4,GO NEURONAL ACTION POTENTIAL,0.004408,0.20964,0.32475,1,0
4,GO DETECTION OF CALCIUM ION,0.024288,0.2091,0.27066,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.015203,0.20901,0.17537,1,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.013465,0.20837,0.17303,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.038561,0.20824,0.24491,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00031859,0.20761,0.20478,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.017137,0.20745,0.18131,1,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,0.20634,0.174,1,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.02166,0.20615,0.13401,1,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.0029794,0.20347,0.2327,1,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0041716,0.20326,0.16644,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0050528,0.20322,0.13778,1,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.043763,0.20263,0.20746,1,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.20246,0.24385,1,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00087311,0.20231,0.20384,1,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.033166,0.20074,0.15801,1,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.0013457,0.20038,0.20885,1,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0062634,0.19991,0.26874,1,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.034637,0.19948,0.18274,1,0
4,GO RESPONSE TO TESTOSTERONE,0.034637,0.19874,0.12865,1,0
4,GO POSITIVE REGULATION OF HEART RATE,0.044685,0.1984,0.18945,1,0
4,GO NATURAL KILLER CELL ACTIVATION,0.00098941,0.19821,0.16822,1,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.027188,0.19758,0.1489,1,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0037331,0.19701,0.17317,1,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.031059,0.19582,0.19392,1,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.019739,0.19577,0.14653,1,0
4,GO CELLULAR RESPONSE TO VIRUS,0.0017641,0.19575,0.18286,1,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.053746,0.19508,0.14189,1,0
4,GO SYNCYTIUM FORMATION,0.014841,0.1933,0.13692,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00353,0.19275,0.19204,1,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00019079,0.19223,0.2252,1,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0036303,0.19202,0.13546,1,0
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0051916,0.19134,0.17665,1,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.05161,0.19132,0.10109,1,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.038561,0.19111,0.17869,1,0
4,GO PLATELET AGGREGATION,0.016339,0.19067,0.13849,1,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0014299,0.1902,0.19234,1,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.023205,0.18984,0.12696,1,0
4,GO REPLICATIVE SENESCENCE,0.024288,0.18949,0.20074,1,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00042998,0.18911,0.22142,1,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.052669,0.18911,0.14651,1,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.022165,0.18886,0.11619,1,0
4,GO PEPTIDE CATABOLIC PROCESS,0.02268,0.18795,0.19701,1,0
4,GO RIG I SIGNALING PATHWAY,0.0085714,0.18775,0.13716,1,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.029068,0.18707,0.1713,1,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0018173,0.18675,0.22752,1,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0038387,0.18603,0.17678,1,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0051916,0.18584,0.17879,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0034322,0.18538,0.16571,1,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00072223,0.18424,0.25263,1,0
4,GO TRNA 5 LEADER REMOVAL,0.035393,0.18415,0.14327,1,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.046579,0.18397,0.11594,1,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.017549,0.18392,0.15496,1,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.00054072,0.18315,0.15422,1,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0027346,0.18207,0.23741,1,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.02843,0.18163,0.16701,1,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.036948,0.18134,0.20166,1,0
4,GO EPIDERMIS DEVELOPMENT,0.0013872,0.181,0.1593,1,0
4,GO DEVELOPMENTAL PIGMENTATION,0.0039469,0.18071,0.14793,1,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0026572,0.18033,0.22347,1,0
4,GO VIRION ASSEMBLY,0.0016129,0.1799,0.14198,1,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.033166,0.17918,0.25697,1,0
4,GO MEMBRANE DEPOLARIZATION,0.042857,0.17845,0.13582,1,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.004408,0.1783,0.18916,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.03245,0.17824,0.14511,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.03245,0.17823,0.14837,1,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.0028141,0.17784,0.15554,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.010506,0.1778,0.21318,1,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.016339,0.17776,0.14004,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0075304,0.17754,0.23338,1,0
4,GO NIK NF KAPPAB SIGNALING,0.0029794,0.17749,0.13803,1,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.019739,0.17734,0.17801,1,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.023205,0.17729,0.16739,1,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.049546,0.17707,0.14904,1,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.02166,0.17694,0.24375,1,0
4,GO VIRAL LIFE CYCLE,0.0029794,0.17671,0.13785,1,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.033894,0.17582,0.14059,1,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.029068,0.17556,0.18128,1,0
4,GO VASCULAR WOUND HEALING,0.033894,0.17554,0.29142,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.011047,0.17523,0.15433,1,0
4,GO LIPID IMPORT INTO CELL,0.04854,0.17515,0.18536,1,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.02268,0.17476,0.1793,1,0
4,GO INTERACTION WITH HOST,0.0039469,0.17377,0.15276,1,0
4,GO ERAD PATHWAY,0.0085714,0.17308,0.13569,1,0
4,GO DNA DEAMINATION,0.04854,0.17275,0.19492,1,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0028141,0.17205,0.18271,1,0
4,GO ACETYL COA METABOLIC PROCESS,0.04854,0.17187,0.13901,1,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.023741,0.17156,0.21375,1,0
4,GO SELECTIVE AUTOPHAGY,0.00052342,0.17151,0.2043,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0083534,0.17134,0.11959,1,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.05161,0.17119,0.2327,1,0
4,GO OLIGODENDROCYTE DEVELOPMENT,0.015203,0.17064,0.15435,1,0
4,GO SKIN DEVELOPMENT,0.0021689,0.17044,0.15286,1,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0030654,0.16956,0.18477,1,0
4,GO REGULATION OF CELLULAR RESPIRATION,0.036164,0.16947,0.20013,1,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0028957,0.16919,0.17923,1,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0021689,0.16915,0.20802,1,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.036164,0.16911,0.11644,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.001872,0.16856,0.15518,1,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.045624,0.16853,0.085663,1,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.031748,0.16754,0.11893,1,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0050528,0.16743,0.24276,1,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.010773,0.16681,0.13668,1,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.024846,0.16677,0.13057,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.018836,0.16673,0.17915,1,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0045306,0.16597,0.25851,1,0
4,GO ANIMAL ORGAN REGENERATION,0.0081404,0.16579,0.14485,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0064317,0.16507,0.17376,1,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0099891,0.16491,0.19926,1,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0036303,0.1645,0.19015,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0081404,0.16432,0.15698,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.010506,0.16276,0.20762,1,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.029719,0.16268,0.13056,1,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0015653,0.1616,0.21477,1,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.015953,0.161,0.20307,1,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.047551,0.16045,0.18516,1,0
4,GO RESPONSE TO INSECTICIDE,0.023741,0.15947,0.27876,1,0
4,GO INTERFERON BETA PRODUCTION,0.020205,0.1591,0.13292,1,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.018398,0.15874,0.20738,1,0
4,GO COMPLEMENT ACTIVATION,0.036164,0.15869,0.1554,1,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0039469,0.15861,0.18463,1,0
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.027803,0.1586,0.20265,1,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.02843,0.15821,0.16053,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.050569,0.15808,0.10533,1,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.022165,0.15761,0.13184,1,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0022992,0.1565,0.16932,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.036164,0.1563,0.12862,1,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.012203,0.15615,0.20553,1,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.009256,0.15581,0.24584,1,0
4,GO DE NOVO PROTEIN FOLDING,0.0016129,0.15524,0.17719,1,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.015203,0.15515,0.21035,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.050569,0.15502,0.082719,1,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.012508,0.1538,0.14289,1,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.044685,0.15357,0.12551,1,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.011047,0.15335,0.13061,1,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.025414,0.15332,0.12531,1,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0028141,0.15251,0.15419,1,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0020453,0.15146,0.19937,1,0
4,GO T CELL APOPTOTIC PROCESS,0.040234,0.15121,0.12613,1,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.00353,0.15084,0.24769,1,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.017137,0.15081,0.10842,1,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.015953,0.15039,0.12896,1,0
4,GO PHAGOCYTOSIS,0.023741,0.15018,0.10914,1,0
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0027346,0.14993,0.14455,1,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.0073363,0.14935,0.11607,1,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.045624,0.14896,0.08754,1,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.036164,0.14802,0.12346,1,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00055855,0.14799,0.16052,1,0
4,GO VIRAL RELEASE FROM HOST CELL,0.0046564,0.14725,0.15961,1,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0049174,0.14694,0.19834,1,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0030654,0.14602,0.13162,1,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.034637,0.14591,0.13987,1,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.009256,0.14572,0.15066,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.011047,0.14378,0.14072,1,0
4,GO SYMBIOTIC PROCESS,0.0060989,0.14353,0.10162,1,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0010528,0.14286,0.16052,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0030654,0.1418,0.24956,1,0
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00025131,0.14125,0.16084,1,0
4,GO REGULATION OF STEROL TRANSPORT,0.014138,0.14094,0.14824,1,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.041093,0.14087,0.21542,1,0
4,GO MITOPHAGY,0.010773,0.14069,0.14588,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.034637,0.14046,0.12824,1,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.010773,0.14014,0.17579,1,0
4,GO REGULATION OF DENDRITE EXTENSION,0.02166,0.1401,0.28079,1,0
4,GO SPHINGOID METABOLIC PROCESS,0.010506,0.1393,0.22272,1,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.017549,0.13794,0.18246,1,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.033166,0.13776,0.11047,1,0
4,GO ZINC ION TRANSPORT,0.011326,0.13768,0.16873,1,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.049546,0.13755,0.16153,1,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.025414,0.13752,0.1488,1,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015953,0.13733,0.14701,1,0
4,GO REGULATION OF VASOCONSTRICTION,0.0062634,0.13653,0.1777,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016734,0.13628,0.21395,1,0
4,GO CHOLESTEROL EFFLUX,0.019739,0.13527,0.161,1,0
4,GO MAINTENANCE OF LOCATION,0.0094949,0.13503,0.10683,1,0
4,GO ENDOTHELIAL CELL MIGRATION,0.041093,0.13457,0.1215,1,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0049174,0.13391,0.1638,1,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.036948,0.13322,0.16853,1,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.040234,0.1331,0.28898,1,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.029068,0.13291,0.10024,1,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.03939,0.13281,0.15364,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.018398,0.13271,0.13807,1,0
4,GO CELLULAR RESPIRATION,0.013465,0.13199,0.15293,1,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.022165,0.13108,0.16467,1,0
4,GO NOTCH SIGNALING PATHWAY,0.004408,0.13085,0.13608,1,0
4,GO SPERM CAPACITATION,0.0069616,0.13052,0.20051,1,0
4,GO DRUG CATABOLIC PROCESS,0.02268,0.13028,0.18779,1,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.015953,0.12951,0.21193,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.04854,0.1295,0.12037,1,0
4,GO RESPONSE TO INTERLEUKIN 7,0.050569,0.12829,0.10275,1,0
4,GO CELL CELL RECOGNITION,0.016734,0.12724,0.13245,1,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.044685,0.12703,0.14437,1,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.030383,0.12694,0.13947,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0047853,0.12683,0.12809,1,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.041967,0.1267,0.18789,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0081404,0.12637,0.13181,1,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.0034322,0.12583,0.12405,1,0
4,GO PROTEASOME ASSEMBLY,0.016734,0.12571,0.14692,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.049546,0.12406,0.10959,1,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.023205,0.12386,0.10438,1,0
4,GO REGULATION OF VACUOLE ORGANIZATION,0.011326,0.12306,0.14446,1,0
4,GO OXIDATIVE PHOSPHORYLATION,0.017969,0.12298,0.15484,1,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.034637,0.12279,0.1293,1,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.013465,0.12213,0.14331,1,0
4,GO RESPONSE TO LEPTIN,0.031748,0.12209,0.17453,1,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.036164,0.12197,0.098166,1,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.031748,0.12008,0.10746,1,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.035393,0.12002,0.28548,1,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.0021689,0.11948,0.17001,1,0
4,GO MAINTENANCE OF LOCATION IN CELL,0.0060989,0.11945,0.10565,1,0
4,GO GLOMERULUS DEVELOPMENT,0.038561,0.1192,0.13791,1,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.013465,0.1187,0.12248,1,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00353,0.11648,0.11052,1,0
4,GO ORGANELLE INHERITANCE,0.013139,0.11621,0.10519,1,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.0028957,0.11597,0.12965,1,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014486,0.11534,0.20607,1,0
4,GO THIOESTER METABOLIC PROCESS,0.0049174,0.11519,0.16383,1,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.035393,0.11428,0.19144,1,0
4,GO REGULATION OF PROTEIN MATURATION,0.045624,0.11365,0.098719,1,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.050569,0.11358,0.15553,1,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.027188,0.11286,0.10746,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.012508,0.11266,0.11149,1,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.031748,0.11148,0.1106,1,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.014841,0.11114,0.17507,1,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.03939,0.11076,0.095224,1,0
4,GO CYTOKINETIC PROCESS,0.046579,0.11062,0.095748,1,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.03245,0.1106,0.080867,1,0
4,GO STEROL IMPORT,0.037747,0.11024,0.2157,1,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.014138,0.10979,0.12612,1,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.038561,0.1091,0.13903,1,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.027803,0.10902,0.12559,1,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.031748,0.10796,0.11468,1,0
4,GO POSITIVE T CELL SELECTION,0.0066042,0.10739,0.11536,1,0
4,GO RESPONSE TO MISFOLDED PROTEIN,0.024288,0.10714,0.15451,1,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.038561,0.10577,0.12822,1,0
4,GO RESPONSE TO OXYGEN RADICAL,0.013139,0.1056,0.15137,1,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.023741,0.10518,0.11182,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0056288,0.10491,0.11323,1,0
4,GO AMINE CATABOLIC PROCESS,0.035393,0.10464,0.23965,1,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.01282,0.10452,0.11457,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.013139,0.10414,0.15476,1,0
4,GO ATP METABOLIC PROCESS,0.019739,0.10359,0.11022,1,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.049546,0.10336,0.11283,1,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.042857,0.10272,0.12079,1,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.0075304,0.10121,0.11817,1,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.020205,0.10046,0.09941,1,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.025994,0.099777,0.10028,1,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.027188,0.099634,0.16772,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00084609,0.099376,0.12572,1,0
4,GO PROTEIN CATABOLIC PROCESS,0.0040578,0.09857,0.093498,1,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.019283,0.09854,0.088967,1,0
4,GO URONIC ACID METABOLIC PROCESS,0.042857,0.098422,0.13137,1,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.049546,0.098326,0.09127,1,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.031748,0.097972,0.15852,1,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.001986,0.097957,0.099021,1,0
4,GO TRICARBOXYLIC ACID CYCLE,0.038561,0.097923,0.19569,1,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.045624,0.097895,0.13687,1,0
4,GO SPERM EGG RECOGNITION,0.02268,0.097501,0.11511,1,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.019283,0.09503,0.17374,1,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.024846,0.094829,0.094671,1,0
4,GO TOXIN TRANSPORT,0.046579,0.094751,0.1406,1,0
4,GO CELLULAR SENESCENCE,0.016734,0.093098,0.093146,1,0
4,GO VACUOLAR TRANSPORT,0.0067808,0.092025,0.13459,1,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.05161,0.09192,0.1085,1,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.052669,0.09178,0.086741,1,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.017137,0.091521,0.15995,1,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0037331,0.091289,0.11363,1,0
4,GO AEROBIC RESPIRATION,0.010245,0.090649,0.18198,1,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.025414,0.089631,0.063804,1,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.037747,0.089531,0.13991,1,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.018836,0.089218,0.16186,1,0
4,GO PROTEIN POLYUBIQUITINATION,0.00059588,0.088812,0.10325,1,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.038561,0.088208,0.098473,1,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.01282,0.087206,0.14281,1,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.023205,0.086976,0.060626,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.017969,0.086123,0.078566,1,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.020205,0.085655,0.099941,1,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.050569,0.085226,0.13045,1,0
4,GO CELL AGING,0.030383,0.083612,0.07908,1,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.034637,0.082727,0.088638,1,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.031748,0.082419,0.1166,1,0
4,GO PROTEIN FOLDING,0.025414,0.081151,0.11429,1,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.053746,0.079228,0.11728,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.012203,0.079081,0.11839,1,0
4,GO ENDOSOMAL TRANSPORT,0.0034322,0.078663,0.088482,1,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.036164,0.078546,0.10047,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.030383,0.078293,0.095488,1,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.043763,0.077522,0.089207,1,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.041967,0.076955,0.12686,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.043763,0.074822,0.091599,1,0
4,GO POLYOL METABOLIC PROCESS,0.045624,0.073453,0.0986,1,0
4,GO MYELOID CELL HOMEOSTASIS,0.018398,0.072106,0.10372,1,0
4,GO LYSOSOMAL TRANSPORT,0.029068,0.070243,0.12701,1,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.033166,0.069333,0.062123,1,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.052669,0.066927,0.13919,1,0
4,GO PROTEIN TARGETING TO VACUOLE,0.038561,0.06184,0.12533,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.018836,0.059997,0.087956,1,0
4,GO MACROAUTOPHAGY,0.0023671,0.059919,0.12053,1,0
4,GO REGULATION OF CATABOLIC PROCESS,0.045624,0.059871,0.062066,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.038561,0.059548,0.069751,1,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.041093,0.054812,0.049397,1,0
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0094949,0.052568,0.072943,1,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.041967,0.052073,0.066478,1,0
4,GO PROTEIN STABILIZATION,0.053746,0.05099,0.074659,1,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.029068,0.04984,0.15539,1,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.015953,0.048722,0.069849,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.017969,0.047865,0.050008,1,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.036948,0.04613,0.069987,1,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.042857,0.045244,0.077283,1,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.044685,0.045093,0.10351,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.029719,0.043911,0.090728,1,0
4,GO GOLGI VESICLE TRANSPORT,0.035393,0.031774,0.090812,1,0
4,GO REGULATION OF MACROAUTOPHAGY,0.025414,0.029753,0.091929,1,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.031748,-0.027699,-0.042205,1,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.049546,-0.039987,-0.053294,1,0
4,GO CHROMATIN ORGANIZATION,0.017137,-0.042201,-0.056505,1,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.02068,-0.045618,-0.081052,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.017137,-0.048006,-0.061701,1,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.034637,-0.048567,-0.054378,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.025994,-0.050154,-0.073937,1,0
4,GO CHROMOSOME ORGANIZATION,0.027188,-0.052348,-0.046704,1,0
4,GO REGULATION OF RNA SPLICING,0.011047,-0.054545,-0.068976,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.029068,-0.064015,-0.086252,1,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.018398,-0.064389,-0.11254,1,0
4,GO PEPTIDYL LYSINE METHYLATION,0.030383,-0.066973,-0.067572,1,0
4,GO SPINDLE LOCALIZATION,0.02268,-0.067106,-0.090594,1,0
4,GO DNA GEOMETRIC CHANGE,0.014841,-0.067792,-0.093908,1,0
4,GO MRNA PROCESSING,0.0057817,-0.068111,-0.077346,1,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.050569,-0.06831,-0.093971,1,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.013798,-0.070864,-0.12886,1,0
4,GO RECOMBINATIONAL REPAIR,0.017137,-0.072603,-0.090423,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.014138,-0.07497,-0.086278,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.010773,-0.075353,-0.098817,1,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.050569,-0.077229,-0.087258,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.0094949,-0.078775,-0.13751,1,0
4,GO MRNA 3 END PROCESSING,0.036164,-0.080111,-0.08344,1,0
4,GO DNA CONFORMATION CHANGE,0.0083534,-0.080599,-0.079058,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0051916,-0.080634,-0.090106,1,0
4,GO CELL CYCLE DNA REPLICATION,0.011047,-0.080856,-0.12016,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.044685,-0.081362,-0.094421,1,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.0079323,-0.082316,-0.072069,1,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011904,-0.084249,-0.10523,1,0
4,GO CELL PROJECTION ORGANIZATION,0.045624,-0.084935,-0.072892,1,0
4,GO CELL DIVISION,0.010506,-0.084949,-0.070963,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014841,-0.085342,-0.091593,1,0
4,GO HEAD DEVELOPMENT,0.046579,-0.085839,-0.070097,1,0
4,GO RNA SPLICING,0.0015653,-0.087869,-0.094453,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0041716,-0.088532,-0.096752,1,0
4,GO BASE EXCISION REPAIR,0.013139,-0.09013,-0.099782,1,0
4,GO NUCLEOSOME ORGANIZATION,0.0028957,-0.091677,-0.11759,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.035393,-0.091808,-0.15962,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.030383,-0.09226,-0.10493,1,0
4,GO STRESS GRANULE ASSEMBLY,0.03939,-0.094838,-0.11873,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0040578,-0.095354,-0.097358,1,0
4,GO MUSCLE FILAMENT SLIDING,0.025414,-0.095402,-0.18906,1,0
4,GO DNA REPLICATION,0.0094949,-0.095889,-0.086444,1,0
4,GO CELLULAR RESPONSE TO X RAY,0.0073363,-0.096077,-0.21127,1,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.02268,-0.096314,-0.15055,1,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.013139,-0.096581,-0.14652,1,0
4,GO CHROMOSOME SEGREGATION,0.011326,-0.0972,-0.071875,1,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.033166,-0.09733,-0.081317,1,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033894,-0.098672,-0.20191,1,0
4,GO RNA STABILIZATION,0.052669,-0.10006,-0.10074,1,0
4,GO REGULATION OF DNA REPLICATION,0.041967,-0.10034,-0.071644,1,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0029794,-0.10036,-0.091061,1,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.035393,-0.10094,-0.071672,1,0
4,GO NEUROGENESIS,0.037747,-0.10129,-0.086218,1,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.018836,-0.10166,-0.10627,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.01282,-0.10173,-0.18384,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.031059,-0.10182,-0.084975,1,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.0037331,-0.1043,-0.1601,1,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.015953,-0.10591,-0.10371,1,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.033894,-0.10683,-0.095642,1,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.012508,-0.10831,-0.22011,1,0
4,GO L GLUTAMATE IMPORT,0.049546,-0.10966,-0.143,1,0
4,GO DNA REPLICATION INITIATION,0.0011549,-0.1105,-0.17035,1,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.041967,-0.11081,-0.12584,1,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.034637,-0.11113,-0.14438,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.038561,-0.11138,-0.075541,1,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.0079323,-0.11141,-0.095485,1,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.01282,-0.11202,-0.15198,1,0
4,GO DNA PACKAGING,0.0050528,-0.11295,-0.090719,1,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.029068,-0.11526,-0.13694,1,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.001872,-0.11583,-0.11555,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.00022676,-0.11585,-0.1288,1,0
4,GO CHROMOSOME CONDENSATION,0.0031536,-0.11723,-0.13185,1,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.05161,-0.11807,-0.12584,1,0
4,GO BONE MORPHOGENESIS,0.014841,-0.11894,-0.15681,1,0
4,GO HISTONE H3 K9 ACETYLATION,0.033894,-0.11948,-0.096869,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.025994,-0.12066,-0.14088,1,0
4,GO REGULATION OF ORGAN GROWTH,0.031748,-0.12104,-0.11347,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0006154,-0.12105,-0.11924,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023205,-0.12212,-0.14234,1,0
4,GO CHROMATIN REMODELING,0.00059588,-0.12218,-0.10389,1,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.019739,-0.12253,-0.12554,1,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.031748,-0.12334,-0.10156,1,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00098941,-0.12359,-0.10843,1,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.031748,-0.12485,-0.18624,1,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0081404,-0.12668,-0.1556,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.015574,-0.12882,-0.18402,1,0
4,GO G0 TO G1 TRANSITION,0.0030654,-0.12892,-0.14434,1,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0062634,-0.12961,-0.15071,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0024367,-0.12993,-0.14036,1,0
4,GO CENTRIOLE ASSEMBLY,0.017549,-0.13039,-0.10033,1,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03939,-0.13056,-0.14808,1,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.052669,-0.13079,-0.097707,1,0
4,GO APPENDAGE DEVELOPMENT,0.014486,-0.13134,-0.1213,1,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.021165,-0.13171,-0.090098,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0060989,-0.13265,-0.13584,1,0
4,GO STEM CELL PROLIFERATION,0.037747,-0.13328,-0.095583,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.012203,-0.13422,-0.17536,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.011612,-0.13455,-0.13821,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0064317,-0.13478,-0.13691,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0083534,-0.13535,-0.17404,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,5.6174e-05,-0.13577,-0.14515,1,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0032441,-0.1359,-0.13543,1,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0099891,-0.13635,-0.15199,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.0046564,-0.13722,-0.19245,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0014299,-0.13725,-0.11811,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0023671,-0.14068,-0.14994,1,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0059384,-0.14116,-0.17847,1,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0024367,-0.14176,-0.16751,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.038561,-0.14318,-0.12537,1,0
4,GO FOREBRAIN DEVELOPMENT,0.0033369,-0.14352,-0.12118,1,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.050569,-0.14371,-0.098525,1,0
4,GO HISTONE EXCHANGE,0.009256,-0.14457,-0.12237,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0054795,-0.14506,-0.12933,1,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,5.6174e-05,-0.14507,-0.13134,1,0
4,GO REGULATION OF MYELINATION,0.00063551,-0.14533,-0.17066,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0094949,-0.14586,-0.18375,1,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0017641,-0.14613,-0.14667,1,0
4,GO REGULATION OF MRNA PROCESSING,0.00029782,-0.14619,-0.12279,1,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0087944,-0.14655,-0.14329,1,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.025414,-0.14657,-0.11269,1,0
4,GO DNA REPLICATION CHECKPOINT,0.0027346,-0.14707,-0.17776,1,0
4,GO REPLICATION FORK PROCESSING,0.012203,-0.14812,-0.15968,1,0
4,GO NEURAL CREST CELL MIGRATION,0.0071468,-0.14829,-0.23401,1,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.016734,-0.14905,-0.16546,1,0
4,GO NUCLEOSOME ASSEMBLY,0.02843,-0.15041,-0.11592,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0056288,-0.15063,-0.11383,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.01282,-0.15149,-0.18723,1,0
4,GO PROTEIN DEMETHYLATION,0.0025083,-0.152,-0.17269,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.025994,-0.1538,-0.18763,1,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.03245,-0.15384,-0.21141,1,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.033166,-0.15411,-0.1384,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.049546,-0.1543,-0.24029,1,0
4,GO HISTONE H3 K27 METHYLATION,0.0038387,-0.1546,-0.17271,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0071468,-0.15545,-0.1592,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0099891,-0.15601,-0.17613,1,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.01282,-0.15603,-0.13138,1,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.046579,-0.15716,-0.1301,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.040234,-0.15718,-0.12546,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00054072,-0.15905,-0.13859,1,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.02166,-0.15921,-0.1124,1,0
4,GO NEURAL TUBE PATTERNING,0.0039469,-0.16047,-0.18367,1,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.013465,-0.16102,-0.24814,1,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0020453,-0.1624,-0.29811,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0001165,-0.16383,-0.15955,1,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00049035,-0.16468,-0.15938,1,0
4,GO REGULATION OF HEART GROWTH,0.0056288,-0.16494,-0.15208,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0051916,-0.16646,-0.11023,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00067758,-0.16695,-0.13105,1,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0085714,-0.16741,-0.13629,1,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0025817,-0.16788,-0.22463,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00042998,-0.16881,-0.14588,1,0
4,GO HISTONE H4 DEACETYLATION,0.018836,-0.16912,-0.1855,1,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0016129,-0.16925,-0.20523,1,0
4,GO LYMPHANGIOGENESIS,0.013465,-0.16959,-0.2091,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0050528,-0.16973,-0.18001,1,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.02166,-0.17047,-0.12744,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0010528,-0.17444,-0.12794,1,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.052669,-0.17568,-0.26318,1,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.014138,-0.17598,-0.15542,1,0
4,GO AXIS ELONGATION,0.040234,-0.1761,-0.16886,1,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.0028957,-0.17622,-0.13696,1,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.035393,-0.17628,-0.2247,1,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0087944,-0.1768,-0.13037,1,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.017549,-0.17693,-0.13038,1,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0064317,-0.17726,-0.20317,1,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.007729,-0.18069,-0.21777,1,0
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0069616,-0.18175,-0.19166,1,0
4,GO MEMBRANE BIOGENESIS,0.044685,-0.18209,-0.16514,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.023205,-0.18427,-0.19745,1,0
4,GO HISTONE H4 K16 ACETYLATION,0.021165,-0.18486,-0.13515,1,0
4,GO NEURON PROJECTION REGENERATION,0.024288,-0.18675,-0.16213,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.001986,-0.18875,-0.23924,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.022165,-0.18905,-0.15381,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.017137,-0.18938,-0.24142,1,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00065623,-0.18989,-0.16055,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.001872,-0.19191,-0.18563,1,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.053746,-0.19279,-0.1649,1,0
4,GO REGULATION OF HIPPO SIGNALING,0.03245,-0.19294,-0.20944,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0090226,-0.19314,-0.17617,1,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.02268,-0.19323,-0.23358,1,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.013798,-0.19324,-0.18289,1,0
4,GO KINETOCHORE ORGANIZATION,0.013139,-0.19359,-0.16309,1,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0042883,-0.19374,-0.14332,1,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.053746,-0.19391,-0.30888,1,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.014138,-0.19392,-0.221,1,0
4,GO TRACHEA DEVELOPMENT,0.034637,-0.19401,-0.17891,1,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0032441,-0.19575,-0.14231,1,0
4,GO COCHLEA MORPHOGENESIS,0.0028141,-0.19654,-0.23798,1,0
4,GO KINETOCHORE ASSEMBLY,0.029068,-0.19911,-0.15885,1,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0036303,-0.20009,-0.185,1,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.036948,-0.20235,-0.1719,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.0013457,-0.20301,-0.21484,1,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.015953,-0.2045,-0.14344,1,0
4,GO SYNAPSE ORGANIZATION,0.02068,-0.2059,-0.14643,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.001228,-0.20671,-0.25153,1,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.027803,-0.20926,-0.19401,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.027803,-0.2102,-0.2004,1,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.013465,-0.21162,-0.20101,1,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.011047,-0.21173,-0.35667,1,0
4,GO MITOCHONDRION DISTRIBUTION,0.0097392,-0.21277,-0.15303,1,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0013872,-0.21379,-0.18709,1,0
4,GO NEURAL CREST FORMATION,0.03939,-0.21498,-0.19153,1,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.019739,-0.21503,-0.22492,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00017796,-0.21658,-0.2559,1,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.00029782,-0.2177,-0.21722,1,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.014841,-0.21872,-0.19993,1,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00095906,-0.22048,-0.18977,1,0
4,GO RESPONSE TO ACETYLCHOLINE,0.020205,-0.22125,-0.23483,1,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.0025817,-0.22143,-0.18571,1,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.012508,-0.22183,-0.27525,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.016339,-0.22252,-0.16647,1,0
4,GO CARDIOBLAST DIFFERENTIATION,0.001872,-0.22261,-0.3,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0025817,-0.22326,-0.28292,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.001662,-0.22369,-0.22703,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,2.9532e-05,-0.22695,-0.27773,1,0
4,GO PROSTATE GLAND GROWTH,0.033166,-0.22826,-0.20669,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.014486,-0.23169,-0.22083,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.0056288,-0.23199,-0.2566,1,0
4,GO COCHLEA DEVELOPMENT,0.0028141,-0.23271,-0.21418,1,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00098941,-0.23273,-0.32986,1,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0037331,-0.23509,-0.32516,1,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0099891,-0.23659,-0.23458,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.04854,-0.23874,-0.14364,1,0
4,GO BONE GROWTH,0.0013872,-0.23884,-0.29087,1,0
4,GO LEUKOCYTE AGGREGATION,0.05161,-0.23928,-0.27426,1,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.014486,-0.23931,-0.22502,1,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.03939,-0.2401,-0.18426,1,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.024846,-0.24045,-0.27726,1,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.014841,-0.24229,-0.1836,1,0
4,GO NEUROBLAST PROLIFERATION,0.00014418,-0.24291,-0.22943,1,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.001191,-0.24296,-0.20508,1,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00079435,-0.24299,-0.32092,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,8.1192e-05,-0.24308,-0.21767,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.011612,-0.24328,-0.23767,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0094949,-0.2434,-0.17083,1,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.014486,-0.24472,-0.1988,1,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,1.7118e-05,-0.24538,-0.33009,1,0
4,GO RECEPTOR CLUSTERING,0.00063551,-0.24547,-0.23892,1,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0025083,-0.24602,-0.33095,1,0
4,GO HIPPO SIGNALING,0.00055855,-0.24735,-0.28794,1,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.027803,-0.25636,-0.23089,1,0
4,GO BRAIN MORPHOGENESIS,0.00035231,-0.25668,-0.20978,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00016023,-0.25693,-0.21269,1,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.0010206,-0.2573,-0.21506,1,0
4,GO DNA LIGATION,0.0039469,-0.25733,-0.21068,1,0
4,GO POSTSYNAPSE ORGANIZATION,0.0007696,-0.25844,-0.22954,1,0
4,GO MRNA SPLICE SITE SELECTION,0.00057693,-0.25873,-0.22117,1,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.035393,-0.25968,-0.22727,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,4.1617e-05,-0.26014,-0.34741,1,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.011326,-0.26183,-0.17473,1,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.0006154,-0.26194,-0.45594,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00041602,-0.26501,-0.21202,1,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0022992,-0.26761,-0.18413,1,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0034322,-0.26896,-0.28092,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00054072,-0.26926,-0.26181,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,1.1493e-05,-0.27333,-0.31162,1,0
4,GO BONE TRABECULA FORMATION,0.011612,-0.27394,-0.39708,1,0
4,GO LATERAL MESODERM DEVELOPMENT,0.0021062,-0.27639,-0.34062,1,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.036164,-0.27801,-0.29127,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.045624,-0.27923,-0.15732,1,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.029719,-0.28201,-0.29205,1,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0034322,-0.28523,-0.31921,1,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.029719,-0.28732,-0.27326,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0039469,-0.28744,-0.3044,1,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.010245,-0.28925,-0.20151,1,0
4,GO NEURON PROJECTION ORGANIZATION,0.00081984,-0.29112,-0.23085,1,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.011612,-0.29113,-0.2458,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0028957,-0.29435,-0.22202,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0032441,-0.29602,-0.32057,1,0
4,GO DENDRITE SELF AVOIDANCE,0.0060989,-0.29787,-0.26756,1,0
4,GO DENDRITIC TRANSPORT,0.00038934,-0.29821,-0.31095,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00087311,-0.29981,-0.30936,1,0
4,GO RESPONSE TO L GLUTAMATE,0.0049174,-0.30437,-0.2984,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00010462,-0.30513,-0.37808,1,0
4,GO NEPHRON TUBULE FORMATION,0.0097392,-0.30669,-0.29811,1,0
4,GO FOREBRAIN REGIONALIZATION,0.0057817,-0.30889,-0.2502,1,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00025131,-0.30947,-0.27495,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.00011241,-0.31077,-0.28503,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0021062,-0.31187,-0.26088,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,7.3528e-06,-0.31294,-0.39063,1,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.010506,-0.31892,-0.22961,1,0
4,GO DENTATE GYRUS DEVELOPMENT,0.011904,-0.3199,-0.24393,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0027346,-0.32378,-0.31818,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00010092,-0.32416,-0.36743,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.026586,-0.32596,-0.29936,1,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0018173,-0.32692,-0.28101,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.001228,-0.32874,-0.33586,1,0
4,GO CHROMATIN DISASSEMBLY,1.7118e-05,-0.33013,-0.31117,1,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.004408,-0.33057,-0.31719,1,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.00040247,-0.34159,-0.29787,1,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0049174,-0.34682,-0.39027,1,0
4,GO MYOBLAST MIGRATION,0.0064317,-0.35045,-0.36247,1,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.00074557,-0.35087,-0.30571,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00018427,-0.35198,-0.39142,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00014418,-0.35231,-0.3677,1,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.0023671,-0.35291,-0.38146,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00019079,-0.35702,-0.37513,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,5.4121e-05,-0.36056,-0.38175,1,0
4,GO SYNAPTIC VESICLE MATURATION,0.024288,-0.36215,-0.22775,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,1.8521e-05,-0.37353,-0.48912,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0047853,-0.37583,-0.27303,1,0
4,GO HEART VALVE FORMATION,0.0056288,-0.37628,-0.33975,1,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.011612,-0.37635,-0.25179,1,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.011047,-0.3821,-0.34248,1,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.0006154,-0.38866,-0.40473,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.03245,-0.3992,-0.27265,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,8.4205e-05,-0.40257,-0.34502,1,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0039469,-0.40746,-0.40672,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,8.4205e-05,-0.40755,-0.46295,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,3.0689e-05,-0.41589,-0.37995,1,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00072223,-0.42569,-0.34896,1,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.010245,-0.42774,-0.34652,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.8251e-06,-0.43152,-0.52981,1,0
4,GO TONGUE MORPHOGENESIS,0.013798,-0.43224,-0.31883,1,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0022332,-0.43308,-0.449,1,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00010845,-0.45603,-0.45026,1,0
4,GO TELENCEPHALON REGIONALIZATION,0.0097392,-0.45818,-0.36885,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0011549,-0.46011,-0.39714,1,0
4,GO LIMB BUD FORMATION,0.0020453,-0.48537,-0.4094,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00054072,-0.50104,-0.39808,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,1.349e-05,-0.50373,-0.44079,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,3.0689e-05,-0.5251,-0.54096,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,3.8583e-05,-0.53612,-0.61558,1,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00022676,-0.54181,-0.47155,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,3.0689e-05,-0.55437,-0.53403,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.1888e-05,-0.56336,-0.63951,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,2.8418e-05,-0.58407,-0.5169,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,2.5308e-05,-0.59831,-0.58321,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,5.2139e-05,-0.6405,-0.61022,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,8.7323e-05,-0.64578,-0.77341,1,0
4,GO CARDIAC CHAMBER FORMATION,5.6174e-05,-0.67356,-0.58233,1,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0033369,-0.68927,-0.50338,1,0
4,GO CARDIAC VENTRICLE FORMATION,0.00010092,-0.73374,-0.60822,1,0
4,GO POSTSYNAPSE ASSEMBLY,0.00011241,-0.75716,-0.58507,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.2524e-05,-0.89578,-0.8249,1,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.073629,0.37664,0.3733,0,1
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.11039,0.3255,0.2258,0,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.072231,0.32137,0.24264,0,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.059411,0.31603,0.257,0,1
4,GO NADPH REGENERATION,0.15015,0.30417,0.14732,0,1
4,GO HEPARIN METABOLIC PROCESS,0.2,0.29268,0.12584,0,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.097379,0.29115,0.20162,0,1
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.15264,0.25365,0.092515,0,1
4,GO REGULATION OF RECEPTOR BINDING,0.1028,0.25344,0.16702,0,1
4,GO T CELL CYTOKINE PRODUCTION,0.068167,0.25196,0.1602,0,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.10465,0.24681,0.20644,0,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.065563,0.24281,0.11829,0,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.072231,0.24278,0.16074,0,1
4,GO LYSINE METABOLIC PROCESS,0.063042,0.23549,0.20068,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.13814,0.23518,0.17185,0,1
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13583,0.23368,0.13855,0,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.12259,0.23225,0.13963,0,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.084046,0.22897,0.13319,0,1
4,GO DETOXIFICATION,0.064293,0.22467,0.16182,0,1
4,GO PANCREATIC JUICE SECRETION,0.087232,0.22159,0.14169,0,1
4,GO FUCOSE METABOLIC PROCESS,0.18219,0.22121,0.19831,0,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.070855,0.21982,0.16093,0,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.19095,0.2167,0.13501,0,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.097379,0.2161,0.16143,0,1
4,GO PROTEIN KINASE C SIGNALING,0.064293,0.21255,0.14583,0,1
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.21256,0.20693,0.13535,0,1
4,GO GANGLIOSIDE METABOLIC PROCESS,0.088862,0.20543,0.11622,0,1
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.12049,0.20526,0.10458,0,1
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.072231,0.20036,0.1347,0,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.076492,0.19969,0.11671,0,1
4,GO DENDRITIC CELL MIGRATION,0.068167,0.19791,0.10528,0,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.084046,0.19533,0.18266,0,1
4,GO PODOSOME ASSEMBLY,0.29586,0.194,0.046862,0,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.085627,0.19201,0.12967,0,1
4,GO PARENTAL BEHAVIOR,0.057089,0.19182,0.2035,0,1
4,GO DRINKING BEHAVIOR,0.072231,0.19107,0.14082,0,1
4,GO REGULATION OF RESPONSE TO FOOD,0.18508,0.18361,0.060193,0,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.064293,0.18121,0.1038,0,1
4,GO ESTROGEN METABOLIC PROCESS,0.061812,0.18119,0.15407,0,1
4,GO INTERLEUKIN 13 PRODUCTION,0.14285,0.18082,0.10783,0,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11841,0.18012,0.061055,0,1
4,GO RESPONSE TO UV B,0.26471,0.17994,0.061762,0,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.20621,0.17991,0.078346,0,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.063042,0.17881,0.13354,0,1
4,GO NOREPINEPHRINE TRANSPORT,0.097379,0.17638,0.11809,0,1
4,GO PROTEIN ADP RIBOSYLATION,0.076492,0.17407,0.11401,0,1
4,GO PARAXIAL MESODERM DEVELOPMENT,0.19095,0.1732,0.10736,0,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.2,0.16967,0.11199,0,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.12049,0.16843,0.12208,0,1
4,GO RENAL WATER HOMEOSTASIS,0.24288,0.16828,0.046822,0,1
4,GO AMMONIUM TRANSPORT,0.16828,0.16649,0.073982,0,1
4,GO AMYLOID BETA FORMATION,0.093897,0.16401,0.12054,0,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.061812,0.16324,0.16304,0,1
4,GO CELLULAR EXTRAVASATION,0.10096,0.16255,0.076908,0,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.073629,0.1614,0.13246,0,1
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.14048,0.16114,0.097444,0,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.082489,0.15987,0.11091,0,1
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.093897,0.15983,0.11946,0,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.099158,0.15903,0.15749,0,1
4,GO REGULATION OF EXCRETION,0.40349,0.15872,0.058554,0,1
4,GO RESPONSE TO AMINE,0.40843,0.15816,0.052978,0,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.10845,0.15608,0.14622,0,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.17099,0.15595,0.14334,0,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.099158,0.1558,0.075408,0,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.075049,0.15443,0.085795,0,1
4,GO LAMELLIPODIUM MORPHOGENESIS,0.080955,0.15149,0.14632,0,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.073629,0.15071,0.076602,0,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.11434,0.15001,0.1178,0,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.061812,0.14822,0.089533,0,1
4,GO FIBROBLAST PROLIFERATION,0.12259,0.14784,0.086804,0,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.10654,0.14782,0.13409,0,1
4,GO ATP TRANSPORT,0.082489,0.14664,0.086181,0,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.40843,0.14661,0.067373,0,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.23245,0.14534,0.066076,0,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.14769,0.14518,0.10897,0,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.063042,0.14447,0.1031,0,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.32077,0.14403,0.052248,0,1
4,GO RESPONSE TO VITAMIN,0.56666,0.144,0.023806,0,1
4,GO CHLORIDE ION HOMEOSTASIS,0.14769,0.13986,0.094684,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.11841,0.13801,0.10627,0,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.073629,0.13753,0.070908,0,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.23937,0.13619,0.12643,0,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.47049,0.13359,0.089119,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.14048,0.13306,0.070047,0,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.19095,0.13232,0.050411,0,1
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26098,0.13179,0.077815,0,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.12908,0.13157,0.10754,0,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.095625,0.13142,0.096826,0,1
4,GO RESPONSE TO ESTRADIOL,0.16032,0.1296,0.05793,0,1
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.16294,0.12836,0.075247,0,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.054842,0.12727,0.12657,0,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.090515,0.12636,0.10241,0,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.15264,0.12507,0.14051,0,1
4,GO KERATINOCYTE MIGRATION,0.12908,0.12486,0.088252,0,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.073629,0.12354,0.10867,0,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.188,0.12295,0.061778,0,1
4,GO RESPONSE TO NITRIC OXIDE,0.088862,0.12225,0.065395,0,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.13355,0.12221,0.12318,0,1
4,GO BIOLOGICAL ADHESION,0.068167,0.12103,0.0833,0,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.059411,0.12098,0.12681,0,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.05824,0.1194,0.072511,0,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.19393,0.11695,0.065413,0,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.29586,0.11644,0.074083,0,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.15264,0.11618,0.085417,0,1
4,GO CARDIAC CONDUCTION,0.23937,0.11568,0.057402,0,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.057089,0.11538,0.072257,0,1
4,GO RESPONSE TO ZINC ION,0.11235,0.11453,0.15537,0,1
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.15517,0.11286,0.063461,0,1
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.085627,0.11191,0.11096,0,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.12259,0.11174,0.079733,0,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.068167,0.11088,0.11028,0,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.14285,0.11032,0.079577,0,1
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.27999,0.11008,0.037225,0,1
4,GO HEART PROCESS,0.10465,0.10908,0.068179,0,1
4,GO POTASSIUM ION HOMEOSTASIS,0.30815,0.10853,0.062933,0,1
4,GO TERPENOID METABOLIC PROCESS,0.077957,0.10774,0.12401,0,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.26471,0.10732,0.059626,0,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.068167,0.10686,0.073389,0,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.19393,0.10613,0.067157,0,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.079444,0.10584,0.077442,0,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.25001,0.10507,0.07332,0,1
4,GO KERATINOCYTE PROLIFERATION,0.075049,0.10478,0.095051,0,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.31232,0.10336,0.048062,0,1
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.47049,0.10251,0.04941,0,1
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.52594,0.10229,0.047542,0,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.090515,0.10054,0.067526,0,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.055956,0.10047,0.076384,0,1
4,GO INTERLEUKIN 4 PRODUCTION,0.21905,0.10025,0.087973,0,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.14769,0.10002,0.099264,0,1
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.12259,0.099789,0.060607,0,1
4,GO RESPONSE TO CAMP,0.12473,0.099053,0.10706,0,1
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.80989,0.098506,-0.0074468,0,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.070855,0.098169,0.10841,0,1
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.095625,0.097363,0.053247,0,1
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.14769,0.097034,0.10726,0,1
4,GO CELL MOTILITY,0.092194,0.096439,0.064928,0,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.12049,0.095875,0.051583,0,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.16559,0.09571,0.087574,0,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.05824,0.095617,0.072965,0,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.16032,0.095315,0.062168,0,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.15517,0.094685,0.055351,0,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.065563,0.094638,0.086805,0,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.20309,0.094152,0.090885,0,1
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.19695,0.09405,0.10876,0,1
4,GO NEGATIVE REGULATION OF SECRETION,0.099158,0.093619,0.061002,0,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.11841,0.093525,0.057514,0,1
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.38888,0.093061,0.015937,0,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.1028,0.09199,0.068305,0,1
4,GO VESICLE LOCALIZATION,0.060602,0.091012,0.088529,0,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.11434,0.089606,0.051186,0,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.21579,0.089125,0.042643,0,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.075049,0.088536,0.14383,0,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.26471,0.088369,0.063569,0,1
4,GO PEPTIDYL METHIONINE MODIFICATION,0.25001,0.087858,0.14784,0,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.073629,0.087372,0.127,0,1
4,GO REGULATION OF METAL ION TRANSPORT,0.2,0.086063,0.045102,0,1
4,GO ENDOCYTOSIS,0.17934,0.085587,0.05568,0,1
4,GO REPRODUCTION,0.061812,0.084408,0.052676,0,1
4,GO RESPONSE TO GLUCAGON,0.21256,0.084355,0.083687,0,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.054842,0.084218,0.074991,0,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.14769,0.084203,0.054436,0,1
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.60883,0.083941,0.010014,0,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.12908,0.0836,0.17064,0,1
4,GO PHOSPHATE ION TRANSPORT,0.17374,0.083012,0.068624,0,1
4,GO PROTEIN PALMITOYLATION,0.18219,0.082938,0.088586,0,1
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.2839,0.082188,0.07391,0,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.11039,0.08097,0.073048,0,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.072231,0.080916,0.051662,0,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.075049,0.080617,0.063868,0,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.33373,0.080467,0.062745,0,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.1313,0.078864,0.057613,0,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.060602,0.078139,0.075722,0,1
4,GO MULTI ORGANISM PROCESS,0.092194,0.078084,0.049666,0,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.24643,0.078007,0.044056,0,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.2,0.078,0.077022,0,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.25363,0.077202,0.038187,0,1
4,GO VISUAL BEHAVIOR,0.19393,0.076352,0.085336,0,1
4,GO PHOTOTRANSDUCTION,0.088862,0.075914,0.058743,0,1
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.20621,0.075427,0.087666,0,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.1028,0.073192,0.048944,0,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.12473,0.071887,0.046825,0,1
4,GO REGULATION OF SYSTEM PROCESS,0.17374,0.071569,0.049087,0,1
4,GO FEMALE SEX DIFFERENTIATION,0.26098,0.071405,0.039038,0,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.066855,0.070842,0.059069,0,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.20937,0.06942,0.046507,0,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.084046,0.069411,0.048405,0,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.21905,0.069147,0.046529,0,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.15264,0.067732,0.04409,0,1
4,GO TUBE DEVELOPMENT,0.188,0.067629,0.045474,0,1
4,GO DNA MODIFICATION,0.17099,0.067275,0.035121,0,1
4,GO CELL JUNCTION ASSEMBLY,0.32938,0.06715,0.04419,0,1
4,GO DEPHOSPHORYLATION,0.088862,0.067137,0.04752,0,1
4,GO MODIFIED AMINO ACID TRANSPORT,0.12473,0.06642,0.1042,0,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.11039,0.064879,0.073971,0,1
4,GO MESONEPHROS DEVELOPMENT,0.14769,0.06426,0.066729,0,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.090515,0.063625,0.057004,0,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.14526,0.061269,0.035667,0,1
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.44402,0.061205,0.042945,0,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.080955,0.060525,0.090441,0,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.13355,0.06041,0.034429,0,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.10845,0.059854,0.066852,0,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15517,0.059723,0.056982,0,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.057089,0.059009,0.074166,0,1
4,GO DEVELOPMENTAL MATURATION,0.23245,0.056617,0.054887,0,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.061812,0.056129,0.077521,0,1
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.21905,0.055846,0.026025,0,1
4,GO POSITIVE REGULATION OF BINDING,0.25363,0.055779,0.041735,0,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.1028,0.0554,0.057824,0,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.092194,0.055081,0.059654,0,1
4,GO RESPONSE TO LIGHT STIMULUS,0.4978,0.05274,0.0065245,0,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.23589,0.052218,0.047319,0,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.30402,0.051115,0.0508,0,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.24643,0.046934,0.039605,0,1
4,GO REGULATION OF GTPASE ACTIVITY,0.12259,0.045046,0.051039,0,1
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.095625,0.043456,0.048481,0,1
4,GO RESPONSE TO RADIATION,0.24288,0.042581,0.021539,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.29992,0.040691,0.027372,0,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.14526,0.039763,0.038851,0,1
4,GO VITAMIN CATABOLIC PROCESS,0.17374,0.03947,0.18173,0,1
4,GO DNA METHYLATION OR DEMETHYLATION,0.30815,0.038123,0.026958,0,1
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.36526,0.037755,0.036835,0,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.22235,0.035328,0.027084,0,1
4,GO REGULATION OF GROWTH,0.36991,0.034819,0.026756,0,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.082489,0.50479,0.34462,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.085627,0.44747,0.2993,0,0
4,GO LEYDIG CELL DIFFERENTIATION,0.0014299,0.42624,0.45041,0,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.007729,0.4232,0.37467,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.001191,0.3998,0.33076,0,0
4,GO CYSTEINE METABOLIC PROCESS,0.19695,0.38533,0.24468,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.11039,0.36123,0.21777,0,0
4,GO PHOSPHOLIPID EFFLUX,0.00072223,0.33175,0.36054,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.13814,0.32941,0.17551,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.010245,0.30555,0.2817,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.12473,0.28713,0.14866,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.12689,0.2751,0.13813,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.007729,0.27288,0.23467,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.017549,0.26707,0.32422,0,0
4,GO MALE MEIOSIS I,0.093897,0.26686,0.17779,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.041093,0.26414,0.16754,0,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.14526,0.26178,0.14818,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.065563,0.25532,0.18178,0,0
4,GO BEHAVIORAL RESPONSE TO PAIN,0.084046,0.25296,0.16667,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.055956,0.25258,0.2153,0,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.17099,0.24757,0.1545,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.17099,0.24755,0.15245,0,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.10096,0.24704,0.1427,0,0
4,GO RESPONSE TO HISTAMINE,0.070855,0.24619,0.26404,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.10096,0.24426,0.1144,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.027803,0.24356,0.24061,0,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.1028,0.24193,0.10627,0,0
4,GO PROTEIN HYDROXYLATION,0.017549,0.24171,0.22805,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.066855,0.23991,0.20764,0,0
4,GO HEART INDUCTION,0.14769,0.23948,0.18854,0,0
4,GO REGULATION OF TRANSPOSITION,0.0695,0.2383,0.16227,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.22235,0.23763,0.12991,0,0
4,GO EPOXYGENASE P450 PATHWAY,0.059411,0.23366,0.17836,0,0
4,GO LIPOXYGENASE PATHWAY,0.079444,0.23157,0.19784,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.084046,0.23149,0.15646,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,0.23125,0.068359,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.019739,0.23111,0.23901,0,0
4,GO MYELIN MAINTENANCE,0.068167,0.23102,0.19485,0,0
4,GO CAMP BIOSYNTHETIC PROCESS,0.072231,0.23005,0.1697,0,0
4,GO RESPONSE TO WATER,0.10096,0.22601,0.1559,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.068167,0.22442,0.21967,0,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.10845,0.223,0.099517,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.018836,0.22173,0.32539,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0028957,0.22091,0.2948,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.082489,0.2204,0.16504,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.31232,0.21726,0.076349,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0695,0.21661,0.17819,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.17934,0.21601,0.10167,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.10654,0.21576,0.11523,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.27999,0.2096,0.12454,0,0
4,GO RESPONSE TO FORSKOLIN,0.12473,0.20939,0.1734,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18508,0.20726,0.12757,0,0
4,GO ENAMEL MINERALIZATION,0.16294,0.20554,0.14451,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.14048,0.20546,0.18456,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.15773,0.20469,0.15001,0,0
4,GO PROTEIN ACTIVATION CASCADE,0.054842,0.20135,0.22915,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10465,0.20131,0.19553,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.37932,0.20051,0.082552,0,0
4,GO TYPE 2 IMMUNE RESPONSE,0.070855,0.19941,0.1336,0,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.05824,0.19639,0.15223,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.2,0.19508,0.17219,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.76281,0.19451,0.016745,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.40843,0.19428,0.0022373,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.97557,0.19352,-0.045521,0,0
4,GO RECEPTOR CATABOLIC PROCESS,0.076492,0.19254,0.093854,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.26098,0.19234,0.12466,0,0
4,GO CYTOLYSIS,0.076492,0.19213,0.12886,0,0
4,GO MIDGUT DEVELOPMENT,0.064293,0.19175,0.21509,0,0
4,GO AMYLOID FIBRIL FORMATION,0.063042,0.19106,0.15011,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.17374,0.18968,0.059114,0,0
4,GO INCLUSION BODY ASSEMBLY,0.040234,0.18901,0.21036,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.10654,0.18832,0.13277,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.0695,0.18728,0.10533,0,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.065563,0.18588,0.12482,0,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.17374,0.18339,0.12164,0,0
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.077957,0.18095,0.12859,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0069616,0.18094,0.28406,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.12908,0.18057,0.14323,0,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.23937,0.17549,0.10775,0,0
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.11039,0.17545,0.18175,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.1028,0.17477,0.12112,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.05824,0.17434,0.11526,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.1313,0.17389,0.10485,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.065563,0.17307,0.16042,0,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.079444,0.17294,0.10935,0,0
4,GO PINOCYTOSIS,0.14285,0.17254,0.056638,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.29992,0.17219,0.14856,0,0
4,GO OXYGEN TRANSPORT,0.78962,0.17191,-0.00024988,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.53742,0.1719,-0.0061349,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.35607,0.17117,0.044585,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.4978,0.17113,0.099032,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.072231,0.16828,0.17792,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.072231,0.16817,0.13378,0,0
4,GO CAMP METABOLIC PROCESS,0.25363,0.16804,0.1073,0,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.059411,0.16776,0.13194,0,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.029719,0.16741,0.17593,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.20309,0.16724,0.092401,0,0
4,GO ARGININE METABOLIC PROCESS,0.064293,0.1671,0.28706,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.072231,0.1667,0.22246,0,0
4,GO STORE OPERATED CALCIUM ENTRY,0.42347,0.16443,0.091316,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.060602,0.16434,0.14724,0,0
4,GO LACTATE METABOLIC PROCESS,0.16559,0.16432,0.087028,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.064293,0.16391,0.21399,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.68418,0.16318,0.050046,0,0
4,GO REGULATION OF ACROSOME REACTION,0.092194,0.16186,0.25642,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.27227,0.16119,0.087262,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.076492,0.1592,0.1189,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.48131,0.15901,0.038377,0,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.088862,0.15856,0.14498,0,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.52025,0.15842,0.0011408,0,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.065563,0.15839,0.12499,0,0
4,GO PROTEIN OXIDATION,0.18508,0.15749,0.071848,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.23245,0.15673,0.12427,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.10096,0.15668,0.13131,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.17374,0.15619,0.083076,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.30815,0.15611,0.098159,0,0
4,GO GLIAL CELL PROLIFERATION,0.20937,0.15542,0.099931,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.090515,0.15531,0.10236,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.092194,0.15468,0.095787,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.38888,0.15442,0.14246,0,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.066855,0.15382,0.095927,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.43367,0.15343,0.055515,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.26847,0.15326,0.10344,0,0
4,GO GLIAL CELL ACTIVATION,0.20621,0.15285,0.065538,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.34256,0.15243,0.057443,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.095625,0.15231,0.067918,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.19095,0.15187,0.090166,0,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.17934,0.15161,0.1546,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.15264,0.15131,0.070691,0,0
4,GO RESPONSE TO LEUCINE,0.068167,0.15121,0.18534,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.30402,0.15114,0.1083,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.060602,0.15102,0.17803,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.24288,0.15065,0.092652,0,0
4,GO MIDBODY ABSCISSION,0.0022332,0.15021,0.22625,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.19393,0.14861,0.089203,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.22235,0.14847,0.048921,0,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.32506,0.14841,0.12013,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.054842,0.14834,0.14022,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.057089,0.14824,0.094834,0,0
4,GO CELL MATRIX ADHESION,0.05824,0.14791,0.095455,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.30815,0.14772,0.066577,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.068167,0.14768,0.14751,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.30815,0.14697,0.057577,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.26098,0.14695,0.062692,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.16828,0.14691,0.077425,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.19695,0.14668,0.085744,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.11039,0.14545,0.11806,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.10654,0.145,0.13343,0,0
4,GO ANION HOMEOSTASIS,0.14048,0.145,0.10493,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.054842,0.14454,0.11241,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041967,0.14419,0.17714,0,0
4,GO RNA 5 END PROCESSING,0.18219,0.14367,0.080534,0,0
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.29992,0.14312,0.066546,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.023205,0.14296,0.19617,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.15517,0.14282,0.091259,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.097379,0.1426,0.20167,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.12049,0.14248,0.10755,0,0
4,GO RESPONSE TO HYPEROXIA,0.34702,0.14234,0.035863,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.092194,0.14182,0.12285,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.085627,0.14179,0.13217,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.1028,0.14109,0.1492,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.23245,0.14104,0.098155,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.21579,0.1409,0.1613,0,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.49227,0.14039,0.0087122,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.070855,0.14039,0.14187,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.42855,0.14035,0.060532,0,0
4,GO PIGMENT ACCUMULATION,0.14285,0.14031,0.087171,0,0
4,GO RESPONSE TO LIGHT INTENSITY,0.15015,0.14031,0.08595,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.57857,0.13975,-0.01812,0,0
4,GO STRIATED MUSCLE ADAPTATION,0.070855,0.13962,0.13469,0,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.079444,0.13913,0.18647,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.11841,0.13912,0.24801,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.029068,0.13908,0.22024,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.29992,0.13874,0.063287,0,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.076492,0.13859,0.20125,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.52594,0.1384,0.093453,0,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.061812,0.13794,0.10172,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.057089,0.13786,0.16522,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.21905,0.13778,0.20306,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.065563,0.13748,0.089202,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.97557,0.13718,-0.021315,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.16294,0.13676,0.1433,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.30815,0.13671,0.041346,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.48131,0.13658,0.024753,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.73628,0.13634,0.011786,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.055956,0.13618,0.10299,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.26471,0.13582,0.061919,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.19095,0.13546,0.10212,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.084046,0.13531,0.1628,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.065563,0.13528,0.1888,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.090515,0.1352,0.14564,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.2,0.13512,0.12445,0,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.21256,0.13485,0.055265,0,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.14285,0.13419,0.11229,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.020205,0.13388,0.11506,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.10465,0.13352,0.12304,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.33812,0.13323,0.089786,0,0
4,GO MEMBRANE FISSION,0.18219,0.13252,0.10696,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.099158,0.13238,0.13195,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.29184,0.13168,0.057365,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.12049,0.13102,0.12266,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.23589,0.13036,0.04982,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.15517,0.13017,0.14853,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.11235,0.12999,0.20538,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.0695,0.12954,0.12695,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.71006,0.12935,-0.027296,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.1313,0.12906,0.13663,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.60883,0.12871,-0.0039361,0,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.084046,0.12844,0.14355,0,0
4,GO GLYCINE TRANSPORT,0.36526,0.1284,0.11893,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.2,0.12815,0.053456,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.66501,0.12764,0.034596,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.075049,0.12763,0.1044,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.21256,0.12746,0.12925,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.095625,0.12695,0.19869,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.23589,0.12659,0.072955,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.12049,0.12641,0.11756,0,0
4,GO NOREPINEPHRINE SECRETION,0.27611,0.12619,0.095261,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.21905,0.1257,0.039138,0,0
4,GO RESPONSE TO ESTROGEN,0.47049,0.12569,0.039231,0,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.064293,0.12569,0.10498,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.059411,0.12519,0.10877,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.15773,0.12495,0.089213,0,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.15015,0.12495,0.066019,0,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.14285,0.12426,0.18311,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.05824,0.12393,0.090293,0,0
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.070855,0.1239,0.12337,0,0
4,GO FATTY ACID HOMEOSTASIS,0.27611,0.12384,0.1026,0,0
4,GO RNA INTERFERENCE,0.17653,0.12339,0.082075,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.26847,0.12299,0.089408,0,0
4,GO MUSCLE CELL PROLIFERATION,0.057089,0.12276,0.079094,0,0
4,GO MITOTIC DNA REPLICATION,0.23589,0.12255,0.069696,0,0
4,GO REGULATION OF DNA METHYLATION,0.27999,0.12251,0.052563,0,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.079444,0.1224,0.118,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.082489,0.12197,0.077892,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.075049,0.12192,0.064717,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.37932,0.12189,0.084647,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.11434,0.12127,0.052707,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.22905,0.12115,0.11932,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.055956,0.12113,0.097131,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.1313,0.12104,0.10961,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.25363,0.12061,0.024895,0,0
4,GO FIBRINOLYSIS,0.38408,0.12057,0.17139,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.12473,0.1204,0.0859,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.46512,0.12031,0.046238,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.40843,0.12003,0.085572,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.12049,0.11974,0.13039,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.23245,0.11902,0.20252,0,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.64605,0.11876,0.066765,0,0
4,GO MACROPHAGE MIGRATION,0.11841,0.11855,0.07081,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.61497,0.11829,0.037599,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.13355,0.11807,0.10933,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.10845,0.11771,0.10858,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.099158,0.11731,0.067123,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.095625,0.11705,0.06979,0,0
4,GO ERBB SIGNALING PATHWAY,0.21256,0.11667,0.072396,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.35153,0.11644,0.094123,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.56075,0.11626,0.039684,0,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.063042,0.11624,0.13819,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.064293,0.116,0.13524,0,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.22905,0.11593,0.056461,0,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.088862,0.11552,0.083918,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.46512,0.11543,0.050948,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.033166,0.11525,0.20226,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.80312,0.11514,-0.019261,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.15264,0.1149,0.048316,0,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.05824,0.11488,0.10632,0,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.12689,0.11487,0.14488,0,0
4,GO LYMPH NODE DEVELOPMENT,0.026586,0.11476,0.17387,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.085627,0.11468,0.099509,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.26847,0.11457,0.053939,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.20309,0.11423,0.097027,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.20309,0.11402,0.063507,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.3746,0.11392,0.036676,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.30815,0.11373,0.085864,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.85082,0.11352,0.0053885,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.44402,0.11352,0.052085,0,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.10654,0.11344,0.087374,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.20937,0.11336,0.046746,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.15773,0.11335,0.10467,0,0
4,GO MACROPHAGE CHEMOTAXIS,0.095625,0.11289,0.069715,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.060602,0.11281,0.15433,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.063042,0.11244,0.14107,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.46512,0.11239,-0.0033436,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.12908,0.11209,0.1157,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.15517,0.11207,0.068421,0,0
4,GO PYRUVATE METABOLIC PROCESS,0.070855,0.11206,0.09372,0,0
4,GO DNA DEMETHYLATION,0.33373,0.11146,0.047891,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.29992,0.11137,0.051442,0,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.080955,0.11126,0.13697,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.17374,0.11096,0.068221,0,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.16828,0.11083,0.081615,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.17934,0.11082,0.15869,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.17374,0.11076,0.088695,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.74288,0.11037,0.037762,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.43883,0.11031,0.014915,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.1313,0.11025,0.1035,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.057089,0.11002,0.074425,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.34256,0.10962,0.068334,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.059411,0.10926,0.11486,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.25729,0.10925,0.10053,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.13814,0.10911,0.090512,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.060602,0.10908,0.11782,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.18508,0.10878,0.082573,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.060602,0.10851,0.12802,0,0
4,GO REGENERATION,0.31653,0.10809,0.029357,0,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.19095,0.10804,0.14619,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.11039,0.10797,0.090154,0,0
4,GO AXONEME ASSEMBLY,0.14526,0.10775,0.093382,0,0
4,GO REGULATION OF HAIR CYCLE,0.080955,0.1077,0.12125,0,0
4,GO COPPER ION HOMEOSTASIS,0.2,0.10731,0.093549,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.2,0.10727,0.11002,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.30815,0.10718,0.083669,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.66501,0.10698,0.037025,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.11841,0.10676,0.095466,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.14285,0.10628,0.063885,0,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.076492,0.10618,0.2632,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.10654,0.10608,0.06242,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.17934,0.106,0.07547,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.079444,0.1059,0.087665,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.15015,0.10583,0.080969,0,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.80989,0.10572,-0.0047597,0,0
4,GO P38MAPK CASCADE,0.10465,0.1057,0.12677,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.23937,0.10556,0.053997,0,0
4,GO GASTRULATION,0.29586,0.10554,0.048401,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.14769,0.10553,0.12113,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.10096,0.10547,0.085805,0,0
4,GO ENDODERM DEVELOPMENT,0.38888,0.10532,0.04264,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.17934,0.10495,0.10857,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12259,0.10493,0.11837,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.10096,0.10442,0.099046,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.20309,0.10431,0.11237,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.17099,0.10427,0.047339,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.14526,0.1042,0.11757,0,0
4,GO TRNA 5 END PROCESSING,0.17653,0.10416,0.080925,0,0
4,GO RESPONSE TO RETINOIC ACID,0.29586,0.10411,0.046225,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.15773,0.10406,0.085167,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.060602,0.10378,0.093737,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.0090226,0.10372,0.13138,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.14285,0.10371,0.066013,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.10654,0.10331,0.10404,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.55487,0.10325,0.085321,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.22235,0.10324,0.064376,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.14048,0.10302,0.10777,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.17099,0.10289,0.04444,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.52594,0.10284,0.0096494,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.8303,0.10267,0.004957,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.19095,0.10221,0.094068,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.25363,0.10199,0.053251,0,0
4,GO AMP METABOLIC PROCESS,0.15773,0.10188,0.14103,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.2839,0.10171,0.048404,0,0
4,GO GDP METABOLIC PROCESS,0.39858,0.10169,0.077976,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.11841,0.10149,0.091956,0,0
4,GO RESPONSE TO UV C,0.14285,0.10124,0.083097,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.7495,0.10114,-0.0095011,0,0
4,GO CRISTAE FORMATION,0.34702,0.10094,0.067758,0,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.17653,0.10087,0.078437,0,0
4,GO IMMATURE T CELL PROLIFERATION,0.33373,0.1007,0.11311,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.24643,0.1007,0.073415,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.033166,0.10068,0.10972,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.27227,0.10059,0.051093,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.10465,0.10059,0.07789,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.12908,0.10058,0.17057,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.064293,0.10052,0.18455,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.85082,0.1004,0.0055613,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.22905,0.10033,0.072039,0,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.64605,0.10025,0.019108,0,0
4,GO TRNA METHYLATION,0.53742,0.10011,0.02486,0,0
4,GO ACTION POTENTIAL,0.11841,0.099981,0.095658,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.58456,0.099887,0.030492,0,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.072231,0.099574,0.23158,0,0
4,GO TRANSLATIONAL TERMINATION,0.32077,0.099448,0.053955,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.10845,0.099279,0.06697,0,0
4,GO MACROPHAGE PROLIFERATION,0.17653,0.099247,0.15374,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.31653,0.099191,0.10248,0,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.17934,0.098909,0.067876,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.05824,0.098589,0.13326,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.69707,0.098386,0.030644,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.21256,0.098339,0.094126,0,0
4,GO RRNA CATABOLIC PROCESS,0.15015,0.098336,0.082656,0,0
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.27999,0.098278,0.060813,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.21579,0.098023,0.079583,0,0
4,GO GLIAL CELL DEVELOPMENT,0.36991,0.097947,0.042218,0,0
4,GO TRNA METABOLIC PROCESS,0.24288,0.097888,0.050575,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.32938,0.09765,0.067292,0,0
4,GO REGULATION OF VESICLE FUSION,0.20621,0.097437,0.13467,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.11235,0.097224,0.09507,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.079444,0.097155,0.082811,0,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.26098,0.097123,0.042241,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0695,0.097116,0.11187,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.065563,0.09699,0.096109,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.92682,0.096907,-0.072823,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.44924,0.09664,0.04629,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.19095,0.096635,0.082446,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.12049,0.096632,0.18457,0,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.53167,0.096619,0.034772,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.44924,0.096417,0.053385,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.33812,0.096378,0.065957,0,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.44924,0.096319,0.073282,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.59664,0.096226,-0.052657,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.30402,0.096201,0.078994,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.96163,0.096008,-0.013488,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.70355,0.096006,0.066529,0,0
4,GO L AMINO ACID TRANSPORT,0.14769,0.095975,0.1239,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.32938,0.095868,0.10749,0,0
4,GO VESICLE CARGO LOADING,0.43367,0.095769,0.080042,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.30815,0.095609,0.063802,0,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.046579,0.095335,0.11386,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.20937,0.094988,0.17416,0,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.4598,0.09481,0.04606,0,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.12259,0.094683,0.10534,0,0
4,GO OOCYTE MATURATION,0.21256,0.094403,0.055582,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.14769,0.094199,0.08468,0,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.079444,0.094129,0.04529,0,0
4,GO IRON ION HOMEOSTASIS,0.057089,0.093646,0.12266,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.22235,0.0936,0.072464,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.4545,0.093498,0.030975,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.14526,0.093484,0.11214,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.15773,0.093458,0.18502,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.059411,0.093325,0.066911,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.48678,0.093254,0.024584,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.25729,0.093036,0.10364,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.50337,0.092984,0.033732,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.57857,0.0929,0.030555,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.27611,0.092699,0.17893,0,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.21579,0.092655,0.053841,0,0
4,GO POSTREPLICATION REPAIR,0.18508,0.092559,0.038427,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.44924,0.092512,-0.020236,0,0
4,GO PENTOSE METABOLIC PROCESS,0.4545,0.092298,0.078681,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.4598,0.092153,0.034145,0,0
4,GO ASTROCYTE ACTIVATION,0.90599,0.091998,-0.017973,0,0
4,GO RESPONSE TO NICOTINE,0.32938,0.091793,0.045005,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.084046,0.091373,0.086256,0,0
4,GO RNA MODIFICATION,0.13355,0.090974,0.056091,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.087232,0.090811,0.098646,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.087232,0.090749,0.10734,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.095625,0.090622,0.056424,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.54321,0.090371,0.044556,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10465,0.090161,0.15711,0,0
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.91987,0.090152,-0.020832,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.26471,0.090088,0.096182,0,0
4,GO MATURATION OF 5 8S RRNA,0.76281,0.08968,-0.011728,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.36064,0.089591,-0.024222,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.19095,0.089556,0.052204,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.10465,0.089547,0.088559,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.54903,0.089353,0.049362,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.29184,0.088935,0.017323,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.073629,0.088622,0.19161,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0695,0.088194,0.14565,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.070855,0.088182,0.070008,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.084046,0.088115,0.10782,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.30402,0.088058,0.073887,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.17099,0.087829,0.077907,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.35607,0.087509,0.073018,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.16559,0.087323,0.095578,0,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.48678,0.087296,0.10643,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.69707,0.086977,0.02043,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.073629,0.086875,0.081895,0,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.14048,0.086791,0.10962,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.83713,0.086691,-0.017955,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.61497,0.086649,0.034624,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.082489,0.086522,0.08477,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.69707,0.08605,0.012518,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.063042,0.086034,0.098685,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.39858,0.086006,0.091461,0,0
4,GO PIGMENT GRANULE MATURATION,0.29184,0.085968,0.043673,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.69061,0.085703,-0.0085325,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.14285,0.085604,0.16732,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.96163,0.085518,0.03422,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.69061,0.085437,0.013614,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.17099,0.085375,0.041848,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.21256,0.08535,0.060641,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.21256,0.085177,0.051957,0,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.13583,0.084961,0.060999,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.1028,0.08464,0.11182,0,0
4,GO PIGMENT METABOLIC PROCESS,0.064293,0.084409,0.12653,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.2,0.084257,0.060072,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.14048,0.084071,0.084221,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.26471,0.084047,0.066498,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.39371,0.084014,0.049123,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.063042,0.083562,0.081207,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.10465,0.083491,0.084074,0,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.14769,0.083428,0.072081,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.40349,0.08319,0.040872,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.26847,0.083036,0.038121,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.1028,0.083013,0.17321,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.29992,0.082901,0.038972,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.27999,0.082811,0.048179,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.87144,0.082773,-0.018035,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.69061,0.082411,0.0024865,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.20621,0.082332,0.046568,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.16828,0.082256,0.066039,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.13583,0.081693,0.086419,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.44924,0.081495,0.051914,0,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.4978,0.08148,0.040262,0,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.16032,0.081291,0.10347,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.84397,0.080975,0.036779,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.76281,0.080915,0.0086688,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.26098,0.080907,0.054145,0,0
4,GO TUBE MORPHOGENESIS,0.29586,0.080824,0.031712,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.1313,0.080218,0.046225,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.064293,0.080143,0.081676,0,0
4,GO SEX DETERMINATION,0.56075,0.080007,0.025927,0,0
4,GO VASCULATURE DEVELOPMENT,0.43367,0.080004,0.022273,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.59059,0.079852,0.0098054,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.04854,0.07985,0.14983,0,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.073629,0.079676,0.087189,0,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.47588,0.079059,0.052036,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.46512,0.078878,0.078083,0,0
4,GO SULFATE TRANSPORT,0.21256,0.078866,0.06445,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.29586,0.078836,0.044766,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.088862,0.078541,0.15407,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.17934,0.078527,0.043941,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.8303,0.07833,-0.0059611,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.093897,0.078201,0.090868,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.29586,0.078125,0.087239,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.066855,0.07804,0.10931,0,0
4,GO ANIMAL ORGAN MATURATION,0.11841,0.077877,0.092029,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.070855,0.077637,0.065494,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.11434,0.077379,0.083549,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.15517,0.077317,0.057835,0,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.3746,0.077264,0.055457,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.15517,0.076811,0.10805,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.68418,0.076799,-0.0091236,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.39858,0.076743,0.041102,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.86455,0.076716,0.0027293,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.27999,0.076703,0.017428,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.35153,0.076641,0.066026,0,0
4,GO INTERACTION WITH SYMBIONT,0.15015,0.076522,0.036496,0,0
4,GO PIGMENT GRANULE ORGANIZATION,0.10654,0.076322,0.075608,0,0
4,GO TRANSLESION SYNTHESIS,0.077957,0.076189,0.06445,0,0
4,GO REGULATION OF PINOCYTOSIS,0.59059,0.076125,-0.01664,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.076492,0.075942,0.12742,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.22568,0.075714,0.05549,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.83713,0.075474,0.00097027,0,0
4,GO RESPONSE TO AMPHETAMINE,0.54321,0.075056,0.054155,0,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.19095,0.074985,0.093515,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.21256,0.07498,0.10054,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.093897,0.074929,0.056242,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.50337,0.074908,0.0054394,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.69707,0.074793,0.015454,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.79636,0.074715,0.010439,0,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.061812,0.074601,0.058987,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.71006,0.074561,0.0042504,0,0
4,GO RIBOSOME ASSEMBLY,0.74288,0.074489,0.014046,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.060602,0.074283,0.033555,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.62113,0.074264,0.042653,0,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.057089,0.074194,0.079991,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.54903,0.074108,0.056716,0,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.11841,0.074064,0.092501,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.064293,0.073977,0.089169,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.54903,0.073949,0.045184,0,0
4,GO ENDODERM FORMATION,0.58456,0.073841,0.010384,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.57857,0.073714,0.034594,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.35153,0.073623,0.054868,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.4978,0.07361,0.048251,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.17374,0.073517,0.14097,0,0
4,GO PERICARDIUM DEVELOPMENT,0.8303,0.073507,-0.01636,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.56075,0.073401,0.052846,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.015203,0.073279,0.22102,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.48678,0.073203,-0.023251,0,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.50337,0.073191,0.016935,0,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.059411,0.073128,0.06619,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.16294,0.07296,0.060458,0,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.26847,0.072879,0.072795,0,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.21256,0.072692,0.051607,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.43367,0.072647,0.074138,0,0
4,GO MESODERM MORPHOGENESIS,0.33812,0.072637,0.03172,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.21256,0.072621,0.028994,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.69061,0.072369,0.036935,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.24643,0.072298,0.047413,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.19695,0.0721,0.10531,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.5726,0.072051,0.02911,0,0
4,GO TRNA MODIFICATION,0.67776,0.071986,0.0058221,0,0
4,GO NEGATIVE T CELL SELECTION,0.32077,0.071921,0.042566,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.23589,0.071848,0.070304,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.099158,0.071454,0.065745,0,0
4,GO MUSCLE SYSTEM PROCESS,0.12689,0.071436,0.066062,0,0
4,GO PLACENTA DEVELOPMENT,0.2,0.071397,0.064933,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.12473,0.071109,0.12508,0,0
4,GO REGULATION OF EXOCYTOSIS,0.099158,0.071015,0.088199,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.29992,0.070997,0.061564,0,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.075049,0.070941,0.076193,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.27227,0.070731,0.061428,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.065563,0.070636,0.10861,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.51459,0.070488,0.037095,0,0
4,GO PROTEIN TARGETING,0.27227,0.070337,0.045967,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.27611,0.070257,0.11411,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.61497,0.070095,-0.008664,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.068167,0.070085,0.11118,0,0
4,GO NEURON REMODELING,0.66501,0.07008,0.0043744,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.48131,0.070014,0.023329,0,0
4,GO RNA METHYLATION,0.38888,0.069944,0.03204,0,0
4,GO ASSOCIATIVE LEARNING,0.4978,0.069736,0.030551,0,0
4,GO OSSIFICATION,0.12908,0.069636,0.056975,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.27999,0.06963,0.046863,0,0
4,GO GLAND MORPHOGENESIS,0.25729,0.069372,0.051873,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.4978,0.069369,0.034721,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.88523,0.069233,0.0061575,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.061812,0.069178,0.14276,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.32077,0.069153,0.072466,0,0
4,GO ASTROCYTE DEVELOPMENT,0.96163,0.0691,-0.0034172,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.1313,0.069087,0.095427,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16559,0.068923,0.063283,0,0
4,GO ORGAN INDUCTION,0.50896,0.068696,0.012606,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.71658,0.068493,0.009106,0,0
4,GO SKIN MORPHOGENESIS,0.86455,0.068428,-0.081571,0,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.24643,0.068395,0.028969,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.20621,0.068352,0.041333,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.26847,0.068325,0.043844,0,0
4,GO REGULATION OF ODONTOGENESIS,0.9686,0.068154,-0.047173,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.26098,0.068139,0.049265,0,0
4,GO MYELOID CELL DEVELOPMENT,0.033894,0.06812,0.094257,0,0
4,GO TRNA CATABOLIC PROCESS,0.16828,0.068093,0.15814,0,0
4,GO FEAR RESPONSE,0.20937,0.068036,0.071358,0,0
4,GO DNA DEALKYLATION,0.64605,0.067793,0.0057031,0,0
4,GO AORTA MORPHOGENESIS,0.75615,0.067731,0.0068719,0,0
4,GO TRNA PROCESSING,0.69061,0.067666,0.0037599,0,0
4,GO REGULATION OF OSSIFICATION,0.060602,0.067597,0.083519,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.32506,0.067558,0.038085,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.43883,0.06755,0.036783,0,0
4,GO RELAXATION OF MUSCLE,0.42855,0.067439,0.051635,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.65234,0.067439,-0.0037898,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.17099,0.067201,0.085173,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.29586,0.067104,0.088672,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.33812,0.067094,0.032348,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.15015,0.067078,0.11668,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.4545,0.067003,0.031025,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.3746,0.067001,0.072178,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.2839,0.066945,0.12428,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.24643,0.066931,0.11802,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.24288,0.06689,0.04417,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.20937,0.066834,0.25711,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.65234,0.066789,-0.033758,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.093897,0.066736,0.16272,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.99651,0.066675,-0.023241,0,0
4,GO NEURON MATURATION,0.12908,0.066574,0.11997,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.85768,0.066495,0.038653,0,0
4,GO STRESS FIBER ASSEMBLY,0.52025,0.066364,0.024822,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.68418,0.066235,0.022335,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.59059,0.065952,0.019285,0,0
4,GO NCRNA METABOLIC PROCESS,0.39858,0.065875,0.025624,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.17099,0.065858,0.047954,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.44402,0.065736,0.063389,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.12689,0.065683,0.062982,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.71658,0.065644,-0.011236,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.4545,0.065568,0.049961,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.37932,0.065517,0.035382,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.55487,0.065336,0.009538,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.18508,0.065265,0.048205,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY,0.063042,0.06525,0.064784,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.71006,0.065231,0.034722,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.088862,0.065176,0.069595,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.36064,0.065101,0.056358,0,0
4,GO HEME METABOLIC PROCESS,0.13355,0.065083,0.17541,0,0
4,GO PENILE ERECTION,0.90599,0.065066,0.0067957,0,0
4,GO REGULATION OF MRNA BINDING,0.71658,0.065014,-0.011391,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.097379,0.064912,0.038831,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.47049,0.064868,0.066699,0,0
4,GO NOTOCHORD DEVELOPMENT,0.94073,0.064791,-0.060266,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.56666,0.064787,0.0060609,0,0
4,GO SINGLE FERTILIZATION,0.068167,0.064767,0.069569,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.36064,0.064717,0.026607,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.57857,0.064639,0.01018,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.43367,0.064633,0.029235,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.25001,0.064372,0.020842,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.85082,0.064167,-0.0040609,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.61497,0.064162,-0.083913,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.10096,0.064154,0.079558,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.39371,0.064142,0.10575,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.19095,0.063947,0.11891,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.98953,0.063806,0.00078076,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.8303,0.06376,-0.013695,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.43367,0.063596,0.038642,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.24643,0.063468,0.11929,0,0
4,GO ALDITOL METABOLIC PROCESS,0.54903,0.063249,0.031907,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.77618,0.063066,-0.071749,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.1028,0.06301,0.057055,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.66501,0.062817,-0.016984,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.73628,0.062762,0.062074,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2,0.062732,0.050103,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.99651,0.062443,-0.022486,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.44924,0.062362,0.044901,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.74288,0.061948,0.0044995,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.14526,0.061925,0.065982,0,0
4,GO REGULATION OF URINE VOLUME,0.82348,0.061881,-0.028291,0,0
4,GO CERAMIDE TRANSPORT,0.21905,0.061779,0.2106,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.37932,0.06172,0.030533,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.40349,0.061615,0.048699,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.51459,0.061611,0.031689,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.72969,0.061581,-0.056051,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.62113,0.061482,-0.007934,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.27611,0.061457,0.052561,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.23589,0.061282,0.048067,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.31653,0.061171,0.042659,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.053746,0.061087,0.067128,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.22905,0.061,0.12071,0,0
4,GO GLIAL CELL MIGRATION,0.87833,0.060722,-0.034827,0,0
4,GO MEMBRANE INVAGINATION,0.22235,0.06052,0.055686,0,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.40843,0.060517,0.033431,0,0
4,GO RESPONSE TO MUSCLE INACTIVITY,0.188,0.060478,0.11453,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.26471,0.060357,0.18399,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.35607,0.060273,0.049046,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.73628,0.060262,0.015097,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.84397,0.060238,-0.072859,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.94769,0.06011,-0.015114,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.53742,0.060036,0.041087,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.43367,0.05997,0.075949,0,0
4,GO MALE SEX DIFFERENTIATION,0.16559,0.059969,0.046777,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.14285,0.059883,0.099624,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.16032,0.05976,0.070197,0,0
4,GO ARTERY MORPHOGENESIS,0.15264,0.059703,0.03275,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.27999,0.059653,0.16693,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.67776,0.059284,0.0037006,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.11636,0.059275,0.069881,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.14526,0.059115,0.051697,0,0
4,GO PRIMARY MIRNA PROCESSING,0.50896,0.059045,0.014651,0,0
4,GO MRNA MODIFICATION,0.62113,0.058905,0.01497,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.78289,0.058698,-0.089023,0,0
4,GO REGULATION OF ENDOCYTOSIS,0.25001,0.05859,0.046132,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.21579,0.058558,0.081619,0,0
4,GO TISSUE REGENERATION,0.35153,0.058509,0.044861,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.072231,0.058463,0.040863,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.70355,0.058413,-0.047093,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.50896,0.058372,0.019528,0,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.17374,0.058371,0.040748,0,0
4,GO LUNG MORPHOGENESIS,0.40349,0.058301,0.029015,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.11434,0.058204,0.18502,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.47588,0.058182,0.027122,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.12049,0.058077,0.051637,0,0
4,GO MEMBRANE REPOLARIZATION,0.41341,0.057997,0.05658,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.17653,0.057874,0.039609,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.24643,0.057552,0.049536,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.31232,0.057471,0.049709,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.12473,0.057423,0.11496,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.42855,0.057387,0.0446,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.31653,0.057359,0.035833,0,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.054842,0.057132,0.075121,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.15773,0.057123,0.087723,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.24288,0.057064,0.08079,0,0
4,GO MYOFIBRIL ASSEMBLY,0.064293,0.056969,0.082063,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.28785,0.056944,0.030559,0,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.56075,0.056844,-0.015477,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.32938,0.056824,0.035189,0,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,0.056647,0.056225,0,0
4,GO POTASSIUM ION TRANSPORT,0.18508,0.056528,0.079049,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.65234,0.0565,0.021822,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.19095,0.056366,0.08024,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.16032,0.056362,0.025211,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.1028,0.056269,0.20293,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.13814,0.05622,0.047253,0,0
4,GO REGULATION OF ERAD PATHWAY,0.65866,0.055932,0.019912,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.24288,0.055733,0.033613,0,0
4,GO NCRNA 3 END PROCESSING,0.40349,0.055362,0.0011613,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.36991,0.055265,0.015262,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.89907,0.055215,0.00939,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.55487,0.055178,0.028146,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.59059,0.055081,0.050638,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.13814,0.055003,0.10992,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.44924,0.054942,0.071824,0,0
4,GO FEVER GENERATION,0.61497,0.0549,0.02018,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.21256,0.054721,0.060258,0,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.89215,0.054667,0.039407,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.097379,0.054305,0.054751,0,0
4,GO FERTILIZATION,0.10096,0.054236,0.055599,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.090515,0.054159,0.14443,0,0
4,GO NERVE DEVELOPMENT,0.36526,0.054119,0.053839,0,0
4,GO DEVELOPMENTAL INDUCTION,0.25001,0.053997,0.061309,0,0
4,GO IMPORT INTO CELL,0.18508,0.053907,0.071885,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.11841,0.053868,0.061498,0,0
4,GO PROTEIN IMPORT,0.22568,0.053849,0.050175,0,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.20309,0.053821,0.043833,0,0
4,GO HISTONE H2B UBIQUITINATION,0.15015,0.053747,0.06667,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.79636,0.053683,0.015658,0,0
4,GO SEGMENT SPECIFICATION,0.92682,0.05363,0.025214,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.50337,0.053591,0.020047,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.61497,0.053462,0.0068007,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.36991,0.053299,0.035187,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.61497,0.053214,-0.0036106,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.80989,0.053154,-0.030774,0,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.89907,0.053153,0.0087924,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.32506,0.053139,0.029035,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.090515,0.053003,0.069091,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.30402,0.052934,0.031388,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.84397,0.052921,0.012523,0,0
4,GO TISSUE MORPHOGENESIS,0.25363,0.05288,0.023524,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.76281,0.052709,0.0081634,0,0
4,GO MOLTING CYCLE,0.23245,0.052637,0.036074,0,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.063042,0.052553,0.040311,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.20937,0.052525,0.13186,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.19095,0.052495,0.039308,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.44402,0.052355,0.01614,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.48678,0.052097,0.053178,0,0
4,GO EXTRACELLULAR TRANSPORT,0.36526,0.052048,0.062899,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.7495,0.052016,0.017228,0,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.1028,0.052005,0.060653,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.092194,0.051916,0.067864,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.91293,0.051907,-0.0093724,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.22235,0.051897,0.078211,0,0
4,GO NEPHRON DEVELOPMENT,0.20621,0.051774,0.048272,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.27611,0.051649,0.075431,0,0
4,GO SOMITE DEVELOPMENT,0.1313,0.051469,0.058567,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.80989,0.051461,0.021084,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.33812,0.051403,0.09442,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.37932,0.051338,0.04995,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.64605,0.051105,0.011779,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.48678,0.050914,0.031134,0,0
4,GO REGULATION OF CELL AGING,0.67776,0.050901,0.013188,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.53742,0.050898,0.047349,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.41842,0.050757,0.018757,0,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.13583,0.050574,0.05489,0,0
4,GO NEURON DEATH,0.11039,0.050421,0.045445,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.18508,0.050331,0.084468,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.94769,0.050255,0.044802,0,0
4,GO RNA DECAPPING,1,0.050027,-0.0047972,0,0
4,GO ESTROUS CYCLE,0.86455,0.049904,0.017119,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.36064,0.049833,0.047887,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.24643,0.049801,0.058086,0,0
4,GO THYMIC T CELL SELECTION,0.52594,0.049739,0.026756,0,0
4,GO GERM CELL DEVELOPMENT,0.23589,0.049707,0.031382,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.27999,0.049701,0.038336,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.73628,0.049632,0.0020358,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.42347,0.049561,0.021414,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.21579,0.049495,0.059543,0,0
4,GO SNRNA METABOLIC PROCESS,0.24288,0.049449,0.025792,0,0
4,GO CELL SUBSTRATE ADHESION,0.41842,0.049312,0.021529,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.81668,0.049238,-0.0028526,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.51459,0.049183,0.013825,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.62732,0.049161,0.020155,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.20621,0.049051,0.043755,0,0
4,GO COENZYME A METABOLIC PROCESS,0.54903,0.048815,0.048832,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.72313,0.048576,0.043677,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.40843,0.048535,0.023491,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.48678,0.048511,0.034152,0,0
4,GO CILIUM MOVEMENT,0.23589,0.048502,0.02958,0,0
4,GO PRENYLATION,0.67776,0.048443,0.007808,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.29184,0.048414,0.033351,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.70355,0.048367,0.02051,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.30815,0.048214,0.02965,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.17934,0.048134,0.072021,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.65234,0.048109,0.022209,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.8303,0.047894,0.0098796,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.29992,0.047795,0.093221,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.21905,0.04777,0.056575,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.62113,0.047688,0.015438,0,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.99651,0.047539,0.00748,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.48131,0.04753,0.11896,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.36991,0.047427,0.064119,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.71006,0.047419,0.0066604,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.11235,0.047217,0.049902,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.49227,0.047143,0.046763,0,0
4,GO PROTEIN TETRAMERIZATION,0.53167,0.046882,0.024431,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.14048,0.046817,0.081248,0,0
4,GO GAS TRANSPORT,0.98953,0.0467,-0.040939,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.26847,0.046589,0.10546,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.53742,0.046548,0.033564,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.33373,0.046482,0.043056,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.33373,0.046319,0.059661,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.17099,0.04627,0.081997,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.099158,0.046265,0.047273,0,0
4,GO EXOCYTIC PROCESS,0.061812,0.046168,0.14486,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.86455,0.046077,-0.074864,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.47049,0.045877,0.088293,0,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.065563,0.045851,0.062864,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.3746,0.045649,0.033736,0,0
4,GO MITOCHONDRION ORGANIZATION,0.011612,0.045591,0.093989,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.36064,0.045409,0.051159,0,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.060602,0.045233,0.072237,0,0
4,GO PRO B CELL DIFFERENTIATION,0.30815,0.045148,0.063238,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.48678,0.04514,0.13821,0,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.11235,0.044976,0.08757,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.47588,0.044959,0.015758,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.64605,0.04492,0.027435,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.92682,0.044907,-0.017638,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.69061,0.04483,0.0083917,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.18219,0.044819,0.038362,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.61497,0.044559,0.061433,0,0
4,GO BONE MINERALIZATION,0.11235,0.044556,0.078366,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.1028,0.044488,0.055454,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.96163,0.044374,-0.049243,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.35607,0.044319,0.02235,0,0
4,GO AMINO ACID TRANSPORT,0.095625,0.044217,0.12262,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.4545,0.044167,0.040195,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.57857,0.044111,0.039908,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.44924,0.044086,0.024533,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.36526,0.044077,0.0069341,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.076492,0.043913,0.094854,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.48131,0.043664,0.022493,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.16559,0.043633,0.046192,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.77618,0.043573,0.038712,0,0
4,GO REGULATION OF GASTRULATION,0.85082,0.043568,-0.014949,0,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.34702,0.043445,0.074424,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.92682,0.043405,-0.012095,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.10096,0.04333,0.1418,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.22568,0.043324,0.086549,0,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.31653,0.043288,0.026468,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.58456,0.043214,0.039258,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.60883,0.042949,0.0331,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.49227,0.042892,0.029248,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.24288,0.042784,0.062437,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.80989,0.04268,-0.0085114,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.74288,0.042552,-0.064046,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.49227,0.042477,0.016847,0,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.76948,0.042441,0.019082,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.14526,0.042384,0.074679,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.58456,0.042238,0.011712,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.76948,0.042107,0.02379,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.53167,0.041972,0.03181,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.52594,0.041866,0.0015667,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.59059,0.041628,0.004161,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.25363,0.041456,0.039411,0,0
4,GO MYOBLAST DIFFERENTIATION,0.7495,0.041219,-0.010265,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.36526,0.041208,0.067055,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.20309,0.041074,0.053207,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.51459,0.040964,0.022984,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.26847,0.040956,0.040325,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.67137,0.040874,0.011891,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.44924,0.040792,0.025742,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.91987,0.040725,-0.020119,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.48678,0.040633,0.015381,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.74288,0.040487,-0.024672,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.85768,0.040471,-0.023205,0,0
4,GO CELL GROWTH,0.92682,0.040454,-0.00012484,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.8303,0.040361,0.0041729,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.48678,0.04025,0.038606,0,0
4,GO INNERVATION,0.78289,0.040206,0.072928,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.18219,0.040189,0.091285,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.14769,0.040104,0.076782,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.16559,0.040079,0.074111,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.47588,0.040054,-0.060808,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.25363,0.039903,0.09167,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.4978,0.039875,0.062211,0,0
4,GO NUCLEOSIDE SALVAGE,0.69061,0.039869,0.010109,0,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.62732,0.039867,0.018485,0,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.62732,0.03981,0.022349,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.34702,0.039809,0.012755,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.82348,0.039447,-0.048481,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.3746,0.039287,0.026741,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.12259,0.039246,0.076695,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.188,0.03921,0.08615,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.43883,0.039107,0.085087,0,0
4,GO REGULATION OF BINDING,0.17653,0.039091,0.047886,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.89215,0.038959,-0.017731,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.21905,0.038862,0.071263,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.55487,0.038793,0.03006,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.91987,0.038681,-0.065315,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.94073,0.038663,0.0055049,0,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.087232,0.038577,0.042643,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.11841,0.03852,0.04286,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.188,0.038374,0.052935,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.44402,0.038345,0.027896,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.16032,0.038344,0.077514,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.39858,0.038293,0.07893,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.72313,0.038207,0.019466,0,0
4,GO PRE MIRNA PROCESSING,0.80312,0.038176,-0.020821,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.17374,0.038081,0.065548,0,0
4,GO MALE GAMETE GENERATION,0.14048,0.038051,0.034925,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.2839,0.038012,0.036974,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.34256,0.03797,0.01187,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.59059,0.037919,0.028618,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.29992,0.037678,0.041924,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.20309,0.037601,0.028709,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.54321,0.037568,0.034258,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.69061,0.037409,0.011617,0,0
4,GO MUSCLE CONTRACTION,0.23245,0.037399,0.048783,0,0
4,GO RESPONSE TO HYDROXYUREA,0.25363,0.037323,0.075406,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.96163,0.037264,-0.0056435,0,0
4,GO VESICLE DOCKING,0.39371,0.036687,0.071803,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.43883,0.036668,0.05683,0,0
4,GO LACTATION,0.41842,0.036634,0.045201,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.46512,0.036545,0.023102,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.54903,0.036541,0.069583,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.49227,0.036393,0.086155,0,0
4,GO SEX DIFFERENTIATION,0.50896,0.036358,0.01717,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.7495,0.03633,0.0046111,0,0
4,GO SEXUAL REPRODUCTION,0.13355,0.036253,0.034678,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.59059,0.036203,0.038083,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.29586,0.036186,0.05469,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.31232,0.036166,0.041176,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.14048,0.036081,0.07077,0,0
4,GO GOLGI LOCALIZATION,0.80312,0.035852,0.01602,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.89215,0.03571,-0.00031703,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.97557,0.035641,-0.033141,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.46512,0.035495,0.022212,0,0
4,GO HYPEROSMOTIC RESPONSE,0.60272,0.035385,0.042431,0,0
4,GO SPERM MOTILITY,0.87833,0.035378,0.0035352,0,0
4,GO GAMETE GENERATION,0.20937,0.035288,0.028808,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.69707,0.035052,0.013112,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.78289,0.03502,-0.020895,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.5726,0.034922,0.0099034,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.81668,0.034911,-0.020982,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.98255,0.034891,-0.0287,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.44402,0.034865,0.035722,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.60883,0.034853,-0.036439,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.17653,0.03482,0.061537,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.25363,0.03476,0.15836,0,0
4,GO METHYLATION,0.34256,0.03475,0.0091332,0,0
4,GO STARTLE RESPONSE,0.95466,0.034676,-0.0089447,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.54903,0.034513,0.050946,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.47588,0.034406,0.021987,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.86455,0.034331,0.0025012,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.85768,0.034231,0.030518,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.66501,0.034163,0.017788,0,0
4,GO PROTEIN TRIMERIZATION,0.59059,0.034152,0.02154,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.50337,0.034151,0.029622,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.17934,0.034125,0.10613,0,0
4,GO PEPTIDYL SERINE MODIFICATION,0.14769,0.034071,0.044368,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.72313,0.034001,-0.058571,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.90599,0.033974,-0.025939,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.32077,0.033922,0.080796,0,0
4,GO RESPONSE TO INACTIVITY,0.22905,0.033873,0.10528,0,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.19393,0.033862,0.077247,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.98255,0.033829,-0.0060153,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.75615,0.033824,-0.059863,0,0
4,GO PEPTIDE CROSS LINKING,0.42347,0.033795,0.0318,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.98953,0.03373,0.0016829,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.59664,0.033721,0.0072,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.88523,0.033565,0.011798,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.19393,0.033557,0.054989,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.52025,0.033547,0.089956,0,0
4,GO NCRNA PROCESSING,0.75615,0.033378,-0.0047864,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.22905,0.033319,0.052842,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.91293,0.033286,-0.040455,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.22905,0.032765,0.1047,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.51459,0.032668,0.02867,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.76281,0.03258,0.066303,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42855,0.032556,0.026139,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.44924,0.032451,0.046021,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.2,0.032348,0.078061,0,0
4,GO HISTONE DEACETYLATION,0.92682,0.032323,-0.0064622,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.63978,0.032268,-0.0048059,0,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.28785,0.032099,0.025673,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.54321,0.031998,0.016218,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.80312,0.031991,0.001867,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.78962,0.031991,0.034154,0,0
4,GO NAD METABOLIC PROCESS,0.29184,0.031909,0.09007,0,0
4,GO MEIOTIC CELL CYCLE,0.15773,0.031908,0.032779,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.53742,0.031803,0.01177,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.91987,0.031774,-0.018016,0,0
4,GO TRABECULA MORPHOGENESIS,0.89215,0.031577,-0.01459,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42855,0.031575,0.035651,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.38888,0.0315,0.029665,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.88523,0.031422,-0.01779,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.42347,0.0313,0.024154,0,0
4,GO OOGENESIS,0.5726,0.031289,0.027358,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.94769,0.031234,-0.024218,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.87833,0.031023,-0.068834,0,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.38408,0.030696,0.031756,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.40349,0.030654,0.052413,0,0
4,GO AUTOPHAGIC CELL DEATH,0.27999,0.030618,0.061082,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.42855,0.03053,0.08255,0,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.17374,0.030422,0.069193,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.72969,0.030276,0.0085246,0,0
4,GO RRNA TRANSCRIPTION,0.68418,0.03019,-0.044405,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.90599,0.030074,-0.034739,0,0
4,GO SPERMATID DIFFERENTIATION,0.26471,0.030038,0.035076,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.67137,0.029995,0.00043555,0,0
4,GO P BODY ASSEMBLY,0.52594,0.029911,0.028045,0,0
4,GO RESPONSE TO FOOD,0.60272,0.029787,0.022247,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.40349,0.029474,0.025718,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.26471,0.029255,0.035781,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.4598,0.029206,0.024882,0,0
4,GO BLASTOCYST FORMATION,0.29184,0.02916,0.079389,0,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.34256,0.029067,0.024407,0,0
4,GO RHYTHMIC PROCESS,0.2,0.029044,0.045544,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.30815,0.028988,0.022179,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.67776,0.028664,0.074919,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.63978,0.02836,0.018084,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.4978,0.028241,0.035063,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.31232,0.028238,0.028102,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.74288,0.028195,0.014959,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.39858,0.02814,0.04346,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.48678,0.028053,0.11588,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.77618,0.027977,-0.034364,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.29184,0.027969,0.049961,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.94073,0.027805,-0.01627,0,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.34702,0.027773,0.038298,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.62113,0.027732,0.011953,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.43367,0.02773,0.21903,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.38408,0.027652,0.070692,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.35153,0.02748,0.028602,0,0
4,GO EPITHELIAL CELL MATURATION,0.54903,0.027377,0.074081,0,0
4,GO BODY MORPHOGENESIS,0.96163,0.027249,-0.012056,0,0
4,GO SPERM AXONEME ASSEMBLY,0.82348,0.027162,-0.0074979,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.37932,0.027151,0.016929,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.30402,0.027134,0.039101,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.39371,0.027,0.038,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.57857,0.026918,0.074079,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.8303,0.026787,-0.0048631,0,0
4,GO SARCOMERE ORGANIZATION,0.27999,0.026711,0.064244,0,0
4,GO SNRNA PROCESSING,0.50896,0.026652,-0.0052453,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.71658,0.026564,0.011962,0,0
4,GO FACE DEVELOPMENT,0.93377,0.026484,-0.010784,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.16032,0.026427,0.059561,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.40349,0.026418,0.047756,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.68418,0.026394,-0.067313,0,0
4,GO URETER DEVELOPMENT,0.80989,0.02618,-0.017163,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.90599,0.026056,-0.022284,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.85082,0.025881,0.012878,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.42347,0.025867,0.053578,0,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.12473,0.025803,0.063824,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.91987,0.025657,-0.017296,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.44402,0.02555,0.048958,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.66501,0.025528,0.064562,0,0
4,GO SENSORY PERCEPTION OF PAIN,0.27999,0.025239,0.064316,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.52594,0.025095,0.10152,0,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.33812,0.025076,0.03388,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.87833,0.024863,0.047441,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.4545,0.024829,0.065286,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.22568,0.024776,0.07591,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.92682,0.024752,-0.0042538,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.71006,0.024658,0.011625,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.47588,0.02464,0.015663,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.8303,0.024574,0.016346,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.47588,0.024521,0.012984,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.98255,0.024227,-0.024406,0,0
4,GO ENSHEATHMENT OF NEURONS,0.79636,0.024136,0.0096719,0,0
4,GO MITOCHONDRIAL FUSION,0.54903,0.024112,0.068217,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.33373,0.02411,0.063553,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.67776,0.024088,0.0071809,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.81668,0.024077,0.0018549,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.73628,0.023984,0.015027,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.36064,0.023844,0.072676,0,0
4,GO ORGANELLE LOCALIZATION,0.53167,0.023763,0.014885,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.62732,0.023741,0.033275,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.87833,0.023625,-0.0053511,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.38888,0.023402,0.060758,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,0.023329,-0.039748,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.38888,0.023322,0.036532,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.54321,0.023037,0.032924,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.4978,0.022867,0.03271,0,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.21905,0.022835,0.094692,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.53742,0.022821,0.029468,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.74288,0.022781,0.0058583,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.56075,0.022587,0.079253,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.66501,0.022487,0.021255,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.17099,0.022483,0.07818,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.63978,0.022216,0.012449,0,0
4,GO IMPORT INTO NUCLEUS,0.68418,0.022015,0.018124,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.72313,0.021989,0.014606,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.61497,0.02182,0.02114,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.32506,0.021813,0.097431,0,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.43883,0.02179,0.065651,0,0
4,GO TRANSLATIONAL INITIATION,0.76948,0.021599,-0.039916,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.2839,0.021547,0.063082,0,0
4,GO SEGMENTATION,0.65866,0.021313,0.02509,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.47588,0.021223,0.01748,0,0
4,GO BLASTODERM SEGMENTATION,0.81668,0.021177,-0.070321,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.55487,0.020998,-0.03084,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.65234,0.020762,0.017567,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.44924,0.020715,0.025106,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.89907,0.020621,-0.0091531,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.85768,0.020619,-0.045595,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.75615,0.020581,0.0094135,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.39371,0.020525,0.080173,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.65234,0.020513,0.0030552,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.93377,0.020346,-0.0020204,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.87833,0.020244,0.036659,0,0
4,GO SEROTONIN SECRETION,0.91987,0.020188,0.017402,0,0
4,GO CYTOPLASMIC TRANSLATION,0.78289,0.020155,-0.047296,0,0
4,GO FEMALE GAMETE GENERATION,0.5726,0.020124,0.019045,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.69707,0.020014,0.0016208,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.91293,0.019969,0.032426,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.68418,0.019627,0.00013877,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.36991,0.019587,0.020439,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.36064,0.019542,0.035358,0,0
4,GO IMP METABOLIC PROCESS,1,0.019529,-0.017839,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.56666,0.019101,0.038531,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.94769,0.019061,-0.020067,0,0
4,GO HEAD MORPHOGENESIS,0.87144,0.018931,-0.041562,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.80312,0.018833,-0.024206,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.65234,0.018736,0.026976,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.84397,0.018736,-0.017754,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.23589,0.018731,0.058978,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.73628,0.018641,0.0039437,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.62113,0.01858,0.0029852,0,0
4,GO GONADOTROPIN SECRETION,0.70355,0.018578,0.031397,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.41842,0.018493,0.028015,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.188,0.01837,0.067342,0,0
4,GO CELL FATE DETERMINATION,0.78289,0.018261,0.012154,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.79636,0.01822,0.010008,0,0
4,GO RNA CATABOLIC PROCESS,0.88523,0.018206,-0.0016579,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.68418,0.018167,0.00010595,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.87833,0.017938,-0.0048278,0,0
4,GO SPROUTING ANGIOGENESIS,0.91293,0.017933,-0.019575,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.25363,0.017907,0.0509,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.40349,0.017767,0.028468,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.46512,0.017743,0.03214,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.85768,0.017653,-0.00042459,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.88523,0.017453,-0.034317,0,0
4,GO REGULATION OF HEAT GENERATION,0.88523,0.017297,0.032451,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.37932,0.017129,0.027463,0,0
4,GO MATING,0.33373,0.017122,0.042041,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.32077,0.017044,0.051572,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.91293,0.017008,-0.011655,0,0
4,GO GENITALIA DEVELOPMENT,0.98953,0.016948,-0.0027488,0,0
4,GO RESPONSE TO BMP,0.40349,0.016908,0.025881,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.63978,0.016904,0.028915,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.31232,0.01689,0.10246,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.95466,0.016838,0.020832,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.81668,0.016648,0.0053708,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.69061,0.01657,0.03182,0,0
4,GO MITOCHONDRIAL FISSION,0.36064,0.016455,0.10492,0,0
4,GO PHOTOPERIODISM,0.65866,0.016444,0.045241,0,0
4,GO ODONTOGENESIS,0.43367,0.016367,-0.075809,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.36064,0.016249,0.047453,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.99651,0.016183,0.0034246,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.52025,0.015958,-0.040751,0,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.69061,0.015823,0.0078802,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.52594,0.01568,0.013646,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.59059,0.015538,0.0098851,0,0
4,GO MEMBRANE RAFT ASSEMBLY,0.41842,0.015503,0.059492,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.72969,0.015467,-0.045585,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.32506,0.015393,0.070747,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.30815,0.015391,-0.083551,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.3746,0.015312,0.095844,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.3746,0.015191,0.059443,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.71006,0.015179,0.016151,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.55487,0.015178,0.024009,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.81668,0.015161,0.042263,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.86455,0.01511,-0.014974,0,0
4,GO VAGINA DEVELOPMENT,0.70355,0.014969,-0.0030162,0,0
4,GO RESPONSE TO HEAT,0.44402,0.014784,0.052611,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.52594,0.014718,0.027929,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.97557,0.014506,-0.01026,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.34256,0.014497,0.11456,0,0
4,GO EPITHELIAL TUBE FORMATION,0.80312,0.014419,-0.026762,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.74288,0.014412,-0.019127,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.33812,0.014372,0.027409,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.97557,0.014365,-0.027729,0,0
4,GO MACROMOLECULE DEACYLATION,0.56075,0.014309,0.015709,0,0
4,GO HISTONE H3 ACETYLATION,0.9686,0.014106,-0.010644,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.74288,0.013925,-0.12281,0,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.12259,0.013914,0.058836,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.39371,0.013914,0.046659,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.23937,0.013818,0.054949,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.75615,0.01377,0.019867,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.56075,0.013743,0.008208,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.98255,0.013689,0.00071472,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.77618,0.013613,0.014727,0,0
4,GO CELL CYCLE ARREST,0.81668,0.013531,0.0094295,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.30402,0.013475,0.086833,0,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.55487,0.013377,0.039625,0,0
4,GO BLEB ASSEMBLY,0.89215,0.013363,-0.12282,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.40843,0.013243,0.061876,0,0
4,GO CARTILAGE DEVELOPMENT,0.84397,0.013,-0.028794,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.98953,0.012978,0.0011847,0,0
4,GO GMP METABOLIC PROCESS,0.89215,0.012972,-0.010399,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.76281,0.01297,0.026351,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.68418,0.012962,0.017789,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.71006,0.01268,0.031233,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.87144,0.012524,0.0066728,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.71006,0.012488,0.0065539,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.40843,0.012468,0.03325,0,0
4,GO TRANSLATIONAL ELONGATION,0.59059,0.012396,0.018159,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.85768,0.012241,-0.010538,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.71658,0.012071,0.043626,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.76948,0.011984,-0.024969,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.59664,0.011769,0.049578,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.46512,0.011678,0.030768,0,0
4,GO DECIDUALIZATION,0.5726,0.011634,-0.059311,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.98953,0.011477,-0.0058084,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.47588,0.011412,0.082479,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.56666,0.011322,-0.067099,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.76948,0.011248,0.044301,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.81668,0.010939,0.017975,0,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.50896,0.010889,0.029622,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.65234,0.010639,0.013226,0,0
4,GO TAXIS,0.60883,0.01056,-0.029546,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.84397,0.010464,-0.0056443,0,0
4,GO ORGANELLE FISSION,0.98953,0.010439,-0.0026145,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.90599,0.010398,-0.0073743,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.61497,0.010313,0.013695,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.43883,0.01029,0.023898,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.79636,0.010236,0.016015,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.95466,0.0099877,-0.00051204,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.86455,0.0099717,-0.042849,0,0
4,GO KIDNEY MORPHOGENESIS,0.77618,0.0099393,0.0036558,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.78962,0.0098926,0.011178,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.65234,0.0098537,0.0095393,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.98255,0.0098461,-0.01031,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.36991,0.0098398,-0.061733,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.42855,0.0097919,-0.073263,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.91293,0.0097054,0.0063923,0,0
4,GO MALE SEX DETERMINATION,0.30402,0.0096116,0.090238,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.81668,0.0095508,-0.027574,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.69707,0.0095099,-0.038701,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.48131,0.0092685,0.091096,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.84397,0.0092559,0.01105,0,0
4,GO GLIOGENESIS,0.99651,0.0091959,0.0015446,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.16828,0.0089687,0.07881,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.36526,0.0088858,0.043756,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.65866,0.0087945,0.021327,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.4978,0.008714,0.026137,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46512,0.0086416,-0.03948,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.40843,0.0085675,0.021715,0,0
4,GO NUCLEUS LOCALIZATION,0.65234,0.0085506,-0.042842,0,0
4,GO NERVOUS SYSTEM PROCESS,0.52025,0.0084899,0.021223,0,0
4,GO ACTIN FILAMENT BASED PROCESS,0.51459,0.0084755,0.018125,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.91293,0.0084107,0.00052088,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.8303,0.0084058,0.024766,0,0
4,GO DOSAGE COMPENSATION,0.80989,0.0084009,0.011071,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.37932,0.0082777,0.063344,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.68418,0.008067,-0.034489,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.59664,0.0079118,0.010638,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.98953,0.0078998,-0.0068291,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.47049,0.0077152,0.076447,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.91293,0.0076733,-0.010337,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.78962,0.0075994,0.0017438,0,0
4,GO NADH METABOLIC PROCESS,0.47588,0.0075794,0.081514,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.96163,0.0073588,-0.0049653,0,0
4,GO EAR DEVELOPMENT,0.84397,0.0072526,-0.0072351,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.32077,0.0071725,0.077907,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.60883,0.0070206,0.020391,0,0
4,GO T CELL CHEMOTAXIS,0.80312,0.0069262,0.020816,0,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.19393,0.006909,0.091943,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.9686,0.0068524,-0.012751,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.96163,0.0067618,0.010382,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.9686,0.0067367,-0.0099676,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.43883,0.0067236,0.10492,0,0
4,GO VIRAL GENE EXPRESSION,1,0.0067181,-0.017919,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.62113,0.006657,0.014341,0,0
4,GO METANEPHROS DEVELOPMENT,0.90599,0.0066448,-0.016147,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.78962,0.0066312,-0.0236,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.7495,0.0065842,-0.049207,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.53742,0.0065272,-0.063334,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.86455,0.0064815,0.0034337,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.60883,0.0064053,0.077752,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.95466,0.0063608,-0.022969,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.84397,0.0061817,-0.015458,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.84397,0.0061545,-0.0087428,0,0
4,GO EPIBOLY,0.89907,0.0061151,-0.073735,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.59664,0.0060843,0.018827,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.54903,0.006049,0.032838,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.84397,0.0057673,0.028847,0,0
4,GO RRNA METABOLIC PROCESS,0.89215,0.005711,-0.004833,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.10654,0.0055791,0.045863,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.56075,0.0055021,-0.032228,0,0
4,GO THYMUS DEVELOPMENT,0.97557,0.0054596,-0.0075126,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.71006,0.0053035,-0.012619,0,0
4,GO PROTEIN NEDDYLATION,0.53167,0.0049875,-0.04031,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.42855,0.0049476,0.033126,0,0
4,GO CENTROSOME SEPARATION,0.92682,0.0049136,0.01706,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.89215,0.0048527,-0.0018315,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.73628,0.0048396,-0.053264,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.60883,0.0047877,0.023214,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.9686,0.0043722,0.0016527,0,0
4,GO NEURAL TUBE FORMATION,0.74288,0.0043032,-0.025399,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.44924,0.0041961,-0.041455,0,0
4,GO RIBOSOME BIOGENESIS,0.89215,0.0040756,-0.0084806,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.92682,0.003977,-0.0019609,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.80989,0.0039272,-0.030354,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.69707,0.0038851,-0.019935,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.59664,0.0037098,0.064547,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.21256,0.0036031,0.10635,0,0
4,GO RESPONSE TO SALT STRESS,0.89215,0.0033891,-0.042937,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.49227,0.0033647,0.035082,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.79636,0.0033347,-0.0071943,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.93377,0.0033181,-0.010573,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.71658,0.0032827,0.0037275,0,0
4,GO AXIS SPECIFICATION,0.85768,0.0032499,0.009444,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.54321,0.003237,-0.079541,0,0
4,GO NUCLEUS ORGANIZATION,0.66501,0.0032186,0.017894,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.9686,0.0031868,-0.0095721,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.55487,0.0031868,0.024221,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.67776,0.0030511,0.0084558,0,0
4,GO PORE COMPLEX ASSEMBLY,0.9686,0.0030176,0.0084361,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.70355,0.0028385,0.036388,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.79636,0.0026829,0.0045636,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.85768,0.0026287,0.0013283,0,0
4,GO GENE SILENCING,0.88523,0.0026218,-0.0086712,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.94769,0.0025523,-0.0030458,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.62732,0.0025241,-0.023591,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.65866,0.0023919,-0.090823,0,0
4,GO MAST CELL MIGRATION,0.94073,0.002289,-0.0019988,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.77618,0.0022233,-0.032833,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.49227,0.002079,0.067733,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.25729,0.0020693,-0.071742,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.89907,0.0017845,-0.00027088,0,0
4,GO NCRNA TRANSCRIPTION,0.35153,0.0016621,-0.046084,0,0
4,GO CELLULAR RESPONSE TO ATP,0.71006,0.0013033,0.034714,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.76948,0.0011253,0.064874,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.8303,0.001125,-0.0093253,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.70355,0.0010698,-0.075497,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.52025,0.0010561,-0.052977,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.94769,0.00099671,0.057852,0,0
4,GO PROTEIN NITROSYLATION,0.59664,0.00099404,-0.070532,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.8303,0.00045089,-9.9977e-05,0,0
4,GO REGULATION OF CELL SHAPE,0.59059,0.00034061,0.0056359,0,0
4,GO HEART TRABECULA FORMATION,0.31653,0.0003164,0.14378,0,0
4,GO OVULATION,0.4545,0.00021118,0.074631,0,0
4,GO CELL CELL SIGNALING,0.85082,0.00020379,0.0026086,0,0
4,GO ORGANELLE ASSEMBLY,0.95466,0.00019558,-0.0048833,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.59664,0.00019282,-0.022397,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.83713,0.00018724,0.063944,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.90599,-9.7957e-05,-0.028552,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.63354,-0.0001431,-0.017322,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.42347,-0.00014456,0.062391,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.8303,-0.00021615,-0.023913,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.86455,-0.00023073,-0.0065916,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.83713,-0.00023917,0.023639,0,0
4,GO NEPHRON MORPHOGENESIS,0.99651,-0.00026506,-0.0026095,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.96163,-0.00027321,-0.0013493,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.95466,-0.00049884,-0.0086948,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.41842,-0.00080327,-0.026663,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.93377,-0.00088807,-0.016338,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.87144,-0.00089449,0.0020969,0,0
4,GO REGULATION OF RNA BINDING,0.48131,-0.00092479,-0.065657,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.67137,-0.00095972,-0.018385,0,0
4,GO MESODERM DEVELOPMENT,0.43883,-0.0011554,-0.04759,0,0
4,GO LOCOMOTORY BEHAVIOR,0.90599,-0.0011554,0.031024,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.96163,-0.0012966,-0.0061892,0,0
4,GO HYPOTONIC RESPONSE,0.59059,-0.0013745,-0.071425,0,0
4,GO SULFATION,0.97557,-0.0014007,-0.0016516,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.86455,-0.0014374,0.024468,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.87144,-0.0017773,0.00068901,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.39371,-0.0018082,0.031757,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.89215,-0.0018616,-0.0087895,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.9686,-0.0019052,-0.0027728,0,0
4,GO LIVER REGENERATION,0.36526,-0.002251,0.048549,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.74288,-0.0023913,-0.040387,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.83713,-0.0024903,-0.014434,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.40349,-0.0025105,0.090977,0,0
4,GO STRIATUM DEVELOPMENT,0.47049,-0.0027939,0.077643,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.85768,-0.0028882,-0.00089147,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.76948,-0.0033367,-0.024637,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.68418,-0.0033842,0.011157,0,0
4,GO NEURON APOPTOTIC PROCESS,0.90599,-0.0034004,0.0045114,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.94073,-0.0034902,0.017933,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.76281,-0.0035149,-0.037585,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.82348,-0.0035256,-0.0034497,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.94073,-0.0036472,-0.013673,0,0
4,GO FAT CELL PROLIFERATION,0.98255,-0.0039363,0.020332,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.87144,-0.0039395,-0.026125,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.91293,-0.0039985,0.0060439,0,0
4,GO MITOTIC CYTOKINESIS,0.4545,-0.0041427,-0.03203,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.98255,-0.0041523,-0.056968,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.41842,-0.0041873,0.027406,0,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.88523,-0.0042236,-0.04887,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.67776,-0.0042473,0.028131,0,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.57857,-0.004333,-0.066448,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.85082,-0.0043654,-0.018701,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.60272,-0.0044112,0.02999,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.62113,-0.0045812,-0.053584,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.47588,-0.0046548,0.021204,0,0
4,GO LIPID PHOSPHORYLATION,0.67776,-0.0047318,0.037344,0,0
4,GO METANEPHROS MORPHOGENESIS,0.75615,-0.0047559,0.021648,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.90599,-0.0048199,0.003917,0,0
4,GO MISMATCH REPAIR,0.69061,-0.0048811,-0.026906,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.79636,-0.0049153,0.0015689,0,0
4,GO GLYCINE METABOLIC PROCESS,0.7495,-0.0049271,0.029886,0,0
4,GO GROWTH HORMONE SECRETION,0.80312,-0.0049312,0.051015,0,0
4,GO RESPONSE TO MANGANESE ION,0.41842,-0.0050432,0.084494,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.65866,-0.0050746,-0.013096,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.44924,-0.0051114,-0.024069,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.73628,-0.0051204,-0.01356,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.85768,-0.0051216,-0.0095597,0,0
4,GO DNA METHYLATION,0.80989,-0.0052058,0.0096575,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.50896,-0.0052619,0.026191,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.86455,-0.0053101,-0.00087712,0,0
4,GO RESPONSE TO ATP,0.89215,-0.0053677,0.023522,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.99651,-0.0054353,-0.0022372,0,0
4,GO MESENCHYME MORPHOGENESIS,0.85768,-0.0055283,-0.045439,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.63354,-0.0057975,-0.025481,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.99651,-0.0058365,0.0026382,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.76281,-0.0059077,-0.01803,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.89907,-0.0060714,0.029151,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.87833,-0.0061337,-0.0032585,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.83713,-0.0061779,-0.050727,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.71006,-0.0062157,-0.019906,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.62113,-0.006267,-0.074855,0,0
4,GO OVULATION CYCLE,0.98953,-0.0063929,0.0067082,0,0
4,GO CELL JUNCTION ORGANIZATION,0.94073,-0.0064762,-0.0095652,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.29184,-0.0064846,-0.085109,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.51459,-0.0068238,-0.029238,0,0
4,GO MYELIN ASSEMBLY,0.66501,-0.0069621,0.032051,0,0
4,GO NODAL SIGNALING PATHWAY,0.90599,-0.0071763,-0.013667,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.76948,-0.0072477,-0.073141,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.72969,-0.0076424,-0.037371,0,0
4,GO GROWTH,0.85082,-0.0077548,-0.01372,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.60272,-0.007842,-0.027097,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.81668,-0.0078619,-0.034154,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.93377,-0.0078673,0.011597,0,0
4,GO MESENCHYME DEVELOPMENT,0.3746,-0.0080495,-0.063311,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.85768,-0.0081162,-0.028323,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.48678,-0.0082446,-0.062523,0,0
4,GO HISTONE ARGININE METHYLATION,0.91293,-0.0085445,0.0071129,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.96163,-0.0086171,-0.010709,0,0
4,GO EMBRYO DEVELOPMENT,0.72969,-0.0086607,-0.014974,0,0
4,GO TOOTH MINERALIZATION,0.50896,-0.0086739,-0.068159,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.90599,-0.0087498,0.0025823,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.93377,-0.0087704,-0.037307,0,0
4,GO TELOMERE ORGANIZATION,0.41341,-0.0089091,-0.040608,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.94769,-0.0089108,0.00029842,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.71006,-0.0090009,0.03712,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.24643,-0.009062,-0.13077,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.34256,-0.0093739,0.05124,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.73628,-0.009529,0.010809,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.30815,-0.0098002,-0.081708,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.91987,-0.0098712,0.015002,0,0
4,GO CELL PROJECTION ASSEMBLY,0.42347,-0.0098957,-0.026533,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.5726,-0.010061,-0.013484,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.34702,-0.010099,-0.02692,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.63354,-0.010114,0.042233,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.78962,-0.010172,-0.015563,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.63978,-0.010176,-0.10335,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.48678,-0.010179,-0.02796,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.49227,-0.0102,-0.043007,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.62113,-0.010209,-0.028832,0,0
4,GO RNA POLYADENYLATION,0.33373,-0.010402,-0.046486,0,0
4,GO RNA PROCESSING,0.43367,-0.010418,-0.036466,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.96163,-0.010434,-0.013965,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.47588,-0.010523,0.075843,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.78962,-0.010628,0.015528,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.63978,-0.0108,0.018272,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.93377,-0.0108,0.015017,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.85082,-0.010894,-0.035421,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.59059,-0.011012,-0.068339,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.92682,-0.011296,0.0019947,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.57857,-0.01154,0.050556,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.58456,-0.011586,-0.017935,0,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.83713,-0.011604,0.015474,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.43367,-0.01176,-0.029031,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.64605,-0.011818,-0.062329,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.68418,-0.012058,-0.023117,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.89215,-0.01211,-0.0096681,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.60883,-0.012126,-0.042022,0,0
4,GO RECEPTOR RECYCLING,0.62113,-0.012315,0.039115,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80312,-0.012416,-0.008576,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.43883,-0.012524,-0.036309,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.74288,-0.01255,0.038784,0,0
4,GO ACTIN CROSSLINK FORMATION,0.24288,-0.012591,-0.10019,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.31232,-0.012612,-0.063549,0,0
4,GO MIRNA METABOLIC PROCESS,0.69707,-0.012755,-0.022558,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.76948,-0.013049,-0.013515,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.88523,-0.013183,0.01855,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.60883,-0.013293,-0.049612,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.62113,-0.01331,-0.018857,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.99651,-0.013363,0.0077185,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.84397,-0.013417,-0.026914,0,0
4,GO PROTEIN ACYLATION,0.41341,-0.013425,-0.015301,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.59059,-0.013471,-0.012108,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.88523,-0.01358,-0.05886,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.65866,-0.013582,0.02713,0,0
4,GO NOSE DEVELOPMENT,0.99651,-0.013647,0.10227,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.49227,-0.013743,0.043763,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.8303,-0.0138,0.080912,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.99651,-0.013829,-0.0056176,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.72969,-0.014215,-0.022828,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.26098,-0.014349,0.074973,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.65234,-0.014678,0.013225,0,0
4,GO CELL FATE COMMITMENT,0.56666,-0.014725,-0.021189,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.61497,-0.014859,0.055188,0,0
4,GO RRNA METHYLATION,0.93377,-0.014975,-0.0025088,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.79636,-0.01498,-0.034694,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.7495,-0.015017,0.010392,0,0
4,GO PROTEIN DENEDDYLATION,0.74288,-0.015244,-0.019523,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.35607,-0.015257,-0.14955,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.40843,-0.01549,-0.042865,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.19393,-0.015562,-0.066662,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.77618,-0.015611,0.084169,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.71006,-0.015621,-0.016076,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.94769,-0.015676,0.0289,0,0
4,GO REGULATION OF GENE SILENCING,0.84397,-0.015886,-0.02292,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.82348,-0.015887,-0.005628,0,0
4,GO PROTEIN SUMOYLATION,0.37932,-0.015912,-0.026118,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.94769,-0.016074,-0.022594,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.62113,-0.016214,0.030313,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.67137,-0.016352,0.062729,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.8303,-0.016396,-0.066572,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.84397,-0.01667,0.0060883,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.78962,-0.016683,-0.055041,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.40843,-0.016742,-0.066046,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.90599,-0.016746,-0.002842,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.48131,-0.016941,0.031786,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.43883,-0.01695,-0.056797,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.50337,-0.016966,-0.046843,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.85082,-0.017036,-0.033385,0,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.65866,-0.017069,0.022368,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.63354,-0.017132,0.069385,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.85768,-0.017284,0.011876,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.2,-0.017329,-0.046893,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.83713,-0.017357,0.017474,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.23937,-0.017421,-0.051593,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.92682,-0.017487,0.014793,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.93377,-0.017848,0.011709,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.4978,-0.017862,-0.03161,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.61497,-0.01799,-0.027964,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.85768,-0.018023,-0.010839,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.62732,-0.018063,-0.043674,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.5726,-0.018162,-0.055423,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.40349,-0.018231,-0.067178,0,0
4,GO MATING BEHAVIOR,0.85082,-0.018315,-0.035126,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.64605,-0.018348,-0.042566,0,0
4,GO RNA LOCALIZATION,0.15264,-0.018488,-0.069103,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.13583,-0.018624,-0.069155,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.89907,-0.018636,-0.0058944,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.62732,-0.018674,-0.042394,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.63978,-0.018759,-0.023558,0,0
4,GO DENDRITE EXTENSION,0.89215,-0.018793,0.074042,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.56075,-0.018819,-0.035042,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.23589,-0.018833,-0.051286,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.84397,-0.018905,-0.0055059,0,0
4,GO CYTOKINESIS,0.25363,-0.019,-0.036024,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.54321,-0.019063,-0.028631,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.76948,-0.019244,-0.031069,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.53742,-0.019426,0.042608,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.39371,-0.019472,-0.022692,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.85768,-0.019547,-0.019335,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.64605,-0.019656,0.039775,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.99651,-0.019747,-0.018885,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.80312,-0.019787,-0.061269,0,0
4,GO RHYTHMIC BEHAVIOR,0.93377,-0.020152,0.025127,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.78289,-0.020162,0.053232,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.61497,-0.02022,-0.017598,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.20937,-0.02024,-0.064434,0,0
4,GO ACROSOME REACTION,0.25363,-0.020284,0.11672,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.52594,-0.020441,-0.021716,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.98953,-0.020628,-0.0045776,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.29992,-0.020631,-0.047505,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.54903,-0.020641,0.093184,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.39858,-0.020756,-0.021313,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.88523,-0.020789,0.018667,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.52594,-0.02082,-0.081303,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.19095,-0.020929,-0.094584,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.21256,-0.020983,-0.05635,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.47588,-0.021072,-0.05546,0,0
4,GO FIBROBLAST ACTIVATION,0.97557,-0.021258,-0.023427,0,0
4,GO CELL CELL SIGNALING BY WNT,0.36991,-0.021332,-0.036092,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.76948,-0.02136,-0.03027,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.53742,-0.021503,0.11383,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.22568,-0.021589,-0.074129,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.63354,-0.021608,-0.014705,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.70355,-0.021625,-0.026299,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.47049,-0.021644,-0.026921,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.91987,-0.021704,0.01724,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.50896,-0.021819,-0.051254,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.40843,-0.021921,-0.059358,0,0
4,GO HISTONE MONOUBIQUITINATION,0.20937,-0.021926,-0.052989,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.70355,-0.021947,-0.019527,0,0
4,GO REGULATION OF CELL CYCLE,0.81668,-0.021961,-0.004588,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.36064,-0.021968,0.08062,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.86455,-0.022102,0.05009,0,0
4,GO NUCLEAR EXPORT,0.36991,-0.02217,-0.046209,0,0
4,GO MICROVILLUS ASSEMBLY,0.85768,-0.022222,-0.0063504,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.94769,-0.022294,0.0037363,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.72313,-0.022309,-0.020419,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.44402,-0.022356,-0.080476,0,0
4,GO BRONCHUS DEVELOPMENT,0.95466,-0.022403,0.019973,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.67776,-0.02253,-0.030479,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.89907,-0.022617,-0.01395,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.87833,-0.022797,-0.049597,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.46512,-0.022839,-0.073651,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.27611,-0.022855,-0.034813,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.099158,-0.022925,-0.085447,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.80989,-0.022927,0.0039235,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.71658,-0.022951,-0.0067204,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.48131,-0.022951,-0.065959,0,0
4,GO RNA SURVEILLANCE,0.67137,-0.023094,-0.026065,0,0
4,GO HEART FIELD SPECIFICATION,0.72969,-0.023252,-0.035284,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.91293,-0.023306,0.0033113,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.63978,-0.023314,-0.029235,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.5726,-0.023377,-0.067512,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.56075,-0.023553,-0.070042,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.60883,-0.02364,0.13539,0,0
4,GO RRNA MODIFICATION,0.95466,-0.023728,-0.019645,0,0
4,GO TUBE FORMATION,0.49227,-0.023794,-0.041386,0,0
4,GO MATURATION OF SSU RRNA,0.94769,-0.02394,-0.031267,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.35607,-0.023958,-0.07606,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.65866,-0.023972,-0.031518,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.69707,-0.02399,-0.03304,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.73628,-0.024029,0.025759,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.91293,-0.024063,-0.013811,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.86455,-0.024185,0.014391,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.36991,-0.024307,-0.09596,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.23937,-0.024459,-0.054724,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.69707,-0.024511,-0.044496,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.2839,-0.02461,-0.084552,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.80312,-0.024621,0.025105,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.76281,-0.024643,0.015143,0,0
4,GO CYTOSKELETON ORGANIZATION,0.58456,-0.024675,-0.02005,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.93377,-0.024823,-0.0014587,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.96163,-0.02483,-0.0027437,0,0
4,GO CELL JUNCTION MAINTENANCE,0.57857,-0.024832,-0.038909,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.53742,-0.024861,-0.017722,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.91987,-0.024988,-1.3572e-05,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.21905,-0.025042,-0.067584,0,0
4,GO CELL CYCLE CHECKPOINT,0.29184,-0.025048,-0.027655,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.77618,-0.025074,0.044157,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.35607,-0.025157,-0.039656,0,0
4,GO MRNA TRANSCRIPTION,0.4978,-0.025321,-0.04714,0,0
4,GO SLEEP,0.94769,-0.025636,0.0033635,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.43367,-0.025747,-0.047878,0,0
4,GO HEART DEVELOPMENT,0.58456,-0.02577,-0.029449,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.71006,-0.025932,-0.0063878,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.41842,-0.025936,-0.017037,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.71658,-0.026073,-0.044447,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.79636,-0.026098,0.038472,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.5726,-0.026317,-0.034199,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.54903,-0.026352,-0.029693,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.4598,-0.02646,-0.017554,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.81668,-0.026477,0.024983,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.65866,-0.026523,-0.012394,0,0
4,GO CHROMOSOME LOCALIZATION,0.39858,-0.026631,-0.029276,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.24288,-0.026726,-0.039143,0,0
4,GO RESPONSE TO COCAINE,0.71006,-0.026744,-0.014886,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.10465,-0.026987,-0.13872,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.96163,-0.026988,0.0036941,0,0
4,GO BEHAVIOR,0.87833,-0.027167,-0.0015112,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.98953,-0.027181,0.0020346,0,0
4,GO CELL CYCLE,0.54321,-0.027196,-0.015852,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.43883,-0.027233,-0.049457,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.68418,-0.02726,-0.038373,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.41341,-0.027476,-0.069226,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.59059,-0.027674,-0.025412,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.39858,-0.027772,-0.04796,0,0
4,GO NUCLEAR TRANSPORT,0.67776,-0.027835,-0.017641,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.63978,-0.028116,-0.044178,0,0
4,GO RECEPTOR INTERNALIZATION,0.2839,-0.028176,-0.062836,0,0
4,GO RRNA 3 END PROCESSING,0.85082,-0.02818,-0.0076592,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1,-0.028237,-0.0043044,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.15015,-0.028263,-0.087061,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.25363,-0.028321,-0.058985,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.57857,-0.028375,0.009466,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.29586,-0.028494,-0.049367,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.86455,-0.028502,-0.024023,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.027188,-0.02868,-0.055507,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.44924,-0.028729,-0.096407,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.51459,-0.028732,-0.055824,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.62113,-0.028796,-0.018752,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.14048,-0.02928,-0.08344,0,0
4,GO PROTEIN KINASE A SIGNALING,0.35607,-0.029519,-0.057037,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.29586,-0.029576,-0.024727,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.28785,-0.029633,-0.028454,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.54321,-0.029652,-0.0044631,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.89907,-0.029675,-0.006355,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.81668,-0.029731,0.009887,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.21579,-0.02976,-0.057477,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.27611,-0.029792,-0.053618,0,0
4,GO RESPONSE TO UV,0.23589,-0.029819,-0.044233,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.43367,-0.029987,-0.036444,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.79636,-0.030054,-0.021909,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.17374,-0.030079,-0.1024,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.16828,-0.030223,-0.092384,0,0
4,GO EMBRYO IMPLANTATION,0.8303,-0.030245,-0.01363,0,0
4,GO SNRNA TRANSCRIPTION,0.16559,-0.030362,-0.04956,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.4545,-0.030682,-0.086216,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.90599,-0.030689,0.0019938,0,0
4,GO REGULATION OF GTP BINDING,0.77618,-0.030724,-0.0468,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.51459,-0.030749,-0.043315,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.15015,-0.030917,-0.045263,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.26471,-0.030991,-0.033661,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.15517,-0.031004,-0.031651,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.91987,-0.031052,-0.011647,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.54321,-0.031066,-0.056401,0,0
4,GO DEMETHYLATION,0.85768,-0.03114,-0.010178,0,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.86455,-0.031253,0.047733,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.4598,-0.031471,-0.035887,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.27611,-0.031475,-0.062077,0,0
4,GO RESPONSE TO VITAMIN A,0.46512,-0.031562,-0.073221,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.80989,-0.031588,-0.024116,0,0
4,GO MEMORY,0.55487,-0.031596,-0.027211,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.65234,-0.031709,0.027733,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.19695,-0.031843,-0.037319,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.70355,-0.031924,-0.027443,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.62732,-0.031966,-0.014577,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.53167,-0.032045,-0.050299,0,0
4,GO HISTONE PHOSPHORYLATION,0.77618,-0.032227,-0.013174,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.14526,-0.032352,-0.030959,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.93377,-0.032356,-0.00063514,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.52594,-0.032452,-0.040309,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.98255,-0.032492,-0.052514,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.97557,-0.03258,0.018274,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.69061,-0.032753,-0.025825,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.32506,-0.032815,-0.043067,0,0
4,GO HEAT GENERATION,0.85768,-0.032861,0.021496,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.36526,-0.032969,-0.051979,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.67137,-0.033022,-0.022777,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.52594,-0.033102,-0.071414,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.22905,-0.033118,-0.088071,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.72313,-0.033254,-0.046091,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.56075,-0.033399,-0.033204,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.17374,-0.033557,-0.042076,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.60883,-0.033728,0.035361,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.34702,-0.03373,-0.056773,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.15517,-0.033769,-0.065214,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.61497,-0.033813,-0.029985,0,0
4,GO PROTEIN POLYMERIZATION,0.76281,-0.033862,-0.011932,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.53742,-0.034335,-0.032101,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.10845,-0.034338,-0.071426,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.81668,-0.03452,-0.069388,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.89215,-0.034716,-0.0097383,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.46512,-0.034749,-0.064983,0,0
4,GO MRNA METHYLATION,0.43883,-0.034825,-0.048296,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.7495,-0.034901,-0.0084355,0,0
4,GO STEM CELL DIFFERENTIATION,0.32077,-0.035093,-0.038477,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.29586,-0.035155,-0.059136,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.27611,-0.035373,-0.10164,0,0
4,GO OXIDATIVE DEMETHYLATION,0.3746,-0.035383,-0.033921,0,0
4,GO DNA METABOLIC PROCESS,0.25001,-0.035413,-0.026513,0,0
4,GO CHONDROCYTE PROLIFERATION,0.23245,-0.035419,-0.1444,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.47049,-0.035895,-0.013827,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.62113,-0.036107,-0.0097819,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.73628,-0.036191,-0.029422,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.33812,-0.036202,-0.054538,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.63354,-0.036213,-0.039915,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.82348,-0.036399,-0.011516,0,0
4,GO REGULATION OF CYTOKINESIS,0.25001,-0.03642,-0.034975,0,0
4,GO HISTONE H4 ACETYLATION,0.16828,-0.036449,-0.040817,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.32938,-0.036458,-0.081883,0,0
4,GO VIRAL TRANSLATION,0.34256,-0.036513,-0.094061,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.64605,-0.036625,-0.024056,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.50896,-0.036667,-0.04419,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.36526,-0.036709,-0.02939,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.50896,-0.036898,-0.027143,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.5726,-0.036972,-0.029526,0,0
4,GO BONE DEVELOPMENT,0.20937,-0.036974,-0.071741,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.26098,-0.037074,-0.025293,0,0
4,GO CGMP MEDIATED SIGNALING,0.77618,-0.037154,-0.0085909,0,0
4,GO DNA REPAIR,0.057089,-0.037565,-0.044865,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.49227,-0.037954,0.19419,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.77618,-0.03801,-0.021582,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.87833,-0.038173,0.016857,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.56075,-0.038231,-0.064462,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.065563,-0.038582,-0.084215,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.95466,-0.038624,0.012937,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.42855,-0.03882,-0.057394,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.57857,-0.038838,-0.099177,0,0
4,GO VIRAL LATENCY,0.16294,-0.038953,-0.11841,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,-0.03931,0.020195,0,0
4,GO METAPHASE PLATE CONGRESSION,0.46512,-0.039602,-0.018471,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.58456,-0.039687,-0.062034,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.42347,-0.039863,-0.081566,0,0
4,GO ACROSOME ASSEMBLY,0.27227,-0.039946,-0.076107,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.20309,-0.040125,-0.14341,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.20621,-0.040274,-0.097705,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.76948,-0.040407,-0.0075855,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.14769,-0.040479,-0.07018,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.81668,-0.040562,-0.041972,0,0
4,GO NEUROMUSCULAR PROCESS,0.30815,-0.040712,-0.061267,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.72313,-0.040776,0.05004,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.42347,-0.040838,-0.027186,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.55487,-0.040921,-0.03222,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.27999,-0.041224,-0.053789,0,0
4,GO SPINDLE ASSEMBLY,0.17653,-0.041367,-0.037278,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.71006,-0.041373,-0.044389,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.48131,-0.041385,-0.065645,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.51459,-0.041557,-0.042722,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.56666,-0.041606,-0.056897,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.89907,-0.04173,-0.0046925,0,0
4,GO SPECIFICATION OF SYMMETRY,0.29586,-0.041761,-0.047226,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.10096,-0.041832,-0.037419,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.59059,-0.041887,-0.053317,0,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.42855,-0.041936,-0.063615,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.44924,-0.042036,-0.024099,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.19095,-0.042041,-0.067799,0,0
4,GO CELL CYCLE PROCESS,0.077957,-0.042373,-0.03343,0,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.14526,-0.042647,-0.083156,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.47588,-0.042688,-0.046159,0,0
4,GO REGULATION OF GLIOGENESIS,0.79636,-0.042736,-0.00060128,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.76281,-0.043019,-0.019162,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.89215,-0.043059,-0.023924,0,0
4,GO PROTEIN METHYLATION,0.15517,-0.04314,-0.03077,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.78289,-0.043184,0.0085346,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.65234,-0.043379,-0.042196,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.41341,-0.04376,-0.030751,0,0
4,GO TRNA TRANSPORT,0.42347,-0.043769,-0.058804,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.71658,-0.044313,-0.035211,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.58456,-0.044345,-0.025628,0,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.3746,-0.044669,-0.075233,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.94073,-0.044677,0.002249,0,0
4,GO CENTROSOME DUPLICATION,0.44924,-0.044841,-0.026363,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.68418,-0.044846,-0.029323,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.47588,-0.044974,-0.019389,0,0
4,GO REGULATION OF CELL DIVISION,0.63354,-0.045086,-0.016715,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.17099,-0.045107,-0.032033,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.69707,-0.045199,-0.031377,0,0
4,GO ORGAN GROWTH,0.13355,-0.045302,-0.075792,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.81668,-0.045424,-0.019039,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.78962,-0.045545,0.082604,0,0
4,GO RNA DESTABILIZATION,0.56666,-0.04561,-0.041765,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.18508,-0.045621,-0.053407,0,0
4,GO FIBROBLAST MIGRATION,0.59059,-0.045862,-0.04218,0,0
4,GO HISTONE H2A ACETYLATION,0.36064,-0.04595,-0.064616,0,0
4,GO MEMBRANE DOCKING,0.27611,-0.046085,-0.027542,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.65234,-0.046162,-0.14257,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.44924,-0.046673,-0.035014,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.39858,-0.046691,-0.035202,0,0
4,GO MRNA METABOLIC PROCESS,0.17934,-0.046781,-0.047967,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.38888,-0.046864,-0.10088,0,0
4,GO EAR MORPHOGENESIS,0.29586,-0.046932,-0.059493,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.10654,-0.047061,-0.085108,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.063042,-0.047172,-0.092358,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.11636,-0.04723,-0.034825,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.78962,-0.047316,0.037428,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.23245,-0.047438,-0.064612,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.36064,-0.04744,-0.062055,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.69707,-0.047509,-0.033775,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.87833,-0.047661,-0.027392,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.11636,-0.047706,-0.082358,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.50896,-0.047765,-0.047252,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.35153,-0.048077,-0.089652,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.30815,-0.048081,-0.066091,0,0
4,GO MIDBRAIN DEVELOPMENT,0.21905,-0.048133,-0.044534,0,0
4,GO RNA CAPPING,0.43367,-0.04816,-0.034526,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.97557,-0.04818,0.037985,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.79636,-0.048219,-0.0066695,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.57857,-0.048308,-0.038114,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.50896,-0.048567,-0.031487,0,0
4,GO OVULATION CYCLE PROCESS,0.90599,-0.04867,0.0252,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.33812,-0.048796,-0.06588,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.10465,-0.049041,-0.045498,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.74288,-0.049417,-0.049148,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.32938,-0.049546,-0.068016,0,0
4,GO RNA 3 END PROCESSING,0.22568,-0.049772,-0.059437,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.12473,-0.049797,-0.057813,0,0
4,GO PROTEIN ACETYLATION,0.065563,-0.049997,-0.034978,0,0
4,GO RETINA LAYER FORMATION,0.63978,-0.050294,-0.0074931,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.52025,-0.0504,-0.03854,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.55487,-0.05048,-0.029664,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.55487,-0.050655,0.060388,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.40843,-0.050679,-0.10479,0,0
4,GO HISTONE UBIQUITINATION,0.12689,-0.050728,-0.053132,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.72313,-0.050834,-0.025477,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.20621,-0.051036,-0.068973,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.40349,-0.051132,-0.037937,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.23245,-0.051283,-0.051386,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.42347,-0.05134,-0.1123,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.2,-0.051399,-0.11643,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.23589,-0.051587,-0.063427,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.83713,-0.051594,-0.012662,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.11841,-0.051694,-0.066908,0,0
4,GO THYROID GLAND DEVELOPMENT,0.14285,-0.052154,-0.14679,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.42855,-0.052475,-0.014711,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.85768,-0.052698,0.012364,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.72313,-0.052852,-0.03033,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.31232,-0.052881,-0.051166,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.32506,-0.052948,-0.031579,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.21579,-0.052992,-0.083106,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.29586,-0.053314,-0.042948,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.33373,-0.053426,-0.052245,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.39858,-0.053575,-0.097817,0,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.010773,-0.053629,-0.093397,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.36064,-0.053805,-0.052909,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.71006,-0.053833,0.014049,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.19695,-0.05403,-0.14646,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.32938,-0.054056,-0.043707,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.48131,-0.054086,-0.07886,0,0
4,GO MITOTIC CELL CYCLE,0.11434,-0.054253,-0.034629,0,0
4,GO FOREGUT MORPHOGENESIS,0.11235,-0.054261,-0.12905,0,0
4,GO REGULATION OF DNA BINDING,0.21256,-0.054306,-0.036096,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.34702,-0.054311,-0.070573,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.67776,-0.054397,-0.010569,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.41842,-0.054482,-0.03454,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.72313,-0.0545,0.011436,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.13814,-0.054774,-0.11114,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.29992,-0.054801,-0.080612,0,0
4,GO HISTONE METHYLATION,0.031059,-0.054826,-0.060969,0,0
4,GO RUFFLE ASSEMBLY,0.76948,-0.054946,0.032782,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.17099,-0.055203,-0.049827,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.59664,-0.05555,0.1045,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.13814,-0.05563,-0.06985,0,0
4,GO ASYMMETRIC CELL DIVISION,0.64605,-0.055704,-0.050045,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.12473,-0.055746,-0.074073,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.30815,-0.056041,-0.058316,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.16828,-0.056149,-0.093067,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36526,-0.056187,-0.071611,0,0
4,GO EYE MORPHOGENESIS,0.24643,-0.056271,-0.058872,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.12473,-0.056451,-0.14778,0,0
4,GO HISTONE H3 K4 METHYLATION,0.1028,-0.05663,-0.058505,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.91987,-0.056697,-0.020556,0,0
4,GO REGULATION OF OOGENESIS,0.62113,-0.056738,-0.0016911,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.4545,-0.056968,-0.02547,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.47049,-0.056979,-0.033564,0,0
4,GO GENITALIA MORPHOGENESIS,0.36526,-0.056984,-0.11429,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.11434,-0.057162,-0.064885,0,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.097379,-0.057195,-0.061394,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.41842,-0.05722,-0.044298,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.60883,-0.057404,-0.048861,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15264,-0.057436,-0.092125,0,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.16559,-0.057899,-0.060461,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.61497,-0.058024,-0.040214,0,0
4,GO RENAL FILTRATION,0.76281,-0.05813,-0.0070467,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.36991,-0.058136,-0.12268,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.22235,-0.058151,-0.12997,0,0
4,GO ARTERY DEVELOPMENT,0.25363,-0.058181,-0.078127,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.29184,-0.058194,-0.060885,0,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.12689,-0.058408,-0.058783,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.92682,-0.058518,-0.0050384,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.72313,-0.058763,-0.018306,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.14285,-0.05907,-0.09325,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.33373,-0.059178,-0.047828,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.90599,-0.059221,-0.022421,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.13814,-0.059367,-0.063711,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.42347,-0.059445,-0.14234,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.4978,-0.05971,-0.041247,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.47588,-0.05988,-0.090478,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.58456,-0.060002,-0.045544,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.88523,-0.060074,-0.032712,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.35153,-0.060821,-0.082879,0,0
4,GO MATURATION OF LSU RRNA,0.68418,-0.061092,-0.069117,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.57857,-0.06124,-0.028007,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.088862,-0.061464,-0.1132,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.095625,-0.061666,-0.082833,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.43367,-0.06182,-0.032551,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.36526,-0.062008,-0.0547,0,0
4,GO HINDBRAIN DEVELOPMENT,0.71658,-0.062292,-0.017343,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.49227,-0.062363,-0.038804,0,0
4,GO REGULATION OF CELL SIZE,0.087232,-0.062432,-0.096674,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.50337,-0.06247,-0.028879,0,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.065563,-0.062519,-0.091207,0,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.4978,-0.062636,-0.052513,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.64605,-0.063017,-0.046727,0,0
4,GO CILIUM ORGANIZATION,0.15015,-0.063199,-0.054966,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.59059,-0.063443,-0.10431,0,0
4,GO CELLULAR RESPONSE TO PH,0.32938,-0.063651,-0.063101,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.48131,-0.063868,-0.044169,0,0
4,GO DNA RECOMBINATION,0.11636,-0.064102,-0.042377,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.97557,-0.06414,0.02683,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.41341,-0.064168,-0.14746,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.26847,-0.064203,-0.085183,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18508,-0.064245,-0.10961,0,0
4,GO SEQUESTERING OF METAL ION,0.7495,-0.064592,-0.037252,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.4598,-0.064723,-0.015145,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.13583,-0.064838,-0.079484,0,0
4,GO METENCEPHALON DEVELOPMENT,0.3746,-0.064856,-0.031403,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.27611,-0.064926,-0.1083,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.71006,-0.064972,-0.0052007,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.32506,-0.065273,-0.11705,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.21905,-0.06546,-0.057881,0,0
4,GO VASCULOGENESIS,0.41341,-0.065787,-0.091617,0,0
4,GO RESPONSE TO DOPAMINE,0.77618,-0.065809,-0.0087546,0,0
4,GO MRNA CLEAVAGE,0.26098,-0.065953,-0.044868,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.057089,-0.066179,-0.083927,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.41842,-0.066225,-0.058696,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.79636,-0.066248,-0.035108,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.86455,-0.06647,-0.011102,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.32077,-0.066912,-0.092223,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.60883,-0.06701,-0.038959,0,0
4,GO EXIT FROM MITOSIS,0.46512,-0.067065,-0.02488,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.3746,-0.067097,-0.031908,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.8303,-0.06713,0.15161,0,0
4,GO DEVELOPMENTAL GROWTH,0.13814,-0.067364,-0.065103,0,0
4,GO HISTONE H2A UBIQUITINATION,0.12473,-0.067892,-0.075076,0,0
4,GO INNER EAR MORPHOGENESIS,0.16032,-0.06799,-0.073257,0,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.036164,-0.068249,-0.14458,0,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.36526,-0.068519,-0.068067,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.077957,-0.068544,-0.16971,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.29586,-0.068657,-0.04174,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.12259,-0.068679,-0.069013,0,0
4,GO GASTRIC ACID SECRETION,0.7495,-0.068788,0.028544,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.50896,-0.068823,-0.042266,0,0
4,GO TELOMERE CAPPING,0.20621,-0.068847,-0.041751,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.92682,-0.068866,-0.0096098,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.89215,-0.068888,0.036979,0,0
4,GO GANGLION DEVELOPMENT,0.78962,-0.069354,0.029392,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.35607,-0.069452,-0.066302,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.12689,-0.069559,-0.049821,0,0
4,GO HEART MORPHOGENESIS,0.21905,-0.069578,-0.06396,0,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.22905,-0.069612,-0.064046,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.068167,-0.069837,-0.087844,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.05161,-0.070136,-0.059922,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.079444,-0.070188,-0.082253,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.63978,-0.070238,-0.0508,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.28785,-0.070252,-0.16796,0,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.021165,-0.07031,-0.085015,0,0
4,GO HEART GROWTH,0.17934,-0.070474,-0.066283,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.76948,-0.070476,0.039752,0,0
4,GO ECTODERM DEVELOPMENT,0.27999,-0.070485,-0.066604,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.24643,-0.070501,-0.049375,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.94073,-0.070543,0.0087706,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.20937,-0.070597,-0.11752,0,0
4,GO CHROMATIN SILENCING,0.070855,-0.070903,-0.08033,0,0
4,GO MICROTUBULE ANCHORING,0.16559,-0.070942,-0.058627,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.40843,-0.071029,-0.082986,0,0
4,GO CELL RECOGNITION,0.2839,-0.071583,-0.066227,0,0
4,GO PROSTATIC BUD FORMATION,0.20621,-0.071723,-0.19485,0,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.20937,-0.071881,-0.064771,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.14285,-0.072011,-0.11794,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.0695,-0.072183,-0.084365,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.17934,-0.072563,-0.05382,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.12259,-0.072736,-0.11368,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.47049,-0.072891,-0.096832,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.27999,-0.073132,-0.081645,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.25729,-0.07314,-0.096455,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.088862,-0.073169,-0.13902,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.29992,-0.073293,-0.069211,0,0
4,GO RESPONSE TO AMYLOID BETA,0.4545,-0.073294,-0.034484,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.53167,-0.073714,-0.04257,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.14526,-0.073805,-0.054171,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.17099,-0.073819,-0.080788,0,0
4,GO BLASTOCYST GROWTH,0.44402,-0.073836,-0.027731,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.26847,-0.074135,-0.08284,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.49227,-0.074571,-0.031257,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.054842,-0.075389,-0.10022,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.025414,-0.075535,-0.058357,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0017641,-0.075545,-0.080998,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.60883,-0.075602,-0.028731,0,0
4,GO SNORNA METABOLIC PROCESS,0.17374,-0.075645,-0.099133,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.12689,-0.075656,-0.063103,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.73628,-0.075758,-0.036576,0,0
4,GO HISTONE H3 DEACETYLATION,0.15517,-0.075824,-0.07695,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.20309,-0.075986,-0.172,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.42347,-0.076061,-0.050326,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.97557,-0.076066,0.042649,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.061812,-0.076352,-0.066733,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.46512,-0.076507,-0.065952,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.84397,-0.076614,-0.0038441,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.14048,-0.076809,-0.05189,0,0
4,GO ADULT FEEDING BEHAVIOR,0.32077,-0.077099,-0.083959,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.4598,-0.077106,-0.057158,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.88523,-0.077352,0.042525,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.20937,-0.077383,-0.057174,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.1028,-0.077523,-0.055945,0,0
4,GO HAIR FOLLICLE MATURATION,0.50896,-0.077855,-0.055891,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.47588,-0.078133,-0.039248,0,0
4,GO MICROTUBULE NUCLEATION,0.12689,-0.078206,-0.067618,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.98953,-0.07832,-0.011656,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.0014299,-0.078352,-0.094144,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.19695,-0.078434,-0.083085,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.3746,-0.078464,-0.067674,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.041967,-0.078624,-0.064538,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.13583,-0.078967,-0.15274,0,0
4,GO MRNA TRANSPORT,0.054842,-0.079114,-0.080412,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.070855,-0.079286,-0.16912,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.16032,-0.079411,-0.078353,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.19393,-0.079414,-0.060762,0,0
4,GO WALKING BEHAVIOR,0.14526,-0.079427,-0.1122,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.50896,-0.079453,-0.013245,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.43367,-0.07963,-0.039591,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.59059,-0.079879,-0.057142,0,0
4,GO SISTER CHROMATID SEGREGATION,0.035393,-0.079998,-0.065092,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.13583,-0.080131,-0.086349,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.068167,-0.080132,-0.097704,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.20309,-0.080431,-0.12912,0,0
4,GO REGULATION OF BEHAVIOR,0.16294,-0.080472,-0.085534,0,0
4,GO NUCLEAR MIGRATION,0.18219,-0.080513,-0.099699,0,0
4,GO ANIMAL ORGAN FORMATION,0.05824,-0.080646,-0.11636,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.082489,-0.080725,-0.11812,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.22568,-0.081017,-0.11099,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.69061,-0.081018,-0.012204,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.10465,-0.081073,-0.069914,0,0
4,GO MICROTUBULE BASED PROCESS,0.0026572,-0.081194,-0.075335,0,0
4,GO COGNITION,0.11636,-0.081291,-0.079349,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.27999,-0.081298,-0.12479,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.15015,-0.081319,-0.065183,0,0
4,GO HEART VALVE DEVELOPMENT,0.34702,-0.081473,-0.066578,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.49227,-0.081561,-0.037053,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.097379,-0.081692,-0.12829,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.32938,-0.081767,-0.10787,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.31653,-0.081785,-0.048561,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.60883,-0.082083,-0.027049,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.038561,-0.082177,-0.062428,0,0
4,GO V D J RECOMBINATION,0.28785,-0.082195,-0.096338,0,0
4,GO PREPULSE INHIBITION,0.63354,-0.082202,-0.045445,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.36526,-0.082257,-0.12039,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.17374,-0.082311,-0.15668,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.068167,-0.082767,-0.078624,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.17653,-0.082932,-0.055296,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.59059,-0.083142,-0.10108,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.22905,-0.083991,-0.057545,0,0
4,GO TRABECULA FORMATION,0.57857,-0.084074,-0.062465,0,0
4,GO CONVERGENT EXTENSION,0.32506,-0.084125,-0.08524,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.40349,-0.084153,-0.05967,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.49227,-0.084195,-0.076441,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.0695,-0.08448,-0.10561,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.4598,-0.084534,-0.030854,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.26098,-0.084632,-0.071628,0,0
4,GO CELLULAR RESPONSE TO UV,0.1313,-0.084657,-0.060579,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.50337,-0.084808,-0.042698,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.027188,-0.084822,-0.096834,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.060602,-0.084943,-0.12547,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.17099,-0.085313,-0.048227,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.029068,-0.085394,-0.070963,0,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072231,-0.085537,-0.11321,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.0695,-0.086113,-0.083805,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.11434,-0.086974,-0.094344,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.63978,-0.087115,-0.010825,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.47049,-0.087193,-0.061636,0,0
4,GO DNA STRAND ELONGATION,0.084046,-0.087503,-0.096362,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.16559,-0.087585,-0.083934,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.43883,-0.087618,-0.076179,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.084046,-0.087756,-0.062162,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.22568,-0.087821,-0.071539,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.2839,-0.087843,-0.037543,0,0
4,GO SEROTONIN TRANSPORT,0.71006,-0.088026,-0.0018933,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.72313,-0.088076,-0.052613,0,0
4,GO TUBULIN DEACETYLATION,0.19393,-0.088078,-0.072844,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.15517,-0.088459,-0.057664,0,0
4,GO REGIONALIZATION,0.54321,-0.088851,-0.017111,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.10096,-0.089028,-0.10315,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.13355,-0.089653,-0.091113,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.31232,-0.089814,-0.06671,0,0
4,GO CELL MORPHOGENESIS,0.041093,-0.089966,-0.093336,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.10845,-0.090071,-0.091886,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.36526,-0.090193,-0.041753,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.4978,-0.090491,-0.033876,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.56666,-0.090667,-0.011832,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.12259,-0.090668,-0.065072,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.38888,-0.09068,-0.039616,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.29992,-0.09077,-0.10563,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.19393,-0.091058,-0.084702,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.50337,-0.091129,-0.06147,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.072231,-0.09115,-0.2443,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.13583,-0.091635,-0.071604,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.063042,-0.091829,-0.058934,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.097379,-0.091923,-0.10248,0,0
4,GO THALAMUS DEVELOPMENT,0.29992,-0.092041,-0.072609,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.32506,-0.092227,-0.078677,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.52594,-0.09227,-0.078773,0,0
4,GO SPINDLE ORGANIZATION,0.0036303,-0.09231,-0.083842,0,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.075049,-0.0924,-0.12166,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.18219,-0.092841,-0.088185,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.16032,-0.093003,-0.10323,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.15773,-0.093173,-0.06261,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.27999,-0.093534,-0.15714,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0051916,-0.093592,-0.13754,0,0
4,GO HISTONE DEUBIQUITINATION,0.13583,-0.094097,-0.05589,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.02166,-0.094216,-0.12302,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.095625,-0.094727,-0.12347,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.02068,-0.095924,-0.1036,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.82348,-0.096388,-0.020193,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.21579,-0.096631,-0.021286,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.24288,-0.09676,-0.084471,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.057089,-0.096769,-0.095649,0,0
4,GO AORTA DEVELOPMENT,0.084046,-0.096866,-0.13097,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.26098,-0.097077,-0.076226,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.42347,-0.097294,-0.011163,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.21579,-0.0976,-0.067797,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.26847,-0.097827,-0.086458,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.05824,-0.098182,-0.075119,0,0
4,GO HISTONE H3 K9 METHYLATION,0.025414,-0.098263,-0.11928,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.25363,-0.098365,-0.052144,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.2,-0.098907,-0.10891,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.10654,-0.099083,-0.15524,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.05824,-0.099371,-0.14592,0,0
4,GO CHROMOSOME SEPARATION,0.088862,-0.099817,-0.065013,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.11434,-0.099953,-0.076116,0,0
4,GO MITOTIC RECOMBINATION,0.15773,-0.10006,-0.084498,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.020205,-0.10127,-0.11863,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.20937,-0.1013,-0.086004,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.29184,-0.10155,-0.11686,0,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.56075,-0.10163,-0.098658,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.14526,-0.10223,-0.10032,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.20309,-0.10235,-0.097407,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.29184,-0.10249,-0.10743,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.21256,-0.10266,-0.089422,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.30815,-0.10311,-0.05142,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.014486,-0.10336,-0.16257,0,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.0087944,-0.10336,-0.10456,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.33812,-0.10362,-0.046557,0,0
4,GO CELL AGGREGATION,0.097379,-0.1037,-0.13095,0,0
4,GO MEMBRANE DISASSEMBLY,0.090515,-0.10385,-0.11175,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.67137,-0.10398,0.032738,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.36991,-0.10399,-0.078935,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.34256,-0.10428,-0.12082,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.10096,-0.10432,-0.056465,0,0
4,GO BONE MATURATION,0.21905,-0.1044,-0.092619,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.057089,-0.10478,-0.15195,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.3746,-0.10507,-0.090906,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.084046,-0.1052,-0.19063,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.56075,-0.10578,-0.052489,0,0
4,GO ERYTHROCYTE MATURATION,0.32938,-0.10592,-0.083538,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.70355,-0.10618,-0.0067752,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.50896,-0.10637,-0.042999,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.00063551,-0.10654,-0.11141,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.25001,-0.10758,-0.09593,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.073629,-0.10759,-0.0601,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.21579,-0.10765,-0.052181,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.58456,-0.10766,-0.044908,0,0
4,GO LEARNING,0.055956,-0.10836,-0.12719,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.35153,-0.1087,-0.035838,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.082489,-0.1088,-0.071282,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.10096,-0.10943,-0.1026,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.26098,-0.10978,-0.1862,0,0
4,GO MYOBLAST PROLIFERATION,0.20621,-0.10987,-0.098762,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.14526,-0.11015,-0.13496,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.23937,-0.11025,-0.11705,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.13583,-0.11027,-0.0901,0,0
4,GO REGULATION OF DNA REPAIR,0.00014935,-0.11029,-0.12063,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.064293,-0.11065,-0.10523,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.62113,-0.11126,-0.064509,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0066042,-0.11133,-0.1163,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.20621,-0.11159,-0.052607,0,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.064293,-0.1117,-0.099811,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.05824,-0.1117,-0.14887,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.37932,-0.11227,-0.067204,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.40349,-0.1125,-0.12479,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.48678,-0.11312,-0.05404,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.01282,-0.1132,-0.15715,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.59059,-0.11327,-0.13371,0,0
4,GO MICROTUBULE POLYMERIZATION,0.0038387,-0.11378,-0.14561,0,0
4,GO OTIC VESICLE MORPHOGENESIS,0.082489,-0.1138,-0.18483,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.63978,-0.11383,-0.027499,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.14769,-0.1139,-0.080716,0,0
4,GO NEURON DEVELOPMENT,0.02166,-0.11396,-0.10505,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.40349,-0.11411,-0.11861,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.33373,-0.11413,-0.1088,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.19095,-0.11437,-0.12118,0,0
4,GO SHORT TERM MEMORY,0.31232,-0.11453,-0.12568,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.095625,-0.11464,-0.11381,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.61497,-0.11465,-0.036383,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0049174,-0.11515,-0.15855,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.093897,-0.11518,-0.11062,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.064293,-0.11521,-0.17848,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.02068,-0.11545,-0.11564,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.12473,-0.11611,-0.096205,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.099158,-0.11612,-0.17115,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.27999,-0.11615,-0.12132,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.079444,-0.11672,-0.087422,0,0
4,GO EXPLORATION BEHAVIOR,0.12473,-0.117,-0.19119,0,0
4,GO LONG TERM MEMORY,0.063042,-0.11706,-0.14137,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.87833,-0.11707,-0.0099999,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.4598,-0.11733,-0.063042,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.10845,-0.11736,-0.15928,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.092194,-0.11754,-0.071458,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.35607,-0.1181,-0.06507,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.44924,-0.11812,-0.087112,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.077957,-0.11875,-0.11501,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.087232,-0.11913,-0.156,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.0028141,-0.11916,-0.1227,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.068167,-0.11988,-0.13462,0,0
4,GO MITOCHONDRION LOCALIZATION,0.0062634,-0.11991,-0.1141,0,0
4,GO ADULT BEHAVIOR,0.52025,-0.12012,-0.00087678,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.16559,-0.12019,-0.10528,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.11235,-0.12044,-0.071547,0,0
4,GO AXONAL FASCICULATION,0.082489,-0.12078,-0.22855,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.25363,-0.12104,-0.087446,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.010773,-0.12116,-0.1113,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.59059,-0.12121,-0.061541,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.33373,-0.1216,-0.094865,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.046579,-0.12165,-0.12698,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.11636,-0.12173,-0.096974,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.012508,-0.12218,-0.11665,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.15015,-0.12241,-0.10259,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.18219,-0.12242,-0.06493,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.35153,-0.12245,-0.05016,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.070855,-0.12297,-0.078588,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.12908,-0.12326,-0.12673,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.00037661,-0.12333,-0.13128,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.088862,-0.124,-0.085627,0,0
4,GO DIVALENT METAL ION EXPORT,0.22568,-0.1246,-0.17377,0,0
4,GO NEURON DIFFERENTIATION,0.020205,-0.12487,-0.10507,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.076492,-0.12548,-0.14152,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.15517,-0.12693,-0.10639,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.00065623,-0.12712,-0.14788,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.16828,-0.12726,-0.097995,0,0
4,GO NEUROTRANSMITTER SECRETION,0.14526,-0.12753,-0.049397,0,0
4,GO L SERINE METABOLIC PROCESS,0.53167,-0.12759,-0.073124,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.060602,-0.12782,-0.076023,0,0
4,GO STEM CELL DIVISION,0.070855,-0.12786,-0.11469,0,0
4,GO SNORNA 3 END PROCESSING,0.084046,-0.12868,-0.12111,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.070855,-0.12925,-0.11901,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.029068,-0.12956,-0.19996,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.10096,-0.1297,-0.084459,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19695,-0.12985,-0.099744,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.25363,-0.12999,-0.087437,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.0069616,-0.13036,-0.10991,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.010506,-0.13113,-0.099351,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.52025,-0.13122,-0.0041859,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.0099891,-0.13136,-0.12834,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.0030654,-0.13137,-0.1699,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.20937,-0.13159,-0.12718,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.16559,-0.13159,-0.11541,0,0
4,GO RESPONSE TO AXON INJURY,0.19393,-0.13169,-0.069174,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.16032,-0.13207,-0.26529,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.19095,-0.13216,-0.090273,0,0
4,GO INTRACILIARY TRANSPORT,0.019283,-0.13223,-0.16168,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.31653,-0.13266,-0.1205,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.12049,-0.13268,-0.11642,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.018398,-0.13317,-0.1268,0,0
4,GO SUCKLING BEHAVIOR,0.15773,-0.13319,-0.13444,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.061812,-0.13319,-0.12382,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.30402,-0.13327,-0.062563,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.13355,-0.1336,-0.077332,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.10654,-0.13375,-0.15435,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.188,-0.1339,-0.085165,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.082489,-0.13501,-0.085484,0,0
4,GO ADULT HEART DEVELOPMENT,0.1028,-0.13568,-0.15673,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0069616,-0.13649,-0.18214,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.2839,-0.13705,-0.078375,0,0
4,GO HEART FORMATION,0.23937,-0.13724,-0.091138,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.24288,-0.13746,-0.082243,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.0059384,-0.13752,-0.14037,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.044685,-0.13755,-0.14825,0,0
4,GO SYNAPSE MATURATION,0.2,-0.13791,-0.19564,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.16032,-0.13795,-0.13173,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.19095,-0.13805,-0.092532,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.0057817,-0.13806,-0.12907,0,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.088862,-0.13814,-0.18885,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.093897,-0.13865,-0.1153,0,0
4,GO FILOPODIUM ASSEMBLY,0.043763,-0.13873,-0.1314,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.10845,-0.14013,-0.10387,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.1028,-0.14057,-0.098502,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.20937,-0.14136,-0.14553,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.036164,-0.14169,-0.17527,0,0
4,GO GLUTAMATE SECRETION,0.17099,-0.14183,-0.073947,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.019283,-0.14193,-0.096873,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.35607,-0.14218,-0.1599,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.2,-0.14235,-0.12719,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.075049,-0.14237,-0.13444,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.070855,-0.14373,-0.11413,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.068167,-0.14395,-0.11376,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.2,-0.14403,-0.06428,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.42347,-0.14421,-0.071366,0,0
4,GO GTP METABOLIC PROCESS,0.061812,-0.14424,-0.14568,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.026586,-0.14455,-0.1405,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.54903,-0.14487,-0.070094,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0054795,-0.14494,-0.14509,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.012203,-0.14562,-0.14648,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.049546,-0.14651,-0.18154,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.10096,-0.14674,-0.13856,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.015574,-0.14698,-0.20864,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.073629,-0.147,-0.095412,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.76948,-0.14716,-0.0053535,0,0
4,GO CELL FATE SPECIFICATION,0.064293,-0.14744,-0.096452,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.13583,-0.14762,-0.11754,0,0
4,GO SISTER CHROMATID COHESION,0.0083534,-0.14776,-0.11036,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.073629,-0.14843,-0.17099,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.052669,-0.14883,-0.10461,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.073629,-0.14889,-0.10969,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.99651,-0.14893,0.054227,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.67776,-0.14988,-0.03495,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.061812,-0.14994,-0.13218,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0045306,-0.14996,-0.19453,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.13583,-0.15099,-0.14292,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.015203,-0.15104,-0.14419,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.00057693,-0.1511,-0.19861,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.0028141,-0.15152,-0.1637,0,0
4,GO RESPONSE TO LEAD ION,0.029719,-0.15156,-0.11921,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.087232,-0.15229,-0.1463,0,0
4,GO REGULATION OF AXON GUIDANCE,0.036164,-0.15241,-0.1818,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.001662,-0.15276,-0.15678,0,0
4,GO PALLIUM DEVELOPMENT,0.00057693,-0.15299,-0.14511,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.66501,-0.1541,0.031812,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.27227,-0.15432,-0.097044,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.019283,-0.15476,-0.16305,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.24288,-0.15481,-0.091438,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.015203,-0.15533,-0.13219,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.39371,-0.15544,-0.071872,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.015953,-0.15548,-0.29717,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.085627,-0.15571,-0.22731,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.059411,-0.15635,-0.15433,0,0
4,GO COLLATERAL SPROUTING,0.093897,-0.15665,-0.14041,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.16559,-0.15728,-0.10274,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0069616,-0.15753,-0.15034,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.0090226,-0.15756,-0.2006,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.23245,-0.15773,-0.080535,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.03939,-0.15812,-0.096101,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.29586,-0.15892,-0.06233,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.15015,-0.15894,-0.07708,0,0
4,GO HISTONE H3 K36 METHYLATION,0.052669,-0.15933,-0.12164,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.024846,-0.16007,-0.17346,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.13583,-0.16073,-0.12894,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.12689,-0.1611,-0.146,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.25729,-0.16124,-0.10828,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.0094949,-0.1614,-0.24645,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.13814,-0.16143,-0.071647,0,0
4,GO CELL PART MORPHOGENESIS,0.0022332,-0.16155,-0.17051,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.15773,-0.16173,-0.091278,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.17099,-0.16199,-0.077276,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.018398,-0.16286,-0.22142,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.097379,-0.16403,-0.13926,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.00063551,-0.16405,-0.18762,0,0
4,GO BIOLOGICAL PHASE,0.75615,-0.16448,-0.012058,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0064317,-0.16448,-0.14439,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.030383,-0.16454,-0.097923,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.26098,-0.16455,-0.09089,0,0
4,GO AXO DENDRITIC TRANSPORT,0.0020453,-0.16459,-0.14973,0,0
4,GO RESPONSE TO X RAY,0.061812,-0.1648,-0.14554,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.009256,-0.16487,-0.14071,0,0
4,GO SYNAPTIC SIGNALING,0.13583,-0.16529,-0.08298,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.14048,-0.16544,-0.089748,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.075049,-0.16557,-0.10397,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.001662,-0.16586,-0.19554,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.016339,-0.16713,-0.19058,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.05161,-0.1673,-0.23378,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.063042,-0.16746,-0.12688,0,0
4,GO FOREBRAIN CELL MIGRATION,0.0049174,-0.16785,-0.19197,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.10654,-0.16799,-0.25954,0,0
4,GO APPENDAGE MORPHOGENESIS,0.0060989,-0.16877,-0.15588,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0012662,-0.16998,-0.19406,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.0695,-0.17092,-0.13527,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.00079435,-0.17172,-0.15239,0,0
4,GO TRACHEA MORPHOGENESIS,0.13355,-0.17237,-0.10804,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.04854,-0.17266,-0.14304,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.057089,-0.17269,-0.14765,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.25001,-0.17346,-0.1652,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0021062,-0.1736,-0.18004,0,0
4,GO REPLACEMENT OSSIFICATION,0.076492,-0.17423,-0.15405,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.0051916,-0.17441,-0.147,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.20937,-0.17485,-0.099531,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.018836,-0.17491,-0.12112,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.095625,-0.17517,-0.1143,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0013054,-0.17532,-0.14667,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.0046564,-0.17606,-0.21848,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.087232,-0.17635,-0.12848,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.69061,-0.17652,-0.025313,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.004408,-0.17673,-0.17029,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.059411,-0.17675,-0.13264,0,0
4,GO GENETIC IMPRINTING,0.064293,-0.17676,-0.12721,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.072231,-0.17713,-0.15482,0,0
4,GO RESPONSE TO POTASSIUM ION,0.21905,-0.17818,-0.097747,0,0
4,GO SOMATIC STEM CELL DIVISION,0.070855,-0.17851,-0.27619,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.44924,-0.18092,-0.046277,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.10845,-0.18099,-0.080889,0,0
4,GO NEURON PROJECTION EXTENSION,0.02268,-0.18121,-0.1563,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.17653,-0.18142,-0.092618,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0056288,-0.18187,-0.15887,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.064293,-0.18296,-0.13409,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.12473,-0.18331,-0.19953,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.076492,-0.18342,-0.13133,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.33373,-0.18354,-0.12093,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.13583,-0.18357,-0.10523,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.2839,-0.18382,-0.1056,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.072231,-0.18413,-0.12338,0,0
4,GO AXONAL TRANSPORT,0.0017123,-0.18509,-0.15978,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.16828,-0.18512,-0.14342,0,0
4,GO CARDIOBLAST PROLIFERATION,0.055956,-0.18632,-0.31202,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.78962,-0.18716,-0.016035,0,0
4,GO UTERUS DEVELOPMENT,0.13814,-0.18809,-0.14403,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.085627,-0.18879,-0.16973,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.015574,-0.18959,-0.14259,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.013465,-0.1896,-0.15709,0,0
4,GO SIALYLATION,0.33373,-0.19032,-0.11558,0,0
4,GO RESPONSE TO VITAMIN D,0.23937,-0.19032,-0.10757,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0075304,-0.19048,-0.16463,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00098941,-0.19249,-0.20286,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.097379,-0.19266,-0.1527,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0062634,-0.19304,-0.17652,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0021062,-0.1931,-0.16906,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0081404,-0.19343,-0.15154,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.12908,-0.19402,-0.11223,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.29586,-0.19553,-0.084758,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.10096,-0.19599,-0.10022,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.025994,-0.19653,-0.23382,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.093897,-0.19705,-0.15634,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.076492,-0.19753,-0.20124,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00026003,-0.19797,-0.22095,0,0
4,GO NEUROBLAST DIVISION,0.073629,-0.19906,-0.18773,0,0
4,GO DENDRITE DEVELOPMENT,0.0034322,-0.19936,-0.1532,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.041967,-0.20031,-0.16415,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0018173,-0.20042,-0.1676,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.11039,-0.20064,-0.18489,0,0
4,GO SPINAL CORD PATTERNING,0.43367,-0.20195,-0.053456,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.025414,-0.20222,-0.26907,0,0
4,GO MICROTUBULE SEVERING,0.077957,-0.2026,-0.11793,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.13583,-0.20319,-0.13442,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00054072,-0.20354,-0.18961,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0022992,-0.20417,-0.2033,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.059411,-0.20463,-0.14775,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.0024367,-0.20473,-0.26475,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.026586,-0.2051,-0.18235,0,0
4,GO SPINAL CORD DEVELOPMENT,0.0050528,-0.20543,-0.17626,0,0
4,GO NEURON FATE COMMITMENT,0.070855,-0.2078,-0.14127,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.16294,-0.20952,-0.15746,0,0
4,GO NEGATIVE CHEMOTAXIS,0.059411,-0.2107,-0.20123,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0025817,-0.21103,-0.22045,0,0
4,GO FORELIMB MORPHOGENESIS,0.0042883,-0.21114,-0.24754,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.060602,-0.21285,-0.20307,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.12689,-0.21343,-0.2402,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00032948,-0.21485,-0.24844,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.046579,-0.21524,-0.12263,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.015953,-0.21634,-0.29612,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0013872,-0.21699,-0.19271,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0094949,-0.21803,-0.2013,0,0
4,GO SYNAPSE ASSEMBLY,0.14048,-0.21945,-0.10328,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.30815,-0.21974,-0.047378,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.26847,-0.22013,-0.08066,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.12908,-0.22029,-0.14005,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.054842,-0.22054,-0.22298,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.019283,-0.22139,-0.1718,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.0695,-0.22248,-0.13788,0,0
4,GO CGMP METABOLIC PROCESS,0.18508,-0.22443,-0.10928,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.14769,-0.22501,-0.11476,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.69707,-0.2258,-0.073896,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.029719,-0.22621,-0.12399,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.001228,-0.22761,-0.19517,0,0
4,GO AXON DEVELOPMENT,0.0014299,-0.22813,-0.21923,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.0040578,-0.22816,-0.26688,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.05161,-0.22969,-0.20725,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.015203,-0.23069,-0.17091,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.031059,-0.23107,-0.19249,0,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.00020448,-0.23206,-0.21472,0,0
4,GO AXON EXTENSION,0.0017123,-0.23261,-0.2402,0,0
4,GO REGULATION OF NEURON MIGRATION,0.00011241,-0.23512,-0.31826,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.011047,-0.23514,-0.18121,0,0
4,GO NEURON PROJECTION GUIDANCE,0.00025131,-0.23768,-0.25781,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.0028957,-0.23809,-0.31834,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0014299,-0.23918,-0.20277,0,0
4,GO NEURON CELL CELL ADHESION,0.31653,-0.24015,-0.086399,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0034322,-0.24078,-0.18235,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.10465,-0.24086,-0.13839,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.30815,-0.24087,-0.056472,0,0
4,GO RETROGRADE AXONAL TRANSPORT,0.0020453,-0.24109,-0.2535,0,0
4,GO NEURON MIGRATION,0.0021062,-0.24151,-0.22432,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.16828,-0.24205,-0.22888,0,0
4,GO HINDLIMB MORPHOGENESIS,0.0081404,-0.24242,-0.20175,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.0094949,-0.24302,-0.19609,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.0027346,-0.2464,-0.21189,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.00037661,-0.24713,-0.24682,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0051916,-0.24795,-0.23424,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.023741,-0.24917,-0.20142,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.031059,-0.24972,-0.26266,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0023671,-0.25353,-0.25431,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.012508,-0.25396,-0.22556,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00037661,-0.25418,-0.26186,0,0
4,GO DENDRITE MORPHOGENESIS,0.00067758,-0.25486,-0.20166,0,0
4,GO REGULATION OF AXONOGENESIS,0.0042883,-0.25591,-0.2215,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.30815,-0.2573,-0.075411,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0042883,-0.2573,-0.22989,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.046579,-0.25871,-0.1925,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.16294,-0.25915,-0.15233,0,0
4,GO FOREBRAIN MORPHOGENESIS,0.0041716,-0.25917,-0.22032,0,0
4,GO TONGUE DEVELOPMENT,0.0083534,-0.26131,-0.27607,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.0033369,-0.26247,-0.23116,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.0013872,-0.26293,-0.2132,0,0
4,GO UV PROTECTION,0.1028,-0.26304,-0.14451,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.58456,-0.27071,-0.060924,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0039469,-0.27161,-0.25476,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.34702,-0.27237,-0.096201,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00092958,-0.27309,-0.22183,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.019283,-0.27469,-0.19051,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.085627,-0.27512,-0.17293,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0013872,-0.27569,-0.29301,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.015574,-0.27637,-0.23454,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.00072223,-0.2784,-0.24994,0,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,3.4421e-05,-0.28274,-0.3021,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.036164,-0.28288,-0.25698,0,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0047853,-0.28291,-0.265,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0017641,-0.28802,-0.21406,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0030654,-0.29039,-0.29619,0,0
4,GO PLASMA MEMBRANE REPAIR,0.072231,-0.29357,-0.17746,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0067808,-0.29735,-0.19123,0,0
4,GO RESPIRATORY SYSTEM PROCESS,0.00027832,-0.29761,-0.25394,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0025817,-0.29905,-0.30505,0,0
4,GO PRESYNAPSE ORGANIZATION,0.055956,-0.30233,-0.18132,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0016129,-0.30607,-0.23924,0,0
4,GO NEURON RECOGNITION,0.012203,-0.30704,-0.25757,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.021165,-0.30906,-0.31725,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.099158,-0.31143,-0.16005,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.045624,-0.3115,-0.22188,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,3.8583e-05,-0.31349,-0.30575,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00081984,-0.31499,-0.26635,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00034072,-0.32295,-0.31448,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0033369,-0.323,-0.2234,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00081984,-0.3239,-0.30607,0,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,7.547e-05,-0.32422,-0.30931,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00026903,-0.32479,-0.26421,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.021165,-0.32562,-0.32773,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00026903,-0.32819,-0.27578,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,4.4878e-05,-0.33409,-0.37451,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00067758,-0.33451,-0.28225,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0049174,-0.33573,-0.29254,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,1.906e-06,-0.337,-0.40072,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,4.1112e-06,-0.34084,-0.3554,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00022676,-0.34446,-0.36844,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,2.1663e-05,-0.34553,-0.32531,0,0
4,GO EMBRYONIC EYE MORPHOGENESIS,2.5774e-06,-0.35329,-0.35121,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00012964,-0.35721,-0.34491,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.23245,-0.35849,-0.17673,0,0
4,GO NEURON FATE SPECIFICATION,0.25729,-0.36137,-0.10283,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0013457,-0.36166,-0.26803,0,0
4,GO CENTRIOLE CENTRIOLE COHESION,1.6455e-05,-0.37393,-0.34965,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.016339,-0.37549,-0.25765,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00090094,-0.3755,-0.31337,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.001872,-0.38019,-0.34316,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.00027832,-0.40846,-0.35103,0,0
4,GO CARTILAGE MORPHOGENESIS,0.0045306,-0.4127,-0.36018,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.049546,-0.41807,-0.21193,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,8.7323e-05,-0.4183,-0.36749,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.00014935,-0.4224,-0.30865,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0013457,-0.43119,-0.37553,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0014299,-0.44474,-0.36933,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0029794,-0.44821,-0.3701,0,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.0056288,-0.45399,-0.41262,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0067808,-0.48216,-0.3699,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0017641,-0.4852,-0.39762,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0010859,-0.50231,-0.43243,0,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0056288,-0.50783,-0.36081,0,0
4,GO VOCALIZATION BEHAVIOR,0.0042883,-0.50987,-0.45839,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,8.4205e-05,-0.52188,-0.49723,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00020448,-0.54665,-0.49245,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,5.8301e-05,-0.57459,-0.59532,0,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00025131,-0.58462,-0.56561,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,5.9841e-06,-0.63199,-0.66331,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,9.7346e-05,-0.74652,-0.64192,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0001165,1.4705,1.2051,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,5.0226e-05,1.3173,1.0493,1,1
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00026903,0.97764,0.93919,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,5.2837e-06,0.96372,1.0244,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00028792,0.9206,0.65636,1,1
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.8379e-05,0.8948,0.78918,1,1
5,GO CYTIDINE TO URIDINE EDITING,0.0001165,0.85495,0.70006,1,1
5,GO RESPONSE TO INTERFERON ALPHA,0.00098941,0.79168,0.59036,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00037661,0.78837,0.56159,1,1
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016023,0.78462,0.56666,1,1
5,GO TOLERANCE INDUCTION,6.5149e-05,0.78315,0.64551,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.3916e-06,0.76102,0.64734,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00017186,0.75855,0.57548,1,1
5,GO T CELL MEDIATED CYTOTOXICITY,0.00032948,0.69462,0.46489,1,1
5,GO LIVER MORPHOGENESIS,6.4994e-06,0.69023,0.54486,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,5.7413e-06,0.68781,0.61927,1,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00013433,0.67978,0.59502,1,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,3.0576e-06,0.66579,0.68364,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00041602,0.66437,0.43974,1,1
5,GO NEGATIVE REGULATION OF CELL KILLING,0.0011549,0.66407,0.44856,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.1904e-06,0.66155,0.64919,1,1
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.03939,0.65647,0.40533,1,1
5,GO RESPONSE TO TYPE I INTERFERON,1.5201e-05,0.65391,0.64012,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00044439,0.64697,0.53105,1,1
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.9263e-05,0.64213,0.55082,1,1
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00026903,0.63915,0.52255,1,1
5,GO HISTAMINE SECRETION,0.00069957,0.63903,0.51411,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00019753,0.63881,0.482,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,8.6584e-06,0.62823,0.55122,1,1
5,GO EOSINOPHIL CHEMOTAXIS,7.547e-05,0.62597,0.55242,1,1
5,GO LIPID DROPLET FORMATION,2.5774e-06,0.62311,0.67704,1,1
5,GO TYPE B PANCREATIC CELL PROLIFERATION,4.1802e-07,0.61781,0.68271,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.5308e-05,0.61642,0.63116,1,1
5,GO SEROTONIN METABOLIC PROCESS,1.6015e-06,0.61609,0.68674,1,1
5,GO EOSINOPHIL MIGRATION,5.6174e-05,0.61533,0.52705,1,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.6174e-05,0.60371,0.465,1,1
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00042998,0.60169,0.41704,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,2.6307e-05,0.5953,0.63048,1,1
5,GO GLIAL CELL FATE COMMITMENT,0.00013917,0.5951,0.51817,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.0689e-05,0.58844,0.70014,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,5.9841e-06,0.58839,0.56694,1,1
5,GO REGULATION OF VASCULOGENESIS,2.0833e-05,0.58453,0.54908,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.2862e-06,0.58332,0.60314,1,1
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.014841,0.58247,0.34089,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.104e-05,0.57985,0.49998,1,1
5,GO DETECTION OF OTHER ORGANISM,2.9532e-05,0.57735,0.52266,1,1
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,3.4421e-05,0.5732,0.54136,1,1
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00010462,0.57291,0.51736,1,1
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00079435,0.57157,0.39425,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,5.0683e-06,0.56821,0.55318,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.2139e-05,0.56637,0.42838,1,1
5,GO IMMUNOGLOBULIN SECRETION,3.3132e-05,0.56546,0.44892,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.8418e-05,0.56463,0.50519,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9263e-05,0.56174,0.45522,1,1
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,2.2524e-05,0.55839,0.46994,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,9.7346e-05,0.55828,0.39683,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00030804,0.55168,0.44297,1,1
5,GO KERATINOCYTE DEVELOPMENT,0.00010845,0.54974,0.47056,1,1
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.00012074,0.54918,0.43792,1,1
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0011199,0.54291,0.40856,1,1
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00044439,0.54264,0.45967,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.0094949,0.53995,0.30324,1,1
5,GO REGULATION OF PLATELET AGGREGATION,2.1663e-05,0.53961,0.46883,1,1
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00016595,0.53687,0.49434,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,0.00021909,0.53139,0.39641,1,1
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00010092,0.52981,0.44562,1,1
5,GO GERMINAL CENTER FORMATION,0.00041602,0.52748,0.51324,1,1
5,GO LIPOXYGENASE PATHWAY,0.0001547,0.52719,0.45634,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,1.4044e-06,0.52674,0.65287,1,1
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00054072,0.52616,0.37168,1,1
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.00037661,0.52522,0.55724,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,2.9532e-05,0.52481,0.53725,1,1
5,GO O GLYCAN PROCESSING,3.7145e-05,0.52388,0.404,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,2.1663e-05,0.52306,0.38943,1,1
5,GO LUNG CELL DIFFERENTIATION,7.8282e-05,0.52117,0.51109,1,1
5,GO DNA DEAMINATION,0.0022992,0.51892,0.37802,1,1
5,GO REGULATION OF TRANSPOSITION,0.00044439,0.51863,0.38081,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00028792,0.51801,0.45377,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00012512,0.51753,0.41192,1,1
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.7806e-05,0.51735,0.51145,1,1
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,4.6623e-06,0.51396,0.54644,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,5.0226e-05,0.5111,0.49782,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0032441,0.50993,0.3752,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0053338,0.50976,0.555,1,1
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.040234,0.50919,0.31541,1,1
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,5.6174e-05,0.50882,0.55954,1,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0007696,0.50509,0.39277,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,9.4334e-07,0.50439,0.48269,1,1
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,5.0226e-05,0.50141,0.5601,1,1
5,GO NEGATIVE REGULATION OF ANOIKIS,2.2524e-05,0.50139,0.62582,1,1
5,GO MUCUS SECRETION,0.013465,0.50074,0.37249,1,1
5,GO N GLYCAN PROCESSING,4.4712e-06,0.50059,0.47949,1,1
5,GO HISTAMINE TRANSPORT,0.00055855,0.49981,0.4591,1,1
5,GO RESPONSE TO WATER,2.6307e-05,0.49941,0.45571,1,1
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0060989,0.49924,0.45608,1,1
5,GO REGULATION OF RECEPTOR CLUSTERING,6.2786e-05,0.49909,0.4781,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,9.389e-05,0.49877,0.43639,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,2.3418e-05,0.4975,0.45459,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00017186,0.49695,0.34889,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00029782,0.49603,0.47639,1,1
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.00021909,0.49531,0.4828,1,1
5,GO TRANSPOSITION,5.6174e-05,0.49027,0.40095,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.0016129,0.48981,0.31006,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00017186,0.48963,0.41492,1,1
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00098941,0.48809,0.32614,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,3.0689e-05,0.48716,0.4112,1,1
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00025131,0.48692,0.38759,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00018427,0.48396,0.37802,1,1
5,GO RESPONSE TO MUSCLE STRETCH,0.00034072,0.48281,0.40273,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00012074,0.47967,0.40695,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.0604e-05,0.47952,0.50538,1,1
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.4609e-05,0.47789,0.43297,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0041716,0.47733,0.35898,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4757,0.32211,1,1
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0022332,0.47494,0.43903,1,1
5,GO REFLEX,0.010245,0.47397,0.41514,1,1
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.011326,0.4734,0.46296,1,1
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,5.2139e-05,0.47295,0.48633,1,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.1964e-05,0.47206,0.38379,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00016023,0.4712,0.43868,1,1
5,GO RESPONSE TO INTERLEUKIN 18,0.0027346,0.47031,0.35866,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,8.7323e-05,0.47018,0.40104,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.011904,0.46951,0.35313,1,1
5,GO MICROVILLUS ASSEMBLY,0.00037661,0.46912,0.40986,1,1
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0025817,0.46835,0.35845,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.4712e-06,0.46666,0.44681,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,5.8301e-05,0.46621,0.35238,1,1
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.0073e-05,0.46542,0.43338,1,1
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0007696,0.46535,0.49368,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,3.7145e-05,0.46387,0.43392,1,1
5,GO T CELL MEDIATED IMMUNITY,0.00017186,0.46362,0.31333,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.1964e-05,0.46264,0.44357,1,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,1.5816e-05,0.46048,0.44254,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00042998,0.46035,0.41117,1,1
5,GO CORTICOSTEROID HORMONE SECRETION,0.00040247,0.45903,0.39076,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.0032441,0.45627,0.41795,1,1
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0071468,0.45539,0.38568,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00069957,0.45449,0.42038,1,1
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,9.3916e-06,0.45188,0.42308,1,1
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,7.2754e-05,0.45171,0.3163,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00084609,0.45053,0.28829,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,1.7806e-05,0.44944,0.37052,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,5.7413e-06,0.44943,0.53699,1,1
5,GO MYELIN MAINTENANCE,2.3418e-05,0.44886,0.43148,1,1
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00072223,0.44872,0.38595,1,1
5,GO MEMBRANE RAFT ORGANIZATION,0.0033369,0.44866,0.30305,1,1
5,GO SYNAPTIC MEMBRANE ADHESION,0.0085714,0.44852,0.32707,1,1
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,1.9263e-05,0.44788,0.42349,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0010206,0.44761,0.39071,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.00036427,0.44739,0.40474,1,1
5,GO T CELL EXTRAVASATION,0.00026003,0.44719,0.46245,1,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,1.0604e-05,0.44678,0.38144,1,1
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,1.7806e-05,0.44672,0.46811,1,1
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00054072,0.44672,0.46241,1,1
5,GO RESPONSE TO PAIN,0.00036427,0.44636,0.32515,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,0.0001547,0.44495,0.46294,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00063551,0.44411,0.35761,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,5.4121e-05,0.44411,0.46871,1,1
5,GO B CELL APOPTOTIC PROCESS,0.00042998,0.44408,0.3792,1,1
5,GO RESPONSE TO COLD,1.5816e-05,0.4426,0.38448,1,1
5,GO GLIAL CELL APOPTOTIC PROCESS,0.00028792,0.44183,0.47113,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00035231,0.44097,0.30852,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,3.3132e-05,0.43924,0.3552,1,1
5,GO MYOBLAST FUSION,5.2139e-05,0.43896,0.35794,1,1
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00020448,0.43886,0.28821,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00042998,0.43873,0.40504,1,1
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026903,0.43627,0.32734,1,1
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.015574,0.43358,0.32173,1,1
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0030654,0.43292,0.31064,1,1
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.00072223,0.43282,0.33949,1,1
5,GO CELLULAR RESPONSE TO COPPER ION,0.0027346,0.43172,0.42256,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0017641,0.42938,0.37001,1,1
5,GO REGULATION OF EXOSOMAL SECRETION,0.00019079,0.42821,0.29307,1,1
5,GO RESPONSE TO DIETARY EXCESS,5.2139e-05,0.42755,0.43927,1,1
5,GO REGULATION OF MYOBLAST FUSION,0.0016129,0.42725,0.32271,1,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00023468,0.426,0.42378,1,1
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.013465,0.42553,0.32407,1,1
5,GO ZYMOGEN ACTIVATION,0.00035231,0.42489,0.37919,1,1
5,GO REGULATION OF PLATELET ACTIVATION,3.0689e-05,0.42458,0.39006,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,8.6584e-06,0.42449,0.40676,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7474e-06,0.42382,0.5218,1,1
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00042998,0.42349,0.41872,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.00014935,0.42232,0.43495,1,1
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0097392,0.42211,0.29518,1,1
5,GO PROSTATE GLAND MORPHOGENESIS,0.016339,0.42078,0.28116,1,1
5,GO SIALYLATION,0.0022992,0.41957,0.30614,1,1
5,GO REGULATION OF B CELL PROLIFERATION,2.2524e-05,0.41947,0.34433,1,1
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,1.2454e-05,0.41899,0.45682,1,1
5,GO CELLULAR DEFENSE RESPONSE,0.001228,0.41847,0.25571,1,1
5,GO CAMP BIOSYNTHETIC PROCESS,4.8379e-05,0.41758,0.38963,1,1
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.040234,0.4163,0.38497,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,6.0504e-05,0.41601,0.41177,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.001191,0.41586,0.38542,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00074557,0.41575,0.32907,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,5.0226e-05,0.41575,0.40489,1,1
5,GO REGULATION OF VIRAL LIFE CYCLE,0.0023671,0.41516,0.28016,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00025131,0.41481,0.28252,1,1
5,GO FUCOSE METABOLIC PROCESS,0.00011241,0.41471,0.31452,1,1
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00050664,0.41402,0.30961,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00034072,0.41361,0.42412,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,3.9418e-06,0.41288,0.35677,1,1
5,GO INTERLEUKIN 10 PRODUCTION,5.0226e-05,0.41222,0.28806,1,1
5,GO RESPONSE TO INTERFERON GAMMA,3.5759e-05,0.41161,0.41657,1,1
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,8.7323e-05,0.41155,0.32576,1,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0016129,0.41089,0.47276,1,1
5,GO PROTEIN KINASE C SIGNALING,5.8301e-05,0.41043,0.37041,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00019079,0.40996,0.41562,1,1
5,GO MYELIN ASSEMBLY,0.00021909,0.40967,0.33233,1,1
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0060989,0.40924,0.30246,1,1
5,GO TOXIN METABOLIC PROCESS,7.2754e-05,0.40916,0.40373,1,1
5,GO REGULATION OF TISSUE REMODELING,2.9532e-05,0.40913,0.31746,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00016023,0.40906,0.27706,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,6.0504e-05,0.40878,0.3512,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.0016129,0.40828,0.27927,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00011241,0.40806,0.42595,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,1.9263e-05,0.40782,0.28794,1,1
5,GO VIRAL GENOME REPLICATION,0.0010206,0.40778,0.27906,1,1
5,GO AMINE BIOSYNTHETIC PROCESS,1.349e-05,0.40629,0.39726,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,4.1617e-05,0.40625,0.42112,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,3.3287e-06,0.40589,0.37475,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,7.013e-05,0.40557,0.334,1,1
5,GO REGULATION OF BONE REMODELING,2.4346e-05,0.40482,0.34042,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.011612,0.40455,0.30577,1,1
5,GO GLIAL CELL PROLIFERATION,0.00037661,0.40442,0.2808,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0097392,0.40421,0.22544,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,1.2454e-05,0.40416,0.40788,1,1
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0024367,0.40396,0.34186,1,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.0022332,0.40391,0.35451,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00021909,0.4039,0.3142,1,1
5,GO MICROVILLUS ORGANIZATION,0.0015189,0.40312,0.29128,1,1
5,GO STEROID ESTERIFICATION,0.00013917,0.40268,0.45,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,9.0551e-05,0.40204,0.34603,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0027346,0.40123,0.23796,1,1
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00047456,0.40029,0.36818,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00019753,0.40012,0.35584,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0041716,0.39935,0.4042,1,1
5,GO STEROID HORMONE SECRETION,0.00044439,0.39896,0.32443,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0028957,0.39895,0.28922,1,1
5,GO AMYLOID FIBRIL FORMATION,0.0012662,0.39882,0.31417,1,1
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010092,0.39859,0.44928,1,1
5,GO RELAXATION OF CARDIAC MUSCLE,0.00098941,0.39857,0.36219,1,1
5,GO KETONE CATABOLIC PROCESS,0.0012662,0.39846,0.35288,1,1
5,GO MAGNESIUM ION TRANSPORT,8.1192e-05,0.39815,0.29817,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,2.9532e-05,0.39808,0.37597,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0066042,0.39753,0.31566,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.9263e-05,0.3969,0.40521,1,1
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00059588,0.39672,0.38513,1,1
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.00014935,0.39646,0.46902,1,1
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.004408,0.39459,0.26357,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0010528,0.39387,0.34059,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,4.4878e-05,0.39298,0.41209,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00011241,0.39222,0.46475,1,1
5,GO XENOBIOTIC CATABOLIC PROCESS,0.033166,0.3912,0.2712,1,1
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00042998,0.3903,0.33174,1,1
5,GO ESTROUS CYCLE,2.3418e-05,0.39026,0.39322,1,1
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00027832,0.39006,0.31066,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,9.0551e-05,0.38925,0.35113,1,1
5,GO VASCULAR WOUND HEALING,3.7145e-05,0.38848,0.46227,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,5.8301e-05,0.38827,0.3046,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.00087311,0.38803,0.36627,1,1
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0018173,0.38755,0.37852,1,1
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00049035,0.38743,0.28364,1,1
5,GO BONE RESORPTION,7.2754e-05,0.38696,0.2838,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,2.6307e-05,0.38675,0.33254,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00013917,0.38668,0.3555,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,9.7346e-05,0.38574,0.37754,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,6.4994e-06,0.38551,0.32592,1,1
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.0833e-05,0.38477,0.342,1,1
5,GO TYPE 2 IMMUNE RESPONSE,0.00022676,0.38474,0.41645,1,1
5,GO SMOOTH MUSCLE CELL MIGRATION,8.7323e-05,0.38462,0.33186,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.7806e-05,0.38462,0.38399,1,1
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00021167,0.38456,0.38896,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,0.00010845,0.38431,0.30671,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.001191,0.38428,0.41895,1,1
5,GO DEFENSE RESPONSE TO VIRUS,0.00034072,0.3841,0.28382,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00036427,0.38312,0.32923,1,1
5,GO LUNG EPITHELIUM DEVELOPMENT,3.7145e-05,0.38307,0.3846,1,1
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0013872,0.38287,0.33587,1,1
5,GO MECHANOSENSORY BEHAVIOR,0.0099891,0.38276,0.38809,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00022676,0.38258,0.30762,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00030804,0.38182,0.37205,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,7.5427e-07,0.38093,0.36317,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,4.0073e-05,0.38056,0.3022,1,1
5,GO VASODILATION,0.00025131,0.37998,0.30832,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00012074,0.37983,0.30584,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00011241,0.37938,0.31565,1,1
5,GO ASYMMETRIC CELL DIVISION,0.0010528,0.37848,0.30099,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.4878e-05,0.37837,0.35159,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00012512,0.37786,0.3204,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00084609,0.37771,0.28287,1,1
5,GO RESPONSE TO COPPER ION,0.00022676,0.37641,0.40105,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00026903,0.37621,0.33406,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00019079,0.37556,0.38226,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.7806e-05,0.37531,0.37471,1,1
5,GO GLYCINE TRANSPORT,0.0064317,0.37514,0.31496,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,1.1493e-05,0.37481,0.33396,1,1
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00018427,0.37478,0.29642,1,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.011326,0.37473,0.30715,1,1
5,GO SYNAPSE MATURATION,0.0010206,0.37443,0.44265,1,1
5,GO LIPID DROPLET ORGANIZATION,2.8077e-06,0.37349,0.3625,1,1
5,GO GLAND MORPHOGENESIS,0.00016595,0.37323,0.31556,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.4878e-05,0.37323,0.34143,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0066042,0.37273,0.2791,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00028792,0.37188,0.33026,1,1
5,GO ASTROCYTE ACTIVATION,7.2754e-05,0.37182,0.35429,1,1
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0010206,0.3712,0.30636,1,1
5,GO REGULATION OF AMINO ACID TRANSPORT,2.0833e-05,0.37075,0.33309,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,9.389e-05,0.37039,0.24945,1,1
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.0042883,0.37034,0.32047,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,7.2754e-05,0.37007,0.38782,1,1
5,GO GALACTOSE METABOLIC PROCESS,0.0064317,0.36957,0.26773,1,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0034322,0.36944,0.31647,1,1
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00054072,0.36918,0.27602,1,1
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00026903,0.36896,0.28984,1,1
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00040247,0.3688,0.27473,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00092958,0.36872,0.27148,1,1
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.547e-05,0.36853,0.24707,1,1
5,GO ENTRY INTO HOST,0.0014299,0.36832,0.2341,1,1
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0015189,0.36784,0.3032,1,1
5,GO OSTEOBLAST PROLIFERATION,2.0033e-05,0.36775,0.37047,1,1
5,GO REGULATION OF ANOIKIS,0.00012512,0.3676,0.44921,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.2962e-05,0.36751,0.29422,1,1
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,0.36739,0.24479,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,5.8301e-05,0.36709,0.35463,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.3418e-05,0.36693,0.31454,1,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.009256,0.36628,0.30724,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,7.0571e-06,0.36539,0.3027,1,1
5,GO VITAMIN D METABOLIC PROCESS,3.5759e-05,0.36539,0.34887,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00090094,0.36482,0.29643,1,1
5,GO DETECTION OF CALCIUM ION,0.0042883,0.36405,0.31678,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.010245,0.36357,0.2641,1,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.024288,0.36339,0.24982,1,1
5,GO NERVE DEVELOPMENT,1.5201e-05,0.36274,0.32314,1,1
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0027346,0.36248,0.27729,1,1
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00049035,0.36048,0.30667,1,1
5,GO REGULATION OF DENDRITE EXTENSION,0.0032441,0.36048,0.35919,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.01282,0.36005,0.32167,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00031859,0.35933,0.27761,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,5.9841e-06,0.35932,0.34063,1,1
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00018427,0.35925,0.45777,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.0016129,0.3591,0.3413,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00024286,0.35895,0.3099,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00014935,0.35876,0.27265,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,6.2786e-05,0.3586,0.32266,1,1
5,GO CELL MIGRATION IN HINDBRAIN,0.00022676,0.35849,0.39326,1,1
5,GO TISSUE REMODELING,5.8301e-05,0.35846,0.28436,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0011549,0.35803,0.287,1,1
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00045924,0.35775,0.2767,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,5.0226e-05,0.35733,0.36437,1,1
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00024286,0.35732,0.30055,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00035231,0.35717,0.32026,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,8.3127e-06,0.35669,0.39446,1,1
5,GO RESPONSE TO THYROID HORMONE,0.0024367,0.35641,0.30341,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,4.8612e-06,0.35627,0.31138,1,1
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,8.1192e-05,0.35614,0.28984,1,1
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00021909,0.35606,0.34796,1,1
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,5.6174e-05,0.35604,0.31051,1,1
5,GO LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,0.35571,0.29162,1,1
5,GO B CELL MEDIATED IMMUNITY,0.00010092,0.35547,0.34518,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,1.1964e-05,0.35545,0.33784,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00028792,0.35516,0.23867,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.8521e-05,0.35503,0.31049,1,1
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00095906,0.35488,0.28553,1,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0042883,0.35479,0.26485,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00014935,0.3546,0.24443,1,1
5,GO RETINAL ROD CELL DIFFERENTIATION,0.013139,0.35441,0.26568,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00079435,0.35398,0.33118,1,1
5,GO RESPONSE TO FORSKOLIN,0.0014738,0.35395,0.33743,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,4.3218e-05,0.35358,0.28536,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00017186,0.35317,0.31479,1,1
5,GO ASTROCYTE DIFFERENTIATION,0.00016023,0.3525,0.2833,1,1
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,8.1192e-05,0.35237,0.29769,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00092958,0.35204,0.27245,1,1
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00014935,0.35166,0.29314,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,4.1617e-05,0.35082,0.27783,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00035231,0.35074,0.26362,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.1493e-05,0.3506,0.28573,1,1
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0090226,0.35055,0.30381,1,1
5,GO THALAMUS DEVELOPMENT,0.0017641,0.35048,0.32742,1,1
5,GO FOAM CELL DIFFERENTIATION,0.0001547,0.34981,0.35845,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,9.3916e-06,0.34961,0.33707,1,1
5,GO ENDOTHELIAL CELL DEVELOPMENT,2.8418e-05,0.34933,0.27961,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.00023468,0.34931,0.37252,1,1
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0075304,0.34907,0.25738,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.049546,0.34821,0.18547,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,0.00036427,0.34818,0.30469,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,1.0311e-06,0.34817,0.30918,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00010462,0.34815,0.29052,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,2.6322e-07,0.34807,0.34916,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00020448,0.34805,0.30554,1,1
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,7.8282e-05,0.34794,0.36257,1,1
5,GO SYNCYTIUM FORMATION,0.00023468,0.34746,0.26279,1,1
5,GO T CELL CYTOKINE PRODUCTION,0.00026903,0.34742,0.23582,1,1
5,GO RESPONSE TO MAGNESIUM ION,0.0047853,0.34739,0.27046,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00029782,0.34731,0.26299,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00059588,0.3473,0.30764,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00029782,0.3465,0.31681,1,1
5,GO MESENCHYMAL CELL PROLIFERATION,0.0024367,0.34597,0.25881,1,1
5,GO GABAERGIC NEURON DIFFERENTIATION,0.0066042,0.34564,0.45169,1,1
5,GO ADRENAL GLAND DEVELOPMENT,3.4421e-05,0.34487,0.41326,1,1
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0032441,0.34465,0.33426,1,1
5,GO RESPONSE TO AMPHETAMINE,0.00012074,0.34454,0.3179,1,1
5,GO SEQUESTERING OF ACTIN MONOMERS,0.00020448,0.34452,0.44057,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00084609,0.34442,0.24628,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00021167,0.34409,0.28462,1,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.001872,0.3439,0.24229,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.012203,0.3439,0.2318,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.7806e-05,0.34387,0.3066,1,1
5,GO EPITHELIAL CELL MATURATION,0.00038934,0.34385,0.33467,1,1
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0053338,0.34355,0.30963,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0059384,0.34341,0.27284,1,1
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00055855,0.34335,0.25675,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,4.1617e-05,0.34315,0.36958,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0013054,0.3431,0.33892,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.00041602,0.34263,0.31122,1,1
5,GO B CELL PROLIFERATION,5.6174e-05,0.34254,0.26054,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.6455e-05,0.34244,0.40596,1,1
5,GO MAST CELL MEDIATED IMMUNITY,5.2139e-05,0.34231,0.30449,1,1
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00081984,0.34182,0.28091,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00029782,0.34169,0.27519,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001872,0.34116,0.27339,1,1
5,GO REGULATION OF B CELL ACTIVATION,3.3287e-06,0.33997,0.29303,1,1
5,GO ENDOTHELIUM DEVELOPMENT,2.6902e-06,0.33937,0.29422,1,1
5,GO ENDOCARDIUM DEVELOPMENT,0.00013433,0.33894,0.38228,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.00044439,0.33885,0.275,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00024286,0.33883,0.33083,1,1
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0001547,0.33866,0.26628,1,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00016023,0.33835,0.30269,1,1
5,GO RESPONSE TO INTERLEUKIN 2,0.00013433,0.33808,0.28782,1,1
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00016023,0.33742,0.27979,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010092,0.33721,0.2312,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0049174,0.33721,0.24964,1,1
5,GO PROTEIN DEMANNOSYLATION,5.6174e-05,0.33632,0.29424,1,1
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0020453,0.33629,0.18961,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.6174e-05,0.33593,0.33894,1,1
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,9.389e-05,0.3359,0.27034,1,1
5,GO AMMONIUM TRANSPORT,0.00019079,0.33492,0.31882,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00035231,0.33492,0.43363,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,5.9841e-06,0.3349,0.33631,1,1
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.017969,0.3347,0.41842,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0056288,0.33449,0.35494,1,1
5,GO FAT CELL DIFFERENTIATION,4.1802e-07,0.33447,0.29173,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.001872,0.33445,0.28071,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0028141,0.33433,0.24895,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.0007696,0.33423,0.32718,1,1
5,GO GLIAL CELL DEVELOPMENT,5.2837e-06,0.33396,0.28694,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.6307e-05,0.33381,0.29268,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0017123,0.33379,0.21797,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,8.7323e-05,0.33353,0.28025,1,1
5,GO REGULATION OF POSITIVE CHEMOTAXIS,3.1888e-05,0.33316,0.33286,1,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00090094,0.33302,0.30368,1,1
5,GO LIPID TRANSLOCATION,1.2862e-06,0.33301,0.34597,1,1
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.001191,0.33219,0.32183,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00021167,0.33209,0.28562,1,1
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00069957,0.3319,0.2963,1,1
5,GO RESPONSE TO LITHIUM ION,0.00022676,0.33085,0.36914,1,1
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0022332,0.33085,0.30029,1,1
5,GO AMMONIUM ION METABOLIC PROCESS,0.00014935,0.33081,0.34148,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0046564,0.33054,0.21556,1,1
5,GO MONOCYTE CHEMOTAXIS,0.0013054,0.33054,0.21625,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.0073e-05,0.33027,0.36248,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,5.9841e-06,0.32978,0.27977,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0016129,0.32944,0.2646,1,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0037331,0.32921,0.20546,1,1
5,GO METANEPHROS MORPHOGENESIS,0.00010092,0.32917,0.28992,1,1
5,GO MAST CELL ACTIVATION,1.7806e-05,0.32814,0.29746,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0069616,0.32806,0.2765,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00067758,0.32805,0.29793,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,4.8379e-05,0.32787,0.25826,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00019079,0.32686,0.28652,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.1964e-05,0.32663,0.30084,1,1
5,GO CGMP METABOLIC PROCESS,0.020205,0.32632,0.21612,1,1
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00059588,0.32629,0.21426,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00031859,0.32618,0.27135,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,6.7728e-06,0.32617,0.2957,1,1
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.02268,0.32589,0.23683,1,1
5,GO RESPONSE TO INTERLEUKIN 15,0.0034322,0.32569,0.26257,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.349e-05,0.32562,0.38784,1,1
5,GO APICAL JUNCTION ASSEMBLY,1.8521e-05,0.32562,0.32392,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.5816e-05,0.3254,0.31707,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00013433,0.32492,0.30237,1,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00038934,0.3249,0.33686,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,1.7118e-05,0.32482,0.30241,1,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00027832,0.32432,0.26905,1,1
5,GO BONE REMODELING,3.4421e-05,0.32424,0.31132,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,8.1192e-05,0.32422,0.27416,1,1
5,GO POSITIVE REGULATION OF OSSIFICATION,8.4205e-05,0.32416,0.3219,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00049035,0.32414,0.38693,1,1
5,GO CELLULAR RESPONSE TO VITAMIN,0.004408,0.32399,0.29022,1,1
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.001662,0.32311,0.25388,1,1
5,GO REGULATION OF CELL MATRIX ADHESION,2.6307e-05,0.32238,0.29293,1,1
5,GO ANOIKIS,3.3132e-05,0.32204,0.36997,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00021167,0.32202,0.32914,1,1
5,GO PRO B CELL DIFFERENTIATION,0.0059384,0.32193,0.24784,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.001986,0.32155,0.17801,1,1
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0006154,0.32141,0.36758,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00017186,0.32141,0.2922,1,1
5,GO MEMBRANE DEPOLARIZATION,8.1192e-05,0.32132,0.2849,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00041602,0.3213,0.28093,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.00092958,0.32105,0.3281,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,2.4692e-06,0.32082,0.29684,1,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.013798,0.32071,0.27598,1,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.00044439,0.32049,0.32982,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,1.8521e-05,0.32044,0.27044,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.8583e-05,0.32033,0.33457,1,1
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.031748,0.32025,0.17845,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,7.9801e-06,0.32021,0.30269,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0022992,0.3202,0.29298,1,1
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.00012512,0.31981,0.26457,1,1
5,GO BLOOD VESSEL REMODELING,0.001986,0.31837,0.2232,1,1
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0081404,0.31787,0.33676,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.31759,0.2796,1,1
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,2.1663e-05,0.31719,0.31615,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.00072223,0.31716,0.23337,1,1
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00030804,0.31709,0.21304,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0037331,0.31694,0.27023,1,1
5,GO REGULATION OF AMYLOID BETA FORMATION,8.4205e-05,0.31668,0.35779,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,1.9263e-05,0.31656,0.29847,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001165,0.31653,0.26336,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,8.6584e-06,0.31623,0.25904,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00017796,0.31616,0.27085,1,1
5,GO STRIATED MUSCLE ADAPTATION,0.00016023,0.31611,0.25318,1,1
5,GO AMYLOID BETA FORMATION,1.9263e-05,0.31609,0.33496,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0028957,0.31593,0.23828,1,1
5,GO NEGATIVE REGULATION OF COAGULATION,0.0066042,0.31578,0.21864,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00029782,0.31553,0.27302,1,1
5,GO REGULATION OF CELL KILLING,0.00050664,0.3154,0.24902,1,1
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00084609,0.31492,0.21404,1,1
5,GO RESPONSE TO VIRUS,0.00035231,0.31482,0.23504,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.4039e-05,0.31476,0.27779,1,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00072223,0.3143,0.24241,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.023741,0.31374,0.23761,1,1
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00025131,0.31355,0.28336,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,2.3418e-05,0.31302,0.25541,1,1
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.053746,0.31285,0.20908,1,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00050664,0.31268,0.33251,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0067808,0.31257,0.32388,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,6.7728e-06,0.31229,0.28684,1,1
5,GO MOVEMENT IN HOST ENVIRONMENT,0.0021062,0.31229,0.20086,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,1.3605e-07,0.31227,0.32428,1,1
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,5.7413e-06,0.3122,0.33932,1,1
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.02166,0.31215,0.5051,1,1
5,GO INTERFERON ALPHA PRODUCTION,8.7323e-05,0.31211,0.30276,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,7.3528e-06,0.31206,0.27162,1,1
5,GO CELLULAR RESPONSE TO VITAMIN D,0.015574,0.31203,0.25257,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0014738,0.31197,0.24253,1,1
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0017123,0.31158,0.20542,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.023741,0.31141,0.2037,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,9.7801e-06,0.31135,0.28355,1,1
5,GO INTERFERON BETA PRODUCTION,0.00026903,0.31123,0.238,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0017641,0.31106,0.30352,1,1
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.04854,0.31092,0.15977,1,1
5,GO SKELETAL MUSCLE ADAPTATION,2.2524e-05,0.31068,0.31164,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,9.0221e-07,0.31054,0.276,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00047456,0.31039,0.30718,1,1
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00030804,0.31027,0.22368,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.7323e-05,0.31017,0.24906,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.4878e-05,0.31007,0.30028,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.2454e-05,0.30996,0.33553,1,1
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.00063551,0.30995,0.22957,1,1
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.027803,0.30972,0.31975,1,1
5,GO RESPONSE TO PROTOZOAN,0.001191,0.30944,0.26033,1,1
5,GO REGULATION OF GTP BINDING,0.016339,0.3094,0.23562,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00084609,0.30902,0.27402,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00019753,0.30873,0.37041,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0013054,0.30864,0.39948,1,1
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.00098941,0.30856,0.3057,1,1
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0031536,0.30854,0.25514,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,0.30853,0.39837,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.012508,0.30828,0.16348,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00081984,0.30822,0.20348,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,3.4772e-07,0.30805,0.31539,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.010773,0.30796,0.23563,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0030654,0.30788,0.25851,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,3.3287e-06,0.30783,0.27934,1,1
5,GO LIPID STORAGE,1.9263e-05,0.30741,0.26119,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0036303,0.3066,0.23894,1,1
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00026003,0.30621,0.33207,1,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00047456,0.30589,0.23578,1,1
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,6.2786e-05,0.30583,0.3056,1,1
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00047456,0.30581,0.25421,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.0016129,0.30565,0.35347,1,1
5,GO NEPHRON MORPHOGENESIS,0.00036427,0.30562,0.20848,1,1
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0073363,0.30558,0.28764,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010845,0.30545,0.23846,1,1
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00025131,0.30495,0.23708,1,1
5,GO KERATINOCYTE PROLIFERATION,0.016734,0.30475,0.18674,1,1
5,GO RENAL FILTRATION,0.015203,0.30466,0.32712,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00026903,0.30455,0.22085,1,1
5,GO MYOTUBE DIFFERENTIATION,8.6584e-06,0.30438,0.25841,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00054072,0.30426,0.26428,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,3.7145e-05,0.30354,0.25073,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,7.013e-05,0.30352,0.25023,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00047456,0.30336,0.26573,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.5149e-05,0.30334,0.30722,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,4.1112e-06,0.30331,0.29175,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00010845,0.30328,0.23415,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00013433,0.30319,0.25669,1,1
5,GO REGULATION OF COAGULATION,0.0027346,0.30309,0.2325,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,2.7343e-05,0.30295,0.2299,1,1
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0085714,0.30272,0.304,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00017796,0.30271,0.2707,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0014299,0.30242,0.42624,1,1
5,GO REGULATION OF CELL CELL ADHESION,7.0571e-06,0.30238,0.25739,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00063551,0.30232,0.33011,1,1
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0034322,0.30232,0.26662,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0028957,0.30211,0.27773,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.8583e-05,0.30211,0.26213,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.1493e-05,0.30203,0.27825,1,1
5,GO PARTURITION,0.0054795,0.3016,0.28162,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00050664,0.30112,0.25498,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00016595,0.30103,0.45185,1,1
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00038934,0.30096,0.27681,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.030383,0.30076,0.22531,1,1
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.011904,0.30065,0.20435,1,1
5,GO MACROPHAGE DIFFERENTIATION,5.2139e-05,0.30058,0.24418,1,1
5,GO ADAPTIVE IMMUNE RESPONSE,5.4121e-05,0.30053,0.29698,1,1
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00041602,0.3005,0.29736,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,1.1964e-05,0.30042,0.25218,1,1
5,GO EPITHELIAL CELL PROLIFERATION,3.7145e-05,0.30007,0.24075,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.00035231,0.30001,0.29414,1,1
5,GO ASTROCYTE DEVELOPMENT,0.001872,0.29984,0.27219,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,5.9841e-06,0.29983,0.28157,1,1
5,GO CRANIAL NERVE DEVELOPMENT,1.8521e-05,0.29978,0.30955,1,1
5,GO LUNG MORPHOGENESIS,0.0045306,0.29921,0.20896,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.0006154,0.2992,0.2771,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,6.5149e-05,0.29919,0.31291,1,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,2.0033e-05,0.29907,0.26925,1,1
5,GO MALE SEX DETERMINATION,0.011612,0.29888,0.23258,1,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0062634,0.29881,0.25687,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00017796,0.29881,0.28894,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.022165,0.29874,0.28465,1,1
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00034072,0.29856,0.27051,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.4609e-05,0.29848,0.24456,1,1
5,GO INNATE IMMUNE RESPONSE,0.00013433,0.29824,0.22635,1,1
5,GO REGULATION OF WOUND HEALING,0.0010206,0.29818,0.24148,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00095906,0.29798,0.28753,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00016595,0.29786,0.21688,1,1
5,GO RENAL TUBULE DEVELOPMENT,0.00024286,0.29778,0.22314,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0037331,0.29752,0.24463,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0053338,0.29718,0.21313,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,1.8521e-05,0.29713,0.25815,1,1
5,GO REGULATION OF LYMPHOCYTE MIGRATION,5.2139e-05,0.29689,0.25879,1,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.0069616,0.29676,0.27746,1,1
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,6.5149e-05,0.29672,0.3158,1,1
5,GO LEUKOCYTE PROLIFERATION,2.4346e-05,0.29671,0.24561,1,1
5,GO SPINAL CORD PATTERNING,0.012203,0.2966,0.2545,1,1
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.03939,0.29641,0.29252,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0551e-05,0.29637,0.24658,1,1
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00090094,0.29603,0.19959,1,1
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0010528,0.29602,0.30372,1,1
5,GO SECONDARY PALATE DEVELOPMENT,2.0833e-05,0.29594,0.33606,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0017641,0.29591,0.21273,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0015189,0.29562,0.20792,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00012512,0.2955,0.30716,1,1
5,GO CHEMOKINE PRODUCTION,8.4205e-05,0.29549,0.27671,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00010092,0.29537,0.20594,1,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.014841,0.29531,0.26256,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,8.1192e-05,0.29449,0.28428,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,2.8077e-06,0.29414,0.28136,1,1
5,GO RESPONSE TO AXON INJURY,0.00019753,0.29412,0.24319,1,1
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.010245,0.29408,0.30403,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0090226,0.29407,0.24104,1,1
5,GO GANGLION DEVELOPMENT,0.027188,0.29405,0.31594,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00095906,0.29397,0.21928,1,1
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.02068,0.29395,0.20309,1,1
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00353,0.29383,0.33418,1,1
5,GO REGULATION OF RESPIRATORY BURST,0.0013457,0.29379,0.27784,1,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.042857,0.29359,0.15985,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00025131,0.29309,0.26243,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0029794,0.29298,0.2937,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.0073e-05,0.29294,0.26734,1,1
5,GO PROTEIN TARGETING TO LYSOSOME,0.0056288,0.29289,0.24635,1,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0011199,0.29288,0.21366,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00022676,0.29286,0.26828,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00069957,0.29245,0.28444,1,1
5,GO SPHINGOID METABOLIC PROCESS,0.00014418,0.29242,0.27355,1,1
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0037331,0.29235,0.25644,1,1
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00084609,0.29212,0.33813,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,3.0576e-06,0.29196,0.28253,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,1.9904e-06,0.29192,0.27601,1,1
5,GO TYPE I INTERFERON PRODUCTION,0.00098941,0.2918,0.2141,1,1
5,GO REGULATION OF NEURON MATURATION,0.0027346,0.29163,0.27229,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0031536,0.29147,0.29605,1,1
5,GO DETECTION OF BIOTIC STIMULUS,0.00065623,0.29146,0.33029,1,1
5,GO MUSCLE CELL MIGRATION,0.00042998,0.29121,0.26814,1,1
5,GO RESPONSE TO IRON ION,0.00055855,0.29098,0.23747,1,1
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0021062,0.29088,0.35697,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,3.8583e-05,0.29082,0.25021,1,1
5,GO ENDOTHELIAL CELL PROLIFERATION,5.6174e-05,0.29081,0.24958,1,1
5,GO LEUKOCYTE MIGRATION,1.5816e-05,0.29077,0.24515,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,6.5149e-05,0.29057,0.24761,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,2.4346e-05,0.29029,0.24113,1,1
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0053338,0.29015,0.18942,1,1
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,3.8583e-05,0.29013,0.24484,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.6455e-05,0.29011,0.26087,1,1
5,GO REGULATION OF SYMBIOTIC PROCESS,0.0051916,0.29003,0.18426,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00045924,0.28953,0.30677,1,1
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00022676,0.2895,0.30191,1,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,4.3218e-05,0.28946,0.29364,1,1
5,GO REGULATION OF ODONTOGENESIS,0.0059384,0.28931,0.31016,1,1
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00092958,0.28931,0.3841,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00063551,0.28919,0.24326,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0014738,0.28917,0.32716,1,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.104e-05,0.2891,0.27328,1,1
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00030804,0.28904,0.27635,1,1
5,GO KIDNEY MORPHOGENESIS,0.00036427,0.28899,0.21667,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.4674e-06,0.28893,0.25288,1,1
5,GO NEURON CELL CELL ADHESION,0.01282,0.28893,0.40063,1,1
5,GO PARAXIAL MESODERM DEVELOPMENT,0.0019282,0.28883,0.29394,1,1
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00041602,0.28849,0.23982,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.004408,0.28832,0.20139,1,1
5,GO GLYCOSYLATION,4.6623e-06,0.28817,0.24681,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00353,0.28814,0.22593,1,1
5,GO FATTY ACID HOMEOSTASIS,0.0018173,0.28811,0.31366,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,7.013e-05,0.28802,0.25735,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,1.7118e-05,0.28801,0.24853,1,1
5,GO BEHAVIORAL RESPONSE TO PAIN,0.010506,0.28794,0.27138,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00014418,0.28756,0.28581,1,1
5,GO HEART TRABECULA FORMATION,0.0026572,0.28756,0.29249,1,1
5,GO INTERLEUKIN 13 PRODUCTION,0.0060989,0.28753,0.26487,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00023468,0.28746,0.23733,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,2.8077e-06,0.28694,0.28703,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00047456,0.28678,0.2168,1,1
5,GO PLATELET ACTIVATION,0.00016023,0.28675,0.21215,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00054072,0.28666,0.28205,1,1
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.031748,0.28648,0.18615,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0013457,0.28627,0.24715,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,5.2533e-07,0.28622,0.28949,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,2.6307e-05,0.28621,0.23935,1,1
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0014738,0.28618,0.27604,1,1
5,GO PROTEIN DEGLYCOSYLATION,0.00087311,0.28611,0.24597,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,3.8583e-05,0.28603,0.21328,1,1
5,GO PLASMA MEMBRANE FUSION,0.00057693,0.28596,0.27903,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00017796,0.28593,0.3002,1,1
5,GO REGULATION OF ACROSOME REACTION,0.0031536,0.28583,0.24242,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00013917,0.28578,0.30404,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.0551e-05,0.2856,0.2829,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,8.1192e-05,0.28537,0.23084,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00016023,0.28497,0.28671,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00045924,0.28485,0.25409,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.00024286,0.28479,0.23764,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,4.8379e-05,0.28453,0.22734,1,1
5,GO GLIAL CELL DIFFERENTIATION,7.3528e-06,0.2844,0.25245,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.013e-05,0.28434,0.23098,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00036427,0.28414,0.22685,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010462,0.28413,0.25277,1,1
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.001872,0.28411,0.52034,1,1
5,GO MIDGUT DEVELOPMENT,0.0094949,0.28409,0.28321,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.1888e-05,0.28397,0.2317,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.034637,0.28395,0.30263,1,1
5,GO COCHLEA MORPHOGENESIS,0.042857,0.28356,0.18298,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,0.00050664,0.28339,0.2338,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.004408,0.28332,0.21169,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,5.0683e-06,0.28291,0.27914,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0025083,0.28279,0.18785,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,7.8282e-05,0.28247,0.24485,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0015189,0.28227,0.35543,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,8.1192e-05,0.28226,0.27703,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,2.4346e-05,0.28224,0.22216,1,1
5,GO PLACENTA DEVELOPMENT,0.00026903,0.28206,0.21533,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.017969,0.282,0.19649,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,2.4346e-05,0.28199,0.22685,1,1
5,GO REGULATION OF CELL ADHESION,4.3218e-05,0.28193,0.23128,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,7.889e-07,0.28153,0.26718,1,1
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.5816e-05,0.28153,0.259,1,1
5,GO REGULATION OF CELL ACTIVATION,2.7343e-05,0.28133,0.20932,1,1
5,GO B CELL ACTIVATION,2.7343e-05,0.28122,0.22007,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00018427,0.28116,0.25536,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.349e-05,0.28114,0.35374,1,1
5,GO ALPHA BETA T CELL ACTIVATION,7.547e-05,0.28101,0.24011,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00063551,0.2808,0.32995,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.02268,0.28065,0.20864,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,0.28048,0.22638,1,1
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0014299,0.28036,0.22841,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0033369,0.28008,0.16131,1,1
5,GO CELL CELL ADHESION,1.0604e-05,0.27989,0.21908,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.01282,0.27983,0.24583,1,1
5,GO CELL MATRIX ADHESION,9.389e-05,0.27968,0.22629,1,1
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0081404,0.27946,0.20644,1,1
5,GO INTERLEUKIN 12 PRODUCTION,1.5816e-05,0.27932,0.27607,1,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0081404,0.27924,0.2149,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,5.4121e-05,0.27891,0.23172,1,1
5,GO REGULATION OF SYNAPSE MATURATION,0.014138,0.27883,0.26532,1,1
5,GO POSITIVE REGULATION OF FERTILIZATION,0.015574,0.27866,0.23412,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,5.9841e-06,0.27849,0.26406,1,1
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0039469,0.27848,0.28566,1,1
5,GO FUCOSYLATION,1.9263e-05,0.27821,0.2794,1,1
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00019753,0.27816,0.23979,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.037747,0.27812,0.20209,1,1
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0064317,0.27808,0.37857,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.2524e-05,0.27784,0.25065,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.001228,0.27777,0.22006,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0050528,0.27773,0.22017,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0057817,0.27768,0.35072,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0012662,0.2774,0.30828,1,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.00084609,0.27698,0.19011,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.017137,0.27684,0.20318,1,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00047456,0.27664,0.24842,1,1
5,GO CAMP METABOLIC PROCESS,0.0039469,0.27652,0.19225,1,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.0047853,0.27646,0.29102,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00031859,0.27623,0.27099,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00026003,0.27601,0.2526,1,1
5,GO GLIOGENESIS,2.0833e-05,0.27577,0.22888,1,1
5,GO INTERLEUKIN 4 PRODUCTION,8.7323e-05,0.27569,0.26059,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,0.0050528,0.27529,0.28137,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,4.3218e-05,0.27519,0.22873,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,3.0689e-05,0.27499,0.21938,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.0689e-05,0.27497,0.2318,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0001547,0.2749,0.2699,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.024846,0.27481,0.20713,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00021909,0.27477,0.19855,1,1
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.016734,0.27466,0.24032,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00027832,0.27462,0.24119,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0019282,0.27447,0.249,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.00059588,0.27428,0.35327,1,1
5,GO IMMUNE EFFECTOR PROCESS,0.00035231,0.27424,0.2094,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010859,0.27415,0.28936,1,1
5,GO CARDIAC CONDUCTION,9.7346e-05,0.27406,0.24967,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,0.00010845,0.27395,0.23166,1,1
5,GO MEMBRANE REPOLARIZATION,0.00047456,0.2738,0.25232,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,0.00010845,0.27362,0.2678,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,0.0017123,0.27347,0.23492,1,1
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00012074,0.27327,0.22895,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.018398,0.27326,0.2384,1,1
5,GO CELL CHEMOTAXIS,1.5201e-05,0.27325,0.25428,1,1
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0042883,0.27298,0.29481,1,1
5,GO REGULATION OF T CELL ACTIVATION,1.9263e-05,0.27254,0.2287,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0097392,0.27223,0.21252,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00059588,0.27221,0.2191,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.0087944,0.27209,0.16966,1,1
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.00067758,0.27202,0.22634,1,1
5,GO RETINA LAYER FORMATION,0.036948,0.27199,0.27869,1,1
5,GO INTESTINAL ABSORPTION,0.0016129,0.27197,0.23903,1,1
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00021909,0.27187,0.2326,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,0.0038387,0.27184,0.23693,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00098941,0.27184,0.27321,1,1
5,GO STEROL HOMEOSTASIS,6.7596e-05,0.27086,0.22829,1,1
5,GO T CELL PROLIFERATION,3.8583e-05,0.27077,0.23869,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.0689e-05,0.27041,0.2293,1,1
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0017641,0.27041,0.22841,1,1
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0018173,0.27012,0.25623,1,1
5,GO INNERVATION,0.022165,0.27011,0.26918,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00020448,0.26993,0.2067,1,1
5,GO HAIR CELL DIFFERENTIATION,9.7346e-05,0.26977,0.23196,1,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,9.0179e-06,0.2697,0.26716,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0064317,0.26968,0.27117,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0094949,0.26961,0.18948,1,1
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00024286,0.2694,0.20461,1,1
5,GO AMINO SUGAR CATABOLIC PROCESS,0.0069616,0.26928,0.20732,1,1
5,GO METANEPHROS DEVELOPMENT,0.00069957,0.26921,0.20028,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.014138,0.26902,0.28735,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,1.5201e-05,0.26902,0.24721,1,1
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0040578,0.26864,0.27566,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,0.26829,0.19486,1,1
5,GO CYTOKINE PRODUCTION,0.00011241,0.26823,0.21327,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.0064317,0.26815,0.20889,1,1
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0057817,0.2679,0.21785,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0001547,0.26777,0.24804,1,1
5,GO RESPONSE TO GROWTH HORMONE,0.0031536,0.26772,0.21089,1,1
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,2.5308e-05,0.26768,0.23621,1,1
5,GO LEUKOCYTE CHEMOTAXIS,3.0689e-05,0.26764,0.23029,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,7.2754e-05,0.26751,0.20867,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00012074,0.26749,0.29515,1,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0073363,0.26749,0.16896,1,1
5,GO CERAMIDE METABOLIC PROCESS,4.6597e-05,0.26742,0.21796,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0036303,0.26739,0.20456,1,1
5,GO WATER HOMEOSTASIS,2.0833e-05,0.26729,0.27452,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.00045924,0.26712,0.20136,1,1
5,GO INTERACTION WITH HOST,0.0037331,0.26696,0.15918,1,1
5,GO AXIS ELONGATION,0.010245,0.26665,0.18155,1,1
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0017641,0.26648,0.24761,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,4.4878e-05,0.2661,0.20558,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,5.0226e-05,0.26594,0.21603,1,1
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00072223,0.26576,0.20612,1,1
5,GO MUSCLE ATROPHY,0.014486,0.26561,0.19161,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00014418,0.26548,0.22756,1,1
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0041716,0.2654,0.30631,1,1
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0007696,0.26528,0.28344,1,1
5,GO SODIUM ION TRANSPORT,3.0576e-06,0.26528,0.23323,1,1
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.3418e-05,0.26525,0.2517,1,1
5,GO DEVELOPMENTAL INDUCTION,3.3132e-05,0.26521,0.26108,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.00016595,0.2647,0.21481,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00057693,0.26468,0.2159,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.00026903,0.26465,0.26166,1,1
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.019739,0.26455,0.30579,1,1
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0025083,0.26451,0.15408,1,1
5,GO ENGULFMENT OF APOPTOTIC CELL,0.00029782,0.2644,0.29758,1,1
5,GO T CELL ACTIVATION,5.2139e-05,0.26402,0.21646,1,1
5,GO RESPONSE TO CYTOKINE,0.00026003,0.26399,0.18981,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00019753,0.26396,0.27768,1,1
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.040234,0.26388,0.20317,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,8.1192e-05,0.2638,0.21978,1,1
5,GO RESPONSE TO ACIDIC PH,0.001191,0.26352,0.26664,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,9.3916e-06,0.26334,0.24129,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0090226,0.26332,0.29373,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00057693,0.26323,0.21696,1,1
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0023671,0.26308,0.25846,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.1493e-05,0.26288,0.24325,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.024288,0.26264,0.26034,1,1
5,GO MULTICELLULAR ORGANISM AGING,1.9263e-05,0.26244,0.22792,1,1
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00044439,0.26237,0.19847,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,9.0551e-05,0.26218,0.2475,1,1
5,GO RENAL SYSTEM PROCESS,1.8521e-05,0.26217,0.22916,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.1888e-05,0.26182,0.24705,1,1
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0069616,0.2617,0.22168,1,1
5,GO REGULATION OF GLIOGENESIS,1.8521e-05,0.26165,0.23995,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0079323,0.26161,0.22339,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00041602,0.26107,0.19726,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.001986,0.26104,0.19298,1,1
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00017186,0.26102,0.23588,1,1
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.03939,0.26081,0.12467,1,1
5,GO GLIAL CELL MIGRATION,0.007729,0.26067,0.16315,1,1
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0015653,0.26062,0.2348,1,1
5,GO RESPONSE TO TUMOR CELL,0.0034322,0.25995,0.26009,1,1
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.0083534,0.2596,0.3415,1,1
5,GO SODIUM ION HOMEOSTASIS,2.9532e-05,0.25951,0.24732,1,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.004408,0.25951,0.20856,1,1
5,GO REGULATION OF TUBULIN DEACETYLATION,0.024288,0.25943,0.22425,1,1
5,GO SERTOLI CELL DEVELOPMENT,0.0025083,0.25938,0.33961,1,1
5,GO INACTIVATION OF MAPK ACTIVITY,0.0010859,0.25931,0.28288,1,1
5,GO BIOLOGICAL ADHESION,5.8301e-05,0.25917,0.20082,1,1
5,GO RESPONSE TO CORTICOSTERONE,0.007729,0.25911,0.24061,1,1
5,GO RESPONSE TO INSECTICIDE,0.001191,0.25911,0.32019,1,1
5,GO CARDIAC CELL DEVELOPMENT,0.00012964,0.25904,0.20108,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0047853,0.25897,0.28766,1,1
5,GO INFLAMMATORY RESPONSE,3.3132e-05,0.25875,0.22379,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.010245,0.25875,0.25717,1,1
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.0083534,0.25869,0.22359,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,3.4421e-05,0.2584,0.22473,1,1
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.025414,0.25837,0.21315,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0017123,0.25819,0.21138,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00012964,0.25818,0.30095,1,1
5,GO INTERLEUKIN 6 PRODUCTION,1.4609e-05,0.25816,0.22499,1,1
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00010092,0.25809,0.28449,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,0.25802,0.17299,1,1
5,GO REGULATION OF GONAD DEVELOPMENT,0.030383,0.25782,0.15973,1,1
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00018427,0.25769,0.24962,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00084609,0.25765,0.24669,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.5759e-05,0.25751,0.24117,1,1
5,GO INTERLEUKIN 1 PRODUCTION,0.00098941,0.25736,0.22885,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,6.7596e-05,0.25702,0.22583,1,1
5,GO REGULATION OF FATTY ACID TRANSPORT,1.2962e-05,0.257,0.29852,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0042883,0.25663,0.21172,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,1.0184e-05,0.25647,0.27121,1,1
5,GO TUBE MORPHOGENESIS,0.00012512,0.25629,0.18492,1,1
5,GO PROGRAMMED NECROTIC CELL DEATH,0.0015653,0.25613,0.25454,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,4.0073e-05,0.25613,0.19194,1,1
5,GO RESPONSE TO WOUNDING,0.00092958,0.25603,0.18975,1,1
5,GO BLOOD VESSEL MORPHOGENESIS,0.00050664,0.25593,0.17984,1,1
5,GO REGULATION OF RESPONSE TO FOOD,4.6597e-05,0.25591,0.25733,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.023741,0.25585,0.17018,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,1.6455e-05,0.25583,0.21522,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00027832,0.25579,0.2442,1,1
5,GO DIOL METABOLIC PROCESS,0.00024286,0.25561,0.24063,1,1
5,GO DEFENSE RESPONSE,6.0504e-05,0.25539,0.21036,1,1
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00069957,0.25537,0.37301,1,1
5,GO ANATOMICAL STRUCTURE REGRESSION,0.036164,0.25506,0.24692,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.0015189,0.25489,0.17586,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.0504e-05,0.25482,0.25305,1,1
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.033166,0.25479,0.21644,1,1
5,GO MESONEPHROS DEVELOPMENT,2.5308e-05,0.25479,0.25642,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010845,0.25476,0.1974,1,1
5,GO OXALATE TRANSPORT,0.0059384,0.25468,0.17439,1,1
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00092958,0.25466,0.24209,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,2.2524e-05,0.25465,0.27173,1,1
5,GO DRUG CATABOLIC PROCESS,0.0022992,0.25464,0.1746,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,1.104e-05,0.25464,0.24433,1,1
5,GO MYOTUBE CELL DEVELOPMENT,0.00042998,0.25452,0.23829,1,1
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0022992,0.2544,0.24819,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,5.4121e-05,0.25424,0.23108,1,1
5,GO T CELL MIGRATION,0.00042998,0.25423,0.21492,1,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00040247,0.25421,0.2188,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0049174,0.25421,0.16561,1,1
5,GO VIRAL LIFE CYCLE,0.0064317,0.2542,0.15918,1,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.014138,0.25416,0.1992,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,0.00013917,0.25396,0.22356,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,3.0689e-05,0.25388,0.23428,1,1
5,GO INSEMINATION,0.030383,0.25382,0.24606,1,1
5,GO NECROTIC CELL DEATH,0.00063551,0.25362,0.26121,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00023468,0.25361,0.18627,1,1
5,GO RESPONSE TO CAFFEINE,0.001872,0.25352,0.23,1,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,5.2139e-05,0.25349,0.33577,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.349e-05,0.25348,0.22309,1,1
5,GO POSITIVE CHEMOTAXIS,0.00016023,0.25328,0.25212,1,1
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.011612,0.25322,0.14777,1,1
5,GO DNA DEMETHYLATION,0.00087311,0.25287,0.22601,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0062634,0.25286,0.32457,1,1
5,GO ICOSANOID METABOLIC PROCESS,0.00059588,0.25267,0.22957,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0032441,0.25262,0.20391,1,1
5,GO LYMPHOCYTE MIGRATION,8.4205e-05,0.25253,0.21855,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.00010462,0.2525,0.25857,1,1
5,GO CELL KILLING,0.00021167,0.25244,0.2055,1,1
5,GO INTERLEUKIN 8 PRODUCTION,0.0040578,0.25238,0.20487,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00010462,0.25235,0.23305,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00063551,0.2523,0.25979,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00010845,0.25222,0.31295,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,6.2367e-06,0.25219,0.21279,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00019079,0.25218,0.23789,1,1
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.023205,0.25216,0.20791,1,1
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0039469,0.25203,0.19557,1,1
5,GO MEMBRANE BIOGENESIS,0.0017123,0.2518,0.2487,1,1
5,GO LYMPHOCYTE ACTIVATION,4.0073e-05,0.25177,0.19108,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0014299,0.25163,0.18651,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.00034072,0.25149,0.20533,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0056288,0.25137,0.25008,1,1
5,GO CELL ACTIVATION,0.00020448,0.25127,0.1826,1,1
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0015189,0.25122,0.27878,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0030654,0.25108,0.16803,1,1
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.045624,0.25105,0.15243,1,1
5,GO B CELL HOMEOSTASIS,0.00072223,0.25091,0.2521,1,1
5,GO ENDOCRINE HORMONE SECRETION,3.4728e-06,0.25061,0.3007,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0064317,0.25037,0.18377,1,1
5,GO NEGATIVE REGULATION OF GLIOGENESIS,3.7145e-05,0.25025,0.34212,1,1
5,GO NOTCH SIGNALING PATHWAY,7.0571e-06,0.24999,0.23588,1,1
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0059384,0.24977,0.28794,1,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00055855,0.24966,0.27367,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.0054795,0.24959,0.20174,1,1
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00031859,0.24955,0.27465,1,1
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0013872,0.24947,0.23894,1,1
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0057817,0.24943,0.20297,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0056288,0.2494,0.22555,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,9.7801e-06,0.24923,0.23923,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.033166,0.24917,0.12553,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0054795,0.24904,0.20377,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,6.2786e-05,0.24889,0.20867,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00019079,0.24884,0.2116,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.0042883,0.24881,0.24988,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,3.7145e-05,0.2488,0.18454,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,1.4039e-05,0.2486,0.19533,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00012074,0.2485,0.3004,1,1
5,GO ANION HOMEOSTASIS,0.0011199,0.24835,0.18807,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00023468,0.24834,0.21532,1,1
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.031748,0.24817,0.1841,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.5774e-06,0.24815,0.27008,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00095906,0.24786,0.18677,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,6.0504e-05,0.24778,0.22265,1,1
5,GO POSITIVE REGULATION OF CELL DIVISION,8.4205e-05,0.24777,0.2134,1,1
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.033166,0.2476,0.15566,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,6.5149e-05,0.24745,0.23307,1,1
5,GO MACROPHAGE MIGRATION,0.001228,0.24735,0.20586,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.0007696,0.2473,0.21347,1,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00018427,0.24727,0.24235,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,1.7118e-05,0.24718,0.23391,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00012074,0.24714,0.26222,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.0184e-05,0.24662,0.21456,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.001662,0.24643,0.17802,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00010462,0.24636,0.18206,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0081404,0.24626,0.20867,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0007696,0.246,0.18586,1,1
5,GO MACROPHAGE APOPTOTIC PROCESS,0.041093,0.24579,0.16866,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.2962e-05,0.24575,0.2251,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00014935,0.24557,0.1943,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,4.6597e-05,0.24542,0.20648,1,1
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00035231,0.24533,0.25154,1,1
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.001662,0.24532,0.18384,1,1
5,GO REGULATION OF ICOSANOID SECRETION,9.7346e-05,0.2452,0.26903,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.00031859,0.24501,0.18087,1,1
5,GO PROTEIN KINASE B SIGNALING,0.00018427,0.24484,0.18174,1,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0033369,0.24479,0.2362,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00049035,0.24472,0.18165,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,4.6597e-05,0.24419,0.25848,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0018173,0.24406,0.19843,1,1
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.010773,0.24389,0.16077,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,3.5759e-05,0.24375,0.24452,1,1
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.001872,0.24349,0.2937,1,1
5,GO LIPID LOCALIZATION,7.2754e-05,0.24345,0.18282,1,1
5,GO REGULATION OF OSSIFICATION,4.1617e-05,0.24338,0.26116,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00013433,0.24334,0.23676,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.0019282,0.24309,0.21227,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,2.3418e-05,0.24307,0.23031,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00016023,0.24292,0.18678,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0031536,0.24283,0.15784,1,1
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.020205,0.24282,0.28253,1,1
5,GO EATING BEHAVIOR,4.4712e-06,0.24277,0.25669,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0056288,0.24212,0.18289,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001165,0.24204,0.26692,1,1
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.010773,0.24203,0.20221,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,4.3218e-05,0.24189,0.22938,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.00081984,0.24181,0.17714,1,1
5,GO OUTER DYNEIN ARM ASSEMBLY,0.0028957,0.2417,0.20533,1,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.0031536,0.24125,0.23492,1,1
5,GO NEUROINFLAMMATORY RESPONSE,0.00047456,0.2411,0.2123,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00018427,0.24102,0.20817,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00013433,0.24097,0.20664,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00047456,0.24076,0.21261,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00084609,0.24071,0.20579,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,8.4205e-05,0.24067,0.25,1,1
5,GO MACROPHAGE CHEMOTAXIS,0.0015653,0.2406,0.25193,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.00040247,0.24049,0.20774,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00072223,0.24043,0.28978,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001165,0.24038,0.19754,1,1
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00087311,0.24028,0.31726,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0011199,0.24016,0.20357,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00067758,0.24011,0.17078,1,1
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0046564,0.23999,0.20189,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00059588,0.23996,0.24559,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00034072,0.23992,0.22337,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0021689,0.23987,0.2076,1,1
5,GO PROTEIN PROCESSING,0.00014935,0.23977,0.19179,1,1
5,GO B CELL DIFFERENTIATION,1.2454e-05,0.23959,0.19455,1,1
5,GO FACIAL NERVE MORPHOGENESIS,0.015574,0.23956,0.29062,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.00022676,0.23952,0.21297,1,1
5,GO TISSUE REGENERATION,0.015574,0.2395,0.17362,1,1
5,GO EMBRYONIC HEMOPOIESIS,0.0014738,0.23947,0.22804,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0001165,0.23943,0.22484,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0001165,0.23941,0.19578,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00079435,0.23933,0.1853,1,1
5,GO NEURONAL ACTION POTENTIAL,0.0085714,0.23913,0.29912,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,5.4121e-05,0.23903,0.20409,1,1
5,GO PROTEIN N LINKED GLYCOSYLATION,0.00067758,0.239,0.20666,1,1
5,GO MUSCLE HYPERTROPHY,0.00054072,0.23891,0.1929,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.007729,0.23881,0.17918,1,1
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.047551,0.23852,0.23636,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00052342,0.23846,0.1654,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015653,0.23843,0.17481,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,2.1663e-05,0.23842,0.18539,1,1
5,GO GONADOTROPIN SECRETION,0.0021689,0.23841,0.27498,1,1
5,GO CHONDROCYTE DIFFERENTIATION,0.0060989,0.23829,0.18443,1,1
5,GO BONE MINERALIZATION,0.00023468,0.23821,0.22668,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00018427,0.23821,0.25973,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,4.8379e-05,0.23813,0.20138,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.001228,0.238,0.21847,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0013457,0.23775,0.22342,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0014299,0.23748,0.24343,1,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00079435,0.2373,0.26144,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.00029782,0.23695,0.18482,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0032441,0.23693,0.2171,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0053338,0.23689,0.21107,1,1
5,GO VASCULATURE DEVELOPMENT,0.00092958,0.23682,0.15811,1,1
5,GO POSITIVE REGULATION OF HEART RATE,0.0013457,0.23667,0.29673,1,1
5,GO STEROID METABOLIC PROCESS,0.00020448,0.2366,0.18649,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001191,0.23657,0.18109,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0079323,0.23644,0.16973,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0013457,0.23644,0.1714,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00045924,0.23636,0.2188,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0014299,0.23626,0.20395,1,1
5,GO AMINE TRANSPORT,0.00040247,0.23618,0.29946,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,1.4609e-05,0.23616,0.21691,1,1
5,GO CELL SUBSTRATE ADHESION,0.0013054,0.23616,0.19074,1,1
5,GO REGULATION OF MACROPHAGE MIGRATION,0.00044439,0.23602,0.20529,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.8583e-05,0.23599,0.18007,1,1
5,GO STARTLE RESPONSE,0.0022332,0.23594,0.2708,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00017796,0.23586,0.18557,1,1
5,GO WOUND HEALING,0.001662,0.23575,0.17433,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00010092,0.23572,0.28082,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00092958,0.23571,0.19342,1,1
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.0016129,0.23564,0.20807,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.00010092,0.2356,0.21428,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00054072,0.23551,0.20452,1,1
5,GO DIOL BIOSYNTHETIC PROCESS,0.00098941,0.23516,0.18697,1,1
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00020448,0.23466,0.21332,1,1
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0054795,0.23459,0.21757,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.0007696,0.23434,0.2191,1,1
5,GO NOTCH RECEPTOR PROCESSING,0.0029794,0.23434,0.34556,1,1
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0015653,0.23416,0.18221,1,1
5,GO NEPHRIC DUCT DEVELOPMENT,0.042857,0.2341,0.17931,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,6.2367e-06,0.23409,0.24246,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,5.4121e-05,0.23388,0.21953,1,1
5,GO MUSCLE ADAPTATION,0.00092958,0.2338,0.17997,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00013917,0.23377,0.25426,1,1
5,GO ENSHEATHMENT OF NEURONS,8.1192e-05,0.23369,0.19781,1,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0007696,0.23368,0.20861,1,1
5,GO MYELOID CELL HOMEOSTASIS,0.00023468,0.23351,0.17353,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00052342,0.23348,0.19361,1,1
5,GO LYMPHOCYTE CHEMOTAXIS,0.00079435,0.23343,0.19657,1,1
5,GO TUBE DEVELOPMENT,7.547e-05,0.23342,0.18197,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,0.00012964,0.23325,0.16986,1,1
5,GO MAST CELL MIGRATION,0.027803,0.23313,0.29862,1,1
5,GO POTASSIUM ION HOMEOSTASIS,3.4421e-05,0.23292,0.25678,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.2754e-05,0.23292,0.19019,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,2.5308e-05,0.23248,0.28118,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,2.6307e-05,0.23233,0.17356,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0017123,0.23226,0.17374,1,1
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00045924,0.23216,0.24562,1,1
5,GO EPIDERMIS DEVELOPMENT,0.00014935,0.23201,0.19574,1,1
5,GO GLAND DEVELOPMENT,6.4994e-06,0.23191,0.20491,1,1
5,GO GRANULOCYTE MIGRATION,0.00079435,0.23178,0.17617,1,1
5,GO NEURON MATURATION,2.2524e-05,0.23169,0.28643,1,1
5,GO REGULATION OF ANION TRANSPORT,5.2139e-05,0.23146,0.20141,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00027832,0.23145,0.27146,1,1
5,GO STEROL METABOLIC PROCESS,0.0010859,0.23137,0.17423,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.0075304,0.23129,0.1648,1,1
5,GO STEM CELL DIVISION,0.016339,0.23112,0.15396,1,1
5,GO REGULATION OF CHEMOTAXIS,4.8379e-05,0.23108,0.2168,1,1
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00092958,0.23102,0.27082,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0054795,0.23095,0.22342,1,1
5,GO PEPTIDYL TYROSINE MODIFICATION,8.1192e-05,0.23088,0.20679,1,1
5,GO MOLTING CYCLE,0.00092958,0.23081,0.15815,1,1
5,GO MUSCLE CELL DIFFERENTIATION,2.7343e-05,0.23074,0.18881,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.00020448,0.2306,0.17897,1,1
5,GO ORGANIC CATION TRANSPORT,0.00055855,0.23051,0.22674,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0064317,0.23051,0.17507,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.2454e-05,0.23046,0.21387,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.0028141,0.23043,0.20466,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,2.0033e-05,0.23041,0.19993,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,9.7346e-05,0.2304,0.17281,1,1
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0017123,0.23002,0.19621,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00057693,0.23002,0.16912,1,1
5,GO PHOSPHOLIPID TRANSPORT,1.2454e-05,0.22998,0.21246,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.001191,0.22993,0.19044,1,1
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.0039469,0.22989,0.17719,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0010528,0.22981,0.17462,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00055855,0.22976,0.21478,1,1
5,GO ENDOCRINE PROCESS,0.00032948,0.2295,0.2117,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0011549,0.22946,0.30252,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00031859,0.22912,0.19697,1,1
5,GO BIOMINERALIZATION,0.00012512,0.22907,0.21322,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.0079323,0.22891,0.16973,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0050528,0.22879,0.24128,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0025083,0.22872,0.22344,1,1
5,GO ACTIVATED T CELL PROLIFERATION,3.4421e-05,0.22866,0.22077,1,1
5,GO MAGNESIUM ION HOMEOSTASIS,0.047551,0.22861,0.15323,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.00029782,0.22861,0.24021,1,1
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00010462,0.22858,0.22847,1,1
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00047456,0.22857,0.21334,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.22845,0.19944,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00037661,0.22833,0.18837,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00074557,0.22826,0.24992,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00021167,0.22773,0.19277,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,1.6455e-05,0.22767,0.20825,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00012964,0.22751,0.18172,1,1
5,GO REGULATION OF BLOOD CIRCULATION,5.7413e-06,0.22747,0.22958,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,0.22727,0.22898,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00012074,0.22708,0.20587,1,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.035393,0.22694,0.17929,1,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00079435,0.22688,0.16456,1,1
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.0094949,0.22678,0.16407,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00090094,0.22663,0.16877,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00026003,0.22655,0.22088,1,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0046564,0.22648,0.17837,1,1
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00098941,0.22627,0.2125,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,4.6597e-05,0.22604,0.20022,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0010859,0.22603,0.20743,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0013054,0.22586,0.16825,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,0.00031859,0.22583,0.17755,1,1
5,GO STEROL TRANSPORT,0.0030654,0.22579,0.15294,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0020453,0.2257,0.1768,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00022676,0.2257,0.18764,1,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,1.104e-05,0.22569,0.21065,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.0006154,0.2255,0.20761,1,1
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0023671,0.22544,0.27032,1,1
5,GO FIBROBLAST MIGRATION,0.0019282,0.22541,0.1826,1,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.00016023,0.22532,0.18658,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.00081984,0.22528,0.18229,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00092958,0.22523,0.18804,1,1
5,GO COCHLEA DEVELOPMENT,0.00353,0.22518,0.20308,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00026903,0.22512,0.28233,1,1
5,GO CYTOKINE METABOLIC PROCESS,0.0014738,0.22492,0.23585,1,1
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.012508,0.2248,0.20728,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00022676,0.22475,0.16272,1,1
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0017123,0.22475,0.22259,1,1
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0032441,0.22438,0.24345,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0085714,0.22438,0.17252,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00035231,0.22407,0.16634,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00021167,0.22405,0.1825,1,1
5,GO ENDOTHELIAL CELL MIGRATION,0.00063551,0.22362,0.21097,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00054072,0.22356,0.21059,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,1.7118e-05,0.22325,0.23565,1,1
5,GO LYTIC VACUOLE ORGANIZATION,0.00047456,0.22318,0.17495,1,1
5,GO INTERLEUKIN 5 PRODUCTION,0.033894,0.22309,0.18728,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00010462,0.22306,0.21415,1,1
5,GO RESPONSE TO NICOTINE,0.0013054,0.22305,0.20885,1,1
5,GO CYTOKINE SECRETION,0.00040247,0.22298,0.20522,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00020448,0.22279,0.20714,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0024367,0.22278,0.25337,1,1
5,GO IMMUNOGLOBULIN PRODUCTION,0.00065623,0.22244,0.15252,1,1
5,GO BODY MORPHOGENESIS,0.0060989,0.22231,0.18522,1,1
5,GO NEPHRON DEVELOPMENT,0.00031859,0.22223,0.19131,1,1
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0022332,0.22215,0.20733,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00028792,0.22197,0.21208,1,1
5,GO DECIDUALIZATION,0.014138,0.2219,0.20482,1,1
5,GO RESPONSE TO MINERALOCORTICOID,0.03939,0.22187,0.13473,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00087311,0.2217,0.17271,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00035231,0.22163,0.23798,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00021909,0.22156,0.18921,1,1
5,GO CELL MOTILITY,5.8301e-05,0.22149,0.181,1,1
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00012964,0.22147,0.21672,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.015574,0.22134,0.12678,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.02843,0.22132,0.1968,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0010859,0.22114,0.19417,1,1
5,GO PANCREAS DEVELOPMENT,0.0023671,0.22112,0.1963,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.0022332,0.22094,0.16022,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.00032948,0.22092,0.18618,1,1
5,GO COAGULATION,0.0022992,0.22048,0.15453,1,1
5,GO CELL MATURATION,2.1831e-07,0.22044,0.21707,1,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.041967,0.22044,0.1943,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,4.4878e-05,0.22035,0.16989,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0028141,0.21972,0.16773,1,1
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0090226,0.21968,0.20567,1,1
5,GO MONONUCLEAR CELL MIGRATION,0.0010528,0.21948,0.20049,1,1
5,GO REPRODUCTIVE BEHAVIOR,0.027188,0.21937,0.14392,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0051916,0.21931,0.20868,1,1
5,GO RESPONSE TO NUTRIENT,0.00098941,0.21923,0.17608,1,1
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0040578,0.2192,0.25017,1,1
5,GO MEMBRANE FISSION,0.0054795,0.21917,0.21971,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.7413e-06,0.21908,0.20349,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0018173,0.21894,0.16844,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.025994,0.21892,0.21379,1,1
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.010773,0.21866,0.22679,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.0011549,0.21828,0.18169,1,1
5,GO ACTION POTENTIAL,0.00036427,0.21824,0.20415,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,0.00020448,0.21818,0.20038,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.0038387,0.21818,0.17562,1,1
5,GO TRANSLESION SYNTHESIS,0.00016595,0.21806,0.17646,1,1
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.029719,0.21798,0.14319,1,1
5,GO PEPTIDE SECRETION,1.3441e-06,0.21792,0.21031,1,1
5,GO TISSUE HOMEOSTASIS,0.00014418,0.21792,0.16181,1,1
5,GO REGULATION OF BIOMINERALIZATION,0.00095906,0.21779,0.18501,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0053338,0.21764,0.21093,1,1
5,GO REGULATION OF HEMOPOIESIS,6.2786e-05,0.21759,0.16965,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.001228,0.21757,0.17604,1,1
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0001165,0.2175,0.25389,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,2.2524e-05,0.21669,0.19757,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.00020448,0.21661,0.20539,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.024288,0.21653,0.2497,1,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0011549,0.21647,0.18294,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0018173,0.21645,0.24423,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.00014418,0.21639,0.18703,1,1
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.009256,0.21596,0.24918,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,4.6597e-05,0.21588,0.20957,1,1
5,GO GPI ANCHOR METABOLIC PROCESS,0.00079435,0.21577,0.1761,1,1
5,GO REGULATION OF HEART RATE,0.00036427,0.21571,0.22586,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0032441,0.21561,0.14863,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0001165,0.21539,0.16873,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,4.1802e-07,0.21536,0.22884,1,1
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.2524e-05,0.21522,0.2262,1,1
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0001547,0.2152,0.22436,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.012203,0.21503,0.13919,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.0010206,0.21502,0.25144,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0013054,0.21482,0.14209,1,1
5,GO SKIN DEVELOPMENT,0.00021167,0.21466,0.20172,1,1
5,GO REGULATION OF FERTILIZATION,0.0045306,0.21465,0.17022,1,1
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0051916,0.21456,0.16409,1,1
5,GO LEUKOCYTE DIFFERENTIATION,2.0833e-05,0.21443,0.18459,1,1
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.037747,0.21442,0.13398,1,1
5,GO GRANULOCYTE DIFFERENTIATION,0.0067808,0.21427,0.17561,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00090094,0.21417,0.17212,1,1
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0011199,0.21416,0.17794,1,1
5,GO RESPONSE TO AMINE,0.00353,0.21412,0.17757,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,4.8612e-06,0.21396,0.18924,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0021689,0.21386,0.15296,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.0013872,0.21381,0.22314,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0067808,0.21371,0.13931,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00050664,0.21363,0.20568,1,1
5,GO POSITIVE REGULATION OF SECRETION,1.3441e-06,0.21358,0.22064,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0001165,0.21345,0.20435,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0033369,0.21343,0.19071,1,1
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0013872,0.21342,0.18013,1,1
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.001191,0.21341,0.18111,1,1
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.0053338,0.2134,0.26411,1,1
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00353,0.21336,0.20814,1,1
5,GO EXOCYTOSIS,0.00012074,0.2133,0.17312,1,1
5,GO NEURON PROJECTION REGENERATION,0.0023671,0.21323,0.19254,1,1
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.011326,0.21303,0.32239,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0050528,0.21286,0.21971,1,1
5,GO MONOAMINE TRANSPORT,0.001872,0.21284,0.27081,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0094949,0.21281,0.3612,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00098941,0.21275,0.18805,1,1
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.02166,0.21272,0.20324,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.4039e-05,0.21256,0.19189,1,1
5,GO RESPONSE TO BMP,0.00026903,0.21255,0.19267,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,1.4609e-05,0.2125,0.20255,1,1
5,GO PROTEIN PALMITOYLATION,0.00019753,0.21247,0.22873,1,1
5,GO REGULATION OF PEPTIDE SECRETION,9.0221e-07,0.21245,0.20863,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.001191,0.2123,0.21926,1,1
5,GO RESPONSE TO STEROL,0.0021062,0.21228,0.18188,1,1
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0017123,0.21228,0.1892,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.019739,0.2122,0.19062,1,1
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.004408,0.21219,0.14981,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0097392,0.21218,0.19199,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.00079435,0.2121,0.28433,1,1
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0033369,0.2121,0.21098,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,4.8379e-05,0.21209,0.19963,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.00044439,0.21194,0.16231,1,1
5,GO OSSIFICATION,0.00012074,0.2119,0.22115,1,1
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.018398,0.21182,0.14796,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0053338,0.21172,0.2025,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.011047,0.21158,0.18029,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.00067758,0.21156,0.17947,1,1
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.023741,0.2115,0.24649,1,1
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00026003,0.21147,0.23372,1,1
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.015574,0.21131,0.20395,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0073363,0.21116,0.15828,1,1
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.037747,0.21094,0.20096,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,9.7346e-05,0.21084,0.21036,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00072223,0.21063,0.17201,1,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00047456,0.21061,0.20266,1,1
5,GO PHAGOCYTOSIS,0.0047853,0.21043,0.14354,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.023205,0.2104,0.21006,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,5.8301e-05,0.21017,0.17523,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00067758,0.21013,0.19286,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,8.4205e-05,0.21002,0.18307,1,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00050664,0.21001,0.16475,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0030654,0.21,0.17812,1,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.00021909,0.20999,0.16854,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,3.5759e-05,0.20978,0.21079,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.01282,0.20977,0.13158,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,7.013e-05,0.20956,0.19482,1,1
5,GO TISSUE MIGRATION,0.001662,0.20941,0.18613,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0037331,0.20941,0.16573,1,1
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.001986,0.20933,0.17837,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00063551,0.20929,0.21152,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,4.6597e-05,0.20922,0.16613,1,1
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0054795,0.20921,0.1837,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0012662,0.20914,0.16456,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,3.8583e-05,0.20913,0.21494,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,5.6174e-05,0.20902,0.17639,1,1
5,GO ETHER METABOLIC PROCESS,0.044685,0.20851,0.14522,1,1
5,GO PHOSPHOLIPID HOMEOSTASIS,0.017969,0.20843,0.16687,1,1
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0083534,0.20841,0.16384,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00018427,0.20832,0.16782,1,1
5,GO REGULATION OF TUBE SIZE,0.0001165,0.20831,0.17749,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.00013433,0.20828,0.23251,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.001986,0.20815,0.165,1,1
5,GO FLUID TRANSPORT,0.0022992,0.20814,0.17632,1,1
5,GO LOCOMOTORY BEHAVIOR,0.0007696,0.20793,0.18989,1,1
5,GO REGULATION OF GLUTAMATE SECRETION,0.0031536,0.20787,0.28641,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0030654,0.20778,0.17436,1,1
5,GO RESPONSE TO PEPTIDOGLYCAN,0.0024367,0.20777,0.18134,1,1
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.047551,0.20758,0.14902,1,1
5,GO RESPONSE TO CATECHOLAMINE,0.00031859,0.20752,0.19773,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0034322,0.20731,0.17967,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00084609,0.20729,0.19185,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.011047,0.20721,0.19152,1,1
5,GO RESPONSE TO VITAMIN,0.012203,0.20713,0.17205,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0025817,0.20708,0.18917,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.00095906,0.20701,0.15504,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00025131,0.20697,0.18796,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0019282,0.20673,0.20118,1,1
5,GO SEX DETERMINATION,0.0010206,0.2067,0.21599,1,1
5,GO MEMORY,0.00047456,0.20669,0.19289,1,1
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.009256,0.20657,0.16064,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.0036303,0.20655,0.21386,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.010506,0.20635,0.13659,1,1
5,GO STRESS FIBER ASSEMBLY,0.0014299,0.20627,0.18676,1,1
5,GO DETECTION OF MECHANICAL STIMULUS,7.8282e-05,0.20624,0.20928,1,1
5,GO T CELL DIFFERENTIATION,7.2754e-05,0.20616,0.17427,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.001662,0.20615,0.18512,1,1
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00059588,0.20582,0.18018,1,1
5,GO RESPONSE TO DEXAMETHASONE,0.0051916,0.20558,0.15448,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.00034072,0.20546,0.18237,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.010773,0.20537,0.20997,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,8.4205e-05,0.20528,0.17382,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0042883,0.20517,0.19867,1,1
5,GO ORGANELLE MEMBRANE FUSION,0.0011549,0.20499,0.16257,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.00087311,0.20495,0.17256,1,1
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.011612,0.20494,0.11883,1,1
5,GO REGULATION OF HORMONE SECRETION,1.2962e-05,0.20478,0.21033,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.00031859,0.20459,0.15101,1,1
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.014841,0.20457,0.15259,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0026572,0.20443,0.22002,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,5.8301e-05,0.20426,0.16754,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00072223,0.20423,0.18334,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0017123,0.2042,0.187,1,1
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00012964,0.20412,0.25642,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,0.00041602,0.20408,0.27253,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,2.1663e-05,0.20402,0.16203,1,1
5,GO REGULATION OF APPETITE,0.00036427,0.20394,0.20832,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00011241,0.20381,0.20464,1,1
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.0504e-05,0.20366,0.17691,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00020448,0.20351,0.17003,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.031748,0.20339,0.16594,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00098941,0.20329,0.18215,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,5.4121e-05,0.20307,0.25373,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.0012662,0.20279,0.14519,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.9418e-06,0.2027,0.19063,1,1
5,GO MUSCLE CELL DEVELOPMENT,0.00013917,0.20251,0.19394,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00012512,0.2024,0.21208,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.00017796,0.20238,0.1521,1,1
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0018173,0.20212,0.22735,1,1
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,7.013e-05,0.20204,0.18873,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0053338,0.20193,0.17116,1,1
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0013457,0.20185,0.20942,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.0042883,0.20175,0.13717,1,1
5,GO DEVELOPMENTAL MATURATION,2.1702e-06,0.20166,0.20656,1,1
5,GO MEMBRANE HYPERPOLARIZATION,0.0062634,0.20161,0.23987,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00030804,0.20155,0.15036,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0015653,0.2015,0.15203,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.00032948,0.20136,0.16587,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00090094,0.2013,0.16772,1,1
5,GO EPITHELIUM DEVELOPMENT,4.6597e-05,0.20116,0.17244,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0015653,0.20111,0.17411,1,1
5,GO MAMMARY GLAND DEVELOPMENT,0.00014418,0.20105,0.18649,1,1
5,GO INTEGRIN ACTIVATION,0.0025817,0.20102,0.21258,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0062634,0.20099,0.20745,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,1.5816e-05,0.20089,0.19417,1,1
5,GO HEART PROCESS,1.0184e-05,0.20084,0.21906,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0051916,0.20068,0.19072,1,1
5,GO ACUTE PHASE RESPONSE,0.00044439,0.20065,0.19398,1,1
5,GO CELLULAR ANION HOMEOSTASIS,0.010506,0.20047,0.22182,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.0032441,0.20043,0.14088,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,2.9532e-05,0.20042,0.19857,1,1
5,GO PLATELET AGGREGATION,0.0011549,0.20033,0.21795,1,1
5,GO POLYOL TRANSPORT,0.021165,0.20011,0.15941,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0036303,0.20011,0.1827,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.4421e-05,0.19996,0.18781,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0034322,0.19993,0.17665,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0027346,0.19991,0.15264,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0097392,0.19979,0.27977,1,1
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.001228,0.19957,0.21426,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.026586,0.19955,0.19323,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00019753,0.19944,0.19991,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.014841,0.19941,0.16492,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0017123,0.19935,0.18699,1,1
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.011326,0.19926,0.18798,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.0069616,0.1991,0.25188,1,1
5,GO SPERM CAPACITATION,0.0018173,0.19902,0.1786,1,1
5,GO RESPONSE TO GONADOTROPIN,0.0081404,0.19897,0.16062,1,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.0032441,0.19892,0.17557,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,0.00045924,0.19891,0.17508,1,1
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.012203,0.19888,0.15684,1,1
5,GO TERPENOID METABOLIC PROCESS,0.001662,0.1988,0.15692,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0051916,0.19878,0.18491,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,1.8521e-05,0.19873,0.16674,1,1
5,GO REGULATION OF BONE MINERALIZATION,0.0022332,0.1987,0.20047,1,1
5,GO NEGATIVE REGULATION OF GROWTH,4.6597e-05,0.19855,0.17778,1,1
5,GO POSITIVE REGULATION OF SIGNALING,9.3916e-06,0.19853,0.15927,1,1
5,GO BRAIN MORPHOGENESIS,0.02843,0.19825,0.13348,1,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0014738,0.19821,0.23011,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0016129,0.19814,0.16029,1,1
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,2.4346e-05,0.19808,0.19122,1,1
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00035231,0.19789,0.19406,1,1
5,GO REGULATION OF DEFENSE RESPONSE,0.00024286,0.19771,0.16989,1,1
5,GO CELL JUNCTION ASSEMBLY,0.00011241,0.19764,0.17933,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,8.4205e-05,0.19755,0.16793,1,1
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0057817,0.19745,0.23697,1,1
5,GO CHLORIDE TRANSPORT,4.4878e-05,0.19736,0.19471,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0007696,0.19732,0.14241,1,1
5,GO CATECHOLAMINE METABOLIC PROCESS,0.0051916,0.19729,0.23558,1,1
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.019283,0.19714,0.16327,1,1
5,GO RESPONSE TO POTASSIUM ION,0.0046564,0.19713,0.24542,1,1
5,GO LIPID HOMEOSTASIS,0.00010845,0.19709,0.16348,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0015653,0.19707,0.17531,1,1
5,GO SECRETION,9.7801e-06,0.19689,0.17197,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0028957,0.19666,0.18721,1,1
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.001662,0.19658,0.29057,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0022992,0.19652,0.15073,1,1
5,GO THYMIC T CELL SELECTION,0.00027832,0.19641,0.1833,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010528,0.19635,0.16217,1,1
5,GO NATURAL KILLER CELL ACTIVATION,0.00067758,0.19634,0.1801,1,1
5,GO CATECHOLAMINE SECRETION,0.0071468,0.19631,0.28702,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,7.8282e-05,0.19616,0.17114,1,1
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0075304,0.19598,0.14852,1,1
5,GO REGULATION OF LIPID STORAGE,0.00027832,0.19552,0.19676,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00020448,0.1955,0.17853,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0054795,0.19547,0.11664,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.001191,0.19522,0.20416,1,1
5,GO RECEPTOR CLUSTERING,0.014841,0.19519,0.15786,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,5.8301e-05,0.19517,0.16578,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,6.7596e-05,0.19502,0.19707,1,1
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0045306,0.19498,0.2084,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0012662,0.1949,0.1602,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00072223,0.19476,0.14347,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.00016595,0.19476,0.15622,1,1
5,GO REGULATION OF PROTEOLYSIS,0.00095906,0.19468,0.1583,1,1
5,GO TUMOR NECROSIS FACTOR SECRETION,0.0040578,0.1946,0.14075,1,1
5,GO RESPONSE TO FATTY ACID,0.0037331,0.19458,0.16312,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00020448,0.19441,0.21086,1,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0038387,0.1944,0.15811,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.0001547,0.19438,0.1984,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0081404,0.19435,0.21532,1,1
5,GO HUMORAL IMMUNE RESPONSE,1.4609e-05,0.19426,0.24977,1,1
5,GO MALE SEX DIFFERENTIATION,0.00044439,0.19425,0.16142,1,1
5,GO INNER EAR MORPHOGENESIS,0.00079435,0.1939,0.15953,1,1
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.033166,0.19388,0.18038,1,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.053746,0.19372,0.095748,1,1
5,GO RESPONSE TO DRUG,0.00090094,0.1937,0.15286,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,6.2786e-05,0.19356,0.16204,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.00025131,0.19334,0.27098,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00084609,0.19333,0.20107,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0013054,0.19303,0.16733,1,1
5,GO RESPONSE TO METAL ION,1.0604e-05,0.19299,0.19662,1,1
5,GO CELLULAR KETONE METABOLIC PROCESS,0.014841,0.19296,0.11131,1,1
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00098941,0.19293,0.1843,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00018427,0.19288,0.16428,1,1
5,GO PROTEIN MATURATION,0.00063551,0.19278,0.14228,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,6.5149e-05,0.19272,0.20252,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,3.5759e-05,0.19248,0.1697,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00059588,0.19237,0.1794,1,1
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00030804,0.19219,0.19958,1,1
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.033894,0.19204,0.17911,1,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.015574,0.19197,0.099104,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00069957,0.19154,0.19617,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00036427,0.19141,0.20901,1,1
5,GO SECRETION BY TISSUE,0.010245,0.19139,0.1658,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00017796,0.19136,0.15634,1,1
5,GO AMINE METABOLIC PROCESS,0.00036427,0.19134,0.16829,1,1
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.014486,0.19106,0.14153,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0067808,0.19093,0.12792,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.00079435,0.1909,0.16039,1,1
5,GO RELAXATION OF MUSCLE,0.0083534,0.19063,0.18436,1,1
5,GO REGULATION OF SECRETION,2.0784e-06,0.19057,0.18813,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.7343e-05,0.19029,0.17722,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0040578,0.19021,0.21031,1,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0097392,0.18997,0.14502,1,1
5,GO HORMONE TRANSPORT,5.508e-06,0.18997,0.22444,1,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.012203,0.18985,0.20734,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.012508,0.1898,0.2039,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00090094,0.18961,0.17177,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0049174,0.18938,0.1606,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0012662,0.18933,0.18683,1,1
5,GO REGULATION OF HORMONE LEVELS,4.2876e-06,0.18924,0.19768,1,1
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.020205,0.18923,0.12188,1,1
5,GO RESPONSE TO DOPAMINE,0.0010206,0.18919,0.18305,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,7.8282e-05,0.18903,0.15797,1,1
5,GO RESPONSE TO CALCIUM ION,0.00074557,0.18892,0.16588,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00034072,0.1889,0.24696,1,1
5,GO TISSUE MORPHOGENESIS,0.00047456,0.18886,0.14331,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00034072,0.18886,0.23671,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0013054,0.18884,0.19335,1,1
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0085714,0.18861,0.14124,1,1
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0023671,0.18853,0.22297,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,5.8301e-05,0.18849,0.16169,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00081984,0.18844,0.24708,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.023205,0.18844,0.17891,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00017186,0.18839,0.18307,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00010092,0.18837,0.15422,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.9801e-06,0.18812,0.18684,1,1
5,GO RESPONSE TO AMYLOID BETA,0.0006154,0.18796,0.19957,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00012512,0.18791,0.1688,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00031859,0.18783,0.13475,1,1
5,GO RESPONSE TO BACTERIUM,0.00065623,0.18759,0.1677,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0001165,0.18749,0.16629,1,1
5,GO TUBULIN DEACETYLATION,0.015953,0.18746,0.17695,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.0007696,0.18745,0.18679,1,1
5,GO ERBB SIGNALING PATHWAY,0.001191,0.18745,0.16772,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0049174,0.18744,0.18443,1,1
5,GO NEUTROPHIL MIGRATION,0.0017641,0.18725,0.13198,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.017137,0.18709,0.23426,1,1
5,GO AXONEME ASSEMBLY,0.0023671,0.18703,0.18732,1,1
5,GO ENDOCYTIC RECYCLING,0.00095906,0.18693,0.16015,1,1
5,GO REGULATION OF PHOSPHORYLATION,8.7323e-05,0.18687,0.1458,1,1
5,GO REGULATION OF SYSTEM PROCESS,1.5201e-05,0.18681,0.1757,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00012074,0.18678,0.15793,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,7.2754e-05,0.18669,0.13956,1,1
5,GO ACTIN CROSSLINK FORMATION,0.020205,0.18668,0.15524,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0021062,0.18666,0.17999,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00010092,0.18641,0.17647,1,1
5,GO RESPONSE TO ISCHEMIA,0.0032441,0.18612,0.16068,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00012964,0.1861,0.21096,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00054072,0.18605,0.13455,1,1
5,GO FIBROBLAST PROLIFERATION,0.0030654,0.1856,0.23013,1,1
5,GO ACID SECRETION,0.00079435,0.18559,0.19513,1,1
5,GO FEMALE GENITALIA DEVELOPMENT,0.0029794,0.18554,0.20569,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,8.2505e-07,0.18544,0.18223,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.013e-05,0.18525,0.15689,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,7.547e-05,0.18514,0.15217,1,1
5,GO CELLULAR RESPONSE TO VIRUS,0.0075304,0.18512,0.12663,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0021689,0.18501,0.1777,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0007696,0.18493,0.14258,1,1
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00038934,0.18483,0.17338,1,1
5,GO POTASSIUM ION TRANSPORT,0.00026003,0.18478,0.1989,1,1
5,GO INORGANIC ANION TRANSPORT,3.3132e-05,0.18477,0.17389,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,6.5149e-05,0.18477,0.16847,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.0030654,0.18453,0.18299,1,1
5,GO REGULATION OF ION TRANSPORT,3.7145e-05,0.18447,0.17151,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.4346e-05,0.18423,0.20026,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0014738,0.18421,0.19078,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.011612,0.18418,0.098846,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,4.3218e-05,0.18402,0.17561,1,1
5,GO MEMBRANE FUSION,9.7346e-05,0.18392,0.18462,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.1964e-05,0.18376,0.15774,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.001986,0.18365,0.18426,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00095906,0.18358,0.17048,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.00079435,0.18328,0.1564,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00019079,0.18326,0.14543,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00034072,0.18323,0.1481,1,1
5,GO MITOTIC CELL CYCLE ARREST,0.019283,0.18318,0.16835,1,1
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.04854,0.1831,0.12401,1,1
5,GO REGULATION OF EXIT FROM MITOSIS,0.009256,0.18297,0.12802,1,1
5,GO EAR DEVELOPMENT,0.0006154,0.18295,0.15761,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00018427,0.18289,0.14659,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00013917,0.18289,0.13566,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.007729,0.18283,0.16056,1,1
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0059384,0.18233,0.1211,1,1
5,GO MANNOSYLATION,0.015953,0.18209,0.1489,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0020453,0.18201,0.21142,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00022676,0.18192,0.2793,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0018173,0.1819,0.22806,1,1
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.021165,0.18144,0.13961,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0022332,0.1814,0.13584,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.0038387,0.18138,0.14082,1,1
5,GO REGULATION OF MAPK CASCADE,0.00022676,0.18136,0.18492,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.1617e-05,0.18135,0.1837,1,1
5,GO STRIATED MUSCLE CONTRACTION,0.00028792,0.18127,0.16446,1,1
5,GO CELL GROWTH,5.2139e-05,0.18126,0.1673,1,1
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.044685,0.18114,0.12569,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0013872,0.18112,0.17568,1,1
5,GO GROWTH HORMONE SECRETION,0.0069616,0.18104,0.24425,1,1
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013054,0.18085,0.18067,1,1
5,GO LIPID METABOLIC PROCESS,0.00012512,0.18073,0.14801,1,1
5,GO DETECTION OF STIMULUS,1.104e-05,0.1806,0.15697,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00014418,0.18047,0.17015,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0090226,0.18034,0.2288,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00019753,0.18025,0.13943,1,1
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,9.389e-05,0.17988,0.16065,1,1
5,GO CELL AGGREGATION,0.011047,0.17981,0.17437,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,0.00016023,0.17964,0.15437,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.014138,0.17955,0.14589,1,1
5,GO REGULATION OF PH,0.00067758,0.17953,0.11973,1,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.013139,0.17945,0.32098,1,1
5,GO RESPONSE TO LIPID,0.0013872,0.17924,0.14358,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,3.7145e-05,0.17919,0.153,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,9.3916e-06,0.17908,0.2088,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00353,0.179,0.14508,1,1
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00026003,0.1789,0.18026,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0013054,0.17877,0.13243,1,1
5,GO CELL JUNCTION ORGANIZATION,0.00019079,0.17867,0.16385,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.027803,0.17864,0.14521,1,1
5,GO P38MAPK CASCADE,0.021165,0.1786,0.14761,1,1
5,GO ER NUCLEUS SIGNALING PATHWAY,0.0030654,0.17854,0.15682,1,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.013139,0.17839,0.17488,1,1
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.05161,0.17836,0.13745,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,2.6307e-05,0.17817,0.17577,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.2454e-05,0.17793,0.15363,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,3.7145e-05,0.17788,0.17384,1,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.009256,0.17782,0.2093,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.03245,0.17753,0.12371,1,1
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0051916,0.17743,0.19365,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0010528,0.17742,0.13195,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0006154,0.17741,0.17265,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.0025817,0.17724,0.14777,1,1
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.023741,0.17706,0.14906,1,1
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0083534,0.17701,0.16409,1,1
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.034637,0.17689,0.19146,1,1
5,GO REGULATION OF T CELL MIGRATION,0.00016023,0.17687,0.21874,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00013917,0.17686,0.13997,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.00025131,0.17676,0.14899,1,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0060989,0.1767,0.11886,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00029782,0.17662,0.14243,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00072223,0.17657,0.22452,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,5.2139e-05,0.17652,0.17094,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0071468,0.17639,0.20205,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0032441,0.17611,0.19434,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,5.6174e-05,0.1761,0.13961,1,1
5,GO IMPORT INTO CELL,0.00057693,0.17609,0.16949,1,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0071468,0.17605,0.15227,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,3.3132e-05,0.17604,0.24132,1,1
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.03939,0.17602,0.10199,1,1
5,GO PEPTIDE HORMONE SECRETION,4.4878e-05,0.176,0.20989,1,1
5,GO DIET INDUCED THERMOGENESIS,0.016734,0.17595,0.14875,1,1
5,GO LIPID MODIFICATION,0.00010092,0.17584,0.14805,1,1
5,GO CIRCULATORY SYSTEM PROCESS,7.9801e-06,0.1758,0.17958,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.013465,0.17561,0.21914,1,1
5,GO CARBOHYDRATE TRANSPORT,8.4205e-05,0.17556,0.16425,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0012662,0.1755,0.18117,1,1
5,GO SKELETAL MUSCLE CONTRACTION,0.0015653,0.17532,0.17905,1,1
5,GO ISOPRENOID METABOLIC PROCESS,0.0021062,0.17515,0.14587,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.00098941,0.17499,0.21157,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,2.7343e-05,0.17488,0.18027,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0028957,0.17482,0.1355,1,1
5,GO TEMPERATURE HOMEOSTASIS,4.1112e-06,0.17464,0.1962,1,1
5,GO RESPONSE TO GROWTH FACTOR,0.00059588,0.17452,0.14811,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0071468,0.17449,0.18619,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,6.7596e-05,0.17449,0.14635,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,9.0179e-06,0.17443,0.16355,1,1
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.016734,0.17427,0.16689,1,1
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.04854,0.17416,0.16884,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0011199,0.17389,0.12334,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0022992,0.17383,0.16356,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.004408,0.17376,0.19688,1,1
5,GO REGULATION OF LIPID TRANSPORT,0.0006154,0.17375,0.16514,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.00026903,0.17374,0.1313,1,1
5,GO REGULATION OF LIPID LOCALIZATION,0.0016129,0.17373,0.15133,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00065623,0.17361,0.14423,1,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.033894,0.1736,0.17213,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.013465,0.17344,0.14271,1,1
5,GO CHEMICAL HOMEOSTASIS,3.4728e-06,0.17343,0.16754,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.0015653,0.17342,0.20972,1,1
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.004408,0.1734,0.21892,1,1
5,GO VESICLE TARGETING,0.02843,0.17314,0.09559,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.041093,0.17314,0.12871,1,1
5,GO ACROSOME REACTION,0.0071468,0.17312,0.15687,1,1
5,GO SPROUTING ANGIOGENESIS,0.014841,0.17288,0.12316,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.00014935,0.17285,0.1479,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.001228,0.17282,0.13726,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00035231,0.17278,0.12492,1,1
5,GO DRUG METABOLIC PROCESS,0.0010859,0.17266,0.20198,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.0017123,0.17258,0.12772,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.042857,0.17239,0.15554,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,2.1663e-05,0.17206,0.14977,1,1
5,GO EXCRETION,0.00010845,0.17204,0.18324,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.015574,0.17191,0.1351,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0025817,0.17184,0.17979,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0014299,0.17182,0.1496,1,1
5,GO INSULIN SECRETION,8.4205e-05,0.17172,0.20182,1,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0033369,0.17167,0.1597,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00023468,0.17144,0.17911,1,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.015574,0.17138,0.095045,1,1
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.018398,0.17138,0.12615,1,1
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.012508,0.17117,0.10893,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0024367,0.17101,0.20302,1,1
5,GO POSITIVE T CELL SELECTION,0.00067758,0.17099,0.15461,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00019753,0.17059,0.12309,1,1
5,GO REGULATION OF HAIR CYCLE,0.0047853,0.17053,0.15134,1,1
5,GO RESPONSE TO UV C,0.017549,0.17037,0.12329,1,1
5,GO LOCALIZATION WITHIN MEMBRANE,0.018836,0.17032,0.12664,1,1
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.011326,0.17021,0.18823,1,1
5,GO MICROTUBULE BUNDLE FORMATION,0.0028141,0.16973,0.13752,1,1
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.010773,0.16929,0.16456,1,1
5,GO REGULATION OF CHROMATIN BINDING,0.0050528,0.16911,0.15583,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.00016023,0.16911,0.13426,1,1
5,GO CELLULAR RESPONSE TO STARVATION,5.4121e-05,0.16911,0.18229,1,1
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0056288,0.16911,0.25391,1,1
5,GO RESPONSE TO INSULIN,0.00012512,0.1691,0.1467,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.00035231,0.16886,0.14988,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00010092,0.16877,0.13997,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00045924,0.16876,0.14258,1,1
5,GO TRANSFERRIN TRANSPORT,0.014138,0.1687,0.11383,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING,0.0045306,0.16856,0.15914,1,1
5,GO REGULATION OF INTEGRIN ACTIVATION,0.0047853,0.16853,0.19368,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,0.0011199,0.16846,0.11321,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0014738,0.16841,0.1586,1,1
5,GO VACUOLAR TRANSPORT,0.0051916,0.16838,0.1077,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.011326,0.16828,0.13332,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.1663e-05,0.16817,0.22448,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0022332,0.16812,0.20344,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.00012074,0.16777,0.15148,1,1
5,GO JNK CASCADE,0.0001547,0.16761,0.15289,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00353,0.1676,0.19618,1,1
5,GO PIGMENTATION,0.00087311,0.16752,0.12996,1,1
5,GO T CELL SELECTION,0.00017186,0.16751,0.16425,1,1
5,GO CGMP MEDIATED SIGNALING,0.033166,0.16749,0.12234,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.00079435,0.1674,0.13532,1,1
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0087944,0.16738,0.13604,1,1
5,GO AUTOPHAGOSOME ORGANIZATION,0.00074557,0.16729,0.14349,1,1
5,GO CELLULAR RESPONSE TO ALKALOID,0.00029782,0.16716,0.20017,1,1
5,GO METAL ION HOMEOSTASIS,1.2962e-05,0.16707,0.15093,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00069957,0.16694,0.15862,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.018836,0.16694,0.12119,1,1
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.024846,0.16654,0.12641,1,1
5,GO ION HOMEOSTASIS,1.5816e-05,0.1664,0.14553,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00012074,0.16629,0.12657,1,1
5,GO LYSOSOME LOCALIZATION,0.00034072,0.16625,0.15841,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,9.0551e-05,0.16619,0.1454,1,1
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.014841,0.16605,0.19576,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.0034322,0.16597,0.12551,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00092958,0.16592,0.14971,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00017796,0.16576,0.13944,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0026572,0.16568,0.17001,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00041602,0.16567,0.17383,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.00032948,0.16555,0.14096,1,1
5,GO HINDBRAIN MORPHOGENESIS,0.012508,0.1654,0.12379,1,1
5,GO REGULATION OF TRANSPORT,1.5201e-05,0.1654,0.14347,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.019739,0.16525,0.096974,1,1
5,GO HOMEOSTATIC PROCESS,2.5308e-05,0.16516,0.13084,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00011241,0.16469,0.15778,1,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0028957,0.16468,0.17655,1,1
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0066042,0.16457,0.19338,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0011199,0.16456,0.14669,1,1
5,GO ORGAN INDUCTION,0.0019282,0.16434,0.18318,1,1
5,GO TAXIS,0.00010462,0.16427,0.16142,1,1
5,GO VACUOLE ORGANIZATION,0.00026903,0.16424,0.13901,1,1
5,GO CIRCADIAN RHYTHM,9.0221e-07,0.16407,0.17717,1,1
5,GO RESPONSE TO FOOD,0.0029794,0.16398,0.13743,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00054072,0.16397,0.14287,1,1
5,GO SLEEP,0.0030654,0.16383,0.15182,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,7.547e-05,0.16374,0.13828,1,1
5,GO GLUTAMATE METABOLIC PROCESS,0.0015653,0.16372,0.15115,1,1
5,GO HINDBRAIN DEVELOPMENT,0.00025131,0.16368,0.19623,1,1
5,GO DEFINITIVE HEMOPOIESIS,0.029719,0.16351,0.15128,1,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.012203,0.1635,0.17006,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.16349,0.19342,1,1
5,GO METAL ION TRANSPORT,5.0226e-05,0.16327,0.14615,1,1
5,GO MESENCHYME DEVELOPMENT,0.0046564,0.16326,0.13067,1,1
5,GO EXPLORATION BEHAVIOR,0.0097392,0.16304,0.20762,1,1
5,GO RESPONSE TO ACETYLCHOLINE,0.017137,0.16302,0.1961,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.00024286,0.163,0.14027,1,1
5,GO PROTEIN DESTABILIZATION,0.00030804,0.16294,0.1644,1,1
5,GO RESPONSE TO INTERLEUKIN 1,0.011904,0.1629,0.10261,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0010206,0.16269,0.15809,1,1
5,GO CALCIUM MEDIATED SIGNALING,1.7806e-05,0.16264,0.15101,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00090094,0.16256,0.12419,1,1
5,GO PROTEOLYSIS,0.0007696,0.16243,0.1092,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0023671,0.16238,0.10313,1,1
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0016129,0.16229,0.11914,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00013433,0.1622,0.14654,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0045306,0.16159,0.11804,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.00072223,0.16153,0.14499,1,1
5,GO DETERMINATION OF ADULT LIFESPAN,0.0097392,0.16147,0.16523,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,4.1617e-05,0.16107,0.15259,1,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.00021167,0.16106,0.18594,1,1
5,GO NUCLEOTIDE TRANSPORT,0.012508,0.161,0.12749,1,1
5,GO GOLGI RIBBON FORMATION,0.010773,0.16079,0.16227,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00092958,0.16075,0.16765,1,1
5,GO FEEDING BEHAVIOR,0.00027832,0.16075,0.15494,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.0010859,0.16037,0.11279,1,1
5,GO CHONDROCYTE DEVELOPMENT,0.033894,0.16,0.14817,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0011199,0.15999,0.13602,1,1
5,GO REGULATION OF EXCRETION,0.043763,0.15982,0.13229,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00072223,0.1597,0.14059,1,1
5,GO VESICLE ORGANIZATION,0.00041602,0.15967,0.1278,1,1
5,GO RESPONSE TO HORMONE,0.00063551,0.15957,0.12661,1,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.016339,0.15951,0.12655,1,1
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.017137,0.15945,0.11197,1,1
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.013139,0.15919,0.16526,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0033369,0.1591,0.22053,1,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00050664,0.15906,0.13334,1,1
5,GO IRON ION TRANSPORT,0.007729,0.15891,0.091802,1,1
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.017137,0.15885,0.13481,1,1
5,GO CATION TRANSPORT,7.8282e-05,0.15877,0.14171,1,1
5,GO SENSORY PERCEPTION OF PAIN,0.0024367,0.15864,0.15028,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0025817,0.15854,0.14445,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0024367,0.15851,0.13959,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0029794,0.15843,0.17279,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00050664,0.15837,0.14197,1,1
5,GO REGULATION OF TRANSFERASE ACTIVITY,9.7346e-05,0.15824,0.13158,1,1
5,GO LIPID OXIDATION,0.0032441,0.15822,0.1597,1,1
5,GO GLUCOSE METABOLIC PROCESS,5.6174e-05,0.15813,0.15718,1,1
5,GO CHOLESTEROL STORAGE,0.0028141,0.15808,0.21981,1,1
5,GO OSTEOCLAST DIFFERENTIATION,0.0033369,0.15805,0.12635,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00024286,0.15788,0.15415,1,1
5,GO RESPONSE TO RETINOIC ACID,0.013139,0.15773,0.13317,1,1
5,GO DENDRITIC SPINE MAINTENANCE,0.0069616,0.1577,0.14933,1,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00050664,0.15762,0.14891,1,1
5,GO ANIMAL ORGAN MATURATION,0.0013872,0.15759,0.2161,1,1
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.00065623,0.15749,0.11631,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.015574,0.15723,0.092093,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00012074,0.15714,0.15967,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.00014935,0.1571,0.13814,1,1
5,GO VESICLE BUDDING FROM MEMBRANE,0.013139,0.157,0.10284,1,1
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.035393,0.15689,0.12806,1,1
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.050569,0.15664,0.23705,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0099891,0.15659,0.13278,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0010206,0.15637,0.1495,1,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.010245,0.15627,0.15963,1,1
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00065623,0.15604,0.161,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00044439,0.15573,0.1477,1,1
5,GO EAR MORPHOGENESIS,0.001662,0.15562,0.12658,1,1
5,GO REGULATION OF INSULIN SECRETION,0.00026003,0.1556,0.1774,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00055855,0.15558,0.17035,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,4.6597e-05,0.15549,0.16424,1,1
5,GO RESPONSE TO COCAINE,0.013798,0.15548,0.15719,1,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.031748,0.15547,0.084076,1,1
5,GO REGULATION OF CELL SHAPE,0.00095906,0.15533,0.16702,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.02166,0.15515,0.14205,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00027832,0.15502,0.13199,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00012512,0.15465,0.12334,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.00019753,0.15464,0.13819,1,1
5,GO RESPONSE TO STEROID HORMONE,0.0016129,0.1545,0.14027,1,1
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00098941,0.15449,0.15279,1,1
5,GO NEGATIVE T CELL SELECTION,0.0038387,0.15443,0.20543,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.00028792,0.15409,0.16154,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.015203,0.15396,0.12246,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00019079,0.15394,0.13949,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.021165,0.15383,0.15819,1,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0026572,0.15376,0.14416,1,1
5,GO LYSOSOMAL TRANSPORT,0.0059384,0.15362,0.12089,1,1
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.042857,0.15359,0.18901,1,1
5,GO SARCOMERE ORGANIZATION,0.0028957,0.15348,0.15729,1,1
5,GO PRESYNAPSE ORGANIZATION,0.031748,0.15343,0.16138,1,1
5,GO ENDOSOME ORGANIZATION,0.016734,0.15339,0.089259,1,1
5,GO POSTSYNAPSE ORGANIZATION,0.033166,0.15327,0.13897,1,1
5,GO RESPONSE TO ALKALOID,0.0032441,0.15325,0.13591,1,1
5,GO DIGESTION,0.0020453,0.15317,0.1536,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,2.1663e-05,0.15275,0.16329,1,1
5,GO CARTILAGE DEVELOPMENT,0.01282,0.15267,0.12159,1,1
5,GO GOLGI VESICLE BUDDING,0.015574,0.15266,0.08543,1,1
5,GO ANION TRANSPORT,5.2139e-05,0.15257,0.13057,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0018173,0.15246,0.16043,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.0024367,0.1524,0.11792,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.00034072,0.15237,0.1123,1,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.001662,0.15234,0.13362,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.0015653,0.15232,0.14885,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0085714,0.15204,0.13106,1,1
5,GO REGULATION OF CELLULAR PH,0.001986,0.15195,0.10133,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0025083,0.15179,0.23297,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.00081984,0.15171,0.11661,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0037331,0.1517,0.12655,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.037747,0.15141,0.10736,1,1
5,GO REGULATION OF GLIAL CELL MIGRATION,0.0050528,0.15132,0.14321,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0025817,0.1513,0.13947,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.0040578,0.15129,0.18431,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00040247,0.15128,0.13714,1,1
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.03245,0.15121,0.13137,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00067758,0.15099,0.16695,1,1
5,GO APOPTOTIC PROCESS,0.00027832,0.15097,0.12405,1,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.0031536,0.15097,0.10858,1,1
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.001662,0.15088,0.18698,1,1
5,GO COLLATERAL SPROUTING,0.031748,0.15077,0.14328,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,2.1663e-05,0.15076,0.15002,1,1
5,GO HEART TRABECULA MORPHOGENESIS,0.014486,0.15061,0.14123,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0010528,0.1506,0.12761,1,1
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.047551,0.15057,0.12823,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0054795,0.15051,0.13837,1,1
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00090094,0.15037,0.18503,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00098941,0.15014,0.12294,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.00055855,0.15006,0.12807,1,1
5,GO ZINC ION TRANSPORT,0.013465,0.15,0.12236,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,0.0037331,0.14993,0.13576,1,1
5,GO GROWTH,0.0001165,0.14991,0.13954,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.00013917,0.14986,0.16983,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,4.8612e-06,0.14985,0.14796,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.013798,0.14965,0.09137,1,1
5,GO ION TRANSPORT,2.9532e-05,0.14951,0.14438,1,1
5,GO ADAPTIVE THERMOGENESIS,1.7118e-05,0.14949,0.1885,1,1
5,GO POSITIVE REGULATION OF NEURON DEATH,0.00044439,0.14942,0.17324,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.0001165,0.14924,0.14568,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.0012662,0.1488,0.11752,1,1
5,GO REGULATION OF GROWTH,2.1663e-05,0.1487,0.15532,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00026903,0.14865,0.12451,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00079435,0.14856,0.11563,1,1
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.029068,0.14819,0.11974,1,1
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0030654,0.14804,0.0934,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0040578,0.14803,0.094486,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.0069616,0.14796,0.13639,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001191,0.14781,0.11437,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00044439,0.14779,0.12662,1,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.031059,0.14778,0.14993,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0081404,0.14775,0.10471,1,1
5,GO BEHAVIOR,0.00084609,0.14763,0.14373,1,1
5,GO RESPONSE TO PEPTIDE,0.00021167,0.14758,0.13137,1,1
5,GO MEMBRANE ORGANIZATION,0.00032948,0.14746,0.12175,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,4.8379e-05,0.14735,0.14433,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.00042998,0.14718,0.121,1,1
5,GO SENSORY PERCEPTION,3.0689e-05,0.14709,0.12829,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00098941,0.14704,0.11472,1,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.020205,0.14702,0.11471,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,9.389e-05,0.14695,0.12244,1,1
5,GO LIPID CATABOLIC PROCESS,0.0010206,0.1468,0.12892,1,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.02068,0.14672,0.14723,1,1
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0097392,0.14667,0.1309,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0018173,0.14662,0.12267,1,1
5,GO NERVOUS SYSTEM PROCESS,9.0551e-05,0.14661,0.13681,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00018427,0.14653,0.16456,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00012512,0.14647,0.12087,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.0066042,0.1463,0.15086,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00038934,0.14627,0.16304,1,1
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0036303,0.146,0.13222,1,1
5,GO REGULATION OF CILIUM MOVEMENT,0.00090094,0.14597,0.15213,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0054795,0.14588,0.1023,1,1
5,GO REPRODUCTION,0.00017186,0.14587,0.11984,1,1
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0010528,0.14574,0.1308,1,1
5,GO ODONTOGENESIS,0.013798,0.14567,0.16429,1,1
5,GO MAINTENANCE OF LOCATION,0.00084609,0.14556,0.12953,1,1
5,GO ORGANELLE FUSION,0.0021689,0.14555,0.12205,1,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0050528,0.1454,0.16301,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00040247,0.14523,0.12468,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00031859,0.14523,0.14124,1,1
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0087944,0.1451,0.11895,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.00092958,0.14508,0.13862,1,1
5,GO RESPONSE TO STARVATION,0.00012964,0.14495,0.1703,1,1
5,GO AGING,0.0029794,0.14481,0.11408,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,8.7323e-05,0.14479,0.12366,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,4.3218e-05,0.14468,0.13706,1,1
5,GO RESPONSE TO ETHANOL,0.0007696,0.14451,0.144,1,1
5,GO REGULATION OF CELL DEATH,0.00052342,0.14434,0.11849,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.0047853,0.1443,0.11789,1,1
5,GO SIGNAL RELEASE,2.1663e-05,0.14421,0.17899,1,1
5,GO COPII COATED VESICLE BUDDING,0.026586,0.14406,0.067897,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,0.0042883,0.14396,0.10813,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0006154,0.14391,0.11624,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,9.389e-05,0.14383,0.12668,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.030383,0.1436,0.08011,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0025083,0.14344,0.11141,1,1
5,GO POLYOL CATABOLIC PROCESS,0.021165,0.1433,0.12687,1,1
5,GO LIPID EXPORT FROM CELL,0.02843,0.14322,0.13616,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.0018173,0.14309,0.12351,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0059384,0.14301,0.13682,1,1
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.031748,0.14299,0.10117,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0013457,0.14293,0.16026,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.014486,0.14282,0.13835,1,1
5,GO CELL CELL SIGNALING,9.0551e-05,0.14281,0.14294,1,1
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.052669,0.14271,0.13314,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0015653,0.14271,0.10662,1,1
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.052669,0.1427,0.1771,1,1
5,GO MUSCLE SYSTEM PROCESS,0.00079435,0.14258,0.1243,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.00027832,0.14256,0.1374,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.0024367,0.14251,0.14305,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00054072,0.14245,0.12148,1,1
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.018398,0.14208,0.10909,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0062634,0.14173,0.13148,1,1
5,GO REGULATION OF VASOCONSTRICTION,0.0024367,0.14172,0.13763,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001191,0.14135,0.14572,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0026572,0.14131,0.12868,1,1
5,GO SINGLE FERTILIZATION,0.0018173,0.1412,0.10869,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00098941,0.14118,0.10944,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00026903,0.14101,0.14619,1,1
5,GO RESPONSE TO ESTRADIOL,0.0018173,0.14093,0.13615,1,1
5,GO GLUCOSE IMPORT,0.016339,0.14076,0.1087,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.044685,0.14063,0.18315,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,0.017137,0.14056,0.096734,1,1
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.00013917,0.14051,0.14783,1,1
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.031748,0.14049,0.11415,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00353,0.14044,0.13432,1,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.011047,0.13963,0.11465,1,1
5,GO ORGANIC ANION TRANSPORT,0.0001547,0.13941,0.12199,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0026572,0.1391,0.10046,1,1
5,GO KERATINOCYTE MIGRATION,0.017969,0.13904,0.14009,1,1
5,GO TRANSMEMBRANE TRANSPORT,8.7323e-05,0.13898,0.12471,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00036427,0.13896,0.14324,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0034322,0.13888,0.12414,1,1
5,GO CELLULAR EXTRAVASATION,0.004408,0.13866,0.1378,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.00044439,0.13849,0.11537,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0064317,0.13844,0.1272,1,1
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0042883,0.13844,0.14615,1,1
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.050569,0.13842,0.10211,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.001986,0.13824,0.12038,1,1
5,GO RHYTHMIC BEHAVIOR,0.0041716,0.13823,0.14217,1,1
5,GO RESPONSE TO ANTIBIOTIC,0.0021689,0.13813,0.15791,1,1
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.040234,0.13808,0.11309,1,1
5,GO EMBRYONIC MORPHOGENESIS,0.00050664,0.13807,0.13249,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0039469,0.13789,0.15535,1,1
5,GO NEURAL CREST CELL DIFFERENTIATION,0.05161,0.13781,0.12814,1,1
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.013465,0.13779,0.11388,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.015203,0.13779,0.075397,1,1
5,GO NEUROBLAST PROLIFERATION,0.018836,0.13762,0.1285,1,1
5,GO WATER TRANSPORT,0.017137,0.13757,0.12375,1,1
5,GO DEMETHYLATION,0.00019753,0.1375,0.14273,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,6.0504e-05,0.13736,0.13541,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,0.014841,0.1373,0.13142,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.022165,0.13723,0.12342,1,1
5,GO SYNAPSE ORGANIZATION,0.014138,0.1371,0.14312,1,1
5,GO DIGESTIVE SYSTEM PROCESS,0.0027346,0.13691,0.14783,1,1
5,GO DEVELOPMENTAL PIGMENTATION,0.03245,0.13681,0.086853,1,1
5,GO REGULATION OF MUSCLE CONTRACTION,0.0022992,0.13676,0.11808,1,1
5,GO POSTREPLICATION REPAIR,0.00353,0.13662,0.11256,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,7.547e-05,0.13657,0.1579,1,1
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.010506,0.1365,0.24481,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0032441,0.13627,0.12491,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00065623,0.13625,0.13829,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0010859,0.13607,0.12688,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0010206,0.13594,0.12374,1,1
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.010506,0.13577,0.14432,1,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.0050528,0.13556,0.12191,1,1
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.013798,0.1355,0.15858,1,1
5,GO NEURON DEATH,2.7343e-05,0.13531,0.14266,1,1
5,GO SEX DIFFERENTIATION,0.00032948,0.13513,0.12032,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.010245,0.13511,0.13162,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.013e-05,0.13486,0.15926,1,1
5,GO ASSOCIATIVE LEARNING,0.0060989,0.13486,0.13947,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.00072223,0.13464,0.11215,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0029794,0.1346,0.11939,1,1
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0030654,0.13455,0.14269,1,1
5,GO REGULATION OF PROTEIN BINDING,0.00030804,0.13439,0.14248,1,1
5,GO NEGATIVE REGULATION OF SECRETION,0.00032948,0.1341,0.11948,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00012964,0.13367,0.12222,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0039469,0.13359,0.11245,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0071468,0.13358,0.18147,1,1
5,GO ROOF OF MOUTH DEVELOPMENT,0.031748,0.13355,0.11652,1,1
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00030804,0.13354,0.1321,1,1
5,GO RUFFLE ASSEMBLY,0.011047,0.13353,0.15094,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0049174,0.13335,0.087322,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0040578,0.13327,0.1089,1,1
5,GO DNA DEALKYLATION,0.0067808,0.13325,0.15762,1,1
5,GO CELLULAR ION HOMEOSTASIS,4.0073e-05,0.13322,0.12678,1,1
5,GO CALCIUM ION IMPORT,0.0050528,0.13299,0.14762,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.00017796,0.13288,0.13342,1,1
5,GO CELLULAR PIGMENTATION,0.014138,0.13286,0.099176,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0046564,0.13274,0.11572,1,1
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.019739,0.13258,0.26048,1,1
5,GO ENDOCYTOSIS,0.0041716,0.13251,0.10522,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00019079,0.13244,0.14276,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.02843,0.13225,0.11557,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0064317,0.13223,0.094871,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.004408,0.13206,0.11893,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00044439,0.13205,0.14736,1,1
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0099891,0.13204,0.12943,1,1
5,GO MUSCLE FIBER DEVELOPMENT,0.015953,0.13203,0.13333,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.0038387,0.13199,0.1418,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,7.2754e-05,0.13178,0.13675,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.019739,0.13167,0.097403,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00069957,0.13158,0.12877,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.0010206,0.13149,0.14463,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.034637,0.1312,0.10538,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,0.00090094,0.13104,0.1194,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.011612,0.13103,0.091924,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00353,0.1309,0.14589,1,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.023741,0.13081,0.11649,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.012508,0.13078,0.10577,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0010859,0.1307,0.1349,1,1
5,GO EXOCYTIC PROCESS,0.0067808,0.13069,0.16065,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00054072,0.13064,0.13817,1,1
5,GO NEUROMUSCULAR PROCESS,0.0066042,0.13061,0.14391,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0011549,0.12998,0.14583,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.038561,0.12989,0.082845,1,1
5,GO NEGATIVE REGULATION OF CELL DEATH,0.0013872,0.12989,0.1126,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00024286,0.12979,0.14913,1,1
5,GO HORMONE METABOLIC PROCESS,0.00098941,0.12966,0.14449,1,1
5,GO APPENDAGE DEVELOPMENT,0.037747,0.12949,0.1077,1,1
5,GO REGULATION OF AUTOPHAGY,0.00026003,0.12919,0.10902,1,1
5,GO LONG TERM MEMORY,0.027803,0.1289,0.1508,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.010506,0.12873,0.1148,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0029794,0.12872,0.11295,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0056288,0.12848,0.097527,1,1
5,GO PHOSPHATE ION TRANSPORT,0.017969,0.12828,0.12069,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0051916,0.12824,0.11264,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0038387,0.12813,0.11389,1,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.044685,0.1277,0.08672,1,1
5,GO CARDIAC MUSCLE CONTRACTION,0.0023671,0.12732,0.14608,1,1
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.012203,0.12716,0.15532,1,1
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.00072223,0.12715,0.12834,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0001165,0.12703,0.14018,1,1
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.010773,0.12702,0.12048,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0010528,0.12697,0.13913,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.020205,0.1268,0.13125,1,1
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.03245,0.12679,0.14923,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00069957,0.12657,0.13296,1,1
5,GO ACTIN MEDIATED CELL CONTRACTION,0.015953,0.12641,0.11137,1,1
5,GO MIDBRAIN DEVELOPMENT,0.0038387,0.12641,0.10713,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0069616,0.12631,0.095309,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.034637,0.12629,0.12719,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0034322,0.12588,0.11053,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.031059,0.12577,0.12102,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.0097392,0.12568,0.11122,1,1
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.053746,0.12563,0.084523,1,1
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0021062,0.12508,0.18685,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.034637,0.12493,0.12911,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.004408,0.12481,0.086566,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00092958,0.12454,0.14746,1,1
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.034637,0.12454,0.12521,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0016129,0.12438,0.10277,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.025994,0.12419,0.086685,1,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.018398,0.12405,0.16334,1,1
5,GO MACROPHAGE ACTIVATION,0.0033369,0.1239,0.19988,1,1
5,GO T CELL LINEAGE COMMITMENT,0.0023671,0.12389,0.13373,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00025131,0.12373,0.12363,1,1
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0081404,0.1235,0.097452,1,1
5,GO REGULATION OF CELL DEVELOPMENT,0.00098941,0.12336,0.12824,1,1
5,GO DNA CATABOLIC PROCESS,0.00040247,0.12335,0.1302,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.0087944,0.12326,0.11608,1,1
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.030383,0.12313,0.17456,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.017549,0.12313,0.10671,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.035393,0.12308,0.076226,1,1
5,GO RESPONSE TO CHEMOKINE,0.001986,0.12288,0.1231,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.0034322,0.12285,0.10502,1,1
5,GO NEGATIVE REGULATION OF BINDING,0.00084609,0.12242,0.12538,1,1
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0031536,0.12204,0.15348,1,1
5,GO PEPTIDYL SERINE MODIFICATION,0.0011199,0.122,0.095855,1,1
5,GO SULFATE TRANSPORT,0.041093,0.12189,0.11098,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0013054,0.12181,0.096633,1,1
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0033369,0.12175,0.14482,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.030383,0.12151,0.092029,1,1
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.016339,0.12133,0.13724,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.0067808,0.12113,0.081885,1,1
5,GO PH REDUCTION,0.03245,0.12107,0.072662,1,1
5,GO SPERM MOTILITY,0.0036303,0.12092,0.092348,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0034322,0.12086,0.12318,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,0.0046564,0.12086,0.13574,1,1
5,GO FATTY ACID TRANSPORT,0.017137,0.12066,0.093689,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.00038934,0.12043,0.12148,1,1
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.029068,0.1204,0.12549,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0006154,0.12009,0.095523,1,1
5,GO RHYTHMIC PROCESS,4.0073e-05,0.11993,0.12773,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.004408,0.11897,0.099267,1,1
5,GO ONE CARBON COMPOUND TRANSPORT,0.021165,0.11887,0.1433,1,1
5,GO RUFFLE ORGANIZATION,0.012203,0.11868,0.13653,1,1
5,GO ADHERENS JUNCTION ORGANIZATION,0.010506,0.11864,0.14813,1,1
5,GO REGULATION OF BINDING,0.00041602,0.11861,0.11949,1,1
5,GO CELLULAR HOMEOSTASIS,0.00012512,0.11839,0.11591,1,1
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.016339,0.11831,0.13723,1,1
5,GO DORSAL VENTRAL PATTERN FORMATION,0.010506,0.11827,0.14515,1,1
5,GO CELL PROJECTION ASSEMBLY,0.0057817,0.11826,0.092905,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0067808,0.11814,0.10005,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0054795,0.11793,0.092706,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0025083,0.11768,0.16149,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00054072,0.11759,0.11859,1,1
5,GO EYE MORPHOGENESIS,0.0017123,0.11754,0.12826,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0085714,0.11733,0.15551,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.0010528,0.11723,0.079625,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0013054,0.11716,0.14622,1,1
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.012508,0.11709,0.16998,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.021165,0.11696,0.084023,1,1
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0006154,0.11692,0.12869,1,1
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0029794,0.11689,0.1259,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,0.0030654,0.11661,0.095808,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00040247,0.11658,0.10607,1,1
5,GO PROTEIN CATABOLIC PROCESS,0.014486,0.11656,0.063484,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.023741,0.11626,0.10897,1,1
5,GO POSITIVE THYMIC T CELL SELECTION,0.0020453,0.11605,0.2374,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0087944,0.11597,0.093631,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0069616,0.11594,0.10077,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00037661,0.11592,0.13748,1,1
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.014486,0.1159,0.076785,1,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.017549,0.11582,0.091373,1,1
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.034637,0.1156,0.11879,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.02068,0.11553,0.11445,1,1
5,GO MUSCLE CONTRACTION,0.0016129,0.1154,0.12094,1,1
5,GO STEM CELL PROLIFERATION,0.0042883,0.11521,0.12947,1,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.033894,0.11479,0.096633,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.00050664,0.11411,0.12246,1,1
5,GO REGULATION OF CELL SIZE,0.0081404,0.11409,0.11891,1,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.030383,0.11391,0.080049,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.031059,0.11386,0.12304,1,1
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.024846,0.11382,0.10645,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.022165,0.11358,0.087217,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.001986,0.1135,0.10933,1,1
5,GO SKELETAL SYSTEM DEVELOPMENT,0.0051916,0.11317,0.10307,1,1
5,GO MULTI ORGANISM PROCESS,0.0014738,0.11298,0.089932,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00032948,0.11294,0.099072,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.035393,0.11273,0.080147,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0022992,0.11271,0.089991,1,1
5,GO PROTEIN DEPHOSPHORYLATION,0.0056288,0.11233,0.072729,1,1
5,GO DENDRITE EXTENSION,0.030383,0.11228,0.24677,1,1
5,GO CILIUM MOVEMENT,0.0047853,0.11221,0.095904,1,1
5,GO DEVELOPMENTAL CELL GROWTH,0.0041716,0.11213,0.14746,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.024288,0.112,0.077166,1,1
5,GO CELLULAR RESPONSE TO CAMP,0.0011199,0.11051,0.15324,1,1
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0059384,0.11033,0.13621,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.00065623,0.11023,0.11625,1,1
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0046564,0.11017,0.11507,1,1
5,GO PROTEIN INSERTION INTO MEMBRANE,0.0099891,0.11011,0.11056,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.012508,0.10971,0.1086,1,1
5,GO NEURON APOPTOTIC PROCESS,0.00014935,0.1097,0.12785,1,1
5,GO CELL CELL SIGNALING BY WNT,0.0029794,0.10957,0.10232,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0066042,0.10939,0.082047,1,1
5,GO POSITIVE REGULATION OF GROWTH,0.00031859,0.10886,0.1315,1,1
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.034637,0.10872,0.083325,1,1
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0067808,0.1085,0.10614,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0029794,0.10848,0.10005,1,1
5,GO SENSORY ORGAN DEVELOPMENT,0.00065623,0.10775,0.11702,1,1
5,GO DEVELOPMENTAL GROWTH,0.001191,0.10761,0.12197,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00034072,0.10752,0.1177,1,1
5,GO DEPHOSPHORYLATION,0.0013054,0.10732,0.086554,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,0.0022992,0.10702,0.1063,1,1
5,GO ARACHIDONIC ACID SECRETION,0.041093,0.10686,0.075707,1,1
5,GO COGNITION,0.0085714,0.10671,0.12664,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,4.3218e-05,0.1067,0.11662,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.017549,0.10623,0.066727,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.029719,0.10605,0.082642,1,1
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.024846,0.10487,0.070912,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.014841,0.10442,0.090603,1,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.0026572,0.10393,0.092329,1,1
5,GO GOLGI ORGANIZATION,0.0050528,0.10386,0.087486,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.0049174,0.1038,0.10754,1,1
5,GO LACTATE METABOLIC PROCESS,0.026586,0.10376,0.19588,1,1
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.017137,0.10374,0.085101,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,0.0059384,0.10367,0.12424,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0032441,0.10354,0.13876,1,1
5,GO REGULATION OF DNA BINDING,0.0020453,0.1029,0.11433,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.030383,0.10272,0.065709,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.027188,0.10239,0.099958,1,1
5,GO REGULATION OF CELL DIVISION,0.012203,0.10237,0.089601,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.001986,0.10229,0.084918,1,1
5,GO EMBRYO DEVELOPMENT,0.0016129,0.10215,0.098436,1,1
5,GO RESPONSE TO ACTIVITY,0.033166,0.10211,0.092892,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0010206,0.10193,0.1322,1,1
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.05161,0.10178,0.094546,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0075304,0.10149,0.07921,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.012203,0.10147,0.13431,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.00084609,0.10134,0.12437,1,1
5,GO ORGANIC ACID TRANSPORT,0.00069957,0.10116,0.092756,1,1
5,GO HEART DEVELOPMENT,0.0040578,0.10084,0.099078,1,1
5,GO POLYOL METABOLIC PROCESS,0.0033369,0.10083,0.092968,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0050528,0.099633,0.11051,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0054795,0.099016,0.11732,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0067808,0.098776,0.090506,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.035393,0.098746,0.067181,1,1
5,GO REGULATION OF GLUCONEOGENESIS,0.022165,0.098622,0.087091,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.024846,0.098597,0.13236,1,1
5,GO REGULATION OF EXOCYTOSIS,0.0025817,0.098219,0.16344,1,1
5,GO DETECTION OF LIGHT STIMULUS,0.019739,0.098109,0.073634,1,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.052669,0.097709,0.11216,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0036303,0.097481,0.09007,1,1
5,GO MESODERM DEVELOPMENT,0.02843,0.097307,0.08028,1,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013465,0.097149,0.11384,1,1
5,GO SEXUAL REPRODUCTION,0.0020453,0.096918,0.079569,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.011612,0.096687,0.088268,1,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.0040578,0.096677,0.14079,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,7.2754e-05,0.096551,0.10629,1,1
5,GO GERM CELL DEVELOPMENT,0.0041716,0.096506,0.088094,1,1
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.026586,0.096107,0.10917,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.018398,0.095527,0.11381,1,1
5,GO REGULATION OF CIRCADIAN RHYTHM,0.0060989,0.095093,0.11821,1,1
5,GO HEAD DEVELOPMENT,0.00072223,0.09502,0.1288,1,1
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.045624,0.094286,0.11743,1,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.035393,0.094264,0.079786,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0006154,0.094192,0.10253,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.02068,0.093854,0.13784,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.017969,0.093811,0.079975,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00026903,0.093445,0.088794,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,0.0039469,0.093319,0.086496,1,1
5,GO ENDOSOMAL TRANSPORT,0.02068,0.092771,0.067638,1,1
5,GO REGULATION OF TOR SIGNALING,0.00098941,0.092668,0.099557,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.019739,0.092549,0.10182,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00013917,0.092133,0.11691,1,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0054795,0.091791,0.097731,1,1
5,GO LEUKOCYTE TETHERING OR ROLLING,0.0037331,0.091756,0.11518,1,1
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.044685,0.091626,0.07751,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.014486,0.091594,0.084039,1,1
5,GO ANDROGEN METABOLIC PROCESS,0.025414,0.09143,0.12843,1,1
5,GO EXIT FROM MITOSIS,0.025994,0.091301,0.097154,1,1
5,GO CILIUM ORGANIZATION,0.014486,0.091195,0.083252,1,1
5,GO HEART MORPHOGENESIS,0.0083534,0.091192,0.098118,1,1
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0024367,0.090982,0.11968,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0056288,0.090935,0.077486,1,1
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.030383,0.090836,0.1666,1,1
5,GO CELL PROJECTION ORGANIZATION,0.0027346,0.090437,0.10711,1,1
5,GO STEROID CATABOLIC PROCESS,0.053746,0.090174,0.15381,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.037747,0.089922,0.067295,1,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.037747,0.089464,0.083202,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0046564,0.089008,0.078845,1,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.018398,0.088879,0.066694,1,1
5,GO ORGAN GROWTH,0.024288,0.088271,0.082028,1,1
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.016734,0.088126,0.081786,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.018398,0.087683,0.093514,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.018398,0.087673,0.061805,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0017641,0.087544,0.079975,1,1
5,GO NEUROGENESIS,0.0033369,0.087435,0.11379,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00057693,0.087093,0.079616,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0081404,0.086408,0.10634,1,1
5,GO SYNAPTIC SIGNALING,0.030383,0.08566,0.13748,1,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.010773,0.085424,0.10994,1,1
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0064317,0.085232,0.087716,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0051916,0.084586,0.082434,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0019282,0.084358,0.070138,1,1
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.02166,0.083791,0.13221,1,1
5,GO TOR SIGNALING,0.0059384,0.083163,0.067177,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0090226,0.08264,0.07842,1,1
5,GO SMOOTH MUSCLE CONTRACTION,0.02843,0.082636,0.098668,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.031748,0.082563,0.10151,1,1
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.047551,0.081203,0.13995,1,1
5,GO CELL FATE COMMITMENT,0.0056288,0.080769,0.11094,1,1
5,GO RESPONSE TO CAMP,0.012508,0.080733,0.10278,1,1
5,GO POSITIVE REGULATION OF BINDING,0.027188,0.080253,0.080541,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.0041716,0.079585,0.081887,1,1
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.03245,0.079242,0.085883,1,1
5,GO SENSORY SYSTEM DEVELOPMENT,0.00353,0.079139,0.10712,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0085714,0.078338,0.073543,1,1
5,GO GAMETE GENERATION,0.0067808,0.077942,0.069929,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0057817,0.077516,0.12706,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0079323,0.077162,0.10999,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.017137,0.076012,0.08877,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.04854,0.074517,0.053201,1,1
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.034637,0.074394,0.18286,1,1
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0079323,0.074306,0.16665,1,1
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.012508,0.072824,0.094544,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.043763,0.072064,0.051701,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.024846,0.071784,0.059691,1,1
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.021165,0.071643,0.082975,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0014738,0.071512,0.081336,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.027188,0.070707,0.052641,1,1
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.0071468,0.070331,0.073632,1,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.02843,0.069995,0.045681,1,1
5,GO CYTOSKELETON ORGANIZATION,0.0097392,0.069243,0.080522,1,1
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.050569,0.068953,0.072718,1,1
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.045624,0.068827,0.080451,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0066042,0.06715,0.059749,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,0.0075304,0.066803,0.067593,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.050569,0.065793,0.079743,1,1
5,GO MALE GAMETE GENERATION,0.01282,0.064423,0.067384,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0064317,0.064353,0.084787,1,1
5,GO PROTEIN POLYUBIQUITINATION,0.033894,0.063543,0.057027,1,1
5,GO MACROMOLECULE DEACYLATION,0.02268,0.061741,0.064805,1,1
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.02068,0.060143,0.077192,1,1
5,GO FOREBRAIN DEVELOPMENT,0.015574,0.05837,0.12131,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.029068,0.057993,0.075936,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.031059,0.054909,0.043462,1,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.038561,0.054637,0.049925,1,1
5,GO CELL CYCLE ARREST,0.053746,0.051223,0.052882,1,1
5,GO RESPONSE TO RADIATION,0.04854,0.042287,0.044706,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0013457,0.75019,0.61013,1,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,7.013e-05,0.6765,0.66431,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0039469,0.66696,0.42784,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0071468,0.55929,0.37687,1,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0025817,0.53733,0.38299,1,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00018427,0.51981,0.53353,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0056288,0.50641,0.2838,1,0
5,GO BLEB ASSEMBLY,0.016734,0.49643,0.49303,1,0
5,GO RESPONSE TO INTERFERON BETA,0.00353,0.48732,0.48434,1,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00072223,0.48402,0.45444,1,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0022992,0.47209,0.35799,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0039469,0.47031,0.31075,1,0
5,GO REGULATION OF WATER LOSS VIA SKIN,0.00016595,0.44317,0.41856,1,0
5,GO MEMBRANE RAFT ASSEMBLY,0.044685,0.44205,0.28804,1,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.02068,0.44065,0.29111,1,0
5,GO RENAL ABSORPTION,0.0014738,0.43644,0.37102,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00047456,0.41491,0.40805,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0071468,0.4124,0.28666,1,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.020205,0.39702,0.23844,1,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.001191,0.39551,0.33459,1,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00050664,0.38757,0.37652,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,9.7346e-05,0.38128,0.459,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00040247,0.37876,0.35153,1,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.0075304,0.36849,0.28593,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.052669,0.36333,0.22392,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,0.0015189,0.3519,0.2802,1,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.013e-05,0.34351,0.26558,1,0
5,GO EPIBOLY,0.04854,0.34341,0.17864,1,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.001228,0.34105,0.21378,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00067758,0.33949,0.24738,1,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.023741,0.33181,0.25117,1,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0013872,0.33017,0.2995,1,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.018836,0.32916,0.29053,1,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00047456,0.3256,0.32894,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00022676,0.32392,0.28091,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,0.3232,0.25165,1,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00092958,0.31926,0.25096,1,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0010206,0.31829,0.2531,1,0
5,GO LABYRINTHINE LAYER DEVELOPMENT,4.6597e-05,0.31706,0.34116,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.0010528,0.30722,0.2713,1,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.012203,0.30253,0.22976,1,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0083534,0.3018,0.1968,1,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.00028792,0.30047,0.28612,1,0
5,GO VASCULOGENESIS,0.004408,0.29738,0.19855,1,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.001191,0.29521,0.34644,1,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.036948,0.29131,0.27558,1,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.024846,0.29019,0.29446,1,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0037331,0.28948,0.2386,1,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.0015653,0.28878,0.28361,1,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.036164,0.28662,0.20111,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0062634,0.28642,0.32039,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00047456,0.2829,0.28166,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0030654,0.28117,0.23293,1,0
5,GO COLLAGEN CATABOLIC PROCESS,0.0024367,0.27525,0.18848,1,0
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,9.0551e-05,0.27282,0.28325,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.015953,0.27124,0.21536,1,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.045624,0.26932,0.20041,1,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.00090094,0.26733,0.22017,1,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001872,0.26593,0.25144,1,0
5,GO ENERGY HOMEOSTASIS,0.00013917,0.26447,0.2717,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.041093,0.26389,0.1517,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0029794,0.26156,0.21554,1,0
5,GO ZYMOGEN INHIBITION,0.010773,0.26106,0.20866,1,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.020205,0.25789,0.21687,1,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.035393,0.25779,0.21186,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.00095906,0.25765,0.28816,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0011199,0.25461,0.25622,1,0
5,GO ALANINE TRANSPORT,0.0062634,0.25382,0.18103,1,0
5,GO REGULATION OF DOPAMINE SECRETION,0.0081404,0.25039,0.36423,1,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.045624,0.24863,0.21437,1,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.016734,0.24844,0.25662,1,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.033894,0.24692,0.13032,1,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.012508,0.24612,0.24579,1,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0010528,0.24589,0.20563,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0062634,0.24269,0.18074,1,0
5,GO AMELOGENESIS,0.0028141,0.24226,0.25554,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0045306,0.24176,0.1798,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0094949,0.24127,0.23057,1,0
5,GO ENAMEL MINERALIZATION,0.021165,0.24025,0.22606,1,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.029068,0.23996,0.28772,1,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0060989,0.23939,0.22795,1,0
5,GO PLATELET DEGRANULATION,0.0017641,0.23782,0.2331,1,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.03939,0.23756,0.13459,1,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0033369,0.23756,0.23905,1,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.001872,0.23675,0.21517,1,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.011326,0.23515,0.27584,1,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.015574,0.23431,0.17686,1,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.033894,0.2311,0.24563,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.0045306,0.22952,0.19928,1,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.035393,0.22748,0.17131,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0029794,0.22744,0.19876,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0038387,0.22729,0.29218,1,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0056288,0.22673,0.15069,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.038561,0.22661,0.13411,1,0
5,GO COPPER ION HOMEOSTASIS,0.0039469,0.22571,0.21161,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.027803,0.22507,0.14069,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0033369,0.22415,0.17023,1,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.026586,0.22401,0.26567,1,0
5,GO MACROPHAGE PROLIFERATION,0.023205,0.22301,0.27945,1,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0094949,0.22196,0.1712,1,0
5,GO CELLULAR RESPONSE TO DSRNA,0.0032441,0.22105,0.18755,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0045306,0.22105,0.19661,1,0
5,GO HYALURONAN METABOLIC PROCESS,0.020205,0.221,0.12791,1,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.029719,0.22047,0.15806,1,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0090226,0.21979,0.2286,1,0
5,GO TOOTH MINERALIZATION,0.011326,0.21847,0.2241,1,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.021165,0.21837,0.3158,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.024846,0.21504,0.21678,1,0
5,GO VITAMIN CATABOLIC PROCESS,0.049546,0.21503,0.12582,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.019739,0.21489,0.17077,1,0
5,GO STORE OPERATED CALCIUM ENTRY,0.020205,0.21286,0.15091,1,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.013798,0.21207,0.21924,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.0075304,0.21053,0.23009,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.015203,0.20923,0.17641,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0010528,0.2088,0.17173,1,0
5,GO PROTEIN LOCALIZATION TO AXON,0.047551,0.20875,0.29074,1,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.023205,0.20789,0.16634,1,0
5,GO RESPONSE TO CADMIUM ION,0.02268,0.20642,0.1589,1,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.0087944,0.20447,0.31206,1,0
5,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.017137,0.20367,0.17623,1,0
5,GO DOPAMINE METABOLIC PROCESS,0.00092958,0.20342,0.27869,1,0
5,GO REGULATION OF PHAGOCYTOSIS,0.0099891,0.20295,0.16099,1,0
5,GO PSEUDOPODIUM ORGANIZATION,0.014486,0.20254,0.29181,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.042857,0.2025,0.12121,1,0
5,GO DOPAMINE TRANSPORT,0.010245,0.20249,0.30572,1,0
5,GO ANIMAL ORGAN REGENERATION,0.015953,0.20183,0.12549,1,0
5,GO CYTOLYSIS,0.0085714,0.20097,0.19992,1,0
5,GO I KAPPAB PHOSPHORYLATION,0.047551,0.20003,0.13218,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.010245,0.19885,0.12724,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0085714,0.19821,0.18747,1,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0011549,0.19796,0.17626,1,0
5,GO CATECHOLAMINE UPTAKE,0.033166,0.19614,0.19885,1,0
5,GO NOSE DEVELOPMENT,0.016339,0.19606,0.35268,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.044685,0.19503,0.10747,1,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0069616,0.19501,0.17413,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.044685,0.19474,0.28537,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0094949,0.1928,0.23859,1,0
5,GO LOCOMOTOR RHYTHM,0.043763,0.19272,0.13949,1,0
5,GO SALIVARY GLAND DEVELOPMENT,0.024288,0.19112,0.17712,1,0
5,GO AMYLOID BETA CLEARANCE,0.044685,0.19046,0.12554,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.031748,0.19041,0.14083,1,0
5,GO LEFT RIGHT PATTERN FORMATION,0.016734,0.18964,0.15209,1,0
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025083,0.18935,0.15667,1,0
5,GO NEUTROPHIL HOMEOSTASIS,0.047551,0.18905,0.12072,1,0
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0038387,0.18858,0.20106,1,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.019283,0.1884,0.19814,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0062634,0.18683,0.56124,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0097392,0.18671,0.22847,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00059588,0.18583,0.31376,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.053746,0.18561,0.15152,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.026586,0.18557,0.16012,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0019282,0.18495,0.18732,1,0
5,GO KERATINIZATION,0.0021689,0.18481,0.19467,1,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0073363,0.18342,0.21911,1,0
5,GO GLIAL CELL ACTIVATION,0.0045306,0.18164,0.19748,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,0.013465,0.18157,0.11102,1,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.05161,0.18027,0.16814,1,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.052669,0.1801,0.1137,1,0
5,GO CORNIFICATION,0.0069616,0.18004,0.19499,1,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.040234,0.17926,0.17659,1,0
5,GO APOPTOTIC CELL CLEARANCE,0.010245,0.17903,0.2915,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0087944,0.17855,0.16668,1,0
5,GO SUPEROXIDE METABOLIC PROCESS,0.0053338,0.17851,0.16018,1,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.018836,0.17843,0.15135,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0085714,0.17737,0.13655,1,0
5,GO HORMONE BIOSYNTHETIC PROCESS,0.01282,0.17677,0.14877,1,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.0020453,0.17656,0.15947,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.024846,0.17522,0.15141,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.03245,0.175,0.10903,1,0
5,GO PROTEIN TARGETING TO VACUOLE,0.029068,0.1737,0.12282,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0071468,0.17342,0.20351,1,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0060989,0.17181,0.15084,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.018398,0.17177,0.23727,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.036164,0.17131,0.14053,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0042883,0.17059,0.24729,1,0
5,GO BILE ACID METABOLIC PROCESS,0.0046564,0.1702,0.15263,1,0
5,GO AMINO ACID IMPORT,0.036948,0.17006,0.13344,1,0
5,GO MYOBLAST DIFFERENTIATION,0.0054795,0.16998,0.17902,1,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0042883,0.16842,0.121,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0046564,0.16814,0.14671,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.018398,0.16783,0.088654,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.010506,0.16637,0.15364,1,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.017549,0.16629,0.18604,1,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00027832,0.16552,0.20329,1,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0045306,0.16498,0.32453,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.02068,0.16459,0.18084,1,0
5,GO REGULATION OF PROTEIN MATURATION,0.04854,0.16351,0.11002,1,0
5,GO RESPONSE TO LEPTIN,0.014138,0.16308,0.1538,1,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.022165,0.16216,0.12764,1,0
5,GO CHOLESTEROL EFFLUX,0.0018173,0.1618,0.14352,1,0
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,1.9263e-05,0.16167,0.25455,1,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.046579,0.16141,0.13294,1,0
5,GO EPITHELIAL CELL CELL ADHESION,0.02268,0.16132,0.26024,1,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0087944,0.16073,0.097986,1,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.011612,0.1604,0.16188,1,0
5,GO GLOMERULUS DEVELOPMENT,0.010506,0.16035,0.17301,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.05161,0.16024,0.094843,1,0
5,GO RECEPTOR CATABOLIC PROCESS,0.014138,0.16019,0.11706,1,0
5,GO KETONE BIOSYNTHETIC PROCESS,0.021165,0.16015,0.137,1,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.022165,0.1585,0.13793,1,0
5,GO REGENERATION,0.0066042,0.15713,0.13556,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.013798,0.15661,0.14408,1,0
5,GO OSTEOBLAST DIFFERENTIATION,0.0040578,0.15587,0.17287,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.023205,0.15559,0.156,1,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0042883,0.15534,0.11129,1,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.05161,0.15519,0.15093,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.02843,0.15512,0.14557,1,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.027803,0.15489,0.11526,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0060989,0.15459,0.12611,1,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.013139,0.15417,0.16861,1,0
5,GO CELLULAR RESPONSE TO IRON ION,0.018398,0.15234,0.19607,1,0
5,GO RESPONSE TO PH,0.0037331,0.15092,0.15929,1,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.016339,0.14975,0.1085,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.011047,0.14953,0.16907,1,0
5,GO COMPLEMENT ACTIVATION,0.013465,0.14942,0.26941,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.027803,0.14907,0.28958,1,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.010773,0.14887,0.11908,1,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.00020448,0.14706,0.15107,1,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.02166,0.14692,0.20119,1,0
5,GO MUSCLE CELL PROLIFERATION,0.033166,0.14502,0.10073,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.024288,0.14437,0.10285,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.025994,0.14394,0.1034,1,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.03245,0.1438,0.11862,1,0
5,GO REPLICATIVE SENESCENCE,0.047551,0.1438,0.14803,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.038561,0.14337,0.13196,1,0
5,GO GASTRIC ACID SECRETION,0.03939,0.14289,0.14782,1,0
5,GO NATURAL KILLER CELL PROLIFERATION,0.0081404,0.14261,0.23628,1,0
5,GO RESPONSE TO DSRNA,0.0097392,0.14157,0.11851,1,0
5,GO VITAMIN TRANSPORT,0.03939,0.13927,0.094973,1,0
5,GO T CELL APOPTOTIC PROCESS,0.046579,0.13907,0.13109,1,0
5,GO RESPONSE TO FUNGUS,0.0017123,0.13891,0.14247,1,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.030383,0.13811,0.17457,1,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.04854,0.13802,0.11918,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.052669,0.13767,0.13692,1,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.018836,0.13739,0.07435,1,0
5,GO RESPONSE TO PROGESTERONE,0.019283,0.13711,0.15938,1,0
5,GO ERK1 AND ERK2 CASCADE,0.0054795,0.13679,0.19185,1,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.011326,0.13566,0.14603,1,0
5,GO SCHWANN CELL DEVELOPMENT,0.011326,0.13519,0.13328,1,0
5,GO PROTEIN AUTOPROCESSING,0.041093,0.13491,0.15048,1,0
5,GO CELL CELL RECOGNITION,0.021165,0.13485,0.1107,1,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.025414,0.13454,0.16656,1,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.03245,0.13438,0.16971,1,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.034637,0.13426,0.10782,1,0
5,GO AMINE CATABOLIC PROCESS,0.02068,0.13378,0.16954,1,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0028957,0.13265,0.12942,1,0
5,GO NIK NF KAPPAB SIGNALING,0.042857,0.1325,0.078042,1,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.016339,0.13233,0.16668,1,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.035393,0.13208,0.11393,1,0
5,GO PURINE NUCLEOTIDE TRANSPORT,0.043763,0.13201,0.099769,1,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0028141,0.129,0.12244,1,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.017137,0.12835,0.13329,1,0
5,GO RETINOL METABOLIC PROCESS,0.045624,0.12642,0.096367,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.033166,0.12639,0.089545,1,0
5,GO ERAD PATHWAY,0.024846,0.12635,0.055174,1,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.042857,0.12504,0.12107,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0021689,0.1244,0.15167,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.010506,0.12426,0.092248,1,0
5,GO REGULATION OF GLUCOSE IMPORT,0.047551,0.12306,0.089781,1,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.036164,0.1229,0.14168,1,0
5,GO RESPONSE TO ALCOHOL,0.0090226,0.12285,0.10493,1,0
5,GO CHEMOSENSORY BEHAVIOR,0.015953,0.12253,0.21063,1,0
5,GO INTERFERON GAMMA PRODUCTION,0.0059384,0.12238,0.13112,1,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.01282,0.12208,0.12577,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.013465,0.12178,0.09361,1,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.018836,0.12146,0.12553,1,0
5,GO SULFUR COMPOUND TRANSPORT,0.022165,0.12138,0.091667,1,0
5,GO SECONDARY METABOLIC PROCESS,0.02068,0.12082,0.1186,1,0
5,GO REGULATION OF ACTION POTENTIAL,0.046579,0.11856,0.13204,1,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.023741,0.1181,0.10144,1,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.019739,0.11774,0.093636,1,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.035393,0.11579,0.1142,1,0
5,GO REGULATION OF STEROL TRANSPORT,0.029068,0.11571,0.10194,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,0.0062634,0.11558,0.10219,1,0
5,GO EPITHELIAL TUBE FORMATION,0.0046564,0.11509,0.10392,1,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.043763,0.11419,0.10221,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.001872,0.11417,0.17751,1,0
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0041716,0.11276,0.088089,1,0
5,GO RESPONSE TO KETONE,0.0083534,0.11252,0.11799,1,0
5,GO NEURAL TUBE DEVELOPMENT,0.021165,0.11103,0.086544,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0099891,0.11047,0.067693,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.016339,0.10996,0.086825,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.053746,0.10878,0.079577,1,0
5,GO NEURON PROJECTION ARBORIZATION,0.041093,0.10716,0.19054,1,0
5,GO FATTY ACID CATABOLIC PROCESS,0.017549,0.10671,0.11295,1,0
5,GO FC RECEPTOR SIGNALING PATHWAY,0.040234,0.10584,0.077825,1,0
5,GO REGULATION OF CELL MATURATION,0.025994,0.10573,0.10565,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.02843,0.1057,0.091211,1,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.045624,0.10564,0.10811,1,0
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.027188,0.10333,0.087566,1,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.022165,0.10328,0.076354,1,0
5,GO LEARNING,0.05161,0.10229,0.12095,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.04854,0.10146,0.099439,1,0
5,GO HYPOTHALAMUS DEVELOPMENT,0.041093,0.10118,0.16542,1,0
5,GO SOMITOGENESIS,0.016734,0.09987,0.087952,1,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0094949,0.099562,0.091142,1,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.031059,0.099479,0.085625,1,0
5,GO OXIDATION REDUCTION PROCESS,0.026586,0.099203,0.081269,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.042857,0.097579,0.084304,1,0
5,GO HEART GROWTH,0.017969,0.09746,0.1011,1,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.035393,0.097426,0.12813,1,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.053746,0.097307,0.15674,1,0
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.053746,0.097192,0.087518,1,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.025414,0.094221,0.099221,1,0
5,GO OOCYTE DIFFERENTIATION,0.010506,0.094006,0.1158,1,0
5,GO ACTIVATION OF GTPASE ACTIVITY,0.03939,0.090938,0.074878,1,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.047551,0.090789,0.11533,1,0
5,GO PIGMENT GRANULE LOCALIZATION,0.036164,0.090399,0.10654,1,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.090082,0.063005,1,0
5,GO BICARBONATE TRANSPORT,0.02166,0.089991,0.1709,1,0
5,GO REGULATION OF VACUOLE ORGANIZATION,0.015953,0.088744,0.1058,1,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.040234,0.088247,0.14298,1,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.040234,0.087156,0.080734,1,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.02843,0.086394,0.12059,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.029068,0.085242,0.086989,1,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.019739,0.084329,0.091656,1,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.025994,0.083733,0.095916,1,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.025414,0.083649,0.10811,1,0
5,GO SCHWANN CELL DIFFERENTIATION,0.014841,0.083444,0.12118,1,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.050569,0.083067,0.062291,1,0
5,GO RETINA HOMEOSTASIS,0.031748,0.080778,0.074184,1,0
5,GO ORGANIC ACID METABOLIC PROCESS,0.041967,0.08076,0.066857,1,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.021165,0.080386,0.097016,1,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.053746,0.079288,0.049193,1,0
5,GO INTERLEUKIN 17 PRODUCTION,0.030383,0.076617,0.10606,1,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.027803,0.076124,0.078771,1,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.03939,0.069278,0.039033,1,0
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.05161,0.06821,0.068831,1,0
5,GO REGULATION OF PROTEIN TARGETING,0.02268,0.06583,0.079761,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02843,0.063834,0.061083,1,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.03245,0.055701,0.04997,1,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.025994,0.055635,0.069167,1,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.027803,0.052261,0.10387,1,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.037747,0.04521,0.11821,1,0
5,GO MACROAUTOPHAGY,0.046579,0.041445,0.051434,1,0
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.023205,0.038,0.08358,1,0
5,GO REGULATION OF DNA METABOLIC PROCESS,0.04854,-0.036732,-0.053342,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.029068,-0.038532,-0.089336,1,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0097392,-0.058448,-0.05028,1,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.049546,-0.062918,-0.070118,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.027803,-0.064517,-0.051721,1,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.043763,-0.064642,-0.088606,1,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.041093,-0.064895,-0.070939,1,0
5,GO NUCLEAR TRANSPORT,0.025414,-0.067333,-0.075804,1,0
5,GO GENE SILENCING,0.037747,-0.068295,-0.072159,1,0
5,GO BASE EXCISION REPAIR,0.0056288,-0.069581,-0.098706,1,0
5,GO RECOMBINATIONAL REPAIR,0.025994,-0.070068,-0.070487,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.011904,-0.070796,-0.11138,1,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.042857,-0.070977,-0.10258,1,0
5,GO SNRNA TRANSCRIPTION,0.0017123,-0.071267,-0.096848,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.037747,-0.071892,-0.14361,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.049546,-0.07298,-0.097566,1,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.034637,-0.075104,-0.089755,1,0
5,GO CHROMOSOME ORGANIZATION,0.052669,-0.07661,-0.040775,1,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.046579,-0.080183,-0.079753,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0033369,-0.081427,-0.11572,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.031748,-0.081473,-0.073646,1,0
5,GO CHROMATIN SILENCING,0.015574,-0.08261,-0.14018,1,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.036164,-0.083228,-0.098983,1,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.014138,-0.083862,-0.13592,1,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.02068,-0.08454,-0.12549,1,0
5,GO HISTONE H3 ACETYLATION,0.053746,-0.087545,-0.048978,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.012203,-0.087561,-0.092533,1,0
5,GO PROTEIN TARGETING,0.035393,-0.087905,-0.08958,1,0
5,GO METHYLATION,0.0030654,-0.088499,-0.078564,1,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.029068,-0.089185,-0.076107,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.02268,-0.090605,-0.10711,1,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.052669,-0.091125,-0.062307,1,0
5,GO CHROMATIN REMODELING,0.03939,-0.094524,-0.059199,1,0
5,GO RNA MODIFICATION,0.0013054,-0.095532,-0.15012,1,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.036948,-0.096029,-0.12727,1,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.0083534,-0.096316,-0.088505,1,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.013139,-0.096538,-0.11818,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.007729,-0.096585,-0.13662,1,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.017137,-0.097241,-0.086393,1,0
5,GO PROTEIN SUMOYLATION,0.035393,-0.097315,-0.075488,1,0
5,GO REGULATION OF GENE SILENCING,0.011612,-0.097528,-0.11822,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0054795,-0.097633,-0.10469,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.014138,-0.098015,-0.097198,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0027346,-0.098509,-0.13338,1,0
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.025414,-0.098718,-0.090535,1,0
5,GO MRNA CLEAVAGE,0.030383,-0.09875,-0.076816,1,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0075304,-0.10023,-0.10966,1,0
5,GO NUCLEAR EXPORT,0.009256,-0.10047,-0.10242,1,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.033166,-0.10166,-0.12308,1,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.035393,-0.1021,-0.097528,1,0
5,GO HISTONE H3 K9 ACETYLATION,0.036948,-0.10225,-0.11579,1,0
5,GO TRNA 5 LEADER REMOVAL,0.047551,-0.10339,-0.16021,1,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.033894,-0.10567,-0.12536,1,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.03939,-0.10618,-0.06223,1,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.015203,-0.10653,-0.093661,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0023671,-0.10711,-0.1067,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0075304,-0.10786,-0.11334,1,0
5,GO DNA CONFORMATION CHANGE,0.0064317,-0.11129,-0.082675,1,0
5,GO PROTEIN NEDDYLATION,0.025994,-0.1115,-0.10706,1,0
5,GO TRNA METHYLATION,0.0022992,-0.11218,-0.18424,1,0
5,GO DNA GEOMETRIC CHANGE,0.0024367,-0.11408,-0.12077,1,0
5,GO MRNA 3 END PROCESSING,0.0024367,-0.11464,-0.10932,1,0
5,GO PENTOSE METABOLIC PROCESS,0.017969,-0.1147,-0.19853,1,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.033894,-0.11472,-0.12594,1,0
5,GO REPLICATION FORK PROCESSING,0.02068,-0.11596,-0.11011,1,0
5,GO RNA POLYADENYLATION,0.0087944,-0.11839,-0.10756,1,0
5,GO MRNA TRANSPORT,0.004408,-0.11879,-0.11392,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,1.8521e-05,-0.12002,-0.15567,1,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.0036303,-0.12056,-0.18129,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.031059,-0.12072,-0.1186,1,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0011549,-0.1208,-0.11692,1,0
5,GO REGULATION OF RNA SPLICING,0.010245,-0.12118,-0.082262,1,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00024286,-0.12138,-0.14563,1,0
5,GO DNA METHYLATION,0.037747,-0.12222,-0.086999,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.016734,-0.12282,-0.19095,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.004408,-0.12325,-0.12867,1,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.00012964,-0.12325,-0.11884,1,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0059384,-0.12483,-0.20184,1,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0011549,-0.12485,-0.17834,1,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.026586,-0.12539,-0.117,1,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.00012074,-0.12636,-0.12911,1,0
5,GO TELOMERE ORGANIZATION,7.547e-05,-0.12687,-0.13842,1,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.017137,-0.1277,-0.10027,1,0
5,GO PEPTIDE METABOLIC PROCESS,0.0079323,-0.12814,-0.11543,1,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.0010206,-0.12931,-0.16731,1,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.00018427,-0.12945,-0.1502,1,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0029794,-0.13023,-0.11979,1,0
5,GO MRNA METHYLATION,0.031059,-0.13109,-0.12827,1,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.027803,-0.13176,-0.14123,1,0
5,GO REGULATION OF DNA METHYLATION,0.045624,-0.13213,-0.1034,1,0
5,GO GLYCINE METABOLIC PROCESS,0.031059,-0.13313,-0.20324,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,3.5759e-05,-0.13347,-0.14138,1,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.02843,-0.1337,-0.14276,1,0
5,GO MIRNA METABOLIC PROCESS,0.0038387,-0.13381,-0.16507,1,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0042883,-0.13413,-0.1265,1,0
5,GO AMIDE BIOSYNTHETIC PROCESS,0.0062634,-0.1357,-0.12374,1,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0094949,-0.13648,-0.20026,1,0
5,GO PEPTIDYL ARGININE METHYLATION,0.0046564,-0.13745,-0.14412,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.4609e-05,-0.13747,-0.16491,1,0
5,GO RNA STABILIZATION,0.0047853,-0.13759,-0.13932,1,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.014486,-0.13944,-0.11052,1,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0036303,-0.1407,-0.15041,1,0
5,GO TRANSLATIONAL TERMINATION,0.0053338,-0.14104,-0.19972,1,0
5,GO DNA STRAND ELONGATION,0.041967,-0.14172,-0.10886,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.011612,-0.14209,-0.14073,1,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.019739,-0.14276,-0.14826,1,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0022332,-0.14281,-0.10958,1,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00055855,-0.1443,-0.16981,1,0
5,GO RNA INTERFERENCE,0.037747,-0.1448,-0.13177,1,0
5,GO REGULATION OF MRNA PROCESSING,0.0036303,-0.14578,-0.10391,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,1.7118e-05,-0.14584,-0.16898,1,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,2.7343e-05,-0.14634,-0.15544,1,0
5,GO NCRNA TRANSCRIPTION,2.2524e-05,-0.14643,-0.15299,1,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.011326,-0.14672,-0.2064,1,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.02068,-0.1476,-0.20334,1,0
5,GO HISTONE ARGININE METHYLATION,0.0031536,-0.14942,-0.14575,1,0
5,GO NUCLEOSOME ORGANIZATION,0.0085714,-0.1496,-0.096474,1,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0034322,-0.14985,-0.13701,1,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0081404,-0.15004,-0.12188,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.016339,-0.15029,-0.18816,1,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.018398,-0.15125,-0.15612,1,0
5,GO RNA 5 END PROCESSING,0.0064317,-0.15302,-0.20814,1,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.040234,-0.1533,-0.094065,1,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00098941,-0.15436,-0.15189,1,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0042883,-0.15453,-0.11785,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.2786e-05,-0.1547,-0.13887,1,0
5,GO MRNA EXPORT FROM NUCLEUS,0.00026903,-0.15498,-0.14428,1,0
5,GO MITOCHONDRIAL TRANSLATION,0.0045306,-0.15509,-0.20325,1,0
5,GO TRNA MODIFICATION,0.00010092,-0.15733,-0.22978,1,0
5,GO RNA CAPPING,0.00011241,-0.15824,-0.14525,1,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0060989,-0.15847,-0.15674,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00050664,-0.15874,-0.15509,1,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.9904e-06,-0.15882,-0.18377,1,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.0046564,-0.15998,-0.13972,1,0
5,GO PEPTIDYL ARGININE N METHYLATION,0.023741,-0.16006,-0.15311,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE,9.0179e-06,-0.16018,-0.1793,1,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,-0.16081,-0.21847,1,0
5,GO GLUTAMINE METABOLIC PROCESS,0.035393,-0.16157,-0.14304,1,0
5,GO TRNA METABOLIC PROCESS,0.00026903,-0.16172,-0.18806,1,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.00090094,-0.16176,-0.14986,1,0
5,GO RNA LOCALIZATION,0.00016595,-0.16192,-0.15645,1,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.012203,-0.16202,-0.17723,1,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.025414,-0.16224,-0.14722,1,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0081404,-0.16229,-0.11488,1,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.017549,-0.16237,-0.14357,1,0
5,GO PROTEIN NITROSYLATION,0.043763,-0.16238,-0.20144,1,0
5,GO TRANSLATIONAL ELONGATION,0.0032441,-0.16297,-0.19118,1,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001872,-0.16323,-0.11833,1,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.041093,-0.16343,-0.0883,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,3.5759e-05,-0.16509,-0.19252,1,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.012508,-0.16513,-0.13127,1,0
5,GO MRNA PROCESSING,0.00016023,-0.16675,-0.12485,1,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0028141,-0.16785,-0.16924,1,0
5,GO RNA METHYLATION,2.3418e-05,-0.168,-0.20076,1,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.0029794,-0.16871,-0.18481,1,0
5,GO STRESS GRANULE ASSEMBLY,0.0007696,-0.16891,-0.17841,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00063551,-0.16909,-0.1341,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,4.6597e-05,-0.1704,-0.15663,1,0
5,GO SNRNA METABOLIC PROCESS,1.9263e-05,-0.17093,-0.21939,1,0
5,GO TRNA 5 END PROCESSING,0.0090226,-0.17137,-0.19438,1,0
5,GO MRNA METABOLIC PROCESS,7.2754e-05,-0.17273,-0.15899,1,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.024846,-0.1731,-0.16739,1,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0037331,-0.17318,-0.17663,1,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.001662,-0.17468,-0.19155,1,0
5,GO RNA 3 END PROCESSING,3.8583e-05,-0.17551,-0.1618,1,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0051916,-0.17567,-0.13395,1,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00054072,-0.17614,-0.1801,1,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00045924,-0.17677,-0.12934,1,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0022992,-0.17699,-0.12103,1,0
5,GO PROTEASOME ASSEMBLY,0.0053338,-0.17701,-0.18805,1,0
5,GO RNA SPLICING,0.00014418,-0.17717,-0.13391,1,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0066042,-0.17932,-0.15811,1,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.017137,-0.18036,-0.211,1,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.0033369,-0.18089,-0.20437,1,0
5,GO PROTEIN DENEDDYLATION,0.00029782,-0.18208,-0.22671,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.015953,-0.18271,-0.20126,1,0
5,GO RNA EXPORT FROM NUCLEUS,0.00012964,-0.18272,-0.16516,1,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0051916,-0.18313,-0.20867,1,0
5,GO TRNA TRANSPORT,0.0014299,-0.18344,-0.20271,1,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,2.2658e-06,-0.18427,-0.19554,1,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00012964,-0.18468,-0.14879,1,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0038387,-0.18521,-0.16277,1,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00011241,-0.1871,-0.17951,1,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.024846,-0.1873,-0.13026,1,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.02166,-0.18737,-0.20386,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,2.0833e-05,-0.18772,-0.25356,1,0
5,GO HISTONE DEUBIQUITINATION,0.00020448,-0.18904,-0.15541,1,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.00012074,-0.18917,-0.18421,1,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.05161,-0.19004,-0.17774,1,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0085714,-0.19053,-0.17278,1,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0040578,-0.19057,-0.18834,1,0
5,GO HISTONE H2A ACETYLATION,0.0014738,-0.19105,-0.15451,1,0
5,GO TRNA PROCESSING,3.4421e-05,-0.19139,-0.22074,1,0
5,GO BLASTOCYST GROWTH,0.0019282,-0.19181,-0.18176,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00021167,-0.19263,-0.21014,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,2.0833e-05,-0.1936,-0.19909,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0017641,-0.19501,-0.24694,1,0
5,GO RNA CATABOLIC PROCESS,0.00054072,-0.19508,-0.18454,1,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.011326,-0.19921,-0.17481,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0033369,-0.20118,-0.16184,1,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.015953,-0.20141,-0.18519,1,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.00020448,-0.20184,-0.19418,1,0
5,GO RNA PROCESSING,4.1112e-06,-0.20349,-0.18135,1,0
5,GO PEPTIDYL HISTIDINE MODIFICATION,0.00011241,-0.20355,-0.24552,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0027346,-0.2051,-0.28438,1,0
5,GO MEMBRANE DISASSEMBLY,0.017549,-0.2059,-0.14618,1,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0033369,-0.20901,-0.14974,1,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.004408,-0.20955,-0.24182,1,0
5,GO NUCLEAR PORE ORGANIZATION,0.0075304,-0.2101,-0.23611,1,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,5.0226e-05,-0.2117,-0.31977,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00037661,-0.21206,-0.17545,1,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.0075304,-0.21209,-0.1879,1,0
5,GO SNRNA PROCESSING,4.8379e-05,-0.21232,-0.24631,1,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.043763,-0.21329,-0.1528,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0025083,-0.21371,-0.1976,1,0
5,GO FOLIC ACID METABOLIC PROCESS,0.0083534,-0.21704,-0.20887,1,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00038934,-0.21715,-0.22344,1,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,6.0504e-05,-0.22006,-0.18945,1,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.013798,-0.22123,-0.16798,1,0
5,GO CHROMATIN DISASSEMBLY,0.019283,-0.22159,-0.15989,1,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.0022992,-0.22221,-0.17977,1,0
5,GO DNA REPLICATION CHECKPOINT,0.0050528,-0.22326,-0.20822,1,0
5,GO AMINO ACID ACTIVATION,0.00063551,-0.22652,-0.25252,1,0
5,GO DNA REPLICATION INITIATION,0.00016595,-0.22789,-0.21265,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,3.5759e-05,-0.22827,-0.3032,1,0
5,GO MRNA MODIFICATION,0.0012662,-0.22877,-0.19719,1,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0050528,-0.22942,-0.18007,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,1.7118e-05,-0.22963,-0.22739,1,0
5,GO NCRNA METABOLIC PROCESS,7.3528e-06,-0.23019,-0.25156,1,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.0015189,-0.23038,-0.36875,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.00063551,-0.23345,-0.22007,1,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.00038934,-0.23621,-0.27362,1,0
5,GO NCRNA 3 END PROCESSING,4.1617e-05,-0.23682,-0.25305,1,0
5,GO IMP METABOLIC PROCESS,0.0087944,-0.2376,-0.27645,1,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,-0.23942,-0.30708,1,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,1.8521e-05,-0.24014,-0.26804,1,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0060989,-0.24066,-0.21055,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,7.8282e-05,-0.24119,-0.2449,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0050528,-0.24275,-0.26355,1,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,5.8301e-05,-0.24334,-0.2426,1,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0017123,-0.24369,-0.20415,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0001547,-0.24446,-0.21289,1,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,1.1964e-05,-0.24614,-0.26722,1,0
5,GO PSEUDOURIDINE SYNTHESIS,0.00012512,-0.24731,-0.34583,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0047853,-0.24748,-0.17,1,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.001872,-0.24851,-0.24309,1,0
5,GO REGULATION OF RNA BINDING,9.0551e-05,-0.25307,-0.25332,1,0
5,GO MATURATION OF 5 8S RRNA,3.1888e-05,-0.25817,-0.33929,1,0
5,GO NCRNA PROCESSING,2.3654e-06,-0.25908,-0.28652,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,1.0604e-05,-0.25945,-0.22176,1,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,1.4044e-06,-0.26438,-0.28095,1,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,5.6174e-05,-0.26491,-0.28736,1,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,1.8521e-05,-0.265,-0.36674,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,1.4609e-05,-0.26517,-0.23296,1,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.00017796,-0.27084,-0.21451,1,0
5,GO REGULATION OF MRNA BINDING,4.0073e-05,-0.2714,-0.3102,1,0
5,GO ADULT HEART DEVELOPMENT,0.0031536,-0.27466,-0.25321,1,0
5,GO RRNA MODIFICATION,2.8077e-06,-0.27584,-0.33165,1,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0001547,-0.27898,-0.24344,1,0
5,GO RRNA METHYLATION,2.0784e-06,-0.27933,-0.3068,1,0
5,GO RRNA TRANSCRIPTION,1.2962e-05,-0.2794,-0.29085,1,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,4.8379e-05,-0.28821,-0.34922,1,0
5,GO DENDRITIC TRANSPORT,0.033166,-0.28822,-0.14589,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,6.7596e-05,-0.28965,-0.37281,1,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.00050664,-0.29528,-0.32936,1,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.0010528,-0.29812,-0.27493,1,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00055855,-0.29873,-0.35018,1,0
5,GO RRNA METABOLIC PROCESS,4.2876e-06,-0.29915,-0.31848,1,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.4205e-05,-0.29951,-0.38816,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,3.9418e-06,-0.30163,-0.32392,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,1.2308e-06,-0.30662,-0.28723,1,0
5,GO MITOCHONDRIAL TRNA PROCESSING,0.0013872,-0.31472,-0.2657,1,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.00036427,-0.31525,-0.4298,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00095906,-0.31799,-0.34068,1,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011047,-0.31874,-0.27758,1,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,1.6015e-06,-0.32562,-0.32379,1,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0057817,-0.32774,-0.30045,1,0
5,GO VIRAL GENE EXPRESSION,0.00019753,-0.3284,-0.32367,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,1.2308e-06,-0.33001,-0.31976,1,0
5,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0029794,-0.3446,-0.26433,1,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,2.1663e-05,-0.34735,-0.3687,1,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.3654e-06,-0.348,-0.38404,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00012964,-0.34963,-0.30451,1,0
5,GO RIBOSOME BIOGENESIS,1.8251e-06,-0.35601,-0.35884,1,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,2.2658e-06,-0.35787,-0.35163,1,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,1.0779e-06,-0.36336,-0.42038,1,0
5,GO L SERINE METABOLIC PROCESS,0.010245,-0.36384,-0.29739,1,0
5,GO RNA SURVEILLANCE,2.6902e-06,-0.36464,-0.31178,1,0
5,GO MATURATION OF SSU RRNA,1.4674e-06,-0.3647,-0.39325,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,5.508e-06,-0.36597,-0.38273,1,0
5,GO RRNA PSEUDOURIDINE SYNTHESIS,4.4712e-06,-0.37174,-0.44045,1,0
5,GO TELOMERASE RNA LOCALIZATION,1.2308e-06,-0.37586,-0.43646,1,0
5,GO TRANSLATIONAL INITIATION,0.00020448,-0.38598,-0.36311,1,0
5,GO CYTOPLASMIC TRANSLATION,2.3418e-05,-0.38871,-0.42706,1,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,3.1888e-05,-0.39338,-0.3771,1,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,7.5427e-07,-0.3976,-0.47958,1,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,5.7413e-06,-0.39842,-0.47395,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00047456,-0.4004,-0.4517,1,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,3.3287e-06,-0.41145,-0.42392,1,0
5,GO RIBOSOME ASSEMBLY,1.4674e-06,-0.42011,-0.47484,1,0
5,GO SNORNA METABOLIC PROCESS,1.7806e-05,-0.42319,-0.38605,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,1.9904e-06,-0.42556,-0.44514,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,1.5331e-06,-0.42694,-0.47896,1,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.00063551,-0.43015,-0.30451,1,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,4.6623e-06,-0.43192,-0.4695,1,0
5,GO VIRAL TRANSLATION,4.6623e-06,-0.43562,-0.43439,1,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,1.7118e-05,-0.43613,-0.38687,1,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,4.0073e-05,-0.43842,-0.43458,1,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,8.7323e-05,-0.43936,-0.43152,1,0
5,GO SNORNA 3 END PROCESSING,7.3528e-06,-0.43959,-0.43447,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00014418,-0.44168,-0.46996,1,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.012203,-0.44371,-0.29768,1,0
5,GO CARDIAC CHAMBER FORMATION,0.045624,-0.45221,-0.25521,1,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00038934,-0.47353,-0.51026,1,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,7.0571e-06,-0.48193,-0.50165,1,0
5,GO MATURATION OF LSU RRNA,6.4994e-06,-0.49381,-0.46191,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,1.1776e-06,-0.49538,-0.53167,1,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,4.1617e-05,-0.52532,-0.52134,1,0
5,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.0028957,-0.64913,-0.39532,1,0
5,GO NEPHRIC DUCT MORPHOGENESIS,0.065563,0.40401,0.19378,0,1
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.059411,0.37736,0.29498,0,1
5,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.1028,0.37266,0.22485,0,1
5,GO PLASMINOGEN ACTIVATION,0.054842,0.34098,0.21867,0,1
5,GO TONGUE DEVELOPMENT,0.059411,0.33857,0.21623,0,1
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0695,0.32828,0.20906,0,1
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.10096,0.31648,0.26197,0,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.085627,0.31165,0.15059,0,1
5,GO SHORT TERM MEMORY,0.093897,0.30109,0.1669,0,1
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.17653,0.27683,0.28436,0,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.063042,0.26737,0.19047,0,1
5,GO RESPONSE TO EPINEPHRINE,0.05824,0.26474,0.20085,0,1
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.059411,0.26425,0.20225,0,1
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.076492,0.26031,0.15925,0,1
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.98953,0.25789,-0.064797,0,1
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.23937,0.25659,0.046927,0,1
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.066855,0.24984,0.12178,0,1
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.088862,0.24888,0.14755,0,1
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.087232,0.23995,0.16083,0,1
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.12689,0.23537,0.10884,0,1
5,GO BASIC AMINO ACID TRANSPORT,0.11841,0.23291,0.05344,0,1
5,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.092194,0.23245,0.18383,0,1
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.53742,0.22902,0.031816,0,1
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.092194,0.22585,0.21419,0,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.087232,0.22562,0.21302,0,1
5,GO PROSTATE GLAND DEVELOPMENT,0.087232,0.22318,0.12059,0,1
5,GO SYNAPTIC VESICLE MATURATION,0.26847,0.2224,0.18755,0,1
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.11841,0.21623,0.14241,0,1
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.16559,0.21211,0.12386,0,1
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.063042,0.2089,0.1104,0,1
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.090515,0.20692,0.17541,0,1
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.054842,0.2051,0.11417,0,1
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.087232,0.19929,0.10383,0,1
5,GO RESPONSE TO REDOX STATE,0.11636,0.19665,0.14939,0,1
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.097379,0.19184,0.18782,0,1
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.097379,0.19157,0.12761,0,1
5,GO SNARE COMPLEX ASSEMBLY,0.17099,0.18694,0.13622,0,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.084046,0.18136,0.15213,0,1
5,GO FAT CELL PROLIFERATION,0.084046,0.17825,0.19474,0,1
5,GO L PHENYLALANINE METABOLIC PROCESS,0.11841,0.17599,0.099186,0,1
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.23245,0.17115,0.090546,0,1
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.088862,0.17101,0.18163,0,1
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.068167,0.17097,0.16511,0,1
5,GO NEUROTRANSMITTER REUPTAKE,0.21579,0.16947,0.10118,0,1
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.079444,0.16872,0.17513,0,1
5,GO INCLUSION BODY ASSEMBLY,0.16032,0.16842,0.12013,0,1
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.077957,0.16754,0.1284,0,1
5,GO CARNITINE METABOLIC PROCESS,0.057089,0.16623,0.15975,0,1
5,GO ER OVERLOAD RESPONSE,0.073629,0.16493,0.12608,0,1
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.085627,0.16234,0.15791,0,1
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.10096,0.16226,0.087724,0,1
5,GO RESPONSE TO MUSCLE ACTIVITY,0.22235,0.16087,0.10503,0,1
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.11039,0.16039,0.064302,0,1
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.082489,0.15924,0.0862,0,1
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.065563,0.1588,0.14438,0,1
5,GO BLASTODERM SEGMENTATION,0.27611,0.1585,0.1043,0,1
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.057089,0.15762,0.088808,0,1
5,GO SIGNAL PEPTIDE PROCESSING,0.088862,0.1572,0.11683,0,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.1028,0.15308,0.11033,0,1
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.12908,0.15198,0.17453,0,1
5,GO RESPONSE TO VITAMIN A,0.066855,0.15153,0.13499,0,1
5,GO NEUROTRANSMITTER UPTAKE,0.17099,0.15134,0.099013,0,1
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.073629,0.15127,0.12105,0,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.05824,0.15092,0.11341,0,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.068167,0.15033,0.28487,0,1
5,GO REGULATION OF CALCIUM ION IMPORT,0.072231,0.14948,0.095023,0,1
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.077957,0.14506,0.18418,0,1
5,GO RENAL SODIUM EXCRETION,0.064293,0.14501,0.13392,0,1
5,GO RESPONSE TO TESTOSTERONE,0.076492,0.14383,0.13392,0,1
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.060602,0.14375,0.12017,0,1
5,GO URETER DEVELOPMENT,0.11434,0.14231,0.15041,0,1
5,GO POLYAMINE METABOLIC PROCESS,0.064293,0.14086,0.1139,0,1
5,GO ARTERY MORPHOGENESIS,0.070855,0.14031,0.062351,0,1
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.15773,0.14021,0.1364,0,1
5,GO MITOTIC CYTOKINETIC PROCESS,0.19095,0.13963,0.073027,0,1
5,GO SEROTONIN SECRETION,0.097379,0.13727,0.15872,0,1
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.066855,0.13543,0.099593,0,1
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.085627,0.13445,0.11916,0,1
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.14285,0.13381,0.11684,0,1
5,GO CYTOKINETIC PROCESS,0.16294,0.13269,0.060099,0,1
5,GO REGULATION OF CILIUM BEAT FREQUENCY,0.32077,0.13034,0.038,0,1
5,GO MITRAL VALVE DEVELOPMENT,0.23937,0.12994,0.09814,0,1
5,GO POSITIVE REGULATION OF MYELINATION,0.23589,0.12925,0.058901,0,1
5,GO QUINONE METABOLIC PROCESS,0.082489,0.12909,0.057849,0,1
5,GO GLYCOSIDE METABOLIC PROCESS,0.20621,0.12841,-0.0053819,0,1
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.15517,0.12727,0.1071,0,1
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.11434,0.12681,0.13365,0,1
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.29992,0.12639,0.090491,0,1
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.22905,0.12607,0.050574,0,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.059411,0.12427,0.07761,0,1
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.14048,0.12357,0.062815,0,1
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.11235,0.12194,0.07844,0,1
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.28785,0.12015,0.027878,0,1
5,GO MALE GENITALIA DEVELOPMENT,0.17099,0.11951,0.087414,0,1
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.073629,0.11935,0.19183,0,1
5,GO PHAGOSOME MATURATION,0.064293,0.11928,0.076289,0,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.073629,0.11845,0.074097,0,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.066855,0.11836,0.1348,0,1
5,GO STEROL BIOSYNTHETIC PROCESS,0.23589,0.118,0.031308,0,1
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.068167,0.11733,0.079494,0,1
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.087232,0.11703,0.15851,0,1
5,GO T HELPER CELL LINEAGE COMMITMENT,0.18219,0.11587,0.077233,0,1
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.35153,0.11527,0.043539,0,1
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.188,0.11514,0.090036,0,1
5,GO MICROTUBULE SEVERING,0.15015,0.11344,0.09216,0,1
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.070855,0.11332,0.13151,0,1
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.13355,0.10871,0.082724,0,1
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.061812,0.10771,0.13961,0,1
5,GO APICAL PROTEIN LOCALIZATION,0.10845,0.10757,0.14488,0,1
5,GO ALCOHOL CATABOLIC PROCESS,0.097379,0.10741,0.066157,0,1
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.10845,0.10672,0.067656,0,1
5,GO RESPONSE TO LEUCINE,0.18508,0.10615,0.13571,0,1
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.1028,0.10485,0.085996,0,1
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.057089,0.10438,0.082146,0,1
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.17374,0.1034,0.11503,0,1
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.084046,0.10215,0.061731,0,1
5,GO LIMBIC SYSTEM DEVELOPMENT,0.0695,0.097302,0.10244,0,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.20309,0.096764,0.088013,0,1
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.065563,0.096554,0.098818,0,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.054842,0.092477,0.09195,0,1
5,GO SMOOTHENED SIGNALING PATHWAY,0.14769,0.092218,0.058487,0,1
5,GO NOREPINEPHRINE SECRETION,0.25363,0.09186,0.11726,0,1
5,GO MAINTENANCE OF CELL NUMBER,0.10654,0.090872,0.045888,0,1
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.18508,0.090818,0.074426,0,1
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.11434,0.089929,0.098698,0,1
5,GO DENDRITIC SPINE DEVELOPMENT,0.076492,0.089825,0.096049,0,1
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.057089,0.08937,0.13744,0,1
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.1028,0.088162,0.090631,0,1
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.087232,0.08793,0.064935,0,1
5,GO PHOTOTRANSDUCTION,0.085627,0.08737,0.045553,0,1
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.50337,0.086317,0.011763,0,1
5,GO STEROL IMPORT,0.20621,0.085656,0.050333,0,1
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.12689,0.085393,0.099909,0,1
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.36064,0.084201,0.063132,0,1
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.20937,0.084164,0.048041,0,1
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.19095,0.083746,0.037351,0,1
5,GO EMBRYONIC EYE MORPHOGENESIS,0.31232,0.082312,0.071122,0,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.076492,0.082231,0.08847,0,1
5,GO OVULATION CYCLE,0.063042,0.081088,0.083268,0,1
5,GO RECEPTOR INTERNALIZATION,0.084046,0.080743,0.076051,0,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.16294,0.079822,0.057732,0,1
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.76281,0.078215,0.022569,0,1
5,GO ARTERY DEVELOPMENT,0.48678,0.077998,-0.001674,0,1
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.065563,0.074943,0.11814,0,1
5,GO VIRAL BUDDING,0.19095,0.072944,0.064396,0,1
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.095625,0.070986,0.04733,0,1
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.092194,0.069477,0.054896,0,1
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.12689,0.066802,0.049441,0,1
5,GO RESPONSE TO GLUCAGON,0.18508,0.066193,0.060863,0,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.073629,0.061885,0.071799,0,1
5,GO STEM CELL DIFFERENTIATION,0.090515,0.061638,0.062968,0,1
5,GO RESPONSE TO PROSTAGLANDIN,0.29992,0.059198,0.048383,0,1
5,GO FEMALE GAMETE GENERATION,0.14048,0.059148,0.046253,0,1
5,GO CYTOSOLIC TRANSPORT,0.13355,0.057066,0.044967,0,1
5,GO REGULATION OF STEM CELL PROLIFERATION,0.30815,0.054438,0.054291,0,1
5,GO RECEPTOR RECYCLING,0.16559,0.054079,0.064326,0,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.24288,0.05246,0.069229,0,1
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.055956,0.046585,0.050158,0,1
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.070855,0.046233,0.041128,0,1
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.17099,0.041563,0.047507,0,1
5,GO VESICLE LOCALIZATION,0.10845,0.040863,0.048432,0,1
5,GO REGULATION OF CELL CYCLE,0.087232,0.037468,0.033662,0,1
5,GO LIPID PHOSPHORYLATION,0.26471,0.035384,0.046695,0,1
5,GO MISMATCH REPAIR,0.12049,0.035026,0.064059,0,1
5,GO ORGANELLE LOCALIZATION,0.072231,0.024998,0.050294,0,1
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,6.2786e-05,0.52911,0.53469,0,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.088862,0.41955,0.25906,0,0
5,GO PARENTAL BEHAVIOR,0.0054795,0.36367,0.26098,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00087311,0.35396,0.38519,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0022992,0.3426,0.37935,0,0
5,GO BRONCHUS DEVELOPMENT,0.0031536,0.33349,0.38095,0,0
5,GO PHOSPHOLIPID EFFLUX,0.0017123,0.32079,0.24166,0,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.099158,0.316,0.16282,0,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.077957,0.31282,0.21248,0,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.10654,0.31213,0.16056,0,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.15015,0.30598,0.21406,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0060989,0.30018,0.30828,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.00035231,0.29906,0.31575,0,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.090515,0.29688,0.23206,0,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.21905,0.26998,0.1471,0,0
5,GO REGULATION OF RECEPTOR BINDING,0.010245,0.26715,0.20268,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.10096,0.26638,0.32993,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.068167,0.26058,0.25492,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.02268,0.26017,0.31702,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.092194,0.25971,0.16766,0,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0079323,0.25862,0.32703,0,0
5,GO HEART VALVE FORMATION,0.12049,0.25828,0.18168,0,0
5,GO RESPONSE TO UV B,0.041967,0.25545,0.16312,0,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.12908,0.25485,0.086397,0,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.084046,0.25337,0.14889,0,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.036948,0.25309,0.22724,0,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.031748,0.25182,0.24389,0,0
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.012508,0.25116,0.3435,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00072223,0.24699,0.28047,0,0
5,GO VOCALIZATION BEHAVIOR,0.035393,0.24647,0.33239,0,0
5,GO PREPULSE INHIBITION,0.02068,0.24594,0.30542,0,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.010245,0.24542,0.21133,0,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.018836,0.24505,0.19097,0,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.015203,0.24237,0.18114,0,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.67137,0.24154,0.035366,0,0
5,GO LEYDIG CELL DIFFERENTIATION,0.033166,0.23735,0.24197,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.05824,0.23603,0.27028,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049035,0.23572,0.3247,0,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.13355,0.23431,0.13736,0,0
5,GO ADENOHYPOPHYSIS DEVELOPMENT,0.047551,0.23242,0.28715,0,0
5,GO FORELIMB MORPHOGENESIS,0.043763,0.23213,0.17218,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.084046,0.23003,0.15434,0,0
5,GO EPIDERMIS MORPHOGENESIS,0.011904,0.22983,0.16072,0,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.14526,0.22982,0.10195,0,0
5,GO POSTSYNAPSE ASSEMBLY,0.082489,0.22622,0.2318,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.15264,0.22555,0.12472,0,0
5,GO DIENCEPHALON DEVELOPMENT,4.6597e-05,0.22409,0.27598,0,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.068167,0.21948,0.1388,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.14048,0.21649,0.17985,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.057089,0.21572,0.12603,0,0
5,GO RESPIRATORY BURST,0.076492,0.21315,0.14082,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.063042,0.21105,0.12439,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.21905,0.21088,0.16885,0,0
5,GO NEUROBLAST DIVISION,0.059411,0.20918,0.17826,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.17099,0.20792,0.087133,0,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.03939,0.20692,0.20182,0,0
5,GO HYALURONAN CATABOLIC PROCESS,0.22235,0.20655,0.074536,0,0
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0027346,0.20595,0.20894,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0056288,0.20491,0.24315,0,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.11841,0.20457,0.2012,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.090515,0.2022,0.13894,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.029068,0.20211,0.22559,0,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.41341,0.2019,0.04537,0,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.047551,0.20175,0.17528,0,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.13355,0.20127,0.093021,0,0
5,GO CARDIAC ATRIUM DEVELOPMENT,0.015203,0.20004,0.16934,0,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.11841,0.19962,0.13035,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.17374,0.19941,0.10233,0,0
5,GO GDP METABOLIC PROCESS,0.054842,0.19937,0.18267,0,0
5,GO PROGESTERONE METABOLIC PROCESS,0.20309,0.19801,0.054107,0,0
5,GO BARBED END ACTIN FILAMENT CAPPING,0.12259,0.19632,0.093895,0,0
5,GO CD40 SIGNALING PATHWAY,0.068167,0.19591,0.1042,0,0
5,GO ACTIN FILAMENT SEVERING,0.32938,0.1929,0.068396,0,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.059411,0.19264,0.1791,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.076492,0.19263,0.27038,0,0
5,GO MAINTENANCE OF CELL POLARITY,0.02068,0.19078,0.154,0,0
5,GO CELL FATE DETERMINATION,0.11039,0.19047,0.12402,0,0
5,GO SEGMENT SPECIFICATION,0.075049,0.18995,0.19455,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.037747,0.18985,0.1112,0,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.23589,0.18852,0.089104,0,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14526,0.18771,0.11683,0,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.041967,0.18765,0.14858,0,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.12259,0.18701,0.17187,0,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.077957,0.18633,0.1121,0,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.25363,0.18599,0.076933,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.013798,0.18559,0.21794,0,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.082489,0.185,0.19594,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.063042,0.18415,0.2275,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.61497,0.18372,0.054502,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.16032,0.18311,0.19696,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0081404,0.1804,0.17506,0,0
5,GO OLIGOPEPTIDE TRANSPORT,0.057089,0.17962,0.11546,0,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.16294,0.1796,0.1557,0,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.087232,0.17845,0.12627,0,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.070855,0.17831,0.10916,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.21579,0.17762,0.083839,0,0
5,GO TRABECULA FORMATION,0.22235,0.17741,0.060938,0,0
5,GO POSITIVE REGULATION OF CELL SIZE,0.10465,0.17712,0.096918,0,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.29184,0.17708,0.11448,0,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.18219,0.17608,0.079636,0,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.041093,0.17595,0.13189,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.11039,0.17581,0.11579,0,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.079444,0.17544,0.14396,0,0
5,GO ELASTIC FIBER ASSEMBLY,0.36991,0.17349,0.069914,0,0
5,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.10465,0.17224,0.11611,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0032441,0.17196,0.2309,0,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.14285,0.17194,0.13098,0,0
5,GO INTESTINAL LIPID ABSORPTION,0.064293,0.17188,0.13396,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.019739,0.1715,0.14812,0,0
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.00072223,0.171,0.17971,0,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.20937,0.17086,0.094582,0,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.095625,0.1693,0.10039,0,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.055956,0.16907,0.18928,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.23589,0.16903,0.064576,0,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.19393,0.16787,0.065393,0,0
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.41341,0.16663,0.20283,0,0
5,GO AUTOPHAGY OF NUCLEUS,0.12049,0.16658,0.10517,0,0
5,GO COLLAGEN METABOLIC PROCESS,0.079444,0.16657,0.095918,0,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.25729,0.16645,0.16007,0,0
5,GO SKIN MORPHOGENESIS,0.15517,0.16579,0.10771,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15773,0.16574,0.11955,0,0
5,GO MUSCLE CELL FATE COMMITMENT,0.20937,0.16561,0.095366,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.065563,0.16532,0.19676,0,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.015574,0.16444,0.17347,0,0
5,GO NEURAL RETINA DEVELOPMENT,0.084046,0.16336,0.11677,0,0
5,GO CEREBELLAR CORTEX FORMATION,0.063042,0.16304,0.15175,0,0
5,GO PROTEIN OXIDATION,0.057089,0.16153,0.14937,0,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.090515,0.16015,0.095852,0,0
5,GO CYTOPLASM ORGANIZATION,0.093897,0.15894,0.10526,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.070855,0.15818,0.19333,0,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.2839,0.15776,0.0077129,0,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.2,0.15775,0.094336,0,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.54321,0.1577,0.034137,0,0
5,GO RIG I SIGNALING PATHWAY,0.10845,0.15755,0.075025,0,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.092194,0.15586,0.096227,0,0
5,GO RESPONSE TO ZINC ION,0.02068,0.15517,0.17359,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.070855,0.15484,0.083257,0,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.084046,0.15413,0.1038,0,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.34256,0.15407,0.036288,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.054842,0.15384,0.1356,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.05824,0.15356,0.17297,0,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0034322,0.15302,0.13079,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.080955,0.15299,0.1762,0,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.13814,0.15275,0.18628,0,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.19393,0.1517,0.076298,0,0
5,GO HINDLIMB MORPHOGENESIS,0.34256,0.1515,0.056589,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.44924,0.15125,0.066927,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.11636,0.15119,0.13477,0,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.084046,0.15109,0.12645,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.066855,0.15041,0.13063,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.059411,0.15024,0.22895,0,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.057089,0.14985,0.16317,0,0
5,GO RESPONSE TO HYPEROXIA,0.1313,0.14959,0.11382,0,0
5,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.72969,0.14932,-0.017004,0,0
5,GO LIPID IMPORT INTO CELL,0.097379,0.14882,0.13677,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.30815,0.14857,0.081411,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.17934,0.14822,0.086932,0,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.041093,0.14808,0.14562,0,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.14285,0.14611,0.11848,0,0
5,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.15264,0.14606,0.068359,0,0
5,GO RETINAL METABOLIC PROCESS,0.17653,0.14605,0.078711,0,0
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.03245,0.14599,0.11315,0,0
5,GO GAP JUNCTION ASSEMBLY,0.057089,0.14598,0.18172,0,0
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.055956,0.14547,0.21553,0,0
5,GO ACTIN FILAMENT BASED TRANSPORT,0.093897,0.14527,0.13982,0,0
5,GO RENAL VESICLE DEVELOPMENT,0.20937,0.14466,0.089115,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.1028,0.14421,0.27711,0,0
5,GO LEFT RIGHT AXIS SPECIFICATION,0.14526,0.14413,0.12238,0,0
5,GO DRINKING BEHAVIOR,0.072231,0.14388,0.28068,0,0
5,GO ADULT FEEDING BEHAVIOR,0.068167,0.14341,0.11389,0,0
5,GO FOREBRAIN MORPHOGENESIS,0.23245,0.14295,0.076819,0,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.10465,0.14283,0.18359,0,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.22568,0.14259,0.05902,0,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.093897,0.14258,0.10605,0,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.22568,0.14247,0.092736,0,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.11434,0.14223,0.22126,0,0
5,GO LIPID DIGESTION,0.25363,0.14213,0.070018,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.25001,0.14196,0.10055,0,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.12473,0.14194,0.05752,0,0
5,GO MOTILE CILIUM ASSEMBLY,0.28785,0.1416,0.083039,0,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0046564,0.14146,0.23808,0,0
5,GO VAGINA DEVELOPMENT,0.070855,0.14144,0.12554,0,0
5,GO MATING BEHAVIOR,0.38888,0.14128,0.055076,0,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.16559,0.14107,0.12537,0,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.14048,0.14101,0.072721,0,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.023205,0.14097,0.15072,0,0
5,GO TONGUE MORPHOGENESIS,0.18508,0.14055,0.19409,0,0
5,GO HEPARIN METABOLIC PROCESS,0.47049,0.14053,0.045352,0,0
5,GO IRON ION HOMEOSTASIS,0.088862,0.14038,0.087023,0,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.066855,0.14029,0.10485,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.020205,0.1394,0.15931,0,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0079323,0.13926,0.14627,0,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.076492,0.13877,0.053382,0,0
5,GO PROSTANOID METABOLIC PROCESS,0.33812,0.13825,0.045946,0,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.00024286,0.13821,0.17859,0,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.26847,0.13814,0.047389,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.049546,0.13807,0.21931,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.33812,0.13734,0.025113,0,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.12689,0.13717,0.064402,0,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.56075,0.13686,0.025548,0,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0039469,0.13673,0.11808,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.082489,0.13641,0.11743,0,0
5,GO SEQUESTERING OF TRIGLYCERIDE,0.14048,0.13625,0.10607,0,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.073629,0.13581,0.142,0,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.11841,0.13572,0.082448,0,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.12473,0.13571,0.097121,0,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.009256,0.13564,0.15036,0,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.37932,0.13542,0.032687,0,0
5,GO UBIQUINONE METABOLIC PROCESS,0.12908,0.13526,0.049483,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.11636,0.13524,0.079845,0,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.075049,0.13514,0.10677,0,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.10845,0.13501,0.074734,0,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0037331,0.13495,0.1191,0,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.088862,0.13484,0.084454,0,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.15015,0.13426,0.20473,0,0
5,GO IMMATURE B CELL DIFFERENTIATION,0.20937,0.13365,0.088386,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.12689,0.1335,0.10792,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.47588,0.1335,0.11299,0,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.14526,0.13328,0.11372,0,0
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.070855,0.13318,0.069669,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.15773,0.13306,0.096731,0,0
5,GO REGULATION OF MEMBRANE INVAGINATION,0.33812,0.13292,0.05378,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.14769,0.13289,0.12984,0,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.21579,0.1328,0.13908,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.74288,0.13273,-0.092636,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.35607,0.13253,0.09634,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.1313,0.13221,0.12914,0,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.23937,0.1322,0.048148,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.17653,0.13219,0.1191,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.02268,0.13129,0.14716,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.15015,0.13127,0.14527,0,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.32938,0.13086,0.096264,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.004408,0.13066,0.20066,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.001662,0.13047,0.15478,0,0
5,GO REGIONALIZATION,0.00065623,0.13007,0.15034,0,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.088862,0.12993,0.085542,0,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.1028,0.12965,0.14892,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.28785,0.12936,0.14106,0,0
5,GO PROTEIN HYDROXYLATION,0.14769,0.12891,0.10711,0,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.12259,0.12883,0.15614,0,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.10654,0.1288,0.14245,0,0
5,GO NOTOCHORD DEVELOPMENT,0.079444,0.12862,0.14401,0,0
5,GO SYNAPSE ASSEMBLY,0.0071468,0.12828,0.18097,0,0
5,GO SPERM EGG RECOGNITION,0.055956,0.1281,0.081223,0,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.1028,0.12809,0.14118,0,0
5,GO EXTRACELLULAR TRANSPORT,0.19095,0.12796,0.074512,0,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.038561,0.12792,0.16831,0,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.02843,0.12785,0.16287,0,0
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.02166,0.1276,0.15698,0,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.62113,0.1272,0.046515,0,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.21579,0.12715,0.063599,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.12689,0.12709,0.14315,0,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.20937,0.12681,0.1722,0,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.71006,0.12659,-0.0018028,0,0
5,GO NEURAL TUBE PATTERNING,0.26098,0.12618,0.043839,0,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.046579,0.12593,0.13521,0,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.35607,0.1259,0.084162,0,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.082489,0.12563,0.17429,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.087232,0.12561,0.12574,0,0
5,GO EMBRYO IMPLANTATION,0.17374,0.1255,0.062318,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.33812,0.12515,0.05357,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0038387,0.12505,0.13234,0,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.42855,0.12469,0.059055,0,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.10096,0.12466,0.10074,0,0
5,GO DENDRITIC CELL MIGRATION,0.082489,0.12452,0.1626,0,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.057089,0.12434,0.11127,0,0
5,GO DETOXIFICATION,0.19695,0.12425,0.063813,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.32938,0.1242,0.07102,0,0
5,GO FATTY ACYL COA METABOLIC PROCESS,0.023205,0.12416,0.1364,0,0
5,GO ARGININE METABOLIC PROCESS,0.2,0.12411,0.09318,0,0
5,GO MEMBRANE INVAGINATION,0.090515,0.12392,0.071976,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.31232,0.12389,0.026089,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.47049,0.12377,0.043997,0,0
5,GO PHAGOSOME ACIDIFICATION,0.064293,0.12377,0.082322,0,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.30815,0.12362,0.097859,0,0
5,GO TRACHEA DEVELOPMENT,0.11841,0.12355,0.1885,0,0
5,GO HEAD MORPHOGENESIS,0.097379,0.12339,0.11213,0,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.27999,0.12322,0.097849,0,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.13814,0.12315,0.20235,0,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.20937,0.12293,0.072056,0,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.065563,0.12242,0.11231,0,0
5,GO TETRAPYRROLE METABOLIC PROCESS,0.23589,0.12238,0.050218,0,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.46512,0.1222,0.0077206,0,0
5,GO FACE DEVELOPMENT,0.057089,0.12206,0.12021,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.12259,0.12202,0.13343,0,0
5,GO DIVALENT METAL ION EXPORT,0.19095,0.12195,0.083308,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.11434,0.12182,0.40847,0,0
5,GO L GLUTAMATE IMPORT,0.19095,0.1211,0.071983,0,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.12908,0.12086,0.15758,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.059411,0.12057,0.14016,0,0
5,GO BONE MATURATION,0.025414,0.12024,0.15549,0,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.12689,0.12012,0.13607,0,0
5,GO MIDBODY ABSCISSION,0.11841,0.11965,0.10773,0,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.12689,0.11947,0.11858,0,0
5,GO REGULATION OF PROTEIN FOLDING,0.12049,0.11941,0.069612,0,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.12473,0.11913,0.070205,0,0
5,GO FEMALE SEX DIFFERENTIATION,0.00030804,0.11899,0.13902,0,0
5,GO CHYLOMICRON ASSEMBLY,0.085627,0.1187,0.055866,0,0
5,GO NEURON PROJECTION ORGANIZATION,0.21579,0.11869,0.073502,0,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.10096,0.11851,0.063106,0,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.10465,0.11817,0.11291,0,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.16294,0.11809,0.052759,0,0
5,GO SOMATIC STEM CELL DIVISION,0.34702,0.1178,0.12164,0,0
5,GO SEROTONIN TRANSPORT,0.12908,0.11767,0.14093,0,0
5,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.23245,0.11764,0.068705,0,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.097379,0.11744,0.095404,0,0
5,GO SPERM AXONEME ASSEMBLY,0.029719,0.11743,0.18012,0,0
5,GO ADULT BEHAVIOR,0.013465,0.11736,0.15989,0,0
5,GO VESICLE DOCKING,0.041093,0.11718,0.10522,0,0
5,GO RENAL WATER HOMEOSTASIS,0.014486,0.1169,0.12003,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.073629,0.11674,0.10543,0,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.064293,0.11658,0.093155,0,0
5,GO HEPATOCYTE DIFFERENTIATION,0.090515,0.11644,0.14565,0,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.10465,0.11605,0.087949,0,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.044685,0.11587,0.096296,0,0
5,GO RESPONSE TO LIGHT INTENSITY,0.21579,0.11569,0.10076,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.17374,0.11517,0.069651,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.088862,0.11513,0.14898,0,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.12259,0.11509,0.092719,0,0
5,GO TUBE FORMATION,0.0038387,0.11483,0.1071,0,0
5,GO HYPOTONIC RESPONSE,0.47588,0.11478,0.057527,0,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.068167,0.11451,0.075668,0,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.075049,0.11418,0.17984,0,0
5,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.29586,0.11406,0.026051,0,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.49227,0.11399,0.025987,0,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.20309,0.11373,0.069534,0,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.063042,0.11356,0.083034,0,0
5,GO REGULATION OF FIBRINOLYSIS,0.092194,0.11338,0.16974,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.18219,0.11337,0.14282,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0056288,0.11327,0.16207,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.23245,0.11323,0.079593,0,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.072231,0.11289,0.13055,0,0
5,GO INTRACELLULAR STEROL TRANSPORT,0.066855,0.11285,0.12991,0,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.12908,0.11267,0.10432,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0695,0.1124,0.16462,0,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.045624,0.11216,0.17966,0,0
5,GO PERICARDIUM DEVELOPMENT,0.20309,0.11212,0.082074,0,0
5,GO FOREBRAIN REGIONALIZATION,0.11841,0.11193,0.15925,0,0
5,GO RESPONSE TO INTERLEUKIN 4,0.41842,0.11179,0.026563,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.035393,0.11179,0.077309,0,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.39371,0.11158,0.030736,0,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.26471,0.11141,0.043154,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.088862,0.11079,0.17762,0,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.063042,0.11076,0.13088,0,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.099158,0.1107,0.07454,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.055956,0.11029,0.15316,0,0
5,GO HORMONE CATABOLIC PROCESS,0.54903,0.11025,0.049312,0,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.42347,0.1102,0.034876,0,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.17653,0.1102,0.15411,0,0
5,GO FIBROBLAST ACTIVATION,0.67776,0.1102,0.0086987,0,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.17099,0.10944,0.025664,0,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.22568,0.10934,0.038839,0,0
5,GO REGULATION OF CHLORIDE TRANSPORT,0.39858,0.10858,0.04786,0,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.27227,0.10852,0.13141,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.030383,0.10848,0.19418,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.021165,0.10818,0.12282,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.03245,0.10811,0.11859,0,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.15517,0.10804,0.10163,0,0
5,GO HEART INDUCTION,0.19393,0.10802,0.18131,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.088862,0.10797,0.23753,0,0
5,GO NEGATIVE CHEMOTAXIS,0.084046,0.10757,0.11706,0,0
5,GO INTERMEMBRANE LIPID TRANSFER,0.12689,0.10754,0.049889,0,0
5,GO NUCLEOTIDE SALVAGE,0.48131,0.10699,0.025078,0,0
5,GO ENDODERM DEVELOPMENT,0.14526,0.10691,0.089611,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.15015,0.10685,0.077555,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.52025,0.10659,0.031547,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.43883,0.10659,0.10099,0,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0085714,0.1064,0.16149,0,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.42855,0.10593,0.053451,0,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.44924,0.10591,0.096656,0,0
5,GO ATRIAL SEPTUM DEVELOPMENT,0.084046,0.10588,0.16814,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21579,0.10573,0.063651,0,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.17374,0.10534,0.15997,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.38408,0.10533,0.042624,0,0
5,GO THIOESTER METABOLIC PROCESS,0.095625,0.10531,0.069013,0,0
5,GO CELL REDOX HOMEOSTASIS,0.41341,0.1053,0.033395,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.11636,0.10525,0.14523,0,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.019283,0.10469,0.094049,0,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.13583,0.10441,0.09746,0,0
5,GO SUCKLING BEHAVIOR,0.43367,0.10441,0.038972,0,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0081404,0.10436,0.13811,0,0
5,GO CARDIOCYTE DIFFERENTIATION,0.037747,0.10393,0.093159,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.092194,0.10388,0.068218,0,0
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.068167,0.10372,0.071156,0,0
5,GO THYMUS DEVELOPMENT,0.079444,0.10368,0.086852,0,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.90599,0.10362,-0.026608,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.38888,0.10331,0.021807,0,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.087232,0.10309,0.096768,0,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,0.17934,0.10286,0.12098,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.95466,0.10283,-0.041415,0,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.23937,0.10261,0.10828,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.027188,0.10229,0.13396,0,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.080955,0.10178,0.25991,0,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.14526,0.10177,0.11465,0,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.19393,0.10167,0.02621,0,0
5,GO RESPONSE TO PROSTAGLANDIN E,0.2,0.10153,0.083815,0,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.076492,0.10151,0.075378,0,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.38408,0.10146,0.055498,0,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.063042,0.10132,0.15486,0,0
5,GO LENS FIBER CELL DEVELOPMENT,0.093897,0.10125,0.167,0,0
5,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.20621,0.1011,0.13844,0,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.28785,0.10099,0.090461,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.35607,0.10094,0.073359,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.47049,0.10062,0.014474,0,0
5,GO MALE MEIOSIS I,0.80312,0.10054,0.04179,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.05824,0.10052,0.099421,0,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.22905,0.10043,0.13237,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.36526,0.10032,0.088777,0,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.11235,0.10022,0.15028,0,0
5,GO GLUTATHIONE METABOLIC PROCESS,0.23937,0.10014,0.046633,0,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.053746,0.099702,0.12259,0,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.11636,0.099496,0.14062,0,0
5,GO TRABECULA MORPHOGENESIS,0.088862,0.099203,0.057035,0,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.061812,0.099058,0.092481,0,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.072231,0.098977,0.072408,0,0
5,GO ENDODERM FORMATION,0.27227,0.098905,0.051137,0,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.59059,0.098879,0.068788,0,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.22568,0.098874,0.055577,0,0
5,GO FIBRINOLYSIS,0.23589,0.09866,0.059269,0,0
5,GO NEPHRON TUBULE FORMATION,0.33373,0.098532,0.089002,0,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.088862,0.098391,0.24974,0,0
5,GO GASTRULATION,0.090515,0.098134,0.078668,0,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.061812,0.09809,0.13218,0,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.073629,0.098011,0.088092,0,0
5,GO OOGENESIS,0.016339,0.097786,0.091253,0,0
5,GO RESPONSE TO ESTROGEN,0.10096,0.0977,0.061069,0,0
5,GO MANGANESE ION TRANSPORT,0.36064,0.097509,0.019366,0,0
5,GO GOLGI LOCALIZATION,0.065563,0.097383,0.095468,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.064293,0.09722,0.15263,0,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.40843,0.097069,0.052632,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.14048,0.096766,0.060256,0,0
5,GO SEQUESTERING OF CALCIUM ION,0.05824,0.096725,0.098496,0,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.25001,0.096722,0.039705,0,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.29992,0.096612,0.15868,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.059411,0.096448,0.074577,0,0
5,GO INTRACELLULAR LIPID TRANSPORT,0.059411,0.096348,0.10112,0,0
5,GO NUCLEOSIDE SALVAGE,0.39371,0.09631,0.022412,0,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0042883,0.09613,0.10612,0,0
5,GO CORPUS CALLOSUM DEVELOPMENT,0.42855,0.096066,0.078923,0,0
5,GO PROTEIN POLYGLUTAMYLATION,0.092194,0.095906,0.095122,0,0
5,GO TRANSCYTOSIS,0.13814,0.095861,0.069257,0,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.32506,0.095592,0.01142,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.19695,0.095323,0.055461,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,0.013465,0.095201,0.12221,0,0
5,GO CELL MORPHOGENESIS,0.0085714,0.095071,0.10278,0,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.15517,0.095048,0.19407,0,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.58456,0.094911,0.039513,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.16559,0.094841,0.082634,0,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.23937,0.094818,0.058864,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.095625,0.094742,0.31309,0,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.14285,0.094715,0.050437,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17934,0.094676,0.070262,0,0
5,GO ZINC ION HOMEOSTASIS,0.079444,0.094595,0.1405,0,0
5,GO CELL FATE SPECIFICATION,0.082489,0.094561,0.12949,0,0
5,GO REGULATION OF VESICLE FUSION,0.48131,0.094335,0.068899,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.13814,0.094276,0.07982,0,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.32938,0.094172,0.043058,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.042857,0.094166,0.16444,0,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.14769,0.093955,0.10314,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0033369,0.093836,0.12809,0,0
5,GO GOLGI TO ENDOSOME TRANSPORT,0.38888,0.093809,0.042104,0,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.092194,0.093772,0.097272,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.064293,0.093617,0.16743,0,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0023671,0.093345,0.094163,0,0
5,GO NEURAL TUBE FORMATION,0.024288,0.093297,0.089126,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.24643,0.093227,0.11222,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.05161,0.09277,0.12943,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.084046,0.092393,0.11107,0,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.20309,0.092103,0.039736,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.12908,0.092019,0.071416,0,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.05161,0.091431,0.13729,0,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.017549,0.090995,0.12208,0,0
5,GO AXIS SPECIFICATION,0.020205,0.090977,0.11745,0,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.25363,0.090967,0.072409,0,0
5,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.29184,0.090935,0.068496,0,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.12908,0.090839,0.10969,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.54321,0.090764,0.10448,0,0
5,GO REGULATION OF ACTIN NUCLEATION,0.22568,0.090668,0.088023,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.18508,0.090662,0.091982,0,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.3746,0.090647,0.052225,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.72313,0.090625,-0.015473,0,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.27611,0.09057,0.055951,0,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.085627,0.090512,0.12813,0,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.093897,0.090403,0.18735,0,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.095625,0.090203,0.12171,0,0
5,GO REGULATION OF CATABOLIC PROCESS,0.057089,0.09012,0.048819,0,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.38888,0.090074,0.057153,0,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.13355,0.09,0.12998,0,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.090515,0.089985,0.064636,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.16559,0.089575,0.077835,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.15773,0.089553,0.19569,0,0
5,GO PYRUVATE METABOLIC PROCESS,0.15015,0.089552,0.063416,0,0
5,GO BONE CELL DEVELOPMENT,0.30815,0.089018,0.074766,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.57857,0.088705,0.077147,0,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.10845,0.088558,0.10018,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.34256,0.08853,0.15229,0,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.26471,0.088222,0.044776,0,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12689,0.088188,0.056383,0,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.027803,0.088124,0.12297,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.40843,0.087969,0.067335,0,0
5,GO MEGAKARYOCYTE DEVELOPMENT,0.53167,0.087932,0.08754,0,0
5,GO CELLULAR RESPONSE TO PH,0.40843,0.087757,0.040615,0,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.13583,0.087432,0.070208,0,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.079444,0.087425,0.044025,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.65234,0.087369,0.032575,0,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.26098,0.087245,0.098992,0,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.58456,0.086889,0.052759,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.68418,0.086658,0.013632,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.075049,0.086503,0.12134,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.5726,0.086451,0.020341,0,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.11841,0.086241,0.095541,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.41842,0.086149,0.058728,0,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.18508,0.085971,0.10224,0,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.12689,0.085709,0.070174,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.62113,0.085555,0.035736,0,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.55487,0.085499,0.022171,0,0
5,GO STRIATUM DEVELOPMENT,0.66501,0.085223,0.026544,0,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.49227,0.085193,0.024602,0,0
5,GO FERTILIZATION,0.0047853,0.084976,0.088249,0,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.15517,0.08474,0.063198,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.26098,0.084738,0.056419,0,0
5,GO L AMINO ACID TRANSPORT,0.15517,0.084721,0.059949,0,0
5,GO APPENDAGE MORPHOGENESIS,0.079444,0.084492,0.1021,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.29586,0.084425,0.052088,0,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.092194,0.084369,0.11093,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.14526,0.084282,0.12066,0,0
5,GO HEART VALVE DEVELOPMENT,0.054842,0.083913,0.11277,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.9686,0.083909,-0.012874,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.56075,0.0839,0.047331,0,0
5,GO METENCEPHALON DEVELOPMENT,0.026586,0.083795,0.13876,0,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.14769,0.083269,0.074677,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.11235,0.083132,0.07868,0,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.035393,0.083059,0.071787,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.36064,0.082887,0.090082,0,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.11841,0.082642,0.13522,0,0
5,GO LYMPH VESSEL DEVELOPMENT,0.30815,0.082553,0.043155,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.29992,0.082236,0.040766,0,0
5,GO RESPONSE TO INACTIVITY,0.53742,0.082077,0.021792,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.29992,0.081887,0.041336,0,0
5,GO REGULATION OF HEART GROWTH,0.65866,0.081864,0.016149,0,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.12689,0.081848,0.067316,0,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.066855,0.081815,0.27589,0,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.15015,0.081767,0.069096,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.077957,0.081739,0.088342,0,0
5,GO FEAR RESPONSE,0.068167,0.081712,0.081593,0,0
5,GO ESTROGEN METABOLIC PROCESS,0.063042,0.08159,0.077508,0,0
5,GO ECTODERM DEVELOPMENT,0.045624,0.081501,0.10008,0,0
5,GO BONE GROWTH,0.64605,0.081474,0.014609,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.28785,0.081386,0.055671,0,0
5,GO ESTROGEN BIOSYNTHETIC PROCESS,0.14526,0.081318,0.072841,0,0
5,GO PATTERN SPECIFICATION PROCESS,0.0094949,0.081313,0.10773,0,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.22568,0.081203,0.090097,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.1313,0.080988,0.12284,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.11039,0.080936,0.23061,0,0
5,GO CELLULAR RESPONSE TO DRUG,0.17374,0.080903,0.064136,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.13583,0.080902,0.071407,0,0
5,GO MESODERM MORPHOGENESIS,0.11841,0.080797,0.073718,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.14048,0.080718,0.16304,0,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.12049,0.080625,0.064001,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.30402,0.080619,0.10295,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.54321,0.080565,0.079945,0,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.17099,0.080288,0.08441,0,0
5,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.24643,0.080213,0.075408,0,0
5,GO AXONAL FASCICULATION,0.24643,0.080197,0.14241,0,0
5,GO GENITALIA DEVELOPMENT,0.12049,0.080083,0.067068,0,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.85768,0.080047,-0.029949,0,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.1313,0.079738,0.069,0,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.68418,0.079393,-0.0043911,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.10845,0.079174,0.088876,0,0
5,GO PROTEIN DEMETHYLATION,0.42855,0.079156,0.035079,0,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.17653,0.079125,0.10393,0,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.11434,0.079032,0.17334,0,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.15015,0.078867,0.064273,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.29586,0.078704,0.069453,0,0
5,GO REGULATION OF BONE DEVELOPMENT,0.36064,0.078674,0.044756,0,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.85768,0.078616,-0.096181,0,0
5,GO GOLGI VESICLE TRANSPORT,0.061812,0.078356,0.050994,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.63354,0.078354,0.022043,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.81668,0.078251,-0.073578,0,0
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.66501,0.078227,0.015453,0,0
5,GO CONVERGENT EXTENSION,0.64605,0.078081,0.039854,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.03939,0.077767,0.087287,0,0
5,GO GROOMING BEHAVIOR,0.94769,0.077682,0.017134,0,0
5,GO CELL RECOGNITION,0.20621,0.07744,0.055146,0,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.14769,0.077383,0.077086,0,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.093897,0.077289,0.086282,0,0
5,GO SEGMENTATION,0.072231,0.077151,0.080235,0,0
5,GO PROSTAGLANDIN TRANSPORT,0.32506,0.077136,0.049279,0,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.34256,0.076995,0.0431,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.14048,0.076966,0.073802,0,0
5,GO RESPONSE TO VITAMIN D,0.12259,0.076929,0.11952,0,0
5,GO RESPONSE TO SALT,0.19393,0.076588,0.05925,0,0
5,GO CELL JUNCTION DISASSEMBLY,0.43367,0.076566,0.034616,0,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.16828,0.076565,0.081266,0,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.043763,0.07656,0.12408,0,0
5,GO BIOLOGICAL PHASE,0.52025,0.076424,0.063392,0,0
5,GO SYMBIOTIC PROCESS,0.20309,0.076325,0.036041,0,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.19095,0.076026,0.097522,0,0
5,GO AORTIC VALVE DEVELOPMENT,0.27611,0.07592,0.057657,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.35153,0.07592,0.048485,0,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.17653,0.07567,0.06779,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.19393,0.075656,0.028593,0,0
5,GO GENITALIA MORPHOGENESIS,0.24288,0.075381,0.081883,0,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.057089,0.075253,0.090648,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.44924,0.075042,0.026145,0,0
5,GO REGULATION OF URINE VOLUME,0.25001,0.075026,0.050565,0,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0695,0.074587,0.09045,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.095625,0.07454,0.10107,0,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.11434,0.074376,0.059022,0,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.188,0.074237,0.06586,0,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.40349,0.074187,0.040744,0,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.35607,0.074158,0.11154,0,0
5,GO HEAT GENERATION,0.37932,0.074104,0.064973,0,0
5,GO NOREPINEPHRINE TRANSPORT,0.26471,0.074041,0.091262,0,0
5,GO AUTOPHAGIC CELL DEATH,0.082489,0.074035,0.12429,0,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.073629,0.073866,0.11415,0,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.090515,0.073852,0.1149,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.95466,0.073822,0.033378,0,0
5,GO NEURON DIFFERENTIATION,0.014138,0.073651,0.10906,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.036948,0.07362,0.10144,0,0
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.0695,0.073346,0.074213,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.10654,0.073194,0.13583,0,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.43367,0.073126,0.14821,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.15015,0.073039,0.042196,0,0
5,GO CHONDROCYTE PROLIFERATION,0.51459,0.073008,0.025719,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.32938,0.07293,0.041974,0,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.29184,0.072889,0.059302,0,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.26098,0.072873,0.10193,0,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.15264,0.072726,0.25138,0,0
5,GO NUCLEOTIDE PHOSPHORYLATION,0.1313,0.072705,0.066069,0,0
5,GO VACUOLAR ACIDIFICATION,0.29184,0.072406,0.022178,0,0
5,GO ORGANIC ACID CATABOLIC PROCESS,0.18219,0.072403,0.045818,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.25001,0.072183,0.054353,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.32938,0.072117,0.066414,0,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.22568,0.072,0.12553,0,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.25363,0.071991,0.093506,0,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.53742,0.071801,0.036693,0,0
5,GO REGULATION OF AXONOGENESIS,0.063042,0.071598,0.11585,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.33812,0.071438,0.048709,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.088862,0.071431,0.080577,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.188,0.071345,0.052836,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.33812,0.071265,0.056773,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.30402,0.071164,0.086059,0,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.35153,0.071006,0.12182,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.65866,0.070984,0.038206,0,0
5,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.32938,0.070974,0.065688,0,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.088862,0.070928,0.063681,0,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.16032,0.070867,0.093516,0,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.18508,0.070862,0.051577,0,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.2839,0.07054,0.059991,0,0
5,GO PANCREATIC JUICE SECRETION,0.32506,0.070499,0.083537,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.34702,0.070261,0.089953,0,0
5,GO PHOTOPERIODISM,0.092194,0.070162,0.11297,0,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.19695,0.070032,0.12686,0,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.25001,0.06989,0.014792,0,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.082489,0.069879,0.20055,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.78289,0.069647,0.028864,0,0
5,GO NEURON DEVELOPMENT,0.017137,0.069221,0.11103,0,0
5,GO VIRAL RNA GENOME REPLICATION,0.087232,0.069201,0.089504,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.2839,0.069183,0.053133,0,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.24288,0.069122,0.038427,0,0
5,GO HISTONE H3 DEACETYLATION,0.4978,0.068993,0.027179,0,0
5,GO RNA DESTABILIZATION,0.43367,0.068921,0.0077156,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.54903,0.068889,0.026446,0,0
5,GO REGULATION OF HEAT GENERATION,0.52025,0.06888,0.074482,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.22568,0.068665,0.19528,0,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.57857,0.06811,0.033971,0,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.54321,0.067457,0.015376,0,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18219,0.067395,0.088146,0,0
5,GO MYOFIBRIL ASSEMBLY,0.059411,0.067112,0.081863,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.33812,0.066854,0.032906,0,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.12049,0.066816,0.079954,0,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.70355,0.066638,-0.014453,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.19695,0.066595,0.068709,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.32077,0.066236,0.037544,0,0
5,GO FOREBRAIN CELL MIGRATION,0.18508,0.066148,0.091519,0,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.073629,0.065997,0.078861,0,0
5,GO BONE DEVELOPMENT,0.24643,0.065982,0.032933,0,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.025414,0.065392,0.077477,0,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.32938,0.065388,0.032287,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.15517,0.065056,0.058791,0,0
5,GO REGULATION OF GTPASE ACTIVITY,0.014138,0.06504,0.088692,0,0
5,GO VISUAL BEHAVIOR,0.05161,0.064967,0.10263,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.20937,0.064932,0.10515,0,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.095625,0.064917,0.045431,0,0
5,GO SPINAL CORD DEVELOPMENT,0.12473,0.064899,0.11451,0,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.12259,0.064834,0.064705,0,0
5,GO RESPONSE TO MUSCLE INACTIVITY,0.97557,0.064768,-0.026968,0,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.87144,0.064679,-0.066012,0,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.75615,0.064542,-0.0015932,0,0
5,GO PIGMENT GRANULE ORGANIZATION,0.25001,0.064523,0.043815,0,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.43883,0.064397,0.056869,0,0
5,GO VITAMIN METABOLIC PROCESS,0.19393,0.064235,0.049022,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.44924,0.064169,0.060792,0,0
5,GO NEURON REMODELING,0.1313,0.064128,0.15203,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.15015,0.064106,0.069595,0,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.073629,0.063851,0.086595,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.47049,0.063406,0.079064,0,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.48131,0.063357,0.09276,0,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.16294,0.06333,0.0811,0,0
5,GO CARDIAC CHAMBER DEVELOPMENT,0.13355,0.063319,0.062441,0,0
5,GO PROTEIN STABILIZATION,0.12049,0.063313,0.052031,0,0
5,GO AORTA MORPHOGENESIS,0.28785,0.062963,0.043316,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.63354,0.062886,0.02176,0,0
5,GO HEART FIELD SPECIFICATION,0.62732,0.062734,0.056357,0,0
5,GO SPECIFICATION OF SYMMETRY,0.13814,0.062657,0.04129,0,0
5,GO T CELL HOMEOSTASIS,0.084046,0.062549,0.10645,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.17099,0.062548,0.052024,0,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.53742,0.062531,0.017986,0,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.36526,0.062512,0.029932,0,0
5,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.53167,0.062302,0.038111,0,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.15773,0.062292,0.070211,0,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.52025,0.062241,0.028088,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.79636,0.062183,-0.0069184,0,0
5,GO AMINO ACID TRANSPORT,0.060602,0.061984,0.076629,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.188,0.061766,0.072818,0,0
5,GO ANIMAL ORGAN FORMATION,0.23589,0.06174,0.040259,0,0
5,GO INTERLEUKIN 2 PRODUCTION,0.1313,0.061464,0.060722,0,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.17653,0.061464,0.10395,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.34256,0.061179,0.038126,0,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.35607,0.061116,0.031187,0,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.16294,0.060821,0.083874,0,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.68418,0.060733,0.0093726,0,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.29586,0.060642,0.059291,0,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.22235,0.060549,0.043688,0,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.67776,0.060457,0.01023,0,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.14526,0.060437,0.044424,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.37932,0.060365,0.011857,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.27227,0.060051,0.093753,0,0
5,GO PEPTIDYL THREONINE MODIFICATION,0.011612,0.059939,0.088811,0,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16032,0.059877,0.075231,0,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.14769,0.059749,0.052815,0,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.54321,0.059638,0.019793,0,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.11434,0.059255,0.038543,0,0
5,GO OSTEOCLAST DEVELOPMENT,0.53167,0.059081,0.063411,0,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.19695,0.059018,0.093284,0,0
5,GO REGULATION OF MYELINATION,0.4545,0.058861,0.048191,0,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.48131,0.05869,0.032058,0,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.26847,0.058599,0.056301,0,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.62113,0.058528,-0.010779,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.62113,0.058519,0.025982,0,0
5,GO MESENCHYME MORPHOGENESIS,0.19095,0.058235,0.034858,0,0
5,GO FATTY ACID BETA OXIDATION,0.13355,0.058188,0.060491,0,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.030383,0.058059,0.068503,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.47049,0.058056,0.035585,0,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.26098,0.058007,0.035261,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.19393,0.058006,0.066818,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.1028,0.057928,0.051362,0,0
5,GO OUTFLOW TRACT MORPHOGENESIS,0.38408,0.057552,0.041375,0,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.76281,0.05747,-0.017494,0,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.68418,0.057381,-0.0011766,0,0
5,GO PROTEIN MANNOSYLATION,0.22568,0.057356,0.07452,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.090515,0.057326,0.15511,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.54321,0.057092,0.047974,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.25729,0.057042,0.040542,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.80989,0.057028,0.009113,0,0
5,GO CELL JUNCTION MAINTENANCE,0.32938,0.056978,0.088017,0,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.56666,0.056814,0.02919,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.33373,0.056672,0.053125,0,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.15015,0.056413,0.051045,0,0
5,GO VIRION ASSEMBLY,0.24288,0.05631,0.038794,0,0
5,GO FOREGUT MORPHOGENESIS,0.35607,0.056177,0.052238,0,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.85768,0.056147,-0.040094,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.61497,0.055835,0.047642,0,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.077957,0.054753,0.030216,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.10096,0.054618,0.1135,0,0
5,GO PROTEIN TETRAMERIZATION,0.080955,0.054497,0.065253,0,0
5,GO IMMATURE T CELL PROLIFERATION,0.7495,0.054287,-0.046564,0,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.34256,0.053733,0.044726,0,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.080955,0.053608,0.063935,0,0
5,GO RESPONSE TO ATP,0.11235,0.053495,0.088304,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.19393,0.053486,0.056177,0,0
5,GO PULMONARY VALVE DEVELOPMENT,0.36064,0.053435,0.072916,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.47049,0.053317,0.057396,0,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.188,0.053283,0.070389,0,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.76281,0.053057,-0.021952,0,0
5,GO BLASTOCYST DEVELOPMENT,0.15264,0.053022,0.037486,0,0
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.25001,0.052794,0.044749,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.53167,0.052743,0.03814,0,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.42347,0.052733,0.027749,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.2839,0.05258,0.082065,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.72969,0.052487,0.02907,0,0
5,GO CARNITINE SHUTTLE,0.40843,0.052403,0.059018,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.1028,0.052251,0.073937,0,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.25729,0.052223,0.091706,0,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.96163,0.051991,-0.086642,0,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.47588,0.051877,0.039685,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.43367,0.051667,0.076485,0,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.69707,0.051667,0.0049894,0,0
5,GO BODY FLUID SECRETION,0.20937,0.051664,0.042739,0,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.16559,0.051438,0.074723,0,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.42347,0.051342,0.020969,0,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.40843,0.051273,0.012426,0,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.85082,0.051219,-0.044171,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.26098,0.051215,0.02815,0,0
5,GO BONE MORPHOGENESIS,0.39858,0.051198,0.031975,0,0
5,GO OVULATION,0.75615,0.051069,-0.01941,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.59664,0.05079,0.077764,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.44402,0.050674,0.038871,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.38408,0.050543,0.074214,0,0
5,GO GENETIC IMPRINTING,0.21579,0.050501,0.093449,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.80989,0.050276,-0.002896,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.15264,0.050258,0.10837,0,0
5,GO BASEMENT MEMBRANE ASSEMBLY,0.27227,0.050183,0.19961,0,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.34702,0.049982,0.046308,0,0
5,GO REGULATION OF ORGAN GROWTH,0.40349,0.049972,0.028931,0,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.16294,0.049746,0.11835,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.79636,0.04973,0.028555,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.27611,0.049668,0.09167,0,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.04854,0.049659,0.12071,0,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.88523,0.049616,-0.0094238,0,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.2839,0.049616,0.037838,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.15015,0.049359,0.091421,0,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.24288,0.049317,0.069086,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.087232,0.049255,0.091207,0,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.16032,0.049107,0.16237,0,0
5,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.32938,0.049069,0.058044,0,0
5,GO MUSCLE FILAMENT SLIDING,0.80312,0.048938,0.0069902,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.13814,0.048884,0.049673,0,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.35607,0.048865,0.031487,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.34256,0.048779,0.051669,0,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.61497,0.048736,-0.00057065,0,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.54321,0.048705,0.075838,0,0
5,GO NEURAL CREST FORMATION,0.94073,0.048587,-0.027321,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.1028,0.048004,0.14566,0,0
5,GO PLASMA MEMBRANE TUBULATION,0.4978,0.047945,0.039536,0,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.32506,0.04774,0.057167,0,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.34702,0.047343,0.065265,0,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.063042,0.047271,0.11583,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.59059,0.047175,0.0091259,0,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.4545,0.04717,0.03262,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.63354,0.04712,0.0072133,0,0
5,GO SPERMATID DIFFERENTIATION,0.035393,0.046911,0.066408,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.77618,0.046899,-0.027764,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.52594,0.046805,0.024451,0,0
5,GO RESPONSE TO HEAT,0.80989,0.04677,0.00091835,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.13583,0.046661,0.054693,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.11841,0.046567,0.14709,0,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.12259,0.046556,0.078051,0,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.29992,0.046474,0.04606,0,0
5,GO NEURAL CREST CELL MIGRATION,0.54903,0.046442,0.064195,0,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.49227,0.046303,0.020635,0,0
5,GO SELECTIVE AUTOPHAGY,0.188,0.046149,0.030122,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.91293,0.046076,0.026496,0,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.41341,0.045964,0.044521,0,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.71006,0.045793,0.050265,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.56666,0.045603,0.022513,0,0
5,GO LYMPH NODE DEVELOPMENT,0.11235,0.045516,0.092549,0,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.91293,0.045496,-0.012521,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.4545,0.045466,0.034321,0,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.65234,0.045319,0.02654,0,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.14048,0.04522,0.11978,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.61497,0.045023,0.028361,0,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.92682,0.045003,0.00013378,0,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.37932,0.0448,0.064495,0,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.30402,0.044689,0.060178,0,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.12689,0.044511,0.074293,0,0
5,GO REPLACEMENT OSSIFICATION,0.29184,0.044252,0.080409,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.12689,0.043789,0.13646,0,0
5,GO PEROXISOMAL TRANSPORT,0.15264,0.043716,0.080351,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.88523,0.043681,-0.0031525,0,0
5,GO RNA DECAPPING,0.61497,0.043558,0.013793,0,0
5,GO SPLEEN DEVELOPMENT,0.12259,0.043328,0.093343,0,0
5,GO SULFATION,0.96163,0.043178,-0.021407,0,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.87144,0.043034,-0.019876,0,0
5,GO INOSITOL METABOLIC PROCESS,0.30402,0.042924,0.066013,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.52025,0.042813,0.1063,0,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.27227,0.042791,0.042054,0,0
5,GO SYNAPTIC VESICLE DOCKING,0.18219,0.042725,0.17713,0,0
5,GO CELLULAR RESPONSE TO ATP,0.27227,0.042448,0.046547,0,0
5,GO AXON DEVELOPMENT,0.14048,0.04224,0.087391,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.34256,0.042109,0.041174,0,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.21905,0.042079,0.09386,0,0
5,GO HISTONE DEACETYLATION,0.18508,0.041794,0.044506,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.4598,0.041784,0.014209,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.22568,0.041753,0.086355,0,0
5,GO AUTOPHAGOSOME MATURATION,0.10096,0.04153,0.084429,0,0
5,GO COPULATION,0.62113,0.041321,0.04662,0,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.38408,0.041214,0.026825,0,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.71658,0.04092,0.095013,0,0
5,GO MICROTUBULE ANCHORING,0.61497,0.040838,0.029713,0,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.22905,0.040742,0.051026,0,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.29586,0.040723,0.028069,0,0
5,GO PROTEIN POLYMERIZATION,0.10654,0.040666,0.06315,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.56666,0.04035,0.027767,0,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.78289,0.040302,-0.049126,0,0
5,GO RESPONSE TO MANGANESE ION,0.65866,0.040252,0.018712,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.21579,0.040028,0.050021,0,0
5,GO POST EMBRYONIC DEVELOPMENT,0.15015,0.040003,0.09016,0,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.21256,0.039953,0.086378,0,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.54903,0.039756,-0.00099193,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.16828,0.039723,0.030556,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.35607,0.039547,0.065901,0,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.29184,0.039441,0.03473,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.47588,0.039436,0.051796,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.090515,0.039408,0.038707,0,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.15773,0.039256,0.07188,0,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.20309,0.039236,0.048183,0,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.25001,0.039196,0.059692,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.48131,0.039195,0.018027,0,0
5,GO RESPONSE TO LIGHT STIMULUS,0.041967,0.039136,0.048633,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.41341,0.039121,0.050456,0,0
5,GO NEURON PROJECTION EXTENSION,0.070855,0.039012,0.11922,0,0
5,GO NEURON FATE COMMITMENT,0.52025,0.038994,0.12819,0,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.076492,0.038926,0.083734,0,0
5,GO MICROTUBULE BASED MOVEMENT,0.41842,0.038822,0.019612,0,0
5,GO DENDRITIC SPINE MORPHOGENESIS,0.5726,0.038714,0.036161,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.079444,0.03866,0.051941,0,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.11434,0.038644,0.069175,0,0
5,GO MATING,0.29586,0.038642,0.057515,0,0
5,GO NADP METABOLIC PROCESS,0.55487,0.038178,-0.0046985,0,0
5,GO REGULATION OF LIPASE ACTIVITY,0.17374,0.037696,0.06189,0,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.69707,0.037659,0.032591,0,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.78289,0.037585,0.0084963,0,0
5,GO MACROMOLECULE CATABOLIC PROCESS,0.62113,0.037396,0.0058304,0,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.58456,0.037319,0.013862,0,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.13814,0.037209,0.075526,0,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.69061,0.037028,0.030047,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.11235,0.03688,0.074133,0,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.39858,0.036871,0.042862,0,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.98255,0.036709,0.0039394,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE,0.025994,0.03669,0.053541,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.91293,0.036467,0.011117,0,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.11841,0.036275,0.19678,0,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.188,0.035643,0.030561,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.33812,0.035574,0.053851,0,0
5,GO MEMBRANE DOCKING,0.059411,0.035248,0.066465,0,0
5,GO REGULATION OF ATPASE ACTIVITY,0.40843,0.035143,0.015808,0,0
5,GO HYPEROSMOTIC RESPONSE,0.63978,0.035099,0.049548,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.2,0.035026,0.045666,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.62732,0.035008,0.0059654,0,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.94073,0.034855,-0.030768,0,0
5,GO PIGMENT METABOLIC PROCESS,0.78962,0.034678,-0.042662,0,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.66501,0.034677,0.021897,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.8303,0.034546,-0.027884,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.18508,0.03449,0.043484,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.14285,0.034419,0.028,0,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.81668,0.034156,-0.024155,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.3746,0.034119,0.021058,0,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.76281,0.034105,0.016716,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.36526,0.034048,0.047494,0,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.58456,0.034042,0.062111,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.4598,0.033834,0.034067,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.31232,0.033597,0.028375,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.47049,0.033584,0.014844,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.4978,0.033478,0.026961,0,0
5,GO COENZYME A METABOLIC PROCESS,0.88523,0.033455,-0.0096497,0,0
5,GO RESPONSE TO ANGIOTENSIN,0.56075,0.033237,0.016445,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.94769,0.033162,0.0041813,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.9686,0.033031,-0.013954,0,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.67776,0.033024,0.029348,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.35153,0.03283,0.049326,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.5726,0.032338,0.021188,0,0
5,GO REGULATION OF BEHAVIOR,0.20937,0.032332,0.06984,0,0
5,GO TRACHEA MORPHOGENESIS,0.31232,0.032189,0.12019,0,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.19393,0.031918,0.076608,0,0
5,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.34256,0.031845,0.09982,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.59059,0.031555,0.021556,0,0
5,GO DENDRITIC CELL CHEMOTAXIS,0.27611,0.031545,0.11902,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.21579,0.031448,0.060602,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.50896,0.031412,0.052598,0,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.27227,0.031249,0.076627,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.1028,0.031186,0.062801,0,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.24288,0.031116,0.079244,0,0
5,GO PROSTATIC BUD FORMATION,0.78289,0.031082,0.055924,0,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.15773,0.031017,0.060601,0,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.18219,0.0309,0.022787,0,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.50337,0.030894,0.043643,0,0
5,GO MITOTIC DNA REPLICATION,0.61497,0.030349,0.026993,0,0
5,GO PEPTIDYL PROLINE MODIFICATION,0.77618,0.030196,-0.0052714,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.35153,0.029963,0.030725,0,0
5,GO OOCYTE MATURATION,0.36991,0.029946,0.045083,0,0
5,GO NUCLEOSIDE METABOLIC PROCESS,0.65234,0.029893,0.010892,0,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.22235,0.029853,0.037262,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.31653,0.029827,0.094951,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.88523,0.029592,0.030178,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.29184,0.02953,0.1167,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.93377,0.029522,0.017573,0,0
5,GO SOMITE DEVELOPMENT,0.099158,0.029272,0.065601,0,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.52025,0.029237,0.030351,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.14526,0.029198,0.06806,0,0
5,GO REGULATION OF DNA RECOMBINATION,0.43883,0.029114,0.020348,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.47049,0.029114,0.038244,0,0
5,GO NEURON FATE SPECIFICATION,0.25729,0.028971,0.23518,0,0
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.87833,0.028934,-0.0031418,0,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.61497,0.028719,0.0039883,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.64605,0.028545,-0.0054362,0,0
5,GO CELL PART MORPHOGENESIS,0.2,0.028545,0.076085,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.52594,0.028473,0.030862,0,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.69061,0.028151,0.044291,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.34256,0.028146,0.10777,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.56666,0.027689,0.13406,0,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.27611,0.027599,0.072824,0,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.38888,0.027488,0.038566,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.43367,0.027312,0.01267,0,0
5,GO PROSTAGLANDIN SECRETION,0.70355,0.02725,0.02181,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.53742,0.027161,0.054766,0,0
5,GO UV DAMAGE EXCISION REPAIR,0.53167,0.02704,0.027657,0,0
5,GO RESPIRATORY SYSTEM PROCESS,0.76948,0.026847,-0.013998,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.93377,0.026735,-0.010658,0,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.62113,0.026701,0.020584,0,0
5,GO PEROXISOME ORGANIZATION,0.2,0.026664,0.070101,0,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.80312,0.026436,0.028381,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.54321,0.026307,0.0070581,0,0
5,GO REGULATION OF HISTONE MODIFICATION,0.20937,0.026236,0.04939,0,0
5,GO INTRACELLULAR TRANSPORT,0.36526,0.026024,0.012029,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.4978,0.02587,0.040417,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.23245,0.025846,0.21806,0,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.76948,0.025777,0.011073,0,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.48678,0.025736,0.028938,0,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.68418,0.025645,-0.06926,0,0
5,GO REGULATION OF MITOTIC CELL CYCLE,0.32506,0.025543,0.022199,0,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.21579,0.025261,0.053334,0,0
5,GO NADPH REGENERATION,0.65234,0.025216,-0.063191,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.58456,0.025213,0.032519,0,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.11636,0.025197,0.13594,0,0
5,GO HEMIDESMOSOME ASSEMBLY,0.95466,0.02512,-0.09006,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.62113,0.02504,0.0432,0,0
5,GO RESPONSE TO ETHER,0.62732,0.025033,0.015621,0,0
5,GO PROTEIN FOLDING,0.74288,0.024902,-0.0035091,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.47588,0.024615,0.046312,0,0
5,GO HEMOGLOBIN METABOLIC PROCESS,0.90599,0.024583,-0.027021,0,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.39858,0.024571,0.034102,0,0
5,GO MITOCHONDRIAL FISSION,0.78289,0.024283,0.0061686,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.94769,0.024241,-0.017534,0,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.83713,0.024236,-0.03924,0,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.89215,0.024194,0.00027741,0,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.89215,0.024136,-0.014112,0,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.59664,0.023985,0.080884,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.29992,0.023939,0.06481,0,0
5,GO HISTONE H2B UBIQUITINATION,0.85768,0.023654,-0.0098478,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.67776,0.023477,0.016286,0,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.32077,0.023405,0.034594,0,0
5,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.79636,0.023348,-0.023501,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.88523,0.023289,-0.010117,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59059,0.02321,0.01562,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.67137,0.023174,0.046143,0,0
5,GO REGULATION OF MACROAUTOPHAGY,0.077957,0.022978,0.05733,0,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.77618,0.022809,-0.0022022,0,0
5,GO COPPER ION TRANSPORT,0.42347,0.022775,0.10969,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.87144,0.02261,-0.011343,0,0
5,GO ORGANELLE DISASSEMBLY,0.4545,0.02234,0.026425,0,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.51459,0.022035,0.026758,0,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.35607,0.021891,0.057865,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.40349,0.021807,0.11774,0,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.89215,0.021792,-0.017332,0,0
5,GO NEURON PROJECTION GUIDANCE,0.34702,0.021762,0.072019,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.67137,0.021762,0.018778,0,0
5,GO DETECTION OF VISIBLE LIGHT,0.27227,0.02169,0.019515,0,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.34702,0.021678,0.055182,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.93377,0.021619,-0.0036598,0,0
5,GO MEIOTIC CELL CYCLE,0.31653,0.021587,0.041313,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.33373,0.02157,0.016729,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.69707,0.02146,-0.041273,0,0
5,GO OTIC VESICLE MORPHOGENESIS,0.35607,0.021198,-0.12402,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.36064,0.021182,0.083922,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.81668,0.021175,0.0003279,0,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.3746,0.021168,0.026222,0,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.25001,0.021072,0.082312,0,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.62732,0.021058,0.025501,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.59059,0.020969,0.014847,0,0
5,GO DENDRITE DEVELOPMENT,0.29586,0.020951,0.070095,0,0
5,GO HEART FORMATION,0.77618,0.020916,0.028404,0,0
5,GO REGULATION OF OOGENESIS,0.73628,0.020857,0.00011445,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.83713,0.020712,0.061186,0,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.30402,0.020577,0.078239,0,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.72313,0.020294,-0.046135,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.37932,0.020019,0.049263,0,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.88523,0.01999,-0.0054247,0,0
5,GO HIPPOCAMPUS DEVELOPMENT,0.49227,0.019787,0.044332,0,0
5,GO AXON EXTENSION,0.52025,0.019744,0.063714,0,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.63978,0.019713,0.0082554,0,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.41842,0.019587,0.051371,0,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.8303,0.019518,0.016103,0,0
5,GO TELENCEPHALON DEVELOPMENT,0.12689,0.019485,0.08692,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.98953,0.019478,0.0013451,0,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.77618,0.019425,-0.0028537,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.47049,0.019356,0.037168,0,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.98255,0.019321,-0.025534,0,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.76281,0.019272,0.011398,0,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.47588,0.019263,0.090266,0,0
5,GO CARDIAC SEPTUM DEVELOPMENT,0.3746,0.019144,0.050585,0,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.94073,0.019126,-0.031898,0,0
5,GO REGULATION OF MICROTUBULE BINDING,0.91293,0.019124,0.0093124,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.39371,0.019081,0.056146,0,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.95466,0.018896,-0.012301,0,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.70355,0.01886,0.011387,0,0
5,GO DENDRITE MORPHOGENESIS,0.32077,0.018677,0.062411,0,0
5,GO MYELOID CELL DEVELOPMENT,0.24643,0.018612,0.05772,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.22235,0.018525,0.10753,0,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.36064,0.018499,0.020826,0,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.90599,0.01787,-0.02078,0,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.20621,0.017493,0.057979,0,0
5,GO PROTEIN TRIMERIZATION,0.72313,0.017379,-0.047774,0,0
5,GO PEPTIDE CATABOLIC PROCESS,0.63354,0.01714,0.0066871,0,0
5,GO VIRAL RELEASE FROM HOST CELL,0.43883,0.017129,0.033058,0,0
5,GO PROTEIN LOCALIZATION TO CILIUM,0.91293,0.017116,-0.0020195,0,0
5,GO ERBB2 SIGNALING PATHWAY,0.81668,0.017106,-0.00065923,0,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.87833,0.016952,0.007026,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.66501,0.016818,0.024236,0,0
5,GO MITOCHONDRIAL FUSION,0.9686,0.016786,-0.0094608,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.88523,0.01657,0.0099218,0,0
5,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.8303,0.016188,0.0090351,0,0
5,GO CELL CYCLE,0.4598,0.016136,0.016737,0,0
5,GO ACTIN NUCLEATION,0.26847,0.016074,0.061042,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.63978,0.016056,-0.047185,0,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.78962,0.015882,-0.052732,0,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,0.015865,0.0031458,0,0
5,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.98255,0.015493,-0.0055059,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.79636,0.01547,0.00056729,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.50896,0.015327,-0.067443,0,0
5,GO REGULATION OF LYASE ACTIVITY,0.95466,0.015308,0.0019249,0,0
5,GO TORC1 SIGNALING,0.72969,0.01508,0.0015453,0,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.89215,0.015049,-0.020615,0,0
5,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.89215,0.015036,-0.025521,0,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.71006,0.014915,0.0038156,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.14285,0.01486,0.31074,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.98953,0.0148,-0.0052357,0,0
5,GO THYROID GLAND DEVELOPMENT,0.53742,0.014518,0.063268,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.56666,0.014124,-0.095525,0,0
5,GO TRANSEPITHELIAL TRANSPORT,0.93377,0.014085,-0.01962,0,0
5,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.73628,0.013979,0.016979,0,0
5,GO NEGATIVE REGULATION OF CELL SIZE,0.60272,0.013915,0.032204,0,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.4598,0.013911,0.031057,0,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.36991,0.01382,0.054963,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.29184,0.013592,-0.076852,0,0
5,GO PROTEIN ACTIVATION CASCADE,0.24288,0.013544,0.086517,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.62732,0.013403,0.045221,0,0
5,GO SEQUESTERING OF METAL ION,0.61497,0.012901,-0.065405,0,0
5,GO XENOBIOTIC TRANSPORT,0.41341,0.012551,0.021603,0,0
5,GO HISTONE H3 K27 METHYLATION,0.78289,0.012517,0.033695,0,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.43883,0.012176,0.062436,0,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.76281,0.012016,-0.009927,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.24288,0.011928,0.097414,0,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.78962,0.011713,0.0083906,0,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.85768,0.011598,-0.0082926,0,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.56666,0.011589,0.073003,0,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.63978,0.011507,0.010187,0,0
5,GO REGULATION OF NEURON MIGRATION,0.88523,0.011493,-0.0033158,0,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.80312,0.011292,-0.018141,0,0
5,GO RESPONSE TO UV,0.87144,0.011046,0.0033611,0,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.97557,0.010938,0.0046744,0,0
5,GO INTRACILIARY TRANSPORT,0.50337,0.010892,0.054249,0,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.92682,0.010734,-0.0072614,0,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.91293,0.010646,-4.9169e-05,0,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.94769,0.01031,-0.028282,0,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.64605,0.010276,-0.038488,0,0
5,GO RESPONSE TO IONIZING RADIATION,0.66501,0.010233,0.010809,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.29992,0.010079,0.049487,0,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.7495,0.010072,-0.052584,0,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.72313,0.0098216,-0.021947,0,0
5,GO CELLULAR RESPONSE TO X RAY,0.65866,0.0097546,-0.083775,0,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.78289,0.0097449,-0.012166,0,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.88523,0.0097014,0.0083764,0,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.78289,0.0095406,-0.054916,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.99651,0.0094884,-0.006795,0,0
5,GO MICROTUBULE BASED TRANSPORT,0.95466,0.0092962,-0.0088767,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.48131,0.0092647,0.047482,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.91987,0.0092427,-0.03328,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.39371,0.009234,0.069458,0,0
5,GO DOSAGE COMPENSATION,0.74288,0.0089842,-0.018421,0,0
5,GO PIGMENT ACCUMULATION,0.79636,0.0088624,0.022378,0,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.99651,0.0088201,-0.013491,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.43883,0.0088104,0.043508,0,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.72969,0.0086748,0.021227,0,0
5,GO NEUROTRANSMITTER TRANSPORT,0.26471,0.0086721,0.11352,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.56666,0.0085864,0.017369,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.90599,0.0083289,0.00011593,0,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.56666,0.0083221,0.029107,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.32938,0.0082717,0.079571,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY,0.94769,0.0081015,-0.0035554,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.94769,0.0080369,0.011062,0,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.91987,0.0079734,0.0028452,0,0
5,GO T CELL CHEMOTAXIS,0.82348,0.0077865,-0.011322,0,0
5,GO CELL DIVISION,0.78962,0.007676,0.007195,0,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.76948,0.0076106,-0.01519,0,0
5,GO NAD BIOSYNTHETIC PROCESS,0.48678,0.007554,0.069757,0,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.7495,0.0072121,-0.011756,0,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.91293,0.0071665,-0.020183,0,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.94769,0.0071235,-0.024702,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,0.76281,0.0070865,-0.0020344,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.99651,0.0068817,-0.006953,0,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.60883,0.0066935,0.037186,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.51459,0.0065746,0.016707,0,0
5,GO REGULATION OF PODOSOME ASSEMBLY,0.65234,0.0065668,0.034199,0,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.77618,0.0065189,-0.020989,0,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.29992,0.0064755,0.059144,0,0
5,GO CELLULAR RESPONSE TO RADIATION,0.90599,0.0064157,0.0052978,0,0
5,GO LIVER REGENERATION,0.43367,0.006402,-0.0060453,0,0
5,GO REGULATION OF MITOPHAGY,0.69061,0.0061136,0.018126,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.60272,0.0058527,0.020343,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.36526,0.0058046,0.097335,0,0
5,GO CELLULAR RESPONSE TO HEAT,0.56666,0.005744,-0.032809,0,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.25729,0.0055944,0.12548,0,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.83713,0.00551,0.016097,0,0
5,GO TOXIN TRANSPORT,0.86455,0.0054354,-0.016694,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.52025,0.0052576,-0.052764,0,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.91293,0.0051207,-0.021782,0,0
5,GO SYNAPTIC VESICLE RECYCLING,0.21256,0.0049504,0.1138,0,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.67137,0.0048165,-0.069187,0,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.63354,0.0047992,0.026827,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.31653,0.0047076,0.12732,0,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.89907,0.0046696,-0.0015105,0,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.99651,0.0045551,-0.048919,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.35607,0.0045307,-0.058062,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.67776,0.0044712,-0.013325,0,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.69061,0.0044027,0.0013193,0,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.64605,0.0042638,0.064736,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.72313,0.0042506,0.0057088,0,0
5,GO MITOTIC CELL CYCLE,0.66501,0.0041378,-0.0086576,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.43883,0.0041037,-0.03976,0,0
5,GO PHAGOCYTOSIS RECOGNITION,0.62113,0.0040993,-0.075024,0,0
5,GO GLUTAMATE SECRETION,0.44402,0.0040432,0.079917,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.75615,0.0040221,0.030714,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.63978,0.0037706,0.020419,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.85768,0.0036978,0.0092531,0,0
5,GO HISTONE H2A UBIQUITINATION,0.67776,0.0035973,0.017926,0,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.87144,0.0035217,-0.0045003,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.42347,0.003421,0.037506,0,0
5,GO CENTROSOME SEPARATION,0.4978,0.0033475,0.050982,0,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.96163,0.0030444,-0.014128,0,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.42855,0.0028891,-0.028042,0,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.64605,0.0028668,-0.0036673,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.69707,0.0027717,0.012039,0,0
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.10654,0.0026898,0.31173,0,0
5,GO PEPTIDYL LYSINE ACETYLATION,0.89907,0.0026119,0.0049761,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.56075,0.0025956,0.020802,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.87144,0.0022911,0.017576,0,0
5,GO CELL CYCLE PROCESS,0.83713,0.0021171,-0.0039954,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.83713,0.0018872,0.0038913,0,0
5,GO CARTILAGE MORPHOGENESIS,0.99651,0.0018791,-0.0035693,0,0
5,GO UV PROTECTION,0.72313,0.001789,-0.053669,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.98255,0.0014678,-0.014281,0,0
5,GO NUCLEUS ORGANIZATION,0.70355,0.0014587,-0.014187,0,0
5,GO FILOPODIUM ASSEMBLY,0.39858,0.0014486,0.072546,0,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.79636,0.0012666,0.0060476,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.75615,0.0012426,-0.059064,0,0
5,GO HIPPO SIGNALING,0.93377,0.0012185,-0.046872,0,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.89907,0.0010676,-0.03062,0,0
5,GO ORGANELLE ASSEMBLY,0.4545,0.001036,0.018169,0,0
5,GO CYTOKINESIS,0.85082,0.00095921,-0.0035093,0,0
5,GO PROTEIN ACYLATION,0.4978,0.00087762,0.022455,0,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.90599,0.00077163,0.0072643,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.5726,0.00071604,-0.043055,0,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.49227,0.00069329,-0.071811,0,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.52594,0.00058742,-0.037568,0,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.59059,0.00055696,0.1012,0,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.91293,0.00045656,-0.0066602,0,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.67137,0.00036575,-0.048661,0,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.62732,4.7901e-06,-0.068099,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.79636,-8.3474e-05,0.0061243,0,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.87833,-0.00010891,-0.054552,0,0
5,GO HISTONE H3 K36 METHYLATION,0.58456,-0.0001146,-0.035722,0,0
5,GO URONIC ACID METABOLIC PROCESS,0.55487,-0.00018876,-0.052362,0,0
5,GO DNA MODIFICATION,0.79636,-0.00020111,0.011829,0,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.58456,-0.00033498,0.046621,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.19393,-0.00054871,-0.052129,0,0
5,GO TELOMERIC LOOP DISASSEMBLY,0.19095,-0.00056186,-0.093259,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.56075,-0.00061662,0.019909,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.19393,-0.0008371,0.084526,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.8303,-0.0010159,-0.017036,0,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.95466,-0.0012683,0.0016536,0,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.33812,-0.0012744,0.042287,0,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.98953,-0.0014663,-0.0367,0,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.78962,-0.0016299,-0.012842,0,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.9686,-0.0018012,-0.011413,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.66501,-0.0021293,-0.069022,0,0
5,GO CELL AGING,0.69707,-0.0024299,0.0051204,0,0
5,GO HISTONE H4 K16 ACETYLATION,0.91987,-0.0025923,0.0020082,0,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.97557,-0.0027399,0.025011,0,0
5,GO HISTONE H4 K5 ACETYLATION,0.78962,-0.0028982,0.039921,0,0
5,GO MITOCHONDRION ORGANIZATION,0.96163,-0.0030242,-0.0056183,0,0
5,GO POSITIVE REGULATION OF CELL AGING,0.23589,-0.0032472,0.091676,0,0
5,GO TRNA CATABOLIC PROCESS,0.17099,-0.0032864,0.18837,0,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.90599,-0.0037935,-0.0041064,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.25001,-0.0039815,-0.093993,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.74288,-0.0040321,-0.0063624,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.38888,-0.0041739,-0.0555,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.81668,-0.0042041,0.016309,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.90599,-0.0042844,-0.0098818,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.69707,-0.004507,0.01497,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.4598,-0.00451,0.065637,0,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.94073,-0.0046705,-0.016874,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.8303,-0.0051822,0.0026331,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.68418,-0.0053026,0.015716,0,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.36526,-0.0053539,-0.042464,0,0
5,GO MRNA TRANSCRIPTION,0.97557,-0.0053852,-0.0092518,0,0
5,GO IMPORT INTO NUCLEUS,0.42855,-0.0055704,-0.037822,0,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.64605,-0.0056967,0.058482,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.7495,-0.0057292,-0.022854,0,0
5,GO PROTEIN KINASE A SIGNALING,0.66501,-0.0057659,-0.03021,0,0
5,GO OVULATION CYCLE PROCESS,0.94073,-0.0057745,-0.011632,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.71658,-0.0060813,0.036741,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.72969,-0.0061375,0.0080139,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.56666,-0.0063646,0.030703,0,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.77618,-0.0067374,-0.050078,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.64605,-0.0068369,0.02698,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.76281,-0.0070111,-0.022797,0,0
5,GO MITOPHAGY,0.83713,-0.0071292,0.0080968,0,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.65234,-0.007232,0.002983,0,0
5,GO HISTONE MONOUBIQUITINATION,0.96163,-0.007345,-0.0005282,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.9686,-0.0073488,-0.0056286,0,0
5,GO MITOCHONDRIAL TRANSPORT,0.78289,-0.0076282,-0.014503,0,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.20309,-0.0076601,0.16118,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.85768,-0.007841,0.0014988,0,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.41341,-0.0079476,0.040399,0,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.50337,-0.0079504,0.033763,0,0
5,GO RESPONSE TO X RAY,0.77618,-0.008144,-0.044843,0,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.77618,-0.0081564,-0.025773,0,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.42347,-0.0084103,-0.021077,0,0
5,GO PRIMARY MIRNA PROCESSING,0.90599,-0.0084191,-0.025632,0,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.69707,-0.0084972,0.033133,0,0
5,GO PINOCYTOSIS,0.96163,-0.0087351,-0.018106,0,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.93377,-0.008752,-0.0063089,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.85082,-0.0088232,-0.021698,0,0
5,GO PROTEIN IMPORT,0.42347,-0.0088856,-0.035147,0,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.70355,-0.008927,-0.047672,0,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.48678,-0.0089984,-0.032252,0,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.090515,-0.0090463,-0.06076,0,0
5,GO ORGANELLE INHERITANCE,0.94769,-0.0090563,0.0044104,0,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.42855,-0.0094073,-0.025457,0,0
5,GO AORTA DEVELOPMENT,1,-0.0097455,-0.036912,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.72313,-0.0099167,0.042552,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.70355,-0.0099237,-0.038787,0,0
5,GO CENTROSOME DUPLICATION,0.80989,-0.0099355,-0.00032574,0,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.99651,-0.010012,0.01639,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.69707,-0.010293,-0.0024417,0,0
5,GO REGULATION OF CELL AGING,0.98255,-0.010402,-0.011745,0,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.84397,-0.010489,0.038919,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.80989,-0.010565,-0.0073834,0,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.87144,-0.010827,-0.01193,0,0
5,GO HISTONE H4 DEACETYLATION,0.86455,-0.011127,0.00497,0,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.72969,-0.011477,-0.040154,0,0
5,GO REGULATION OF DNA REPLICATION,0.65234,-0.01158,0.011505,0,0
5,GO HISTONE H3 K9 MODIFICATION,0.85768,-0.011622,0.015045,0,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.4978,-0.011682,-0.11041,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.88523,-0.011802,-0.010424,0,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.4598,-0.011874,0.074942,0,0
5,GO PODOSOME ASSEMBLY,0.89907,-0.011988,0.0089642,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.188,-0.01203,-0.053431,0,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.53742,-0.012098,-0.061429,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.78289,-0.012116,-0.020664,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.82348,-0.012329,-0.010465,0,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.76948,-0.012555,0.021927,0,0
5,GO LIPOPROTEIN LOCALIZATION,0.77618,-0.012722,-0.041773,0,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.56075,-0.012931,-0.040388,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.32077,-0.012954,0.15153,0,0
5,GO COVALENT CHROMATIN MODIFICATION,0.85768,-0.013034,0.00095235,0,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.62113,-0.013074,-0.057664,0,0
5,GO ACROSOME ASSEMBLY,0.87833,-0.01337,0.019301,0,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.76281,-0.013612,-0.01395,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.51459,-0.013616,-0.038073,0,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.85082,-0.013729,-0.026983,0,0
5,GO P BODY ASSEMBLY,0.4978,-0.013754,-0.029374,0,0
5,GO OXYGEN TRANSPORT,0.87833,-0.0138,-0.082963,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.54321,-0.014023,-0.02265,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.59664,-0.014154,-0.051534,0,0
5,GO DE NOVO PROTEIN FOLDING,0.81668,-0.014162,0.0032911,0,0
5,GO REGULATION OF PROTEIN IMPORT,0.96163,-0.014296,-0.024042,0,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.4598,-0.01438,0.04651,0,0
5,GO HISTONE H4 ACETYLATION,0.94073,-0.014498,0.013225,0,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.71658,-0.01478,0.050295,0,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.38888,-0.014814,0.10255,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.39371,-0.01484,-0.039704,0,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.8303,-0.014846,0.014393,0,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.8303,-0.015051,0.029518,0,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.94769,-0.015081,-0.017875,0,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.97557,-0.015218,-0.013186,0,0
5,GO RESPONSE TO INTERLEUKIN 12,0.36991,-0.015283,-0.074065,0,0
5,GO CHROMATIN ORGANIZATION,0.63978,-0.015712,-0.010155,0,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.84397,-0.015946,-0.0025565,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.24288,-0.015972,-0.047076,0,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.58456,-0.016066,-0.03564,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.69061,-0.016168,-0.012891,0,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.84397,-0.016532,-0.012262,0,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.43367,-0.016696,-0.083895,0,0
5,GO G2 DNA DAMAGE CHECKPOINT,0.89907,-0.01672,0.0093381,0,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.76948,-0.016782,0.023957,0,0
5,GO NEURON MIGRATION,0.68418,-0.016892,0.052401,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.74288,-0.016905,-0.0037244,0,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.83713,-0.016914,-0.0037312,0,0
5,GO REGULATION OF CYCLASE ACTIVITY,0.86455,-0.017287,-0.00083671,0,0
5,GO NEUROTRANSMITTER SECRETION,0.56666,-0.017547,0.095086,0,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.97557,-0.017711,-0.025612,0,0
5,GO LYSINE METABOLIC PROCESS,0.33373,-0.018032,-0.12043,0,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.63354,-0.018154,-0.01264,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.81668,-0.018192,-0.017238,0,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.76281,-0.018224,-0.022712,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.70355,-0.018356,-0.018699,0,0
5,GO HEME METABOLIC PROCESS,0.9686,-0.018533,-0.051595,0,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.87144,-0.018816,0.0049589,0,0
5,GO GAS TRANSPORT,0.9686,-0.018983,-0.056925,0,0
5,GO RESPONSE TO OXYGEN RADICAL,0.4545,-0.019191,0.036476,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.4598,-0.019268,-0.034994,0,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.44924,-0.019276,-0.023996,0,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.83713,-0.019292,-0.0030441,0,0
5,GO TRANSPORT ALONG MICROTUBULE,0.54321,-0.019371,-0.020949,0,0
5,GO COLLECTING DUCT DEVELOPMENT,0.83713,-0.019672,0.01473,0,0
5,GO MICROTUBULE BASED PROCESS,0.9686,-0.019751,0.013698,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.86455,-0.01986,0.023053,0,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.86455,-0.019976,-0.001009,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.88523,-0.019999,-0.049844,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.71006,-0.02,-0.019079,0,0
5,GO PALLIUM DEVELOPMENT,0.4598,-0.020023,0.054553,0,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.85082,-0.020399,-0.015101,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.9686,-0.020585,0.00086538,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.78962,-0.020732,-0.0088601,0,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.35153,-0.020751,-0.070305,0,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.53742,-0.020821,-0.034087,0,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.65234,-0.020916,0.036368,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.53742,-0.021265,0.039558,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.32938,-0.021497,-0.038269,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.62732,-0.021732,-0.032923,0,0
5,GO UTERUS DEVELOPMENT,0.67137,-0.021792,-0.033747,0,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.99651,-0.021891,-0.0112,0,0
5,GO ATP TRANSPORT,0.94073,-0.022221,-0.0049393,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.51459,-0.022418,-0.021958,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.7495,-0.022485,-0.012123,0,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.73628,-0.022485,-0.02543,0,0
5,GO ATP METABOLIC PROCESS,0.98953,-0.022575,-0.0033688,0,0
5,GO MYOBLAST PROLIFERATION,0.34256,-0.022827,-0.10995,0,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.91987,-0.022866,-0.0045918,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.60883,-0.022968,0.023527,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.85768,-0.022998,-0.010191,0,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.65866,-0.023027,-0.02541,0,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.65234,-0.023035,0.065629,0,0
5,GO HISTONE METHYLATION,0.34702,-0.023196,-0.055448,0,0
5,GO LEUKOCYTE AGGREGATION,0.56075,-0.023204,-0.11461,0,0
5,GO DNA RECOMBINATION,0.33373,-0.023332,-0.022917,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.62113,-0.023599,0.055854,0,0
5,GO HISTONE H3 K4 METHYLATION,0.3746,-0.023606,-0.057164,0,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.19393,-0.023659,-0.056088,0,0
5,GO INTERACTION WITH SYMBIONT,0.55487,-0.023686,-0.048986,0,0
5,GO REGULATION OF PINOCYTOSIS,0.97557,-0.024114,-0.015842,0,0
5,GO ONE CARBON METABOLIC PROCESS,0.88523,-0.024158,-0.0070222,0,0
5,GO ELECTRON TRANSPORT CHAIN,0.51459,-0.024235,-0.05307,0,0
5,GO GLUCOSE CATABOLIC PROCESS,0.65866,-0.024238,-0.032403,0,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.82348,-0.024347,-0.0031142,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.42855,-0.024452,-0.05329,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.97557,-0.025188,0.019369,0,0
5,GO PEPTIDYL LYSINE MODIFICATION,0.16559,-0.025364,-0.022343,0,0
5,GO PLATELET MORPHOGENESIS,0.73628,-0.025399,-0.02715,0,0
5,GO DNA INTEGRITY CHECKPOINT,0.40349,-0.025527,-0.022061,0,0
5,GO RESPONSE TO NITRIC OXIDE,0.60883,-0.025845,-0.0072918,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.49227,-0.026166,-0.041981,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.7495,-0.026334,-0.01579,0,0
5,GO REGULATION OF AXON GUIDANCE,0.99651,-0.026435,0.02865,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.89907,-0.026641,-0.0057603,0,0
5,GO MULTI ORGANISM LOCALIZATION,0.36991,-0.027113,-0.070579,0,0
5,GO METHIONINE METABOLIC PROCESS,0.82348,-0.027246,-0.012739,0,0
5,GO HISTONE PHOSPHORYLATION,0.52594,-0.027309,-0.038659,0,0
5,GO ERYTHROCYTE DEVELOPMENT,0.91987,-0.027452,0.011987,0,0
5,GO PEPTIDE CROSS LINKING,0.7495,-0.027485,-0.0031945,0,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.53742,-0.027625,-0.015852,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.84397,-0.027725,-0.015518,0,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.72969,-0.02779,-0.032311,0,0
5,GO DNA REPLICATION,0.57857,-0.027791,-0.016058,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.76948,-0.027891,-0.025884,0,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.94073,-0.028119,-0.0037961,0,0
5,GO POSITIVE REGULATION OF DNA REPAIR,0.35607,-0.028439,-0.035073,0,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.81668,-0.028449,0.0085904,0,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.69707,-0.028557,0.054185,0,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.70355,-0.028761,-0.046764,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.34256,-0.028797,-0.060326,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.85082,-0.028945,-0.02374,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.40349,-0.029358,-0.084918,0,0
5,GO RESPONSE TO HYDROXYUREA,0.89907,-0.029622,0.011306,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.4598,-0.029824,-0.051424,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.32077,-0.029969,-0.057524,0,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.85768,-0.030028,0.0085646,0,0
5,GO PROTEIN MONOUBIQUITINATION,0.89907,-0.030304,-0.0066125,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.23589,-0.030308,-0.025419,0,0
5,GO NADH METABOLIC PROCESS,0.51459,-0.030459,-0.039723,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.52594,-0.030519,-0.043671,0,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,1,-0.030733,0.012566,0,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.59059,-0.030928,0.072175,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.3746,-0.031161,-0.041708,0,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.63978,-0.031251,-0.035797,0,0
5,GO HISTONE H3 K9 METHYLATION,0.82348,-0.031406,0.022631,0,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.41341,-0.031545,-0.04025,0,0
5,GO REGULATION OF ERAD PATHWAY,0.67137,-0.031611,-0.019075,0,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.73628,-0.031662,0.066153,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.21579,-0.031676,0.20186,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.9686,-0.031808,0.083479,0,0
5,GO MITOTIC CYTOKINESIS,0.56075,-0.032081,-0.0263,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.89907,-0.032176,0.030332,0,0
5,GO CYCLOOXYGENASE PATHWAY,0.37932,-0.032249,-0.13025,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.42347,-0.032779,-0.048412,0,0
5,GO MOTOR NEURON AXON GUIDANCE,0.51459,-0.033362,-0.016402,0,0
5,GO NEURON RECOGNITION,0.91987,-0.033415,0.031482,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.26098,-0.033473,-0.027144,0,0
5,GO REGULATION OF CYTOKINESIS,0.72969,-0.033502,-0.0021222,0,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.95466,-0.033598,0.004062,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.4978,-0.033647,-0.038359,0,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.67137,-0.033742,0.010336,0,0
5,GO SPINDLE LOCALIZATION,0.48131,-0.033757,-0.021472,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.79636,-0.033866,-0.019616,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.35153,-0.033954,-0.10387,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.79636,-0.033979,0.011872,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.51459,-0.034104,-0.066653,0,0
5,GO MICROTUBULE POLYMERIZATION,0.91987,-0.034105,0.024369,0,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.85082,-0.034399,-0.045668,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.39858,-0.034497,-0.067046,0,0
5,GO RESPONSE TO HISTAMINE,0.76281,-0.034639,0.039134,0,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.94073,-0.034786,0.01215,0,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.80989,-0.034798,0.0075009,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.35153,-0.035028,-0.068498,0,0
5,GO ACETYL COA METABOLIC PROCESS,0.62732,-0.035097,-0.040963,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.51459,-0.035262,-0.065515,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.13814,-0.035335,-0.088413,0,0
5,GO HISTONE H2A MONOUBIQUITINATION,0.74288,-0.035394,-0.00021048,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.89907,-0.035544,0.032872,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.7495,-0.035594,-0.0030136,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.063042,-0.035661,-0.04074,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.17099,-0.035693,-0.095538,0,0
5,GO PORE COMPLEX ASSEMBLY,0.91987,-0.035704,0.0010059,0,0
5,GO COPII COATED VESICLE CARGO LOADING,0.68418,-0.036101,-0.029493,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.9686,-0.036297,0.061249,0,0
5,GO PIGMENT GRANULE MATURATION,0.46512,-0.036299,-0.067533,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.27227,-0.03634,-0.037911,0,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.40349,-0.036444,-0.049478,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.32938,-0.036646,-0.042775,0,0
5,GO PEPTIDYL LYSINE METHYLATION,0.49227,-0.036653,-0.0304,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.32938,-0.036673,-0.03222,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.30402,-0.037045,-0.027765,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.53742,-0.037077,-0.025516,0,0
5,GO CELL CYCLE DNA REPLICATION,0.32506,-0.037093,-0.051442,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25729,-0.037249,-0.026007,0,0
5,GO RESPONSE TO INTERLEUKIN 7,0.43367,-0.037394,-0.054029,0,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.63978,-0.037506,-0.042091,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.72313,-0.037525,-0.010995,0,0
5,GO REGULATION OF CILIUM ASSEMBLY,0.59059,-0.037595,-0.0030727,0,0
5,GO DNA METABOLIC PROCESS,0.16294,-0.037662,-0.030907,0,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.39858,-0.037827,-0.084538,0,0
5,GO GMP METABOLIC PROCESS,0.88523,-0.037842,0.015488,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.64605,-0.037863,-0.0032162,0,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.092194,-0.037884,-0.097504,0,0
5,GO HEXOSE CATABOLIC PROCESS,0.4978,-0.038327,-0.035491,0,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.20621,-0.038383,-0.042343,0,0
5,GO ALDITOL METABOLIC PROCESS,0.97557,-0.038814,-0.010094,0,0
5,GO LONG TERM SYNAPTIC DEPRESSION,0.74288,-0.038918,0.028674,0,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.87833,-0.038931,-0.00064029,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.63354,-0.038934,-0.040605,0,0
5,GO PROSTATE GLAND GROWTH,0.34256,-0.038946,-0.14395,0,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.71006,-0.039085,-0.018924,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.67776,-0.039107,-0.008905,0,0
5,GO PROTEIN ACETYLATION,0.29184,-0.039336,-0.012239,0,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.91987,-0.039459,0.019616,0,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.87833,-0.039913,-0.0059704,0,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.28785,-0.039969,-0.080407,0,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.73628,-0.040098,0.05345,0,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.98953,-0.040339,-0.015197,0,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.91293,-0.040414,-0.024511,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.48131,-0.040559,-0.022569,0,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.31232,-0.040696,-0.065272,0,0
5,GO CELLULAR RESPONSE TO SALT STRESS,0.81668,-0.040936,-0.02887,0,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.14048,-0.041243,-0.12919,0,0
5,GO CELLULAR SENESCENCE,0.63978,-0.041292,-0.015946,0,0
5,GO PROTEIN METHYLATION,0.31232,-0.041401,-0.043871,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.34702,-0.041416,-0.061932,0,0
5,GO SISTER CHROMATID COHESION,0.51459,-0.041542,-0.023747,0,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.39858,-0.0416,-0.058108,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.83713,-0.041916,0.067978,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.12908,-0.041949,-0.068376,0,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.89907,-0.042349,-0.040295,0,0
5,GO NUCLEAR MIGRATION,0.7495,-0.042411,0.0014782,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.13355,-0.042478,-0.037625,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.47588,-0.042698,-0.050041,0,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.44402,-0.042742,-0.0376,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.62732,-0.042843,0.14409,0,0
5,GO VASCULAR TRANSPORT,0.84397,-0.042937,-0.083739,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.41341,-0.042938,-0.039113,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.43883,-0.043116,-0.028588,0,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.51459,-0.043504,-0.034931,0,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.92682,-0.044058,0.027073,0,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.62113,-0.044474,0.077689,0,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.14285,-0.045287,-0.071078,0,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.78962,-0.045324,-0.017878,0,0
5,GO HAIR FOLLICLE MATURATION,0.79636,-0.045369,-0.05477,0,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.64605,-0.045502,-0.034775,0,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.83713,-0.045708,0.015586,0,0
5,GO ORGANELLE FISSION,0.56075,-0.045726,-0.0053601,0,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.40349,-0.045753,-0.080299,0,0
5,GO LACTATION,0.76948,-0.045792,-0.015304,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.088862,-0.046218,-0.078594,0,0
5,GO LAMELLIPODIUM ASSEMBLY,0.92682,-0.046355,0.0090558,0,0
5,GO RESPONSE TO LEAD ION,0.35153,-0.046532,-0.052223,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.58456,-0.04654,0.060063,0,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.51459,-0.046876,-0.043501,0,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.27227,-0.046939,-0.077804,0,0
5,GO LYMPHANGIOGENESIS,0.33373,-0.046966,-0.088681,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.40349,-0.046976,-0.077165,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.47049,-0.047047,0.064817,0,0
5,GO HISTONE UBIQUITINATION,0.093897,-0.047346,-0.04823,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.58456,-0.047728,0.11895,0,0
5,GO CELL CYCLE CHECKPOINT,0.14769,-0.047742,-0.031747,0,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.093897,-0.048358,-0.070587,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.89907,-0.048754,0.0024181,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.55487,-0.048761,-0.018129,0,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.61497,-0.048895,-0.042153,0,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.14769,-0.049177,-0.12086,0,0
5,GO CELLULAR RESPONSE TO UV,0.3746,-0.049208,-0.034129,0,0
5,GO AXO DENDRITIC TRANSPORT,0.16828,-0.049334,-0.064422,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.57857,-0.049946,-0.086957,0,0
5,GO G0 TO G1 TRANSITION,0.26847,-0.050446,-0.042824,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.18219,-0.050535,-0.088929,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.50896,-0.050939,-0.038876,0,0
5,GO MITOCHONDRION LOCALIZATION,0.54321,-0.051009,-0.016773,0,0
5,GO MITOTIC RECOMBINATION,0.54321,-0.051291,-0.043471,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.80989,-0.051364,-0.045318,0,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.48131,-0.051581,-0.065784,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.17374,-0.051752,-0.057981,0,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.7495,-0.051872,-0.021103,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.54321,-0.052051,-0.024984,0,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.86455,-0.052054,0.023434,0,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.13583,-0.052176,-0.056239,0,0
5,GO REGULATION OF PROTEIN ACETYLATION,0.15264,-0.052212,-0.052779,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.30402,-0.052714,-0.05464,0,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.89215,-0.053052,-0.026663,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.84397,-0.053062,-0.020424,0,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.86455,-0.053203,0.036367,0,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.22235,-0.053308,-0.05019,0,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.48678,-0.053479,-0.026505,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.92682,-0.053592,0.01486,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.33812,-0.053673,-0.053336,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.20621,-0.053698,-0.042152,0,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.34256,-0.053784,-0.022975,0,0
5,GO TROPHOBLAST CELL MIGRATION,0.23245,-0.053839,-0.19386,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.29184,-0.053982,-0.12867,0,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.82348,-0.054354,0.02392,0,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.85768,-0.054646,-0.025116,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.23937,-0.054694,-0.081123,0,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.25001,-0.054696,-0.043536,0,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.26098,-0.054984,-0.082157,0,0
5,GO CENTRIOLE ASSEMBLY,0.32938,-0.055297,-0.039808,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.15264,-0.055624,-0.065867,0,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.5726,-0.055751,0.078214,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.097379,-0.056448,-0.12541,0,0
5,GO LATERAL MESODERM DEVELOPMENT,0.90599,-0.056583,-0.013178,0,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.67776,-0.056743,-0.026028,0,0
5,GO NCRNA CATABOLIC PROCESS,0.43883,-0.056886,-0.043419,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.40349,-0.056988,-0.046097,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.2839,-0.05701,-0.066213,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.48131,-0.057842,-0.056918,0,0
5,GO HISTONE H3 K9 DEMETHYLATION,0.98255,-0.057853,0.0098454,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.85082,-0.057889,0.083702,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.99651,-0.058357,0.01412,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.31653,-0.05878,-0.070023,0,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.52594,-0.058853,-0.051974,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.62732,-0.058922,-0.042593,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.43883,-0.058986,-0.06748,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.19695,-0.059104,-0.046951,0,0
5,GO REGULATION OF CENTROSOME CYCLE,0.64605,-0.059184,-0.0013084,0,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.079444,-0.059446,-0.10737,0,0
5,GO ERYTHROCYTE MATURATION,0.22568,-0.059468,-0.083153,0,0
5,GO NUCLEUS LOCALIZATION,0.65866,-0.059707,-0.0086135,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.17374,-0.059781,-0.075355,0,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.16032,-0.059859,-0.06198,0,0
5,GO CERAMIDE TRANSPORT,0.65866,-0.059882,-0.026313,0,0
5,GO DOUBLE STRAND BREAK REPAIR,0.070855,-0.05999,-0.054897,0,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.69707,-0.060531,-0.046617,0,0
5,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.25729,-0.061035,-0.15126,0,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.23589,-0.061302,-0.051328,0,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.99651,-0.061328,0.063928,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.43883,-0.061478,-0.053685,0,0
5,GO LAMELLIPODIUM ORGANIZATION,0.89907,-0.061712,-0.0068878,0,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.1313,-0.061992,-0.066356,0,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.29184,-0.062059,-0.0646,0,0
5,GO TRICARBOXYLIC ACID CYCLE,0.073629,-0.062217,-0.1215,0,0
5,GO REGULATION OF DNA REPAIR,0.02268,-0.062219,-0.073739,0,0
5,GO CHROMOSOME LOCALIZATION,0.15264,-0.062307,-0.031316,0,0
5,GO RESPONSE TO SALT STRESS,0.54903,-0.062858,-0.043349,0,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.052669,-0.062867,-0.076252,0,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.15773,-0.063379,-0.086058,0,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.47049,-0.063775,-0.035107,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.035393,-0.063992,-0.082832,0,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.10096,-0.064069,-0.11,0,0
5,GO METAPHASE PLATE CONGRESSION,0.23245,-0.064795,-0.02263,0,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.13355,-0.065183,-0.096286,0,0
5,GO DNA REPAIR,0.026586,-0.065424,-0.051433,0,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.20621,-0.065848,-0.072193,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.52594,-0.065996,-0.10863,0,0
5,GO AEROBIC RESPIRATION,0.068167,-0.066389,-0.11796,0,0
5,GO MYOBLAST MIGRATION,0.84397,-0.066427,-0.050483,0,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.80989,-0.066699,-0.0056269,0,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.12259,-0.066978,-0.052257,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76948,-0.067425,0.029407,0,0
5,GO BLASTOCYST FORMATION,0.31653,-0.067519,-0.051341,0,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.14285,-0.067724,-0.094719,0,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.44924,-0.06814,-0.085895,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.12908,-0.068342,-0.036975,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.1028,-0.069106,-0.054837,0,0
5,GO VIRAL LATENCY,0.3746,-0.06918,-0.052699,0,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.32506,-0.069199,-0.093889,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.54321,-0.069533,-0.043176,0,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.15264,-0.069613,-0.11607,0,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.67137,-0.069616,0.040253,0,0
5,GO AMP METABOLIC PROCESS,0.4598,-0.069949,-0.079519,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.10465,-0.070136,-0.081882,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.54903,-0.070315,-0.05393,0,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.73628,-0.070607,0.045966,0,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.16828,-0.071428,-0.088223,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.16294,-0.071695,-0.093738,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17099,-0.072041,-0.087355,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.1028,-0.072273,-0.092165,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.080955,-0.072705,-0.07389,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.68418,-0.073651,-0.0087733,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.12473,-0.073808,-0.074426,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.90599,-0.073809,0.028915,0,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.23589,-0.073975,-0.033714,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.35153,-0.074063,-0.060823,0,0
5,GO OSTEOBLAST DEVELOPMENT,0.56666,-0.074523,-0.074647,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.71006,-0.074682,-0.013563,0,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.15015,-0.075513,-0.10776,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.46512,-0.075557,-0.038424,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.32077,-0.075594,-0.059072,0,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.17374,-0.075726,-0.10469,0,0
5,GO NUCLEOSOME ASSEMBLY,0.16559,-0.076466,-0.059824,0,0
5,GO RESPONSE TO L GLUTAMATE,0.72969,-0.076895,-0.045083,0,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.76948,-0.076928,-0.056467,0,0
5,GO MITOCHONDRION DISTRIBUTION,0.26098,-0.077057,-0.02868,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.14048,-0.07739,-0.072278,0,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.53742,-0.077417,-0.049433,0,0
5,GO PIRNA METABOLIC PROCESS,0.34256,-0.077604,-0.085242,0,0
5,GO SYNAPTIC VESICLE LOCALIZATION,0.51459,-0.077659,0.0079904,0,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.78289,-0.077719,-0.029491,0,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.026586,-0.077805,-0.065584,0,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.49227,-0.077844,-0.045163,0,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.15015,-0.078785,-0.081845,0,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.22235,-0.078806,-0.05902,0,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.0695,-0.078834,-0.046344,0,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.30402,-0.079034,-0.085037,0,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.60272,-0.079233,-0.038454,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.3746,-0.079898,-0.10369,0,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.89907,-0.08013,0.046744,0,0
5,GO VESICLE CARGO LOADING,0.42347,-0.080304,-0.060741,0,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.60272,-0.08083,-0.030895,0,0
5,GO CRISTAE FORMATION,0.14048,-0.081162,-0.10713,0,0
5,GO PLASMA MEMBRANE REPAIR,0.43367,-0.081421,-0.083207,0,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.19393,-0.081511,-0.062314,0,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.39371,-0.081867,-0.025175,0,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.12259,-0.082562,-0.108,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0083534,-0.082764,-0.10341,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.21905,-0.083289,-0.14143,0,0
5,GO OXIDATIVE DEMETHYLATION,0.084046,-0.083571,-0.067641,0,0
5,GO AXONAL TRANSPORT,0.11636,-0.084006,-0.08123,0,0
5,GO NODAL SIGNALING PATHWAY,0.10845,-0.085813,-0.077129,0,0
5,GO TELOMERE CAPPING,0.044685,-0.086377,-0.057983,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.30402,-0.086401,-0.056808,0,0
5,GO HISTONE EXCHANGE,0.20621,-0.086745,-0.053702,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.23937,-0.086752,-0.041803,0,0
5,GO CELLULAR RESPIRATION,0.059411,-0.086959,-0.10966,0,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.13355,-0.087073,-0.1029,0,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.27227,-0.087086,-0.10585,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.29992,-0.087599,-0.061842,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.21256,-0.087876,-0.060879,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.43883,-0.088244,-0.052006,0,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.12473,-0.088353,-0.1055,0,0
5,GO REGULATION OF GASTRULATION,0.24288,-0.088881,-0.080336,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.001228,-0.089593,-0.095411,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.35607,-0.089614,-0.094975,0,0
5,GO DNA DEPENDENT DNA REPLICATION,0.017969,-0.089819,-0.093274,0,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.087232,-0.090022,-0.062957,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.28785,-0.090248,-0.030105,0,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.57857,-0.090541,-0.035011,0,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.16559,-0.090997,-0.10329,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.32077,-0.091002,-0.024277,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.83713,-0.091116,-0.010628,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.20621,-0.091596,-0.1075,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.19695,-0.091652,-0.10441,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.33373,-0.091705,-0.086122,0,0
5,GO CHROMOSOME SEGREGATION,0.059411,-0.092198,-0.052226,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.23245,-0.092224,-0.044151,0,0
5,GO RRNA CATABOLIC PROCESS,0.76948,-0.09349,0.029987,0,0
5,GO WALKING BEHAVIOR,0.16559,-0.09392,-0.067431,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.2839,-0.093924,-0.068115,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.12689,-0.094261,-0.080686,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.39858,-0.094558,-0.03224,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.055956,-0.094873,-0.14034,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.76948,-0.095658,-0.037381,0,0
5,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.73628,-0.095659,-0.083336,0,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.4598,-0.095739,-0.031476,0,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.24643,-0.095755,-0.046898,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.10465,-0.095844,-0.15357,0,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.15517,-0.096038,-0.12893,0,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.25729,-0.096296,-0.030627,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.11841,-0.096558,-0.20747,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.090515,-0.097076,-0.095712,0,0
5,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.17374,-0.097403,-0.12016,0,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.080955,-0.09749,-0.083784,0,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.61497,-0.097648,-0.03268,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.23937,-0.097731,-0.081509,0,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.50896,-0.097861,-0.080977,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.19393,-0.098324,-0.069631,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.27227,-0.098367,-0.035717,0,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.74288,-0.098992,-0.04251,0,0
5,GO NAD METABOLIC PROCESS,0.33373,-0.09951,-0.067419,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.11235,-0.099582,-0.069094,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.33373,-0.099678,-0.092064,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.047551,-0.099726,-0.077396,0,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.24288,-0.099732,-0.10051,0,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.075049,-0.10051,-0.14773,0,0
5,GO KETONE BODY METABOLIC PROCESS,0.26847,-0.10078,-0.098859,0,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.24288,-0.1011,-0.10263,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.63978,-0.10171,-0.057817,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.42347,-0.10342,-0.049324,0,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.16032,-0.1036,-0.074609,0,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.31653,-0.10366,-0.13478,0,0
5,GO MICROTUBULE NUCLEATION,0.11636,-0.10422,-0.034955,0,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.19095,-0.10479,-0.044228,0,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.10096,-0.10507,-0.10833,0,0
5,GO DNA PACKAGING,0.05824,-0.10531,-0.059578,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.13583,-0.10534,-0.079702,0,0
5,GO CHROMOSOME CONDENSATION,0.066855,-0.10561,-0.069575,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.43883,-0.1062,-0.068527,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.21256,-0.10637,-0.073633,0,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.33373,-0.10734,-0.091866,0,0
5,GO SPINDLE ASSEMBLY,0.033166,-0.10821,-0.069948,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.18508,-0.10822,-0.092419,0,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.56075,-0.10901,-0.088205,0,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.10845,-0.10904,-0.050276,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.13814,-0.11088,-0.12735,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.14769,-0.11147,-0.086284,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.25001,-0.11194,-0.047262,0,0
5,GO PROTEIN REFOLDING,0.26471,-0.11308,-0.081077,0,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.14769,-0.11431,-0.11632,0,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.16032,-0.11436,-0.067789,0,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.15015,-0.11457,-0.055958,0,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.15517,-0.11459,-0.1293,0,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.16559,-0.11466,-0.087899,0,0
5,GO FEVER GENERATION,0.16828,-0.11519,-0.096164,0,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.12259,-0.11543,-0.11388,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.22905,-0.11559,-0.0763,0,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.087232,-0.11578,-0.10045,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.05824,-0.11611,-0.086404,0,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.26847,-0.11615,-0.054237,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.36064,-0.11658,-0.033453,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.015203,-0.11726,-0.13237,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.35153,-0.11738,-0.046196,0,0
5,GO SPINDLE ORGANIZATION,0.043763,-0.11822,-0.062144,0,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.188,-0.11857,-0.14131,0,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.060602,-0.11954,-0.16541,0,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.029068,-0.12005,-0.20714,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.10845,-0.12052,-0.073919,0,0
5,GO OXIDATIVE PHOSPHORYLATION,0.11434,-0.12157,-0.10101,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.043763,-0.12166,-0.094784,0,0
5,GO LIMB BUD FORMATION,0.4978,-0.12211,-0.015699,0,0
5,GO PRE MIRNA PROCESSING,0.14769,-0.1238,-0.11199,0,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.35607,-0.12393,-0.10448,0,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.87144,-0.12488,0.036867,0,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.11235,-0.12515,-0.092435,0,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.16559,-0.12584,-0.097125,0,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.076492,-0.12603,-0.076118,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.12908,-0.12614,-0.096334,0,0
5,GO SISTER CHROMATID SEGREGATION,0.016339,-0.12721,-0.085471,0,0
5,GO REGULATION OF HIPPO SIGNALING,0.11636,-0.12733,-0.14856,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.05824,-0.12747,-0.1357,0,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.43367,-0.1305,-0.075283,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.072231,-0.13093,-0.067251,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.02843,-0.13109,-0.15728,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.14285,-0.13256,-0.0746,0,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.27611,-0.13336,-0.10636,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.2,-0.1336,-0.072162,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.097379,-0.13486,-0.10052,0,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.38408,-0.13528,-0.082326,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.030383,-0.13544,-0.097616,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.26847,-0.13595,-0.097235,0,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.061812,-0.13634,-0.13316,0,0
5,GO V D J RECOMBINATION,0.31232,-0.13714,-0.05936,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.0067808,-0.13747,-0.10413,0,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.89907,-0.13766,0.026388,0,0
5,GO CARDIOBLAST PROLIFERATION,0.46512,-0.14003,-0.12996,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.092194,-0.14013,-0.11386,0,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.080955,-0.14035,-0.19802,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.068167,-0.14132,-0.1195,0,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.090515,-0.14336,-0.14532,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.40843,-0.14456,-0.079715,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.30815,-0.14494,-0.080373,0,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0695,-0.14543,-0.21864,0,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.027188,-0.14586,-0.10724,0,0
5,GO CHROMOSOME SEPARATION,0.00069957,-0.14669,-0.1341,0,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.0046564,-0.14671,-0.10196,0,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.068167,-0.14677,-0.1533,0,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.001986,-0.14734,-0.12579,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.52594,-0.14746,-0.083464,0,0
5,GO PENILE ERECTION,0.097379,-0.14994,-0.14115,0,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.23937,-0.15142,-0.094604,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.15195,-0.13196,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.80312,-0.15268,0.10635,0,0
5,GO ETHANOL CATABOLIC PROCESS,0.082489,-0.15344,-0.14262,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.075049,-0.15441,-0.092272,0,0
5,GO KINETOCHORE ORGANIZATION,0.40843,-0.15491,-0.044068,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.060602,-0.16013,-0.1485,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.084046,-0.16179,-0.095775,0,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.29184,-0.16236,-0.067321,0,0
5,GO CENTRIOLE CENTRIOLE COHESION,0.12473,-0.1645,-0.081023,0,0
5,GO CARDIOBLAST DIFFERENTIATION,0.29992,-0.16525,-0.10974,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.060602,-0.16557,-0.15104,0,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.093897,-0.16694,-0.094522,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.035393,-0.16839,-0.087401,0,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.50896,-0.16934,-0.075784,0,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.31653,-0.17055,-0.14221,0,0
5,GO MRNA SPLICE SITE SELECTION,0.066855,-0.17199,-0.10622,0,0
5,GO ETHANOL METABOLIC PROCESS,0.1313,-0.17466,-0.14631,0,0
5,GO FRUCTOSE METABOLIC PROCESS,0.34256,-0.17595,-0.12451,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.037747,-0.17835,-0.14997,0,0
5,GO DENDRITE SELF AVOIDANCE,0.090515,-0.18002,-0.14304,0,0
5,GO KINETOCHORE ASSEMBLY,0.2,-0.18016,-0.077742,0,0
5,GO PYRAMIDAL NEURON DIFFERENTIATION,0.20309,-0.18069,-0.14924,0,0
5,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.52025,-0.18353,-0.071073,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.01282,-0.18366,-0.17931,0,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.14048,-0.1858,-0.10495,0,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.22235,-0.18639,-0.14095,0,0
5,GO GTP METABOLIC PROCESS,0.14048,-0.18863,-0.11447,0,0
5,GO DNA LIGATION,0.099158,-0.1901,-0.11706,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.05161,-0.19212,-0.14207,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.00353,-0.19293,-0.14168,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.053746,-0.19475,-0.11754,0,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.076492,-0.19509,-0.11817,0,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.39371,-0.19539,-0.081697,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.62113,-0.19572,-0.01265,0,0
5,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.16828,-0.19602,-0.11575,0,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.077957,-0.19721,-0.12073,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.17653,-0.19844,-0.16058,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.063042,-0.20066,-0.161,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.052669,-0.20233,-0.14613,0,0
5,GO CYSTEINE METABOLIC PROCESS,0.090515,-0.2049,-0.22618,0,0
5,GO BONE TRABECULA FORMATION,0.26471,-0.20546,-0.20117,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.068167,-0.20787,-0.15239,0,0
5,GO RRNA 3 END PROCESSING,0.004408,-0.20883,-0.19393,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.3746,-0.21666,-0.075727,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.025994,-0.21757,-0.18849,0,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.090515,-0.21847,-0.13646,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.0028957,-0.22049,-0.22702,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.082489,-0.2217,-0.13369,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.57857,-0.22199,-0.038215,0,0
5,GO ETHANOL OXIDATION,0.063042,-0.22269,-0.27037,0,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.12689,-0.22759,-0.18174,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.018836,-0.22799,-0.18849,0,0
5,GO SECRETORY GRANULE LOCALIZATION,0.073629,-0.23802,-0.15905,0,0
5,GO DISTAL TUBULE DEVELOPMENT,0.087232,-0.23886,-0.11869,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.023741,-0.24023,-0.1357,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.047551,-0.24419,-0.19459,0,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.065563,-0.2463,-0.23766,0,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.36526,-0.25828,-0.17291,0,0
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.32938,-0.26804,-0.070352,0,0
5,GO PRENYLATION,0.0069616,-0.27344,-0.18783,0,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.084046,-0.2754,-0.12632,0,0
5,GO RETROGRADE AXONAL TRANSPORT,0.0038387,-0.28122,-0.19512,0,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0023671,-0.28157,-0.23009,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.00057693,-0.30926,-0.28557,0,0
5,GO CARDIAC VENTRICLE FORMATION,0.065563,-0.34471,-0.22858,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,5.7413e-06,-0.35389,-0.35283,0,0
6,GO FOREBRAIN NEURON FATE COMMITMENT,9.7801e-06,0.81479,0.91256,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0011549,0.56017,0.47345,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00079435,0.51584,0.44216,1,1
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.4878e-05,0.4627,0.46137,1,1
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00047456,0.37703,0.47374,1,1
6,GO NEURON FATE COMMITMENT,6.2786e-05,0.37058,0.40268,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00026903,0.37051,0.36989,1,1
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.4121e-05,0.35264,0.39055,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0056288,0.34707,0.38877,1,1
6,GO THALAMUS DEVELOPMENT,0.0059384,0.33888,0.27404,1,1
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.011326,0.28946,0.25551,1,1
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0042883,0.28826,0.32332,1,1
6,GO NOSE DEVELOPMENT,0.0013457,0.28635,0.47707,1,1
6,GO VIRAL LATENCY,0.0014738,0.2738,0.21297,1,1
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0025817,0.26395,0.25197,1,1
6,GO V D J RECOMBINATION,0.0012662,0.26271,0.2526,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0033369,0.25949,0.34081,1,1
6,GO MRNA SPLICE SITE SELECTION,1.7118e-05,0.25779,0.2887,1,1
6,GO KINETOCHORE ORGANIZATION,0.00069957,0.25256,0.222,1,1
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00038934,0.2498,0.35072,1,1
6,GO SINGLE STRAND BREAK REPAIR,0.00081984,0.2246,0.19523,1,1
6,GO KINETOCHORE ASSEMBLY,0.0012662,0.22456,0.20442,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.024288,0.22136,0.17864,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.00027832,0.22114,0.20333,1,1
6,GO CHROMATIN REMODELING AT CENTROMERE,0.00028792,0.21491,0.21371,1,1
6,GO HISTONE H4 K16 ACETYLATION,7.6603e-06,0.21251,0.23571,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0022992,0.20775,0.20371,1,1
6,GO NEURON PROJECTION ARBORIZATION,0.027803,0.19822,0.16437,1,1
6,GO FOREBRAIN REGIONALIZATION,0.0041716,0.19775,0.23619,1,1
6,GO DENDRITE SELF AVOIDANCE,0.040234,0.19426,0.15621,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,0.00016023,0.19233,0.21475,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.7118e-05,0.19231,0.21603,1,1
6,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0037331,0.19077,0.1552,1,1
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00013917,0.19055,0.17989,1,1
6,GO DENDRITIC TRANSPORT,0.022165,0.19045,0.17703,1,1
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.017549,0.18588,0.15829,1,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.010773,0.18427,0.1371,1,1
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0062634,0.18055,0.15002,1,1
6,GO REGULATION OF SISTER CHROMATID COHESION,0.0046564,0.17143,0.15277,1,1
6,GO HISTONE H4 K5 ACETYLATION,0.00045924,0.17139,0.21176,1,1
6,GO REGULATION OF HELICASE ACTIVITY,0.014486,0.17106,0.1849,1,1
6,GO GENETIC IMPRINTING,0.0019282,0.17101,0.19427,1,1
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00098941,0.16889,0.16602,1,1
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.036948,0.1682,0.13995,1,1
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0024367,0.16548,0.18472,1,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0057817,0.16464,0.1379,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00084609,0.16197,0.16225,1,1
6,GO HISTONE H3 K9 TRIMETHYLATION,0.0037331,0.16147,0.14555,1,1
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.026586,0.15991,0.13787,1,1
6,GO RESPONSE TO HYDROXYUREA,0.0099891,0.15834,0.18411,1,1
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.05161,0.158,0.12441,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0042883,0.15698,0.13713,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0046564,0.15284,0.13043,1,1
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.023741,0.1525,0.13675,1,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.010506,0.15239,0.16356,1,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0014299,0.1504,0.16297,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00087311,0.14947,0.13492,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,5.0226e-05,0.14905,0.17995,1,1
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0045306,0.14783,0.14935,1,1
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0038387,0.14546,0.14541,1,1
6,GO MAINTENANCE OF ORGANELLE LOCATION,0.03245,0.14426,0.087117,1,1
6,GO NUCLEOSOME ASSEMBLY,0.001228,0.14404,0.15267,1,1
6,GO DNA REPLICATION CHECKPOINT,0.012508,0.14369,0.11845,1,1
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.027188,0.14333,0.12099,1,1
6,GO CENTRIOLE ASSEMBLY,0.0047853,0.13945,0.11324,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.02166,0.13808,0.15719,1,1
6,GO HISTONE H2A UBIQUITINATION,0.0042883,0.13737,0.13472,1,1
6,GO HISTONE H2A ACETYLATION,0.0018173,0.13688,0.16283,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,0.0040578,0.13674,0.10822,1,1
6,GO HISTONE EXCHANGE,0.0040578,0.13378,0.12309,1,1
6,GO MITOTIC CHROMOSOME CONDENSATION,0.0039469,0.13352,0.1687,1,1
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.043763,0.13329,0.15168,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,0.00031859,0.13302,0.14714,1,1
6,GO POST ANAL TAIL MORPHOGENESIS,0.017549,0.13141,0.12828,1,1
6,GO DNA STRAND ELONGATION,0.004408,0.12951,0.12782,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.001191,0.12899,0.12024,1,1
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.010773,0.12734,0.16416,1,1
6,GO CENTROSOME DUPLICATION,0.007729,0.12624,0.11754,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.018398,0.12462,0.084787,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00074557,0.12228,0.15622,1,1
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.016734,0.12213,0.13818,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.036164,0.12172,0.094288,1,1
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0060989,0.12056,0.12496,1,1
6,GO HISTONE H4 ACETYLATION,7.013e-05,0.11952,0.1322,1,1
6,GO INTERSTRAND CROSS LINK REPAIR,0.0010206,0.11936,0.10516,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.025414,0.1165,0.080705,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00090094,0.11605,0.13348,1,1
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0054795,0.11323,0.10278,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0064317,0.11293,0.11039,1,1
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.017969,0.11285,0.11877,1,1
6,GO CELL CYCLE DNA REPLICATION,0.0073363,0.11205,0.096904,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.027188,0.11098,0.13146,1,1
6,GO PEPTIDYL LYSINE ACETYLATION,0.00020448,0.11007,0.095479,1,1
6,GO HISTONE H3 K4 TRIMETHYLATION,0.027188,0.10928,0.11286,1,1
6,GO REPLICATION FORK PROCESSING,0.010773,0.10873,0.097718,1,1
6,GO G0 TO G1 TRANSITION,0.001228,0.10827,0.14352,1,1
6,GO HISTONE MONOUBIQUITINATION,0.0007696,0.10776,0.12626,1,1
6,GO DOSAGE COMPENSATION,0.014138,0.10692,0.10333,1,1
6,GO NUCLEOSOME ORGANIZATION,0.0014299,0.10243,0.11266,1,1
6,GO HISTONE H3 K27 METHYLATION,0.035393,0.10205,0.092682,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00098941,0.10178,0.11715,1,1
6,GO REGULATION OF MRNA PROCESSING,0.009256,0.10008,0.085387,1,1
6,GO HISTONE H3 K4 METHYLATION,0.0030654,0.096238,0.13904,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0066042,0.095555,0.084301,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.015574,0.095273,0.086956,1,1
6,GO DNA REPLICATION INITIATION,0.033166,0.093732,0.089037,1,1
6,GO REGULATION OF PROTEIN ACETYLATION,0.017549,0.093142,0.073608,1,1
6,GO PROTEIN ACETYLATION,0.00054072,0.092997,0.076003,1,1
6,GO ERROR PRONE TRANSLESION SYNTHESIS,0.02166,0.088259,0.10079,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.025414,0.086986,0.088262,1,1
6,GO HISTONE UBIQUITINATION,0.019283,0.086052,0.076243,1,1
6,GO PEPTIDYL LYSINE METHYLATION,0.0069616,0.085453,0.091618,1,1
6,GO RECOMBINATIONAL REPAIR,0.007729,0.082085,0.071637,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.044685,0.081414,0.072278,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.018398,0.079725,0.077727,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0010206,0.07714,0.10846,1,1
6,GO CHROMATIN REMODELING,0.0036303,0.073783,0.085931,1,1
6,GO CHROMATIN SILENCING,0.031748,0.07168,0.082856,1,1
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.016734,0.07068,0.085705,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,0.0083534,0.066732,0.050054,1,1
6,GO CHROMOSOME SEGREGATION,0.035393,0.066098,0.052337,1,1
6,GO CELL CYCLE CHECKPOINT,0.015953,0.06405,0.055213,1,1
6,GO DNA PACKAGING,0.0019282,0.063587,0.096256,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.042857,0.063284,0.059921,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.019283,0.060958,0.070494,1,1
6,GO HETEROCHROMATIN ORGANIZATION,0.024288,0.059165,0.078217,1,1
6,GO DNA INTEGRITY CHECKPOINT,0.024846,0.05762,0.050771,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.034637,0.057433,0.096752,1,1
6,GO REGULATION OF RNA SPLICING,0.025994,0.056808,0.056323,1,1
6,GO PROTEIN MONOUBIQUITINATION,0.029068,0.055354,0.059128,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.029068,0.051795,0.081252,1,1
6,GO CHROMATIN ORGANIZATION,0.014138,0.049741,0.051198,1,1
6,GO DNA REPLICATION,0.047551,0.048134,0.0454,1,1
6,GO PROTEIN ACYLATION,0.04854,0.0439,0.041298,1,1
6,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.042857,0.33744,0.34129,1,0
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.017137,0.30733,0.2235,1,0
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.037747,0.28497,0.50584,1,0
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.013139,0.27628,0.26329,1,0
6,GO GANGLION DEVELOPMENT,0.026586,0.2691,0.30294,1,0
6,GO COMMISSURAL NEURON AXON GUIDANCE,0.03939,0.23318,0.21298,1,0
6,GO SPINAL CORD PATTERNING,0.0024367,0.23312,0.32246,1,0
6,GO CELL MIGRATION IN HINDBRAIN,0.053746,0.22009,0.16041,1,0
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.021165,0.21902,0.24625,1,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.030383,0.19996,0.209,1,0
6,GO RETINAL ROD CELL DIFFERENTIATION,0.038561,0.1975,0.21954,1,0
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.041093,0.1899,0.16943,1,0
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.043763,0.15906,0.18397,1,0
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.010245,0.15825,0.26731,1,0
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.023205,0.14431,0.32969,1,0
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.05161,0.12768,0.17649,1,0
6,GO DORSAL VENTRAL PATTERN FORMATION,0.012508,0.11122,0.13448,1,0
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.027803,0.10679,0.12877,1,0
6,GO SPERMATID NUCLEUS DIFFERENTIATION,0.042857,0.099975,0.10634,1,0
6,GO RDNA HETEROCHROMATIN ASSEMBLY,0.027803,0.099357,0.12643,1,0
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.029719,0.096452,0.15499,1,0
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.031748,0.092177,0.1065,1,0
6,GO POSITIVE REGULATION OF MRNA PROCESSING,0.052669,0.076501,0.073121,1,0
6,GO DNA CONFORMATION CHANGE,0.017549,0.066699,0.062549,1,0
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.025994,0.063698,0.052929,1,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.038561,0.060533,0.06765,1,0
6,GO MITOTIC CELL CYCLE CHECKPOINT,0.033894,0.055663,0.049656,1,0
6,GO DOUBLE STRAND BREAK REPAIR,0.044685,0.049911,0.04499,1,0
6,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.027803,-0.037701,-0.067521,1,0
6,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.043763,-0.038961,-0.074684,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.036948,-0.043511,-0.05913,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.034637,-0.043827,-0.061236,1,0
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.023741,-0.046021,-0.058814,1,0
6,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.035393,-0.048505,-0.061316,1,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0071468,-0.049911,-0.056059,1,0
6,GO REGULATION OF CELL DIFFERENTIATION,0.0053338,-0.050378,-0.086229,1,0
6,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.025414,-0.051726,-0.063403,1,0
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.033894,-0.053961,-0.076101,1,0
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.03939,-0.055777,-0.066132,1,0
6,GO TISSUE HOMEOSTASIS,0.05161,-0.055792,-0.086822,1,0
6,GO CELL CELL SIGNALING,0.044685,-0.057666,-0.062445,1,0
6,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.014841,-0.058405,-0.11898,1,0
6,GO RHYTHMIC PROCESS,0.046579,-0.058602,-0.065749,1,0
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0021062,-0.05932,-0.069677,1,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0014299,-0.059642,-0.06457,1,0
6,GO IMPORT INTO NUCLEUS,0.019283,-0.059684,-0.074155,1,0
6,GO REGULATION OF ORGANELLE ORGANIZATION,0.0013457,-0.059689,-0.06702,1,0
6,GO REGULATION OF CELLULAR PH,0.026586,-0.060363,-0.080917,1,0
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.011047,-0.060426,-0.091887,1,0
6,GO MALE SEX DIFFERENTIATION,0.024846,-0.061317,-0.10993,1,0
6,GO MULTI ORGANISM PROCESS,0.0053338,-0.061347,-0.074438,1,0
6,GO CELL VOLUME HOMEOSTASIS,0.038561,-0.061983,-0.083105,1,0
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0039469,-0.062001,-0.099146,1,0
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.033166,-0.062043,-0.079566,1,0
6,GO RESPONSE TO BMP,0.036948,-0.062145,-0.10422,1,0
6,GO PROTEIN DESTABILIZATION,0.045624,-0.063698,-0.079754,1,0
6,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.038561,-0.063708,-0.11161,1,0
6,GO REGULATION OF PH,0.015953,-0.06412,-0.084525,1,0
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0018173,-0.06472,-0.087588,1,0
6,GO REGULATION OF MRNA CATABOLIC PROCESS,0.01282,-0.064772,-0.10984,1,0
6,GO EPITHELIAL TUBE FORMATION,0.053746,-0.064859,-0.088042,1,0
6,GO NERVOUS SYSTEM PROCESS,0.052669,-0.06504,-0.060969,1,0
6,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.043763,-0.065251,-0.096662,1,0
6,GO DETECTION OF STIMULUS,0.0071468,-0.065475,-0.073926,1,0
6,GO SENSORY PERCEPTION OF SMELL,0.0018173,-0.06594,-0.13057,1,0
6,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.04854,-0.066688,-0.13178,1,0
6,GO METHIONINE METABOLIC PROCESS,0.036164,-0.067235,-0.12079,1,0
6,GO DNA BIOSYNTHETIC PROCESS,0.053746,-0.067305,-0.053455,1,0
6,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.033166,-0.06737,-0.068901,1,0
6,GO REGULATION OF VIRAL TRANSCRIPTION,0.010506,-0.068025,-0.11441,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.025414,-0.068136,-0.067437,1,0
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.036948,-0.068488,-0.080699,1,0
6,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.017969,-0.068736,-0.083103,1,0
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.025414,-0.070016,-0.10734,1,0
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.015574,-0.070163,-0.094652,1,0
6,GO CYTOSKELETON ORGANIZATION,0.011904,-0.070265,-0.077997,1,0
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0081404,-0.070811,-0.10468,1,0
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0018173,-0.071722,-0.069498,1,0
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.00030804,-0.071733,-0.082295,1,0
6,GO RIG I SIGNALING PATHWAY,0.027188,-0.072202,-0.14548,1,0
6,GO PROTEIN O LINKED GLYCOSYLATION,0.027803,-0.072213,-0.13659,1,0
6,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.040234,-0.072294,-0.10052,1,0
6,GO VIRION ASSEMBLY,0.049546,-0.072477,-0.081716,1,0
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0064317,-0.072535,-0.083223,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.031059,-0.072543,-0.13171,1,0
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.00081984,-0.072571,-0.080737,1,0
6,GO MESODERM DEVELOPMENT,0.0045306,-0.072697,-0.1256,1,0
6,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.00090094,-0.07295,-0.10728,1,0
6,GO LYMPHOCYTE DIFFERENTIATION,0.010245,-0.072969,-0.099514,1,0
6,GO HISTONE DEACETYLATION,0.017549,-0.073637,-0.083901,1,0
6,GO REPRODUCTION,0.0083534,-0.073802,-0.077458,1,0
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.02843,-0.074196,-0.060079,1,0
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0069616,-0.074306,-0.12303,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.019283,-0.074461,-0.12381,1,0
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.010245,-0.075099,-0.078686,1,0
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.029719,-0.075332,-0.16644,1,0
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.03245,-0.075519,-0.090743,1,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0025083,-0.075857,-0.1019,1,0
6,GO GOLGI TO VACUOLE TRANSPORT,0.03939,-0.076186,-0.11745,1,0
6,GO RESPONSE TO IONIZING RADIATION,0.011904,-0.076217,-0.088676,1,0
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0013054,-0.07643,-0.087419,1,0
6,GO OOCYTE DIFFERENTIATION,0.023741,-0.076969,-0.10714,1,0
6,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.02068,-0.077731,-0.14722,1,0
6,GO T CELL DIFFERENTIATION,0.047551,-0.077743,-0.09256,1,0
6,GO ENDOSOMAL TRANSPORT,0.007729,-0.077933,-0.0733,1,0
6,GO DEFENSE RESPONSE TO FUNGUS,0.047551,-0.078217,-0.10413,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0023671,-0.078317,-0.11013,1,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.030383,-0.078466,-0.06989,1,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0026572,-0.078496,-0.084032,1,0
6,GO CELL CELL SIGNALING BY WNT,0.009256,-0.078684,-0.090989,1,0
6,GO NUCLEAR ENVELOPE ORGANIZATION,0.021165,-0.078932,-0.079602,1,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0071468,-0.07894,-0.088503,1,0
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00042998,-0.079077,-0.081028,1,0
6,GO EMBRYO DEVELOPMENT,0.010506,-0.079107,-0.087255,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.030383,-0.079202,-0.062923,1,0
6,GO BLASTOCYST DEVELOPMENT,0.0085714,-0.079663,-0.083357,1,0
6,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.010245,-0.079881,-0.16771,1,0
6,GO IN UTERO EMBRYONIC DEVELOPMENT,0.017137,-0.080263,-0.077303,1,0
6,GO RHYTHMIC BEHAVIOR,0.0097392,-0.080475,-0.1116,1,0
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.013798,-0.080553,-0.090748,1,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0021689,-0.080659,-0.09577,1,0
6,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.045624,-0.080766,-0.11398,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.023205,-0.080923,-0.067423,1,0
6,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0022332,-0.080938,-0.10634,1,0
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.04854,-0.080945,-0.092899,1,0
6,GO PROTON TRANSMEMBRANE TRANSPORT,0.0038387,-0.080947,-0.1093,1,0
6,GO REGULATION OF GASTRULATION,0.038561,-0.080965,-0.13887,1,0
6,GO REGULATION OF CELLULAR LOCALIZATION,0.0025083,-0.08129,-0.078456,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION,0.0016129,-0.081369,-0.08714,1,0
6,GO RNA MODIFICATION,0.0071468,-0.081517,-0.12029,1,0
6,GO ALPHA BETA T CELL ACTIVATION,0.011612,-0.081673,-0.13619,1,0
6,GO LIPID DROPLET ORGANIZATION,0.044685,-0.081755,-0.12781,1,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.04854,-0.082005,-0.14195,1,0
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.018836,-0.082057,-0.073725,1,0
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0013457,-0.082586,-0.11021,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.013798,-0.082603,-0.071053,1,0
6,GO SKELETAL SYSTEM MORPHOGENESIS,0.015574,-0.082964,-0.12225,1,0
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.029719,-0.083204,-0.097043,1,0
6,GO REGULATION OF ANION TRANSPORT,0.027188,-0.083294,-0.098508,1,0
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.017549,-0.083372,-0.1317,1,0
6,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.015203,-0.083532,-0.13875,1,0
6,GO COPII COATED VESICLE CARGO LOADING,0.009256,-0.084142,-0.13955,1,0
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.035393,-0.084162,-0.15354,1,0
6,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0028141,-0.084226,-0.11309,1,0
6,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.024288,-0.084473,-0.13295,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0017123,-0.084839,-0.11777,1,0
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.00098941,-0.084951,-0.086179,1,0
6,GO PLACENTA DEVELOPMENT,0.053746,-0.085247,-0.11374,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION,0.035393,-0.08536,-0.093758,1,0
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.041093,-0.085483,-0.12685,1,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.012508,-0.085804,-0.12699,1,0
6,GO CELL GROWTH,0.0014299,-0.085843,-0.11383,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.022165,-0.085859,-0.086935,1,0
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.022165,-0.08597,-0.12918,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.02268,-0.086225,-0.12114,1,0
6,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.035393,-0.086483,-0.14952,1,0
6,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00035231,-0.086862,-0.096483,1,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.031748,-0.086946,-0.13466,1,0
6,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.010773,-0.087019,-0.09977,1,0
6,GO CELLULAR MACROMOLECULE LOCALIZATION,2.2524e-05,-0.087129,-0.090644,1,0
6,GO ENDOSOME ORGANIZATION,0.014138,-0.087132,-0.10043,1,0
6,GO TAXIS,0.0013872,-0.087174,-0.11652,1,0
6,GO ASTROCYTE DIFFERENTIATION,0.03939,-0.087519,-0.13671,1,0
6,GO IMMUNOGLOBULIN PRODUCTION,0.010773,-0.087601,-0.10897,1,0
6,GO REGULATION OF CELL SIZE,0.027188,-0.087742,-0.083878,1,0
6,GO EXECUTION PHASE OF APOPTOSIS,0.036948,-0.087872,-0.068032,1,0
6,GO NEUTROPHIL CHEMOTAXIS,0.031748,-0.08789,-0.11075,1,0
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.011612,-0.087958,-0.067732,1,0
6,GO REGULATION OF DEPHOSPHORYLATION,0.0054795,-0.0881,-0.069606,1,0
6,GO OLIGODENDROCYTE DEVELOPMENT,0.034637,-0.088271,-0.13337,1,0
6,GO CRISTAE FORMATION,0.007729,-0.088297,-0.19251,1,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0019282,-0.088603,-0.079252,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.021165,-0.088742,-0.13274,1,0
6,GO CELL AGING,0.0069616,-0.089129,-0.10005,1,0
6,GO LEUKOCYTE TETHERING OR ROLLING,0.022165,-0.0892,-0.090355,1,0
6,GO AMINO ACID TRANSPORT,0.024846,-0.089747,-0.082373,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.035393,-0.089861,-0.11938,1,0
6,GO CELLULAR RESPONSE TO ALCOHOL,0.023741,-0.089903,-0.10601,1,0
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.027803,-0.089934,-0.099328,1,0
6,GO EMBRYONIC ORGAN DEVELOPMENT,0.010773,-0.090324,-0.10386,1,0
6,GO CALCIUM ION IMPORT,0.017969,-0.09034,-0.10472,1,0
6,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0056288,-0.090497,-0.094047,1,0
6,GO DEVELOPMENTAL GROWTH,0.0025817,-0.090841,-0.098127,1,0
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.014841,-0.091348,-0.10557,1,0
6,GO ESTABLISHMENT OF CELL POLARITY,0.034637,-0.091348,-0.0715,1,0
6,GO CANONICAL WNT SIGNALING PATHWAY,0.0064317,-0.091435,-0.10724,1,0
6,GO PROTEIN DEPHOSPHORYLATION,0.0028957,-0.091457,-0.083146,1,0
6,GO RRNA METHYLATION,0.042857,-0.091626,-0.14172,1,0
6,GO SENSORY PERCEPTION,0.001662,-0.091788,-0.094526,1,0
6,GO DEPHOSPHORYLATION,0.00067758,-0.091808,-0.094771,1,0
6,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0081404,-0.091953,-0.1744,1,0
6,GO RESPONSE TO ALKALOID,0.031059,-0.091995,-0.092503,1,0
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0034322,-0.092303,-0.087523,1,0
6,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.017137,-0.092457,-0.12211,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.02843,-0.092582,-0.095789,1,0
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,9.3916e-06,-0.092802,-0.096013,1,0
6,GO REGULATION OF TRANSLATIONAL INITIATION,0.0021689,-0.092948,-0.1184,1,0
6,GO REGULATION OF PHOSPHATASE ACTIVITY,0.010245,-0.092975,-0.069761,1,0
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.043763,-0.092986,-0.15314,1,0
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.027803,-0.093263,-0.13265,1,0
6,GO GLIOGENESIS,0.018398,-0.093349,-0.10717,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.050569,-0.093468,-0.1277,1,0
6,GO MOLTING CYCLE,0.0045306,-0.093714,-0.13789,1,0
6,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.014841,-0.093734,-0.094527,1,0
6,GO PROTEOLYSIS,4.0073e-05,-0.093768,-0.12235,1,0
6,GO REGULATION OF PROTEIN TARGETING,0.009256,-0.093996,-0.096474,1,0
6,GO REGULATION OF PEPTIDE TRANSPORT,0.0017641,-0.094138,-0.090882,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.01282,-0.094278,-0.11218,1,0
6,GO MITOPHAGY,0.044685,-0.09431,-0.097819,1,0
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0057817,-0.09431,-0.11266,1,0
6,GO PROTEIN IMPORT,0.0007696,-0.094415,-0.10985,1,0
6,GO REGULATION OF PROTEIN FOLDING,0.0036303,-0.094658,-0.14031,1,0
6,GO IMMUNE SYSTEM DEVELOPMENT,0.0013054,-0.09469,-0.11115,1,0
6,GO INTERLEUKIN 6 PRODUCTION,0.030383,-0.094817,-0.10344,1,0
6,GO GROWTH,0.00036427,-0.094867,-0.10837,1,0
6,GO POSITIVE REGULATION OF GROWTH,0.0071468,-0.094906,-0.087517,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0054795,-0.094988,-0.090881,1,0
6,GO GOLGI ORGANIZATION,0.00025131,-0.094994,-0.12983,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00016023,-0.095141,-0.10353,1,0
6,GO CELL CYCLE ARREST,0.00069957,-0.095335,-0.099861,1,0
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0016129,-0.095392,-0.11406,1,0
6,GO ACTIVATION OF GTPASE ACTIVITY,0.0081404,-0.095548,-0.11276,1,0
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.031748,-0.095976,-0.1316,1,0
6,GO REGULATION OF GROWTH,0.00029782,-0.096024,-0.11934,1,0
6,GO REGULATION OF DEVELOPMENTAL GROWTH,0.012508,-0.096095,-0.09058,1,0
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0047853,-0.096126,-0.10247,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.03245,-0.096244,-0.2061,1,0
6,GO ORGANELLE INHERITANCE,0.025994,-0.09627,-0.093201,1,0
6,GO SMOOTH MUSCLE CELL MIGRATION,0.02268,-0.09634,-0.19061,1,0
6,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00040247,-0.096523,-0.10977,1,0
6,GO SENSORY PERCEPTION OF TASTE,0.021165,-0.096533,-0.11793,1,0
6,GO SENSORY PERCEPTION OF PAIN,0.031748,-0.096542,-0.087323,1,0
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.021165,-0.096596,-0.11927,1,0
6,GO TRANSFERRIN TRANSPORT,0.0062634,-0.096633,-0.15189,1,0
6,GO REGULATION OF SECRETION,0.010245,-0.09695,-0.090295,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.029719,-0.096986,-0.072236,1,0
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00016023,-0.097344,-0.12549,1,0
6,GO MUSCLE ORGAN DEVELOPMENT,0.00027832,-0.097404,-0.12511,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.052669,-0.097477,-0.075119,1,0
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0064317,-0.097636,-0.14032,1,0
6,GO RESPONSE TO IRON ION,0.035393,-0.097964,-0.11369,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.018836,-0.098077,-0.16415,1,0
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0045306,-0.098163,-0.13221,1,0
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.011904,-0.098281,-0.091948,1,0
6,GO LIPOPROTEIN METABOLIC PROCESS,0.0032441,-0.098306,-0.12731,1,0
6,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.040234,-0.098653,-0.14591,1,0
6,GO REGULATION OF FERTILIZATION,0.019739,-0.098833,-0.15975,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0062634,-0.098837,-0.15061,1,0
6,GO BASIC AMINO ACID TRANSPORT,0.05161,-0.098911,-0.18968,1,0
6,GO SEX DIFFERENTIATION,0.001986,-0.098957,-0.10784,1,0
6,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.004408,-0.09914,-0.17213,1,0
6,GO CYTOSOLIC TRANSPORT,0.0028957,-0.099353,-0.099579,1,0
6,GO RESPONSE TO ESTRADIOL,0.00063551,-0.099389,-0.13579,1,0
6,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.025994,-0.099496,-0.22231,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00052342,-0.099582,-0.10032,1,0
6,GO AMINE METABOLIC PROCESS,0.0018173,-0.099826,-0.13792,1,0
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.052669,-0.099881,-0.13509,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.02843,-0.099889,-0.11797,1,0
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0036303,-0.09995,-0.10082,1,0
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.00049035,-0.099974,-0.13847,1,0
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.049546,-0.1,-0.10593,1,0
6,GO REGULATION OF TELOMERASE ACTIVITY,0.017549,-0.10007,-0.11474,1,0
6,GO REGULATION OF HORMONE LEVELS,0.0046564,-0.10019,-0.11903,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.010773,-0.1008,-0.087066,1,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.03245,-0.10081,-0.1008,1,0
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.0551e-05,-0.10097,-0.10417,1,0
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.024846,-0.10104,-0.084776,1,0
6,GO ORGANELLE DISASSEMBLY,0.0015653,-0.10111,-0.11278,1,0
6,GO MODULATION BY VIRUS OF HOST PROCESS,0.03245,-0.10124,-0.10621,1,0
6,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.017137,-0.10128,-0.12898,1,0
6,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0036303,-0.10149,-0.10703,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.03939,-0.10152,-0.13232,1,0
6,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00041602,-0.10163,-0.11535,1,0
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.012508,-0.10174,-0.17531,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0073363,-0.10195,-0.16337,1,0
6,GO LYMPHOCYTE HOMEOSTASIS,0.0066042,-0.10196,-0.10768,1,0
6,GO MACROMOLECULE DEACYLATION,0.0022992,-0.10197,-0.086448,1,0
6,GO HISTONE PHOSPHORYLATION,0.0030654,-0.10224,-0.13535,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.026586,-0.10226,-0.16533,1,0
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0027346,-0.10227,-0.15026,1,0
6,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.05161,-0.10234,-0.14977,1,0
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0053338,-0.10238,-0.1476,1,0
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.041093,-0.10244,-0.10801,1,0
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.023205,-0.10245,-0.15073,1,0
6,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0071468,-0.10248,-0.12599,1,0
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.029719,-0.10255,-0.098733,1,0
6,GO EPIDERMAL CELL DIFFERENTIATION,0.04854,-0.10256,-0.11891,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.024288,-0.10308,-0.10353,1,0
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0024367,-0.10321,-0.11755,1,0
6,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0012662,-0.10339,-0.12529,1,0
6,GO RNA METHYLATION,0.0073363,-0.10347,-0.12164,1,0
6,GO REGULATION OF TOR SIGNALING,0.0050528,-0.10355,-0.089255,1,0
6,GO CHEMOKINE PRODUCTION,0.013465,-0.10355,-0.17582,1,0
6,GO TOR SIGNALING,0.00032948,-0.10356,-0.097583,1,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00059588,-0.10368,-0.11726,1,0
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0021062,-0.1037,-0.09157,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0012662,-0.10377,-0.10768,1,0
6,GO RESPONSE TO ACTIVITY,0.0053338,-0.10391,-0.12117,1,0
6,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.011612,-0.10424,-0.14731,1,0
6,GO BILE ACID METABOLIC PROCESS,0.031059,-0.1043,-0.15527,1,0
6,GO POSITIVE REGULATION OF CELL AGING,0.015953,-0.1043,-0.14637,1,0
6,GO PHAGOSOME MATURATION,0.027803,-0.10435,-0.11744,1,0
6,GO EPITHELIUM DEVELOPMENT,0.0033369,-0.10437,-0.11997,1,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.033166,-0.10452,-0.15399,1,0
6,GO EMBRYONIC MORPHOGENESIS,0.0050528,-0.10474,-0.11846,1,0
6,GO ANATOMICAL STRUCTURE MATURATION,0.046579,-0.10493,-0.075368,1,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0022992,-0.10503,-0.094869,1,0
6,GO REGULATION OF JUN KINASE ACTIVITY,0.021165,-0.10508,-0.11286,1,0
6,GO MULTI ORGANISM LOCALIZATION,0.0033369,-0.1051,-0.13923,1,0
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.042857,-0.10512,-0.059025,1,0
6,GO PEPTIDYL SERINE MODIFICATION,0.0066042,-0.10513,-0.080417,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.035393,-0.10527,-0.093279,1,0
6,GO PROTEIN CATABOLIC PROCESS,3.1888e-05,-0.1053,-0.10362,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0016129,-0.10531,-0.13106,1,0
6,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0042883,-0.10545,-0.13974,1,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0087944,-0.10567,-0.10077,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001228,-0.10575,-0.12564,1,0
6,GO MESENCHYME DEVELOPMENT,0.00090094,-0.10578,-0.15023,1,0
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00010845,-0.1058,-0.12058,1,0
6,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.045624,-0.10588,-0.15193,1,0
6,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.041093,-0.10601,-0.084976,1,0
6,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,4.1112e-06,-0.1061,-0.1211,1,0
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.047551,-0.10614,-0.14191,1,0
6,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00011241,-0.10615,-0.1369,1,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.018398,-0.10621,-0.12322,1,0
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.8583e-05,-0.10625,-0.10762,1,0
6,GO EPIDERMIS DEVELOPMENT,0.024846,-0.10632,-0.13154,1,0
6,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.05161,-0.10642,-0.13478,1,0
6,GO PROTEIN N LINKED GLYCOSYLATION,0.0014299,-0.10647,-0.14998,1,0
6,GO TOXIN TRANSPORT,0.036164,-0.10652,-0.10172,1,0
6,GO PROTEIN KINASE A SIGNALING,0.0064317,-0.10652,-0.12532,1,0
6,GO LIVER REGENERATION,0.001872,-0.10656,-0.22176,1,0
6,GO MYELOID CELL DIFFERENTIATION,0.0001547,-0.10664,-0.1482,1,0
6,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.0029794,-0.10665,-0.20093,1,0
6,GO ARACHIDONIC ACID SECRETION,0.0081404,-0.10696,-0.14264,1,0
6,GO SKELETAL SYSTEM DEVELOPMENT,0.00095906,-0.10705,-0.12531,1,0
6,GO PEPTIDYL ASPARAGINE MODIFICATION,0.010773,-0.10717,-0.13439,1,0
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0014299,-0.10726,-0.12009,1,0
6,GO CYTOKINE SECRETION,0.030383,-0.10726,-0.10421,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0081404,-0.10728,-0.14907,1,0
6,GO REGULATION OF TRANSPORT,0.00025131,-0.10729,-0.11342,1,0
6,GO PROTEIN HETEROTETRAMERIZATION,0.012508,-0.10768,-0.12328,1,0
6,GO NEUTRAL AMINO ACID TRANSPORT,0.0041716,-0.10769,-0.18608,1,0
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.023205,-0.10795,-0.12356,1,0
6,GO T CELL RECEPTOR SIGNALING PATHWAY,0.001191,-0.10823,-0.14177,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.025994,-0.10828,-0.10132,1,0
6,GO NEUTROPHIL MIGRATION,0.0037331,-0.1083,-0.14528,1,0
6,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00090094,-0.10834,-0.13472,1,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.021165,-0.10865,-0.13108,1,0
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,1.9263e-05,-0.10873,-0.1035,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0066042,-0.10874,-0.12975,1,0
6,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.015953,-0.10875,-0.15728,1,0
6,GO EPITHELIAL TUBE MORPHOGENESIS,0.0025817,-0.10892,-0.12431,1,0
6,GO CELLULAR PIGMENTATION,0.0047853,-0.10911,-0.12572,1,0
6,GO GOLGI VESICLE TRANSPORT,6.5149e-05,-0.10928,-0.12531,1,0
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.049546,-0.10933,-0.16651,1,0
6,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.011047,-0.10933,-0.091622,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0023671,-0.10934,-0.17786,1,0
6,GO REGULATION OF PROTEIN DEACETYLATION,0.041093,-0.10935,-0.092339,1,0
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0047853,-0.10938,-0.090159,1,0
6,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.015953,-0.1094,-0.12159,1,0
6,GO VIRAL GENOME REPLICATION,0.034637,-0.10948,-0.16735,1,0
6,GO LEUKOCYTE DIFFERENTIATION,0.00030804,-0.10953,-0.14436,1,0
6,GO POSITIVE REGULATION OF SECRETION,0.0071468,-0.10961,-0.097955,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.013798,-0.10964,-0.14242,1,0
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.036948,-0.10966,-0.10933,1,0
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.050569,-0.10973,-0.094864,1,0
6,GO REGULATION OF MACROAUTOPHAGY,2.3418e-05,-0.10978,-0.13733,1,0
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.014486,-0.10995,-0.14138,1,0
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0033369,-0.10998,-0.12426,1,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.041967,-0.11001,-0.11534,1,0
6,GO VACUOLAR TRANSPORT,0.0034322,-0.11004,-0.11614,1,0
6,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.043763,-0.11013,-0.21946,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.015574,-0.1102,-0.11516,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00055855,-0.11033,-0.12712,1,0
6,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.035393,-0.11034,-0.13715,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013054,-0.11047,-0.1221,1,0
6,GO VIRAL RELEASE FROM HOST CELL,0.015953,-0.11061,-0.1245,1,0
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.004408,-0.11067,-0.15788,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.02068,-0.11068,-0.19455,1,0
6,GO INTERLEUKIN 4 PRODUCTION,0.0067808,-0.11099,-0.16692,1,0
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.011612,-0.11102,-0.15436,1,0
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0022332,-0.1112,-0.11902,1,0
6,GO REGULATION OF CELL POPULATION PROLIFERATION,9.7346e-05,-0.1113,-0.13902,1,0
6,GO TOOTH MINERALIZATION,0.042857,-0.11132,-0.19596,1,0
6,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0033369,-0.11143,-0.13851,1,0
6,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0013054,-0.11151,-0.11268,1,0
6,GO NEUROINFLAMMATORY RESPONSE,0.0094949,-0.11164,-0.15716,1,0
6,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.00029782,-0.11167,-0.13401,1,0
6,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.0033369,-0.11168,-0.17169,1,0
6,GO NEGATIVE REGULATION OF CELL GROWTH,0.00057693,-0.11212,-0.13771,1,0
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00065623,-0.11212,-0.098275,1,0
6,GO INTRACELLULAR TRANSPORT,5.0683e-06,-0.11213,-0.10272,1,0
6,GO CELLULAR RESPONSE TO HEAT,0.0056288,-0.11217,-0.11175,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.1126,-0.10563,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0047853,-0.1127,-0.16012,1,0
6,GO GLYCOSYLATION,0.00095906,-0.11272,-0.14189,1,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.011612,-0.11279,-0.16219,1,0
6,GO WHITE FAT CELL DIFFERENTIATION,0.03245,-0.11285,-0.15565,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0028957,-0.113,-0.16718,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.017549,-0.11314,-0.095924,1,0
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00021909,-0.11314,-0.12306,1,0
6,GO REGULATION OF CELL AGING,0.0073363,-0.1132,-0.12838,1,0
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.018398,-0.11328,-0.13626,1,0
6,GO DEVELOPMENTAL PIGMENTATION,0.0062634,-0.11358,-0.12628,1,0
6,GO LIPOSACCHARIDE METABOLIC PROCESS,0.010773,-0.11359,-0.131,1,0
6,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00038934,-0.11366,-0.13406,1,0
6,GO REGULATION OF BMP SIGNALING PATHWAY,0.025414,-0.11367,-0.13733,1,0
6,GO NEURAL CREST CELL DIFFERENTIATION,0.023741,-0.11383,-0.13476,1,0
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0099891,-0.11385,-0.10661,1,0
6,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.011904,-0.11386,-0.16119,1,0
6,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0045306,-0.11387,-0.13901,1,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,9.0551e-05,-0.114,-0.12474,1,0
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0067808,-0.11402,-0.15007,1,0
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0060989,-0.11407,-0.13717,1,0
6,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0042883,-0.11409,-0.14623,1,0
6,GO CELLULAR RESPONSE TO CAMP,0.02166,-0.11412,-0.12766,1,0
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,9.0551e-05,-0.11419,-0.14743,1,0
6,GO AUTOPHAGY OF MITOCHONDRION,0.00072223,-0.11424,-0.13236,1,0
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.017549,-0.1143,-0.11907,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0010206,-0.11436,-0.12637,1,0
6,GO OSTEOCLAST DIFFERENTIATION,0.0038387,-0.11439,-0.12749,1,0
6,GO ANIMAL ORGAN MORPHOGENESIS,0.0006154,-0.11442,-0.12855,1,0
6,GO LEUKOTRIENE METABOLIC PROCESS,0.010773,-0.11467,-0.18835,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.015203,-0.11468,-0.14922,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0059384,-0.11472,-0.13294,1,0
6,GO PROTEIN LOCALIZATION TO VACUOLE,0.0027346,-0.11481,-0.14209,1,0
6,GO PROTEIN LOCALIZATION TO ORGANELLE,3.7145e-05,-0.11483,-0.098105,1,0
6,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.007729,-0.11486,-0.17453,1,0
6,GO HISTONE ARGININE METHYLATION,0.050569,-0.11492,-0.092569,1,0
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,1.2454e-05,-0.11546,-0.1523,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00065623,-0.11547,-0.15477,1,0
6,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0085714,-0.11566,-0.16534,1,0
6,GO CYTOLYSIS,0.03939,-0.11569,-0.1838,1,0
6,GO NUCLEOTIDE TRANSPORT,0.025414,-0.11571,-0.11003,1,0
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.7596e-05,-0.11576,-0.15011,1,0
6,GO POSITIVE REGULATION OF TRANSPORT,0.00032948,-0.11581,-0.11831,1,0
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.017969,-0.11584,-0.10262,1,0
6,GO LEUKOCYTE HOMEOSTASIS,0.0010859,-0.11588,-0.14458,1,0
6,GO MYOBLAST DIFFERENTIATION,0.037747,-0.11588,-0.12749,1,0
6,GO PURINE NUCLEOTIDE TRANSPORT,0.026586,-0.11594,-0.12072,1,0
6,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0012662,-0.11595,-0.14195,1,0
6,GO SYNAPTIC TRANSMISSION GABAERGIC,0.016339,-0.11596,-0.13343,1,0
6,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.027188,-0.11596,-0.14838,1,0
6,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.046579,-0.11597,-0.12123,1,0
6,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0056288,-0.11598,-0.14263,1,0
6,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0025083,-0.11602,-0.15499,1,0
6,GO REGULATION OF B CELL ACTIVATION,0.001872,-0.11603,-0.15475,1,0
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.025414,-0.11612,-0.11621,1,0
6,GO LIPOPROTEIN CATABOLIC PROCESS,0.024846,-0.11617,-0.18436,1,0
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00049035,-0.11634,-0.14584,1,0
6,GO REGULATION OF MEMBRANE REPOLARIZATION,0.026586,-0.11647,-0.13439,1,0
6,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0067808,-0.11648,-0.1887,1,0
6,GO REGULATION OF PROTEIN MATURATION,0.0031536,-0.11656,-0.17252,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.011326,-0.11688,-0.13332,1,0
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.04854,-0.1171,-0.097836,1,0
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.021165,-0.11718,-0.12107,1,0
6,GO TRNA METHYLATION,0.017969,-0.11739,-0.13418,1,0
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0022332,-0.11749,-0.13886,1,0
6,GO MACROMOLECULE CATABOLIC PROCESS,1.2308e-06,-0.1175,-0.13062,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.03245,-0.11755,-0.15275,1,0
6,GO MYELOID LEUKOCYTE DIFFERENTIATION,8.4205e-05,-0.11756,-0.18249,1,0
6,GO RESPONSE TO PROGESTERONE,0.031748,-0.11772,-0.16948,1,0
6,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0013457,-0.1179,-0.18012,1,0
6,GO SINGLE FERTILIZATION,0.0017123,-0.11794,-0.12604,1,0
6,GO INTRACELLULAR PROTEIN TRANSPORT,6.2367e-06,-0.11815,-0.10763,1,0
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00067758,-0.11836,-0.1319,1,0
6,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00026003,-0.11839,-0.12642,1,0
6,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.05161,-0.11839,-0.15331,1,0
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0081404,-0.11842,-0.1614,1,0
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,7.013e-05,-0.11858,-0.12425,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.012508,-0.11862,-0.13131,1,0
6,GO MUSCLE TISSUE DEVELOPMENT,0.00047456,-0.11871,-0.1157,1,0
6,GO RENAL SYSTEM PROCESS,0.016734,-0.11878,-0.13081,1,0
6,GO REGULATION OF HEMOPOIESIS,0.00052342,-0.11888,-0.1407,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.011047,-0.11911,-0.15095,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.018836,-0.11913,-0.11053,1,0
6,GO FC RECEPTOR SIGNALING PATHWAY,0.0053338,-0.11927,-0.11129,1,0
6,GO NEGATIVE REGULATION OF CELL DEATH,4.4878e-05,-0.11937,-0.13531,1,0
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.02068,-0.11947,-0.15918,1,0
6,GO TISSUE MORPHOGENESIS,0.00021909,-0.11953,-0.14544,1,0
6,GO RESPONSE TO ABIOTIC STIMULUS,7.6603e-06,-0.11957,-0.13533,1,0
6,GO POSITIVE REGULATION OF SIGNALING,0.00010845,-0.11959,-0.12275,1,0
6,GO HEMOGLOBIN METABOLIC PROCESS,0.019739,-0.11977,-0.15158,1,0
6,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.015574,-0.11979,-0.18129,1,0
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00041602,-0.11993,-0.14744,1,0
6,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0081404,-0.12003,-0.16968,1,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0057817,-0.1201,-0.12182,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.045624,-0.12013,-0.14403,1,0
6,GO REGULATION OF RESPONSE TO STRESS,6.2786e-05,-0.12026,-0.13291,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,3.8583e-05,-0.12027,-0.14239,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.015953,-0.1203,-0.12914,1,0
6,GO B CELL DIFFERENTIATION,0.0079323,-0.12032,-0.1213,1,0
6,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00055855,-0.12034,-0.12076,1,0
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00025131,-0.12037,-0.14236,1,0
6,GO LUNG MORPHOGENESIS,0.014138,-0.12041,-0.17055,1,0
6,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0021062,-0.12041,-0.16018,1,0
6,GO TRNA MODIFICATION,0.017969,-0.1207,-0.12772,1,0
6,GO ENDOTHELIUM DEVELOPMENT,0.02843,-0.12074,-0.11711,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0057817,-0.12075,-0.14346,1,0
6,GO CALCIUM MEDIATED SIGNALING,0.0025083,-0.12086,-0.09769,1,0
6,GO REGULATION OF HYDROLASE ACTIVITY,3.8583e-05,-0.12087,-0.14021,1,0
6,GO INTERLEUKIN 12 PRODUCTION,0.031748,-0.12094,-0.10103,1,0
6,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0071468,-0.12095,-0.13972,1,0
6,GO REGULATION OF FATTY ACID TRANSPORT,0.024846,-0.12096,-0.13927,1,0
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.037747,-0.12108,-0.1446,1,0
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.021165,-0.12116,-0.15764,1,0
6,GO PHOSPHATE ION TRANSPORT,0.0087944,-0.12125,-0.11535,1,0
6,GO I KAPPAB PHOSPHORYLATION,0.0079323,-0.12127,-0.17257,1,0
6,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00029782,-0.12145,-0.14589,1,0
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,2.3418e-05,-0.12157,-0.12628,1,0
6,GO REGULATION OF PROTEIN STABILITY,5.7413e-06,-0.12173,-0.1389,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0037331,-0.12193,-0.16317,1,0
6,GO REGULATION OF PROTEIN IMPORT,0.011047,-0.12195,-0.15924,1,0
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0039469,-0.12196,-0.12889,1,0
6,GO RRNA MODIFICATION,0.027188,-0.12205,-0.16025,1,0
6,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0024367,-0.12219,-0.14686,1,0
6,GO NCRNA PROCESSING,0.011612,-0.12222,-0.15305,1,0
6,GO REGULATION OF T CELL ACTIVATION,0.0021062,-0.12243,-0.14131,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0013872,-0.1226,-0.13094,1,0
6,GO ENSHEATHMENT OF NEURONS,0.0022992,-0.12265,-0.13483,1,0
6,GO REGULATION OF MITOCHONDRIAL FISSION,0.014486,-0.12279,-0.11979,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION,0.00079435,-0.12285,-0.13534,1,0
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00017186,-0.12298,-0.14348,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00092958,-0.12308,-0.13563,1,0
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.036948,-0.12309,-0.090358,1,0
6,GO LYMPH VESSEL MORPHOGENESIS,0.020205,-0.12314,-0.17047,1,0
6,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.4878e-05,-0.12325,-0.13377,1,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0036303,-0.12331,-0.22619,1,0
6,GO ZINC ION TRANSPORT,0.0028957,-0.12345,-0.16934,1,0
6,GO PEPTIDE SECRETION,0.0015653,-0.1235,-0.11896,1,0
6,GO RESPONSE TO MONOSACCHARIDE,8.4205e-05,-0.12357,-0.14227,1,0
6,GO APOPTOTIC PROCESS,1.0184e-05,-0.12366,-0.13528,1,0
6,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0069616,-0.12368,-0.15705,1,0
6,GO CARDIOLIPIN METABOLIC PROCESS,0.00072223,-0.12388,-0.21839,1,0
6,GO ERAD PATHWAY,0.00026003,-0.12397,-0.15048,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0036303,-0.12407,-0.14366,1,0
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.041967,-0.12411,-0.22786,1,0
6,GO TYPE I INTERFERON PRODUCTION,0.0099891,-0.12413,-0.15666,1,0
6,GO MESODERMAL CELL DIFFERENTIATION,0.015953,-0.12428,-0.18017,1,0
6,GO NEPHRON MORPHOGENESIS,0.012203,-0.1243,-0.11797,1,0
6,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0032441,-0.1243,-0.14319,1,0
6,GO OSSIFICATION,0.0001165,-0.1244,-0.17115,1,0
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.8301e-05,-0.1244,-0.14254,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00079435,-0.12443,-0.14671,1,0
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0001547,-0.12446,-0.14,1,0
6,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.038561,-0.12447,-0.14998,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0081404,-0.12459,-0.19755,1,0
6,GO CELLULAR RESPONSE TO KETONE,0.0013054,-0.12464,-0.15739,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0083534,-0.1247,-0.15574,1,0
6,GO REGULATION OF CELL DEATH,1.2962e-05,-0.12482,-0.1342,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.042857,-0.1249,-0.16068,1,0
6,GO IRON ION TRANSPORT,0.00027832,-0.12493,-0.14511,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00028792,-0.12513,-0.13253,1,0
6,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00013433,-0.12532,-0.16082,1,0
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.019283,-0.12535,-0.092008,1,0
6,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0039469,-0.12538,-0.18992,1,0
6,GO INOSITOL LIPID MEDIATED SIGNALING,0.00026903,-0.12545,-0.15114,1,0
6,GO INTERLEUKIN 2 PRODUCTION,0.0033369,-0.12554,-0.1579,1,0
6,GO EPITHELIAL CELL DEVELOPMENT,0.0066042,-0.12567,-0.14522,1,0
6,GO REGULATION OF MEMBRANE POTENTIAL,0.036948,-0.12575,-0.093247,1,0
6,GO NEGATIVE REGULATION OF SIGNALING,0.0001165,-0.12599,-0.12416,1,0
6,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.018836,-0.12608,-0.15681,1,0
6,GO UROGENITAL SYSTEM DEVELOPMENT,0.0025817,-0.12612,-0.14092,1,0
6,GO ORGAN GROWTH,0.0025083,-0.12617,-0.12426,1,0
6,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.001986,-0.1262,-0.13767,1,0
6,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,8.3127e-06,-0.12621,-0.14995,1,0
6,GO HOMEOSTATIC PROCESS,3.6228e-06,-0.12623,-0.13335,1,0
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0031536,-0.12624,-0.12601,1,0
6,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0079323,-0.12634,-0.15265,1,0
6,GO GLAND DEVELOPMENT,0.00024286,-0.12641,-0.14465,1,0
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00010092,-0.12701,-0.12633,1,0
6,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,8.4205e-05,-0.12706,-0.14866,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.010773,-0.12717,-0.15675,1,0
6,GO FEEDING BEHAVIOR,0.02843,-0.12725,-0.092725,1,0
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.036164,-0.12733,-0.10214,1,0
6,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.0784e-06,-0.12736,-0.1368,1,0
6,GO PROTEIN HETEROOLIGOMERIZATION,0.007729,-0.12738,-0.12771,1,0
6,GO MUSCLE FIBER DEVELOPMENT,0.0049174,-0.12741,-0.12528,1,0
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00063551,-0.12757,-0.1302,1,0
6,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.018398,-0.12774,-0.25352,1,0
6,GO PROTEIN STABILIZATION,4.6597e-05,-0.12781,-0.13732,1,0
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.049546,-0.12784,-0.16537,1,0
6,GO NIK NF KAPPAB SIGNALING,0.0045306,-0.12796,-0.15285,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0010528,-0.128,-0.14136,1,0
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.022165,-0.12801,-0.12428,1,0
6,GO TETRAHYDROFOLATE INTERCONVERSION,0.017549,-0.12803,-0.17629,1,0
6,GO LYMPHOCYTE ACTIVATION,0.00042998,-0.12818,-0.14303,1,0
6,GO KERATINOCYTE DIFFERENTIATION,0.033166,-0.12823,-0.14445,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00027832,-0.12865,-0.13283,1,0
6,GO MACROAUTOPHAGY,2.6307e-05,-0.12865,-0.12976,1,0
6,GO NEGATIVE REGULATION OF TRANSPORT,7.547e-05,-0.12868,-0.12869,1,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS,2.8418e-05,-0.12871,-0.11529,1,0
6,GO CELL JUNCTION ORGANIZATION,0.0041716,-0.12875,-0.12161,1,0
6,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.5774e-06,-0.12877,-0.14924,1,0
6,GO TRNA PROCESSING,0.024846,-0.12883,-0.1101,1,0
6,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0022992,-0.12888,-0.14376,1,0
6,GO REGULATION OF INSULIN SECRETION,0.011904,-0.12892,-0.10389,1,0
6,GO CARBOHYDRATE TRANSPORT,0.00019079,-0.12903,-0.14833,1,0
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0013872,-0.12927,-0.12987,1,0
6,GO RESPONSE TO MECHANICAL STIMULUS,0.0037331,-0.12935,-0.14453,1,0
6,GO CHONDROCYTE DIFFERENTIATION,0.013139,-0.1294,-0.14314,1,0
6,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0062634,-0.12949,-0.1122,1,0
6,GO OVARIAN FOLLICLE DEVELOPMENT,0.035393,-0.12974,-0.10846,1,0
6,GO JNK CASCADE,6.2786e-05,-0.12974,-0.1448,1,0
6,GO AMYLOID FIBRIL FORMATION,0.036164,-0.12979,-0.18977,1,0
6,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.001986,-0.12983,-0.17224,1,0
6,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0022332,-0.1299,-0.14964,1,0
6,GO GLUTAMINE METABOLIC PROCESS,0.020205,-0.12991,-0.13052,1,0
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.0041716,-0.13004,-0.18166,1,0
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,1.7118e-05,-0.13006,-0.11155,1,0
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.05161,-0.13016,-0.11725,1,0
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00017186,-0.13025,-0.13758,1,0
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,3.3132e-05,-0.13029,-0.14407,1,0
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00041602,-0.13038,-0.1529,1,0
6,GO RESPONSE TO VITAMIN,0.01282,-0.13044,-0.15463,1,0
6,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.0081404,-0.13048,-0.14766,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0025817,-0.13067,-0.17625,1,0
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00040247,-0.13068,-0.19256,1,0
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0037331,-0.13074,-0.12759,1,0
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0099891,-0.13083,-0.14079,1,0
6,GO HUMORAL IMMUNE RESPONSE,3.0689e-05,-0.13084,-0.18335,1,0
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,3.7145e-05,-0.13105,-0.15293,1,0
6,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0090226,-0.13105,-0.17225,1,0
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0038387,-0.13109,-0.19254,1,0
6,GO RESPONSE TO CARBOHYDRATE,1.0604e-05,-0.1311,-0.15562,1,0
6,GO CATION TRANSPORT,0.00031859,-0.13114,-0.13096,1,0
6,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00079435,-0.13119,-0.14608,1,0
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0007696,-0.13119,-0.15541,1,0
6,GO REGULATION OF BINDING,0.00011241,-0.13145,-0.12829,1,0
6,GO REGULATION OF CATABOLIC PROCESS,1.5331e-06,-0.13151,-0.13649,1,0
6,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.034637,-0.13157,-0.16455,1,0
6,GO PROTEIN TARGETING TO MITOCHONDRION,0.00037661,-0.13159,-0.15142,1,0
6,GO URONIC ACID METABOLIC PROCESS,0.007729,-0.1316,-0.14413,1,0
6,GO LYSOSOMAL TRANSPORT,0.0012662,-0.13167,-0.13655,1,0
6,GO NEGATIVE REGULATION OF OSSIFICATION,0.0036303,-0.13167,-0.17532,1,0
6,GO ERBB SIGNALING PATHWAY,0.0011199,-0.13176,-0.15422,1,0
6,GO LINOLEIC ACID METABOLIC PROCESS,0.042857,-0.13178,-0.24417,1,0
6,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.013139,-0.13188,-0.19543,1,0
6,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0020453,-0.1319,-0.18038,1,0
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.02166,-0.13197,-0.12853,1,0
6,GO REGULATION OF REPRODUCTIVE PROCESS,3.5759e-05,-0.13218,-0.1378,1,0
6,GO VESICLE CARGO LOADING,0.00098941,-0.13264,-0.19039,1,0
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,7.547e-05,-0.13266,-0.14679,1,0
6,GO PRIMARY MIRNA PROCESSING,0.0085714,-0.13271,-0.1796,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,2.7343e-05,-0.13272,-0.13474,1,0
6,GO MESENCHYMAL CELL DIFFERENTIATION,0.00074557,-0.13273,-0.17484,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00012512,-0.13284,-0.14416,1,0
6,GO REGULATION OF URINE VOLUME,0.0042883,-0.133,-0.14946,1,0
6,GO CONNECTIVE TISSUE DEVELOPMENT,0.0013457,-0.13303,-0.14455,1,0
6,GO T CELL ACTIVATION,0.0014299,-0.13307,-0.14958,1,0
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00067758,-0.13321,-0.16892,1,0
6,GO CGMP MEDIATED SIGNALING,0.007729,-0.13323,-0.17164,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.013465,-0.13329,-0.10267,1,0
6,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00054072,-0.13329,-0.13556,1,0
6,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0075304,-0.13333,-0.15684,1,0
6,GO RESPONSE TO VIRUS,0.011904,-0.13339,-0.15445,1,0
6,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00063551,-0.13353,-0.13087,1,0
6,GO CELLULAR DEFENSE RESPONSE,0.0023671,-0.13356,-0.21025,1,0
6,GO MACROPHAGE DIFFERENTIATION,0.0019282,-0.1337,-0.19975,1,0
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0017641,-0.13372,-0.21017,1,0
6,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0010206,-0.13377,-0.16726,1,0
6,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0011549,-0.13382,-0.16219,1,0
6,GO RESPONSE TO PEPTIDE,1.5331e-06,-0.13383,-0.1617,1,0
6,GO CELL MOTILITY,0.00021909,-0.13385,-0.14797,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00012964,-0.13397,-0.22784,1,0
6,GO REGULATION OF CELL ACTIVATION,0.00067758,-0.13401,-0.15092,1,0
6,GO POSITIVE REGULATION OF CELL DEATH,2.9532e-05,-0.1341,-0.14403,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,3.1888e-05,-0.13411,-0.14482,1,0
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00031859,-0.13413,-0.14262,1,0
6,GO PROTEIN KINASE B SIGNALING,0.0028141,-0.13413,-0.13996,1,0
6,GO CERAMIDE METABOLIC PROCESS,0.00017796,-0.13434,-0.16408,1,0
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.029719,-0.13441,-0.12971,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.012203,-0.13443,-0.12563,1,0
6,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0022992,-0.13443,-0.17159,1,0
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,9.0179e-06,-0.13446,-0.15112,1,0
6,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0085714,-0.1345,-0.14238,1,0
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00049035,-0.13461,-0.13422,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0041716,-0.13465,-0.14529,1,0
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0050528,-0.13468,-0.11742,1,0
6,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00038934,-0.13478,-0.20143,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00019079,-0.1349,-0.19912,1,0
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00050664,-0.13491,-0.1433,1,0
6,GO ENDOCYTIC RECYCLING,0.0094949,-0.13502,-0.12106,1,0
6,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00059588,-0.13505,-0.17281,1,0
6,GO VACUOLAR ACIDIFICATION,0.0032441,-0.13513,-0.1735,1,0
6,GO COENZYME A BIOSYNTHETIC PROCESS,0.009256,-0.13519,-0.18417,1,0
6,GO REGULATION OF TRANSFERASE ACTIVITY,3.3132e-05,-0.13523,-0.13543,1,0
6,GO ION TRANSMEMBRANE TRANSPORT,0.0001165,-0.13535,-0.13614,1,0
6,GO NEGATIVE REGULATION OF SECRETION,0.00030804,-0.13539,-0.12873,1,0
6,GO MUSCLE CELL DIFFERENTIATION,0.00038934,-0.13543,-0.13149,1,0
6,GO INSULIN SECRETION,0.018836,-0.13546,-0.10371,1,0
6,GO CELLULAR EXTRAVASATION,0.0073363,-0.13553,-0.1388,1,0
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.0038387,-0.13556,-0.18221,1,0
6,GO HEART DEVELOPMENT,0.00013917,-0.13575,-0.14359,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.001191,-0.13576,-0.13871,1,0
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0013054,-0.1358,-0.14935,1,0
6,GO APOPTOTIC SIGNALING PATHWAY,2.7343e-05,-0.1358,-0.15493,1,0
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.0184e-05,-0.13583,-0.14196,1,0
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.00047456,-0.13583,-0.12975,1,0
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0030654,-0.13589,-0.1622,1,0
6,GO ACTIN FILAMENT ORGANIZATION,0.00016023,-0.13603,-0.14895,1,0
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.00041602,-0.13605,-0.1239,1,0
6,GO POSITIVE REGULATION OF TRANSLATION,3.4421e-05,-0.13606,-0.19287,1,0
6,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0039469,-0.13608,-0.18278,1,0
6,GO PROTEIN TARGETING TO VACUOLE,0.0024367,-0.13608,-0.15726,1,0
6,GO SKIN DEVELOPMENT,0.014138,-0.13612,-0.15179,1,0
6,GO CELL JUNCTION ASSEMBLY,0.0030654,-0.13614,-0.12408,1,0
6,GO CARTILAGE DEVELOPMENT,0.0039469,-0.13622,-0.14379,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0049174,-0.13625,-0.21609,1,0
6,GO RESPONSE TO GROWTH FACTOR,0.00017796,-0.1363,-0.14307,1,0
6,GO ALPHA AMINO ACID CATABOLIC PROCESS,8.7323e-05,-0.13631,-0.19489,1,0
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.037747,-0.13636,-0.10271,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00098941,-0.1364,-0.16739,1,0
6,GO TRANSMEMBRANE TRANSPORT,1.4039e-05,-0.13654,-0.14223,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.018398,-0.13656,-0.14904,1,0
6,GO MEMBRANE LIPID METABOLIC PROCESS,0.00036427,-0.13662,-0.1707,1,0
6,GO TRANSEPITHELIAL TRANSPORT,0.0015189,-0.13664,-0.16995,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.02166,-0.13665,-0.15624,1,0
6,GO VESICLE ORGANIZATION,2.6307e-05,-0.13671,-0.15025,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00090094,-0.13681,-0.15911,1,0
6,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.030383,-0.13686,-0.15156,1,0
6,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.033166,-0.13689,-0.20858,1,0
6,GO REGULATION OF SYSTEM PROCESS,0.0014299,-0.13695,-0.1312,1,0
6,GO SYMBIOTIC PROCESS,1.4039e-05,-0.13696,-0.16477,1,0
6,GO CATION TRANSMEMBRANE TRANSPORT,0.00036427,-0.13696,-0.13226,1,0
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0041716,-0.13698,-0.2016,1,0
6,GO CELL CELL ADHESION,0.00023468,-0.1371,-0.16159,1,0
6,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0026572,-0.13712,-0.19523,1,0
6,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00032948,-0.13719,-0.13352,1,0
6,GO MEMBRANE ORGANIZATION,1.1964e-05,-0.13719,-0.14589,1,0
6,GO GOLGI RIBBON FORMATION,0.018398,-0.13726,-0.13426,1,0
6,GO AGING,3.1888e-05,-0.13731,-0.15415,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,6.7596e-05,-0.13747,-0.15051,1,0
6,GO NEGATIVE REGULATION OF BINDING,0.0015189,-0.13749,-0.11828,1,0
6,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,7.013e-05,-0.13756,-0.16402,1,0
6,GO POSITIVE REGULATION OF ANION TRANSPORT,0.016734,-0.13757,-0.13647,1,0
6,GO RESPONSE TO AMYLOID BETA,0.0045306,-0.13761,-0.15997,1,0
6,GO VIRAL LIFE CYCLE,0.00084609,-0.13762,-0.17932,1,0
6,GO TRANSITION METAL ION TRANSPORT,7.8282e-05,-0.13769,-0.13398,1,0
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00036427,-0.13773,-0.13398,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.023741,-0.13797,-0.13113,1,0
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00012512,-0.13797,-0.1961,1,0
6,GO KERATINOCYTE PROLIFERATION,0.02843,-0.13802,-0.18009,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0083534,-0.13805,-0.13963,1,0
6,GO MITOCHONDRIAL TRANSPORT,2.7343e-05,-0.1381,-0.12785,1,0
6,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00028792,-0.13827,-0.14467,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.010773,-0.13829,-0.2345,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00022676,-0.13833,-0.16104,1,0
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0010859,-0.13834,-0.13542,1,0
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00012964,-0.13837,-0.13018,1,0
6,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00074557,-0.13854,-0.13374,1,0
6,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.001662,-0.1389,-0.19007,1,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.00019753,-0.13895,-0.15251,1,0
6,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,4.3218e-05,-0.13895,-0.137,1,0
6,GO RESPONSE TO ENDOGENOUS STIMULUS,1.5201e-05,-0.139,-0.1409,1,0
6,GO REGULATION OF LYASE ACTIVITY,0.019283,-0.13909,-0.13906,1,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00079435,-0.13926,-0.14566,1,0
6,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00031859,-0.13927,-0.14819,1,0
6,GO RESPONSE TO INTERLEUKIN 1,3.5759e-05,-0.13931,-0.18602,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE,1.7806e-05,-0.13931,-0.14723,1,0
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00021167,-0.13934,-0.1331,1,0
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0053338,-0.13935,-0.16013,1,0
6,GO NCRNA METABOLIC PROCESS,0.0034322,-0.13941,-0.15488,1,0
6,GO CELL CELL JUNCTION ORGANIZATION,0.018836,-0.13944,-0.13369,1,0
6,GO TUBE DEVELOPMENT,0.00029782,-0.13946,-0.15526,1,0
6,GO REGULATION OF PEPTIDE SECRETION,0.0026572,-0.13952,-0.11273,1,0
6,GO METAL ION TRANSPORT,0.00012512,-0.13954,-0.1379,1,0
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0025083,-0.13959,-0.15841,1,0
6,GO OSTEOBLAST DIFFERENTIATION,6.2786e-05,-0.13985,-0.19856,1,0
6,GO LUNG ALVEOLUS DEVELOPMENT,0.015203,-0.13993,-0.15162,1,0
6,GO REGULATION OF HAIR CYCLE,0.0060989,-0.14004,-0.19785,1,0
6,GO ACTIN FILAMENT BASED PROCESS,0.00018427,-0.14022,-0.14466,1,0
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.033894,-0.14031,-0.1333,1,0
6,GO PEPTIDYL ARGININE METHYLATION,0.02068,-0.14038,-0.1279,1,0
6,GO CELL CELL JUNCTION ASSEMBLY,0.011612,-0.14043,-0.13629,1,0
6,GO ORGANIC ACID TRANSPORT,9.3916e-06,-0.1405,-0.15364,1,0
6,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.2837e-06,-0.1405,-0.14883,1,0
6,GO ESTABLISHMENT OF TISSUE POLARITY,0.00067758,-0.14063,-0.13514,1,0
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00069957,-0.14064,-0.15035,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.001986,-0.14071,-0.22572,1,0
6,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00012964,-0.14082,-0.21728,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.016339,-0.14084,-0.14402,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.02068,-0.14094,-0.149,1,0
6,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0042883,-0.14098,-0.22137,1,0
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.05161,-0.14099,-0.15237,1,0
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0046564,-0.14134,-0.13184,1,0
6,GO DRUG CATABOLIC PROCESS,3.0689e-05,-0.1415,-0.23542,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.010506,-0.14154,-0.15108,1,0
6,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.026586,-0.14154,-0.1305,1,0
6,GO MODULATION OF PROCESS OF OTHER ORGANISM,8.4205e-05,-0.14178,-0.16489,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0038387,-0.14184,-0.14151,1,0
6,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.011904,-0.14195,-0.15214,1,0
6,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.02166,-0.14222,-0.1599,1,0
6,GO PROTEIN TRANSMEMBRANE TRANSPORT,5.0683e-06,-0.14225,-0.17108,1,0
6,GO LIPID BIOSYNTHETIC PROCESS,6.7728e-06,-0.14229,-0.16962,1,0
6,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.4044e-06,-0.14241,-0.14028,1,0
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.015203,-0.1426,-0.15523,1,0
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.033166,-0.1427,-0.11456,1,0
6,GO POSITIVE REGULATION OF TOR SIGNALING,0.00065623,-0.1427,-0.13213,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0060989,-0.14278,-0.15218,1,0
6,GO RESPONSE TO SALT STRESS,0.014138,-0.14279,-0.15796,1,0
6,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0007696,-0.1428,-0.14409,1,0
6,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0029794,-0.14297,-0.22571,1,0
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0021062,-0.14303,-0.15547,1,0
6,GO REGULATION OF CELL SHAPE,0.014486,-0.14304,-0.11897,1,0
6,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00030804,-0.14304,-0.12782,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0094949,-0.14317,-0.15925,1,0
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.023741,-0.14318,-0.17672,1,0
6,GO CELLULAR COMPONENT DISASSEMBLY,1.5331e-06,-0.14324,-0.15312,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,2.4346e-05,-0.1433,-0.13804,1,0
6,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0011549,-0.14339,-0.16325,1,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.013798,-0.14341,-0.16161,1,0
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.033166,-0.14347,-0.13587,1,0
6,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.01282,-0.14351,-0.13926,1,0
6,GO REGULATION OF MUSCLE ADAPTATION,0.00065623,-0.14356,-0.17041,1,0
6,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00032948,-0.14368,-0.16176,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.030383,-0.1437,-0.14001,1,0
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.022165,-0.14386,-0.18416,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00025131,-0.14412,-0.11452,1,0
6,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00019079,-0.14423,-0.15932,1,0
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.2524e-05,-0.14425,-0.18921,1,0
6,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00019079,-0.14429,-0.15067,1,0
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.041967,-0.14436,-0.10912,1,0
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,1.2454e-05,-0.14439,-0.14012,1,0
6,GO RNA 5 END PROCESSING,0.004408,-0.1444,-0.18155,1,0
6,GO SULFATE TRANSPORT,0.0050528,-0.14442,-0.16066,1,0
6,GO REGULATION OF PHOSPHORYLATION,1.1493e-05,-0.14448,-0.14867,1,0
6,GO REGULATION OF DEFENSE RESPONSE,9.7346e-05,-0.14449,-0.15702,1,0
6,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0087944,-0.1446,-0.13759,1,0
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0056288,-0.14495,-0.15385,1,0
6,GO MATURATION OF 5 8S RRNA,0.030383,-0.14499,-0.17501,1,0
6,GO SPHINGOLIPID METABOLIC PROCESS,0.00010462,-0.14501,-0.18768,1,0
6,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00010462,-0.14503,-0.14104,1,0
6,GO CELLULAR AMINO ACID CATABOLIC PROCESS,4.1617e-05,-0.14508,-0.20445,1,0
6,GO RESPONSE TO PEPTIDE HORMONE,1.906e-06,-0.14508,-0.16286,1,0
6,GO RESPONSE TO LEPTIN,0.0051916,-0.14511,-0.16992,1,0
6,GO REGULATION OF CALCIUM ION IMPORT,0.0030654,-0.14512,-0.16496,1,0
6,GO ER NUCLEUS SIGNALING PATHWAY,0.014841,-0.1452,-0.13561,1,0
6,GO INORGANIC ANION TRANSPORT,3.9418e-06,-0.14521,-0.16974,1,0
6,GO RESPONSE TO MURAMYL DIPEPTIDE,0.034637,-0.14521,-0.21275,1,0
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00027832,-0.14529,-0.14758,1,0
6,GO RESPONSE TO KETONE,4.8379e-05,-0.1453,-0.18394,1,0
6,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00010845,-0.14537,-0.15893,1,0
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.8282e-05,-0.1454,-0.13443,1,0
6,GO POSITIVE REGULATION OF CELL KILLING,0.012508,-0.14542,-0.17294,1,0
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00057693,-0.14548,-0.13364,1,0
6,GO ANION TRANSPORT,2.0784e-06,-0.14548,-0.16028,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0024367,-0.14561,-0.12731,1,0
6,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00084609,-0.1459,-0.16503,1,0
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.041967,-0.14591,-0.16663,1,0
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0097392,-0.14609,-0.11489,1,0
6,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.038561,-0.1461,-0.11489,1,0
6,GO CHYLOMICRON ASSEMBLY,0.00041602,-0.14611,-0.21472,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0066042,-0.14638,-0.17541,1,0
6,GO ORGANIC ANION TRANSPORT,3.1904e-06,-0.1465,-0.16537,1,0
6,GO ACETYL COA METABOLIC PROCESS,0.0087944,-0.14653,-0.1589,1,0
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027803,-0.14656,-0.12962,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.044685,-0.14658,-0.1243,1,0
6,GO SODIUM ION TRANSPORT,0.0010859,-0.14658,-0.14396,1,0
6,GO REGULATION OF SYMBIOTIC PROCESS,0.0064317,-0.14693,-0.16975,1,0
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00074557,-0.14701,-0.14956,1,0
6,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0017641,-0.14705,-0.18577,1,0
6,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.00059588,-0.14713,-0.16455,1,0
6,GO ASTROCYTE DEVELOPMENT,0.014138,-0.14713,-0.19991,1,0
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0031536,-0.14718,-0.1551,1,0
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0026572,-0.14718,-0.12253,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.040234,-0.14719,-0.15493,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,6.2786e-05,-0.14727,-0.15054,1,0
6,GO GRANULOCYTE CHEMOTAXIS,0.00072223,-0.14728,-0.18188,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0059384,-0.14751,-0.15973,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0022332,-0.14755,-0.18712,1,0
6,GO T CELL CHEMOTAXIS,0.011612,-0.14756,-0.14515,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.041093,-0.14762,-0.23392,1,0
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0083534,-0.14763,-0.18026,1,0
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00072223,-0.14769,-0.14032,1,0
6,GO RESPONSE TO INSULIN,1.2862e-06,-0.1477,-0.17417,1,0
6,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,1.8521e-05,-0.14776,-0.14133,1,0
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,6.2786e-05,-0.14788,-0.17163,1,0
6,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.05161,-0.14808,-0.21944,1,0
6,GO REGULATION OF DEACETYLASE ACTIVITY,0.037747,-0.14815,-0.12894,1,0
6,GO VESICLE BUDDING FROM MEMBRANE,1.8521e-05,-0.14821,-0.17991,1,0
6,GO RNA CATABOLIC PROCESS,0.00034072,-0.14822,-0.16908,1,0
6,GO GLIAL CELL ACTIVATION,0.00069957,-0.14845,-0.21204,1,0
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0013457,-0.14849,-0.14475,1,0
6,GO REGULATION OF CELLULAR CATABOLIC PROCESS,5.0194e-07,-0.1485,-0.15677,1,0
6,GO L GLUTAMATE IMPORT,0.020205,-0.14854,-0.17077,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0085714,-0.14856,-0.21201,1,0
6,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0049174,-0.14861,-0.20476,1,0
6,GO GLYCINE METABOLIC PROCESS,0.021165,-0.14864,-0.24459,1,0
6,GO GLYCOPROTEIN METABOLIC PROCESS,0.00013917,-0.14867,-0.15817,1,0
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,4.3218e-05,-0.14867,-0.15892,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0097392,-0.14872,-0.13256,1,0
6,GO INTERMEMBRANE LIPID TRANSFER,0.00047456,-0.14877,-0.16321,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0099891,-0.14879,-0.17399,1,0
6,GO RESPONSE TO TEMPERATURE STIMULUS,6.2786e-05,-0.1488,-0.14486,1,0
6,GO ACTIVATION OF IMMUNE RESPONSE,0.00028792,-0.14884,-0.15253,1,0
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.02068,-0.14886,-0.15257,1,0
6,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.001986,-0.14886,-0.14347,1,0
6,GO PROTEIN NITROSYLATION,0.02166,-0.14897,-0.17388,1,0
6,GO REGULATION OF CELL KILLING,0.0056288,-0.1491,-0.17825,1,0
6,GO MYELOID CELL HOMEOSTASIS,0.00030804,-0.14912,-0.15957,1,0
6,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00049035,-0.14922,-0.16339,1,0
6,GO RESPONSE TO RETINOIC ACID,6.7596e-05,-0.14923,-0.2244,1,0
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00032948,-0.14944,-0.14666,1,0
6,GO PHOSPHOLIPID TRANSPORT,0.00019753,-0.1496,-0.1788,1,0
6,GO MUSCLE CELL PROLIFERATION,0.00025131,-0.14974,-0.18884,1,0
6,GO REGULATION OF T CELL MIGRATION,0.0056288,-0.14976,-0.15905,1,0
6,GO PIGMENTATION,0.00012512,-0.1498,-0.16158,1,0
6,GO MODULATION BY HOST OF SYMBIONT PROCESS,9.0551e-05,-0.14998,-0.19388,1,0
6,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.018836,-0.15002,-0.18188,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00037661,-0.15002,-0.22063,1,0
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0034322,-0.15004,-0.15988,1,0
6,GO CELLULAR ION HOMEOSTASIS,1.906e-06,-0.15009,-0.16014,1,0
6,GO TRANSLATIONAL ELONGATION,0.0014299,-0.1501,-0.19925,1,0
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,8.7323e-05,-0.15012,-0.16392,1,0
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00090094,-0.15016,-0.16186,1,0
6,GO RECEPTOR METABOLIC PROCESS,0.00032948,-0.15017,-0.14357,1,0
6,GO PROTEIN HOMOOLIGOMERIZATION,3.4421e-05,-0.15029,-0.1405,1,0
6,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0012662,-0.15036,-0.16047,1,0
6,GO ION TRANSPORT,4.4878e-05,-0.15037,-0.14702,1,0
6,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00050664,-0.15054,-0.18283,1,0
6,GO ODONTOGENESIS,0.0056288,-0.15057,-0.16459,1,0
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0062634,-0.15065,-0.17182,1,0
6,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.013798,-0.15073,-0.13561,1,0
6,GO LIPID HOMEOSTASIS,0.00010092,-0.15074,-0.17726,1,0
6,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0054795,-0.15081,-0.27619,1,0
6,GO REGULATION OF TUBE SIZE,0.0013054,-0.15082,-0.14991,1,0
6,GO PROTEIN COMPLEX OLIGOMERIZATION,8.3127e-06,-0.15087,-0.15761,1,0
6,GO CORONARY VASCULATURE DEVELOPMENT,0.0010206,-0.15087,-0.2027,1,0
6,GO RESPONSE TO OSMOTIC STRESS,0.00017186,-0.15091,-0.19111,1,0
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.02166,-0.15094,-0.1989,1,0
6,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0034322,-0.15094,-0.17318,1,0
6,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00095906,-0.15096,-0.1782,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00052342,-0.15106,-0.15579,1,0
6,GO LEUKOCYTE CELL CELL ADHESION,0.00019753,-0.15108,-0.18312,1,0
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,5.0226e-05,-0.1511,-0.17401,1,0
6,GO RESPONSE TO ISCHEMIA,0.0049174,-0.15118,-0.15092,1,0
6,GO NON CANONICAL WNT SIGNALING PATHWAY,0.00037661,-0.15145,-0.14611,1,0
6,GO RECEPTOR RECYCLING,0.0021689,-0.15153,-0.14198,1,0
6,GO AUTOPHAGOSOME ORGANIZATION,0.00034072,-0.15155,-0.17795,1,0
6,GO STEM CELL DIVISION,0.021165,-0.15163,-0.13864,1,0
6,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0013054,-0.15167,-0.25331,1,0
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0014738,-0.15174,-0.13875,1,0
6,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00013433,-0.15179,-0.15825,1,0
6,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.053746,-0.15192,-0.18862,1,0
6,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0011549,-0.15197,-0.16526,1,0
6,GO POTASSIUM ION TRANSPORT,0.029719,-0.15198,-0.099075,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0016129,-0.15209,-0.15662,1,0
6,GO CELLULAR KETONE METABOLIC PROCESS,0.00041602,-0.15212,-0.16877,1,0
6,GO PINOCYTOSIS,0.0026572,-0.15213,-0.20739,1,0
6,GO FACE DEVELOPMENT,0.011326,-0.15213,-0.15239,1,0
6,GO DIGESTION,0.013798,-0.15221,-0.13487,1,0
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.009256,-0.15227,-0.13077,1,0
6,GO RESPONSE TO NITROGEN COMPOUND,5.9841e-06,-0.1523,-0.1421,1,0
6,GO PEPTIDYL PROLINE MODIFICATION,6.7596e-05,-0.15231,-0.27104,1,0
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,6.4994e-06,-0.15231,-0.15854,1,0
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.013139,-0.15246,-0.15169,1,0
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,5.7413e-06,-0.15248,-0.17048,1,0
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,3.1888e-05,-0.15263,-0.17423,1,0
6,GO METANEPHROS DEVELOPMENT,0.0056288,-0.15265,-0.14542,1,0
6,GO RENAL TUBULE DEVELOPMENT,0.0028141,-0.1527,-0.15987,1,0
6,GO MUSCLE STRUCTURE DEVELOPMENT,8.7323e-05,-0.15271,-0.14617,1,0
6,GO CHEMICAL HOMEOSTASIS,1.9904e-06,-0.15271,-0.16309,1,0
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0012662,-0.15272,-0.14548,1,0
6,GO RESPONSE TO PROSTAGLANDIN E,0.0069616,-0.15272,-0.14487,1,0
6,GO REGULATION OF POSITIVE CHEMOTAXIS,0.041967,-0.15272,-0.14637,1,0
6,GO LIPID MODIFICATION,5.9841e-06,-0.15289,-0.17907,1,0
6,GO GLUTAMATE METABOLIC PROCESS,0.019739,-0.1529,-0.1145,1,0
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.6307e-05,-0.15291,-0.15846,1,0
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.6455e-05,-0.15304,-0.14725,1,0
6,GO TRNA METABOLIC PROCESS,0.0049174,-0.15304,-0.13976,1,0
6,GO COAGULATION,0.00010092,-0.15317,-0.18987,1,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00026003,-0.15318,-0.12283,1,0
6,GO TRANSLATIONAL TERMINATION,0.0053338,-0.15319,-0.19345,1,0
6,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.036948,-0.1532,-0.13106,1,0
6,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00065623,-0.1532,-0.17961,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION,0.01282,-0.1532,-0.12283,1,0
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.0071468,-0.15324,-0.14094,1,0
6,GO SECRETION,1.1964e-05,-0.15324,-0.16163,1,0
6,GO REGULATION OF PROTEOLYSIS,1.1964e-05,-0.15342,-0.16826,1,0
6,GO PROTEASOME ASSEMBLY,0.029068,-0.15346,-0.14561,1,0
6,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00084609,-0.15351,-0.18182,1,0
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00036427,-0.15352,-0.16395,1,0
6,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.00023468,-0.15353,-0.14983,1,0
6,GO REGULATION OF B CELL PROLIFERATION,0.0014299,-0.15368,-0.18995,1,0
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.023741,-0.15369,-0.2603,1,0
6,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00012964,-0.15373,-0.16846,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.0551e-05,-0.15376,-0.1682,1,0
6,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00017186,-0.15379,-0.18065,1,0
6,GO PHOSPHOLIPID METABOLIC PROCESS,2.0784e-06,-0.15411,-0.15774,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0013457,-0.15425,-0.17663,1,0
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0079323,-0.1543,-0.13855,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0024367,-0.15433,-0.16415,1,0
6,GO REGULATION OF PROTEIN KINASE ACTIVITY,5.6174e-05,-0.15442,-0.14534,1,0
6,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.017549,-0.15446,-0.20059,1,0
6,GO CELL KILLING,0.00021167,-0.15454,-0.18738,1,0
6,GO DENDRITIC CELL MIGRATION,0.0056288,-0.15456,-0.21849,1,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0047853,-0.15492,-0.16528,1,0
6,GO GLIAL CELL DEVELOPMENT,0.0026572,-0.15506,-0.16597,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION,0.0018173,-0.15512,-0.17452,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00012074,-0.15513,-0.1913,1,0
6,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0010206,-0.15515,-0.15973,1,0
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00054072,-0.15523,-0.14707,1,0
6,GO ANATOMICAL STRUCTURE REGRESSION,0.018836,-0.15524,-0.22038,1,0
6,GO ALPHA AMINO ACID METABOLIC PROCESS,4.1617e-05,-0.15528,-0.19409,1,0
6,GO REGULATION OF RIBOSOME BIOGENESIS,0.0066042,-0.15532,-0.23445,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0010206,-0.15541,-0.17648,1,0
6,GO NERVE DEVELOPMENT,0.03245,-0.15542,-0.14214,1,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00059588,-0.1555,-0.1456,1,0
6,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.547e-05,-0.15552,-0.1579,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,4.0073e-05,-0.1556,-0.17251,1,0
6,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,2.6307e-05,-0.15561,-0.14942,1,0
6,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0021689,-0.1557,-0.16119,1,0
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0069616,-0.15576,-0.15984,1,0
6,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00092958,-0.15584,-0.18381,1,0
6,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0029794,-0.15584,-0.18098,1,0
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.024846,-0.15588,-0.14113,1,0
6,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.5816e-05,-0.15595,-0.1539,1,0
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,-0.15603,-0.19297,1,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.049546,-0.15609,-0.17487,1,0
6,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,3.7791e-06,-0.15615,-0.15386,1,0
6,GO FEAR RESPONSE,0.00047456,-0.15621,-0.17741,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.019739,-0.15637,-0.20619,1,0
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0021689,-0.15638,-0.14784,1,0
6,GO ANION TRANSMEMBRANE TRANSPORT,2.8077e-06,-0.1564,-0.16998,1,0
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,9.7346e-05,-0.15647,-0.19696,1,0
6,GO ACID SECRETION,0.0050528,-0.15656,-0.15899,1,0
6,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,5.9841e-06,-0.15657,-0.17228,1,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00034072,-0.15662,-0.21495,1,0
6,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0064317,-0.15672,-0.17117,1,0
6,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,2.4346e-05,-0.15682,-0.1775,1,0
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00020448,-0.15686,-0.15935,1,0
6,GO FATTY ACID DERIVATIVE TRANSPORT,0.0016129,-0.15688,-0.15443,1,0
6,GO HYALURONAN METABOLIC PROCESS,0.00012074,-0.15694,-0.2323,1,0
6,GO LIPOXYGENASE PATHWAY,0.037747,-0.15694,-0.22927,1,0
6,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,2.2524e-05,-0.15702,-0.16244,1,0
6,GO INTRACELLULAR STEROL TRANSPORT,0.0071468,-0.15705,-0.18665,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0007696,-0.15712,-0.13689,1,0
6,GO SARCOMERE ORGANIZATION,0.017969,-0.15713,-0.13473,1,0
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0036303,-0.15718,-0.1289,1,0
6,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.050569,-0.15749,-0.11679,1,0
6,GO CELLULAR RESPONSE TO OXYGEN LEVELS,2.1663e-05,-0.15753,-0.16649,1,0
6,GO REGULATION OF MULTI ORGANISM PROCESS,6.7596e-05,-0.15754,-0.18403,1,0
6,GO REGULATION OF CHOLESTEROL EFFLUX,0.0023671,-0.15758,-0.17104,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0021062,-0.15758,-0.21385,1,0
6,GO TEMPERATURE HOMEOSTASIS,0.00017796,-0.15762,-0.15922,1,0
6,GO PEPTIDYL ARGININE MODIFICATION,0.0011199,-0.15763,-0.15164,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.547e-05,-0.15769,-0.15877,1,0
6,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,3.7791e-06,-0.15778,-0.13918,1,0
6,GO GRANULOCYTE MIGRATION,9.7346e-05,-0.1578,-0.20052,1,0
6,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00010462,-0.15781,-0.17166,1,0
6,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.052669,-0.15791,-0.13213,1,0
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00022676,-0.15793,-0.1855,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00047456,-0.15799,-0.17653,1,0
6,GO RESPONSE TO ACID CHEMICAL,6.0504e-05,-0.15802,-0.1754,1,0
6,GO METAL ION HOMEOSTASIS,1.8251e-06,-0.15806,-0.16772,1,0
6,GO INNATE IMMUNE RESPONSE,0.00021167,-0.15826,-0.1925,1,0
6,GO DIGESTIVE SYSTEM PROCESS,0.007729,-0.15843,-0.13736,1,0
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00029782,-0.15843,-0.17177,1,0
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.043763,-0.15853,-0.12086,1,0
6,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00032948,-0.15853,-0.18694,1,0
6,GO CELLULAR IRON ION HOMEOSTASIS,0.00041602,-0.15855,-0.1634,1,0
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0017641,-0.15855,-0.15135,1,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00069957,-0.15866,-0.18931,1,0
6,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0028957,-0.15877,-0.16363,1,0
6,GO ACTIN FILAMENT DEPOLYMERIZATION,0.014486,-0.15885,-0.12784,1,0
6,GO NEPHRON DEVELOPMENT,0.0013457,-0.15891,-0.16298,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00024286,-0.15901,-0.20785,1,0
6,GO ISOPRENOID METABOLIC PROCESS,0.0020453,-0.15913,-0.17608,1,0
6,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,9.3916e-06,-0.15914,-0.16369,1,0
6,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00036427,-0.15917,-0.1918,1,0
6,GO TUBE MORPHOGENESIS,8.7323e-05,-0.15924,-0.17564,1,0
6,GO RESPONSE TO INTERLEUKIN 4,0.0021062,-0.15929,-0.15961,1,0
6,GO INTERACTION WITH SYMBIONT,2.6307e-05,-0.15935,-0.18856,1,0
6,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00025131,-0.1594,-0.17158,1,0
6,GO TERPENOID METABOLIC PROCESS,0.0024367,-0.15941,-0.18577,1,0
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0013872,-0.15942,-0.21637,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0064317,-0.15949,-0.18983,1,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.014486,-0.15952,-0.18144,1,0
6,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00067758,-0.15961,-0.16698,1,0
6,GO RESPONSE TO FATTY ACID,0.0007696,-0.15977,-0.18808,1,0
6,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00012074,-0.15985,-0.16375,1,0
6,GO COMPLEMENT ACTIVATION,0.00021909,-0.15986,-0.22866,1,0
6,GO L AMINO ACID TRANSPORT,0.0006154,-0.15987,-0.17711,1,0
6,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.015574,-0.15987,-0.18326,1,0
6,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0042883,-0.15989,-0.1368,1,0
6,GO ELECTRON TRANSPORT CHAIN,0.00067758,-0.15992,-0.17366,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0021689,-0.15994,-0.17098,1,0
6,GO B CELL ACTIVATION,0.00040247,-0.15995,-0.15269,1,0
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0087944,-0.16002,-0.23749,1,0
6,GO RESPONSE TO INTERLEUKIN 7,0.001191,-0.16014,-0.17705,1,0
6,GO ACTIVATION OF MAPK ACTIVITY,5.8301e-05,-0.16016,-0.15887,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00065623,-0.16017,-0.23362,1,0
6,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,4.4712e-06,-0.16021,-0.15542,1,0
6,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00353,-0.16028,-0.119,1,0
6,GO SMOOTH MUSCLE CONTRACTION,7.013e-05,-0.16029,-0.18214,1,0
6,GO PLATELET ACTIVATION,0.00098941,-0.1604,-0.17353,1,0
6,GO REGULATION OF ION TRANSPORT,0.00087311,-0.16041,-0.1422,1,0
6,GO CELLULAR RESPONSE TO CALCIUM ION,0.0036303,-0.16043,-0.20127,1,0
6,GO CHLORIDE ION HOMEOSTASIS,0.044685,-0.16063,-0.13548,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.015203,-0.16065,-0.23108,1,0
6,GO REGULATION OF EXOSOMAL SECRETION,0.0081404,-0.16069,-0.19196,1,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00047456,-0.16071,-0.17163,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.00016023,-0.16073,-0.1716,1,0
6,GO MONOCARBOXYLIC ACID TRANSPORT,1.5201e-05,-0.16075,-0.1685,1,0
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.001986,-0.16076,-0.19509,1,0
6,GO REGULATION OF SODIUM ION TRANSPORT,0.0045306,-0.16085,-0.16333,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.030383,-0.16091,-0.13763,1,0
6,GO PROTEIN TARGETING TO LYSOSOME,0.0087944,-0.16093,-0.19182,1,0
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0014299,-0.16094,-0.17082,1,0
6,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00017796,-0.16101,-0.18206,1,0
6,GO PROSTATE GLAND DEVELOPMENT,0.02068,-0.16111,-0.19626,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00038934,-0.1612,-0.17585,1,0
6,GO REGULATION OF GASTRIC ACID SECRETION,0.053746,-0.1613,-0.16775,1,0
6,GO REGULATION OF BODY FLUID LEVELS,5.8301e-05,-0.16133,-0.17764,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,7.013e-05,-0.1614,-0.16891,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00020448,-0.16152,-0.21199,1,0
6,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.00084609,-0.16164,-0.20438,1,0
6,GO CELLULAR RESPIRATION,0.0011549,-0.16169,-0.18604,1,0
6,GO REGULATION OF VIRAL LIFE CYCLE,0.02068,-0.1617,-0.19325,1,0
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0026572,-0.16173,-0.1745,1,0
6,GO NEGATIVE REGULATION OF GROWTH,1.4609e-05,-0.16182,-0.18723,1,0
6,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0014738,-0.16188,-0.21366,1,0
6,GO MECHANORECEPTOR DIFFERENTIATION,0.0056288,-0.16189,-0.16806,1,0
6,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.014138,-0.16192,-0.15789,1,0
6,GO ACYLGLYCEROL HOMEOSTASIS,0.0006154,-0.1621,-0.21143,1,0
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.104e-05,-0.16218,-0.15902,1,0
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.001662,-0.16226,-0.17572,1,0
6,GO CIRCULATORY SYSTEM DEVELOPMENT,7.013e-05,-0.16227,-0.16975,1,0
6,GO MEMBRANE REPOLARIZATION,0.0045306,-0.16237,-0.17003,1,0
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.022165,-0.16244,-0.13719,1,0
6,GO LIPOPROTEIN LOCALIZATION,0.0007696,-0.16247,-0.19823,1,0
6,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.0551e-05,-0.16251,-0.19552,1,0
6,GO COLLAGEN FIBRIL ORGANIZATION,0.0075304,-0.16255,-0.25107,1,0
6,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.1964e-05,-0.16262,-0.15927,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,1.2454e-05,-0.16288,-0.15972,1,0
6,GO REGULATION OF NUCLEASE ACTIVITY,0.001872,-0.16296,-0.18239,1,0
6,GO CELLULAR RESPONSE TO STARVATION,0.00030804,-0.16301,-0.15847,1,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0001547,-0.16323,-0.14937,1,0
6,GO NEURAL CREST CELL MIGRATION,0.02068,-0.16334,-0.17313,1,0
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,1.9263e-05,-0.16334,-0.16825,1,0
6,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00059588,-0.1634,-0.19286,1,0
6,GO CIRCULATORY SYSTEM PROCESS,4.4878e-05,-0.16344,-0.16357,1,0
6,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.038561,-0.16347,-0.15682,1,0
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,7.6603e-06,-0.16354,-0.15281,1,0
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0083534,-0.16356,-0.25365,1,0
6,GO CARBOHYDRATE HOMEOSTASIS,1.7118e-05,-0.16359,-0.17886,1,0
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.029719,-0.16361,-0.17921,1,0
6,GO EPITHELIAL CELL PROLIFERATION,7.2754e-05,-0.16361,-0.19566,1,0
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,7.9801e-06,-0.16366,-0.17996,1,0
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0013054,-0.16368,-0.14825,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.001986,-0.16374,-0.21832,1,0
6,GO PHOSPHATIDIC ACID METABOLIC PROCESS,4.0073e-05,-0.16375,-0.18492,1,0
6,GO VITAMIN CATABOLIC PROCESS,0.052669,-0.16376,-0.19931,1,0
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00021167,-0.16383,-0.20046,1,0
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0022992,-0.1639,-0.2145,1,0
6,GO REGULATION OF ORGAN GROWTH,0.0013872,-0.16395,-0.16049,1,0
6,GO NEUROMUSCULAR PROCESS,0.0090226,-0.16398,-0.12399,1,0
6,GO ADIPOSE TISSUE DEVELOPMENT,0.01282,-0.16401,-0.12938,1,0
6,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.8583e-05,-0.16419,-0.15219,1,0
6,GO OXIDATIVE PHOSPHORYLATION,0.00055855,-0.16428,-0.20633,1,0
6,GO POSITIVE REGULATION OF ION TRANSPORT,0.00013433,-0.16428,-0.162,1,0
6,GO PROTEIN FOLDING,2.9532e-05,-0.16431,-0.17384,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.6597e-05,-0.16439,-0.1558,1,0
6,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0017123,-0.16452,-0.22763,1,0
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00047456,-0.16453,-0.16442,1,0
6,GO RESPONSE TO HORMONE,1.4674e-06,-0.16455,-0.17929,1,0
6,GO ERYTHROCYTE HOMEOSTASIS,0.00032948,-0.16476,-0.15499,1,0
6,GO B CELL PROLIFERATION,0.00026903,-0.16476,-0.18928,1,0
6,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00057693,-0.1648,-0.17297,1,0
6,GO ALCOHOL CATABOLIC PROCESS,0.0012662,-0.16485,-0.15932,1,0
6,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0042883,-0.16487,-0.17057,1,0
6,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.017549,-0.16493,-0.1663,1,0
6,GO COPII COATED VESICLE BUDDING,2.3654e-06,-0.16494,-0.1989,1,0
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00019079,-0.16496,-0.19239,1,0
6,GO AMMONIUM ION METABOLIC PROCESS,0.030383,-0.16502,-0.20381,1,0
6,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0062634,-0.16502,-0.26547,1,0
6,GO TRNA 5 LEADER REMOVAL,0.0040578,-0.16529,-0.1957,1,0
6,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00079435,-0.1653,-0.17965,1,0
6,GO ORGANELLE FUSION,0.00026903,-0.16532,-0.14279,1,0
6,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,1.1493e-05,-0.16539,-0.17325,1,0
6,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.050569,-0.16541,-0.18656,1,0
6,GO PIGMENT ACCUMULATION,0.0094949,-0.16541,-0.1805,1,0
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0053338,-0.1656,-0.18519,1,0
6,GO DIVALENT INORGANIC CATION TRANSPORT,4.3218e-05,-0.16565,-0.15221,1,0
6,GO BIOLOGICAL ADHESION,2.6307e-05,-0.16571,-0.18526,1,0
6,GO REGULATION OF GLUCONEOGENESIS,0.00087311,-0.1659,-0.14311,1,0
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0007696,-0.16591,-0.16218,1,0
6,GO ACUTE PHASE RESPONSE,0.0015189,-0.16592,-0.20827,1,0
6,GO RRNA METABOLIC PROCESS,0.0064317,-0.16595,-0.18496,1,0
6,GO RIBOSOME BIOGENESIS,0.0087944,-0.16597,-0.19118,1,0
6,GO CELL ACTIVATION,3.3132e-05,-0.16603,-0.18411,1,0
6,GO STEROID BIOSYNTHETIC PROCESS,4.8379e-05,-0.16609,-0.19306,1,0
6,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.025414,-0.16614,-0.13917,1,0
6,GO IMMUNOGLOBULIN SECRETION,0.00092958,-0.16631,-0.24302,1,0
6,GO PURINE NUCLEOSIDE METABOLIC PROCESS,1.349e-05,-0.16633,-0.18981,1,0
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0050528,-0.16641,-0.14558,1,0
6,GO GLIAL CELL PROLIFERATION,0.0060989,-0.16644,-0.16065,1,0
6,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,1.5331e-06,-0.16661,-0.16893,1,0
6,GO IMMATURE T CELL PROLIFERATION,0.0075304,-0.16665,-0.20534,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00012964,-0.16676,-0.17146,1,0
6,GO TRNA 5 END PROCESSING,0.007729,-0.16678,-0.16818,1,0
6,GO TRICARBOXYLIC ACID CYCLE,0.001986,-0.16684,-0.19929,1,0
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.014486,-0.16689,-0.14786,1,0
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.017549,-0.16691,-0.14065,1,0
6,GO GLYCEROLIPID METABOLIC PROCESS,3.7791e-06,-0.16698,-0.16634,1,0
6,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0069616,-0.16698,-0.1563,1,0
6,GO PROTEIN MATURATION,1.5816e-05,-0.16716,-0.17716,1,0
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0038387,-0.16733,-0.25513,1,0
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,1.6729e-06,-0.16734,-0.17716,1,0
6,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.021165,-0.16746,-0.1387,1,0
6,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00014935,-0.16746,-0.19035,1,0
6,GO PROTEIN CONTAINING COMPLEX REMODELING,0.011047,-0.16749,-0.15094,1,0
6,GO REGULATION OF IMMUNE RESPONSE,8.1192e-05,-0.16753,-0.16877,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.001662,-0.1676,-0.21224,1,0
6,GO PEPTIDYL ARGININE N METHYLATION,0.023741,-0.1677,-0.16008,1,0
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0001165,-0.16774,-0.17027,1,0
6,GO CELLULAR AMINO ACID METABOLIC PROCESS,7.013e-05,-0.16777,-0.18227,1,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00074557,-0.16779,-0.21074,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00026903,-0.16794,-0.19292,1,0
6,GO BONE REMODELING,0.0010859,-0.16794,-0.21767,1,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.011612,-0.16797,-0.17192,1,0
6,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.031059,-0.1682,-0.22214,1,0
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0015653,-0.16831,-0.1815,1,0
6,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,5.4121e-05,-0.16833,-0.17302,1,0
6,GO REGULATION OF BLOOD CIRCULATION,0.00095906,-0.16843,-0.16201,1,0
6,GO DEFENSE RESPONSE TO OTHER ORGANISM,8.1192e-05,-0.16846,-0.19175,1,0
6,GO HEART GROWTH,0.0006154,-0.16854,-0.16041,1,0
6,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0011199,-0.16854,-0.16146,1,0
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.011326,-0.16863,-0.18098,1,0
6,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0036303,-0.16864,-0.16116,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0031536,-0.16866,-0.15839,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00018427,-0.16884,-0.19714,1,0
6,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.018398,-0.16884,-0.16331,1,0
6,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0038387,-0.16894,-0.16913,1,0
6,GO ADAPTIVE THERMOGENESIS,9.7346e-05,-0.16898,-0.17099,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE,2.4346e-05,-0.16905,-0.19892,1,0
6,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00057693,-0.16908,-0.1724,1,0
6,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,7.3528e-06,-0.1691,-0.15904,1,0
6,GO CELLULAR RESPONSE TO DSRNA,0.015953,-0.16913,-0.17706,1,0
6,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.4609e-05,-0.1692,-0.16391,1,0
6,GO LYMPHOCYTE MIGRATION,0.00014418,-0.16926,-0.18775,1,0
6,GO REGULATION OF LIPASE ACTIVITY,1.9904e-06,-0.16933,-0.21799,1,0
6,GO NEGATIVE REGULATION OF CELL SIZE,0.0046564,-0.16934,-0.18116,1,0
6,GO PROTEIN AUTOPHOSPHORYLATION,3.7145e-05,-0.16935,-0.1607,1,0
6,GO CELLULAR RESPONSE TO FATTY ACID,0.021165,-0.16945,-0.16655,1,0
6,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00022676,-0.1695,-0.23575,1,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.01282,-0.16951,-0.16733,1,0
6,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00041602,-0.16951,-0.18072,1,0
6,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.018836,-0.16958,-0.18007,1,0
6,GO GOLGI VESICLE BUDDING,8.628e-07,-0.16958,-0.20599,1,0
6,GO RESPONSE TO IMMOBILIZATION STRESS,0.010245,-0.1696,-0.21371,1,0
6,GO CHLORIDE TRANSPORT,0.00011241,-0.16969,-0.16592,1,0
6,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00029782,-0.16973,-0.19011,1,0
6,GO RESPONSE TO CORTICOSTERONE,0.012203,-0.16975,-0.22993,1,0
6,GO REGULATION OF ATP METABOLIC PROCESS,2.6307e-05,-0.16985,-0.16114,1,0
6,GO CELLULAR RESPONSE TO LIPID,5.508e-06,-0.16988,-0.18516,1,0
6,GO RESPONSE TO ALCOHOL,6.2786e-05,-0.17,-0.16417,1,0
6,GO GOLGI TO ENDOSOME TRANSPORT,0.0045306,-0.17006,-0.17336,1,0
6,GO REGULATION OF SYNAPSE ASSEMBLY,0.036164,-0.17014,-0.12944,1,0
6,GO STRIATED MUSCLE ADAPTATION,0.0022332,-0.17016,-0.18827,1,0
6,GO REGULATION OF AUTOPHAGY,2.3654e-06,-0.17021,-0.17256,1,0
6,GO SUPEROXIDE METABOLIC PROCESS,0.0057817,-0.17038,-0.16505,1,0
6,GO CELLULAR HOMEOSTASIS,9.8628e-07,-0.17057,-0.16042,1,0
6,GO POSITIVE REGULATION OF HEART GROWTH,0.0015189,-0.17068,-0.19856,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,2.4346e-05,-0.17069,-0.20009,1,0
6,GO FATTY ACID TRANSPORT,7.6603e-06,-0.17073,-0.19495,1,0
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0034322,-0.17081,-0.20522,1,0
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00017796,-0.17081,-0.22199,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00045924,-0.1709,-0.25421,1,0
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.011904,-0.17093,-0.21158,1,0
6,GO FAT CELL DIFFERENTIATION,0.00010845,-0.17102,-0.18616,1,0
6,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,4.1617e-05,-0.17116,-0.17765,1,0
6,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,5.0226e-05,-0.17123,-0.19495,1,0
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0001165,-0.17136,-0.16457,1,0
6,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,9.8628e-07,-0.17139,-0.1711,1,0
6,GO PROTEIN DEMANNOSYLATION,0.0011549,-0.1715,-0.26293,1,0
6,GO PEPTIDYL HISTIDINE MODIFICATION,0.0034322,-0.17161,-0.19887,1,0
6,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.6597e-05,-0.17167,-0.17165,1,0
6,GO REGULATION OF ENDOCRINE PROCESS,0.00087311,-0.17183,-0.18099,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0081404,-0.17188,-0.18258,1,0
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.03245,-0.1719,-0.16024,1,0
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.6603e-06,-0.17226,-0.17487,1,0
6,GO STRESS FIBER ASSEMBLY,0.00017186,-0.17228,-0.2203,1,0
6,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00054072,-0.1723,-0.17545,1,0
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,3.7145e-05,-0.17236,-0.20072,1,0
6,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0085714,-0.17236,-0.167,1,0
6,GO GAP JUNCTION ASSEMBLY,0.03245,-0.17241,-0.23696,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.013139,-0.1725,-0.17384,1,0
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0017641,-0.17251,-0.22488,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.011612,-0.17256,-0.19374,1,0
6,GO MAMMARY GLAND DEVELOPMENT,0.00010092,-0.17271,-0.18519,1,0
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.034637,-0.17272,-0.15881,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00012964,-0.17295,-0.18528,1,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.036948,-0.17296,-0.14057,1,0
6,GO SEQUESTERING OF METAL ION,0.033894,-0.17298,-0.15381,1,0
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.013798,-0.17327,-0.14944,1,0
6,GO LIVER MORPHOGENESIS,0.033894,-0.17334,-0.2135,1,0
6,GO MESONEPHROS DEVELOPMENT,0.0079323,-0.17338,-0.16145,1,0
6,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.041967,-0.17339,-0.16446,1,0
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0001547,-0.1735,-0.18891,1,0
6,GO CELLULAR LIPID METABOLIC PROCESS,1.4674e-06,-0.17361,-0.18877,1,0
6,GO HEART MORPHOGENESIS,0.00095906,-0.17375,-0.1455,1,0
6,GO NEGATIVE REGULATION OF HEMOPOIESIS,4.1617e-05,-0.17376,-0.21927,1,0
6,GO REGULATION OF RUFFLE ASSEMBLY,0.0060989,-0.17378,-0.15733,1,0
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,2.9532e-05,-0.1738,-0.16777,1,0
6,GO RESPONSE TO OXYGEN LEVELS,4.7955e-07,-0.17383,-0.21613,1,0
6,GO ALPHA BETA T CELL PROLIFERATION,0.014138,-0.17398,-0.17913,1,0
6,GO NUCLEOSIDE METABOLIC PROCESS,0.00037661,-0.17409,-0.14254,1,0
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0069616,-0.1741,-0.16943,1,0
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00087311,-0.17421,-0.20354,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.020205,-0.17436,-0.14903,1,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0021689,-0.17437,-0.14944,1,0
6,GO DEFENSE RESPONSE TO BACTERIUM,4.8379e-05,-0.17448,-0.19096,1,0
6,GO ENDOCRINE HORMONE SECRETION,0.0060989,-0.1747,-0.16092,1,0
6,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0073363,-0.17473,-0.17858,1,0
6,GO INTERLEUKIN 1 BETA PRODUCTION,0.0050528,-0.17477,-0.21208,1,0
6,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00081984,-0.17478,-0.14016,1,0
6,GO REGULATION OF HEART GROWTH,0.0042883,-0.17482,-0.14708,1,0
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00026003,-0.17484,-0.16132,1,0
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.2862e-06,-0.17484,-0.18492,1,0
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0014738,-0.17487,-0.17673,1,0
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.015953,-0.17488,-0.24559,1,0
6,GO AORTA DEVELOPMENT,0.0015653,-0.17492,-0.19764,1,0
6,GO REGULATION OF STEROL TRANSPORT,0.00019753,-0.17495,-0.22906,1,0
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,1.349e-05,-0.17496,-0.19586,1,0
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,1.349e-05,-0.17498,-0.1966,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0083534,-0.17499,-0.18156,1,0
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0026572,-0.17503,-0.24243,1,0
6,GO RENAL ABSORPTION,0.04854,-0.17503,-0.27656,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,9.389e-05,-0.17504,-0.20748,1,0
6,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,2.1663e-05,-0.1751,-0.17281,1,0
6,GO REGULATION OF RECEPTOR RECYCLING,0.021165,-0.17511,-0.13227,1,0
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00026903,-0.17515,-0.21009,1,0
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.011047,-0.17525,-0.18471,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.0226e-05,-0.17528,-0.2191,1,0
6,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.031059,-0.17532,-0.2266,1,0
6,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0057817,-0.17542,-0.1565,1,0
6,GO RESPONSE TO OXIDATIVE STRESS,5.9841e-06,-0.17561,-0.1912,1,0
6,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0028141,-0.17578,-0.17318,1,0
6,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,9.0551e-05,-0.17583,-0.16116,1,0
6,GO REGULATION OF MACROPHAGE MIGRATION,0.00022676,-0.17586,-0.20914,1,0
6,GO PROTEIN PROCESSING,8.7323e-05,-0.17604,-0.18524,1,0
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0081404,-0.17606,-0.15298,1,0
6,GO MESODERM MORPHOGENESIS,0.00079435,-0.17611,-0.2121,1,0
6,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0022332,-0.17612,-0.20785,1,0
6,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.038561,-0.17613,-0.21075,1,0
6,GO ENDOCYTOSIS,2.3418e-05,-0.17616,-0.16326,1,0
6,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00074557,-0.17627,-0.20355,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00012964,-0.17634,-0.18806,1,0
6,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00026003,-0.17639,-0.25275,1,0
6,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.018398,-0.17641,-0.17415,1,0
6,GO BONE RESORPTION,0.0016129,-0.17644,-0.19612,1,0
6,GO ION HOMEOSTASIS,1.3441e-06,-0.17644,-0.17241,1,0
6,GO MUSCLE ADAPTATION,2.5308e-05,-0.17652,-0.21795,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0036303,-0.17666,-0.17578,1,0
6,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,7.8282e-05,-0.17681,-0.19314,1,0
6,GO DIVALENT INORGANIC CATION HOMEOSTASIS,4.8612e-06,-0.17702,-0.1717,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0031536,-0.17702,-0.20326,1,0
6,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0039469,-0.17711,-0.15157,1,0
6,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.8077e-06,-0.17715,-0.20281,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00072223,-0.17719,-0.25536,1,0
6,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.014486,-0.17736,-0.29011,1,0
6,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00026003,-0.1775,-0.2004,1,0
6,GO INTEGRIN ACTIVATION,0.0056288,-0.17754,-0.19753,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,3.3287e-06,-0.17765,-0.16421,1,0
6,GO LIPID EXPORT FROM CELL,0.00072223,-0.17765,-0.18625,1,0
6,GO PSEUDOURIDINE SYNTHESIS,0.0090226,-0.17768,-0.2309,1,0
6,GO BLASTODERM SEGMENTATION,0.046579,-0.17769,-0.23112,1,0
6,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0020453,-0.17793,-0.23205,1,0
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,2.5774e-06,-0.17796,-0.19445,1,0
6,GO NUCLEAR ENVELOPE REASSEMBLY,0.012203,-0.178,-0.12229,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00045924,-0.17806,-0.1863,1,0
6,GO FEVER GENERATION,0.0087944,-0.17814,-0.19127,1,0
6,GO FATTY ACID BETA OXIDATION,0.00014418,-0.17818,-0.20553,1,0
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,5.0683e-06,-0.17834,-0.17715,1,0
6,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00035231,-0.17835,-0.21428,1,0
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0025083,-0.17843,-0.19983,1,0
6,GO RESPONSE TO BIOTIC STIMULUS,1.9263e-05,-0.17853,-0.19113,1,0
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,2.6307e-05,-0.17855,-0.18586,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.027803,-0.17872,-0.18985,1,0
6,GO VASCULATURE DEVELOPMENT,5.0226e-05,-0.17872,-0.20137,1,0
6,GO RESPONSE TO STEROL,0.0021689,-0.17878,-0.20255,1,0
6,GO VACUOLE ORGANIZATION,2.0784e-06,-0.17881,-0.18653,1,0
6,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00018427,-0.17882,-0.26392,1,0
6,GO ENDODERMAL CELL DIFFERENTIATION,0.00026003,-0.17885,-0.33994,1,0
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00030804,-0.17893,-0.19201,1,0
6,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0081404,-0.17901,-0.18085,1,0
6,GO CARDIAC SEPTUM MORPHOGENESIS,0.033166,-0.17906,-0.16938,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,4.6623e-06,-0.17915,-0.16876,1,0
6,GO CELLULAR RESPONSE TO ATP,0.0020453,-0.17921,-0.1682,1,0
6,GO NEGATIVE REGULATION OF GENE SILENCING,0.0026572,-0.17921,-0.18483,1,0
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00063551,-0.17925,-0.256,1,0
6,GO REGULATION OF BLOOD PRESSURE,6.0504e-05,-0.17926,-0.17817,1,0
6,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00026003,-0.17946,-0.18247,1,0
6,GO MEMBRANE FUSION,3.5759e-05,-0.17953,-0.18078,1,0
6,GO RESPONSE TO ORGANOPHOSPHORUS,3.5759e-05,-0.17969,-0.18881,1,0
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00010092,-0.17971,-0.16612,1,0
6,GO REGULATION OF TRANSPORTER ACTIVITY,0.0010206,-0.17971,-0.15674,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS,5.7413e-06,-0.17997,-0.18302,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.015203,-0.17998,-0.20161,1,0
6,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.012203,-0.18007,-0.17773,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,6.0504e-05,-0.18011,-0.17106,1,0
6,GO REGULATION OF CELL CELL ADHESION,0.00013433,-0.18018,-0.19647,1,0
6,GO LYMPHOCYTE CHEMOTAXIS,0.00026003,-0.1802,-0.19295,1,0
6,GO REGULATION OF CELL ADHESION,8.7323e-05,-0.18025,-0.20079,1,0
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0090226,-0.18027,-0.1595,1,0
6,GO AMINO SUGAR METABOLIC PROCESS,0.00038934,-0.18027,-0.1959,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0006154,-0.18033,-0.23483,1,0
6,GO MODIFIED AMINO ACID TRANSPORT,0.00019079,-0.18041,-0.2093,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00012074,-0.18044,-0.23342,1,0
6,GO T CELL PROLIFERATION,8.1192e-05,-0.18055,-0.20864,1,0
6,GO CYTOKINE PRODUCTION,5.4121e-05,-0.18062,-0.18891,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0022332,-0.18062,-0.22707,1,0
6,GO COENZYME A METABOLIC PROCESS,0.0053338,-0.18064,-0.17397,1,0
6,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,9.389e-05,-0.18066,-0.25614,1,0
6,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.1964e-05,-0.18066,-0.22534,1,0
6,GO MYOBLAST PROLIFERATION,0.017137,-0.18067,-0.16124,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0060989,-0.18077,-0.20945,1,0
6,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00067758,-0.18077,-0.27392,1,0
6,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00052342,-0.18098,-0.25153,1,0
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,7.3528e-06,-0.18109,-0.18297,1,0
6,GO FOCAL ADHESION ASSEMBLY,0.00050664,-0.18113,-0.21908,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0022332,-0.18113,-0.22207,1,0
6,GO RESPONSE TO AXON INJURY,0.0056288,-0.18138,-0.14078,1,0
6,GO REGULATION OF METAL ION TRANSPORT,1.8521e-05,-0.18143,-0.16855,1,0
6,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0053338,-0.18147,-0.23319,1,0
6,GO REGULATION OF MAST CELL ACTIVATION,0.025994,-0.18154,-0.13537,1,0
6,GO REGULATION OF MUSCLE HYPERTROPHY,0.00014418,-0.1816,-0.20804,1,0
6,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00049035,-0.18163,-0.1978,1,0
6,GO INTERLEUKIN 17 PRODUCTION,0.00017186,-0.18164,-0.23576,1,0
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.4609e-05,-0.18173,-0.16533,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION,0.00037661,-0.18178,-0.21555,1,0
6,GO RESPONSE TO DSRNA,0.00023468,-0.18179,-0.19788,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00087311,-0.18182,-0.17216,1,0
6,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,5.508e-06,-0.1819,-0.1943,1,0
6,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0041716,-0.18191,-0.21696,1,0
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0037331,-0.18199,-0.20331,1,0
6,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0011549,-0.18205,-0.1483,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00016023,-0.18206,-0.171,1,0
6,GO MACROPHAGE MIGRATION,7.547e-05,-0.18215,-0.24226,1,0
6,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00072223,-0.18218,-0.2267,1,0
6,GO APICAL JUNCTION ASSEMBLY,0.037747,-0.18228,-0.13263,1,0
6,GO ASYMMETRIC CELL DIVISION,0.0090226,-0.18231,-0.19856,1,0
6,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.349e-05,-0.18233,-0.22894,1,0
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0018173,-0.18238,-0.184,1,0
6,GO DICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,-0.18238,-0.20026,1,0
6,GO METANEPHRIC NEPHRON DEVELOPMENT,0.016339,-0.18239,-0.16524,1,0
6,GO GLUCOSE METABOLIC PROCESS,3.9418e-06,-0.18245,-0.17623,1,0
6,GO ATP METABOLIC PROCESS,6.4994e-06,-0.18248,-0.18067,1,0
6,GO LONG TERM MEMORY,0.023205,-0.18249,-0.15855,1,0
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,4.6597e-05,-0.18249,-0.19353,1,0
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00026003,-0.18267,-0.18343,1,0
6,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00072223,-0.18268,-0.14377,1,0
6,GO MYOTUBE DIFFERENTIATION,0.00052342,-0.18291,-0.16833,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0025817,-0.18294,-0.25766,1,0
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,4.1617e-05,-0.18298,-0.23296,1,0
6,GO AUTOPHAGOSOME MATURATION,0.00069957,-0.18304,-0.1911,1,0
6,GO OSTEOCLAST DEVELOPMENT,0.018836,-0.18311,-0.16636,1,0
6,GO RESPONSE TO CAMP,7.013e-05,-0.18312,-0.20158,1,0
6,GO PROTEIN TARGETING TO MEMBRANE,0.00055855,-0.18314,-0.23101,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0038387,-0.18318,-0.19465,1,0
6,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,6.0198e-07,-0.18322,-0.17932,1,0
6,GO PROTEIN HOMOTETRAMERIZATION,7.547e-05,-0.18324,-0.15377,1,0
6,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00040247,-0.1833,-0.21095,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.4421e-05,-0.18339,-0.23002,1,0
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.050569,-0.1834,-0.20928,1,0
6,GO REGULATION OF TISSUE REMODELING,0.00054072,-0.18346,-0.20583,1,0
6,GO MACROPHAGE ACTIVATION,0.0001547,-0.18347,-0.20181,1,0
6,GO PROTEIN TARGETING,6.2367e-06,-0.18352,-0.201,1,0
6,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.018836,-0.18359,-0.12467,1,0
6,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.6307e-05,-0.1837,-0.20151,1,0
6,GO LEUKOCYTE CHEMOTAXIS,0.00040247,-0.18377,-0.18481,1,0
6,GO RESPONSE TO INTERLEUKIN 12,0.00079435,-0.18378,-0.22923,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0057817,-0.18384,-0.18845,1,0
6,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.2786e-05,-0.1839,-0.23637,1,0
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,1.4609e-05,-0.18397,-0.19793,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,2.7343e-05,-0.18409,-0.23811,1,0
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,9.0179e-06,-0.18409,-0.16693,1,0
6,GO VIRAL TRANSLATION,0.0071468,-0.18411,-0.2348,1,0
6,GO POSITIVE REGULATION OF BINDING,3.4421e-05,-0.18416,-0.1634,1,0
6,GO REGULATION OF PEPTIDASE ACTIVITY,0.00013433,-0.18424,-0.18685,1,0
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00027832,-0.18427,-0.20973,1,0
6,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0057817,-0.18428,-0.20403,1,0
6,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00049035,-0.18432,-0.23642,1,0
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,4.6623e-06,-0.18449,-0.21986,1,0
6,GO ENDODERM DEVELOPMENT,0.00067758,-0.1845,-0.27544,1,0
6,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0059384,-0.18453,-0.18405,1,0
6,GO MITOCHONDRIAL TRANSLATION,0.001191,-0.18453,-0.20999,1,0
6,GO LIPID METABOLIC PROCESS,1.2862e-06,-0.1846,-0.1864,1,0
6,GO PROTEIN TETRAMERIZATION,5.8301e-05,-0.18476,-0.15777,1,0
6,GO RESPONSE TO STEROID HORMONE,5.508e-06,-0.18487,-0.2049,1,0
6,GO ORGAN INDUCTION,0.0010206,-0.18489,-0.20822,1,0
6,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0075304,-0.18506,-0.1997,1,0
6,GO SECONDARY METABOLIC PROCESS,0.0099891,-0.18511,-0.17341,1,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,3.8583e-05,-0.18525,-0.18647,1,0
6,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.00040247,-0.18527,-0.21077,1,0
6,GO RESPONSE TO STARVATION,4.1617e-05,-0.18528,-0.18372,1,0
6,GO CYTOPLASMIC TRANSLATION,0.0040578,-0.18529,-0.2697,1,0
6,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00087311,-0.18532,-0.25392,1,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.5816e-05,-0.18533,-0.20408,1,0
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,1.4039e-05,-0.18533,-0.18271,1,0
6,GO CHOLESTEROL EFFLUX,6.7596e-05,-0.18536,-0.21759,1,0
6,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00010092,-0.18538,-0.21389,1,0
6,GO EXOCYTOSIS,6.2367e-06,-0.18543,-0.19804,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0054795,-0.1855,-0.16447,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00095906,-0.18551,-0.2146,1,0
6,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00012512,-0.18568,-0.15748,1,0
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00022676,-0.18569,-0.19611,1,0
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0094949,-0.18573,-0.33959,1,0
6,GO VESICLE TARGETING,9.7801e-06,-0.18581,-0.21115,1,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00037661,-0.18582,-0.22584,1,0
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0075304,-0.18587,-0.1509,1,0
6,GO INTERLEUKIN 1 PRODUCTION,0.0045306,-0.18594,-0.21997,1,0
6,GO DEFENSE RESPONSE,2.8418e-05,-0.18594,-0.18964,1,0
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.6597e-05,-0.18605,-0.17456,1,0
6,GO SELECTIVE AUTOPHAGY,2.3418e-05,-0.1861,-0.2058,1,0
6,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00098941,-0.1864,-0.18928,1,0
6,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0073363,-0.18641,-0.15966,1,0
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.031748,-0.18648,-0.20951,1,0
6,GO ETHER BIOSYNTHETIC PROCESS,0.010773,-0.1865,-0.28473,1,0
6,GO FLUID TRANSPORT,0.00052342,-0.18654,-0.19597,1,0
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0040578,-0.18663,-0.20289,1,0
6,GO REGULATION OF PHAGOCYTOSIS,0.00018427,-0.18666,-0.21294,1,0
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00028792,-0.18676,-0.17174,1,0
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.011612,-0.18684,-0.19518,1,0
6,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.043763,-0.18695,-0.13117,1,0
6,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00036427,-0.187,-0.26277,1,0
6,GO REGENERATION,2.0033e-05,-0.18704,-0.21743,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0037331,-0.18712,-0.22354,1,0
6,GO REGULATION OF LIPID METABOLIC PROCESS,1.8251e-06,-0.18713,-0.1966,1,0
6,GO TISSUE REMODELING,0.00087311,-0.18713,-0.21237,1,0
6,GO DIET INDUCED THERMOGENESIS,0.0033369,-0.18714,-0.20229,1,0
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00087311,-0.18723,-0.17751,1,0
6,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.00042998,-0.18739,-0.17313,1,0
6,GO PROTEIN ACTIVATION CASCADE,0.00021167,-0.18742,-0.26191,1,0
6,GO RESPONSE TO CADMIUM ION,0.0041716,-0.18751,-0.22886,1,0
6,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00018427,-0.18751,-0.2755,1,0
6,GO POSITIVE REGULATION OF COAGULATION,0.0046564,-0.18757,-0.19791,1,0
6,GO RESPONSE TO TOXIC SUBSTANCE,2.6307e-05,-0.18769,-0.19787,1,0
6,GO ANTIMICROBIAL HUMORAL RESPONSE,6.2367e-06,-0.1877,-0.21867,1,0
6,GO ELASTIC FIBER ASSEMBLY,0.024846,-0.18779,-0.32723,1,0
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,3.1904e-06,-0.18796,-0.1812,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00090094,-0.18799,-0.16679,1,0
6,GO EXCRETION,0.0010859,-0.18799,-0.16579,1,0
6,GO REGULATION OF LYSOSOMAL LUMEN PH,0.018398,-0.18814,-0.15917,1,0
6,GO NEUTRAL LIPID METABOLIC PROCESS,5.2837e-06,-0.18826,-0.21052,1,0
6,GO DENDRITIC CELL CHEMOTAXIS,0.0042883,-0.1883,-0.20703,1,0
6,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00011241,-0.18837,-0.23459,1,0
6,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.03939,-0.18838,-0.17909,1,0
6,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.016734,-0.18848,-0.29201,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0017641,-0.18863,-0.25206,1,0
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,4.4712e-06,-0.18876,-0.19328,1,0
6,GO INTRACELLULAR LIPID TRANSPORT,0.00092958,-0.18883,-0.19175,1,0
6,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0012662,-0.18887,-0.2017,1,0
6,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0081404,-0.18903,-0.20902,1,0
6,GO PLASMA MEMBRANE TUBULATION,0.012508,-0.18915,-0.16706,1,0
6,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,3.8583e-05,-0.18922,-0.1994,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00032948,-0.18929,-0.22814,1,0
6,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0020453,-0.18929,-0.20965,1,0
6,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00052342,-0.1893,-0.26087,1,0
6,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0013054,-0.18936,-0.21854,1,0
6,GO IMPORT INTO CELL,0.00014935,-0.18955,-0.18329,1,0
6,GO RESPONSE TO MUSCLE ACTIVITY,0.019739,-0.18955,-0.19226,1,0
6,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.018836,-0.18977,-0.1841,1,0
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0024367,-0.1898,-0.19809,1,0
6,GO AEROBIC RESPIRATION,2.6307e-05,-0.18981,-0.24084,1,0
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0014738,-0.18981,-0.21899,1,0
6,GO VITAMIN METABOLIC PROCESS,5.4121e-05,-0.18987,-0.192,1,0
6,GO SULFUR COMPOUND TRANSPORT,6.0504e-05,-0.19004,-0.19037,1,0
6,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0027346,-0.19006,-0.20555,1,0
6,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,2.5308e-05,-0.19012,-0.21752,1,0
6,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0054795,-0.19013,-0.2602,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,5.0683e-06,-0.19022,-0.18133,1,0
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00023468,-0.19027,-0.1851,1,0
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0010859,-0.19034,-0.17295,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,7.0571e-06,-0.19036,-0.17753,1,0
6,GO MEMBRANE BIOGENESIS,0.011047,-0.19048,-0.18653,1,0
6,GO ANOIKIS,0.025414,-0.19052,-0.1684,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.4878e-05,-0.19057,-0.19585,1,0
6,GO RESPONSE TO COLD,0.0027346,-0.19063,-0.25051,1,0
6,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010845,-0.19066,-0.22239,1,0
6,GO RESPONSE TO NUTRIENT,0.00029782,-0.19072,-0.18631,1,0
6,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0090226,-0.19089,-0.21952,1,0
6,GO IMMUNE EFFECTOR PROCESS,3.0689e-05,-0.19092,-0.20659,1,0
6,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00029782,-0.19093,-0.19958,1,0
6,GO RIBOSE PHOSPHATE METABOLIC PROCESS,1.1776e-06,-0.19104,-0.18764,1,0
6,GO REGULATION OF CHLORIDE TRANSPORT,0.02843,-0.19108,-0.19422,1,0
6,GO POLYSACCHARIDE METABOLIC PROCESS,1.5201e-05,-0.19108,-0.20365,1,0
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00026903,-0.19109,-0.21468,1,0
6,GO PROSTANOID METABOLIC PROCESS,0.0066042,-0.19114,-0.27423,1,0
6,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.2139e-05,-0.19155,-0.18489,1,0
6,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,1.4044e-06,-0.1916,-0.18028,1,0
6,GO RRNA PSEUDOURIDINE SYNTHESIS,0.038561,-0.19161,-0.21071,1,0
6,GO GENITALIA DEVELOPMENT,0.00035231,-0.19168,-0.17603,1,0
6,GO POSITIVE REGULATION OF OSSIFICATION,0.00023468,-0.19175,-0.2367,1,0
6,GO P38MAPK CASCADE,0.00012074,-0.19176,-0.23197,1,0
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0064317,-0.19182,-0.16658,1,0
6,GO LONG CHAIN FATTY ACID TRANSPORT,5.2837e-06,-0.19186,-0.20126,1,0
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0081404,-0.19188,-0.18737,1,0
6,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0032441,-0.19193,-0.16419,1,0
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,9.7346e-05,-0.19196,-0.25422,1,0
6,GO REGULATION OF VASCULAR PERMEABILITY,0.00021167,-0.19206,-0.22228,1,0
6,GO ORGANOPHOSPHATE METABOLIC PROCESS,5.4977e-07,-0.1921,-0.1708,1,0
6,GO REGULATION OF OSSIFICATION,7.2754e-05,-0.19214,-0.20372,1,0
6,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,6.7728e-06,-0.19219,-0.22973,1,0
6,GO REGULATION OF VASCULATURE DEVELOPMENT,6.0504e-05,-0.19226,-0.21939,1,0
6,GO MYELOID LEUKOCYTE MIGRATION,2.7343e-05,-0.19235,-0.21981,1,0
6,GO LAMELLIPODIUM ASSEMBLY,0.00012512,-0.19247,-0.18311,1,0
6,GO ORGANIC CATION TRANSPORT,0.0022332,-0.19251,-0.18599,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.001986,-0.1927,-0.1875,1,0
6,GO LIPID OXIDATION,1.2962e-05,-0.19272,-0.22259,1,0
6,GO REGULATION OF LIPID TRANSPORT,2.1663e-05,-0.19273,-0.20276,1,0
6,GO STEROID METABOLIC PROCESS,6.4994e-06,-0.19278,-0.2141,1,0
6,GO ENGULFMENT OF APOPTOTIC CELL,0.00092958,-0.19285,-0.22214,1,0
6,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.038561,-0.19287,-0.21393,1,0
6,GO PENTOSE METABOLIC PROCESS,0.0013054,-0.19287,-0.27154,1,0
6,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0029794,-0.19288,-0.28702,1,0
6,GO DIOL BIOSYNTHETIC PROCESS,0.0059384,-0.19295,-0.18721,1,0
6,GO NEGATIVE REGULATION OF CELL ACTIVATION,1.9263e-05,-0.19301,-0.22393,1,0
6,GO AMIDE BIOSYNTHETIC PROCESS,1.4609e-05,-0.19311,-0.19359,1,0
6,GO CD40 SIGNALING PATHWAY,0.00042998,-0.19312,-0.28198,1,0
6,GO SKELETAL MUSCLE CONTRACTION,0.0028141,-0.19319,-0.20111,1,0
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00016595,-0.19326,-0.23439,1,0
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0050528,-0.19327,-0.30121,1,0
6,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00063551,-0.19333,-0.23384,1,0
6,GO REGULATION OF T CELL CHEMOTAXIS,0.0056288,-0.19335,-0.17303,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,2.6902e-06,-0.19343,-0.18037,1,0
6,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00032948,-0.19358,-0.19072,1,0
6,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.010506,-0.19358,-0.17904,1,0
6,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,3.8583e-05,-0.1936,-0.2447,1,0
6,GO NEGATIVE REGULATION OF MAPK CASCADE,1.6455e-05,-0.19366,-0.20548,1,0
6,GO AMINE CATABOLIC PROCESS,0.0025083,-0.19367,-0.26816,1,0
6,GO LIPID LOCALIZATION,2.2658e-06,-0.1937,-0.20746,1,0
6,GO STEROL HOMEOSTASIS,0.00038934,-0.19377,-0.21121,1,0
6,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.2524e-05,-0.19379,-0.19906,1,0
6,GO RESPONSE TO WOUNDING,8.1192e-05,-0.19384,-0.21045,1,0
6,GO PIGMENT GRANULE MATURATION,0.001191,-0.19387,-0.26814,1,0
6,GO CARDIAC SEPTUM DEVELOPMENT,0.0027346,-0.19392,-0.18077,1,0
6,GO CELLULAR RESPONSE TO PH,0.0010528,-0.19405,-0.1929,1,0
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,1.1493e-05,-0.19422,-0.2288,1,0
6,GO PYRUVATE METABOLIC PROCESS,4.4712e-06,-0.1944,-0.20525,1,0
6,GO CARBOHYDRATE METABOLIC PROCESS,3.4772e-07,-0.19461,-0.19845,1,0
6,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0028141,-0.19467,-0.19867,1,0
6,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0015189,-0.19477,-0.1913,1,0
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0021062,-0.19479,-0.14635,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.7806e-05,-0.19483,-0.21926,1,0
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0007696,-0.19488,-0.22015,1,0
6,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.014841,-0.19488,-0.28752,1,0
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00072223,-0.19492,-0.22662,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.001872,-0.19494,-0.31465,1,0
6,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00019753,-0.19494,-0.19828,1,0
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.010506,-0.19495,-0.15905,1,0
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0013457,-0.19508,-0.26905,1,0
6,GO INFLAMMATORY RESPONSE,2.8418e-05,-0.19513,-0.20501,1,0
6,GO BLOOD VESSEL MORPHOGENESIS,4.8379e-05,-0.19515,-0.21633,1,0
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00063551,-0.19516,-0.18477,1,0
6,GO MACROPHAGE CHEMOTAXIS,0.0001165,-0.19529,-0.24856,1,0
6,GO REGULATION OF SULFUR METABOLIC PROCESS,0.023741,-0.19533,-0.17977,1,0
6,GO SERTOLI CELL DEVELOPMENT,0.033166,-0.19538,-0.18367,1,0
6,GO PIGMENT GRANULE ORGANIZATION,0.0042883,-0.1954,-0.1787,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.023205,-0.19541,-0.26636,1,0
6,GO REGULATION OF MUSCLE CONTRACTION,2.5308e-05,-0.19545,-0.19453,1,0
6,GO ANIMAL ORGAN MATURATION,0.013139,-0.19548,-0.16142,1,0
6,GO FOLIC ACID METABOLIC PROCESS,0.001986,-0.19567,-0.19832,1,0
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,2.5308e-05,-0.19571,-0.1958,1,0
6,GO HEART TRABECULA MORPHOGENESIS,0.001191,-0.19572,-0.22044,1,0
6,GO REGULATION OF BONE MINERALIZATION,4.4878e-05,-0.19575,-0.24332,1,0
6,GO RESPONSE TO ESTROGEN,2.0833e-05,-0.19578,-0.24776,1,0
6,GO PROSTAGLANDIN TRANSPORT,0.0028141,-0.19593,-0.18266,1,0
6,GO RESPONSE TO CYTOKINE,2.2524e-05,-0.196,-0.20518,1,0
6,GO BONE MINERALIZATION,2.0833e-05,-0.19607,-0.23789,1,0
6,GO RESPIRATORY BURST,0.0007696,-0.19609,-0.25535,1,0
6,GO AMYLOID BETA CLEARANCE,0.00065623,-0.19611,-0.24706,1,0
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,2.0784e-06,-0.19617,-0.19767,1,0
6,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.0504e-05,-0.19618,-0.18987,1,0
6,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.2139e-05,-0.1962,-0.22208,1,0
6,GO CERAMIDE TRANSPORT,0.0038387,-0.19622,-0.22251,1,0
6,GO IRON SULFUR CLUSTER ASSEMBLY,0.0011549,-0.19635,-0.23355,1,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,4.6597e-05,-0.19636,-0.19665,1,0
6,GO AUTOPHAGY OF NUCLEUS,0.00049035,-0.19672,-0.22308,1,0
6,GO CYTOKINE METABOLIC PROCESS,0.00023468,-0.19678,-0.2294,1,0
6,GO CELLULAR GLUCOSE HOMEOSTASIS,2.9532e-05,-0.19679,-0.17593,1,0
6,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.4044e-06,-0.1968,-0.23695,1,0
6,GO T CELL CYTOKINE PRODUCTION,0.00050664,-0.19683,-0.22032,1,0
6,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00029782,-0.19691,-0.21197,1,0
6,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00063551,-0.19714,-0.34779,1,0
6,GO RESPONSE TO LIPID,1.5331e-06,-0.19717,-0.19818,1,0
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.029068,-0.19729,-0.16232,1,0
6,GO B CELL MEDIATED IMMUNITY,0.001872,-0.19742,-0.19438,1,0
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0032441,-0.19746,-0.21308,1,0
6,GO REGULATION OF BONE REMODELING,0.0075304,-0.19747,-0.19412,1,0
6,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.0226e-05,-0.19757,-0.22598,1,0
6,GO RESPONSE TO ANGIOTENSIN,0.0011549,-0.19766,-0.23421,1,0
6,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,5.0683e-06,-0.19772,-0.19323,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.019739,-0.19782,-0.16365,1,0
6,GO CELLULAR RESPONSE TO IRON ION,0.033166,-0.19783,-0.16944,1,0
6,GO SULFUR AMINO ACID METABOLIC PROCESS,6.7596e-05,-0.19794,-0.24823,1,0
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.013139,-0.19797,-0.24668,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00065623,-0.19804,-0.21653,1,0
6,GO REGULATION OF CALCIUM ION TRANSPORT,3.9418e-06,-0.19817,-0.20224,1,0
6,GO LAMELLIPODIUM ORGANIZATION,2.4346e-05,-0.19824,-0.20875,1,0
6,GO IMP METABOLIC PROCESS,0.027803,-0.1984,-0.23581,1,0
6,GO REGULATION OF PROTEIN BINDING,3.4728e-06,-0.1984,-0.19881,1,0
6,GO ORGANELLE MEMBRANE FUSION,0.00018427,-0.19853,-0.17743,1,0
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.049546,-0.19861,-0.16428,1,0
6,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0056288,-0.19866,-0.17138,1,0
6,GO NEGATIVE CHEMOTAXIS,0.00090094,-0.1987,-0.26456,1,0
6,GO LAMELLIPODIUM MORPHOGENESIS,0.0060989,-0.19876,-0.23227,1,0
6,GO POLYOL BIOSYNTHETIC PROCESS,8.6584e-06,-0.1989,-0.21168,1,0
6,GO ORGANIC ACID METABOLIC PROCESS,6.5896e-07,-0.19891,-0.19679,1,0
6,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.011612,-0.19892,-0.17732,1,0
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0010206,-0.19913,-0.2206,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.6597e-05,-0.19916,-0.22929,1,0
6,GO BLOOD VESSEL REMODELING,0.00031859,-0.19916,-0.26698,1,0
6,GO RESPONSE TO MINERALOCORTICOID,0.00067758,-0.19919,-0.23493,1,0
6,GO CELLULAR RESPONSE TO STEROL,0.014841,-0.19941,-0.18385,1,0
6,GO WOUND HEALING,7.8282e-05,-0.19962,-0.22274,1,0
6,GO INTERACTION WITH HOST,5.6174e-05,-0.19972,-0.21958,1,0
6,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.0833e-05,-0.19972,-0.22938,1,0
6,GO NUCLEOTIDE PHOSPHORYLATION,7.0571e-06,-0.19975,-0.20364,1,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.00059588,-0.19988,-0.27691,1,0
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.010506,-0.19992,-0.15139,1,0
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,1.1267e-06,-0.19999,-0.19781,1,0
6,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0094949,-0.20005,-0.20339,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.022165,-0.2001,-0.20737,1,0
6,GO CELLULAR AMIDE METABOLIC PROCESS,6.0198e-07,-0.20013,-0.2024,1,0
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0023671,-0.20023,-0.24028,1,0
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,9.7346e-05,-0.20051,-0.20477,1,0
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,3.4728e-06,-0.20065,-0.18924,1,0
6,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.015953,-0.20066,-0.37144,1,0
6,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0017123,-0.20069,-0.31347,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.014138,-0.20078,-0.21271,1,0
6,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0031536,-0.20091,-0.29962,1,0
6,GO OXALATE TRANSPORT,0.0001547,-0.20098,-0.27482,1,0
6,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0085714,-0.20107,-0.1784,1,0
6,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0001165,-0.20116,-0.20612,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00031859,-0.20127,-0.17209,1,0
6,GO REGULATION OF BIOMINERALIZATION,3.3132e-05,-0.20129,-0.23129,1,0
6,GO CYTOKINE MEDIATED SIGNALING PATHWAY,8.4205e-05,-0.20129,-0.21967,1,0
6,GO REGULATION OF ENDOCYTOSIS,2.0033e-05,-0.20148,-0.1752,1,0
6,GO REGULATION OF MACROPHAGE ACTIVATION,0.00010092,-0.20152,-0.21434,1,0
6,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0042883,-0.20163,-0.2106,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00065623,-0.20165,-0.22966,1,0
6,GO LYTIC VACUOLE ORGANIZATION,6.5149e-05,-0.20172,-0.20414,1,0
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00067758,-0.20181,-0.20801,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0011199,-0.20186,-0.18736,1,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0039469,-0.20194,-0.17709,1,0
6,GO NOTCH SIGNALING PATHWAY,0.0010206,-0.20208,-0.16817,1,0
6,GO PEPTIDYL TYROSINE MODIFICATION,4.8379e-05,-0.20209,-0.18393,1,0
6,GO LEUKOCYTE MEDIATED IMMUNITY,1.7118e-05,-0.20212,-0.22417,1,0
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00047456,-0.20219,-0.19352,1,0
6,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00012512,-0.20222,-0.22582,1,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0034322,-0.20231,-0.23595,1,0
6,GO RESPONSE TO INORGANIC SUBSTANCE,3.0576e-06,-0.20235,-0.1907,1,0
6,GO INTERFERON GAMMA PRODUCTION,0.00011241,-0.20241,-0.19488,1,0
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00038934,-0.20244,-0.17815,1,0
6,GO RESPONSE TO SALT,0.00067758,-0.2025,-0.16254,1,0
6,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00026003,-0.20261,-0.18367,1,0
6,GO GLAND MORPHOGENESIS,0.0029794,-0.20295,-0.23422,1,0
6,GO REGULATION OF ACTION POTENTIAL,0.0014299,-0.20298,-0.20392,1,0
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,4.8379e-05,-0.20306,-0.18359,1,0
6,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00087311,-0.20309,-0.31177,1,0
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.8583e-05,-0.20314,-0.24816,1,0
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0060989,-0.20319,-0.16405,1,0
6,GO URETER DEVELOPMENT,0.0054795,-0.20326,-0.23451,1,0
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00072223,-0.20339,-0.1533,1,0
6,GO STEROID HORMONE SECRETION,0.0039469,-0.20342,-0.23232,1,0
6,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,4.3218e-05,-0.20357,-0.19281,1,0
6,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.2962e-05,-0.20384,-0.226,1,0
6,GO ENERGY RESERVE METABOLIC PROCESS,2.8418e-05,-0.20425,-0.21372,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00010845,-0.20451,-0.21563,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00047456,-0.20465,-0.21697,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0017123,-0.20475,-0.20774,1,0
6,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,1.5816e-05,-0.20476,-0.20116,1,0
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0090226,-0.20487,-0.27362,1,0
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0028957,-0.2049,-0.23783,1,0
6,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,7.013e-05,-0.20494,-0.21933,1,0
6,GO FATTY ACID CATABOLIC PROCESS,4.2876e-06,-0.20505,-0.23237,1,0
6,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.6597e-05,-0.20516,-0.26787,1,0
6,GO ORGANIC ACID CATABOLIC PROCESS,1.8251e-06,-0.20519,-0.22525,1,0
6,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,4.5813e-07,-0.20527,-0.20304,1,0
6,GO PEPTIDE METABOLIC PROCESS,2.9301e-06,-0.20536,-0.20648,1,0
6,GO RESPONSE TO CALCIUM ION,0.00013917,-0.20537,-0.20656,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00022676,-0.20547,-0.20774,1,0
6,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0064317,-0.20567,-0.15874,1,0
6,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,9.0221e-07,-0.20569,-0.19447,1,0
6,GO HORMONE METABOLIC PROCESS,7.8282e-05,-0.20573,-0.2054,1,0
6,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00013917,-0.20576,-0.21952,1,0
6,GO RESPONSE TO CHEMOKINE,1.0779e-06,-0.2058,-0.21948,1,0
6,GO ACROSOME REACTION,0.022165,-0.20583,-0.15476,1,0
6,GO MUSCLE CELL FATE COMMITMENT,0.0046564,-0.20587,-0.25238,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0010206,-0.20593,-0.3481,1,0
6,GO MUSCLE CELL DEVELOPMENT,3.1888e-05,-0.20593,-0.19216,1,0
6,GO REGULATION OF LIPID LOCALIZATION,1.9904e-06,-0.20597,-0.23062,1,0
6,GO IRON ION HOMEOSTASIS,4.6597e-05,-0.20613,-0.20393,1,0
6,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00029782,-0.20622,-0.24515,1,0
6,GO SPROUTING ANGIOGENESIS,8.1192e-05,-0.20635,-0.21839,1,0
6,GO GASTRULATION,0.00021909,-0.2064,-0.21566,1,0
6,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0046564,-0.20675,-0.20509,1,0
6,GO LEUKOCYTE PROLIFERATION,4.4878e-05,-0.20677,-0.20787,1,0
6,GO HYPOTONIC RESPONSE,0.00045924,-0.20687,-0.26869,1,0
6,GO POSITIVE REGULATION OF CELL SIZE,0.02843,-0.20689,-0.16479,1,0
6,GO MYELIN ASSEMBLY,0.00095906,-0.20692,-0.23694,1,0
6,GO T CELL MIGRATION,0.00035231,-0.20702,-0.22658,1,0
6,GO CATECHOLAMINE UPTAKE,0.023205,-0.20715,-0.20278,1,0
6,GO HEART PROCESS,0.00041602,-0.20716,-0.17954,1,0
6,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00037661,-0.20721,-0.24514,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0050528,-0.20724,-0.33149,1,0
6,GO T CELL APOPTOTIC PROCESS,0.0001547,-0.20738,-0.22509,1,0
6,GO REGULATION OF MAPK CASCADE,6.2367e-06,-0.2074,-0.19794,1,0
6,GO PHOSPHOLIPID CATABOLIC PROCESS,2.4346e-05,-0.20745,-0.25124,1,0
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,1.7118e-05,-0.20748,-0.23694,1,0
6,GO TRIGLYCERIDE METABOLIC PROCESS,4.6623e-06,-0.20751,-0.23174,1,0
6,GO PEPTIDE CATABOLIC PROCESS,0.0012662,-0.20752,-0.21236,1,0
6,GO DETOXIFICATION,5.2139e-05,-0.20754,-0.24593,1,0
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,5.508e-06,-0.20758,-0.19903,1,0
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.6623e-06,-0.20759,-0.2029,1,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0014738,-0.20762,-0.21501,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00023468,-0.20766,-0.22374,1,0
6,GO POSITIVE REGULATION OF LIPID TRANSPORT,5.4121e-05,-0.20776,-0.18886,1,0
6,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0020453,-0.20782,-0.19931,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.02166,-0.20787,-0.2002,1,0
6,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00010845,-0.20812,-0.21326,1,0
6,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.017137,-0.20817,-0.15967,1,0
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.1112e-06,-0.20817,-0.21233,1,0
6,GO MUSCLE ORGAN MORPHOGENESIS,0.00040247,-0.20834,-0.17925,1,0
6,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00353,-0.20835,-0.20663,1,0
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0032441,-0.20838,-0.22824,1,0
6,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00047456,-0.20846,-0.2745,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION,4.6597e-05,-0.20852,-0.22325,1,0
6,GO INOSITOL PHOSPHATE METABOLIC PROCESS,2.3654e-06,-0.20858,-0.20891,1,0
6,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.036948,-0.2089,-0.38042,1,0
6,GO REGULATION OF AUTOPHAGOSOME MATURATION,8.4205e-05,-0.20914,-0.2651,1,0
6,GO CELLULAR RESPONSE TO CHEMICAL STRESS,5.0683e-06,-0.20914,-0.21338,1,0
6,GO REGULATION OF CHEMOTAXIS,0.00018427,-0.20916,-0.18289,1,0
6,GO DE NOVO PROTEIN FOLDING,0.0020453,-0.20922,-0.17051,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.017137,-0.2093,-0.23895,1,0
6,GO MUSCLE CONTRACTION,1.1267e-06,-0.20931,-0.20663,1,0
6,GO PROTEIN AUTOPROCESSING,0.00059588,-0.20933,-0.242,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.014138,-0.20943,-0.22918,1,0
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0069616,-0.20943,-0.25945,1,0
6,GO AMINO ACID IMPORT,0.00010462,-0.20963,-0.2525,1,0
6,GO MONOSACCHARIDE METABOLIC PROCESS,3.8131e-07,-0.20967,-0.22214,1,0
6,GO LEUKOCYTE MIGRATION,0.00012074,-0.20997,-0.19931,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,3.7145e-05,-0.21,-0.30707,1,0
6,GO ADAPTIVE IMMUNE RESPONSE,0.00012964,-0.21008,-0.22459,1,0
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,9.7346e-05,-0.21008,-0.19018,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00067758,-0.21017,-0.18784,1,0
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,8.4205e-05,-0.21022,-0.21149,1,0
6,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00018427,-0.21027,-0.23342,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.001191,-0.21027,-0.24457,1,0
6,GO LOCOMOTOR RHYTHM,0.017137,-0.21034,-0.19497,1,0
6,GO RESPONSE TO INTERLEUKIN 15,0.00026903,-0.21039,-0.30622,1,0
6,GO MAINTENANCE OF LOCATION,2.0784e-06,-0.21056,-0.19613,1,0
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00012964,-0.21067,-0.26428,1,0
6,GO MYELOID LEUKOCYTE ACTIVATION,5.508e-06,-0.21068,-0.2368,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0015189,-0.2107,-0.1985,1,0
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00010845,-0.21076,-0.28942,1,0
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0081404,-0.21079,-0.17871,1,0
6,GO PROTEIN KINASE C SIGNALING,0.0054795,-0.21085,-0.19057,1,0
6,GO RESPONSE TO ETHANOL,1.7118e-05,-0.21085,-0.19135,1,0
6,GO ALCOHOL METABOLIC PROCESS,3.6228e-06,-0.21094,-0.21664,1,0
6,GO STEROID CATABOLIC PROCESS,0.00087311,-0.21099,-0.22128,1,0
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00026003,-0.2111,-0.20873,1,0
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00063551,-0.2112,-0.29149,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.4346e-05,-0.21137,-0.20669,1,0
6,GO GLYCEROL ETHER METABOLIC PROCESS,0.0013054,-0.21149,-0.2316,1,0
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00020448,-0.21151,-0.24947,1,0
6,GO MATURATION OF LSU RRNA,0.034637,-0.2119,-0.21182,1,0
6,GO MYELOID CELL APOPTOTIC PROCESS,0.00041602,-0.21193,-0.27512,1,0
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0014738,-0.21205,-0.23044,1,0
6,GO RESPONSE TO PH,7.013e-05,-0.21224,-0.25837,1,0
6,GO REGULATION OF LEUKOCYTE MIGRATION,3.3132e-05,-0.21225,-0.21145,1,0
6,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0056288,-0.21242,-0.2455,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.001662,-0.21247,-0.21339,1,0
6,GO AMINO ACID BETAINE METABOLIC PROCESS,0.001191,-0.21254,-0.26687,1,0
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.001228,-0.21259,-0.15327,1,0
6,GO REGULATION OF GONAD DEVELOPMENT,0.017549,-0.21277,-0.17883,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.6584e-06,-0.21298,-0.24668,1,0
6,GO SPERM EGG RECOGNITION,4.1112e-06,-0.21308,-0.24589,1,0
6,GO MEMBRANE INVAGINATION,2.0033e-05,-0.21309,-0.24841,1,0
6,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.030383,-0.21313,-0.14455,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00074557,-0.21314,-0.21785,1,0
6,GO POSITIVE REGULATION OF T CELL MIGRATION,4.3218e-05,-0.21352,-0.23591,1,0
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00020448,-0.21365,-0.20452,1,0
6,GO LIPID CATABOLIC PROCESS,3.8131e-07,-0.21369,-0.22277,1,0
6,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00020448,-0.21389,-0.2821,1,0
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00026003,-0.21405,-0.19157,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0073363,-0.21407,-0.21176,1,0
6,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00013433,-0.2141,-0.24884,1,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00072223,-0.21411,-0.27606,1,0
6,GO CELLULAR HORMONE METABOLIC PROCESS,0.0001165,-0.21412,-0.24316,1,0
6,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,2.1663e-05,-0.21415,-0.2417,1,0
6,GO RESPONSE TO METAL ION,2.5308e-05,-0.21426,-0.18696,1,0
6,GO AMELOGENESIS,0.011612,-0.21459,-0.22441,1,0
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.046579,-0.21481,-0.13346,1,0
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.7728e-06,-0.21487,-0.24513,1,0
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.007729,-0.21489,-0.23766,1,0
6,GO TRANSITION METAL ION HOMEOSTASIS,1.1493e-05,-0.21503,-0.21543,1,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,6.5149e-05,-0.21506,-0.21071,1,0
6,GO CARNITINE METABOLIC PROCESS,0.027188,-0.21535,-0.15967,1,0
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.00090094,-0.21541,-0.23594,1,0
6,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00014418,-0.21546,-0.25308,1,0
6,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00054072,-0.21547,-0.18759,1,0
6,GO IMPORT ACROSS PLASMA MEMBRANE,2.4346e-05,-0.21558,-0.20178,1,0
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00065623,-0.21562,-0.25542,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.014486,-0.21578,-0.25393,1,0
6,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,6.4994e-06,-0.21578,-0.21502,1,0
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0057817,-0.216,-0.35263,1,0
6,GO ETHER METABOLIC PROCESS,0.00081984,-0.21601,-0.25296,1,0
6,GO B CELL HOMEOSTASIS,0.00026003,-0.21612,-0.20952,1,0
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0013872,-0.21619,-0.17901,1,0
6,GO INTERLEUKIN 8 PRODUCTION,0.00019753,-0.21619,-0.24375,1,0
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00029782,-0.21637,-0.24298,1,0
6,GO REGULATION OF MAP KINASE ACTIVITY,1.4039e-05,-0.21666,-0.18971,1,0
6,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00044439,-0.21679,-0.26373,1,0
6,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.4728e-06,-0.2168,-0.22334,1,0
6,GO DIOL METABOLIC PROCESS,0.00084609,-0.21682,-0.23135,1,0
6,GO MUSCLE SYSTEM PROCESS,3.9926e-07,-0.21695,-0.20904,1,0
6,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.010773,-0.21706,-0.25411,1,0
6,GO FIBROBLAST PROLIFERATION,0.00022676,-0.21727,-0.2556,1,0
6,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.011047,-0.21732,-0.19965,1,0
6,GO ICOSANOID METABOLIC PROCESS,0.00041602,-0.21742,-0.22909,1,0
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00074557,-0.21748,-0.19998,1,0
6,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.033894,-0.2176,-0.15159,1,0
6,GO REGULATION OF STRIATED MUSCLE CONTRACTION,6.2786e-05,-0.21768,-0.2281,1,0
6,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.0184e-05,-0.21789,-0.26987,1,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0062634,-0.21796,-0.19244,1,0
6,GO SPHINGOID METABOLIC PROCESS,2.9532e-05,-0.21803,-0.28725,1,0
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00049035,-0.21806,-0.28446,1,0
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00021167,-0.21813,-0.24445,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0051916,-0.21821,-0.21113,1,0
6,GO REGULATION OF BONE DEVELOPMENT,0.00063551,-0.21823,-0.21265,1,0
6,GO CELLULAR RESPONSE TO DRUG,1.0604e-05,-0.21827,-0.20753,1,0
6,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0049174,-0.21843,-0.26013,1,0
6,GO PLATELET MORPHOGENESIS,0.00011241,-0.21844,-0.21386,1,0
6,GO SMALL MOLECULE CATABOLIC PROCESS,1.2308e-06,-0.21865,-0.20807,1,0
6,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0083534,-0.21874,-0.21878,1,0
6,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.00081984,-0.21881,-0.17587,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0054795,-0.21892,-0.21461,1,0
6,GO CARDIAC CHAMBER MORPHOGENESIS,0.00072223,-0.21917,-0.1951,1,0
6,GO POSITIVE REGULATION OF MAPK CASCADE,3.3287e-06,-0.21926,-0.20838,1,0
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,7.3528e-06,-0.21942,-0.21439,1,0
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0026572,-0.21944,-0.22716,1,0
6,GO COCHLEA MORPHOGENESIS,0.013139,-0.21944,-0.20595,1,0
6,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00021167,-0.21956,-0.23453,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.023205,-0.21966,-0.25953,1,0
6,GO NEGATIVE REGULATION OF AUTOPHAGY,1.1493e-05,-0.21967,-0.22056,1,0
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,7.6603e-06,-0.21987,-0.23766,1,0
6,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00029782,-0.21987,-0.2191,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00035231,-0.21999,-0.1971,1,0
6,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0006154,-0.22016,-0.23697,1,0
6,GO FOAM CELL DIFFERENTIATION,0.0013872,-0.22035,-0.23909,1,0
6,GO VASCULAR TRANSPORT,0.023741,-0.22063,-0.2835,1,0
6,GO I KAPPAB KINASE NF KAPPAB SIGNALING,5.4121e-05,-0.22065,-0.22935,1,0
6,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0015653,-0.22066,-0.30631,1,0
6,GO CELL CHEMOTAXIS,7.8282e-05,-0.22079,-0.21629,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0018173,-0.22082,-0.34649,1,0
6,GO OXIDATION REDUCTION PROCESS,3.0264e-07,-0.22096,-0.21794,1,0
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.021165,-0.22104,-0.20737,1,0
6,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.4039e-05,-0.22109,-0.21722,1,0
6,GO FIBROBLAST APOPTOTIC PROCESS,0.0075304,-0.2211,-0.20007,1,0
6,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.001191,-0.22114,-0.26029,1,0
6,GO REGULATION OF FIBRINOLYSIS,2.6902e-06,-0.22115,-0.39898,1,0
6,GO REGULATION OF LIPID CATABOLIC PROCESS,2.2524e-05,-0.22134,-0.20837,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0099891,-0.22154,-0.28111,1,0
6,GO LENS FIBER CELL DIFFERENTIATION,0.0056288,-0.22159,-0.20225,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0019282,-0.22159,-0.20737,1,0
6,GO STORE OPERATED CALCIUM ENTRY,0.0014299,-0.22172,-0.24151,1,0
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00032948,-0.22191,-0.22837,1,0
6,GO FATTY ACID BIOSYNTHETIC PROCESS,2.9301e-06,-0.22199,-0.25135,1,0
6,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00017796,-0.222,-0.1932,1,0
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0045306,-0.22215,-0.21492,1,0
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0013054,-0.22228,-0.24121,1,0
6,GO FATTY ACID METABOLIC PROCESS,9.4334e-07,-0.2223,-0.23303,1,0
6,GO CYTOCHROME COMPLEX ASSEMBLY,0.0017641,-0.22233,-0.2179,1,0
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.016339,-0.22236,-0.15551,1,0
6,GO CELLULAR OXIDANT DETOXIFICATION,0.0011199,-0.22248,-0.18555,1,0
6,GO MYELIN MAINTENANCE,0.0024367,-0.22259,-0.31262,1,0
6,GO REGULATION OF ACROSOME REACTION,0.02068,-0.2227,-0.22167,1,0
6,GO HISTONE SERINE PHOSPHORYLATION,0.00017796,-0.22276,-0.26596,1,0
6,GO PHAGOCYTOSIS,7.0571e-06,-0.22281,-0.23994,1,0
6,GO STEROL METABOLIC PROCESS,6.5149e-05,-0.22309,-0.19679,1,0
6,GO POSITIVE REGULATION OF JNK CASCADE,3.0689e-05,-0.22314,-0.18214,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.7323e-05,-0.22314,-0.2744,1,0
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,1.5816e-05,-0.22317,-0.21386,1,0
6,GO MITOCHONDRIAL GENE EXPRESSION,0.00087311,-0.22353,-0.215,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.7806e-05,-0.22362,-0.27583,1,0
6,GO RADIAL GLIAL CELL DIFFERENTIATION,0.013798,-0.22372,-0.25688,1,0
6,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.053746,-0.22373,-0.20887,1,0
6,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0013457,-0.22375,-0.23321,1,0
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0045306,-0.22393,-0.26907,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0099891,-0.22401,-0.24035,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0051916,-0.22403,-0.23488,1,0
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0025817,-0.2241,-0.21071,1,0
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0025817,-0.22417,-0.21534,1,0
6,GO ERK1 AND ERK2 CASCADE,2.2524e-05,-0.22423,-0.2255,1,0
6,GO CARDIAC CONDUCTION,0.0017123,-0.22434,-0.18868,1,0
6,GO RECEPTOR MEDIATED ENDOCYTOSIS,7.013e-05,-0.22461,-0.16965,1,0
6,GO REGULATION OF CARDIAC CONDUCTION,7.547e-05,-0.22463,-0.2266,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.010773,-0.22466,-0.33802,1,0
6,GO MOVEMENT IN HOST ENVIRONMENT,4.1617e-05,-0.2247,-0.25761,1,0
6,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0018173,-0.22472,-0.263,1,0
6,GO RESPONSE TO BACTERIUM,1.9904e-06,-0.22479,-0.22939,1,0
6,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00074557,-0.22481,-0.22356,1,0
6,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,1.4674e-06,-0.22482,-0.23622,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.9532e-05,-0.22491,-0.29852,1,0
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0054795,-0.22524,-0.22799,1,0
6,GO RESPONSE TO DRUG,1.5331e-06,-0.22532,-0.23343,1,0
6,GO NEGATIVE REGULATION OF PROTEIN BINDING,3.5759e-05,-0.22544,-0.19735,1,0
6,GO SCHWANN CELL DIFFERENTIATION,0.00057693,-0.2255,-0.17642,1,0
6,GO DENDRITIC CELL DIFFERENTIATION,0.00084609,-0.22559,-0.30113,1,0
6,GO REVERSE CHOLESTEROL TRANSPORT,0.0034322,-0.22563,-0.25922,1,0
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,2.0833e-05,-0.22585,-0.26128,1,0
6,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00059588,-0.22586,-0.22892,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.011047,-0.22587,-0.17071,1,0
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,6.2786e-05,-0.22594,-0.21909,1,0
6,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00031859,-0.22599,-0.24667,1,0
6,GO TRABECULA MORPHOGENESIS,0.00067758,-0.22603,-0.21128,1,0
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00017796,-0.22616,-0.29651,1,0
6,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00026903,-0.22635,-0.20937,1,0
6,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00012512,-0.2266,-0.21661,1,0
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00081984,-0.22664,-0.23432,1,0
6,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.036164,-0.22665,-0.2501,1,0
6,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.001662,-0.22672,-0.25456,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.3218e-05,-0.22681,-0.24426,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00013917,-0.22686,-0.23169,1,0
6,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0014738,-0.22692,-0.22916,1,0
6,GO HOMOCYSTEINE METABOLIC PROCESS,0.0025817,-0.22708,-0.32867,1,0
6,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.041967,-0.22713,-0.17141,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.004408,-0.22719,-0.20596,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00067758,-0.2272,-0.28232,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0007696,-0.22721,-0.23881,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00031859,-0.22752,-0.20954,1,0
6,GO SULFUR COMPOUND METABOLIC PROCESS,4.5813e-07,-0.22765,-0.23443,1,0
6,GO CHOLESTEROL STORAGE,0.0024367,-0.22781,-0.23605,1,0
6,GO ANDROGEN METABOLIC PROCESS,0.0036303,-0.22802,-0.21657,1,0
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0010859,-0.22815,-0.18144,1,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0067808,-0.22824,-0.20669,1,0
6,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0046564,-0.22825,-0.15913,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.00023468,-0.2283,-0.25689,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,7.547e-05,-0.22839,-0.22652,1,0
6,GO MEMBRANE DEPOLARIZATION,0.010506,-0.22885,-0.17319,1,0
6,GO FEMALE GENITALIA DEVELOPMENT,0.014841,-0.22887,-0.15564,1,0
6,GO ENDOCRINE PROCESS,0.00014935,-0.22896,-0.22061,1,0
6,GO BONE TRABECULA FORMATION,0.017549,-0.22904,-0.39922,1,0
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00081984,-0.2291,-0.21208,1,0
6,GO SYNCYTIUM FORMATION,2.2524e-05,-0.22934,-0.27333,1,0
6,GO RESPONSE TO PEPTIDOGLYCAN,2.9532e-05,-0.22934,-0.29099,1,0
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00052342,-0.22945,-0.19398,1,0
6,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0019282,-0.22975,-0.21776,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0081404,-0.22977,-0.20932,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00017796,-0.22978,-0.31924,1,0
6,GO RESPONSE TO ACIDIC PH,0.00027832,-0.22978,-0.32216,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00087311,-0.22983,-0.27378,1,0
6,GO PIGMENT BIOSYNTHETIC PROCESS,0.00035231,-0.22984,-0.21694,1,0
6,GO CELL CELL RECOGNITION,1.8251e-06,-0.22987,-0.26721,1,0
6,GO BROWN FAT CELL DIFFERENTIATION,0.00092958,-0.22991,-0.20895,1,0
6,GO STEROL TRANSPORT,2.5308e-05,-0.22992,-0.24024,1,0
6,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00018427,-0.22994,-0.23688,1,0
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0007696,-0.23018,-0.24679,1,0
6,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.5308e-05,-0.23026,-0.2717,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.547e-05,-0.23028,-0.2436,1,0
6,GO GASTRIC ACID SECRETION,0.02166,-0.23035,-0.17126,1,0
6,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0042883,-0.23043,-0.26932,1,0
6,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,4.4712e-06,-0.23067,-0.22958,1,0
6,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00074557,-0.23091,-0.21665,1,0
6,GO MODULATION BY HOST OF VIRAL PROCESS,5.7413e-06,-0.23111,-0.27843,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0022332,-0.23116,-0.30532,1,0
6,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00038934,-0.23128,-0.24907,1,0
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00019079,-0.23132,-0.24437,1,0
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00038934,-0.23135,-0.26581,1,0
6,GO REGULATION OF LIPID STORAGE,2.7343e-05,-0.23141,-0.26759,1,0
6,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0010206,-0.23145,-0.26471,1,0
6,GO LIPID STORAGE,7.547e-05,-0.23157,-0.24927,1,0
6,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.00098941,-0.23158,-0.23739,1,0
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00019079,-0.23168,-0.21003,1,0
6,GO MAINTENANCE OF LOCATION IN CELL,4.6623e-06,-0.2317,-0.20045,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0015189,-0.23172,-0.20969,1,0
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.02843,-0.23205,-0.15898,1,0
6,GO BODY FLUID SECRETION,2.5774e-06,-0.23208,-0.24105,1,0
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,8.3127e-06,-0.23212,-0.20007,1,0
6,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0006154,-0.23219,-0.215,1,0
6,GO MUSCLE ATROPHY,0.042857,-0.23232,-0.17725,1,0
6,GO GLIAL CELL MIGRATION,0.00034072,-0.23261,-0.22618,1,0
6,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.00026903,-0.23265,-0.29306,1,0
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00017186,-0.2333,-0.2399,1,0
6,GO RESPONSE TO DEXAMETHASONE,4.0073e-05,-0.23331,-0.28588,1,0
6,GO CARBOHYDRATE CATABOLIC PROCESS,2.7578e-07,-0.23336,-0.2328,1,0
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0042883,-0.23346,-0.18357,1,0
6,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0056288,-0.2335,-0.26949,1,0
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00019753,-0.23367,-0.28993,1,0
6,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,6.2985e-07,-0.23369,-0.25935,1,0
6,GO DOPAMINE TRANSPORT,0.044685,-0.23369,-0.14044,1,0
6,GO CHEMOSENSORY BEHAVIOR,1.0184e-05,-0.2337,-0.2708,1,0
6,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.012203,-0.2337,-0.20213,1,0
6,GO RESPONSE TO TESTOSTERONE,0.0017123,-0.23373,-0.20547,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00016595,-0.23393,-0.27238,1,0
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.015574,-0.23394,-0.27723,1,0
6,GO MATURATION OF SSU RRNA,0.0031536,-0.23397,-0.24828,1,0
6,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0047853,-0.234,-0.19868,1,0
6,GO T CELL MEDIATED IMMUNITY,4.0073e-05,-0.23402,-0.31037,1,0
6,GO PRIMARY ALCOHOL METABOLIC PROCESS,3.0689e-05,-0.23413,-0.27504,1,0
6,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,7.0571e-06,-0.23424,-0.30204,1,0
6,GO ZINC ION HOMEOSTASIS,0.011326,-0.23429,-0.24752,1,0
6,GO POLYOL METABOLIC PROCESS,2.8891e-07,-0.23451,-0.23109,1,0
6,GO BIOMINERALIZATION,7.6603e-06,-0.23455,-0.23184,1,0
6,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.4772e-07,-0.23457,-0.28109,1,0
6,GO FIBRINOLYSIS,0.00017796,-0.23477,-0.36618,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00069957,-0.23479,-0.3633,1,0
6,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,2.3418e-05,-0.23484,-0.24997,1,0
6,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.4772e-07,-0.23489,-0.25533,1,0
6,GO AMEBOIDAL TYPE CELL MIGRATION,1.0604e-05,-0.23505,-0.23745,1,0
6,GO OSTEOBLAST PROLIFERATION,0.0018173,-0.23507,-0.27319,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0050528,-0.23519,-0.29842,1,0
6,GO ENTRY INTO HOST,1.5816e-05,-0.23536,-0.30483,1,0
6,GO SUPEROXIDE ANION GENERATION,0.0083534,-0.23536,-0.26026,1,0
6,GO REGULATION OF RESPONSE TO WOUNDING,0.0007696,-0.23537,-0.22001,1,0
6,GO REGULATION OF STEROID METABOLIC PROCESS,2.4346e-05,-0.23551,-0.25555,1,0
6,GO RESPONSE TO REDOX STATE,0.00057693,-0.23552,-0.24534,1,0
6,GO PLASMA MEMBRANE ORGANIZATION,2.3418e-05,-0.23586,-0.23605,1,0
6,GO MUSCLE CELL APOPTOTIC PROCESS,9.7801e-06,-0.23596,-0.23364,1,0
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.3132e-05,-0.23609,-0.26835,1,0
6,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00026003,-0.23612,-0.30465,1,0
6,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.0576e-06,-0.23643,-0.25548,1,0
6,GO POSITIVE REGULATION OF P38MAPK CASCADE,6.0504e-05,-0.23648,-0.27088,1,0
6,GO EXPORT ACROSS PLASMA MEMBRANE,0.0007696,-0.23653,-0.22232,1,0
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.001986,-0.23657,-0.25814,1,0
6,GO RESPONSE TO CORTICOSTEROID,2.2658e-06,-0.2366,-0.27476,1,0
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0015189,-0.23674,-0.27261,1,0
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00024286,-0.23691,-0.22277,1,0
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0029794,-0.237,-0.28964,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,8.4205e-05,-0.23709,-0.3,1,0
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0006154,-0.23737,-0.31518,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0014738,-0.23768,-0.20658,1,0
6,GO REGULATION OF PLATELET ACTIVATION,0.00067758,-0.23771,-0.29826,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,8.7323e-05,-0.23772,-0.24581,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0011199,-0.2378,-0.32161,1,0
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00052342,-0.23786,-0.24633,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00055855,-0.23831,-0.24215,1,0
6,GO TROPHOBLAST CELL MIGRATION,0.0007696,-0.23861,-0.35942,1,0
6,GO ENDOTHELIAL CELL PROLIFERATION,7.6603e-06,-0.23862,-0.24827,1,0
6,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.00027832,-0.23867,-0.21754,1,0
6,GO CARBOHYDRATE PHOSPHORYLATION,0.00090094,-0.23902,-0.219,1,0
6,GO PHAGOCYTOSIS RECOGNITION,0.0099891,-0.23927,-0.26084,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.015203,-0.23927,-0.17263,1,0
6,GO MUSCLE HYPERTROPHY,9.7801e-06,-0.23939,-0.23066,1,0
6,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.011326,-0.23945,-0.18914,1,0
6,GO CELL MATRIX ADHESION,4.1617e-05,-0.23961,-0.26047,1,0
6,GO TETRAPYRROLE METABOLIC PROCESS,1.0184e-05,-0.24017,-0.26908,1,0
6,GO VIRAL GENE EXPRESSION,0.0011199,-0.2404,-0.26287,1,0
6,GO NEGATIVE REGULATION OF CELL AGING,0.05161,-0.2405,-0.16728,1,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.001191,-0.24057,-0.21467,1,0
6,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.00049035,-0.2406,-0.28747,1,0
6,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,1.1267e-06,-0.24094,-0.25455,1,0
6,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00012512,-0.24103,-0.24641,1,0
6,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0040578,-0.24108,-0.25077,1,0
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,2.3418e-05,-0.24112,-0.30445,1,0
6,GO SIGNAL PEPTIDE PROCESSING,0.007729,-0.24121,-0.21546,1,0
6,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,6.7596e-05,-0.24186,-0.27655,1,0
6,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.014486,-0.24191,-0.17823,1,0
6,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00040247,-0.24211,-0.24226,1,0
6,GO DRUG METABOLIC PROCESS,3.8583e-05,-0.24214,-0.29561,1,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0011199,-0.24223,-0.33194,1,0
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,5.9841e-06,-0.24236,-0.25291,1,0
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00079435,-0.24244,-0.24539,1,0
6,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00020448,-0.24276,-0.29881,1,0
6,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.3418e-05,-0.2429,-0.30044,1,0
6,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0026572,-0.24294,-0.38487,1,0
6,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00041602,-0.2432,-0.23019,1,0
6,GO CELLULAR LIPID CATABOLIC PROCESS,3.4772e-07,-0.24328,-0.24341,1,0
6,GO ACTIN FILAMENT BASED MOVEMENT,7.547e-05,-0.24329,-0.22782,1,0
6,GO NCRNA CATABOLIC PROCESS,0.0013872,-0.24375,-0.179,1,0
6,GO MUSCLE FILAMENT SLIDING,0.00019753,-0.24411,-0.27687,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.019739,-0.24445,-0.15952,1,0
6,GO VITAMIN TRANSPORT,1.8521e-05,-0.24464,-0.26437,1,0
6,GO RESPONSE TO AMPHETAMINE,0.00092958,-0.24465,-0.2757,1,0
6,GO THIOESTER METABOLIC PROCESS,1.104e-05,-0.24469,-0.23357,1,0
6,GO FUCOSYLATION,6.5149e-05,-0.24478,-0.28696,1,0
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.017549,-0.24505,-0.21287,1,0
6,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.022165,-0.24512,-0.23811,1,0
6,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.024288,-0.24531,-0.22538,1,0
6,GO T HELPER 1 CELL DIFFERENTIATION,0.0056288,-0.2454,-0.31642,1,0
6,GO ADAPTATION OF SIGNALING PATHWAY,0.0085714,-0.2455,-0.19956,1,0
6,GO XENOBIOTIC TRANSPORT,4.8379e-05,-0.24561,-0.25776,1,0
6,GO REGULATION OF CELL SUBSTRATE ADHESION,6.2786e-05,-0.24579,-0.25874,1,0
6,GO LYMPHOCYTE APOPTOTIC PROCESS,2.7343e-05,-0.24601,-0.22709,1,0
6,GO MALE GENITALIA DEVELOPMENT,0.0016129,-0.24621,-0.22866,1,0
6,GO POSITIVE CHEMOTAXIS,4.0073e-05,-0.24633,-0.25019,1,0
6,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00353,-0.24639,-0.25797,1,0
6,GO SEQUESTERING OF TRIGLYCERIDE,0.0007696,-0.24658,-0.37629,1,0
6,GO PLATELET AGGREGATION,0.00010092,-0.24659,-0.27414,1,0
6,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0026572,-0.24676,-0.28979,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0087944,-0.24677,-0.22535,1,0
6,GO REGULATION OF VACUOLE ORGANIZATION,1.2862e-06,-0.2471,-0.2634,1,0
6,GO RIBOSOME ASSEMBLY,0.0028141,-0.24731,-0.27946,1,0
6,GO VITAMIN BIOSYNTHETIC PROCESS,0.0060989,-0.24742,-0.20813,1,0
6,GO POSITIVE REGULATION OF AUTOPHAGY,2.2658e-06,-0.24745,-0.22853,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00017186,-0.24765,-0.2431,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0015653,-0.24767,-0.24131,1,0
6,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,3.7145e-05,-0.24808,-0.29858,1,0
6,GO REGULATION OF FATTY ACID OXIDATION,0.00044439,-0.24848,-0.22921,1,0
6,GO TISSUE REGENERATION,6.5149e-05,-0.24851,-0.26743,1,0
6,GO CELLULAR RESPONSE TO SALT STRESS,0.0018173,-0.24866,-0.28604,1,0
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00018427,-0.2487,-0.28796,1,0
6,GO CELLULAR GLUCAN METABOLIC PROCESS,3.3132e-05,-0.24875,-0.22628,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00045924,-0.24878,-0.24724,1,0
6,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0094949,-0.24895,-0.23682,1,0
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0013054,-0.24905,-0.22883,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0034322,-0.24909,-0.23154,1,0
6,GO COLLAGEN CATABOLIC PROCESS,7.3528e-06,-0.24926,-0.33056,1,0
6,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.9263e-05,-0.24938,-0.28485,1,0
6,GO ANION HOMEOSTASIS,0.00059588,-0.24952,-0.21401,1,0
6,GO RESPONSE TO XENOBIOTIC STIMULUS,2.1663e-05,-0.24952,-0.24923,1,0
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0067808,-0.24957,-0.25614,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.2754e-05,-0.24959,-0.27227,1,0
6,GO CARDIAC CELL DEVELOPMENT,1.0311e-06,-0.25006,-0.25462,1,0
6,GO FORMATION OF PRIMARY GERM LAYER,6.2786e-05,-0.25031,-0.27627,1,0
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0011549,-0.25032,-0.23798,1,0
6,GO PEROXISOME ORGANIZATION,3.4772e-07,-0.25043,-0.28292,1,0
6,GO SPHINGOMYELIN METABOLIC PROCESS,8.4205e-05,-0.2506,-0.30733,1,0
6,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.001228,-0.25076,-0.4001,1,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0028957,-0.25087,-0.27001,1,0
6,GO PROSTAGLANDIN SECRETION,0.00012964,-0.25088,-0.25471,1,0
6,GO POSITIVE REGULATION OF LIPID LOCALIZATION,3.4728e-06,-0.25094,-0.25381,1,0
6,GO CELL SUBSTRATE ADHESION,2.0033e-05,-0.25095,-0.2603,1,0
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0012662,-0.25109,-0.27557,1,0
6,GO REGULATION OF CELL MATRIX ADHESION,9.389e-05,-0.25114,-0.28457,1,0
6,GO VASCULOGENESIS,0.00044439,-0.25121,-0.30496,1,0
6,GO SCHWANN CELL DEVELOPMENT,1.104e-05,-0.2514,-0.22795,1,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00017796,-0.25146,-0.26458,1,0
6,GO SEQUESTERING OF CALCIUM ION,9.3916e-06,-0.25152,-0.23383,1,0
6,GO NEUROBLAST DIVISION,0.0010528,-0.25152,-0.30888,1,0
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0053338,-0.25153,-0.26936,1,0
6,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00098941,-0.25178,-0.28363,1,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.010506,-0.25207,-0.33441,1,0
6,GO ENAMEL MINERALIZATION,0.02843,-0.2521,-0.25923,1,0
6,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.0033e-05,-0.25228,-0.26269,1,0
6,GO LEUKOCYTE APOPTOTIC PROCESS,3.7145e-05,-0.2523,-0.2437,1,0
6,GO RESPONSE TO PROTOZOAN,8.1192e-05,-0.25231,-0.26463,1,0
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,6.4994e-06,-0.25248,-0.27829,1,0
6,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015574,-0.25254,-0.27896,1,0
6,GO STRIATED MUSCLE CONTRACTION,7.2754e-05,-0.25264,-0.21459,1,0
6,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,4.6623e-06,-0.25288,-0.26355,1,0
6,GO RESPONSE TO HYDROGEN PEROXIDE,2.3654e-06,-0.2529,-0.27245,1,0
6,GO ESTROGEN METABOLIC PROCESS,3.1888e-05,-0.25314,-0.25827,1,0
6,GO RETINAL METABOLIC PROCESS,0.025994,-0.25334,-0.28637,1,0
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0010859,-0.25364,-0.31986,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.1112e-06,-0.25367,-0.26509,1,0
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0067808,-0.25389,-0.2873,1,0
6,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,4.6597e-05,-0.25395,-0.31108,1,0
6,GO RESPONSE TO FLUID SHEAR STRESS,4.8379e-05,-0.25422,-0.28848,1,0
6,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00012512,-0.25423,-0.38562,1,0
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.00017796,-0.25432,-0.28065,1,0
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.00098941,-0.25459,-0.2502,1,0
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.015203,-0.25485,-0.19608,1,0
6,GO HEPATOCYTE DIFFERENTIATION,0.010245,-0.25496,-0.26729,1,0
6,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,8.7323e-05,-0.25514,-0.25978,1,0
6,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0069616,-0.25557,-0.16232,1,0
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00019753,-0.25558,-0.2571,1,0
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.014841,-0.25571,-0.31366,1,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0042883,-0.25581,-0.30548,1,0
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0079323,-0.25591,-0.33943,1,0
6,GO BLASTOCYST FORMATION,4.0073e-05,-0.25592,-0.21432,1,0
6,GO ENDODERM FORMATION,0.00014418,-0.25606,-0.33497,1,0
6,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.0184e-05,-0.25607,-0.27086,1,0
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00014935,-0.25638,-0.26299,1,0
6,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00040247,-0.25642,-0.26157,1,0
6,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0011549,-0.25649,-0.26498,1,0
6,GO TRANSLATIONAL INITIATION,0.00069957,-0.25661,-0.29155,1,0
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00016023,-0.25669,-0.25044,1,0
6,GO CAMP METABOLIC PROCESS,0.00095906,-0.25686,-0.23773,1,0
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0085714,-0.25695,-0.25126,1,0
6,GO KETONE BIOSYNTHETIC PROCESS,0.00013917,-0.25698,-0.26601,1,0
6,GO KETONE BODY METABOLIC PROCESS,0.001228,-0.25729,-0.28104,1,0
6,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,7.2754e-05,-0.25733,-0.22346,1,0
6,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00014418,-0.25735,-0.24052,1,0
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.03939,-0.25751,-0.16974,1,0
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0001547,-0.25761,-0.33371,1,0
6,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.001986,-0.25763,-0.27592,1,0
6,GO AMINO SUGAR CATABOLIC PROCESS,0.00031859,-0.25791,-0.26446,1,0
6,GO RESPONSE TO MISFOLDED PROTEIN,9.389e-05,-0.25805,-0.24209,1,0
6,GO CELLULAR ALDEHYDE METABOLIC PROCESS,4.1617e-05,-0.25811,-0.28478,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00047456,-0.25823,-0.29304,1,0
6,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,1.104e-05,-0.25824,-0.27053,1,0
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00027832,-0.25829,-0.28103,1,0
6,GO RESPONSE TO TYPE I INTERFERON,0.010773,-0.25838,-0.3312,1,0
6,GO CARDIAC MUSCLE CONTRACTION,8.7323e-05,-0.25847,-0.21787,1,0
6,GO AMINOGLYCAN METABOLIC PROCESS,7.2754e-05,-0.25855,-0.22917,1,0
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00031859,-0.25884,-0.26615,1,0
6,GO GLYCEROLIPID CATABOLIC PROCESS,5.4121e-05,-0.25894,-0.22148,1,0
6,GO EXTRACELLULAR STRUCTURE ORGANIZATION,2.8077e-06,-0.25913,-0.30116,1,0
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00052342,-0.25914,-0.25574,1,0
6,GO REGULATION OF KIDNEY DEVELOPMENT,0.00014935,-0.25943,-0.24487,1,0
6,GO REGULATION OF COAGULATION,0.00012964,-0.25951,-0.30314,1,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0050528,-0.25951,-0.26536,1,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,3.8583e-05,-0.25979,-0.31648,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.7806e-05,-0.26007,-0.31459,1,0
6,GO BILE ACID AND BILE SALT TRANSPORT,0.021165,-0.26017,-0.22026,1,0
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.014138,-0.26038,-0.16016,1,0
6,GO MICROVILLUS ASSEMBLY,0.0033369,-0.2604,-0.27838,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00045924,-0.26054,-0.21816,1,0
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,7.9801e-06,-0.26062,-0.31291,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00079435,-0.2607,-0.26107,1,0
6,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00035231,-0.26102,-0.24452,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.030383,-0.26147,-0.2769,1,0
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.016339,-0.2618,-0.24019,1,0
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,6.7728e-06,-0.26181,-0.28737,1,0
6,GO PROTEIN DEGLYCOSYLATION,2.4346e-05,-0.2619,-0.33895,1,0
6,GO HAIR FOLLICLE MATURATION,0.0001547,-0.26237,-0.33267,1,0
6,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.3287e-06,-0.26242,-0.25949,1,0
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,7.2754e-05,-0.26286,-0.25406,1,0
6,GO EMBRYO IMPLANTATION,0.0020453,-0.26287,-0.21943,1,0
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.00018427,-0.26314,-0.2555,1,0
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,1.6455e-05,-0.26405,-0.2586,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.6902e-06,-0.26412,-0.25997,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0090226,-0.26413,-0.21721,1,0
6,GO MITOCHONDRIAL DEPOLARIZATION,0.00019753,-0.26425,-0.29566,1,0
6,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00074557,-0.26434,-0.26364,1,0
6,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,2.8077e-06,-0.26437,-0.28162,1,0
6,GO POSITIVE REGULATION OF WOUND HEALING,0.0021062,-0.26459,-0.23821,1,0
6,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.104e-05,-0.26506,-0.32028,1,0
6,GO B CELL APOPTOTIC PROCESS,0.00055855,-0.26508,-0.24663,1,0
6,GO ACTION POTENTIAL,0.0015653,-0.26509,-0.18528,1,0
6,GO CHRONIC INFLAMMATORY RESPONSE,0.00019753,-0.26525,-0.34104,1,0
6,GO PROGRAMMED NECROTIC CELL DEATH,4.3218e-05,-0.26526,-0.31331,1,0
6,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012203,-0.26529,-0.20439,1,0
6,GO CARNITINE SHUTTLE,0.0079323,-0.26533,-0.20476,1,0
6,GO GLUCOCORTICOID METABOLIC PROCESS,0.00012512,-0.26558,-0.28375,1,0
6,GO POSITIVE REGULATION OF PROTEIN BINDING,8.6584e-06,-0.26564,-0.23248,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,6.5149e-05,-0.26569,-0.24764,1,0
6,GO REGULATION OF MEMBRANE INVAGINATION,0.0071468,-0.26578,-0.25171,1,0
6,GO ALDITOL METABOLIC PROCESS,1.6455e-05,-0.26579,-0.30033,1,0
6,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,3.0689e-05,-0.26585,-0.26259,1,0
6,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0034322,-0.26609,-0.31323,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00013917,-0.26614,-0.38279,1,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,6.2786e-05,-0.2666,-0.29912,1,0
6,GO DETECTION OF OTHER ORGANISM,0.0019282,-0.2667,-0.32614,1,0
6,GO SERTOLI CELL DIFFERENTIATION,0.0022332,-0.26675,-0.23462,1,0
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,3.7145e-05,-0.26692,-0.33212,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,2.2524e-05,-0.26709,-0.31048,1,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0051916,-0.26723,-0.23415,1,0
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00040247,-0.26727,-0.29059,1,0
6,GO CELL REDOX HOMEOSTASIS,4.1617e-05,-0.26729,-0.26642,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00017796,-0.26733,-0.31348,1,0
6,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.00011241,-0.26788,-0.31887,1,0
6,GO RESPONSE TO AMINE,8.6584e-06,-0.26799,-0.30805,1,0
6,GO BICARBONATE TRANSPORT,1.104e-05,-0.26801,-0.25793,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00084609,-0.26802,-0.34153,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00014935,-0.26831,-0.33426,1,0
6,GO CELL JUNCTION DISASSEMBLY,0.00020448,-0.26836,-0.26603,1,0
6,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,1.5816e-05,-0.26848,-0.24986,1,0
6,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.001662,-0.26848,-0.25877,1,0
6,GO MYOBLAST FUSION,9.7801e-06,-0.26875,-0.32047,1,0
6,GO NADP METABOLIC PROCESS,0.00025131,-0.26879,-0.25909,1,0
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0029794,-0.26891,-0.25898,1,0
6,GO REGULATION OF KERATINOCYTE MIGRATION,0.00035231,-0.26899,-0.24247,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00035231,-0.26903,-0.28144,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,2.4346e-05,-0.26925,-0.3252,1,0
6,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0024367,-0.26931,-0.33581,1,0
6,GO PODOSOME ASSEMBLY,0.0034322,-0.26938,-0.23613,1,0
6,GO VITAMIN D BIOSYNTHETIC PROCESS,0.041967,-0.26954,-0.23725,1,0
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,5.0226e-05,-0.2696,-0.29203,1,0
6,GO HYALURONAN CATABOLIC PROCESS,0.00084609,-0.26974,-0.36903,1,0
6,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,5.4121e-05,-0.26996,-0.27506,1,0
6,GO SULFUR COMPOUND CATABOLIC PROCESS,2.3654e-06,-0.26996,-0.28982,1,0
6,GO VITAMIN D METABOLIC PROCESS,0.001228,-0.27054,-0.26172,1,0
6,GO MAMMARY GLAND MORPHOGENESIS,0.0021062,-0.27059,-0.25143,1,0
6,GO POLYSACCHARIDE CATABOLIC PROCESS,4.7955e-07,-0.27064,-0.30216,1,0
6,GO APOPTOTIC CELL CLEARANCE,3.0689e-05,-0.27075,-0.32865,1,0
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00012964,-0.27076,-0.26332,1,0
6,GO AMYLOID BETA FORMATION,6.0504e-05,-0.27123,-0.27361,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,9.389e-05,-0.27141,-0.26056,1,0
6,GO REGULATION OF T CELL APOPTOTIC PROCESS,3.7145e-05,-0.27172,-0.2945,1,0
6,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.023205,-0.27241,-0.24197,1,0
6,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00026003,-0.27245,-0.26684,1,0
6,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00095906,-0.27257,-0.31156,1,0
6,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0062634,-0.27271,-0.2559,1,0
6,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0018173,-0.27274,-0.25203,1,0
6,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0042883,-0.27283,-0.31941,1,0
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,5.2139e-05,-0.27287,-0.28095,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.3132e-05,-0.27304,-0.30556,1,0
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,2.0833e-05,-0.27307,-0.29178,1,0
6,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00063551,-0.27324,-0.31367,1,0
6,GO PROTEIN REFOLDING,0.0049174,-0.27384,-0.19851,1,0
6,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0045306,-0.2746,-0.29495,1,0
6,GO THIOESTER BIOSYNTHETIC PROCESS,2.0833e-05,-0.2753,-0.26891,1,0
6,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00026903,-0.2756,-0.30916,1,0
6,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00027832,-0.27565,-0.28732,1,0
6,GO MEMBRANE LIPID CATABOLIC PROCESS,1.4609e-05,-0.27566,-0.33547,1,0
6,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00023468,-0.27568,-0.27934,1,0
6,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00057693,-0.27594,-0.34936,1,0
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.031059,-0.27595,-0.22245,1,0
6,GO REGULATION OF MYOBLAST FUSION,0.00074557,-0.27601,-0.31811,1,0
6,GO MULTI ORGANISM CELLULAR PROCESS,0.00050664,-0.27623,-0.36394,1,0
6,GO PEROXISOMAL TRANSPORT,3.0264e-07,-0.27648,-0.30224,1,0
6,GO RECEPTOR CATABOLIC PROCESS,0.00020448,-0.27663,-0.23846,1,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS,1.9263e-05,-0.27674,-0.3161,1,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00090094,-0.27732,-0.23711,1,0
6,GO INACTIVATION OF MAPK ACTIVITY,0.0038387,-0.27751,-0.25668,1,0
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00012512,-0.27817,-0.28087,1,0
6,GO OVULATION,0.0015189,-0.27836,-0.27162,1,0
6,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.1964e-05,-0.27838,-0.2944,1,0
6,GO CELLULAR RESPONSE TO COPPER ION,0.0040578,-0.27873,-0.39146,1,0
6,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,4.3763e-07,-0.27895,-0.2801,1,0
6,GO ETHANOL METABOLIC PROCESS,0.001228,-0.27901,-0.28443,1,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,7.9801e-06,-0.27908,-0.28005,1,0
6,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0034322,-0.27932,-0.3224,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00021909,-0.27945,-0.3121,1,0
6,GO PLATELET DEGRANULATION,4.1112e-06,-0.27969,-0.3194,1,0
6,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.033894,-0.27985,-0.28425,1,0
6,GO ANIMAL ORGAN REGENERATION,6.4994e-06,-0.28019,-0.29249,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0017641,-0.28057,-0.27752,1,0
6,GO REGULATION OF RESPIRATORY BURST,0.015574,-0.28123,-0.21366,1,0
6,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0069616,-0.28141,-0.24176,1,0
6,GO GENITALIA MORPHOGENESIS,0.0060989,-0.28151,-0.27775,1,0
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00012964,-0.2816,-0.29799,1,0
6,GO MONOSACCHARIDE CATABOLIC PROCESS,6.7728e-06,-0.28174,-0.28694,1,0
6,GO LENS FIBER CELL DEVELOPMENT,0.00052342,-0.28204,-0.33441,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,6.5149e-05,-0.28209,-0.29273,1,0
6,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5201e-05,-0.28238,-0.27759,1,0
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00067758,-0.28239,-0.26436,1,0
6,GO PIGMENT METABOLIC PROCESS,5.4121e-05,-0.28241,-0.25577,1,0
6,GO RESPONSE TO MANGANESE ION,0.00026003,-0.28273,-0.26525,1,0
6,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00034072,-0.28275,-0.21965,1,0
6,GO NECROTIC CELL DEATH,2.1663e-05,-0.28295,-0.3178,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00036427,-0.28309,-0.25764,1,0
6,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0085714,-0.28324,-0.35923,1,0
6,GO SKELETAL MUSCLE TISSUE REGENERATION,6.0198e-07,-0.28324,-0.35479,1,0
6,GO HEXOSE CATABOLIC PROCESS,1.5816e-05,-0.28341,-0.30715,1,0
6,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.001662,-0.28375,-0.35854,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00027832,-0.28395,-0.28517,1,0
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.014138,-0.28406,-0.30282,1,0
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00026003,-0.28444,-0.34043,1,0
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0006154,-0.28512,-0.3707,1,0
6,GO CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,-0.28516,-0.32012,1,0
6,GO REGULATION OF HEART RATE,0.0001547,-0.28525,-0.24613,1,0
6,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,9.3916e-06,-0.28547,-0.32014,1,0
6,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001662,-0.28556,-0.30749,1,0
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,7.2754e-05,-0.28559,-0.3842,1,0
6,GO AORTIC VALVE DEVELOPMENT,0.00012964,-0.28561,-0.3481,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,1.104e-05,-0.28586,-0.33281,1,0
6,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00095906,-0.28592,-0.28407,1,0
6,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0020453,-0.28609,-0.29306,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.011612,-0.28617,-0.29545,1,0
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00024286,-0.28618,-0.27594,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00019079,-0.28624,-0.38782,1,0
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0006154,-0.28625,-0.27078,1,0
6,GO KERATINOCYTE MIGRATION,1.7118e-05,-0.28626,-0.28088,1,0
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.00065623,-0.28635,-0.38061,1,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0022332,-0.28639,-0.28708,1,0
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.010245,-0.28649,-0.21632,1,0
6,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.8612e-06,-0.28712,-0.32821,1,0
6,GO REGULATION OF ANOIKIS,0.0034322,-0.28772,-0.29519,1,0
6,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.001662,-0.2881,-0.30329,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0017641,-0.28839,-0.28752,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00014418,-0.28865,-0.30204,1,0
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.6015e-06,-0.28876,-0.33958,1,0
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.017969,-0.28924,-0.22538,1,0
6,GO DETECTION OF BIOTIC STIMULUS,9.0551e-05,-0.28975,-0.33095,1,0
6,GO PEPTIDE CROSS LINKING,0.00010092,-0.28978,-0.34692,1,0
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,2.5308e-05,-0.29007,-0.29513,1,0
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,4.1112e-06,-0.29011,-0.28341,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,6.4994e-06,-0.29021,-0.31477,1,0
6,GO AMYLOID BETA METABOLIC PROCESS,6.0504e-05,-0.29064,-0.25489,1,0
6,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0097392,-0.2907,-0.37976,1,0
6,GO COLLAGEN METABOLIC PROCESS,5.2139e-05,-0.29097,-0.31399,1,0
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0013457,-0.2911,-0.28776,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00021909,-0.2916,-0.26825,1,0
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0022992,-0.29175,-0.25895,1,0
6,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,2.6902e-06,-0.29235,-0.30631,1,0
6,GO REGULATION OF B CELL APOPTOTIC PROCESS,4.4878e-05,-0.29259,-0.3221,1,0
6,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00017186,-0.29293,-0.27829,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00067758,-0.29304,-0.33993,1,0
6,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0015653,-0.29356,-0.28928,1,0
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00012512,-0.29359,-0.28907,1,0
6,GO REGULATION OF WOUND HEALING,0.00014418,-0.29411,-0.27129,1,0
6,GO REGULATION OF MONONUCLEAR CELL MIGRATION,4.2876e-06,-0.29421,-0.29438,1,0
6,GO COPPER ION TRANSPORT,9.389e-05,-0.29439,-0.29208,1,0
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,8.7323e-05,-0.29455,-0.31962,1,0
6,GO AMINO ACID ACTIVATION,0.00084609,-0.29464,-0.23615,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.0576e-06,-0.29476,-0.31229,1,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0001547,-0.29526,-0.26183,1,0
6,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.004408,-0.29526,-0.25317,1,0
6,GO ARACHIDONIC ACID METABOLIC PROCESS,1.2308e-06,-0.29571,-0.33336,1,0
6,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,6.7596e-05,-0.2958,-0.31259,1,0
6,GO RESPONSE TO GROWTH HORMONE,2.1663e-05,-0.29614,-0.31966,1,0
6,GO GLOMERULUS DEVELOPMENT,5.6174e-05,-0.2968,-0.30683,1,0
6,GO PROTEIN OXIDATION,3.4421e-05,-0.29681,-0.36422,1,0
6,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,3.5759e-05,-0.29685,-0.32727,1,0
6,GO GLUCOSE CATABOLIC PROCESS,0.00026003,-0.29701,-0.29131,1,0
6,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0011199,-0.29706,-0.2929,1,0
6,GO EXOCRINE SYSTEM DEVELOPMENT,0.00034072,-0.29707,-0.29837,1,0
6,GO POSITIVE REGULATION OF HAIR CYCLE,0.00084609,-0.29727,-0.34661,1,0
6,GO FUCOSE METABOLIC PROCESS,0.00038934,-0.29796,-0.29316,1,0
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,1.1267e-06,-0.29873,-0.29417,1,0
6,GO TYPE 2 IMMUNE RESPONSE,7.013e-05,-0.29878,-0.33841,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.1493e-05,-0.2992,-0.39061,1,0
6,GO GLUTATHIONE METABOLIC PROCESS,3.0689e-05,-0.29958,-0.36008,1,0
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,2.5774e-06,-0.29974,-0.29867,1,0
6,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0054795,-0.29991,-0.2847,1,0
6,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.018836,-0.30004,-0.22812,1,0
6,GO AMINOGLYCAN CATABOLIC PROCESS,0.00021167,-0.3003,-0.3154,1,0
6,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1964e-05,-0.30051,-0.31163,1,0
6,GO SECRETION BY TISSUE,0.00019079,-0.30105,-0.2783,1,0
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.1904e-06,-0.30151,-0.34059,1,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0085714,-0.30159,-0.27958,1,0
6,GO CORTICOSTEROID HORMONE SECRETION,0.00081984,-0.30169,-0.3139,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0011199,-0.30225,-0.29546,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.6597e-05,-0.30239,-0.38281,1,0
6,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,6.2786e-05,-0.3031,-0.2622,1,0
6,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.0073e-05,-0.30316,-0.29459,1,0
6,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0041716,-0.30324,-0.26621,1,0
6,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00038934,-0.30349,-0.26622,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00013917,-0.3035,-0.32104,1,0
6,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0036303,-0.30353,-0.29234,1,0
6,GO RESPONSE TO INTERFERON GAMMA,1.349e-05,-0.30389,-0.37942,1,0
6,GO MACROPHAGE CYTOKINE PRODUCTION,0.00019079,-0.30391,-0.3436,1,0
6,GO ACUTE INFLAMMATORY RESPONSE,8.6584e-06,-0.30405,-0.32368,1,0
6,GO REGULATION OF AMYLOID BETA FORMATION,1.2962e-05,-0.30408,-0.33286,1,0
6,GO RESPONSE TO STEROL DEPLETION,0.0011199,-0.30446,-0.26453,1,0
6,GO RESPONSE TO GONADOTROPIN,1.7806e-05,-0.30457,-0.317,1,0
6,GO REGULATION OF NECROTIC CELL DEATH,7.547e-05,-0.30472,-0.35244,1,0
6,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0012662,-0.30521,-0.29809,1,0
6,GO NEPHRIC DUCT DEVELOPMENT,0.00054072,-0.30532,-0.32185,1,0
6,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00021167,-0.30557,-0.41695,1,0
6,GO MICROVILLUS ORGANIZATION,0.0012662,-0.30566,-0.29233,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00041602,-0.30596,-0.33814,1,0
6,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00067758,-0.30602,-0.37333,1,0
6,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.4421e-05,-0.30604,-0.47118,1,0
6,GO RESPONSE TO MUSCLE STRETCH,0.00069957,-0.30625,-0.3368,1,0
6,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.01282,-0.30702,-0.24222,1,0
6,GO KERATAN SULFATE METABOLIC PROCESS,1.5331e-06,-0.30703,-0.3549,1,0
6,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.5759e-05,-0.30771,-0.2925,1,0
6,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00028792,-0.30798,-0.28814,1,0
6,GO LIPID IMPORT INTO CELL,1.349e-05,-0.3083,-0.31216,1,0
6,GO STEROID ESTERIFICATION,6.2786e-05,-0.30831,-0.38874,1,0
6,GO ETHANOL OXIDATION,0.0026572,-0.3086,-0.41574,1,0
6,GO RELAXATION OF MUSCLE,0.00028792,-0.30861,-0.29054,1,0
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0064317,-0.30892,-0.33087,1,0
6,GO DETOXIFICATION OF INORGANIC COMPOUND,0.046579,-0.30947,-0.50309,1,0
6,GO RETINOL METABOLIC PROCESS,1.2962e-05,-0.30947,-0.33891,1,0
6,GO CARDIAC MUSCLE CELL CONTRACTION,0.00029782,-0.31008,-0.23432,1,0
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,9.0551e-05,-0.3101,-0.31727,1,0
6,GO T CELL EXTRAVASATION,0.001662,-0.31072,-0.38502,1,0
6,GO HORMONE BIOSYNTHETIC PROCESS,2.4692e-06,-0.31108,-0.30873,1,0
6,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0028141,-0.3112,-0.36629,1,0
6,GO DISACCHARIDE METABOLIC PROCESS,0.00016023,-0.31201,-0.31668,1,0
6,GO PURINE CONTAINING COMPOUND SALVAGE,0.00072223,-0.31205,-0.29351,1,0
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00019079,-0.31207,-0.29682,1,0
6,GO TISSUE MIGRATION,2.8077e-06,-0.31262,-0.28927,1,0
6,GO SEMI LUNAR VALVE DEVELOPMENT,9.0551e-05,-0.31304,-0.36077,1,0
6,GO MACROPHAGE APOPTOTIC PROCESS,0.00092958,-0.31348,-0.28301,1,0
6,GO REGULATION OF CELLULAR RESPIRATION,8.3127e-06,-0.31389,-0.3292,1,0
6,GO OLIGOPEPTIDE TRANSPORT,0.0015189,-0.31394,-0.35418,1,0
6,GO RESPONSE TO TUMOR CELL,1.2962e-05,-0.31395,-0.37981,1,0
6,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00044439,-0.31409,-0.40114,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6729e-06,-0.31485,-0.37794,1,0
6,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00037661,-0.31564,-0.37399,1,0
6,GO NEGATIVE REGULATION OF WOUND HEALING,2.5308e-05,-0.31653,-0.32652,1,0
6,GO ZYMOGEN INHIBITION,0.0020453,-0.31679,-0.30644,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00092958,-0.31689,-0.3763,1,0
6,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00031859,-0.31696,-0.32171,1,0
6,GO RESPONSE TO MAGNESIUM ION,0.0027346,-0.31793,-0.3168,1,0
6,GO VAGINA DEVELOPMENT,0.0023671,-0.31882,-0.26398,1,0
6,GO REGULATION OF MEMBRANE DEPOLARIZATION,4.1112e-06,-0.31917,-0.3206,1,0
6,GO HYPEROSMOTIC RESPONSE,0.001986,-0.32025,-0.22551,1,0
6,GO RESPONSE TO PAIN,0.00012074,-0.32045,-0.33675,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.7474e-06,-0.32106,-0.3861,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013872,-0.32146,-0.25685,1,0
6,GO MONONUCLEAR CELL MIGRATION,2.2658e-06,-0.32189,-0.30843,1,0
6,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,3.5759e-05,-0.32194,-0.3521,1,0
6,GO EPIBOLY,0.00030804,-0.3222,-0.34938,1,0
6,GO ENDOTHELIAL CELL MIGRATION,3.0576e-06,-0.32332,-0.30343,1,0
6,GO SNARE COMPLEX ASSEMBLY,0.00081984,-0.32345,-0.2609,1,0
6,GO NAD METABOLIC PROCESS,0.00012964,-0.32355,-0.31249,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0016129,-0.32366,-0.28873,1,0
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0033369,-0.32371,-0.26191,1,0
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00059588,-0.3241,-0.45124,1,0
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,8.628e-07,-0.32454,-0.3643,1,0
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0014738,-0.32455,-0.35948,1,0
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0087944,-0.3247,-0.24753,1,0
6,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.001662,-0.32521,-0.358,1,0
6,GO RESPONSE TO HYPEROXIA,0.00010845,-0.32545,-0.35157,1,0
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0027346,-0.32576,-0.33594,1,0
6,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00027832,-0.32626,-0.29792,1,0
6,GO REGULATION OF WATER LOSS VIA SKIN,0.011612,-0.32632,-0.27177,1,0
6,GO MACROPHAGE PROLIFERATION,0.0013872,-0.32636,-0.35469,1,0
6,GO ACTIN FILAMENT SEVERING,0.0021689,-0.32654,-0.33251,1,0
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,2.0833e-05,-0.32695,-0.40147,1,0
6,GO GERMINAL CENTER FORMATION,0.00013917,-0.32704,-0.43697,1,0
6,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001986,-0.32715,-0.39454,1,0
6,GO KERATAN SULFATE CATABOLIC PROCESS,8.6584e-06,-0.32723,-0.36614,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00024286,-0.32742,-0.35693,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00020448,-0.32771,-0.3316,1,0
6,GO CELL ADHESION MEDIATED BY INTEGRIN,1.9904e-06,-0.32803,-0.42505,1,0
6,GO L ASCORBIC ACID METABOLIC PROCESS,0.001191,-0.32852,-0.36392,1,0
6,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0028957,-0.32918,-0.33853,1,0
6,GO INFLAMMATORY CELL APOPTOTIC PROCESS,7.013e-05,-0.32974,-0.35541,1,0
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00045924,-0.32978,-0.31791,1,0
6,GO BEHAVIORAL RESPONSE TO PAIN,3.4421e-05,-0.33,-0.46033,1,0
6,GO REGULATION OF PODOSOME ASSEMBLY,0.0099891,-0.33017,-0.25002,1,0
6,GO NEUTROPHIL HOMEOSTASIS,0.00095906,-0.33088,-0.38047,1,0
6,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.0033e-05,-0.33109,-0.34357,1,0
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00067758,-0.33198,-0.34824,1,0
6,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.021165,-0.33285,-0.32975,1,0
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0034322,-0.33285,-0.28352,1,0
6,GO T HELPER 2 CELL DIFFERENTIATION,0.0011199,-0.33287,-0.42342,1,0
6,GO TRABECULA FORMATION,6.5149e-05,-0.33303,-0.35772,1,0
6,GO THYMOCYTE APOPTOTIC PROCESS,0.00032948,-0.33371,-0.32279,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00027832,-0.33372,-0.26885,1,0
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.00019753,-0.33388,-0.37643,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00072223,-0.33401,-0.30781,1,0
6,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00014418,-0.33403,-0.29262,1,0
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,2.6902e-06,-0.33416,-0.31147,1,0
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0049174,-0.33576,-0.32091,1,0
6,GO ACTIN MEDIATED CELL CONTRACTION,1.1493e-05,-0.33586,-0.28871,1,0
6,GO INTERLEUKIN 5 PRODUCTION,0.00042998,-0.33624,-0.33311,1,0
6,GO CELLULAR COPPER ION HOMEOSTASIS,4.1617e-05,-0.33642,-0.34366,1,0
6,GO AMP METABOLIC PROCESS,1.349e-05,-0.33777,-0.39694,1,0
6,GO REGULATION OF TOLERANCE INDUCTION,0.00044439,-0.33857,-0.39497,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,8.1192e-05,-0.3386,-0.2982,1,0
6,GO RESPONSE TO CAFFEINE,0.00013433,-0.33875,-0.29485,1,0
6,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0069616,-0.33891,-0.28078,1,0
6,GO COPPER ION HOMEOSTASIS,2.7343e-05,-0.33921,-0.31803,1,0
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00016023,-0.33964,-0.27365,1,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00024286,-0.34028,-0.35581,1,0
6,GO MATURE B CELL DIFFERENTIATION,0.00030804,-0.34078,-0.33652,1,0
6,GO HEART TRABECULA FORMATION,0.00014935,-0.34099,-0.37033,1,0
6,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.012203,-0.34104,-0.31608,1,0
6,GO RESPONSE TO THYROID HORMONE,4.3218e-05,-0.34168,-0.35717,1,0
6,GO NEGATIVE REGULATION OF COAGULATION,1.4039e-05,-0.34316,-0.3934,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0021062,-0.34382,-0.35986,1,0
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.0051916,-0.3443,-0.36127,1,0
6,GO REGULATION OF HORMONE METABOLIC PROCESS,2.6307e-05,-0.34456,-0.39333,1,0
6,GO T CELL MEDIATED CYTOTOXICITY,0.00017186,-0.34483,-0.44894,1,0
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0015189,-0.34551,-0.32666,1,0
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,4.4878e-05,-0.34619,-0.36953,1,0
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00012512,-0.34724,-0.38774,1,0
6,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00079435,-0.34734,-0.3692,1,0
6,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,1.0604e-05,-0.3474,-0.41359,1,0
6,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,1.8521e-05,-0.34749,-0.35858,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0015189,-0.34774,-0.3396,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,8.3127e-06,-0.34849,-0.34624,1,0
6,GO RELAXATION OF CARDIAC MUSCLE,0.00084609,-0.35109,-0.33285,1,0
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.00059588,-0.35214,-0.39709,1,0
6,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00012964,-0.3522,-0.38554,1,0
6,GO SALIVARY GLAND DEVELOPMENT,0.00014935,-0.35229,-0.33747,1,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0013054,-0.35284,-0.24702,1,0
6,GO POSITIVE REGULATION OF HEART CONTRACTION,5.2139e-05,-0.35292,-0.29693,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0017123,-0.35397,-0.41358,1,0
6,GO HOMOTYPIC CELL CELL ADHESION,6.5149e-05,-0.35412,-0.31279,1,0
6,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,5.2139e-05,-0.35566,-0.29743,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00063551,-0.35673,-0.44284,1,0
6,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00081984,-0.35705,-0.36754,1,0
6,GO GTP METABOLIC PROCESS,7.2754e-05,-0.35759,-0.32701,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,6.5896e-07,-0.3576,-0.37291,1,0
6,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0023671,-0.35861,-0.29696,1,0
6,GO MONOCYTE CHEMOTAXIS,3.7791e-06,-0.35898,-0.34615,1,0
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0037331,-0.35918,-0.36861,1,0
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.9418e-06,-0.35929,-0.41749,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.050569,-0.35929,-0.23874,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,3.7145e-05,-0.35995,-0.32465,1,0
6,GO NUCLEOTIDE SALVAGE,3.3132e-05,-0.36107,-0.43414,1,0
6,GO PLASMINOGEN ACTIVATION,1.6455e-05,-0.36118,-0.4254,1,0
6,GO CELLULAR RESPONSE TO ETHANOL,0.00050664,-0.36229,-0.29418,1,0
6,GO NEGATIVE REGULATION OF BONE REMODELING,0.00019753,-0.36229,-0.36537,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00095906,-0.36259,-0.3951,1,0
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0014738,-0.36262,-0.40292,1,0
6,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,5.9841e-06,-0.36269,-0.36307,1,0
6,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,4.4878e-05,-0.3635,-0.38196,1,0
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.8583e-05,-0.3642,-0.40974,1,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.5331e-06,-0.36447,-0.33131,1,0
6,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00081984,-0.36491,-0.42541,1,0
6,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.2524e-05,-0.36554,-0.39464,1,0
6,GO RESPONSE TO INTERFERON BETA,0.0031536,-0.36555,-0.42581,1,0
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,2.4692e-06,-0.36563,-0.37549,1,0
6,GO ACTIN FILAMENT NETWORK FORMATION,0.00092958,-0.36597,-0.37383,1,0
6,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00095906,-0.36644,-0.43442,1,0
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0016129,-0.3667,-0.39495,1,0
6,GO HEME METABOLIC PROCESS,5.2139e-05,-0.36725,-0.3809,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00028792,-0.36742,-0.40401,1,0
6,GO CERAMIDE CATABOLIC PROCESS,3.8583e-05,-0.36829,-0.39736,1,0
6,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.001662,-0.36881,-0.29956,1,0
6,GO FATTY ACID HOMEOSTASIS,5.2139e-05,-0.36919,-0.38695,1,0
6,GO NEURON REMODELING,0.00012964,-0.36951,-0.37739,1,0
6,GO NEGATIVE REGULATION OF ANOIKIS,0.0064317,-0.36993,-0.3356,1,0
6,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,2.2524e-05,-0.37081,-0.43281,1,0
6,GO ZYMOGEN ACTIVATION,1.4039e-05,-0.37143,-0.41968,1,0
6,GO MINERALOCORTICOID METABOLIC PROCESS,0.00024286,-0.37161,-0.39915,1,0
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.8379e-05,-0.37365,-0.35715,1,0
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,7.2754e-05,-0.37402,-0.40884,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.8251e-06,-0.37504,-0.35016,1,0
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.0784e-06,-0.37523,-0.42462,1,0
6,GO PULMONARY VALVE DEVELOPMENT,6.0504e-05,-0.3759,-0.45605,1,0
6,GO STEROL IMPORT,2.9532e-05,-0.37654,-0.3561,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00057693,-0.377,-0.38235,1,0
6,GO GLYCOPROTEIN CATABOLIC PROCESS,9.3916e-06,-0.3774,-0.52909,1,0
6,GO POSITIVE REGULATION OF HEART RATE,0.00011241,-0.37863,-0.36964,1,0
6,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,5.0226e-05,-0.3791,-0.33377,1,0
6,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00029782,-0.37939,-0.35904,1,0
6,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.1267e-06,-0.38007,-0.4031,1,0
6,GO EXTRACELLULAR MATRIX DISASSEMBLY,5.753e-07,-0.38061,-0.38979,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00092958,-0.38083,-0.3698,1,0
6,GO CHAPERONE MEDIATED AUTOPHAGY,0.00016595,-0.38092,-0.4479,1,0
6,GO POSITIVE REGULATION OF LIPID STORAGE,2.0784e-06,-0.38169,-0.40205,1,0
6,GO VASODILATION,5.0226e-05,-0.38234,-0.35522,1,0
6,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.037747,-0.38284,-0.22598,1,0
6,GO FRUCTOSE METABOLIC PROCESS,0.0049174,-0.38333,-0.38068,1,0
6,GO BASEMENT MEMBRANE ASSEMBLY,0.0015653,-0.38372,-0.36928,1,0
6,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0056288,-0.38376,-0.30109,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,6.5149e-05,-0.38574,-0.36212,1,0
6,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.6455e-05,-0.38587,-0.49965,1,0
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00035231,-0.38664,-0.36229,1,0
6,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0011199,-0.38714,-0.2934,1,0
6,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.011326,-0.38744,-0.29567,1,0
6,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0015189,-0.38748,-0.34862,1,0
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,3.3287e-06,-0.38751,-0.44233,1,0
6,GO MEMBRANE RAFT ORGANIZATION,7.8282e-05,-0.38791,-0.49382,1,0
6,GO CYSTEINE METABOLIC PROCESS,4.4878e-05,-0.38819,-0.49038,1,0
6,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.00037661,-0.38819,-0.37615,1,0
6,GO RESPONSE TO COPPER ION,0.00014418,-0.38823,-0.40706,1,0
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.4609e-05,-0.38859,-0.4159,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00047456,-0.38863,-0.2898,1,0
6,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00069957,-0.38888,-0.37958,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00041602,-0.38985,-0.36477,1,0
6,GO HEMIDESMOSOME ASSEMBLY,0.00063551,-0.39013,-0.50109,1,0
6,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,4.6597e-05,-0.39034,-0.47727,1,0
6,GO BASEMENT MEMBRANE ORGANIZATION,5.2837e-06,-0.39073,-0.45298,1,0
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00063551,-0.39104,-0.38864,1,0
6,GO MITOCHONDRIAL TRANSCRIPTION,3.9418e-06,-0.39117,-0.39272,1,0
6,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00035231,-0.39118,-0.45526,1,0
6,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00054072,-0.39131,-0.33393,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.0833e-05,-0.39156,-0.41424,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,8.1192e-05,-0.39203,-0.33948,1,0
6,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,8.7323e-05,-0.39241,-0.36979,1,0
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0010528,-0.39287,-0.31471,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0073363,-0.39315,-0.28346,1,0
6,GO GAS TRANSPORT,0.00098941,-0.39381,-0.36588,1,0
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0001547,-0.3957,-0.3682,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,7.013e-05,-0.39677,-0.45584,1,0
6,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.00045924,-0.39677,-0.3975,1,0
6,GO PLASMA MEMBRANE FUSION,0.0001165,-0.39709,-0.37467,1,0
6,GO POLYOL TRANSPORT,9.0179e-06,-0.39715,-0.36534,1,0
6,GO HISTAMINE TRANSPORT,0.00012964,-0.39737,-0.42936,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.6902e-06,-0.3974,-0.49479,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.3287e-06,-0.39747,-0.41601,1,0
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00017186,-0.39788,-0.44372,1,0
6,GO INTERLEUKIN 13 PRODUCTION,0.00013433,-0.39798,-0.3632,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00049035,-0.39862,-0.36344,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00013433,-0.39935,-0.43391,1,0
6,GO HISTAMINE SECRETION,0.00037661,-0.40067,-0.42413,1,0
6,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.00022676,-0.40155,-0.3934,1,0
6,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,9.8628e-07,-0.40183,-0.50345,1,0
6,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,3.8583e-05,-0.40332,-0.38347,1,0
6,GO GLYCOLIPID CATABOLIC PROCESS,2.0033e-05,-0.40441,-0.45183,1,0
6,GO DENDRITIC CELL APOPTOTIC PROCESS,3.4728e-06,-0.40526,-0.47953,1,0
6,GO POSITIVE REGULATION OF ACTION POTENTIAL,4.8612e-06,-0.40675,-0.43017,1,0
6,GO EOSINOPHIL MIGRATION,3.1888e-05,-0.40881,-0.44558,1,0
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,4.3218e-05,-0.40892,-0.44575,1,0
6,GO REGULATION OF METANEPHROS DEVELOPMENT,2.4346e-05,-0.40952,-0.49864,1,0
6,GO NOTOCHORD DEVELOPMENT,0.00018427,-0.40982,-0.3855,1,0
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,2.6322e-07,-0.40983,-0.4133,1,0
6,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,9.0551e-05,-0.41277,-0.45317,1,0
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0025083,-0.41296,-0.41525,1,0
6,GO ARGININE METABOLIC PROCESS,4.4878e-05,-0.41435,-0.42105,1,0
6,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,1.5816e-05,-0.41751,-0.44583,1,0
6,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00050664,-0.41782,-0.35775,1,0
6,GO L PHENYLALANINE METABOLIC PROCESS,0.00026903,-0.41834,-0.36004,1,0
6,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,1.349e-05,-0.41976,-0.40626,1,0
6,GO IMMUNE RESPONSE TO TUMOR CELL,2.4346e-05,-0.41982,-0.45468,1,0
6,GO GLYCINE TRANSPORT,0.00023468,-0.42097,-0.41523,1,0
6,GO EPOXYGENASE P450 PATHWAY,5.508e-06,-0.42127,-0.4139,1,0
6,GO ESTROGEN BIOSYNTHETIC PROCESS,1.0604e-05,-0.42256,-0.39295,1,0
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,2.1663e-05,-0.42346,-0.44281,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0022332,-0.42438,-0.50655,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00011241,-0.42951,-0.35074,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,5.9841e-06,-0.43015,-0.51345,1,0
6,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0001547,-0.43385,-0.59526,1,0
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00017796,-0.43467,-0.41392,1,0
6,GO RESPONSE TO INTERLEUKIN 18,0.0014299,-0.43821,-0.45628,1,0
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00036427,-0.43839,-0.52131,1,0
6,GO RESPONSE TO EPINEPHRINE,0.009256,-0.43987,-0.33095,1,0
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00044439,-0.44325,-0.443,1,0
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00013917,-0.44404,-0.39146,1,0
6,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.010245,-0.44469,-0.4077,1,0
6,GO BIOLOGICAL PHASE,4.1617e-05,-0.44525,-0.55844,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00059588,-0.44562,-0.52301,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00037661,-0.44603,-0.37474,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00010462,-0.44997,-0.37857,1,0
6,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00017186,-0.45047,-0.48312,1,0
6,GO NEGATIVE REGULATION OF CELL KILLING,0.00021167,-0.45409,-0.51331,1,0
6,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,1.3441e-06,-0.45755,-0.44594,1,0
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.3441e-06,-0.45794,-0.48445,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,7.9801e-06,-0.45823,-0.44388,1,0
6,GO CYCLOOXYGENASE PATHWAY,1.0604e-05,-0.46481,-0.59314,1,0
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00013917,-0.46657,-0.43065,1,0
6,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00045924,-0.46791,-0.36986,1,0
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0042883,-0.46883,-0.35241,1,0
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,5.9841e-06,-0.47052,-0.50215,1,0
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.011326,-0.47208,-0.34247,1,0
6,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,8.4205e-05,-0.47279,-0.53746,1,0
6,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0023671,-0.47622,-0.39722,1,0
6,GO INFLAMMATORY RESPONSE TO WOUNDING,0.013465,-0.48254,-0.36076,1,0
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,4.6623e-06,-0.48285,-0.49143,1,0
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00014418,-0.48896,-0.47996,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0079323,-0.48978,-0.62097,1,0
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0051916,-0.48998,-0.5859,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.4994e-06,-0.4922,-0.52806,1,0
6,GO PULMONARY VALVE MORPHOGENESIS,2.1663e-05,-0.49246,-0.5729,1,0
6,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,1.7118e-05,-0.49479,-0.52405,1,0
6,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,6.7728e-06,-0.49518,-0.57426,1,0
6,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00059588,-0.49775,-0.58765,1,0
6,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.5331e-06,-0.49791,-0.60564,1,0
6,GO REGULATION OF PLASMINOGEN ACTIVATION,2.9532e-05,-0.498,-0.58377,1,0
6,GO PEPTIDYL PROLINE HYDROXYLATION,1.349e-05,-0.49813,-0.51882,1,0
6,GO EOSINOPHIL CHEMOTAXIS,5.4121e-05,-0.49912,-0.48343,1,0
6,GO XENOBIOTIC CATABOLIC PROCESS,0.00022676,-0.50014,-0.55677,1,0
6,GO TOLERANCE INDUCTION,5.7413e-06,-0.50042,-0.56776,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,7.5427e-07,-0.50142,-0.47295,1,0
6,GO MONOACYLGLYCEROL METABOLIC PROCESS,1.9904e-06,-0.50304,-0.48337,1,0
6,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.2139e-05,-0.50605,-0.48135,1,0
6,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,4.0073e-05,-0.5067,-0.48691,1,0
6,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0051916,-0.51119,-0.33957,1,0
6,GO REGULATION OF MONOCYTE DIFFERENTIATION,1.7474e-06,-0.51125,-0.55907,1,0
6,GO ADHESION OF SYMBIONT TO HOST,1.7118e-05,-0.51716,-0.44706,1,0
6,GO GALACTOSE METABOLIC PROCESS,2.0784e-06,-0.51778,-0.52735,1,0
6,GO MONONUCLEAR CELL DIFFERENTIATION,1.3605e-07,-0.51931,-0.5254,1,0
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.1888e-05,-0.52089,-0.4646,1,0
6,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.0689e-05,-0.52426,-0.5619,1,0
6,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,8.1192e-05,-0.54096,-0.48893,1,0
6,GO BLEB ASSEMBLY,0.00041602,-0.54548,-0.61431,1,0
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,6.0504e-05,-0.55212,-0.59183,1,0
6,GO OXYGEN TRANSPORT,0.0025083,-0.55267,-0.45659,1,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,9.0221e-07,-0.55427,-0.61159,1,0
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.4039e-05,-0.56005,-0.54022,1,0
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,5.753e-07,-0.56341,-0.59321,1,0
6,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,5.8301e-05,-0.56594,-0.63359,1,0
6,GO REGULATION OF VASCULOGENESIS,0.00016595,-0.57698,-0.52289,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,5.8301e-05,-0.58027,-0.57323,1,0
6,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,3.4772e-07,-0.60164,-0.53771,1,0
6,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00031859,-0.62068,-0.52277,1,0
6,GO MUCUS SECRETION,0.0001547,-0.63707,-0.61644,1,0
6,GO MEMBRANE RAFT ASSEMBLY,7.8282e-05,-0.69531,-0.77824,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0062634,-0.70253,-0.79698,1,0
6,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.05824,0.34017,0.23543,0,1
6,GO MYOBLAST MIGRATION,0.080955,0.24757,0.14627,0,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.20621,0.23425,0.097695,0,1
6,GO ESTROUS CYCLE,0.076492,0.22779,0.15602,0,1
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.10465,0.22229,0.27135,0,1
6,GO GDP METABOLIC PROCESS,0.14769,0.20235,0.11465,0,1
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.061812,0.18326,0.11147,0,1
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.099158,0.18271,0.12088,0,1
6,GO CELL PROLIFERATION IN HINDBRAIN,0.18219,0.17912,0.10799,0,1
6,GO REGULATION OF STEM CELL DIVISION,0.076492,0.16735,0.12067,0,1
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.26098,0.14831,0.081994,0,1
6,GO FOREBRAIN MORPHOGENESIS,0.42855,0.14249,0.036322,0,1
6,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.061812,0.13766,0.10752,0,1
6,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.12689,0.12846,0.084839,0,1
6,GO MICROTUBULE SEVERING,0.13583,0.12577,0.10501,0,1
6,GO DNA DOUBLE STRAND BREAK PROCESSING,0.063042,0.12546,0.085066,0,1
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.066855,0.12329,0.062651,0,1
6,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.11636,0.12297,0.1226,0,1
6,GO RESPIRATORY SYSTEM PROCESS,0.16828,0.12024,0.087668,0,1
6,GO REGULATION OF CHROMATIN BINDING,0.15517,0.11885,0.076893,0,1
6,GO PROTEIN DEMETHYLATION,0.2839,0.11736,0.055594,0,1
6,GO HISTONE H3 K9 ACETYLATION,0.061812,0.1158,0.075333,0,1
6,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.15264,0.1051,0.073161,0,1
6,GO RESPONSE TO FOOD,0.2839,0.10019,0.047283,0,1
6,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.20621,0.099623,0.093898,0,1
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.076492,0.096627,0.094263,0,1
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.087232,0.090911,0.062765,0,1
6,GO MRNA EXPORT FROM NUCLEUS,0.061812,0.082124,0.065712,0,1
6,GO ERYTHROCYTE DEVELOPMENT,0.15517,0.080411,0.048815,0,1
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.11636,0.077481,0.073603,0,1
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.099158,0.0642,0.071049,0,1
6,GO REGULATION OF CIRCADIAN RHYTHM,0.088862,0.056651,0.045703,0,1
6,GO NEGATIVE REGULATION OF DNA BINDING,0.44924,0.055316,0.040707,0,1
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.14048,0.051918,0.040489,0,1
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.27611,0.051142,0.037367,0,1
6,GO DEMETHYLATION,0.17653,0.038839,0.039188,0,1
6,GO TRIGEMINAL NERVE DEVELOPMENT,0.0021689,0.53409,0.38505,0,0
6,GO NEURON FATE SPECIFICATION,0.0027346,0.43077,0.42048,0,0
6,GO CARDIOBLAST PROLIFERATION,0.02068,0.38234,0.32872,0,0
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0042883,0.35171,0.39859,0,0
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0046564,0.33905,0.39208,0,0
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0046564,0.28024,0.32259,0,0
6,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00012074,0.26176,0.45056,0,0
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.049546,0.25808,0.21614,0,0
6,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.017549,0.25183,0.29857,0,0
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.023205,0.23374,0.18268,0,0
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.076492,0.23095,0.22126,0,0
6,GO MICROTUBULE DEPOLYMERIZATION,0.029068,0.22212,0.15886,0,0
6,GO GABAERGIC NEURON DIFFERENTIATION,0.11235,0.21409,0.31178,0,0
6,GO ECTODERMAL PLACODE DEVELOPMENT,0.097379,0.21144,0.17752,0,0
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.088862,0.2063,0.20711,0,0
6,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00079435,0.2051,0.2014,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.18508,0.20417,0.10022,0,0
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.40843,0.20158,0.073819,0,0
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.29586,0.19634,0.16129,0,0
6,GO POSITIVE REGULATION OF BEHAVIOR,0.076492,0.19603,0.13801,0,0
6,GO NEPHRON TUBULE FORMATION,0.22905,0.19595,0.10698,0,0
6,GO EMBRYONIC BRAIN DEVELOPMENT,0.14526,0.19446,0.095269,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0087944,0.19271,0.18507,0,0
6,GO LONG TERM SYNAPTIC DEPRESSION,0.045624,0.18521,0.14802,0,0
6,GO GAMMA DELTA T CELL DIFFERENTIATION,0.053746,0.1806,0.28075,0,0
6,GO SUBPALLIUM DEVELOPMENT,0.079444,0.1791,0.173,0,0
6,GO LATERAL MESODERM DEVELOPMENT,0.36991,0.17847,0.039628,0,0
6,GO RESPONSE TO FORSKOLIN,0.15517,0.1781,0.14992,0,0
6,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.79636,0.17604,-0.019582,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.50337,0.17357,0.076294,0,0
6,GO SYNAPTIC VESICLE CLUSTERING,0.10845,0.17301,0.29214,0,0
6,GO LIMB BUD FORMATION,0.15015,0.1718,0.12706,0,0
6,GO REGULATION OF GROWTH HORMONE SECRETION,0.092194,0.16973,0.20774,0,0
6,GO OLFACTORY LOBE DEVELOPMENT,0.059411,0.16913,0.17283,0,0
6,GO MEGAKARYOCYTE DEVELOPMENT,0.070855,0.16875,0.17744,0,0
6,GO CARDIAC CELL FATE COMMITMENT,0.0090226,0.16616,0.31918,0,0
6,GO CARDIAC VENTRICLE FORMATION,0.19695,0.16529,0.22016,0,0
6,GO DNA LIGATION,0.070855,0.16335,0.12333,0,0
6,GO ATRIAL SEPTUM MORPHOGENESIS,0.075049,0.16215,0.1868,0,0
6,GO TONGUE DEVELOPMENT,0.32938,0.16197,0.055009,0,0
6,GO ADENOHYPOPHYSIS DEVELOPMENT,0.74288,0.16137,0.039176,0,0
6,GO AXO DENDRITIC PROTEIN TRANSPORT,0.22568,0.16092,0.10947,0,0
6,GO REGULATION OF RECEPTOR CLUSTERING,0.23937,0.1586,0.13703,0,0
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.14526,0.1579,0.18303,0,0
6,GO FOREBRAIN NEURON DIFFERENTIATION,0.065563,0.1555,0.19107,0,0
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.093897,0.15498,0.18364,0,0
6,GO APICAL PROTEIN LOCALIZATION,0.020205,0.15435,0.14409,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.060602,0.15342,0.1938,0,0
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.20621,0.14904,0.082554,0,0
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.055956,0.14503,0.17547,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.011904,0.14365,0.14607,0,0
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.082489,0.14253,0.20115,0,0
6,GO REGULATION OF MICROTUBULE BINDING,0.015203,0.14103,0.17558,0,0
6,GO MITOTIC SISTER CHROMATID COHESION,0.0029794,0.14086,0.17838,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.13583,0.14072,0.12399,0,0
6,GO REGULATION OF TRANSPOSITION,0.79636,0.13798,0.001824,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.059411,0.13727,0.1484,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.075049,0.13702,0.19122,0,0
6,GO CEREBELLAR CORTEX FORMATION,0.029068,0.13685,0.1885,0,0
6,GO INTRACILIARY TRANSPORT,0.013465,0.13557,0.1717,0,0
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.090515,0.13551,0.14394,0,0
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.21905,0.13531,0.091244,0,0
6,GO CEREBELLAR CORTEX MORPHOGENESIS,0.023205,0.13371,0.15224,0,0
6,GO MITOTIC DNA REPLICATION,0.12908,0.1337,0.097365,0,0
6,GO CELL FATE SPECIFICATION,0.02843,0.1324,0.13007,0,0
6,GO CARDIAC CHAMBER FORMATION,0.30402,0.13143,0.17066,0,0
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.10654,0.13039,0.12625,0,0
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.17934,0.13029,0.093345,0,0
6,GO RESPONSE TO ACETYLCHOLINE,0.15264,0.13014,0.12921,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.018398,0.12962,0.16052,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.52594,0.12814,0.057843,0,0
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0097392,0.12664,0.15356,0,0
6,GO DNA DEMETHYLATION,0.11039,0.12627,0.082475,0,0
6,GO REGULATION OF HISTONE H4 ACETYLATION,0.036164,0.12606,0.12724,0,0
6,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.47049,0.12578,0.079953,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.26471,0.12571,0.064986,0,0
6,GO TRANSPOSITION,0.62732,0.12515,0.033502,0,0
6,GO FOREBRAIN GENERATION OF NEURONS,0.070855,0.12496,0.1452,0,0
6,GO NOREPINEPHRINE METABOLIC PROCESS,0.17374,0.12479,0.15293,0,0
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0094949,0.12441,0.25941,0,0
6,GO FORELIMB MORPHOGENESIS,0.099158,0.1241,0.10765,0,0
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.02843,0.12394,0.14965,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.099158,0.12291,0.14029,0,0
6,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.22905,0.12285,0.13544,0,0
6,GO HISTONE H3 K9 METHYLATION,0.0053338,0.12193,0.13377,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.021165,0.12158,0.12497,0,0
6,GO RETINA LAYER FORMATION,0.12473,0.12114,0.17047,0,0
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.020205,0.12062,0.14291,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.23937,0.12039,0.098463,0,0
6,GO ESCRT COMPLEX DISASSEMBLY,0.11434,0.11921,0.10127,0,0
6,GO NATURAL KILLER CELL PROLIFERATION,0.26098,0.11892,0.083671,0,0
6,GO SEGMENT SPECIFICATION,0.25001,0.11849,0.12427,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.087232,0.11757,0.14332,0,0
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.044685,0.11744,0.15799,0,0
6,GO CELLULAR RESPONSE TO LITHIUM ION,0.2839,0.11703,0.076587,0,0
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.4978,0.1157,0.031626,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.037747,0.11545,0.12498,0,0
6,GO DNA DEAMINATION,0.70355,0.11446,-0.0096122,0,0
6,GO NEURAL RETINA DEVELOPMENT,0.11841,0.11433,0.098544,0,0
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.093897,0.11383,0.12257,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.2839,0.11366,0.07051,0,0
6,GO CEREBELLAR CORTEX DEVELOPMENT,0.068167,0.11365,0.12433,0,0
6,GO PROTEIN LOCALIZATION TO CHROMATIN,0.049546,0.11298,0.073633,0,0
6,GO TELENCEPHALON REGIONALIZATION,0.16032,0.11288,0.18232,0,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.60883,0.11281,0.038001,0,0
6,GO PHOTORECEPTOR CELL DEVELOPMENT,0.075049,0.11184,0.099018,0,0
6,GO SPINAL CORD DEVELOPMENT,0.033894,0.11175,0.11335,0,0
6,GO INSEMINATION,0.32077,0.10883,0.053341,0,0
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0075304,0.10879,0.16518,0,0
6,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.097379,0.10858,0.14345,0,0
6,GO NEURAL TUBE PATTERNING,0.19695,0.10777,0.066138,0,0
6,GO SEROTONIN SECRETION,0.19695,0.10708,0.11637,0,0
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.063042,0.10665,0.12979,0,0
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.12049,0.106,0.11478,0,0
6,GO ACROSOME ASSEMBLY,0.16828,0.1056,0.077967,0,0
6,GO RETROGRADE AXONAL TRANSPORT,0.025994,0.10533,0.16254,0,0
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.11841,0.10531,0.18034,0,0
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.10845,0.10484,0.066159,0,0
6,GO FAT CELL PROLIFERATION,0.18219,0.10405,0.11781,0,0
6,GO SYNAPTIC VESICLE LOCALIZATION,0.02068,0.10371,0.18392,0,0
6,GO CARDIOBLAST DIFFERENTIATION,0.0695,0.1034,0.13713,0,0
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.087232,0.10289,0.12569,0,0
6,GO SIALYLATION,0.42855,0.10075,0.076657,0,0
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.80989,0.10067,0.018662,0,0
6,GO VENTRAL SPINAL CORD DEVELOPMENT,0.090515,0.10022,0.11342,0,0
6,GO PROTEIN AUTO ADP RIBOSYLATION,0.14048,0.099822,0.15699,0,0
6,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.63354,0.099696,0.0083845,0,0
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.12259,0.098822,0.087937,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.082489,0.097942,0.10265,0,0
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.13583,0.097917,0.071385,0,0
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.23245,0.097566,0.11383,0,0
6,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.92682,0.097016,-0.029208,0,0
6,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.44402,0.096571,0.03222,0,0
6,GO REGULATION OF CENTRIOLE REPLICATION,0.090515,0.094657,0.069481,0,0
6,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.093897,0.094643,0.25643,0,0
6,GO SISTER CHROMATID COHESION,0.0067808,0.093519,0.11804,0,0
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.099158,0.093316,0.085052,0,0
6,GO MALE SEX DETERMINATION,0.35153,0.093212,0.093799,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.59059,0.092981,0.013017,0,0
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.48678,0.092514,0.021719,0,0
6,GO RESPONSE TO DOPAMINE,0.66501,0.092416,0.021838,0,0
6,GO REGULATION OF CILIUM ASSEMBLY,0.012508,0.092372,0.10377,0,0
6,GO OTIC VESICLE DEVELOPMENT,0.27999,0.092368,0.10536,0,0
6,GO PARENTAL BEHAVIOR,0.37932,0.091568,0.15215,0,0
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.74288,0.090741,0.0091552,0,0
6,GO NON RECOMBINATIONAL REPAIR,0.12259,0.090314,0.048642,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.27611,0.090281,0.083977,0,0
6,GO LACTATE METABOLIC PROCESS,0.47588,0.089269,0.05814,0,0
6,GO SECONDARY HEART FIELD SPECIFICATION,0.56075,0.089181,0.063186,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.36064,0.089175,0.11127,0,0
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.23937,0.088874,0.26093,0,0
6,GO MEIOTIC CHROMOSOME SEPARATION,0.40349,0.088759,0.026257,0,0
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.47588,0.088578,0.081428,0,0
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.43883,0.088499,0.085951,0,0
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.025414,0.085509,0.21176,0,0
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.18508,0.085095,0.064534,0,0
6,GO CENTROSOME SEPARATION,0.050569,0.084959,0.12997,0,0
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.65866,0.084848,0.034835,0,0
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.19393,0.084406,0.17505,0,0
6,GO DENSE CORE GRANULE TRANSPORT,0.34256,0.083989,0.17785,0,0
6,GO REGULATION OF STEM CELL PROLIFERATION,0.12908,0.083949,0.047475,0,0
6,GO CHROMOSOME LOCALIZATION,0.02068,0.083948,0.069288,0,0
6,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.093897,0.083488,0.11709,0,0
6,GO DNA DEPENDENT DNA REPLICATION,0.03245,0.083455,0.070408,0,0
6,GO PEPTIDYL LYSINE TRIMETHYLATION,0.023741,0.083377,0.08454,0,0
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.092194,0.083285,0.07387,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.2839,0.083168,0.072315,0,0
6,GO ERYTHROCYTE MATURATION,0.65234,0.082673,0.022019,0,0
6,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.60883,0.082491,0.035481,0,0
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.4978,0.08189,0.034953,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.57857,0.081041,0.074681,0,0
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.25001,0.080727,0.12871,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.077957,0.080659,0.092841,0,0
6,GO NON MOTILE CILIUM ASSEMBLY,0.043763,0.080543,0.11497,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.30815,0.080223,0.11607,0,0
6,GO DNA DEALKYLATION,0.16559,0.079103,0.06024,0,0
6,GO MITOTIC SPINDLE ASSEMBLY,0.075049,0.078513,0.062371,0,0
6,GO NEGATIVE REGULATION OF RNA SPLICING,0.0079323,0.078214,0.10981,0,0
6,GO REGULATION OF NEUROBLAST PROLIFERATION,0.17099,0.078,0.090156,0,0
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.097379,0.076788,0.11147,0,0
6,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.53742,0.076691,0.054231,0,0
6,GO CELL JUNCTION MAINTENANCE,0.15773,0.076456,0.10942,0,0
6,GO HISTONE H3 K9 MODIFICATION,0.0056288,0.076112,0.1157,0,0
6,GO MAGNESIUM ION HOMEOSTASIS,0.98255,0.075417,-0.019058,0,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.31232,0.075401,0.095578,0,0
6,GO SECRETORY GRANULE LOCALIZATION,0.56666,0.074619,0.06358,0,0
6,GO GAMMA DELTA T CELL ACTIVATION,0.20309,0.074426,0.13113,0,0
6,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.10096,0.074141,0.1589,0,0
6,GO RETINAL GANGLION CELL AXON GUIDANCE,0.2839,0.073912,0.16784,0,0
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.020205,0.073482,0.097828,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.4598,0.073217,-0.15788,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.042857,0.072643,0.09614,0,0
6,GO METAPHASE PLATE CONGRESSION,0.099158,0.072573,0.048501,0,0
6,GO MIDDLE EAR MORPHOGENESIS,0.86455,0.071801,-0.022255,0,0
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.33373,0.071638,0.083646,0,0
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.33812,0.071364,0.038233,0,0
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.23589,0.071228,0.045247,0,0
6,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0695,0.071177,0.11137,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.2,0.070954,0.040822,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.12473,0.070871,0.083385,0,0
6,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.82348,0.070806,0.0089446,0,0
6,GO GLIAL CELL FATE COMMITMENT,0.13814,0.070765,0.2201,0,0
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.40349,0.070359,0.089599,0,0
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.42347,0.070173,0.03854,0,0
6,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.68418,0.070011,-0.0078783,0,0
6,GO DNA GEOMETRIC CHANGE,0.13814,0.069915,0.044598,0,0
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.23589,0.068225,0.038756,0,0
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.19695,0.068057,0.13187,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.088862,0.067332,0.11504,0,0
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.72969,0.067167,0.013503,0,0
6,GO COPULATION,0.14769,0.06679,0.10036,0,0
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.13814,0.066432,0.040178,0,0
6,GO RETINAL CONE CELL DIFFERENTIATION,0.36064,0.066093,0.061242,0,0
6,GO MICROTUBULE NUCLEATION,0.50896,0.066058,0.030744,0,0
6,GO REGULATION OF DNA REPAIR,0.027188,0.065502,0.059044,0,0
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.26471,0.065434,0.061206,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.31653,0.065184,0.047547,0,0
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.23245,0.064983,0.05525,0,0
6,GO REGULATION OF GLUTAMATE SECRETION,0.087232,0.064673,0.21281,0,0
6,GO REGULATION OF MESODERM DEVELOPMENT,0.55487,0.064423,0.035184,0,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.38408,0.064291,0.045605,0,0
6,GO ANTEROGRADE AXONAL TRANSPORT,0.16559,0.063987,0.067441,0,0
6,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.42347,0.063712,0.031406,0,0
6,GO NEURAL NUCLEUS DEVELOPMENT,0.35153,0.063706,0.094975,0,0
6,GO SYNAPTIC VESICLE TRANSPORT,0.059411,0.063664,0.13243,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.49227,0.063023,0.048172,0,0
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.44924,0.062824,0.10267,0,0
6,GO KERATINOCYTE DEVELOPMENT,0.48131,0.062748,0.10131,0,0
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.54321,0.062432,0.053042,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.19095,0.062394,0.030331,0,0
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.38888,0.061452,0.10151,0,0
6,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.71658,0.060902,-0.013654,0,0
6,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.72313,0.060875,-0.022,0,0
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.14048,0.060762,0.045075,0,0
6,GO AXONAL TRANSPORT,0.10654,0.060269,0.088187,0,0
6,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.43883,0.059548,0.032296,0,0
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.59664,0.059038,0.028817,0,0
6,GO MITOTIC SPINDLE ORGANIZATION,0.27611,0.058944,0.025558,0,0
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.044685,0.058823,0.067573,0,0
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.34702,0.05851,0.055498,0,0
6,GO PROTEIN K11 LINKED UBIQUITINATION,0.63978,0.058097,0.0071667,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.13814,0.05774,0.084198,0,0
6,GO AXO DENDRITIC TRANSPORT,0.22235,0.057371,0.068523,0,0
6,GO SISTER CHROMATID SEGREGATION,0.019739,0.057264,0.068996,0,0
6,GO RESPONSE TO LITHIUM ION,0.40843,0.056877,0.14308,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.98953,0.056489,0.020073,0,0
6,GO CELL CELL JUNCTION MAINTENANCE,0.36991,0.056477,0.096935,0,0
6,GO T HELPER CELL LINEAGE COMMITMENT,0.4545,0.056457,0.029617,0,0
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.16294,0.056019,0.079977,0,0
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.63354,0.056004,0.024921,0,0
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.99651,0.055857,-0.026643,0,0
6,GO INTRACILIARY RETROGRADE TRANSPORT,0.89215,0.055746,0.056368,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.61497,0.055373,0.031026,0,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.67137,0.05537,0.055132,0,0
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.5726,0.055247,0.014517,0,0
6,GO PYRAMIDAL NEURON DIFFERENTIATION,0.4978,0.054875,0.06336,0,0
6,GO EMBRYONIC HEMOPOIESIS,0.43883,0.054335,0.061887,0,0
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.24288,0.053219,0.09244,0,0
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.8303,0.05308,0.0042627,0,0
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.94073,0.052908,0.0039795,0,0
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.78962,0.052741,-0.029437,0,0
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.42347,0.052449,0.11424,0,0
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.38888,0.05241,0.079388,0,0
6,GO NOREPINEPHRINE SECRETION,0.40843,0.052232,0.059388,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.56666,0.052201,0.017955,0,0
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.70355,0.052036,0.0093221,0,0
6,GO MRNA 3 END PROCESSING,0.188,0.051605,0.040322,0,0
6,GO CHROMATIN DISASSEMBLY,0.71006,0.051484,0.022262,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.33373,0.051074,0.056962,0,0
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.26847,0.050323,0.064661,0,0
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.055956,0.050071,0.071957,0,0
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.41341,0.050011,0.045646,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.33812,0.049571,0.039686,0,0
6,GO CELL DIFFERENTIATION IN HINDBRAIN,0.2,0.049549,0.10097,0,0
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.19393,0.049465,0.05226,0,0
6,GO MRNA METHYLATION,0.72969,0.049071,0.011701,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.86455,0.048979,0.056081,0,0
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.18219,0.048933,0.074761,0,0
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.44402,0.048663,0.055435,0,0
6,GO INNER CELL MASS CELL PROLIFERATION,0.40843,0.048572,0.01827,0,0
6,GO NUCLEAR CHROMOSOME SEGREGATION,0.05824,0.048262,0.044775,0,0
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.38408,0.047708,0.052617,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.26847,0.047702,0.055892,0,0
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.027188,0.047493,0.080634,0,0
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.14769,0.047475,0.052739,0,0
6,GO PHOTORECEPTOR CELL MAINTENANCE,0.25001,0.047448,0.047435,0,0
6,GO SPERM AXONEME ASSEMBLY,0.29184,0.046763,0.094936,0,0
6,GO RNA SPLICING,0.072231,0.046695,0.051232,0,0
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.2,0.04657,0.0615,0,0
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.63978,0.046443,0.035632,0,0
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.35153,0.046394,0.11814,0,0
6,GO NOTCH RECEPTOR PROCESSING,0.53167,0.046323,0.049687,0,0
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.71006,0.046312,0.031847,0,0
6,GO RNA EXPORT FROM NUCLEUS,0.36526,0.04621,0.027238,0,0
6,GO REGULATION OF CENTROSOME CYCLE,0.11039,0.045877,0.069286,0,0
6,GO IMMATURE B CELL DIFFERENTIATION,0.62732,0.045461,0.03646,0,0
6,GO REGULATION OF CILIUM BEAT FREQUENCY,0.66501,0.045242,0.024636,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.3746,0.045195,0.015714,0,0
6,GO SMOOTHENED SIGNALING PATHWAY,0.48678,0.045121,0.019673,0,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.35153,0.045098,0.081618,0,0
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.21579,0.045015,0.066311,0,0
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.093897,0.044809,0.040681,0,0
6,GO OXIDATIVE DEMETHYLATION,0.17099,0.044768,0.061725,0,0
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.28785,0.044765,0.066665,0,0
6,GO NEURAL PRECURSOR CELL PROLIFERATION,0.16294,0.044715,0.058267,0,0
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.19695,0.044712,-0.19351,0,0
6,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.4598,0.044585,0.047744,0,0
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.31232,0.044459,0.056012,0,0
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.17099,0.044414,0.1033,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS,0.69061,0.044352,0.050967,0,0
6,GO DNA REPAIR,0.060602,0.04408,0.032977,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.60272,0.044031,0.041684,0,0
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.12049,0.04403,0.063164,0,0
6,GO MRNA PROCESSING,0.092194,0.044011,0.042859,0,0
6,GO DETERMINATION OF ADULT LIFESPAN,0.70355,0.043835,0.0078576,0,0
6,GO RESPONSE TO ETHER,0.19695,0.043776,0.062529,0,0
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.16032,0.043054,0.045555,0,0
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.50337,0.043029,0.041127,0,0
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.63354,0.042856,0.01449,0,0
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.17934,0.042829,0.051587,0,0
6,GO NEURON CELL CELL ADHESION,0.31232,0.042828,0.18943,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.74288,0.042763,0.097197,0,0
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25729,0.042646,0.049236,0,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.91987,0.042622,-0.021546,0,0
6,GO HISTONE METHYLATION,0.1028,0.042373,0.054216,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.85768,0.042249,-0.084899,0,0
6,GO REGULATION OF MICROTUBULE BASED PROCESS,0.3746,0.042077,0.026933,0,0
6,GO SNRNA TRANSCRIPTION,0.39858,0.041779,0.013807,0,0
6,GO ASTRAL MICROTUBULE ORGANIZATION,0.070855,0.041564,0.12191,0,0
6,GO GRANULOCYTE DIFFERENTIATION,0.56666,0.04133,-0.068406,0,0
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.31232,0.041247,0.03599,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.53742,0.040991,0.024902,0,0
6,GO ER OVERLOAD RESPONSE,0.88523,0.040911,0.025234,0,0
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.50896,0.040862,0.03193,0,0
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.44924,0.040853,0.07793,0,0
6,GO MATERNAL PLACENTA DEVELOPMENT,0.74288,0.040184,0.021834,0,0
6,GO REGULATION OF SPINDLE ORGANIZATION,0.76948,0.039891,-6.7971e-05,0,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.24288,0.039712,0.03772,0,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.55487,0.039358,0.030058,0,0
6,GO SPINDLE ORGANIZATION,0.29992,0.039113,0.021686,0,0
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.50337,0.038884,0.028218,0,0
6,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.70355,0.038716,0.015216,0,0
6,GO 3 UTR MEDIATED MRNA STABILIZATION,0.85768,0.038712,-0.021473,0,0
6,GO CILIUM ORGANIZATION,0.15015,0.038619,0.062901,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.44402,0.038428,0.021501,0,0
6,GO HISTONE H3 ACETYLATION,0.31653,0.038366,0.023623,0,0
6,GO METENCEPHALON DEVELOPMENT,0.22235,0.038354,0.074202,0,0
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.63354,0.038258,0.053592,0,0
6,GO PROTEIN METHYLATION,0.13583,0.038013,0.042303,0,0
6,GO POSITIVE T CELL SELECTION,0.36991,0.037788,0.034491,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.13814,0.037786,0.12778,0,0
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.9686,0.037754,-0.021216,0,0
6,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.5726,0.037635,-0.12347,0,0
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.82348,0.037379,0.0066554,0,0
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.91987,0.037319,-0.0056376,0,0
6,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.40843,0.037135,0.031306,0,0
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.60272,0.037127,-0.10564,0,0
6,GO TRANSPORT ALONG MICROTUBULE,0.072231,0.037088,0.062361,0,0
6,GO T CELL SELECTION,0.34702,0.037008,0.040483,0,0
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.34702,0.036987,0.036966,0,0
6,GO EPITHELIAL CELL MATURATION,0.69707,0.036931,0.044937,0,0
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.56666,0.036894,0.0047435,0,0
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.072231,0.036789,0.052717,0,0
6,GO STEM CELL PROLIFERATION,0.29586,0.036576,0.031113,0,0
6,GO HISTONE H3 K36 METHYLATION,0.43367,0.036455,0.04699,0,0
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.14526,0.036243,0.070436,0,0
6,GO PROTEIN SUMOYLATION,0.50896,0.036029,0.018957,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.25001,0.035157,0.022125,0,0
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.34256,0.035066,0.02941,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.25001,0.034991,0.027977,0,0
6,GO POSITIVE REGULATION OF BONE RESORPTION,0.93377,0.034953,-0.011328,0,0
6,GO CENTRIOLE CENTRIOLE COHESION,0.23589,0.034951,0.086843,0,0
6,GO REGULATION OF HISTONE METHYLATION,0.13583,0.034886,0.065855,0,0
6,GO CLATHRIN COAT ASSEMBLY,0.87833,0.03476,0.013879,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32506,0.033942,0.046481,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.87144,0.033768,-0.020057,0,0
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.3746,0.033497,0.049714,0,0
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.93377,0.033071,-0.001811,0,0
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.4978,0.03303,0.019532,0,0
6,GO BRANCHING MORPHOGENESIS OF A NERVE,0.84397,0.032396,0.031063,0,0
6,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.91293,0.032328,0.0084445,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.47049,0.032179,0.032085,0,0
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.60883,0.032166,-0.077942,0,0
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.64605,0.032097,0.043744,0,0
6,GO CAMERA TYPE EYE MORPHOGENESIS,0.4545,0.031762,0.022568,0,0
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.29586,0.031524,0.035485,0,0
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.93377,0.03138,-0.029649,0,0
6,GO CHROMOSOME ORGANIZATION,0.05824,0.030993,0.0315,0,0
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.36991,0.030681,0.026211,0,0
6,GO SNORNA 3 END PROCESSING,0.39858,0.03057,0.075154,0,0
6,GO RESPONSE TO POTASSIUM ION,0.53742,0.030532,0.082787,0,0
6,GO CHROMATIN SILENCING AT TELOMERE,0.72969,0.030476,0.018813,0,0
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.24643,0.030435,0.082522,0,0
6,GO CELLULAR COMPONENT MAINTENANCE,0.56666,0.030218,0.03808,0,0
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.62113,0.029932,0.018377,0,0
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.33373,0.029912,0.083227,0,0
6,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.77618,0.029832,-0.0049439,0,0
6,GO NEURAL CREST FORMATION,0.4978,0.029727,0.056076,0,0
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.37932,0.029155,0.052201,0,0
6,GO OLIGODENDROCYTE DIFFERENTIATION,0.98255,0.029046,-0.0030517,0,0
6,GO REGULATION OF AXONOGENESIS,0.98255,0.028882,-0.0040999,0,0
6,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.92682,0.028634,-0.0072856,0,0
6,GO MEGAKARYOCYTE DIFFERENTIATION,0.35607,0.028508,0.02708,0,0
6,GO IMMUNOLOGICAL MEMORY PROCESS,0.60272,0.028484,0.048481,0,0
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.8303,0.02846,0.0090567,0,0
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.76281,0.02845,0.017731,0,0
6,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.89907,0.028395,-0.00172,0,0
6,GO DENDRITE MORPHOGENESIS,0.36064,0.028164,0.068811,0,0
6,GO HIPPOCAMPUS DEVELOPMENT,0.44402,0.028136,0.034266,0,0
6,GO CELLULAR RESPONSE TO VITAMIN D,0.85768,0.028064,-0.05363,0,0
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.11434,0.028036,0.11131,0,0
6,GO PANCREAS DEVELOPMENT,0.87144,0.027726,-0.014813,0,0
6,GO RENAL WATER HOMEOSTASIS,0.72969,0.027619,0.029589,0,0
6,GO DIGESTIVE TRACT MORPHOGENESIS,0.91293,0.027556,-0.023619,0,0
6,GO MRNA TRANSPORT,0.54321,0.0275,0.012759,0,0
6,GO MYELOID CELL DEVELOPMENT,0.47588,0.027297,0.026239,0,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.53742,0.027173,0.019656,0,0
6,GO MITOCHONDRIAL FUSION,0.85082,0.027168,0.0014957,0,0
6,GO PHAGOSOME ACIDIFICATION,0.98255,0.02716,-0.026864,0,0
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.86455,0.02692,0.0115,0,0
6,GO PROTEIN INSERTION INTO MEMBRANE,0.26098,0.02688,0.042286,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.78962,0.02685,-0.077618,0,0
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.58456,0.026735,0.071316,0,0
6,GO VOCALIZATION BEHAVIOR,0.42347,0.026623,0.14411,0,0
6,GO GROWTH HORMONE SECRETION,0.52594,0.02591,0.071914,0,0
6,GO BRAIN MORPHOGENESIS,0.44402,0.025813,0.028212,0,0
6,GO REGULATION OF CENTROSOME DUPLICATION,0.52594,0.025558,0.034966,0,0
6,GO SPINDLE ASSEMBLY,0.2839,0.025547,0.025772,0,0
6,GO PROTEIN LOCALIZATION TO SYNAPSE,0.49227,0.025528,0.060461,0,0
6,GO CARDIAC ATRIUM MORPHOGENESIS,0.61497,0.025449,0.042056,0,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.59059,0.025418,0.015229,0,0
6,GO COVALENT CHROMATIN MODIFICATION,0.12473,0.0254,0.033053,0,0
6,GO SECRETORY GRANULE ORGANIZATION,0.84397,0.025367,0.0022865,0,0
6,GO REGULATION OF CHROMOSOME SEGREGATION,0.41842,0.024937,0.035081,0,0
6,GO DNA CATABOLIC PROCESS,0.51459,0.024865,0.021301,0,0
6,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.89907,0.024787,-0.023242,0,0
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.91987,0.02463,-0.0020604,0,0
6,GO DNA METHYLATION,0.88523,0.024589,0.0103,0,0
6,GO MITOCHONDRION LOCALIZATION,0.64605,0.024322,0.025788,0,0
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.7495,0.02428,0.0018696,0,0
6,GO HISTONE DEUBIQUITINATION,0.58456,0.024258,0.016272,0,0
6,GO SUBSTANTIA NIGRA DEVELOPMENT,0.81668,0.024169,0.013622,0,0
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.89907,0.024164,-0.015697,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.83713,0.024156,-0.041333,0,0
6,GO RNA CAPPING,0.77618,0.024118,-0.019846,0,0
6,GO REGULATION OF SPINDLE CHECKPOINT,0.58456,0.023905,0.032905,0,0
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.057089,0.023903,0.05622,0,0
6,GO TONGUE MORPHOGENESIS,0.67776,0.02363,0.06414,0,0
6,GO DNA METHYLATION OR DEMETHYLATION,0.29184,0.023578,0.028229,0,0
6,GO OOGENESIS,0.98953,0.023532,0.0037782,0,0
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.78962,0.023202,0.010021,0,0
6,GO PROTEIN LOCALIZATION TO CILIUM,0.52025,0.023121,0.048122,0,0
6,GO T CELL LINEAGE COMMITMENT,0.80989,0.022719,0.017861,0,0
6,GO REGULATION OF PROTEIN SUMOYLATION,0.90599,0.02255,0.012502,0,0
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.89907,0.022255,0.011179,0,0
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21579,0.022177,0.03147,0,0
6,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.83713,0.02209,0.034476,0,0
6,GO VIRAL RNA GENOME REPLICATION,0.48678,0.022034,-0.058434,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.76281,0.021865,0.044336,0,0
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.77618,0.021792,0.017108,0,0
6,GO DNA RECOMBINATION,0.087232,0.021763,0.035421,0,0
6,GO DENDRITE DEVELOPMENT,0.67137,0.021492,0.03188,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.9686,0.021159,-8.5111e-05,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.63354,0.021151,-0.086817,0,0
6,GO REGULATION OF CYTOKINESIS,0.59059,0.020645,0.0058855,0,0
6,GO REGULATION OF DNA METABOLIC PROCESS,0.42855,0.020359,0.01084,0,0
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.82348,0.020328,0.0039875,0,0
6,GO COLLECTING DUCT DEVELOPMENT,0.52594,0.020304,0.036063,0,0
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.94073,0.020246,-0.0078669,0,0
6,GO ECTODERM DEVELOPMENT,0.72969,0.020182,-0.0054871,0,0
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.69707,0.02006,0.017739,0,0
6,GO POSITIVE REGULATION OF RNA SPLICING,0.63354,0.020003,0.017646,0,0
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.73628,0.019961,-0.024062,0,0
6,GO CELLULAR RESPONSE TO X RAY,0.98255,0.019887,-0.052116,0,0
6,GO NEURON PROJECTION REGENERATION,0.34702,0.019567,-0.056734,0,0
6,GO MULTICELLULAR ORGANISM AGING,0.94073,0.01945,-0.0098498,0,0
6,GO NCRNA TRANSCRIPTION,0.92682,0.019367,-0.00044775,0,0
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.82348,0.019284,-0.0025476,0,0
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.66501,0.019072,-0.058285,0,0
6,GO LUNG CELL DIFFERENTIATION,0.99651,0.019025,0.045178,0,0
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.80312,0.018964,-0.00057075,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.72969,0.018879,0.0060333,0,0
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.89215,0.018671,-0.021149,0,0
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.96163,0.018542,0.0079628,0,0
6,GO SEX DETERMINATION,0.98255,0.018443,0.0090243,0,0
6,GO MICROTUBULE BASED PROCESS,0.53742,0.018347,0.018597,0,0
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.39371,0.018268,0.018942,0,0
6,GO HINDBRAIN DEVELOPMENT,0.54903,0.018137,0.041427,0,0
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.53742,0.018102,0.058034,0,0
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.81668,0.018071,-0.018146,0,0
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.80989,0.018048,0.025642,0,0
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.41341,0.017804,0.085056,0,0
6,GO REGULATION OF TORC1 SIGNALING,0.91987,0.017717,-0.015976,0,0
6,GO REGULATION OF FIBROBLAST MIGRATION,0.90599,0.017676,-0.017964,0,0
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.97557,0.017649,-0.020269,0,0
6,GO TELOMERE CAPPING,0.51459,0.017522,0.022822,0,0
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.63978,0.017489,0.097349,0,0
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.12908,0.017458,-0.13492,0,0
6,GO DNA METABOLIC PROCESS,0.59664,0.017356,0.0047965,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.80312,0.017267,0.011838,0,0
6,GO REGULATION OF NEURON MIGRATION,0.62732,0.017133,0.024354,0,0
6,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.95466,0.017041,0.0032116,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.93377,0.01695,-0.0020887,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.83713,0.016884,0.019224,0,0
6,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.92682,0.016844,-0.013348,0,0
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.97557,0.016663,-0.024578,0,0
6,GO NUCLEOTIDE EXCISION REPAIR,0.75615,0.016447,0.0060014,0,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.93377,0.016372,0.011325,0,0
6,GO REGULATION OF DNA RECOMBINATION,0.40349,0.016271,0.014463,0,0
6,GO MICROTUBULE POLYMERIZATION,0.91293,0.016079,0.0033729,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.95466,0.015983,-0.0087965,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.73628,0.015788,-0.033754,0,0
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.69707,0.015741,-0.00067227,0,0
6,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.32506,0.015547,-0.095264,0,0
6,GO POSITIVE REGULATION OF AXONOGENESIS,0.76281,0.015528,0.020654,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.92682,0.015469,0.014133,0,0
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.92682,0.015442,0.0058424,0,0
6,GO REGULATION OF CHROMOSOME SEPARATION,0.90599,0.015097,0.0075448,0,0
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.99651,0.014988,-0.0037763,0,0
6,GO RESPONSE TO L GLUTAMATE,0.62113,0.014907,0.051845,0,0
6,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.67137,0.014757,0.02272,0,0
6,GO RESPONSE TO CATECHOLAMINE,0.52594,0.014272,-0.035821,0,0
6,GO REGULATION OF RECEPTOR INTERNALIZATION,0.85082,0.014171,-0.029502,0,0
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.73628,0.014046,0.016049,0,0
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.86455,0.013903,0.0071375,0,0
6,GO REGULATION OF EXTENT OF CELL GROWTH,0.7495,0.013833,-0.029441,0,0
6,GO NEURON MIGRATION,0.44924,0.013753,0.078958,0,0
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.91293,0.013667,-0.0044881,0,0
6,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.91987,0.013602,-0.0042111,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.91987,0.013527,-0.0063319,0,0
6,GO RESPONSE TO UV,0.80312,0.013462,0.00091749,0,0
6,GO FOREBRAIN DEVELOPMENT,0.58456,0.013351,0.02296,0,0
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.32506,0.013185,0.021337,0,0
6,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.4978,0.013166,0.10746,0,0
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.60883,0.013069,0.010585,0,0
6,GO RESPONSE TO NERVE GROWTH FACTOR,0.41842,0.012493,0.04392,0,0
6,GO AROMATIC AMINO ACID TRANSPORT,0.86455,0.012473,-0.063379,0,0
6,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.57857,0.012421,0.040775,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.76281,0.012415,0.045332,0,0
6,GO PROTEIN NEDDYLATION,0.91293,0.012335,-0.018469,0,0
6,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.88523,0.012325,-0.029919,0,0
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.84397,0.012205,-0.0031823,0,0
6,GO CELLULAR RESPONSE TO VITAMIN,0.76948,0.011808,-0.078923,0,0
6,GO SOMITE DEVELOPMENT,0.92682,0.011804,-0.017956,0,0
6,GO CELL FATE COMMITMENT,0.87144,0.011589,-0.00092413,0,0
6,GO MITOTIC NUCLEAR DIVISION,0.36526,0.011584,0.026708,0,0
6,GO CGMP METABOLIC PROCESS,0.92682,0.011575,-0.013844,0,0
6,GO DETECTION OF VISIBLE LIGHT,0.43367,0.011543,0.009696,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.98255,0.011524,0.00017124,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.78962,0.01139,-0.030928,0,0
6,GO SPINDLE LOCALIZATION,0.89215,0.011378,-0.0038789,0,0
6,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.97557,0.01136,-0.007237,0,0
6,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.5726,0.011358,0.031836,0,0
6,GO REGULATION OF CELL FATE COMMITMENT,0.98255,0.011297,0.00089995,0,0
6,GO REGULATION OF PROTON TRANSPORT,0.87144,0.011205,-0.0083287,0,0
6,GO DETECTION OF ABIOTIC STIMULUS,0.94073,0.011151,-0.0012573,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.94073,0.011132,-0.030347,0,0
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.54321,0.010892,-0.032204,0,0
6,GO MEIOTIC SPINDLE ORGANIZATION,0.85768,0.010855,0.0045149,0,0
6,GO DORSAL SPINAL CORD DEVELOPMENT,0.56075,0.01084,0.11593,0,0
6,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.62732,0.010831,0.046065,0,0
6,GO RECEPTOR CLUSTERING,0.89215,0.010779,0.0046575,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.52594,0.01072,-0.082611,0,0
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.95466,0.010475,0.0008569,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.35153,0.010474,0.020079,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.94769,0.01043,-0.012964,0,0
6,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.98953,0.010318,-0.0038606,0,0
6,GO MEIOTIC CHROMOSOME SEGREGATION,0.8303,0.010251,0.0015253,0,0
6,GO REGULATION OF DENDRITE MORPHOGENESIS,0.80312,0.010087,0.019294,0,0
6,GO LYMPHANGIOGENESIS,0.50896,0.010077,-0.081486,0,0
6,GO C4 DICARBOXYLATE TRANSPORT,0.94073,0.0099322,0.001272,0,0
6,GO POSITIVE REGULATION OF DNA REPLICATION,0.86455,0.0096067,0.010991,0,0
6,GO REGULATION OF MITOTIC CELL CYCLE,0.59059,0.0095393,-0.020916,0,0
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.41842,0.0095074,-0.042074,0,0
6,GO HINDBRAIN MORPHOGENESIS,0.30402,0.0093342,0.050728,0,0
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.62732,0.0093312,0.033355,0,0
6,GO TRANSCYTOSIS,0.98255,0.009291,-0.018845,0,0
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.65234,0.008486,-0.020236,0,0
6,GO APPENDAGE MORPHOGENESIS,0.87144,0.0084306,-0.0090937,0,0
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.98255,0.008424,-0.0054403,0,0
6,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.98255,0.0083557,-0.0070079,0,0
6,GO REGULATION OF SPINDLE ASSEMBLY,0.85768,0.0081677,0.00025838,0,0
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.95466,0.0081153,0.018725,0,0
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.69061,0.0079891,-0.042343,0,0
6,GO PROTEIN MANNOSYLATION,0.94073,0.0079463,-0.0016475,0,0
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.85082,0.0078153,-0.019376,0,0
6,GO PROTEIN O LINKED MANNOSYLATION,0.72969,0.007448,-0.019025,0,0
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.4598,0.0073617,-0.029907,0,0
6,GO GERM CELL DEVELOPMENT,0.84397,0.0072977,0.0085961,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.87833,0.0071605,-0.016495,0,0
6,GO MICROTUBULE BASED TRANSPORT,0.35153,0.006862,0.03473,0,0
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.86455,0.0068484,-0.013183,0,0
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.58456,0.0068287,0.021502,0,0
6,GO SULFATION,0.8303,0.0067846,-0.028569,0,0
6,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.54321,0.0067633,-0.079164,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.82348,0.0065783,-0.0013518,0,0
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.57857,0.0065413,0.12304,0,0
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.7495,0.0063437,0.0019229,0,0
6,GO MICROTUBULE ANCHORING,0.63354,0.0062169,0.016806,0,0
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.78962,0.00607,-0.018071,0,0
6,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.76281,0.0059208,-0.07343,0,0
6,GO CELLULAR RESPONSE TO UV,0.98953,0.0058525,-0.0058304,0,0
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.94769,0.0056571,0.014299,0,0
6,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.43883,0.0056003,-0.057073,0,0
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.63354,0.0055803,-0.055846,0,0
6,GO P BODY ASSEMBLY,0.39858,0.005518,0.033948,0,0
6,GO EYE MORPHOGENESIS,0.94769,0.0054502,-0.0065056,0,0
6,GO CELL FATE DETERMINATION,0.92682,0.0054391,-0.0064854,0,0
6,GO CELL PROLIFERATION IN FOREBRAIN,0.91293,0.0052748,-0.019426,0,0
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.65866,0.0052085,-0.041176,0,0
6,GO INTRACELLULAR MRNA LOCALIZATION,0.91987,0.0051215,-0.018286,0,0
6,GO PALLIUM DEVELOPMENT,0.8303,0.0050815,0.015294,0,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.5726,0.0050803,0.095121,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.66501,0.00498,0.017873,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.89215,0.0047362,-0.0011214,0,0
6,GO NUCLEAR BODY ORGANIZATION,0.90599,0.004624,0.013863,0,0
6,GO PHOTOTRANSDUCTION,0.83713,0.0043157,-0.025847,0,0
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.87144,0.00414,-8.9079e-05,0,0
6,GO REGULATION OF DNA REPLICATION,0.62113,0.0041086,0.012103,0,0
6,GO UV DAMAGE EXCISION REPAIR,0.98953,0.0040999,0.00063468,0,0
6,GO RRNA 3 END PROCESSING,0.52594,0.0040998,-0.04897,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.94073,0.0040528,0.0084121,0,0
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.80312,0.0040119,0.011392,0,0
6,GO TELOMERIC LOOP DISASSEMBLY,0.88523,0.0040057,0.00015805,0,0
6,GO APOPTOTIC DNA FRAGMENTATION,0.89907,0.0039636,0.0059253,0,0
6,GO POSITIVE REGULATION OF GLIOGENESIS,0.90599,0.0038707,0.0086011,0,0
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.38888,0.0037309,0.023292,0,0
6,GO MITOTIC RECOMBINATION,0.37932,0.0035116,0.052344,0,0
6,GO QUINONE METABOLIC PROCESS,0.70355,0.0034662,-0.097033,0,0
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.89215,0.00344,-0.0060561,0,0
6,GO HISTONE MRNA METABOLIC PROCESS,0.8303,0.00339,-0.00025763,0,0
6,GO THYROID GLAND DEVELOPMENT,0.67776,0.003099,-0.024813,0,0
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.94769,0.0030704,0.0069237,0,0
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.88523,0.0025874,-0.013421,0,0
6,GO CHROMOSOME CONDENSATION,0.16294,0.0025336,0.063856,0,0
6,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.17374,0.0025111,-0.11397,0,0
6,GO CELL DIVISION,0.77618,0.0023794,0.0034259,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.58456,0.0022898,-0.059817,0,0
6,GO REGULATION OF MRNA POLYADENYLATION,0.95466,0.0021115,-0.0085027,0,0
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.80989,0.0020487,-0.0063342,0,0
6,GO REGULATION OF TELOMERE MAINTENANCE,0.81668,0.0020276,-0.019224,0,0
6,GO GAMETE GENERATION,0.51459,0.0020205,-0.020227,0,0
6,GO MESODERMAL CELL FATE SPECIFICATION,0.85768,0.0020064,-0.0093921,0,0
6,GO REGULATION OF GLUCOSE IMPORT,0.44402,0.0018641,-0.036828,0,0
6,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.91987,0.0018505,0.0024994,0,0
6,GO NEGATIVE T CELL SELECTION,0.63354,0.0016768,-0.072939,0,0
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.76281,0.0016234,0.018618,0,0
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91987,0.0015333,-0.0065611,0,0
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.63354,0.0015055,0.013748,0,0
6,GO CELLULAR RESPONSE TO RADIATION,0.46512,0.001505,-0.034338,0,0
6,GO ORGANELLE LOCALIZATION,0.3746,0.0014771,-0.018652,0,0
6,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.63978,0.0013992,-0.055439,0,0
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.7495,0.0013856,0.01793,0,0
6,GO GENE SILENCING,0.72313,0.001352,-0.010767,0,0
6,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.3746,0.0013001,-0.087561,0,0
6,GO SYNAPTIC VESICLE MATURATION,0.93377,0.0010208,0.038254,0,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.87144,0.0010114,-0.035333,0,0
6,GO SEQUESTERING OF ACTIN MONOMERS,0.89907,0.00049403,0.091551,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.44924,0.00045416,0.019864,0,0
6,GO REGULATION OF CELL DIVISION,0.90599,0.00040656,-0.011195,0,0
6,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.66501,0.00026442,0.056076,0,0
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.94073,0.00016263,-0.058475,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.95466,0.00015129,-0.013343,0,0
6,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1,-5.2568e-05,0.0072681,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.68418,-0.000205,-0.017668,0,0
6,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.78962,-0.00036798,0.014324,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.70355,-0.00046375,-0.017632,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.80312,-0.00046744,-0.0044069,0,0
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.69707,-0.00048821,0.022528,0,0
6,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.43883,-0.0005193,-0.10474,0,0
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.37932,-0.00062496,-0.086056,0,0
6,GO BLASTOCYST GROWTH,0.8303,-0.00065327,-0.0080127,0,0
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.85082,-0.0010382,-0.0099545,0,0
6,GO TELENCEPHALON DEVELOPMENT,0.79636,-0.0010937,0.0066585,0,0
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.41341,-0.0011678,0.041057,0,0
6,GO REGULATION OF CHROMATIN ASSEMBLY,0.91293,-0.0011681,0.0085619,0,0
6,GO REGULATION OF CELL MATURATION,0.67776,-0.0013623,-0.02181,0,0
6,GO RESPONSE TO COCAINE,0.86455,-0.0014056,0.005769,0,0
6,GO MITRAL VALVE DEVELOPMENT,0.74288,-0.001598,-0.065202,0,0
6,GO DIENCEPHALON DEVELOPMENT,0.7495,-0.0018012,0.033973,0,0
6,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.67776,-0.0018441,-0.0089228,0,0
6,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.79636,-0.0019108,0.032163,0,0
6,GO G2 DNA DAMAGE CHECKPOINT,0.78289,-0.0020771,0.016456,0,0
6,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.8303,-0.0021096,-0.018756,0,0
6,GO CYTOKINESIS,0.5726,-0.0022524,-0.022561,0,0
6,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.68418,-0.0022729,-0.01788,0,0
6,GO LOCALIZATION WITHIN MEMBRANE,0.81668,-0.0022986,-0.016713,0,0
6,GO SPERMATID DIFFERENTIATION,0.80312,-0.0024153,0.0067916,0,0
6,GO VENTRICULAR SYSTEM DEVELOPMENT,0.94769,-0.0024344,-0.00034639,0,0
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.76948,-0.0024814,0.08249,0,0
6,GO NEURON PROJECTION GUIDANCE,0.98953,-0.0025662,-0.00025898,0,0
6,GO PITUITARY GLAND DEVELOPMENT,0.91293,-0.0027607,0.01552,0,0
6,GO REGULATION OF CHROMOSOME ORGANIZATION,0.72969,-0.0027835,0.010103,0,0
6,GO MITOTIC CELL CYCLE,0.69707,-0.0028162,-0.017155,0,0
6,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.80989,-0.002818,-0.078844,0,0
6,GO AMINE BIOSYNTHETIC PROCESS,0.50896,-0.0028402,-0.049368,0,0
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.48678,-0.0028563,-0.094377,0,0
6,GO CEREBRAL CORTEX DEVELOPMENT,0.95466,-0.0028579,0.0091373,0,0
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.85768,-0.0030302,-0.0072289,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.81668,-0.0031439,0.022655,0,0
6,GO HISTONE H3 K14 ACETYLATION,0.65234,-0.0031469,0.028794,0,0
6,GO CHROMOSOME SEPARATION,0.63978,-0.0031588,0.019954,0,0
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.50337,-0.0033151,-0.022876,0,0
6,GO RNA LOCALIZATION,0.61497,-0.0033351,-0.031906,0,0
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.95466,-0.0036763,-0.011341,0,0
6,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.62113,-0.0037153,-0.015011,0,0
6,GO POSITIVE REGULATION OF TISSUE REMODELING,0.89215,-0.0037208,-0.016284,0,0
6,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.91293,-0.0037668,-0.064332,0,0
6,GO REGULATION OF SYNAPTIC PLASTICITY,0.78962,-0.0037874,-0.0056964,0,0
6,GO REGULATION OF CELL CYCLE PROCESS,0.85768,-0.0039861,-0.0092976,0,0
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.94073,-0.0040041,0.0052312,0,0
6,GO REGULATION OF CELL CYCLE,0.25001,-0.004061,-0.028974,0,0
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.73628,-0.0040814,0.016965,0,0
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.52594,-0.0041137,0.055177,0,0
6,GO DENDRITIC SPINE MORPHOGENESIS,0.97557,-0.0046797,-0.0071179,0,0
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.7495,-0.0047439,-0.0099341,0,0
6,GO POSTREPLICATION REPAIR,0.76281,-0.0047454,-0.0091004,0,0
6,GO MEMBRANE DOCKING,0.63354,-0.0050232,-0.011349,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.52025,-0.0051623,-0.07506,0,0
6,GO SNORNA METABOLIC PROCESS,0.85082,-0.0052166,0.010929,0,0
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.89907,-0.0053769,-0.011722,0,0
6,GO NEUROBLAST PROLIFERATION,0.59059,-0.0054861,0.035716,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.98953,-0.0055147,-0.0062624,0,0
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.74288,-0.00562,-0.015418,0,0
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.39371,-0.0057451,0.042914,0,0
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.84397,-0.0057965,0.0207,0,0
6,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.54321,-0.0059101,-0.037961,0,0
6,GO PROGESTERONE METABOLIC PROCESS,0.69707,-0.0062676,-0.1474,0,0
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.35607,-0.0063246,-0.027678,0,0
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.66501,-0.0063535,0.028051,0,0
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1,-0.0064214,0.030831,0,0
6,GO MEIOSIS I CELL CYCLE PROCESS,0.74288,-0.006435,-0.015781,0,0
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.95466,-0.006481,0.001218,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.37932,-0.006498,-0.094229,0,0
6,GO CELL CYCLE PHASE TRANSITION,0.86455,-0.0066149,-0.013577,0,0
6,GO AXON EXTENSION,0.58456,-0.0066289,-0.037602,0,0
6,GO PROTEIN DEPOLYMERIZATION,0.96163,-0.0066302,0.00079491,0,0
6,GO CARTILAGE MORPHOGENESIS,0.7495,-0.0066979,0.028574,0,0
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.53742,-0.0067538,0.056253,0,0
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.89907,-0.0068813,0.016667,0,0
6,GO LEUKOCYTE AGGREGATION,0.71006,-0.0069031,-0.061752,0,0
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.66501,-0.0069424,0.02369,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.69061,-0.0071062,-0.018767,0,0
6,GO RNA SURVEILLANCE,0.70355,-0.0074058,0.042537,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.97557,-0.0075433,-0.00062017,0,0
6,GO REGULATION OF CHROMATIN ORGANIZATION,0.94769,-0.0076054,-0.0014687,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.98953,-0.0077453,-0.01521,0,0
6,GO CELL CYCLE,0.29184,-0.0079831,-0.023764,0,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.72313,-0.0081655,-0.017975,0,0
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.9686,-0.0081983,0.062211,0,0
6,GO HISTONE H3 K9 DEMETHYLATION,0.71006,-0.0082402,-0.018394,0,0
6,GO LYMPHOCYTE COSTIMULATION,0.38408,-0.0084207,-0.051254,0,0
6,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.28785,-0.0084318,-0.040603,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.53167,-0.008576,-0.058543,0,0
6,GO MALE GAMETE GENERATION,0.30815,-0.0086885,-0.031819,0,0
6,GO DETECTION OF LIGHT STIMULUS,0.85768,-0.0088382,-0.024751,0,0
6,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.78289,-0.0089548,0.039142,0,0
6,GO DENDRITIC SPINE DEVELOPMENT,0.50896,-0.0091383,-0.048678,0,0
6,GO REGULATION OF COLLATERAL SPROUTING,0.94073,-0.009174,0.0026503,0,0
6,GO DNA MODIFICATION,0.86455,-0.0092481,-0.0046346,0,0
6,GO NUCLEAR PORE ORGANIZATION,0.89907,-0.0092589,-0.0084083,0,0
6,GO BONE CELL DEVELOPMENT,0.95466,-0.0093698,-0.004569,0,0
6,GO MAINTENANCE OF CELL NUMBER,0.42347,-0.0094031,-0.048935,0,0
6,GO REGULATION OF HISTONE MODIFICATION,0.95466,-0.0094308,-0.0029842,0,0
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.87144,-0.0095142,-0.029401,0,0
6,GO REGULATION OF NEURON DIFFERENTIATION,0.48678,-0.0097873,-0.02473,0,0
6,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.98953,-0.0099145,-0.050949,0,0
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.82348,-0.010072,-0.01531,0,0
6,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.33373,-0.010166,-0.072998,0,0
6,GO ORGANELLE FISSION,0.98255,-0.010533,-0.0050471,0,0
6,GO AXON DEVELOPMENT,0.69061,-0.010602,-0.0093357,0,0
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.56666,-0.010689,-0.03751,0,0
6,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.8303,-0.010731,0.010605,0,0
6,GO POSITIVE REGULATION OF CELL DIVISION,0.98255,-0.010746,-0.018008,0,0
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.94073,-0.010785,0.030345,0,0
6,GO RESPONSE TO AUDITORY STIMULUS,0.63978,-0.010902,0.097998,0,0
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.87833,-0.010936,0.014826,0,0
6,GO RETINOIC ACID METABOLIC PROCESS,0.71658,-0.011027,-0.040955,0,0
6,GO REGULATION OF AMINO ACID TRANSPORT,0.98953,-0.011052,0.0083552,0,0
6,GO CELL PROJECTION ASSEMBLY,0.24288,-0.01106,-0.030825,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.92682,-0.011117,-0.027676,0,0
6,GO MICROTUBULE BUNDLE FORMATION,0.62113,-0.011183,0.049189,0,0
6,GO REGULATION OF DNA METHYLATION,0.34702,-0.011251,-0.057965,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.2839,-0.011259,-0.040517,0,0
6,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.64605,-0.011263,-0.062493,0,0
6,GO FOREBRAIN NEURON DEVELOPMENT,0.94769,-0.011324,0.03399,0,0
6,GO BASE EXCISION REPAIR,0.99651,-0.011622,-0.016075,0,0
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.7495,-0.011644,0.040373,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.91987,-0.01165,0.010437,0,0
6,GO REGULATION OF CELL CYCLE ARREST,0.80312,-0.011862,-0.0061526,0,0
6,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.51459,-0.011997,-0.056452,0,0
6,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.55487,-0.012178,-0.059958,0,0
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.84397,-0.012276,-0.00025936,0,0
6,GO CELL PART MORPHOGENESIS,0.89215,-0.012319,-0.0012744,0,0
6,GO HEAD DEVELOPMENT,0.56075,-0.012408,-0.013674,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.76948,-0.01257,-0.030673,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.85082,-0.012601,-0.018059,0,0
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.74288,-0.01263,-0.05873,0,0
6,GO MYOTUBE CELL DEVELOPMENT,0.95466,-0.012723,-0.0039101,0,0
6,GO REGULATION OF TELOMERE CAPPING,0.65234,-0.012736,-0.021706,0,0
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.52025,-0.012804,-0.03641,0,0
6,GO MICROTUBULE BASED MOVEMENT,0.59664,-0.013289,0.021938,0,0
6,GO NUCLEAR EXPORT,0.63354,-0.013298,-0.02229,0,0
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.97557,-0.01334,0.003862,0,0
6,GO INHIBITORY SYNAPSE ASSEMBLY,0.86455,-0.013526,0.056005,0,0
6,GO ACTIN FILAMENT BASED TRANSPORT,0.78289,-0.013648,0.028776,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.67137,-0.013729,0.025735,0,0
6,GO REGULATION OF DENDRITE DEVELOPMENT,0.87833,-0.013761,-0.00044577,0,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.79636,-0.01397,-0.09974,0,0
6,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.29992,-0.014022,-0.049494,0,0
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.71006,-0.014187,-0.064087,0,0
6,GO REGULATION OF CELL FATE SPECIFICATION,0.69707,-0.014207,-0.025566,0,0
6,GO ENDOCARDIUM DEVELOPMENT,0.58456,-0.014257,0.08417,0,0
6,GO LIPID DROPLET FORMATION,0.52025,-0.014298,-0.093089,0,0
6,GO ESTABLISHMENT OF RNA LOCALIZATION,0.56666,-0.014346,-0.032053,0,0
6,GO NEGATIVE REGULATION OF AXON EXTENSION,0.53742,-0.014576,-0.050756,0,0
6,GO RESPONSE TO UV C,0.97557,-0.014816,-0.0074061,0,0
6,GO DENDRITIC SPINE MAINTENANCE,0.31232,-0.01483,-0.075344,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.81668,-0.014922,-0.017738,0,0
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.34256,-0.015074,-0.031311,0,0
6,GO MISMATCH REPAIR,0.60883,-0.015182,-0.022286,0,0
6,GO ADRENAL GLAND DEVELOPMENT,0.4978,-0.015275,-0.075788,0,0
6,GO MEIOTIC CELL CYCLE PROCESS,0.43883,-0.015472,-0.023133,0,0
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.97557,-0.015576,-0.0069838,0,0
6,GO AXONAL FASCICULATION,0.69061,-0.015692,-0.040179,0,0
6,GO REGULATION OF RNA BINDING,0.64605,-0.015755,-0.047639,0,0
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.94769,-0.015809,-0.0041372,0,0
6,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.29992,-0.015832,-0.079021,0,0
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.87833,-0.016006,0.0084407,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.4978,-0.016018,-0.015881,0,0
6,GO SODIUM ION HOMEOSTASIS,0.9686,-0.016101,0.0081621,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.96163,-0.016911,0.00056386,0,0
6,GO CELL CYCLE PROCESS,0.34256,-0.017077,-0.026255,0,0
6,GO REGULATION OF BEHAVIOR,0.64605,-0.017139,-0.033857,0,0
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.53167,-0.017171,-0.043929,0,0
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.84397,-0.017219,-0.030413,0,0
6,GO SEXUAL REPRODUCTION,0.16828,-0.01729,-0.03973,0,0
6,GO RNA DECAPPING,0.36991,-0.01732,-0.058793,0,0
6,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.19095,-0.017372,-0.092445,0,0
6,GO VISUAL BEHAVIOR,0.48678,-0.017498,-0.028989,0,0
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.43367,-0.017546,-0.065253,0,0
6,GO RNA 3 END PROCESSING,0.89907,-0.017584,-0.0083992,0,0
6,GO DETECTION OF MECHANICAL STIMULUS,0.77618,-0.017602,0.00050054,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.87144,-0.017612,-0.0093908,0,0
6,GO MALE MEIOSIS I,0.29586,-0.017709,-0.10925,0,0
6,GO REGULATION OF ACTIN NUCLEATION,0.32077,-0.017732,-0.071464,0,0
6,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.78962,-0.017773,-0.058323,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.73628,-0.017979,-0.046398,0,0
6,GO CELL CYCLE G1 S PHASE TRANSITION,0.26471,-0.018231,-0.03698,0,0
6,GO CYTOPLASM ORGANIZATION,0.84397,-0.018234,-0.024225,0,0
6,GO THYMIC T CELL SELECTION,0.60883,-0.018365,-0.024327,0,0
6,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.89907,-0.018434,0.00052554,0,0
6,GO COLLATERAL SPROUTING,0.41341,-0.018473,-0.048532,0,0
6,GO CIRCADIAN RHYTHM,0.25001,-0.01848,-0.047503,0,0
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.57857,-0.018501,0.057081,0,0
6,GO NEUROGENESIS,0.38408,-0.018515,-0.026425,0,0
6,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.23245,-0.018517,-0.091643,0,0
6,GO REGULATION OF SENSORY PERCEPTION,0.23245,-0.018527,-0.084874,0,0
6,GO RUFFLE ASSEMBLY,0.34702,-0.018603,-0.04949,0,0
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.80312,-0.018689,0.038594,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.69061,-0.018805,-0.067078,0,0
6,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.32938,-0.018828,-0.063274,0,0
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.4598,-0.018884,-0.06919,0,0
6,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.16828,-0.018888,-0.060111,0,0
6,GO ROOF OF MOUTH DEVELOPMENT,0.89215,-0.01892,-0.0082744,0,0
6,GO HOMOLOGOUS RECOMBINATION,0.4978,-0.018994,-0.035788,0,0
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.98255,-0.019244,0.013745,0,0
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.5726,-0.019275,0.040313,0,0
6,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.35153,-0.019343,-0.046854,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.43883,-0.01946,-0.064773,0,0
6,GO REGULATION OF ATPASE ACTIVITY,0.40843,-0.019578,-0.029102,0,0
6,GO MEIOTIC CELL CYCLE,0.69707,-0.019664,-0.01333,0,0
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.81668,-0.019821,-0.012379,0,0
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.78289,-0.020139,-0.021173,0,0
6,GO PH REDUCTION,0.97557,-0.020183,-0.011136,0,0
6,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.30815,-0.020183,-0.041304,0,0
6,GO PROTEIN DENEDDYLATION,0.83713,-0.020399,-0.012429,0,0
6,GO ATRIAL SEPTUM DEVELOPMENT,0.63354,-0.020473,0.055058,0,0
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.67776,-0.020519,-0.0048122,0,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.18219,-0.020538,-0.062452,0,0
6,GO DECIDUALIZATION,0.88523,-0.020552,0.00053591,0,0
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0695,-0.020635,-0.041301,0,0
6,GO LIMBIC SYSTEM DEVELOPMENT,0.86455,-0.020665,-0.011166,0,0
6,GO NUCLEAR TRANSPORT,0.12049,-0.020667,-0.04496,0,0
6,GO REGULATION OF ODONTOGENESIS,0.4598,-0.020684,-0.088082,0,0
6,GO RESPONSE TO LIGHT STIMULUS,0.35607,-0.020806,-0.026974,0,0
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.25001,-0.021176,-0.076096,0,0
6,GO NEURON DIFFERENTIATION,0.60883,-0.021237,-0.011425,0,0
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.98953,-0.021305,0.011984,0,0
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.72969,-0.021345,-0.023047,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.51459,-0.021472,-0.01835,0,0
6,GO REGULATION OF LIGASE ACTIVITY,0.52025,-0.021545,-0.058158,0,0
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.9686,-0.021727,-0.027638,0,0
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.97557,-0.021753,0.0026619,0,0
6,GO MULTIVESICULAR BODY ORGANIZATION,0.59664,-0.02183,-0.020309,0,0
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.71006,-0.022058,-0.01146,0,0
6,GO REGULATION OF EXIT FROM MITOSIS,0.51459,-0.022117,-0.034376,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE,0.060602,-0.022315,-0.049581,0,0
6,GO STRIATUM DEVELOPMENT,0.48131,-0.022324,-0.064618,0,0
6,GO INTRA S DNA DAMAGE CHECKPOINT,0.40843,-0.022406,-0.038769,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.29992,-0.022471,-0.040866,0,0
6,GO MEMBRANE FISSION,0.65234,-0.022511,0.051417,0,0
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.98953,-0.022548,-0.011402,0,0
6,GO NEURON PROJECTION ORGANIZATION,0.73628,-0.022615,-0.033418,0,0
6,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.60883,-0.022855,-0.045499,0,0
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.68418,-0.022893,-0.027107,0,0
6,GO PENILE ERECTION,0.62113,-0.022959,0.07435,0,0
6,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.83713,-0.022988,-0.010214,0,0
6,GO HIPPO SIGNALING,0.59664,-0.023011,-0.097243,0,0
6,GO N GLYCAN PROCESSING,0.60272,-0.023022,-0.04527,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.33373,-0.023346,-0.036458,0,0
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.9686,-0.023398,0.0083801,0,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.78962,-0.023429,-0.01387,0,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.60883,-0.023523,-0.06822,0,0
6,GO MESODERMAL CELL FATE COMMITMENT,0.40843,-0.02354,-0.058949,0,0
6,GO SHORT TERM MEMORY,0.88523,-0.023547,-0.029053,0,0
6,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.54321,-0.023557,-0.040454,0,0
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.89215,-0.023629,-0.007265,0,0
6,GO NEURON APOPTOTIC PROCESS,0.73628,-0.023721,-0.0045286,0,0
6,GO EXIT FROM MITOSIS,0.60272,-0.02378,-0.02445,0,0
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.74288,-0.023857,-0.077349,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.81668,-0.023955,-0.028791,0,0
6,GO REGULATION OF MYELINATION,0.56075,-0.023982,-0.033408,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.61497,-0.024042,-0.031694,0,0
6,GO SENSORY PERCEPTION OF BITTER TASTE,0.22235,-0.024122,-0.075501,0,0
6,GO SPERM MOTILITY,0.66501,-0.024196,-0.007266,0,0
6,GO REGULATION OF CELL DEVELOPMENT,0.22905,-0.024432,-0.043338,0,0
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.63354,-0.024507,-0.08107,0,0
6,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.063042,-0.02463,-0.084458,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.49227,-0.024924,-0.056887,0,0
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.4978,-0.024971,-0.15206,0,0
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.49227,-0.025163,-0.027052,0,0
6,GO STRESS GRANULE ASSEMBLY,0.22568,-0.025223,-0.069473,0,0
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.56666,-0.025295,-0.039742,0,0
6,GO REGULATION OF DNA BINDING,0.67137,-0.025304,-0.015508,0,0
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.57857,-0.025464,-0.034487,0,0
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.97557,-0.025586,0.011057,0,0
6,GO REGULATION OF APPETITE,0.47588,-0.025626,-0.041586,0,0
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.32506,-0.025775,-0.041284,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.44402,-0.025995,-0.081867,0,0
6,GO NUCLEAR MIGRATION,0.73628,-0.026036,-0.030742,0,0
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.88523,-0.026074,-0.011669,0,0
6,GO MRNA CLEAVAGE,0.44924,-0.026101,-0.025699,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.43883,-0.026125,-0.068286,0,0
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.40349,-0.026445,-0.036461,0,0
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.49227,-0.026488,-0.031556,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.68418,-0.026506,-0.028614,0,0
6,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.59059,-0.026781,-0.065958,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24643,-0.026928,-0.085836,0,0
6,GO TELOMERE ORGANIZATION,0.36991,-0.027134,-0.035314,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.64605,-0.027445,-0.063612,0,0
6,GO ASTROCYTE ACTIVATION,0.50896,-0.027489,-0.068577,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.38888,-0.027493,-0.074767,0,0
6,GO HISTONE H4 DEACETYLATION,0.4545,-0.027548,-0.047145,0,0
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.42347,-0.027879,-0.028771,0,0
6,GO LONG TERM SYNAPTIC POTENTIATION,0.41842,-0.027976,-0.058139,0,0
6,GO REGULATION OF GENE SILENCING,0.14285,-0.027979,-0.062996,0,0
6,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.39371,-0.028148,-0.056741,0,0
6,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.23589,-0.028399,-0.19403,0,0
6,GO CELLULAR RESPONSE TO NUTRIENT,0.25001,-0.028429,-0.10892,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.56075,-0.028521,-0.02215,0,0
6,GO NUCLEUS ORGANIZATION,0.43883,-0.028732,-0.028928,0,0
6,GO REGULATION OF CILIUM MOVEMENT,0.5726,-0.028747,-0.015969,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE,0.15773,-0.028816,-0.029077,0,0
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.94073,-0.028992,-0.013998,0,0
6,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.75615,-0.029005,-0.01763,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.72969,-0.029049,-0.033103,0,0
6,GO ALDEHYDE CATABOLIC PROCESS,0.74288,-0.029079,-0.03972,0,0
6,GO NUCLEUS LOCALIZATION,0.52594,-0.029086,-0.03286,0,0
6,GO POST EMBRYONIC DEVELOPMENT,0.63978,-0.029323,-0.012216,0,0
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.67776,-0.029358,-0.020308,0,0
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.22568,-0.029379,-0.045964,0,0
6,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.75615,-0.029431,-0.063437,0,0
6,GO POSTSYNAPSE ASSEMBLY,0.94769,-0.029456,0.011637,0,0
6,GO MITOTIC CYTOKINETIC PROCESS,0.43883,-0.029484,-0.038896,0,0
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.97557,-0.02949,-0.0018742,0,0
6,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.40349,-0.029749,-0.042617,0,0
6,GO SYNAPTIC VESICLE PRIMING,0.80312,-0.029843,0.05304,0,0
6,GO METHYLATION,0.093897,-0.029856,-0.035957,0,0
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.76281,-0.029938,0.03185,0,0
6,GO SPINDLE MIDZONE ASSEMBLY,0.34702,-0.030066,-0.055818,0,0
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.48678,-0.030112,-0.066582,0,0
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.21579,-0.030173,-0.08522,0,0
6,GO FIBROBLAST ACTIVATION,0.29586,-0.03023,-0.097897,0,0
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.32506,-0.030232,-0.030246,0,0
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.28785,-0.030272,-0.061893,0,0
6,GO NEURON RECOGNITION,0.66501,-0.030365,0.039,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.85082,-0.030371,-0.023968,0,0
6,GO T CELL HOMEOSTASIS,0.66501,-0.030473,-0.016514,0,0
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.58456,-0.030497,-0.017764,0,0
6,GO NATURAL KILLER CELL ACTIVATION,0.52594,-0.030521,-0.051197,0,0
6,GO REGULATION OF GLIOGENESIS,0.83713,-0.030609,0.0025141,0,0
6,GO ACTIVATION OF MAPKK ACTIVITY,0.42347,-0.030671,-0.060091,0,0
6,GO SEROTONIN TRANSPORT,0.68418,-0.031048,-0.057622,0,0
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.064293,-0.03112,-0.0491,0,0
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.27999,-0.031141,-0.082453,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.36064,-0.031262,-0.074295,0,0
6,GO MULTICELLULAR ORGANISM REPRODUCTION,0.10845,-0.031335,-0.043099,0,0
6,GO CEREBRAL CORTEX CELL MIGRATION,0.62732,-0.031339,-0.029211,0,0
6,GO CELLULAR COMPONENT MORPHOGENESIS,0.46512,-0.031363,-0.020397,0,0
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.44924,-0.031419,-0.03258,0,0
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.23937,-0.031505,-0.056549,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.82348,-0.031786,-0.023758,0,0
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.23245,-0.031793,-0.034973,0,0
6,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.53742,-0.031892,-0.053656,0,0
6,GO STEROL BIOSYNTHETIC PROCESS,0.188,-0.031912,-0.088516,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.13814,-0.032157,-0.031671,0,0
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.42855,-0.032249,-0.031297,0,0
6,GO CARDIAC ATRIUM DEVELOPMENT,0.96163,-0.032585,0.0042842,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.05824,-0.032646,-0.05521,0,0
6,GO NEURON DEVELOPMENT,0.42347,-0.032703,-0.02824,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.90599,-0.032899,0.0078702,0,0
6,GO AXONEME ASSEMBLY,0.81668,-0.032947,0.049547,0,0
6,GO COBALAMIN METABOLIC PROCESS,0.28785,-0.033012,-0.09504,0,0
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0695,-0.033165,-0.043939,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.5726,-0.033262,0.016897,0,0
6,GO MITOCHONDRION MORPHOGENESIS,0.50337,-0.033275,-0.035238,0,0
6,GO SENSORY ORGAN MORPHOGENESIS,0.38888,-0.033278,-0.037849,0,0
6,GO REGULATION OF ORGANIC ACID TRANSPORT,0.38888,-0.033296,-0.066249,0,0
6,GO SYNAPTIC MEMBRANE ADHESION,0.91987,-0.033302,-0.020091,0,0
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.34702,-0.033425,-0.057161,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.16828,-0.033587,-0.068044,0,0
6,GO RESPONSE TO RADIATION,0.060602,-0.033593,-0.044538,0,0
6,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.188,-0.033673,-0.10606,0,0
6,GO POSITIVE THYMIC T CELL SELECTION,0.67137,-0.033678,-0.018216,0,0
6,GO SPECIFICATION OF SYMMETRY,0.29992,-0.033683,-0.024179,0,0
6,GO REGULATION OF OOGENESIS,0.91293,-0.033887,-0.0092963,0,0
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.56075,-0.033962,-0.07331,0,0
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.59664,-0.033966,0.044786,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0695,-0.033966,-0.06707,0,0
6,GO REPRODUCTIVE BEHAVIOR,0.42347,-0.03405,-0.055338,0,0
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.88523,-0.034082,0.032117,0,0
6,GO REGULATION OF PINOCYTOSIS,0.090515,-0.034153,-0.16529,0,0
6,GO MITOTIC CYTOKINESIS,0.39371,-0.034165,-0.037483,0,0
6,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.77618,-0.034285,-0.021353,0,0
6,GO SYNAPTIC SIGNALING,0.58456,-0.034301,-0.0055273,0,0
6,GO CELLULAR SENESCENCE,0.15517,-0.034334,-0.054704,0,0
6,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.25729,-0.034455,-0.10351,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.092194,-0.034598,-0.059241,0,0
6,GO POSTSYNAPSE ORGANIZATION,0.77618,-0.034655,-0.014282,0,0
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.16559,-0.034819,-0.041327,0,0
6,GO COGNITION,0.65234,-0.034938,-0.01898,0,0
6,GO REGULATION OF STEM CELL DIFFERENTIATION,0.25001,-0.034954,-0.081699,0,0
6,GO RNA POLYADENYLATION,0.21905,-0.035,-0.061018,0,0
6,GO APPENDAGE DEVELOPMENT,0.31653,-0.035031,-0.055449,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.26098,-0.035112,-0.072902,0,0
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.26847,-0.035153,-0.1208,0,0
6,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.33812,-0.035235,-0.12682,0,0
6,GO GANGLIOSIDE METABOLIC PROCESS,0.62113,-0.035273,-0.037785,0,0
6,GO SNRNA METABOLIC PROCESS,0.38888,-0.035403,-0.083317,0,0
6,GO MOTOR NEURON AXON GUIDANCE,0.61497,-0.03556,-0.023286,0,0
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.65234,-0.035577,-0.028288,0,0
6,GO RESPONSE TO NITROSATIVE STRESS,0.31232,-0.035619,-0.16057,0,0
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.58456,-0.035651,-0.044595,0,0
6,GO LEARNING,0.83713,-0.035666,-0.0048788,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.4545,-0.036311,-0.055062,0,0
6,GO NEGATIVE REGULATION OF GLIOGENESIS,0.93377,-0.036453,0.0045712,0,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.23245,-0.036525,-0.050124,0,0
6,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.67776,-0.036628,-0.056557,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.30402,-0.036797,-0.10699,0,0
6,GO MIDGUT DEVELOPMENT,0.2839,-0.036834,-0.13457,0,0
6,GO ACIDIC AMINO ACID TRANSPORT,0.63978,-0.036866,-0.010576,0,0
6,GO ENDOCRINE PANCREAS DEVELOPMENT,0.27611,-0.036867,-0.070725,0,0
6,GO FEMALE GAMETE GENERATION,0.17653,-0.037104,-0.04534,0,0
6,GO PATTERN SPECIFICATION PROCESS,0.32077,-0.037302,-0.042437,0,0
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.13583,-0.03732,-0.066258,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.10654,-0.037351,-0.12591,0,0
6,GO TORC1 SIGNALING,0.42855,-0.037373,-0.04567,0,0
6,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.32938,-0.037438,-0.061809,0,0
6,GO PROTEIN K63 LINKED UBIQUITINATION,0.095625,-0.037439,-0.056764,0,0
6,GO MRNA METABOLIC PROCESS,0.10845,-0.037641,-0.055013,0,0
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.56666,-0.037695,0.06923,0,0
6,GO EMBRYONIC EYE MORPHOGENESIS,0.98953,-0.037912,0.0058869,0,0
6,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.22905,-0.037958,-0.11811,0,0
6,GO POSITIVE REGULATION OF CYTOKINESIS,0.38888,-0.038419,-0.025568,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.48131,-0.0385,-0.018595,0,0
6,GO PROTEIN ADP RIBOSYLATION,0.55487,-0.038605,-0.020088,0,0
6,GO REGULATION OF ERAD PATHWAY,0.23245,-0.03862,-0.053188,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.78289,-0.038642,-0.04351,0,0
6,GO EMBRYONIC AXIS SPECIFICATION,0.41341,-0.038729,-0.050981,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.39371,-0.038832,-0.038436,0,0
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.070855,-0.038876,-0.081818,0,0
6,GO CYTIDINE TO URIDINE EDITING,0.26471,-0.039082,-0.21075,0,0
6,GO CELLULAR RESPONSE TO MANGANESE ION,0.54321,-0.039084,-0.039622,0,0
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.21579,-0.039172,-0.10817,0,0
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.21905,-0.039174,-0.040853,0,0
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.41341,-0.039176,-0.065972,0,0
6,GO WALKING BEHAVIOR,0.86455,-0.039183,0.0071899,0,0
6,GO CHONDROCYTE DEVELOPMENT,0.63978,-0.039184,-0.061306,0,0
6,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.61497,-0.03927,-0.034546,0,0
6,GO MULTICELLULAR ORGANISM GROWTH,0.080955,-0.039314,-0.057429,0,0
6,GO LIPID PHOSPHORYLATION,0.12908,-0.039483,-0.059065,0,0
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.29184,-0.039497,-0.071433,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.10654,-0.039574,-0.048338,0,0
6,GO VESICLE LOCALIZATION,0.033166,-0.039637,-0.061667,0,0
6,GO HISTONE H2B UBIQUITINATION,0.72313,-0.039764,-0.019909,0,0
6,GO PHOTOPERIODISM,0.30815,-0.039814,-0.049483,0,0
6,GO REGULATION OF NUCLEAR DIVISION,0.38408,-0.03989,-0.025392,0,0
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.4545,-0.039974,-0.032397,0,0
6,GO REGULATION OF INTEGRIN ACTIVATION,0.2839,-0.040151,-0.099237,0,0
6,GO RESPONSE TO VITAMIN D,0.53167,-0.040184,-0.083526,0,0
6,GO GMP METABOLIC PROCESS,0.70355,-0.040223,-0.042894,0,0
6,GO POSITIVE REGULATION OF CELL GROWTH,0.22568,-0.040225,-0.044636,0,0
6,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.44924,-0.040286,-0.026602,0,0
6,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.26847,-0.040291,-0.075567,0,0
6,GO OOCYTE MATURATION,0.3746,-0.04042,-0.036206,0,0
6,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.090515,-0.040476,-0.11275,0,0
6,GO ERBB2 SIGNALING PATHWAY,0.23937,-0.040478,-0.080994,0,0
6,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.34702,-0.040621,-0.057203,0,0
6,GO REGULATION OF DNA CATABOLIC PROCESS,0.48131,-0.04074,-0.027234,0,0
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.80989,-0.040794,0.0055719,0,0
6,GO NEGATIVE REGULATION OF CELL DIVISION,0.84397,-0.040822,-0.022678,0,0
6,GO CHONDROCYTE PROLIFERATION,0.59059,-0.040825,-0.088778,0,0
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.69061,-0.040885,0.020777,0,0
6,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.34256,-0.040929,-0.10716,0,0
6,GO UBIQUINONE METABOLIC PROCESS,0.15517,-0.041019,-0.088796,0,0
6,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.76281,-0.041125,-0.018091,0,0
6,GO NEGATIVE REGULATION OF NEURON DEATH,0.19393,-0.04133,-0.037565,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0060989,-0.041409,-0.061042,0,0
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.60272,-0.04144,-0.039761,0,0
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.087232,-0.041573,-0.13688,0,0
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.25001,-0.041628,-0.054549,0,0
6,GO TUMOR NECROSIS FACTOR SECRETION,0.4978,-0.041694,-0.038979,0,0
6,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.35153,-0.041841,-0.064594,0,0
6,GO PEPTIDYL LYSINE DIMETHYLATION,0.94769,-0.041872,0.0076642,0,0
6,GO CAMERA TYPE EYE DEVELOPMENT,0.20309,-0.041885,-0.048324,0,0
6,GO REGULATION OF MRNA 3 END PROCESSING,0.44402,-0.041886,-0.040509,0,0
6,GO HYPOTHALAMUS DEVELOPMENT,0.36526,-0.041917,-0.071626,0,0
6,GO NEURON PROJECTION EXTENSION,0.41341,-0.041947,-0.043182,0,0
6,GO REGULATION OF MITOCHONDRIAL FUSION,0.47049,-0.042246,-0.041542,0,0
6,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.72969,-0.042246,-0.034972,0,0
6,GO CELLULAR RESPONSE TO ALKALOID,0.24643,-0.042305,-0.055542,0,0
6,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.1313,-0.04241,-0.052003,0,0
6,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.10654,-0.04246,-0.092644,0,0
6,GO REGULATION OF GOLGI ORGANIZATION,0.43367,-0.042563,-0.026662,0,0
6,GO SLEEP,0.17374,-0.042581,-0.076534,0,0
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.64605,-0.042587,-0.056776,0,0
6,GO CALCINEURIN MEDIATED SIGNALING,0.13814,-0.042735,-0.070843,0,0
6,GO SPLEEN DEVELOPMENT,0.4978,-0.042813,-0.033398,0,0
6,GO ORGANELLE ASSEMBLY,0.044685,-0.042988,-0.044384,0,0
6,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.24643,-0.04301,-0.067388,0,0
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.62732,-0.043077,-0.025013,0,0
6,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.16559,-0.043079,-0.069196,0,0
6,GO RESPONSE TO GLUCAGON,0.2839,-0.04323,-0.053687,0,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.11235,-0.043236,-0.077015,0,0
6,GO DORSAL AORTA DEVELOPMENT,0.69061,-0.043259,-0.027507,0,0
6,GO RESPONSE TO ELECTRICAL STIMULUS,0.78962,-0.043311,-0.017841,0,0
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.47049,-0.043355,-0.061928,0,0
6,GO SENSORY SYSTEM DEVELOPMENT,0.15015,-0.043573,-0.051418,0,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.47588,-0.043642,-0.045627,0,0
6,GO REGULATION OF MITOPHAGY,0.41842,-0.043721,-0.043392,0,0
6,GO DEVELOPMENTAL CELL GROWTH,0.079444,-0.044035,-0.076563,0,0
6,GO CELL MATURATION,0.16559,-0.044071,-0.050771,0,0
6,GO REGULATION OF HISTONE PHOSPHORYLATION,0.33812,-0.044094,-0.083568,0,0
6,GO EMBRYONIC BODY MORPHOGENESIS,0.48131,-0.044143,-0.046102,0,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION,0.29586,-0.044186,-0.04429,0,0
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.67776,-0.044347,0.028244,0,0
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.065563,-0.044348,-0.073293,0,0
6,GO PRENYLATION,0.7495,-0.044412,-0.0095696,0,0
6,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.26098,-0.044463,-0.06611,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.52594,-0.044528,-0.096853,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.50337,-0.044541,-0.055059,0,0
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.26471,-0.044609,-0.056136,0,0
6,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.46512,-0.044633,-0.079418,0,0
6,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.32506,-0.044697,-0.087722,0,0
6,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.22235,-0.045105,-0.067822,0,0
6,GO NEGATIVE REGULATION OF BEHAVIOR,0.34256,-0.045319,-0.063799,0,0
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.21905,-0.045435,-0.04028,0,0
6,GO REGULATION OF B CELL DIFFERENTIATION,0.28785,-0.04545,-0.082271,0,0
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.25363,-0.045563,-0.014531,0,0
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.24288,-0.04579,-0.057183,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.27611,-0.045797,-0.065193,0,0
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.51459,-0.045862,-0.049628,0,0
6,GO CELL PROJECTION ORGANIZATION,0.20621,-0.045967,-0.039005,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.4978,-0.045977,-0.017324,0,0
6,GO PROTEIN POLYUBIQUITINATION,0.17099,-0.046034,-0.043869,0,0
6,GO POSITIVE REGULATION OF DNA BINDING,0.26471,-0.046203,-0.044425,0,0
6,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.58456,-0.046226,-0.040091,0,0
6,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.25729,-0.04627,-0.068209,0,0
6,GO TRANSLESION SYNTHESIS,0.36991,-0.046286,-0.034384,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.36991,-0.046415,-0.040578,0,0
6,GO NCRNA EXPORT FROM NUCLEUS,0.42855,-0.046449,-0.046459,0,0
6,GO CRANIAL NERVE DEVELOPMENT,0.19695,-0.046512,-0.10242,0,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.26098,-0.04653,-0.070672,0,0
6,GO REPLICATIVE SENESCENCE,0.21256,-0.046602,-0.13666,0,0
6,GO ADULT BEHAVIOR,0.60272,-0.04663,-0.00011537,0,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.33373,-0.0467,-0.054586,0,0
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.56666,-0.046796,0.0016261,0,0
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.12049,-0.046964,-0.060293,0,0
6,GO POSITIVE REGULATION OF HORMONE SECRETION,0.2839,-0.047026,-0.042262,0,0
6,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.3746,-0.047063,-0.059979,0,0
6,GO PORE COMPLEX ASSEMBLY,0.41842,-0.047161,-0.046052,0,0
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.17099,-0.047245,-0.074878,0,0
6,GO POTASSIUM ION HOMEOSTASIS,0.42347,-0.047457,-0.050064,0,0
6,GO MEMORY,0.17374,-0.047513,-0.067301,0,0
6,GO SEGMENTATION,0.079444,-0.047559,-0.087491,0,0
6,GO SPERM CAPACITATION,0.62732,-0.047767,-0.030988,0,0
6,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.46512,-0.047826,-0.031818,0,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.26847,-0.047891,-0.085882,0,0
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.74288,-0.048126,-0.037625,0,0
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.56075,-0.048232,-0.010743,0,0
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.35153,-0.048448,-0.069182,0,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.27999,-0.048459,-0.084636,0,0
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.059411,-0.048506,-0.069664,0,0
6,GO PROTEIN AUTOUBIQUITINATION,0.085627,-0.048508,-0.053969,0,0
6,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.17653,-0.048573,-0.074778,0,0
6,GO RNA DESTABILIZATION,0.48131,-0.04889,-0.041146,0,0
6,GO MIDBODY ABSCISSION,0.51459,-0.048947,-0.0050871,0,0
6,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.35153,-0.048966,-0.14296,0,0
6,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.43367,-0.048974,-0.042413,0,0
6,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.085627,-0.049101,-0.098565,0,0
6,GO EAR DEVELOPMENT,0.079444,-0.049171,-0.079809,0,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.15015,-0.049184,-0.03064,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.42855,-0.049217,-0.041131,0,0
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.28785,-0.049273,-0.021299,0,0
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.30402,-0.0493,-0.048361,0,0
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.12049,-0.049392,-0.092916,0,0
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.13355,-0.049448,-0.06477,0,0
6,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.80312,-0.049459,-0.021386,0,0
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.80312,-0.049589,0.026271,0,0
6,GO ATP BIOSYNTHETIC PROCESS,0.2839,-0.049706,-0.081194,0,0
6,GO CAMP BIOSYNTHETIC PROCESS,0.97557,-0.04977,0.0095154,0,0
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.1313,-0.04977,-0.072842,0,0
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.11841,-0.049855,-0.052685,0,0
6,GO MRNA MODIFICATION,0.27999,-0.049869,-0.072875,0,0
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.24643,-0.04995,-0.079578,0,0
6,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.42347,-0.049973,-0.03984,0,0
6,GO TELOMERASE RNA LOCALIZATION,0.44402,-0.050019,-0.088204,0,0
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.20309,-0.050238,-0.066425,0,0
6,GO SYNAPTIC VESICLE DOCKING,0.27611,-0.05026,-0.02023,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.060602,-0.050616,-0.10956,0,0
6,GO HEPATOCYTE APOPTOTIC PROCESS,0.84397,-0.050701,0.076045,0,0
6,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.10845,-0.050717,-0.068495,0,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0050528,-0.05078,-0.0585,0,0
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11235,-0.050844,-0.078726,0,0
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.26471,-0.050915,-0.044381,0,0
6,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.27227,-0.050924,-0.16546,0,0
6,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.14769,-0.050945,-0.065412,0,0
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.35153,-0.051112,-0.12103,0,0
6,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.29992,-0.051147,-0.10996,0,0
6,GO PEPTIDYL THREONINE MODIFICATION,0.047551,-0.051804,-0.064499,0,0
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.44402,-0.051917,-0.046799,0,0
6,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.38408,-0.051964,-0.060191,0,0
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.21256,-0.052186,-0.036656,0,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.76281,-0.052339,0.0028783,0,0
6,GO SENSORY ORGAN DEVELOPMENT,0.12908,-0.05234,-0.055544,0,0
6,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.076492,-0.052352,-0.077904,0,0
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.25363,-0.052357,-0.061095,0,0
6,GO SYNAPTIC VESICLE BUDDING,0.42855,-0.052517,-0.0548,0,0
6,GO DENTATE GYRUS DEVELOPMENT,0.5726,-0.052554,-0.062599,0,0
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.079444,-0.052571,-0.061787,0,0
6,GO POSITIVE REGULATION OF ERAD PATHWAY,0.23937,-0.052575,-0.098214,0,0
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.036948,-0.052663,-0.07186,0,0
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.26471,-0.052794,-0.048507,0,0
6,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.17099,-0.052902,-0.078732,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.16032,-0.053022,-0.15104,0,0
6,GO THYMUS DEVELOPMENT,0.87144,-0.053047,0.0011291,0,0
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.60272,-0.053274,-0.02137,0,0
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.1313,-0.053462,-0.071361,0,0
6,GO ACTIN NUCLEATION,0.068167,-0.053486,-0.0793,0,0
6,GO RESPONSE TO LEAD ION,0.31653,-0.053553,-0.058706,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.63978,-0.05356,-0.031126,0,0
6,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.2839,-0.053656,-0.11046,0,0
6,GO RNA PROCESSING,0.22568,-0.053773,-0.046841,0,0
6,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.099158,-0.053989,-0.10536,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.35153,-0.05419,-0.029068,0,0
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.4598,-0.054212,-0.04265,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.54321,-0.0545,-0.015109,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.19695,-0.054542,-0.093091,0,0
6,GO GPI ANCHOR METABOLIC PROCESS,0.059411,-0.054554,-0.10487,0,0
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.36526,-0.054635,-0.072344,0,0
6,GO REGULATION OF MRNA BINDING,0.188,-0.05466,-0.11952,0,0
6,GO NEURAL TUBE DEVELOPMENT,0.12473,-0.054765,-0.07951,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.21905,-0.054804,-0.06689,0,0
6,GO SNRNA PROCESSING,0.34702,-0.054872,-0.10721,0,0
6,GO SOMATIC STEM CELL DIVISION,0.74288,-0.054957,0.094923,0,0
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.65866,-0.055134,-0.036914,0,0
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.14526,-0.055194,-0.10889,0,0
6,GO NEURONAL ION CHANNEL CLUSTERING,0.43883,-0.055268,-0.097856,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.20621,-0.055477,-0.057186,0,0
6,GO VIRAL BUDDING,0.3746,-0.055611,-0.018454,0,0
6,GO WATER TRANSPORT,0.29586,-0.055673,-0.028121,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.54903,-0.055856,-0.014091,0,0
6,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.14769,-0.056035,-0.10453,0,0
6,GO POSITIVE REGULATION OF AXON EXTENSION,0.34702,-0.05617,-0.049208,0,0
6,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.1313,-0.056261,-0.10708,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.17934,-0.056289,-0.11351,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.87833,-0.05631,-0.01461,0,0
6,GO ADULT FEEDING BEHAVIOR,0.5726,-0.05637,-0.063509,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.24643,-0.056515,-0.14563,0,0
6,GO SYNAPTIC VESICLE RECYCLING,0.44402,-0.056555,-0.030143,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.085627,-0.056827,-0.055602,0,0
6,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.12049,-0.056893,-0.084413,0,0
6,GO CELL MORPHOGENESIS,0.12908,-0.056969,-0.054195,0,0
6,GO NEGATIVE REGULATION OF JNK CASCADE,0.13583,-0.057076,-0.074878,0,0
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.14048,-0.057124,-0.072022,0,0
6,GO AMMONIUM TRANSPORT,0.50337,-0.05716,-0.0358,0,0
6,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.40349,-0.057191,-0.03813,0,0
6,GO POLYAMINE METABOLIC PROCESS,0.188,-0.057477,-0.074764,0,0
6,GO FOREBRAIN CELL MIGRATION,0.43883,-0.057569,-0.029852,0,0
6,GO REGULATORY T CELL DIFFERENTIATION,0.79636,-0.057667,-0.049474,0,0
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.23937,-0.057852,-0.072373,0,0
6,GO POSITIVE REGULATION OF NEURON DEATH,0.16294,-0.058289,-0.051504,0,0
6,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.34702,-0.058349,-0.10604,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.42855,-0.058379,-0.027882,0,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.3746,-0.058407,-0.046151,0,0
6,GO MANNOSYLATION,0.31653,-0.058413,-0.063017,0,0
6,GO MIRNA METABOLIC PROCESS,0.090515,-0.058515,-0.072696,0,0
6,GO LYSINE METABOLIC PROCESS,0.43883,-0.058528,-0.094815,0,0
6,GO HINDLIMB MORPHOGENESIS,0.39371,-0.058552,-0.069036,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.14769,-0.058731,-0.1695,0,0
6,GO SKELETAL MUSCLE ADAPTATION,0.29184,-0.05911,-0.073072,0,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.10845,-0.059427,-0.12662,0,0
6,GO REGULATION OF HISTONE UBIQUITINATION,0.1028,-0.059505,-0.061077,0,0
6,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.38888,-0.059514,-0.053415,0,0
6,GO TERPENOID BIOSYNTHETIC PROCESS,0.72969,-0.059651,-0.039096,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.90599,-0.059755,-0.0023571,0,0
6,GO REGULATION OF CELL MORPHOGENESIS,0.12473,-0.059906,-0.062632,0,0
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.98953,-0.060029,0.0017297,0,0
6,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.076492,-0.060052,-0.076192,0,0
6,GO SYNAPSE MATURATION,0.37932,-0.060054,-0.1006,0,0
6,GO EXCITATORY SYNAPSE ASSEMBLY,0.63978,-0.060069,-0.036774,0,0
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.10845,-0.060154,-0.071333,0,0
6,GO LIPID DIGESTION,0.11841,-0.06018,-0.16488,0,0
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.19695,-0.060243,-0.086331,0,0
6,GO PRESYNAPSE ORGANIZATION,0.43883,-0.060439,-0.032715,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.22568,-0.060454,-0.05541,0,0
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.35153,-0.060505,-0.060915,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.15773,-0.060529,-0.060799,0,0
6,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.059411,-0.060632,-0.12877,0,0
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.37932,-0.06067,-0.038499,0,0
6,GO SKIN EPIDERMIS DEVELOPMENT,0.054842,-0.060793,-0.12411,0,0
6,GO STEM CELL DIFFERENTIATION,0.066855,-0.061096,-0.065224,0,0
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.54321,-0.061101,-0.039971,0,0
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.14048,-0.061146,-0.071957,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.25363,-0.061177,-0.091254,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32506,-0.06118,-0.053614,0,0
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.52025,-0.061209,-0.036455,0,0
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.91987,-0.061215,-0.057881,0,0
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.56666,-0.061249,-0.0086974,0,0
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.10654,-0.061333,-0.14443,0,0
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.17374,-0.061334,-0.064482,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.81668,-0.061393,-0.074242,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.78289,-0.061398,-0.016126,0,0
6,GO PREPULSE INHIBITION,0.69061,-0.06143,-0.042218,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.79636,-0.061588,0.062388,0,0
6,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.71658,-0.061601,-0.026834,0,0
6,GO CILIUM MOVEMENT,0.27227,-0.061666,-0.029454,0,0
6,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.19095,-0.061792,-0.10093,0,0
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.60272,-0.061797,-0.068499,0,0
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.188,-0.061799,-0.049667,0,0
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.057089,-0.061825,-0.090962,0,0
6,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.075049,-0.061828,-0.086638,0,0
6,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.064293,-0.061832,-0.18987,0,0
6,GO GLUTAMATE SECRETION,0.98953,-0.061852,0.025724,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.11235,-0.061868,-0.060644,0,0
6,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.22235,-0.061935,-0.056336,0,0
6,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.13583,-0.062053,-0.082714,0,0
6,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.7495,-0.062176,-0.028111,0,0
6,GO RNA STABILIZATION,0.33812,-0.062333,-0.049292,0,0
6,GO PROTEIN POLYGLUTAMYLATION,0.74288,-0.062358,-0.011423,0,0
6,GO NEGATIVE REGULATION OF DNA REPLICATION,0.63978,-0.062378,-0.039515,0,0
6,GO PHOSPHOLIPID HOMEOSTASIS,0.30402,-0.06246,-0.097768,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.36526,-0.062487,-0.11606,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE,0.5726,-0.062656,-0.039761,0,0
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.30815,-0.062714,-0.063302,0,0
6,GO RESPONSE TO GAMMA RADIATION,0.16559,-0.062951,-0.063557,0,0
6,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.79636,-0.063038,-0.017307,0,0
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.076492,-0.063274,-0.080982,0,0
6,GO PROXIMAL DISTAL PATTERN FORMATION,1,-0.063313,0.0034111,0,0
6,GO WATER HOMEOSTASIS,0.14769,-0.063373,-0.084388,0,0
6,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.33812,-0.063416,-0.1401,0,0
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.25363,-0.063422,-0.081285,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.50337,-0.063485,-0.043125,0,0
6,GO DISTAL TUBULE DEVELOPMENT,0.64605,-0.063594,-0.075921,0,0
6,GO REGULATION OF RENAL SYSTEM PROCESS,0.20621,-0.063734,-0.09689,0,0
6,GO HISTONE H3 DEACETYLATION,0.26098,-0.063741,-0.050706,0,0
6,GO AXIS SPECIFICATION,0.052669,-0.063743,-0.097891,0,0
6,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.27611,-0.063877,-0.074007,0,0
6,GO COCHLEA DEVELOPMENT,0.34702,-0.064018,-0.039429,0,0
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.85082,-0.064139,0.05178,0,0
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.14285,-0.064241,-0.072852,0,0
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.14048,-0.064365,-0.080751,0,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.050569,-0.06438,-0.074127,0,0
6,GO SYNAPSE ASSEMBLY,0.36526,-0.064505,-0.023281,0,0
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.25363,-0.064592,-0.11375,0,0
6,GO FIBROBLAST MIGRATION,0.24643,-0.064611,-0.062851,0,0
6,GO CELLULAR RESPONSE TO VIRUS,0.16294,-0.064674,-0.084914,0,0
6,GO RESPONSE TO NICOTINE,0.71658,-0.064675,0.0041219,0,0
6,GO TRNA TRANSPORT,0.47588,-0.064692,-0.03404,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.24288,-0.064928,-0.070943,0,0
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.4598,-0.065085,-0.054603,0,0
6,GO NEURON MATURATION,0.19095,-0.065364,-0.065803,0,0
6,GO ACTIN CYTOSKELETON REORGANIZATION,0.076492,-0.065616,-0.087355,0,0
6,GO MAGNESIUM ION TRANSPORT,0.36526,-0.065816,-0.048423,0,0
6,GO LEFT RIGHT AXIS SPECIFICATION,0.40349,-0.066008,-0.096623,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.41842,-0.066087,-0.095396,0,0
6,GO HAIR CELL DIFFERENTIATION,0.13355,-0.066111,-0.10109,0,0
6,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.20937,-0.066149,-0.095981,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0695,-0.066244,-0.06759,0,0
6,GO BEHAVIOR,0.21905,-0.066258,-0.048841,0,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.5726,-0.066264,-0.051132,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.066855,-0.066302,-0.059207,0,0
6,GO ACTIN CROSSLINK FORMATION,0.54321,-0.066403,-0.053796,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.11841,-0.066422,-0.048939,0,0
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.11434,-0.066646,-0.064082,0,0
6,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.15517,-0.066806,-0.15302,0,0
6,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.35607,-0.066825,-0.11894,0,0
6,GO REGULATION OF EXCRETION,0.57857,-0.066882,-0.033522,0,0
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.21256,-0.066942,-0.078677,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.064293,-0.066966,-0.072967,0,0
6,GO ENDOCRINE SYSTEM DEVELOPMENT,0.61497,-0.067072,-0.024531,0,0
6,GO SOMITOGENESIS,0.073629,-0.067307,-0.080607,0,0
6,GO GLUCOSE IMPORT,0.059411,-0.067313,-0.080258,0,0
6,GO ASSOCIATIVE LEARNING,0.17934,-0.067371,-0.063723,0,0
6,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.097379,-0.067435,-0.10934,0,0
6,GO KETONE CATABOLIC PROCESS,0.49227,-0.067561,-0.11775,0,0
6,GO NCRNA 3 END PROCESSING,0.33812,-0.067594,-0.083224,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.29586,-0.06784,-0.004184,0,0
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.30815,-0.067863,-0.053262,0,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.8303,-0.067902,0.029687,0,0
6,GO POSITIVE REGULATION OF URINE VOLUME,0.072231,-0.067987,-0.11578,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.98255,-0.068058,-0.011671,0,0
6,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.070855,-0.068395,-0.1674,0,0
6,GO NEURON DEATH,0.079444,-0.068472,-0.049696,0,0
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.025994,-0.068495,-0.10442,0,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.1028,-0.068661,-0.09049,0,0
6,GO SYNAPTIC VESICLE EXOCYTOSIS,0.37932,-0.068732,0.010793,0,0
6,GO METHIONINE BIOSYNTHETIC PROCESS,0.066855,-0.068844,-0.14463,0,0
6,GO NAD BIOSYNTHETIC PROCESS,0.4545,-0.068903,-0.058737,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.079444,-0.06896,-0.082109,0,0
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.23245,-0.068994,-0.085908,0,0
6,GO REGULATION OF PROTEIN POLYMERIZATION,0.066855,-0.069127,-0.062423,0,0
6,GO PARTURITION,0.81668,-0.069158,-0.048241,0,0
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.30815,-0.06964,-0.066074,0,0
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.27611,-0.069831,-0.027853,0,0
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.045624,-0.069855,-0.093248,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.084046,-0.069899,-0.059504,0,0
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.11841,-0.069999,-0.059368,0,0
6,GO TELENCEPHALON GLIAL CELL MIGRATION,0.42855,-0.070001,-0.074317,0,0
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.27611,-0.070006,-0.061738,0,0
6,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.21579,-0.070034,-0.075274,0,0
6,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.39858,-0.070062,-0.081025,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.51459,-0.070203,-0.072643,0,0
6,GO LOCOMOTORY BEHAVIOR,0.27999,-0.070347,-0.041408,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.15015,-0.070365,-0.079716,0,0
6,GO NEUROTRANSMITTER SECRETION,0.56666,-0.070379,0.015638,0,0
6,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.62732,-0.070622,-0.038344,0,0
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.7495,-0.070854,-0.054199,0,0
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.21256,-0.071197,-0.12445,0,0
6,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.12908,-0.071237,-0.11077,0,0
6,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.084046,-0.071245,-0.09827,0,0
6,GO GLIAL CELL DIFFERENTIATION,0.084046,-0.071276,-0.088335,0,0
6,GO CARDIAC MUSCLE CELL PROLIFERATION,0.11235,-0.071322,-0.096164,0,0
6,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.17099,-0.071414,-0.083406,0,0
6,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.082489,-0.071478,-0.19842,0,0
6,GO BONE MORPHOGENESIS,0.076492,-0.071501,-0.11883,0,0
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.21256,-0.071652,-0.12852,0,0
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.19095,-0.071857,-0.11748,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.076492,-0.071927,-0.16075,0,0
6,GO REGULATION OF CYCLASE ACTIVITY,0.11235,-0.071982,-0.093833,0,0
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.22235,-0.072035,-0.19336,0,0
6,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.24643,-0.072057,-0.049418,0,0
6,GO RESPONSE TO INTERLEUKIN 6,0.17099,-0.072093,-0.087947,0,0
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.19695,-0.072203,-0.047175,0,0
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.36991,-0.072671,-0.061937,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11434,-0.072847,-0.12621,0,0
6,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.21256,-0.07289,-0.08198,0,0
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.11039,-0.072926,-0.12275,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.16559,-0.073247,-0.084305,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.12049,-0.073441,-0.16893,0,0
6,GO ALPHA BETA T CELL DIFFERENTIATION,0.079444,-0.073471,-0.10737,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.11235,-0.073548,-0.095939,0,0
6,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.188,-0.073556,-0.13052,0,0
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.26098,-0.073601,-0.050557,0,0
6,GO RESPONSE TO LEUCINE,0.4598,-0.07368,-0.040613,0,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.55487,-0.073698,-0.077897,0,0
6,GO REGIONALIZATION,0.20937,-0.073729,-0.058525,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.49227,-0.074021,-0.047575,0,0
6,GO PROTEIN POLYMERIZATION,0.015203,-0.074126,-0.075105,0,0
6,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.095625,-0.074183,-0.10202,0,0
6,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.35607,-0.074299,-0.054309,0,0
6,GO LYMPH VESSEL DEVELOPMENT,0.16294,-0.074337,-0.11964,0,0
6,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.090515,-0.075135,-0.15338,0,0
6,GO NODAL SIGNALING PATHWAY,0.53167,-0.075354,-0.0451,0,0
6,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.065563,-0.075384,-0.087574,0,0
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.34702,-0.075528,-0.035324,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE I,0.36991,-0.075564,-0.040488,0,0
6,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.93377,-0.075721,0.079139,0,0
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.21256,-0.075754,-0.077594,0,0
6,GO MITOCHONDRION DISTRIBUTION,0.53742,-0.075942,-0.01772,0,0
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0695,-0.075949,-0.087232,0,0
6,GO MANGANESE ION TRANSPORT,0.077957,-0.075979,-0.10847,0,0
6,GO REGULATION OF EXOCYTOSIS,0.068167,-0.076451,-0.061888,0,0
6,GO EPITHELIAL CELL FATE COMMITMENT,0.39371,-0.076587,-0.069437,0,0
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.16828,-0.076603,-0.05725,0,0
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.21905,-0.076687,-0.057223,0,0
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.33373,-0.077222,-0.078178,0,0
6,GO MYELOID DENDRITIC CELL ACTIVATION,0.11636,-0.077224,-0.097319,0,0
6,GO MULTIVESICULAR BODY SORTING PATHWAY,0.093897,-0.077637,-0.069636,0,0
6,GO RUFFLE ORGANIZATION,0.12689,-0.077643,-0.071178,0,0
6,GO VESICLE FUSION TO PLASMA MEMBRANE,0.27999,-0.077895,-0.015666,0,0
6,GO PIGMENT GRANULE LOCALIZATION,0.22905,-0.077903,-0.060247,0,0
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.093897,-0.077922,-0.18904,0,0
6,GO MACROMOLECULE DEPALMITOYLATION,0.11636,-0.078144,-0.12004,0,0
6,GO PERICARDIUM DEVELOPMENT,0.21579,-0.078178,-0.10595,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.48131,-0.078188,-0.044613,0,0
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.25001,-0.07824,-0.071625,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.75615,-0.078253,0.00049595,0,0
6,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.42855,-0.078259,-0.077884,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.23245,-0.07845,-0.055365,0,0
6,GO RETINA HOMEOSTASIS,0.16032,-0.078501,-0.055101,0,0
6,GO STRIATED MUSCLE CELL PROLIFERATION,0.12259,-0.078523,-0.085825,0,0
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0099891,-0.078608,-0.080146,0,0
6,GO NEGATIVE REGULATION OF AXONOGENESIS,0.33812,-0.078648,-0.062508,0,0
6,GO RESPONSE TO FUNGUS,0.12049,-0.078694,-0.06354,0,0
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.19695,-0.078806,-0.11626,0,0
6,GO MIDBRAIN DEVELOPMENT,0.063042,-0.078813,-0.07109,0,0
6,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.38408,-0.078915,-0.065171,0,0
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.62732,-0.079004,-0.040476,0,0
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.22568,-0.079262,-0.10101,0,0
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.39371,-0.079288,-0.025965,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.082489,-0.079333,-0.13003,0,0
6,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.21256,-0.079348,-0.13628,0,0
6,GO EPIDERMIS MORPHOGENESIS,0.21579,-0.079464,-0.11487,0,0
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.17374,-0.07953,-0.044305,0,0
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.18219,-0.079629,-0.068598,0,0
6,GO ACTIVATED T CELL PROLIFERATION,0.16032,-0.079632,-0.078002,0,0
6,GO SECONDARY PALATE DEVELOPMENT,0.15015,-0.079801,-0.10602,0,0
6,GO ADULT HEART DEVELOPMENT,0.5726,-0.079883,-0.061635,0,0
6,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.15264,-0.079893,-0.11379,0,0
6,GO REGULATION OF MEIOTIC CELL CYCLE,0.12049,-0.079952,-0.057839,0,0
6,GO FOREGUT MORPHOGENESIS,0.19695,-0.080032,-0.1196,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.60883,-0.080073,-0.015266,0,0
6,GO REGULATION OF VASOCONSTRICTION,0.097379,-0.08008,-0.10397,0,0
6,GO EAR MORPHOGENESIS,0.092194,-0.080129,-0.081336,0,0
6,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.46512,-0.08021,-0.080265,0,0
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.58456,-0.080291,-0.066325,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.15773,-0.080425,-0.14519,0,0
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.61497,-0.080441,-0.052988,0,0
6,GO RNA INTERFERENCE,0.075049,-0.080459,-0.10785,0,0
6,GO BRANCH ELONGATION OF AN EPITHELIUM,0.079444,-0.080513,-0.23114,0,0
6,GO LEFT RIGHT PATTERN FORMATION,0.33373,-0.080526,-0.066052,0,0
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.031748,-0.080533,-0.15255,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.060602,-0.080556,-0.056098,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.16828,-0.080581,-0.086003,0,0
6,GO MITOCHONDRIAL TRNA PROCESSING,0.32077,-0.080611,-0.087188,0,0
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.11841,-0.08073,-0.12315,0,0
6,GO CYTOKINETIC PROCESS,0.057089,-0.081018,-0.11122,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.18508,-0.08127,-0.1251,0,0
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.21579,-0.081409,-0.056218,0,0
6,GO MAST CELL MIGRATION,0.75615,-0.081724,-0.0055838,0,0
6,GO T CELL DIFFERENTIATION IN THYMUS,0.12689,-0.081994,-0.077461,0,0
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.30815,-0.082051,-0.18632,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.13583,-0.082104,-0.066283,0,0
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.15517,-0.082259,-0.094533,0,0
6,GO TRACHEA MORPHOGENESIS,0.54903,-0.082271,-0.046074,0,0
6,GO MALE MEIOTIC NUCLEAR DIVISION,0.14526,-0.082434,-0.10059,0,0
6,GO RRNA TRANSCRIPTION,0.21579,-0.082809,-0.079766,0,0
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.16828,-0.082938,-0.087696,0,0
6,GO REGULATION OF HEAT GENERATION,0.67776,-0.083075,0.010754,0,0
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.19095,-0.083085,-0.0713,0,0
6,GO LYSOSOME LOCALIZATION,0.11235,-0.083107,-0.057033,0,0
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.31232,-0.083256,-0.06271,0,0
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.22235,-0.083367,-0.10692,0,0
6,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.12259,-0.083694,-0.078159,0,0
6,GO REGULATION OF POTASSIUM ION TRANSPORT,0.17934,-0.083755,-0.073454,0,0
6,GO HORMONE TRANSPORT,0.063042,-0.083839,-0.075766,0,0
6,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.31653,-0.083878,-0.083386,0,0
6,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.16828,-0.083937,-0.071477,0,0
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.41842,-0.083987,-0.047922,0,0
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.59059,-0.084117,-0.094724,0,0
6,GO LUNG EPITHELIUM DEVELOPMENT,0.64605,-0.084209,-0.023747,0,0
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.014841,-0.084256,-0.11266,0,0
6,GO INNER EAR MORPHOGENESIS,0.15015,-0.084398,-0.073321,0,0
6,GO ENDODERMAL CELL FATE COMMITMENT,0.29184,-0.084454,-0.067104,0,0
6,GO REGULATION OF ISOTYPE SWITCHING,0.53167,-0.084545,-0.081831,0,0
6,GO DEVELOPMENTAL MATURATION,0.065563,-0.084564,-0.07428,0,0
6,GO DEVELOPMENTAL INDUCTION,0.072231,-0.084794,-0.10551,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.23937,-0.084807,-0.085662,0,0
6,GO INTERFERON ALPHA PRODUCTION,0.22905,-0.084868,-0.083058,0,0
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.16559,-0.084884,-0.065381,0,0
6,GO BODY MORPHOGENESIS,0.061812,-0.084966,-0.10847,0,0
6,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.10096,-0.085043,-0.094746,0,0
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.20621,-0.085158,-0.030053,0,0
6,GO REGULATION OF ORGANELLE ASSEMBLY,0.013798,-0.085252,-0.064662,0,0
6,GO DENDRITE EXTENSION,0.7495,-0.085253,0.07643,0,0
6,GO EXTRACELLULAR VESICLE BIOGENESIS,0.17099,-0.085294,-0.078293,0,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.14526,-0.085434,-0.096424,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0695,-0.085507,-0.12824,0,0
6,GO TUBE FORMATION,0.02843,-0.085511,-0.099205,0,0
6,GO SIGNAL RELEASE,0.084046,-0.085549,-0.051864,0,0
6,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.072231,-0.085683,-0.18115,0,0
6,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.19393,-0.085717,-0.20747,0,0
6,GO HETEROTYPIC CELL CELL ADHESION,0.12908,-0.085899,-0.10037,0,0
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.38408,-0.085926,-0.03955,0,0
6,GO UTERUS DEVELOPMENT,0.72969,-0.086214,-0.029172,0,0
6,GO NEGATIVE REGULATION OF TOR SIGNALING,0.11434,-0.086223,-0.074992,0,0
6,GO RESPONSE TO UV B,0.62732,-0.086292,-0.026219,0,0
6,GO INOSITOL METABOLIC PROCESS,0.41842,-0.086331,-0.059106,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.27999,-0.086411,-0.10624,0,0
6,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.72969,-0.086466,-0.061642,0,0
6,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.18508,-0.086561,-0.093231,0,0
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.054842,-0.08657,-0.078445,0,0
6,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.35607,-0.086634,-0.039459,0,0
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.4978,-0.086691,-0.07451,0,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.060602,-0.086706,-0.12672,0,0
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.097379,-0.087026,-0.17237,0,0
6,GO REGULATION OF FEEDING BEHAVIOR,0.17653,-0.08704,-0.10136,0,0
6,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.35607,-0.087056,-0.062829,0,0
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.26471,-0.087125,-0.1713,0,0
6,GO EMBRYONIC DIGIT MORPHOGENESIS,0.21579,-0.087238,-0.075354,0,0
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.69707,-0.087358,-0.045189,0,0
6,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.082489,-0.087592,-0.15037,0,0
6,GO DICARBOXYLIC ACID TRANSPORT,0.15517,-0.087785,-0.049854,0,0
6,GO PROSTATE GLAND MORPHOGENESIS,0.39858,-0.088126,-0.12033,0,0
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.044685,-0.088179,-0.098713,0,0
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.1028,-0.08851,-0.080026,0,0
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.077957,-0.088519,-0.074281,0,0
6,GO REGULATION OF ICOSANOID SECRETION,0.20309,-0.08869,-0.079851,0,0
6,GO MEMBRANE DISASSEMBLY,0.22905,-0.08871,-0.0848,0,0
6,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.068167,-0.088876,-0.12281,0,0
6,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.30402,-0.088891,-0.085098,0,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00084609,-0.088932,-0.090543,0,0
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.1028,-0.08895,-0.07942,0,0
6,GO TRNA WOBBLE BASE MODIFICATION,0.054842,-0.08911,-0.12116,0,0
6,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.1028,-0.089152,-0.065784,0,0
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.1028,-0.089233,-0.059071,0,0
6,GO ADHERENS JUNCTION ORGANIZATION,0.1313,-0.089285,-0.074836,0,0
6,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.38408,-0.089379,-0.069859,0,0
6,GO MUSCLE CELL MIGRATION,0.085627,-0.089421,-0.13447,0,0
6,GO BONE DEVELOPMENT,0.0090226,-0.089487,-0.11068,0,0
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.33373,-0.089601,-0.048751,0,0
6,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.41341,-0.089664,-0.045077,0,0
6,GO REGULATION OF CELL PROJECTION SIZE,0.31232,-0.089695,-0.11127,0,0
6,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.16294,-0.08982,-0.057134,0,0
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.11841,-0.089896,-0.086916,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.38408,-0.089906,-0.053043,0,0
6,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.087232,-0.090029,-0.10163,0,0
6,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.090515,-0.090099,-0.11345,0,0
6,GO HEART FORMATION,0.33812,-0.090167,-0.069976,0,0
6,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.073629,-0.090268,-0.20493,0,0
6,GO POLYOL CATABOLIC PROCESS,0.085627,-0.090329,-0.077107,0,0
6,GO NEURAL TUBE FORMATION,0.036164,-0.090432,-0.099177,0,0
6,GO RESPONSE TO INACTIVITY,0.088862,-0.09047,-0.15086,0,0
6,GO REGULATION OF HORMONE SECRETION,0.055956,-0.090474,-0.079117,0,0
6,GO PRESYNAPTIC ENDOCYTOSIS,0.31653,-0.090716,-0.042189,0,0
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.21905,-0.090767,-0.095951,0,0
6,GO OTIC VESICLE MORPHOGENESIS,0.50337,-0.09083,-0.065098,0,0
6,GO RESPONSE TO ANTIBIOTIC,0.054842,-0.090887,-0.094371,0,0
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.39371,-0.090945,-0.08442,0,0
6,GO PROSTATIC BUD FORMATION,0.17374,-0.091046,-0.20592,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.16032,-0.091145,-0.15138,0,0
6,GO BONE TRABECULA MORPHOGENESIS,0.11039,-0.091304,-0.21879,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.20309,-0.091389,-0.13348,0,0
6,GO SYNAPSE ORGANIZATION,0.19095,-0.091392,-0.057426,0,0
6,GO MEMBRANE HYPERPOLARIZATION,0.18508,-0.091412,-0.12512,0,0
6,GO ARTERY MORPHOGENESIS,0.029068,-0.091574,-0.12271,0,0
6,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.60272,-0.091585,-0.059016,0,0
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.22905,-0.09163,-0.092068,0,0
6,GO EMBRYONIC PATTERN SPECIFICATION,0.14769,-0.091949,-0.079038,0,0
6,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.56075,-0.0921,-0.030555,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.14769,-0.092136,-0.11889,0,0
6,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.1313,-0.092667,-0.12275,0,0
6,GO INTESTINAL LIPID ABSORPTION,0.12473,-0.092691,-0.17943,0,0
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.26471,-0.092873,-0.13751,0,0
6,GO MATING,0.12473,-0.092974,-0.06353,0,0
6,GO UV PROTECTION,0.14285,-0.093031,-0.13215,0,0
6,GO REGULATION OF ANIMAL ORGAN FORMATION,0.40843,-0.093065,-0.083058,0,0
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.073629,-0.093524,-0.1406,0,0
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0097392,-0.09361,-0.096533,0,0
6,GO CELL AGGREGATION,0.18508,-0.093752,-0.095323,0,0
6,GO HEAD MORPHOGENESIS,0.12908,-0.093978,-0.088113,0,0
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.099158,-0.094048,-0.099582,0,0
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.40349,-0.094056,-0.037084,0,0
6,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.0695,-0.094084,-0.14008,0,0
6,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.095625,-0.094176,-0.10369,0,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.22235,-0.094242,-0.093866,0,0
6,GO MRNA TRANSCRIPTION,0.31653,-0.094259,-0.06509,0,0
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.12908,-0.094286,-0.10487,0,0
6,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.16294,-0.09437,-0.12162,0,0
6,GO GOLGI LOCALIZATION,0.13814,-0.09456,-0.089634,0,0
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.26098,-0.094833,-0.086776,0,0
6,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.17099,-0.09487,-0.077662,0,0
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.007729,-0.094939,-0.11426,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.19393,-0.095015,-0.12925,0,0
6,GO NUCLEOBASE METABOLIC PROCESS,0.057089,-0.095127,-0.13258,0,0
6,GO REGULATION OF TRANSLATIONAL TERMINATION,0.11235,-0.095452,-0.13057,0,0
6,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.11841,-0.095597,-0.10604,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.23937,-0.095728,-0.094992,0,0
6,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.25729,-0.095791,-0.060929,0,0
6,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.15015,-0.096142,-0.092151,0,0
6,GO RESPONSE TO AMINO ACID STARVATION,0.0695,-0.096506,-0.095207,0,0
6,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.10096,-0.096862,-0.2249,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.16032,-0.096919,-0.077177,0,0
6,GO THYROID HORMONE METABOLIC PROCESS,0.27611,-0.097116,-0.045511,0,0
6,GO VESICLE DOCKING,0.0069616,-0.097299,-0.12851,0,0
6,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.29992,-0.097425,-0.038589,0,0
6,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.20309,-0.097727,-0.15844,0,0
6,GO MAST CELL MEDIATED IMMUNITY,0.19393,-0.097829,-0.072535,0,0
6,GO MITOCHONDRIAL DNA REPLICATION,0.077957,-0.097952,-0.093316,0,0
6,GO RESPONSE TO X RAY,0.23937,-0.098013,-0.10593,0,0
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.27611,-0.098183,-0.08336,0,0
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.084046,-0.09834,-0.093352,0,0
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.020205,-0.09835,-0.13014,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.099158,-0.09858,-0.16427,0,0
6,GO EPITHELIAL CELL CELL ADHESION,0.36526,-0.09859,-0.074106,0,0
6,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.068167,-0.098667,-0.15363,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.063042,-0.098705,-0.16025,0,0
6,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.060602,-0.099307,-0.089118,0,0
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.27611,-0.099324,-0.075585,0,0
6,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.014486,-0.099408,-0.15718,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.15015,-0.0997,-0.065695,0,0
6,GO PIRNA METABOLIC PROCESS,0.055956,-0.099782,-0.16154,0,0
6,GO AORTA MORPHOGENESIS,0.13583,-0.10043,-0.10817,0,0
6,GO OVULATION CYCLE,0.036164,-0.10086,-0.11207,0,0
6,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.11235,-0.10086,-0.23839,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.1028,-0.10122,-0.14949,0,0
6,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.038561,-0.10131,-0.13398,0,0
6,GO RESPONSE TO MUSCLE INACTIVITY,0.24643,-0.10141,-0.073474,0,0
6,GO ENERGY HOMEOSTASIS,0.18508,-0.10172,-0.090656,0,0
6,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.080955,-0.10177,-0.088343,0,0
6,GO PEPTIDE HORMONE SECRETION,0.066855,-0.10193,-0.073364,0,0
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.19393,-0.10197,-0.12636,0,0
6,GO NEUROTRANSMITTER TRANSPORT,0.27999,-0.10201,-0.022808,0,0
6,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.11841,-0.10212,-0.085004,0,0
6,GO DERMATAN SULFATE METABOLIC PROCESS,0.27611,-0.10243,-0.1686,0,0
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.11039,-0.10252,-0.13481,0,0
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.075049,-0.10284,-0.21182,0,0
6,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.068167,-0.10299,-0.10611,0,0
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0041716,-0.10308,-0.10751,0,0
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.25729,-0.10309,-0.16255,0,0
6,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0695,-0.1031,-0.1271,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.038561,-0.10313,-0.10312,0,0
6,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.16559,-0.10381,-0.11402,0,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.25363,-0.10413,-0.050239,0,0
6,GO TONIC SMOOTH MUSCLE CONTRACTION,0.14526,-0.10428,-0.14904,0,0
6,GO INTERFERON BETA PRODUCTION,0.055956,-0.10441,-0.11932,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.084046,-0.10442,-0.13038,0,0
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.05824,-0.10448,-0.10488,0,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.14285,-0.10452,-0.10028,0,0
6,GO PROSTATE GLAND GROWTH,0.10845,-0.10461,-0.17475,0,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0039469,-0.10464,-0.10652,0,0
6,GO BRONCHUS DEVELOPMENT,0.44924,-0.10464,-0.11554,0,0
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.087232,-0.10473,-0.097127,0,0
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.25729,-0.10486,-0.064336,0,0
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.44924,-0.10496,-0.036248,0,0
6,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.087232,-0.10513,-0.12039,0,0
6,GO ACTIVATION OF JNKK ACTIVITY,0.12908,-0.10514,-0.084591,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.11636,-0.10516,-0.15671,0,0
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.17099,-0.10544,-0.16524,0,0
6,GO DORSAL VENTRAL AXIS SPECIFICATION,0.25001,-0.10561,-0.10791,0,0
6,GO HEAT GENERATION,0.27999,-0.10571,-0.043926,0,0
6,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.075049,-0.10586,-0.16372,0,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.21579,-0.10591,-0.095917,0,0
6,GO REGULATION OF PLATELET AGGREGATION,0.0695,-0.10596,-0.2041,0,0
6,GO KERATINIZATION,0.27999,-0.10603,-0.083723,0,0
6,GO EMBRYONIC ORGAN MORPHOGENESIS,0.013465,-0.10608,-0.11005,0,0
6,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.34256,-0.10632,-0.050442,0,0
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.52025,-0.10635,-0.077339,0,0
6,GO IRON COORDINATION ENTITY TRANSPORT,0.33373,-0.10644,-0.068719,0,0
6,GO PRE MIRNA PROCESSING,0.13583,-0.10655,-0.10585,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.11841,-0.10659,-0.17753,0,0
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.18508,-0.10663,-0.10506,0,0
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.29184,-0.10665,-0.12693,0,0
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.19695,-0.10667,-0.15878,0,0
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.20937,-0.10674,-0.065602,0,0
6,GO RESPONSE TO PARATHYROID HORMONE,0.087232,-0.10697,-0.15486,0,0
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.20309,-0.10731,-0.10443,0,0
6,GO BASE EXCISION REPAIR AP SITE FORMATION,0.10654,-0.10761,-0.10945,0,0
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.027803,-0.10772,-0.1009,0,0
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.055956,-0.10786,-0.15307,0,0
6,GO REGULATION OF HISTONE DEACETYLATION,0.073629,-0.10811,-0.10175,0,0
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.75615,-0.10834,0.023848,0,0
6,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.02166,-0.10837,-0.10466,0,0
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.079444,-0.10845,-0.10902,0,0
6,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.12473,-0.10874,-0.093444,0,0
6,GO REGULATION OF AXON GUIDANCE,0.12049,-0.10875,-0.089435,0,0
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.89907,-0.1088,-0.033267,0,0
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.025994,-0.10883,-0.12019,0,0
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.29992,-0.10899,-0.052187,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.12689,-0.10915,-0.090288,0,0
6,GO REGULATION OF MEMBRANE PERMEABILITY,0.15773,-0.10946,-0.059018,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.42347,-0.10953,-0.082761,0,0
6,GO MITOCHONDRIAL RNA PROCESSING,0.085627,-0.10959,-0.14286,0,0
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.17099,-0.1096,-0.16645,0,0
6,GO PROTEIN PALMITOYLATION,0.092194,-0.10962,-0.070368,0,0
6,GO MESENCHYMAL CELL PROLIFERATION,0.22568,-0.1098,-0.12532,0,0
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.12049,-0.1101,-0.16426,0,0
6,GO POSITIVE REGULATION OF MITOPHAGY,0.21256,-0.11012,-0.091368,0,0
6,GO MITOCHONDRIAL FISSION,0.017969,-0.1103,-0.11138,0,0
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.29184,-0.11123,-0.04144,0,0
6,GO CONVERGENT EXTENSION,0.068167,-0.11124,-0.12967,0,0
6,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.070855,-0.11134,-0.11972,0,0
6,GO MOTILE CILIUM ASSEMBLY,0.69707,-0.11142,-0.0087914,0,0
6,GO REGULATION OF GTP BINDING,0.066855,-0.11198,-0.16891,0,0
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.079444,-0.1122,-0.10812,0,0
6,GO MATING BEHAVIOR,0.14048,-0.11221,-0.098608,0,0
6,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00014935,-0.11244,-0.11262,0,0
6,GO TRACHEA DEVELOPMENT,0.15517,-0.11244,-0.14143,0,0
6,GO INNER DYNEIN ARM ASSEMBLY,0.54903,-0.11257,-0.02653,0,0
6,GO NOREPINEPHRINE TRANSPORT,0.35607,-0.11267,-0.058123,0,0
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.085627,-0.11356,-0.21927,0,0
6,GO ADHERENS JUNCTION ASSEMBLY,0.17099,-0.11359,-0.081523,0,0
6,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.26471,-0.11413,-0.037555,0,0
6,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.14526,-0.11414,-0.17311,0,0
6,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.031748,-0.11429,-0.11077,0,0
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.20621,-0.11431,-0.064025,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.14769,-0.11438,-0.12854,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.20937,-0.11451,-0.077121,0,0
6,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.23245,-0.11454,-0.081985,0,0
6,GO RESPONSE TO NITRIC OXIDE,0.025414,-0.11458,-0.08839,0,0
6,GO DEFINITIVE HEMOPOIESIS,0.092194,-0.11459,-0.1224,0,0
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.37932,-0.11462,-0.075053,0,0
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.39371,-0.11471,-0.05824,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.068167,-0.11471,-0.072846,0,0
6,GO REGULATION OF LIPID KINASE ACTIVITY,0.00063551,-0.11501,-0.15588,0,0
6,GO REGULATION OF GLIAL CELL MIGRATION,0.47588,-0.11502,-0.036925,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.17099,-0.11513,-0.091131,0,0
6,GO RENAL VESICLE DEVELOPMENT,0.12908,-0.1152,-0.12988,0,0
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.066855,-0.11562,-0.13821,0,0
6,GO ENDOTHELIAL CELL MORPHOGENESIS,0.36526,-0.11569,-0.12882,0,0
6,GO DEFENSE RESPONSE TO VIRUS,0.054842,-0.11581,-0.14942,0,0
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.073629,-0.11582,-0.16954,0,0
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0010528,-0.11609,-0.10602,0,0
6,GO O GLYCAN PROCESSING,0.066855,-0.11617,-0.16513,0,0
6,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.78289,-0.11629,-0.019732,0,0
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.02843,-0.11691,-0.11572,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.27227,-0.11695,-0.067373,0,0
6,GO CRANIAL NERVE MORPHOGENESIS,0.093897,-0.11706,-0.17348,0,0
6,GO REGULATION OF RESPONSE TO FOOD,0.073629,-0.11712,-0.10452,0,0
6,GO DIGESTIVE SYSTEM DEVELOPMENT,0.070855,-0.11722,-0.093346,0,0
6,GO EATING BEHAVIOR,0.12908,-0.11725,-0.073551,0,0
6,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.15517,-0.11763,-0.13482,0,0
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.099158,-0.11764,-0.11732,0,0
6,GO RESPONSE TO INSECTICIDE,0.46512,-0.11768,-0.037139,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.50896,-0.11782,-0.046714,0,0
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.065563,-0.11783,-0.1499,0,0
6,GO EXOCYTIC PROCESS,0.079444,-0.11788,-0.069679,0,0
6,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.63978,-0.11795,-0.02624,0,0
6,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.073629,-0.11873,-0.15232,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0695,-0.11887,-0.14343,0,0
6,GO HYPEROSMOTIC SALINITY RESPONSE,0.11039,-0.11916,-0.087762,0,0
6,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.2839,-0.11929,-0.084114,0,0
6,GO ALANINE TRANSPORT,0.055956,-0.11933,-0.15348,0,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.063042,-0.11975,-0.16465,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.063042,-0.11976,-0.1009,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.32506,-0.11988,-0.080238,0,0
6,GO MAST CELL ACTIVATION,0.079444,-0.11989,-0.10767,0,0
6,GO FILOPODIUM ASSEMBLY,0.14285,-0.12014,-0.080547,0,0
6,GO RESPONSE TO OXYGEN RADICAL,0.087232,-0.12026,-0.096027,0,0
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.065563,-0.12059,-0.11431,0,0
6,GO MESENCHYME MORPHOGENESIS,0.0046564,-0.12066,-0.19004,0,0
6,GO REGULATION OF VIRAL GENOME REPLICATION,0.059411,-0.12131,-0.17118,0,0
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00090094,-0.12133,-0.09936,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.082489,-0.12172,-0.12164,0,0
6,GO MELANOCYTE DIFFERENTIATION,0.11434,-0.12173,-0.090909,0,0
6,GO ONE CARBON COMPOUND TRANSPORT,0.059411,-0.12195,-0.14792,0,0
6,GO GLIAL CELL APOPTOTIC PROCESS,0.47049,-0.12319,-0.070658,0,0
6,GO SUCKLING BEHAVIOR,0.36526,-0.12324,-0.059107,0,0
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.054842,-0.12336,-0.17479,0,0
6,GO NUCLEOSIDE CATABOLIC PROCESS,0.082489,-0.12338,-0.14679,0,0
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.070855,-0.12367,-0.12915,0,0
6,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.18508,-0.12402,-0.10899,0,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.059411,-0.1241,-0.13818,0,0
6,GO RESPONSE TO PROSTAGLANDIN,0.063042,-0.1242,-0.14476,0,0
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.1028,-0.12429,-0.20681,0,0
6,GO CELL RECOGNITION,0.0027346,-0.12432,-0.13303,0,0
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.10845,-0.12473,-0.18094,0,0
6,GO REGULATION OF HIPPO SIGNALING,0.073629,-0.12485,-0.19238,0,0
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.13583,-0.12548,-0.11909,0,0
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.36064,-0.12549,-0.067249,0,0
6,GO PHAGOLYSOSOME ASSEMBLY,0.097379,-0.12551,-0.16257,0,0
6,GO INTERLEUKIN 10 PRODUCTION,0.075049,-0.12571,-0.098756,0,0
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.46512,-0.12577,-0.065544,0,0
6,GO POSITIVE REGULATION OF FERTILIZATION,0.1028,-0.12591,-0.16414,0,0
6,GO PEPTIDYL METHIONINE MODIFICATION,0.057089,-0.12596,-0.13004,0,0
6,GO CATECHOLAMINE METABOLIC PROCESS,0.39371,-0.12632,-0.035965,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.17099,-0.12633,-0.13362,0,0
6,GO MITOCHONDRION ORGANIZATION,3.0689e-05,-0.12633,-0.12315,0,0
6,GO RENAL SODIUM EXCRETION,0.060602,-0.12644,-0.1117,0,0
6,GO MAINTENANCE OF CELL POLARITY,0.024846,-0.12647,-0.14136,0,0
6,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.16294,-0.12679,-0.12304,0,0
6,GO CORPUS CALLOSUM DEVELOPMENT,0.076492,-0.12702,-0.15026,0,0
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.11841,-0.12726,-0.13666,0,0
6,GO LAYER FORMATION IN CEREBRAL CORTEX,0.24643,-0.12745,-0.082767,0,0
6,GO BONE MATURATION,0.085627,-0.12756,-0.1114,0,0
6,GO REGULATION OF FILOPODIUM ASSEMBLY,0.072231,-0.12777,-0.1142,0,0
6,GO INTESTINAL ABSORPTION,0.092194,-0.1282,-0.15409,0,0
6,GO REGULATION OF GLIAL CELL PROLIFERATION,0.097379,-0.12832,-0.10254,0,0
6,GO NUCLEOSIDE SALVAGE,0.1313,-0.12881,-0.11772,0,0
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.0069616,-0.12886,-0.10972,0,0
6,GO VASCULAR WOUND HEALING,0.076492,-0.12896,-0.17498,0,0
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.057089,-0.12902,-0.11667,0,0
6,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.15517,-0.12913,-0.24088,0,0
6,GO TUBULIN DEACETYLATION,0.077957,-0.12913,-0.10497,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.15015,-0.12925,-0.11389,0,0
6,GO LYMPH NODE DEVELOPMENT,0.10654,-0.12929,-0.095173,0,0
6,GO ATP TRANSPORT,0.031059,-0.12929,-0.10983,0,0
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.12259,-0.12997,-0.18014,0,0
6,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.090515,-0.13015,-0.21864,0,0
6,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.14048,-0.13072,-0.11809,0,0
6,GO BONE GROWTH,0.075049,-0.13094,-0.16913,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.9686,-0.13103,0.056233,0,0
6,GO AMINE TRANSPORT,0.36526,-0.13109,-0.033586,0,0
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.054842,-0.13125,-0.11954,0,0
6,GO ADULT LOCOMOTORY BEHAVIOR,0.18508,-0.1317,-0.063647,0,0
6,GO NEURON CELLULAR HOMEOSTASIS,0.16294,-0.13202,-0.1284,0,0
6,GO RESPONSE TO WATER,0.11235,-0.13208,-0.14514,0,0
6,GO DOPAMINE METABOLIC PROCESS,0.43883,-0.13237,-0.030384,0,0
6,GO MONOAMINE TRANSPORT,0.12908,-0.13253,-0.056709,0,0
6,GO CARDIAC MYOFIBRIL ASSEMBLY,0.11235,-0.13263,-0.11266,0,0
6,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.2,-0.13309,-0.15011,0,0
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.38888,-0.13312,-0.047093,0,0
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.0695,-0.13316,-0.13373,0,0
6,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17934,-0.13358,-0.10842,0,0
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.14048,-0.13358,-0.12896,0,0
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.10465,-0.13361,-0.098615,0,0
6,GO POSITIVE REGULATION OF EXOCYTOSIS,0.080955,-0.13385,-0.086208,0,0
6,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.19695,-0.13388,-0.10551,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.11636,-0.13391,-0.13917,0,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.17099,-0.13423,-0.16291,0,0
6,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.14526,-0.1345,-0.13079,0,0
6,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.075049,-0.13565,-0.14069,0,0
6,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.054842,-0.13566,-0.18354,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.1028,-0.13595,-0.075519,0,0
6,GO REGULATION OF GTPASE ACTIVITY,9.7346e-05,-0.13636,-0.13692,0,0
6,GO REGULATION OF HEART MORPHOGENESIS,0.13355,-0.13649,-0.13812,0,0
6,GO PANCREATIC JUICE SECRETION,0.035393,-0.1368,-0.1358,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.065563,-0.13723,-0.16929,0,0
6,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0022992,-0.13789,-0.12494,0,0
6,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.15015,-0.13863,-0.14305,0,0
6,GO PARAXIAL MESODERM DEVELOPMENT,0.15773,-0.13863,-0.13415,0,0
6,GO POSITIVE REGULATION OF NEURON MIGRATION,0.26847,-0.13903,-0.11992,0,0
6,GO FERTILIZATION,0.00020448,-0.13904,-0.13789,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0029794,-0.13953,-0.34088,0,0
6,GO KIDNEY MORPHOGENESIS,0.090515,-0.13961,-0.079379,0,0
6,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.1313,-0.13978,-0.22988,0,0
6,GO LATERAL VENTRICLE DEVELOPMENT,0.16559,-0.14015,-0.10909,0,0
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.14526,-0.14032,-0.20709,0,0
6,GO TRANSMISSION OF NERVE IMPULSE,0.075049,-0.14095,-0.11448,0,0
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0085714,-0.14099,-0.13315,0,0
6,GO MECHANOSENSORY BEHAVIOR,0.53167,-0.14104,-0.037896,0,0
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.15773,-0.14249,-0.13851,0,0
6,GO ARTERY DEVELOPMENT,0.00044439,-0.14257,-0.17699,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0042883,-0.14293,-0.13945,0,0
6,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.017549,-0.14329,-0.14548,0,0
6,GO RECEPTOR INTERNALIZATION,0.0013872,-0.14335,-0.134,0,0
6,GO STARTLE RESPONSE,0.20937,-0.14368,-0.1232,0,0
6,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.065563,-0.14396,-0.16284,0,0
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.099158,-0.14412,-0.11078,0,0
6,GO RESPONSE TO INTERLEUKIN 2,0.11841,-0.14571,-0.10541,0,0
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.085627,-0.14587,-0.15657,0,0
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.12689,-0.14587,-0.12212,0,0
6,GO DETECTION OF CALCIUM ION,0.39858,-0.1459,-0.087507,0,0
6,GO OSTEOBLAST DEVELOPMENT,0.070855,-0.14653,-0.14378,0,0
6,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.099158,-0.14672,-0.17148,0,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.02166,-0.14719,-0.13522,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.027803,-0.14783,-0.16708,0,0
6,GO HORMONE CATABOLIC PROCESS,0.16032,-0.1479,-0.11464,0,0
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.188,-0.14796,-0.13638,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.080955,-0.14815,-0.12256,0,0
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.068167,-0.14815,-0.11373,0,0
6,GO FEMALE SEX DIFFERENTIATION,0.0030654,-0.14923,-0.13931,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.080955,-0.14924,-0.13891,0,0
6,GO RESPONSE TO HEAT,0.00041602,-0.14955,-0.14127,0,0
6,GO DRINKING BEHAVIOR,0.10845,-0.14973,-0.15154,0,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.060602,-0.14989,-0.097456,0,0
6,GO EMBRYONIC PLACENTA DEVELOPMENT,0.10465,-0.1502,-0.11801,0,0
6,GO NEPHRIC DUCT MORPHOGENESIS,0.03245,-0.15033,-0.26051,0,0
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.093897,-0.15035,-0.148,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.064293,-0.15052,-0.16815,0,0
6,GO EPITHELIAL CELL MORPHOGENESIS,0.25729,-0.15053,-0.098096,0,0
6,GO OVULATION CYCLE PROCESS,0.0027346,-0.15056,-0.1722,0,0
6,GO AUTOPHAGIC CELL DEATH,0.041093,-0.15065,-0.13532,0,0
6,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0050528,-0.15084,-0.16571,0,0
6,GO CATECHOLAMINE SECRETION,0.16294,-0.15191,-0.043272,0,0
6,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.050569,-0.15269,-0.11884,0,0
6,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.097379,-0.15275,-0.19571,0,0
6,GO REGULATION OF DENDRITE EXTENSION,0.15773,-0.153,-0.040994,0,0
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.11039,-0.15311,-0.085381,0,0
6,GO GROOMING BEHAVIOR,0.56666,-0.15313,-0.0048374,0,0
6,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.26847,-0.15355,-0.11016,0,0
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.36064,-0.15363,-0.054619,0,0
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.036948,-0.15392,-0.12538,0,0
6,GO FACIAL NERVE MORPHOGENESIS,0.40349,-0.15436,-0.077843,0,0
6,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.10096,-0.15449,-0.14302,0,0
6,GO METANEPHROS MORPHOGENESIS,0.27611,-0.15456,-0.064118,0,0
6,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26847,-0.1546,-0.086685,0,0
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.11235,-0.15553,-0.098681,0,0
6,GO PRO B CELL DIFFERENTIATION,0.47588,-0.15562,-0.058607,0,0
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.072231,-0.15589,-0.12582,0,0
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.17934,-0.15642,-0.079091,0,0
6,GO PROTEIN LOCALIZATION TO AXON,0.54321,-0.15655,-0.058918,0,0
6,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.066855,-0.15671,-0.13564,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.061812,-0.15672,-0.12653,0,0
6,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.12473,-0.15761,-0.13779,0,0
6,GO DIVALENT METAL ION EXPORT,0.076492,-0.15766,-0.15136,0,0
6,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.10096,-0.15807,-0.15096,0,0
6,GO KIDNEY MESENCHYME DEVELOPMENT,0.12908,-0.15835,-0.13603,0,0
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.070855,-0.15874,-0.22321,0,0
6,GO CORONARY VASCULATURE MORPHOGENESIS,0.050569,-0.15902,-0.16314,0,0
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031059,-0.15908,-0.11647,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.11636,-0.15912,-0.21225,0,0
6,GO ETHANOL CATABOLIC PROCESS,0.073629,-0.15933,-0.13839,0,0
6,GO RESPONSE TO ATP,0.00087311,-0.15939,-0.15348,0,0
6,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.1028,-0.15977,-0.16572,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.087232,-0.15994,-0.14687,0,0
6,GO RESPONSE TO HISTAMINE,0.088862,-0.1604,-0.22124,0,0
6,GO CELLULAR ANION HOMEOSTASIS,0.070855,-0.16077,-0.14054,0,0
6,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.070855,-0.16077,-0.14156,0,0
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.39858,-0.16085,-0.033941,0,0
6,GO OUTER DYNEIN ARM ASSEMBLY,0.18219,-0.16098,-0.074131,0,0
6,GO ANIMAL ORGAN FORMATION,0.0023671,-0.16111,-0.1695,0,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.085627,-0.16115,-0.15696,0,0
6,GO BARBED END ACTIN FILAMENT CAPPING,0.055956,-0.16182,-0.19117,0,0
6,GO LIPID TRANSLOCATION,0.077957,-0.16184,-0.12325,0,0
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.031059,-0.16254,-0.13388,0,0
6,GO PROTEIN LOCALIZATION TO MEMBRANE,1.7806e-05,-0.16258,-0.13347,0,0
6,GO REGULATION OF SYNAPSE MATURATION,0.25363,-0.16262,-0.14706,0,0
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.05824,-0.16301,-0.13934,0,0
6,GO TOXIN METABOLIC PROCESS,0.073629,-0.1638,-0.17834,0,0
6,GO CARDIOCYTE DIFFERENTIATION,0.00065623,-0.16401,-0.1607,0,0
6,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.29184,-0.16451,-0.13202,0,0
6,GO RESPONSE TO VITAMIN A,0.065563,-0.16494,-0.13406,0,0
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0010206,-0.16531,-0.17646,0,0
6,GO LABYRINTHINE LAYER MORPHOGENESIS,0.21905,-0.16542,-0.12627,0,0
6,GO LABYRINTHINE LAYER DEVELOPMENT,0.11235,-0.16554,-0.11306,0,0
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.015574,-0.16579,-0.15604,0,0
6,GO GLYCOSIDE METABOLIC PROCESS,0.27227,-0.16607,-0.18695,0,0
6,GO PIGMENT CELL DIFFERENTIATION,0.0083534,-0.16658,-0.14303,0,0
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.00063551,-0.16671,-0.14913,0,0
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.035393,-0.16705,-0.1738,0,0
6,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00040247,-0.16717,-0.16996,0,0
6,GO ACTIVATION OF JUN KINASE ACTIVITY,0.11841,-0.1674,-0.084469,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.02268,-0.16829,-0.1478,0,0
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.19393,-0.16856,-0.12259,0,0
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.090515,-0.17008,-0.12726,0,0
6,GO LEYDIG CELL DIFFERENTIATION,0.16032,-0.17042,-0.1542,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.25001,-0.17099,-0.099225,0,0
6,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.16828,-0.17136,-0.10109,0,0
6,GO REPLACEMENT OSSIFICATION,0.05161,-0.17198,-0.16859,0,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.073629,-0.17209,-0.17775,0,0
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.12259,-0.17217,-0.2101,0,0
6,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.23937,-0.17231,-0.057258,0,0
6,GO REGULATION OF NEURON MATURATION,0.15264,-0.17262,-0.10741,0,0
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.17934,-0.173,-0.16743,0,0
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.12473,-0.173,-0.12169,0,0
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.1313,-0.17354,-0.14251,0,0
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.093897,-0.17357,-0.16386,0,0
6,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.14769,-0.17414,-0.15713,0,0
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.26471,-0.17475,-0.094713,0,0
6,GO REGULATION OF RECEPTOR BINDING,0.050569,-0.17557,-0.20147,0,0
6,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.15015,-0.17612,-0.14165,0,0
6,GO POSITIVE REGULATION OF MYELINATION,0.0062634,-0.17671,-0.1564,0,0
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.088862,-0.17736,-0.15581,0,0
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.15015,-0.17846,-0.17677,0,0
6,GO RENAL FILTRATION,0.27999,-0.17878,-0.1292,0,0
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.088862,-0.1788,-0.15462,0,0
6,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.12908,-0.17915,-0.16319,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.00049035,-0.17948,-0.20962,0,0
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.05161,-0.18024,-0.11509,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.077957,-0.18072,-0.15947,0,0
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.22235,-0.18165,-0.069615,0,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.014486,-0.18175,-0.19027,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.17934,-0.1823,-0.14668,0,0
6,GO EXTRACELLULAR TRANSPORT,0.041967,-0.18247,-0.11965,0,0
6,GO HEART FIELD SPECIFICATION,0.32077,-0.18306,-0.084342,0,0
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.065563,-0.18334,-0.16571,0,0
6,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.092194,-0.18532,-0.19313,0,0
6,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.087232,-0.18608,-0.11822,0,0
6,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.011326,-0.18655,-0.21669,0,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.15015,-0.1867,-0.14852,0,0
6,GO PARAXIAL MESODERM MORPHOGENESIS,0.10465,-0.18732,-0.16882,0,0
6,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00027832,-0.18761,-0.21564,0,0
6,GO AXIS ELONGATION,0.072231,-0.18764,-0.15531,0,0
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.053746,-0.18807,-0.17286,0,0
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0097392,-0.18906,-0.192,0,0
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.32077,-0.18919,-0.077275,0,0
6,GO HEART VALVE DEVELOPMENT,0.0051916,-0.18944,-0.19842,0,0
6,GO REFLEX,0.13814,-0.19049,-0.1545,0,0
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.14285,-0.19073,-0.11711,0,0
6,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.070855,-0.19216,-0.19111,0,0
6,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,-0.19295,-0.10906,0,0
6,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.082489,-0.19323,-0.15529,0,0
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0695,-0.19403,-0.1651,0,0
6,GO EXPLORATION BEHAVIOR,0.059411,-0.1941,-0.1555,0,0
6,GO CARDIAC CHAMBER DEVELOPMENT,0.00038934,-0.19487,-0.17639,0,0
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.05824,-0.19534,-0.22494,0,0
6,GO MITOTIC CELL CYCLE ARREST,0.11434,-0.19671,-0.10367,0,0
6,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0012662,-0.19711,-0.24142,0,0
6,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.053746,-0.19859,-0.23162,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.084046,-0.19951,-0.075842,0,0
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.05824,-0.19986,-0.19736,0,0
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0053338,-0.20024,-0.20855,0,0
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0047853,-0.20084,-0.23002,0,0
6,GO RESPONSE TO INTERFERON ALPHA,0.23245,-0.20153,-0.27542,0,0
6,GO HEART VALVE FORMATION,0.16828,-0.2016,-0.17192,0,0
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0087944,-0.20216,-0.25435,0,0
6,GO OPTIC NERVE DEVELOPMENT,0.16032,-0.20292,-0.14745,0,0
6,GO LACTATION,0.00013917,-0.20317,-0.22829,0,0
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,3.3132e-05,-0.20369,-0.20028,0,0
6,GO REGULATION OF TUBULIN DEACETYLATION,0.076492,-0.20588,-0.13512,0,0
6,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.15015,-0.20644,-0.20837,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.16294,-0.20654,-0.11245,0,0
6,GO CORNIFICATION,0.093897,-0.20685,-0.15245,0,0
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.27611,-0.20743,-0.07924,0,0
6,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0060989,-0.20745,-0.16108,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.11039,-0.20789,-0.094288,0,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.12259,-0.20793,-0.13799,0,0
6,GO MYOFIBRIL ASSEMBLY,0.0021689,-0.20798,-0.15743,0,0
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.1028,-0.20801,-0.12931,0,0
6,GO NEURONAL ACTION POTENTIAL,0.20937,-0.20824,-0.099114,0,0
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.097379,-0.20829,-0.17283,0,0
6,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.0012662,-0.20971,-0.22571,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.22905,-0.20995,-0.11216,0,0
6,GO REGULATION OF GLOMERULAR FILTRATION,0.29992,-0.21044,-0.12391,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.044685,-0.2108,-0.17968,0,0
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.060602,-0.2124,-0.16767,0,0
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.065563,-0.21453,-0.15958,0,0
6,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.057089,-0.21872,-0.15178,0,0
6,GO ENDOCARDIAL CUSHION FORMATION,0.013139,-0.21885,-0.22664,0,0
6,GO RRNA CATABOLIC PROCESS,0.15264,-0.21887,-0.074021,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.041967,-0.21918,-0.11505,0,0
6,GO ONE CARBON METABOLIC PROCESS,0.00038934,-0.22156,-0.20166,0,0
6,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,7.8282e-05,-0.22158,-0.18309,0,0
6,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.15015,-0.22225,-0.12902,0,0
6,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,1.2308e-06,-0.22314,-0.21732,0,0
6,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0025083,-0.22377,-0.19668,0,0
6,GO REGULATION OF DOPAMINE SECRETION,0.12049,-0.22556,-0.1219,0,0
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.090515,-0.22673,-0.12126,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.041093,-0.22692,-0.10679,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.093897,-0.22719,-0.14452,0,0
6,GO PLASMA MEMBRANE REPAIR,0.05824,-0.22723,-0.15805,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00074557,-0.22735,-0.20892,0,0
6,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0016129,-0.23069,-0.22758,0,0
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.12049,-0.23077,-0.16358,0,0
6,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.024846,-0.2311,-0.17825,0,0
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.038561,-0.23349,-0.19961,0,0
6,GO RESPONSE TO DIETARY EXCESS,0.057089,-0.23381,-0.17562,0,0
6,GO RESPONSE TO LIGHT INTENSITY,0.0027346,-0.23457,-0.23182,0,0
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0023671,-0.23467,-0.20835,0,0
6,GO OUTFLOW TRACT MORPHOGENESIS,0.00084609,-0.23585,-0.22397,0,0
6,GO CARDIAC VENTRICLE DEVELOPMENT,0.00074557,-0.23797,-0.18282,0,0
6,GO POSITIVE REGULATION OF CELL MATURATION,0.18219,-0.23803,-0.18847,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0023671,-0.23907,-0.2041,0,0
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.001872,-0.23918,-0.20529,0,0
6,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0014299,-0.24206,-0.18238,0,0
6,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.095625,-0.24216,-0.25147,0,0
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,5.6174e-05,-0.24505,-0.21501,0,0
6,GO REGULATION OF VESICLE FUSION,0.0067808,-0.24961,-0.27011,0,0
6,GO TRIGLYCERIDE CATABOLIC PROCESS,0.041093,-0.24964,-0.12685,0,0
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.061812,-0.25053,-0.15956,0,0
6,GO SEROTONIN METABOLIC PROCESS,0.19695,-0.25134,-0.13778,0,0
6,GO INNERVATION,0.13583,-0.2521,-0.11499,0,0
6,GO INTERMEDIATE FILAMENT BASED PROCESS,9.0551e-05,-0.25265,-0.25832,0,0
6,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0001547,-0.25342,-0.28455,0,0
6,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0066042,-0.25411,-0.24128,0,0
6,GO PSEUDOPODIUM ORGANIZATION,0.055956,-0.25462,-0.2403,0,0
6,GO ALDITOL PHOSPHATE METABOLIC PROCESS,8.1192e-05,-0.25636,-0.33128,0,0
6,GO REGULATION OF CELLULAR EXTRAVASATION,0.00036427,-0.25695,-0.28663,0,0
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.065563,-0.25795,-0.24973,0,0
6,GO NEUROTRANSMITTER UPTAKE,0.011047,-0.25811,-0.17761,0,0
6,GO GONADOTROPIN SECRETION,0.054842,-0.26101,-0.15126,0,0
6,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.16294,-0.26295,-0.15869,0,0
6,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00026003,-0.26434,-0.24802,0,0
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.027188,-0.27592,-0.26314,0,0
6,GO RESPONSE TO ZINC ION,0.00074557,-0.27599,-0.27967,0,0
6,GO FATTY ACYL COA METABOLIC PROCESS,0.0006154,-0.27614,-0.23354,0,0
6,GO NADPH REGENERATION,0.0049174,-0.27928,-0.22938,0,0
6,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0081404,-0.28131,-0.29962,0,0
6,GO PROTEIN TRIMERIZATION,0.00028792,-0.28139,-0.33521,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,4.1617e-05,-0.2855,-0.34619,0,0
6,GO L SERINE METABOLIC PROCESS,0.11636,-0.29036,-0.15863,0,0
6,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,5.753e-07,-0.29106,-0.3248,0,0
6,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0050528,-0.29321,-0.26058,0,0
6,GO SKIN MORPHOGENESIS,0.0060989,-0.29356,-0.33001,0,0
6,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.00041602,-0.29416,-0.24452,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.00026903,-0.30363,-0.28563,0,0
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00059588,-0.30463,-0.23225,0,0
6,GO NEUROTRANSMITTER REUPTAKE,0.0094949,-0.30499,-0.22075,0,0
6,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.060602,-0.30836,-0.21469,0,0
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.27999,-0.30857,-0.1306,0,0
6,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0007696,-0.31427,-0.26666,0,0
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0047853,-0.31694,-0.24279,0,0
6,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.00054072,-0.31814,-0.32151,0,0
6,GO PHOSPHOLIPID EFFLUX,0.00017796,-0.32177,-0.33082,0,0
6,GO PROTEIN HYDROXYLATION,6.0504e-05,-0.32225,-0.39419,0,0
6,GO INCLUSION BODY ASSEMBLY,0.0013872,-0.33098,-0.25909,0,0
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,3.5759e-05,-0.34111,-0.36337,0,0
6,GO INTERMEDIATE FILAMENT ORGANIZATION,1.2962e-05,-0.35195,-0.34087,0,0
6,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,3.0689e-05,-0.35804,-0.35797,0,0
6,GO CELLULAR RESPONSE TO ZINC ION,0.0021062,-0.36153,-0.44987,0,0
6,GO RESPONSE TO HYDROPEROXIDE,0.0085714,-0.362,-0.26068,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,6.5149e-05,-0.37248,-0.36424,0,0
6,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00029782,-0.37285,-0.38633,0,0
6,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.035393,-0.37558,-0.22619,0,0
6,GO POSITIVE REGULATION OF VESICLE FUSION,0.0013054,-0.37807,-0.44949,0,0
6,GO NADH METABOLIC PROCESS,0.00012512,-0.37911,-0.30403,0,0
6,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,8.6584e-06,-0.38899,-0.39101,0,0
6,GO DOPAMINE BIOSYNTHETIC PROCESS,0.29992,-0.39148,-0.15361,0,0
6,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00026003,-0.39897,-0.43141,0,0
6,GO HEPARIN METABOLIC PROCESS,3.0689e-05,-0.42313,-0.44376,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.00028792,-0.43217,-0.39608,0,0
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0017123,-0.44233,-0.38757,0,0
6,GO HEART INDUCTION,0.0012662,-0.46333,-0.36622,0,0
6,GO TRNA CATABOLIC PROCESS,0.01282,-0.48916,-0.2877,0,0
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.00019753,-0.53409,-0.43371,0,0
